<SEC-DOCUMENT>0001178913-17-002643.txt : 20170907
<SEC-HEADER>0001178913-17-002643.hdr.sgml : 20170907
<ACCEPTANCE-DATETIME>20170907160928
ACCESSION NUMBER:		0001178913-17-002643
CONFORMED SUBMISSION TYPE:	10-K
PUBLIC DOCUMENT COUNT:		79
CONFORMED PERIOD OF REPORT:	20170630
FILED AS OF DATE:		20170907
DATE AS OF CHANGE:		20170907

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			PLURISTEM THERAPEUTICS INC
		CENTRAL INDEX KEY:			0001158780
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		IRS NUMBER:				980351734
		STATE OF INCORPORATION:			NV
		FISCAL YEAR END:			0630

	FILING VALUES:
		FORM TYPE:		10-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-31392
		FILM NUMBER:		171074024

	BUSINESS ADDRESS:	
		STREET 1:		MATAM ADVANCED TECHNOLOGY PARK
		STREET 2:		BUILDING NO. 5
		CITY:			HAIFA
		STATE:			L3
		ZIP:			31905
		BUSINESS PHONE:		972-74-710-7171

	MAIL ADDRESS:	
		STREET 1:		MATAM ADVANCED TECHNOLOGY PARK
		STREET 2:		BUILDING NO. 5
		CITY:			HAIFA
		STATE:			L3
		ZIP:			31905

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	PLURISTEM LIFE SYSTEMS INC
		DATE OF NAME CHANGE:	20030701

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	AI SOFTWARE INC
		DATE OF NAME CHANGE:	20010906
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-K
<SEQUENCE>1
<FILENAME>zk1720512.htm
<DESCRIPTION>10-K
<TEXT>
<html>
<head>
<title></title>
<!--Licensed to: ZKG
    Document created using EDGARfilings PROfile 4.3.2.0
    Copyright 1995 - 2017 Summit Financial Printing, LLC.  All rights reserved.-->
</head>
<body style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif" bgcolor="#ffffff" text="#000000">
<div>
<hr style="BORDER-TOP: black 4px solid; HEIGHT: 10px; BORDER-RIGHT: medium none; BORDER-BOTTOM: black 1px solid; COLOR: #ffffff; TEXT-ALIGN: center; MARGIN-LEFT: auto; BORDER-LEFT: medium none; BACKGROUND-COLOR: #ffffff; MARGIN-RIGHT: auto" align="center">
<div id="DSPFPageHeader">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25"><font id="DSPFPageNumber"></font>&#160;</div>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25"><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-VARIANT: normal; FONT-WEIGHT: bold; FONT-STYLE: normal">UNITED STATES</font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><br>
</font><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-VARIANT: normal; FONT-WEIGHT: bold; FONT-STYLE: normal">SECURITIES AND EXCHANGE COMMISSION</font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><br>
</font> Washington, D.C. 20549</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: center; FONT: bold 14pt/1.25 'Times New Roman', Times, serif">FORM 10-K</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">(Mark One)</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div>
<table id="z7f75ff1ab2164b409fd460957a87e90e" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr style="VERTICAL-ALIGN: top">
<td style="VERTICAL-ALIGN: top; WIDTH: 36pt; align: right">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#9746;</div>
</td>
<td style="VERTICAL-ALIGN: top; WIDTH: auto; align: left">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">For the fiscal year ended&#160;<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold"><u>June 30, 2017</u></font></div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div>
<table id="z88ba4bde8c1e4321a1b35cf62288b46c" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr style="VERTICAL-ALIGN: top">
<td style="VERTICAL-ALIGN: top; WIDTH: 36pt; align: right">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#9744;</div>
</td>
<td style="VERTICAL-ALIGN: top; WIDTH: auto; align: left">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">For the transition period from&#160;[&#160;&#160; ] to&#160;[&#160;&#160; ]</div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 36pt; LINE-HEIGHT: 1.25">Commission file number&#160;<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold"><u>001-31392</u></font></div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 36pt; LINE-HEIGHT: 1.25">&#160;</div>

<table id="zef075d2de1554b74ba8b9a371ece743a" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="FONT-SIZE: 16pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-VARIANT: normal; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 2px solid; FONT-WEIGHT: bold; FONT-STYLE: normal; WIDTH: 100%">
<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25">PLURISTEM THERAPEUTICS INC.</div>
</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 100%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">(Exact name of registrant as specified in its charter)</div>
</td>
</tr>
</table>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<table id="zc59e450000c844e89178aac9176844e4" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0" border="0">
<tr>
<td style="VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 2px solid; WIDTH: 48%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">Nevada</div>
</td>
<td style="VERTICAL-ALIGN: top; WIDTH: 4%">&#160;</td>
<td style="VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 2px solid; FONT-WEIGHT: bold; WIDTH: 48%">
<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25">98-0351734</div>
</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 48%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">(State or other jurisdiction of incorporation or organization)</div>
</td>
<td style="VERTICAL-ALIGN: top; WIDTH: 4%">&#160;</td>
<td style="VERTICAL-ALIGN: top; WIDTH: 48%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">(I.R.S. Employer Identification No.)</div>
</td>
</tr>
</table>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<table id="z490ec96cd84e4353b165af6b33f996dd" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0" border="0">
<tr>
<td style="VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 2px solid; WIDTH: 48%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">MATAM Advanced Technology Park,<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><br>
</font> Building No. 5, Haifa, Israel</div>
</td>
<td style="VERTICAL-ALIGN: top; WIDTH: 4%">&#160;</td>
<td style="VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 2px solid; WIDTH: 48%">
<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">31905</div>
</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 48%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">(Address of principal executive offices)</div>
</td>
<td style="VERTICAL-ALIGN: top; WIDTH: 4%">&#160;</td>
<td style="VERTICAL-ALIGN: top; WIDTH: 48%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">(Zip Code)</div>
</td>
</tr>
</table>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Registrant's telephone number&#160;&#160;<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold"><u>011-972-74-7107259</u></font></div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Securities registered pursuant to Section 12(b) of the Act:</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<table id="z887e11ac04db44a288d04f9a0efd4767" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0" border="0">
<tr>
<td style="VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 2px solid; WIDTH: 48%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">Title of each class<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><br>
</font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold">Common Stock, par value $0.00001</font></div>
</td>
<td style="VERTICAL-ALIGN: top; WIDTH: 4%">&#160;</td>
<td style="VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 2px solid; WIDTH: 48%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">Name of each exchange on which registered<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><br>
</font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold">Nasdaq Capital Market</font></div>
</td>
</tr>
</table>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Securities registered pursuant to Section 12(g) of the Act:</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<table id="z0853bb016bfc47909969b9db47412303" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 2px solid; WIDTH: 100%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">None.</div>
</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 100%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">(Title of class)</div>
</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 100%">&#160;</td>
</tr>
</table>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule&#160;405 of the Securities Act.&#160;&#160;&#160; &#160; &#160;&#160; </div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">Yes &#9744;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;No&#160;&#9746;</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Indicate by check mark if the registrant is not required to file reports pursuant to Section&#160;13 or Section&#160;15(d) of the Act.&#160;&#160;&#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; </div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">Yes &#9744;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;No&#160;&#9746;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">&#160;</div>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Indicate by check mark whether the registrant (1)&#160;has filed all reports required to be filed by Section&#160;13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12&#160;months (or for such shorter period that the registrant was required to file such reports), and (2)&#160;has been subject to such filing requirements for the past 90 days.</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">Yes &#9746;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;No &#9744;</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; WIDTH: 100%; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Website, if any, every Interactive Data File required to be submitted and posted pursuant to Rule&#160;405 of Regulation&#160;S-T during the preceding 12&#160;months (or for such shorter period that the registrant was required to submit and post such files).&#160;&#160;&#160;&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">&#9746;&#160;Yes&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#9744; No</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Indicate by check mark if disclosure of delinquent filers pursuant to Item&#160;405 of Regulation&#160;S-K is not contained herein, and will not be contained, to the best of registrant's knowledge, in definitive proxy or information statements incorporated by reference in Part&#160;III of this Form 10-K or any amendment to this Form 10-K.&#160; &#61551;</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of &#8220;large accelerated filer&#8221;, &#8220;accelerated filer,&#8221; &#8220;smaller reporting company,&#8221; and "emerging growth company" in Rule 12b-2 of the Exchange Act.</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div style="LINE-HEIGHT: 1.25">
<div id="DSPFPageHeader"></div>

<table id="z0f51b513d89341f4b5891e3aaae12af9" style="FONT-SIZE: 10pt; BORDER-TOP: medium none; FONT-FAMILY: 'Times New Roman', Times, serif; BORDER-RIGHT: medium none; BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; WIDTH: 100%" cellspacing="0" cellpadding="0" border="0">
<tr style="HEIGHT: 16px">
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: top; BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; WIDTH: 19.82%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">Large accelerated filer &#9744;</div>
</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: top; BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; WIDTH: 20%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">Accelerated filer &#9746;</div>
</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: top; BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; WIDTH: 20%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">Non-accelerated filer &#9744;</div>
</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: top; BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; WIDTH: 20%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">Smaller reporting company &#9744;</div>
</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: top; BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; WIDTH: 20%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">Emerging growth company &#9744;</div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. &#61551;Indicate by check mark whether the registrant is a shell company (as defined in Rule&#160;12b-2 of the Act).&#160;&#160;&#160; &#160; &#160; &#160; &#160; </div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">Yes &#9744;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;No&#160;&#9746;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">&#160;</div>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">State the aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked prices of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">$107,969,302</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Indicate the number of shares outstanding of each of the registrant's classes of common stock, as of the latest practicable date.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">97,473,652 as of August 31, 2017</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; WIDTH: 100%; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div id="DSPFPageHeader">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">TABLE OF CONTENTS</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<table id="z8aaa07e85acd4a9ba65e7b3e200b765e" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="2" border="0">
<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 8%">&#160;</td>
<td style="VERTICAL-ALIGN: top; WIDTH: 86%">&#160;</td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-VARIANT: normal; VERTICAL-ALIGN: top; FONT-WEIGHT: normal; FONT-STYLE: normal; TEXT-ALIGN: right; WIDTH: 6.46%">
<div><u>Page</u></div>
</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 8%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25"><a href="#PARTI">PART I</a></div>
</td>
<td style="VERTICAL-ALIGN: top; WIDTH: 86%">&#160;</td>
<td style="FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; TEXT-ALIGN: right; WIDTH: 6.46%">
<div>3</div>
</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 8%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25"><!--Anchor--><a href="#Item1">Item&#160;1.</a></div>
</td>
<td style="VERTICAL-ALIGN: top; WIDTH: 86%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25"><a href="#Item1">Business.</a></div>
</td>
<td style="FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; TEXT-ALIGN: right; WIDTH: 6.46%">
<div>3</div>
</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 8%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25"><a href="#Item1a">Item 1A.</a></div>
</td>
<td style="VERTICAL-ALIGN: top; WIDTH: 86%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25"><a href="#Item1a">Risk Factors.</a></div>
</td>
<td style="FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; TEXT-ALIGN: right; WIDTH: 6.46%">
<div>17</div>
</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 8%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25"><a href="#Item1b">Item 1B.</a></div>
</td>
<td style="VERTICAL-ALIGN: top; WIDTH: 86%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25"><a href="#Item1b">Unresolved Staff Comments.</a></div>
</td>
<td style="FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; TEXT-ALIGN: right; WIDTH: 6.46%">
<div>32</div>
</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 8%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25"><a href="#Item2">Item&#160;2.</a></div>
</td>
<td style="VERTICAL-ALIGN: top; WIDTH: 86%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25"><a href="#Item2">Properties.</a></div>
</td>
<td style="FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; TEXT-ALIGN: right; WIDTH: 6.46%">
<div>32</div>
</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 8%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25"><a href="#Item3">Item 3.</a></div>
</td>
<td style="VERTICAL-ALIGN: top; WIDTH: 86%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25"><a href="#Item3">Legal Proceedings.</a></div>
</td>
<td style="FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; TEXT-ALIGN: right; WIDTH: 6.46%">
<div>32</div>
</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 8%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25"><a href="#Item4">Item 4.</a></div>
</td>
<td style="VERTICAL-ALIGN: top; WIDTH: 86%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25"><a href="#Item4">Mine Safety Disclosures.</a></div>
</td>
<td style="FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; TEXT-ALIGN: right; WIDTH: 6.46%">
<div>32</div>
</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 8%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25"><a href="#PARTII">PART II</a></div>
</td>
<td style="VERTICAL-ALIGN: top; WIDTH: 86%">&#160;</td>
<td style="FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; TEXT-ALIGN: right; WIDTH: 6.46%">
<div>32</div>
</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 8%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25"><a href="#Item5">Item 5.</a></div>
</td>
<td style="VERTICAL-ALIGN: top; WIDTH: 86%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25"><a href="#Item5">Market for Registrant's Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities.</a></div>
</td>
<td style="FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; TEXT-ALIGN: right; WIDTH: 6.46%">
<div>32</div>
</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 8%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25"><a href="#Item6">Item 6.</a></div>
</td>
<td style="VERTICAL-ALIGN: top; WIDTH: 86%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25"><a href="#Item6">Selected financial data.</a></div>
</td>
<td style="FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; TEXT-ALIGN: right; WIDTH: 6.46%">
<div>33</div>
</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 8%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25"><a href="#Item7">Item 7.</a></div>
</td>
<td style="VERTICAL-ALIGN: top; WIDTH: 86%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25"><a href="#Item7">Management's Discussion and Analysis of Financial Condition and Results of Operations.</a></div>
</td>
<td style="FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; TEXT-ALIGN: right; WIDTH: 6.46%">
<div>34</div>
</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 8%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25"><a href="#Item7A">Item 7A.</a></div>
</td>
<td style="VERTICAL-ALIGN: top; WIDTH: 86%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25"><a href="#Item7A">Quantitative and Qualitative Disclosures About Market Risk.</a></div>
</td>
<td style="FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; TEXT-ALIGN: right; WIDTH: 6.46%">
<div>43</div>
</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 8%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25"><a href="#Item8">Item 8.</a></div>
</td>
<td style="VERTICAL-ALIGN: top; WIDTH: 86%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25"><a href="#Item8">Financial Statements and Supplementary Data.</a></div>
</td>
<td style="FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; TEXT-ALIGN: right; WIDTH: 6.46%">
<div>44</div>
</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 8%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25"><a href="#Item9">Item 9.</a></div>
</td>
<td style="VERTICAL-ALIGN: top; WIDTH: 86%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25"><a href="#Item9">Changes in and Disagreements With Accountants on Accounting and Financial Disclosure.</a></div>
</td>
<td style="FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; TEXT-ALIGN: right; WIDTH: 6.46%">
<div>45</div>
</td>
</tr>

<tr style="HEIGHT: 19px">
<td style="VERTICAL-ALIGN: top; WIDTH: 8%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25"><a href="#Item9A">Item 9A.</a></div>
</td>
<td style="VERTICAL-ALIGN: top; WIDTH: 86%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25"><a href="#Item9A">Controls and Procedures</a>.</div>
</td>
<td style="FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; TEXT-ALIGN: right; WIDTH: 6.46%">
<div>45</div>
</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 8%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25"><a href="#Item9B">Item 9B.</a></div>
</td>
<td style="VERTICAL-ALIGN: top; WIDTH: 86%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25"><a href="#Item9B">Other Information</a>.</div>
</td>
<td style="FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; TEXT-ALIGN: right; WIDTH: 6.46%">
<div>46</div>
</td>
</tr>

<tr style="HEIGHT: 19px">
<td style="VERTICAL-ALIGN: top; WIDTH: 8%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25"><a href="#PARTIII">PART III</a></div>
</td>
<td style="VERTICAL-ALIGN: top; WIDTH: 86%">&#160;</td>
<td style="FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; TEXT-ALIGN: right; WIDTH: 6.46%">
<div>46</div>
</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 8%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25"><a href="#Item10">Item 10.</a></div>
</td>
<td style="VERTICAL-ALIGN: top; WIDTH: 86%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25"><a href="#Item10">Directors, Executive Officers and Corporate Governance.</a></div>
</td>
<td style="FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; TEXT-ALIGN: right; WIDTH: 6.46%">
<div>46</div>
</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 8%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25"><a href="#Item11.">Item&#160;11.</a></div>
</td>
<td style="VERTICAL-ALIGN: top; WIDTH: 86%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25"><a href="#Item11.">Executive Compensation.</a></div>
</td>
<td style="FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; TEXT-ALIGN: right; WIDTH: 6.46%">
<div>52</div>
</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 8%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25"><a href="#Item12">Item 12.</a></div>
</td>
<td style="VERTICAL-ALIGN: top; WIDTH: 86%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25"><a href="#Item12">Security Ownership of Certain Beneficial Owners and Management and Related Stockholders Matters.</a></div>
</td>
<td style="FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; TEXT-ALIGN: right; WIDTH: 6.46%">
<div>62</div>
</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 8%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25"><a href="#Item13">Item 13.</a></div>
</td>
<td style="VERTICAL-ALIGN: top; WIDTH: 86%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25"><a href="#Item13">Certain Relationships and Related Transactions and Director Independence.</a></div>
</td>
<td style="FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; TEXT-ALIGN: right; WIDTH: 6.46%">
<div>64</div>
</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 8%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25"><a href="#Item14">Item 14.</a></div>
</td>
<td style="VERTICAL-ALIGN: top; WIDTH: 86%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25"><a href="#Item14">Principal Accounting Fees and Services.</a></div>
</td>
<td style="FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; TEXT-ALIGN: right; WIDTH: 6.46%">
<div>64</div>
</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 8%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25"><a href="#PARTIV">PART IV</a></div>
</td>
<td style="VERTICAL-ALIGN: top; WIDTH: 86%">&#160;</td>
<td style="FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; TEXT-ALIGN: right; WIDTH: 6.46%">
<div>65</div>
</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 8%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25"><a href="#Item15">Item 15.</a></div>
</td>
<td style="VERTICAL-ALIGN: top; WIDTH: 86%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25"><a href="#Item15">Exhibits.</a></div>
</td>
<td style="FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; TEXT-ALIGN: right; WIDTH: 6.46%">
<div>65</div>
</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 8%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25"><a href="#Item16">Item 16.</a></div>
</td>
<td style="VERTICAL-ALIGN: top; WIDTH: 86%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25"><a href="#Item16">Form 10-K Summary.</a></div>
</td>
<td style="FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; TEXT-ALIGN: right; WIDTH: 6.46%">
<div>68</div>
</td>
</tr>
</table>

<div id="DSPFPageHeader">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25"><font id="DSPFPageNumber"></font>&#160;</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; WIDTH: 100%; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<!--PROfilePageNumberReset%Num%2%%%--></div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Our financial statements are stated in thousands United States Dollars, or US$, and are prepared in accordance with United States Generally Accepted Accounting Principles, or U.S. GAAP.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">In this annual report, unless otherwise specified, all dollar amounts are expressed in U.S. dollars.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">As used in this annual report, the terms "we", "us", "our", "the Company", and "Pluristem" mean Pluristem Therapeutics Inc. and our wholly owned Israeli subsidiary, unless otherwise indicated or required by the context.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 35.45pt">The statements contained in this Annual Report on Form 10-K, or Annual Report, that are not historical facts are "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995 and other federal securities laws. Such forward-looking statements may be identified by, among other things, the use of forward-looking terminology such as "believes," "intends," "plans," "expects," "may," "will," "should," or "anticipates" or the negative thereof or other variations thereon or comparable terminology, and similar expressions are intended to identify forward-looking statements.&#160; We remind readers that forward-looking statements are merely predictions and therefore inherently subject to uncertainties and other factors and involve known and unknown risks that could cause the actual results, performance, levels of activity, or our achievements, or industry results, to be materially different from any future results, performance, levels of activity, or our achievements, or industry results, expressed or implied by such forward-looking statements. Such forward-looking statements appear in Item 1 &#8211; "Business" and Item 7 &#8211; "Management's discussion and Analysis of Financial Condition and Results of Operations," (especially in the section titled "Outlook") as well as elsewhere in this Annual Report and include, among other statements, statements regarding the following:</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<table id="z7ae56c296600406486038200280d6a89" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 18pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: Symbol, serif; VERTICAL-ALIGN: top; WIDTH: 18pt; align: right">&#183;</td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">the expected development and potential benefits from our products in treating various medical conditions;</div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<table id="z9c1b0e584ad0404dbc70d19d996b7ce8" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 18pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: Symbol, serif; VERTICAL-ALIGN: top; WIDTH: 18pt; align: right">&#183;</td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">the clinical trials to be conducted according to our license agreement with CHA Biotech Co. Ltd.;</div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<table id="z28a252912115410ea7b15a2be319489c" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 18pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: Symbol, serif; VERTICAL-ALIGN: top; WIDTH: 18pt; align: right">&#183;</td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">our plan to execute our strategy independently, using our own personnel, and through relationships with research and clinical institutions or in collaboration with other companies;</div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<table id="z084597a21bf0421c80dc8b5c02176dbe" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 18pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: Symbol, serif; VERTICAL-ALIGN: top; WIDTH: 18pt; align: right">&#183;</td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">the prospects of entering into additional license agreements, or other forms of cooperation with other companies and medical institutions;</div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<table id="z1fce018444724eeab23d0d90b4c9d249" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 18pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: Symbol, serif; VERTICAL-ALIGN: top; WIDTH: 18pt; align: right">&#183;</td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">our pre-clinical and clinical trials plans, including timing of initiation, enrollment and conclusion of trials;</div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<table id="zf1d2a1f848ff451fa1ec6a0a557df866" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 18pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: Symbol, serif; VERTICAL-ALIGN: top; WIDTH: 18pt; align: right">&#183;</td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">achieving regulatory approvals, including under accelerated paths;</div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<table id="zda27825495224db690efacc59aa90aea" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 18pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: Symbol, serif; VERTICAL-ALIGN: top; WIDTH: 18pt; align: right">&#183;</td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">receipt of future funding from the Israel Innovation Authority;</div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<table id="z5f84b1c293444f90910400178e149338" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 18pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: Symbol, serif; VERTICAL-ALIGN: top; WIDTH: 18pt; align: right">&#183;</td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">our marketing plans, including timing of marketing our first product candidate, PLX-PAD;</div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<table id="zd2465fe2a5984fb79c9b8fdf707235c1" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 18pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: Symbol, serif; VERTICAL-ALIGN: top; WIDTH: 18pt; align: right">&#183;</td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">developing capabilities for new clinical indications of placenta expanded (PLX) cells and new products;</div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<table id="zda76d8fd4219484da766f75f6fa1e491" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 18pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: Symbol, serif; VERTICAL-ALIGN: top; WIDTH: 18pt; align: right">&#183;</td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">our estimations regarding the size of the global market for our product candidates;</div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal">2</font></div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; WIDTH: 100%; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<table id="zcd18ef3e35454e78b8dea506318f549b" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 18pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: Symbol, serif; VERTICAL-ALIGN: top; WIDTH: 18pt; align: right">&#183;</td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">our expectations regarding our production capacity;</div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<table id="z5dc4a0cd69c74f74b48fa3d7943f2fb4" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 18pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: Symbol, serif; VERTICAL-ALIGN: top; WIDTH: 18pt; align: right">&#183;</td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">our expectation to demonstrate a real-world impact and value from our pipeline, technology platform and commercial-scale manufacturing capacity;</div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<table id="z55b017d91e49492eb88b053497ac500c" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 18pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: Symbol, serif; VERTICAL-ALIGN: top; WIDTH: 18pt; align: right">&#183;</td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">our expectations regarding our short- and long-term capital requirements;</div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<table id="ze210a78cd3e141f1a05865bb1f149678" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 18pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: Symbol, serif; VERTICAL-ALIGN: top; WIDTH: 18pt; align: right">&#183;</td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">the proposed joint venture to be established with Sosei Corporate Venture Capital Ltd. for the clinical development and commercialization of Pluristem&#8217;s PLX-PAD cell therapy product in Japan and the plan to enter into definitive agreements;</div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<table id="z9dc013468ca64615b7bc18341bf397a6" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 18pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: Symbol, serif; VERTICAL-ALIGN: top; WIDTH: 18pt; align: right">&#183;</td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">our outlook for the coming months and future periods, including but not limited to our expectations regarding future revenue and expenses; and</div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<table id="z0d99aeedf80c4c03907334029282ffac" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 18pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: Symbol, serif; VERTICAL-ALIGN: top; WIDTH: 18pt; align: right">&#183;</td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">information with respect to any other plans and strategies for our business.</div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 35.45pt">The factors discussed herein, including those risks described in Item 1A. "Risk Factors", and expressed from time to time in our filings with the Securities and Exchange Commission, or SEC, could cause actual results and developments to be materially different from those expressed in or implied by such statements.&#160; In addition, historic results of scientific research, clinical and preclinical trials do not guarantee that the conclusions of future research or trials would not suggest different conclusions. Also, historic results referred to in this Annual Report would be interpreted differently in light of additional research, clinical and preclinical trials results. The forward-looking statements are made only as of the date of this filing, and except as required by law we undertake no obligation to publicly update such forward-looking statements to reflect subsequent events or circumstances.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25"><a id="PARTI" name="PARTI"><!--Anchor--></a>PART I</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold"><a id="Item1" name="Item1"><!--Anchor--></a>Item&#160;1.</font>&#160; &#160;&#160;<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold">Business.</font></div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Our Current Business </div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">Pluristem Therapeutics Inc. is a leading developer of placenta-based cell therapy product candidates for the treatment of multiple ischemic, inflammatory and hematologic conditions. Our lead indications are critical limb ischemia, or CLI, recovery after surgery for femoral neck fracture, and acute radiation syndrome, or ARS. A pivotal, multinational clinical trial is currently being conducted with our PLX-PAD product candidate in CLI. In addition, pivotal, multinational clinical trials are planned for our PLX-PAD product candidate in femoral neck fractures. The National Institutes of Health&#8217;s, National Institute of Allergy and Infectious Diseases, or NIAID, recently completed a dose selection trial with PLX-R18 in the hematologic component of ARS and a pivotal study is planned under the U.S. Food and Drug Administration, or FDA, animal rule once funding will be secured for this project. Each of these indications is a severe unmet medical need.</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">PLX cells are derived from a class of placental cells that are harvested from donated placentas at the time of full term healthy delivery. PLX cell products require no tissue matching prior to administration. They are produced using our proprietary three-dimensional expansion technology. Our manufacturing facility complies with the FDA&#8217;s current Good Manufacturing Practice requirements and has been approved by the European, Japanese and Israeli regulatory authorities for production of PLX-PAD for late stage trials and marketing. We expect to have in-house production capacity to grow clinical-grade PLX cells in commercial quantities.</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">We were incorporated in Nevada in 2001, and have a wholly owned subsidiary in Israel called Pluristem Ltd., or the Subsidiary. We operate in one segment and our operations are focused on the research, development, clinical trials and manufacturing of cell therapeutics and related technologies.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal">3</font></div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; WIDTH: 100%; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">Our goal is to make significant progress with our robust clinical pipeline and our anticipated pivotal trials in order to ultimately bring innovative, potent therapies to patients who need new treatment options. We intend to shorten the time to commercialization of our product candidates, by leveraging unique accelerated regulatory pathways that exist in the United States, Europe and Japan to bring innovative products that address life-threatening diseases to the market efficiently. We believe that these accelerated pathways create substantial opportunities for us and for the cell therapy industry as a whole. We are pursuing these accelerated pathways for PLX-PAD in CLI and femoral neck fracture. Our second product candidate, PLX R18, is under development in the United States for ARS via the Animal Rule regulatory pathway, which may result in approval without the prior performance of human efficacy trials. We expect to demonstrate a real-world impact and value from our pipeline, technology platform and commercial-scale manufacturing capacity. PLX R18 is also under development in a Phase I trial in the United States for incomplete hematopoietic recovery following hematopoietic cell transplantation (HCT).</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">&#160;In May 2015, we announced that the PLX-PAD cell program in CLI had been selected for the Adaptive Pathways pilot project of the EMA. During fiscal year 2017 the FDA, the United Kingdom&#8217;s Medicines &amp; Healthcare Products Regulatory Agency, the Paul Ehrlich Institute (PEI), and the Austrian Agency for Health and Food Safety (AGES), have cleared our application to begin the pivotal Phase III trial of PLX-PAD cells in the treatment of CLI for patients who are unsuitable for revascularization in the United States, the United Kingdom, Germany, and Austria.&#160;This multinational Phase III trial is being conducted in the United States as well as Europe.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">Our intention is to file a request for marketing authorization in the United States and in Europe following a successful completion of this 250-patient (estimated) trial. An interim efficacy analysis is planned to be conducted based on data from the first 125 patients. If these trials have positive results, these could lead to early conditional marketing approval in Europe.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">In August 2016, our CLI program in the European Union&#160;was awarded a Euro 7,600,000 (approximately $8,700,000) grant. The grant is part of the European Union&#8217;s Horizon 2020 program. The Phase III study of PLX-PAD in CLI will be a collaborative project carried out by an international consortium led by the Berlin-Brandenburg Center for Regenerative Therapies together with us and with participation of additional third parties. The grant will cover a significant portion of the CLI program costs. An amount of Euro 1,900,000 (approximately $2,200,000) is a direct grant allocated to us for manufacturing cost and others, and we also expect to have direct benefit from cost savings resulting from grant amounts allocated to the other consortium members.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">In July 2016, we announced our intent to conduct a Phase III trial assessing our PLX-PAD cells in recovery following surgery for femoral neck fracture in the United States and Europe. In addition, the European Medicines Agency, or EMA, confirmed that this indication would also be eligible for the Adaptive Pathways project.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">&#160;In December 2016, we announced that we signed a binding term sheet with Sosei Corporate Venture Capital Ltd., or Sosei CVC, for the establishment of a new Japanese corporation, or NewCo, for the clinical development and commercialization of our PLX-PAD cell therapy product in Japan for CLI.&#160; The parties plan to establish NewCo in Japan, in which we will own 35% of the equity in return for our contribution of a perpetual license to commercialize PLX-PAD for CLI in Japan. All proprietary rights related to PLX-PAD will be exclusively owned by us. Sosei CVC&#8217;s investment fund, Sosei RMF1, together with additional Japanese investors, will raise and invest approximately $11 million, equivalent to approximately &#165;1.3 billion, in return for ownership of 65% of NewCo. The parties have agreed to extend the deadline to enter into a definitive agreement by December 31, 2017. In December 2015, we reached an agreement with Japan&#8217;s Pharmaceuticals and Medical Devices Agency on the design of the final trial needed to apply for conditional approval of PLX-PAD cells in the treatment of CLI. The approval of the protocol for the 75-patient trial was part of a larger agreement on the development of PLX-PAD via Japan&#8217;s new accelerated regulatory pathway for regenerative medicine.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal">4</font></div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; WIDTH: 100%; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">In May 2017, we announced promising results of our non-human primates, or NHPs, pilot study for PLX-R18 as a treatment for ARS. The study, conducted and funded by the NIAID, was designed to assess the safety and efficacy of PLX-R18 following intramuscular injection into irradiated and non-irradiated NHPs. Efficacy measures included survival as well as level of bone marrow function, which is affected by exposure to high levels of radiation as may occur in a nuclear accident or attack. These data will help inform a pivotal study designed to meet the requirements for a Biologics License Application (BLA) submission under the FDA&#8217;s Animal Rule regulatory pathway. In December 2015, we also signed a Memorandum of Understanding for a collaboration with Fukushima Medical University, Fukushima Global Medical Science Center. The purpose of the collaboration is to develop our PLX-R18 cells for the treatment of ARS, and for morbidities following radiotherapy in cancer patients. In August 2017, we announced that a pilot study of our PLX-R18 cell therapy will be initiated by the U.S. Department of Defense&#8217;s&#160; Armed Forces Radiobiology Research Institute , part of the Uniformed Services University of Health Sciences. The study will examine the effectiveness of PLX-R18 as a treatment for ARS prior to, and within the first 24 hours of exposure to radiation.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">On January 12, 2017, we announced that we had completed enrollment of all 172 patients in the randomized, double blind, placebo controlled, multinational Phase II intermittent claudication (IC) clinical trial. We anticipate data readout in first half of 2018.</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">The FDA cleared our Investigational New Drug, or IND, application to begin a Phase I trial of PLX-R18 cells to treat incomplete hematopoietic recovery following HCT. We initiated the trial in fiscal year 2017.</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Scientific Background</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">Cell therapy is an emerging field within the regenerative medicine area.&#160; The characteristics and properties of cells vary as a function of tissue source and growth conditions.&#160; The human placenta from which our PLX cells are derived provides an uncontroversial source of non-embryonic, adult cells and represents an innovative approach in the cell therapy field. The different factors that PLX cells release suggest that the cells can be used therapeutically for a variety of ischemic, inflammatory, autoimmune and hematological disorders.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">PLX cells do not require tissue matching prior to administration.&#160; This allows for the development of ready-to-use / "off-the-shelf" allogeneic products.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Our Technology</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">We develop, and intend to commercialize, cell therapy production technologies and products that are derived from the human placenta. Our PLX cells are adherent stromal cells, or ASCs, that are expanded using a proprietary 3D process. This system utilizes a synthetic scaffold to create an artificial 3D environment where placental-derived stromal cells can grow. Our 3D process enables the large-scale monitored and controlled production of reproducible, high quality cell products and is capable of manufacturing large numbers of PLX doses originating from different placentas. Additionally, our manufacturing process has demonstrated batch-to-batch consistency, an important manufacturing challenge for biological products.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Product Candidates</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 35.45pt">Our primary objective is to be the leading provider of allogeneic placenta based cell therapy products that are true off-the-shelf products that do not require any matching or additional manipulation prior to administration. From the physician&#8217;s and patient&#8217;s perspective, our PLX products are comparable to any other product delivered in a vial. Our PLX products are administered using a standard needle and syringe. Our PLX products are in clinical stage development for multiple indications.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal">5</font></div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; WIDTH: 100%; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">Our business model for commercialization and revenue generation includes, but is not limited, to the following activities that we may conduct with both pharmaceutical and medical device companies: partnerships, licensing deals, and joint ventures. To date, we have a strategic partnership with CHA Biotech Co. Ltd., or CHA, in South Korea for both IC and CLI for the Korean market only. CHA is currently conducting PLX clinical studies in South Korea, and, following regulatory approval, if received, we contemplate forming a joint venture equally owned by us and CHA to market PLX products in South Korea.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">The relationship with CHA is intended to leverage our expertise in manufacturing high quality, placenta-derived cells, using our proprietary, scalable, efficient 3D cell manufacturing platform that supports the cost-effective mass production of PLX cells. Our policy for this partnership is to retain control of the manufacturing of PLX cell products and their associated intellectual property.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">We believe that using the placenta as a unique cell source, combined with our innovative research, development and high quality manufacturing capabilities, will be the "engine" that drives this platform technology towards the successful development of many PLX cell therapy products</font>.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">&#160;In December 2016, we announced that we signed a binding term sheet with Sosei CVC for the establishment of NewCo for the clinical development and commercialization of our PLX-PAD cell therapy product in Japan for CLI. The parties have agreed to extend the deadline to enter into a definitive agreement to December 31, 2017.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Our Clinical Development Product Candidates</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold">Peripheral and Cardiovascular Diseases &#8211;</font> We are investigating the use of PLX-PAD cells for the treatment of various stages of peripheral arterial disease, from early stage IC to advanced CLI.</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">We have completed two Phase I safety/dose-escalating clinical trials for CLI, one in the United States and one in Germany. These CLI trials demonstrated that no blood type or human leukocyte antigen matching is required, and that the administration of PLX-PAD cells is safe, even if two doses are administered to a patient on two different occasions. In addition, PLX-PAD cells are potentially effective in reducing the frequency of amputations in CLI patients. Generally, the FDA and the EMA require the primary endpoint for pivotal CLI clinical trials to be Amputation Free Survival, or AFS, at one year. The pooled data from the two studies we conducted suggest an AFS rate at one year of 86% in PLX-treated patients versus an AFS ranging between 48% to 66% in patients from placebo arms in other CLI trials.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">Following our promising results from Phase I trials in CLI, a large, international, double-blind, randomized, placebo-controlled, 4-arm Phase II trial was initiated in the United States, Germany, Israel and South Korea, to assess the safety and efficacy of PLX-PAD in&#160; patients suffering from IC. Similar to the Phase I studies in CLI, PLX-PAD cells were administered intramuscularly into the patient&#8217;s affected leg. The primary efficacy endpoint for the study is the patient&#8217;s maximal walking distance on a treadmill. The initial sample size was 150 and we expanded the IC trial to enroll an additional 20 patients to be randomized in order to preserve the study&#8217;s original design to administer two injections to each of 150 patients.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">In April 2015, Japan&#8217;s Pharmaceuticals and Medical Devices Agency, or PMDA, approved our large-scale manufacturing methods and quality for PLX-PAD cells for use in clinical trials. This approval is an important milestone for initiation of a Phase I/II study in CLI<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">&#160;</font>in Japan. We plan to submit an application for conditional, time-limited approval for marketing of PLX-PAD for treatment of CLI through Japan&#8217;s Accelerated Pathway for Regenerative Medicine. The new regulatory pathway could potentially significantly reduce time to market for cell therapies such as PLX-PAD cells. Two additional consultation meetings with PMDA were held at the end of July 2015 to discuss the safety of PLX-PAD and the design of a proposed study in CLI patients to be conducted in Japan. In August 2015, the PMDA granted safety clearance to PLX-PAD cells for use in clinical trials in Japan, and in December 2015 we received clearance for the clinical protocol and agreed with the PMDA on the terms for conditional marketing approval.&#160; As a next step, we plan to submit a clinical trial notification to the PMDA to enable the initiation of the planned Phase I/II study of PLX-PAD in CLI following the expected establishment of a new Japanese corporation with Sosei CVC.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal">6</font></div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; WIDTH: 100%; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">Additionally, in May 2015, the PLX-PAD clinical development program was selected for the EMA&#8217;s Adaptive Pathways pilot project and one of very few companies that successfully passed through the different stages of the project. The goal of the project is to improve timely access for patients to new medicines. It allows for early marketing authorization of a therapy in a restricted patient population, followed by additional assessments and the possibility of later approval for use in broader patient populations. Our first indication to be developed through this new regulatory approach is CLI. It is estimated that there are 500 to 1,000 new cases of CLI per a one million population per year in the United States and Europe, and the prevalence is expected to increase significantly in the coming decades due to an expected increase in diabetic patients and aging population. CLI therefore represents a major commercial opportunity. Acceptance of our cells for the treatment of CLI into the Adaptive Pathways could significantly curtail the time and investment needed to bring this product to market. Pluristem has conducted a parallel scientific advice with EMA and European health technology assessment bodies in March 2016, under the Adaptive Pathways project, in order to discuss the clinical development plan in CLI. We obtained clearance for a Phase III study from the FDA in the United States, as well as regulatory authorities in Europe including the United Kingdom, Germany and Austria. We have initiated the study and we are expecting to include more countries in Europe later this year.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold">Orthopedic Diseases &#8211;</font> A Phase I/II, randomized, double-blind, placebo&#8209;controlled study to assess the safety and efficacy of intramuscular injections of allogeneic PLX&#8209;PAD cells for the regeneration of injured gluteal musculature after total hip replacement has been conducted in Germany under the approval of PEI. In this study, PLX-PAD cells or placebo were injected into the traumatized gluteal muscle during total hip replacement surgery. In July 2013, we announced that enrollment for this clinical trial was completed. In January 2014, we announced that the study met its primary efficacy endpoint, namely the change in maximal voluntary isometric contraction force of the gluteal muscle at six months after total hip replacement. Patients treated with PLX-PAD had a significantly greater improvement of maximal voluntary muscle contraction force than the placebo group (p=0.0067). The one-year safety follow-up of all the patients was completed at the beginning of July 2014. The study was concluded with two year safety follow up in July 2015. At two years of follow-up no case of new cancer was reported.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">In July 2016, we announced our intention to conduct a Phase III trial assessing our PLX-PAD cells in recovery following surgery for femoral neck fracture in the United States and Europe. In addition, the EMA confirmed that this indication would be eligible for the Adaptive Pathway regulatory approval. We are currently in discussions with respect to the FDA submission of the Phase III protocol. In addition, we submitted this protocol to the EMA following consultation with the Adaptive Pathways Project Group.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="LINE-HEIGHT: 1.25">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold">Recovery following Hematopoietic cell transplantation (</font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">"</font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold">HCT</font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">"</font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold">)&#160;&#8211; </font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">In March 2015, we reported positive data from three independent preclinical studies of PLX-R18. Results from these trials, as well as those from nineteen prior studies conducted by the NIAID, Case Western University, Cleveland, Ohio, and Hadassah Medical Center, Jerusalem, Israel, collectively suggest that PLX-R18 is safe and may significantly improve outcomes after bone marrow failure and/or support hematopoietic cell transplantation. Data collected on the mechanism of action show that PLX-R18 acts by enhancing production of platelets and white and red blood cells in cases of severely damaged bone marrow, and may also accelerate engraftment of transplanted hematopoietic cells. With these capabilities, PLX-R18 could potentially treat a broad range of indications related to bone marrow function which, taken together, constitute a substantial global market.</font></div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">In January 2016, the FDA cleared our IND application to begin its Phase I trial of PLX-R18 cells to treat incomplete hematopoietic recovery following HCT. We initiated the Phase I study in the United States in fiscal year 2017.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal">7</font></div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; WIDTH: 100%; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold">ARS &#8211;</font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold">&#160;</font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">We</font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold">&#160;</font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">have conducted several </font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-STYLE: italic">in-vivo</font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"> studies for the evaluation of PLX-R18 for the treatment of ARS, in cooperation with the NIAID.</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">NIH funded and conducted a pilot study in large animals to evaluate </font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">the therapeutic effect of PLX-R18 on hematological aspects of ARS. Results showed improved survival of PLX-R18 treated animals compared to control, placebo treated animals. We plan to continue the discussions with the different government agencies with the goal of receiving their support for pivotal studies in large animals as well as conducting the safety studies required in order to file BLA for this indication. In August 2017, we announced that a pilot study of our PLX-R18 cell therapy will be initiated by the U.S. Department of Defense&#8217;s Armed Forces Radiobiology Research Institute, part of the Uniformed Services University of Health Sciences . The study will examine the effectiveness of PLX-R18 as a treatment for ARS prior to, and within the first 24 hours of exposure to radiation.</font><br style="LINE-HEIGHT: 1.25">
</div>
</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Regulatory and Clinical Affairs Strategy</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">Our cell therapy development strategy is to hold open and frequent discussions with regulators at all stages of development from preclinical trials to more advanced regulatory stages. We utilize this strategy in working with the FDA, the EMA, Japan&#8217;s PMDA, Germany&#8217;s PEI as well as other European national competent authorities and the Israeli Minister of Health, or MOH, and we are also working with the Ministry of Food and Drug Safety, or MFDS, of South Korea authority via our collaborator CHA.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">The Adaptive Pathways pilot project is part of the EMA&#8217;s efforts to improve timely access for patients to new therapies. It targets treatments with the potential to heal serious conditions with an unmet medical need, and may reduce the time to a medicine's approval or to its reimbursement for targeted patient groups. The pilot is open to clinical programs in early stages of development only. After a therapy is selected for the program, the Adaptive Pathways Discussion Group provides detailed guidance to the applicant regarding the formal regulatory processes that precede a trial targeting early approval and further expansion of the indications. We have applied early to this program and have been selected for it.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">The Japanese PMDA, in the framework of regulations for regenerative therapy effective in November 2014, promotes expedited approval for regenerative therapies that are being developed for seriously debilitating or life-threatening indications for which there is a high unmet medical need. We are developing CLI in Japan under this program.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">The U.S. 21st Century Cures Act offers an opportunity for regenerative medicine products, like PLX cells, to bypass the time consuming hurdles on the way to meet patient needs. The Regenerative Medicine Advanced Therapy designation provided by the FDA enables regenerative cell therapies to access the FDA&#8217;s existing expedited programs to help foster the development and approval of these novel products. The FDA has pledged to develop a comprehensive and efficient science-based policy with the aim of accelerating the proper development processes to help bring innovative, scientifically proven regenerative cell therapies to patients more rapidly. We have not received such designation from the FDA yet.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; FONT-STYLE: italic; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Intellectual Property</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">We understand that our success will depend, in part, on maintaining our intellectual property, and therefore we are committed to protecting our technology and product candidates with patents and other methods described below.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">We are the sole owner of 110 issued patents and more than 100 pending patent applications in the United States, Europe, China and Japan, as well as in additional countries worldwide, including Israel, countries in the Far East and South America (in calculating the number of issued patents, each European patent validated in multiple jurisdictions was counted as a single patent). In April 2016, the Subsidiary entered into a licensing agreement with TES Holdings Co., Ltd., a venture company derived from the University of Tokyo, to obtain a key patent in Japan to cover the treatment of ischemic diseases with placental cell therapy. This license is subject to future single low-digit royalties from sales of our product for treatment in the field of ischemic diseases in Japan, until expiry of the patent in 2023. This license follows the grant of two key patents to us by the Japanese Patent Office, which address three dimensional methods for expanding placental and adipose cells, and specified cell therapies produced from placental tissue using these methods. In February 2017, the Subsidiary signed an agreement with founders of a certain patent for a five year option to purchase the certain patent for an amount of 1 million Euro. The agreement includes yearly payments of 75,000, 75,000 and 100,000 Euros to be paid in February 2017, 2018 and 2019, respectively. In case we decide to purchase the certain patent, until January 15, 2019, 50% of the yearly payments will be deducted from the amount of 1 million Euro.&#160; We are entitled to terminate the agreement for convenience upon providing the founders 30 days prior notice.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal">8</font></div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; WIDTH: 100%; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">Based on the well-established understanding that the characteristics and therapeutic potential of a cell product are largely determined by the source of the cells and by the methods and conditions used during their culturing, our patent portfolio includes different types of claims that protect the various unique aspects of our technology.</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">Our multi-national portfolio of patent and patent applications includes the following claims:</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<table id="z7eb0233f0aac49209bb10bcd77eaae58" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 36pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: Symbol, serif; VERTICAL-ALIGN: top; WIDTH: 18pt; align: right">&#183;</td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">Our proprietary expansion methods for 3D stromal cells;</div>
</td>
</tr>
</table>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<table id="ze087d174f7b846d9bd180f6a22a3f5eb" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 36pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: Symbol, serif; VERTICAL-ALIGN: top; WIDTH: 18pt; align: right">&#183;</td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">Composition of matter claims covering the cells;</div>
</td>
</tr>
</table>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<table id="zfe172c3cb05444d6b6a54f10e5622cf7" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 36pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: Symbol, serif; VERTICAL-ALIGN: top; WIDTH: 18pt; align: right">&#183;</td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">The therapeutic use of PLX cells for the treatment of a variety of medical conditions; and</div>
</td>
</tr>
</table>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<table id="z12c8f1e3bc5e4b1c8d00ae4d129ce32f" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 36pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: Symbol, serif; VERTICAL-ALIGN: top; WIDTH: 18pt; align: right">&#183;</td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">Cell-culture, harvest, and thawing devices.</div>
</td>
</tr>
</table>
</div>

<div style="TEXT-ALIGN: left; MARGIN-LEFT: 54pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -18pt"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">Through our experience with ASC-based product development, we have developed expertise and know-how in this field and have established procedures for manufacturing clinical-grade PLX cells in our facilities. Certain aspects of our manufacturing process are covered by patents and patent applications. In addition, specific aspects of our technology are retained as know-how and trade secrets that are protected by our confidentiality agreements with our employees, consultants, contractors, manufacturers and advisors. These agreements generally provide for protection of confidential information, restrictions on the use of materials, and an obligation to assign to us inventions conceived during the course of performing services for us.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">The following table provides a description of our key patents and patent applications and is not intended to represent an assessment of claims, limitations or scope. In some cases, a jurisdiction is listed as both pending and granted for a single patent family. This is due to pending continuation or divisional applications of the granted case.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">There is a risk that our patents will be invalidated, and that our pending patent applications will not result in issued patents.&#160; We also cannot be certain that we will not infringe on any patents that may be issued to others.&#160; See <font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-STYLE: italic">"Risk Factors - We must further protect and develop our technology and products in order to become a profitable company"</font>.&#160; The expiration dates of these patents, based on filing dates, range from 2020 to 2036. Actual expiration dates will be determined according to extensions received based on the Drug Price Competition and Patent Term Restoration Act of 1984 (P.L. 98-417), commonly known as the "Hatch-Waxman" Act, that permits extensions of pharmaceutical patents to reflect regulatory delays encountered in obtaining FDA market approval.&#160; The Hatch-Waxman Act is based on a U.S. federal law and therefore only relevant to U.S. patents.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal">9</font></div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; WIDTH: 100%; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Our Patent Portfolio </div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<table id="zda300438ca1045c083a248aecb20779e" style="FONT-SIZE: 10pt; BORDER-TOP: medium none; FONT-FAMILY: 'Times New Roman', Times, serif; BORDER-RIGHT: medium none; BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; WIDTH: 100%" cellspacing="0" cellpadding="2" border="0">
<tr>
<td style="BORDER-TOP: #000000 2px solid; BORDER-RIGHT: medium none; VERTICAL-ALIGN: top; BORDER-BOTTOM: medium none; BORDER-LEFT: #000000 2px solid; WIDTH: 29.98%; BACKGROUND-COLOR: #bfbfbf">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Patent Name/ Int. App. No.</div>
</td>
<td style="BORDER-TOP: #000000 2px solid; BORDER-RIGHT: medium none; VERTICAL-ALIGN: top; BORDER-BOTTOM: medium none; BORDER-LEFT: #000000 2px solid; WIDTH: 25.22%; BACKGROUND-COLOR: #bfbfbf">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Pending Jurisdictions</div>
</td>
<td style="BORDER-TOP: #000000 2px solid; BORDER-RIGHT: medium none; VERTICAL-ALIGN: top; BORDER-BOTTOM: medium none; BORDER-LEFT: #000000 2px solid; WIDTH: 25.24%; BACKGROUND-COLOR: #bfbfbf">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Granted Jurisdictions</div>
</td>
<td style="BORDER-TOP: #000000 2px solid; BORDER-RIGHT: #000000 2px solid; VERTICAL-ALIGN: top; BORDER-BOTTOM: medium none; BORDER-LEFT: #000000 2px solid; WIDTH: 19.56%; BACKGROUND-COLOR: #bfbfbf">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">Expiry Date</div>
</td>
</tr>

<tr>
<td style="BORDER-TOP: #000000 2px solid; BORDER-RIGHT: medium none; VERTICAL-ALIGN: top; BORDER-BOTTOM: medium none; BORDER-LEFT: #000000 2px solid; WIDTH: 29.98%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">METHOD AND APPARATUS FOR MAINTENANCE AND EXPANSION OF HAEMATOPOIETIC STEM CELLS AND/OR PROGENITOR CELLS</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">PCT/US2000/02688</div>
</td>
<td style="BORDER-TOP: #000000 2px solid; BORDER-RIGHT: medium none; VERTICAL-ALIGN: top; BORDER-BOTTOM: medium none; BORDER-LEFT: #000000 2px solid; WIDTH: 25.22%">&#160;</td>
<td style="BORDER-TOP: #000000 2px solid; BORDER-RIGHT: medium none; VERTICAL-ALIGN: top; BORDER-BOTTOM: medium none; BORDER-LEFT: #000000 2px solid; WIDTH: 25.24%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">United States, Japan, Europe, Mexico, Australia, South Africa, Israel, Russia, New Zealand, India, China, Hong Kong, Canada</div>
</td>
<td style="BORDER-TOP: #000000 2px solid; BORDER-RIGHT: #000000 2px solid; VERTICAL-ALIGN: top; BORDER-BOTTOM: medium none; BORDER-LEFT: #000000 2px solid; WIDTH: 19.56%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">February 4, 2020</div>
</td>
</tr>

<tr>
<td style="BORDER-TOP: #000000 2px solid; BORDER-RIGHT: medium none; VERTICAL-ALIGN: top; BORDER-BOTTOM: medium none; BORDER-LEFT: #000000 2px solid; WIDTH: 29.98%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">METHODS FOR CELL EXPANSION AND USES OF CELLS AND CONDITIONED MEDIA PRODUCED THEREBY FOR THERAPY</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">PCT/IL2007/000380</div>
</td>
<td style="BORDER-TOP: #000000 2px solid; BORDER-RIGHT: medium none; VERTICAL-ALIGN: top; BORDER-BOTTOM: medium none; BORDER-LEFT: #000000 2px solid; WIDTH: 25.22%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">United States, Europe, Israel, China, Hong Kong, Canada, Brazil</div>
</td>
<td style="BORDER-TOP: #000000 2px solid; BORDER-RIGHT: medium none; VERTICAL-ALIGN: top; BORDER-BOTTOM: medium none; BORDER-LEFT: #000000 2px solid; WIDTH: 25.24%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Japan, Europe, Israel, Singapore, Russia, South Africa, Australia, India, Korea, Mexico, Hong Kong, China</div>
</td>
<td style="BORDER-TOP: #000000 2px solid; BORDER-RIGHT: #000000 2px solid; VERTICAL-ALIGN: top; BORDER-BOTTOM: medium none; BORDER-LEFT: #000000 2px solid; WIDTH: 19.56%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">March 23, 2027</div>
</td>
</tr>

<tr>
<td style="BORDER-TOP: #000000 2px solid; BORDER-RIGHT: medium none; VERTICAL-ALIGN: top; BORDER-BOTTOM: medium none; BORDER-LEFT: #000000 2px solid; WIDTH: 29.98%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">ADHERENT CELLS FROM PLACENTA TISSUE AND USE THEREOF IN THERAPY</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">PCT/IL2008/001185</div>
</td>
<td style="BORDER-TOP: #000000 2px solid; BORDER-RIGHT: medium none; VERTICAL-ALIGN: top; BORDER-BOTTOM: medium none; BORDER-LEFT: #000000 2px solid; WIDTH: 25.22%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">United States, Europe,&#160; Israel,&#160; China, Hong Kong,&#160; Brazil, Russia, Japan</div>
</td>
<td style="BORDER-TOP: #000000 2px solid; BORDER-RIGHT: medium none; VERTICAL-ALIGN: top; BORDER-BOTTOM: medium none; BORDER-LEFT: #000000 2px solid; WIDTH: 25.24%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">United States, Europe, Singapore, Australia, Hong Kong, South Africa India, Mexico, Japan, Korea, Canada, China, Israel</div>
</td>
<td style="BORDER-TOP: #000000 2px solid; BORDER-RIGHT: #000000 2px solid; VERTICAL-ALIGN: top; BORDER-BOTTOM: medium none; BORDER-LEFT: #000000 2px solid; WIDTH: 19.56%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">September 2, 2028</div>
</td>
</tr>

<tr>
<td style="BORDER-TOP: #000000 2px solid; BORDER-RIGHT: medium none; VERTICAL-ALIGN: top; BORDER-BOTTOM: medium none; BORDER-LEFT: #000000 2px solid; WIDTH: 29.98%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">METHODS OF TREATING INFLAMMATORY COLON DISEASES</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">PCT/IL2009/000527</div>
</td>
<td style="BORDER-TOP: #000000 2px solid; BORDER-RIGHT: medium none; VERTICAL-ALIGN: top; BORDER-BOTTOM: medium none; BORDER-LEFT: #000000 2px solid; WIDTH: 25.22%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">United States, Brazil, Israel</div>
</td>
<td style="BORDER-TOP: #000000 2px solid; BORDER-RIGHT: medium none; VERTICAL-ALIGN: top; BORDER-BOTTOM: medium none; BORDER-LEFT: #000000 2px solid; WIDTH: 25.24%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">United States, Israel, Russia, South Africa</div>
</td>
<td style="BORDER-TOP: #000000 2px solid; BORDER-RIGHT: #000000 2px solid; VERTICAL-ALIGN: top; BORDER-BOTTOM: medium none; BORDER-LEFT: #000000 2px solid; WIDTH: 19.56%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">May 26, 2029</div>
</td>
</tr>

<tr>
<td style="BORDER-TOP: #000000 2px solid; BORDER-RIGHT: medium none; VERTICAL-ALIGN: top; BORDER-BOTTOM: medium none; BORDER-LEFT: #000000 2px solid; WIDTH: 29.98%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">METHODS OF SELECTION OF CELLS FOR TRANSPLANTATION</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">PCT/IL2009/000844</div>
</td>
<td style="BORDER-TOP: #000000 2px solid; BORDER-RIGHT: medium none; VERTICAL-ALIGN: top; BORDER-BOTTOM: medium none; BORDER-LEFT: #000000 2px solid; WIDTH: 25.22%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">United States</div>
</td>
<td style="BORDER-TOP: #000000 2px solid; BORDER-RIGHT: medium none; VERTICAL-ALIGN: top; BORDER-BOTTOM: medium none; BORDER-LEFT: #000000 2px solid; WIDTH: 25.24%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Europe, Israel</div>
</td>
<td style="BORDER-TOP: #000000 2px solid; BORDER-RIGHT: #000000 2px solid; VERTICAL-ALIGN: top; BORDER-BOTTOM: medium none; BORDER-LEFT: #000000 2px solid; WIDTH: 19.56%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">September 1, 2029</div>
</td>
</tr>

<tr>
<td style="BORDER-TOP: #000000 2px solid; BORDER-RIGHT: medium none; VERTICAL-ALIGN: top; BORDER-BOTTOM: medium none; BORDER-LEFT: #000000 2px solid; WIDTH: 29.98%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">ADHERENT CELLS FROM PLACENTA TISSUE AND USE THEREOF IN THERAPY</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">PCT/IL2009/000846</div>
</td>
<td style="BORDER-TOP: #000000 2px solid; BORDER-RIGHT: medium none; VERTICAL-ALIGN: top; BORDER-BOTTOM: medium none; BORDER-LEFT: #000000 2px solid; WIDTH: 25.22%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">United States, India, Hong Kong, China, Brazil</div>
</td>
<td style="BORDER-TOP: #000000 2px solid; BORDER-RIGHT: medium none; VERTICAL-ALIGN: top; BORDER-BOTTOM: medium none; BORDER-LEFT: #000000 2px solid; WIDTH: 25.24%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">United States, Russia, Australia, South Africa, Mexico, Europe, Canada, Singapore, Hong Kong</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>
</td>
<td style="BORDER-TOP: #000000 2px solid; BORDER-RIGHT: #000000 2px solid; VERTICAL-ALIGN: top; BORDER-BOTTOM: medium none; BORDER-LEFT: #000000 2px solid; WIDTH: 19.56%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">September 1, 2029</div>
</td>
</tr>

<tr>
<td style="BORDER-TOP: #000000 2px solid; BORDER-RIGHT: medium none; VERTICAL-ALIGN: top; BORDER-BOTTOM: medium none; BORDER-LEFT: #000000 2px solid; WIDTH: 29.98%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">ADHERENT CELLS FROM PLACENTA TISSUE AND USE THEREOF IN THERAPY</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">PCT/IL2009/000845</div>
</td>
<td style="BORDER-TOP: #000000 2px solid; BORDER-RIGHT: medium none; VERTICAL-ALIGN: top; BORDER-BOTTOM: medium none; BORDER-LEFT: #000000 2px solid; WIDTH: 25.22%">&#160;</td>
<td style="BORDER-TOP: #000000 2px solid; BORDER-RIGHT: medium none; VERTICAL-ALIGN: top; BORDER-BOTTOM: medium none; BORDER-LEFT: #000000 2px solid; WIDTH: 25.24%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">United States, Europe, Israel</div>
</td>
<td style="BORDER-TOP: #000000 2px solid; BORDER-RIGHT: #000000 2px solid; VERTICAL-ALIGN: top; BORDER-BOTTOM: medium none; BORDER-LEFT: #000000 2px solid; WIDTH: 19.56%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">September 1, 2029</div>
</td>
</tr>

<tr>
<td style="BORDER-TOP: #000000 2px solid; BORDER-RIGHT: medium none; VERTICAL-ALIGN: top; BORDER-BOTTOM: medium none; BORDER-LEFT: #000000 2px solid; WIDTH: 29.98%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">ADHERENT STROMAL CELLS DERIVED FROM PLANCENTAS OF MULTIPLE DONORS AND USES THEREOF</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">PCT/IB2011/001413</div>
</td>
<td style="BORDER-TOP: #000000 2px solid; BORDER-RIGHT: medium none; VERTICAL-ALIGN: top; BORDER-BOTTOM: medium none; BORDER-LEFT: #000000 2px solid; WIDTH: 25.22%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">United States</div>
</td>
<td style="BORDER-TOP: #000000 2px solid; BORDER-RIGHT: medium none; VERTICAL-ALIGN: top; BORDER-BOTTOM: medium none; BORDER-LEFT: #000000 2px solid; WIDTH: 25.24%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Israel, Europe, Hong Kong</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>
</td>
<td style="BORDER-TOP: #000000 2px solid; BORDER-RIGHT: #000000 2px solid; VERTICAL-ALIGN: top; BORDER-BOTTOM: medium none; BORDER-LEFT: #000000 2px solid; WIDTH: 19.56%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">April 21, 2031</div>
</td>
</tr>

<tr>
<td style="BORDER-TOP: #000000 2px solid; BORDER-RIGHT: medium none; VERTICAL-ALIGN: top; BORDER-BOTTOM: medium none; BORDER-LEFT: #000000 2px solid; WIDTH: 29.98%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">ADHERENT CELLS FROM PLACENTA AND USE OF SAME IN DISEASE TREATMENT</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">PCT/IB2010/003219</div>
</td>
<td style="BORDER-TOP: #000000 2px solid; BORDER-RIGHT: medium none; VERTICAL-ALIGN: top; BORDER-BOTTOM: medium none; BORDER-LEFT: #000000 2px solid; WIDTH: 25.22%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">United States,&#160; Canada, China, Europe, Israel, India</div>
</td>
<td style="BORDER-TOP: #000000 2px solid; BORDER-RIGHT: medium none; VERTICAL-ALIGN: top; BORDER-BOTTOM: medium none; BORDER-LEFT: #000000 2px solid; WIDTH: 25.24%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">United States, Europe, China, Australia, New Zealand, South Africa, Hong-Kong, Mexico</div>
</td>
<td style="BORDER-TOP: #000000 2px solid; BORDER-RIGHT: #000000 2px solid; VERTICAL-ALIGN: top; BORDER-BOTTOM: medium none; BORDER-LEFT: #000000 2px solid; WIDTH: 19.56%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">November 29, 2030</div>
</td>
</tr>

<tr>
<td style="BORDER-TOP: #000000 2px solid; BORDER-RIGHT: medium none; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 2px solid; BORDER-LEFT: #000000 2px solid; WIDTH: 29.98%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">METHODS AND SYSTEMS FOR HARVESTING ADHERENT STROMAL CELLS</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">PCT/IB2012/000933</div>
</td>
<td style="BORDER-TOP: #000000 2px solid; BORDER-RIGHT: medium none; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 2px solid; BORDER-LEFT: #000000 2px solid; WIDTH: 25.22%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">United States, Canada, China, Europe, Hong Kong, Israel, India, Korea, Mexico, Singapore</div>
</td>
<td style="BORDER-TOP: #000000 2px solid; BORDER-RIGHT: medium none; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 2px solid; BORDER-LEFT: #000000 2px solid; WIDTH: 25.24%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">United States, Australia, South Africa</div>
</td>
<td style="BORDER-TOP: #000000 2px solid; BORDER-RIGHT: #000000 2px solid; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 2px solid; BORDER-LEFT: #000000 2px solid; WIDTH: 19.56%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">April 15, 2032</div>
</td>
</tr>
</table>

<div>&#160;</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal">10</font></div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; WIDTH: 100%; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<table id="z660842c410014e74bff0852d24512f14" style="FONT-SIZE: 10pt; BORDER-TOP: medium none; FONT-FAMILY: 'Times New Roman', Times, serif; BORDER-RIGHT: medium none; BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; WIDTH: 100%" cellspacing="0" cellpadding="2" border="0">
<tr>
<td style="BORDER-TOP: #000000 2px solid; BORDER-RIGHT: medium none; VERTICAL-ALIGN: top; BORDER-BOTTOM: medium none; BORDER-LEFT: #000000 2px solid; WIDTH: 29.98%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">METHODS FOR TREATING RADIATION OR CHEMICAL INJURY</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">PCT/IB2012/000664</div>
</td>
<td style="BORDER-TOP: #000000 2px solid; BORDER-RIGHT: medium none; VERTICAL-ALIGN: top; BORDER-BOTTOM: medium none; BORDER-LEFT: #000000 2px solid; WIDTH: 25.22%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">United States, Europe, Hong Kong, Israel, Korea, Japan</div>
</td>
<td style="BORDER-TOP: #000000 2px solid; BORDER-RIGHT: medium none; VERTICAL-ALIGN: top; BORDER-BOTTOM: medium none; BORDER-LEFT: #000000 2px solid; WIDTH: 25.24%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Japan</div>
</td>
<td style="BORDER-TOP: #000000 2px solid; BORDER-RIGHT: #000000 2px solid; VERTICAL-ALIGN: top; BORDER-BOTTOM: medium none; BORDER-LEFT: #000000 2px solid; WIDTH: 19.56%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">March 22, 2032</div>
</td>
</tr>

<tr>
<td style="BORDER-TOP: #000000 2px solid; BORDER-RIGHT: medium none; VERTICAL-ALIGN: top; BORDER-BOTTOM: medium none; BORDER-LEFT: #000000 2px solid; WIDTH: 29.98%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">SKELETAL MUSCLE REGENERATION USING MESENCHYMAL STEM CELLS</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">PCT/EP2011/058730</div>
</td>
<td style="BORDER-TOP: #000000 2px solid; BORDER-RIGHT: medium none; VERTICAL-ALIGN: top; BORDER-BOTTOM: medium none; BORDER-LEFT: #000000 2px solid; WIDTH: 25.22%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">United States</div>
</td>
<td style="BORDER-TOP: #000000 2px solid; BORDER-RIGHT: medium none; VERTICAL-ALIGN: top; BORDER-BOTTOM: medium none; BORDER-LEFT: #000000 2px solid; WIDTH: 25.24%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Europe, Israel, Hong Kong</div>
</td>
<td style="BORDER-TOP: #000000 2px solid; BORDER-RIGHT: #000000 2px solid; VERTICAL-ALIGN: top; BORDER-BOTTOM: medium none; BORDER-LEFT: #000000 2px solid; WIDTH: 19.56%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">May 27, 2031</div>
</td>
</tr>

<tr>
<td style="BORDER-TOP: #000000 2px solid; BORDER-RIGHT: medium none; VERTICAL-ALIGN: top; BORDER-BOTTOM: medium none; BORDER-LEFT: #000000 2px solid; WIDTH: 29.98%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">GENE AND PROTEIN EXPRESSION PROPERTIES OF ADHERENT STROMAL CELLS CULTURED IN 3D</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">PCT/IB2014/059114</div>
</td>
<td style="BORDER-TOP: #000000 2px solid; BORDER-RIGHT: medium none; VERTICAL-ALIGN: top; BORDER-BOTTOM: medium none; BORDER-LEFT: #000000 2px solid; WIDTH: 25.22%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">United States, Israel</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>
</td>
<td style="BORDER-TOP: #000000 2px solid; BORDER-RIGHT: medium none; VERTICAL-ALIGN: top; BORDER-BOTTOM: medium none; BORDER-LEFT: #000000 2px solid; WIDTH: 25.24%">&#160;</td>
<td style="BORDER-TOP: #000000 2px solid; BORDER-RIGHT: #000000 2px solid; VERTICAL-ALIGN: top; BORDER-BOTTOM: medium none; BORDER-LEFT: #000000 2px solid; WIDTH: 19.56%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">February 20, 2034</div>
</td>
</tr>

<tr>
<td style="BORDER-TOP: #000000 2px solid; BORDER-RIGHT: medium none; VERTICAL-ALIGN: top; BORDER-BOTTOM: medium none; BORDER-LEFT: #000000 2px solid; WIDTH: 29.98%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">DEVICES AND METHODS FOR CULTURE OF CELLS</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">PCT/IB2013/058184</div>
</td>
<td style="BORDER-TOP: #000000 2px solid; BORDER-RIGHT: medium none; VERTICAL-ALIGN: top; BORDER-BOTTOM: medium none; BORDER-LEFT: #000000 2px solid; WIDTH: 25.22%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Europe, China,&#160; Brazil, India, Mexico</div>
</td>
<td style="BORDER-TOP: #000000 2px solid; BORDER-RIGHT: medium none; VERTICAL-ALIGN: top; BORDER-BOTTOM: medium none; BORDER-LEFT: #000000 2px solid; WIDTH: 25.24%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">United States, Europe, Canada, China, Europe, Israel, Japan, Singapore, Australia, Hong Kong, Korea, Russia,</div>
</td>
<td style="BORDER-TOP: #000000 2px solid; BORDER-RIGHT: #000000 2px solid; VERTICAL-ALIGN: top; BORDER-BOTTOM: medium none; BORDER-LEFT: #000000 2px solid; WIDTH: 19.56%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">August 31, 2033</div>
</td>
</tr>

<tr>
<td style="BORDER-TOP: #000000 2px solid; BORDER-RIGHT: medium none; VERTICAL-ALIGN: top; BORDER-BOTTOM: medium none; BORDER-LEFT: #000000 2px solid; WIDTH: 29.98%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">METHODS FOR PREVENTION AND TREATMENT OF PREECLAMPSIA</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">PCT/IB2013/058186</div>
</td>
<td style="BORDER-TOP: #000000 2px solid; BORDER-RIGHT: medium none; VERTICAL-ALIGN: top; BORDER-BOTTOM: medium none; BORDER-LEFT: #000000 2px solid; WIDTH: 25.22%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">United States, Europe, China, Japan, Korea, Canada, Israel, Singapore, Australia, Hong Kong</div>
</td>
<td style="BORDER-TOP: #000000 2px solid; BORDER-RIGHT: medium none; VERTICAL-ALIGN: top; BORDER-BOTTOM: medium none; BORDER-LEFT: #000000 2px solid; WIDTH: 25.24%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">South Africa</div>
</td>
<td style="BORDER-TOP: #000000 2px solid; BORDER-RIGHT: #000000 2px solid; VERTICAL-ALIGN: top; BORDER-BOTTOM: medium none; BORDER-LEFT: #000000 2px solid; WIDTH: 19.56%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">August 31, 2033</div>
</td>
</tr>

<tr>
<td style="BORDER-TOP: #000000 2px solid; BORDER-RIGHT: medium none; VERTICAL-ALIGN: top; BORDER-BOTTOM: medium none; BORDER-LEFT: #000000 2px solid; WIDTH: 29.98%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">METHOD AND DEVICE FOR THAWING BIOLOGICAL MATERIAL</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">PCT/IB2013/059808</div>
</td>
<td style="BORDER-TOP: #000000 2px solid; BORDER-RIGHT: medium none; VERTICAL-ALIGN: top; BORDER-BOTTOM: medium none; BORDER-LEFT: #000000 2px solid; WIDTH: 25.22%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">United States, Europe, China, Japan, Korea, Canada, Brazil, Israel, India, Russia, Singapore, Hong Kong</div>
</td>
<td style="BORDER-TOP: #000000 2px solid; BORDER-RIGHT: medium none; VERTICAL-ALIGN: top; BORDER-BOTTOM: medium none; BORDER-LEFT: #000000 2px solid; WIDTH: 25.24%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Australia</div>
</td>
<td style="BORDER-TOP: #000000 2px solid; BORDER-RIGHT: #000000 2px solid; VERTICAL-ALIGN: top; BORDER-BOTTOM: medium none; BORDER-LEFT: #000000 2px solid; WIDTH: 19.56%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">October 31, 2033</div>
</td>
</tr>

<tr>
<td style="BORDER-TOP: #000000 2px solid; FONT-FAMILY: 'Times New Roman', Times, serif; BORDER-RIGHT: medium none; VERTICAL-ALIGN: top; BORDER-BOTTOM: medium none; BORDER-LEFT: #000000 2px solid; WIDTH: 29.98%">
<div style="FONT-WEIGHT: bold">SYSTEMS AND METHODS FOR GROWING AND HARVESTING CELLS</div>

<div style="FONT-WEIGHT: bold">PCT/IB2015/051559</div>
</td>
<td style="BORDER-TOP: #000000 2px solid; BORDER-RIGHT: medium none; VERTICAL-ALIGN: top; BORDER-BOTTOM: medium none; BORDER-LEFT: #000000 2px solid; WIDTH: 25.22%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">United States, Europe, Israel, Taiwan</div>
</td>
<td style="BORDER-TOP: #000000 2px solid; BORDER-RIGHT: medium none; VERTICAL-ALIGN: top; BORDER-BOTTOM: medium none; BORDER-LEFT: #000000 2px solid; WIDTH: 25.24%">&#160;</td>
<td style="BORDER-TOP: #000000 2px solid; BORDER-RIGHT: #000000 2px solid; VERTICAL-ALIGN: top; BORDER-BOTTOM: medium none; BORDER-LEFT: #000000 2px solid; WIDTH: 19.56%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">March 3, 2035</div>
</td>
</tr>

<tr>
<td style="BORDER-TOP: #000000 2px solid; BORDER-RIGHT: medium none; VERTICAL-ALIGN: top; BORDER-BOTTOM: medium none; BORDER-LEFT: #000000 2px solid; WIDTH: 29.98%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">METHODS AND COMPOSITIONS FOR TREATING AND PREVENTING MUSCLE WASTING DISORDERS</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">PCT/IB2015/059763</div>
</td>
<td style="BORDER-TOP: #000000 2px solid; BORDER-RIGHT: medium none; VERTICAL-ALIGN: top; BORDER-BOTTOM: medium none; BORDER-LEFT: #000000 2px solid; WIDTH: 25.22%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">United States, Israel</div>
</td>
<td style="BORDER-TOP: #000000 2px solid; BORDER-RIGHT: medium none; VERTICAL-ALIGN: top; BORDER-BOTTOM: medium none; BORDER-LEFT: #000000 2px solid; WIDTH: 25.24%">&#160;</td>
<td style="BORDER-TOP: #000000 2px solid; BORDER-RIGHT: #000000 2px solid; VERTICAL-ALIGN: top; BORDER-BOTTOM: medium none; BORDER-LEFT: #000000 2px solid; WIDTH: 19.56%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">December 18, 2035</div>
</td>
</tr>

<tr>
<td style="BORDER-TOP: #000000 2px solid; BORDER-RIGHT: medium none; VERTICAL-ALIGN: top; BORDER-BOTTOM: medium none; BORDER-LEFT: #000000 2px solid; WIDTH: 29.98%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">USE OF ADHERENT STROMAL CELLS FOR ENHANCING HEMATOPOIESIS IN A SUBJECT IN NEED THEREOF</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">PCT/IB2016/051585</div>
</td>
<td style="BORDER-TOP: #000000 2px solid; BORDER-RIGHT: medium none; VERTICAL-ALIGN: top; BORDER-BOTTOM: medium none; BORDER-LEFT: #000000 2px solid; WIDTH: 25.22%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Patent Cooperation Treaty, Israel</div>
</td>
<td style="BORDER-TOP: #000000 2px solid; BORDER-RIGHT: medium none; VERTICAL-ALIGN: top; BORDER-BOTTOM: medium none; BORDER-LEFT: #000000 2px solid; WIDTH: 25.24%">&#160;</td>
<td style="BORDER-TOP: #000000 2px solid; BORDER-RIGHT: #000000 2px solid; VERTICAL-ALIGN: top; BORDER-BOTTOM: medium none; BORDER-LEFT: #000000 2px solid; WIDTH: 19.56%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">March 21, 2036</div>
</td>
</tr>

<tr>
<td style="BORDER-TOP: #000000 2px solid; BORDER-RIGHT: medium none; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 2px solid; BORDER-LEFT: #000000 2px solid; WIDTH: 29.98%">
<div style="FONT-WEIGHT: bold; LINE-HEIGHT: 1.25">DRUG CONTAINING HUMAN PLACENTA-ORIGIN MESENCHYMAL CELLS AND PROCESS FOR PRODUCING VEGF USING THE CELLS</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">JP20030579842</div>
</td>
<td style="BORDER-TOP: #000000 2px solid; BORDER-RIGHT: medium none; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 2px solid; BORDER-LEFT: #000000 2px solid; WIDTH: 25.22%">&#160;</td>
<td style="BORDER-TOP: #000000 2px solid; BORDER-RIGHT: medium none; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 2px solid; BORDER-LEFT: #000000 2px solid; WIDTH: 25.24%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Japan</div>
</td>
<td style="BORDER-TOP: #000000 2px solid; BORDER-RIGHT: #000000 2px solid; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 2px solid; BORDER-LEFT: #000000 2px solid; WIDTH: 19.56%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">March 28, 2023</div>
</td>
</tr>
</table>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal">11</font></div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; WIDTH: 100%; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; FONT-STYLE: italic; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Research and Development</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">Our research and development expenses were<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">&#160;</font>$24,001,000, $22,856,000 and $23,416,000 in fiscal years 2017, 2016 and 2015, respectively, before deducting the participation by the Israel Innovation Authority, or IIA (previously the Office of the Chief Scientist), participation by the European Union&#160;research and development consortium under the European Union's Horizon 2020 program and grants by other third parties.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25"><u>Foundational Research</u></div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">Our initial technology, the PluriX&#8482; Bioreactor system, was invented at the Technion - Israel Institute of Technology's Rappaport Faculty of Medicine, in collaboration with researchers from the Weizmann Institute of Science. This technology has been further significantly developed by our research and development teams over the ensuing years.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25"><u>Ongoing Research and Development Plans</u></div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">In July 2007, we entered into a five-year collaborative research agreement with the Berlin-Brandenburg Center for Regenerative Therapies at Charit&#233; - University Medicine Berlin, or Charit&#233;. In August 2012, we extended our collaborative research agreement with Charit&#233; for a period of five years through 2017. In June 2017, we extended our collaborative research agreement with Charit&#233; for a period of additional five 5 years, through June 2022.&#160; We and Charit&#233; are collaborating on a variety of indications utilizing PLX cells. According to the agreement, we will be the exclusive owner of the technology and any products produced as a result of the collaboration. Charit&#233; will receive between 1% to 2% royalties from new developments that have been achieved during the joint development.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 35.45pt">In recent years we have also engaged in research and development projects with other leading research institutions such as Hadassah University Medical Center, or Hadassah, in Jerusalem, Israel, and the Texas A&amp;M Health Science Center (Texas A&amp;M) in Round Rock, Texas.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 35.45pt">We used the services of Texas A&amp;M for conducting a pre-clinical trial with PLX cells in a mice model of pre-eclampsia.<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">&#160;</font>We have no current or ongoing obligations to Texas A&amp;M.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 35.45pt">We have used the services of Hadassah to conduct pre-clinical trials from 2011 through 2013, mainly in the field of radiation-induced hematopoietic failure. From time to time, we perform additional studies with Hadassah furthering our understanding of the mechanism of action of the PLX-R18 product. We have no current or ongoing obligations to Hadassah.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 35.45pt">We have performed proof of concept studies from April 2015 to December 2016 in conjunction with the Israeli Duchenne Association, or ADI, to assess the utility of PLX-PAD in alleviating symptoms of Duchenne muscular dystrophy.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 35.45pt">We signed an MOU for a collaboration with Fukushima Medical University, Fukushima Global Medical Science Center. The purpose of the collaboration is to develop Pluristem's PLX-R18 cells for the treatment of ARS, and for morbidities following radiotherapy in cancer patients. The collaboration will proceed alongside research supported by the NIH, which is studying PLX-R18 as a potential treatment for the hematologic component of ARS. The MOU for a collaboration with Fukushima will be renewed automatically on a yearly basis. Each party is entitled to terminate the agreement for convenience upon providing the other party 30 days prior notice.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal">12</font></div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; WIDTH: 100%; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 35.45pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">On June 26, 2013, we entered into an exclusive out-licensing and commercialization agreement, or the CHA Agreement, with CHA, for conducting clinical trials and commercialization of our PLX-PAD product in South Korea in connection with two indications: the treatment of CLI and IC. </font>We will continue to retain rights to our proprietary manufacturing technology and cell-related intellectual property.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 35.45pt">The first clinical study to be performed as part of the CHA Agreement is a Phase II trial in IC. This study is part of our multination phase II study. The Korean arm study was approved in November 2013 by South Korea&#8217;s MFDS.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 35.45pt">Upon the first regulatory approval for a PLX product in South Korea, if granted, for the specified indications, we and CHA will establish an equally owned joint venture. The purpose of the joint venture will be to commercialize PLX cell products in South Korea. Additionally, we will be able to use the data generated by CHA to pursue the development of PLX product candidates outside of South Korea.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 35.45pt">In addition, and as contemplated by the CHA Agreement, in December 2013, we and CHA executed a mutual investment pursuant to which we issued 2,500,000 shares of our common stock in consideration for 1,011,504 shares of CHA, which reflects total consideration to each of us and CHA of approximately $10,414,000.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 35.45pt">The term of the CHA Agreement extends from June 24, 2013 until the later of the expiration, lapse, cancellation, abandonment or invalidation of the last valid patent claim covering the development of the product indications.&#160; The CHA Agreement contains customary termination provisions, including in the event that the parties do not reach an agreement upon a development plan for conducting the clinical trials.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">Upon termination of the CHA Agreement, the license granted thereunder will terminate, and all rights included therein will revert to us, whereupon we will be free to enter into agreements with any other third parties for the granting of a license in or outside South Korea or to deal in any other manner with such rights as it shall see fit in our sole discretion.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">We plan to continue to collaborate with universities and academic institutions and corporate partners worldwide to fully leverage our expertise and explore the use of our cells in other indications.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; FONT-STYLE: italic; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">In-House Clinical Manufacturing</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">We have the in-house capability to perform clinical cell manufacturing. Our state-of-the-art GMP grade manufacturing facility in Haifa has been in use since February 2013 for the main purpose of clinical grade, large-scale manufacturing. The facility&#8217;s new automated manufacturing process and products were approved for production of PLX-PAD for clinical use by the FDA, EMA, Korean MFDS, PMDA and the Israeli MOH. Our second product, PLX R18, was cleared by the FDA and the Israeli Ministry of Health for clinical use. Furthermore, the site was inspected and approved by an EU qualified person (European accreditation body), approving that the site and production processes meet the current GMP for the purpose of manufacturing clinical grade products.&#160; Following the clinical approval of the facility, we are moving forward with our planned clinical trials based on cells manufactured in the new, efficient and improved manufacturing processes.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">We obtain the human placentas used for our research and manufacturing activities from various hospitals in Israel after receiving a written informed consent by the mother and pathogen clearance. Any medical waste related to the use of placentas is treated in compliance with local environmental laws and standards.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Government Regulation</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">The development, manufacturing, and marketing of our cell therapy product candidates are subject to the laws and regulations of governmental authorities in the United States and the European Union as well as other countries in which our products will be marketed in<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"> the future like Japan, Israel and South Korea. In addition, the manufacturing conditions are specifically inspected by the Israeli Ministry of Health.</font></div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal">13</font></div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; WIDTH: 100%; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">The FDA in the United States and the EMA in Europe must approve the product for marketing.&#160; Furthermore, various governmental statutes and regulations also govern or influence testing, manufacturing, safety, labeling, storage and record keeping related to such products and their marketing. Governments in other countries have similar requirements for testing and marketing.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">The process of obtaining these approvals and the subsequent compliance with appropriate statutes and regulations require the expenditure of substantial time, resources and money. There can be no assurance that our product candidates will ultimately receive marketing approval, or, if approved, will be reimbursed by public and private health insurance.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">There are several stages every drug has to go through during its development process. Among these are:</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<table id="zbcdad70f108f4baeb6d252b907b692be" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 18pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: Symbol, serif; VERTICAL-ALIGN: top; WIDTH: 18pt; align: right">&#183;</td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">Performance of nonclinical laboratory and animal studies to assess a drug's biological activity and to identify potential safety problems, and to characterize and document the product's chemistry, manufacturing controls, formulation, and stability. In accordance with regulatory requirements, nonclinical safety and toxicity studies are conducted under&#160;Good Laboratory Practice requirements&#160;to ensure their quality and reliability;</div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<table id="zc88e30002b1b4a7c87111310a2554e84" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 18pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: Symbol, serif; VERTICAL-ALIGN: top; WIDTH: 18pt; align: right">&#183;</td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">Conducting adequate and well-controlled human clinical trials in compliance with Good Clinical Practice, or GCP, to establish the safety and efficacy of the product for its intended indication;</div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<table id="z8bfd705dbb0d4aed80eff1d5c9f4a767" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 18pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: Symbol, serif; VERTICAL-ALIGN: top; WIDTH: 18pt; align: right">&#183;</td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">The manufacture of the product according to GMP regulations and standards; and</div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<table id="z9a4916f6101e4499a3b56e99f79912ce" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 18pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: Symbol, serif; VERTICAL-ALIGN: top; WIDTH: 18pt; align: right">&#183;</td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">Potential<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"> post-marketing clinical testing and surveillance of the product after marketing approval, which can result in additional conditions on the approvals or suspension of clinical use.</font></div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Approval of a drug for clinical studies in humans and approval of marketing are sovereign decisions of states, made by national, or, in case of the European Union, international regulatory competent authorities.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25"><u>The Regulatory Process in the United States</u></div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">In the United States, our product candidates are subject to regulation as a biological product under the Public Health Service Act and the Federal Food, Drug and Cosmetic Act. The FDA, regulating the approval of clinical trials and marketing applications in the United States, generally requires the following steps prior to approving a new biological product either for clinical studies or for commercial sale:</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<table id="z66c1267c3da740bb9373096e39bb7b98" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; WIDTH: 18pt; align: right">&#8226;</td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">Submission of an Investigational New Drug Application, which must become effective before clinical testing in humans can begin;</div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<table id="z0ad5de5702274d71ad721d216823a71a" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; WIDTH: 18pt; align: right">&#8226;</td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">Obtaining approval of Institutional Review Boards, or IRBs, of research institutions or other clinical sites to introduce the drug candidate into humans in clinical trials;</div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<table id="zb929b57841864087a210bf2eaeb67854" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; WIDTH: 18pt; align: right">&#8226;</td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">Submission to the FDA of a Biologics License Application, or BLA, for marketing authorization of the product, which must include adequate results of pre-clinical testing and clinical trials;</div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<table id="zc21c9b9373c744b88e0e0f1b92acbf29" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; WIDTH: 18pt; align: right">&#8226;</td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">Submission<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">&#160;</font>of BLA with a proof of efficacy that is based only on animal studies, where human efficacy studies cannot be conducted because the conduct of such trials is unethical and field trials after an accidental or deliberate exposure are not feasible.</div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<table id="z79246e5ba1944acfaf8615f186cddbfa" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; WIDTH: 18pt; align: right">&#8226;</td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">FDA review of the BLA in order to determine, among other things, whether the product is safe and effective for its intended uses; and</div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<table id="z521db4499e49486abcf4318667ae4763" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; WIDTH: 18pt; align: right">&#8226;</td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">FDA inspection and approval of the product manufacturing facility at which the product will be manufactured.</div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal">14</font></div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; WIDTH: 100%; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25"><u>The Regulatory Process in Europe</u></div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">In the European Union, our investigational cellular products are regulated under the Advanced Therapy Medicinal Product regulation, a regulation specific to cell and tissue products.</font>This European Union regulation requires:</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="LINE-HEIGHT: 1.25">
<div id="DSPFPageHeader"></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<table id="zb1b58fa84ec44983aed8ec4e4d0b2fb9" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; WIDTH: 18pt; align: right">&#8226;</td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">Filing a Clinical Trial Application via a centralized procedure, which makes it possible to obtain a coordinated assessment of an application for a clinical trial that is to take place in several European countries;</div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<table id="z6ba523e04d4b4dd2a5c5249627962230" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; WIDTH: 18pt; align: right">&#8226;</td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">Obtaining</font> approval of affiliated ethics committees of clinical sites to test the investigational product into humans in clinical trials;</div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<table id="z9f642928895a4b02b9b66e930a4a5f4f" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; WIDTH: 18pt; align: right">&#8226;</td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">Adequate and well-controlled clinical trials to establish the safety and efficacy of the investigational product for its intended use; and</div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<table id="zb8046358852a4232aaab90f5c0a545bf" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; WIDTH: 18pt; align: right">&#8226;</td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">Since</font> our investigational cellular products are regulated under the Advanced Therapy Medicinal Product regulation, the application for marketing authorization to the EMA is mandatory within the 28 member states of the EU. The EMA is expected to review and approve the Marketing Authorization Application.</div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 18pt">In April 2015, the EMA designated PLX-PAD as a tissue-engineered product.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 18pt">In April 2015, the Pediatric Committee of the EMA granted PLX-PAD a waiver for the requirement to submit a pediatric investigational plan for all indications falling under "treatment of peripheral atherosclerosis", including IC and CLI.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 18pt">In May 2015, we were selected by EMA for development of PLX-PAD cells via the Adaptive Pathways approach, with the potential to reach the market several years faster than the traditional regulatory approval pathway.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25"><u>Other Regulations</u></div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">In Japan, we have completed the required regulatory interactions with the PMDA, prior to the submission of clinical trial notification, in the framework of the new regulations for regenerative therapy effective in November 2014, which promote expedited approval for regenerative therapies that are being developed for seriously debilitating/life-threatening indications. We intend to develop PLX-PAD for CLI using this regulatory approach, with the potential to reach the market via conditional approval after a Phase I/II study.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">In general, the approval procedure varies among countries, and may involve additional preclinical testing and clinical trials.&#160; The requirements and time required may differ from those required for FDA or EMA approval. Each country may impose certain procedures and requirements of its own. Most countries other than the United States, the European Union and Japan are willing to consider requests for marketing approval only after the product had been approved for marketing by either the FDA, the EMA or the PMDA.&#160; The decision regarding marketing approval is made following the submission of a dossier that is thoroughly assessed and critically addressed.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal">15</font></div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; WIDTH: 100%; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25"><u>Clinical trials</u></div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">Typically, in the United States, the European Union as well as in Japan, clinical testing involves a three-phase process, although the phases may overlap. In Phase&#160;I, clinical trials are conducted with a small number of healthy volunteers, or patients in cases of ethical issues with using healthy volunteers, and are designed to provide information about product safety and to evaluate the pattern of drug distribution and metabolism within the body. In Phase&#160;II, clinical trials are conducted with a homogenous group of patients afflicted with the specific target disease, in order to determine preliminary efficacy, optimal dosages and expanded evidence of safety. In some cases, an initial trial is conducted in diseased patients to assess both preliminary efficacy and preliminary safety and patterns of drug metabolism and distribution, in which case it is referred to as a Phase&#160;I/II trial. Phase&#160;III clinical trials are generally large-scale, multi-center, controlled trials conducted with a heterogeneous group of patients afflicted with the target disease, in order to provide statistically valid proof of efficacy, as well as safety and potency. The Phase III trials represent the trials that are considered for confirmation of efficacy and safety and are the most important ones for the approval. In some circumstances, a regulatory agency may require Phase&#160;IV, or post-marketing, trials if it feels that additional information needs to be collected about the drug after it is on the market.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">During all phases of clinical development, regulatory agencies require extensive monitoring and auditing of all clinical activities, clinical data and clinical trial investigators to minimize risks. The sponsor of a clinical trial is required to submit an annual safety report to the relevant regulatory agencies, in which serious adverse events must be reported, and also to submit in an expedited manner any individual serious adverse events that are suspected to be related to the tested drug. An agency may, at its discretion, re-evaluate, alter, suspend, or terminate the clinical study based upon the data that have been accumulated to that point and its assessment of the risk/benefit ratio to the patient.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; FONT-STYLE: italic; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Employees</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">We presently employ a total of 175 full-time employees and 8 part-time employees, of whom 151 full-time employees and 7 part-time employees are engaged in research, manufacturing and clinical trials.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; FONT-STYLE: italic; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Competition</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">The regenerative medicine field is characterized by intense competition, as global pharma players are becoming more engaged in the cell therapy field based on the advancements made in clinical trials and due to the new favorable regenerative medicine legislation in certain regions. We face competition from both allogeneic and autologous cell therapy companies, academic, commercial and research institutions, pharmaceutical companies, biopharmaceutical companies, and governmental agencies. Some of the clinical indications we currently have under development are also being investigated in preclinical and clinical programs by others.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">While there are hundreds of companies in the regenerative medicine space globally, there are multiple participants in the cell therapy field based in the United States, Europe, Japan, Korea, and Australia such as Athersys, Inc., <font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">Capricor Therapeutics, Inc.</font>,<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"> Celgene Corporation</font>, Tigenix NV, SanBio Inc., Healios K.K., Cytori Therapeutics, Cesca. and Mesoblast LTD. Among other things, we expect to compete based upon our intellectual property portfolio, our in-house manufacturing efficiencies, and the efficacy of our products.&#160; Our ability to compete successfully will depend on our continued ability to attract and retain experienced and skilled executives, scientific and clinical development personnel, to identify and develop viable cellular therapeutic candidates, and exploit these products commercially.<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"> Given the magnitude of the potential opportunity for cell therapy, we expect competition in this area to intensify.</font></div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; FONT-STYLE: italic; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Available Information</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">Additional information about us is contained on our Internet website at www.pluristem.com. Information on our website is not incorporated by reference into this report. Under the "SEC Filings" and &#8220;Financial Information&#8221; sections, under the "Investors &amp; Media" section of our website, we make available free of charge our Annual Reports on Form 10-K, Quarterly Reports on Form 10-Q, Current Reports on Form 8-K, and amendments to those reports filed or furnished pursuant to Section 13(a) of the Securities Exchange Act of 1934, as amended (Exchange Act), as soon as reasonably practicable after we electronically file such material with, or furnish it to, the SEC.&#160; Our reports filed with the SEC are also made available to read and copy at the SEC's Public Reference Room at 100 F Street, NE, Washington, D.C. 20549.&#160; You may obtain information about the Public Reference Room by calling the SEC at 1-800-SEC-0330.&#160; Reports filed with the SEC are also made available on its website at www.sec.gov.&#160; The following Corporate Governance documents are also posted on our website: Code of Business Conduct and Ethics, and the Charters for each of the Committees of our Board of Directors.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal">16</font></div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; WIDTH: 100%; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25"><a id="Item1a" name="Item1a"><!--Anchor--></a>Item 1A. Risk Factors.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">The following risk factors, among others, could affect our actual results of operations and could cause our actual results to differ materially from those expressed in forward-looking statements made by us. These forward-looking statements are based on current expectations and except as required by law we assume no obligation to update this information. You should carefully consider the risks described below and elsewhere in this Annual Report before making an investment decision. Our business, financial condition or results of operations could be materially adversely affected by any of these risks. Our common stock is considered speculative and the trading price of our common stock could decline due to any of these risks, and you may lose all or part of your investment. The following risk factors are not the only risk factors facing our Company. Additional risks and uncertainties not presently known to us or that we currently deem immaterial may also affect our business.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; FONT-STYLE: italic; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Our independent registered public accounting firm&#8217;s report states that there is a substantial doubt that we will be able to continue as a going concern.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">We anticipate that our principal sources of liquidity will only be sufficient to fund our activities into the first quarter of the Company's fiscal year 2019. </font>As of June 30, 2017, we had cash and cash equivalents, short-term bank deposits and marketable securities of $26.1 million. <font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">We need to raise additional funds by the first quarter of the Company's fiscal year 2019 in order to continue to fund our operations, and we cannot provide any assurance that we will be successful in doing so.&#160; </font>Our independent registered public accounting firm, Kost Forer, Gabbay &amp; Kassierer, a Member of Ernst &amp; Young Global, has included an explanatory paragraph in their opinion that accompanies our audited consolidated financial statements as of and for the year ended June 30, 2017, indicating that our current liquidity position raises substantial doubt about our ability to continue as a going concern.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; FONT-STYLE: italic; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">We may need to raise additional financing to support the research, development and manufacturing of our cell therapy products and our products in the future but we cannot be sure we will be able to obtain additional financing on terms favorable to us when needed.&#160; If we are unable to obtain additional financing to meet our needs, our operations may be adversely affected or terminated.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">It is highly likely that we will need to raise significant additional capital in the future.&#160; Although we were successful in raising capital in the past, our current financial resources are limited and may not be sufficient to finance our operations until we become profitable, if that ever happens.&#160; It is likely that we will need to raise additional funds in the near future in order to satisfy our working capital and capital expenditure requirements.&#160; Therefore, we are dependent on our ability to sell our common stock for funds, receive grants or to otherwise raise capital. There can be no assurance that we will be able to obtain financing. Any sale of our common stock in the future will result in dilution to existing stockholders and could adversely affect the market price of our common stock. Also, we may not be able to borrow or raise additional capital in the future to meet our needs or to otherwise provide the capital necessary to conduct the development and commercialization of our potential cell therapy products, which could result in the loss of some or all of one's investment in our common stock.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-STYLE: italic">Our likelihood of profitability depends on our ability to license and/or develop and commercialize products based on our cell production technology, which is currently in the development stage. If we are unable to complete the development and commercialization of our cell therapy products successfully, our likelihood of profitability will be limited severely</font>.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">We are engaged in the business of developing cell therapy products. We have not realized a profit from our operations to date and there is little likelihood that we will realize any profits in the short or medium term. Any profitability in the future from our business will be dependent upon successful commercialization of our potential cell therapy products and/or licensing of our products, which will require significant additional research and development as well as substantial clinical trials.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal">17</font></div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; WIDTH: 100%; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; FONT-STYLE: italic; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">If we are not able to successfully license and/or develop and commercialize our cell therapy product candidates and obtain the necessary regulatory approvals, we may not generate sufficient revenues to continue our business operations.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">So far, the products we are developing have completed only one Phase I/II clinical trial of Gluteal Musculature rehabilitation after total hip arthroplasty (efficacy, ongoing for safety) and two Phase I clinical trials for CLI.&#160; We completed the enrollment in the Phase II clinical trial in IC. Data readout are expected in the first half of 2018. Our early stage cell therapy product candidates may fail to perform as we expect. Moreover, even if our cell therapy product candidates successfully perform as expected, in later stages of development they may fail to show the desired safety and efficacy traits despite having progressed successfully through pre-clinical or initial clinical testing.&#160; We will need to devote significant additional research and development, financial resources and personnel to develop commercially viable products and obtain the necessary regulatory approvals.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">If our cell therapy product candidates do not prove to be safe and effective in clinical trials, we will not obtain the required regulatory approvals. If we fail to obtain such approvals, we may not generate sufficient revenues to continue our business operations.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">Even if we obtain regulatory approval of a product, that approval may be subject to limitations on the indicated uses for which it may be marketed. Even after granting regulatory approval, the FDA, the EMA, the PMDA and regulatory agencies in other countries continue to regulate marketed products, manufacturers and manufacturing facilities, which may create additional regulatory barriers and burdens. Later discovery of previously unknown problems with a product, manufacturer or facility, may result in restrictions on the product or manufacturer, including a withdrawal of the product from the market. Further, regulatory agencies may establish additional regulations that could prevent or delay regulatory approval of our products.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; FONT-STYLE: italic; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">We cannot market and sell our cell therapy product candidates in the United States, Europe, Japan, or in other countries if we fail to obtain the necessary regulatory approvals or licensure.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">We cannot sell our cell therapy product candidates until regulatory agencies grant marketing approval, or licensure. The process of obtaining regulatory approval is lengthy, expensive and uncertain. It is likely to take at least several years to obtain the required regulatory approvals for our cell therapy product candidates, or we may never gain the necessary approvals. Any difficulties that we encounter in obtaining regulatory approval may have a substantial adverse impact on our operations and cause our stock price to decline significantly.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">To obtain marketing approvals in the United States and Europe for cell therapy product candidates we must, among other requirements, complete carefully controlled and well-designed clinical trials sufficient to demonstrate to the FDA, the EMA and the PMDA that the cell therapy product candidates is safe and effective for each disease for which we seek approval.&#160; So far, we have successfully conducted Phase I/II and Phase I clinical trials for our PLX-PAD product. Several factors could prevent completion or cause significant delay of these trials, including an inability to enroll the required number of patients or failure to demonstrate adequately that cell therapy product candidates are safe and effective for use in humans. Negative or inconclusive results from or adverse medical events during a clinical trial could cause the clinical trial to be repeated or a program to be terminated, even if other studies or trials relating to the program are successful. The FDA, the EMA or the PMDA can place a clinical trial on hold if, among other reasons, it finds that patients enrolled in the trial are or would be exposed to an unreasonable and significant risk of illness or injury. If safety concerns develop, we, the FDA, the EMA or the PMDA could stop our trials before completion.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal">18</font></div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; WIDTH: 100%; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; FONT-STYLE: italic; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">If we are not able to conduct our clinical trials properly and on schedule, marketing approval by FDA, EMA, PMDA and other regulatory authorities may be delayed or denied.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">The completion of our clinical trials may be delayed or terminated for many reasons, such as:</div>
</div>

<div>
<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<table id="z40cb4d0ecf914b74908ca953db29aaea" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 36pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; WIDTH: 18pt; align: right">&#8226;</td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">The FDA, the EMA or the PMDA does not grant permission to proceed or places additional trials on clinical hold;</div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<table id="zcfd28507a89441f58fe90d26bba9278b" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 36pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; WIDTH: 18pt; align: right">&#8226;</td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">Subjects do not enroll in our trials at the rate we expect;</div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<table id="z5d67a6fa4141409f93fb1e62deba6315" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 36pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; WIDTH: 18pt; align: right">&#8226;</td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">The regulators may ask to increase subject&#8217;s population in the clinical trials;</div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<table id="zc1387327b4ec4843885cd863d64da420" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 36pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; WIDTH: 18pt; align: right">&#8226;</td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">Subjects experience an unacceptable rate or severity of adverse side effects;</div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<table id="z776c8bf2bb5e423180478fc5ef423114" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 36pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; WIDTH: 18pt; align: right">&#8226;</td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">Third-party clinical investigators do not perform our clinical trials on our anticipated schedule or consistent with the clinical trial protocol, GCP and regulatory requirements, or other third parties do not perform data collection and analysis in a timely or accurate manner;</div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<table id="z4e2627b3cdfc4f7a932ecf652c87bb6f" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 36pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; WIDTH: 18pt; align: right">&#8226;</td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">Inspections of clinical trial sites by the FDA, EMA, PMDA or MFDS and other regulatory authorities find regulatory violations that require us to undertake corrective action, suspend or terminate one or more sites, or prohibit us from using some or all of the data in support of our marketing applications; or</div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<table id="z00e74d541a5048439f70d656fbbcece7" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 36pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; WIDTH: 18pt; align: right">&#8226;</td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">One or more IRBs suspends or terminates the trial at an investigational site, precludes enrollment of additional subjects, or withdraws its approval of the trial.</div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">Our development costs will increase if we have material delays in our clinical trials, or if we are required to modify, suspend, terminate or repeat a clinical trial. If we are unable to conduct our clinical trials properly and on schedule, marketing approval may be delayed or denied by the FDA, EMA, PMDA and other regulatory authorities.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; FONT-STYLE: italic; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">If our processing and storage facility or our clinical manufacturing facilities are damaged or destroyed, our business and prospects would be adversely affected.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">If our processing and storage facility,<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-STYLE: italic">&#160;</font>our clinical manufacturing facilities or the equipment in such facilities were to be damaged or destroyed, the loss of some or all of the stored units of our cell therapy drug candidates would force us to delay or halt our clinical trial processes. &#160;We have one clinical manufacturing facilities located in Haifa, Israel. If these facilities or the equipment in them are significantly damaged or destroyed, we may not be able to quickly or inexpensively replace our manufacturing capacity.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; FONT-STYLE: italic; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">If we encounter problems or delays in the research and development of our potential cell therapy products, we may not be able to raise sufficient capital to finance our operations during the period required to resolve such problems or delays.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">Our cell therapy products are currently in the development stage and we anticipate that we will continue to incur substantial operating expenses and incur net losses until we have successfully completed all necessary research and clinical trials.&#160; We, and any of our potential collaborators, may encounter problems and delays relating to research and development, regulatory approval and intellectual property rights of our technology.&#160; Our research and development programs may not be successful, and our cell culture technology may not facilitate the production of cells outside the human body with the expected result.&#160; Our cell therapy products may not prove to be safe and efficacious in clinical trials.&#160; If any of these events occur, we may not have adequate resources to continue operations for the period required to resolve the issue delaying commercialization and we may not be able to raise capital to finance our continued operation during the period required for resolution of that issue.&#160; Accordingly, we may be forced to discontinue or suspend our operations.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal">19</font></div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; WIDTH: 100%; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; FONT-STYLE: italic; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">We may not be able to secure and maintain research institutions to conduct our clinical trials.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">We rely on research institutions to conduct our clinical trials. Specifically, the limited number of centers experienced with cell therapy product candidates heightens our dependence on such research institutions. Our reliance upon research institutions, including hospitals and clinics, provides us with less control over the timing and cost of clinical trials and the ability to recruit subjects. If we are unable to reach agreements with suitable research institutions on acceptable terms, or if any resulting agreement is terminated, we may be unable to quickly replace the research institution with another qualified institution on acceptable terms. We may not be able to secure and maintain suitable research institutions to conduct our clinical trials.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; FONT-STYLE: italic">Our product development programs are based on novel technologies and are inherently risky.</font></div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">We are subject to the risks of failure inherent in the development of products based on new technologies. The novel nature of our therapeutics creates significant challenges in regards to product development and optimization, manufacturing, government regulation, third-party reimbursement and market acceptance. For example, the FDA, the EMA, the PMDA and other countries&#8217; regulatory authorities have relatively limited experience with cell therapies. Very few cell therapy products have been approved by regulatory authorities to date for commercial sale, and the pathway to regulatory approval for our cell therapy product candidates may accordingly be more complex and lengthy. As a result, the development and commercialization pathway for our therapies may be subject to increased uncertainty, as compared to the pathway for new conventional drugs.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; FONT-STYLE: italic; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">There are very few drugs and limited therapies that the FDA or EMA and other regulatory authorities&#160; have approved as treatments for some of the disease indications we are pursuing. This could complicate and delay FDA, EMA or other countries&#8217; regulatory authorities approval of our biologic drug candidates.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">There are very few drugs and limited therapies currently approved for treatment of CLI, IC, ARS or HCT.&#160; As a result, the clinical efficacy endpoints, or the criteria to measure the intended results of treatment may be difficult to determine. Despite our eligibility for certain accelerated pathways, this could increase the difficulty of our obtaining FDA, EMA or other countries&#8217; regulatory authorities approval to market our products.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; FONT-STYLE: italic; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Our cell therapy drug candidates represent new classes of therapy that the marketplace may not understand or accept.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">Even if we successfully develop and obtain regulatory approval for our cell therapy candidates, the market may not understand or accept them. We are developing cell therapy product candidates that represent novel treatments and will compete with a number of more conventional products and therapies manufactured and marketed by others, including major pharmaceutical companies. The degree of market acceptance of any of our developed and potential products will depend on a number of factors, including:</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<table id="zee1d176fe5db4285a1f4d1adc083b7f4" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 36pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: top; WIDTH: 18pt; align: right">&#9679;</td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">the clinical safety and effectiveness of our cell therapy drug candidates and their perceived advantage over alternative treatment methods, if any;</div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<table id="z6886d899eda24b0a901c9ed80261731e" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 36pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: top; WIDTH: 18pt; align: right">&#9679;</td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">adverse events involving our cell therapy product candidates or the products or product candidates of others that are cell-based; and</div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<table id="z6c81ed47845243a2b59f99260eed06e4" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 36pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: top; WIDTH: 18pt; align: right">&#9679;</td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">the cost of our products and the reimbursement policies of government and private third-party payers.</div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">If the health care community does not accept our potential products for any of the foregoing reasons, or for any other reason, it could affect our sales, having a material adverse effect on our business, financial condition and results of operations.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal">20</font></div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; WIDTH: 100%; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; FONT-STYLE: italic; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">The clinical manufacturing process for cell therapy products is complex and requires meeting high regulatory standards; we have limited manufacturing experience and know-how.&#160; Any delay or problem in the clinical manufacturing of PLX may result in a material adverse effect on our business.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">Our manufacturing process, controls, equipment and quality system for PLX-PAD have received approval from the FDA, EMA, Germany&#8217;s PEI, the Korean MFDS and the PMDA. However, the clinical manufacturing process is complex and we have no experience in manufacturing our product candidates at a commercial level. There can be no guarantee that we will be able to successfully develop and manufacture our product candidates in a manner that is cost-effective or commercially viable, or that our development and manufacturing capabilities might not take much longer than currently anticipated to be ready for the market.&#160; In addition, if we fail to maintain regulatory approvals for our manufacturing facilities, we may suffer delays in our ability to manufacture our product candidates.&#160; This may result in a material adverse effect on our business.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; FONT-STYLE: italic; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Because we received grants from the IIA we are subject to on-going restrictions.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">We have received royalty-bearing grants from the IIA, for research and development programs that meet specified criteria. The terms of the IIA&#8217;s grants limit our ability to transfer know-how developed under an approved research and development program outside of Israel, regardless of whether the royalties are fully paid. Any non-Israeli citizen, resident or entity that, among other things, becomes a holder of 5% or more of our share capital or voting rights, is entitled to appoint one or more of our directors or our Chief Executive Officer, or CEO, serves as a director of our Company or as our CEO is generally required to notify the same to the IIA and to undertake to observe the law governing the grant programs of the IIA, the principal restrictions of which are the transferability limits described above. For more information, see &#8220;Item 7. Management's Discussion and Analysis of Financial Condition and Results of Operations - Liquidity and Capital Resources&#8221;.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; FONT-STYLE: italic; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">We have limited operating history, which raises doubts with respect to our ability to generate revenues in the future.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">We have a limited operating history in our business of developing and commercializing cell production technology.&#160; Until we entered into the United Agreement, which was terminated in December 2015, we did not generate any revenues.&#160; It is not clear when we will generate additional revenues or whether we will experience further delays in recognizing revenues such as resulted from a clinical hold.&#160; Our primary source of funds has been the sale of our common stock and government grants.&#160; We cannot give assurances that we will be able to generate any significant revenues or income in the future.&#160; There is no assurance that we will ever be profitable.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; FONT-STYLE: italic; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">If we do not keep pace with our competitors and with technological and market changes, our technology and products may become obsolete and our business may suffer.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">The cellular therapeutics industry, of which we are a part, is very competitive and is subject to technological changes that can be rapid and intense. We have faced, and will continue to face, intense competition from biotechnology, pharmaceutical and biopharmaceutical companies, academic and research institutions and governmental agencies engaged in cellular therapeutic and drug discovery activities or funding, both in the United States and internationally. Some of these competitors are pursuing the development of cellular therapeutics, drugs and other therapies that target the same diseases and conditions that we target in our clinical and pre-clinical programs.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">Many of our competitors have greater resources, more product candidates and have developed product candidates and processes that directly compete with our products.&#160; Our competitors may have developed, or could develop in the future, new products that compete with our products or even render our products obsolete.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal">21</font></div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; WIDTH: 100%; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; FONT-STYLE: italic; TEXT-ALIGN: left; LINE-HEIGHT: 1.25"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><br>
</font> We depend to a significant extent on certain key personnel, the loss of any of whom may materially and adversely affect our Company.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">Our success depends to a significant extent on the continued services of certain highly qualified scientific and management personnel, in particular, Zami Aberman, our Co-CEO and Chairman, and Yaky Yanay, our Co-CEO and President.&#160; We face competition for qualified personnel from numerous industry sources, and there can be no assurance that we will be able to attract and retain qualified personnel on acceptable terms.&#160; The loss of service of any of our key personnel could have a material adverse effect on our operations or financial condition.&#160; In the event of the loss of services of such personnel, no assurance can be given that we will be able to obtain the services of adequate replacement personnel.&#160; We do not maintain key person insurance on the lives of any of our officers or employees.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; FONT-STYLE: italic; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">The market for our products will be heavily dependent on third party reimbursement policies.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">Our ability to successfully commercialize our product candidates will depend on the extent to which government healthcare programs, as well as private health insurers, health maintenance organizations and other third party payers will pay for our products and related treatments.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">Reimbursement by third party payers depends on a number of factors, including the payer&#8217;s determination that use of the product is safe and effective, not experimental or investigational, medically necessary, appropriate for the specific patient and cost-effective.&#160;&#160;Reimbursement in the United States or foreign countries may not be available or maintained for any of our product candidates. &#160;If we do not obtain approvals for adequate third party reimbursements, we may not be able to establish or maintain price levels sufficient to realize an appropriate return on our investment in product development. &#160;Any limits on reimbursement from third party payers may reduce the demand for, or negatively affect the price of, our products. &#160;The lack of reimbursement for these procedures by insurance payers has negatively affected the market for our products in this indication in the past.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">Managing and reducing health care costs has been a general concern of federal and state governments in the United States and of foreign governments. &#160;In addition, third party payers are increasingly challenging the price and cost-effectiveness of medical products and services, and many limit reimbursement for newly approved health care products. &#160;In particular, third party payers may limit the indications for which they will reimburse patients who use any products that we may develop. &#160;Cost control initiatives could decrease the price for products that we may develop, which would result in lower product revenues to us.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; FONT-STYLE: italic; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Our success depends in large part on our ability to develop and protect our technology and our cell therapy products.&#160; If our patents and proprietary rights agreements do not provide sufficient protection for our technology and our cell therapy products, our business and competitive position will suffer.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">Our success will also depend in part on our ability to develop our technology and commercialize cell therapy products without infringing the proprietary rights of others.&#160; We have not conducted full freedom of use patent searches and no assurance can be given that patents do not exist or could not be filed which would have an adverse effect on our ability to develop our technology or maintain our competitive position with respect to our potential cell therapy products.&#160; If our technology components, devices, designs, products, processes or other subject matter are claimed under other existing United States or foreign patents or are otherwise protected by third party proprietary rights, we may be subject to infringement actions.&#160; In such event, we may challenge the validity of such patents or other proprietary rights or we may be required to obtain licenses from such companies in order to develop, manufacture or market our technology or products.&#160; There can be no assurances that we would be able to obtain such licenses or that such licenses, if available, could be obtained on commercially reasonable terms.&#160; Furthermore, the failure to either develop a commercially viable alternative or obtain such licenses could result in delays in marketing our proposed products or the inability to proceed with the development, manufacture or sale of products requiring such licenses, which could have a material adverse effect on our business, financial condition and results of operations.&#160; If we are required to defend ourselves against charges of patent infringement or to protect our proprietary rights against third parties, substantial costs will be incurred regardless of whether we are successful.&#160; Such proceedings are typically protracted with no certainty of success.&#160; An adverse outcome could subject us to significant liabilities to third parties and force us to curtail or cease our development of our technology and the commercialization our potential cell therapy products.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal">22</font></div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; WIDTH: 100%; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">We have built the ability to manufacture clinical grade ASCs in-house. Through our experience with ASC-based product development, we have developed expertise and know-how in this field. To protect these expertise and know-how, our policies require confidentiality agreements with our employees, consultants, contractors, manufacturers and advisors. These agreements generally provide for protection of confidential information, restrictions on the use of materials and assignment of inventions conceived during the course of performance for us. These agreements might not effectively prevent disclosure of our confidential information.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; FONT-STYLE: italic; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">The price of our common stock may fluctuate significantly.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">The market for our shares of common stock may fluctuate significantly. A number of events and factors may have an adverse impact on the market price of our common stock, such as:</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<table id="z269e86266d4a4da5a8b0a801eb2eb943" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 18pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; WIDTH: 18pt; align: right">&#8226;</td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">results of our clinical trials or adverse events associated with our products;</div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<table id="zd59b85a97fd447c88acc33ed0f9e55a0" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 18pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; WIDTH: 18pt; align: right">&#8226;</td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">the amount of our cash resources and our ability to obtain additional funding;</div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<table id="z04b28e1e6e5c4917a7b0f4a596d1c905" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 18pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; WIDTH: 18pt; align: right">&#8226;</td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">changes in our revenues, expense levels or operating results;</div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<table id="zdd157a5518884c0791e7769c28046df1" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 18pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; WIDTH: 18pt; align: right">&#8226;</td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">entering into or terminating strategic relationships;</div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<table id="z714ac936aa2f44509dcd0a49cd39e980" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 18pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; WIDTH: 18pt; align: right">&#8226;</td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">announcements of technical or product developments by us or our competitors;</div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<table id="zdf774d44d28345588c0265615e4c943f" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 18pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; WIDTH: 18pt; align: right">&#8226;</td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">market conditions for pharmaceutical and biotechnology stocks in particular;</div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<table id="z73332b2cef964bcd9080a3e7abfa8ef1" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 18pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; WIDTH: 18pt; align: right">&#8226;</td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">changes in laws and governmental regulations, including changes in tax, healthcare, competition and patent laws;</div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<table id="z42300154ee1344059d501925b0d30e30" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 18pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; WIDTH: 18pt; align: right">&#8226;</td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">disputes concerning patents or proprietary rights;</div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<table id="z5149bc2549924f9092f06d9e3c2e1b67" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 18pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; WIDTH: 18pt; align: right">&#8226;</td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">new accounting pronouncements or regulatory rulings;</div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<table id="zbe9050fb119d44188cb01399b871cc17" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 18pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; WIDTH: 18pt; align: right">&#8226;</td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">public announcements regarding medical advances in the treatment of the disease states that we are targeting;</div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<table id="z2479012fef24491493fbfb9671b63ae4" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 18pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; WIDTH: 18pt; align: right">&#8226;</td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">patent or proprietary rights developments;</div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<table id="zdca4d05972c24af287c8864ea0b7bd68" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 18pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; WIDTH: 18pt; align: right">&#8226;</td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">regulatory actions that may impact our products;</div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<table id="z5d9a0de51acd4fd2a033f16fe4ffd1c9" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 18pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; WIDTH: 18pt; align: right">&#8226;</td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">disruptions in our manufacturing processes; and</div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<table id="z87dc2cdd12094da9bc6aba1364b7fa04" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 18pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; WIDTH: 18pt; align: right">&#8226;</td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">competition.</div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">In addition, a market downturn in general and/or in the biopharmaceutical sector in particular, may adversely affect the market price of our securities, which may not necessarily reflect the actual or perceived value of our Company.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; FONT-STYLE: italic; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Future sales of our shares may cause the prevailing market price of our shares to decrease.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">Future sales of our common stock, or the perception that such sales may occur, could cause immediate dilution and adversely affect the market price of our common stock.</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal">23</font></div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; WIDTH: 100%; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; FONT-STYLE: italic; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">We are exposed to fluctuations in currency exchange rates.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">A significant portion of our business is conducted outside the United States. Therefore, we are exposed to currency exchange fluctuations in other currencies such as the New Israeli Shekel, or NIS, and the Euro, because a portion of our expenses in Israel and Europe are paid in NIS and Euros, respectively, which subjects us to the risks of foreign currency fluctuations. Our primary expenses paid in NIS are employee salaries, fees for consultants and subcontractors and lease payments on our Israeli facilities. During 2017, we entered into forward contracts and other derivative instruments to hedge against some of the risk of changes in future cash flows from payments of payroll and related expenses and costs of operations denominated in NIS.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; FONT-STYLE: italic; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">The dollar cost of our operations in Israel will increase to the extent increases in the rate of inflation in Israel are not offset by a devaluation of the NIS in relation to the dollar, which would harm our results of operations.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">Since a considerable portion of our expenses such as employees' salaries are linked to an extent to the rate of inflation in Israel, the dollar cost of our operations is influenced by the extent to which any increase in the rate of inflation in Israel is or is not offset by the devaluation of the NIS in relation to the dollar. As a result, we are exposed to the risk that the NIS, after adjustment for inflation in Israel, will appreciate in relation to the dollar. In that event, the dollar cost of our operations in Israel will increase and our dollar-measured results of operations will be adversely affected. We cannot predict whether the NIS will appreciate against the dollar or vice versa in the future. Any increase in the rate of inflation in Israel, unless the increase is offset on a timely basis by a devaluation of the NIS in relation to the dollar, will increase labor and other costs, which will increase the dollar cost of our operations in Israel and harm our results of operations.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; FONT-STYLE: italic; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Potential product liability claims could adversely affect our future earnings and financial condition.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">We face an inherent business risk of exposure to product liability claims in the event that the use of our products results in adverse effects.&#160; We may not be able to maintain adequate levels of insurance for these liabilities at reasonable cost and/or reasonable terms.&#160; Excessive insurance costs or uninsured claims would add to our future operating expenses and adversely affect our financial condition.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; FONT-STYLE: italic; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Our principal research and development and manufacturing facilities are located in Israel and the unstable military and political conditions of Israel may cause interruption or suspension of our business operations without warning.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">Our principal research and development and manufacturing facilities are located in Israel.&#160; As a result, we are directly influenced by the political, economic and military conditions affecting Israel.&#160; Since the establishment of the State of Israel in 1948, a number of armed conflicts have taken place between Israel and its Arab neighbors. During July and August 2014 and November 2012, Israel was engaged in an armed conflict with a militia group and political party which controls the Gaza Strip, and during the summer of 2006, Israel was engaged in an armed conflict with Hezbollah, a Lebanese Islamist Shiite militia group and political party. These conflicts involved missile strikes against civilian targets in various parts of Israel, including areas in which our employees and some of our consultants are located, and negatively affected business conditions in Israel.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">In addition, Israeli-based companies and companies doing business with Israel, have been the subject of an economic boycott by members of the Arab League and certain other predominantly Muslim countries since Israel's establishment.&#160; Although Israel has entered into various agreements with certain Arab countries and the Palestinian Authority, and various declarations have been signed in connection with efforts to resolve some of the economic and political problems in the Middle East, we cannot predict whether or in what manner these problems will be resolved. Wars and acts of terrorism have resulted in significant damage to the Israeli economy, including reducing the level of foreign and local investment.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal">24</font></div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; WIDTH: 100%; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">Furthermore, certain of our officers and employees may be obligated to perform annual reserve duty in the Israel Defense Forces and are subject to being called up for active military duty at any time.&#160; All Israeli male citizens who have served in the army are subject to an obligation to perform reserve duty until they are between 40 and 49 years old, depending upon the nature of their military service.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; FONT-STYLE: italic; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">The trend towards consolidation in the pharmaceutical and biotechnology industries may adversely affect us.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">There is a trend towards consolidation in the pharmaceutical and biotechnology industries. This consolidation trend may result in the remaining companies having greater financial resources and technical discovery capabilities, thus intensifying competition in these industries. This trend may also result in fewer potential collaborators or licensees for our therapeutic product candidates. Also, if a consolidating company is already doing business with our competitors, we may lose existing licensees or collaborators as a result of such consolidation.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">This trend may adversely affect our ability to enter into license agreements or agreements for the development and commercialization of our product candidates, and as a result may materially harm our business.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; FONT-STYLE: italic; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Our cash may be subject to a risk of loss and we may be exposed to fluctuations in the market values of our portfolio investments and in interest rates.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">Our assets include a significant component of cash and cash equivalents, bank deposits and marketable securities.&#160;&#160;We adhere to an investment policy set by our investment committee which aims to preserve our financial assets, maintain adequate liquidity and maximize returns.&#160; We believe that our cash is held in institutions whose credit risk is minimal and that the value and liquidity of our deposits are accurately reflected in our consolidated financial statements as of June 30, 2017.&#160; Currently, we hold part of our current assets in bank deposits and part is invested in government bonds and a combination of corporate bonds and relatively low risk stocks.&#160; However, nearly all of our cash and bank deposits are not insured by the Federal Deposit Insurance Corporation, or the FDIC,&#160;or similar governmental deposit insurance outside the United States.&#160;&#160;Therefore, our cash and any bank deposits that we now hold or may acquire in the future may be subject to risks, including the risk of loss or of reduced value or liquidity, particularly in light of the increased volatility and worldwide pressures in the financial and banking sectors. In the future, should we determine that there is a decline in value of any of our marketable securities which is not temporary in nature, this would result in a loss being recognized in our consolidated statements of operations.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; FONT-STYLE: italic; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Our marketable securities include our investment in CHA shares as part of the license agreement signed with CHA in June 2013; we may be exposed to fluctuations in the market values of the shares, as well as to fluctuations in the KRW exchange rate to U.S. dollar.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">As part of the CHA Agreement, in June 2013 the parties invested in each other&#8217;s equity. As of June 30, 2017, we held 400,368 CHA shares valued at $4.4 million. The shares are listed on the KOSDAQ and the shares' price is denominated in KRW. We are exposed to changes in the market price of CHA shares, as well as to exchange rates fluctuations in the KRW currency compared to the U.S. dollar.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal">25</font></div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; WIDTH: 100%; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; FONT-STYLE: italic; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Although our internal control over financial reporting was considered effective as of June 30, 2017, there is no assurance that our internal control over financial reporting will continue to be effective in the future, which could result in our financial statements being unreliable, government investigations or loss of investor confidence in our financial reports.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">Pursuant to Section 404 of the Sarbanes-Oxley Act of 2002, we are required to furnish an annual report by our management assessing the effectiveness of our internal control over financial reporting. This assessment must include disclosure of any material weaknesses in our internal control over financial reporting identified by management. In addition, our independent registered public accounting firm must annually provide an opinion on the effectiveness of our internal control over financial reporting.&#160; Management's report as of the end of fiscal 2017 concluded that our internal control over financial reporting was effective.&#160; In addition, our registered independent public accounting firm provided an opinion that our internal control over financial reporting was effective as of the end of fiscal 2017.&#160; There is, however, no assurance that we will be able to maintain such effective internal control over financial reporting in the future. Ineffective internal control over financial reporting can result in errors or other problems in our financial statements. In the future, if we or our registered independent public accounting firm are unable to assert that our internal controls are effective, our investors could lose confidence in the accuracy and completeness of our financial reports, which in turn could cause our stock price to decline. Failure to maintain effective internal control over financial reporting could also result in investigation or sanctions by regulatory authorities.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; FONT-STYLE: italic; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Because substantially all of our officers and directors are located in non-U.S. jurisdictions, you may have no effective recourse against the management for misconduct and may not be able to enforce judgment and civil liabilities against our officers, directors, experts and agents.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">Substantially all of our directors and officers are nationals and/or residents of countries other than the United States, and all or a substantial portion of their assets are located outside the United States.&#160; As a result, it may be difficult to enforce within the United States any judgments obtained against our officers or directors, including judgments predicated upon the civil liability provisions of the securities laws of the United States or any U.S. state.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; FONT-STYLE: italic; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Because we do not intend to pay any dividends on our common stock, investors seeking dividend income should not purchase shares of our common stock.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">We have not declared or paid any dividends on our common stock since our inception, and we do not anticipate paying any such dividends for the foreseeable future.&#160; Investors seeking dividend income should not invest in our common stock.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; FONT-STYLE: italic; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">We are dependent upon third-party suppliers for raw materials needed to manufacture PLX; if any of these third parties fails or is unable to perform in a timely manner, our ability to manufacture and deliver will be compromised.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">In addition to the placenta used in the clinical manufacturing process of PLX we require certain raw materials. These items must be manufactured and supplied to us in sufficient quantities and in compliance with current GMP. To meet these requirements, we have entered into supply agreements with firms that manufacture these raw materials to current GMP standards. Our requirements for these items are expected to increase if and when we transition to the manufacture of commercial quantities of our cell-based drug candidates.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">In addition, as we proceed with our clinical trial efforts, we must be able to continuously demonstrate to the FDA, EMA and other regulatory authorities that we can manufacture our cell therapy product candidates with consistent characteristics. Accordingly, we are materially dependent on these suppliers for supply of current GMP-grade materials of consistent quality. Our ability to complete ongoing clinical trials may be negatively affected in the event that we are forced to seek and validate a replacement source for any of these critical materials.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; FONT-STYLE: italic; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">We may not be able to take advantage of the new regulatory pathways in Europe and Japan to shorten our time to market our products.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">Recent regulatory pathways in Europe and Japan may allow for early commercialization of our products and reducing the time to market our products. The purpose of Europe&#8217;s Adaptive Pathways is to shorten the time it takes for innovative medicines to reach patients with serious conditions that lack adequate treatment options. After a therapy is selected for the program, the Adaptive Pathways group conducts high level discussions and provides guidance to the applicant regarding the formal regulatory processes that precede a trial targeting early approval and further expansion of the indications. In Japan, a new law regarding regenerative therapies, including cell therapies, came into effect. The new law allows for conditional, time-limited approval of products for marketing after limited proof of efficacy. &#160;</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal">26</font></div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; WIDTH: 100%; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">In May 2015, the EMA selected our PLX cell program in CLI for its Adaptive Pathway project. In addition, the PMDA approved the proposed quality and large-scale manufacturing methods for PLX-PAD and has cleared our PLX-PAD cells for use in clinical trials in Japan. However, since these new regulatory pathways are relatively new, we may not be able to meet the regulatory requirements and as a result would not benefit from early access to the market.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; FONT-STYLE: italic; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Favorable results from compassionate use treatment or initial interim results from a clinical trial do not ensure that later clinical trials will be successful and success in early stage clinical trials does not ensure success in later-stage clinical trials.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">PLX cells have been administered as part of compassionate use treatments, which permit the administration of the PLX cells outside of clinical trials.&#160; No assurance can be given that any positive results are attributable to the PLX cells, or that administration of PLX cells to other patients will have positive results. Compassionate use is a term that is used to refer to the use of an investigational drug outside of a clinical trial to treat a patient with a serious or immediately life-threatening disease or condition who has no comparable or satisfactory alternative treatment options. Regulators often allow compassionate use on a case-by-case basis for an individual patient or for defined groups of patients with similar treatment needs.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">There is no assurance that we will obtain regulatory approval for PLX cells. We will only obtain regulatory approval to commercialize a product candidate if we can demonstrate to the satisfaction of the FDA, the EMA, the PMDA or other applicable regulatory authorities, in well-designed and conducted clinical trials, that the product candidate is safe and effective and that the product candidate, including the cell production methodology, otherwise meets the appropriate standards required for approval. Clinical trials can be lengthy, complex and extremely expensive processes with uncertain results. A failure of one or more clinical trials may occur at any stage of testing.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">Success in early clinical trials does not ensure that later clinical trials will be successful, and initial results from a clinical trial do not necessarily predict final results. While results from treating patients through compassionate use have in certain cases been successful, we cannot be assured that further trials will ultimately be successful. Results of further clinical trials may be disappointing.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">Even if early stage clinical trials are successful, we may need to conduct additional clinical trials for product candidates with patients receiving the drug for longer periods before we are able to seek approvals to market and sell these product candidates from the FDA and regulatory authorities outside the United States. Even if we are able to obtain approval for our product candidates through an accelerated approval review program, we may still be required to conduct clinical trials after such an approval.&#160; If we are not successful in commercializing any of our lead product candidates, or are significantly delayed in doing so, our business will be materially harmed.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; FONT-STYLE: italic; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">We may not successfully maintain our existing exclusive out-licensing agreement with CHA, or establish new collaborative and licensing arrangements, which could adversely affect our ability to develop and commercialize our product candidates.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">One of the elements of our business strategy is to license our technology to other companies. Our business strategy includes establishing collaborations and licensing agreements with one or more pharmaceutical or biotechnology companies. To date, we have a strategic partnership with CHA for both the IC and CLI indications in Korea. CHA will conduct PLX clinical studies in South Korea, and, following approval, a joint venture equally owned by both parties will be established to market PLX products in South Korea. Our PLX cells are also being used in South Korean sites participating to our International IC study through our partnership with CHA. Notwithstanding, we may not be able to further establish or maintain such licensing and collaboration arrangements necessary to develop and commercialize our product candidates. Even if we are able to maintain or establish licensing or collaboration arrangements, these arrangements may not be on favorable terms and may contain provisions that will restrict our ability to develop, test and market our product candidates. Any failure to maintain or establish licensing or collaboration arrangements on favorable terms could adversely affect our business prospects, financial condition or ability to develop and commercialize our product candidates.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal">27</font></div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; WIDTH: 100%; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">Our agreements with our collaborators and licensees may have provisions that give rise to disputes regarding the rights and obligations of the parties. These and other possible disagreements could lead to termination of the agreement or delays in collaborative research, development, supply, or commercialization of certain product candidates, or could require or result in litigation or arbitration. Moreover, disagreements could arise with our collaborators over rights to intellectual property or our rights to share in any of the future revenues of products developed by our collaborators. These kinds of disagreements could result in costly and time-consuming litigation. Any such conflicts with our collaborators could reduce our ability to obtain future collaboration agreements and could have a negative impact on our relationship with existing collaborators.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; FONT-STYLE: italic; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Although we have entered into a term sheet with Sosei Corporate Venture Capital Ltd. there can be no assurance that a definitive agreement will be signed or that such proposed joint venture will be formed.</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">We have signed a binding term sheet with Sosei CVC for the establishment of for the establishment of a new Japanese corporation, or NewCo, for the clinical development and commercialization of our PLX-PAD cell therapy product in Japan. The parties have agreed to extend the deadline to enter into a definitive agreement by December 31, 2017. While the parties have executed a term sheet and we believe such definitive agreements will be finalized in the coming months, there is no guarantee that we will be successful in executing agreements by then. It is possible that the definitive agreements will not be executed, or that they may be executed on terms and conditions that are materially different than those set forth in the term sheet. There can be no assurance that we will execute the definitive agreements or that the proposed joint venture with Sosei CVC will be completed.</div>
</div>

<div>
<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; FONT-STYLE: italic; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Failure in our information technology systems, including by cybersecurity attacks or other data security incidents, could significantly disrupt our operations.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">Our operations depend, in part, on the continued performance of our information technology systems. Our information technology systems are potentially vulnerable to physical or electronic break-ins, computer viruses and similar disruptions. Failure of our information technology systems could adversely affect our business, profitability and financial condition. Although we have information technology security systems, a successful cybersecurity attack or other data security incident could result in the misappropriation and/or loss of confidential or personal information, create system interruptions, or deploy malicious software that attacks our systems. It is possible that a cybersecurity attack might not be noticed for some period of time. The occurrence of a cybersecurity attack or incident could result in business interruptions from the disruption of our information technology systems, or negative publicity resulting in reputational damage with our shareholders and other stakeholders and/or increased costs to prevent, respond to or mitigate cybersecurity events. In addition, the unauthorized dissemination of sensitive personal information or proprietary or confidential information could expose us or other third-parties to regulatory fines or penalties, litigation and potential liability, or otherwise harm our business.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; FONT-STYLE: italic; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">We have limited experience in conducting Phase III trials. If we fail in the conduct of such trials, our business will be materially harmed.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">Even though we conducted Phase I and Phase II trials and we are currently conducting Phase III for our PLX-PAD product, and Phase I for our PLX-R18 product, and have recruited employees who are experienced in managing and conducting clinical trials, we have limited experience in this area.&#160; We will need to expand our experience and rely on consultants in order to obtain regulatory approvals for our therapeutic product candidates.&#160; The failure to successfully conduct clinical trials could materially harm our business.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal">28</font></div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; WIDTH: 100%; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; FONT-STYLE: italic; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Existing government programs and tax benefits may be terminated.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">We have received certain Israeli government approvals under certain programs and may in the future utilize certain tax benefits in Israel by virtue of these programs. To remain eligible for such tax benefits, we must continue to meet certain conditions. If we fail to comply with these conditions in the future, the benefits we receive could be canceled and have to pay additional taxes. We cannot guarantee that these programs and tax benefits will be continued in the future, at their current levels or at all. If these programs and tax benefits are ended, our business, financial condition and results of operations could be materially adversely affected.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; FONT-STYLE: italic; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">If we fail to obtain or maintain orphan drug exclusivity for our products, our competitors may sell products to treat the same conditions and our revenue will be reduced.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">Our business strategy focuses on the development of drugs that are eligible for FDA and European Union orphan drug designation. Under the Orphan Drug Act, the FDA may designate a product as an orphan drug if it is intended to treat a rare disease or condition, defined as a patient population of fewer than 200,000 in the United States, or a patient population greater than 200,000 in the United States where there is no reasonable expectation that the cost of developing the drug will be recovered from sales in the United States. In the European Union, the EMA&#8217;s Committee for Orphan Medicinal Products, or COMP, grants orphan drug designation to promote the development of products that are intended for the diagnosis, prevention, or treatment of a life-threatening or chronically debilitating condition affecting not more than five in 10,000 persons in the European Union Community. Additionally, designation is granted for products intended for the diagnosis, prevention, or treatment of a life threatening, seriously debilitating or serious and chronic condition and when, without incentives, it is unlikely that sales of the drug in the European Union would be sufficient to justify the necessary investment in developing the drug or biological product.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">In the United States, orphan drug designation entitles a party to financial incentives such as opportunities for grant funding towards clinical trial costs, tax advantages, and user-fee waivers. In addition, if a product receives the first FDA approval for the indication for which it has orphan designation, the product is entitled to orphan drug exclusivity, which means the FDA may not approve any other application to market the same drug for the same indication for a period of seven years, except in limited circumstances, such as a showing of clinical superiority over the product with orphan exclusivity or where the manufacturer is unable to assure sufficient product quantity. In the European Union, orphan drug designation also entitles a party to financial incentives such as reduction of fees or fee waivers and ten years of market exclusivity is granted following drug or biological product approval. This period may be reduced to six years if the orphan drug designation criteria are no longer met, including where it is shown that the product is sufficiently profitable not to justify maintenance of market exclusivity.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">Even if we obtain orphan drug exclusivity for a product, that exclusivity may not effectively protect the product from competition because different drugs with different active moieties can be approved for the same condition. Even with orphan drug exclusivity, if a third party were to prepare or market a product which infringes upon our intellectual property, we may need to initiate litigation, which may be costly, to enforce our rights against such party. After an orphan drug is approved, the FDA can subsequently approve the same drug with the same active moiety for the same condition if the FDA concludes that the later drug is safer, more effective, or makes a major contribution to patient care. Orphan drug designation on its own neither shortens the development time or regulatory review time for a drug.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; FONT-STYLE: italic; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">While orphan drug products are typically sold at a high price relative to other medications, the market may not be receptive to high pricing of our products.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">We develop our product candidates to treat rare and ultra-rare diseases, a space where medications are usually sold at high prices compared with other medications. Accordingly, even if regulatory authorities approve our product candidates, the market may not be receptive to, and it may be difficult for us to achieve, a per-patient per-year price high enough to allow us to realize a return on our investment.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal">29</font></div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; WIDTH: 100%; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; FONT-STYLE: italic; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">The patent approval process is complex and we cannot be sure that our pending patent applications or future patent applications will be approved.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">The patent position of biotechnology and pharmaceutical companies generally is highly uncertain, involves complex legal and factual questions and has in recent years been the subject of much litigation. As a result, the issuance, scope, validity, enforceability and commercial value of our and any future licensors' patent rights are highly uncertain.&#160; Our pending and future patent applications may not result in patents being issued which protect our technology or products or which effectively prevent others from commercializing competitive technologies and products. Changes in either the patent laws or interpretation of the patent laws in the United States and other countries may diminish the value of our patents or narrow the scope of our patent protection. The laws of foreign countries may not protect our rights to the same extent as the laws of the United States and we may not be able to obtain meaningful patent protection for any of our commercial products either in or outside the United States.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">No assurance can be given that the scope of any patent protection granted will exclude competitors or provide us with competitive advantages, that any of the patents that have been or may be issued to us will be held valid if subsequently challenged, or that other parties will not claim rights to or ownership of our patents or other proprietary rights that we hold.&#160; Furthermore, there can be no assurance that others have not developed or will not develop similar products, duplicate any of our technology or products or design around any patents that have been or may be issued to us or any future licensors.&#160; Since patent applications in the United States and in Europe are not publicly disclosed until patents are issued, there can be no assurance that others did not first file applications for products covered by our pending patent applications, nor can we be certain that we will not infringe any patents that may be issued to others.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; FONT-STYLE: italic; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Third parties may initiate legal proceedings alleging that we are infringing their intellectual property rights, the outcome of which would be uncertain and could have a material adverse effect on our business.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">Our commercial success depends upon our ability and the ability of our collaborators to develop, manufacture, market and sell our product candidates and use our proprietary technologies without infringing the proprietary rights of third parties. We have yet to conduct comprehensive freedom-to-operate searches to determine whether our proposed business activities or use of certain of the patent rights owned by us would infringe patents issued to third parties. We may become party to, or threatened with, future adversarial proceedings or litigation regarding intellectual property rights with respect to our products and technology, including interference proceedings before the U.S. Patent and Trademark Office. Third parties may assert infringement claims against us based on existing patents or patents that may be granted in the future. If we are found to infringe a third party's intellectual property rights, we could be required to obtain a license from such third party to continue developing and marketing our products and technology. However, we may not be able to obtain any required license on commercially reasonable terms or at all. Even if we were able to obtain a license, it could be non-exclusive, thereby giving our competitors access to the same technologies licensed to us. We could be forced, including by court order, to cease commercializing the infringing technology or product. In addition, we could be found liable for monetary damages. A finding of infringement could prevent us from commercializing our product candidates or force us to cease some of our business operations, which could materially harm our business. For example, we are aware of issued third party patents directed to placental stem cells and their use for therapy and in treating various diseases.&#160; We may need to seek a license for one or more of these patents.&#160; No assurances can be given that such a license will be available on commercially reasonable terms, if at all.&#160; Claims that we have misappropriated the confidential information or trade secrets of third parties could have a similar negative impact on our business.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal">30</font></div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; WIDTH: 100%; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">Even if resolved in our favor, litigation or other legal proceedings relating to intellectual property claims may cause us to incur significant expenses, and could distract our technical and management personnel from their normal responsibilities. In addition, there could be public announcements of the results of hearings, motions or other interim proceedings or developments and if securities analysts or investors perceive these results to be negative, it could have a substantial adverse effect on the price of our common stock. Such litigation or proceedings could substantially increase our operating losses and reduce the resources available for development activities or any future sales, marketing or distribution activities. We may not have sufficient financial or other resources to adequately conduct such litigation or proceedings. Some of our competitors are able to sustain the costs of such litigation or proceedings more effectively than we can because of their greater financial resources. Uncertainties resulting from the initiation and continuation of patent litigation or other proceedings could have a material adverse effect on our ability to compete in the marketplace.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; FONT-STYLE: italic; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">We must further protect and develop our technology and products in order to become a profitable company.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">If we do not complete the development of our technology and products in development by the time our patents expire, create additional sufficient layers of patents or other intellectual property rights, other companies may use the technology to develop competing products.&#160; If this happens, we may lose our competitive position and our business would likely suffer.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">Furthermore, the scope of our patents may not be sufficiently broad to offer meaningful protection.&#160; In addition, our patents could be successfully challenged, invalidated or circumvented so that our patent rights would not create an effective competitive barrier.&#160; We also intend to seek patent protection for any of our potential cell therapy products once we have completed their development.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">We also rely on trade secrets and unpatentable know-how that we seek to protect, in part, by confidentiality agreements with our employees, consultants, suppliers and licensees.&#160; These agreements may be breached, and we might not have adequate remedies for any breach.&#160; If this were to occur, our business and competitive position would suffer.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; FONT-STYLE: italic; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">We may be exposed to liabilities under the Foreign Corrupt Practices Act, and any determination that we violated the Foreign Corrupt Practices Act could have a material adverse effect on our business.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">We are subject to the Foreign Corrupt Practice Act, or FCPA, and other laws that prohibit U.S. companies or their agents and employees from providing anything of value to a foreign official or political party for the purposes of influencing any act or decision of these individuals in their official capacity to help obtain or retain business, direct business to any person or corporate entity or obtain any unfair advantage. We have operations and agreements with third parties. Our international activities create the risk of unauthorized and illegal payments or offers of payments by our employees or consultants, even though they may not always be subject to our control. We discourage these practices by our employees and consultants. However, our existing safeguards and any future improvements may prove to be less than effective, and our employees or consultants, may engage in conduct for which we might be held responsible for. Any failure by us to adopt appropriate compliance procedures and ensure that our employees and consultants comply with the FCPA and applicable laws and regulations in foreign jurisdictions could result in substantial penalties or restrictions on our ability to conduct business in certain foreign jurisdictions.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">Violations of the FCPA may result in severe criminal or civil sanctions, and we may be subject to other liabilities, which could negatively affect our business, operating results and financial condition. In addition, the U.S. government may seek to hold our Company liable for successor liability FCPA violations committed by companies in which we invest or that we acquire.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal">31</font></div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; WIDTH: 100%; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25"><a id="Item1b" name="Item1b"><!--Anchor--></a>Item 1B.&#160;Unresolved Staff Comments.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">Not Applicable.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold"><a id="Item2" name="Item2"><!--Anchor--></a>Item&#160;2.</font>&#160;&#160;&#160;&#160;<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold">Properties.</font></div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">Our principal executive, manufacturing and research and development offices are located at MATAM Advanced Technology Park, Building No. 5, Haifa, Israel, where we occupy approximately 4,389 square meters. Our monthly rent payment for these leased facilities as of July 2017 was 258,000 NIS (approximately $68,500), excluding MTM - Scientific Industries Center Haifa, Ltd., or MTM, participation as described at Item 7. For the fiscal year ended June 30, 2017, we recognized an expense of $783,000, net, for rent of Building No. 5, which was offset by MATAM participation of $239,000</font>&#160;<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">due to renovations made in Building No. 5. In June 2017, we terminated our operating lease agreement for a facility that is located at MTM, Building No. 20, Haifa, Israel, where we occupied a facility of approximately 1,280 square meters.</font></div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">We believe that the current space we have is adequate to meet our current and near future needs.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25"><a id="Item3" name="Item3"><!--Anchor--></a>Item 3.&#160;&#160;&#160;&#160;Legal Proceedings.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">None.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25"><a id="Item4" name="Item4"><!--Anchor--></a>Item 4.&#160;&#160;&#160; Mine Safety Disclosures.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">Not applicable.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25"><a id="PARTII" name="PARTII"><!--Anchor--></a>PART II</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25"><a id="Item5" name="Item5"><!--Anchor--></a>Item 5.&#160;&#160; &#160;Market for Registrant's Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">Our shares trade on the NASDAQ Capital Market under the symbol PSTI and in the Tel Aviv Stock Exchange under the ticker symbol PLTR.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">The following table sets forth, for the periods indicated, the high and low sales prices of our common stock, as reported on NASDAQ website and may not necessarily represent actual transactions.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<table id="z5e1141e4758a472495ee86ba85647b7c" style="FONT-SIZE: 10pt; BORDER-TOP: medium none; FONT-FAMILY: 'Times New Roman', Times, serif; BORDER-RIGHT: medium none; BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; WIDTH: 80%" cellspacing="0" cellpadding="0" align="center" border="0">
<tr>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: middle; BORDER-BOTTOM: #000000 2px solid; BORDER-LEFT: medium none" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Quarter Ended</div>
</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BORDER-LEFT: medium none" valign="bottom">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: middle; BORDER-BOTTOM: #000000 2px solid; BORDER-LEFT: medium none" valign="bottom" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">High</div>
</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BORDER-LEFT: medium none" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BORDER-LEFT: medium none" valign="bottom">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: middle; BORDER-BOTTOM: #000000 2px solid; BORDER-LEFT: medium none" valign="bottom" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">Low</div>
</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BORDER-LEFT: medium none" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: middle; BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; BACKGROUND-COLOR: #cceeff" valign="bottom" colspan="8">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Fiscal Year Ended June 30, 2016</div>
</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BORDER-LEFT: medium none; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: middle; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 2px; BORDER-LEFT: medium none; WIDTH: 76%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 12.35pt; LINE-HEIGHT: 1.25">September 30, 2015</div>
</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 2px; TEXT-ALIGN: right; BORDER-LEFT: medium none; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; TEXT-ALIGN: left; BORDER-LEFT: medium none; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; TEXT-ALIGN: right; BORDER-LEFT: medium none; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">2.54</div>
</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BORDER-LEFT: medium none; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 2px; TEXT-ALIGN: right; BORDER-LEFT: medium none; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; TEXT-ALIGN: left; BORDER-LEFT: medium none; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; TEXT-ALIGN: right; BORDER-LEFT: medium none; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">1.80</div>
</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BORDER-LEFT: medium none; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr style="HEIGHT: 17px">
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: middle; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 2px; BORDER-LEFT: medium none; WIDTH: 76%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 12.35pt; LINE-HEIGHT: 1.25">December 31, 2015</div>
</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 2px; TEXT-ALIGN: right; BORDER-LEFT: medium none; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; TEXT-ALIGN: left; BORDER-LEFT: medium none; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; TEXT-ALIGN: right; BORDER-LEFT: medium none; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">1.86</div>
</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BORDER-LEFT: medium none; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 2px; TEXT-ALIGN: right; BORDER-LEFT: medium none; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; TEXT-ALIGN: left; BORDER-LEFT: medium none; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; TEXT-ALIGN: right; BORDER-LEFT: medium none; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">0.98</div>
</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BORDER-LEFT: medium none; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: middle; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 2px; BORDER-LEFT: medium none; WIDTH: 76%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 12.35pt; LINE-HEIGHT: 1.25">March 31, 2016</div>
</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 2px; TEXT-ALIGN: right; BORDER-LEFT: medium none; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; TEXT-ALIGN: left; BORDER-LEFT: medium none; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; TEXT-ALIGN: right; BORDER-LEFT: medium none; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">1.72</div>
</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BORDER-LEFT: medium none; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 2px; TEXT-ALIGN: right; BORDER-LEFT: medium none; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; TEXT-ALIGN: left; BORDER-LEFT: medium none; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; TEXT-ALIGN: right; BORDER-LEFT: medium none; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">0.71</div>
</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BORDER-LEFT: medium none; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: middle; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 2px; BORDER-LEFT: medium none; WIDTH: 76%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 12.35pt; LINE-HEIGHT: 1.25">June 30, 2016</div>
</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 2px; TEXT-ALIGN: right; BORDER-LEFT: medium none; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; TEXT-ALIGN: left; BORDER-LEFT: medium none; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; TEXT-ALIGN: right; BORDER-LEFT: medium none; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">1.85</div>
</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BORDER-LEFT: medium none; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 2px; TEXT-ALIGN: right; BORDER-LEFT: medium none; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; TEXT-ALIGN: left; BORDER-LEFT: medium none; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; TEXT-ALIGN: right; BORDER-LEFT: medium none; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">1.20</div>
</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BORDER-LEFT: medium none; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: middle; BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; BACKGROUND-COLOR: #ffffff" valign="bottom" colspan="8">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Fiscal Year Ended June 30, 2017</div>
</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BORDER-LEFT: medium none; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: middle; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 2px; BORDER-LEFT: medium none; WIDTH: 76%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 12.35pt; LINE-HEIGHT: 1.25">September 30, 2016</div>
</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 2px; TEXT-ALIGN: right; BORDER-LEFT: medium none; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; TEXT-ALIGN: left; BORDER-LEFT: medium none; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; TEXT-ALIGN: right; BORDER-LEFT: medium none; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">1.85</div>
</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BORDER-LEFT: medium none; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 2px; TEXT-ALIGN: right; BORDER-LEFT: medium none; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; TEXT-ALIGN: left; BORDER-LEFT: medium none; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; TEXT-ALIGN: right; BORDER-LEFT: medium none; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">1.30</div>
</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BORDER-LEFT: medium none; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: middle; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 2px; BORDER-LEFT: medium none; WIDTH: 76%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 12.35pt; LINE-HEIGHT: 1.25">December 31, 2016</div>
</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 2px; TEXT-ALIGN: right; BORDER-LEFT: medium none; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; TEXT-ALIGN: left; BORDER-LEFT: medium none; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; TEXT-ALIGN: right; BORDER-LEFT: medium none; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">1.65</div>
</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BORDER-LEFT: medium none; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 2px; TEXT-ALIGN: right; BORDER-LEFT: medium none; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; TEXT-ALIGN: left; BORDER-LEFT: medium none; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; TEXT-ALIGN: right; BORDER-LEFT: medium none; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">1.38</div>
</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BORDER-LEFT: medium none; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: middle; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 2px; BORDER-LEFT: medium none; WIDTH: 76%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 12.35pt; LINE-HEIGHT: 1.25">March 31, 2017</div>
</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 2px; TEXT-ALIGN: right; BORDER-LEFT: medium none; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; TEXT-ALIGN: left; BORDER-LEFT: medium none; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; TEXT-ALIGN: right; BORDER-LEFT: medium none; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">1.64</div>
</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BORDER-LEFT: medium none; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 2px; TEXT-ALIGN: right; BORDER-LEFT: medium none; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; TEXT-ALIGN: left; BORDER-LEFT: medium none; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; TEXT-ALIGN: right; BORDER-LEFT: medium none; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">1.04</div>
</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BORDER-LEFT: medium none; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: middle; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 2px; BORDER-LEFT: medium none; WIDTH: 76%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 12.35pt; LINE-HEIGHT: 1.25">June 30, 2017</div>
</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 2px; TEXT-ALIGN: right; BORDER-LEFT: medium none; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; TEXT-ALIGN: left; BORDER-LEFT: medium none; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; TEXT-ALIGN: right; BORDER-LEFT: medium none; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">1.59</div>
</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BORDER-LEFT: medium none; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 2px; TEXT-ALIGN: right; BORDER-LEFT: medium none; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; TEXT-ALIGN: left; BORDER-LEFT: medium none; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; TEXT-ALIGN: right; BORDER-LEFT: medium none; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">1.20</div>
</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BORDER-LEFT: medium none; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>
</table>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">On August 31, 2017, the per share closing price of our common stock, as reported on NASDAQ website, was $1.20.&#160; As of August 31, 2017, there were 112 holders of record, and 97,473,652 of our common shares were issued and outstanding.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal">32</font></div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; WIDTH: 100%; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">American Stock Transfer and Trust Company, LLC is the registrar and transfer agent for our common shares.&#160; Their address is 6201 15th Avenue, 2nd Floor, Brooklyn, NY 11219, telephone: (718) 921-8261, (800) 937-5449.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Comparative Stock Performance Graph</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">The following graph shows how an initial investment of $100 in our common stock would have compared to an equal investment in the Nasdaq Composite Index and to a peer group index (comprised of: Athersys, Inc.; Cytori Therapeutics, Inc.; Capricor Therapeutics, Inc. and Mesoblast, Ltd.) during the period from July 1, 2012 through June 30, 2017. The performance shown is not necessarily indicative of future price performance.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25"><img src="image00002.jpg"></div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-STYLE: italic; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Dividend Policy</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 35.45pt">We have not paid any cash dividends on our common stock and have no present intention of doing so. Our current policy is to retain earnings, if any, for use in our operations and in the development of our business. Our future dividend policy will be determined from time to time by our Board of Directors.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-STYLE: italic; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Recent Sales of Unregistered Securities</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 35.45pt">In May 2017, we issued 57,586 shares of common stock to consultants for services rendered.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 35.45pt">The above issuance was exempt under Section 4(a)(2) of the Securities Act of 1933, as amended.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25"><a id="Item6" name="Item6"><!--Anchor--></a>Item 6.&#160;&#160; &#160;Selected Financial Data.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">The selected data presented below under the captions "Statements of Operations Data," "Statements of Cash Flows Data" and "Balance Sheet Data" for, and as of the end of, each of the fiscal years in the five-year period ended June 30, 2017, are derived from, and should be read in conjunction with, our audited consolidated financial statements.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal">33</font></div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; WIDTH: 100%; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">The information contained in this table should also be read in conjunction with "Management's Discussion and Analysis of Financial Condition and Results of Operations" and the financial statements and related notes thereto included elsewhere in this report (in thousands of dollars except share and per share data):</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<table id="zae9e6b5eec3c4be88cbd0eac4061e3dd" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="VERTICAL-ALIGN: top; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 2px solid" valign="bottom" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">2017</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 2px solid" valign="bottom" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">2016</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 2px solid" valign="bottom" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">2015</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 2px solid" valign="bottom" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">2014</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 2px solid" valign="bottom" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">2013</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Statements of Operations Data:</div>
</td>
<td style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff" valign="bottom" colspan="2">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff" valign="bottom" colspan="2">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff" valign="bottom" colspan="2">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff" valign="bottom" colspan="2">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff" valign="bottom" colspan="2">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 40%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Revenues</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">2,847</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">379</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">379</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">679</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 40%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Cost of revenues</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">100</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">13</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">11</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">20</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: middle; WIDTH: 40%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Gross profit</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">2,747</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">366</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">368</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">659</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 40%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Research and development expenses</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">24,001</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">22,856</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">23,416</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">24,938</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">19,906</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 40%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">R&amp;D participation grants</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">2,909</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">3,276</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">4,243</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">5,396</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">2,673</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 40%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Research and development expenses, net</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">21,092</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">19,580</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">19,173</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">19,542</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">17,233</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 40%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">General and administrative expenses</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">6,927</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">6,486</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">6,460</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">8,676</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">5,649</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 40%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Operating loss</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">28,019</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">23,319</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">25,267</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">27,850</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">22,223</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 40%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Financial income (expenses), net</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">205</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">73</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">590</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">918</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">1,068</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; WIDTH: 40%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Net loss for the period</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">27,814</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">23,246</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">24,677</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">26,932</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">21,155</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; WIDTH: 40%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Basic and diluted net loss per share</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">0.32</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">0.29</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">0.35</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">0.42</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">0.38</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 40%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: middle; PADDING-BOTTOM: 4px; WIDTH: 40%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Weighted average number of shares used in computing basic and diluted net loss&#160; per share</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">87,426,208</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">79,547,989</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">70,284,337</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">63,514,405</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">55,481,357</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: middle; WIDTH: 40%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: middle; WIDTH: 40%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Statements of Cash Flows Data:</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 40%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Net cash used in operating activities</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">21,611</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">18,522</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">20,605</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">19,121</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">16,887</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 40%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Net cash provided by (used in) investing activities</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">4,298</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">1,312</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">21,537</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">1,983</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(19,799</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 40%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Net cash provided by financing activities</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">15,797</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">807</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">17,201</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">12,624</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">36,304</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 40%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Net increase (decrease) in cash</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(1,516</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(16,403</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">18,133</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(4,514</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(382</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 40%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Cash and cash equivalents at beginning of year</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">6,223</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">22,626</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">4,493</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">9,007</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">9,389</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; WIDTH: 40%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Cash and cash equivalents at end of year</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">4,707</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">6,223</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">22,626</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">4,493</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">9,007</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: middle; WIDTH: 40%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: middle; WIDTH: 40%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Balance Sheet Data:</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: middle; WIDTH: 40%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Cash, cash equivalents, short-term bank deposits, restricted cash and short-term deposits, and marketable securities</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">26,665</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">32,750</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">53,119</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">58,819</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">54,213</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 40%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Current assets</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">29,016</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">35,596</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">56,868</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">61,987</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">55,085</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 40%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Long-term assets</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">8,518</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">10,345</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">11,287</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">12,036</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">13,231</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 40%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Total assets</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">37,534</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">45,941</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">68,155</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">74,023</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">68,316</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 40%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Current liabilities</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">5,414</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">5,775</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">6,183</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">7,397</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">5,921</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 40%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Long-term liabilities</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">1,869</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">2,010</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">3,829</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">4,503</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">4,929</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: middle; WIDTH: 40%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Stockholders&#8217; equity</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">30,251</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">38,156</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">58,143</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">62,123</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">57,466</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: middle; WIDTH: 40%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>
</table>

<div style="LINE-HEIGHT: 1.25"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold"><a id="Item7" name="Item7"><!--Anchor--></a>Item 7.</font>&#160;&#160;&#160;&#160;<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold">Management's Discussion and Analysis of Financial Condition and Results of Operations.</font></div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">We are a leading developer of placenta-based cell therapy product candidates for the treatment of multiple ischemic, inflammatory and hematologic conditions. Our lead indications are CLI, recovery after surgery for femoral neck fracture, and ARS. A pivotal, multinational clinical trial is currently being conducted with our PLX-PAD product candidate in CLI. In addition, pivotal, multinational clinical trials are planned for our PLX-PAD product candidate in femoral neck fractures. The National Institutes of Health&#8217;s, NIAID, recently completed a dose selection trial with PLX-R18 in the hematologic component of ARS and a pivotal study is planned under the FDA, animal rule once funding will be secured for this project. Each of these indications is a severe unmet medical need.</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal">34</font></div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; WIDTH: 100%; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">PLX cells are derived from a class of placental cells that are harvested from donated placentas at the time of full term healthy delivery. PLX cell products require no tissue matching prior to administration. They are produced using our proprietary three-dimensional expansion technology. Our manufacturing facility complies with the FDA&#8217;s current Good Manufacturing Practice requirements and has been approved by the European, Japanese and Israeli regulatory authorities for production of PLX-PAD for late stage trials and marketing. We expect to have in-house production capacity to grow clinical-grade PLX cells in commercial quantities.</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">Our goal is to make significant progress with our robust clinical pipeline and our anticipated pivotal trials in order to ultimately bring innovative, potent therapies to patients who need new treatment options. We intend to shorten the time to commercialization of our product candidates, by leveraging unique accelerated regulatory pathways that exist in the United States, Europe and Japan to bring innovative products that address life-threatening diseases to the market efficiently. We believe that these accelerated pathways create substantial opportunities for us and for the cell therapy industry as a whole. We are pursuing these accelerated pathways for PLX-PAD in CLI and femoral neck fracture. Our second product candidate, PLX R18, is under development in the United States for ARS via the Animal Rule regulatory pathway, which may result in approval without the prior performance of human efficacy trials. We expect to demonstrate a real-world impact and value from our pipeline, technology platform and commercial-scale manufacturing capacity. PLX R18 is also under development in a Phase I trial in the United States for incomplete hematopoietic recovery following hematopoietic cell transplantation (HCT).</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-STYLE: italic; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">RESULTS OF OPERATIONS &#8211; YEAR ENDED JUNE 30, 2017 COMPARED TO YEAR ENDED JUNE 30, 2016 AND YEAR ENDED JUNE 30, 2016 COMPARED TO YEAR ENDED JUNE 30, 2015.</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><br>
</font> Revenues</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">We did not recognize revenues in fiscal year 2017, as compared to revenues of $2,847,000 and $379,000 for the fiscal years ended June 30, 2016 and 2015, respectively. All revenues in fiscal year 2016 and fiscal year 2015 were derived from a prior license agreement, or the United Agreement, with United Therapeutics Corporation, or United.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">On December 8, 2015, we received a notice from United terminating the United Agreement, effective immediately. As we had no further obligations towards United, we recognized the remaining upfront payment received in August 2011 as revenues during the year ended June 30, 2016.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Cost of revenues</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">We did not recognize cost of revenues in fiscal 2017, as compared to cost of revenues of $100,000 for the fiscal year ended June 30, 2016. The reason for the decrease in cost of revenues was that we did not recognize any revenues for fiscal 2017 as compared to revenues of $2,847,000 for fiscal year 2016.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 35.45pt">Cost of revenues increased from $13,000 for the year ended June 30, 2015 to $100,000 for the year ended June 30, 2016. This increase is related to the royalties we were obligated to pay to the IIA, which reflects 3.5% of the revenues derived from the United Agreement in fiscal 2016 and fiscal 2015.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal">35</font></div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; WIDTH: 100%; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Research and Development net</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">Research and development net costs (costs less participation and grants by the IIA, Horizon 2020 and other parties) for the year ended June 30, 2017 increased by 8% to $21,092,000 from $19,580,000 for the year ended June 30, 2016. This increase is attributed to a lower participation of the IIA in fiscal 2017 compared to fiscal 2016 ($2,900,000 was approved in calendar year 2015 compared to $3,300,000 that was approved in calendar year 2016 and $1,500,000 that was approved in calendar year 2017), an increase in payments to consultants and subcontractors related to clinical studies such as our CLI and HCT studies, an increase in stock-based compensation expenses due to an increased number of RSUs granted under our 2016 Equity Compensation Plan, or the 2016 Plan, and an increase in market value of our common stock on the day of the grant. The increase was offset by participation from the European Union with respect to the Horizon 2020 grant for CLI commencing in calendar year 2017 and a decrease in materials consumption.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">Research and development net costs (costs less participation and grants by the IIA and other parties) for the year ended June 30, 2016 increased by 2% to $19,580,000 from $19,173,000 for the year ended June 30, 2015. This increase is attributed to a lower participation of the IIA in fiscal 2016 compared to fiscal 2015 ($4,200,000 was approved in calendar year 2014 compared to $2,900,000 that was approved in calendar year 2015 and $3,300,000 that was approved in calendar year 2016). The reduced IIA participation was offset by a decrease in stock-based compensation expenses due to the decrease in the market value of our common stock on the day of the grant.</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><br>
</font> General and Administrative</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">General and administrative expenses increased by 7% from $6,486,000 for the year ended June 30, 2016 to $6,927,000 for the year ended June 30, 2017. This increase is attributed to an increase in corporate activities expenses and an increase in payroll expenses due to differences in exchange rates as well as an increase in the number of employees.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">General and administrative expenses increased by 0.4% from $6,460,000 for the year ended June 30, 2015 to $6,486,000 for the year ended June 30, 2016.&#160; This increase is related to corporate activities, offset by a decrease in stock-based compensation expenses related to our directors and officers and attributable to the timing of the grants under the option plan and the market value of our common stock on the day of the grant.<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><br>
</font></font><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Financial Income, net</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">Financial income increased from $73,000 for the year ended June 30, 2016 to $205,000 for the year ended June 30, 2017. This increase is mainly attributable to income from exchange rates in the year ended June 30, 2017&#160; as compared to expense from exchange rates in the year ended June 30, 2016, since through the year ended June 30, 2017, there was a decrease of 9% in the value of the U.S. dollar against the NIS, compared to an increase of 2% in the value of the U.S. dollar against the NIS through the year ended June 30, 2016, as well as income resulting from the changes in the fair value of our hedging instruments, which is related to the strength of the U.S. dollar against the NIS in the year ended June 30, 2017 as compared to an expense in the year ended June 30, 2016, offset by an expense of $767,000 related to our marketable securities resulting from other-than-temporary impairment loss recognized in the year ended June 30, 2017.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">Financial income decreased from $590,000 for the year ended June 30, 2015 to $73,000 for the year ended June 30, 2016. This decrease is mainly attributable to lower income related to our marketable securities (such as net gains related to sales of the marketable securities, interest and dividend income and accretion of discount, amortization of premium), and a decrease in income related to derivatives, offset by a decrease in exchange rates expenses, related to the strength of the U.S. dollar against the NIS in the year ended June 30, 2016 compared to year ended June 30, 2015.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Net Loss</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">Net loss for the year ended June 30, 2017 was $27,814,000 as compared to a net loss of $23,246,000 for the year ended June 30, 2016. The reasons for the increase in net loss were mainly due to revenues of $2,847,000 in fiscal year 2016 compared to no revenues in fiscal year 2017 and other-than-temporary impairment loss of $38,000 in fiscal year 2016 compared to $767,000 in fiscal year 2017, as well as for the reasons mention above. Net loss per share for the year ended June 30, 2017 was $0.32, as compared to $0.29 for the year ended June 30, 2016.&#160; The net loss per share increased as a result of an increase in our net loss offset by an increase in our weighted average number of shares due to the issuance of additional shares during fiscal 2017.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal">36</font></div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; WIDTH: 100%; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">Net loss for the year ended June 30, 2016 was $23,246,000 as compared to a net loss of $24,677,000 for the year ended June 30, 2015. Net loss per share for the year ended June 30, 2016 was $0.29, as compared to $0.35 for the year ended June 30, 2015.&#160; The net loss per share decreased as a result of the decrease in our net loss, and an increase in our weighted average number of shares due to the issuance of additional shares during fiscal 2016.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Liquidity and Capital Resources</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">As of June 30, 2017, our total current assets were $29,016,000 and our total current liabilities were $5,414,000. On June 30, 2017, we had a working capital surplus of $23,602,000 and an accumulated deficit of $189,571,000.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">As of June 30, 2016, our total current assets were $35,596,000 and our total current liabilities were $5,775,000. On June 30, 2016, we had a working capital surplus of $29,821,000 and an accumulated deficit of $161,757,000.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">Our cash and cash equivalents as of June 30, 2017 amounted to $4,707,000.&#160; This is a decrease of $1,516,000 from the $6,223,000 reported as of June 30, 2016. Cash balances decreased in the year ended June 30, 2017 for the reasons presented below:</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">Operating activities used cash of $21,611,000 in the year ended June 30, 2017. Cash used by operating activities in the year ended June 30, 2017 primarily consisted of payments of salaries to our employees, and payments of fees to our consultants, suppliers, subcontractors, and professional services providers including the costs of clinical studies, offset by an IIA and Horizon 2020 grants.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">Investing activities provided cash of $4,298,000 in the year ended June 30, 2017. The investing activities consisted primarily of proceeds of $5,937,000 from the sale and redemption of marketable securities and redemption of short term deposits of $2,316,000, offset by investing $3,607,000 in marketable securities and the purchase of property and equipment for $378,000.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">Financing activities generated cash in the amount of $15,797,000 during the year ended June 30, 2017. The financing activities are primarily attributable to net proceeds of $15,718,000 from issuing shares of our common stock in the underwritten public offering we closed in January 2017, proceeds related to grant received from the Israel-United States Binational Industrial Research and Development Foundation and exercises of options by employees.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">In July 2017, we entered into an At Market Sales Agreement, or the ATM Agreement, with FBR Capital Markets &amp; Co., MLV &amp; Co. LLC and Oppenheimer &amp; Co. Inc., each an Agent, which provides that, upon the terms and subject to the conditions and limitations set forth in the ATM Agreement, we may elect, from time to time, to issue and sell shares of common stock having an aggregate offering price of up to $80 million through any of the Agents. We are not obligated to make any sales of common stock under the ATM Agreement. As of September 5, we sold 455,731 shares of common stock at an average price of $1.2 per share.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">Our cash and cash equivalents as of June 30, 2016 amounted to $6,223,000.&#160; This is a decrease of $16,403,000 from the $22,626,000 reported as of June 30, 2015. Cash balances decreased in the year ended June 30, 2016 for the reasons presented below:</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal">37</font></div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; WIDTH: 100%; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">Operating activities used cash of $18,522,000 in the year ended June 30, 2016. Cash used by operating activities in the year ended June 30, 2016 primarily consisted of payments of salaries to our employees, and payments of fees to our consultants, suppliers, subcontractors, and professional services providers including the costs of clinical studies, offset by an IIA grant. During the year ended June 30, 2016, operating activities were also offset by the participation of MTM in the cost of constructing additional office space. In October 2015, MTM, participated in the cost of constructing additional office space for us by contributing an amount of NIS 3,683,000 (approximately $944,000) toward the cost of construction.&#160; Such participation was made pursuant to our lease agreement with MTM, and is recognized by rateably deducting from our monthly rent payment over the rent period. We recognized participation of $188,000 in Fiscal 2016.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">Investing activities provided cash of $1,312,000 in the year ended June 30, 2016. The investing activities consisted primarily of proceeds of $8,093,000 from the sale and redemption of marketable securities, offset by investing $4,215,000 in marketable securities and the purchase of property and equipment for $1,750,000.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">Financing activities generated cash in the amount of $807,000 during the year ended June 30, 2016. The financing activities are primarily attributable to proceeds received from shares issued in a private placement in May 2015 as described below and exercises of warrants and options by shareholders.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">From October 2014 through May 2015, we issued shares of common stock in private placements to an investor. In October 2014, we issued 200,000 shares of common stock to an investor for aggregate cash consideration of $528,000. In February 2015, we issued an additional 200,000 shares of common stock to an investor for aggregate cash consideration of $586,000. In May 2015, we issued an additional 300,000 shares of common stock to an investor for consideration in the amount of $790,000, which was received from the investor during September 2015.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">In February 2015, we entered into an agreement with a contractor for the construction of our new laboratories facility for consideration of approximately NIS 3.3 million (approximately $841,000). Under the terms of the agreement, we paid part of the NIS 3.3 million consideration using 100,004 restricted shares of common stock of the Company, linked to performance milestones with respect to the new laboratories construction and which serve as a guarantee.&#160; These restricted shares were issued in December 2014 and were released to the contractor upon the successful completion of the construction.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">In May 2015, we entered into an addendum to the agreement with the contractor for the design and construction of additional office space renovations in our leased facility for additional consideration of approximately NIS 4 million (approximately $1,032,000), which is comprised of NIS 3 million (approximately $774,000) in cash and 90,000 restricted shares, which were issued to the contractor in February 2016, upon the successful completion of the construction by the contractor.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 35.45pt">The construction work was initiated in June 2015. On October 30, 2015, the contractor completed the agreed construction milestones. We have issued a total of 190,004 restricted shares of common stock to the contractor.&#160; As a result, we recognized the fair value of the share-based payments awards, using the fair value of the Company's shares on October 30, 2015, totaling approximately $302,000 as share-based payment to the contractor in "additional paid-in capital" with a corresponding amount included in "property and equipment, net".</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">During the years that ended June 30, 2017, 2016 and 2015, we received cash of approximately $3,258,000, $2,526,000 and $4,405,000, respectively, from the IIA towards our research and development expenses.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">According to the IIA grant terms, we are required to pay royalties at a rate of 3%-4% on sales of products and services derived from technology developed using this and other IIA grants until 100% of the dollar-linked grants amount plus interest are repaid. In the absence of such sales, no payment is required.&#160; During the year ended June 30, 2017, no royalties were paid to the IIA. The IIA may impose certain conditions on any arrangement under which the IIA permits the Company to transfer technology or development out of Israel or outsource manufacturing out of Israel. While the grant is given to the Company over a certain period of time (usually a year), the requirements and restrictions under the Israeli Law for the Encouragement of Industrial Research and Development, 1984 continue and do not have a set expiration period, except for the royalties, which requirement to pay them expires after payment in full.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal">38</font></div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; WIDTH: 100%; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">Our CLI program participates in a European Union&#160;research and development consortium under the Horizon 2020 program. During the year ended June 30, 2017, an amount of approximately $965,000 was received from the Horizon 2020 program, of which $871,000 were recognized as participation in R&amp;D participation grants. The remaining amount of $94 is presented in &#8220;Other accounts payable&#8221; as of June, 30, 2017.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">In February 2013, MTM, our landlord, participated by contributing an amount of NIS 2,990,000 (approximately $816,000) toward the cost of constructing our new facility.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">In accordance with the CHA Agreement, in December 2013, we issued to CHA 2,500,000 shares of our common stock in consideration for the issuance to us of 1,011,504 common shares of CHA, which reflected total consideration of approximately $10,414,000 to each of us and CHA. Each of us and CHA agreed not to sell the other party's shares for at least one year. The parties also agreed to give an irrevocable proxy to the other party&#8217;s management with respect to the shares issued.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">During March 2015, we sold a portion of the CHA shares received in December 2013, resulting in net proceeds of $5,717,000. The net gain was $282,000 and was presented as &#8220;Financial income, net&#8221; in fiscal 2015.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">The remaining investment in CHA shares is presented as &#8220;Marketable Securities&#8221; and classified as available-for-sale in accordance with ASC 320, &#8220;Investments - Debt and Equity Securities&#8221;. The fair value of the remaining investment as of June 30, 2017 is $4,358,000<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">.</font></div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">We adhere to an investment policy set by our investment committee which aims to preserve our financial assets, maintain adequate liquidity and maximize return while minimizing exposure to the NIS.&#160; Such policy further provides that we should hold most of our current assets in bank deposits and the remainder of our current assets is to be invested in government bonds and a combination of corporate bonds and relatively low risk stocks.&#160; As of today, the currency of our financial portfolio is mainly in U.S. dollars and we use options and forward contracts in order to hedge our exposures to NIS.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Outlook</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">We have accumulated a deficit of $189,571,000 since our inception in May 2001. We do not expect to generate any revenues from sales of products in the next twelve months. Our cash needs will increase in the foreseeable future. We expect to generate revenues, which in the short and medium terms will unlikely exceed our costs of operations, from the sale of licenses to use our technology or products.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 5.9pt; TEXT-INDENT: 36pt">We will be required to obtain additional liquidity resources in order to support the commercialization of our products and maintain our research and development and clinical trials activities.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 5.9pt; TEXT-INDENT: 36pt">As of June 30, 2017, our cash position (cash and cash equivalents, short-term bank deposits and marketable securities) totaled approximately $26,106,000. We are addressing our liquidity issues by implementing initiatives to allow the continuation of our activities. Our current operating plan includes various assumptions concerning the level and timing of cash outflows for operating activities and capital expenditures. Our ability to successfully carry out our business plan, which includes a cost-reduction plan should we be unable to raise sufficient additional capital, is primarily dependent upon our ability to (1) obtain sufficient additional capital, (2) entering into license agreements to use or commercialize our products and (3) receive other sources of funding, including non-diluting sources such as the IIA grants, the Horizon 2020 grant and other grants. There are no assurances, however, that we will be successful in obtaining an adequate level of financing needed for the long-term development and commercialization of our products.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal">39</font></div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; WIDTH: 100%; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 5.9pt; TEXT-INDENT: 36pt">According to our management&#8217;s estimates, liquidity resources as of June 30, 2017 will be sufficient to maintain our operations into the first quarter of fiscal year 2019. Our inability to raise funds to carry out our business plan will have a severe negative impact on its ability to remain a viable company. These conditions raise substantial doubt about our ability to continue as a going concern.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">The IIA has supported our activity in the past twelve years. Our last program, for the twelfth year, was approved by the IIA in 2017 and relates to an approximately $1,500,000 grant. The grant will be used to cover research and development expenses for the period January 1, 2017 to December 31, 2017.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">In June 2015, we were awarded a &#8220;Smart Money&#8221; grant of approximately $117,559 from Israel&#8217;s Ministry of Economy. The program&#8217;s aim is to assist companies to extend their activities in international markets. The Israeli government granted us budget resources that we intend to use to advance our product candidate towards marketing in Japan and for regulatory activities there. We will also receive assistance from Israel&#8217;s trade attach&#233;s stationed in Japan, and from experts appointed especially by the "Smart Money" program.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">In July 2017, we were awarded an additional &#8220;Smart Money&#8221; grant of approximately $229,000 from Israel&#8217;s Ministry of Economy. The Israeli government granted us budget resources that we intend to use to advance our product candidate towards marketing in China-Hong Kong markets. We will also receive close support from Israel&#8217;s trade representatives stationed in China, including Hong Kong, along with experts appointed by the Smart Money program.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">In August 2016, our CLI program in the European Union was awarded a Euro 7,600,000 (approximately $8,700,000) grant. The grant is part of the European Union&#8217;s Horizon 2020 program. The Phase III study of PLX-PAD in CLI will be a collaborative project carried out by an international consortium led by the Berlin-Brandenburg Center for Regenerative Therapies together with the Company and with participation of additional third parties. The grant will cover a significant portion of the CLI program costs. An amount of Euro 1,900,000 (approximately $2,200,000) is a direct grant allocated to us, and the Company also expects to benefit from cost savings resulting from grant amounts allocated to the other consortium members.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">On September 5, 2017, we announced that our Phase III study of PLX-PAD cells to support recovery following surgery for femoral neck fracture was awarded a Euro 7,400,000 (approximately $8,700,000) non-dilutive grant from the Horizon 2020 program. Final approval of the grant is subject to the finalization of the consortium and Horizon 2020 grant agreements.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Application of Critical Accounting Policies</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 35.45pt">Our significant accounting policies are more fully described in Note 2 to our consolidated financial statements appearing in this Annual Report. We believe that the accounting policies below are critical for one to fully understand and evaluate our financial condition and results of operations.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 35.3pt">The discussion and analysis of our financial condition and results of operations is based on our financial statements, which we prepared in accordance with U.S. generally accepted accounting principles. The preparation of these financial statements requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities, as well as the reported revenues and expenses during the reporting periods. On an ongoing basis, we evaluate such estimates and judgments, including those described in greater detail below. We base our estimates on historical experience and on various other factors that we believe are reasonable under the circumstances. Actual results may differ from these estimates under different assumptions or conditions.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal">40</font></div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; WIDTH: 100%; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Revenue Recognition from the United Agreement</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">We recognize revenue pursuant to the License Agreement with United in accordance with ASC 605-25, "Revenue Recognition, Multiple-Element Arrangements".</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">Pursuant to ASC 605-25, each deliverable is evaluated to determine whether it qualifies as a separate unit of accounting based on whether the deliverable has &#8220;stand-alone value&#8221; to the customer. The arrangement&#8217;s consideration that is fixed or determinable is then allocated to each separate unit of accounting based on the relative selling price of each deliverable. In general, the consideration allocated to each unit of accounting is recognized as the related goods or services are delivered, limited to the consideration that is not contingent upon future deliverables.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">We received an up-front, non-refundable license payment of $5,000,000. Additional payments totaling $37,500,000 were subject to the achievement of certain regulatory milestones by United.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">Since the deliverables in the United Agreement did not have stand-alone value, none of them qualify as a separate unit of accounting. Accordingly, the non-refundable upfront license fee of $5,000,000 was deferred and was recognized on a straight line basis over the related performance period which was the development period in accordance with Staff Accounting Bulletin, or SAB, No. 104, "Revenue Recognition".</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">We also received an advance payment for the development of $2,000,000 that was deductible against development expenses as it accrued.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">On December 8, 2015, we received a notice from United terminating the United Agreement, effective immediately. Pursuant to the United Agreement termination clause, we regained full rights to PLX in the field of PAH, as well as all clinical data and regulatory submissions. As we have no further obligations towards United, we recognized the remaining upfront payment received in August 2011 as revenues during the year ended June 30, 2016.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Stock-based compensation</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 35.45pt">Stock-based compensation is considered critical accounting policy due to the significant expenses of restricted stock units which were granted to our employees, directors and consultants. In Fiscal 2017, we recorded stock-based compensation expenses related to options, restricted stock and restricted stock units in the amount of $3,662,000.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 35.45pt">In accordance with ASC 718, "Compensation-Stock Compensation", or ASC 718, restricted shares units to employees and directors are measured at their fair value on the grant date. All restricted shares units granted in 2017 and 2016 were granted for no consideration; therefore their fair value was equal to the share price at the date of grant, based on the close trading price of our shares known at the grant date. The restricted shares units to non-employees consultants are remeasured in any future vesting period for the unvested portion of the grants.</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 35.45pt"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">The value of the portion of the award that is ultimately expected to vest is recognized as an expense over the requisite service periods in our consolidated statements of operations. We have graded vesting based on the accelerated method over the requisite service period of each of the awards. The expected pre-vesting forfeiture rate affects the number of the shares. Based on our historical experience, the pre-vesting forfeiture rate per grant is 7% for the shares granted to employees and 0% for the shares granted to our directors, Co-CEOs and non-employees consultants.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Marketable Securities</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">Marketable securities consist of corporate bonds, government bonds and stocks. We determine the appropriate classification of marketable securities at the time of purchase and re-evaluate such designation at each balance sheet date. In accordance with ASC No. 320, "Investment Debt and Equity Securities," we classify marketable securities as available-for-sale. Available-for-sale securities are stated at fair value, with unrealized gains and losses reported in accumulated other comprehensive income (loss), a separate component of stockholders' equity. Realized gains and losses on sales of marketable securities, as determined on a specific identification basis, are included in financial income. The amortized cost of marketable securities is adjusted for amortization of premium and accretion of discount to maturity, both of which, together with interest, are included in financial income.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal">41</font></div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; WIDTH: 100%; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">Marketable securities are classified within Level 1 or Level 2 because marketable securities are valued using quoted market prices or alternative pricing sources and models utilizing market observable inputs.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">We recognize an impairment charge when a decline in the fair value of our investments is below the cost basis and is judged to be other-than-temporary. Factors considered in making such a determination include the duration and severity of the impairment, the reason for the decline in value, the potential recovery period and our intent to sell, including whether it is more likely than not that we will be required to sell the investment before recovery of cost basis. As such, we recognized an impairment charge of $767,000 on outstanding securities during the year ended June 30, 2017.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Research and Development Expenses, Net <font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-STYLE: italic">&#160;</font></div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">We expect our research and development expenses to remain our primary expense in the near future as we continue to develop our product candidates. Our research and development expenses consist primarily of clinical trials expenses, consultant and subcontractor expenses, payroll and related expenses, lab material expenses, stock based compensation expenses, rent and maintenance expenses and patent expenses. The following table provides a breakdown of the related costs for fiscal years 2015 through 2017 (in thousands of dollars):</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<table id="ze24a6b9d67bc40eaa44d6f3d5de0ad0f" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 90%" cellspacing="0" cellpadding="0" align="center" border="0">
<tr>
<td style="VERTICAL-ALIGN: top; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: middle; BORDER-BOTTOM: #000000 2px solid" valign="bottom" colspan="10">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">Year ended June 30,</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 2px solid" valign="bottom" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">2017</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 2px solid" valign="bottom" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">2016</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 2px solid" valign="bottom" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold">201</font>5</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: middle; WIDTH: 64%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 8.65pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 0.7pt">Clinical trials expenses</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">4,461</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">3,048</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">2,540</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: middle; WIDTH: 64%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 8.65pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 0.7pt">Consultants and subcontractor expenses</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">1,485</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">1,734</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">2,863</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: middle; WIDTH: 64%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 8.65pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 0.7pt">Payroll and related expenses</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">8,341</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">7,945</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">7,785</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: middle; WIDTH: 64%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 8.65pt; LINE-HEIGHT: 1.25">Materials expenses</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">3,145</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">3,799</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">3,835</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: middle; WIDTH: 64%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 8.65pt; LINE-HEIGHT: 1.25">Stock based compensation expenses</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">1,584</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">1,021</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">1,601</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: middle; WIDTH: 64%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 8.65pt; LINE-HEIGHT: 1.25">Depreciation expenses</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">2,029</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">2,006</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">1,942</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: middle; WIDTH: 64%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 8.65pt; LINE-HEIGHT: 1.25">Rent and maintenance expenses</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">1,567</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">1,515</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">1,610</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: middle; WIDTH: 64%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 8.65pt; LINE-HEIGHT: 1.25">Patent expenses</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">461</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">640</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">650</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: middle; WIDTH: 64%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 8.65pt; LINE-HEIGHT: 1.25">Other R&amp;D expenses</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">928</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">1,148</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">590</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: middle; WIDTH: 64%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 8.65pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 0.7pt">Total expenses</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">24,001</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">22,856</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">23,416</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: middle; PADDING-BOTTOM: 2px; WIDTH: 64%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 8.65pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 0.7pt">Less: R&amp;D participation grants</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(2,909</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(3,276</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(4,243</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; WIDTH: 64%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 8.65pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 0.7pt">Research and Development Expenses, Net</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">21,092</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">19,580</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">19,173</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>
</table>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal">42</font></div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; WIDTH: 100%; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 35.45pt">We invest heavily in research and development. Research and development expenses, net, were our major operating expenses, representing 75%<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">&#160;</font>of the total operating expenses for each of our fiscal years 2015, 2016 and 2017. We expect that in the upcoming years our research and development expenses, net, will continue to be our major operating expense.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Contractual Obligations</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">The following summarizes our contractual obligations and other commitments on June 30, 2017, and the effect such obligations could have on our liquidity and cash flow in future periods:</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<table id="zcf540ef426cf446a954e6f4db05a4f4d" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="VERTICAL-ALIGN: top; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: top" valign="bottom" colspan="2">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 2px solid" valign="bottom" colspan="14">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Payments due by period</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Contractual Obligations</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid" valign="bottom" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Total</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid" valign="bottom" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Less than 1 year</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid" valign="bottom" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">1-3 years</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid" valign="bottom" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">3-5 years</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid" valign="bottom" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">More than 5 years</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 7.1pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -7.1pt">Operating lease obligations</div>
</td>
<td style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">4,462,000</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">1,109,000</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">2,901,000</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">452,000</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom" colspan="2">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; WIDTH: 40%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 7.1pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -7.1pt">Accrued Severance Pay, net</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">136,000</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">136,000</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; WIDTH: 40%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; MARGIN-LEFT: 7.1pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -7.1pt">Total</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">4,598,000</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">1,109,000</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">2,901,000</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">452,000</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">136,000</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>
</table>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Off Balance Sheet Arrangements</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">We have no off balance sheet arrangements.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25"><a id="Item7A" name="Item7A"><!--Anchor--></a>Item 7A. Quantitative and Qualitative Disclosures About Market Risk.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">We are exposed to a variety of risks, including changes in interest rates, foreign currency exchange rates, changes in the value of our marketable securities and inflation.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">As of June 30, 2017, we had $4.7 million in cash and cash equivalents, $6.8 million in short-term bank deposits and restricted deposits and $15.2 million in marketable securities.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">We adhere to an investment policy set by our investment committee, which aims to preserve our financial assets, maintain adequate liquidity and maximize return while minimizing exposure to the NIS.&#160; Such policy further provides that we should hold most of our current assets in bank deposits and the remainder of our current assets should be invested in government bonds and a combination of corporate bonds and relatively low risk stocks.&#160; As of today, the currency of our financial portfolio is mainly in U.S. dollars and we use options contracts and forward contracts in order to hedge our exposures to currencies other than the U.S. dollar.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Interest Rate Risk</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">We invest a major portion of our cash surplus in bank deposits in banks in Israel. Since the bank deposits typically carry fixed interest rates, financial income over the holding period is not sensitive to changes in interest rates. However, our interest gains from future deposits may decline in the future as a result of changes in the financial markets. In addition, our income from marketable securities is exposed to market risks resulting from changes in interest rates.&#160; In any event, given the historic low levels of the interest rate, we estimate that a further decline in the interest rate we are receiving will not result in a material adverse effect to our business.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal">43</font></div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; WIDTH: 100%; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Foreign Currency Exchange Risk and Inflation</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">A significant portion of our expenditures, including salaries, lab materials, consultants&#8217; fees and office expenses relate to our operations in Israel.&#160; The cost of those Israeli operations, as expressed in U.S. dollars, is influenced by the extent to which any increase in the rate of inflation in Israel is not offset (or is offset on a lagging basis) by a devaluation of the NIS in relation to the U.S. dollar.&#160; If the U.S. dollar declines in value in relation to the NIS, it will become more expensive for us to fund our operations in Israel. In addition, as of June 30, 2017, we own net financial balances in NIS of approximately $1,702,000. Assuming a 10% appreciation of the NIS against the U.S. dollar, we would experience exchange rate gain of approximately $155,000, while assuming a 10% devaluation of the NIS against the U.S. dollars, we would experience an exchange rate loss of approximately $189,000, in both cases excluding the effect of our hedging transactions (as described below).</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">&#160;The exchange rate of the U.S. dollar to the NIS, based on exchange rates published by the Bank of Israel, was as follows:</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<table id="zd5655c46c04142d8913f5cd7f0253d71" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 85%" cellspacing="0" cellpadding="0" align="center" border="0">
<tr>
<td style="VERTICAL-ALIGN: top; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 2px solid" valign="bottom" colspan="10">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">Year Ended June 30,</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 2px solid" valign="bottom" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">2015</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 2px solid" valign="bottom" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">2016</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 2px solid" valign="bottom" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">2017</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 64%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Average rate for period</div>
</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">3.788</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">3.862</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">3.741</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 64%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Rate at period-end</div>
</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">3.769</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">3.846</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">3.496</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>
</table>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">We use currency transactions of forwards and options to decrease the risk of financial exposure from fluctuations in the exchange rate of the U.S. dollar against the NIS.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 35.45pt">As of June 30, 2017, we own 400,368 common shares of CHA, which are presented in our financial statements as marketable securities. The shares are listed on the KOSDAQ and the shares' price is denominated in KRW. We are exposed to changes in the market price of CHA shares, as well as to exchange rates fluctuations in the KRW currency compared to the U.S dollar. In February 2014, we entered into a forward contract with a notional principal of $11 million, to hedge against the foreign currency risk between the KRW and the U.S. dollar. The forward contract expired on December 26, 2014, resulting in a net gain of $59,000.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">For the year ended June 30, 2017, our net gain from hedging transactions that are non-designated and consist primarily of options strategies to minimize the risk associated with the foreign exchange effects of monetary assets and liabilities denominated in NIS was $265,000.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold"><a id="Item8" name="Item8"><!--Anchor--></a>Item 8.</font>&#160;&#160;&#160;&#160;<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold">Financial Statements and Supplementary Data.</font></div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">Our financial statements are stated in thousands United States dollars (US$) and are prepared in accordance with U.S. GAAP.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">The following audited consolidated financial statements are filed as part of this Annual Report:</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">Reports of Independent Registered Public Accounting Firm, dated September 7, 2017.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">Consolidated Balance Sheets.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">Consolidated Statements of Operations.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">Consolidated Statements of Comprehensive Loss.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">Statements of Changes in Equity.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">Consolidated Statements of Cash Flows.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">Notes to the Consolidated Financial Statements.</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always; TEXT-ALIGN: center">44

<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; WIDTH: 100%; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<div><br>
</div>

<div id="DSPFPageHeader"></div>

<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 11.15pt"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 11.15pt">PLURISTEM THERAPEUTICS INC. AND ITS SUBSIDIARY</div>

<div style="FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 11.15pt">&#160;</div>

<div style="FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">CONSOLIDATED FINANCIAL STATEMENTS</div>

<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">As of June 30, 2017</font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><br>
</font></div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; WIDTH: 100%; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 11.15pt">PLURISTEM THERAPEUTICS INC. AND ITS SUBSIDIARY</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; MARGIN-LEFT: 11.15pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 11.15pt">CONSOLIDATED FINANCIAL STATEMENTS</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="TEXT-ALIGN: center; MARGIN-LEFT: 11.15pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 11.15pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold">As of June 30, 2017<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><br>
</font></font><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; MARGIN-LEFT: 11.15pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 11.15pt">&#160;U.S. DOLLARS IN THOUSANDS</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; MARGIN-LEFT: 11.15pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 11.15pt"><u>INDEX</u></div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div>
<table id="z9638a5a0eb464bb6bd111ef635e882f9" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; BORDER-COLLAPSE: collapse; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 87.71%">&#160;</td>
<td style="VERTICAL-ALIGN: top; BORDER-BOTTOM: black 2px solid; WIDTH: 12.29%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; MARGIN-LEFT: 11.15pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 11.15pt">Page</div>
</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 87.71%">&#160;</td>
<td style="VERTICAL-ALIGN: top; WIDTH: 12.29%">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: left; WIDTH: 87.71%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; MARGIN-LEFT: 10.8pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 11.15pt"><a href="#REPORT">Reports of Independent Registered Public Accounting Firm</a></div>
</td>
<td style="VERTICAL-ALIGN: top; WIDTH: 12.29%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; MARGIN-LEFT: 5.6pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 7.6pt">F - 2- F - 3</div>
</td>
</tr>

<tr style="HEIGHT: 14px">
<td style="VERTICAL-ALIGN: top; WIDTH: 87.71%">&#160;</td>
<td style="VERTICAL-ALIGN: top; WIDTH: 12.29%">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 87.71%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 10.8pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 11.15pt"><a href="#BALANCESHEETS">Consolidated Balance Sheets</a></div>
</td>
<td style="VERTICAL-ALIGN: top; WIDTH: 12.29%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; MARGIN-LEFT: 5.6pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 7.6pt">F - 4 - F - 5</div>
</td>
</tr>

<tr style="HEIGHT: 17px">
<td style="VERTICAL-ALIGN: top; WIDTH: 87.71%">&#160;</td>
<td style="VERTICAL-ALIGN: top; WIDTH: 12.29%">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 87.71%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 10.8pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 11.15pt"><a href="#OPERATIONS">Consolidated Statements of Operations</a></div>
</td>
<td style="VERTICAL-ALIGN: top; WIDTH: 12.29%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; MARGIN-LEFT: 5.6pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 7.6pt">F - 6</div>
</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 87.71%">&#160;</td>
<td style="VERTICAL-ALIGN: top; WIDTH: 12.29%">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 87.71%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 10.8pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 11.15pt"><a href="#COMPREHENSIVELOSS">Consolidated Statements of Comprehensive Loss</a></div>
</td>
<td style="VERTICAL-ALIGN: top; WIDTH: 12.29%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; MARGIN-LEFT: 5.6pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 7.6pt">F - 7</div>
</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 87.71%">&#160;</td>
<td style="VERTICAL-ALIGN: top; WIDTH: 12.29%">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 87.71%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 10.8pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 11.15pt"><a href="#STOCKHOLDERSEQUITY">Statements of Changes in Stockholders&#8217; Equity</a></div>
</td>
<td style="VERTICAL-ALIGN: top; WIDTH: 12.29%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; MARGIN-LEFT: 5.6pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 7.6pt">F - 8 - F - 10</div>
</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 87.71%">&#160;</td>
<td style="VERTICAL-ALIGN: top; WIDTH: 12.29%">&#160;</td>
</tr>

<tr style="HEIGHT: 16px">
<td style="VERTICAL-ALIGN: top; WIDTH: 87.71%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 10.8pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 11.15pt"><a href="#CASHFLOWS">Consolidated Statements of Cash Flows</a></div>
</td>
<td style="VERTICAL-ALIGN: top; WIDTH: 12.29%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; MARGIN-LEFT: 5.6pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 7.6pt">F - 11</div>
</td>
</tr>

<tr style="HEIGHT: 18px">
<td style="VERTICAL-ALIGN: top; WIDTH: 87.71%">&#160;</td>
<td style="VERTICAL-ALIGN: top; WIDTH: 12.29%">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 87.71%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 10.8pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 11.15pt"><a href="#NOTES">Notes to Consolidated Financial Statements</a></div>
</td>
<td style="VERTICAL-ALIGN: top; WIDTH: 12.29%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; MARGIN-LEFT: 5.6pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 7.6pt">F - 12 - F - 40</div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; WIDTH: 100%; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<!--PROfilePageNumberReset%Num%2%F - %%-->
<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="LINE-HEIGHT: 1.25">
<table id="z2a3fc6ba81474b989060916ccae88a0d" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; BORDER-COLLAPSE: collapse; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 77.18%"><img style="HEIGHT: 114px; WIDTH: 99px" src="image0.jpg"></td>
<td style="VERTICAL-ALIGN: top; WIDTH: 22.82%"><font style="FONT-WEIGHT: bold">Kost Forer Gabbay &amp; Kasierer</font>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">2 Pal-Yam Ave.</font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><br>
</font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">Haifa 330905, Israel</font></div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Tel:&#160; 972 (4)8654021</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Fax: 972(3)<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold">&#160;</font>5633439</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">www.ey.com</div>
</div>
</td>
</tr>
</table>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25"><a id="REPORT" name="REPORT"><!--Anchor--></a>REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">To The Board of Directors and Stockholders Of</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">PLURISTEM THERAPEUTICS INC.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">We have audited the accompanying consolidated balance sheets of Pluristem Therapeutics Inc. and its subsidiary (the &#8220;Company&#8221;) as of June 30, 2017 and 2016, and the related consolidated statements of <a id="OLE_LINK13" name="OLE_LINK13"><!--Anchor--></a><a id="OLE_LINK14" name="OLE_LINK14"><!--Anchor--></a>operations, comprehensive loss, changes in stockholders&#8217; equity and cash flows for each of the three years in the period ended June 30, 2017. These consolidated financial statements are the responsibility of the Company&#8217;s management. Our responsibility is to express an opinion on these financial statements based on our audits.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">We conducted our audits in accordance with the standards of the Public Company Accounting Oversight Board (United States). Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement. An audit includes examining, on a test basis, evidence supporting the amounts and disclosures in the financial statements. An audit also includes assessing the accounting principles used and significant estimates made by management, as well as evaluating the overall financial statement presentation. We believe that our audits provide a reasonable basis for our opinion.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">In our opinion, the consolidated financial statements referred to above present fairly, in all material respects, the consolidated financial position of the Company as of June 30, 2017 and 2016, and the consolidated results of its operations and its cash flows for each of the three years in the period ended June 30, 2017, in conformity with U.S. generally accepted accounting principles.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">The accompanying consolidated financial statements have been prepared assuming that the Company will continue as a going concern. As discussed in Note 1b to the consolidated financial statements, the Company has recurring losses from operations and has limited liquidity resources that raise substantial doubt about its ability to continue as a going concern. Management&#8217;s plans in regard to these matters are also described in Note 1b. The consolidated financial statements do not include any adjustments that might result from the outcome of this uncertainty</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States), the Company&#8217;s internal control over financial reporting as of June 30, 2017, based on criteria established in Internal Control-Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (2013 framework), and our report dated <font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">September 7, </font>201<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">7, </font>expressed an unqualified opinion thereon.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="LINE-HEIGHT: 1.25">
<table id="z2eaf72819e404b71a252948bf09b480c" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0" border="0">
<tr>
<td style="WIDTH: 50%">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25"><!--Anchor--><!--Anchor--><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">Haifa, Israel</font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25"><!--Anchor--><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">September 7, 2017</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>
</td>
<td style="TEXT-ALIGN: center; WIDTH: 50%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal"><u>/s/ Kost Forer Gabbay &amp; Kasierer </u></font>

<div>Kost Forer Gabbay &amp; Kasierer </div>

<div>A Member of Ernst &amp; Young Global</div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal">F - 2</font></div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; WIDTH: 100%; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="LINE-HEIGHT: 1.25">
<table id="z94c470f2be1c4ed48b94c4dd05fd991b" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; BORDER-COLLAPSE: collapse; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: left; WIDTH: 77.18%"><img style="HEIGHT: 114px; WIDTH: 99px" src="image0.jpg"></td>
<td style="VERTICAL-ALIGN: top; WIDTH: 22.82%"><font style="FONT-WEIGHT: bold">Kost Forer Gabbay &amp; Kasierer</font>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">2 Pal-Yam Ave.</font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><br>
</font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">Haifa 330905, Israel</font></div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Tel:&#160; 972 (4)8654021</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Fax: 972(3)<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold">&#160;</font>5633439</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">www.ey.com</div>
</div>
</td>
</tr>
</table>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">To The Board of Directors and Stockholders Of</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">PLURISTEM THERAPEUTICS INC.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">We have audited Pluristem Therapeutics Inc. and its subsidiary internal control over financial reporting as of June 30, 2017, based on criteria established in Internal Control&#8212;Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (2013 framework) (the &#8220;COSO criteria&#8221;). Pluristem Therapeutics Inc. and its subsidiary&#8217;s management is responsible for maintaining effective internal control over financial reporting, and for its assessment of the effectiveness of&#160; internal control over financial reporting included in the accompanying Management&#8217;s Report on Internal Control over Financial Reporting. Our responsibility is to express an opinion on the company&#8217;s internal control over financial reporting based on our audit.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">We conducted our audit in accordance with the standards of the Public Company Accounting Oversight Board (United States). Those standards require that we plan and perform the audit to obtain reasonable assurance about whether effective internal control over financial reporting was maintained in all material respects. Our audit included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, testing and evaluating the design and operating effectiveness of internal control based on the assessed risk, and performing such other procedures as we considered necessary in the circumstances. We believe that our audit provides a reasonable basis for our opinion.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">A company&#8217;s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company&#8217;s internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company&#8217;s assets that could have a material effect on the financial statements.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">In our opinion, Pluristem Therapeutics Inc. and its subsidiary maintained, in all material respects, effective internal control over financial reporting as of June 30, 2017, based on the COSO criteria.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States), the consolidated balance sheets of Pluristem Therapeutics Inc. and its subsidiary as of June 30, 2017 and 2016 and the related consolidated statements of operations, comprehensive loss, changes in stockholders&#8217; equity and cash flows for each of the three years in the period ended June 30, 2017, and our report dated September 7, 2017, expressed an unqualified opinion thereon that included an explanatory paragraph about Pluristem Therapeutics Inc. and its subsidiary&#8217;s ability to continue as a going concern.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="LINE-HEIGHT: 1.25">
<table id="z558679036d5a4cda99415d596d13f234" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0" border="0">
<tr>
<td style="WIDTH: 50%">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25"><!--Anchor--><!--Anchor--><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">Haifa, Israel</font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25"><!--Anchor--><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">September 7, 2017</font></div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>
</td>
<td style="TEXT-ALIGN: center; WIDTH: 50%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal"><u>/s/ Kost Forer Gabbay &amp; Kasierer </u></div>

<div>Kost Forer Gabbay &amp; Kasierer </div>

<div>A Member of Ernst &amp; Young Global</div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
 &#160;</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal">F - 3</font></div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; WIDTH: 100%; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div style="FONT-WEIGHT: bold; TEXT-ALIGN: right; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-WEIGHT: bold; TEXT-ALIGN: right; LINE-HEIGHT: 1.25">PLURISTEM THERAPEUTICS INC. AND ITS SUBSIDIARY</div>

<div id="DSPFPageHeader">
<table id="z0b1e84daa2d746cb969c0e36e2936d1c" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; BORDER-COLLAPSE: collapse; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 100%">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 2px solid; WIDTH: 100%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">CONSOLIDATED <a id="BALANCESHEETS" name="BALANCESHEETS"><!--Anchor--></a>BALANCE SHEETS</div>
</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 100%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 11.15pt">U.S. Dollars in thousands&#160; (except share and per share data)</div>
</td>
</tr>
</table>

<div style="LINE-HEIGHT: 1.25">&#160;</div>
</div>

<div>
<table id="z5335c37001d840088428269846262a63" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: top; WIDTH: 156px" valign="bottom" colspan="2">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 13px" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 18px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid" valign="bottom" colspan="6">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 2pt">June 30,</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 2px solid; WIDTH: 156px" valign="bottom" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 2pt">Note</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 13px" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 18px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid" valign="bottom" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 2pt">2017</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid" valign="bottom" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 2pt">2016</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr style="HEIGHT: 19px">
<td style="VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; MARGIN-LEFT: 14.15pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 14.15pt; TEXT-INDENT: -11.35pt">ASSETS</div>
</td>
<td style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: top; WIDTH: 156px; BACKGROUND-COLOR: #cceeff" valign="bottom" colspan="2">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 13px; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 18px; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom" colspan="2">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom" colspan="2">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: top; WIDTH: 156px; BACKGROUND-COLOR: #ffffff" valign="bottom" colspan="2">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 13px; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 18px; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom" colspan="2">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom" colspan="2">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 14.15pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 14.15pt; TEXT-INDENT: -11.35pt">CURRENT ASSETS:</div>
</td>
<td style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: top; WIDTH: 156px; BACKGROUND-COLOR: #cceeff" valign="bottom" colspan="2">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 13px; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 18px; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom" colspan="2">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom" colspan="2">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: top; WIDTH: 156px; BACKGROUND-COLOR: #ffffff" valign="bottom" colspan="2">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 13px; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 18px; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff" valign="bottom" colspan="2">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff" valign="bottom" colspan="2">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 14.15pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 14.15pt; TEXT-INDENT: -11.35pt">Cash and cash equivalents</div>
</td>
<td style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: top; WIDTH: 156px; BACKGROUND-COLOR: #cceeff" valign="bottom" colspan="2">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 13px; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 18px; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">4,707</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">6,223</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 14.15pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 14.15pt; TEXT-INDENT: -11.35pt">Short-term bank deposits</div>
</td>
<td style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: top; WIDTH: 156px; BACKGROUND-COLOR: #ffffff" valign="bottom" colspan="2">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 13px; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 18px; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">6,235</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">8,570</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 64%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 14.15pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 14.15pt; TEXT-INDENT: -11.35pt">Restricted cash and short-term bank deposits</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9.1%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">2f</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">&#160;</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 1.17%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">559</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">542</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 64%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 14.15pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 14.15pt; TEXT-INDENT: -11.35pt">Marketable securities</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9.1%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">3</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 1.17%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">15,164</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">17,415</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 64%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 14.15pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 14.15pt; TEXT-INDENT: -11.35pt">Accounts receivable from the Israeli Innovation Authority (&#8220;IIA&#8221;)</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9.1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 1.17%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">1,036</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">2,228</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; PADDING-BOTTOM: 2px; WIDTH: 64%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 14.15pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 14.15pt; TEXT-INDENT: -11.35pt">Other current assets</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: right; WIDTH: 9.1%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">5</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: right; WIDTH: 1.17%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">1,315</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">618</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; WIDTH: 64%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div>&#160; <font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #cceeff"><u>Total</u></font> current assets</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: right; WIDTH: 9.1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: right; WIDTH: 1.17%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">29,016</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">35,596</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 64%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9.1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 1.17%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 64%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 14.15pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 14.15pt; TEXT-INDENT: -11.35pt">LONG-TERM ASSETS:</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9.1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 1.17%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 64%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9.1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 1.17%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr style="HEIGHT: 19px">
<td style="VERTICAL-ALIGN: top; WIDTH: 64%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 14.15pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 14.15pt; TEXT-INDENT: -11.35pt">Long-term deposits and restricted bank deposits</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9.1%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">2g</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">&#160;</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 1.17%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">403</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">363</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr style="HEIGHT: 18px">
<td style="VERTICAL-ALIGN: top; WIDTH: 64%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 14.15pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 14.15pt; TEXT-INDENT: -11.35pt">Severance pay fund</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9.1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 1.17%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">804</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">766</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr style="HEIGHT: 19px">
<td style="VERTICAL-ALIGN: top; WIDTH: 64%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 14.15pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 14.15pt; TEXT-INDENT: -11.35pt">Property and equipment, net</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9.1%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">6</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 1.17%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">7,277</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">9,216</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr style="HEIGHT: 22px">
<td style="VERTICAL-ALIGN: top; PADDING-BOTTOM: 2px; WIDTH: 64%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 14.15pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 14.15pt; TEXT-INDENT: -11.35pt">
<div id="DSPFPageHeader"></div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Other long-term assets</div>
</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: right; WIDTH: 9.1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: right; WIDTH: 1.17%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">34</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr style="HEIGHT: 21px">
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-VARIANT: normal; VERTICAL-ALIGN: top; FONT-WEIGHT: normal; FONT-STYLE: normal; WIDTH: 64%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div>&#160; <font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #cceeff"><u>Total</u></font> long-term assets</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: right; WIDTH: 9.1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: right; WIDTH: 1.17%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">8,518</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">10,345</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 64%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9.1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 1.17%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; WIDTH: 64%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div>&#160; <font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #cceeff"><u>Tota</u></font>l assets</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: right; WIDTH: 9.1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: right; WIDTH: 1.17%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">37,534</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">45,941</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">The accompanying notes are an integral part of the consolidated financial statements.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal">F - 4</font></div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; WIDTH: 100%; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div id="DSPFPageHeader">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: right; MARGIN-LEFT: 72pt; LINE-HEIGHT: 1.25">PLURISTEM THERAPEUTICS INC. AND ITS SUBSIDIARY</div>

<table id="zd0e09320650748029cf693c34a6653af" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; BORDER-COLLAPSE: collapse; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 100%">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 2px solid; WIDTH: 100%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">CONSOLIDATED BALANCE SHEETS</div>
</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 100%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 11.15pt">U.S. Dollars in thousands&#160; (except share and per share data)</div>
</td>
</tr>
</table>

<div style="LINE-HEIGHT: 1.25">&#160;</div>
</div>

<div>
<table id="z4a7d8dc12e9c4e6b9e5366c863c7f9d1" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: top" valign="bottom" colspan="2">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid" valign="bottom" colspan="6">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 2pt">June 30,</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 2px solid" valign="bottom" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 2pt">Note</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid" valign="bottom" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 2pt">2017</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid" valign="bottom" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 2pt">2016</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; MARGIN-LEFT: 14.15pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 14.15pt; TEXT-INDENT: -11.35pt">LIABILITIES AND STOCKHOLDERS&#8217; EQUITY</div>
</td>
<td style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff" valign="bottom" colspan="2">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom" colspan="2">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom" colspan="2">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff" valign="bottom" colspan="2">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom" colspan="2">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom" colspan="2">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 14.15pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 14.15pt; TEXT-INDENT: -11.35pt">CURRENT LIABILITIES</div>
</td>
<td style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff" valign="bottom" colspan="2">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom" colspan="2">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom" colspan="2">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff" valign="bottom" colspan="2">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom" colspan="2">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom" colspan="2">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 14.15pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 14.15pt; TEXT-INDENT: -11.35pt">Trade payables</div>
</td>
<td style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff" valign="bottom" colspan="2">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">1,966</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">2,705</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 14.15pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 14.15pt; TEXT-INDENT: -11.35pt">Accrued expenses</div>
</td>
<td style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff" valign="bottom" colspan="2">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">1,465</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">1,369</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; PADDING-BOTTOM: 2px; WIDTH: 64%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 14.15pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 14.15pt; TEXT-INDENT: -11.35pt">Other accounts payable</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">7,2n</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap"></td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">1,983</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">1,701</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; PADDING-BOTTOM: 2px; WIDTH: 64%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 14.15pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 14.15pt; TEXT-INDENT: -11.35pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #ffffff"><u>Total</u></font> current liabilities</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">5,414</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">5,775</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 64%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 64%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 14.15pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 14.15pt; TEXT-INDENT: -11.35pt">LONG-TERM LIABILITIES</div>
</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 64%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 64%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 14.15pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 14.15pt; TEXT-INDENT: -11.35pt">Accrued severance pay</div>
</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">940</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">910</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr style="HEIGHT: 22px">
<td style="VERTICAL-ALIGN: top; PADDING-BOTTOM: 2px; WIDTH: 64%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 14.15pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 14.15pt; TEXT-INDENT: -11.35pt">Other long-term liabilities</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">2n</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">&#160;</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">929</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">1,100</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; PADDING-BOTTOM: 2px; WIDTH: 64%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 14.15pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 14.15pt; TEXT-INDENT: -11.35pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #ffffff"><u>Total</u></font> long-term liabilities</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">1,869</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">2,010</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 64%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 64%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 14.15pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 14.15pt; TEXT-INDENT: -11.35pt">COMMITMENTS AND CONTINGENCIES</div>
</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">8</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 64%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 64%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 14.15pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 14.15pt; TEXT-INDENT: -11.35pt">STOCKHOLDERS&#8217; EQUITY</div>
</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 64%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 64%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 14.15pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 14.15pt; TEXT-INDENT: -11.35pt">Share capital:</div>
</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">9</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 64%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 14.15pt">&#160;&#160;&#160;&#160;&#160;Common stock&#160; $0.00001 par value per share:</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 14.15pt">&#160;&#160;&#160;&#160;&#160;Authorized: 200,000,000 shares&#160;Issued and </div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 14.15pt">&#160;&#160;&#160;&#160; outstanding:&#160; 96,938,789 shares as of June 30, 2017; </div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 14.15pt">&#160;&#160;&#160;&#160; 80,268,999 shares as of June 30, 2016</div>
</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">1</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">1</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 64%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 14.15pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 14.15pt; TEXT-INDENT: -11.35pt">Additional paid-in capital</div>
</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="TEXT-ALIGN: right">217,822</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="TEXT-ALIGN: right">198,432</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 64%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 14.15pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 14.15pt; TEXT-INDENT: -11.35pt">Accumulated deficit</div>
</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(189,571</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(161,757</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; PADDING-BOTTOM: 2px; WIDTH: 64%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 14.15pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 14.15pt; TEXT-INDENT: -11.35pt">Other comprehensive income</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">1,999</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">1,480</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; PADDING-BOTTOM: 4px; WIDTH: 64%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 14.15pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 14.15pt; TEXT-INDENT: -11.35pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #cceeff"><u>Total</u></font> stockholders&#8217; equity</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">30,251</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">38,156</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 64%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; PADDING-BOTTOM: 4px; WIDTH: 64%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 14.15pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 14.15pt; TEXT-INDENT: -11.35pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #cceeff"><u>Total</u></font> liabilities and stockholders&#8217; equity</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">37,534</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">45,941</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div id="DSPFPageFooter">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">The accompanying notes are an integral part of the consolidated financial statements.</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">&#160;</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal">F - 5</font></div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; WIDTH: 100%; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>
</div>

<div id="DSPFPageHeader">
<div style="LINE-HEIGHT: 1.25">
<div id="DSPFPageHeader"></div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: right; MARGIN-LEFT: 72pt; LINE-HEIGHT: 1.25">PLURISTEM THERAPEUTICS INC. AND ITS SUBSIDIARY</div>

<table id="z0ff1b7e25f46437b9ab0d31f8232a17d" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; BORDER-COLLAPSE: collapse; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 100%">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 2px solid; WIDTH: 100%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">CONSOLIDATED STATEMENTS OF&#160;<a id="OPERATIONS" name="OPERATIONS"><!--Anchor--></a> OPERATIONS</div>
</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 100%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 11.15pt">U.S. Dollars in thousands (except share and per share data)</div>
</td>
</tr>
</table>

<div id="DSPFPageFooter">&#160;</div>
</div>
</div>

<div>
<table id="z9bff2f53c6674c30ae404c7aeaef1fc0" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="VERTICAL-ALIGN: top; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: top" valign="bottom" colspan="2">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 2px solid" valign="bottom" colspan="10">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">Year ended June 30,</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 2px solid" valign="bottom" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">Note</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 2px solid" valign="bottom" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">2017</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 2px solid" valign="bottom" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">2016</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 2px solid" valign="bottom" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">2015</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: top" valign="bottom" colspan="2">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: top" valign="bottom" colspan="2">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: top" valign="bottom" colspan="2">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom" valign="bottom" colspan="2">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr style="HEIGHT: 18px">
<td style="VERTICAL-ALIGN: top; WIDTH: 52%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Revenues</div>
</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">1c, 2i</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">&#160;</div>
</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">2,847</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">379</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; PADDING-BOTTOM: 2px; WIDTH: 52%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Cost of revenues</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(100</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">)&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(13</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: middle; PADDING-BOTTOM: 2px; WIDTH: 52%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Gross profit</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">2,747</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">366</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 52%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Research and development expenses</div>
</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(24,001</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">)&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(22,856</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">)&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(23,416</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">)&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; PADDING-BOTTOM: 2px; WIDTH: 52%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Less R&amp;D participation grants</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">2,909</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">3,276</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">4,243</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 52%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Research and development expenses, net</div>
</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(21,092</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(19,580</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(19,173</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; PADDING-BOTTOM: 2px; WIDTH: 52%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">General and administrative expenses</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(6,927</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(6,486</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(6,460</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 52%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 52%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">Operating </font>loss</div>
</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(28,019</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(23,319</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(25,267</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 52%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; PADDING-BOTTOM: 2px; WIDTH: 52%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Financial income, net</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">10</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">205</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">73</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">590</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 52%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; PADDING-BOTTOM: 4px; WIDTH: 52%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Net loss for the period</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(27,814</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(23,246</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(24,677</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 52%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 52%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Loss per share:</div>
</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; PADDING-BOTTOM: 4px; WIDTH: 52%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Basic and diluted net loss per share</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(0.32</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(0.29</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(0.35</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 52%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; PADDING-BOTTOM: 4px; WIDTH: 52%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="LINE-HEIGHT: 1.25">Weighted average number of shares used&#160; in computing basic and diluted net loss&#160; per share</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">87,426,208</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">79,547,989</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">70,284,337</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div id="DSPFPageFooter">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">The accompanying notes are an integral part of the consolidated financial statements.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal">F - 6</font></div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; WIDTH: 100%; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>
</div>

<div id="DSPFPageHeader">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: right; MARGIN-LEFT: 72pt; LINE-HEIGHT: 1.25">PLURISTEM THERAPEUTICS INC. AND ITS SUBSIDIARY</div>

<table id="z62db96a7df554f0dbc84845797199fdb" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; BORDER-COLLAPSE: collapse; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 100%">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 2px solid; WIDTH: 100%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">CONSOLIDATED STATEMENTS OF <a id="COMPREHENSIVELOSS" name="COMPREHENSIVELOSS"><!--Anchor--></a>COMPREHENSIVE&#160; LOSS</div>
</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 100%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 11.15pt">U.S. Dollars in thousands</div>
</td>
</tr>
</table>

<div style="LINE-HEIGHT: 1.25">&#160;</div>
</div>

<div>
<table id="z1d5fbbc0c5ad46c29f2a0c0f031ffb12" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="VERTICAL-ALIGN: top; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 2px solid; FONT-WEIGHT: bold; TEXT-ALIGN: center" valign="bottom" colspan="10">Year ended June 30,</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 2px solid" valign="bottom" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">2017</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 2px solid" valign="bottom" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">2016</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 2px solid" valign="bottom" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">2015</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom" valign="bottom" colspan="2">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom" valign="bottom" colspan="2">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom" valign="bottom" colspan="2">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 64%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Net loss</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(27,814</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(23,246</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(24,677</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 64%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Other comprehensive income (loss), net:</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 64%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Unrealized gain on derivative instruments</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">285</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 64%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Unrealized gain (loss) on available-for-sale marketable securities, net</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">924</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(1,071</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(1,132</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 64%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">Reclassification adjustment of </font>derivative instruments<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"> losses realized in net loss, net</font></div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(46</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(262</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; PADDING-BOTTOM: 2px; WIDTH: 64%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Reclassification adjustment of available-for-sale marketable securities gains (losses) realized in net loss, net</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(405</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">457</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">290</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: middle; PADDING-BOTTOM: 4px; WIDTH: 64%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Other comprehensive income (loss)</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">519</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(660</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(819</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: middle; PADDING-BOTTOM: 4px; WIDTH: 64%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Total comprehensive loss</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(27,295</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(23,906</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(25,496</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
</tr>
</table>
</div>

<div id="DSPFPageFooter">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">The accompanying notes are an integral part of the consolidated financial statements.</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">&#160;</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal">F - 7</font></div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; WIDTH: 100%; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>
</div>

<div id="DSPFPageHeader">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: right; LINE-HEIGHT: 1.25">PLURISTEM THERAPEUTICS INC. AND ITS SUBSIDIARY</div>

<table id="z3709859df1e34eb5aa7fbe11f8361371" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; BORDER-COLLAPSE: collapse; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 100%">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 2px solid; WIDTH: 100%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">STATEMENTS OF CHANGES IN <a id="STOCKHOLDERSEQUITY" name="STOCKHOLDERSEQUITY"><!--Anchor--></a>STOCKHOLDERS&#8217; EQUITY</div>
</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 100%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 11.15pt">U.S. Dollars in thousands (except share and per share data)</div>
</td>
</tr>
</table>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>
</div>

<div>
<table id="z9079c58129644a1885a43874b6d9f0d0" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="VERTICAL-ALIGN: top" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom" valign="bottom" colspan="6">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">Common Stock</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: center" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; LINE-HEIGHT: 1.25">Additional Paid-in</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: center" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; LINE-HEIGHT: 1.25">Receivables </div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; LINE-HEIGHT: 1.25">on account</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom" valign="bottom" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">Accumulated Other Comprehensive</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom" valign="bottom" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">Accumulated</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom" valign="bottom" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">Total Stockholders&#8217;</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 2px solid" valign="bottom" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">Shares</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 2px solid" valign="bottom" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">Amount</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 2px solid" valign="bottom" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">Capital</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 2px solid" valign="bottom" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">of shares</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 2px solid" valign="bottom" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">Income (Loss)</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 2px solid" valign="bottom" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">Deficit</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 2px solid" valign="bottom" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">Equity</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 16%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; MARGIN-LEFT: 15.3pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -15.3pt">Balance as of July 1, 2014</div>
</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">68,601,452</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(*</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">172,998</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">2,959</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(113,834</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">62,123</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 16%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 15.3pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -15.3pt">Issuance of common stock and warrants related to June 2015 offering, net of issuance costs of $1,200 (Note 9c)</div>
</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">6,800,000</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">1</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">15,799</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">15,800</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 16%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 15.3pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -15.3pt">Exercise of options by employees and&#160; non-employee consultants</div>
</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">39,000</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(*</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">11</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">11</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 16%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 15.3pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -15.3pt">Exercise of warrants by investors and finders</div>
</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">1,134,043</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(*</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">276</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">276</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 16%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 15.3pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -15.3pt">Stock based compensation to employees, directors and non-employee consultants</div>
</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">1,397,406</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(*</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">4,052</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">4,052</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 16%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Issuance of common stock </div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;&#160;&#160;&#160;&#160;&#160; in a private&#160;placement </div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;&#160;&#160;&#160;&#160; (Note 9b)</div>
</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">700,000</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(*</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">1,904</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(790</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">1,114</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 16%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Stock based compensation to </div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;&#160;&#160;&#160;&#160;&#160; contractor (Note 9d)</div>
</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">100,004</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(*</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">263</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="LINE-HEIGHT: 1.25"></div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">263</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 16%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Other comprehensive loss, net</div>
</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(819</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(819</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; PADDING-BOTTOM: 2px; WIDTH: 16%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Net loss</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(24,677</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(24,677</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; PADDING-BOTTOM: 4px; WIDTH: 16%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Balance as of June 30, 2015</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">78,771,905</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">1</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">195,303</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(790</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">2,140</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(138,511</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">58,143</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>
</table>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">(*)&#160; Less than $1</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">The accompanying notes are an integral part of the consolidated financial statements.</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">&#160;</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal">F - 8</font></div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; WIDTH: 100%; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div style="LINE-HEIGHT: 1.25">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: right; LINE-HEIGHT: 1.25">PLURISTEM THERAPEUTICS INC. AND ITS SUBSIDIARY</div>

<table id="z16818b18cd5a44e2bfd882e99a2d8d6f" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; BORDER-COLLAPSE: collapse; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 100%">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 2px solid; WIDTH: 100%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">STATEMENTS OF CHANGES IN STOCKHOLDERS&#8217; EQUITY</div>
</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 100%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 11.15pt">U.S. Dollars in thousands (except share and per share data)</div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div>
<table id="zb04a98fe26db4938b8d00045eeb50892" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="VERTICAL-ALIGN: top" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom" valign="bottom" colspan="6">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">Common Stock</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom" valign="bottom" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">Additional Paid-in</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom" valign="bottom" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">Receivables on account</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom" valign="bottom" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">Accumulated Other Comprehensive</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom" valign="bottom" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">Accumulated</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom" valign="bottom" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">Total Stockholders&#8217;</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid" valign="bottom" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">Shares</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid" valign="bottom" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">Amount</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid" valign="bottom" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">Capital</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid" valign="bottom" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">of shares</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid" valign="bottom" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">Income (Loss)</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid" valign="bottom" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">Deficit</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid" valign="bottom" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">Equity</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 16%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; MARGIN-LEFT: 15.3pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -15.3pt">Balance as of July 1, 2015</div>
</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">78,771,905</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">1</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">195,303</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(790</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">2,140</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(138,511</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">58,143</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 16%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 15.3pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -15.3pt">Exercise of options by employees and&#160; non-employee consultants</div>
</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">28,000</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(*</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">17</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">17</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 16%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 15.3pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -15.3pt">Stock-based compensation to employees, directors and non-employee consultants</div>
</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">1,379,094</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(*</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">3,073</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">3,073</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; WIDTH: 16%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div>Proceeds related to issuance </div>

<div>&#160;&#160;&#160;&#160;&#160; of&#160;common&#160;stock in a </div>

<div>&#160;&#160;&#160;&#160;&#160; private placement </div>

<div>&#160;&#160;&#160;&#160;&#160; (Note 9b)</div>
</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">790</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">790</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; WIDTH: 16%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div>Stock-based compensation to</div>

<div>&#160;&#160;&#160;&#160; &#160;contractor (Note 9d)</div>
</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">90,000</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(*</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">39</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">39</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 16%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Other comprehensive loss, net</div>
</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(660</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(660</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; PADDING-BOTTOM: 2px; WIDTH: 16%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Net loss</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(23,246</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(23,246</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; PADDING-BOTTOM: 4px; WIDTH: 16%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Balance as of June 30, 2016</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">80,268,999</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">1</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">198,432</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">1,480</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(161,757</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">38,156</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>
</table>
</div>

<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">(*)&#160; Less than $1</div>

<br style="LINE-HEIGHT: 1.25">
 The accompanying notes are an integral part of the consolidated financial statements.</div>

<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25">&#160;</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal">F - 9</font></div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; WIDTH: 100%; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div style="LINE-HEIGHT: 1.25">
<div style="TEXT-ALIGN: right; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: right; LINE-HEIGHT: 1.25">PLURISTEM THERAPEUTICS INC. AND ITS SUBSIDIARY</div>

<table id="z6fc7eafc04804dca9edfbaad219ecf0c" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; BORDER-COLLAPSE: collapse; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 100%">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 2px solid; WIDTH: 100%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">STATEMENTS OF CHANGES IN STOCKHOLDERS&#8217; EQUITY</div>
</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 100%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 11.15pt">U.S. Dollars in thousands (except share and per share data)</div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div>
<table id="zb50e0f054ad2486590274513b7818b06" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="VERTICAL-ALIGN: top" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom" valign="bottom" colspan="6">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">Common Stock</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom" valign="bottom" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">Additional Paid-in</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom" valign="bottom" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">Accumulated Other Comprehensive</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom" valign="bottom" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">Accumulated</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom" valign="bottom" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">Total Stockholders&#8217;</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid" valign="bottom" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">Shares</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid" valign="bottom" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">Amount</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid" valign="bottom" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">Capital</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid" valign="bottom" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">Income (Loss)</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid" valign="bottom" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">Deficit</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid" valign="bottom" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">Equity</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 28%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; MARGIN-LEFT: 15.3pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -15.3pt">Balance as of July 1, 2016</div>
</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">80,268,999</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">1</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">198,432</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">1,480</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(161,757</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">38,156</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 28%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 15.3pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -15.3pt">Exercise of options by employees and&#160; non-employee consultants</div>
</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">17,900</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(*</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">10</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">10</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 28%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div>Stock-based compensation to employees, directors </div>

<div>&#160;&#160;&#160;&#160;&#160; and non-employee consultants</div>
</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">2,570,257</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(*</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">3,662</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">3,662</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 28%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Issuance of common stock and warrants related to </div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;&#160;&#160;&#160; January 2017&#160;offering,&#160; net of issuance costs </div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;&#160;&#160;&#160; of $1,532 (Note 9e)</div>
</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">14,081,633</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(*</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">15,718</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">15,718</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 28%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Other comprehensive income, net</div>
</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">519</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">519</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; PADDING-BOTTOM: 2px; WIDTH: 28%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Net loss</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(27,814</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(27,814</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; PADDING-BOTTOM: 4px; WIDTH: 28%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Balance as of June 30, 2017</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">96,938,789</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">1</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">217,822</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">1,999</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(189,571</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">30,251</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>
</table>
</div>

<div id="DSPFPageFooter">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">(*)&#160; Less than $1</div>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">The accompanying notes are an integral part of the consolidated financial statements.</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">&#160;</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal">F - 10</font></div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; WIDTH: 100%; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>
</div>

<div id="DSPFPageHeader">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: right; LINE-HEIGHT: 1.25">PLURISTEM THERAPEUTICS INC. AND ITS SUBSIDIARY</div>

<table id="zbfd72e7937a74e1ea892bfe1a9c74812" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; BORDER-COLLAPSE: collapse; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 100%">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 2px solid; WIDTH: 100%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">CONSOLIDATED STATEMENTS OF<a id="CASHFLOWS" name="CASHFLOWS"><!--Anchor--></a> CASH FLOWS</div>
</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 100%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 11.15pt">U.S. Dollars in thousands</div>
</td>
</tr>
</table>

<div style="LINE-HEIGHT: 1.25">&#160;</div>
</div>

<div>
<table id="z2960cd5e4259437a8d7cf1eb42afef2a" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="VERTICAL-ALIGN: top; PADDING-BOTTOM: 2px; PADDING-LEFT: 9pt" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid" valign="bottom" colspan="10">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 3.4pt">Year ended June 30,</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; PADDING-BOTTOM: 2px; PADDING-LEFT: 9pt" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 2px solid" valign="bottom" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 11pt">2017</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 2px solid" valign="bottom" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 11pt">2016</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 2px solid" valign="bottom" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">2015</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; PADDING-LEFT: 9pt" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: top" valign="bottom" colspan="2">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: top" valign="bottom" colspan="2">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: top" valign="bottom" colspan="2">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; PADDING-LEFT: 9pt; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; MARGIN-LEFT: 3.6pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -0.8pt">CASH FLOWS FROM OPERATING ACTIVITIES:</div>
</td>
<td style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff" valign="bottom" colspan="2">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff" valign="bottom" colspan="2">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff" valign="bottom" colspan="2">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; PADDING-LEFT: 9pt; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom" colspan="2">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom" colspan="2">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom" colspan="2">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; PADDING-LEFT: 9pt; WIDTH: 64%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 14.15pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 14.15pt; TEXT-INDENT: -11.35pt">Net loss</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(27,814</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(23,246</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(24,677</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; PADDING-LEFT: 9pt; WIDTH: 64%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; PADDING-LEFT: 9pt; WIDTH: 64%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 3.6pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 14.15pt">Adjustments to reconcile net loss to net cash used in operating activities:</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; PADDING-LEFT: 9pt; WIDTH: 64%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; PADDING-LEFT: 9pt; WIDTH: 64%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 3.6pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 14.15pt">Depreciation</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">2,177</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">2,150</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">2,074</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; PADDING-LEFT: 9pt; WIDTH: 64%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 14.15pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 14.15pt; TEXT-INDENT: -11.35pt">Loss from sale of property and equipment, net</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">72</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">82</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">20</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; PADDING-LEFT: 9pt; WIDTH: 64%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 3.6pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 14.15pt">Accretion of discount, amortization of premium and changes in accrued interest of marketable securities</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">35</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(114</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">213</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; PADDING-LEFT: 9pt; WIDTH: 64%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 3.6pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 14.15pt">&#160;Loss (gain) from sale of investments of available-for-sale marketable securities</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(362</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">419</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">290</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; PADDING-LEFT: 9pt; WIDTH: 64%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 3.6pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 14.15pt">Other-than-temporary loss of available-for-sale marketable securities</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">767</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">38</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; PADDING-LEFT: 9pt; WIDTH: 64%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 1.1pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 14.15pt">&#160;Stock-based compensation to employees, directors and non-employees consultants</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">3,662</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">3,073</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">4,052</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; PADDING-LEFT: 9pt; WIDTH: 64%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; PADDING-LEFT: 9pt; WIDTH: 64%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 14.15pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 14.15pt; TEXT-INDENT: -11.35pt">Decrease (increase) in Accounts receivable from the IIA</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">1,192</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(537</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">572</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; PADDING-LEFT: 9pt; WIDTH: 64%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 14.15pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 14.15pt; TEXT-INDENT: -11.35pt">Decrease (increase) in other current assets and other long-term assets</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(731</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">1,395</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(1,129</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; PADDING-LEFT: 9pt; WIDTH: 64%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; PADDING-LEFT: 9pt; WIDTH: 64%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 14.15pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 14.15pt; TEXT-INDENT: -11.35pt">Decrease in trade payables</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(701</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(77</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(566</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; PADDING-LEFT: 9pt; WIDTH: 64%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 3.6pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 14.15pt; TEXT-INDENT: -1.55pt">Increase (decrease) in other accounts payable, accrued expenses, other long-term liabilities and other current liabilities</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">138</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">1,225</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(949</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; PADDING-LEFT: 9pt; WIDTH: 64%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 3.6pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 14.15pt; TEXT-INDENT: -1.55pt">Decrease in deferred revenues</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(2,847</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(379</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; PADDING-LEFT: 9pt; WIDTH: 64%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 3.6pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 14.15pt; TEXT-INDENT: -1.55pt">Decrease in advance payment from United</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(93</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(154</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; PADDING-LEFT: 9pt; WIDTH: 64%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 3.6pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 14.15pt; TEXT-INDENT: -1.55pt">Increase (decrease) in interest receivable on short-term deposits</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(24</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(25</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">35</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; PADDING-LEFT: 9pt; WIDTH: 64%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 3.6pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 14.15pt">Linkage differences and interest on short and long-term&#160; deposits and restricted bank deposits</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(14</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(3</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">54</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; PADDING-LEFT: 9pt; WIDTH: 64%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 3.6pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 14.15pt">Accrued severance pay, net</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(8</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">38</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(61</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; PADDING-LEFT: 9pt; WIDTH: 64%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 3.6pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 14.15pt">Net cash used in operating activities</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(21,611</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(18,522</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(20,605</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; PADDING-LEFT: 9pt; WIDTH: 64%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; PADDING-LEFT: 9pt; WIDTH: 64%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; MARGIN-LEFT: 14.15pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -11.35pt">CASH FLOWS FROM INVESTING ACTIVITIES:</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; PADDING-LEFT: 9pt; WIDTH: 64%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; PADDING-LEFT: 9pt; WIDTH: 64%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 14.15pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 14.15pt; TEXT-INDENT: -11.35pt">Purchase of property and equipment</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(378</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(1,750</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(831</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; PADDING-LEFT: 9pt; WIDTH: 64%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 14.15pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 14.15pt; TEXT-INDENT: -11.35pt">Proceeds from sale of property and equipment</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">30</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">28</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">19</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; PADDING-LEFT: 9pt; WIDTH: 64%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 14.15pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 14.15pt; TEXT-INDENT: -11.35pt">Repayment of (investment in) short-term deposits</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">2,316</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(849</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">16,061</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; PADDING-LEFT: 9pt; WIDTH: 64%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 14.15pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 14.15pt; TEXT-INDENT: -11.35pt">Repayment of (investment in)&#160; long-term deposits and restricted bank deposits</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">5</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(78</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; PADDING-LEFT: 9pt; WIDTH: 64%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 14.15pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 14.15pt; TEXT-INDENT: -11.35pt">Proceeds from sale of available-for-sale marketable securities</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">5,527</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">6,999</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">10,635</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; PADDING-LEFT: 9pt; WIDTH: 64%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 14.15pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 14.15pt; TEXT-INDENT: -11.35pt">Proceeds from redemption of available-for-sale marketable securities</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">410</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">1,094</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">634</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; PADDING-BOTTOM: 2px; PADDING-LEFT: 9pt; WIDTH: 64%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 14.15pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 14.15pt; TEXT-INDENT: -11.35pt">Investment in available-for-sale marketable securities</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(3,607</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(4,215</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(4,903</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
</tr>

<tr style="HEIGHT: 18px">
<td style="VERTICAL-ALIGN: top; PADDING-BOTTOM: 2px; PADDING-LEFT: 9pt; WIDTH: 64%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 14.15pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 14.15pt; TEXT-INDENT: -11.35pt">Net cash provided by investing activities</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">4,298</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">1,312</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">21,537</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr style="HEIGHT: 13px">
<td style="VERTICAL-ALIGN: top; WIDTH: 64%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 64%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; MARGIN-LEFT: 12.6pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 14.15pt; TEXT-INDENT: -1.55pt">CASH FLOWS FROM FINANCING ACTIVITIES:</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 64%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 64%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 12.6pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 14.15pt; TEXT-INDENT: -1.55pt">Proceeds related to issuance of common stock and warrants, net of issuance costs</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">15,718</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">790</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">16,914</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 64%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 12.6pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 14.15pt; TEXT-INDENT: -1.55pt">Proceeds in respect of BIRD&#160;liability</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">69</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; PADDING-BOTTOM: 2px; WIDTH: 64%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 12.6pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 14.15pt; TEXT-INDENT: -1.55pt">Exercise of warrants and options</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">10</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">17</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">287</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; PADDING-BOTTOM: 2px; WIDTH: 64%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 23.15pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 14.15pt; TEXT-INDENT: -11.35pt">Net cash provided by financing activities</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">15,797</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">807</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">17,201</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 64%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 64%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 12.6pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 14.15pt; TEXT-INDENT: -1.55pt">Increase (decrease) in cash and cash equivalents</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(1,516</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(16,403</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">18,133</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; PADDING-BOTTOM: 2px; WIDTH: 64%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 12.6pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 14.15pt; TEXT-INDENT: -1.55pt">Cash and cash equivalents at the beginning of the period</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">6,223</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">22,626</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">4,493</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: middle; PADDING-BOTTOM: 4px; WIDTH: 64%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 12.6pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 14.15pt; TEXT-INDENT: -1.55pt">Cash and cash equivalents at the end of the period</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">4,707</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">6,223</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">22,626</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>
</table>
</div>

<div>
<table id="z3c1a41e9081344d880b2b4199cb574c9" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff" valign="bottom" colspan="2">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff" valign="bottom" colspan="2">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom" colspan="2">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; MARGIN-LEFT: 12.6pt; LINE-HEIGHT: 1.25">(a) Supplemental disclosure of cash flow activities:</div>
</td>
<td style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff" valign="bottom" colspan="2">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff" valign="bottom" colspan="2">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom" colspan="2">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: middle; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom" colspan="2">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom" colspan="2">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom" colspan="2">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: middle; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 12.6pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 1.35pt">Cash paid during the period for:</div>
</td>
<td style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom" colspan="2">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom" colspan="2">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom" colspan="2">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: middle; PADDING-BOTTOM: 4px; WIDTH: 64%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 12.6pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 1.35pt">Taxes paid due to non-deductible expenses</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">28</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">66</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">54</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div>
<table id="zffb8f47b50e249c79855b96add4575d0" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; MARGIN-LEFT: 12.6pt; LINE-HEIGHT: 1.25">(b) Supplemental disclosure of non-cash activities:</div>
</td>
<td style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff" valign="bottom" colspan="2">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff" valign="bottom" colspan="2">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom" colspan="2">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: middle; WIDTH: 64%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: middle; PADDING-BOTTOM: 4px; WIDTH: 64%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 12.6pt; LINE-HEIGHT: 1.25">Purchase of property and equipment on credit</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">88</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">126</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">612</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; PADDING-BOTTOM: 4px; WIDTH: 64%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 12.6pt; LINE-HEIGHT: 1.25">Share consideration to constructor</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">39</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">263</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; PADDING-BOTTOM: 4px; WIDTH: 64%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 12.6pt; LINE-HEIGHT: 1.25">Receivables on account of shares</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">790</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>
</table>
</div>

<div id="DSPFPageFooter">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">The accompanying notes are an integral part of the consolidated financial statements.</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">&#160;</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal">F - 11</font></div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; WIDTH: 100%; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>
</div>

<div id="DSPFPageHeader">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: right; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.15pt">PLURISTEM THERAPEUTICS INC. AND ITS SUBSIDIARY</div>

<table id="zbe98025d0b11469394d33f0787704b7a" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; BORDER-COLLAPSE: collapse; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 100%">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 2px solid; WIDTH: 100%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25"><a id="NOTES" name="NOTES"><!--Anchor--></a>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</div>
</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 100%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 11.15pt">U.S. Dollars in thousands (except share and per share amounts)</div>
</td>
</tr>
</table>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; MARGIN-LEFT: 36pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -36pt">NOTE 1:-GENERAL</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">
<table id="z03ca1ab620fc4716b2524dbd7f0ead3c" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; WIDTH: 18pt; align: right">a.</td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: justify; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">Pluristem Therapeutics Inc., a Nevada corporation, was incorporated on May 11, 2001. Pluristem Therapeutics Inc. has a wholly owned subsidiary, Pluristem Ltd. (the &#8220;Subsidiary&#8221;), which is incorporated under the laws of the State of Israel. Pluristem Therapeutics Inc. and the Subsidiary are referred to as the &#8220;Company&#8221; or &#8220;Pluristem&#8221;.</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">The Company&#8217;s shares of common stock are traded on the NASDAQ Capital Market under the symbol &#8220;PSTI&#8221; and on the Tel-Aviv Stock Exchange under the symbol &#8220;PLTR&#8221;.</div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">
<table id="z1f2560ed545f45e4876be47fea69fb87" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; WIDTH: 18pt; align: right">b.</td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: justify; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">The Company is a bio-therapeutics company developing placenta-based cell therapy product candidates for the treatment of multiple ischemic and inflammatory conditions. The Company has incurred an accumulated deficit of approximately $189,571 and incurred recurring operating losses and negative cash flows from operating activities since inception. As of June 30, 2017, the Company&#8217;s total stockholders&#8217; equity amounted to $30,251.</div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; MARGIN-LEFT: 18pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 5.9pt">During the year ended June 30, 2017, the Company incurred operating losses of $27,814 and its negative cash flow from operating activities was $21,611. The Company will be required to obtain additional liquidity resources in the near term in order to support the commercialization of its products and maintain its research and development and clinical trials activities.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; MARGIN-LEFT: 18pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 5.9pt">As of June 30, 2017, the Company&#8217;s cash position (cash and cash equivalents, short-term bank deposits and marketable securities) totaled approximately $26,106. The Company is addressing its liquidity issues by implementing initiatives to allow the continuation of its activities. The Company&#8217;s current operating plan includes various assumptions concerning the level and timing of cash outflows for operating activities and capital expenditures. The Company&#8217;s ability to successfully carry out its business plan, which includes a cost-reduction plan should it be unable to raise sufficient additional capital, is primarily dependent upon its ability to (1) obtain sufficient additional capital, (2) enter into license agreements to use or commercialize the Company&#8217;s products and (3) receive other sources of funding, including non-diluting sources such as the IIA grants, the <font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">European Union&#8217;s Horizon 2020 program (&#8220;Horizon 2020&#8221;)</font> grant and other grants. There are no assurances, however, that the Company will be successful in obtaining an adequate level of financing needed for the long-term development and commercialization of its products.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: justify; MARGIN-LEFT: 18pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 5.9pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">According to management estimates, liquidity resources as of June 30, 2017 </font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">will be sufficient to maintain the Company&#8217;s operations into the first quarter of the Company&#8217;s fiscal year 2019. The Company&#8217;s inability to raise funds to carry out its business plan will have a severe negative impact on its ability to remain a viable company.</font></div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; MARGIN-LEFT: 18pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 5.9pt">These conditions raise substantial doubt about the Company&#8217;s ability to continue as a going concern. The audited consolidated financial statements do not include any adjustments relating to the recoverability and classification of assets or liabilities that might be necessary should the Company be unable to continue as a going concern.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<table id="z2fa9d6ed738141e6935b02c642d6877d" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; WIDTH: 18pt; align: right">c.</td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">License Agreements:</div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 18pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 5.9pt"><u>United Therapeutics Corporation (&#8220;United&#8221;) Agreement</u></div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; MARGIN-LEFT: 18pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 5.9pt">On June 19, 2011, the Company entered into an exclusive license agreement (the &#8220;United Agreement&#8221;) with United for the use of the Company&#8217;s PLX cells to develop and commercialize a cell-based product for the treatment of Pulmonary Hypertension (&#8220;PAH&#8221;). The United Agreement provided that United would receive exclusive worldwide license rights for the development and commercialization of the Company&#8217;s PLX cell-based product to treat PAH.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; MARGIN-LEFT: 18pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 5.9pt">Under the United Agreement the Company received an upfront payment of $7,000 paid in August 2011, which included a $5,000 non-refundable upfront payment and a $2,000 advance payment on development.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal">F - 12</font></div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; WIDTH: 100%; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: right; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.15pt">PLURISTEM THERAPEUTICS INC. AND ITS SUBSIDIARY</div>

<table id="z765dd7426bea483ca144127125fb7e85" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; BORDER-COLLAPSE: collapse; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 100%">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 2px solid; WIDTH: 100%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</div>
</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 100%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 11.15pt">U.S. Dollars in thousands (except share and per share amounts)</div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 5.9pt">NOTE 1:-GENERAL (CONT.)</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; MARGIN-LEFT: 18pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 5.9pt">On December 8, 2015, the Company received a notice from United terminating the United Agreement, effective immediately. Pursuant to the United Agreement termination clause, Pluristem regained full rights to PLX in the field of PAH, as well as all clinical data and regulatory submissions. As the Company has no further obligations towards United, the Company recognized the remaining upfront payment received in August 2011 as revenues during the year ended June 30, 2016.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; MARGIN-LEFT: 18pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 5.9pt"><u>CHA Biotech Co. Ltd. (&#8220;CHA&#8221;) Agreement</u></div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; MARGIN-LEFT: 18pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 5.9pt">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; MARGIN-LEFT: 18pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 5.9pt">On June 26, 2013, Pluristem entered into an exclusive license and commercialization agreement (the &#8220;CHA Agreement&#8221;) with CHA, for conducting clinical trials and commercialization of Pluristem&#8217;s PLX-PAD product in South Korea in connection with two indications: the treatment of Critical Limb Ischemia (&#8220;CLI&#8221;), and Intermediate Claudication (the &#8220;Indications&#8221;). Under the terms of the CHA Agreement, CHA will receive exclusive rights in South Korea for conducting clinical trials with respect to the Indications, and the Company&#160;will continue to retain rights to its proprietary manufacturing technology and cell-related intellectual property.<br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; MARGIN-LEFT: 18pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 5.9pt">The first clinical study as part of the CHA Agreement is a Phase II trial in Intermittent Claudication. South Korea&#8217;s Ministry of Food and Drug Safety approved this study in November 2013.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; MARGIN-LEFT: 18pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 5.9pt">Upon the first regulatory approval for a PLX product in South Korea, for the specified indications, Pluristem and CHA will establish an equally owned joint venture. The purpose of the joint venture will be to commercialize PLX cell products in South Korea.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; MARGIN-LEFT: 18pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 5.9pt">Pluristem will be able to use the data generated by CHA to pursue the development of PLX product candidates outside of South Korea.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; MARGIN-LEFT: 18pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 5.9pt">The CHA Agreement contains customary termination provisions, including in the event the parties do not reach an agreement upon development plan for conducting the clinical trials. Upon termination of this CHA Agreement, the license granted thereunder will terminate and all rights included therein will revert to the Company, whereupon the Company will be free to enter into agreements with any other third parties for the granting of a license in or outside South Korea or to deal in any other manner with such rights as it shall see fit at its sole discretion.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; MARGIN-LEFT: 18pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 5.9pt">In addition, and as contemplated by the CHA Agreement, in December 2013, Pluristem and CHA executed the mutual investment pursuant to which Pluristem issued 2,500,000 shares of its common stock in consideration for 1,011,504 shares of CHA, which reflects total consideration to each of Pluristem and CHA of approximately $10,414. The parties also agreed to give an irrevocable proxy to the other party&#8217;s management with respect to the voting power of the shares issued.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; MARGIN-LEFT: 18pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 5.9pt">During March 2015, the Company sold a portion of the CHA shares received in December 2013.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; MARGIN-LEFT: 18pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 5.9pt">The remaining investment in CHA shares is presented as &#8220;Marketable Securities&#8221; and classified as available-for-sale in accordance with Accounting Standards Codification (&#8220;ASC&#8221;) 320, &#8220;Investments - Debt and Equity Securities&#8221;. The fair value of the remaining investment in CHA&#8217;s shares as of June 30, 2017, is approximately $4,358.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal">F - 13</font></div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; WIDTH: 100%; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="LINE-HEIGHT: 1.25">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: right; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.15pt">PLURISTEM THERAPEUTICS INC. AND ITS SUBSIDIARY</div>

<table id="zb33eca692a16412f9b94e40ecd99ef55" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; BORDER-COLLAPSE: collapse; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 100%">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 2px solid; WIDTH: 100%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</div>
</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 100%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 11.15pt">U.S. Dollars in thousands (except share and per share amounts)</div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: justify; MARGIN-LEFT: 36pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -36pt">NOTE 2:-SIGNIFICANT ACCOUNTING POLICIES</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">The consolidated financial statements have been prepared in accordance with United States generally accepted accounting principles (&#8220;U.S. GAAP&#8221;) applied on consistent basis.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">
<table id="z1af1627d0e9e4dd3b8eac1b4ebf43a64" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; FONT-WEIGHT: bold; WIDTH: 27pt; align: right">a.</td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: justify; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold">Use of estimates</div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; MARGIN-LEFT: 27pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt">The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates, judgments, and assumptions that are reasonable based upon information available at the time they are made. These estimates, judgments and assumptions can affect the amounts reported in the financial statements and accompanying notes. Actual results could differ from those estimates.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">
<table id="za7bc05a3506840d5a83f52e5cf3b45b1" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; FONT-WEIGHT: bold; WIDTH: 27pt; align: right">b.</td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: justify; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold">Functional currency</div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="LINE-HEIGHT: 1.25">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; MARGIN-LEFT: 27pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt">Most of the Pluristem Therapeutics Inc. costs are denominated in United States dollars (&#8220;dollar&#8221;). The Company&#8217;s management believes that the dollar is the primary currency of the economic environment in which Pluristem Therapeutics Inc. and its subsidiary operate. Thus, the dollar is the Company&#8217;s functional and reporting currency. Accordingly, non-dollar denominated transactions and balances have been re-measured into the functional currency in accordance with ASC No. 830, &#8220;Foreign Currency Matters&#8221;. All transaction gains and losses from the re-measured monetary balance sheet items are reflected in the statements of income as financial income or expenses, as appropriate.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>
</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">
<table id="z1f93aca01e5e4ee6a8fdf1dd94b2f8af" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; FONT-WEIGHT: bold; WIDTH: 27pt; align: right">c.</td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: justify; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold">Principles of consolidation</div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; MARGIN-LEFT: 27pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt">The consolidated financial statements include the accounts of Pluristem Therapeutics Inc. and it&#8217;s Subsidiary. Intercompany transactions and balances have been eliminated upon consolidation.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">
<table id="ze0f636e14c5d4c1e86c453d6849bbd2f" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; FONT-WEIGHT: bold; WIDTH: 27pt; align: right">d.</td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: justify; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold">Cash and cash equivalents</div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; MARGIN-LEFT: 28.35pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -1.35pt">Cash equivalents are short-term highly liquid investments that are readily convertible to cash with maturities of three months or less at the date acquired.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">
<table id="zbfbd29a4eb644edbb7c98dcc26a49d3f" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; FONT-WEIGHT: bold; WIDTH: 28.35pt; align: right">e.</td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: justify; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold">Short-term bank deposit</div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; MARGIN-LEFT: 28.35pt; LINE-HEIGHT: 1.25">Bank deposits with original maturities of more than three months but less than one year are presented as part of short-term investments. Deposits are presented at their cost which approximates market values including accrued interest. Interest on deposits is recorded as financial income.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">
<table id="z978469e1fcb646049d8a05cb6166784c" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; FONT-WEIGHT: bold; WIDTH: 27pt; align: right">f.</td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: justify; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold">Restricted cash and short-term bank deposits</div>
</td>
</tr>
</table>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; MARGIN-LEFT: 28.35pt; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; MARGIN-LEFT: 28.35pt; LINE-HEIGHT: 1.25">Short-term restricted bank deposits and restricted cash used to secure derivative and hedging transactions and the Company&#8217;s credit line. The restricted cash and short-term bank deposits are presented at cost which approximates market values including accrued interest.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">
<table id="zd17e0f5d149c4b0dad19bc2e378a5f58" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; FONT-WEIGHT: bold; WIDTH: 27pt; align: right">g.</td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: justify; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold">Long-term restricted bank deposits</div>
</td>
</tr>
</table>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; MARGIN-LEFT: 27pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; MARGIN-LEFT: 27pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt">Long-term restricted bank deposits with maturities of more than one year used to secure operating lease agreement are presented at cost which approximates market values including accrued interest.</div>

<div style="TEXT-ALIGN: justify; MARGIN-LEFT: 27pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -27pt"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">
<table id="zb5071478f8d54ec5a96c5c5ab6b8e7f5" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; FONT-WEIGHT: bold; WIDTH: 27pt; align: right">h.</td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: justify; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold">Investment in marketable securities</div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; MARGIN-LEFT: 28.35pt; LINE-HEIGHT: 1.25">The Company accounts for its investments in marketable securities in accordance with ASC 320,&#8220;Investments &#8211; Debt and Equity Securities&#8221;. The Company determines the classification of marketable securities at the time of purchase and re-evaluates such designations as of each balance sheet date. The Company classifies all of its marketable securities as available-for-sale. Available-for-sale marketable securities are carried at fair value, with the unrealized gain and loss reported at &#8220;Accumulated other comprehensive income (loss)&#8221; in the statement of changes in stockholders&#8217; equity.</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; MARGIN-LEFT: 28.35pt; LINE-HEIGHT: 1.25">&#160;</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal">F - 14</font></div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; WIDTH: 100%; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div style="LINE-HEIGHT: 1.25">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: right; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.15pt">PLURISTEM THERAPEUTICS INC. AND ITS SUBSIDIARY</div>

<table id="z69f570211b0e43b6a461a7c8ec9d2411" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; BORDER-COLLAPSE: collapse; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 100%">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 2px solid; WIDTH: 100%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</div>
</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 100%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 11.15pt">U.S. Dollars in thousands (except share and per share amounts)</div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: justify; MARGIN-LEFT: 36pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -36pt">NOTE 2:-SIGNIFICANT ACCOUNTING POLICIES (CONT.)</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; MARGIN-LEFT: 28.35pt; LINE-HEIGHT: 1.25">Realized gain and loss on sales of marketable securities are included in the Company&#8217;s &#8220;Financial income, net&#8221; and are derived using the specific identification basis for determining the cost of marketable securities sold. The amortized cost of available for sale debt marketable securities is adjusted for amortization of premiums and accretion of discount to maturity. Such amortization, together with coupon interest on available for sale marketable securities, is included in the &#8220;Financial income, net&#8221;.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; MARGIN-LEFT: 28.35pt; LINE-HEIGHT: 1.25">The Company recognizes an impairment charge when a decline in the fair value of its available-for-sale marketable securities below the cost basis is judged to be other-than-temporary. The Company considers various factors in determining whether to recognize an impairment charge, including the length of time the investment has been in a loss position, the extent to which the fair value has been less than the Company&#8217;s cost basis, the reason for the decline in value, the potential recovery period and the Company&#8217;s intent to sell, including whether it is more likely than not that the Company will be required to sell the investment before recovery of cost basis. ASC 320-10-35, &#8220;Investments - Debt and Equity Securities&#8221;, requires another-than-temporary impairment for debt securities to be separated into (a)&#160;the amount representing the credit loss and (b)&#160;the amount related to all other factors (provided that the Company does not intend to sell the security and it is not more likely than not that it will be required to sell it before recovery). For securities that are deemed other-than-temporarily impaired, the amount of impairment is recognized in &#8220;financial income, net&#8221;, in the statement of operations and is limited to the amount related to credit loss, while impairment related to other factors is recognized in &#8220;other comprehensive income (loss)&#8221;.</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; MARGIN-LEFT: 28.35pt; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; MARGIN-LEFT: 28.35pt; LINE-HEIGHT: 1.25">During the years ended June 30, 2017 and 2016, the Company recognized other-than-temporary impairment loss of $767 and $38, respectively. During the year ended June 30, 2015 no impairment losses were identified (see note 3).</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">
<table id="zb4e567880d2a4c168bd77962c3661dd1" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; FONT-WEIGHT: bold; WIDTH: 27pt; align: right">i.</td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: justify; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold">Revenue Recognition from the license Agreement with United</div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; MARGIN-LEFT: 28.35pt; LINE-HEIGHT: 1.25">The Company recognized revenue pursuant to the License Agreement with United in accordance with ASC 605-25, &#8220;Revenue Recognition, Multiple-Element Arrangements&#8221;.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; MARGIN-LEFT: 28.35pt; LINE-HEIGHT: 1.25">Pursuant to ASC 605-25, each deliverable is evaluated to determine whether it qualifies as a separate unit of accounting based on whether the deliverable has &#8220;stand-alone value&#8221; to the customer. The arrangement&#8217;s consideration that is fixed or determinable is then allocated to each separate unit of accounting based on the relative selling price of each deliverable. In general, the consideration allocated to each unit of accounting is recognized as the related goods or services are delivered, limited to the consideration that is not contingent upon future deliverables.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; MARGIN-LEFT: 28.35pt; LINE-HEIGHT: 1.25">The Company received an up-front, non-refundable license payment of $5,000. Additional payments totaling $37,500 were subject to the achievement of certain regulatory milestones by United.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; MARGIN-LEFT: 28.35pt; LINE-HEIGHT: 1.25">Since the deliverables in the United Agreement did not have stand-alone value, none of them qualified as a separate unit of accounting. Accordingly, the non-refundable upfront license fee of $5,000 was deferred and recognized on a straight line basis over the related performance period which was the development period in accordance with Staff Accounting Bulletin (&#8220;SAB&#8221;) 104, &#8220;Revenue Recognition&#8221;.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; MARGIN-LEFT: 28.35pt; LINE-HEIGHT: 1.25">The Company also received an advanced payment for the development, of $2,000 that was deductible against development expenses as it was incurred. The upfront payment which was received <a id="OLE_LINK9" name="OLE_LINK9"><!--Anchor--></a><a id="OLE_LINK10" name="OLE_LINK10"><!--Anchor--></a>was included in the balance sheet as advance payment. The Company deducted the payments from its research and development expenses in accordance with ASC 730-20, &#8220;Research and Development Agreements&#8221;.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal">F - 15</font></div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; WIDTH: 100%; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div style="LINE-HEIGHT: 1.25">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: right; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.15pt">PLURISTEM THERAPEUTICS INC. AND ITS SUBSIDIARY</div>

<table id="zb5660663b96a4730be3e48091a493dd0" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; BORDER-COLLAPSE: collapse; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 100%">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 2px solid; WIDTH: 100%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</div>
</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 100%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 11.15pt">U.S. Dollars in thousands (except share and per share amounts)</div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">NOTE 2:-SIGNIFICANT ACCOUNTING POLICIES (CONT.)</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; MARGIN-LEFT: 28.35pt; LINE-HEIGHT: 1.25">On December 8, 2015, the Company received a notice from United terminating the United Agreement, effective immediately. Pursuant to the United Agreement termination clause, Pluristem regained full rights to PLX in the field of PAH, as well as all clinical data and regulatory submissions. As the Company had no further obligations<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold">&#160;</font>towards United, the Company recognized the remaining upfront payment received in 2011 as revenues during the year ended June 30, 2016.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">
<table id="z18f60214b5e14ae396da878f15bb2f47" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; FONT-WEIGHT: bold; WIDTH: 28.35pt; align: right">j.</td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: justify; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold">Property and Equipment</div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; MARGIN-LEFT: 27pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt">Property and equipment are stated at cost, net of accumulated depreciation. Depreciation is calculated by the straight-line method over the estimated useful lives of the assets, at the following annual rates:</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div>
<table id="z4239811fa84e426982a3190298cf9636" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 60%" cellspacing="0" cellpadding="0" align="center" border="0">
<tr>
<td style="VERTICAL-ALIGN: top; PADDING-BOTTOM: 2px; WIDTH: 40%" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 1%" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 2px solid" valign="bottom" colspan="2">
<div style="LINE-HEIGHT: 1.25">
<div style="LINE-HEIGHT: 1.25"></div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">%</div>
</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 40%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Laboratory equipment</div>
</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 40%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">10-15</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr style="HEIGHT: 16px">
<td style="VERTICAL-ALIGN: top; WIDTH: 40%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Computers and peripheral equipment</div>
</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 40%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">33</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 40%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Office furniture and equipment</div>
</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 40%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">15</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 40%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Vehicles</div>
</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 40%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">15</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr style="HEIGHT: 15px">
<td style="VERTICAL-ALIGN: top; WIDTH: 40%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Leasehold improvements</div>
</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff" valign="bottom" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">The shorter of the expected useful life or the reasonable assumed term of the lease.</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">
<table id="z252d414105c7440bb6165d5bf6b4d15a" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; FONT-WEIGHT: bold; WIDTH: 28.35pt; align: right">k.</td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: justify; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold">Impairment of long-lived assets</div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; MARGIN-LEFT: 27pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt">The Company&#8217;s long-lived assets are reviewed for impairment in accordance with ASC 360, &#8220;Property, Plant and Equipment&#8221;, whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of the assets to the future undiscounted cash flows expected to be generated by the assets. If such assets are considered to be impaired, the impairment to be recognized is measured by the amount by which the carrying amount of the assets exceeds the fair value of the assets. During fiscal years 2017, 2016 and 2015, no impairment losses have been identified.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; MARGIN-LEFT: 27pt; LINE-HEIGHT: 1.25">
<div id="DSPFPageHeader"></div>

<div style="LINE-HEIGHT: 1.25">As required by ASC 820, &#8220;Fair Value Measurements&#8221; (&#8220;ASC 820&#8221;), the Company applies assumptions that marketplace participants would consider in determining the fair value of long-lived assets.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>
</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">
<table id="zb79e5bb96e214148b3fac6f353132e61" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; FONT-WEIGHT: bold; WIDTH: 27pt; align: right">l.</td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: justify; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold">Accounting for stock-based compensation</div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; MARGIN-LEFT: 27pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 0.05pt">The Company accounts for stock-based compensation in accordance with ASC 718, &#8220;Compensation-Stock Compensation&#8221; (&#8220;ASC 718&#8221;) and ASC 505-50, &#8220;Equity-Based Payments to Non-Employees&#8221; (&#8220;ASC 505-50&#8221;). ASC 718 requires companies to estimate the fair value of equity-based payment awards on the date of grant using an option-pricing model. The Company estimates the fair value of stock options granted using the Black-Scholes-Merton option-pricing model. The Company accounts for employee&#8217;s share-based payment awards classified as equity awards (restricted stocks or restricted stock units) using the grant-date fair value method. The fair value of share-based payment transactions is recognized as an expense over the requisite service period, net of estimated forfeitures. The Company estimates forfeitures based on historical experience and anticipated future conditions. The Company elected to recognize compensation cost for an award with service conditions and goals achievement that has a graded vesting schedule using the accelerated method based on the multiple-option award approach.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; MARGIN-LEFT: 27.05pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 0.05pt">During fiscal years 2017, 2016 and 2015, there were no options granted to employees or directors.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; MARGIN-LEFT: 28.35pt; LINE-HEIGHT: 1.25">The assumptions below are relevant to restricted stock and restricted stock units granted in 2017, 2016 and 2015:</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; MARGIN-LEFT: 28.35pt; LINE-HEIGHT: 1.25">In accordance with ASC 718, restricted stock and restricted stock units are measured at their fair value. All restricted stock and restricted stock units to employees, directors and non-employees granted in 2017, 2016 and 2015, were granted for no consideration; therefore, their fair value was equal to the share price at the date of grant.</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; MARGIN-LEFT: 28.35pt; LINE-HEIGHT: 1.25">&#160;</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal">F - 16</font></div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; WIDTH: 100%; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: right; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.15pt">PLURISTEM THERAPEUTICS INC. AND ITS SUBSIDIARY</div>

<table id="zac882b41fe3840c98256b641a70afbf2" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; BORDER-COLLAPSE: collapse; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 100%">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 2px solid; WIDTH: 100%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</div>
</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 100%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 11.15pt">U.S. Dollars in thousands (except share and per share amounts)</div>
</td>
</tr>
</table>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">NOTE 2:-SIGNIFICANT ACCOUNTING POLICIES (CONT.)</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; MARGIN-LEFT: 28.35pt; LINE-HEIGHT: 1.25">The fair value of all restricted stock and restricted stock units was determined based on the close trading price of the Company&#8217;s shares known at the grant date. The weighted average grant date fair value of shares granted during 2017, 2016 and 2015, was $1.41, $1.13 and $2.70, respectively.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">
<table id="z7e07885053824892bd52a1a2cb6999f9" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; FONT-WEIGHT: bold; WIDTH: 28.35pt; align: right">m.</td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: justify; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold">Research and Development expenses and royalty bearing grants</div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; MARGIN-LEFT: 28.35pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt">Research and development expenses, net of participations grants, are charged to the statement of operations as incurred.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="LINE-HEIGHT: 1.25">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; MARGIN-LEFT: 28.35pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt">Pluristem receives grants from the IIA in the Ministry of Economy and Industry (formerly the Office of Chief Scientist&#8217;s) for the purpose of partially funding approved research and development projects. The grants are not to be repaid, but instead Pluristem is obliged to pay royalties as a percentage of future sales if and when sales from the funded projects are generated. These grants are recognized as a deduction from research and development costs at the time the Company is entitled to such grants on the basis of the research and development costs incurred. Since the payment of royalties is not probable when the grants are received, the Company records a liability in the amount of the estimated royalties for each individual contract, when the related revenues are recognized, as part of Cost of revenues. For more information regarding such royalties commitments and regarding grants and participation received, see Note 8.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>
</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">
<table id="zf79edeb6b6264cdebcff1930c5704a4a" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; FONT-WEIGHT: bold; WIDTH: 28.35pt; align: right">n.</td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: justify; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold">Non-royalty bearing grant</div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="LINE-HEIGHT: 1.25">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; MARGIN-LEFT: 28.35pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -1.35pt">T<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">he Company&#8217;s CLI program participates in a European Union&#160;research and development consortium under Horizon 2020.&#160; In August 2016, the CLI program consortium was awarded a Euro 7,600 (approximately $8,700) non-royalty bearing grant. An amount of Euro 1,900 (approximately $2,200) is a direct grant allocated to the Company. </font>The non-royalty bearing grant for funding the projects is recognized at the time the Company is entitled to such grant on the basis of the related costs incurred and recorded as a deduction from research and development expenses.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>
</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">
<table id="zf823a2550b6d46c591eaa4a91db1adeb" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; FONT-WEIGHT: bold; WIDTH: 28.35pt; align: right">o.</td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: justify; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold">Loss per share</div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; MARGIN-LEFT: 28.35pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt">Basic and diluted net loss per share is computed based on the weighted average number of shares of common stock outstanding during each year. All outstanding stock options and unvested restricted stock units have been excluded from the calculation of the diluted loss per common share because all such securities are anti-dilutive for each of the periods presented.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">
<table id="z06d5f9bd8e3e4f4981c1f51ed93f04fe" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; FONT-WEIGHT: bold; WIDTH: 28.35pt; align: right">p.</td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: justify; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold">Income taxes</div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; MARGIN-LEFT: 28.35pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt">The Company accounts for income taxes in accordance with ASC 740, &#8220;Income Taxes&#8221; (&#8220;ASC 740&#8221;). This Topic prescribes the use of the liability method, whereby deferred tax assets and liability account balances are determined based on differences between financial reporting and tax bases of assets and liabilities and are measured using the enacted tax rates and laws that will be in effect when the differences are expected to reverse. The Company provides a valuation allowance, if necessary, to reduce deferred tax assets to their estimated realizable value.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal">F - 17</font></div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; WIDTH: 100%; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: right; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.15pt">PLURISTEM THERAPEUTICS INC. AND ITS SUBSIDIARY</div>

<table id="zcd10a7de03374d5b9dc696d700bb8b3c" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; BORDER-COLLAPSE: collapse; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 100%">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 2px solid; WIDTH: 100%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</div>
</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 100%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 11.15pt">U.S. Dollars in thousands (except share and per share amounts)</div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">NOTE 2:-SIGNIFICANT ACCOUNTING POLICIES (CONT.)</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; MARGIN-LEFT: 28.35pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -1.35pt">ASC 740 establishes a single model to address accounting for uncertain tax positions. ASC 740 clarified the accounting for income taxes by prescribing the minimum recognition threshold a tax position is required to meet before being recognized in the financial statements.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">
<table id="z320736ccd85f45a8b8e69213c3f489d0" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; FONT-WEIGHT: bold; WIDTH: 28.35pt; align: right">q.</td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: justify; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold">Concentration of credit risk</div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; MARGIN-LEFT: 28.35pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt">Financial instruments that potentially subject the Company to concentrations of credit risk consist principally of cash and cash equivalents, short-term deposits, long-term deposits, restricted deposits and marketable securities.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; MARGIN-LEFT: 28.35pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt">The majority of the Company&#8217;s cash and cash equivalents and short-term and long-term deposits are mainly invested in dollar instruments of major banks in Israel and in the United States. Generally, these deposits may be redeemed upon demand and therefore bear minimal risk.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; MARGIN-LEFT: 27.35pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt">The Company invests its surplus cash in cash deposits and marketable securities in financial institutions and has established guidelines, approved by the Company&#8217;s Investment Committee, relating to diversification and maturities to maintain safety and liquidity of the investments.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; MARGIN-LEFT: 27.35pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt">The Company holds an investment portfolio consisting of corporate bonds, government bonds, stocks and index linked notes. The Company intends, and has the ability, to hold such investments until recovery of temporary declines in market value or maturity. However, the Company can provide no assurance that it will recover declines in the market value of its investments.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; MARGIN-LEFT: 27.35pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -27pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>The Company utilizes forward and options contracts to protect against the risk of overall changes in exchange rates. The derivative instruments hedge a portion of the Company&#8217;s non-dollar currency exposure. Counterparties to the Company&#8217;s derivative instruments are all major financial institutions.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">
<table id="zfcbc5e1a8b494fc7b89fd7aa0beaa363" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; FONT-WEIGHT: bold; WIDTH: 28.35pt; align: right">r.</td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: justify; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold">Severance pay</div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; MARGIN-LEFT: 28.35pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -1.35pt">&#160;A majority of the Company&#8217;s agreements with employees in Israel are subject to Section 14 of the Israeli Severance Pay Law, 1963 (<a id="_cp_text_4_75" name="_cp_text_4_75"><!--Anchor--></a>&#8220;Severance Pay Law&#8221;). The Company&#8217;s contributions for severance pay have replaced its severance obligation. Upon contribution of the full amount of the employee&#8217;s monthly salary for each year of employment, no additional calculations are conducted between the parties regarding the matter of severance pay and no additional payments are made by the Company to the employee. Further, the related obligation and amounts deposited on behalf of the employee for such obligation are not stated on the balance sheet, as the Company is legally released from the obligation to employees once the deposit amounts have been paid.</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; MARGIN-LEFT: 28.35pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -1.35pt">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; MARGIN-LEFT: 28.35pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -1.35pt">&#160;For some employees, which their agreement is not subject to Section 14 of the Severance Pay Law, the Subsidiary&#8217;s liability for severance pay is calculated pursuant to Israeli Severance Pay Law, based on the most recent salary of the employees multiplied by the number of years of employment, as of the balance sheet date. Employees are entitled to one month&#8217;s salary for each year of employment or a portion thereof.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; MARGIN-LEFT: 28.35pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -1.35pt">The Company&#8217;s liability for all of its employees is fully provided by monthly deposits with insurance policies and by an accrual. The value of these policies is recorded as an asset in the Company&#8217;s balance sheet. The deposited funds include profits or losses accumulated up to the balance sheet date. The deposited funds may be withdrawn only upon the fulfillment of the obligation pursuant to the Severance Pay Law or labor agreements. The value of the deposited funds is based on the cash surrendered value of these policies, and includes immaterial profits or losses.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; MARGIN-LEFT: 28.35pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -1.35pt">Severance expenses for the years ended June 30, 2017, 2016 and 2015 were $524, $556 and $441, respectively.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal">F - 18</font></div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; WIDTH: 100%; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: right; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.15pt">PLURISTEM THERAPEUTICS INC. AND ITS SUBSIDIARY</div>

<table id="zb7e0a1839ad24ef39ecd71b7fe4af747" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; BORDER-COLLAPSE: collapse; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 100%">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 2px solid; WIDTH: 100%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</div>
</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 100%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 11.15pt">U.S. Dollars in thousands (except share and per share amounts)</div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">NOTE 2:-SIGNIFICANT ACCOUNTING POLICIES (CONT.)</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">
<table id="zd2ea3862cd6c4798b79f39ca5827c19b" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; FONT-WEIGHT: bold; WIDTH: 28.35pt; align: right">s.</td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: justify; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold">Fair value of financial instruments</div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; MARGIN-LEFT: 28.35pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -1.35pt">The carrying amounts of the Company&#8217;s financial instruments, including cash and cash equivalents, short-term and restricted bank deposits, accounts receivable and other current assets, trade payable and other accounts payable and accrued liabilities, approximate fair value because of their generally short term maturities.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="LINE-HEIGHT: 1.25">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; MARGIN-LEFT: 28.35pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -1.35pt">The Company measures its investments in marketable securities and derivative instruments at fair value under ASC 820. Fair value is an exit price, representing the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants. As such, fair value is a market-based measurement that should be determined based on assumptions that market participants would use in pricing an asset or a liability. As a basis for considering such assumptions, ASC 820 establishes a three-tier value hierarchy, which prioritizes the inputs used in the valuation methodologies in measuring fair value:</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; MARGIN-LEFT: 28.35pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -1.35pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold">&#160;Level 1</font> - Quoted prices (unadjusted) in active markets for identical assets or liabilities;</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; MARGIN-LEFT: 28.35pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -1.35pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold">&#160;Level 2</font> - Inputs other than Level 1 that are observable for the asset or liability, either directly or indirectly; and</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; MARGIN-LEFT: 28.35pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -1.35pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold">&#160;Level 3 </font>- Unobservable inputs for the asset or liability.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; MARGIN-LEFT: 28.35pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -1.35pt">The fair value hierarchy also requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. The Company categorized each of its fair value measurements in one of these three levels of hierarchy (see Note 4).</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">
<table id="zcbe558bdfec34c1c9b3738ad0e5c22de" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; FONT-WEIGHT: bold; WIDTH: 28.35pt; align: right">t.</td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: justify; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold">Derivative financial instruments</div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="LINE-HEIGHT: 1.25">
<div id="DSPFPageHeader"></div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; MARGIN-LEFT: 28.35pt; LINE-HEIGHT: 1.25"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">The Company accounts for derivatives and hedging based on ASC 815, </font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">&#8220;Derivatives and hedging&#8221; </font>(&#8220;ASC 815&#8221;)<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">, as amended and related interpretations. ASC 815 requires the Company to recognize all derivatives on the balance sheet at fair value. If a derivative meets the definition of a hedge and is so designated, depending on the nature of the hedge, changes in the fair value of the derivative will either be offset against the change in fair value of the hedged assets, liabilities, or firm commitments through earnings (for fair value hedge transactions) or recognized in other comprehensive income (loss) until the hedged item is recognized in earnings (for cash flow hedge transactions).</font></div>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; MARGIN-LEFT: 28.35pt; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; MARGIN-LEFT: 28.35pt; LINE-HEIGHT: 1.25"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">The ineffective portion of a derivative&#8217;s change in fair value is recognized in earnings. If a derivative does not meet the definition of a hedge, the changes in the fair value are included in earnings. Cash flows related to such hedges are classified as operating activities. The Company enters into forward exchange contracts and option contracts in order to limit the exposure to exchange rate fluctuation associated with expenses mainly incurred in </font>New Israeli Shekels (&#8220;<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">NIS</font>&#8221;)<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">. Since the derivative instruments that the Company holds do not meet the definition of hedging instruments under ASC 815, any gain or loss derived from such instruments is recognized immediately as &#8220;financial income, net&#8221;.</font></div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; MARGIN-LEFT: 28.35pt; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; MARGIN-LEFT: 28.35pt; LINE-HEIGHT: 1.25">The Company measured the fair value of the contracts in accordance with ASC 820. Foreign currency derivative contracts are classified within Level 2 as the valuation inputs are based on quoted prices and market observable data of similar instruments. As of June 30, 2017 and 2016, the fair value of the<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">&#160;</font>options contracts was approximately$ 295<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">&#160;</font>and $65, respectively, presented in &#8220;other current assets&#8221; (see Note 4). The net gains (losses) recognized in &#8220;Financial income, net&#8221; during the years ended June 30, 2017, 2016 and 2015, were $230, ($205) and $248, respectively.</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">
<table id="z3defcc6bbc8f4d2eb779a57c2bdb4a38" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; FONT-WEIGHT: bold; WIDTH: 28.35pt; align: right">u.</td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: justify; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold">Comprehensive income (loss):</div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; MARGIN-LEFT: 28.35pt; LINE-HEIGHT: 1.25">The Company accounts for comprehensive income (loss) in accordance with ASC 220, &#8220;Comprehensive Income&#8221;.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal">F - 19</font></div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; WIDTH: 100%; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div style="LINE-HEIGHT: 1.25">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: right; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.15pt">PLURISTEM THERAPEUTICS INC. AND ITS SUBSIDIARY</div>

<table id="z041ba5935faa40a9b0ed7840cea3fefc" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; BORDER-COLLAPSE: collapse; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 100%">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 2px solid; WIDTH: 100%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</div>
</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 100%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 11.15pt">U.S. Dollars in thousands (except share and per share amounts)</div>
</td>
</tr>
</table>
</div>

<br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">NOTE 2:-SIGNIFICANT ACCOUNTING POLICIES (CONT.)</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; MARGIN-LEFT: 28.35pt; LINE-HEIGHT: 1.25">Comprehensive income generally represents all changes in stockholders&#8217; equity during the period except those resulting from investments by, or distributions to, stockholders&#8217;. The Company determined that its items of other comprehensive income (loss) relate to unrealized gains and losses on available for sale marketable securities.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; MARGIN-LEFT: 28.35pt; LINE-HEIGHT: 1.25">The following table summarizes the changes in accumulated balances of other comprehensive income for the year ended June 30, 2017:</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div>
<table id="z1a49afcc7d73463897c1b4177687276d" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 95%" cellspacing="0" cellpadding="0" align="right" border="0">
<tr>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: center" valign="bottom" colspan="2">Year ended June 30, 2017</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid" valign="bottom" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">Unrealized<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><br>
</font>gains (losses)<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><br>
</font>on marketable<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><br>
</font> securities</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 88%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 4.7pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 5.05pt">Beginning balance</div>
</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">1,480</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 88%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 9.75pt; LINE-HEIGHT: 1.25">Other comprehensive income before reclassifications</div>
</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">924</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; PADDING-BOTTOM: 2px; WIDTH: 88%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 9.75pt; LINE-HEIGHT: 1.25">Amounts reclassified from accumulated other comprehensive loss, net</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(405</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; PADDING-BOTTOM: 2px; WIDTH: 88%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 12pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -2.25pt">Net current-period other comprehensive income</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">519</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; PADDING-BOTTOM: 4px; WIDTH: 88%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 4.7pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 5.05pt">Ending balance</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">1,999</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>
</table>
</div>

<div style="CLEAR: both; LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">
<table id="z6ca6aeb30c4f45c4aa701f0c34367182" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; FONT-WEIGHT: bold; WIDTH: 28.35pt; align: right">v.</td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: justify; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold">Recent Accounting Pronouncement</div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; MARGIN-LEFT: 27pt; LINE-HEIGHT: 1.25"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><u>Accounting Standards Update (&#8220;ASU&#8221;) 2014-09 &#8211; &#8220;Revenue from Contracts with Customers (Topic 606)&#8221;</u></font>:</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="LINE-HEIGHT: 1.25">
<div id="DSPFPageHeader"></div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; MARGIN-LEFT: 28.35pt; LINE-HEIGHT: 1.25">In May 2014, the Financial Accounting Standards Board (&#8220;FASB&#8221;) issued ASU No. 2014-09 (Topic 606) &#8220;Revenue from Contracts with Customers&#8221; (&#8220;Topic 606&#8221;). Topic 606 supersedes the revenue recognition requirements in ASC Topic 605, &#8220;Revenue Recognition&#8221;, and requires entities to recognize revenue when they transfer control of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled to in exchange for those goods or services. We intend to adopt Topic 606 as of July 1, 2017, using the modified retrospective transition method. Prior periods will not be retrospectively adjusted. As the Company currently does not have any contracts with customers which are not completed, as of June 30, 2017, we do not expect the adoption of Topic 606 will have a material impact on our consolidated financial statements, including the presentation of revenues in our consolidated statements of income.</div>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; MARGIN-LEFT: 28.35pt; LINE-HEIGHT: 1.25"><u>ASU 2014-15 - Presentation of Financial Statements - Going Concern (Subtopic 205-40):</u></div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<div id="DSPFPageHeader"></div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; MARGIN-LEFT: 28.35pt; LINE-HEIGHT: 1.25">In August 2014, the FASB issued guidance on disclosure of Uncertainties about an Entity&#8217;s Ability to Continue as a Going Concern (&#8220;ASU 2014-15&#8221;), which defines management&#8217;s responsibility to evaluate whether there is substantial doubt about a company&#8217;s ability to continue as a going concern. ASU 2014-15 also provides principles and definitions that are intended to reduce diversity in the timing and content of disclosures in the financial statement footnotes. This guidance is effective for the annual period ending after December 15, 2016, and for annual periods and interim periods thereafter. The Company adopted the provisions of ASU 2014-15 for the year ended December 31, 2016. The adoption of ASU 2014-15 did not have a material impact on the consolidated financial statements.</div>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; MARGIN-LEFT: 28.35pt; LINE-HEIGHT: 1.25">&#160;</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal">F - 20</font></div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; WIDTH: 100%; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: right; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.15pt">PLURISTEM THERAPEUTICS INC. AND ITS SUBSIDIARY</div>

<table id="z5c8bb53c595b40e99a3045abe16f3bfb" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; BORDER-COLLAPSE: collapse; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 100%">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 2px solid; WIDTH: 100%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</div>
</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 100%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 11.15pt">U.S. Dollars in thousands (except share and per share amounts)</div>
</td>
</tr>
</table>
</div>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">NOTE 2:-SIGNIFICANT ACCOUNTING POLICIES (CONT.)</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="LINE-HEIGHT: 1.25">
<div id="DSPFPageHeader"></div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; MARGIN-LEFT: 28.35pt; LINE-HEIGHT: 1.25"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><u>ASU 2016-13 - Financial Instruments &#8211; Credit Losses (Topic 326), </u></font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><u>&#8220;Measurement of Credit Losses on Financial Instruments&#8221;:</u></font></div>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; MARGIN-LEFT: 28.35pt; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; MARGIN-LEFT: 28.35pt; LINE-HEIGHT: 1.25">In June 2016, the FASB issued ASU 2016-13. This update requires an entity to utilize a new impairment model known as the current expected credit loss (&#8220;CECL&#8221;) model to estimate its lifetime &#8220;expected credit loss&#8221; on a financial asset and record an allowance that, when deducted from the amortized cost basis of the financial asset, presents the net amount expected to be collected on the financial asset. The CECL model is expected to result in more timely recognition of credit losses. The update also requires new disclosures for financial assets measured at amortized cost, loans and available-for-sale debt securities. The update is effective for the interim and annual periods beginning on or after December 15, 2019, or July 1, 2020, for the Company. Early adoption is permitted. The Company is currently evaluating the impact of the update on its consolidated financial statements.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; MARGIN-LEFT: 28.35pt; LINE-HEIGHT: 1.25"><u>ASU 2016-18 - Restricted Cash (Topic 230):</u></div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; MARGIN-LEFT: 28.35pt; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; MARGIN-LEFT: 28.35pt; LINE-HEIGHT: 1.25">In November 2016, the FASB issued ASU 2016-18, &#8220;Statement of Cash Flows&#8221;. This standard requires the presentation of the statement of cash flows to show the changes in the total of cash, cash equivalents, restricted cash and restricted cash equivalents. The standard is effective for the interim and annual periods beginning on or after December 15, 2017, or July 1, 2018 for the Company. Early adoption is permitted. The Company is currently evaluating the impact of the standard on its consolidated financial statements.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; MARGIN-LEFT: 28.35pt; LINE-HEIGHT: 1.25"><u>ASU 2016-02 - Leases (Topic 842):</u></div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<div id="DSPFPageHeader"></div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; MARGIN-LEFT: 28.35pt; LINE-HEIGHT: 1.25">In February 2016, the FASB issued guidance on the recognition, measurement, presentation and disclosure of leases for both parties to a contract (i.e., lessees and lessors). The new standard requires lessees to apply a dual approach, classifying leases as either finance or operating leases based on the principle of whether or not the lease is effectively a financed purchase by the lessee. This classification will determine whether lease expense is recognized based on an effective interest method or on a straight-line basis over the term of the lease, respectively. A lessee is also required to record a right-of-use asset and a lease liability for all leases with a term of greater than 12 months regardless of their classification. Leases with a term of 12 months or less will be accounted for in a manner similar to the accounting under existing guidance for operating leases today. The new standard requires lessors to account for leases using an approach that is substantially equivalent to existing guidance for sales-type leases, direct financing leases and operating leases. Topic 842 supersedes the previous leases standard, ASC 840, &#8220;Leases&#8221;. The guidance is effective for the interim and annual periods beginning on or after December 15, 2018. Early adoption is permitted. The Company is currently evaluating the potential effect of the guidance on its consolidated financial statements.</div>
</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 28.35pt"><u>ASU 2016-01 - Financial Instruments - Overall (Subtopic 825-10):</u></div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<div id="DSPFPageHeader"></div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; MARGIN-LEFT: 28.35pt; LINE-HEIGHT: 1.25">In January 2016, the FASB issued guidance on financial instruments - recognition and measurement of financial assets and financial liabilities. The pronouncement revises the classification and measurement of investments in certain equity investments and the presentation of certain fair value changes for certain financial liabilities measured at fair value. ASU 2016-01 is effective for fiscal years, beginning after December 15, 2017 and interim periods within those years. The Company is currently evaluating the impact of adopting the new standard on its consolidated financial statements.<br style="LINE-HEIGHT: 1.25">
</div>
</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal">F - 21</font></div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; WIDTH: 100%; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="LINE-HEIGHT: 1.25">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: right; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.15pt">PLURISTEM THERAPEUTICS INC. AND ITS SUBSIDIARY</div>

<table id="z201b546e4a604efba3034f24b92a3dde" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; BORDER-COLLAPSE: collapse; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 100%">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 2px solid; WIDTH: 100%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</div>
</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 100%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 11.15pt">U.S. Dollars in thousands (except share and per share amounts)</div>
</td>
</tr>
</table>
</div>

<br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-WEIGHT: bold; LINE-HEIGHT: 1.25">NOTE 2:-SIGNIFICANT ACCOUNTING POLICIES (CONT.)</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 28.35pt"><u>ASU 2016-09 - Compensation - Stock Compensation (Topic 718):</u></div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 28.35pt">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<div id="DSPFPageHeader"></div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; MARGIN-LEFT: 28.35pt; LINE-HEIGHT: 1.25">In March 2016, the FASB issued guidance on improvements to employee share-based payments. The standard requires among others, that excess tax benefits or deficiencies for share-based payments be recorded as income tax benefit or expense, rather then within additional paid in capital, in the period in which the shares vest. Cash flows related to excess tax benefits will be included in operating activities instead of separately classified as a financing activity. The new guidance is effective for fiscal years beginning after December 15, 2016. Early adoption is permitted. The Company does not expect this guidance to have a material effect on its consolidated financial statements at the time of adoption of this standard.</div>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; MARGIN-LEFT: 28.35pt; LINE-HEIGHT: 1.25"><u>ASU 2017-11 - Earnings Per Share (Topic 260); Distinguishing Liabilities from Equity (Topic 480); Derivatives and Hedging (Topic 815): (Part I) Accounting for Certain Financial Instruments with Down Round Features, (Part II) Replacement of the Indefinite Deferral for Mandatorily Redeemable Financial Instruments of Certain Nonpublic Entities and Certain Mandatorily Redeemable Noncontrolling Interests with a Scope Exception:</u></div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<div id="DSPFPageHeader"></div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; MARGIN-LEFT: 28.35pt; LINE-HEIGHT: 1.25"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">In July 2017, the FASB issued ASU No. 2017-11.&#160;The ASU was issued to address the complexity associated with applying U.S. GAAP for certain financial instruments with characteristics of liabilities and equity. The ASU, among other things, eliminates the need to consider the effects of down round features when analyzing convertible debt, warrants and other financing instruments. As a result, a freestanding equity-linked financial instrument (or embedded conversion option) no longer would be accounted for as a derivative liability at fair value as a result of the existence of a down round feature. The amendments are effective for fiscal years beginning after December 15, 2018, and should be applied retrospectively. Early adoption is permitted, including adoption in an interim period. The Company plans to adopt ASU 2017-11 in the first quarter of the Company&#8217;s fiscal year 2018. </font>The Company does not expect the adoption of <font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">ASU 2017-11</font> will have a material impact on its consolidated financial statements and related disclosures.</div>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always; TEXT-ALIGN: center">F - 22

<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; WIDTH: 100%; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div id="DSPFPageHeader">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: right; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.15pt">PLURISTEM THERAPEUTICS INC. AND ITS SUBSIDIARY</div>

<table id="z8ffb6bb9260c40319fed47e3ce57f582" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; BORDER-COLLAPSE: collapse; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 100%">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 2px solid; WIDTH: 100%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</div>
</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 100%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 11.15pt">U.S. Dollars in thousands (except share and per share amounts)</div>
</td>
</tr>
</table>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">NOTE 3:- MARKETABLE SECURITIES</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 35.45pt; LINE-HEIGHT: 1.25">As of June 30, 2017 and 2016, all of the Company&#8217;s marketable securities were classified as available-for-sale.</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 35.45pt; LINE-HEIGHT: 1.25">&#160;</div>

<div>
<table id="z17c89b572ecf496caa4468908301afa4" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 94%" cellspacing="0" cellpadding="0" align="right" border="0">
<tr style="HEIGHT: 12px">
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 2px solid; FONT-WEIGHT: bold; TEXT-ALIGN: center" valign="bottom" colspan="18">June 30, 2017</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid" valign="bottom" colspan="18">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">June 30, 2016</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid" valign="bottom" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold">Amortized cos</font>t</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid" valign="bottom" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">Gross</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">unrealized</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">gain</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid" valign="bottom" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">Gross</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">unrealized</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">loss</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 2px solid" valign="bottom" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">Other-than-temporary impairment</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid" valign="bottom" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">Fair</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">value</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid" valign="bottom" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">Amortized cost</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid" valign="bottom" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">Gross</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">unrealized</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">gain</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid" valign="bottom" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">Gross</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">unrealized</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">loss</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 2px solid" valign="bottom" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">Other-than-temporary impairment</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid" valign="bottom" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">Fair</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">value</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; MARGIN-LEFT: 8.65pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 0.7pt">Available-for-sale - matures within one year:</div>
</td>
<td style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom" colspan="2">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom" colspan="2">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom" colspan="2">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff" valign="bottom" colspan="2">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom" colspan="2">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom" colspan="2">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom" colspan="2">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom" colspan="2">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff" valign="bottom" colspan="2">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom" colspan="2">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 20%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 8.65pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 0.7pt">Stock and index linked notes</div>
</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 5%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">11,988</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 5%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">2,014</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 5%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(47</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 5%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(767</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 5%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">13,188</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 5%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">11,599</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 5%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">1,594</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 5%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(208</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 5%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(38</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 5%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">12,947</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 20%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 8.65pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 0.7pt">Government debentures &#8211; fixed interest rate</div>
</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 5%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">157</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 5%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">1</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 5%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 5%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 5%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">158</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 5%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">786</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 5%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">12</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 5%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 5%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 5%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">798</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 20%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 8.65pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 0.7pt">Corporate debentures &#8211; fixed interest rate</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 5%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">47</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 5%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">1</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 5%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 5%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 5%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">48</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 5%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">439</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 5%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">7</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 5%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 5%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 5%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">446</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 20%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 5%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">12,192</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 5%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">2,016</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 5%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(47</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 5%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(767</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 5%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">13,394</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 5%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">12,824</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 5%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">1,613</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 5%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(208</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 5%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(38</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 5%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">14,191</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 20%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; MARGIN-LEFT: 8.65pt; LINE-HEIGHT: 1.25">Available-for-sale - matures after one year through five years:</div>
</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 5%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 5%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 5%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 5%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 5%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 5%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 5%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 5%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 5%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 5%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 20%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 8.65pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 0.7pt">Government debentures &#8211; fixed interest rate</div>
</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 5%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">468</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 5%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">23</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 5%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 5%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 5%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">491</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 5%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">717</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 5%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">27</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 5%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 5%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 5%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">744</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 20%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 8.65pt; LINE-HEIGHT: 1.25">Corporate debentures &#8211; fixed interest rate</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 5%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">1,255</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 5%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">7</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 5%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(1</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 5%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 5%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">1,261</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 5%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">2,403</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 5%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">47</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 5%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 5%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 5%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">2,450</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 20%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 5%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">1,723</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 5%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">30</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 5%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(1</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 5%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 5%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">1,752</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 5%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">3,120</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 5%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">74</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 5%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 5%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 5%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">3,194</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 20%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; MARGIN-LEFT: 8.65pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 0.7pt">Available-for-sale - matures after five years through ten years:</div>
</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 5%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 5%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 5%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 5%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 5%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 5%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 5%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 5%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 5%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 5%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 20%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 8.65pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 0.7pt">Corporate debentures &#8211; fixed interest rate</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 5%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">17</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 5%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">1</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 5%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 5%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 5%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">18</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 5%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">29</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 5%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">1</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 5%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 5%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 5%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">30</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 20%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 5%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">17</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 5%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">1</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 5%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 5%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 5%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">18</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 5%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">29</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 5%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">1</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 5%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 5%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 5%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">30</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; WIDTH: 20%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; MARGIN-LEFT: 8.65pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 0.7pt">Total</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; WIDTH: 5%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">13,932</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; WIDTH: 5%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">2,047</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; WIDTH: 5%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(48</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; WIDTH: 5%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(767</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; WIDTH: 5%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">15,164</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; WIDTH: 5%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">15,973</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; WIDTH: 5%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">1,688</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; WIDTH: 5%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(208</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; WIDTH: 5%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(38</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; WIDTH: 5%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">17,415</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>
</table>
</div>

<div id="DSPFPageFooter" style="CLEAR: both">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25"><font id="DSPFPageNumber" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal"></font>&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">&#160;</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always; TEXT-ALIGN: center">F - 23

<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; WIDTH: 100%; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>
</div>

<div id="DSPFPageHeader">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: right; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.15pt">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: right; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.15pt">PLURISTEM THERAPEUTICS INC. AND ITS SUBSIDIARY</div>

<table id="z2b50c1049cce4fab845d636b161a1856" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; BORDER-COLLAPSE: collapse; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 100%">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 2px solid; WIDTH: 100%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</div>
</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 100%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 11.15pt">U.S. Dollars in thousands (except share and per share amounts)</div>
</td>
</tr>
</table>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">NOTE 3:- MARKETABLE SECURITIES (CONT.)</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; MARGIN-LEFT: 34.1pt; LINE-HEIGHT: 1.25">The following table presents gross unrealized losses and fair values for those investments that were in an unrealized loss position as of June 30, 2017 and June 30, 2016, and the length of time that those investments have been in a continuous loss position:</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; MARGIN-LEFT: 7.1pt; LINE-HEIGHT: 1.25">&#160;</div>

<div>
<table id="z2ddad5786c9049a9adbfbf0b1b61d13c" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 94%" cellspacing="0" cellpadding="0" align="right" border="0">
<tr>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid" valign="bottom" colspan="6">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">12 months or less</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid" valign="bottom" colspan="6">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">Greater than 12 months</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid" valign="bottom" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">Fair Value</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid" valign="bottom" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">Gross<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><br>
</font> unrealized loss</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid" valign="bottom" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">Fair Value</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid" valign="bottom" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">Gross<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><br>
</font> unrealized loss</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 52%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 8.65pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 0.7pt">As of June 30, 2017</div>
</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">869</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(24</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">106</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">2</font>4</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 52%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 8.65pt; LINE-HEIGHT: 1.25">As of June 30, 2016</div>
</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">1,258</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(143</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">563</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(65</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
</tr>
</table>
</div>

<div style="CLEAR: both; LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; MARGIN-LEFT: 36pt; LINE-HEIGHT: 1.25">The Company typically invests in highly-rated securities. When evaluating the investments for other-than-temporary impairment, the Company reviews factors such as the length of time and extent to which fair value has been below cost basis, the financial condition of the issuer and any changes thereto, and the Company&#8217;s intent to sell, or whether it is more likely than not it will be required to sell, the investment before recovery of the investment&#8217;s amortized cost basis.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; MARGIN-LEFT: 36pt; LINE-HEIGHT: 1.25">Based on the above factors, the Company concluded that unrealized losses in the amount of $48 on all available-for-sale securities were not other-than-temporary and no credit loss was present for any of its investments. The Company recognized other-than-temporary impairment loss on outstanding securities during the year ended June 30, 2017 and 2016, of $767 and $38, respectively.</div>

<div style="MARGIN-LEFT: 9pt; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 27pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 7.1pt">As of June 30, 2017 and 2016, interest receivable amounted to $11 and $28, respectively.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">NOTE 4:- FAIR VALUE OF FINANCIAL INSTRUMENTS</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div>
<table id="z900a4c6ca5f447c0aafaf4e29e3bf035" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 94%" cellspacing="0" cellpadding="0" align="right" border="0">
<tr>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid" valign="bottom" colspan="6">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">June 30, 2017</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid" valign="bottom" colspan="6">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">June 30, 2016</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid" valign="bottom" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">Level 1</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid" valign="bottom" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">Level 2</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid" valign="bottom" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">Level 1</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid" valign="bottom" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">Level 2</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 52%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 8.65pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 0.7pt">Marketable securities</div>
</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">10,523</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">4,641</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">11,228</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">6,187</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 52%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 8.65pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 0.7pt">Foreign currency derivative instruments not designated as hedge instruments</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">295</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">65</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; WIDTH: 52%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 8.65pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 0.7pt">Total financial assets</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">10,523</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">4,936</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">11,228</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">6,252</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>
</table>
</div>

<div style="CLEAR: both; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; MARGIN-LEFT: 36pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -36pt">NOTE 5:-OTHER CURRENT ASSETS</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div>
<table id="zfa607ab951ff484e866f040412187dff" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 94%" cellspacing="0" cellpadding="0" align="right" border="0">
<tr>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid" valign="bottom" colspan="6">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">June 30,</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid" valign="bottom" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">2017</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid" valign="bottom" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">2016</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 76%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 8.65pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 0.7pt">Prepaid expenses</div>
</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">882</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">300</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 76%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 8.65pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 0.7pt">Accounts receivable from the Ministry of Economy</div>
</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">23</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 76%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 8.65pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 0.7pt">Derivatives not designated as hedge instruments</div>
</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">295</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">65</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 76%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 8.65pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 0.7pt">VAT receivables</div>
</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">137</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">167</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; PADDING-BOTTOM: 2px; WIDTH: 76%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 8.65pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 0.7pt">Other receivables</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">1</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">63</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; PADDING-BOTTOM: 4px; WIDTH: 76%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 8.65pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 0.7pt">Total</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">1,315</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">618</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>
</table>
</div>

<div style="CLEAR: both; LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal">F - 24</font></div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; WIDTH: 100%; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: right; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.15pt">PLURISTEM THERAPEUTICS INC. AND ITS SUBSIDIARY</div>

<table id="z7ecf843c2abf4ca9a956182728e2da4d" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; BORDER-COLLAPSE: collapse; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 100%">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 2px solid; WIDTH: 100%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</div>
</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 100%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 11.15pt">U.S. Dollars in thousands (except share and per share amounts)</div>
</td>
</tr>
</table>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; MARGIN-LEFT: 36pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -36pt">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; MARGIN-LEFT: 36pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -36pt">NOTE 6:-PROPERTY AND EQUIPMENT, NET</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div>
<table id="zdc26d7b242f24d7cab1183be09ef8d89" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 94%" cellspacing="0" cellpadding="0" align="right" border="0">
<tr>
<td style="VERTICAL-ALIGN: middle; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 2px solid" valign="bottom" colspan="6">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">June 30,</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; PADDING-BOTTOM: 2px" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 2px solid" valign="bottom" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">2017</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 2px solid" valign="bottom" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">2016</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Cost:</div>
</td>
<td style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff" valign="bottom" colspan="2">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff" valign="bottom" colspan="2">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 76%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Laboratory equipment</div>
</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">6,097</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">6,000</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 76%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Computers and peripheral equipment</div>
</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">1,126</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">1,024</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 76%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Office furniture and equipment</div>
</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">681</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">715</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 76%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Leasehold improvements</div>
</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">8,603</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">9,349</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; PADDING-BOTTOM: 2px; WIDTH: 76%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Vehicles</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="LINE-HEIGHT: 1.25">
<div style="LINE-HEIGHT: 1.25"></div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">-</div>
</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="LINE-HEIGHT: 1.25">
<div style="LINE-HEIGHT: 1.25"></div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">95</div>
</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr style="HEIGHT: 21px">
<td style="VERTICAL-ALIGN: top; PADDING-BOTTOM: 2px; WIDTH: 76%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;Total Cost</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="LINE-HEIGHT: 1.25">
<div style="LINE-HEIGHT: 1.25"></div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">16,507</div>
</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="LINE-HEIGHT: 1.25">
<div style="LINE-HEIGHT: 1.25"></div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">17,183</div>
</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 76%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Accumulated depreciation:</div>
</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 76%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Laboratory equipment</div>
</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">4,164</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">3,401</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 76%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Computers and peripheral equipment</div>
</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">951</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">802</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 76%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Office furniture and equipment</div>
</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">416</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">353</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 76%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Leasehold improvements</div>
</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">3,699</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">3,374</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; PADDING-BOTTOM: 2px; WIDTH: 76%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Vehicles</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="LINE-HEIGHT: 1.25">
<div style="LINE-HEIGHT: 1.25"></div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">-</div>
</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="LINE-HEIGHT: 1.25">
<div style="LINE-HEIGHT: 1.25"></div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">37</div>
</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; PADDING-BOTTOM: 2px; WIDTH: 76%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Total accumulated depreciation</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="LINE-HEIGHT: 1.25">
<div style="LINE-HEIGHT: 1.25"></div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">9,230</div>
</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="LINE-HEIGHT: 1.25">
<div style="LINE-HEIGHT: 1.25"></div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">7,967</div>
</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; PADDING-BOTTOM: 4px; WIDTH: 76%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Property and equipment, net</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">7,277</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">9,216</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>
</table>
</div>

<div style="CLEAR: both; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 34.1pt; LINE-HEIGHT: 1.25">Depreciation expenses amounted to $2,177, $2,150 and $2,074 for the years ended June 30, 2017, 2016 and 2015, respectively.</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 34.1pt; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; MARGIN-LEFT: 36pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -36pt">NOTE 7:-OTHER ACCOUNTS PAYABLE</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div>
<table id="z01e5cbd23ef84c7daf6df4bce26c373c" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 94%" cellspacing="0" cellpadding="0" align="right" border="0">
<tr>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid" valign="bottom" colspan="6">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">June 30,</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid" valign="bottom" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">2017</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid" valign="bottom" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">2016</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 76%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 8.65pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 0.7pt">Accrued payroll</div>
</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">505</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">421</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 76%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 8.65pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 0.7pt">Payroll institutions</div>
</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">345</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">309</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 76%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 8.65pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 0.7pt">Accrued vacation</div>
</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">791</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">720</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; PADDING-BOTTOM: 2px; WIDTH: 76%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 8.65pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 0.7pt">Other payables</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">342</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">251</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; PADDING-BOTTOM: 4px; WIDTH: 76%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 8.65pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 0.7pt">Total</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">1,983</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">1,701</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>
</table>
</div>

<div style="CLEAR: both; LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal">F - 25</font></div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; WIDTH: 100%; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: right; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.15pt">PLURISTEM THERAPEUTICS INC. AND ITS SUBSIDIARY</div>

<table id="z3747fb310b9d4664bbe170f399dbfa99" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; BORDER-COLLAPSE: collapse; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 100%">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 2px solid; WIDTH: 100%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</div>
</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 100%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 11.15pt">U.S. Dollars in thousands (except share and per share amounts)</div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; MARGIN-LEFT: 36pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -36pt">NOTE 8:-COMMITMENTS AND CONTINGENCIES</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">
<table id="zf3dda851cb664819a696bb696ff3f6a6" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 17.45pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; WIDTH: 18pt; align: right">a.</td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: justify; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">In February 2015, the Company signed an addendum to its facility operating lease agreement (the &#8220;Addendum&#8221;) with the lessor, which extended the lease period to December 2021.</div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; MARGIN-LEFT: 35.45pt; LINE-HEIGHT: 1.25">The lessor paid a non-refundable leasehold improvement participation payment, of approximately $947 in October 2015, in addition to the non-refundable payment of approximately $816 received in January 2013.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; MARGIN-LEFT: 35.45pt; LINE-HEIGHT: 1.25">The payments are deductible against lease expenses as they are incurred. The lessor upfront payment is included in the balance sheet as advance payment and recognized as a deduction from lease expenses over the lease term.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; MARGIN-LEFT: 35.45pt; LINE-HEIGHT: 1.25">In June 2017, the Company terminated its operating lease agreement for a facility of 1,280 square meters.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; MARGIN-LEFT: 35.45pt; LINE-HEIGHT: 1.25">The Company recognizes lease expense, net of lessor participation, under such arrangements, on a straight-line basis over the lease term.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; MARGIN-LEFT: 35.45pt; LINE-HEIGHT: 1.25">As of June 30, 2017, aggregate minimum lease commitments under the active operating lease agreements are as follows:</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div>
<table id="za09af2fca2c7484d97018003bd3aaf5a" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 70%" cellspacing="0" cellpadding="0" align="center" border="0">
<tr>
<td style="VERTICAL-ALIGN: top" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 6.95pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -6.95pt">Year ending June 30,</div>
</td>
<td style="VERTICAL-ALIGN: bottom" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom" valign="bottom" colspan="2">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 88%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 6.95pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -6.95pt">2018</div>
</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">884</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 88%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 6.95pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -6.95pt">2019</div>
</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">884</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 88%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 6.95pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -6.95pt">2020</div>
</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">894</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 88%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 6.95pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -6.95pt">2021</div>
</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">904</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; PADDING-BOTTOM: 2px; WIDTH: 88%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 6.95pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -6.95pt">2022</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">452</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; PADDING-BOTTOM: 4px; WIDTH: 88%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 6.95pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -6.95pt">Total</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">4,018</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; MARGIN-LEFT: 35.45pt; LINE-HEIGHT: 1.25">&#160;Lease expenses, net of lessor participation, amounted to $781, $824 and $704 for the years ended June 30, 2017, 2016 and 2015, respectively.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; MARGIN-LEFT: 35.45pt; LINE-HEIGHT: 1.25">&#160;The Subsidiary issued a bank guarantee in favor of the lessors in the amount of approximately $399.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">
<table id="z2db9cf5235734212b65a01ac2b1964a1" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 17.45pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; WIDTH: 18pt; align: right">b.</td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: justify; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">The Subsidiary leases several motor vehicles under operating lease agreements, which expire in various dates during years 2017 through June 2019.</div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; MARGIN-LEFT: 35.45pt; LINE-HEIGHT: 1.25">As of June 30, 2017, future aggregate minimum lease commitments under non-cancelable operating lease agreements are as follows:</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div>
<table id="z4f5dd2bb987c46d5bc7bca52a9a11c62" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 70%" cellspacing="0" cellpadding="0" align="center" border="0">
<tr>
<td style="VERTICAL-ALIGN: top" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Year ending June 30,</div>
</td>
<td style="VERTICAL-ALIGN: bottom" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom" valign="bottom" colspan="2">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 88%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">2018</div>
</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">225</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 88%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">2019</div>
</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">142</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; PADDING-BOTTOM: 2px; WIDTH: 88%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">2020</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">77</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; PADDING-BOTTOM: 4px; WIDTH: 88%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Total</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">444</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 37.35pt; LINE-HEIGHT: 1.25">Lease expenses amounted to $233, $210 and $218 for the years ended June 30, 2017, 2016 and 2015, respectively.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">
<table id="z021c6eda0cb942fc96000b93a8c74f76" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 17.45pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; WIDTH: 18pt; align: right">c.</td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: justify; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">An amount of $559 of cash and deposits was pledged by the Subsidiary to secure certain derivatives and hedging transactions, credit line and bank guarantees as of June 30, 2017.</div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal">F - 26</font></div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; WIDTH: 100%; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: right; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.15pt">PLURISTEM THERAPEUTICS INC. AND ITS SUBSIDIARY</div>

<table id="z4a48bb65e3194b5a93be1d283d42133c" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; BORDER-COLLAPSE: collapse; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 100%">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 2px solid; WIDTH: 100%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</div>
</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 100%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 11.15pt">U.S. Dollars in thousands (except share and per share amounts)</div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">NOTE 8:-COMMITMENTS AND CONTINGENCIES (CONT.)</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">
<table id="zd06be3656474465ca4dfb34832da286c" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 17.45pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; WIDTH: 18pt; align: right">d.</td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: justify; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">Under the Law for the Encouragement of Industrial Research and Development, 1984, (the &#8220;Research Law&#8221;), research and development programs that meet specified criteria and are approved by the IIA are eligible for grants of up to 50% of the project&#8217;s expenditures, as determined by the research committee, in exchange for the payment of royalties from the sale of products developed under the program. Regulations under the Research Law generally provide for the payment of royalties to the IIA of 3%-4% on sales of products and services derived from a technology developed using these grants until 100% of the dollar-linked grant is repaid. The Company&#8217;s obligation to pay these royalties is contingent on its actual sale of such products and services. In the absence of such sales, no payment is required. Outstanding balance of the grants will be subject to interest at a rate equal to the 12 month LIBOR applicable to dollar deposits that is published on the first business day of each calendar year. Following the full repayment of the grant, there is no further liability for royalties.</div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; MARGIN-LEFT: 35.45pt; LINE-HEIGHT: 1.25">Through June 30, 2017, total grants obtained aggregated to approximately $24,461. Through June 30, 2017, total royalties paid and accrued amounted to $166. As of June 30, 2017, the Company&#8217;s contingent liability in respect to royalties to the IIA amounted to $24,295, not including LIBOR interest as described above.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">
<table id="z5c8e462bca1044178dfdf963bc0b6f4e" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 17.45pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; WIDTH: 18pt; align: right">e.</td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: justify; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">The Company has been awarded a marketing grant under the &#8220;Smart Money&#8221; program of the Israeli Ministry of Economy and Industry. The program&#8217;s aim is to assist companies to extend their activities in international markets. The goal market that was chosen was Japan. The Israeli government granted the Company budget resources that are intended to be used to advance the Company&#8217;s product candidate towards marketing in Japan and for regulatory activities there. As part of the program, the Company will repay royalties of 5% from the Company&#8217;s income in Japan during five years, starting the year in which the Company will not be entitled to reimbursement of expenses under the program and will be spread for a period of up to 5 years or until the amount of the grant is fully paid<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">.</font></div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; MARGIN-LEFT: 35.45pt; LINE-HEIGHT: 1.25">Through June 30, 2017, total grants obtained under the Smart Money program amounted to approximately $112. No royalties were paid or accrued as of June 30, 2017.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">
<table id="z53e4cec222574e43af1e7d3c20564ad0" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 17.45pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; WIDTH: 18pt; align: right">f.</td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: justify; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">The Company announced that it will collaborate with the New York Blood Center (&#8220;NYBC&#8221;) on preclinical studies of its placental expanded R-18 cells (&#8220;PLX-R18&#8221;) to enhance the efficacy of umbilical cord blood transplantation. The project has been selected to receive a conditional award of $900 from Israel-United States Binational Industrial Research and Development Foundation (&#8220;BIRD Foundation&#8221;), of which an amount of $585 is a direct grant allocated to the Company. Per the terms of the project, The Company will provide the PLX-R18 cells and the NYBC will be responsible for conducting and supporting the studies. Amounts received in connection with this award are presented in &#8220;Other long-term liabilities&#8221; as the Company does not expect to repay the liability in the next 12 months.</div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; MARGIN-LEFT: 35.45pt; LINE-HEIGHT: 1.25">In accordance with the agreement between the Company and NYBC, if only one party elects to proceed with the development of the product, such party shall be responsible for all repayment obligations to the BIRD Foundation for both parties, if applicable. In addition, in case of conclusion of project development which will trigger the grant repayment to the BIRD Foundation, if the Company will elect to pursue the development of the product, and NYBC elects not to pursue the development of the product, then, unless otherwise agreed by the parties, the Company shall pay NYBC royalties in the amount of 2.5% from its revenues of the product, up to an aggregate royalty amount of approximately $550.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal">F - 27</font></div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; WIDTH: 100%; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: right; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.15pt">PLURISTEM THERAPEUTICS INC. AND ITS SUBSIDIARY</div>

<table id="z52b1d465c3c54a34a89a3474f67ecdfe" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; BORDER-COLLAPSE: collapse; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 100%">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 2px solid; WIDTH: 100%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</div>
</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 100%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 11.15pt">U.S. Dollars in thousands (except share and per share amounts)</div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; MARGIN-LEFT: 36pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -36pt">NOTE 9: - STOCKHOLDERS&#8217; EQUITY</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">The Company&#8217;s authorized common stock consists of 200,000,000 shares with a par value of $0.00001 per share.&#160; All shares have equal voting rights and are entitled to one vote per share in all matters to be voted upon by stockholders. The shares have no pre-emptive, subscription, conversion or redemption rights and may be issued only as fully paid and non-assessable shares. Holders of the common stock are entitled to equal ratable rights to dividends and distributions with respect to the common stock, as may be declared by the Board of Directors out of funds legally available.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">The Company&#8217;s authorized preferred stock consists of 10,000,000 shares of preferred stock, par value $0.00001 per share, with series, rights, preferences, privileges and restrictions as may be designated from time to time by the Company&#8217;s Board of Directors.&#160; No shares of preferred stock have been issued.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">
<table id="z87d2780cdb124755b18b71a7b2347e8b" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 18pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; WIDTH: 18pt; align: right">a.</td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: justify; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">From July 2014 through June 2015, a total of 2,081,303 warrants were exercised via &#8220;cashless&#8221; exercise, resulting in the issuance of 963,876 shares of common stock to investors of the Company. &#160;In addition, 170,167 warrants were exercised for cash and resulted in the issuance of 170,167 shares of common stock to investors of the Company. The aggregate cash consideration received was $276.</div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">
<table id="z2b2818ce06104f87b76ea2231fa00945" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 18pt"></td>
<td style="VERTICAL-ALIGN: top; WIDTH: 18pt; align: right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">b</font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold">.</font></td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: justify; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">From October 2014 through May 2015, the Company issued shares of common stock in private placements to investors. In October 2014, the Company issued 200,000 shares of common stock to an investor for aggregate cash consideration of $528. In February 2015, the Company issued an additional 200,000 shares of common stock to an investor for aggregate cash consideration of $586. In May 2015, the Company issued an additional 300,000 shares of common stock to an investor, for which the consideration in the amount of $790 was received from the investor in September 2015.</div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">
<table id="z491d71b4839c4ba9afe1eabeb698efe0" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 18pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; WIDTH: 18pt; align: right">c.</td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: justify; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">On June 25, 2015, the Company entered into definitive agreements to sell 6,800,000 shares of common stock and warrants to purchase up to 4,080,000 shares of common stock at a combined price of $2.50 per share and related warrants (the &#8220;Offering&#8221;). The gross proceeds from the Offering were $17,000. Issuance costs amounted to $1,200. The warrants have an exercise price of $2.85 per share of common stock, are immediately exercisable and expire 5 years from the closing of the Offering. The Offering was closed on June 30, 2015.</div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">
<table id="zf73f74b46a0544509aace56c79dbe85b" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 18pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; WIDTH: 18pt; align: right">d.</td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: justify; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">In February 2015, the Subsidiary entered into an agreement with a contractor for the construction of its new laboratories facility for a consideration of approximately NIS 3.3 million (approximately $841). Under the terms of the agreement, the Subsidiary agreed to pay part of the NIS 3.3 million consideration using 100,004 restricted shares of common stock of the Company, linked to performance milestones with respect to the new laboratories construction and which serve as a guarantee. These restricted shares were released to the contractor in December 2014 upon the successful completion of the construction.</div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; MARGIN-LEFT: 36pt; LINE-HEIGHT: 1.25">In May 2015, the Subsidiary entered into an addendum to the agreement with the contractor for the design and construction of additional office space renovations in the Subsidiary leased facility for additional consideration of approximately NIS 4 million (approximately $1,032) which is comprised of NIS 3 million (approximately $774) in cash and 90,000 restricted shares which were issued to the contractor in February 2016.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; MARGIN-LEFT: 36pt; LINE-HEIGHT: 1.25">The Company accounted for the abovementioned stock-based payment awards to the contractor in accordance with ASC 505-50, &#8220;Equity based payments to non-employees&#8221;.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal">F - 28</font></div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; WIDTH: 100%; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: right; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.15pt">PLURISTEM THERAPEUTICS INC. AND ITS SUBSIDIARY</div>

<table id="z472bc591d3f74d33825d1b1e736131b9" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; BORDER-COLLAPSE: collapse; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 100%">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 2px solid; WIDTH: 100%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</div>
</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 100%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 11.15pt">U.S. Dollars in thousands (except share and per share amounts)</div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">NOTE 9: - STOCKHOLDERS&#8217; EQUITY </font>(CONT.)</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; MARGIN-LEFT: 36pt; LINE-HEIGHT: 1.25">As performance by the contractor was not deemed complete while the awards were forfeitable (or not issued), the Company measured the fair value of the awards at each reporting period through the performance completion date (until completion of the construction work).</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; MARGIN-LEFT: 36pt; LINE-HEIGHT: 1.25">The construction work was initiated in June 2015. On October 30, 2015, the contractor completed the agreed construction milestones. As a result, the Company recognized the fair value of the stock-based payments awards, using the fair value of the Company&#8217;s shares on October 30, 2015, totaling approximately $302 as stock-based <a id="_cp_text_1_61" name="_cp_text_1_61"><!--Anchor--></a>payment to the contractor in &#8220;Additional paid-in capital&#8221; with a corresponding amount included in &#8220;Property and equipment, net&#8221;.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">
<table id="z521b28fde2ea495c878549854f5db083" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 18pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; WIDTH: 18pt; align: right">e.</td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: justify; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">On January 25, 2017, the Company issued, pursuant to an underwriting agreement relating to a firm commitment public offering, an aggregate of 14,081,633 shares of common stock and warrants to purchase an aggregate of 8,448,980 shares of common stock, inclusive of the underwriter&#8217;s over-allotment option, which was exercised in full, for aggregate gross proceeds of $17,250. The net proceeds, after deducting underwriting commissions, discounts and other expenses related to the offering were approximately $15,718.</div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; MARGIN-LEFT: 36pt; LINE-HEIGHT: 1.25">The warrants issued in the offering are exercisable for a period of five years commencing&#160;six months following issuance and have an exercise price of $1.40 per share. As of June 30, 2017, all of the warrants are outstanding.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">
<table id="z934cc2e6e6574d19885e34f2bb8a716e" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; TEXT-ALIGN: center; WIDTH: 49px; align: right">&#160;f.</td>
<td style="VERTICAL-ALIGN: top; FONT-WEIGHT: normal; TEXT-ALIGN: justify; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">Options, warrants and restricted stock units to employees, directors and consultants:</div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; MARGIN-LEFT: 35.45pt; LINE-HEIGHT: 1.25">The Company has approved incentive option plan from 2005 (the &#8220;2005 Plan&#8221;). Under the Plan, options, restricted stock (&#8220;RS&#8221;) and restricted stock units (&#8220;RSUs&#8221;) (collectively, the &#8220;Awards&#8221;) may be granted to the Company&#8217;s officers, directors, employees and consultants.&#160; Any Awards that are cancelled or forfeited before expiration become available for future grants.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; MARGIN-LEFT: 35.45pt; LINE-HEIGHT: 1.25">In addition, at the Company&#8217;s annual meeting of its stockholders, held on May 31, 2016, the Company&#8217;s stockholders approved the 2016 Equity Compensation Plan (the &#8220;2016 Plan&#8221;). Under the 2016 Plan, options, RS and RSUs may be granted to the Company&#8217;s officers, directors, employees and consultants or the officers, directors, employees and consultants of our subsidiary.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; MARGIN-LEFT: 36pt; LINE-HEIGHT: 1.25">As of June 30, 2017, the number of shares of common stock authorized for issuance under the 2005 Plan amounted to 19,166,082, of which 3,305,428 shares are available for future grant under the 2005 Plan.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; MARGIN-LEFT: 36pt; LINE-HEIGHT: 1.25">As of June 30, 2017, the number of shares of common stock authorized for issuance under the 2016 Plan amounted to 2,584,147 for calendar year 2017, of which 343,327 shares are available for future grant under the 2016 Plan.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
 &#160;</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal">F - 29</font></div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; WIDTH: 100%; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: right; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.15pt">PLURISTEM THERAPEUTICS INC. AND ITS SUBSIDIARY</div>

<table id="zd8bf2c884cce481f822512c4d63a040d" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; BORDER-COLLAPSE: collapse; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 100%">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 2px solid; WIDTH: 100%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</div>
</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 100%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 11.15pt">U.S. Dollars in thousands (except share and per share amounts)</div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-WEIGHT: bold; LINE-HEIGHT: 1.25">NOTE 9: - STOCKHOLDERS&#8217; EQUITY (CONT.)</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="LINE-HEIGHT: 1.25">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: justify; MARGIN-LEFT: 71.45pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -36pt"><u>(1) Options to employees and directors:</u></div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; MARGIN-LEFT: 36pt; LINE-HEIGHT: 1.25">The Company accounts for its options to employees and directors under the fair value method in accordance with ASC 718, &#8220;Compensation&#8212;Stock Compensation&#8221;. A summary of the Company&#8217;s activity for options granted to employees and directors under the 2005 Plan is as follows:</div>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div>
<table id="zc5d82afc4543485a9c7bd20b618b95e2" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 94%" cellspacing="0" cellpadding="0" align="right" border="0">
<tr>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom"></td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid" valign="bottom" colspan="14">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 2pt">Year ended June 30, 2017</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid" valign="bottom" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 2pt">Number</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid" valign="bottom" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 2pt">Weighted Average Exercise Price</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid" valign="bottom" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 2pt">Weighted Average Remaining Contractual Terms (in years)</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid" valign="bottom" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 2pt">Aggregate Intrinsic Value Price</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 8.65pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 0.7pt">Options outstanding at beginning of period</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">1,771,700</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">3.76</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom" colspan="2">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom" colspan="2">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 8.65pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 0.7pt">Options exercised</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(16,000</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">0.62</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom" colspan="2">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom" colspan="2">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 8.65pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 0.7pt">Options forfeited</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(940,050</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">4.49</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom" colspan="2">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom" colspan="2">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; WIDTH: 52%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 8.65pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 0.7pt">Options outstanding at end of the period</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">815,650</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">2.98</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">0.82</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">231</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; WIDTH: 52%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 8.65pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 0.7pt">Options exercisable at the end of the period</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">815,650</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">2.98</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">0.82</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">231</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; WIDTH: 52%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 8.65pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 0.7pt">Options vested at the end of the period</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">815,650</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">2.98</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">0.82</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: right; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">231</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>
</table>
</div>

<div style="CLEAR: both; LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; MARGIN-LEFT: 35.45pt; LINE-HEIGHT: 1.25">Intrinsic value of exercisable options (the difference between the Company&#8217;s closing stock price on the last trading day in the period and the exercise price, multiplied by the number of in-the-money options) represents the amount that would have been received by the employees and directors option holders had all option holders exercised their options on June 30, 2017. This amount changes based on the fair market value of the Company&#8217;s common stock.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: justify; MARGIN-LEFT: 71.45pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -36pt"><u>(2) Options to non-employees:</u></div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 36pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt">A summary of the options to non-employee consultants is as follows:</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 36pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt">&#160;</div>

<div>
<table id="zffa8b47d18a649d3a4152a165d92e716" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 94%" cellspacing="0" cellpadding="0" align="right" border="0">
<tr>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid" valign="bottom" colspan="14">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 2pt">Year ended June 30, 2017</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr style="HEIGHT: 52px">
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid" valign="bottom" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 2pt">Number</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid" valign="bottom" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 2pt">Weighted Average Exercise Price</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid" valign="bottom" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 2pt">Weighted Average Remaining Contractual Terms (in years)</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid" valign="bottom" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 2pt">Aggregate Intrinsic Value Price</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 8.65pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 0.7pt">Options outstanding at beginning of period</div>
</td>
<td style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">237,300</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">5.40</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom" colspan="2">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom" colspan="2">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 8.65pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 0.7pt">Options granted</div>
</td>
<td style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">46,800</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">0.00</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom" colspan="2">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom" colspan="2">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 8.65pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 0.7pt">Options exercised</div>
</td>
<td style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(1,900</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
<td style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">0.00</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom" colspan="2">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom" colspan="2">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 8.65pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 0.7pt">Options forfeited</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(105,000</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">10.98</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom" colspan="2">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom" colspan="2">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; WIDTH: 52%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 8.65pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 0.7pt">Options outstanding at end of the period</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">177,200</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">0.72</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">4.30</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">179</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; WIDTH: 52%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 8.65pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 0.7pt">Options exercisable at the end of the period</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">164,825</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">0.78</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">3.92</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">163</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; WIDTH: 52%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 8.65pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 0.7pt">Options vested&#160; and expected to vest at the end of the period</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">177,200</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">0.72</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">4.30</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">179</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>
</table>
</div>

<div style="CLEAR: both; LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal">F - 30</font></div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; WIDTH: 100%; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: right; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.15pt">PLURISTEM THERAPEUTICS INC. AND ITS SUBSIDIARY</div>

<table id="zc07f074e001e4ccc80e241573478fdf6" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; BORDER-COLLAPSE: collapse; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 100%">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 2px solid; WIDTH: 100%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</div>
</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 100%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 11.15pt">U.S. Dollars in thousands (except share and per share amounts)</div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; MARGIN-LEFT: 36pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -36pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">NOTE 9: - STOCKHOLDERS&#8217; EQUITY </font>(CONT.)</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="MARGIN-LEFT: 36pt; LINE-HEIGHT: 1.25">Compensation expenses related to options granted to consultants were recorded as follows:</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div>
<table id="zd480bd2b1cb94e0484682e7fd7793ed9" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 94%" cellspacing="0" cellpadding="0" align="right" border="0">
<tr>
<td style="VERTICAL-ALIGN: top; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: middle; BORDER-BOTTOM: #000000 2px solid" valign="bottom" colspan="10">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 2pt">Year ended June 30,</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 2px solid" valign="bottom" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">2017</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 2px solid" valign="bottom" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">2016</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 2px solid" valign="bottom" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">2015</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 64%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 8.65pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 0.7pt">Research and development expenses</div>
</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">7</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">22</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">1</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 64%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 8.65pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 0.7pt">General and administrative expenses</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">39</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">2</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">1</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; WIDTH: 64%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">46</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">24</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">2</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>
</table>
</div>

<div style="CLEAR: both; LINE-HEIGHT: 1.25">&#160;</div>

<div style="LINE-HEIGHT: 1.25">
<div id="DSPFPageHeader"></div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: justify; MARGIN-LEFT: 71.45pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -36pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">&#160;</font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><u>(3) RS and RSUs to employees and directors:</u></font></div>

<div style="LINE-HEIGHT: 1.25">
<div id="DSPFPageHeader"></div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; MARGIN-LEFT: 35.45pt; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; MARGIN-LEFT: 35.45pt; LINE-HEIGHT: 1.25">The following table summarizes the activity related to unvested RS and RSUs granted to employees and directors under the 2005 Plan and 2016 Plan for the year ended June 30, 2017:</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>
</div>
</div>

<div>
<table id="zdd176e5c456a4b89a1f51858b7a2875c" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 94%" cellspacing="0" cellpadding="0" align="right" border="0">
<tr>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid" valign="bottom" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 2pt">Number</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 88%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 8.65pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 0.7pt">Unvested at the beginning of period</div>
</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">1,906,619</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 88%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 8.65pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 0.7pt">Granted</div>
</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">6,579,435</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 88%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 8.65pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 0.7pt">Forfeited</div>
</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(107,953</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 88%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 8.65pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 0.7pt">Vested</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(2,313,200</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; WIDTH: 88%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 8.65pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 0.7pt">Unvested at the end of the period</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">6,064,901</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; WIDTH: 88%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 8.65pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 0.7pt">Expected to vest after June 30, 2017</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">5,978,114</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>
</table>
</div>

<div style="CLEAR: both; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; MARGIN-LEFT: 36pt; LINE-HEIGHT: 1.25">Compensation expenses related to RS and RSUs granted to employees and directors were recorded as follows:</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div>
<table id="z89fbe625712c46c7854b12e39917d0a6" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 94%" cellspacing="0" cellpadding="0" align="right" border="0">
<tr>
<td style="VERTICAL-ALIGN: top; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: middle; BORDER-BOTTOM: #000000 2px solid" valign="bottom" colspan="10">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">Year ended June 30,</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 2px solid" valign="bottom" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">2017</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 2px solid" valign="bottom" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">2016</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 2px solid" valign="bottom" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">2015</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 64%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 8.65pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 0.7pt">Research and development expenses</div>
</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">1,558</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">960</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">1,469</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 64%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 8.65pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 0.7pt">General and administrative expenses</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">1,645</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">1,905</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">2,277</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; WIDTH: 64%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">3,203</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">2,865</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">3,746</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>
</table>
</div>

<div style="CLEAR: both; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 35.45pt; LINE-HEIGHT: 1.25">Unamortized compensation expenses related to RS and RSUs granted to employees and directors to be recognized over an average time of approximately 4 years are approximately $6,886.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal">F - 31</font></div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; WIDTH: 100%; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: right; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.15pt">PLURISTEM THERAPEUTICS INC. AND ITS SUBSIDIARY</div>

<table id="zfa59f41ecc414f0da5f9de6be5ff5162" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; BORDER-COLLAPSE: collapse; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 100%">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 2px solid; WIDTH: 100%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</div>
</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 100%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 11.15pt">U.S. Dollars in thousands (except share and per share amounts)</div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">NOTE 9: - STOCKHOLDERS&#8217; EQUITY </font>(CONT.)</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="LINE-HEIGHT: 1.25">
<div id="DSPFPageHeader"></div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: justify; MARGIN-LEFT: 71.45pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -36pt"><u>&#160;(4) RS and RSUs to consultants:</u></div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; MARGIN-LEFT: 36pt; LINE-HEIGHT: 1.25">The following table summarizes the activity related to unvested RS and RSUs granted to consultants for the year ended June 30, 2017:</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; MARGIN-LEFT: 36pt; LINE-HEIGHT: 1.25">&#160;</div>

<div>
<table id="z8e0bf2d3eaa64c13b2ffaf539d67195a" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 94%" cellspacing="0" cellpadding="0" align="right" border="0">
<tr>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid" valign="bottom" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 2pt">Number</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 88%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 8.65pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 0.7pt">Unvested at the beginning of period</div>
</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">26,000</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr style="HEIGHT: 16px">
<td style="VERTICAL-ALIGN: bottom; WIDTH: 88%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 8.65pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 0.7pt">Granted</div>
</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">273,557</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 88%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 8.65pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 0.7pt">Vested</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(257,057</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; WIDTH: 88%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 8.65pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 0.7pt">Unvested at the end of the period</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">42,500</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>
</table>
</div>

<div style="CLEAR: both; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; MARGIN-LEFT: 36pt; LINE-HEIGHT: 1.25">Compensation expenses related to RS and RSUs granted to consultants were recorded as follows:</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div>
<table id="z3f959cbd462043d1b0e75a38e85ac309" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 94%" cellspacing="0" cellpadding="0" align="right" border="0">
<tr>
<td style="VERTICAL-ALIGN: top; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: middle; BORDER-BOTTOM: #000000 2px solid" valign="bottom" colspan="10">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">Year ended June 30,</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 2px solid" valign="bottom" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">2017</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 2px solid" valign="bottom" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">2016</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 2px solid" valign="bottom" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">2015</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 64%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 8.65pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 0.7pt">Research and development expenses</div>
</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">19</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">39</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">131</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 64%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 8.65pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 0.7pt">General and administrative expenses</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">394</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">145</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">173</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; WIDTH: 64%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">413</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">184</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">304</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>
</table>
</div>

<div style="CLEAR: both; LINE-HEIGHT: 1.25">&#160;</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
 &#160;</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal">F - 32</font></div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; WIDTH: 100%; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: right; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.15pt">PLURISTEM THERAPEUTICS INC. AND ITS SUBSIDIARY</div>

<table id="z8afba091ad3448c084313fd30524d1ba" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; BORDER-COLLAPSE: collapse; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 100%">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 2px solid; WIDTH: 100%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</div>
</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 100%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 11.15pt">U.S. Dollars in thousands (except share and per share amounts)</div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">NOTE 9: - STOCKHOLDERS&#8217; EQUITY </font>(CONT.)</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">
<table id="z6be9f75f757044cbae38753b21d4a708" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 18pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; WIDTH: 18pt; align: right">a.</td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: justify; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold">Summary of warrants and options:</div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div>
<table id="z522be72775cb4488b2680c438abfc4d4" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr style="HEIGHT: 60px">
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid" valign="bottom">
<div style="LINE-HEIGHT: 1.25">
<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">Warrants / Options</div>
</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid" valign="bottom" colspan="2">
<div style="LINE-HEIGHT: 1.25">
<div style="LINE-HEIGHT: 1.25"></div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold">Exercise Price</font> </div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">per Share</div>
</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid" valign="bottom" colspan="2">
<div style="LINE-HEIGHT: 1.25">
<div style="LINE-HEIGHT: 1.25"></div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">Options and Warrants </div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">for Common Stock</div>
</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid" valign="bottom" colspan="2">
<div style="LINE-HEIGHT: 1.25">
<div style="LINE-HEIGHT: 1.25"></div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold">Options and Warrants</font> <font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold">Exercisable</font></div>
</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 18px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: center; WIDTH: 151px" colspan="2">
<div style="LINE-HEIGHT: 1.25">
<div style="LINE-HEIGHT: 1.25"></div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold">Weighted Average Remaining Contractual Terms</font> <font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold">(in years)</font></div>
</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 52%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; MARGIN-LEFT: 18pt; LINE-HEIGHT: 1.25">Warrants:</div>
</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">1.40</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">8,448,981</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1.17%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">5.06</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 52%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">2.85</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">4,080,000</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">4,080,000</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1.17%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">3.00</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; PADDING-BOTTOM: 2px; WIDTH: 52%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">5.00</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">3,219,983</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">3,219,983</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 1.17%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">0.22</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; PADDING-BOTTOM: 2px; WIDTH: 52%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; MARGIN-LEFT: 18pt; LINE-HEIGHT: 1.25">Total warrants</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; LINE-HEIGHT: 1.25">15,748,964</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; LINE-HEIGHT: 1.25">7,299,983</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 1.17%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 52%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1.17%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 52%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; MARGIN-LEFT: 18pt; LINE-HEIGHT: 1.25">Options:</div>
</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">0.00</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">137,200</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">124,825</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1.17%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">5.32</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 52%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">0.62</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">345,500</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">345,500</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1.17%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">1.28</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 52%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">1.04</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">25,000</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">25,000</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1.17%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">1.16</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 52%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">2.97</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">20,000</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">20,000</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1.17%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">0.86</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 52%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">3.50</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">30,000</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">30,000</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1.17%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">0.14</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 52%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">3.80</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">1,000</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">1,000</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1.17%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">0.14</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 52%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">4.38</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">372,500</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">372,500</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1.17%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">0.47</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 52%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">4.40</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">400</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">400</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1.17%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">0.14</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 52%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">6.80</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">36,250</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">36,250</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1.17%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">0.37</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 52%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">8.20</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">20,000</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">20,000</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1.17%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">0.16</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; PADDING-BOTTOM: 2px; WIDTH: 52%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">20.00</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">5,000</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">5,000</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 1.17%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">2.62</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; PADDING-BOTTOM: 2px; WIDTH: 52%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; MARGIN-LEFT: 18pt; LINE-HEIGHT: 1.25">Total options</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; LINE-HEIGHT: 1.25">992,850</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; LINE-HEIGHT: 1.25">980,475</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 1.17%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #ffffff" valign="bottom" colspan="4">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 18pt">Total warrants and options</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; LINE-HEIGHT: 1.25">16,741,814</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; LINE-HEIGHT: 1.25">8,280,458</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 18px; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 12px; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">This summary does not include 6,107,401 RS and RSUs that are not vested as of June 30, 2017.</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal">F - 33</font></div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; WIDTH: 100%; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: right; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.15pt">PLURISTEM THERAPEUTICS INC. AND ITS SUBSIDIARY</div>

<table id="z8d0b189dffc04335889953d357d45605" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; BORDER-COLLAPSE: collapse; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 100%">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 2px solid; WIDTH: 100%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</div>
</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 100%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 11.15pt">U.S. Dollars in thousands (except share and per share amounts)</div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; MARGIN-LEFT: 36pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -36pt"><a id="OLE_LINK15" name="OLE_LINK15"><!--Anchor--></a><a id="OLE_LINK16" name="OLE_LINK16"><!--Anchor--></a>NOTE 10:-FINANCIAL INCOME, NET</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div>
<table id="za47e081f166149a880e695ce08148ece" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 94%" cellspacing="0" cellpadding="0" align="right" border="0">
<tr>
<td style="VERTICAL-ALIGN: top; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: middle; BORDER-BOTTOM: #000000 2px solid" valign="bottom" colspan="10">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">Year ended June 30,</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 2px solid" valign="bottom" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">2017</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 2px solid" valign="bottom" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">2016</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 2px solid" valign="bottom" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">2015</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: middle; WIDTH: 64%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 8.65pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 0.7pt">Foreign currency translation differences, net</div>
</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">182</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(174</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(1,109</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: middle; WIDTH: 64%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 8.65pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 0.7pt">Bank and broker commissions</div>
</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(67</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(85</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(37</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: middle; WIDTH: 64%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 8.65pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 0.7pt">Interest income on deposits</div>
</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">122</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">149</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">112</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: middle; WIDTH: 64%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 8.65pt; LINE-HEIGHT: 1.25">Gain (loss) related to marketable securities, net</div>
</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(513</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">190</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">1,229</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: middle; WIDTH: 64%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 8.65pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 0.7pt">Gain (loss) from&#160; derivatives and fair value hedge derivatives</div>
</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">481</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(30</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">395</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: middle; PADDING-BOTTOM: 2px; WIDTH: 64%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 8.65pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 0.7pt">Other financial income</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">23</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; WIDTH: 64%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">205</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">73</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">590</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>
</table>
</div>

<div style="CLEAR: both; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; MARGIN-LEFT: 36pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -36pt">NOTE 11:-TAXES ON INCOME</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">
<table id="z7bcbacf0f42c4d5c93c73efec80a360c" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; WIDTH: 27pt; align: right">A.</td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: justify; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">Tax assessments:</div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; MARGIN-LEFT: 42.55pt; LINE-HEIGHT: 1.25">The Subsidiary has not received final tax assessments since its incorporation; however, the assessments of the Subsidiary are deemed final through 2012.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">
<table id="z0924a5ec76744668a468bba09bab2c68" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; WIDTH: 27pt; align: right">B.</td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: justify; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">Tax rates applicable to the Company:-</div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">
<table id="z66f1373608f746e1aae92f11f2a25673" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 28.35pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; WIDTH: 14.2pt; align: right">1.</td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: justify; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">Pluristem Therapeutics Inc.:</div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; MARGIN-LEFT: 42.55pt; LINE-HEIGHT: 1.25">The tax rates applicable to Pluristem Therapeutics Inc., a Nevada corporation, are corporate (progressive) tax at the rate of up to 35%, excluding state tax and local tax if any, which rates depend on the state and city in which Pluristem Therapeutics Inc. conducts its business.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">
<table id="z1fb4eba8f33d44ab8cf4d66bb28cbda2" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 28.35pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; WIDTH: 14.2pt; align: right">2.</td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: justify; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">The Subsidiary:</div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; MARGIN-LEFT: 42.55pt; LINE-HEIGHT: 1.25">Taxable income of Israeli companies is subject to tax at the rate of 24% in year 2017, 25% in 2016 and 26.5% in 2015.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; MARGIN-LEFT: 42.55pt; LINE-HEIGHT: 1.25">In December 2016, the Israeli Parliament approved the Economic Efficiency Law (Legislative Amendments for Applying the Economic Policy for the 2017 and 2018 Budget Years), 2016, which reduces the corporate income tax rate to 23% effective from January 1, 2018.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; MARGIN-LEFT: 42.55pt; LINE-HEIGHT: 1.25">Under the Foreign Exchange Regulations, the Subsidiary calculates its tax liability in U.S. Dollars according to certain orders. The tax liability, as calculated in U.S. Dollars is translated into New Israeli Shekels according to the exchange rate as of June 30 of each year.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal">F - 34</font></div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; WIDTH: 100%; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: right; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.15pt">PLURISTEM THERAPEUTICS INC. AND ITS SUBSIDIARY</div>

<table id="zf24adb58ce81486384d74e45ab67f3bc" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; BORDER-COLLAPSE: collapse; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 100%">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 2px solid; WIDTH: 100%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</div>
</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 100%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 11.15pt">U.S. Dollars in thousands (except share and per share amounts)</div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">NOTE 11:-TAXES ON INCOME (CONT.)</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: justify; MARGIN-LEFT: 42.55pt; LINE-HEIGHT: 1.25">Tax Benefits Under the Law for Encouragement of Capital Investments.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; MARGIN-LEFT: 42.55pt; LINE-HEIGHT: 1.25">According to the Law for Encouragement of Capital Investments, 1959 (the &#8220;Encouragement Law&#8221;), the Subsidiary is entitled to various tax benefits due to &#8220;Beneficiary Enterprise&#8221; status granted to its enterprise, as implied by the Encouragement Law. The principal benefits by virtue of the Encouragement Law are:</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-STYLE: italic; TEXT-ALIGN: justify; MARGIN-LEFT: 42.55pt; LINE-HEIGHT: 1.25">Tax benefits and reduced tax rates:</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; MARGIN-LEFT: 42.55pt; LINE-HEIGHT: 1.25">On July 7, 2010, the Subsidiary has received a letter of approval (the &#8220;Ruling&#8221;) from the Israeli Tax Authority. According to the Ruling, the Subsidiary&#8217;s expansion program of its plant was granted the status of a &#8220;Beneficiary Enterprise&#8221; under the &#8220;Alternative Track&#8221; (the &#8220;2007 Program&#8221;). The Subsidiary chose the year 2007 as the election year of the 2007 Program.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; MARGIN-LEFT: 42.55pt; LINE-HEIGHT: 1.25">Under the 2007 Program &#8220;Alternative Track&#8221;, the Subsidiary, which was located in a National Priority Zone &#8220;B&#8221; with respect to the year 2007, is tax exempt in the first six years of the benefit period and subject to tax at the reduced rate of 10%-25% for a period of one to four years for the remaining benefit period (dependent on the level of foreign investments).</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; MARGIN-LEFT: 42.55pt; LINE-HEIGHT: 1.25">On June 6, 2013, the Subsidiary informed the Israeli Tax Authority that it has chosen the year 2012 as an election year to the expansion of its &#8220;Beneficiary Enterprise&#8221; program (the &#8220;2012 Program&#8221;).</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; MARGIN-LEFT: 42.55pt; LINE-HEIGHT: 1.25">Under the 2012 Program, the Subsidiary, which was located in the &#8220;Other National Priority Zone&#8221; with respect to the year 2012, would be tax exempt in the first two years of the benefit period and subject to tax at the reduced rate of 10%-25% for a period of five to eight years for the remaining benefit period (dependent on the level of foreign investments).</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; MARGIN-LEFT: 42.55pt; LINE-HEIGHT: 1.25">Following the enactment of Amendment No. 60 to the Encouragement<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold">&#160;</font>Law, subsequent to April 1, 2005, companies whose election year entitled them to a Beneficiary Enterprise status are required, among others, to make a minimum qualifying investment. This condition requires an investment in the acquisition of productive assets such as machinery and equipment, which must be carried out within three years. The minimum qualifying investment required for setting up a plant is NIS&#160;300,000, linked to the Israeli CPI in accordance with the guidelines of the Israeli tax authorities. As for plant expansion, the minimum qualifying investment is the higher of NIS&#160;300,000, linked to the Israeli CPI as stated above, and an amount equivalent to the &#8220;qualifying percentage&#8221; of the value of the productive assets. Productive assets that are used by the plant but not owned by it will also be viewed as productive assets.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; MARGIN-LEFT: 42.55pt; LINE-HEIGHT: 1.25">The qualifying percentage of the value of the productive assets is as follows:</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div>
<table id="z7dd3f999d96e475daadaf09b843306b8" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; BORDER-COLLAPSE: collapse; WIDTH: 94%" cellspacing="0" cellpadding="0" align="right" border="0">
<tr>
<td style="VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 2px solid; WIDTH: 53.57%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; MARGIN-LEFT: 42.55pt; LINE-HEIGHT: 1.25">The value of productive</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; MARGIN-LEFT: 42.55pt; LINE-HEIGHT: 1.25">assets before the expansion</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; MARGIN-LEFT: 42.55pt; LINE-HEIGHT: 1.25">(NIS in millions)</div>
</td>
<td style="VERTICAL-ALIGN: top; WIDTH: 3.58%">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: center; WIDTH: 42.85%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; LINE-HEIGHT: 1.25">The new proportion that the required </div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; LINE-HEIGHT: 1.25">investment bears to the value of productive assets</div>
</td>
</tr>

<tr>
<td style="BORDER-TOP: #000000 2px solid; VERTICAL-ALIGN: top; WIDTH: 53.57%">&#160;</td>
<td style="VERTICAL-ALIGN: top; WIDTH: 3.58%">&#160;</td>
<td style="VERTICAL-ALIGN: top; WIDTH: 42.85%">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 53.57%; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 42.55pt; LINE-HEIGHT: 1.25">Up to NIS&#160;140</div>
</td>
<td style="VERTICAL-ALIGN: top; WIDTH: 3.58%; BACKGROUND-COLOR: #cceeff">&#160;</td>
<td style="VERTICAL-ALIGN: top; WIDTH: 42.85%; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; MARGIN-LEFT: 42.55pt; LINE-HEIGHT: 1.25">12%</div>
</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 53.57%; BACKGROUND-COLOR: #ffffff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 42.55pt; LINE-HEIGHT: 1.25">NIS&#160;140 - NIS&#160;500</div>
</td>
<td style="VERTICAL-ALIGN: top; WIDTH: 3.58%; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="VERTICAL-ALIGN: top; WIDTH: 42.85%; BACKGROUND-COLOR: #ffffff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; MARGIN-LEFT: 42.55pt; LINE-HEIGHT: 1.25">7%</div>
</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 53.57%; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 42.55pt; LINE-HEIGHT: 1.25">More than NIS&#160;500</div>
</td>
<td style="VERTICAL-ALIGN: top; WIDTH: 3.58%; BACKGROUND-COLOR: #cceeff">&#160;</td>
<td style="VERTICAL-ALIGN: top; WIDTH: 42.85%; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; MARGIN-LEFT: 42.55pt; LINE-HEIGHT: 1.25">5%</div>
</td>
</tr>
</table>
</div>

<div style="CLEAR: both; LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal">F - 35</font></div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; WIDTH: 100%; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: right; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.15pt">PLURISTEM THERAPEUTICS INC. AND ITS SUBSIDIARY</div>

<table id="za63d5b27b6074f38ab6e207d7c7939c3" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; BORDER-COLLAPSE: collapse; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 100%">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 2px solid; WIDTH: 100%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</div>
</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 100%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 11.15pt">U.S. Dollars in thousands (except share and per share amounts)</div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">NOTE 11:-TAXES ON INCOME (CONT.)</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">
<table id="z6d2c85f6de9242febd5c127b98788eab" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; WIDTH: 27pt; align: right">B.</td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: justify; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">Tax rates applicable to the Company: (cont. :)</div>
</td>
</tr>
</table>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; MARGIN-LEFT: 42.55pt; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; MARGIN-LEFT: 42.55pt; LINE-HEIGHT: 1.25">The income qualifying for tax benefits under the alternative track is the taxable income of a &#8220;beneficiary company&#8221; that has met certain conditions as determined by the Encouragement<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold">&#160;</font>Law, and which is derived from an industrial enterprise. The Encouragement<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold">&#160;</font>Law specifies the types of qualifying income that is entitled to tax benefits under the alternative track both in respect of an industrial enterprise and of a hotel, whereby income from an industrial enterprise includes, among others, revenues from the production and development of software products and revenues from industrial research and development activities performed for a foreign resident (and approved by the Head of the Administration of Industrial Research and Development).</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; MARGIN-LEFT: 42.55pt; LINE-HEIGHT: 1.25">As stated above, the Subsidiary&#8217;s 2007 Program and 2012 Program were granted the status of a &#8220;Beneficiary Enterprise&#8221;, in accordance with the Encouragement<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold">&#160;</font>Law, under the alternative benefits track. Accordingly, income derived from the Beneficiary Enterprise is subject to the benefits and conditions stated above.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; MARGIN-LEFT: 42.55pt; LINE-HEIGHT: 1.25">In respect of expansion programs pursuant to Amendment No. 60 to the Encouragement<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold">&#160;</font>Law, the benefit period starts at the later of the election year and the first year the Company earns taxable income provided that 12 years have not passed since the beginning of the election year and for companies in National Priority Zone A - 14 years since the beginning of the election year. The benefit period for the Subsidiary&#8217;s 2007 Program will expire in 2018 (12 years since the beginning of the election year&#8211; 2007). The benefit period for the Subsidiary&#8217;s 2012 Program would expire in 2023 (12 years since the beginning of the election year &#8211; 2012).</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; MARGIN-LEFT: 42.55pt; LINE-HEIGHT: 1.25">If a dividend is distributed out of tax exempt profits, as detailed above, the Subsidiary will become liable for tax at the rate applicable to its profits from the Beneficiary Enterprise in the year in which the income was earned, (tax at the rate of 10-25%, dependent on the level of foreign investments) and to a withholding tax rate of 15% (or lower, under an applicable tax treaty).</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; MARGIN-LEFT: 42.55pt; LINE-HEIGHT: 1.25">As for &#8220;Beneficiary Enterprises&#8221; pursuant to Amendment No. 60 to the Encouragement<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold">&#160;</font>Law, the basic condition for receiving the benefits under this track is that the enterprise contributes to Israeli economic growth and is a competitive factor for the gross domestic product. In order to comply with this condition, the Encouragement<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold">&#160;</font>Law prescribes various requirements regarding industrial enterprises.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; MARGIN-LEFT: 42.55pt; LINE-HEIGHT: 1.25">As for industrial enterprises, in each tax year during the benefit period, one of the following conditions must be met:</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">
<table id="z1f4f26a25e074c2091e8e557c8bf5801" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 27pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; WIDTH: 23px; align: right">1.</td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: justify; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">The industrial enterprise&#8217;s main field of activity is biotechnology or nanotechnology as approved by the Head of the Administration of Industrial Research and Development, prior to the approval of the relevant program.</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">&#160;</div>
</td>
</tr>
</table>
</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">
<table id="z6cfa32b48c57460eab06454be6b3102b" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 27pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; WIDTH: 18pt; align: right">2.</td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: justify; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">The industrial enterprise&#8217;s sales revenues in a specific market during the tax year do not exceed 75% of its total sales for that tax year. A &#8220;market&#8221; is defined as a separate country or customs territory.</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">&#160;</div>
</td>
</tr>
</table>
</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">
<table id="z9a10c1ef0035427c96f45e1f3b721a24" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 27pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; WIDTH: 18pt; align: right">3.</td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: justify; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">At least 25% of the industrial enterprise&#8217;s overall revenues during the tax year were generated from the enterprise&#8217;s sales in a specific market with a population of at least 14 million.</div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-STYLE: italic; TEXT-ALIGN: justify; MARGIN-LEFT: 42.55pt; LINE-HEIGHT: 1.25">Accelerated depreciation:</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; MARGIN-LEFT: 42.55pt; LINE-HEIGHT: 1.25">The Subsidiary is eligible for deduction of accelerated depreciation on buildings, machinery and equipment used by the &#8220;Beneficiary Enterprise&#8221; at a rate of 200% (or 400% for buildings) from the first year of the assets operation.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal">F - 36</font></div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; WIDTH: 100%; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: right; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.15pt">PLURISTEM THERAPEUTICS INC. AND ITS SUBSIDIARY</div>

<table id="z22e4f7acd6224e41ab42e1bf4c8f7ff0" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; BORDER-COLLAPSE: collapse; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 100%">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 2px solid; WIDTH: 100%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</div>
</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 100%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 11.15pt">U.S. Dollars in thousands (except share and per share amounts)</div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">NOTE 11:-TAXES ON INCOME (CONT.)</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-STYLE: italic; TEXT-ALIGN: justify; MARGIN-LEFT: 42.55pt; LINE-HEIGHT: 1.25">Conditions for the entitlement to the benefits:</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; MARGIN-LEFT: 42.55pt; LINE-HEIGHT: 1.25">The abovementioned benefits are conditional upon the fulfillment of the conditions stipulated by the Encouragement<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold">&#160;</font>Law, regulations promulgated thereunder, and the Ruling with respect to the beneficiary enterprise. Non-compliance with the conditions may cancel all or part of the benefits and refund of the amount of the benefits, including interest. The management believes that the Subsidiary is meeting the aforementioned conditions.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-STYLE: italic; TEXT-ALIGN: justify; MARGIN-LEFT: 42.55pt; LINE-HEIGHT: 1.25">Amendment to the Encouragement Law:</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; MARGIN-LEFT: 42.55pt; LINE-HEIGHT: 1.25">Effective January 2011, the Knesset (Israeli parliament) enacted a reform to the Encouragement Law. According to the reform a flat rate tax would apply to companies eligible for the &#8220;Preferred Enterprise&#8221; status. In order to be eligible for a &#8220;Preferred Enterprise&#8221; status, a company must meet minimum requirements to establish that it contributes to the country&#8217;s economic growth and is a competitive factor for the Gross Domestic Product (a competitive enterprise).</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; MARGIN-LEFT: 42.55pt; LINE-HEIGHT: 1.25">Israeli companies which currently benefit from an Approved or Privileged Enterprise status and meet the criteria for qualification as a &#8220;Preferred Enterprise&#8221; can elect to apply the new &#8220;Preferred Enterprise&#8221; benefits by waiving their benefits under the &#8220;Approved&#8221; and &#8220;Beneficiary Enterprise&#8221; status.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; MARGIN-LEFT: 42.55pt; LINE-HEIGHT: 1.25">Benefits granted to a &#8220;Preferred Enterprise&#8221; include reduced tax rates. Following the enactment of the National Priorities Law, effective January 1, 2014, the reduced tax rate is 9% in the Development Area A regions and 16% in other regions. &#8220;Preferred Enterprises&#8221; in peripheral regions are also eligible for Israeli government Investment Center grants, as well as the applicable reduced tax rates.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; MARGIN-LEFT: 42.55pt; LINE-HEIGHT: 1.25">A distribution from a &#8220;Preferred Enterprise&#8221; out of the &#8220;Preferred Income&#8221; is&#160; subject to 20% withholding tax for Israeli-resident individuals and non-Israeli residents (subject to applicable treaty rates).</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; MARGIN-LEFT: 42.55pt; LINE-HEIGHT: 1.25">A distribution from a &#8220;Preferred Enterprise&#8221; out of the &#8220;Preferred Income&#8221; would be exempt from withholding tax for an Israeli-resident company.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; MARGIN-LEFT: 42.55pt; LINE-HEIGHT: 1.25">The Subsidiary did not apply the Amendment to the Encouragement Law with respect to the Privileged Enterprise status, but may choose to apply the Amendment in the future<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">.</font></div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-STYLE: italic; TEXT-ALIGN: justify; MARGIN-LEFT: 42.55pt; LINE-HEIGHT: 1.25">Amendment to the Law for the Encouragement of Capital Investments, 1959 (Amendment 71):</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="LINE-HEIGHT: 1.25">
<div id="DSPFPageHeader"></div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; MARGIN-LEFT: 42.55pt; LINE-HEIGHT: 1.25">In August 2013, the Law for Changing National Priorities (Legislative Amendments for Achieving Budget Targets for 2013 and 2014), 2013 which includes Amendment 71 to the Law for the Encouragement of Capital Investments (&#8220;Amendment 71&#8221;) was enacted. According to Amendment 71, the tax rate on preferred income from a preferred enterprise in 2014 and thereafter will be 16% (in development area A - 9%). As for changes in tax rates resulting from the enactment of Amendment 73 to the Law, see below.</div>
</div>

<div style="LINE-HEIGHT: 1.25">
<div id="DSPFPageHeader"></div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; MARGIN-LEFT: 42.55pt; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; MARGIN-LEFT: 42.55pt; LINE-HEIGHT: 1.25">Amendment 71 also prescribes that any dividends distributed to individuals or foreign residents from the preferred enterprise&#8217;s earnings as above will be subject to tax at a rate of 20%.</div>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; MARGIN-LEFT: 42.55pt; LINE-HEIGHT: 1.25">&#160;</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal">F - 37</font></div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; WIDTH: 100%; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: right; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.15pt">PLURISTEM THERAPEUTICS INC. AND ITS SUBSIDIARY</div>

<table id="zc72bf7094acf47feb256cf3a67c1dcb7" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; BORDER-COLLAPSE: collapse; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 100%">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 2px solid; WIDTH: 100%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</div>
</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 100%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 11.15pt">U.S. Dollars in thousands (except share and per share amounts)</div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">NOTE 11:-TAXES ON INCOME (CONT.)</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-STYLE: italic; TEXT-ALIGN: justify; MARGIN-LEFT: 42.55pt; LINE-HEIGHT: 1.25">Amendment to the Law for the Encouragement of Capital Investments, 1959 (Amendment 73):</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="LINE-HEIGHT: 1.25">
<div id="DSPFPageHeader"></div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; MARGIN-LEFT: 42.55pt; LINE-HEIGHT: 1.25">In December 2016, the Economic Efficiency Law (Legislative Amendments for Applying the Economic Policy for the 2017 and 2018 Budget Years), 2016 which includes Amendment 73 to the Law for the Encouragement of Capital Investments (&#8220;Amendment 73&#8221;) was published. According to Amendment 73, a preferred enterprise located in development area A will be subject to a tax rate of 7.5% instead of 9% effective from January 1, 2017 and thereafter (the tax rate applicable to preferred enterprises located in other areas remains at 16%).</div>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="LINE-HEIGHT: 1.25">
<div id="DSPFPageHeader"></div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; MARGIN-LEFT: 42.55pt; LINE-HEIGHT: 1.25">Amendment 73 also prescribes special tax tracks for technological enterprises, which are subject to rules that are to be issued by the Minister of Finance on May 28, 2017, the regulations were approved by the Minister of Finance and the amendment came into effect on January 1, 2017.</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; MARGIN-LEFT: 42.55pt; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; MARGIN-LEFT: 42.55pt; LINE-HEIGHT: 1.25">The new tax tracks under Amendment 73 are as follows:</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; MARGIN-LEFT: 42.55pt; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; MARGIN-LEFT: 42.55pt; LINE-HEIGHT: 1.25">Technological preferred enterprise - an enterprise for which total consolidated revenues of its parent company and all subsidiaries are less than NIS&#160;10 billion. A technological preferred enterprise, as defined in the Encouragement of Capital Investments Law, which is located in the center of Israel will be subject to tax at a rate of 12% on profits deriving from intellectual property (in development area A - a tax rate of 7.5%).</div>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; MARGIN-LEFT: 42.55pt; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; MARGIN-LEFT: 42.55pt; LINE-HEIGHT: 1.25">Special technological preferred enterprise - an enterprise for which total consolidated revenues of its parent company and all subsidiaries exceed NIS&#160;10 billion. Such enterprise will be subject to tax at a rate of 6% on profits deriving from intellectual property, regardless of the enterprise&#8217;s geographical location.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; MARGIN-LEFT: 42.55pt; LINE-HEIGHT: 1.25">Any dividends distributed to &#8220;foreign companies&#8221;, as defined in the Law, deriving from income from the technological enterprises will be subject to tax at a rate of 4%.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">
<table id="zb09b81bc113f46fc99d09e1082987950" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 27pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; WIDTH: 18pt; align: right">C.</td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: justify; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">Carryforward losses for tax purposes</div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; MARGIN-LEFT: 42.55pt; LINE-HEIGHT: 1.25">As of June 30, 2017, the Company had U.S. federal net operating loss carryforward for income tax purposes in the amount of approximately $32,519. Net operating loss carryforward arising in taxable years<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">,</font> can be carried forward and offset against taxable income for 20 years and expiring between <font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">202</font>4 and 2037.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; MARGIN-LEFT: 42.55pt; LINE-HEIGHT: 1.25">Utilization of U.S. net operating losses may be subject to substantial annual limitations due to the &#8220;change in ownership&#8221; provisions of the Internal Revenue Code of 1986 and similar state provisions. The annual limitation may result in the expiration of net operating losses before utilization.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; MARGIN-LEFT: 42.55pt; LINE-HEIGHT: 1.25">The Subsidiary in Israel has accumulated losses for tax purposes as of June 30, 2017, in the amount of approximately $109,480, which may be carried forward and offset against taxable business income and business capital gain in the future for an indefinite period.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal">F - 38</font></div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; WIDTH: 100%; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: right; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.15pt">PLURISTEM THERAPEUTICS INC. AND ITS SUBSIDIARY</div>

<table id="z4f1d222ae57e4fdcb5a20c1d294d2ad4" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; BORDER-COLLAPSE: collapse; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 100%">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 2px solid; WIDTH: 100%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</div>
</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 100%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 11.15pt">U.S. Dollars in thousands (except share and per share amounts)</div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-WEIGHT: bold; LINE-HEIGHT: 1.25">NOTE 11:-TAXES ON INCOME (CONT.)</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: justify; MARGIN-LEFT: 42.55pt; LINE-HEIGHT: 1.25">Deferred income taxes:</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; MARGIN-LEFT: 42.55pt; LINE-HEIGHT: 1.25">Deferred income taxes reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. Significant components of the Company&#8217;s deferred tax assets are as follows:</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div>
<table id="z8c0d601e87a3487a842fe95c2270aaeb" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 94%" cellspacing="0" cellpadding="0" align="right" border="0">
<tr>
<td style="VERTICAL-ALIGN: top; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid" valign="bottom" colspan="6">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 2pt">June 30,</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid" valign="bottom" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">2017</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid" valign="bottom" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">2016</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 8.5pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -8.5pt">Deferred tax assets:</div>
</td>
<td style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom" colspan="2">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom" colspan="2">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 76%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 17pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -8.5pt">U.S. net operating loss carryforward</div>
</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">11,382</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">10,210</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 76%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; MARGIN-LEFT: 17pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -8.5pt">Israeli net operating loss carryforward</div>
</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">26,275</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">22,105</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; PADDING-BOTTOM: 2px; WIDTH: 76%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; MARGIN-LEFT: 17pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -8.5pt">Allowances and reserves</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">222</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">216</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 76%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 76%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; MARGIN-LEFT: 8.5pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -8.5pt">Total deferred tax assets before valuation allowance</div>
</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">37,879</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">32,531</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; PADDING-BOTTOM: 2px; WIDTH: 76%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; MARGIN-LEFT: 8.5pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -8.5pt">Valuation allowance</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(37,879</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(32,531</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 76%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; PADDING-BOTTOM: 4px; WIDTH: 76%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; MARGIN-LEFT: 8.5pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -8.5pt">Net deferred tax asset</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>
</table>
</div>

<div style="CLEAR: both; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; MARGIN-LEFT: 42.55pt; LINE-HEIGHT: 1.25">As of June 30, 2017 and 2016, the Company has provided full valuation allowances in respect of deferred tax assets resulting from tax loss carryforward and other temporary differences, since they have a history of operating losses and current uncertainty concerning its ability to realize these deferred tax assets in the future.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; MARGIN-LEFT: 42.55pt; LINE-HEIGHT: 1.25">The Company accounts for its income tax uncertainties in accordance with ASC&#160;740 which clarifies the accounting for uncertainties in income taxes recognized in a Company&#8217;s financial statements and prescribes a recognition threshold and measurement attribute for the financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; MARGIN-LEFT: 42.55pt; LINE-HEIGHT: 1.25">As of June 30, 2017 and 2016, there were no unrecognized tax benefits that if recognized would affect the annual effective tax rate.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: justify; MARGIN-LEFT: 70.9pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -28.35pt">Reconciliation of the theoretical tax expense (benefit) to the actual tax expense (benefit):</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: justify; MARGIN-LEFT: 70.9pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -28.35pt">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; MARGIN-LEFT: 42.55pt; LINE-HEIGHT: 1.25"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">In 2017, 2016 and 2015, the main reconciling item of the statutory tax rate of the Company (24% to 35% in 2017, 2016 and 2015) to the effective tax rate (0%) is tax loss carryforwards, </font>stock-based compensation<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"> and other deferred tax assets for which a full valuation allowance was provided.</font></div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal">F - 39</font></div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; WIDTH: 100%; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: right; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.15pt">PLURISTEM THERAPEUTICS INC. AND ITS SUBSIDIARY</div>

<table id="z9c8beec457874ed89779bc89f30ffec0" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; BORDER-COLLAPSE: collapse; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 100%">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 2px solid; WIDTH: 100%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</div>
</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 100%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 11.15pt">U.S. Dollars in thousands (except share and per share amounts)</div>
</td>
</tr>
</table>
</div>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">NOTE 12:-SUBSEQUENT EVENTS</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">
<table id="z9d1d848799254f268142eae03288cd90" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 36.2pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; WIDTH: 18pt; align: right">a.</td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: justify; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">Pursuant to a shelf registration on Form S-3 declared effective by the Securities and Exchange Commission on June 23, 2017, in July 2017 the Company entered into an At Market Issuance Sales Agreement (&#8220;ATM Agreement&#8221;) with FBR Capital Markets &amp; Co., MLV &amp; Co. LLC and Oppenheimer &amp; Co. Inc. (collectively, the &#8220;Agents&#8221;), which provides that, upon the terms and subject to the conditions and limitations in the ATM Agreement, the Company may elect, from time to time, to offer and sell shares of common stock having an aggregate offering price of up to $80,000 through the Agents acting as sales agent. As of September 5, 2017, the Company had sold 455,731 shares of common stock at an average price of $1.20 per share.</div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">
<table id="z359d4ff499e3488294820b8b25a6d506" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 36.2pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; WIDTH: 18pt; align: right">b.</td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: justify; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">In July 2017, the Company was awarded an additional &#8220;Smart Money&#8221; grant of approximately $229 from Israel&#8217;s Ministry of Economy and Industry to help penetrate the Chinese market, including Hong Kong, with its advanced cell therapy products.</div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="LINE-HEIGHT: 1.25">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 54.2pt; LINE-HEIGHT: 1.25">The Israeli government granted the Company budget resources that are intended to be used to advance the Company&#8217;s product candidate towards marketing in the China-Hong Kong markets. The Company will also receive close support from Israel&#8217;s trade representatives stationed in China, including Hong Kong, along with experts appointed by the Smart Money program.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="LINE-HEIGHT: 1.25">
<table id="z78ce9a509dd14812a7a6cb3f689514b3" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 36.2pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; WIDTH: 18pt; align: right">c.</td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: justify; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">On September 5, 2017, the Company announced that its phase III study of PLX-PAD cells to support recovery following surgery for femoral neck fracture was awarded a Euro 7,400 (approximately $8,700) non-dilutive grant from the Horizon 2020 program. An amount of Euro 2,400 (approximately $2,800) is a direct grant allocated to the Company, and the Company also expects to benefit from cost savings resulting from grant amounts allocated to the other consortium members. Final approval of the grant is subject to the finalization of the consortium and Horizon 2020 grant agreements.</div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">
<div id="DSPFPageHeader"></div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>
</div>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal">F - 40</font></div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; WIDTH: 100%; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Quarterly Information (unaudited)</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 35.45pt">The following unaudited quarterly financial information includes, in management's opinion, all the normal and recurring adjustments necessary to fairly state the results of operations and related information for the periods presented (in thousands of dollars except share and per share data).</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 35.45pt">&#160;</div>

<table id="z2046e1537f5d443bb0249e9002ee266e" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr style="HEIGHT: 32px">
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid" valign="bottom" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">September 30,</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">2016</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid" valign="bottom" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">December 31,</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">2016</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid" valign="bottom" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">March 31,</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">2017</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid" valign="bottom" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">June 30,</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">2017</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 52%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 7.1pt; LINE-HEIGHT: 1.25">Operating expenses</div>
</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">6,562</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">6,648</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">8,223</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">6,586</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 52%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 7.1pt; LINE-HEIGHT: 1.25">Operating loss</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">6,562</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">6,648</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">8,223</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">6,586</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; WIDTH: 52%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 7.1pt; LINE-HEIGHT: 1.25">Net loss</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">6,324</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">6,610</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">7,864</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">7,016</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; WIDTH: 52%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 7.1pt; LINE-HEIGHT: 1.25">Basic and diluted net loss per share</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">0.08</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">0.08</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">0.09</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">0.07</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>
</table>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<table id="zaf1a8d4017c64247b47f914fa9027eed" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid" valign="bottom" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">September 30,</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">2015</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid" valign="bottom" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">December 31,</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">2015</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid" valign="bottom" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">March 31,</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">2016</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid" valign="bottom" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">June 30,</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">2016</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 52%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 7.1pt; LINE-HEIGHT: 1.25">Revenues</div>
</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">95</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">2,752</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 52%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 7.1pt; LINE-HEIGHT: 1.25">Gross profit</div>
</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">92</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">2,655</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 52%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 7.1pt; LINE-HEIGHT: 1.25">Operating expenses</div>
</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">5,615</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">6,883</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">7,395</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">6,173</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 52%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 7.1pt; LINE-HEIGHT: 1.25">Operating loss</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">5,523</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">4,228</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">7,395</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">6,173</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; WIDTH: 52%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 7.1pt; LINE-HEIGHT: 1.25">Net loss</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">5,876</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">3,962</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">7,203</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">6,205</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; WIDTH: 52%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 7.1pt; LINE-HEIGHT: 1.25">Basic and diluted net loss per share</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">0.07</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">0.05</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">0.09</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">0.08</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>
</table>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold"><a id="Item9" name="Item9"><!--Anchor--></a>Item 9.</font>&#160;&#160;&#160;&#160;<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold">Changes in and Disagreements with Accountants on Accounting and Financial Disclosure.</font></div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">None.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold"><a id="Item9A" name="Item9A"><!--Anchor--></a>Item 9A.</font>&#160;<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold">Controls and Procedures.</font></div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; FONT-STYLE: italic; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Evaluation of Disclosure Controls and Procedures</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 35.45pt">We conducted an evaluation under the supervision of our Co-CEOs and CFO (our principal executive officer and principal financial officer, respectively), regarding the effectiveness of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act) as of June 30, 2017. Based on the aforementioned evaluation, management has concluded that our disclosure controls and procedures were effective as of June 30, 2017.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; FONT-STYLE: italic; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Management's Report on Internal Control over Financial Reporting</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 35.45pt">Our management is responsible for establishing and maintaining adequate internal control over financial reporting. Our internal control over financial reporting has been designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles generally accepted in the United States of America.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 35.45pt">Our internal control over financial reporting includes policies and procedures that pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect transactions and dispositions of our assets; provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with accounting principles generally accepted in the United States of America, and that receipts and expenditures are being made only in accordance with authorization of our management and directors; and provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of our assets that could have a material effect on our financial statements.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal">45</font></div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; WIDTH: 100%; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 35.45pt">Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Therefore, even those systems determined to be effective can provide only reasonable assurance with respect to financial statement preparation and presentation. Projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 35.45pt">Management assessed the effectiveness of our internal control over financial reporting on June 30, 2017. In making this assessment, management used the criteria set forth by the Committee of Sponsoring Organizations of the Treadway Commission 2013 framework, or COSO, in <font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-STYLE: italic">Internal Control&#8212;Integrated Framework</font>. Based on that assessment under those criteria, management has determined that, as of June 30, 2017, our internal control over financial reporting was effective.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 35.45pt">Kost Forer Gabbay &amp; Kasierer, a member of Ernst &amp; Young Global, an independent registered public accounting firm, who audited our consolidated financial statements included elsewhere in this Annual Report, has also issued an attestation report on our internal control over financial reporting, which is included elsewhere in this Annual Report.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; FONT-STYLE: italic; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Changes in Internal Control Over Financial Reporting</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 35.45pt">There have been no changes in our internal control over financial reporting (as such term is defined in Rules&#160;13a-15(f) and 15d-15(f) under the Exchange Act) during the fourth quarter of Fiscal 2017 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold"><a id="Item9B" name="Item9B"><!--Anchor--></a>Item 9B.</font>&#160;<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold">Other Information.</font></div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">None.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25"><a id="PARTIII" name="PARTIII"><!--Anchor--></a>PART III</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25"><a id="Item10" name="Item10"><!--Anchor--></a>Item 10.&#160; Directors, Executive Officers and Corporate Governance.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Our directors and executive officers, their ages, positions held, and duration of such, are as follows:</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<table id="zcd7083b869554f07aa74b5266a665987" style="FONT-SIZE: 10pt; BORDER-TOP: medium none; FONT-FAMILY: 'Times New Roman', Times, serif; BORDER-RIGHT: medium none; BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; WIDTH: 85%" cellspacing="0" cellpadding="1" align="left" border="0">
<tr>
<td style="BORDER-TOP: #000000 2px solid; BORDER-RIGHT: medium none; VERTICAL-ALIGN: top; BORDER-BOTTOM: medium none; BORDER-LEFT: #000000 2px solid; WIDTH: 17.23%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Name</div>
</td>
<td style="BORDER-TOP: #000000 2px solid; BORDER-RIGHT: medium none; VERTICAL-ALIGN: top; BORDER-BOTTOM: medium none; BORDER-LEFT: #000000 2px solid; WIDTH: 54.96%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Position Held With Company</div>
</td>
<td style="BORDER-TOP: #000000 2px solid; BORDER-RIGHT: medium none; VERTICAL-ALIGN: top; BORDER-BOTTOM: medium none; BORDER-LEFT: #000000 2px solid; WIDTH: 6.27%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Age</div>
</td>
<td style="BORDER-TOP: #000000 2px solid; BORDER-RIGHT: #000000 2px solid; VERTICAL-ALIGN: top; BORDER-BOTTOM: medium none; BORDER-LEFT: #000000 2px solid; WIDTH: 21.54%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Date First Elected or Appointed</div>
</td>
</tr>

<tr>
<td style="BORDER-TOP: #000000 2px solid; BORDER-RIGHT: medium none; VERTICAL-ALIGN: top; BORDER-BOTTOM: medium none; BORDER-LEFT: #000000 2px solid; WIDTH: 17.23%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Zami Aberman</div>
</td>
<td style="BORDER-TOP: #000000 2px solid; BORDER-RIGHT: medium none; VERTICAL-ALIGN: top; BORDER-BOTTOM: medium none; BORDER-LEFT: #000000 2px solid; WIDTH: 54.96%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">-Chairman of the Board of Directors</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">-Co-CEO</div>
</td>
<td style="BORDER-TOP: #000000 2px solid; BORDER-RIGHT: medium none; VERTICAL-ALIGN: top; BORDER-BOTTOM: medium none; BORDER-LEFT: #000000 2px solid; WIDTH: 6.27%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">63</div>
</td>
<td style="BORDER-TOP: #000000 2px solid; BORDER-RIGHT: #000000 2px solid; VERTICAL-ALIGN: top; BORDER-BOTTOM: medium none; BORDER-LEFT: #000000 2px solid; WIDTH: 21.54%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">April 3, 2006</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">March 29,2017</div>
</td>
</tr>

<tr>
<td style="BORDER-TOP: #000000 2px solid; BORDER-RIGHT: medium none; VERTICAL-ALIGN: top; BORDER-BOTTOM: medium none; BORDER-LEFT: #000000 2px solid; WIDTH: 17.23%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Yaky Yanay</div>
</td>
<td style="BORDER-TOP: #000000 2px solid; BORDER-RIGHT: medium none; VERTICAL-ALIGN: top; BORDER-BOTTOM: medium none; BORDER-LEFT: #000000 2px solid; WIDTH: 54.96%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">-President</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">-Director</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">-Co-CEO</div>
</td>
<td style="BORDER-TOP: #000000 2px solid; BORDER-RIGHT: medium none; VERTICAL-ALIGN: top; BORDER-BOTTOM: medium none; BORDER-LEFT: #000000 2px solid; WIDTH: 6.27%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">46</div>
</td>
<td style="BORDER-TOP: #000000 2px solid; BORDER-RIGHT: #000000 2px solid; VERTICAL-ALIGN: top; BORDER-BOTTOM: medium none; BORDER-LEFT: #000000 2px solid; WIDTH: 21.54%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">February 4, 2014</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">February 5, 2015</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">March 29,2017</div>
</td>
</tr>

<tr>
<td style="BORDER-TOP: #000000 2px solid; BORDER-RIGHT: medium none; VERTICAL-ALIGN: top; BORDER-BOTTOM: medium none; BORDER-LEFT: #000000 2px solid; WIDTH: 17.23%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Erez Egozi</div>
</td>
<td style="BORDER-TOP: #000000 2px solid; BORDER-RIGHT: medium none; VERTICAL-ALIGN: top; BORDER-BOTTOM: medium none; BORDER-LEFT: #000000 2px solid; WIDTH: 54.96%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">CFO, Treasurer and Secretary</div>
</td>
<td style="BORDER-TOP: #000000 2px solid; BORDER-RIGHT: medium none; VERTICAL-ALIGN: top; BORDER-BOTTOM: medium none; BORDER-LEFT: #000000 2px solid; WIDTH: 6.27%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">43</div>
</td>
<td style="BORDER-TOP: #000000 2px solid; BORDER-RIGHT: #000000 2px solid; VERTICAL-ALIGN: top; BORDER-BOTTOM: medium none; BORDER-LEFT: #000000 2px solid; WIDTH: 21.54%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">March 29,2017</div>
</td>
</tr>

<tr>
<td style="BORDER-TOP: #000000 2px solid; BORDER-RIGHT: medium none; VERTICAL-ALIGN: top; BORDER-BOTTOM: medium none; BORDER-LEFT: #000000 2px solid; WIDTH: 17.23%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Nachum Rosman</div>
</td>
<td style="BORDER-TOP: #000000 2px solid; BORDER-RIGHT: medium none; VERTICAL-ALIGN: top; BORDER-BOTTOM: medium none; BORDER-LEFT: #000000 2px solid; WIDTH: 54.96%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Director</div>
</td>
<td style="BORDER-TOP: #000000 2px solid; BORDER-RIGHT: medium none; VERTICAL-ALIGN: top; BORDER-BOTTOM: medium none; BORDER-LEFT: #000000 2px solid; WIDTH: 6.27%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">71</div>
</td>
<td style="BORDER-TOP: #000000 2px solid; BORDER-RIGHT: #000000 2px solid; VERTICAL-ALIGN: top; BORDER-BOTTOM: medium none; BORDER-LEFT: #000000 2px solid; WIDTH: 21.54%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">October 9, 2007</div>
</td>
</tr>

<tr>
<td style="BORDER-TOP: #000000 2px solid; BORDER-RIGHT: medium none; VERTICAL-ALIGN: top; BORDER-BOTTOM: medium none; BORDER-LEFT: #000000 2px solid; WIDTH: 17.23%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Doron Shorrer</div>
</td>
<td style="BORDER-TOP: #000000 2px solid; BORDER-RIGHT: medium none; VERTICAL-ALIGN: top; BORDER-BOTTOM: medium none; BORDER-LEFT: #000000 2px solid; WIDTH: 54.96%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Director</div>
</td>
<td style="BORDER-TOP: #000000 2px solid; BORDER-RIGHT: medium none; VERTICAL-ALIGN: top; BORDER-BOTTOM: medium none; BORDER-LEFT: #000000 2px solid; WIDTH: 6.27%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">64</div>
</td>
<td style="BORDER-TOP: #000000 2px solid; BORDER-RIGHT: #000000 2px solid; VERTICAL-ALIGN: top; BORDER-BOTTOM: medium none; BORDER-LEFT: #000000 2px solid; WIDTH: 21.54%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">October 2, 2003</div>
</td>
</tr>

<tr>
<td style="BORDER-TOP: #000000 2px solid; BORDER-RIGHT: medium none; VERTICAL-ALIGN: top; BORDER-BOTTOM: medium none; BORDER-LEFT: #000000 2px solid; WIDTH: 17.23%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Hava Meretzki</div>
</td>
<td style="BORDER-TOP: #000000 2px solid; BORDER-RIGHT: medium none; VERTICAL-ALIGN: top; BORDER-BOTTOM: medium none; BORDER-LEFT: #000000 2px solid; WIDTH: 54.96%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Director</div>
</td>
<td style="BORDER-TOP: #000000 2px solid; BORDER-RIGHT: medium none; VERTICAL-ALIGN: top; BORDER-BOTTOM: medium none; BORDER-LEFT: #000000 2px solid; WIDTH: 6.27%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">48</div>
</td>
<td style="BORDER-TOP: #000000 2px solid; BORDER-RIGHT: #000000 2px solid; VERTICAL-ALIGN: top; BORDER-BOTTOM: medium none; BORDER-LEFT: #000000 2px solid; WIDTH: 21.54%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">October 2, 2003</div>
</td>
</tr>

<tr>
<td style="BORDER-TOP: #000000 2px solid; BORDER-RIGHT: medium none; VERTICAL-ALIGN: top; BORDER-BOTTOM: medium none; BORDER-LEFT: #000000 2px solid; WIDTH: 17.23%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Isaac Braun</div>
</td>
<td style="BORDER-TOP: #000000 2px solid; BORDER-RIGHT: medium none; VERTICAL-ALIGN: top; BORDER-BOTTOM: medium none; BORDER-LEFT: #000000 2px solid; WIDTH: 54.96%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Director</div>
</td>
<td style="BORDER-TOP: #000000 2px solid; BORDER-RIGHT: medium none; VERTICAL-ALIGN: top; BORDER-BOTTOM: medium none; BORDER-LEFT: #000000 2px solid; WIDTH: 6.27%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">65</div>
</td>
<td style="BORDER-TOP: #000000 2px solid; BORDER-RIGHT: #000000 2px solid; VERTICAL-ALIGN: top; BORDER-BOTTOM: medium none; BORDER-LEFT: #000000 2px solid; WIDTH: 21.54%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">July 6, 2005</div>
</td>
</tr>

<tr>
<td style="BORDER-TOP: #000000 2px solid; BORDER-RIGHT: medium none; VERTICAL-ALIGN: top; BORDER-BOTTOM: medium none; BORDER-LEFT: #000000 2px solid; WIDTH: 17.23%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Israel Ben-Yoram</div>
</td>
<td style="BORDER-TOP: #000000 2px solid; BORDER-RIGHT: medium none; VERTICAL-ALIGN: top; BORDER-BOTTOM: medium none; BORDER-LEFT: #000000 2px solid; WIDTH: 54.96%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Director</div>
</td>
<td style="BORDER-TOP: #000000 2px solid; BORDER-RIGHT: medium none; VERTICAL-ALIGN: top; BORDER-BOTTOM: medium none; BORDER-LEFT: #000000 2px solid; WIDTH: 6.27%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">57</div>
</td>
<td style="BORDER-TOP: #000000 2px solid; BORDER-RIGHT: #000000 2px solid; VERTICAL-ALIGN: top; BORDER-BOTTOM: medium none; BORDER-LEFT: #000000 2px solid; WIDTH: 21.54%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">January 26, 2005</div>
</td>
</tr>

<tr>
<td style="BORDER-TOP: #000000 2px solid; BORDER-RIGHT: medium none; VERTICAL-ALIGN: top; BORDER-BOTTOM: medium none; BORDER-LEFT: #000000 2px solid; WIDTH: 17.23%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Mark Germain</div>
</td>
<td style="BORDER-TOP: #000000 2px solid; BORDER-RIGHT: medium none; VERTICAL-ALIGN: top; BORDER-BOTTOM: medium none; BORDER-LEFT: #000000 2px solid; WIDTH: 54.96%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Director</div>
</td>
<td style="BORDER-TOP: #000000 2px solid; BORDER-RIGHT: medium none; VERTICAL-ALIGN: top; BORDER-BOTTOM: medium none; BORDER-LEFT: #000000 2px solid; WIDTH: 6.27%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">67</div>
</td>
<td style="BORDER-TOP: #000000 2px solid; BORDER-RIGHT: #000000 2px solid; VERTICAL-ALIGN: top; BORDER-BOTTOM: medium none; BORDER-LEFT: #000000 2px solid; WIDTH: 21.54%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">May 17, 2007</div>
</td>
</tr>

<tr>
<td style="BORDER-TOP: #000000 2px solid; BORDER-RIGHT: medium none; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 2px solid; BORDER-LEFT: #000000 2px solid; WIDTH: 17.23%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Moria Kwiat</div>
</td>
<td style="BORDER-TOP: #000000 2px solid; BORDER-RIGHT: medium none; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 2px solid; BORDER-LEFT: #000000 2px solid; WIDTH: 54.96%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Director</div>
</td>
<td style="BORDER-TOP: #000000 2px solid; BORDER-RIGHT: medium none; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 2px solid; BORDER-LEFT: #000000 2px solid; WIDTH: 6.27%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">38</div>
</td>
<td style="BORDER-TOP: #000000 2px solid; BORDER-RIGHT: #000000 2px solid; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 2px solid; BORDER-LEFT: #000000 2px solid; WIDTH: 21.54%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">May 15, 2012</div>
</td>
</tr>
</table>

<div style="CLEAR: both; LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal">46</font></div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; WIDTH: 100%; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-STYLE: italic; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Business Experience</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 35.45pt">The following is a brief account of the education and business experience of each director and executive officer during at least the past five years, indicating each person's principal occupation during the period, and the name and principal business of the organization by which they were employed.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Zami Aberman</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 35.45pt">Mr. Aberman joined the Company in September 2005 and has served as our Co-CEO since March 2017, as our CEO from November 2005 until March 2017, and from September 2005 until February 2014 as President of the Company.&#160; He changed the Company&#8217;s strategy towards cellular therapeutics. Mr. Aberman&#8217;s vision to use the maternal section of the Placenta (Decidua) as a source for cell therapy, combined with the Company&#8217;s 3D culturing technology, led to the development of our products. Since November 2005, Mr. Aberman has served as a director of the Company, and since April 2006, as Chairman of the Board. He has 25 years of experience in marketing and management in the high technology industry. Mr. Aberman has held positions of CEO and Chairman positions in companies in Israel, the United States, Europe, Japan and Korea.&#160; Mr. Aberman operated within high-tech global companies in the fields of automatic optical inspection, network security, video over IP, software, chip design and robotics. He serves as the chairman of Rose Hitech Ltd., a private investment company. He served in the past as the chairman of VLScom Ltd., a private company specializing in video compression for HDTV and video over IP and as a director of Ori Software Ltd., a company involved in data management.&#160; Prior to that, Mr. Aberman served as the President and CEO of Elbit Vision System Ltd. (EVSNF.OB), a company engaged in automatic optical inspection.&#160; Prior to his service with the Company, Mr. Aberman served as President and CEO of Netect Ltd., specializing in the field of internet security software and was the Co-Founder, President and CEO of Associative Computing Ltd., which developed an associative parallel processor for real-time video processing. He also served as Chairman of Display Inspection Systems Inc., specializing in laser based inspection machines and as President and CEO of Robomatix Technologies Ltd.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 35.45pt">In 1992, Mr. Aberman was awarded the Rothschild Prize for excellence in his field from the President of the State of Israel.&#160;&#160;Mr. Aberman holds a B.Sc. in Mechanical Engineering from Ben Gurion University in Israel.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 35.45pt">We believe that Mr. Aberman&#8217;s qualifications to sit on our Board include his unique multidisciplinary innovative approach, years of experience in the financial markets in Israel and globally, as well as his experience in serving as the CEO of publicly traded entities.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Yaky Yanay</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 35.45pt">Mr. Yaky Yanay has served as our President from February 2014 and as our Co-CEO from March 2017. Mr. Yanay served as our Chief Financial Officer from November 2006 until February 2014 and from February 2015 until March 2017. He also served as our Chief Operating Officer from February 2014 until March 2017. Until February 2014, he also served as our Secretary since November 2006, and Executive Vice President since March 2013. Prior to joining us, Mr. Yanay was the CFO of Elbit Vision Systems Ltd., a public company. Prior to that Mr. Yanay served as manager of audit groups of the technology sector at Ernst &amp; Young Israel. Since September 2015, Mr. Yanay has served as Co-Chairman of Israel Advanced Technology Industries (IATI), the largest umbrella organization representing Israel&#8217;s high tech and life science industries.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 35.45pt">Mr. Yanay is representing Israel&#8217;s life sciences industry and has served on the Board of Directors of IATI for three years before he was appointed as Co-Chairman. Mr. Yanay serves as a director of Elbit Vision System Ltd., and he also founded and served as Chairman of the &#8220;The Life Science Forum&#8221;.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal">47</font></div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; WIDTH: 100%; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 35.45pt">Mr. Yanay holds a bachelor&#8217;s degree with honors in business administration and accounting from the College of Management Academic Studies of Rishon LeZion and is a Certified Public Accountant in Israel.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 35.45pt">We believe that Mr. Yanay&#8217;s qualifications to sit on our Board include his years of experience in the medical technology industry, his vast skill and expertise in accounting and economics, as well as his knowledge and familiarity with corporate finance.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Erez Egozi</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 35.45pt">Mr. Erez Egozi was appointed CFO and Treasurer in March 2017, and as Secretary in September 2015. Prior to his appointment as CFO, Mr. Egozi was our Vice President of Finance from March 2015 until March 2017. Before joining Pluristem, from 2007 to February 2015, Mr. Egozi held several senior financial positions at Verint Systems Inc. (Nasdaq:VRNT), including as senior director of finance - worldwide finance controller of Verint's Communications and Cyber Intelligence Solutions division. From 2003 to 2007, Mr. Egozi held several financial positions at Intel Corporation (Nasdaq:INTC). From 2000 to 2003, Mr. Egozi served as an auditor in the high tech technology sector at Deloitte &amp; Touche.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 35.45pt">Mr. Egozi holds a bachelor's degree in economics and accounting from Beer-Sheva University, and a M.A. degree in law from Bar-Ilan University, and is a certified public accountant in Israel.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Nachum Rosman</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 35.45pt">Mr. Rosman became a director of the Company in October 2007. He provides management and consulting services to startup companies in the financial, organizational and human resource aspects of their operations.&#160; Mr. Rosman also serves as the CEO of Simba Ltd. and as a director at several privately held companies.&#160; Throughout his career, Mr. Rosman held CEO and CFO positions in Israel, the United States and England.&#160; In these positions he was responsible, among other things, for finance management, fund raising, acquisitions and technology sales.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 35.45pt">Mr. Rosman holds a B.Sc. in Management Engineering and an M.Sc. in Operations Research from the Technion, Haifa, Israel.&#160;Mr. Rosman also participated in a Ph.D. program in Investments and Financing at the Tel Aviv University, Israel.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 35.45pt">We believe that Mr. Rosman&#8217;s qualifications to sit on our Board include his years of experience in the high-tech industry, as well as his knowledge and familiarity with corporate finance.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Doron Shorrer</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 35.45pt">Mr. Shorrer became a director of the Company in October 2003.&#160; Mr. Shorrer was one of the Company&#8217;s founders and served as its first Chairman until 2006.&#160; Since 1998, Mr. Shorrer has served as the Chairman and CEO of Shorrer International Ltd., an investment and financial consulting company. Mr. Shorrer also serves as a director of other companies: Provident Fund for employees of the Israel Electric Company Ltd. and for Hebrew University employees, and Massad Bank from the International Bank group.</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 35.45pt">Between 1999 and 2004 he was Chairman of the Boards of Phoenix Insurance Company, one of the largest insurance companies in Israel, and of Mivtachim Pension Funds Group, the largest pension fund in Israel. Prior to serving in these positions, Mr. Shorrer held senior positions that included Arbitrator at the Claims Resolution Tribunal for Dormant Accounts in Switzerland; Economic and Financial Advisor, Commissioner of Insurance and Capital Markets for the State of Israel; Member of the board of directors of &#8220;Nechasim&#8221; of the State of Israel; Member Committee for the Examination of Structural Changes in the Capital Market (The Brodet Committee); General Director of the Ministry of Transport; Founder and managing partner of an accounting firm with offices in Jerusalem, Tel-Aviv and Haifa; Member of the Lecture Staff of the Hebrew University Business Administration School; Chairman of Amal School Chain; Chairman of a Public Committee for Telecommunications; and Economic Consultant to the Ministry of Energy.&#160; Among many areas of expertise, Mr. Shorrer formulates implements and administers business planning in the private and institutional sector in addition to consulting on economic, accounting and taxation issues to a large audience ranging from private concerns to government ministries.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal">48</font></div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; WIDTH: 100%; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 35.45pt">Mr. Shorrer holds a B.A. in Economics and Accounting and an M.A. in Business Administration (specialization in finance and banking) from the Hebrew University of Jerusalem and is a Certified Public Accountant in Israel.</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 35.45pt">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 35.45pt">We believe that Mr. Shorrer&#8217;s qualifications to sit on our Board include his years of experience in the high-tech industry, his vast skill and expertise in accounting and economics, as well as his knowledge and familiarity with corporate finance.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Hava Meretzki</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 35.45pt">Ms. Meretzki became a director of the Company in October 2003. Ms. Meretzki is an attorney and is a partner in Meretzki law firm in Haifa, Israel.&#160; Ms. Meretzki specializes in civil, trade and labor law, and is presently the Chairman of the National Council of the Israel Bar Association. Ms. Meretzki received a Bachelor&#8217;s Degree in Law from the Hebrew University in 1991 and was admitted to the Israel Bar Association in 1993.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 35.45pt">We believe that Ms. Meretzki&#8217;s qualifications to sit on our Board include her years of experience with legal and corporate governance matters.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Isaac Braun</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 35.45pt">Mr. Braun became a director of the Company in July 2005.&#160; Mr. Braun is a business veteran with entrepreneurial, industrial and manufacturing experience.&#160; He is a co-founder and has been a board member of several hi-tech start-ups in the areas of e-commerce, security, messaging, search engines and biotechnology.&#160; Mr. Braun is involved with advising private companies on raising capital and business development.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">We believe that Mr. Braun&#8217;s qualifications to sit on our Board include his years of experience in the high-tech industry, as well as his knowledge and familiarity with corporate finance.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Israel Ben-Yoram</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 35.45pt">Mr. Ben-Yoram became a director of the Company in January 2005.&#160; He has been a director and partner in the accounting firm of Mor, Ben-Yoram and Partners in Israel since 1985.&#160; In addition, since 1992, Mr. Ben-Yoram has been a shareholder and has served as the head director of Mor, Ben-Yoram Ltd., a private company in Israel in parallel to the operation of Mor, Ben-Yoram and Partners.&#160; This company provides management services, economic consulting services and other professional services to businesses. Furthermore, Mr. Ben-Yoram is the founder, owner and CEO of SBY Group (Eshed Dash Ltd., Zonbit Ltd. and Eshed Yuvalim Ltd.). During 2003 to 2004 Mr. Ben-Yoram served as a director of Brainstorm Cell Therapeutics Inc. (BCLI) and Smart Energy solutions, Inc. (SMGY), both of which were traded on the NASDAQ. Mr. Ben-Yoram is also a member of STEP (Society of Trust and Estate Practitioners).</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 35.45pt">Mr. Ben-Yoram received a B.A. in accounting from the University of Tel Aviv, an M.A. in Economics from the Hebrew University of Jerusalem, an LL.B. and an MBA from Tel Aviv University and an LL.M. from Bar Ilan University. In addition, Mr. Ben-Yoram is a Certified Public Accountant in Israel and is qualified in arbitration and in mediation.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 35.45pt">We believe that Mr. Ben-Yoram&#8217;s qualifications to sit on our Board include his years of experience in the high-tech industry, his experience serving as a director of NASDAQ companies, as well as his knowledge and familiarity with corporate finance and accounting.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal">49</font></div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; WIDTH: 100%; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Mark Germain</div>

<div style="FONT: 10pt/1.25 'Times New Roman', Times, serif">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 35.45pt">Mr. Germain became a director of the Company in May 2007.&#160; Between May 2007 and February 2009, Mr. Germain served as Co-Chairman of our Board.&#160; For more than five years, Mr. Germain has been a merchant banker serving primarily the biotech and life sciences industries.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 35.45pt">He has been involved as a founder, director, chairman of the board of, and/or investor in, over twenty companies in the biotech field, and assisted many of them in arranging corporate partnerships, acquiring technology, entering into mergers and acquisitions, and executing financings and going public transactions.&#160; He graduated from New York University School of Law in 1975, Order of the Coif, and was a partner in a New York law firm practicing corporate and securities law before leaving in 1986. Since then, and until he entered the biotech field in 1991, he served in senior executive capacities, including as president of a public company, which was sold in 1991.&#160; In addition to being a director of the Company, Mr. Germain is a Managing Director at The &#198;NTIB Group a boutique merchant bank. Mr Germain also serves or served as a director of the following companies that were reporting companies in the past: Stem Cell Innovations, Inc., Omnimmune Corp. and Collexis Holdings, Inc.&#160; He is also a co-founder and director of a number of private companies in and outside the biotechnology field.</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 35.45pt">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 35.45pt">We believe that Mr. Germain&#8217;s qualifications to sit on our Board include his years of experience in the biotech industry, his experience serving as a director of public companies, as well as his knowledge and familiarity with corporate finance.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Moria Kwiat</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="LINE-HEIGHT: 1.25">
<div id="DSPFPageHeader"></div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 35.45pt">Dr. Kwiat became a director of the Company in May 2012. From <a id="_cp_text_1_14" name="_cp_text_1_14"><!--Anchor--></a>December 2016 to the present, Dr. Kwiat has worked at Frost &amp; Sullivan as an analyst and consultant. From 2015 to 2016, Dr. Kwiat served as a research associate in the Department of Materials and NanoSciences, Faculty of Chemistry at Tel Aviv University. She has broad academic background and scientific experience in inter-disciplinary fields, with specific expertise at the interface between the biology and materials world. She has a strong track record of developing biosensors for diagnostics utilizing electrical devices. She is the co-author of multiple scientific papers.&#160; Dr. Kwiat holds a Post-Doctoral degree in nanotechnology and material sciences, a Ph.D. in Chemistry, a M.Sc and B.Sc. in Biotechnology, all from Tel Aviv University.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 35.45pt">We believe that Dr. Kwiat&#8217;s qualifications to sit on our Board include her knowledge and experience as a scientist and a researcher in the fields of biotechnology, microbiology and nanotechnology.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">There are no family relationships between any of the directors or officers named above.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-STYLE: italic; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Audit Committee and Audit Committee Financial Expert</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">The members of our Audit Committee are Doron Shorrer, Nachum Rosman and Israel Ben-Yoram.&#160; Doron Shorrer is the Chairman of the Audit Committee, and our Board of Directors has determined that Israel Ben-Yoram is an "Audit Committee financial expert" and that all members of the Audit Committee are "independent" as defined by the rules of the SEC and the NASDAQ rules and regulations. The Audit Committee operates under a written charter that is posted on our website at www.pluristem.com. The information on our website is not incorporated by reference into this Annual Report.<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-STYLE: italic">&#160;</font>The primary responsibilities of our Audit Committee include:</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<table id="z8b7885f0943f42dcac6ba85c90649c29" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; WIDTH: 18pt; align: right">&#8226;</td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">Appointing, compensating and retaining our registered independent public accounting firm;</div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<table id="zf6e597718be041b28ae67082a629e84a" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; WIDTH: 18pt; align: right">&#8226;</td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">Overseeing the work performed by any outside accounting firm;</div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal">50</font></div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; WIDTH: 100%; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<table id="z4e50b06a6e4941079799bc8cb576ded6" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; WIDTH: 18pt; align: right">&#8226;</td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">Assisting the Board in fulfilling its responsibilities by reviewing: (i) the financial reports provided by us to the SEC, our stockholders or to the general public, and (ii) our internal financial and accounting controls; and</div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<table id="zd6347f57ab094e4d9f1e79dc40a113e1" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; WIDTH: 18pt; align: right">&#8226;</td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">Recommending, establishing and monitoring procedures designed to improve the quality and reliability of the disclosure of our financial condition and results of operations.</div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Our Audit Committee held nine meetings from July 1, 2016 through June 30, 2017 (Fiscal 2017).</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-STYLE: italic; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Compensation Committee</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">The members of our Compensation Committee are Doron Shorrer, Nachum Rosman and Israel Ben-Yoram. The Board has determined that all of the members of the Compensation Committee are "independent" as defined by the rules of the SEC and NASDAQ rules and regulations. The Compensation Committee operates under a written charter that is posted on our website at www.pluristem.com. The information on our website is not incorporated by reference into this Annual Report. The primary responsibilities of our Compensation Committee include:</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<table id="z9a78a974e08747779b3c01a90bda64a2" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; WIDTH: 18pt; align: right">&#8226;</td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">Reviewing and recommending to our Board of the annual base compensation, the annual incentive bonus, equity compensation, employment agreements and any other benefits of our executive officers;</div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<table id="z73b1bdf1aefe4ee78dcef870e81acb42" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; WIDTH: 18pt; align: right">&#8226;</td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">Administering our equity based plans and making recommendations to our Board with respect to our incentive&#8211;compensation plans and equity&#8211;based plans; and</div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<table id="za887ee68bd9a402d9777cc8a97e866ea" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; WIDTH: 18pt; align: right">&#8226;</td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">Annually reviewing and making recommendations to our Board with respect to the compensation policy for such other officers as directed by our Board.</div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 18pt">Our Compensation Committee held nine meetings during Fiscal 2017.&#160; The Compensation Committee did not receive advice from or retain any consultants during Fiscal 2017.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-STYLE: italic; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Compensation Committee Interlocks and Insider Participation</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">During the fiscal year ended June 30, 2017, Mr. Shorrer, Mr. Rosman, and Mr. Ben-Yoram served as the members of our Compensation Committee.&#160; None of the members of our Compensation Committee is, or has been, an officer or employee of ours or of our subsidiary.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">During the last year, none of our executive officers served as: (1) a member of the compensation committee (or other committee of the board of directors performing equivalent functions or, in the absence of any such committee, the entire board of directors) of another entity, one of whose executive officers served on the compensation committee; (2) a director of another entity, one of whose executive officers served on the compensation committee; or (3) a member of the compensation committee (or other committee of the board of directors performing equivalent functions or, in the absence of any such committee, the entire board of directors) of another entity, one of whose executive officers served as a director on our Board of Directors.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-STYLE: italic; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Nominating/Corporate Governance; Director Candidates.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">The Company does not have a Nominating Committee or Corporate Governance Committee or any committees of a similar nature, nor any charter governing the nomination process.&#160; Our Board does not believe that such committees are needed for a company our size.&#160; However, our independent directors will consider stockholder suggestions for additions to our Board.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal">51</font></div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; WIDTH: 100%; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-STYLE: italic; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Code of Ethics</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">Our Board of Directors has adopted a Code of Business Conduct and Ethics that applies to, among other persons, members of our Board of Directors, our officers including our Co-CEOs (being our principal executive officers) and our CFO (being our principal financial and accounting officer) and our employees.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">Our Code of Business Conduct and Ethics is posted on our Internet website at www.pluristem.com. The information on our website is not incorporated by reference into this Annual Report. We intend to satisfy the disclosure requirement under Item 5.05 of Form 8-K regarding amendment to, or waiver from, a provision of our Code of Conduct by posting such information on the website address specified above.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-STYLE: italic; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Section 16(a) Beneficial Ownership Reporting Compliance</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">Section 16(a) of the Exchange Act requires our executive officers and directors, and persons who own more than 10% of our common stock, to file reports regarding ownership of, and transactions in, our securities with the SEC and to provide us with copies of those filings. Based solely on our review of the copies of such forms received by us, or written representations from certain reporting persons, we believe that during fiscal year ended June 30, 2017, all filing requirements applicable to our officers, directors and ten percent beneficial owners were complied with.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold"><a id="Item11." name="Item11."><!--Anchor--></a>Item&#160;11.</font>&#160;<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold">Executive Compensation.</font></div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-STYLE: italic; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">EXECUTIVE COMPENSATION AND RELATED INFORMATION</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Compensation Discussion and Analysis</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">The Compensation Committee of our Board of Directors is comprised solely of independent directors as defined by NASDAQ, outside directors as defined by Section 162(m) of the Internal Revenue Code and non-employee directors as defined by Rule 16b-3 under the Exchange Act. The Compensation Committee has the authority and responsibility to review and make recommendations to the Board of Directors regarding the compensation of our Co-CEOs and other executive officers.&#160; Our named executive officers for Fiscal 2017 are those three individuals listed in the <font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-STYLE: italic">2017 </font>"<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-STYLE: italic">Summary Compensation Table</font>" below. Other information concerning the structure, roles and responsibilities of our Compensation Committee is set forth in "<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-STYLE: italic">Board Meetings and Committees&#8212;Compensation Committee</font>" section of this Annual Report.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">At our 2017 shareholders meeting, we provided our shareholders with the opportunity to cast an advisory vote on our then named executive officers&#8217; compensation. Over 76% of the votes cast on this "2017 say-on-pay vote" were voted in favor of the proposal. We have considered the 2017 say-on-pay vote and we believe that the support from our shareholders for the 2017 say-on-pay vote proposal indicates that our shareholders are supportive of our approach to executive compensation. At our 2013 shareholders meeting, our shareholders voted in favor of the proposal to hold say-on-pay votes every two years. We will continue to consider the outcome of our say-on-pay votes when making compensation decisions regarding our named executive officers.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">A discussion of the policies and decisions that shape our executive compensation program, including the specific objectives and elements, is set forth below.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Executive Compensation Objectives and Philosophy</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">The objective of our executive compensation program is to attract, retain and motivate talented executives who are critical for our continued growth and success and to align the interests of these executives with those of our shareholders. To this end, our compensation programs for executive officers are designed to achieve the following objectives:</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<table id="z83ac81f6d00f4e07a725256fb2dc20a6" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 36pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; WIDTH: 18pt; align: right">&#8226;</td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">attract, hire, and retain talented and experienced executives;</div>
</td>
</tr>
</table>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal">52</font></div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; WIDTH: 100%; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<table id="z3e414699603c4222b818d12b3d89c142" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 36pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; WIDTH: 18pt; align: right">&#8226;</td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">motivate, reward and retain executives whose knowledge, skills and performance are critical to our success;</div>
</td>
</tr>
</table>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<table id="za81053051c85491491908018a95b9a9c" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 36pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; WIDTH: 18pt; align: right">&#8226;</td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">ensure fairness among the executive management team by recognizing the contributions each executive makes to our success and the tenure of each team member as a factor in achieving such success;</div>
</td>
</tr>
</table>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<table id="zb9a13f75fd354be09805f4c008f9879b" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 36pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; WIDTH: 18pt; align: right">&#8226;</td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">focus executive behavior on achievement of our corporate objectives and strategy;</div>
</td>
</tr>
</table>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<table id="zff02b9ad1a934ce68972e640b6562db4" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 36pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; WIDTH: 18pt; align: right">&#8226;</td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">build a mechanism of "pay for performance"; and</div>
</td>
</tr>
</table>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<table id="zea8e9540dec44189833d70d5ab3075ef" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 36pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; WIDTH: 18pt; align: right">&#8226;</td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">align the interests of management and shareholders by providing management with longer-term incentives through equity ownership.</div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">The Compensation Committee reviews the allocation of compensation components regularly to ensure alignment with strategic and operating goals, competitive market practices and legislative changes. The Compensation Committee does not apply a specific formula to determine the allocation between cash and non-cash forms of compensation. Certain compensation components, such as base salaries, benefits and perquisites, are intended primarily to attract, hire, and retain well-qualified executives. Other compensation elements, such as long-term incentive opportunities, are designed to motivate and reward performance.&#160; Long-term incentives are intended to reward our long-term performance and executing our business strategy, and to strongly align named executive officers' interests with those of shareholders.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">With respect to equity compensation, the Compensation Committee makes awards to executives under our stock option plans and other plans as approved by the Board of Directors. Executive compensation is paid or granted based on such matters as the Compensation Committee deems appropriate, including our financial and operating performance, the alignment of the interests of the executive officers and our shareholders, the performance of our common stock and our ability to attract and retain qualified individuals.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Elements of Executive Officer Compensation</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">Our executive officer compensation program is comprised of: (i) base salary or monthly compensation; (ii) performance based bonus; (iii) long-term equity incentive compensation in the form of periodic stock option and RSU grants; and (iv) benefits and perquisites.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">In establishing overall executive compensation levels and making specific compensation decisions for our executive officers in 2017, the Compensation Committee considered a number of criteria, including the executive's position, scope of responsibilities, prior base salary and annual incentive awards and expected contribution. In that regard, our Compensation Committee has decided to provide our Co-CEOs, Mr. Aberman and Mr. Yaky, base salaries, RSU awards and change of control provisions in their respective employments agreement, as opposed to certain terms contained in our CFO&#8217;s employment agreement and compensation package, based on their respective positions,<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">&#160;</font>seniority<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">&#160;</font>and scope of responsibilities.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">Generally, our Compensation Committee reviews and, as appropriate, approves compensation arrangements for our named executive officers, from time to time but not less than once a year.&#160; The Compensation Committee also takes into consideration our co-CEOs recommendations for executive compensation of other named executive officers. Our co-CEOs generally present these recommendations at the time of our Compensation Committee's review of executive compensation arrangements.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Base Salary</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">The Compensation Committee performs a review of base salaries / monthly compensation for our named executive officers from time to time as appropriate. In determining salaries, the Compensation Committee members also take into consideration their understanding of the compensation practices of comparable companies (based on size and stage of development), especially in Israel, where our named executive officers reside; independent third party market data such as compensation surveys to industry, including information relating to peer companies; individual experience and performance adjusted to reflect individual roles; and contribution to our clinical, regulatory, commercial and operational performance. None of the factors above has a dominant weight in determining the compensation of our executive officers, and our Compensation Committee considers the factors as a whole when considering such compensation.&#160; In addition, our Compensation Committee may, from time to time, use comparative data regarding compensation paid by peer companies in order to obtain a general understanding of current trends in compensation practices and ranges of amounts being awarded by other public companies, and not as part of an analysis or a formula.&#160; We may also change the base salary / monthly compensation of an executive officer at other times due to market conditions. We believe that a competitive base salary / monthly compensation is a necessary element of any compensation program that is designed to attract and retain talented and experienced executives. We also believe that attractive base salaries can motivate and reward executives for their overall performance. Base salaries / monthly compensation are established in part based on the individual experience, skills and expected contributions of our executives and our executives' performance during the prior year. Compensation adjustments are made occasionally based on changes in an executive's level of responsibility, Company progress or on changed local and specific executive employment market conditions.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal">53</font></div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; WIDTH: 100%; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">On June 21, 2017, our Board of Directors, in connection with the appointment of Mr. Yaky Yanay as Co-CEO, increased the monthly base salary of Mr. Yanay from 53,125 NIS to 80,000 NIS, effective July 1, 2017. With respect to the changes in Mr. Yanay&#8217;s monthly base salary, we conducted an analysis of salaries and monthly compensation received by CEO counterparts in public companies in the biotechnology industry and other comparable companies in similar size and stage of development, which are active mainly in Israel, as well as companies which are active in the U.S, which include, among others,&#160; executive compensation information from the recent SEC filings of Athersys, Inc.; Brainstorm Cell Therapeutics Inc.; Capricor Therapeutics, Inc.; Geron Corporation; Mesoblast Limited; Neuroderm Ltd. and Protalix BioTherapeutics, Inc.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Performance Based Bonus</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">Given the nature of our business, the determination of incentives for our executives is generally tied to success in promoting our Company's development.&#160; We are continually seeking non-dilutive sources of funding.&#160; In addition, a key component of our strategy is to develop and manufacture cell therapy products for the treatment of multiple disorders through collaboration with other companies and entering into licensing agreements with such companies, such as our agreement with CHA.&#160; Therefore, in order to reward our Co-CEOs, each of them is entitled to a bonus calculated as a percentage of amounts received by us from non-dilutive funding received, among other things, from corporate partnering and strategic deals (e.g., the United Agreement). This is designed to support our business strategy to enter into multiple license agreements with pharmaceutical companies. The performance based bonus percentages are as follows: Mr. Zami Aberman &#8211; 1.5% of amounts received by us from non-dilutive funding and strategic deals, and Mr. Yaky Yanay &#8211; 1% of such amounts. The difference in the percentage of the performance based bonus was determined based on the Compensation Committee's assessment of the contribution and role of each of them in completing the licensing and strategic agreements. In addition, our executives may be entitled, from time to time, to a discretionary bonus that is in the Compensation Committee sole discretion.&#160;&#160; We paid no bonuses to our named executive officers in Fiscal 2017.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Long-term Equity Incentive Compensation</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">Long-term incentive compensation allows the executive officers to share in any appreciation in the value of our common stock. The Compensation Committee believes that stock participation aligns executive officers&#8217; interests with those of our shareholders. The amounts of the awards are designed to reward past performance and create incentives to meet long-term objectives. Awards are made at a level expected to be competitive within the biotechnology industry, as well as with Israeli based companies.&#160; We do not have a formula relating to, and did not conduct any analysis of, the level of awards that is competitive within the biotechnology industry and Israeli based companies.&#160; In determining the amount of each grant, the Compensation Committee also takes into account the number of shares held by the executive prior to the grant. Awards are made on a discretionary basis and not pursuant to specific criteria set out in advance.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal">54</font></div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; WIDTH: 100%; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">RSU awards provide our executive officers with the right to purchase shares of our common stock at a par value of $0.00001, subject to continued employment with our Company. In recent years we granted our executive officers RSU awards.&#160; We chose to grant RSU awards and not options because RSU awards, once vested, always have an immediate financial value to the holder thereof, unlike options where the exercise price might be below the current market price of the shares and therefore not have any intrinsic value to the holder thereof.&#160; In the past, due to the high volatility of our stock price, options we granted were out of the money, and many of them still are.&#160; In addition, because vested RSU awards always have financial value, as opposed to options, we were able to limit the number of securities issued to our executive officers and other employees, directors and consultants. Our Co-CEOs are entitled to acceleration of the vesting of their stock options and RSUs in the following circumstances: (1) if we terminate their employment, they will be entitled to acceleration of 100% of any unvested options and RSU and (2) if they resign, they will be entitled to acceleration of 50% of any unvested options and RSUs. In addition, Mr. Aberman is entitled to an acceleration of 100% of any unvested options and RSUs in the event of a change in control of us. All grants are approved by our Board of Directors.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Benefits and Perquisites</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">Generally, benefits available to our named executive officers are available to all employees on similar terms and include welfare benefits, paid time-off, life and disability insurance and other customary or mandatory social benefits in Israel.&#160; We provide our named executive officers with a phone and a Company car, or reimbursement for car expenses, which are customary benefits in Israel to managers and officers.&#160; Our Co-CEOs are also entitled to receive, once a year, a fixed sum equal to the amount of the monthly compensation to such Co-CEO.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">In addition, in the event of termination of our Mr. Aberman&#8217; s consulting agreement, he will be entitled to receive an adjustment fee that equals the monthly consulting fees multiplied by 3 plus the number of years the Consulting Agreement is in force from the second year, but in any event no more than nine years in the aggregate. Mr. Yanay may be entitled to a severance payment that equals a month&#8217;s compensation for each twelve-month period of employment or otherwise providing services to the Company, and an additional adjustment fee that equals the monthly base salary multiplied by 2. Our CFO, Erez Egozi, is entitled to severance pay upon termination of employment for any reason, including retirement, based on 8.333% of his monthly base salary, according to section 14 of the Severance Pay Law, 1963.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">We do not believe that the benefits and perquisites described above deviate materially from the customary practice for compensation of executive officers by other companies similar in size and stage of development in Israel.&#160; These benefits represent a relatively small portion of the executive officers' total compensation.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Compensation Committee Report</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">The Compensation Committee has reviewed and discussed the foregoing Compensation Discussion and Analysis required by Item 402(b) of Regulation S-K with our management and, based on such review and discussions, the Compensation Committee recommended to our Board of Directors that the Compensation Discussion and Analysis be included in this Annual Report <font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">on Form 10-K and in our proxy statement relating to our next annual meeting of stockholders</font>.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<table id="z8d23dcc3eca84cff965df37cafde499f" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 50.25%">&#160;</td>
<td style="VERTICAL-ALIGN: top; WIDTH: 49.75%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Compensation Committee Members:</div>
</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 50.25%">&#160;</td>
<td style="VERTICAL-ALIGN: top; WIDTH: 49.75%">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 50.25%">&#160;</td>
<td style="VERTICAL-ALIGN: top; WIDTH: 49.75%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Doron Shorrer</div>
</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 50.25%">&#160;</td>
<td style="VERTICAL-ALIGN: top; WIDTH: 49.75%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Nachum Rosman</div>
</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 50.25%">&#160;</td>
<td style="VERTICAL-ALIGN: top; WIDTH: 49.75%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Israel Ben-Yoram</div>
</td>
</tr>
</table>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal">55</font></div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; WIDTH: 100%; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Summary Compensation Table</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">The following table shows the particulars of compensation paid to our named executive officers for the fiscal years ended June 30, 2017, 2016 and 2015. We do not currently have any other executive officers.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<table id="zf20062b83e7e4790ad1c7365d9acdc1f" style="FONT-SIZE: 10pt; BORDER-TOP: medium none; FONT-FAMILY: 'Times New Roman', Times, serif; BORDER-RIGHT: medium none; BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; WIDTH: 85%" cellspacing="0" cellpadding="0" align="left" border="0">
<tr>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; BORDER-LEFT: medium none; WIDTH: 41%" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Name<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><br>
</font> and Principal Position</div>
</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BORDER-LEFT: medium none; WIDTH: 2%" valign="bottom">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; BORDER-LEFT: medium none; WIDTH: 9%" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Fiscal Year</div>
</td>
<td style="BORDER-TOP: medium none; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BORDER-LEFT: medium none; WIDTH: 1%" valign="bottom">&#160;</td>
<td style="BORDER-TOP: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid" valign="bottom" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Salary<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><br>
</font> ($) (1)</div>
</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="BORDER-TOP: medium none; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BORDER-LEFT: medium none; WIDTH: 1%" valign="bottom">&#160;</td>
<td style="BORDER-TOP: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid" valign="bottom" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Stock-based Awards<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><br>
</font> ($)(2)</div>
</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="BORDER-TOP: medium none; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BORDER-LEFT: medium none; WIDTH: 1%" valign="bottom">&#160;</td>
<td style="BORDER-TOP: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid" valign="bottom" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">All<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><br>
</font>Other Compensation<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><br>
</font> ($)(3)</div>
</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="BORDER-TOP: medium none; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BORDER-LEFT: medium none; WIDTH: 1%" valign="bottom">&#160;</td>
<td style="BORDER-TOP: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid" valign="bottom" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Total<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><br>
</font> ($)</div>
</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="BORDER-RIGHT: medium none; VERTICAL-ALIGN: middle; PADDING-BOTTOM: 2px; BORDER-LEFT: medium none; WIDTH: 41%; BACKGROUND-COLOR: #cceeff" valign="bottom" rowspan="3">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Zami Aberman</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Co-CEO</div>
</td>
<td style="BORDER-RIGHT: medium none; VERTICAL-ALIGN: middle; PADDING-BOTTOM: 2px; BORDER-LEFT: medium none; WIDTH: 2%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="BORDER-RIGHT: medium none; VERTICAL-ALIGN: top; PADDING-BOTTOM: 2px; BORDER-LEFT: medium none; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: right; LINE-HEIGHT: 1.25">2017</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BORDER-LEFT: medium none; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">492,950</div>
</td>
<td style="BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(4)</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BORDER-LEFT: medium none; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">3,050,000</div>
</td>
<td style="BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BORDER-LEFT: medium none; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">16,462</div>
</td>
<td style="BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BORDER-LEFT: medium none; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">3,559,412</div>
</td>
<td style="BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="BORDER-RIGHT: medium none; VERTICAL-ALIGN: middle; PADDING-BOTTOM: 2px; BORDER-LEFT: medium none; WIDTH: 2%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="BORDER-RIGHT: medium none; VERTICAL-ALIGN: top; PADDING-BOTTOM: 2px; BORDER-LEFT: medium none; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: right; LINE-HEIGHT: 1.25">2016</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BORDER-LEFT: medium none; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">519,050</div>
</td>
<td style="BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(4)</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BORDER-LEFT: medium none; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">169,500</div>
</td>
<td style="BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BORDER-LEFT: medium none; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">21,074</div>
</td>
<td style="BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BORDER-LEFT: medium none; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">709,624</div>
</td>
<td style="BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="BORDER-RIGHT: medium none; VERTICAL-ALIGN: middle; PADDING-BOTTOM: 2px; BORDER-LEFT: medium none; WIDTH: 2%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="BORDER-RIGHT: medium none; VERTICAL-ALIGN: top; PADDING-BOTTOM: 2px; BORDER-LEFT: medium none; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: right; LINE-HEIGHT: 1.25">2015</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BORDER-LEFT: medium none; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">484,400</div>
</td>
<td style="BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(4)</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BORDER-LEFT: medium none; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">512,000</div>
</td>
<td style="BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BORDER-LEFT: medium none; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">18,813</div>
</td>
<td style="BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BORDER-LEFT: medium none; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">1,015,213</div>
</td>
<td style="BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="BORDER-RIGHT: medium none; VERTICAL-ALIGN: middle; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BORDER-LEFT: medium none; WIDTH: 41%; BACKGROUND-COLOR: #ffffff" rowspan="3">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">Yaky Yanay</font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><br>
</font> Co-CEO</div>
</td>
<td style="BORDER-RIGHT: medium none; VERTICAL-ALIGN: top; PADDING-BOTTOM: 2px; BORDER-LEFT: medium none; WIDTH: 2%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="BORDER-RIGHT: medium none; VERTICAL-ALIGN: top; PADDING-BOTTOM: 2px; BORDER-LEFT: medium none; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: right; LINE-HEIGHT: 1.25">2017</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BORDER-LEFT: medium none; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">253,037</div>
</td>
<td style="BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BORDER-LEFT: medium none; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">3,050,000</div>
</td>
<td style="BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BORDER-LEFT: medium none; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">22,093</div>
</td>
<td style="BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BORDER-LEFT: medium none; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">3,325,130</div>
</td>
<td style="BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="BORDER-RIGHT: medium none; VERTICAL-ALIGN: top; PADDING-BOTTOM: 2px; BORDER-LEFT: medium none; WIDTH: 2%" valign="bottom">&#160;</td>
<td style="BORDER-RIGHT: medium none; VERTICAL-ALIGN: top; PADDING-BOTTOM: 2px; BORDER-LEFT: medium none; WIDTH: 9%" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: right; LINE-HEIGHT: 1.25">2016</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BORDER-LEFT: medium none; WIDTH: 1%" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; TEXT-ALIGN: left; WIDTH: 1%" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; TEXT-ALIGN: right; WIDTH: 9%" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">245,312</div>
</td>
<td style="BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BORDER-LEFT: medium none; WIDTH: 1%" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; TEXT-ALIGN: left; WIDTH: 1%" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; TEXT-ALIGN: right; WIDTH: 9%" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">169,500</div>
</td>
<td style="BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BORDER-LEFT: medium none; WIDTH: 1%" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; TEXT-ALIGN: left; WIDTH: 1%" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; TEXT-ALIGN: right; WIDTH: 9%" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">21,721</div>
</td>
<td style="BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BORDER-LEFT: medium none; WIDTH: 1%" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; TEXT-ALIGN: left; WIDTH: 1%" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; TEXT-ALIGN: right; WIDTH: 9%" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">436,533</div>
</td>
<td style="BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="BORDER-RIGHT: medium none; VERTICAL-ALIGN: top; PADDING-BOTTOM: 2px; BORDER-LEFT: medium none; WIDTH: 2%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="BORDER-RIGHT: medium none; VERTICAL-ALIGN: top; PADDING-BOTTOM: 2px; BORDER-LEFT: medium none; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: right; LINE-HEIGHT: 1.25">2015</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BORDER-LEFT: medium none; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">249,000</div>
</td>
<td style="BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BORDER-LEFT: medium none; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">512,000</div>
</td>
<td style="BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BORDER-LEFT: medium none; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">25,721</div>
</td>
<td style="BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BORDER-LEFT: medium none; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">786,721</div>
</td>
<td style="BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="BORDER-RIGHT: medium none; VERTICAL-ALIGN: top; PADDING-BOTTOM: 2px; BORDER-LEFT: medium none; WIDTH: 41%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Erez Egozi</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">CFO (5)</div>
</td>
<td style="BORDER-RIGHT: medium none; VERTICAL-ALIGN: top; PADDING-BOTTOM: 2px; BORDER-LEFT: medium none; WIDTH: 2%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: right; BORDER-LEFT: medium none; WIDTH: 9%; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">2017</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BORDER-LEFT: medium none; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">145,649</div>
</td>
<td style="BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BORDER-LEFT: medium none; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">293,821</div>
</td>
<td style="BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BORDER-LEFT: medium none; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">19,289</div>
</td>
<td style="BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BORDER-LEFT: medium none; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">458,759</div>
</td>
<td style="BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>
</table>

<div style="CLEAR: both; LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">(1)</font>&#160;&#160;&#160;&#160;&#160;&#160; &#160;&#160;&#160;&#160;<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">Salary payments which were in NIS, were translated into US$ at the then current exchange rate for each payment.</font></div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">(2)</font>&#160;&#160;&#160;&#160;&#160;&#160; &#160;&#160;&#160;&#160;<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">The fair value recognized for the stock-based awards was determined as of the grant date in accordance with ASC 718. Assumptions used in the calculations for these amounts are included in Note 2(l) to our consolidated financial statements for Fiscal 2017 included elsewhere in this Annual Report.</font></div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">(3)</font>&#160;&#160;&#160;&#160;&#160; &#160;&#160;&#160;&#160;&#160;<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">Represents cost to us in connection with car and a mobile phone expenses. The Company also pays our Co-CEOs the tax associated with this benefit, which is grossed up, and part of the amount in the Salary column in the table above.</font></div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">(4)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160;&#160;&#160;<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">Includes $20,684, $18,910 and $19,054 paid to Mr. Aberman as compensation for services as a director in fiscal 2017, 2016 and 2015, respectively, and $43,503 paid to Mr. Aberman as redemption in cash of 27.5 vacation Days in fiscal 2016.</font></div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">&#160;(5)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">Mr. Egozi was appointed as our Chief Financial Officer on March 29, 2017. The compensation reflects amounts received during the entire fiscal year.</font></div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">We have the following written agreements and other arrangements concerning compensation with our named executive officers:</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">
<table id="z6543463f665845a1923591d65c24f8cf" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; WIDTH: 36pt; align: right">(a)</td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: justify; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">Mr. Aberman is engaged with us as a consultant and receives a monthly consulting fee of $31,250. In addition, Mr. Aberman is entitled once a year to receive an additional amount that equals the monthly consulting fee. The U.S. dollar rate will be not less then 4.35 NIS per $.&#160; All amounts above are paid plus value added tax.&#160; Mr. Aberman is also entitled to one and a half percent (1.5%) from amounts received by us from non diluting funding and strategic deals.</div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal">56</font></div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; WIDTH: 100%; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<table id="z680daa6790e641c58e0aadee43beea33" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; WIDTH: 36pt; align: right">&#160;(b)</td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">During fiscal 2017, Mr. Yanay's monthly salary is 53,125 NIS. In addition, Mr. Yanay is entitled once a year to receive an additional amount that equals his monthly salary.&#160; Mr. Yanay is provided with a cellular phone and a Company car pursuant to the terms of his agreement.&#160; Furthermore, Mr. Yanay is entitled to a bonus of one percent (1.0%) from amounts received by us from non diluting funding and strategic deals.&#160; Since August 2011, Mr. Yanay has been engaged with us as a consultant, in addition to being an employee.&#160; For his services as a consultant he receives a monthly consulting fee.&#160; In addition, he continues to receive salary as an employee, but in an amount reduced by the consulting fee so the total cost to us did not change as a result of this change.</div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 35.45pt; LINE-HEIGHT: 1.25">On June 21, 2017, our Board of Directors, in connection with the recent appointment of Mr. Yaky Yanay as Co-CEO, increased Mr. Yanay&#8217;s base salary to 80,000 NIS, effective July 1, 2017. Mr. Yanay will also receive an annual fee of $20,000 for his services as a director of the Company.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<table id="zdb2cbac2c7a143eead2c011c69578c4c" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; WIDTH: 36pt; align: right">(c)</td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">Mr. Egozi&#8217;s monthly salary is 34,000 NIS.&#160; Mr. Egozi is provided with a cellular phone and a Company car pursuant to the terms of his agreement.</div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-STYLE: italic; TEXT-ALIGN: left; MARGIN-LEFT: 35.45pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -35.45pt">Potential Payments Upon Termination or Change-in-Control</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 35.45pt">We have no plans or arrangements in respect of remuneration received or that may be received by our executive officers to compensate such officers in the event of termination of employment (as a result of resignation, retirement, change-in- control) or a change of responsibilities following a change-in-control, except for the following: (i) in the event of termination of Mr. Aberman&#8217;s Consulting Agreement, he will be entitled to receive an adjustment fee that equals the monthly consulting fees multiplied by 3 plus the number of years the Consulting Agreement has been in force as of the second year, but in any event no more than nine years in the aggregate; (ii) Mr. Yanay may be entitled, under Israeli law and practice, to a severance payment that equals a month's salary for each twelve-month period of employment with the Company and an adjustment fee that equals the monthly base salary multiplied by 2.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">In addition, Mr. Aberman and Mr. Yanay are entitled to acceleration of the vesting of their stock options and restricted stock in the following circumstances: (1) if we terminate their employment, they will be entitled to acceleration of 100% of any unvested options and restricted stock and (2) if they resign, they will be entitled to acceleration of 50% of any unvested options and restricted stock. In addition, Mr. Aberman is entitled to acceleration of 100% of any unvested options and restricted stock in case of our change in control or merger into another company.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal">57</font></div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; WIDTH: 100%; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">The following table displays the value of what Co-CEOs would have received from us had their employment been terminated, or a change in control of us happened on June 30, 2017.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<table id="z4c734f1e609d45c1ab0eb9d31f780e5c" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Officer</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid" valign="bottom" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Salary</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid" valign="bottom" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Accelerated Vesting of Options and Restricted Stock Units (1)</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid" valign="bottom" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Total</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: top" valign="bottom" colspan="2">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: top" valign="bottom" colspan="2">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: top" valign="bottom" colspan="2">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Zami Aberman</div>
</td>
<td style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff" valign="bottom" colspan="2">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff" valign="bottom" colspan="2">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff" valign="bottom" colspan="2">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 64%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;&#160;Terminated due to officer resignation</div>
</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">349,954</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">1,412,000</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(2)</div>
</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">1,761,954</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 64%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;&#160;Terminated due to discharge of officer</div>
</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">349,954</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">2,824,000</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(3)</div>
</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">3,173,954</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 64%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;&#160;Change in control</div>
</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">2,824,000</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(4)</div>
</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">2,824,000</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 64%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 64%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Yaky Yanay</div>
</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 64%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;&#160;Terminated due to officer resignation</div>
</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">134<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">,</font>359</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">1,412,000</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(2)</div>
</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">1,546<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">,</font>359</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 64%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;&#160;Terminated due to discharge of officer</div>
</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">134<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">,</font>359</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">2,824,000</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(3)</div>
</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">2,958<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">,</font>359</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>
</table>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<table id="z105bae0291dc49d8b3c62d92efb7da54" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 18pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; WIDTH: 36pt; align: right">(1)</td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">Value shown represents the difference between the closing market price of our shares of common stock on June 30, 2017 of $1.28 per share and the applicable exercise price of each grant.</div>
</td>
</tr>
</table>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<table id="ze97c5132856f42e3ab2227ebcbb2f0f7" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 18pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; WIDTH: 36pt; align: right">(2)</td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">50% of all unvested options and RSUs issued under the applicable equity incentive plans vest upon a termination without cause under the terms of those plans.</div>
</td>
</tr>
</table>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<table id="z2bb5360f1e404e46835e942a358f1800" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 18pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; WIDTH: 36pt; align: right">(3)</td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">All unvested options and RSUs issued under the applicable equity incentive plans vest upon a termination due to discharge.</div>
</td>
</tr>
</table>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<table id="zc7110990d330402fada86c907effec1c" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 18pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; WIDTH: 36pt; align: right">(4)</td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">All unvested options and RSUs issued under the applicable equity incentive plans vest upon a change of control under the terms of those plans.</div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-STYLE: italic; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Pension, Retirement or Similar Benefit Plans</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 35.45pt">We have no arrangements or plans under which we provide pension, retirement or similar benefits for directors or executive officers. Our directors and executive officers may receive stock options, RSUs or restricted shares at the discretion of our Board in the future.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Grants of Plan-Based Awards</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 35.45pt">The following table shows grants of plan-based equity awards made to our named executive officers during the fiscal year ended June 30, 2017:</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<table id="z2cfc8a898c8e40eca7db07eb7d87b12e" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; WIDTH: 38%" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Name</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 2%" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; WIDTH: 30%" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Grant Date</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 1%" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid" valign="bottom" colspan="2">
<div style="LINE-HEIGHT: 1.25">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">All Other Stock Awards:</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Number of Shares of Stock or Units #</div>
</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 1%" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid" valign="bottom" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Grant Date Fair Value of Stock Awards ($)</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 38%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Zami Aberman</div>
</td>
<td style="VERTICAL-ALIGN: top; WIDTH: 2%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: top; WIDTH: 30%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">12/29/16</div>
</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 12%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">200,000(1</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 12%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">290,000</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 38%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: top; WIDTH: 2%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: top; WIDTH: 30%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">6/22/17</div>
</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 12%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">2,000,000(2</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 12%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">2,760,000</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 38%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: top; WIDTH: 2%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: top; WIDTH: 30%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 12%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 12%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 38%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Yaky Yanay</div>
</td>
<td style="VERTICAL-ALIGN: top; WIDTH: 2%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: top; WIDTH: 30%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">12/29/16</div>
</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 12%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">200,000(1</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 12%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">290,000</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 38%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: top; WIDTH: 2%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: top; WIDTH: 30%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">6/22/17</div>
</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 12%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">2,000,000(2</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 12%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">2,760,000</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 38%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: top; WIDTH: 2%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: top; WIDTH: 30%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 12%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 12%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 38%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Erez Egozi</div>
</td>
<td style="VERTICAL-ALIGN: top; WIDTH: 2%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: top; WIDTH: 30%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">28/12/2016</div>
</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 12%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">7,600(4</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 12%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">11,552</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 38%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: top; WIDTH: 2%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: top; WIDTH: 30%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">29/12/2016</div>
</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 12%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">65,000(5</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 12%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">89,759</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 38%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: top; WIDTH: 2%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: top; WIDTH: 30%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">22/06/2017</div>
</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 12%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">150,000(3</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">)</div>
</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 12%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">192,510</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>
</table>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<table id="z3939ea0a413f4675abb305d017cf6c36" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 18pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; WIDTH: 36pt; align: right">(1)</td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">Grant of RSUs was made pursuant to our 2016 Plan. The grant vests over a two-year period from the date of grant, as follows:<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">&#160;</font>25% after 6 months from grant and the remaining shares vest in 6 equal installments every 3 months thereafter.</div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<table id="z37194a3346b7424d9fa79c891af90881" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 18pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; WIDTH: 36pt; align: right">(2)</td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">Grant of 1,000,000 RSUs was made pursuant to our 2016 Plan, and grant of 1,000,000 RSUs was made pursuant to our amended and restated 2005 Stock Option Plan, or the 2005 Plan. The grant vests over a four-year period from the date of grant, as follows:<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">&#160;</font>12.5% after 6 months from the date of grant and the remaining shares vest in 14 equal installments every 3 months thereafter.</div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal">58</font></div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; WIDTH: 100%; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<table id="z0cfabb486a1a4dfc8dc975ff588d0d9a" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 18pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; WIDTH: 36pt; align: right">(3)</td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">Grant of RSUs was made pursuant to our 2016 Plan. The grant vests over a four-year period from the date of grant, as follows:<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">&#160;</font>12.5% after 6 months from date of grant and the remaining shares vest in 14 equal installments every 3 months thereafter.</div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<table id="z14d5cca2e12740cf8831a139698df3ff" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 18pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; WIDTH: 36pt; align: right">(4)</td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">Grant of RSUs was made pursuant to our 2016 Plan. The grant vested on February 1, 2017. The shares were sold during the quarter ended March 31, 2017.</div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<table id="zd0dbf23ef99c48d4b855723dba7620fd" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 18pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; WIDTH: 36pt; align: right">(5)</td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">Grant of RSUs was made pursuant to our 2016 Plan. 35,000 RSUs vest over a two-year period from the date of grant, as follows:<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">&#160;</font>25% after 6 months from date of grant and the remaining shares vest in 6 equal installments every 3 months thereafter. 30,000 RSUs will vest upon achievement of certain operational and financial goals.</div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; MARGIN-LEFT: 36pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -36pt">Outstanding Equity Awards at the End of Fiscal 2017</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">The following table presents the outstanding equity awards held as of June 30, 2017 by our named executive officers:</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<table id="zaf98f54f14f3445090a57a47736ba5fb" style="FONT-SIZE: 10pt; BORDER-TOP: medium none; FONT-FAMILY: 'Times New Roman', Times, serif; BORDER-RIGHT: medium none; BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; WIDTH: 100%" cellspacing="0" cellpadding="0" border="0">
<tr>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 2px solid; BORDER-LEFT: medium none" valign="bottom" colspan="23">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">Number of Securities Underlying Unexercised</div>
</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BORDER-LEFT: medium none" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: top; PADDING-BOTTOM: 2px; BORDER-LEFT: medium none" valign="bottom">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BORDER-LEFT: medium none" valign="bottom">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 2px solid; BORDER-LEFT: medium none" valign="bottom" colspan="13">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">Option Awards</div>
</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BORDER-LEFT: medium none" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BORDER-LEFT: medium none" valign="bottom">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 2px solid; BORDER-LEFT: medium none" valign="bottom" colspan="6">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">Stock Awards</div>
</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BORDER-LEFT: medium none" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: center; BORDER-LEFT: medium none">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Name</div>
</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: center; BORDER-LEFT: medium none">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: center; BORDER-LEFT: medium none" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; LINE-HEIGHT: 1.25">Number of securities underlying unexercised options (#) exercisable</div>
</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: center; BORDER-LEFT: medium none" nowrap="nowrap">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: center; BORDER-LEFT: medium none">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: center; BORDER-LEFT: medium none" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; LINE-HEIGHT: 1.25">Number of securities underlying unexercised options (#) unexercisable</div>
</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: center; BORDER-LEFT: medium none" nowrap="nowrap">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: center; BORDER-LEFT: medium none">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: center; BORDER-LEFT: medium none" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; LINE-HEIGHT: 1.25">Option exercise price($)</div>
</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: center; BORDER-LEFT: medium none" nowrap="nowrap">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: center; BORDER-LEFT: medium none">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: center; BORDER-LEFT: medium none">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; LINE-HEIGHT: 1.25">Option expiration date</div>
</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: center; BORDER-LEFT: medium none" nowrap="nowrap">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: center; BORDER-LEFT: medium none">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: center; BORDER-LEFT: medium none" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; LINE-HEIGHT: 1.25">Number of shares that have not vested (#)</div>
</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: center; BORDER-LEFT: medium none" nowrap="nowrap">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: center; BORDER-LEFT: medium none">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: center; BORDER-LEFT: medium none" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; LINE-HEIGHT: 1.25">Market value of shares that have not vested ($)</div>
</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: center; BORDER-LEFT: medium none" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: top; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 2px; BORDER-LEFT: medium none; BACKGROUND-COLOR: #cceeff" valign="bottom" rowspan="5">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Zami Aberman</div>
</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 2px; BORDER-LEFT: medium none; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; TEXT-ALIGN: left; BORDER-LEFT: medium none; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; TEXT-ALIGN: right; BORDER-LEFT: medium none; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">105,000</div>
</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BORDER-LEFT: medium none; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 2px; BORDER-LEFT: medium none; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; TEXT-ALIGN: left; BORDER-LEFT: medium none; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; TEXT-ALIGN: right; BORDER-LEFT: medium none; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BORDER-LEFT: medium none; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 2px; BORDER-LEFT: medium none; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; TEXT-ALIGN: left; BORDER-LEFT: medium none; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; TEXT-ALIGN: right; BORDER-LEFT: medium none; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">4.38</div>
</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BORDER-LEFT: medium none; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 2px; BORDER-LEFT: medium none; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: top; BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">12/25/2017</div>
</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BORDER-LEFT: medium none; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 2px; BORDER-LEFT: medium none; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; TEXT-ALIGN: left; BORDER-LEFT: medium none; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; TEXT-ALIGN: right; BORDER-LEFT: medium none; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BORDER-LEFT: medium none; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 2px; BORDER-LEFT: medium none; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; TEXT-ALIGN: left; BORDER-LEFT: medium none; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; TEXT-ALIGN: right; BORDER-LEFT: medium none; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BORDER-LEFT: medium none; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 2px; BORDER-LEFT: medium none; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; TEXT-ALIGN: left; BORDER-LEFT: medium none; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; TEXT-ALIGN: right; BORDER-LEFT: medium none; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">110,000</div>
</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BORDER-LEFT: medium none; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 2px; BORDER-LEFT: medium none; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; TEXT-ALIGN: left; BORDER-LEFT: medium none; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; TEXT-ALIGN: right; BORDER-LEFT: medium none; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BORDER-LEFT: medium none; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 2px; BORDER-LEFT: medium none; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; TEXT-ALIGN: left; BORDER-LEFT: medium none; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; TEXT-ALIGN: right; BORDER-LEFT: medium none; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">0.62</div>
</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BORDER-LEFT: medium none; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 2px; BORDER-LEFT: medium none; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: top; BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">10/30/2018</div>
</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BORDER-LEFT: medium none; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 2px; BORDER-LEFT: medium none; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; TEXT-ALIGN: left; BORDER-LEFT: medium none; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; TEXT-ALIGN: right; BORDER-LEFT: medium none; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BORDER-LEFT: medium none; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 2px; BORDER-LEFT: medium none; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; TEXT-ALIGN: left; BORDER-LEFT: medium none; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; TEXT-ALIGN: right; BORDER-LEFT: medium none; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BORDER-LEFT: medium none; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 2px; BORDER-LEFT: medium none; WIDTH: 1.06%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; TEXT-ALIGN: left; BORDER-LEFT: medium none; WIDTH: 1.06%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; TEXT-ALIGN: right; BORDER-LEFT: medium none; WIDTH: 9.07%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BORDER-LEFT: medium none; WIDTH: 1.06%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 2px; BORDER-LEFT: medium none; WIDTH: 1.06%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; TEXT-ALIGN: left; BORDER-LEFT: medium none; WIDTH: 1.06%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; TEXT-ALIGN: right; BORDER-LEFT: medium none; WIDTH: 9.07%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BORDER-LEFT: medium none; WIDTH: 1.06%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 2px; BORDER-LEFT: medium none; WIDTH: 1.06%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; TEXT-ALIGN: left; BORDER-LEFT: medium none; WIDTH: 1.06%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; TEXT-ALIGN: right; BORDER-LEFT: medium none; WIDTH: 9.07%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BORDER-LEFT: medium none; WIDTH: 1.06%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 2px; BORDER-LEFT: medium none; WIDTH: 1.06%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; TEXT-ALIGN: right; BORDER-LEFT: medium none; WIDTH: 9.07%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BORDER-LEFT: medium none; WIDTH: 1.06%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 2px; BORDER-LEFT: medium none; WIDTH: 1.06%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; TEXT-ALIGN: left; BORDER-LEFT: medium none; WIDTH: 1.06%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; TEXT-ALIGN: right; BORDER-LEFT: medium none; WIDTH: 9.07%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">56,250</div>
</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BORDER-LEFT: medium none; WIDTH: 0.99%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(1)</div>
</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 2px; BORDER-LEFT: medium none; WIDTH: 1.06%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; TEXT-ALIGN: left; BORDER-LEFT: medium none; WIDTH: 1.06%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; TEXT-ALIGN: right; BORDER-LEFT: medium none; WIDTH: 9.07%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">72,000</div>
</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BORDER-LEFT: medium none; WIDTH: 1.06%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 2px; BORDER-LEFT: medium none; WIDTH: 1.06%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; TEXT-ALIGN: left; BORDER-LEFT: medium none; WIDTH: 1.06%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; TEXT-ALIGN: right; BORDER-LEFT: medium none; WIDTH: 9.07%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BORDER-LEFT: medium none; WIDTH: 1.06%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 2px; BORDER-LEFT: medium none; WIDTH: 1.06%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; TEXT-ALIGN: left; BORDER-LEFT: medium none; WIDTH: 1.06%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; TEXT-ALIGN: right; BORDER-LEFT: medium none; WIDTH: 9.07%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BORDER-LEFT: medium none; WIDTH: 1.06%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 2px; BORDER-LEFT: medium none; WIDTH: 1.06%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; TEXT-ALIGN: left; BORDER-LEFT: medium none; WIDTH: 1.06%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; TEXT-ALIGN: right; BORDER-LEFT: medium none; WIDTH: 9.07%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BORDER-LEFT: medium none; WIDTH: 1.06%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 2px; BORDER-LEFT: medium none; WIDTH: 1.06%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; TEXT-ALIGN: right; BORDER-LEFT: medium none; WIDTH: 9.07%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BORDER-LEFT: medium none; WIDTH: 1.06%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 2px; BORDER-LEFT: medium none; WIDTH: 1.06%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; TEXT-ALIGN: left; BORDER-LEFT: medium none; WIDTH: 1.06%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; TEXT-ALIGN: right; BORDER-LEFT: medium none; WIDTH: 9.07%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">150,000</div>
</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BORDER-LEFT: medium none; WIDTH: 0.99%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(2)</div>
</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 2px; BORDER-LEFT: medium none; WIDTH: 1.06%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; TEXT-ALIGN: left; BORDER-LEFT: medium none; WIDTH: 1.06%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; TEXT-ALIGN: right; BORDER-LEFT: medium none; WIDTH: 9.07%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">192,000</div>
</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BORDER-LEFT: medium none; WIDTH: 1.06%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 2px; BORDER-LEFT: medium none; WIDTH: 1.06%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; TEXT-ALIGN: left; BORDER-LEFT: medium none; WIDTH: 1.06%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; TEXT-ALIGN: right; BORDER-LEFT: medium none; WIDTH: 9.07%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BORDER-LEFT: medium none; WIDTH: 1.06%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 2px; BORDER-LEFT: medium none; WIDTH: 1.06%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; TEXT-ALIGN: left; BORDER-LEFT: medium none; WIDTH: 1.06%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; TEXT-ALIGN: right; BORDER-LEFT: medium none; WIDTH: 9.07%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BORDER-LEFT: medium none; WIDTH: 1.06%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 2px; BORDER-LEFT: medium none; WIDTH: 1.06%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; TEXT-ALIGN: left; BORDER-LEFT: medium none; WIDTH: 1.06%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; TEXT-ALIGN: right; BORDER-LEFT: medium none; WIDTH: 9.07%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BORDER-LEFT: medium none; WIDTH: 1.06%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 2px; BORDER-LEFT: medium none; WIDTH: 1.06%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; TEXT-ALIGN: right; BORDER-LEFT: medium none; WIDTH: 9.07%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BORDER-LEFT: medium none; WIDTH: 1.06%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 2px; BORDER-LEFT: medium none; WIDTH: 1.06%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; TEXT-ALIGN: left; BORDER-LEFT: medium none; WIDTH: 1.06%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; TEXT-ALIGN: right; BORDER-LEFT: medium none; WIDTH: 9.07%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">2,000,000</div>
</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BORDER-LEFT: medium none; WIDTH: 0.99%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(3)</div>
</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 2px; BORDER-LEFT: medium none; WIDTH: 1.06%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; TEXT-ALIGN: left; BORDER-LEFT: medium none; WIDTH: 1.06%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; TEXT-ALIGN: right; BORDER-LEFT: medium none; WIDTH: 9.07%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">2,560,000</div>
</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BORDER-LEFT: medium none; WIDTH: 1.06%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: top; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 2px; BORDER-LEFT: medium none; BACKGROUND-COLOR: #ffffff" valign="bottom" rowspan="5">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Yaky Yanay</div>
</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 2px; BORDER-LEFT: medium none; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; TEXT-ALIGN: left; BORDER-LEFT: medium none; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; TEXT-ALIGN: right; BORDER-LEFT: medium none; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">62,500</div>
</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BORDER-LEFT: medium none; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 2px; BORDER-LEFT: medium none; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; TEXT-ALIGN: left; BORDER-LEFT: medium none; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; TEXT-ALIGN: right; BORDER-LEFT: medium none; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BORDER-LEFT: medium none; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 2px; BORDER-LEFT: medium none; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; TEXT-ALIGN: left; BORDER-LEFT: medium none; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; TEXT-ALIGN: right; BORDER-LEFT: medium none; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">4.38</div>
</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BORDER-LEFT: medium none; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 2px; BORDER-LEFT: medium none; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: top; BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">12/25/2017</div>
</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BORDER-LEFT: medium none; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 2px; BORDER-LEFT: medium none; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; TEXT-ALIGN: left; BORDER-LEFT: medium none; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; TEXT-ALIGN: right; BORDER-LEFT: medium none; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BORDER-LEFT: medium none; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 2px; BORDER-LEFT: medium none; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; TEXT-ALIGN: left; BORDER-LEFT: medium none; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; TEXT-ALIGN: right; BORDER-LEFT: medium none; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BORDER-LEFT: medium none; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 2px; BORDER-LEFT: medium none" valign="bottom">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; TEXT-ALIGN: left; BORDER-LEFT: medium none" valign="bottom">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; TEXT-ALIGN: right; BORDER-LEFT: medium none" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">55,000</div>
</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BORDER-LEFT: medium none" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 2px; BORDER-LEFT: medium none" valign="bottom">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; TEXT-ALIGN: left; BORDER-LEFT: medium none" valign="bottom">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; TEXT-ALIGN: right; BORDER-LEFT: medium none" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BORDER-LEFT: medium none" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 2px; BORDER-LEFT: medium none" valign="bottom">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; TEXT-ALIGN: left; BORDER-LEFT: medium none" valign="bottom">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; TEXT-ALIGN: right; BORDER-LEFT: medium none" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">0.62</div>
</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BORDER-LEFT: medium none" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 2px; BORDER-LEFT: medium none" valign="bottom">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: top; BORDER-BOTTOM: medium none; BORDER-LEFT: medium none" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">10/30/2018</div>
</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BORDER-LEFT: medium none" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 2px; BORDER-LEFT: medium none" valign="bottom">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; TEXT-ALIGN: left; BORDER-LEFT: medium none" valign="bottom">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; TEXT-ALIGN: right; BORDER-LEFT: medium none" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BORDER-LEFT: medium none" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 2px; BORDER-LEFT: medium none" valign="bottom">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; TEXT-ALIGN: left; BORDER-LEFT: medium none" valign="bottom">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; TEXT-ALIGN: right; BORDER-LEFT: medium none" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BORDER-LEFT: medium none" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 2px; BORDER-LEFT: medium none; WIDTH: 1.06%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; TEXT-ALIGN: left; BORDER-LEFT: medium none; WIDTH: 1.06%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; TEXT-ALIGN: right; BORDER-LEFT: medium none; WIDTH: 9.07%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BORDER-LEFT: medium none; WIDTH: 1.06%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 2px; BORDER-LEFT: medium none; WIDTH: 1.06%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; TEXT-ALIGN: left; BORDER-LEFT: medium none; WIDTH: 1.06%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; TEXT-ALIGN: right; BORDER-LEFT: medium none; WIDTH: 9.07%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BORDER-LEFT: medium none; WIDTH: 1.06%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 2px; BORDER-LEFT: medium none; WIDTH: 1.06%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; TEXT-ALIGN: left; BORDER-LEFT: medium none; WIDTH: 1.06%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; TEXT-ALIGN: right; BORDER-LEFT: medium none; WIDTH: 9.07%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BORDER-LEFT: medium none; WIDTH: 1.06%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 2px; BORDER-LEFT: medium none; WIDTH: 1.06%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; TEXT-ALIGN: right; BORDER-LEFT: medium none; WIDTH: 9.07%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BORDER-LEFT: medium none; WIDTH: 1.06%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 2px; BORDER-LEFT: medium none; WIDTH: 1.06%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; TEXT-ALIGN: left; BORDER-LEFT: medium none; WIDTH: 1.06%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; TEXT-ALIGN: right; BORDER-LEFT: medium none; WIDTH: 9.07%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">56,250</div>
</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BORDER-LEFT: medium none; WIDTH: 0.99%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(1)</div>
</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 2px; BORDER-LEFT: medium none; WIDTH: 1.06%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; TEXT-ALIGN: left; BORDER-LEFT: medium none; WIDTH: 1.06%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; TEXT-ALIGN: right; BORDER-LEFT: medium none; WIDTH: 9.07%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">72,000</div>
</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BORDER-LEFT: medium none; WIDTH: 1.06%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 2px; BORDER-LEFT: medium none; WIDTH: 1.06%" valign="bottom">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; TEXT-ALIGN: left; BORDER-LEFT: medium none; WIDTH: 1.06%" valign="bottom">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; TEXT-ALIGN: right; BORDER-LEFT: medium none; WIDTH: 9.07%" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BORDER-LEFT: medium none; WIDTH: 1.06%" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 2px; BORDER-LEFT: medium none; WIDTH: 1.06%" valign="bottom">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; TEXT-ALIGN: left; BORDER-LEFT: medium none; WIDTH: 1.06%" valign="bottom">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; TEXT-ALIGN: right; BORDER-LEFT: medium none; WIDTH: 9.07%" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BORDER-LEFT: medium none; WIDTH: 1.06%" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 2px; BORDER-LEFT: medium none; WIDTH: 1.06%" valign="bottom">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; TEXT-ALIGN: left; BORDER-LEFT: medium none; WIDTH: 1.06%" valign="bottom">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; TEXT-ALIGN: right; BORDER-LEFT: medium none; WIDTH: 9.07%" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BORDER-LEFT: medium none; WIDTH: 1.06%" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 2px; BORDER-LEFT: medium none; WIDTH: 1.06%" valign="bottom">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; TEXT-ALIGN: right; BORDER-LEFT: medium none; WIDTH: 9.07%" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BORDER-LEFT: medium none; WIDTH: 1.06%" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 2px; BORDER-LEFT: medium none; WIDTH: 1.06%" valign="bottom">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; TEXT-ALIGN: left; BORDER-LEFT: medium none; WIDTH: 1.06%" valign="bottom">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; TEXT-ALIGN: right; BORDER-LEFT: medium none; WIDTH: 9.07%" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">150,000</div>
</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BORDER-LEFT: medium none; WIDTH: 0.99%" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(2)</div>
</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 2px; BORDER-LEFT: medium none; WIDTH: 1.06%" valign="bottom">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; TEXT-ALIGN: left; BORDER-LEFT: medium none; WIDTH: 1.06%" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; TEXT-ALIGN: right; BORDER-LEFT: medium none; WIDTH: 9.07%" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">192,000</div>
</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BORDER-LEFT: medium none; WIDTH: 1.06%" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 2px; BORDER-LEFT: medium none; WIDTH: 1.06%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; TEXT-ALIGN: left; BORDER-LEFT: medium none; WIDTH: 1.06%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; TEXT-ALIGN: right; BORDER-LEFT: medium none; WIDTH: 9.07%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BORDER-LEFT: medium none; WIDTH: 1.06%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 2px; BORDER-LEFT: medium none; WIDTH: 1.06%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; TEXT-ALIGN: left; BORDER-LEFT: medium none; WIDTH: 1.06%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; TEXT-ALIGN: right; BORDER-LEFT: medium none; WIDTH: 9.07%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BORDER-LEFT: medium none; WIDTH: 1.06%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 2px; BORDER-LEFT: medium none; WIDTH: 1.06%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; TEXT-ALIGN: left; BORDER-LEFT: medium none; WIDTH: 1.06%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; TEXT-ALIGN: right; BORDER-LEFT: medium none; WIDTH: 9.07%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BORDER-LEFT: medium none; WIDTH: 1.06%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 2px; BORDER-LEFT: medium none; WIDTH: 1.06%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; TEXT-ALIGN: right; BORDER-LEFT: medium none; WIDTH: 9.07%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BORDER-LEFT: medium none; WIDTH: 1.06%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 2px; BORDER-LEFT: medium none; WIDTH: 1.06%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; TEXT-ALIGN: left; BORDER-LEFT: medium none; WIDTH: 1.06%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; TEXT-ALIGN: right; BORDER-LEFT: medium none; WIDTH: 9.07%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">2,000,000</div>
</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BORDER-LEFT: medium none; WIDTH: 0.99%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(3)</div>
</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 2px; BORDER-LEFT: medium none; WIDTH: 1.06%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; TEXT-ALIGN: left; BORDER-LEFT: medium none; WIDTH: 1.06%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; TEXT-ALIGN: right; BORDER-LEFT: medium none; WIDTH: 9.07%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">2,560,000</div>
</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BORDER-LEFT: medium none; WIDTH: 1.06%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: top; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 2px; BORDER-LEFT: medium none; WIDTH: 28.06%; BACKGROUND-COLOR: #cceeff" valign="bottom" rowspan="3">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Erez Egozi</div>
</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 2px; BORDER-LEFT: medium none; WIDTH: 1.06%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; TEXT-ALIGN: left; BORDER-LEFT: medium none; WIDTH: 1.06%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; TEXT-ALIGN: right; BORDER-LEFT: medium none; WIDTH: 9.07%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BORDER-LEFT: medium none; WIDTH: 1.06%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 2px; BORDER-LEFT: medium none; WIDTH: 1.06%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; TEXT-ALIGN: left; BORDER-LEFT: medium none; WIDTH: 1.06%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; TEXT-ALIGN: right; BORDER-LEFT: medium none; WIDTH: 9.07%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BORDER-LEFT: medium none; WIDTH: 1.06%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 2px; BORDER-LEFT: medium none; WIDTH: 1.06%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; TEXT-ALIGN: left; BORDER-LEFT: medium none; WIDTH: 1.06%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; TEXT-ALIGN: right; BORDER-LEFT: medium none; WIDTH: 9.07%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BORDER-LEFT: medium none; WIDTH: 1.06%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 2px; BORDER-LEFT: medium none; WIDTH: 1.06%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; TEXT-ALIGN: right; BORDER-LEFT: medium none; WIDTH: 9.07%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BORDER-LEFT: medium none; WIDTH: 1.06%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 2px; BORDER-LEFT: medium none; WIDTH: 1.06%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; TEXT-ALIGN: left; BORDER-LEFT: medium none; WIDTH: 1.06%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; TEXT-ALIGN: right; BORDER-LEFT: medium none; WIDTH: 9.07%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">9,750</div>
</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BORDER-LEFT: medium none; WIDTH: 0.99%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(5)</div>
</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 2px; BORDER-LEFT: medium none; WIDTH: 1.06%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; TEXT-ALIGN: left; BORDER-LEFT: medium none; WIDTH: 1.06%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; TEXT-ALIGN: right; BORDER-LEFT: medium none; WIDTH: 9.07%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">12,480</div>
</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BORDER-LEFT: medium none; WIDTH: 1.06%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 2px; BORDER-LEFT: medium none; WIDTH: 1.06%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; TEXT-ALIGN: left; BORDER-LEFT: medium none; WIDTH: 1.06%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; TEXT-ALIGN: right; BORDER-LEFT: medium none; WIDTH: 9.07%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BORDER-LEFT: medium none; WIDTH: 1.06%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 2px; BORDER-LEFT: medium none; WIDTH: 1.06%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; TEXT-ALIGN: left; BORDER-LEFT: medium none; WIDTH: 1.06%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; TEXT-ALIGN: right; BORDER-LEFT: medium none; WIDTH: 9.07%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BORDER-LEFT: medium none; WIDTH: 1.06%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 2px; BORDER-LEFT: medium none; WIDTH: 1.06%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; TEXT-ALIGN: left; BORDER-LEFT: medium none; WIDTH: 1.06%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; TEXT-ALIGN: right; BORDER-LEFT: medium none; WIDTH: 9.07%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BORDER-LEFT: medium none; WIDTH: 1.06%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 2px; BORDER-LEFT: medium none; WIDTH: 1.06%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; TEXT-ALIGN: right; BORDER-LEFT: medium none; WIDTH: 9.07%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BORDER-LEFT: medium none; WIDTH: 1.06%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 2px; BORDER-LEFT: medium none; WIDTH: 1.06%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; TEXT-ALIGN: left; BORDER-LEFT: medium none; WIDTH: 1.06%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; TEXT-ALIGN: right; BORDER-LEFT: medium none; WIDTH: 9.07%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">44,250</div>
</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BORDER-LEFT: medium none; WIDTH: 0.99%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(6)</div>
</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 2px; BORDER-LEFT: medium none; WIDTH: 1.06%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; TEXT-ALIGN: left; BORDER-LEFT: medium none; WIDTH: 1.06%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; TEXT-ALIGN: right; BORDER-LEFT: medium none; WIDTH: 9.07%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">56,640</div>
</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BORDER-LEFT: medium none; WIDTH: 1.06%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 2px; BORDER-LEFT: medium none; WIDTH: 1.06%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; TEXT-ALIGN: left; BORDER-LEFT: medium none; WIDTH: 1.06%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; TEXT-ALIGN: right; BORDER-LEFT: medium none; WIDTH: 9.07%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BORDER-LEFT: medium none; WIDTH: 1.06%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 2px; BORDER-LEFT: medium none; WIDTH: 1.06%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; TEXT-ALIGN: left; BORDER-LEFT: medium none; WIDTH: 1.06%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; TEXT-ALIGN: right; BORDER-LEFT: medium none; WIDTH: 9.07%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BORDER-LEFT: medium none; WIDTH: 1.06%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 2px; BORDER-LEFT: medium none; WIDTH: 1.06%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; TEXT-ALIGN: left; BORDER-LEFT: medium none; WIDTH: 1.06%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; TEXT-ALIGN: right; BORDER-LEFT: medium none; WIDTH: 9.07%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BORDER-LEFT: medium none; WIDTH: 1.06%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 2px; BORDER-LEFT: medium none; WIDTH: 1.06%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; TEXT-ALIGN: right; BORDER-LEFT: medium none; WIDTH: 9.07%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">-</div>
</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BORDER-LEFT: medium none; WIDTH: 1.06%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 2px; BORDER-LEFT: medium none; WIDTH: 1.06%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; TEXT-ALIGN: left; BORDER-LEFT: medium none; WIDTH: 1.06%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; TEXT-ALIGN: right; BORDER-LEFT: medium none; WIDTH: 9.07%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">150,000</div>
</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BORDER-LEFT: medium none; WIDTH: 0.99%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(4)</div>
</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 2px; BORDER-LEFT: medium none; WIDTH: 1.06%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; TEXT-ALIGN: left; BORDER-LEFT: medium none; WIDTH: 1.06%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; TEXT-ALIGN: right; BORDER-LEFT: medium none; WIDTH: 9.07%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">192,000</div>
</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BORDER-LEFT: medium none; WIDTH: 1.06%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>
</table>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<table id="zca0da1d42cc04af3a5388d911391f4b4" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 18pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; WIDTH: 36pt; align: right">(1)</td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">56,250 RSUs vest in 3 installments of 18,750 shares on July 5, 2017, and every three months thereafter.</div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<table id="za9061322c8e84af1a7765902e1d21026" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 18pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; WIDTH: 36pt; align: right">(2)</td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">150,000 RSUs vest in 6 installments of 25,000 shares on September 29, 2017, and every three months thereafter.</div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<table id="z0b184ea30f2e42f89fb7e2c360a718bb" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 18pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; WIDTH: 36pt; align: right">(3)</td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">2,000,000 RSUs vest as follows: 12.5% on December 21, 2017. The remaining shares vest in 14 equal installments of 125,000 shares every 3 months thereafter.</div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<table id="zebe18bea5f424bb5b7656ff3c7985469" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 18pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; WIDTH: 36pt; align: right">(4)</td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">150,000 RSUs vest as follows: 12.5% on December 21, 2017. The remaining shares vest in 14 equal installments of 9,375 shares every 3 months thereafter.</div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<table id="zcd04320f3d834bc08f1e74e54ffef6a0" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 18pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; WIDTH: 36pt; align: right">(5)</td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">7,500 RSUs vest in 3 installments of 2,500 shares on July 5, 2017 and every three months thereafter. 2,250 RSUs vest upon the achievement of certain operational and financial goals.</div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<table id="z6d5b0244fbe946a6a99504ec12d7a776" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 18pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; WIDTH: 36pt; align: right">(6)</td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">26,250 RSUs vest in 6 installments of 4,375 shares on September 29, 2017 and every three months thereafter. 18,000 RSUs vest upon the achievement of certain operational and financial goals.</div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal">59</font></div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; WIDTH: 100%; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; MARGIN-LEFT: 36pt; LINE-HEIGHT: 1.25; TEXT-INDENT: -36pt">Option Exercises and Stock Vested Table</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">The following table presents the option exercises and stock vested awards during Fiscal 2017 by our named executive officers:</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<table id="z2b13e295a53a4b01ac4ddeb4fd59ab4d" style="FONT-SIZE: 10pt; BORDER-TOP: medium none; FONT-FAMILY: 'Times New Roman', Times, serif; BORDER-RIGHT: medium none; BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; WIDTH: 85%" cellspacing="0" cellpadding="0" align="center" border="0">
<tr>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: top; PADDING-BOTTOM: 2px; BORDER-LEFT: medium none" valign="bottom">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BORDER-LEFT: medium none" valign="bottom">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 2px solid; BORDER-LEFT: medium none" valign="bottom" colspan="6">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">Stock Awards</div>
</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BORDER-LEFT: medium none" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; BORDER-LEFT: medium none">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; LINE-HEIGHT: 1.25">Name</div>
</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BORDER-LEFT: medium none" valign="bottom">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 2px solid; BORDER-LEFT: medium none" valign="bottom" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Number of Shares Acquired on Vesting (#)</div>
</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BORDER-LEFT: medium none" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BORDER-LEFT: medium none" valign="bottom">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; BORDER-LEFT: medium none" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; LINE-HEIGHT: 1.25">Value Realized on Vesting ($)</div>
</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BORDER-LEFT: medium none" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: top; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 2px; BORDER-LEFT: medium none; WIDTH: 76%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Zami Aberman</div>
</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 2px; BORDER-LEFT: medium none; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; TEXT-ALIGN: left; BORDER-LEFT: medium none; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; TEXT-ALIGN: right; BORDER-LEFT: medium none; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">243,750</div>
</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BORDER-LEFT: medium none; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 2px; BORDER-LEFT: medium none; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; TEXT-ALIGN: left; BORDER-LEFT: medium none; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; TEXT-ALIGN: right; BORDER-LEFT: medium none; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">337,250</div>
</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BORDER-LEFT: medium none; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: top; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 2px; BORDER-LEFT: medium none; WIDTH: 76%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Yaky Yanay</div>
</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 2px; BORDER-LEFT: medium none; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; TEXT-ALIGN: left; BORDER-LEFT: medium none; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; TEXT-ALIGN: right; BORDER-LEFT: medium none; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">243,750</div>
</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BORDER-LEFT: medium none; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 2px; BORDER-LEFT: medium none; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; TEXT-ALIGN: left; BORDER-LEFT: medium none; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; TEXT-ALIGN: right; BORDER-LEFT: medium none; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">337,250</div>
</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BORDER-LEFT: medium none; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: top; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 2px; BORDER-LEFT: medium none; WIDTH: 76%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Erez Egozi</div>
</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 2px; BORDER-LEFT: medium none; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; TEXT-ALIGN: left; BORDER-LEFT: medium none; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; TEXT-ALIGN: right; BORDER-LEFT: medium none; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">62,850</div>
</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BORDER-LEFT: medium none; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 2px; BORDER-LEFT: medium none; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; TEXT-ALIGN: left; BORDER-LEFT: medium none; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; TEXT-ALIGN: right; BORDER-LEFT: medium none; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">86,325</div>
</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BORDER-LEFT: medium none; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>
</table>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Long-Term Incentive Plans-Awards in Last Fiscal Year</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">We have no long-term incentive plans, other than the stock option plans described below under Item 12.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Compensation of Directors</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">The following table provides information regarding compensation earned by, awarded or paid to each person for serving as a director who is not an executive officer during Fiscal 2017:</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<table id="zebb0294c2fae409c90548ae082f06038" style="FONT-SIZE: 10pt; BORDER-TOP: medium none; FONT-FAMILY: 'Times New Roman', Times, serif; BORDER-RIGHT: medium none; BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; WIDTH: 90%" cellspacing="0" cellpadding="0" align="center" border="0">
<tr>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 2px solid; BORDER-LEFT: medium none" valign="bottom">
<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Name</div>
</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BORDER-LEFT: medium none" valign="bottom">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 2px solid; BORDER-LEFT: medium none" valign="bottom" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Fees Earned or Paid in Cash ($)</div>
</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BORDER-LEFT: medium none" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BORDER-LEFT: medium none" valign="bottom">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 2px solid; BORDER-LEFT: medium none" valign="bottom" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Stock-based </div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Awards ($) (1)</div>
</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BORDER-LEFT: medium none" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BORDER-LEFT: medium none" valign="bottom">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; BORDER-LEFT: medium none" colspan="2">
<div style="LINE-HEIGHT: 1.25"></div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; LINE-HEIGHT: 1.25">Total ($)</div>
</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BORDER-LEFT: medium none" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: top; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 2px; BORDER-LEFT: medium none; WIDTH: 64%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Mark Germain</div>
</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 2px; BORDER-LEFT: medium none; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; TEXT-ALIGN: left; BORDER-LEFT: medium none; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; TEXT-ALIGN: right; BORDER-LEFT: medium none; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">18,285</div>
</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BORDER-LEFT: medium none; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 2px; BORDER-LEFT: medium none; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; TEXT-ALIGN: left; BORDER-LEFT: medium none; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; TEXT-ALIGN: right; BORDER-LEFT: medium none; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">94,975</div>
</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BORDER-LEFT: medium none; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 2px; BORDER-LEFT: medium none; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; TEXT-ALIGN: left; BORDER-LEFT: medium none; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; TEXT-ALIGN: right; BORDER-LEFT: medium none; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">113,260</div>
</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BORDER-LEFT: medium none; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: top; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 2px; BORDER-LEFT: medium none; WIDTH: 64%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Nachum Rosman</div>
</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 2px; BORDER-LEFT: medium none; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; TEXT-ALIGN: left; BORDER-LEFT: medium none; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; TEXT-ALIGN: right; BORDER-LEFT: medium none; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">26,366</div>
</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BORDER-LEFT: medium none; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 2px; BORDER-LEFT: medium none; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; TEXT-ALIGN: left; BORDER-LEFT: medium none; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; TEXT-ALIGN: right; BORDER-LEFT: medium none; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">96,425</div>
</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BORDER-LEFT: medium none; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 2px; BORDER-LEFT: medium none; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; TEXT-ALIGN: left; BORDER-LEFT: medium none; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; TEXT-ALIGN: right; BORDER-LEFT: medium none; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">122,791</div>
</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BORDER-LEFT: medium none; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: top; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 2px; BORDER-LEFT: medium none; WIDTH: 64%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Doron Shorrer</div>
</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 2px; BORDER-LEFT: medium none; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; TEXT-ALIGN: left; BORDER-LEFT: medium none; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; TEXT-ALIGN: right; BORDER-LEFT: medium none; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">31,580</div>
</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BORDER-LEFT: medium none; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 2px; BORDER-LEFT: medium none; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; TEXT-ALIGN: left; BORDER-LEFT: medium none; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; TEXT-ALIGN: right; BORDER-LEFT: medium none; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">96,425</div>
</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BORDER-LEFT: medium none; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 2px; BORDER-LEFT: medium none; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; TEXT-ALIGN: left; BORDER-LEFT: medium none; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; TEXT-ALIGN: right; BORDER-LEFT: medium none; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">128,005</div>
</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BORDER-LEFT: medium none; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: top; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 2px; BORDER-LEFT: medium none; WIDTH: 64%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Hava Meretzki</div>
</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 2px; BORDER-LEFT: medium none; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; TEXT-ALIGN: left; BORDER-LEFT: medium none; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; TEXT-ALIGN: right; BORDER-LEFT: medium none; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">21,040</div>
</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BORDER-LEFT: medium none; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 2px; BORDER-LEFT: medium none; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; TEXT-ALIGN: left; BORDER-LEFT: medium none; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; TEXT-ALIGN: right; BORDER-LEFT: medium none; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">65,250</div>
</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BORDER-LEFT: medium none; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 2px; BORDER-LEFT: medium none; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; TEXT-ALIGN: left; BORDER-LEFT: medium none; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; TEXT-ALIGN: right; BORDER-LEFT: medium none; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">86,290</div>
</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BORDER-LEFT: medium none; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: top; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 2px; BORDER-LEFT: medium none; WIDTH: 64%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Isaac Braun</div>
</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 2px; BORDER-LEFT: medium none; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; TEXT-ALIGN: left; BORDER-LEFT: medium none; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; TEXT-ALIGN: right; BORDER-LEFT: medium none; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">23,906</div>
</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BORDER-LEFT: medium none; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 2px; BORDER-LEFT: medium none; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; TEXT-ALIGN: left; BORDER-LEFT: medium none; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; TEXT-ALIGN: right; BORDER-LEFT: medium none; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">65,250</div>
</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BORDER-LEFT: medium none; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 2px; BORDER-LEFT: medium none; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; TEXT-ALIGN: left; BORDER-LEFT: medium none; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; TEXT-ALIGN: right; BORDER-LEFT: medium none; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">89,156</div>
</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BORDER-LEFT: medium none; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: top; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 2px; BORDER-LEFT: medium none; WIDTH: 64%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Israel Ben-Yoram</div>
</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 2px; BORDER-LEFT: medium none; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; TEXT-ALIGN: left; BORDER-LEFT: medium none; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; TEXT-ALIGN: right; BORDER-LEFT: medium none; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">28,101</div>
</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BORDER-LEFT: medium none; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 2px; BORDER-LEFT: medium none; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; TEXT-ALIGN: left; BORDER-LEFT: medium none; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; TEXT-ALIGN: right; BORDER-LEFT: medium none; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">96,425</div>
</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BORDER-LEFT: medium none; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 2px; BORDER-LEFT: medium none; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; TEXT-ALIGN: left; BORDER-LEFT: medium none; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; TEXT-ALIGN: right; BORDER-LEFT: medium none; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">124,526</div>
</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BORDER-LEFT: medium none; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: top; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 2px; BORDER-LEFT: medium none; WIDTH: 64%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Moria Kwiat</div>
</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 2px; BORDER-LEFT: medium none; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; TEXT-ALIGN: left; BORDER-LEFT: medium none; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; TEXT-ALIGN: right; BORDER-LEFT: medium none; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">23,398</div>
</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BORDER-LEFT: medium none; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 2px; BORDER-LEFT: medium none; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; TEXT-ALIGN: left; BORDER-LEFT: medium none; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; TEXT-ALIGN: right; BORDER-LEFT: medium none; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">65,250</div>
</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BORDER-LEFT: medium none; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 2px; BORDER-LEFT: medium none; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; TEXT-ALIGN: left; BORDER-LEFT: medium none; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; TEXT-ALIGN: right; BORDER-LEFT: medium none; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">88,648</div>
</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BORDER-LEFT: medium none; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>
</table>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<table id="z53600719d2f241ab9f11b3389c7cf865" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 2.25pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; WIDTH: 33.75pt; align: right">(1)</td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">The fair value recognized for the stock-based awards was determined as of the grant date in accordance with ASC 718. <font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">Assumptions used in the calculations for these amounts are included in Note 2(l) to our consolidated financial statements for Fiscal 2017 included elsewhere in this Annual Report</font>.</div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">We reimburse our directors for expenses incurred in connection with attending board meetings and provide the following compensation for directors: annual compensation of $12,500; meeting participation fees of $935 per in-person meeting; and for meeting participation by telephone, $435 per meeting. The Board has determined that the dollar rate would be not less than 4.25 NIS per dollar. The directors are also entitled to two and a half percent (2.5%) in cash based on amounts received by us from non-diluting funding and strategic deals.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal">60</font></div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; WIDTH: 100%; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">During Fiscal 2017 we paid a total of $172,677 in cash to directors as compensation. This amount does not include compensation to Mr. Aberman and Mr. Yanay in his capacity as a director, which is reflected in the Summary Compensation Table for Fiscal 2017 above. As of June 30, 2017, we granted our directors (not including our Co-CEOs) 3,761,998 options, restricted shares and RSUs (not including 440,147 options that expired by June 30, 2017) of which 2,843,880 were exercisable or vested, as the case may be, as follows:</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<table id="z475330d79b6341528f4f1a15030440b3" style="FONT-SIZE: 10pt; BORDER-TOP: medium none; FONT-FAMILY: 'Times New Roman', Times, serif; BORDER-RIGHT: medium none; BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; WIDTH: 100%" cellspacing="0" cellpadding="0" align="left" border="0">
<tr>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; BORDER-LEFT: medium none" valign="bottom">
<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Name</div>
</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BORDER-LEFT: medium none" valign="bottom">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; BORDER-LEFT: medium none" valign="bottom" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">Total of Options, restricted shares and RSUs Granted</div>
</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BORDER-LEFT: medium none" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; BORDER-LEFT: medium none" valign="bottom">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; BORDER-LEFT: medium none" valign="bottom" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">Total of Options, restricted shares and RSUs exercisable and vested</div>
</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BORDER-LEFT: medium none" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 2px; BORDER-LEFT: medium none; WIDTH: 76%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Mark Germain</div>
</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 2px; BORDER-LEFT: medium none; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; TEXT-ALIGN: left; BORDER-LEFT: medium none; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; TEXT-ALIGN: right; BORDER-LEFT: medium none; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">621,208</div>
</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BORDER-LEFT: medium none; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(1)</div>
</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 2px; BORDER-LEFT: medium none; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; TEXT-ALIGN: left; BORDER-LEFT: medium none; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; TEXT-ALIGN: right; BORDER-LEFT: medium none; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">443,011</div>
</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BORDER-LEFT: medium none; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 2px; BORDER-LEFT: medium none; WIDTH: 76%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Nachum Rosman</div>
</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 2px; BORDER-LEFT: medium none; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; TEXT-ALIGN: left; BORDER-LEFT: medium none; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; TEXT-ALIGN: right; BORDER-LEFT: medium none; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">653,458</div>
</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BORDER-LEFT: medium none; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 2px; BORDER-LEFT: medium none; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; TEXT-ALIGN: left; BORDER-LEFT: medium none; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; TEXT-ALIGN: right; BORDER-LEFT: medium none; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">382,966</div>
</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BORDER-LEFT: medium none; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 2px; BORDER-LEFT: medium none; WIDTH: 76%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Doron Shorrer</div>
</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 2px; BORDER-LEFT: medium none; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; TEXT-ALIGN: left; BORDER-LEFT: medium none; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; TEXT-ALIGN: right; BORDER-LEFT: medium none; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">682,208</div>
</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BORDER-LEFT: medium none; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(2)</div>
</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 2px; BORDER-LEFT: medium none; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; TEXT-ALIGN: left; BORDER-LEFT: medium none; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; TEXT-ALIGN: right; BORDER-LEFT: medium none; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">613,958</div>
</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BORDER-LEFT: medium none; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 2px; BORDER-LEFT: medium none; WIDTH: 76%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Hava Meretzki</div>
</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 2px; BORDER-LEFT: medium none; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; TEXT-ALIGN: left; BORDER-LEFT: medium none; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; TEXT-ALIGN: right; BORDER-LEFT: medium none; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">467,708</div>
</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BORDER-LEFT: medium none; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(3)</div>
</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 2px; BORDER-LEFT: medium none; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; TEXT-ALIGN: left; BORDER-LEFT: medium none; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; TEXT-ALIGN: right; BORDER-LEFT: medium none; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">420,833</div>
</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BORDER-LEFT: medium none; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 2px; BORDER-LEFT: medium none; WIDTH: 76%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Isaac Braun</div>
</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 2px; BORDER-LEFT: medium none; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; TEXT-ALIGN: left; BORDER-LEFT: medium none; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; TEXT-ALIGN: right; BORDER-LEFT: medium none; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">467,708</div>
</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BORDER-LEFT: medium none; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(4)</div>
</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 2px; BORDER-LEFT: medium none; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; TEXT-ALIGN: left; BORDER-LEFT: medium none; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; TEXT-ALIGN: right; BORDER-LEFT: medium none; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">420,833</div>
</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BORDER-LEFT: medium none; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 2px; BORDER-LEFT: medium none; WIDTH: 76%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Israel Ben-Yoram</div>
</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 2px; BORDER-LEFT: medium none; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; TEXT-ALIGN: left; BORDER-LEFT: medium none; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; TEXT-ALIGN: right; BORDER-LEFT: medium none; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">669,708</div>
</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BORDER-LEFT: medium none; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(5)</div>
</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 2px; BORDER-LEFT: medium none; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; TEXT-ALIGN: left; BORDER-LEFT: medium none; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; TEXT-ALIGN: right; BORDER-LEFT: medium none; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">421,654</div>
</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BORDER-LEFT: medium none; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 2px; BORDER-LEFT: medium none; WIDTH: 76%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Moria Kwiat</div>
</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 2px; BORDER-LEFT: medium none; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; TEXT-ALIGN: left; BORDER-LEFT: medium none; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; TEXT-ALIGN: right; BORDER-LEFT: medium none; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">200,000</div>
</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BORDER-LEFT: medium none; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 2px; BORDER-LEFT: medium none; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; TEXT-ALIGN: left; BORDER-LEFT: medium none; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; TEXT-ALIGN: right; BORDER-LEFT: medium none; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">140,625</div>
</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BORDER-LEFT: medium none; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 2px; BORDER-LEFT: medium none; WIDTH: 76%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Total</div>
</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 2px; BORDER-LEFT: medium none; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; TEXT-ALIGN: left; BORDER-LEFT: medium none; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; TEXT-ALIGN: right; BORDER-LEFT: medium none; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; LINE-HEIGHT: 1.25">3,761,998</div>
</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BORDER-LEFT: medium none; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 2px; BORDER-LEFT: medium none; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; TEXT-ALIGN: left; BORDER-LEFT: medium none; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; TEXT-ALIGN: right; BORDER-LEFT: medium none; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; LINE-HEIGHT: 1.25">2,843,880</div>
</td>
<td style="BORDER-TOP: medium none; BORDER-RIGHT: medium none; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; BORDER-LEFT: medium none; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>
</table>

<div style="CLEAR: both; LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<table id="ze1585ccffb134488828b00023e82b492" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 7.1pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; WIDTH: 18pt; align: right">(1)</td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">Excludes 250,000 options that expired by June 30, 2017.</div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<table id="za41a08440d694b3c967a424d6ee33f16" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 7.1pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; WIDTH: 18pt; align: right">(2)</td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">Excludes 64,256 options that expired by June 30, 2017.</div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<table id="z70f168dc94a64bc69496b7c6cf3eef33" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 7.1pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; WIDTH: 18pt; align: right">(3)</td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">Excludes 42,692 options that expired by June 30, 2017.</div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<table id="zd94cd0af73a745fea81d1fcec0a54afb" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 7.1pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; WIDTH: 18pt; align: right">(4)</td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">Excludes 41,423 options that expired by June 30, 2017.</div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<table id="zc156f76f917a4055baed8a577956eca7" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 7.1pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; WIDTH: 18pt; align: right">(5)</td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">Excludes 41,776 options that expired by June 30, 2017.</div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">The vesting of directors' stock options, RSUs and restricted stock accelerates in the following circumstances: (1) termination of a director&#8217;s position by the stockholders will result in the acceleration of 100% of any unvested options, RSUs and restricted stock and (2) termination of a director&#8217;s position by resignation will result in the acceleration of 50% of any unvested options, RSUs and restricted stock.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">Other than as described in the preceding four paragraphs, we have no present formal plan for compensating our directors for their service in their capacity as directors. Directors are entitled to reimbursement for reasonable travel and other out-of-pocket expenses incurred in connection with attendance at meetings of our Board. The Board may award special remuneration to any director undertaking any special services on our behalf other than services ordinarily required of a director. Other than indicated above, no director received and/or accrued any compensation for his or her services as a director, including committee participation and/or special assignments during Fiscal 2017.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal">61</font></div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; WIDTH: 100%; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25"><a id="Item12" name="Item12"><!--Anchor--></a>Item 12. Security Ownership of Certain Beneficial Owners and Management and Related Stockholders Matters.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 35.45pt">The following table sets forth certain information, to the best knowledge and belief of the Company, as of August&#160;22, 2017 (unless provided herein otherwise), with respect to holdings of our common stock by (1) each person known by us to be the beneficial owner of more than 5% of the total number of shares of our common stock outstanding as of such date; (2) each of our directors; (3) each of our named executive officers; and (4) all of our directors and our executive officers as a group.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<table id="zd24cd3ca231e43999fa1db62335e9c21" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">Name and Address of Beneficial Owner</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 2px solid" valign="bottom" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Beneficial Number </div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">of Shares</font>(1)</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">Percentage</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr style="HEIGHT: 13px">
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-VARIANT: normal; VERTICAL-ALIGN: top; FONT-WEIGHT: normal; FONT-STYLE: normal" valign="bottom"></td>
<td style="VERTICAL-ALIGN: bottom" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: middle" valign="bottom" colspan="2">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: top" valign="bottom" colspan="2">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-VARIANT: normal; VERTICAL-ALIGN: top; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25"><u>Directors and Named Executive Officers</u></div>
</td>
<td style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: middle; BACKGROUND-COLOR: #cceeff" valign="bottom" colspan="2">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff" valign="bottom" colspan="2">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: middle; BACKGROUND-COLOR: #ffffff" valign="bottom" colspan="2">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff" valign="bottom" colspan="2">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 76%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Zami Aberman</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Co-CEO, Chairman of the Board and Director</div>
</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">2,500,948</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(2)</div>
</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">2.6</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">%</div>
</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 76%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 76%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Yaky Yanay</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Co-CEO, President and Director</div>
</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">1,691,865</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(3)</div>
</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">1.7</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">%</div>
</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 76%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 76%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Erez Egozi</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">CFO</div>
</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">85,375</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">*</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 76%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 76%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Israel Ben-Yoram</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Director</div>
</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">457,217</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(4)</div>
</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">*</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 76%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr style="HEIGHT: 32px">
<td style="VERTICAL-ALIGN: top; WIDTH: 76%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Isaac Braun</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Director</div>
</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">435,208</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(5)</div>
</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">*</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 76%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 76%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Mark Germain</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Director</div>
</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">463,199</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(6)</div>
</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">*</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 76%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 76%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Moria Kwiat</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Director</div>
</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">155,000</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">*</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 76%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 76%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Hava Meretzki</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Director</div>
</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">435,208</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(7)</div>
</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">*</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 76%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 76%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Nachum Rosman</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Director</div>
</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">403,529</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(8)</div>
</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">*</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 76%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 76%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Doron Shorrer</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Director</div>
</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">634,521</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(9)</div>
</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">*</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 76%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 76%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; BACKGROUND-COLOR: #cceeff"><u>Directors and Executive Officers as a group (10 persons)</u></font></div>
</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">7,262,070</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">(10)</div>
</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">7.5</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">%</div>
</td>
</tr>
</table>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">_________________</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">* = less than 1%</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">(1)&#160; Based on 94,044,707 shares of common stock issued and outstanding as of August 22, 2017. Except as otherwise indicated, we believe that the beneficial owners of the common stock listed above, based on information furnished by such owners, have sole investment and voting power with respect to such shares, subject to community property laws where applicable. Beneficial ownership is determined in accordance with the rules of the SEC and generally includes voting or investment power with respect to securities. Shares of common stock subject to options, warrants or right to purchase or through the conversion of a security currently exercisable or convertible, or exercisable or convertible within 60 days, are reflected in the table above and are deemed outstanding for purposes of computing the percentage ownership of the person holding such option or warrants, but are not deemed outstanding for purposes of computing the percentage ownership of any other person.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">(2)&#160; Includes options to acquire 215,000 shares.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal">62</font></div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; WIDTH: 100%; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">(3)&#160; Includes options to acquire 117,500 shares.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">(4)&#160; Includes options to acquire 25,000 shares.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">(5)&#160; Includes options to acquire 52,500 shares.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">(6)&#160; Includes options to acquire 57,500 shares.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">(7)&#160; Includes options to acquire 52,500 shares.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">(8)&#160; Includes options to acquire 63,750 shares.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">(9)&#160; Includes options to acquire 52,500 shares.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">(10)&#160; Includes options to acquire 636,250 shares.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Equity Compensation Plan Information</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 35.45pt">On November 25, 2003, our Board of Directors adopted the 2003 stock option plan.&#160; The 2003 stock option plan has expired, and we do not grant additional options under it.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 35.45pt">On November 21, 2005, our Board of Directors adopted the 2005 Plan. Under the 2005 Plan, options may be granted to our officers, directors, employees and consultants or the officers, directors, employees and consultants of our subsidiary.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 35.45pt">At our annual meeting of our stockholders held on January 21, 2009, our stockholders approved the adoption of the Amended and Restated 2005 Plan of the Company, amending the 2005 Plan in order to: (i) increase the number of shares of common stock authorized for issuance thereunder from 1,990,000 to be equal to 16% of the number of shares of common stock issued and outstanding on a fully diluted basis immediately prior to the grant of securities; (ii) allow the issuance of shares of common stock and units for such shares of common stock; and (iii) set the termination date of the 2005 Plan to December 31, 2018.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 35.45pt">In addition, at our annual meeting of our stockholders held on May 31, 2016, our stockholders approved the 2016 Equity Compensation Plan, or the 2016 Plan. Under the 2016 Plan, options, restricted stock and RSUs may be granted to our officers, directors, employees and consultants or the officers, directors, employees and consultants of our subsidiary. Under the 2016 Plan, the plan administrator is authorized to grant awards to acquire shares of Common Stock, shares of restricted stock and restricted stock units, in each calendar year, in a number not exceeding two and three-quarters percent (2.75%) of the number of shares of our Common Stock issued and outstanding on a fully diluted basis on the immediately preceding December 31.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 35.45pt">The following table summarizes certain information regarding our equity compensation plans as of June 30, 2017:</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<table id="zdaab0f27d31b4f95be3c61dc0502bcb8" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Plan Category</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid" valign="bottom" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Number of securities to be issued upon exercise of outstanding options</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid" valign="bottom" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Weighted-average exercise price of outstanding options</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid" valign="bottom" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Number of securities remaining available for future issuance under equity compensation plans (2005 and 2016 Plan)</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 64%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Equity compensation plan approved by security holders</div>
</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">992,850</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">2.57</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM-COLOR: ; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">3,648,755</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>
</table>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal">63</font></div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; WIDTH: 100%; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25"><a id="Item13" name="Item13"><!--Anchor--></a>Item 13.&#160;Certain Relationships and Related Transactions and Director Independence.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">Except for the arrangements described in Item II, no director, executive officer, principal shareholder holding at least 5% of our common shares, or any family member thereof, had any material interest, direct or indirect, in any transaction, or proposed transaction, during Fiscal 2017, in which the amount involved in the transaction exceeded or exceeds $120,000.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">The Board of Directors has determined that Doron Shorrer, Nachum Rosman and Israel Ben-Yoram are "independent" as defined by the rules of the SEC and the NASDAQ rules and regulations.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25"><a id="Item14" name="Item14"><!--Anchor--></a>Item 14.&#160;Principal Accounting Fees and Services</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">The fees for services provided by Kost Forer Gabbay &amp; Kasierer, a member of Ernst &amp; Young Global, to the Company in the last two fiscal years were as follows:</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<table id="za56edd4cd5c347f98f28d0df077b9111" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="VERTICAL-ALIGN: top; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 2px solid" valign="bottom" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Twelve months ended on June 30, 2017</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 2px solid" valign="bottom" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Twelve months ended on June 30, 2016</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: top" valign="bottom" colspan="2">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: top" valign="bottom" colspan="2">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 76%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">Audit Fees</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div>
</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">147,000</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">103,000</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 76%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">Audit-Related Fees</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div>
</td>
<td style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff" valign="bottom" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: right; LINE-HEIGHT: 1.25">None</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff" valign="bottom" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: right; LINE-HEIGHT: 1.25">None</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 76%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 76%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">Tax Fees</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div>
</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">18,283</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">8,284</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 76%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; PADDING-BOTTOM: 2px; WIDTH: 76%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">All Other Fees</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">29,706</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">16,747</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 76%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; PADDING-BOTTOM: 4px; WIDTH: 76%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">Total Fees</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">194,989</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; LINE-HEIGHT: 1.25">128,031</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>
</table>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-STYLE: italic">Audit Fees</font>. These fees were comprised of (i) professional services rendered in connection with the audit of our consolidated financial statements for our Annual Report on Form 10-K and internal control over financial reporting, (ii) the review of our quarterly consolidated financial statements for our quarterly reports on Form 10-Q, (iii) audit services provided in connection with other regulatory or statutory fillings and (iv) fees related to the offering we closed in January 2017.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-STYLE: italic">Tax Fees.</font> These fees relate to our tax compliance and tax advisory projects.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-STYLE: italic">All Other Fees</font>. These fees were comprised of fees related to assistance in preparation of IIA and Horizon 2020 applications as well as other grant applications.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">SEC rules require that before Kost Forer Gabbay &amp; Kasierer, a member of Ernst &amp; Young Global, is engaged by us to render any auditing or permitted non-audit related service, the engagement be:</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<table id="zae430bd9631d4986ab2e124ff71548fd" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; WIDTH: 36pt; align: right">1.</td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">pre-approved by our Audit Committee; or</div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<table id="z24204238b4fc43a292914c3dea5c5fbd" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; WIDTH: 36pt; align: right">2.</td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">entered into pursuant to pre-approval policies and procedures established by the Audit Committee, provided the policies and procedures are detailed as to the particular service, the Audit Committee is informed of each service, and such policies and procedures do not include delegation of the Audit Committee's responsibilities to management.</div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">The Audit Committee pre-approves all services provided by our independent registered public accounting firm. All of the above services and fees were reviewed and approved by the Audit Committee before the services were rendered.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">The Audit Committee has considered the nature and amount of fees billed by Kost Forer Gabbay &amp; Kasierer, a member of Ernst &amp; Young Global, and believes that the provision of services for activities unrelated to the audit is compatible with maintaining Kost Forer Gabbay &amp; Kasierer's independence.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal">64</font></div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; WIDTH: 100%; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25"><a id="PARTIV" name="PARTIV"><!--Anchor--></a>PART IV</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25"><a id="Item15" name="Item15"><!--Anchor--></a>Item 15.&#160;Exhibits.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<table id="zdb3762d05d2d464cb4e8cb15a3c45a4d" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; WIDTH: 36pt; align: right"><a href="http://www.sec.gov/Archives/edgar/data/1158780/000117891314001990/exhibit_4-1.htm">3.1</a></td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><a href="http://www.sec.gov/Archives/edgar/data/1158780/000117891314001990/exhibit_4-1.htm">Composite Copy of the Company&#8217;s Articles of Incorporation as amended on May 22, 2014 (incorporated by reference to Exhibit 4.1 of our Registration Statement on Form S-8 filed June 5, 2014).</a></div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<table id="z221a0c4285a74f7185706aa15131171b" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; WIDTH: 36pt; align: right"><a href="http://www.sec.gov/Archives/edgar/data/1158780/000117891317000962/exhibit_3-1.htm">3.2</a></td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><a href="http://www.sec.gov/Archives/edgar/data/1158780/000117891317000962/exhibit_3-1.htm">Amended and Restated By-laws (incorporated by reference to Exhibit 3.1 of our current report on Form 8-K filed on March 29, 2017).</a></div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<table id="zdf84d783c4a647f2936841edb775e0f2" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; WIDTH: 36pt; align: right"><a href="http://www.sec.gov/Archives/edgar/data/1158780/000117891310002631/exhibit_4-1.htm">4.1</a></td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><a href="http://www.sec.gov/Archives/edgar/data/1158780/000117891310002631/exhibit_4-1.htm">Form of Common Stock Purchase Warrant dated October 18, 2010 (incorporated by reference to Exhibit 4.1 of our current report on Form 8-K filed on October 12, 2010).</a></div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<table id="zadb9ed7f0e5440b7b03560dfab6d7dfa" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; WIDTH: 36pt; align: right"><a href="http://www.sec.gov/Archives/edgar/data/1158780/000117891311000404/exhibit_4-2.htm">4.2</a></td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><a href="http://www.sec.gov/Archives/edgar/data/1158780/000117891311000404/exhibit_4-2.htm">Form of Warrant Agreement by and between Pluristem Therapeutics Inc. and&#160;&#160;American Stock Transfer &amp; Trust Company, LLC (including the form of Warrant certificate) (incorporate by reference to Exhibit 4.2 of our quarterly report on Form 10-Q filed on February 9, 2011).</a></div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<table id="z5fdf816d9ca14c93bbed1a7e690ab80b" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; WIDTH: 36pt; align: right"><a href="http://www.sec.gov/Archives/edgar/data/1158780/000117891317000130/exhibit_4-1.htm">4.3</a></td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><a href="http://www.sec.gov/Archives/edgar/data/1158780/000117891317000130/exhibit_4-1.htm">Form of Common Stock Purchase Warrant dated January 25, 2017 (incorporated by reference to Exhibit 4.1 of our current report on Form 8-K filed on January 20, 2017).</a></div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<table id="z299ea41ed2b5422aaf47e0453066f946" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; WIDTH: 36pt; align: right"><a href="http://www.sec.gov/Archives/edgar/data/1158780/000108503706000247/consultingagt.htm">10.1</a></td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><a href="http://www.sec.gov/Archives/edgar/data/1158780/000108503706000247/consultingagt.htm">Consulting Agreement dated September 26, 2005 between Pluristem Ltd. and Rose High Tech Ltd. (incorporated by reference to Exhibit 10.25 of our quarterly report on Form 10-QSB filed February 9, 2006).+</a></div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<table id="z1373bfefe8a94c88aca81d0c82682f2b" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; WIDTH: 36pt; align: right"><a href="http://www.sec.gov/Archives/edgar/data/1158780/000117891311002580/exhibit_10-2.htm">10.2</a></td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><a href="http://www.sec.gov/Archives/edgar/data/1158780/000117891311002580/exhibit_10-2.htm">Summary of Lease Agreement dated January 22, 2003, by and between Pluristem Ltd. and MTM &#8211; Scientific Industries Center Haifa Ltd., as supplemented on December 11, 2005, June 12, 2007 and July 19, 2011 (incorporated by reference to Exhibit 10.2 of our annual report on Form 10-K filed September 12, 2011).</a></div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<table id="z47ab81d1797d4b859d68d5e7c8c6f48c" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; WIDTH: 36pt; align: right"><a href="http://www.sec.gov/Archives/edgar/data/1158780/000117891313002659/exhibit_10-3.htm">10.3</a></td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><a href="http://www.sec.gov/Archives/edgar/data/1158780/000117891313002659/exhibit_10-3.htm">Summary of Supplement to the Lease Agreement by and between Pluristem Ltd. and MTM &#8211; Scientific Industries Center Haifa Ltd dated July 31, 2012 (incorporated by reference to Exhibit 10.3 of our annual report on Form 10-K filed on September 11, 2013).</a></div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<table id="zaadd10bb70d540f28a578b8a0d371fb9" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; WIDTH: 36pt; align: right"><a href="http://www.sec.gov/Archives/edgar/data/1158780/000117891313002659/exhibit_10-4.htm">10.4</a></td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><a href="http://www.sec.gov/Archives/edgar/data/1158780/000117891313002659/exhibit_10-4.htm">Summary of Supplement to the Lease Agreement by and between Pluristem Ltd. and MTM &#8211; Scientific Industries Center Haifa Ltd dated December 31, 2012 (incorporated by reference to Exhibit 10.4 of our annual report on Form 10-K filed on September 11, 2013).</a></div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<table id="zc4a091daf88a491282c70ae7f7d4bb52" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; WIDTH: 36pt; align: right"><a href="http://www.sec.gov/Archives/edgar/data/1158780/000117891315001496/exhibit_10-1.htm">10.5</a></td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><a href="http://www.sec.gov/Archives/edgar/data/1158780/000117891315001496/exhibit_10-1.htm">Summary of Supplement to the Lease Agreement by and between Pluristem Ltd. and MTM &#8211; Scientific Industries Center Haifa Ltd dated February 3, 2015 (incorporated by reference to Exhibit 10.1 of our quarterly report on Form 10-Q filed on May 6, 2015).</a></div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<table id="zdfda4fa4216f464197fc4f71e63c88b5" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; WIDTH: 36pt; align: right"><a href="http://www.sec.gov/Archives/edgar/data/1158780/000108503707001248/ex10-1.htm">10.6</a></td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><a href="http://www.sec.gov/Archives/edgar/data/1158780/000108503707001248/ex10-1.htm">Assignment Agreement dated May 15, 2007 between Pluristem Therapeutics Inc. and each of Technion Research and Development Foundation Ltd., Shai Meretzki, Dr. Shoshana Merchav (incorporated by reference to Exhibit 10.1 of our current report on Form 8-K filed on May 24, 2007).</a></div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<table id="zb6434a8ba6114380bc9e44e7c39c5e50" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; WIDTH: 36pt; align: right"><a href="http://www.sec.gov/Archives/edgar/data/1158780/000108503707001248/ex10-2.htm">10.7</a></td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><a href="http://www.sec.gov/Archives/edgar/data/1158780/000108503707001248/ex10-2.htm">Assignment Agreement dated May 15, 2007 between Pluristem Therapeutics Inc. and Yeda Research and Development Ltd. in (incorporated by reference to Exhibit 10.2 of our current report on Form 8-K filed on May 24, 2007).</a></div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<table id="z883a601adb3940f9ae241acbcbfe3f0e" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; WIDTH: 36pt; align: right"><a href="http://www.sec.gov/Archives/edgar/data/1158780/000117891311002580/exhibit_10-5.htm">10.8^</a></td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><a href="http://www.sec.gov/Archives/edgar/data/1158780/000117891311002580/exhibit_10-5.htm">Exclusive License Agreement dated June 19, 2011, between Pluristem Ltd. and United Therapeutics Corporation (incorporated by reference to Exhibit 10.5 of our annual report on Form 10-K filed on September 12, 2011).</a></div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal">65</font></div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; WIDTH: 100%; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<table id="ze1ccd459d0a84a509231a377ac5954ef" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; WIDTH: 36pt; align: right"><a href="http://www.sec.gov/Archives/edgar/data/1158780/000117891313002659/exhibit_10-8.htm">10.9</a></td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><a href="http://www.sec.gov/Archives/edgar/data/1158780/000117891313002659/exhibit_10-8.htm">Exclusive License and Commercialization Agreement dated June 26, 2013, between Pluristem Ltd. and CHA (incorporated by reference to Exhibit 10.8 of our annual report on Form 10-K filed on September 11, 2013).</a></div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<table id="z95b5a0a390604d848a6966f760eb5fb4" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; WIDTH: 36pt; align: right"><a href="http://www.sec.gov/Archives/edgar/data/1158780/000117891311002580/exhibit_10-8.htm">10.10</a></td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><a href="http://www.sec.gov/Archives/edgar/data/1158780/000117891311002580/exhibit_10-8.htm">Summary of Directors&#8217; Ongoing Compensation. (incorporated by reference to Exhibit 10.8 of our annual report on Form 10-K filed September 12, 2011). +</a></div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<table id="z42823058321442ad92516eebbdccb59f" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; WIDTH: 36pt; align: right"><a href="http://www.sec.gov/Archives/edgar/data/1158780/000117891309000154/exhibit_10-1.htm">10.12</a></td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><a href="http://www.sec.gov/Archives/edgar/data/1158780/000117891309000154/exhibit_10-1.htm">The Amended and Restated 2005 Stock Option Plan (incorporated by reference to Exhibit 10.1 of our current report on Form 8-K filed on January 23, 2009). +</a></div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<table id="ze7391fe98b8146b499eb87213beed403" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; WIDTH: 36pt; align: right"><a href="http://www.sec.gov/Archives/edgar/data/1158780/000117891316004972/zk1618299.htm">10.13</a></td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><a href="http://www.sec.gov/Archives/edgar/data/1158780/000117891316004972/zk1618299.htm">2016 Equity Compensation Plan (incorporated by reference to our Definitive Proxy Statement on Schedule 14A filed on April 4, 2016). +</a></div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<table id="zebe01f99fb9b4db697cb919655887772" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; WIDTH: 36pt; align: right"><a href="http://www.sec.gov/Archives/edgar/data/1158780/000117891309002251/exhibit_10-4.htm">10.14</a></td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><a href="http://www.sec.gov/Archives/edgar/data/1158780/000117891309002251/exhibit_10-4.htm">Form of Stock Option Agreement under the Amended and Restated 2005 Stock Option Plan. (incorporated by reference to Exhibit 10.4 of our annual report on Form 10-K filed on September 23, 2009). +</a></div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<table id="zb9663e39f925492c87e1361f8583e951" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; WIDTH: 36pt; align: right"><a href="http://www.sec.gov/Archives/edgar/data/1158780/000117891309002251/exhibit_10-16.htm">10.15</a></td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><a href="http://www.sec.gov/Archives/edgar/data/1158780/000117891309002251/exhibit_10-16.htm">Form of Restricted Stock Agreement under the Amended and Restated 2005 Stock Option Plan. (incorporated by reference to Exhibit 10.16 of our annual report on Form 10-K filed on September 23, 2009). +</a></div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<table id="zfd9ea7876ec74639af172f29b7c087ec" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; WIDTH: 36pt; align: right"><a href="http://www.sec.gov/Archives/edgar/data/1158780/000117891309002251/exhibit_10-17.htm">10.16</a></td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><a href="http://www.sec.gov/Archives/edgar/data/1158780/000117891309002251/exhibit_10-17.htm">Form of Restricted Stock Agreement (Israeli directors and officers) under the Amended and Restated 2005 Stock Option Plan. (incorporated by reference to Exhibit 10.17 of our annual report on Form 10-K filed on September 23, 2009). +</a></div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<table id="z1ddfdd765ecb444eb67543ff410a8449" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; WIDTH: 36pt; align: right"><a href="http://www.sec.gov/Archives/edgar/data/1158780/000117891316006442/exhibit_10-17.htm">10.17</a></td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><a href="http://www.sec.gov/Archives/edgar/data/1158780/000117891316006442/exhibit_10-17.htm">Form of Stock Option Agreement under the 2016 Equity Compensation Plan (incorporated by reference to Exhibit 10.17 of our annual report on Form 10-K filed on September 7, 2016). +</a></div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<table id="zd4b5e7f844b54632ad4cf0f4e918b9bc" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; WIDTH: 36pt; align: right"><a href="http://www.sec.gov/Archives/edgar/data/1158780/000117891316006442/exhibit_10-18.htm">10.18</a></td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><a href="http://www.sec.gov/Archives/edgar/data/1158780/000117891316006442/exhibit_10-18.htm">Form of Restricted Stock Agreement under the 2016 Equity Compensation Plan (incorporated by reference to Exhibit 10.18 of our annual report on Form 10-K filed on September 7, 2016). +.</a></div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<table id="zd4064f6d26284754892317e7e826485c" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; WIDTH: 36pt; align: right"><a href="http://www.sec.gov/Archives/edgar/data/1158780/000117891316006442/exhibit_10-19.htm">10.19</a></td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><a href="http://www.sec.gov/Archives/edgar/data/1158780/000117891316006442/exhibit_10-19.htm">Form of Restricted Stock Agreement (Israeli directors and officers) under the 2016 Equity Compensation Plan (incorporated by reference to Exhibit 10.19 of our annual report on Form 10-K filed on September 7, 2016). +.</a></div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<table id="zfbeab96a7d1740adbfea76d85fc4f3e0" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; WIDTH: 36pt; align: right"><a href="http://www.sec.gov/Archives/edgar/data/1158780/000117891314002913/exhibit_10-16.htm">10.20</a></td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><a href="http://www.sec.gov/Archives/edgar/data/1158780/000117891314002913/exhibit_10-16.htm">Letter of Approval Number 37245 to Pluristem Ltd. from Israel&#8217;s Office of the Chief Scientist (translation from Hebrew) (incorporated by reference to Exhibit 10.16 of our annual report on Form 10-K filed on September 11, 2014).</a></div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<table id="z7f5f2580490f473c9ea9727a0d4baf05" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; WIDTH: 36pt; align: right"><a href="http://www.sec.gov/Archives/edgar/data/1158780/000117891314002913/exhibit_10-17.htm">10.21</a></td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><a href="http://www.sec.gov/Archives/edgar/data/1158780/000117891314002913/exhibit_10-17.htm">Letter of Approval Number 38481 to Pluristem Ltd. from Israel&#8217;s Office of the Chief Scientist (translation from Hebrew) (incorporated by reference to Exhibit 10.17 of our annual report on Form 10-K filed on September 11, 2014).</a></div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<table id="z311bdf4791d6423c8cf21c62bf6f89eb" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; WIDTH: 36pt; align: right"><a href="http://www.sec.gov/Archives/edgar/data/1158780/000117891314002913/exhibit_10-18.htm">10.22</a></td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><a href="http://www.sec.gov/Archives/edgar/data/1158780/000117891314002913/exhibit_10-18.htm">Letter of Approval Number 40100 to Pluristem Ltd. from Israel&#8217;s Office of the Chief Scientist (translation from Hebrew) (incorporated by reference to Exhibit 10.18 of our annual report on Form 10-K filed on September 11, 2014).</a></div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<table id="z15ba4bf64b494463aa964de23f74b1ac" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; WIDTH: 36pt; align: right"><a href="http://www.sec.gov/Archives/edgar/data/1158780/000117891314002913/exhibit_10-19.htm">10.23</a></td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><a href="http://www.sec.gov/Archives/edgar/data/1158780/000117891314002913/exhibit_10-19.htm">Letter of Approval Number 41702 to Pluristem Ltd. from Israel&#8217;s Office of the Chief Scientist (translation from Hebrew) (incorporated by reference to Exhibit 10.19 of our annual report on Form 10-K filed on September 11, 2014).</a></div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<table id="z242a1f7760804f91a60b3e8908e01a77" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; WIDTH: 36pt; align: right"><a href="http://www.sec.gov/Archives/edgar/data/1158780/000117891314002913/exhibit_10-20.htm">10.24</a></td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><a href="http://www.sec.gov/Archives/edgar/data/1158780/000117891314002913/exhibit_10-20.htm">Letter of Approval Number 42075 to Pluristem Ltd. from Israel&#8217;s Office of the Chief Scientist (translation from Hebrew) (incorporated by reference to Exhibit 10.20 of our annual report on Form 10-K filed on September 11, 2014).</a></div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal">66</font></div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; WIDTH: 100%; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<table id="zcf2b6141e6a943f49e859b415f24d708" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; WIDTH: 36pt; align: right"><a href="http://www.sec.gov/Archives/edgar/data/1158780/000117891314002913/exhibit_10-21.htm">10.25</a></td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><a href="http://www.sec.gov/Archives/edgar/data/1158780/000117891314002913/exhibit_10-21.htm">Letter of Approval Number 43729 to Pluristem Ltd. from Israel&#8217;s Office of the Chief Scientist (translation from Hebrew) (incorporated by reference to Exhibit 10.21 of our annual report on Form 10-K filed on September 11, 2014).</a></div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<table id="zee9eba547f2f4921b26c51e222c2986f" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; WIDTH: 36pt; align: right"><a href="http://www.sec.gov/Archives/edgar/data/1158780/000117891314002913/exhibit_10-22.htm">10.26</a></td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><a href="http://www.sec.gov/Archives/edgar/data/1158780/000117891314002913/exhibit_10-22.htm">Letter of Approval Number 44056 to Pluristem Ltd. from Israel&#8217;s Office of the Chief Scientist (translation from Hebrew) (incorporated by reference to Exhibit 10.22 of our annual report on Form 10-K filed on September 11, 2014).</a></div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<table id="z9f5f830f16e9428cb4454c8fbd8f5f37" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; WIDTH: 36pt; align: right"><a href="http://www.sec.gov/Archives/edgar/data/1158780/000117891314002913/exhibit_10-23.htm">10.27</a></td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><a href="http://www.sec.gov/Archives/edgar/data/1158780/000117891314002913/exhibit_10-23.htm">Letter of Approval Number 45703 to Pluristem Ltd. from Israel&#8217;s Office of the Chief Scientist (translation from Hebrew) (incorporated by reference to Exhibit 10.23 of our annual report on Form 10-K filed on September 11, 2014).</a></div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<table id="ze49727148e5448d3b20efabf0909b341" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; WIDTH: 36pt; align: right"><a href="http://www.sec.gov/Archives/edgar/data/1158780/000117891314002913/exhibit_10-24.htm">10.28</a></td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><a href="http://www.sec.gov/Archives/edgar/data/1158780/000117891314002913/exhibit_10-24.htm">Letter of Approval Number 46927 to Pluristem Ltd. from Israel&#8217;s Office of the Chief Scientist (translation from Hebrew) (incorporated by reference to Exhibit 10.24 of our annual report on Form 10-K filed on September 11, 2014).</a></div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<table id="zb94bfa7d506d483cb793b8d054e32bc4" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; WIDTH: 36pt; align: right"><a href="http://www.sec.gov/Archives/edgar/data/1158780/000117891314002913/exhibit_10-25.htm">10.29</a></td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><a href="http://www.sec.gov/Archives/edgar/data/1158780/000117891314002913/exhibit_10-25.htm">Letter of Approval Number 47578 to Pluristem Ltd. from Israel&#8217;s Office of the Chief Scientist (translation from Hebrew) (incorporated by reference to Exhibit 10.25 of our annual report on Form 10-K filed on September 11, 2014).</a></div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<table id="z2853bcd043e643c996e2b76b65f84415" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; WIDTH: 36pt; align: right"><a href="http://www.sec.gov/Archives/edgar/data/1158780/000117891314002913/exhibit_10-26.htm">10.30</a></td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><a href="http://www.sec.gov/Archives/edgar/data/1158780/000117891314002913/exhibit_10-26.htm">Letter of Approval Number 48070 to Pluristem Ltd. from Israel&#8217;s Office of the Chief Scientist (translation from Hebrew) (incorporated by reference to Exhibit 10.26 of our annual report on Form 10-K filed on September 11, 2014).</a></div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<table id="z08a072cf254949f2958d99282bce8b21" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; WIDTH: 36pt; align: right"><a href="http://www.sec.gov/Archives/edgar/data/1158780/000117891314002913/exhibit_10-27.htm">10.31</a></td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><a href="http://www.sec.gov/Archives/edgar/data/1158780/000117891314002913/exhibit_10-27.htm">Letter of Approval Number 49845 to Pluristem Ltd. from Israel&#8217;s Office of the Chief Scientist (translation from Hebrew) (incorporated by reference to Exhibit 10.27 of our annual report on Form 10-K filed on September 11, 2014).</a></div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<table id="z9389bf548a4c4f469e07d5782c22327b" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; WIDTH: 36pt; align: right"><a href="http://www.sec.gov/Archives/edgar/data/1158780/000117891314002913/exhibit_10-28.htm">10.32</a></td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><a href="http://www.sec.gov/Archives/edgar/data/1158780/000117891314002913/exhibit_10-28.htm">Letter of Approval Number 50435 to Pluristem Ltd. from Israel&#8217;s Office of the Chief Scientist (translation from Hebrew) (incorporated by reference to Exhibit 10.28 of our annual report on Form 10-K filed on September 11, 2014).</a></div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<table id="zeda741df5b1c4dbeb29a17765374b8ca" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; WIDTH: 36pt; align: right"><a href="http://www.sec.gov/Archives/edgar/data/1158780/000117891314002913/exhibit_10-29.htm">10.33</a></td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><a href="http://www.sec.gov/Archives/edgar/data/1158780/000117891314002913/exhibit_10-29.htm">Letter of Approval Number 52103 to Pluristem Ltd. from Israel&#8217;s Office of the Chief Scientist (translation from Hebrew) (incorporated by reference to Exhibit 10.29 of our annual report on Form 10-K filed on September 11, 2014).</a></div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<table id="z89774e7d694a43ecaf635f00b9a478bd" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; WIDTH: 36pt; align: right"><a href="http://www.sec.gov/Archives/edgar/data/1158780/000117891314002913/exhibit_10-30.htm">10.34</a></td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><a href="http://www.sec.gov/Archives/edgar/data/1158780/000117891314002913/exhibit_10-30.htm">Letter of Approval Number 52802 to Pluristem Ltd. from Israel&#8217;s Office of the Chief Scientist (translation from Hebrew) (incorporated by reference to Exhibit 10.30 of our annual report on Form 10-K filed on September 11, 2014).</a></div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<table id="z2c1114b60c54443da59284437a0f4167" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; WIDTH: 36pt; align: right"><a href="http://www.sec.gov/Archives/edgar/data/1158780/000117891315002818/exhibit_10-32.htm">10.35</a></td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><a href="http://www.sec.gov/Archives/edgar/data/1158780/000117891315002818/exhibit_10-32.htm">Letter of Approval Number 54516 to Pluristem Ltd. from Israel&#8217;s Office of the Chief Scientist (translation from Hebrew) (incorporated by reference to Exhibit 10.32 of our annual report on Form 10-K filed on September 9, 2015).</a></div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<table id="z2ba52436633f4ae2b37abb83f4d3138e" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; WIDTH: 36pt; align: right"><a href="http://www.sec.gov/Archives/edgar/data/1158780/000117891316006442/exhibit_10-36.htm">10.36</a></td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><a href="http://www.sec.gov/Archives/edgar/data/1158780/000117891316006442/exhibit_10-36.htm">Letter of Approval Number 56904 to Pluristem Ltd. from the Israel Innovation Authority (previously the Office of the Chief Scientist) (translation from Hebrew) (incorporated by reference to Exhibit 10.36 of our annual report on Form 10-K filed on September 7, 2016).</a></div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<table id="zd5ce5cf275f1494589576d2b2e4f3756" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; WIDTH: 36pt; align: right"><a href="http://www.sec.gov/Archives/edgar/data/1158780/000117891316006442/exhibit_10-37.htm">10.37</a></td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><a href="http://www.sec.gov/Archives/edgar/data/1158780/000117891316006442/exhibit_10-37.htm">Letter of Approval Number 57989 to Pluristem Ltd. from the Israel Innovation Authority (previously the Office of the Chief Scientist) (translation from Hebrew) (incorporated by reference to Exhibit 10.37 of our annual report on Form 10-K filed on September 7, 2016).</a></div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<table id="z75db4aa215024d519f1d1041671ed9bb" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; WIDTH: 36pt; align: right"><a href="http://www.sec.gov/Archives/edgar/data/1158780/000117891317000364/exhibit_10-2.htm">10.38</a></td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><a href="http://www.sec.gov/Archives/edgar/data/1158780/000117891317000364/exhibit_10-2.htm">Binding Term Sheet by and between Pluristem Therapeutics Inc. and Sosei Corporate Venture Capital Ltd., dated December 20, 2016 (English version only) (incorporated by reference to Exhibit 10.2 of our quarterly report on Form 10-Q filed on February 8, 2017).</a></div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal">67</font></div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; WIDTH: 100%; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<table id="z5723ee499f22444bb443d373c75e2e95" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; WIDTH: 36pt; align: right"><a href="http://www.sec.gov/Archives/edgar/data/1158780/000117891317001317/exhibit_10-1.htm">10.39</a></td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><a href="http://www.sec.gov/Archives/edgar/data/1158780/000117891317001317/exhibit_10-1.htm">Amendment No. 1 to Binding Term Sheet by and between Pluristem Therapeutics Inc. and Sosei Corporate Venture Capital Ltd., dated March 30, 2017 (English version only).&#160;(incorporated by reference to Exhibit 10.1 of our quarterly report on Form 10-Q filed on May 8, 2017)</a></div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<table id="ze75085805a9b4ea5aee96ff0c8a4b9c1" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; WIDTH: 36pt; align: right"><a href="exhibit_10-40.htm">10.40*</a></td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><a href="exhibit_10-40.htm">Amendment No. 2 to Binding Term Sheet by and between Pluristem Therapeutics Inc. and Sosei Corporate Venture Capital Ltd., dated August 15, 2017 (English version only).</a></div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<table id="zb1cbc8341ced4f7a9136a0c40cf4297d" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; WIDTH: 36pt; align: right"><a href="exhibit_10-41.htm">10.41*</a></td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><a href="exhibit_10-41.htm">Amendment to Consulting Agreement between Pluristem Ltd. and Rose High Tech Ltd. dated May 5, 2017. +</a></div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<table id="z95ebae2763ed41ab91990006ec9b88fb" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; WIDTH: 36pt; align: right"><a href="http://www.sec.gov/Archives/edgar/data/1158780/000117891317002009/exhibit_1-1.htm">10.42</a></td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><a href="http://www.sec.gov/Archives/edgar/data/1158780/000117891317002009/exhibit_1-1.htm">At Market Issuance Sales Agreement, dated July 7, 2017, by and among the Company, Oppenheimer &amp; Co. Inc., FBR Capital Markets &amp; Co. and MLV &amp; Co. LLC (incorporated by reference to Exhibit 1.1 of our current report on Form 8-K filed on July 7, 2017).</a></div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<table id="zb6de20c6594447f7ba8569d25b68d722" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; WIDTH: 36pt; align: right"><a href="http://www.sec.gov/Archives/edgar/data/1158780/000117891308002558/exhibit_21-1.htm">21.1</a></td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><a href="http://www.sec.gov/Archives/edgar/data/1158780/000117891308002558/exhibit_21-1.htm">List of Subsidiaries of the Company (incorporated by reference to Exhibit 21.1 of our annual report on Form 10-K filed on September 29, 2008).</a></div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<table id="z0d16fe7a3c5e40d682f395528fc4c472" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; WIDTH: 36pt; align: right"><a href="exhibit_23-1.htm">23.1*</a></td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><a href="exhibit_23-1.htm">Consent of Kost Forer Gabbay &amp; Kasierer, A member of Ernst &amp; Young Global.</a></div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<table id="zfee5fd0891a14339844581b844400f21" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; WIDTH: 36pt; align: right"><a href="exhibit_31-1.htm">31.1*</a></td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><a href="exhibit_31-1.htm">Certification pursuant to Rule 13a-14(a)/15d-14(a) of Zami Aberman.</a></div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<table id="z3f8f059cf010451ab3a210dd7bb43fc4" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; WIDTH: 36pt; align: right"><a href="exhibit_31-2.htm">31.2*</a></td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><a href="exhibit_31-2.htm">Certification pursuant to Rule 13a-14(a)/15d-14(a) of Yaky Yanay.</a></div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<table id="ze6d72dd271344a94878b0a0ef9888cc6" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; WIDTH: 36pt; align: right"><a href="exhibit_31-3.htm">31.3*</a></td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><a href="exhibit_31-3.htm">Certification pursuant to Rule 13a-14(a)/15d-14(a) of Erez Egozi.</a></div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<table id="zeea6891292cc4a5b98841c428b2b6961" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; WIDTH: 36pt; align: right"><a href="exhibit_32-1.htm">32.1**</a></td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><a href="exhibit_32-1.htm">Certification pursuant to 18 U.S.C. Section 1350 of Zami Aberman.</a></div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<table id="zb561e6da37e34c3aa2bfe5fdf65a29af" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; WIDTH: 36pt; align: right"><a href="exhibit_32-2.htm">32.2**</a></td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><a href="exhibit_32-2.htm">Certification pursuant to 18 U.S.C. Section 1350 of Yaky Yanay.</a></div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25"><a href="exhibit_32-3.htm">32.3**</a>&#160;&#160;&#160;&#160;<a href="exhibit_32-3.htm">Certification pursuant to 18 U.S.C. Section 1350 of Erez Egozi.</a></div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<table id="zc6e6548ca2e94286a78f8582a033f5d5" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; WIDTH: 36pt; align: right">101 *</td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">The following materials from our Annual Report on Form 10-K for the fiscal year ended June 30, 2017 formatted in XBRL (eXtensible Business Reporting Language): (i) the Consolidated Balance Sheets, (ii) the Consolidated Statements of Operations, (iii) the Consolidated Statements of Comprehensive Loss, (iv) the Statements of Changes in Equity, (v) the Consolidated Statements of Cash Flows, and (vi) the Notes to the Consolidated Financial Statements, tagged as blocks of text and in detail.</div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">* Filed herewith.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">** Furnished herewith.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">+ Management contract or compensation plan.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">^ Confidential treatment granted as to certain portions.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25"><a id="Item16" name="Item16"><!--Anchor--></a>Item 16.&#160;&#160; Form 10-K Summary.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25"><u>None.</u></div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal">68</font></div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; WIDTH: 100%; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">SIGNATURES</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Pluristem Therapeutics Inc.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">By: <font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><u>/s/ Zami Aberman</u></font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><br>
</font>Zami Aberman, Co-Chief Executive Officer<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><br>
</font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><br>
</font> Dated:&#160; September 7, 2017</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">By:<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal"> /s/ </font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><u>Yaky Yanay</u></font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><br>
</font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">Yaky Yanay</font>, Co-Chief Executive Officer and President</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Dated: September 7, 2017</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">By: <font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><u>/s/ Zami Aberman</u></font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><br>
</font>Zami Aberman, Co-Chief Executive Officer<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><br>
</font>(Principal Executive Officer)<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><br>
</font>Chairman of the Board and Director<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><br>
</font> Dated:&#160; September 7, 2017</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">By:<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">&#160;</font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><u>/s/ Yaky Yanay</u></font></div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">Yaky Yanay</font>, Co-Chief Executive Officer, President and Director<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><br>
</font>(Principal Executive Officer)<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><br>
</font> Dated: September 7, 2017</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">By:<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">&#160;</font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><u>/s/ Erez Egozi</u></font></div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">Erez Egozi</font>, Chief Financial Officer</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">(Principal Financial Officer and Principal Accounting Officer)<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><br>
</font> Dated: September 7, 2017</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><br>
</font>By: <font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><u>/s/ Israel Ben-Yoram</u></font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><br>
</font>Israel Ben-Yoram, Director<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><br>
</font> Dated: September 7, 2017</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">By:<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">&#160;</font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><u>/s/ Is</u></font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><u>aac Braun</u></font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><br>
</font>Isaac Braun, Director<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><br>
</font> Dated: September 7, 2017</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">By: <font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><u>/s/ </u></font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><u>Mark Germain</u></font></div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Mark Germain, Director<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><br>
</font> Dated: September 7, 2017</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">By: <font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><u>/s/ Moria Kwiat</u></font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><br>
</font>Moria Kwiat, Director<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><br>
</font> Dated: September 7, 2017</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">By: <font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><u>/s/ Hava Meretzki</u></font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><br>
</font>Hava Meretzki, Director<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><br>
</font> Dated: September 7, 2017</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">By: <font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><u>/s/ Nachum Rosman</u></font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><br>
</font>Nachum Rosman, Director<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><br>
</font> Dated: September 7, 2017</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">By: <font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><u>/s/ Doron Shorrer</u></font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><br>
</font>Doron Shorrer, Director<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><br>
</font> Dated: September 7, 2017</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="LINE-HEIGHT: 1.25">
<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal">69</font></div>
</div>

<div style="LINE-HEIGHT: 1.25">
<hr style="BORDER-TOP: black 1px solid; HEIGHT: 10px; BORDER-RIGHT: medium none; BORDER-BOTTOM: black 4px solid; COLOR: #ffffff; TEXT-ALIGN: center; MARGIN-LEFT: auto; BORDER-LEFT: medium none; BACKGROUND-COLOR: #ffffff; MARGIN-RIGHT: auto" align="center">
</div>
</div>

<div id="DSPFPageNumberArea" style="TEXT-ALIGN: center"><font id="DSPFPageNumber" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: normal; FONT-STYLE: normal"></font>&#160;</div>
</body>
</html>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.40
<SEQUENCE>2
<FILENAME>exhibit_10-40.htm
<DESCRIPTION>EXHIBIT 10.40
<TEXT>
<html>
<head>
<title></title>
<!--Licensed to: ZKG
    Document created using EDGARfilings PROfile 4.3.2.0
    Copyright 1995 - 2017 Summit Financial Printing, LLC.  All rights reserved.-->
</head>
<body style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif" bgcolor="#ffffff" text="#000000">
<div>
<hr style="BORDER-TOP: black 4px solid; HEIGHT: 10px; BORDER-RIGHT: medium none; BORDER-BOTTOM: black 1px solid; COLOR: #ffffff; TEXT-ALIGN: center; MARGIN-LEFT: auto; BORDER-LEFT: medium none; BACKGROUND-COLOR: #ffffff; MARGIN-RIGHT: auto" align="center">
</div>

<div>&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-VARIANT: normal; FONT-WEIGHT: bold; FONT-STYLE: normal; TEXT-ALIGN: right"><u>Exhibit 10.40</u></div>

<div><br>
</div>

<div id="DSPFPageHeader">
<div style="TEXT-ALIGN: right; LINE-HEIGHT: 1.25"><img src="plu.jpg"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: right; LINE-HEIGHT: 1.25">&#160;August 15, 2017</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">To:</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Sosei Corporate Venture Capital Ltd.</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25"><u>Attn: Mr. Peter Bains</u></div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">Re: <font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold"><u>Extension of Term Sheet Period</u></font></div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">Reference is hereby made to a certain Term Sheet dated December 19, 2016, by and between Pluristem Ltd. and Sosei Corporate Venture Capital Ltd. (the &#8220;<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold">Term Sheet</font>&#8221;).</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">Pursuant to the &#8220;Timing and Expenses&#8221; clause in the Term Sheet, the parties hereby extend the term sheet period by additional 180 days starting from July 1<sup style="vertical-align: text-top; line-height: 1; font-size: smaller">st</sup>, 2017 and ending on December 31<sup style="vertical-align: text-top; line-height: 1; font-size: smaller">st</sup>, 2017.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="LINE-HEIGHT: 1.25">
<table id="zc7fdb2b8ff244b4884c9a9ef64fdf605" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0" border="0">
<tr>
<td style="WIDTH: 51.43%">
<div>&#160;</div>
</td>
<td style="WIDTH: 48.57%">
<div style="LINE-HEIGHT: 1.25">Very truly yours,</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="LINE-HEIGHT: 1.25"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold">Pluristem</font>&#160;<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold">Ltd.</font></div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="LINE-HEIGHT: 1.25">By: <font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><u>/s/ Zami Aberman</u></font></div>

<div style="LINE-HEIGHT: 1.25">Name: Zami Aberman</div>

<div style="LINE-HEIGHT: 1.25">Title: Chairman and Co-CEO</div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">The abovementioned decision is agreed and accepted by:</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 2.2pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold">Sosei Corporate Venture Capital</font>&#160;<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold">Ltd.</font></div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 272.2pt">By: <font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><u>/s/ Peter Bains</u></font></div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 272.15pt">Name: Peter Bains</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 272.15pt">Title: CEO</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div id="DSPFPageFooter">
<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25"><img style="HEIGHT: 52px; WIDTH: 684px" src="image2.jpg"></div>

<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25">
<hr style="BORDER-TOP: black 1px solid; HEIGHT: 10px; BORDER-RIGHT: medium none; BORDER-BOTTOM: black 4px solid; COLOR: #ffffff; TEXT-ALIGN: center; MARGIN-LEFT: auto; BORDER-LEFT: medium none; BACKGROUND-COLOR: #ffffff; MARGIN-RIGHT: auto" align="center">
</div>
</div>
</body>
</html>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.41
<SEQUENCE>3
<FILENAME>exhibit_10-41.htm
<DESCRIPTION>EXHIBIT 10.41
<TEXT>
<html>
<head>
<title></title>
<!--Licensed to: ZKG
    Document created using EDGARfilings PROfile 4.3.2.0
    Copyright 1995 - 2017 Summit Financial Printing, LLC.  All rights reserved.-->
</head>
<body style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif" bgcolor="#ffffff" text="#000000">
<div><br>
<hr style="BORDER-TOP: black 4px solid; HEIGHT: 10px; BORDER-RIGHT: medium none; BORDER-BOTTOM: black 1px solid; COLOR: #ffffff; TEXT-ALIGN: center; MARGIN-LEFT: auto; BORDER-LEFT: medium none; BACKGROUND-COLOR: #ffffff; MARGIN-RIGHT: auto" align="center">
</div>

<div>&#160;</div>

<div>
<div id="DSPFPageHeader">
<div style="TEXT-ALIGN: right; LINE-HEIGHT: 1.25"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-VARIANT: normal; FONT-WEIGHT: bold; FONT-STYLE: normal"><u>Exhibit 10.41</u></font><br style="LINE-HEIGHT: 1.25">
</div>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">AMENDMENT TO CONSULTING AGREEMENT</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">This <font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold">AMENDMENT TO CONSULTING AGREEMENT</font> (this &#8220;Amendment&#8221;) is effective as of June 1, 2017 by and between Pluristem Ltd., a company incorporated under the laws of the State of Israel (the &#8220;Company&#8221;) and Rose High Tech Ltd., a company incorporated under the laws of the State of Israel (the &#8220;Consultant).&#160; Each of the Company and the Consultant shall be referred to collectively as the &#8220;Parties&#8221; and individually as a &#8220;Party.&#8221;</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><u>W</u></font>&#160;<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><u>I</u></font>&#160;<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><u>T</u></font>&#160;<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><u>N</u></font>&#160;<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><u>E</u></font>&#160;<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><u>S</u></font>&#160;<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><u>S</u></font>&#160;<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><u>E</u></font>&#160;<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><u>T</u></font>&#160;<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><u>H</u></font>:</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold">WHEREAS</font>, the Company and the Consultant entered into a consulting agreement effective November 10, 2005, which was thereafter amended (the &#8220;Original Consulting Agreement&#8221;) pursuant to which the Consultant agreed to provide certain services to the Company upon the terms and conditions contained therein; and</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold">WHEREAS</font>, the parties desire to amend certain provisions of the Original Consulting Agreement as set forth below.</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold">NOW, THEREFORE</font>, in consideration of the mutual promises and other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, each of the parties agree with the others as follows:</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">1.</font><font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; DISPLAY: inline-block; WIDTH: 36pt">&#160;</font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">Unless otherwise defined herein, all terms and conditions used in this Amendment shall have the meanings assigned to such terms in the Original Consulting Agreement.</font></div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">2.</font><font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; DISPLAY: inline-block; WIDTH: 36pt">&#160;</font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">Section 3.7 of the Original Consulting Agreement is hereby deleted in its entirety and replaced with the following:</font></div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="TEXT-ALIGN: justify; MARGIN-LEFT: 90pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 54pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">&#8220;3.7</font><font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; DISPLAY: inline-block; WIDTH: 36pt">&#160;</font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">The Company shall reimburse the Consultant for all reasonable expenses incurred with respect to the vehicle. The Company shall reimburse the Consultant for all actual maintenance, tax and insurance expenses relating to such vehicle. The Company will reimburse the Consultant for tax amounts paid by the Consultant relating to the vehicle that are required to keep the Consultant Fee unaffected. The Company shall not reimburse the Consultant for the payment of tickets or fines resulting from state and/or municipal traffic violations.&#8221;</font></div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">3.</font><font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; DISPLAY: inline-block; WIDTH: 18pt">&#160;</font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">Except as herein amended, the Original Consulting Agreement shall remain in full force and effect.</font></div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">4.</font><font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; DISPLAY: inline-block; WIDTH: 18pt">&#160;</font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><u>Further Assurances</u></font>.&#160; Each Party hereto, without additional consideration, shall cooperate, shall take such further action and shall execute and deliver such further documents as may be reasonably requested by the other Party hereto in order to carry out the provisions and purposes of this Amendment.</font></div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">5.</font><font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; DISPLAY: inline-block; WIDTH: 18pt">&#160;</font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><u>Counterparts</u></font>.&#160; This Amendment may be signed in counterparts with the same effect as if the signature on each counterpart were upon the same instrument.&#160; In the event that any signature is delivered by facsimile transmission or by e-mail delivery of a &#8220;.pdf&#8221; format data file, such signature shall create a valid and binding obligation of the party executing (or on whose behalf such signature is executed) with the same force and effect as if such facsimile or &#8220;.pdf&#8221; signature page were an original thereof.</font></div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">&#160;</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; WIDTH: 100%; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">6.</font><font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; DISPLAY: inline-block; WIDTH: 18pt">&#160;</font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><u>Headings</u></font>.&#160; The headings of Articles and Sections in this Amendment are provided for convenience only and will not affect its construction or interpretation.</font></div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">7.</font><font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; DISPLAY: inline-block; WIDTH: 18pt">&#160;</font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><u>Waiver</u></font>.&#160; Neither any failure nor any delay by any party in exercising any right, power or privilege under this Amendment or any of the documents referred to in this Amendment will operate as a waiver of such right, power or privilege, and no single or partial exercise of any such right, power or privilege will preclude any other or further exercise of such right, power or privilege.</font></div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">8.</font><font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; DISPLAY: inline-block; WIDTH: 18pt">&#160;</font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><u>Severability</u></font>.&#160; The invalidity or unenforceability of any provisions of this Amendment pursuant to any applicable law shall not affect the validity of the remaining provisions hereof, but this Amendment shall be construed as if not containing the provision held invalid or unenforceable in the jurisdiction in which so held, and the remaining provisions of this Amendment shall remain in full force and effect.&#160; If the Amendment may not be effectively construed as if not containing the provision held invalid or unenforceable, then the provision contained herein that is held invalid or unenforceable shall be reformed so that it meets such requirements as to make it valid or enforceable.<a id="_Toc109227174" name="_Toc109227174"><!--Anchor--></a></font></div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">[REMAINDER OF PAGE LEFT BLANK INTENTIONALLY]</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">&#160;</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; WIDTH: 100%; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt">IN WITNESS WHEREOF, the parties hereto have caused this Amendment to Consulting Agreement to be duly executed as of the day and year first above written.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<table id="z30afbb0c185145648c0c4a0451593c11" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; BORDER-COLLAPSE: collapse; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 50.46%">&#160;</td>
<td style="VERTICAL-ALIGN: top; WIDTH: 49.54%">
<div style="TEXT-ALIGN: left; FONT: 10pt/1.25 'Times New Roman', Times, serif"><u>Company:</u></div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Pluristem Ltd.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">By:<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-VARIANT: normal; FONT-STYLE: normal"><u><font style="FONT-WEIGHT: bold">&#160;</font>/s/ Yaky Yanay</u></font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><br>
</font>Name: Yaky Yannay<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><br>
</font>Title: Co-CEO<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><br>
</font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><br>
</font> May 5, 2017</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">By:<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-VARIANT: normal; FONT-STYLE: normal"><u><font style="FONT-WEIGHT: bold">&#160;</font>/s/ Erez Egozi</u></font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><br>
</font>Name: Erez Egozi<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><br>
</font>Title: Chief Financial Officer<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><br>
</font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><br>
</font> May 5, 2017</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: left; FONT: 10pt/1.25 'Times New Roman', Times, serif"><u>Consultant:</u></div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Rose High Tech Ltd.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">By:<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-VARIANT: normal; FONT-STYLE: normal"><u><font style="FONT-WEIGHT: bold">&#160;</font>/s/ Zami Aberman</u></font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><br>
</font>Name: Zami Aberman<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><br>
</font> Title: Chairman</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">May 5, 2017</div>
</td>
</tr>
</table>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="LINE-HEIGHT: 1.25">
<hr style="BORDER-TOP: black 1px solid; HEIGHT: 10px; BORDER-RIGHT: medium none; BORDER-BOTTOM: black 4px solid; COLOR: #ffffff; TEXT-ALIGN: center; MARGIN-LEFT: auto; BORDER-LEFT: medium none; BACKGROUND-COLOR: #ffffff; MARGIN-RIGHT: auto" align="center">
</div>
</div>
</body>
</html>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>4
<FILENAME>exhibit_23-1.htm
<DESCRIPTION>EXHIBIT 23.1
<TEXT>
<html>
<head>
<title></title>
<!--Licensed to: ZKG
    Document created using EDGARfilings PROfile 4.3.2.0
    Copyright 1995 - 2017 Summit Financial Printing, LLC.  All rights reserved.-->
</head>
<body style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif" bgcolor="#ffffff" text="#000000">
<div>
<hr style="BORDER-TOP: black 4px solid; HEIGHT: 10px; BORDER-RIGHT: medium none; BORDER-BOTTOM: black 1px solid; COLOR: #ffffff; TEXT-ALIGN: center; MARGIN-LEFT: auto; BORDER-LEFT: medium none; BACKGROUND-COLOR: #ffffff; MARGIN-RIGHT: auto" align="center">
<div style="FONT-WEIGHT: bold; TEXT-ALIGN: right; LINE-HEIGHT: 1.25"><u>Exhibit 23.1</u></div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25"><u>CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</u></div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: justify; LINE-HEIGHT: 1.25">We consent to the incorporation by reference in the Registration Statement on Form S-3 (Registration No. 333-218916) and in the related prospectus and in the Registration Statements on Form S-8 (Registration No. 333-217770, 333-212299, 333-206848, 333-196537, 333-173777 and 333-162577) of Pluristem Therapeutics Inc. of our reports dated September 7, 2017, with respect to the consolidated financial statements of Pluristem Therapeutics Inc., and the effectiveness of internal control over financial reporting of Pluristem Therapeutics Inc., included in this Annual Report (Form 10-K) for the year ended June 30, 2017.</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<table id="z3d9bd4b931fa4f0f80e3a25c19e18789" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0" border="0">
<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 47%">&#160;</td>
<td style="VERTICAL-ALIGN: top; WIDTH: 2.9%">&#160;</td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-VARIANT: normal; VERTICAL-ALIGN: top; FONT-WEIGHT: normal; FONT-STYLE: normal; WIDTH: 50%"><u> </u>

<div><u>/s/ Kost Forer Gabbay &amp; Kasierer</u></div>
</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 47%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Haifa, Israel</div>
</td>
<td style="VERTICAL-ALIGN: top; WIDTH: 2.9%">&#160;</td>
<td style="FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; WIDTH: 50%">
<div>Kost Forer Gabbay &amp; Kasierer</div>
</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 47%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">September 7, 2017</div>
</td>
<td style="VERTICAL-ALIGN: top; WIDTH: 2.9%">&#160;</td>
<td style="FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; WIDTH: 50%">
<div>A Member of Ernst &amp; Young Global</div>
</td>
</tr>
</table>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="LINE-HEIGHT: 1.25">
<hr style="BORDER-TOP: black 1px solid; HEIGHT: 10px; BORDER-RIGHT: medium none; BORDER-BOTTOM: black 4px solid; COLOR: #ffffff; TEXT-ALIGN: center; MARGIN-LEFT: auto; BORDER-LEFT: medium none; BACKGROUND-COLOR: #ffffff; MARGIN-RIGHT: auto" align="center">
</div>
</div>
</body>
</html>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>5
<FILENAME>exhibit_31-1.htm
<DESCRIPTION>EXHIBIT 31.1
<TEXT>
<html>
<head>
<title></title>
<!--Licensed to: ZKG
    Document created using EDGARfilings PROfile 4.3.2.0
    Copyright 1995 - 2017 Summit Financial Printing, LLC.  All rights reserved.-->
</head>
<body style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif" bgcolor="#ffffff" text="#000000">
<div>
<hr style="BORDER-TOP: black 4px solid; HEIGHT: 10px; BORDER-RIGHT: medium none; BORDER-BOTTOM: black 1px solid; COLOR: #ffffff; TEXT-ALIGN: center; MARGIN-LEFT: auto; BORDER-LEFT: medium none; BACKGROUND-COLOR: #ffffff; MARGIN-RIGHT: auto" align="center">
<div style="FONT-WEIGHT: bold; TEXT-ALIGN: right; LINE-HEIGHT: 1.25"><u>Exhibit 31.1</u></div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">CERTIFICATIONS</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">I, Zami Aberman, certify that:</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<table id="z6878e431c7874c428f0e653b4cb12934" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; WIDTH: 36pt; align: right">1.</td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">I have reviewed this annual report on Form 10-K for the year ended June 30, 2017, of Pluristem Therapeutics Inc.;</div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<table id="ze85fb6bfb1b948d7b1da423510b70519" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; WIDTH: 36pt; align: right">2.</td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;</div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<table id="z25e1f2fceddf486a9c32a2577c80ff8f" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; WIDTH: 36pt; align: right">3.</td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;</div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<table id="z9047a0066a7547c6a34d20b5605d3c2d" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; WIDTH: 36pt; align: right">4.</td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) and have:</div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<table id="zebe45b759bc647d88ef9f386d1fbceec" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 36pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; WIDTH: 36pt; align: right">(a)</td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;</div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<table id="z4d1d092644404a4796a1747fc4a02886" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 36pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; WIDTH: 36pt; align: right">(b)</td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;</div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<table id="z0e2d2937edd64e95a3772b96877eb1fe" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 36pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; WIDTH: 36pt; align: right">(c)</td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and</div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<table id="z30a66f0d9dbd41dab6f3642ef2f36746" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 36pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; WIDTH: 36pt; align: right">(d)</td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and</div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<table id="zb8f351cd98c84faa89567ef4eddf96bf" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; WIDTH: 36pt; align: right">5.</td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):</div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<table id="z91ca5ca3289243e4966626b546942e29" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 36pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; WIDTH: 36pt; align: right">(a)</td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and</div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<table id="z2025ee3215ee42dca0f726ffd939d49c" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 36pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; WIDTH: 36pt; align: right">(b)</td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.</div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Dated: September 7, 2017</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="LINE-HEIGHT: 1.25">
<table id="z37578157e6fc42daa0929cf54ea261a0" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0" border="0">
<tr>
<td style="WIDTH: 50%">
<div>&#160;</div>
</td>
<td style="WIDTH: 50%">
<div>
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25"><u>/s/ Zami Aberman</u></div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Zami Aberman</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Co-Chief Executive Officer</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">(Principal Executive Officer)</div>
</div>
</td>
</tr>
</table>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<hr style="BORDER-TOP: black 1px solid; HEIGHT: 10px; BORDER-RIGHT: medium none; BORDER-BOTTOM: black 4px solid; COLOR: #ffffff; TEXT-ALIGN: center; MARGIN-LEFT: auto; BORDER-LEFT: medium none; BACKGROUND-COLOR: #ffffff; MARGIN-RIGHT: auto" align="center">
</div>
</div>
</body>
</html>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>6
<FILENAME>exhibit_31-2.htm
<DESCRIPTION>EXHIBIT 31.2
<TEXT>
<html>
<head>
<title></title>
<!--Licensed to: ZKG
    Document created using EDGARfilings PROfile 4.3.2.0
    Copyright 1995 - 2017 Summit Financial Printing, LLC.  All rights reserved.-->
</head>
<body style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif" bgcolor="#ffffff" text="#000000">
<div>
<hr style="BORDER-TOP: black 4px solid; HEIGHT: 10px; BORDER-RIGHT: medium none; BORDER-BOTTOM: black 1px solid; COLOR: #ffffff; TEXT-ALIGN: center; MARGIN-LEFT: auto; BORDER-LEFT: medium none; BACKGROUND-COLOR: #ffffff; MARGIN-RIGHT: auto" align="center">
<div style="FONT-WEIGHT: bold; TEXT-ALIGN: right; LINE-HEIGHT: 1.25"><u>Exhibit 31.2</u></div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">CERTIFICATIONS</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">I, Yaky Yanay, certify that:</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<table id="zc1453847320142639445207139163c1a" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; WIDTH: 36pt; align: right">1.</td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">I have reviewed this annual report on Form 10-K for the year ended June 30, 2017, of Pluristem Therapeutics Inc.;</div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<table id="z20ebcc40e4d9409f8788fbf703b78171" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; WIDTH: 36pt; align: right">2.</td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;</div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<table id="zd115f7bf7e074390b45b70a227fcbdb4" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; WIDTH: 36pt; align: right">3.</td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;</div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<table id="z74152caa567b4a8fae1da15da9da4f9a" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; WIDTH: 35.45pt; align: right">4.</td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) and have:</div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<table id="z577d61ee1b7841448d15923737e89f49" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 36pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; WIDTH: 36pt; align: right">(a)</td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;</div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<table id="za1723b0bab854e12863cf4616d82412a" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 36pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; WIDTH: 36pt; align: right">(b)</td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;</div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<table id="ze578ca2d229e400d9b39604e319bdef5" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 36pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; WIDTH: 36pt; align: right">(c)</td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and</div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<table id="z8380071bf50a40cebcd7440d9515bb4e" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 36pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; WIDTH: 36pt; align: right">(d)</td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and</div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<table id="z90c110a99d86486e916c6e9c54bf5074" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; WIDTH: 36pt; align: right">5.</td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):</div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<table id="z32d5be17ecfb4aee9043f703a42e58f3" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 36pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; WIDTH: 36pt; align: right">(a)</td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and</div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<table id="ze8617c7de7164a308e043538bed60c3d" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 36pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; WIDTH: 36pt; align: right">(b)</td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.</div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Dated: September 7, 2017</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="LINE-HEIGHT: 1.25">
<div style="LINE-HEIGHT: 1.25">
<table id="zcad48c6ceccc4a199ba3781742a23182" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0" border="0">
<tr>
<td style="WIDTH: 50%">
<div>&#160;</div>
</td>
<td style="FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 50%">
<div>
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal"><u>/s/ Yaky Yanay</u></div>

<div>Yaky Yanay</div>

<div>Co-Chief Executive Officer, President</div>

<div>(Principal Financial Officer)</div>
</div>
</td>
</tr>
</table>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 252pt; LINE-HEIGHT: 1.25">&#160;</div>
</div>

<div style="LINE-HEIGHT: 1.25">
<hr style="BORDER-TOP: black 1px solid; HEIGHT: 10px; BORDER-RIGHT: medium none; BORDER-BOTTOM: black 4px solid; COLOR: #ffffff; TEXT-ALIGN: center; MARGIN-LEFT: auto; BORDER-LEFT: medium none; BACKGROUND-COLOR: #ffffff; MARGIN-RIGHT: auto" align="center">
</div>
</div>
</body>
</html>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.3
<SEQUENCE>7
<FILENAME>exhibit_31-3.htm
<DESCRIPTION>EXHIBIT 31.3
<TEXT>
<html>
<head>
<title></title>
<!--Licensed to: ZKG
    Document created using EDGARfilings PROfile 4.3.2.0
    Copyright 1995 - 2017 Summit Financial Printing, LLC.  All rights reserved.-->
</head>
<body style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif" bgcolor="#ffffff" text="#000000">
<div>
<hr style="BORDER-TOP: black 4px solid; HEIGHT: 10px; BORDER-RIGHT: medium none; BORDER-BOTTOM: black 1px solid; COLOR: #ffffff; TEXT-ALIGN: center; MARGIN-LEFT: auto; BORDER-LEFT: medium none; BACKGROUND-COLOR: #ffffff; MARGIN-RIGHT: auto" align="center">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: right; LINE-HEIGHT: 1.25"><u>Exhibit 31.3</u></div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">CERTIFICATIONS</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">I, Erez Egozi, certify that:</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<table id="z0f694d780f624a9bb7b312965c3bef48" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; WIDTH: 36pt; align: right">1.</td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">I have reviewed this annual report on Form 10-K for the year ended June 30, 2017, of Pluristem Therapeutics Inc.;</div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<table id="z57ae15b927cd4181a3277d17c1254679" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; WIDTH: 36pt; align: right">2.</td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;</div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<table id="zb03f44b03fe3462bb5fab4b6c18aa8c1" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; WIDTH: 36pt; align: right">3.</td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;</div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<table id="z3c452748f2104b8f94e2c799fcc426e1" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; WIDTH: 35.45pt; align: right">4.</td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) and have:</div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<table id="z26219a3f510c464db5518c179369e016" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 36pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; WIDTH: 36pt; align: right">(a)</td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;</div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<table id="z884adc888f2445ada2f7249b820ced73" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 36pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; WIDTH: 36pt; align: right">(b)</td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;</div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<table id="zc3d519661f8e472288c0086a8495929b" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 36pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; WIDTH: 36pt; align: right">(c)</td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and</div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<table id="ze3d31f42193d4fdb82f04b413da38662" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 36pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; WIDTH: 36pt; align: right">(d)</td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and</div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<table id="z971bd223550a404c9d6f2bccce99a677" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; WIDTH: 36pt; align: right">5.</td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):</div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<table id="z2a9c0a0d8230490fbba8945344d821d8" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 36pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; WIDTH: 36pt; align: right">(a)</td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and</div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<table id="ze006eaa0a823449a83429d8113d5d061" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 36pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; WIDTH: 36pt; align: right">(b)</td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.</div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Dated: September 7, 2017</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="line-height: 1.25;">
<table id="z2095ac218a0042d6b9d0faa95ca7a557" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0" border="0">
<tr>
<td style="WIDTH: 50%">
<div>&#160;</div>
</td>
<td style="FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 50%">
<div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-variant: normal; font-weight: normal; font-style: normal; line-height: 1.25;"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal"><u>By: /s/ Erez Egozi</u></font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><br>
</font>Erez Egozi<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><br>
</font>Chief Financial Officer<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><br>
</font> (Principal Financial Officer)</div>
</td>
</tr>
</table>
</div>

<div id="DSPFPageHeader">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<hr style="BORDER-TOP: black 1px solid; HEIGHT: 10px; BORDER-RIGHT: medium none; BORDER-BOTTOM: black 4px solid; COLOR: #ffffff; TEXT-ALIGN: center; MARGIN-LEFT: auto; BORDER-LEFT: medium none; BACKGROUND-COLOR: #ffffff; MARGIN-RIGHT: auto" align="center">
</div>
</div>
</div>
</body>
</html>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>8
<FILENAME>exhibit_32-1.htm
<DESCRIPTION>EXHIBIT 32.1
<TEXT>
<html>
<head>
<title></title>
<!--Licensed to: ZKG
    Document created using EDGARfilings PROfile 4.3.2.0
    Copyright 1995 - 2017 Summit Financial Printing, LLC.  All rights reserved.-->
</head>
<body style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif" bgcolor="#ffffff" text="#000000">
<div>
<hr style="BORDER-TOP: black 4px solid; HEIGHT: 10px; BORDER-RIGHT: medium none; BORDER-BOTTOM: black 1px solid; COLOR: #ffffff; TEXT-ALIGN: center; MARGIN-LEFT: auto; BORDER-LEFT: medium none; BACKGROUND-COLOR: #ffffff; MARGIN-RIGHT: auto" align="center">
<div id="DSPFPageHeader" style="FONT-WEIGHT: bold">
<div style="TEXT-ALIGN: right; LINE-HEIGHT: 1.25"><u>Exhibit 32.1</u></div>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">CERTIFICATION PURSUANT TO<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><br>
</font> 18 U.S.C. SECTION 1350</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">In connection with the Annual Report on Form 10-K of Pluristem Therapeutics Inc. (the "Company") for the period ended June 30, 2017, as filed with the Securities and Exchange Commission on the date hereof (the "Report"), the undersigned, as the Co-Chief Executive Officer of the Company, hereby certifies pursuant to 18 U.S.C. Section 1350,&#160; that, to my knowledge:</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<table id="z7c3eb9733bf44369a0be6ff64abb8be1" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; WIDTH: 36pt; align: right">(1)</td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and</div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<table id="z5fd7c7aea38b4a6aa0d470c3a6dea9ba" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; WIDTH: 36pt; align: right">(2)</td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.</div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Dated: September 7, 2017</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">&#160;</div>

<div style="LINE-HEIGHT: 1.25">
<table id="zbd5acb9ce93640fca1829a93e51e7c36" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0" border="0">
<tr>
<td style="WIDTH: 50%">
<div>&#160;</div>
</td>
<td style="FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 50%">
<div style="FONT: 10pt/1.25 'Times New Roman', Times, serif">
<div style="TEXT-ALIGN: left; FONT: 10pt/1.25 'Times New Roman', Times, serif"><u>/s/ Zami Aberman</u></div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Zami Aberman</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Co-Chief Executive Officer</div>
</div>
</td>
</tr>
</table>
</div>

<div id="DSPFPageHeader">
<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="LINE-HEIGHT: 1.25">
<hr style="BORDER-TOP: black 1px solid; HEIGHT: 10px; BORDER-RIGHT: medium none; BORDER-BOTTOM: black 4px solid; COLOR: #ffffff; TEXT-ALIGN: center; MARGIN-LEFT: auto; BORDER-LEFT: medium none; BACKGROUND-COLOR: #ffffff; MARGIN-RIGHT: auto" align="center">
</div>
</div>
</div>
</body>
</html>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.2
<SEQUENCE>9
<FILENAME>exhibit_32-2.htm
<DESCRIPTION>EXHIBIT 32.2
<TEXT>
<html>
<head>
<title></title>
<!--Licensed to: ZKG
    Document created using EDGARfilings PROfile 4.3.2.0
    Copyright 1995 - 2017 Summit Financial Printing, LLC.  All rights reserved.-->
</head>
<body style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif" bgcolor="#ffffff" text="#000000">
<div>
<hr style="BORDER-TOP: black 4px solid; HEIGHT: 10px; BORDER-RIGHT: medium none; BORDER-BOTTOM: black 1px solid; COLOR: #ffffff; TEXT-ALIGN: center; MARGIN-LEFT: auto; BORDER-LEFT: medium none; BACKGROUND-COLOR: #ffffff; MARGIN-RIGHT: auto" align="center">
<div id="DSPFPageHeader" style="FONT-WEIGHT: bold">
<div style="TEXT-ALIGN: right; LINE-HEIGHT: 1.25"><u>Exhibit 32.2</u></div>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">CERTIFICATION PURSUANT TO<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><br>
</font> 18 U.S.C. SECTION 1350</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">In connection with the Annual Report on Form 10-K of Pluristem Therapeutics Inc. (the "Company") for the period ended June 30, 2017, as filed with the Securities and Exchange Commission on the date hereof (the "Report"), the undersigned, as the Co-Chief Executive Officer of the Company, hereby certifies pursuant to 18 U.S.C. Section 1350 that, to my knowledge:</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<table id="zb528e0929a794ed29de0b31505298559" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; WIDTH: 36pt; align: right">(1)</td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and</div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25">
<table id="z2d0716d7fba844c79971ee539f46796a" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; VERTICAL-ALIGN: top; WIDTH: 36pt; align: right">(2)</td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.</div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Dated: September 7, 2017</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="line-height: 1.25;">
<table id="z5fa4f9861ae14cf18dfbdeec737deb6c" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0" border="0">
<tr>
<td style="WIDTH: 50%">
<div>&#160;</div>
</td>
<td style="FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 50%">
<div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-variant: normal; font-weight: normal; font-style: normal; line-height: 1.25; text-align: left; font: 10pt/1.25 'Times New Roman', Times, serif;">
<div style="TEXT-ALIGN: left; FONT: 10pt/1.25 'Times New Roman', Times, serif"><u>/s/ Yaky Yanay</u></div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Yaky Yanay</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Co-Chief Executive Officer, President</div>
</div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<div style="LINE-HEIGHT: 1.25">
<hr style="BORDER-TOP: black 1px solid; HEIGHT: 10px; BORDER-RIGHT: medium none; BORDER-BOTTOM: black 4px solid; COLOR: #ffffff; TEXT-ALIGN: center; MARGIN-LEFT: auto; BORDER-LEFT: medium none; BACKGROUND-COLOR: #ffffff; MARGIN-RIGHT: auto" align="center">
</div>
</div>
</body>
</html>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.3
<SEQUENCE>10
<FILENAME>exhibit_32-3.htm
<DESCRIPTION>EXHIBIT 32.3
<TEXT>
<html>
<head>
<title></title>
<!--Licensed to: ZKG
    Document created using EDGARfilings PROfile 4.3.2.0
    Copyright 1995 - 2017 Summit Financial Printing, LLC.  All rights reserved.-->
</head>
<body style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif" bgcolor="#ffffff" text="#000000">
<div>
<hr style="BORDER-TOP: black 4px solid; HEIGHT: 10px; BORDER-RIGHT: medium none; BORDER-BOTTOM: black 1px solid; COLOR: #ffffff; TEXT-ALIGN: center; MARGIN-LEFT: auto; BORDER-LEFT: medium none; BACKGROUND-COLOR: #ffffff; MARGIN-RIGHT: auto" align="center">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: right; LINE-HEIGHT: 1.25"><u>Exhibit 32.3</u></div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center; LINE-HEIGHT: 1.25">CERTIFICATION PURSUANT TO<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><br>
</font> 18 U.S.C. SECTION 1350</div>

<div style="text-align: center; line-height: 1.25; font-size: 10pt; font-family: 'Times New Roman', Times, serif;">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">In connection with the Annual Report on Form 10-K of Pluristem Therapeutics Inc. (the "Company")&#160; for the period ended June 30, 2017, as filed with the Securities and Exchange Commission on the date hereof (the "Report"), the undersigned, as the Chief Financial Officer of the Company, hereby certifies pursuant to 18 U.S.C. Section 1350 that, to my knowledge:</div>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<table id="ze1a62a31348246edbdb1c6be627d07fa" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 5.15%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.8pt">1.</div>
</td>
<td style="VERTICAL-ALIGN: top; WIDTH: 94.85%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.8pt">The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and</div>
</td>
</tr>
</table>

<div style="LINE-HEIGHT: 1.25"><br style="LINE-HEIGHT: 1.25">
</div>

<table id="z64a01001c93e420694fd14a12daf7bee" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 5.16%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.8pt">2.</div>
</td>
<td style="VERTICAL-ALIGN: top; WIDTH: 94.84%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0.8pt">The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</div>
</td>
</tr>
</table>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="LINE-HEIGHT: 1.25">Date:&#160; September 7, 2017</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="LINE-HEIGHT: 1.25">
<div style="LINE-HEIGHT: 1.25">
<table id="zf403e31571ca4ee7a02f7a2212338f48" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0" border="0">
<tr>
<td style="WIDTH: 50%">
<div>&#160;</div>
</td>
<td style="FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 50%">
<div style="TEXT-ALIGN: left; FONT: 10pt/1.25 'Times New Roman', Times, serif">
<div style="TEXT-ALIGN: left; FONT: 10pt/1.25 'Times New Roman', Times, serif"><u>By: /s/ Erez Egozi</u></div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Erez Egozi</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; LINE-HEIGHT: 1.25">Chief Financial Officer</div>
</div>
</td>
</tr>
</table>
</div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="LINE-HEIGHT: 1.25">
<hr style="BORDER-TOP: black 1px solid; HEIGHT: 10px; BORDER-RIGHT: medium none; BORDER-BOTTOM: black 4px solid; COLOR: #ffffff; TEXT-ALIGN: center; MARGIN-LEFT: auto; BORDER-LEFT: medium none; BACKGROUND-COLOR: #ffffff; MARGIN-RIGHT: auto" align="center">
</div>
</div>
</div>
</body>
</html>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.INS
<SEQUENCE>11
<FILENAME>psti-20170630.xml
<DESCRIPTION>XBRL INSTANCE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoXBRL; Version: 4.19b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: http://www.novaworks.co -->
    <!-- Field: Doc-Info; Name: Source; Value: psti%2D0617 10K Steve Fix.xfr; Date: 2017%2D09%2D07T12:28:18Z -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x800B0001 -->
<xbrli:xbrl xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2014-01-31" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:us-gaap="http://fasb.org/us-gaap/2017-01-31" xmlns:us-roles="http://fasb.org/us-roles/2017-01-31" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:us-types="http://fasb.org/us-types/2017-01-31" xmlns:currency="http://xbrl.sec.gov/currency/2017-01-31" xmlns:invest="http://xbrl.sec.gov/invest/2013-01-31" xmlns:psti="http://pluristem.com/20170630">
    <link:schemaRef xlink:href="psti-20170630.xsd" xlink:type="simple" />
    <xbrli:context id="I2016-06-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="I2015-06-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2015-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-06-30_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueMeasurementsRecurringMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-06-30_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueMeasurementsRecurringMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2013-12-01to2013-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2013-12-01</xbrli:startDate>
        <xbrli:endDate>2013-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="D2016-07-01_To_2017-06-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-07-01</xbrli:startDate>
        <xbrli:endDate>2017-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="D2014-07-01_To_2015-06-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2014-07-01</xbrli:startDate>
        <xbrli:endDate>2015-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="D2014-07-01_To_2015-06-30_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2014-07-01</xbrli:startDate>
        <xbrli:endDate>2015-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="D2015-07-01_To_2016-06-30_AccumulatedOtherComprehensiveIncomeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-07-01</xbrli:startDate>
        <xbrli:endDate>2016-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="D2015-07-01_To_2016-06-30_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-07-01</xbrli:startDate>
        <xbrli:endDate>2016-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="D2015-07-01_To_2016-06-30_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-07-01</xbrli:startDate>
        <xbrli:endDate>2016-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="D2015-07-01_To_2016-06-30_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-07-01</xbrli:startDate>
        <xbrli:endDate>2016-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="D2014-07-01_To_2015-06-30_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2014-07-01</xbrli:startDate>
        <xbrli:endDate>2015-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="D2014-07-01_To_2015-06-30_AccumulatedOtherComprehensiveIncomeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2014-07-01</xbrli:startDate>
        <xbrli:endDate>2015-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="D2014-07-01_To_2015-06-30_ReceivablesFromStockholderMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ReceivablesFromStockholderMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2014-07-01</xbrli:startDate>
        <xbrli:endDate>2015-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="D2014-07-01_To_2015-06-30_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2014-07-01</xbrli:startDate>
        <xbrli:endDate>2015-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2015-07-01to2016-06-30_us-gaap_ReceivablesFromStockholderMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ReceivablesFromStockholderMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-07-01</xbrli:startDate>
        <xbrli:endDate>2016-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="D2014-10-01_To_2014-10-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2014-10-01</xbrli:startDate>
        <xbrli:endDate>2014-10-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="D2015-05-01_To_2015-05-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-05-01</xbrli:startDate>
        <xbrli:endDate>2015-05-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="D2015-02-01_To_2015-02-28">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-02-01</xbrli:startDate>
        <xbrli:endDate>2015-02-28</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="I2016-06-30_ConsultantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis">psti:ConsultantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-07-01to2017-06-30_us-gaap_RestrictedStockUnitsRSUMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-07-01</xbrli:startDate>
        <xbrli:endDate>2017-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-07-01to2017-06-30_us-gaap_EmployeeStockOptionMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-07-01</xbrli:startDate>
        <xbrli:endDate>2017-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="I2014-06-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2014-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="D2011-08-01_To_2011-08-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2011-08-01</xbrli:startDate>
        <xbrli:endDate>2011-08-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="I2016-06-30_AccumulatedNetUnrealizedInvestmentGainLossMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-06-30_us-gaap_EquitySecuritiesMember_custom_AvailableForSaleSecuritiesMaturesWithinOneYearMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="psti:MaturityDateRangeAxis">psti:AvailableForSaleSecuritiesMaturesWithinOneYearMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:MajorTypesOfDebtAndEquitySecuritiesAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-06-30_custom_GovernmentDebtSecuritiesMember_custom_AvailableForSaleSecuritiesMaturesWithinOneYearMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="psti:MaturityDateRangeAxis">psti:AvailableForSaleSecuritiesMaturesWithinOneYearMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:MajorTypesOfDebtAndEquitySecuritiesAxis">psti:GovernmentDebtSecuritiesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-06-30_us-gaap_CorporateDebtSecuritiesMember_custom_AvailableForSaleSecuritiesMaturesWithinOneYearMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="psti:MaturityDateRangeAxis">psti:AvailableForSaleSecuritiesMaturesWithinOneYearMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:MajorTypesOfDebtAndEquitySecuritiesAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="I2016-06-30_AvailableForSaleSecuritiesMaturesWithinOneYearMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="psti:MaturityDateRangeAxis">psti:AvailableForSaleSecuritiesMaturesWithinOneYearMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-06-30_custom_GovernmentDebtSecuritiesMember_custom_AvailableForSaleSecuritiesMaturesAfterOneYearThroughFiveYearsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="psti:MaturityDateRangeAxis">psti:AvailableForSaleSecuritiesMaturesAfterOneYearThroughFiveYearsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:MajorTypesOfDebtAndEquitySecuritiesAxis">psti:GovernmentDebtSecuritiesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="I2016-06-30_CorporateDebtSecuritiesMember_AvailableForSaleSecuritiesMaturesAfterOneYearThroughFiveYearsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="psti:MaturityDateRangeAxis">psti:AvailableForSaleSecuritiesMaturesAfterOneYearThroughFiveYearsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:MajorTypesOfDebtAndEquitySecuritiesAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="I2016-06-30_AvailableForSaleSecuritiesMaturesAfterOneYearThroughFiveYearsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="psti:MaturityDateRangeAxis">psti:AvailableForSaleSecuritiesMaturesAfterOneYearThroughFiveYearsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-06-30_us-gaap_CorporateDebtSecuritiesMember_custom_AvailableForSaleSecuritiesMaturesAfterFiveYearsThroughTenYearsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="psti:MaturityDateRangeAxis">psti:AvailableForSaleSecuritiesMaturesAfterFiveYearsThroughTenYearsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:MajorTypesOfDebtAndEquitySecuritiesAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="I2016-06-30_AvailableForSaleSecuritiesMaturesAfterFiveYearsThroughTenYearsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="psti:MaturityDateRangeAxis">psti:AvailableForSaleSecuritiesMaturesAfterFiveYearsThroughTenYearsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="D2015-07-01_To_2016-06-30_MaximumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MaximumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-07-01</xbrli:startDate>
        <xbrli:endDate>2016-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="D2015-07-01_To_2016-06-30_MinimumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MinimumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-07-01</xbrli:startDate>
        <xbrli:endDate>2016-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2015-07-01to2016-06-30_us-gaap_RestrictedStockUnitsRSUMember_us-gaap_ResearchAndDevelopmentExpenseMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-07-01</xbrli:startDate>
        <xbrli:endDate>2016-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="D2014-07-01_To_2015-06-30_RestrictedStockUnitsRSUMember_ResearchAndDevelopmentExpenseMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2014-07-01</xbrli:startDate>
        <xbrli:endDate>2015-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="D2014-07-01_To_2015-06-30_RestrictedStockUnitsRSUMember_GeneralAndAdministrativeExpenseMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2014-07-01</xbrli:startDate>
        <xbrli:endDate>2015-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="D2014-07-01_To_2015-06-30_RestrictedStockUnitsRSUMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2014-07-01</xbrli:startDate>
        <xbrli:endDate>2015-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="D2015-07-01_To_2016-06-30_RestrictedStockUnitsRSUMember_ResearchAndDevelopmentExpenseMember_ConsultantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis">psti:ConsultantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-07-01</xbrli:startDate>
        <xbrli:endDate>2016-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="D2014-07-01_To_2015-06-30_RestrictedStockUnitsRSUMember_ResearchAndDevelopmentExpenseMember_ConsultantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis">psti:ConsultantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2014-07-01</xbrli:startDate>
        <xbrli:endDate>2015-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="D2015-07-01_To_2016-06-30_RestrictedStockUnitsRSUMember_GeneralAndAdministrativeExpenseMember_ConsultantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis">psti:ConsultantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-07-01</xbrli:startDate>
        <xbrli:endDate>2016-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="D2014-07-01_To_2015-06-30_RestrictedStockUnitsRSUMember_GeneralAndAdministrativeExpenseMember_ConsultantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis">psti:ConsultantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2014-07-01</xbrli:startDate>
        <xbrli:endDate>2015-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="D2015-07-01_To_2016-06-30_RestrictedStockUnitsRSUMember_ConsultantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis">psti:ConsultantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-07-01</xbrli:startDate>
        <xbrli:endDate>2016-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="D2014-07-01_To_2015-06-30_RestrictedStockUnitsRSUMember_ConsultantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis">psti:ConsultantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2014-07-01</xbrli:startDate>
        <xbrli:endDate>2015-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2015-07-01to2016-06-30_us-gaap_EmployeeStockOptionMember_us-gaap_ResearchAndDevelopmentExpenseMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-07-01</xbrli:startDate>
        <xbrli:endDate>2016-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2014-07-01to2015-06-30_us-gaap_EmployeeStockOptionMember_us-gaap_ResearchAndDevelopmentExpenseMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2014-07-01</xbrli:startDate>
        <xbrli:endDate>2015-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2015-07-01to2016-06-30_us-gaap_RestrictedStockUnitsRSUMember_us-gaap_GeneralAndAdministrativeExpenseMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-07-01</xbrli:startDate>
        <xbrli:endDate>2016-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2015-07-01to2016-06-30_us-gaap_EmployeeStockOptionMember_us-gaap_GeneralAndAdministrativeExpenseMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-07-01</xbrli:startDate>
        <xbrli:endDate>2016-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2014-07-01to2015-06-30_us-gaap_EmployeeStockOptionMember_us-gaap_GeneralAndAdministrativeExpenseMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2014-07-01</xbrli:startDate>
        <xbrli:endDate>2015-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="I2016-06-30_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="I2016-06-30_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="I2016-06-30_AccumulatedOtherComprehensiveIncomeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="I2014-06-30_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2014-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="I2014-06-30_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2014-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="I2014-06-30_ReceivablesFromStockholderMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ReceivablesFromStockholderMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2014-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="I2015-06-30_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2015-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="I2015-06-30_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2015-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="I2015-06-30_AccumulatedOtherComprehensiveIncomeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2015-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="I2015-06-30_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2015-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="I2014-06-30_AccumulatedOtherComprehensiveIncomeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2014-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="I2014-06-30_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2014-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="I2016-06-30_ReceivablesFromStockholderMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ReceivablesFromStockholderMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="I2016-06-30_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="I2015-06-30_ReceivablesFromStockholderMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ReceivablesFromStockholderMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2015-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2013-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2013-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-06-30_us-gaap_OtherMachineryAndEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:OtherMachineryAndEquipmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-06-30_us-gaap_ComputerEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-06-30_us-gaap_OfficeEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:OfficeEquipmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-06-30_us-gaap_LeaseholdImprovementsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-06-30_us-gaap_VehiclesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:VehiclesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2015-07-01to2016-06-30_us-gaap_LandAndBuildingMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LandAndBuildingMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-07-01</xbrli:startDate>
        <xbrli:endDate>2016-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="C920255">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LandAndBuildingMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2014-07-01</xbrli:startDate>
        <xbrli:endDate>2015-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-07-01to2017-06-30_us-gaap_LandAndBuildingMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LandAndBuildingMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-07-01</xbrli:startDate>
        <xbrli:endDate>2017-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2015-07-01to2016-06-30_us-gaap_AutomobilesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:AutomobilesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-07-01</xbrli:startDate>
        <xbrli:endDate>2016-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="C920256">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:AutomobilesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2014-07-01</xbrli:startDate>
        <xbrli:endDate>2015-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-07-01to2017-06-30_us-gaap_AutomobilesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:AutomobilesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-07-01</xbrli:startDate>
        <xbrli:endDate>2017-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-07-01to2017-06-30_us-gaap_EmployeeStockOptionMember_us-gaap_ResearchAndDevelopmentExpenseMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-07-01</xbrli:startDate>
        <xbrli:endDate>2017-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-07-01to2017-06-30_us-gaap_EmployeeStockOptionMember_us-gaap_GeneralAndAdministrativeExpenseMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-07-01</xbrli:startDate>
        <xbrli:endDate>2017-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-07-01to2017-06-30_us-gaap_RestrictedStockUnitsRSUMember_us-gaap_ResearchAndDevelopmentExpenseMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-07-01</xbrli:startDate>
        <xbrli:endDate>2017-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-07-01to2017-06-30_us-gaap_RestrictedStockUnitsRSUMember_us-gaap_GeneralAndAdministrativeExpenseMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-07-01</xbrli:startDate>
        <xbrli:endDate>2017-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-07-01to2017-06-30_us-gaap_RestrictedStockUnitsRSUMember_us-gaap_ResearchAndDevelopmentExpenseMember_custom_ConsultantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis">psti:ConsultantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-07-01</xbrli:startDate>
        <xbrli:endDate>2017-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-07-01to2017-06-30_us-gaap_RestrictedStockUnitsRSUMember_us-gaap_GeneralAndAdministrativeExpenseMember_custom_ConsultantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis">psti:ConsultantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-07-01</xbrli:startDate>
        <xbrli:endDate>2017-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-07-01to2017-06-30_us-gaap_RestrictedStockUnitsRSUMember_custom_ConsultantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis">psti:ConsultantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-07-01</xbrli:startDate>
        <xbrli:endDate>2017-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2014-07-01to2015-06-30_custom_InvestorWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">psti:InvestorWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2014-07-01</xbrli:startDate>
        <xbrli:endDate>2015-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2014-07-01to2015-06-30_us-gaap_WarrantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2014-07-01</xbrli:startDate>
        <xbrli:endDate>2015-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2015-06-30_us-gaap_WarrantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2015-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-06-30_custom_Plan2005Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">psti:Plan2005Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-06-30_custom_Plan2016Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">psti:Plan2016Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-06-30_us-gaap_WarrantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-06-30_us-gaap_EmployeeStockOptionMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2015-07-01to2016-06-30_us-gaap_EmployeeStockOptionMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-07-01</xbrli:startDate>
        <xbrli:endDate>2016-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-06-30_us-gaap_WarrantMember_custom_ExercisePriceRangeOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">psti:ExercisePriceRangeOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-07-01to2017-06-30_us-gaap_WarrantMember_custom_ExercisePriceRangeOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">psti:ExercisePriceRangeOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-07-01</xbrli:startDate>
        <xbrli:endDate>2017-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-06-30_us-gaap_WarrantMember_custom_ExercisePriceRangeTwoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">psti:ExercisePriceRangeTwoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-07-01to2017-06-30_us-gaap_WarrantMember_custom_ExercisePriceRangeTwoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">psti:ExercisePriceRangeTwoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-07-01</xbrli:startDate>
        <xbrli:endDate>2017-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-06-30_us-gaap_WarrantMember_custom_ExercisePriceRangeThreeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">psti:ExercisePriceRangeThreeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-07-01to2017-06-30_us-gaap_WarrantMember_custom_ExercisePriceRangeThreeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">psti:ExercisePriceRangeThreeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-07-01</xbrli:startDate>
        <xbrli:endDate>2017-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-06-30_us-gaap_EmployeeStockOptionMember_custom_ExercisePriceRangeFourMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">psti:ExercisePriceRangeFourMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-07-01to2017-06-30_us-gaap_EmployeeStockOptionMember_custom_ExercisePriceRangeFourMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">psti:ExercisePriceRangeFourMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-07-01</xbrli:startDate>
        <xbrli:endDate>2017-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-06-30_us-gaap_EmployeeStockOptionMember_custom_ExercisePriceRangeFiveMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">psti:ExercisePriceRangeFiveMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-07-01to2017-06-30_us-gaap_EmployeeStockOptionMember_custom_ExercisePriceRangeFiveMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">psti:ExercisePriceRangeFiveMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-07-01</xbrli:startDate>
        <xbrli:endDate>2017-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-06-30_us-gaap_EmployeeStockOptionMember_custom_ExercisePriceRangeSixMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">psti:ExercisePriceRangeSixMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-07-01to2017-06-30_us-gaap_EmployeeStockOptionMember_custom_ExercisePriceRangeSixMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">psti:ExercisePriceRangeSixMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-07-01</xbrli:startDate>
        <xbrli:endDate>2017-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-06-30_us-gaap_EmployeeStockOptionMember_custom_ExercisePriceRangeSevenMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">psti:ExercisePriceRangeSevenMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-07-01to2017-06-30_us-gaap_EmployeeStockOptionMember_custom_ExercisePriceRangeSevenMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">psti:ExercisePriceRangeSevenMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-07-01</xbrli:startDate>
        <xbrli:endDate>2017-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-06-30_us-gaap_EmployeeStockOptionMember_custom_ExercisePriceRangeEightMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">psti:ExercisePriceRangeEightMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-07-01to2017-06-30_us-gaap_EmployeeStockOptionMember_custom_ExercisePriceRangeEightMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">psti:ExercisePriceRangeEightMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-07-01</xbrli:startDate>
        <xbrli:endDate>2017-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-06-30_us-gaap_EmployeeStockOptionMember_custom_ExercisePriceRangeNineMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">psti:ExercisePriceRangeNineMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-07-01to2017-06-30_us-gaap_EmployeeStockOptionMember_custom_ExercisePriceRangeNineMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">psti:ExercisePriceRangeNineMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-07-01</xbrli:startDate>
        <xbrli:endDate>2017-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-06-30_us-gaap_EmployeeStockOptionMember_custom_ExercisePriceRangeTenMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">psti:ExercisePriceRangeTenMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-07-01to2017-06-30_us-gaap_EmployeeStockOptionMember_custom_ExercisePriceRangeTenMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">psti:ExercisePriceRangeTenMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-07-01</xbrli:startDate>
        <xbrli:endDate>2017-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-06-30_us-gaap_EmployeeStockOptionMember_custom_ExercisePriceRangeElevenMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">psti:ExercisePriceRangeElevenMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-07-01to2017-06-30_us-gaap_EmployeeStockOptionMember_custom_ExercisePriceRangeElevenMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">psti:ExercisePriceRangeElevenMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-07-01</xbrli:startDate>
        <xbrli:endDate>2017-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-06-30_us-gaap_EmployeeStockOptionMember_custom_ExercisePriceRangeTwelveMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">psti:ExercisePriceRangeTwelveMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-07-01to2017-06-30_us-gaap_EmployeeStockOptionMember_custom_ExercisePriceRangeTwelveMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">psti:ExercisePriceRangeTwelveMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-07-01</xbrli:startDate>
        <xbrli:endDate>2017-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-06-30_us-gaap_EmployeeStockOptionMember_custom_ExercisePriceRangeThirteenMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">psti:ExercisePriceRangeThirteenMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-07-01to2017-06-30_us-gaap_EmployeeStockOptionMember_custom_ExercisePriceRangeThirteenMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">psti:ExercisePriceRangeThirteenMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-07-01</xbrli:startDate>
        <xbrli:endDate>2017-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-06-30_us-gaap_EmployeeStockOptionMember_custom_ExercisePriceRangeFourteenMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">psti:ExercisePriceRangeFourteenMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-07-01to2017-06-30_us-gaap_EmployeeStockOptionMember_custom_ExercisePriceRangeFourteenMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">psti:ExercisePriceRangeFourteenMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-07-01</xbrli:startDate>
        <xbrli:endDate>2017-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-07-01to2017-06-30_us-gaap_InternalRevenueServiceIRSMember_us-gaap_EarliestTaxYearMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:InternalRevenueServiceIRSMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TaxPeriodAxis">us-gaap:EarliestTaxYearMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-07-01</xbrli:startDate>
        <xbrli:endDate>2017-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-07-01to2017-06-30_us-gaap_InternalRevenueServiceIRSMember_us-gaap_LatestTaxYearMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:InternalRevenueServiceIRSMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TaxPeriodAxis">us-gaap:LatestTaxYearMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-07-01</xbrli:startDate>
        <xbrli:endDate>2017-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-06-30_us-gaap_IsraelTaxAuthorityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:IsraelTaxAuthorityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2014-07-01to2015-06-30_us-gaap_MinimumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MinimumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2014-07-01</xbrli:startDate>
        <xbrli:endDate>2015-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2014-07-01to2015-06-30_us-gaap_MaximumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MaximumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2014-07-01</xbrli:startDate>
        <xbrli:endDate>2015-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2015-10-01to2015-10-31_us-gaap_LandAndBuildingMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LandAndBuildingMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-10-01</xbrli:startDate>
        <xbrli:endDate>2015-10-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2013-01-01to2013-01-31_us-gaap_LandAndBuildingMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LandAndBuildingMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2013-01-01</xbrli:startDate>
        <xbrli:endDate>2013-01-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2015-02-01to2015-02-28_currency_ILS">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:CurrencyAxis">currency:ILS</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-02-01</xbrli:startDate>
        <xbrli:endDate>2015-02-28</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2015-05-01to2015-05-31_currency_ILS">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:CurrencyAxis">currency:ILS</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-05-01</xbrli:startDate>
        <xbrli:endDate>2015-05-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-08-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-08-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-06-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2015-07-01to2016-06-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-07-01</xbrli:startDate>
        <xbrli:endDate>2016-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-07-01to2017-06-30_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-07-01</xbrli:startDate>
        <xbrli:endDate>2017-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-06-30_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-07-01to2017-06-30_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-07-01</xbrli:startDate>
        <xbrli:endDate>2017-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-06-30_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-07-01to2017-06-30_us-gaap_ReceivablesFromStockholderMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ReceivablesFromStockholderMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-07-01</xbrli:startDate>
        <xbrli:endDate>2017-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-06-30_us-gaap_ReceivablesFromStockholderMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ReceivablesFromStockholderMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-07-01to2017-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-07-01</xbrli:startDate>
        <xbrli:endDate>2017-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-07-01to2017-06-30_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-07-01</xbrli:startDate>
        <xbrli:endDate>2017-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-06-30_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-07-01to2017-06-30_us-gaap_OtherMachineryAndEquipmentMember_us-gaap_MinimumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:OtherMachineryAndEquipmentMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MinimumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-07-01</xbrli:startDate>
        <xbrli:endDate>2017-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-07-01to2017-06-30_us-gaap_OtherMachineryAndEquipmentMember_us-gaap_MaximumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:OtherMachineryAndEquipmentMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MaximumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-07-01</xbrli:startDate>
        <xbrli:endDate>2017-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-07-01to2017-06-30_us-gaap_ComputerEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-07-01</xbrli:startDate>
        <xbrli:endDate>2017-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-07-01to2017-06-30_us-gaap_OfficeEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:OfficeEquipmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-07-01</xbrli:startDate>
        <xbrli:endDate>2017-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-07-01to2017-06-30_us-gaap_VehiclesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:VehiclesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-07-01</xbrli:startDate>
        <xbrli:endDate>2017-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-07-01to2017-06-30_us-gaap_LeaseholdImprovementsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-07-01</xbrli:startDate>
        <xbrli:endDate>2017-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-07-01to2017-06-30_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-07-01</xbrli:startDate>
        <xbrli:endDate>2017-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-06-30_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-06-30_custom_AvailableForSaleSecuritiesMaturesAfterFiveYearsThroughTenYearsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="psti:MaturityDateRangeAxis">psti:AvailableForSaleSecuritiesMaturesAfterFiveYearsThroughTenYearsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-06-30_custom_AvailableForSaleSecuritiesMaturesAfterFiveYearsThroughTenYearsMember_us-gaap_CorporateDebtSecuritiesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="psti:MaturityDateRangeAxis">psti:AvailableForSaleSecuritiesMaturesAfterFiveYearsThroughTenYearsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:MajorTypesOfDebtAndEquitySecuritiesAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-06-30_custom_AvailableForSaleSecuritiesMaturesAfterOneYearThroughFiveYearsMember_us-gaap_CorporateDebtSecuritiesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="psti:MaturityDateRangeAxis">psti:AvailableForSaleSecuritiesMaturesAfterOneYearThroughFiveYearsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:MajorTypesOfDebtAndEquitySecuritiesAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-06-30_custom_AvailableForSaleSecuritiesMaturesAfterOneYearThroughFiveYearsMember_custom_GovernmentDebtSecuritiesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="psti:MaturityDateRangeAxis">psti:AvailableForSaleSecuritiesMaturesAfterOneYearThroughFiveYearsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:MajorTypesOfDebtAndEquitySecuritiesAxis">psti:GovernmentDebtSecuritiesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-06-30_custom_AvailableForSaleSecuritiesMaturesAfterOneYearThroughFiveYearsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="psti:MaturityDateRangeAxis">psti:AvailableForSaleSecuritiesMaturesAfterOneYearThroughFiveYearsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-06-30_custom_AvailableForSaleSecuritiesMaturesWithinOneYearMember_us-gaap_CorporateDebtSecuritiesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="psti:MaturityDateRangeAxis">psti:AvailableForSaleSecuritiesMaturesWithinOneYearMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:MajorTypesOfDebtAndEquitySecuritiesAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-06-30_custom_AvailableForSaleSecuritiesMaturesWithinOneYearMember_custom_GovernmentDebtSecuritiesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="psti:MaturityDateRangeAxis">psti:AvailableForSaleSecuritiesMaturesWithinOneYearMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:MajorTypesOfDebtAndEquitySecuritiesAxis">psti:GovernmentDebtSecuritiesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-06-30_custom_AvailableForSaleSecuritiesMaturesWithinOneYearMember_us-gaap_EquitySecuritiesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="psti:MaturityDateRangeAxis">psti:AvailableForSaleSecuritiesMaturesWithinOneYearMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:MajorTypesOfDebtAndEquitySecuritiesAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-06-30_custom_AvailableForSaleSecuritiesMaturesWithinOneYearMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="psti:MaturityDateRangeAxis">psti:AvailableForSaleSecuritiesMaturesWithinOneYearMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-06-30_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueMeasurementsRecurringMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-06-30_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueMeasurementsRecurringMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-06-30_us-gaap_OtherMachineryAndEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:OtherMachineryAndEquipmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-06-30_us-gaap_ComputerEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-06-30_us-gaap_OfficeEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:OfficeEquipmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-06-30_us-gaap_LeaseholdImprovementsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-06-30_us-gaap_VehiclesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:VehiclesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-07-01to2017-06-30_us-gaap_MinimumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MinimumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-07-01</xbrli:startDate>
        <xbrli:endDate>2017-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-07-01to2017-06-30_us-gaap_MaximumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MaximumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-07-01</xbrli:startDate>
        <xbrli:endDate>2017-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-06-30_us-gaap_LandAndBuildingMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LandAndBuildingMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-06-30_us-gaap_AutomobilesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:AutomobilesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2015-07-01to2016-06-30_us-gaap_RestrictedStockUnitsRSUMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-07-01</xbrli:startDate>
        <xbrli:endDate>2016-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-06-30_us-gaap_RestrictedStockUnitsRSUMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-07-01to2017-06-30_custom_ConsultantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis">psti:ConsultantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-07-01</xbrli:startDate>
        <xbrli:endDate>2017-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-06-30_custom_ConsultantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis">psti:ConsultantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-06-30_us-gaap_InternalRevenueServiceIRSMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:InternalRevenueServiceIRSMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-08-01to2016-08-31_currency_EUR">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:CurrencyAxis">currency:EUR</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-08-01</xbrli:startDate>
        <xbrli:endDate>2016-08-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-08-01to2016-08-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-08-01</xbrli:startDate>
        <xbrli:endDate>2016-08-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-07-01to2017-06-30_custom_BinationalIndustrialResearchAndDevelopmentFoundationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">psti:BinationalIndustrialResearchAndDevelopmentFoundationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-07-01</xbrli:startDate>
        <xbrli:endDate>2017-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-06-30_custom_SmartMoneyGrantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">psti:SmartMoneyGrantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-07-01to2017-06-30_custom_SmartMoneyGrantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">psti:SmartMoneyGrantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-07-01</xbrli:startDate>
        <xbrli:endDate>2017-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-07-01to2017-06-30_custom_NewYorkBloodCenterIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">psti:NewYorkBloodCenterIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-07-01</xbrli:startDate>
        <xbrli:endDate>2017-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-06-30_custom_NewYorkBloodCenterIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">psti:NewYorkBloodCenterIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-02-01to2016-02-29_custom_ContractorMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis">psti:ContractorMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-02-01</xbrli:startDate>
        <xbrli:endDate>2016-02-29</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2015-10-01to2015-10-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-10-01</xbrli:startDate>
        <xbrli:endDate>2015-10-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-01-25_custom_UnderwritingAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">psti:UnderwritingAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-01-25</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-01-01to2017-01-25_custom_UnderwritingAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">psti:UnderwritingAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-01-01</xbrli:startDate>
        <xbrli:endDate>2017-01-25</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-07-01to2017-06-30_custom_EmployeesAndDirectorsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TitleOfIndividualAxis">psti:EmployeesAndDirectorsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-07-01</xbrli:startDate>
        <xbrli:endDate>2017-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-06-30_custom_EmployeesAndDirectorsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TitleOfIndividualAxis">psti:EmployeesAndDirectorsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-06-30_custom_EmployeesAndDirectorsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TitleOfIndividualAxis">psti:EmployeesAndDirectorsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-07-01to2017-06-30_custom_NonemployeesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TitleOfIndividualAxis">psti:NonemployeesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-07-01</xbrli:startDate>
        <xbrli:endDate>2017-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-06-30_custom_NonemployeesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TitleOfIndividualAxis">psti:NonemployeesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-06-30_custom_NonemployeesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TitleOfIndividualAxis">psti:NonemployeesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2014-07-01to2015-06-30_us-gaap_EmployeeStockOptionMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2014-07-01</xbrli:startDate>
        <xbrli:endDate>2015-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-07-01to2017-06-30_custom_EmployeesAndDirectorsMember_us-gaap_RestrictedStockUnitsRSUMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TitleOfIndividualAxis">psti:EmployeesAndDirectorsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-07-01</xbrli:startDate>
        <xbrli:endDate>2017-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-06-30_us-gaap_RestrictedStockUnitsRSUMember_custom_EmployeesAndDirectorsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TitleOfIndividualAxis">psti:EmployeesAndDirectorsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-06-30_us-gaap_RestrictedStockUnitsRSUMember_custom_EmployeesAndDirectorsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TitleOfIndividualAxis">psti:EmployeesAndDirectorsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-07-31_us-gaap_SubsequentEventMember_custom_SmartMoneyGrantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">psti:SmartMoneyGrantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-07-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-09-05_us-gaap_SubsequentEventMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-09-05</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-07-01to2017-09-05_us-gaap_SubsequentEventMember_custom_AtMarketIssuanceSalesAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">psti:AtMarketIssuanceSalesAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-07-01</xbrli:startDate>
        <xbrli:endDate>2017-09-05</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-07-01to2017-06-30_custom_TechnologicalPreferredEnterpriseMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">psti:TechnologicalPreferredEnterpriseMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-07-01</xbrli:startDate>
        <xbrli:endDate>2017-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-07-01to2017-06-30_custom_SpecialTechnologicalPreferredEnterpriseMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">psti:SpecialTechnologicalPreferredEnterpriseMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-07-01</xbrli:startDate>
        <xbrli:endDate>2017-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-07-01to2017-06-30_custom_PreferredEnterpriseMember_custom_DevelopmentAreaMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">psti:PreferredEnterpriseMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementGeographicalAxis">psti:DevelopmentAreaMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-07-01</xbrli:startDate>
        <xbrli:endDate>2017-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-07-01to2017-06-30_custom_PreferredEnterpriseMember_custom_RestOfCountryMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">psti:PreferredEnterpriseMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementGeographicalAxis">psti:RestOfCountryMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-07-01</xbrli:startDate>
        <xbrli:endDate>2017-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-07-01to2017-06-30_custom_TechnologicalPreferredEnterpriseMember_custom_DevelopmentAreaMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">psti:TechnologicalPreferredEnterpriseMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementGeographicalAxis">psti:DevelopmentAreaMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-07-01</xbrli:startDate>
        <xbrli:endDate>2017-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-07-01to2017-06-30_custom_PreferredEnterpriseMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">psti:PreferredEnterpriseMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-07-01</xbrli:startDate>
        <xbrli:endDate>2017-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-07-01to2017-06-30_custom_TechnologicalEnterpriseMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">psti:TechnologicalEnterpriseMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-07-01</xbrli:startDate>
        <xbrli:endDate>2017-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-07-01to2017-06-30_custom_NonemployeesMember_us-gaap_RestrictedStockUnitsRSUMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TitleOfIndividualAxis">psti:NonemployeesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-07-01</xbrli:startDate>
        <xbrli:endDate>2017-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-09-04to2017-09-05_us-gaap_SubsequentEventMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-09-04</xbrli:startDate>
        <xbrli:endDate>2017-09-05</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-09-04to2017-09-05_us-gaap_SubsequentEventMember_currency_EUR">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:CurrencyAxis">currency:EUR</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-09-04</xbrli:startDate>
        <xbrli:endDate>2017-09-05</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="usdpershare">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Pure">
      <xbrli:measure>xbrli:pure</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="ils">
      <xbrli:measure>iso4217:ILS</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="euro">
      <xbrli:measure>iso4217:EUR</xbrli:measure>
    </xbrli:unit>
    <us-gaap:MarketableSecuritiesCurrent contextRef="I2016-06-30" unitRef="USD" decimals="-3">17415000</us-gaap:MarketableSecuritiesCurrent>
    <us-gaap:MarketableSecuritiesCurrent contextRef="AsOf2016-06-30_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueMeasurementsRecurringMember" unitRef="USD" decimals="-3">11228000</us-gaap:MarketableSecuritiesCurrent>
    <us-gaap:MarketableSecuritiesCurrent contextRef="AsOf2016-06-30_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueMeasurementsRecurringMember" unitRef="USD" decimals="-3">6187000</us-gaap:MarketableSecuritiesCurrent>
    <us-gaap:MarketableSecuritiesCurrent contextRef="AsOf2017-06-30" unitRef="USD" decimals="-3">15164000</us-gaap:MarketableSecuritiesCurrent>
    <us-gaap:MarketableSecuritiesCurrent contextRef="AsOf2017-06-30_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueMeasurementsRecurringMember" unitRef="USD" decimals="-3">10523000</us-gaap:MarketableSecuritiesCurrent>
    <us-gaap:MarketableSecuritiesCurrent contextRef="AsOf2017-06-30_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueMeasurementsRecurringMember" unitRef="USD" decimals="-3">4641000</us-gaap:MarketableSecuritiesCurrent>
    <us-gaap:StockIssuedDuringPeriodSharesPurchaseOfAssets contextRef="From2013-12-01to2013-12-31" unitRef="Shares" decimals="INF">2500000</us-gaap:StockIssuedDuringPeriodSharesPurchaseOfAssets>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax contextRef="D2016-07-01_To_2017-06-30" unitRef="USD" decimals="-3">519000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax contextRef="D2014-07-01_To_2015-06-30" unitRef="USD" decimals="-3">-819000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax contextRef="D2014-07-01_To_2015-06-30_CommonStockMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax contextRef="D2015-07-01_To_2016-06-30_AccumulatedOtherComprehensiveIncomeMember" unitRef="USD" decimals="-3">-660000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax contextRef="D2015-07-01_To_2016-06-30_RetainedEarningsMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax contextRef="D2015-07-01_To_2016-06-30_CommonStockMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax contextRef="D2015-07-01_To_2016-06-30_AdditionalPaidInCapitalMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax contextRef="D2014-07-01_To_2015-06-30_AdditionalPaidInCapitalMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax contextRef="D2014-07-01_To_2015-06-30_AccumulatedOtherComprehensiveIncomeMember" unitRef="USD" decimals="-3">-819000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax contextRef="D2014-07-01_To_2015-06-30_ReceivablesFromStockholderMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax contextRef="D2014-07-01_To_2015-06-30_RetainedEarningsMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax contextRef="From2015-07-01to2016-06-30_us-gaap_ReceivablesFromStockholderMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax contextRef="From2015-07-01to2016-06-30" unitRef="USD" decimals="-3">-660000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax contextRef="From2016-07-01to2017-06-30_us-gaap_CommonStockMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax contextRef="From2016-07-01to2017-06-30_us-gaap_AdditionalPaidInCapitalMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax contextRef="From2016-07-01to2017-06-30_us-gaap_ReceivablesFromStockholderMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax contextRef="From2016-07-01to2017-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember" unitRef="USD" decimals="-3">519000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax contextRef="From2016-07-01to2017-06-30_us-gaap_RetainedEarningsMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax contextRef="From2016-07-01to2017-06-30_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember" unitRef="USD" decimals="-3">519000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:DerivativeAssetsLiabilitiesAtFairValueNet contextRef="AsOf2016-06-30_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueMeasurementsRecurringMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:DerivativeAssetsLiabilitiesAtFairValueNet contextRef="AsOf2016-06-30_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueMeasurementsRecurringMember" unitRef="USD" decimals="-3">65000</us-gaap:DerivativeAssetsLiabilitiesAtFairValueNet>
    <us-gaap:DerivativeAssetsLiabilitiesAtFairValueNet contextRef="AsOf2017-06-30_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueMeasurementsRecurringMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:DerivativeAssetsLiabilitiesAtFairValueNet contextRef="AsOf2017-06-30_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueMeasurementsRecurringMember" unitRef="USD" decimals="-3">295000</us-gaap:DerivativeAssetsLiabilitiesAtFairValueNet>
    <psti:StockIssuedDuringPeriodValuePrivatePlacement contextRef="D2014-07-01_To_2015-06-30" unitRef="USD" decimals="-3">1114000</psti:StockIssuedDuringPeriodValuePrivatePlacement>
    <psti:StockIssuedDuringPeriodValuePrivatePlacement contextRef="D2014-07-01_To_2015-06-30_CommonStockMember" unitRef="USD" id="Foot-00-0" xsi:nil="true" />
    <psti:StockIssuedDuringPeriodValuePrivatePlacement contextRef="D2015-07-01_To_2016-06-30_AccumulatedOtherComprehensiveIncomeMember" unitRef="USD" xsi:nil="true" />
    <psti:StockIssuedDuringPeriodValuePrivatePlacement contextRef="D2015-07-01_To_2016-06-30_RetainedEarningsMember" unitRef="USD" xsi:nil="true" />
    <psti:StockIssuedDuringPeriodValuePrivatePlacement contextRef="D2015-07-01_To_2016-06-30_CommonStockMember" unitRef="USD" xsi:nil="true" />
    <psti:StockIssuedDuringPeriodValuePrivatePlacement contextRef="D2015-07-01_To_2016-06-30_AdditionalPaidInCapitalMember" unitRef="USD" xsi:nil="true" />
    <psti:StockIssuedDuringPeriodValuePrivatePlacement contextRef="D2014-07-01_To_2015-06-30_AdditionalPaidInCapitalMember" unitRef="USD" decimals="-3">1904000</psti:StockIssuedDuringPeriodValuePrivatePlacement>
    <psti:StockIssuedDuringPeriodValuePrivatePlacement contextRef="D2014-07-01_To_2015-06-30_AccumulatedOtherComprehensiveIncomeMember" unitRef="USD" xsi:nil="true" />
    <psti:StockIssuedDuringPeriodValuePrivatePlacement contextRef="D2014-07-01_To_2015-06-30_ReceivablesFromStockholderMember" unitRef="USD" decimals="-3">-790000</psti:StockIssuedDuringPeriodValuePrivatePlacement>
    <psti:StockIssuedDuringPeriodValuePrivatePlacement contextRef="D2014-07-01_To_2015-06-30_RetainedEarningsMember" unitRef="USD" xsi:nil="true" />
    <psti:StockIssuedDuringPeriodValuePrivatePlacement contextRef="From2015-07-01to2016-06-30_us-gaap_ReceivablesFromStockholderMember" unitRef="USD" decimals="-3">790000</psti:StockIssuedDuringPeriodValuePrivatePlacement>
    <psti:StockIssuedDuringPeriodValuePrivatePlacement contextRef="D2014-10-01_To_2014-10-31" unitRef="USD" decimals="-3">528000</psti:StockIssuedDuringPeriodValuePrivatePlacement>
    <psti:StockIssuedDuringPeriodValuePrivatePlacement contextRef="D2015-05-01_To_2015-05-31" unitRef="USD" decimals="-3">790000</psti:StockIssuedDuringPeriodValuePrivatePlacement>
    <psti:StockIssuedDuringPeriodValuePrivatePlacement contextRef="D2015-02-01_To_2015-02-28" unitRef="USD" decimals="-3">586000</psti:StockIssuedDuringPeriodValuePrivatePlacement>
    <psti:StockIssuedDuringPeriodValuePrivatePlacement contextRef="From2015-07-01to2016-06-30" unitRef="USD" decimals="-3">790000</psti:StockIssuedDuringPeriodValuePrivatePlacement>
    <psti:StockIssuedDuringPeriodSharesPrivatePlacement contextRef="D2014-07-01_To_2015-06-30_CommonStockMember" unitRef="Shares" decimals="INF">700000</psti:StockIssuedDuringPeriodSharesPrivatePlacement>
    <psti:StockIssuedDuringPeriodSharesPrivatePlacement contextRef="D2014-10-01_To_2014-10-31" unitRef="Shares" decimals="INF">200000</psti:StockIssuedDuringPeriodSharesPrivatePlacement>
    <psti:StockIssuedDuringPeriodSharesPrivatePlacement contextRef="D2015-05-01_To_2015-05-31" unitRef="Shares" decimals="INF">300000</psti:StockIssuedDuringPeriodSharesPrivatePlacement>
    <psti:StockIssuedDuringPeriodSharesPrivatePlacement contextRef="D2015-02-01_To_2015-02-28" unitRef="Shares" decimals="INF">200000</psti:StockIssuedDuringPeriodSharesPrivatePlacement>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber contextRef="I2016-06-30_ConsultantsMember" unitRef="Shares" decimals="INF">26000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber contextRef="AsOf2017-06-30" unitRef="Shares" decimals="INF">6107401</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber contextRef="AsOf2017-06-30_custom_ConsultantsMember" unitRef="Shares" decimals="INF">42500</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber contextRef="AsOf2016-06-30_us-gaap_RestrictedStockUnitsRSUMember_custom_EmployeesAndDirectorsMember" unitRef="Shares" decimals="INF">1906619</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber contextRef="AsOf2017-06-30_us-gaap_RestrictedStockUnitsRSUMember_custom_EmployeesAndDirectorsMember" unitRef="Shares" decimals="INF">6064901</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod contextRef="From2016-07-01to2017-06-30_custom_ConsultantsMember" unitRef="Shares" decimals="INF">273557</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod contextRef="From2016-07-01to2017-06-30_custom_EmployeesAndDirectorsMember_us-gaap_RestrictedStockUnitsRSUMember" unitRef="Shares" decimals="INF">6579435</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod contextRef="From2016-07-01to2017-06-30_custom_ConsultantsMember" unitRef="Shares" decimals="INF">257057</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod contextRef="From2016-07-01to2017-06-30_custom_EmployeesAndDirectorsMember_us-gaap_RestrictedStockUnitsRSUMember" unitRef="Shares" decimals="INF">2313200</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1 contextRef="From2016-07-01to2017-06-30_us-gaap_RestrictedStockUnitsRSUMember">P4Y</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices contextRef="D2014-07-01_To_2015-06-30" unitRef="USD" decimals="-3">263000</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices contextRef="D2014-07-01_To_2015-06-30_CommonStockMember" unitRef="USD" id="Foot-00-1" xsi:nil="true" />
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices contextRef="D2015-07-01_To_2016-06-30_AccumulatedOtherComprehensiveIncomeMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices contextRef="D2015-07-01_To_2016-06-30_RetainedEarningsMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices contextRef="D2015-07-01_To_2016-06-30_CommonStockMember" unitRef="USD" id="Foot-00-2" xsi:nil="true" />
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices contextRef="D2015-07-01_To_2016-06-30_AdditionalPaidInCapitalMember" unitRef="USD" decimals="-3">39000</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices contextRef="D2014-07-01_To_2015-06-30_AdditionalPaidInCapitalMember" unitRef="USD" decimals="-3">263000</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices contextRef="D2014-07-01_To_2015-06-30_AccumulatedOtherComprehensiveIncomeMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices contextRef="D2014-07-01_To_2015-06-30_ReceivablesFromStockholderMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices contextRef="D2014-07-01_To_2015-06-30_RetainedEarningsMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices contextRef="From2015-07-01to2016-06-30_us-gaap_ReceivablesFromStockholderMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices contextRef="D2015-02-01_To_2015-02-28" unitRef="USD" decimals="-3">841000</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices contextRef="From2015-02-01to2015-02-28_currency_ILS" unitRef="ils" decimals="-3">3300000</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices contextRef="From2015-07-01to2016-06-30" unitRef="USD" decimals="-3">39000</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodSharesIssuedForServices contextRef="D2014-07-01_To_2015-06-30_CommonStockMember" unitRef="Shares" decimals="INF">100004</us-gaap:StockIssuedDuringPeriodSharesIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodSharesIssuedForServices contextRef="D2015-07-01_To_2016-06-30_CommonStockMember" unitRef="Shares" decimals="INF">90000</us-gaap:StockIssuedDuringPeriodSharesIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodSharesIssuedForServices contextRef="D2015-02-01_To_2015-02-28" unitRef="Shares" decimals="INF">100004</us-gaap:StockIssuedDuringPeriodSharesIssuedForServices>
    <us-gaap:ConstructionInProgressExpendituresIncurredButNotYetPaid contextRef="D2015-05-01_To_2015-05-31" unitRef="USD" decimals="-3">774000</us-gaap:ConstructionInProgressExpendituresIncurredButNotYetPaid>
    <us-gaap:ConstructionInProgressExpendituresIncurredButNotYetPaid contextRef="From2015-05-01to2015-05-31_currency_ILS" unitRef="ils" decimals="-3">3000000</us-gaap:ConstructionInProgressExpendituresIncurredButNotYetPaid>
    <psti:ShareBasedGoodsAndNonemployeeServicesTransactionQuantityOfSecuritiesToBeIssued contextRef="From2016-02-01to2016-02-29_custom_ContractorMember" unitRef="Shares" decimals="INF">90000</psti:ShareBasedGoodsAndNonemployeeServicesTransactionQuantityOfSecuritiesToBeIssued>
    <us-gaap:ShareBasedGoodsAndNonemployeeServicesTransactionCapitalizedCost contextRef="From2015-10-01to2015-10-31" unitRef="USD" decimals="-3">302000</us-gaap:ShareBasedGoodsAndNonemployeeServicesTransactionCapitalizedCost>
    <dei:EntityRegistrantName contextRef="D2016-07-01_To_2017-06-30">PLURISTEM THERAPEUTICS INC</dei:EntityRegistrantName>
    <dei:DocumentPeriodEndDate contextRef="D2016-07-01_To_2017-06-30">2017-06-30</dei:DocumentPeriodEndDate>
    <dei:CurrentFiscalYearEndDate contextRef="D2016-07-01_To_2017-06-30">--06-30</dei:CurrentFiscalYearEndDate>
    <dei:EntityFilerCategory contextRef="D2016-07-01_To_2017-06-30">Accelerated Filer</dei:EntityFilerCategory>
    <dei:DocumentFiscalYearFocus contextRef="D2016-07-01_To_2017-06-30">2017</dei:DocumentFiscalYearFocus>
    <dei:AmendmentFlag contextRef="D2016-07-01_To_2017-06-30">false</dei:AmendmentFlag>
    <us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax contextRef="D2016-07-01_To_2017-06-30" unitRef="USD" xsi:nil="true" />
    <us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax contextRef="D2014-07-01_To_2015-06-30" unitRef="USD" decimals="-3">285000</us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax contextRef="From2015-07-01to2016-06-30" unitRef="USD" xsi:nil="true" />
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax contextRef="D2016-07-01_To_2017-06-30" unitRef="USD" decimals="-3">924000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax contextRef="D2014-07-01_To_2015-06-30" unitRef="USD" decimals="-3">-1132000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax contextRef="From2015-07-01to2016-06-30" unitRef="USD" decimals="-3">-1071000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax contextRef="D2016-07-01_To_2017-06-30" unitRef="USD" xsi:nil="true" />
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax contextRef="D2014-07-01_To_2015-06-30" unitRef="USD" decimals="-3">262000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax contextRef="From2015-07-01to2016-06-30" unitRef="USD" decimals="-3">46000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax contextRef="D2016-07-01_To_2017-06-30" unitRef="USD" decimals="-3">405000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax contextRef="D2014-07-01_To_2015-06-30" unitRef="USD" decimals="-3">-290000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax contextRef="From2015-07-01to2016-06-30" unitRef="USD" decimals="-3">-457000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent contextRef="D2016-07-01_To_2017-06-30" unitRef="USD" decimals="-3">519000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent contextRef="D2014-07-01_To_2015-06-30" unitRef="USD" decimals="-3">-819000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent contextRef="From2015-07-01to2016-06-30" unitRef="USD" decimals="-3">-660000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:ComprehensiveIncomeNetOfTax contextRef="D2016-07-01_To_2017-06-30" unitRef="USD" decimals="-3">-27295000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax contextRef="D2014-07-01_To_2015-06-30" unitRef="USD" decimals="-3">-25496000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax contextRef="From2015-07-01to2016-06-30" unitRef="USD" decimals="-3">-23906000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized contextRef="AsOf2017-06-30_us-gaap_RestrictedStockUnitsRSUMember" unitRef="USD" decimals="-3">6886000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized>
    <dei:EntityCentralIndexKey contextRef="D2016-07-01_To_2017-06-30">0001158780</dei:EntityCentralIndexKey>
    <dei:DocumentFiscalPeriodFocus contextRef="D2016-07-01_To_2017-06-30">FY</dei:DocumentFiscalPeriodFocus>
    <dei:DocumentType contextRef="D2016-07-01_To_2017-06-30">10-K</dei:DocumentType>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice contextRef="AsOf2017-06-30_us-gaap_WarrantMember_custom_ExercisePriceRangeOneMember" unitRef="usdpershare" decimals="INF">1.40</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice contextRef="AsOf2017-06-30_us-gaap_WarrantMember_custom_ExercisePriceRangeTwoMember" unitRef="usdpershare" decimals="INF">2.85</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice contextRef="AsOf2017-06-30_us-gaap_WarrantMember_custom_ExercisePriceRangeThreeMember" unitRef="usdpershare" decimals="INF">5.00</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice contextRef="AsOf2017-06-30_us-gaap_EmployeeStockOptionMember_custom_ExercisePriceRangeFourMember" unitRef="usdpershare" decimals="INF">0.00</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice contextRef="AsOf2017-06-30_us-gaap_EmployeeStockOptionMember_custom_ExercisePriceRangeFiveMember" unitRef="usdpershare" decimals="INF">0.62</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice contextRef="AsOf2017-06-30_us-gaap_EmployeeStockOptionMember_custom_ExercisePriceRangeSixMember" unitRef="usdpershare" decimals="INF">1.04</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice contextRef="AsOf2017-06-30_us-gaap_EmployeeStockOptionMember_custom_ExercisePriceRangeSevenMember" unitRef="usdpershare" decimals="INF">2.97</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice contextRef="AsOf2017-06-30_us-gaap_EmployeeStockOptionMember_custom_ExercisePriceRangeEightMember" unitRef="usdpershare" decimals="INF">3.50</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice contextRef="AsOf2017-06-30_us-gaap_EmployeeStockOptionMember_custom_ExercisePriceRangeNineMember" unitRef="usdpershare" decimals="INF">3.80</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice contextRef="AsOf2017-06-30_us-gaap_EmployeeStockOptionMember_custom_ExercisePriceRangeTenMember" unitRef="usdpershare" decimals="INF">4.38</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice contextRef="AsOf2017-06-30_us-gaap_EmployeeStockOptionMember_custom_ExercisePriceRangeElevenMember" unitRef="usdpershare" decimals="INF">4.40</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice contextRef="AsOf2017-06-30_us-gaap_EmployeeStockOptionMember_custom_ExercisePriceRangeTwelveMember" unitRef="usdpershare" decimals="INF">6.80</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice contextRef="AsOf2017-06-30_us-gaap_EmployeeStockOptionMember_custom_ExercisePriceRangeThirteenMember" unitRef="usdpershare" decimals="INF">8.20</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice contextRef="AsOf2017-06-30_us-gaap_EmployeeStockOptionMember_custom_ExercisePriceRangeFourteenMember" unitRef="usdpershare" decimals="INF">20.00</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice contextRef="AsOf2016-06-30_custom_EmployeesAndDirectorsMember" unitRef="usdpershare" decimals="INF">3.76</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice contextRef="AsOf2017-06-30_custom_EmployeesAndDirectorsMember" unitRef="usdpershare" decimals="INF">2.98</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice contextRef="AsOf2016-06-30_custom_NonemployeesMember" unitRef="usdpershare" decimals="INF">5.40</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice contextRef="AsOf2017-06-30_custom_NonemployeesMember" unitRef="usdpershare" decimals="INF">0.72</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 contextRef="From2016-07-01to2017-06-30_us-gaap_WarrantMember_custom_ExercisePriceRangeOneMember">P5Y0M22D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 contextRef="From2016-07-01to2017-06-30_us-gaap_WarrantMember_custom_ExercisePriceRangeTwoMember">P3Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 contextRef="From2016-07-01to2017-06-30_us-gaap_WarrantMember_custom_ExercisePriceRangeThreeMember">P0Y2M19D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 contextRef="From2016-07-01to2017-06-30_us-gaap_EmployeeStockOptionMember_custom_ExercisePriceRangeFourMember">P5Y3M26D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 contextRef="From2016-07-01to2017-06-30_us-gaap_EmployeeStockOptionMember_custom_ExercisePriceRangeFiveMember">P1Y3M11D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 contextRef="From2016-07-01to2017-06-30_us-gaap_EmployeeStockOptionMember_custom_ExercisePriceRangeSixMember">P1Y1M27D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 contextRef="From2016-07-01to2017-06-30_us-gaap_EmployeeStockOptionMember_custom_ExercisePriceRangeSevenMember">P0Y10M10D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 contextRef="From2016-07-01to2017-06-30_us-gaap_EmployeeStockOptionMember_custom_ExercisePriceRangeEightMember">P0Y1M20D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 contextRef="From2016-07-01to2017-06-30_us-gaap_EmployeeStockOptionMember_custom_ExercisePriceRangeNineMember">P0Y1M20D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 contextRef="From2016-07-01to2017-06-30_us-gaap_EmployeeStockOptionMember_custom_ExercisePriceRangeTenMember">P0Y5M20D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 contextRef="From2016-07-01to2017-06-30_us-gaap_EmployeeStockOptionMember_custom_ExercisePriceRangeElevenMember">P0Y1M20D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 contextRef="From2016-07-01to2017-06-30_us-gaap_EmployeeStockOptionMember_custom_ExercisePriceRangeTwelveMember">P0Y4M13D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 contextRef="From2016-07-01to2017-06-30_us-gaap_EmployeeStockOptionMember_custom_ExercisePriceRangeThirteenMember">P0Y1M27D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 contextRef="From2016-07-01to2017-06-30_us-gaap_EmployeeStockOptionMember_custom_ExercisePriceRangeFourteenMember">P2Y7M13D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 contextRef="From2016-07-01to2017-06-30_custom_EmployeesAndDirectorsMember">P0Y9M25D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 contextRef="From2016-07-01to2017-06-30_custom_NonemployeesMember">P4Y3M19D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:CommonStockParOrStatedValuePerShare contextRef="I2016-06-30" unitRef="usdpershare" decimals="INF">0.00001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare contextRef="AsOf2017-06-30" unitRef="usdpershare" decimals="INF">0.00001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized contextRef="I2016-06-30" unitRef="Shares" decimals="INF">200000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized contextRef="AsOf2017-06-30" unitRef="Shares" decimals="INF">200000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued contextRef="I2016-06-30" unitRef="Shares" decimals="INF">80268999</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued contextRef="AsOf2017-06-30" unitRef="Shares" decimals="INF">96938789</us-gaap:CommonStockSharesIssued>
    <us-gaap:AssetsCurrent contextRef="I2016-06-30" unitRef="USD" decimals="-3">35596000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent contextRef="AsOf2017-06-30" unitRef="USD" decimals="-3">29016000</us-gaap:AssetsCurrent>
    <us-gaap:AccountsPayableCurrent contextRef="I2016-06-30" unitRef="USD" decimals="-3">2705000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent contextRef="AsOf2017-06-30" unitRef="USD" decimals="-3">1966000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccruedLiabilitiesCurrent contextRef="I2016-06-30" unitRef="USD" decimals="-3">1369000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent contextRef="AsOf2017-06-30" unitRef="USD" decimals="-3">1465000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccountsPayableOtherCurrent contextRef="I2016-06-30" unitRef="USD" decimals="-3">1701000</us-gaap:AccountsPayableOtherCurrent>
    <us-gaap:AccountsPayableOtherCurrent contextRef="AsOf2017-06-30" unitRef="USD" decimals="-3">1983000</us-gaap:AccountsPayableOtherCurrent>
    <us-gaap:LiabilitiesCurrent contextRef="I2016-06-30" unitRef="USD" decimals="-3">5775000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent contextRef="AsOf2017-06-30" unitRef="USD" decimals="-3">5414000</us-gaap:LiabilitiesCurrent>
    <us-gaap:PostemploymentBenefitsLiabilityNoncurrent contextRef="I2016-06-30" unitRef="USD" decimals="-3">910000</us-gaap:PostemploymentBenefitsLiabilityNoncurrent>
    <us-gaap:PostemploymentBenefitsLiabilityNoncurrent contextRef="AsOf2017-06-30" unitRef="USD" decimals="-3">940000</us-gaap:PostemploymentBenefitsLiabilityNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent contextRef="I2016-06-30" unitRef="USD" decimals="-3">1100000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent contextRef="AsOf2017-06-30" unitRef="USD" decimals="-3">929000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:LiabilitiesNoncurrent contextRef="I2016-06-30" unitRef="USD" decimals="-3">2010000</us-gaap:LiabilitiesNoncurrent>
    <us-gaap:LiabilitiesNoncurrent contextRef="AsOf2017-06-30" unitRef="USD" decimals="-3">1869000</us-gaap:LiabilitiesNoncurrent>
    <us-gaap:CommonStockValue contextRef="I2016-06-30" unitRef="USD" decimals="-3">1000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue contextRef="AsOf2017-06-30" unitRef="USD" decimals="-3">1000</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapital contextRef="I2016-06-30" unitRef="USD" decimals="-3">198432000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AdditionalPaidInCapital contextRef="AsOf2017-06-30" unitRef="USD" decimals="-3">217822000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="I2016-06-30" unitRef="USD" decimals="-3">-161757000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="AsOf2017-06-30" unitRef="USD" decimals="-3">-189571000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="I2016-06-30" unitRef="USD" decimals="-3">45941000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="AsOf2017-06-30" unitRef="USD" decimals="-3">37534000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="I2016-06-30" unitRef="USD" decimals="-3">6223000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="I2015-06-30" unitRef="USD" decimals="-3">22626000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="I2014-06-30" unitRef="USD" decimals="-3">4493000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="AsOf2017-06-30" unitRef="USD" decimals="-3">4707000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:LicensesRevenue contextRef="D2011-08-01_To_2011-08-31" unitRef="USD" decimals="-3">7000000</us-gaap:LicensesRevenue>
    <us-gaap:ProceedsFromCustomers contextRef="D2011-08-01_To_2011-08-31" unitRef="USD" decimals="-3">2000000</us-gaap:ProceedsFromCustomers>
    <psti:AvailableForSaleMarketableSecuritiesNumber contextRef="AsOf2013-12-31" unitRef="Shares" decimals="INF">1011504</psti:AvailableForSaleMarketableSecuritiesNumber>
    <us-gaap:StockIssuedDuringPeriodValuePurchaseOfAssets contextRef="From2013-12-01to2013-12-31" unitRef="USD" decimals="-3">10414000</us-gaap:StockIssuedDuringPeriodValuePurchaseOfAssets>
    <us-gaap:AvailableForSaleSecuritiesCurrent contextRef="AsOf2017-06-30" unitRef="USD" decimals="-3">4358000</us-gaap:AvailableForSaleSecuritiesCurrent>
    <us-gaap:DerivativeGainLossOnDerivativeNet contextRef="D2016-07-01_To_2017-06-30" unitRef="USD" decimals="-3">230000</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeGainLossOnDerivativeNet contextRef="D2014-07-01_To_2015-06-30" unitRef="USD" decimals="-3">248000</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeGainLossOnDerivativeNet contextRef="From2015-07-01to2016-06-30" unitRef="USD" decimals="-3">-205000</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax contextRef="I2016-06-30" unitRef="USD" decimals="-3">1480000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax contextRef="I2016-06-30_AccumulatedNetUnrealizedInvestmentGainLossMember" unitRef="USD" decimals="-3">1480000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax contextRef="AsOf2017-06-30" unitRef="USD" decimals="-3">1999000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax contextRef="AsOf2017-06-30_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember" unitRef="USD" decimals="-3">1999000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax contextRef="From2016-07-01to2017-06-30_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember" unitRef="USD" decimals="-3">924000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax contextRef="From2016-07-01to2017-06-30_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember" unitRef="USD" decimals="-3">405000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:AvailableForSaleSecuritiesAmortizedCost contextRef="I2016-06-30" unitRef="USD" decimals="-3">15973000</us-gaap:AvailableForSaleSecuritiesAmortizedCost>
    <us-gaap:AvailableForSaleSecuritiesAmortizedCost contextRef="AsOf2016-06-30_us-gaap_EquitySecuritiesMember_custom_AvailableForSaleSecuritiesMaturesWithinOneYearMember" unitRef="USD" decimals="-3">11599000</us-gaap:AvailableForSaleSecuritiesAmortizedCost>
    <us-gaap:AvailableForSaleSecuritiesAmortizedCost contextRef="AsOf2016-06-30_custom_GovernmentDebtSecuritiesMember_custom_AvailableForSaleSecuritiesMaturesWithinOneYearMember" unitRef="USD" decimals="-3">786000</us-gaap:AvailableForSaleSecuritiesAmortizedCost>
    <us-gaap:AvailableForSaleSecuritiesAmortizedCost contextRef="AsOf2016-06-30_us-gaap_CorporateDebtSecuritiesMember_custom_AvailableForSaleSecuritiesMaturesWithinOneYearMember" unitRef="USD" decimals="-3">439000</us-gaap:AvailableForSaleSecuritiesAmortizedCost>
    <us-gaap:AvailableForSaleSecuritiesAmortizedCost contextRef="I2016-06-30_AvailableForSaleSecuritiesMaturesWithinOneYearMember" unitRef="USD" decimals="-3">12824000</us-gaap:AvailableForSaleSecuritiesAmortizedCost>
    <us-gaap:AvailableForSaleSecuritiesAmortizedCost contextRef="AsOf2016-06-30_custom_GovernmentDebtSecuritiesMember_custom_AvailableForSaleSecuritiesMaturesAfterOneYearThroughFiveYearsMember" unitRef="USD" decimals="-3">717000</us-gaap:AvailableForSaleSecuritiesAmortizedCost>
    <us-gaap:AvailableForSaleSecuritiesAmortizedCost contextRef="I2016-06-30_CorporateDebtSecuritiesMember_AvailableForSaleSecuritiesMaturesAfterOneYearThroughFiveYearsMember" unitRef="USD" decimals="-3">2403000</us-gaap:AvailableForSaleSecuritiesAmortizedCost>
    <us-gaap:AvailableForSaleSecuritiesAmortizedCost contextRef="I2016-06-30_AvailableForSaleSecuritiesMaturesAfterOneYearThroughFiveYearsMember" unitRef="USD" decimals="-3">3120000</us-gaap:AvailableForSaleSecuritiesAmortizedCost>
    <us-gaap:AvailableForSaleSecuritiesAmortizedCost contextRef="AsOf2016-06-30_us-gaap_CorporateDebtSecuritiesMember_custom_AvailableForSaleSecuritiesMaturesAfterFiveYearsThroughTenYearsMember" unitRef="USD" decimals="-3">29000</us-gaap:AvailableForSaleSecuritiesAmortizedCost>
    <us-gaap:AvailableForSaleSecuritiesAmortizedCost contextRef="I2016-06-30_AvailableForSaleSecuritiesMaturesAfterFiveYearsThroughTenYearsMember" unitRef="USD" decimals="-3">29000</us-gaap:AvailableForSaleSecuritiesAmortizedCost>
    <us-gaap:AvailableForSaleSecuritiesAmortizedCost contextRef="AsOf2017-06-30" unitRef="USD" decimals="-3">13932000</us-gaap:AvailableForSaleSecuritiesAmortizedCost>
    <us-gaap:AvailableForSaleSecuritiesAmortizedCost contextRef="AsOf2017-06-30_custom_AvailableForSaleSecuritiesMaturesAfterFiveYearsThroughTenYearsMember" unitRef="USD" decimals="-3">17000</us-gaap:AvailableForSaleSecuritiesAmortizedCost>
    <us-gaap:AvailableForSaleSecuritiesAmortizedCost contextRef="AsOf2017-06-30_custom_AvailableForSaleSecuritiesMaturesAfterFiveYearsThroughTenYearsMember_us-gaap_CorporateDebtSecuritiesMember" unitRef="USD" decimals="-3">17000</us-gaap:AvailableForSaleSecuritiesAmortizedCost>
    <us-gaap:AvailableForSaleSecuritiesAmortizedCost contextRef="AsOf2017-06-30_custom_AvailableForSaleSecuritiesMaturesAfterOneYearThroughFiveYearsMember_us-gaap_CorporateDebtSecuritiesMember" unitRef="USD" decimals="-3">1255000</us-gaap:AvailableForSaleSecuritiesAmortizedCost>
    <us-gaap:AvailableForSaleSecuritiesAmortizedCost contextRef="AsOf2017-06-30_custom_AvailableForSaleSecuritiesMaturesAfterOneYearThroughFiveYearsMember_custom_GovernmentDebtSecuritiesMember" unitRef="USD" decimals="-3">468000</us-gaap:AvailableForSaleSecuritiesAmortizedCost>
    <us-gaap:AvailableForSaleSecuritiesAmortizedCost contextRef="AsOf2017-06-30_custom_AvailableForSaleSecuritiesMaturesAfterOneYearThroughFiveYearsMember" unitRef="USD" decimals="-3">1723000</us-gaap:AvailableForSaleSecuritiesAmortizedCost>
    <us-gaap:AvailableForSaleSecuritiesAmortizedCost contextRef="AsOf2017-06-30_custom_AvailableForSaleSecuritiesMaturesWithinOneYearMember_us-gaap_CorporateDebtSecuritiesMember" unitRef="USD" decimals="-3">47000</us-gaap:AvailableForSaleSecuritiesAmortizedCost>
    <us-gaap:AvailableForSaleSecuritiesAmortizedCost contextRef="AsOf2017-06-30_custom_AvailableForSaleSecuritiesMaturesWithinOneYearMember_custom_GovernmentDebtSecuritiesMember" unitRef="USD" decimals="-3">157000</us-gaap:AvailableForSaleSecuritiesAmortizedCost>
    <us-gaap:AvailableForSaleSecuritiesAmortizedCost contextRef="AsOf2017-06-30_custom_AvailableForSaleSecuritiesMaturesWithinOneYearMember_us-gaap_EquitySecuritiesMember" unitRef="USD" decimals="-3">11988000</us-gaap:AvailableForSaleSecuritiesAmortizedCost>
    <us-gaap:AvailableForSaleSecuritiesAmortizedCost contextRef="AsOf2017-06-30_custom_AvailableForSaleSecuritiesMaturesWithinOneYearMember" unitRef="USD" decimals="-3">12192000</us-gaap:AvailableForSaleSecuritiesAmortizedCost>
    <us-gaap:AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedGainBeforeTax contextRef="I2016-06-30" unitRef="USD" decimals="-3">1688000</us-gaap:AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedGainBeforeTax contextRef="AsOf2016-06-30_us-gaap_EquitySecuritiesMember_custom_AvailableForSaleSecuritiesMaturesWithinOneYearMember" unitRef="USD" decimals="-3">1594000</us-gaap:AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedGainBeforeTax contextRef="AsOf2016-06-30_custom_GovernmentDebtSecuritiesMember_custom_AvailableForSaleSecuritiesMaturesWithinOneYearMember" unitRef="USD" decimals="-3">12000</us-gaap:AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedGainBeforeTax contextRef="AsOf2016-06-30_us-gaap_CorporateDebtSecuritiesMember_custom_AvailableForSaleSecuritiesMaturesWithinOneYearMember" unitRef="USD" decimals="-3">7000</us-gaap:AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedGainBeforeTax contextRef="I2016-06-30_AvailableForSaleSecuritiesMaturesWithinOneYearMember" unitRef="USD" decimals="-3">1613000</us-gaap:AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedGainBeforeTax contextRef="AsOf2016-06-30_custom_GovernmentDebtSecuritiesMember_custom_AvailableForSaleSecuritiesMaturesAfterOneYearThroughFiveYearsMember" unitRef="USD" decimals="-3">27000</us-gaap:AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedGainBeforeTax contextRef="I2016-06-30_CorporateDebtSecuritiesMember_AvailableForSaleSecuritiesMaturesAfterOneYearThroughFiveYearsMember" unitRef="USD" decimals="-3">47000</us-gaap:AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedGainBeforeTax contextRef="I2016-06-30_AvailableForSaleSecuritiesMaturesAfterOneYearThroughFiveYearsMember" unitRef="USD" decimals="-3">74000</us-gaap:AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedGainBeforeTax contextRef="AsOf2016-06-30_us-gaap_CorporateDebtSecuritiesMember_custom_AvailableForSaleSecuritiesMaturesAfterFiveYearsThroughTenYearsMember" unitRef="USD" decimals="-3">1000</us-gaap:AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedGainBeforeTax contextRef="I2016-06-30_AvailableForSaleSecuritiesMaturesAfterFiveYearsThroughTenYearsMember" unitRef="USD" decimals="-3">1000</us-gaap:AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedGainBeforeTax contextRef="AsOf2017-06-30" unitRef="USD" decimals="-3">2047000</us-gaap:AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedGainBeforeTax contextRef="AsOf2017-06-30_custom_AvailableForSaleSecuritiesMaturesAfterFiveYearsThroughTenYearsMember" unitRef="USD" decimals="-3">1000</us-gaap:AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedGainBeforeTax contextRef="AsOf2017-06-30_custom_AvailableForSaleSecuritiesMaturesAfterFiveYearsThroughTenYearsMember_us-gaap_CorporateDebtSecuritiesMember" unitRef="USD" decimals="-3">1000</us-gaap:AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedGainBeforeTax contextRef="AsOf2017-06-30_custom_AvailableForSaleSecuritiesMaturesAfterOneYearThroughFiveYearsMember_us-gaap_CorporateDebtSecuritiesMember" unitRef="USD" decimals="-3">7000</us-gaap:AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedGainBeforeTax contextRef="AsOf2017-06-30_custom_AvailableForSaleSecuritiesMaturesAfterOneYearThroughFiveYearsMember_custom_GovernmentDebtSecuritiesMember" unitRef="USD" decimals="-3">23000</us-gaap:AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedGainBeforeTax contextRef="AsOf2017-06-30_custom_AvailableForSaleSecuritiesMaturesAfterOneYearThroughFiveYearsMember" unitRef="USD" decimals="-3">30000</us-gaap:AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedGainBeforeTax contextRef="AsOf2017-06-30_custom_AvailableForSaleSecuritiesMaturesWithinOneYearMember_us-gaap_CorporateDebtSecuritiesMember" unitRef="USD" decimals="-3">1000</us-gaap:AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedGainBeforeTax contextRef="AsOf2017-06-30_custom_AvailableForSaleSecuritiesMaturesWithinOneYearMember_custom_GovernmentDebtSecuritiesMember" unitRef="USD" decimals="-3">1000</us-gaap:AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedGainBeforeTax contextRef="AsOf2017-06-30_custom_AvailableForSaleSecuritiesMaturesWithinOneYearMember_us-gaap_EquitySecuritiesMember" unitRef="USD" decimals="-3">2014000</us-gaap:AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedGainBeforeTax contextRef="AsOf2017-06-30_custom_AvailableForSaleSecuritiesMaturesWithinOneYearMember" unitRef="USD" decimals="-3">2016000</us-gaap:AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedLossBeforeTax contextRef="I2016-06-30" unitRef="USD" decimals="-3">208000</us-gaap:AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedLossBeforeTax contextRef="AsOf2016-06-30_us-gaap_EquitySecuritiesMember_custom_AvailableForSaleSecuritiesMaturesWithinOneYearMember" unitRef="USD" decimals="-3">208000</us-gaap:AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedLossBeforeTax contextRef="AsOf2016-06-30_custom_GovernmentDebtSecuritiesMember_custom_AvailableForSaleSecuritiesMaturesWithinOneYearMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedLossBeforeTax contextRef="AsOf2016-06-30_us-gaap_CorporateDebtSecuritiesMember_custom_AvailableForSaleSecuritiesMaturesWithinOneYearMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedLossBeforeTax contextRef="I2016-06-30_AvailableForSaleSecuritiesMaturesWithinOneYearMember" unitRef="USD" decimals="-3">208000</us-gaap:AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedLossBeforeTax contextRef="AsOf2016-06-30_custom_GovernmentDebtSecuritiesMember_custom_AvailableForSaleSecuritiesMaturesAfterOneYearThroughFiveYearsMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedLossBeforeTax contextRef="I2016-06-30_CorporateDebtSecuritiesMember_AvailableForSaleSecuritiesMaturesAfterOneYearThroughFiveYearsMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedLossBeforeTax contextRef="I2016-06-30_AvailableForSaleSecuritiesMaturesAfterOneYearThroughFiveYearsMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedLossBeforeTax contextRef="AsOf2016-06-30_us-gaap_CorporateDebtSecuritiesMember_custom_AvailableForSaleSecuritiesMaturesAfterFiveYearsThroughTenYearsMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedLossBeforeTax contextRef="I2016-06-30_AvailableForSaleSecuritiesMaturesAfterFiveYearsThroughTenYearsMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedLossBeforeTax contextRef="AsOf2017-06-30" unitRef="USD" decimals="-3">48000</us-gaap:AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedLossBeforeTax contextRef="AsOf2017-06-30_custom_AvailableForSaleSecuritiesMaturesAfterFiveYearsThroughTenYearsMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedLossBeforeTax contextRef="AsOf2017-06-30_custom_AvailableForSaleSecuritiesMaturesAfterFiveYearsThroughTenYearsMember_us-gaap_CorporateDebtSecuritiesMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedLossBeforeTax contextRef="AsOf2017-06-30_custom_AvailableForSaleSecuritiesMaturesAfterOneYearThroughFiveYearsMember_us-gaap_CorporateDebtSecuritiesMember" unitRef="USD" decimals="-3">1000</us-gaap:AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedLossBeforeTax contextRef="AsOf2017-06-30_custom_AvailableForSaleSecuritiesMaturesAfterOneYearThroughFiveYearsMember_custom_GovernmentDebtSecuritiesMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedLossBeforeTax contextRef="AsOf2017-06-30_custom_AvailableForSaleSecuritiesMaturesAfterOneYearThroughFiveYearsMember" unitRef="USD" decimals="-3">1000</us-gaap:AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedLossBeforeTax contextRef="AsOf2017-06-30_custom_AvailableForSaleSecuritiesMaturesWithinOneYearMember_us-gaap_CorporateDebtSecuritiesMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedLossBeforeTax contextRef="AsOf2017-06-30_custom_AvailableForSaleSecuritiesMaturesWithinOneYearMember_custom_GovernmentDebtSecuritiesMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedLossBeforeTax contextRef="AsOf2017-06-30_custom_AvailableForSaleSecuritiesMaturesWithinOneYearMember_us-gaap_EquitySecuritiesMember" unitRef="USD" decimals="-3">47000</us-gaap:AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedLossBeforeTax contextRef="AsOf2017-06-30_custom_AvailableForSaleSecuritiesMaturesWithinOneYearMember" unitRef="USD" decimals="-3">47000</us-gaap:AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecurities contextRef="I2016-06-30" unitRef="USD" decimals="-3">17415000</us-gaap:AvailableForSaleSecurities>
    <us-gaap:AvailableForSaleSecurities contextRef="AsOf2016-06-30_us-gaap_EquitySecuritiesMember_custom_AvailableForSaleSecuritiesMaturesWithinOneYearMember" unitRef="USD" decimals="-3">12947000</us-gaap:AvailableForSaleSecurities>
    <us-gaap:AvailableForSaleSecurities contextRef="AsOf2016-06-30_custom_GovernmentDebtSecuritiesMember_custom_AvailableForSaleSecuritiesMaturesWithinOneYearMember" unitRef="USD" decimals="-3">798000</us-gaap:AvailableForSaleSecurities>
    <us-gaap:AvailableForSaleSecurities contextRef="AsOf2016-06-30_us-gaap_CorporateDebtSecuritiesMember_custom_AvailableForSaleSecuritiesMaturesWithinOneYearMember" unitRef="USD" decimals="-3">446000</us-gaap:AvailableForSaleSecurities>
    <us-gaap:AvailableForSaleSecurities contextRef="I2016-06-30_AvailableForSaleSecuritiesMaturesWithinOneYearMember" unitRef="USD" decimals="-3">14191000</us-gaap:AvailableForSaleSecurities>
    <us-gaap:AvailableForSaleSecurities contextRef="AsOf2016-06-30_custom_GovernmentDebtSecuritiesMember_custom_AvailableForSaleSecuritiesMaturesAfterOneYearThroughFiveYearsMember" unitRef="USD" decimals="-3">744000</us-gaap:AvailableForSaleSecurities>
    <us-gaap:AvailableForSaleSecurities contextRef="I2016-06-30_CorporateDebtSecuritiesMember_AvailableForSaleSecuritiesMaturesAfterOneYearThroughFiveYearsMember" unitRef="USD" decimals="-3">2450000</us-gaap:AvailableForSaleSecurities>
    <us-gaap:AvailableForSaleSecurities contextRef="I2016-06-30_AvailableForSaleSecuritiesMaturesAfterOneYearThroughFiveYearsMember" unitRef="USD" decimals="-3">3194000</us-gaap:AvailableForSaleSecurities>
    <us-gaap:AvailableForSaleSecurities contextRef="AsOf2016-06-30_us-gaap_CorporateDebtSecuritiesMember_custom_AvailableForSaleSecuritiesMaturesAfterFiveYearsThroughTenYearsMember" unitRef="USD" decimals="-3">30000</us-gaap:AvailableForSaleSecurities>
    <us-gaap:AvailableForSaleSecurities contextRef="I2016-06-30_AvailableForSaleSecuritiesMaturesAfterFiveYearsThroughTenYearsMember" unitRef="USD" decimals="-3">30000</us-gaap:AvailableForSaleSecurities>
    <us-gaap:AvailableForSaleSecurities contextRef="AsOf2017-06-30" unitRef="USD" decimals="-3">15164000</us-gaap:AvailableForSaleSecurities>
    <us-gaap:AvailableForSaleSecurities contextRef="AsOf2017-06-30_custom_AvailableForSaleSecuritiesMaturesAfterFiveYearsThroughTenYearsMember" unitRef="USD" decimals="-3">18000</us-gaap:AvailableForSaleSecurities>
    <us-gaap:AvailableForSaleSecurities contextRef="AsOf2017-06-30_custom_AvailableForSaleSecuritiesMaturesAfterFiveYearsThroughTenYearsMember_us-gaap_CorporateDebtSecuritiesMember" unitRef="USD" decimals="-3">18000</us-gaap:AvailableForSaleSecurities>
    <us-gaap:AvailableForSaleSecurities contextRef="AsOf2017-06-30_custom_AvailableForSaleSecuritiesMaturesAfterOneYearThroughFiveYearsMember_us-gaap_CorporateDebtSecuritiesMember" unitRef="USD" decimals="-3">1261000</us-gaap:AvailableForSaleSecurities>
    <us-gaap:AvailableForSaleSecurities contextRef="AsOf2017-06-30_custom_AvailableForSaleSecuritiesMaturesAfterOneYearThroughFiveYearsMember_custom_GovernmentDebtSecuritiesMember" unitRef="USD" decimals="-3">491000</us-gaap:AvailableForSaleSecurities>
    <us-gaap:AvailableForSaleSecurities contextRef="AsOf2017-06-30_custom_AvailableForSaleSecuritiesMaturesAfterOneYearThroughFiveYearsMember" unitRef="USD" decimals="-3">1752000</us-gaap:AvailableForSaleSecurities>
    <us-gaap:AvailableForSaleSecurities contextRef="AsOf2017-06-30_custom_AvailableForSaleSecuritiesMaturesWithinOneYearMember_us-gaap_CorporateDebtSecuritiesMember" unitRef="USD" decimals="-3">48000</us-gaap:AvailableForSaleSecurities>
    <us-gaap:AvailableForSaleSecurities contextRef="AsOf2017-06-30_custom_AvailableForSaleSecuritiesMaturesWithinOneYearMember_custom_GovernmentDebtSecuritiesMember" unitRef="USD" decimals="-3">158000</us-gaap:AvailableForSaleSecurities>
    <us-gaap:AvailableForSaleSecurities contextRef="AsOf2017-06-30_custom_AvailableForSaleSecuritiesMaturesWithinOneYearMember_us-gaap_EquitySecuritiesMember" unitRef="USD" decimals="-3">13188000</us-gaap:AvailableForSaleSecurities>
    <us-gaap:AvailableForSaleSecurities contextRef="AsOf2017-06-30_custom_AvailableForSaleSecuritiesMaturesWithinOneYearMember" unitRef="USD" decimals="-3">13394000</us-gaap:AvailableForSaleSecurities>
    <us-gaap:AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue contextRef="I2016-06-30" unitRef="USD" decimals="-3">1258000</us-gaap:AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue>
    <us-gaap:AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue contextRef="AsOf2017-06-30" unitRef="USD" decimals="-3">869000</us-gaap:AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue>
    <us-gaap:AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss contextRef="I2016-06-30" unitRef="USD" decimals="-3">143000</us-gaap:AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss contextRef="AsOf2017-06-30" unitRef="USD" decimals="-3">24000</us-gaap:AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:AvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValue contextRef="I2016-06-30" unitRef="USD" decimals="-3">563000</us-gaap:AvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValue>
    <us-gaap:AvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValue contextRef="AsOf2017-06-30" unitRef="USD" decimals="-3">106000</us-gaap:AvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValue>
    <us-gaap:AvailableForSaleSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss contextRef="I2016-06-30" unitRef="USD" decimals="-3">65000</us-gaap:AvailableForSaleSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:AvailableForSaleSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss contextRef="AsOf2017-06-30" unitRef="USD" decimals="-3">24000</us-gaap:AvailableForSaleSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:FairValueNetAssetLiability contextRef="AsOf2016-06-30_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueMeasurementsRecurringMember" unitRef="USD" decimals="-3">11228000</us-gaap:FairValueNetAssetLiability>
    <us-gaap:FairValueNetAssetLiability contextRef="AsOf2016-06-30_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueMeasurementsRecurringMember" unitRef="USD" decimals="-3">6252000</us-gaap:FairValueNetAssetLiability>
    <us-gaap:FairValueNetAssetLiability contextRef="AsOf2017-06-30_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueMeasurementsRecurringMember" unitRef="USD" decimals="-3">10523000</us-gaap:FairValueNetAssetLiability>
    <us-gaap:FairValueNetAssetLiability contextRef="AsOf2017-06-30_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueMeasurementsRecurringMember" unitRef="USD" decimals="-3">4936000</us-gaap:FairValueNetAssetLiability>
    <psti:AggregateGrantsReceived contextRef="AsOf2017-06-30" unitRef="USD" decimals="-3">24461000</psti:AggregateGrantsReceived>
    <psti:AggregateGrantsReceived contextRef="AsOf2017-06-30_custom_SmartMoneyGrantMember" unitRef="USD" decimals="-3">112000</psti:AggregateGrantsReceived>
    <psti:PercentageOfQualifiedExpenditures contextRef="D2016-07-01_To_2017-06-30" unitRef="Pure" decimals="INF">0.50</psti:PercentageOfQualifiedExpenditures>
    <psti:RoyaltyRateSales contextRef="From2016-07-01to2017-06-30_us-gaap_MinimumMember" unitRef="Pure" decimals="INF">0.03</psti:RoyaltyRateSales>
    <psti:RoyaltyRateSales contextRef="From2016-07-01to2017-06-30_us-gaap_MaximumMember" unitRef="Pure" decimals="INF">0.04</psti:RoyaltyRateSales>
    <psti:RoyaltyRateSales contextRef="From2016-07-01to2017-06-30_custom_SmartMoneyGrantMember" unitRef="Pure" decimals="INF">0.05</psti:RoyaltyRateSales>
    <psti:RoyaltyRatePayableOnGrantsReceived contextRef="D2016-07-01_To_2017-06-30" unitRef="Pure" decimals="INF">1.00</psti:RoyaltyRatePayableOnGrantsReceived>
    <psti:RoyaltyRatePayableOnGrantsReceived contextRef="From2016-07-01to2017-06-30_custom_NewYorkBloodCenterIncMember" unitRef="Pure" decimals="INF">0.025</psti:RoyaltyRatePayableOnGrantsReceived>
    <psti:RoyaltiesAmountPaidAndAccrued contextRef="AsOf2017-06-30" unitRef="USD" decimals="-3">166000</psti:RoyaltiesAmountPaidAndAccrued>
    <us-gaap:RoyaltyGuaranteesCommitmentsAmount contextRef="AsOf2017-06-30" unitRef="USD" decimals="-3">24295000</us-gaap:RoyaltyGuaranteesCommitmentsAmount>
    <us-gaap:RoyaltyGuaranteesCommitmentsAmount contextRef="AsOf2017-06-30_custom_NewYorkBloodCenterIncMember" unitRef="USD" decimals="-3">550000</us-gaap:RoyaltyGuaranteesCommitmentsAmount>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="From2016-07-01to2017-06-30_us-gaap_RestrictedStockUnitsRSUMember" unitRef="USD" decimals="-3">3203000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="From2016-07-01to2017-06-30_us-gaap_EmployeeStockOptionMember" unitRef="USD" decimals="-3">46000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="From2015-07-01to2016-06-30_us-gaap_RestrictedStockUnitsRSUMember_us-gaap_ResearchAndDevelopmentExpenseMember" unitRef="USD" decimals="-3">960000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="D2014-07-01_To_2015-06-30_RestrictedStockUnitsRSUMember_ResearchAndDevelopmentExpenseMember" unitRef="USD" decimals="-3">1469000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="D2014-07-01_To_2015-06-30_RestrictedStockUnitsRSUMember_GeneralAndAdministrativeExpenseMember" unitRef="USD" decimals="-3">2277000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="D2014-07-01_To_2015-06-30_RestrictedStockUnitsRSUMember" unitRef="USD" decimals="-3">3746000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="D2015-07-01_To_2016-06-30_RestrictedStockUnitsRSUMember_ResearchAndDevelopmentExpenseMember_ConsultantsMember" unitRef="USD" decimals="-3">39000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="D2014-07-01_To_2015-06-30_RestrictedStockUnitsRSUMember_ResearchAndDevelopmentExpenseMember_ConsultantsMember" unitRef="USD" decimals="-3">131000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="D2015-07-01_To_2016-06-30_RestrictedStockUnitsRSUMember_GeneralAndAdministrativeExpenseMember_ConsultantsMember" unitRef="USD" decimals="-3">145000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="D2014-07-01_To_2015-06-30_RestrictedStockUnitsRSUMember_GeneralAndAdministrativeExpenseMember_ConsultantsMember" unitRef="USD" decimals="-3">173000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="D2015-07-01_To_2016-06-30_RestrictedStockUnitsRSUMember_ConsultantsMember" unitRef="USD" decimals="-3">184000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="D2014-07-01_To_2015-06-30_RestrictedStockUnitsRSUMember_ConsultantsMember" unitRef="USD" decimals="-3">304000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="From2015-07-01to2016-06-30_us-gaap_EmployeeStockOptionMember_us-gaap_ResearchAndDevelopmentExpenseMember" unitRef="USD" decimals="-3">22000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="From2014-07-01to2015-06-30_us-gaap_EmployeeStockOptionMember_us-gaap_ResearchAndDevelopmentExpenseMember" unitRef="USD" decimals="-3">1000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="From2015-07-01to2016-06-30_us-gaap_RestrictedStockUnitsRSUMember_us-gaap_GeneralAndAdministrativeExpenseMember" unitRef="USD" decimals="-3">1905000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="From2015-07-01to2016-06-30_us-gaap_EmployeeStockOptionMember_us-gaap_GeneralAndAdministrativeExpenseMember" unitRef="USD" decimals="-3">2000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="From2014-07-01to2015-06-30_us-gaap_EmployeeStockOptionMember_us-gaap_GeneralAndAdministrativeExpenseMember" unitRef="USD" decimals="-3">1000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="From2016-07-01to2017-06-30_us-gaap_EmployeeStockOptionMember_us-gaap_ResearchAndDevelopmentExpenseMember" unitRef="USD" decimals="-3">7000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="From2016-07-01to2017-06-30_us-gaap_EmployeeStockOptionMember_us-gaap_GeneralAndAdministrativeExpenseMember" unitRef="USD" decimals="-3">39000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="From2016-07-01to2017-06-30_us-gaap_RestrictedStockUnitsRSUMember_us-gaap_ResearchAndDevelopmentExpenseMember" unitRef="USD" decimals="-3">1558000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="From2016-07-01to2017-06-30_us-gaap_RestrictedStockUnitsRSUMember_us-gaap_GeneralAndAdministrativeExpenseMember" unitRef="USD" decimals="-3">1645000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="From2016-07-01to2017-06-30_us-gaap_RestrictedStockUnitsRSUMember_us-gaap_ResearchAndDevelopmentExpenseMember_custom_ConsultantsMember" unitRef="USD" decimals="-3">19000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="From2016-07-01to2017-06-30_us-gaap_RestrictedStockUnitsRSUMember_us-gaap_GeneralAndAdministrativeExpenseMember_custom_ConsultantsMember" unitRef="USD" decimals="-3">394000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="From2016-07-01to2017-06-30_us-gaap_RestrictedStockUnitsRSUMember_custom_ConsultantsMember" unitRef="USD" decimals="-3">413000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="From2015-07-01to2016-06-30_us-gaap_EmployeeStockOptionMember" unitRef="USD" decimals="-3">24000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="From2015-07-01to2016-06-30_us-gaap_RestrictedStockUnitsRSUMember" unitRef="USD" decimals="-3">2865000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="From2014-07-01to2015-06-30_us-gaap_EmployeeStockOptionMember" unitRef="USD" decimals="-3">2000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:CommitmentsAndContingencies contextRef="I2016-06-30" unitRef="USD" xsi:nil="true" />
    <us-gaap:CommitmentsAndContingencies contextRef="AsOf2017-06-30" unitRef="USD" xsi:nil="true" />
    <us-gaap:UnrecordedUnconditionalPurchaseObligationBalanceSheetAmount contextRef="I2015-06-30" unitRef="USD" decimals="-3">1032000</us-gaap:UnrecordedUnconditionalPurchaseObligationBalanceSheetAmount>
    <us-gaap:CommonStockSharesOutstanding contextRef="I2016-06-30" unitRef="Shares" decimals="INF">80268999</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesOutstanding contextRef="I2015-06-30" unitRef="Shares" decimals="INF">78771905</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesOutstanding contextRef="I2016-06-30_CommonStockMember" unitRef="Shares" decimals="INF">80268999</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesOutstanding contextRef="I2014-06-30_CommonStockMember" unitRef="Shares" decimals="INF">68601452</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesOutstanding contextRef="I2015-06-30_CommonStockMember" unitRef="Shares" decimals="INF">78771905</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesOutstanding contextRef="AsOf2017-06-30" unitRef="Shares" decimals="INF">96938789</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesOutstanding contextRef="AsOf2017-06-30_us-gaap_CommonStockMember" unitRef="Shares" decimals="INF">96938789</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised contextRef="D2014-07-01_To_2015-06-30_CommonStockMember" unitRef="Shares" decimals="INF">39000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised contextRef="D2015-07-01_To_2016-06-30_CommonStockMember" unitRef="Shares" decimals="INF">28000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised contextRef="From2016-07-01to2017-06-30_us-gaap_CommonStockMember" unitRef="Shares" decimals="INF">17900</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised contextRef="From2016-07-01to2017-06-30_custom_EmployeesAndDirectorsMember" unitRef="Shares" decimals="INF">16000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised contextRef="From2016-07-01to2017-06-30_custom_NonemployeesMember" unitRef="Shares" decimals="INF">1900</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <dei:EntityVoluntaryFilers contextRef="D2016-07-01_To_2017-06-30">No</dei:EntityVoluntaryFilers>
    <dei:EntityWellKnownSeasonedIssuer contextRef="D2016-07-01_To_2017-06-30">No</dei:EntityWellKnownSeasonedIssuer>
    <dei:EntityCurrentReportingStatus contextRef="D2016-07-01_To_2017-06-30">Yes</dei:EntityCurrentReportingStatus>
    <us-gaap:OtherAssetsCurrent contextRef="I2016-06-30" unitRef="USD" decimals="-3">618000</us-gaap:OtherAssetsCurrent>
    <us-gaap:OtherAssetsCurrent contextRef="AsOf2017-06-30" unitRef="USD" decimals="-3">1315000</us-gaap:OtherAssetsCurrent>
    <us-gaap:EarningsPerShareBasicAndDiluted contextRef="D2016-07-01_To_2017-06-30" unitRef="usdpershare" decimals="INF">-0.32</us-gaap:EarningsPerShareBasicAndDiluted>
    <us-gaap:EarningsPerShareBasicAndDiluted contextRef="D2014-07-01_To_2015-06-30" unitRef="usdpershare" decimals="INF">-0.35</us-gaap:EarningsPerShareBasicAndDiluted>
    <us-gaap:EarningsPerShareBasicAndDiluted contextRef="From2015-07-01to2016-06-30" unitRef="usdpershare" decimals="INF">-0.29</us-gaap:EarningsPerShareBasicAndDiluted>
    <us-gaap:IncreaseDecreaseInPensionAndPostretirementObligations contextRef="D2016-07-01_To_2017-06-30" unitRef="USD" decimals="-3">-8000</us-gaap:IncreaseDecreaseInPensionAndPostretirementObligations>
    <us-gaap:IncreaseDecreaseInPensionAndPostretirementObligations contextRef="D2014-07-01_To_2015-06-30" unitRef="USD" decimals="-3">-61000</us-gaap:IncreaseDecreaseInPensionAndPostretirementObligations>
    <us-gaap:IncreaseDecreaseInPensionAndPostretirementObligations contextRef="From2015-07-01to2016-06-30" unitRef="USD" decimals="-3">38000</us-gaap:IncreaseDecreaseInPensionAndPostretirementObligations>
    <psti:LinkageDifferencesAndInterestOnShortAndLongTermRestrictedLeaseDeposit contextRef="D2016-07-01_To_2017-06-30" unitRef="USD" decimals="-3">-14000</psti:LinkageDifferencesAndInterestOnShortAndLongTermRestrictedLeaseDeposit>
    <psti:LinkageDifferencesAndInterestOnShortAndLongTermRestrictedLeaseDeposit contextRef="D2014-07-01_To_2015-06-30" unitRef="USD" decimals="-3">54000</psti:LinkageDifferencesAndInterestOnShortAndLongTermRestrictedLeaseDeposit>
    <psti:LinkageDifferencesAndInterestOnShortAndLongTermRestrictedLeaseDeposit contextRef="From2015-07-01to2016-06-30" unitRef="USD" decimals="-3">-3000</psti:LinkageDifferencesAndInterestOnShortAndLongTermRestrictedLeaseDeposit>
    <us-gaap:IncreaseDecreaseInAccruedInterestReceivableNet contextRef="D2016-07-01_To_2017-06-30" unitRef="USD" decimals="-3">24000</us-gaap:IncreaseDecreaseInAccruedInterestReceivableNet>
    <us-gaap:IncreaseDecreaseInAccruedInterestReceivableNet contextRef="D2014-07-01_To_2015-06-30" unitRef="USD" decimals="-3">-35000</us-gaap:IncreaseDecreaseInAccruedInterestReceivableNet>
    <us-gaap:IncreaseDecreaseInAccruedInterestReceivableNet contextRef="From2015-07-01to2016-06-30" unitRef="USD" decimals="-3">25000</us-gaap:IncreaseDecreaseInAccruedInterestReceivableNet>
    <us-gaap:IncreaseDecreaseInCustomerAdvances contextRef="D2016-07-01_To_2017-06-30" unitRef="USD" xsi:nil="true" />
    <us-gaap:IncreaseDecreaseInCustomerAdvances contextRef="D2014-07-01_To_2015-06-30" unitRef="USD" decimals="-3">-154000</us-gaap:IncreaseDecreaseInCustomerAdvances>
    <us-gaap:IncreaseDecreaseInCustomerAdvances contextRef="From2015-07-01to2016-06-30" unitRef="USD" decimals="-3">-93000</us-gaap:IncreaseDecreaseInCustomerAdvances>
    <us-gaap:IncreaseDecreaseInDeferredRevenue contextRef="D2016-07-01_To_2017-06-30" unitRef="USD" xsi:nil="true" />
    <us-gaap:IncreaseDecreaseInDeferredRevenue contextRef="D2014-07-01_To_2015-06-30" unitRef="USD" decimals="-3">-379000</us-gaap:IncreaseDecreaseInDeferredRevenue>
    <us-gaap:IncreaseDecreaseInDeferredRevenue contextRef="From2015-07-01to2016-06-30" unitRef="USD" decimals="-3">-2847000</us-gaap:IncreaseDecreaseInDeferredRevenue>
    <us-gaap:IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities contextRef="D2016-07-01_To_2017-06-30" unitRef="USD" decimals="-3">138000</us-gaap:IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities contextRef="D2014-07-01_To_2015-06-30" unitRef="USD" decimals="-3">-949000</us-gaap:IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities contextRef="From2015-07-01to2016-06-30" unitRef="USD" decimals="-3">1225000</us-gaap:IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccountsPayable contextRef="D2016-07-01_To_2017-06-30" unitRef="USD" decimals="-3">-701000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccountsPayable contextRef="D2014-07-01_To_2015-06-30" unitRef="USD" decimals="-3">-566000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccountsPayable contextRef="From2015-07-01to2016-06-30" unitRef="USD" decimals="-3">-77000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInOtherOperatingAssets contextRef="D2016-07-01_To_2017-06-30" unitRef="USD" decimals="-3">731000</us-gaap:IncreaseDecreaseInOtherOperatingAssets>
    <us-gaap:IncreaseDecreaseInOtherOperatingAssets contextRef="D2014-07-01_To_2015-06-30" unitRef="USD" decimals="-3">1129000</us-gaap:IncreaseDecreaseInOtherOperatingAssets>
    <us-gaap:IncreaseDecreaseInOtherOperatingAssets contextRef="From2015-07-01to2016-06-30" unitRef="USD" decimals="-3">-1395000</us-gaap:IncreaseDecreaseInOtherOperatingAssets>
    <us-gaap:IncreaseDecreaseInOtherReceivables contextRef="D2016-07-01_To_2017-06-30" unitRef="USD" decimals="-3">-1192000</us-gaap:IncreaseDecreaseInOtherReceivables>
    <us-gaap:IncreaseDecreaseInOtherReceivables contextRef="D2014-07-01_To_2015-06-30" unitRef="USD" decimals="-3">-572000</us-gaap:IncreaseDecreaseInOtherReceivables>
    <us-gaap:IncreaseDecreaseInOtherReceivables contextRef="From2015-07-01to2016-06-30" unitRef="USD" decimals="-3">537000</us-gaap:IncreaseDecreaseInOtherReceivables>
    <us-gaap:ShareBasedCompensation contextRef="D2016-07-01_To_2017-06-30" unitRef="USD" decimals="-3">3662000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation contextRef="D2014-07-01_To_2015-06-30" unitRef="USD" decimals="-3">4052000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation contextRef="From2015-07-01to2016-06-30" unitRef="USD" decimals="-3">3073000</us-gaap:ShareBasedCompensation>
    <us-gaap:MarketableSecuritiesRealizedGainLoss contextRef="D2016-07-01_To_2017-06-30" unitRef="USD" decimals="-3">362000</us-gaap:MarketableSecuritiesRealizedGainLoss>
    <us-gaap:MarketableSecuritiesRealizedGainLoss contextRef="D2014-07-01_To_2015-06-30" unitRef="USD" decimals="-3">-290000</us-gaap:MarketableSecuritiesRealizedGainLoss>
    <us-gaap:MarketableSecuritiesRealizedGainLoss contextRef="From2015-07-01to2016-06-30" unitRef="USD" decimals="-3">-419000</us-gaap:MarketableSecuritiesRealizedGainLoss>
    <psti:AmortizationOfDiscountAndPremiumAndChangesInAccruedInterestFromMarketableSecurities contextRef="D2016-07-01_To_2017-06-30" unitRef="USD" decimals="-3">35000</psti:AmortizationOfDiscountAndPremiumAndChangesInAccruedInterestFromMarketableSecurities>
    <psti:AmortizationOfDiscountAndPremiumAndChangesInAccruedInterestFromMarketableSecurities contextRef="D2014-07-01_To_2015-06-30" unitRef="USD" decimals="-3">213000</psti:AmortizationOfDiscountAndPremiumAndChangesInAccruedInterestFromMarketableSecurities>
    <psti:AmortizationOfDiscountAndPremiumAndChangesInAccruedInterestFromMarketableSecurities contextRef="From2015-07-01to2016-06-30" unitRef="USD" decimals="-3">-114000</psti:AmortizationOfDiscountAndPremiumAndChangesInAccruedInterestFromMarketableSecurities>
    <us-gaap:GainLossOnSaleOfPropertyPlantEquipment contextRef="D2016-07-01_To_2017-06-30" unitRef="USD" decimals="-3">-72000</us-gaap:GainLossOnSaleOfPropertyPlantEquipment>
    <us-gaap:GainLossOnSaleOfPropertyPlantEquipment contextRef="D2014-07-01_To_2015-06-30" unitRef="USD" decimals="-3">-20000</us-gaap:GainLossOnSaleOfPropertyPlantEquipment>
    <us-gaap:GainLossOnSaleOfPropertyPlantEquipment contextRef="From2015-07-01to2016-06-30" unitRef="USD" decimals="-3">-82000</us-gaap:GainLossOnSaleOfPropertyPlantEquipment>
    <us-gaap:Depreciation contextRef="D2016-07-01_To_2017-06-30" unitRef="USD" decimals="-3">2177000</us-gaap:Depreciation>
    <us-gaap:Depreciation contextRef="D2014-07-01_To_2015-06-30" unitRef="USD" decimals="-3">2074000</us-gaap:Depreciation>
    <us-gaap:Depreciation contextRef="From2015-07-01to2016-06-30" unitRef="USD" decimals="-3">2150000</us-gaap:Depreciation>
    <us-gaap:OtherThanTemporaryImpairmentLossesInvestmentsPortionRecognizedInEarningsNet contextRef="D2016-07-01_To_2017-06-30" unitRef="USD" decimals="-3">767000</us-gaap:OtherThanTemporaryImpairmentLossesInvestmentsPortionRecognizedInEarningsNet>
    <us-gaap:OtherThanTemporaryImpairmentLossesInvestmentsPortionRecognizedInEarningsNet contextRef="D2014-07-01_To_2015-06-30" unitRef="USD" xsi:nil="true" />
    <us-gaap:OtherThanTemporaryImpairmentLossesInvestmentsPortionRecognizedInEarningsNet contextRef="From2015-07-01to2016-06-30" unitRef="USD" decimals="-3">38000</us-gaap:OtherThanTemporaryImpairmentLossesInvestmentsPortionRecognizedInEarningsNet>
    <psti:RepaymentOfInvestmentInLongtermDepositsAndRestrictedBankDeposits contextRef="D2016-07-01_To_2017-06-30" unitRef="USD" xsi:nil="true" />
    <psti:RepaymentOfInvestmentInLongtermDepositsAndRestrictedBankDeposits contextRef="D2014-07-01_To_2015-06-30" unitRef="USD" decimals="-3">78000</psti:RepaymentOfInvestmentInLongtermDepositsAndRestrictedBankDeposits>
    <psti:RepaymentOfInvestmentInLongtermDepositsAndRestrictedBankDeposits contextRef="From2015-07-01to2016-06-30" unitRef="USD" decimals="-3">-5000</psti:RepaymentOfInvestmentInLongtermDepositsAndRestrictedBankDeposits>
    <us-gaap:PaymentsForProceedsFromShortTermInvestments contextRef="D2016-07-01_To_2017-06-30" unitRef="USD" decimals="-3">-2316000</us-gaap:PaymentsForProceedsFromShortTermInvestments>
    <us-gaap:PaymentsForProceedsFromShortTermInvestments contextRef="D2014-07-01_To_2015-06-30" unitRef="USD" decimals="-3">-16061000</us-gaap:PaymentsForProceedsFromShortTermInvestments>
    <us-gaap:PaymentsForProceedsFromShortTermInvestments contextRef="From2015-07-01to2016-06-30" unitRef="USD" decimals="-3">849000</us-gaap:PaymentsForProceedsFromShortTermInvestments>
    <us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment contextRef="D2016-07-01_To_2017-06-30" unitRef="USD" decimals="-3">30000</us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment>
    <us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment contextRef="D2014-07-01_To_2015-06-30" unitRef="USD" decimals="-3">19000</us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment>
    <us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment contextRef="From2015-07-01to2016-06-30" unitRef="USD" decimals="-3">28000</us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment contextRef="D2016-07-01_To_2017-06-30" unitRef="USD" decimals="-3">378000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment contextRef="D2014-07-01_To_2015-06-30" unitRef="USD" decimals="-3">831000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment contextRef="From2015-07-01to2016-06-30" unitRef="USD" decimals="-3">1750000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:ProceedsFromSaleOfAvailableForSaleSecurities contextRef="D2016-07-01_To_2017-06-30" unitRef="USD" decimals="-3">5527000</us-gaap:ProceedsFromSaleOfAvailableForSaleSecurities>
    <us-gaap:ProceedsFromSaleOfAvailableForSaleSecurities contextRef="D2014-07-01_To_2015-06-30" unitRef="USD" decimals="-3">10635000</us-gaap:ProceedsFromSaleOfAvailableForSaleSecurities>
    <us-gaap:ProceedsFromSaleOfAvailableForSaleSecurities contextRef="From2015-07-01to2016-06-30" unitRef="USD" decimals="-3">6999000</us-gaap:ProceedsFromSaleOfAvailableForSaleSecurities>
    <us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities contextRef="D2016-07-01_To_2017-06-30" unitRef="USD" decimals="-3">410000</us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities>
    <us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities contextRef="D2014-07-01_To_2015-06-30" unitRef="USD" decimals="-3">634000</us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities>
    <us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities contextRef="From2015-07-01to2016-06-30" unitRef="USD" decimals="-3">1094000</us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities>
    <us-gaap:PaymentsToAcquireAvailableForSaleSecurities contextRef="D2016-07-01_To_2017-06-30" unitRef="USD" decimals="-3">3607000</us-gaap:PaymentsToAcquireAvailableForSaleSecurities>
    <us-gaap:PaymentsToAcquireAvailableForSaleSecurities contextRef="D2014-07-01_To_2015-06-30" unitRef="USD" decimals="-3">4903000</us-gaap:PaymentsToAcquireAvailableForSaleSecurities>
    <us-gaap:PaymentsToAcquireAvailableForSaleSecurities contextRef="From2015-07-01to2016-06-30" unitRef="USD" decimals="-3">4215000</us-gaap:PaymentsToAcquireAvailableForSaleSecurities>
    <us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease contextRef="D2016-07-01_To_2017-06-30" unitRef="USD" decimals="-3">-1516000</us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease>
    <us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease contextRef="D2014-07-01_To_2015-06-30" unitRef="USD" decimals="-3">18133000</us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease>
    <us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease contextRef="From2015-07-01to2016-06-30" unitRef="USD" decimals="-3">-16403000</us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease>
    <us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions contextRef="D2016-07-01_To_2017-06-30" unitRef="USD" decimals="-3">10000</us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions>
    <us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions contextRef="D2014-07-01_To_2015-06-30" unitRef="USD" decimals="-3">287000</us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions>
    <us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions contextRef="From2015-07-01to2016-06-30" unitRef="USD" decimals="-3">17000</us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions>
    <us-gaap:ProceedsFromIssuanceOfCommonStock contextRef="D2016-07-01_To_2017-06-30" unitRef="USD" decimals="-3">15718000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:ProceedsFromIssuanceOfCommonStock contextRef="D2014-07-01_To_2015-06-30" unitRef="USD" decimals="-3">16914000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:ProceedsFromIssuanceOfCommonStock contextRef="From2015-07-01to2016-06-30" unitRef="USD" decimals="-3">790000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:ProceedsFromIssuanceOfCommonStock contextRef="From2017-01-01to2017-01-25_custom_UnderwritingAgreementMember" unitRef="USD" decimals="-3">15718000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:IncomeTaxesPaid contextRef="D2016-07-01_To_2017-06-30" unitRef="USD" decimals="-3">28000</us-gaap:IncomeTaxesPaid>
    <us-gaap:IncomeTaxesPaid contextRef="D2014-07-01_To_2015-06-30" unitRef="USD" decimals="-3">54000</us-gaap:IncomeTaxesPaid>
    <us-gaap:IncomeTaxesPaid contextRef="From2015-07-01to2016-06-30" unitRef="USD" decimals="-3">66000</us-gaap:IncomeTaxesPaid>
    <us-gaap:CapitalExpendituresIncurredButNotYetPaid contextRef="D2016-07-01_To_2017-06-30" unitRef="USD" decimals="-3">88000</us-gaap:CapitalExpendituresIncurredButNotYetPaid>
    <us-gaap:CapitalExpendituresIncurredButNotYetPaid contextRef="D2014-07-01_To_2015-06-30" unitRef="USD" decimals="-3">612000</us-gaap:CapitalExpendituresIncurredButNotYetPaid>
    <us-gaap:CapitalExpendituresIncurredButNotYetPaid contextRef="From2015-07-01to2016-06-30" unitRef="USD" decimals="-3">126000</us-gaap:CapitalExpendituresIncurredButNotYetPaid>
    <us-gaap:StockIssued1 contextRef="D2016-07-01_To_2017-06-30" unitRef="USD" xsi:nil="true" />
    <us-gaap:StockIssued1 contextRef="D2014-07-01_To_2015-06-30" unitRef="USD" decimals="-3">263000</us-gaap:StockIssued1>
    <us-gaap:StockIssued1 contextRef="From2015-07-01to2016-06-30" unitRef="USD" decimals="-3">39000</us-gaap:StockIssued1>
    <us-gaap:OtherSignificantNoncashTransactionValueOfConsiderationGiven1 contextRef="D2016-07-01_To_2017-06-30" unitRef="USD" xsi:nil="true" />
    <us-gaap:OtherSignificantNoncashTransactionValueOfConsiderationGiven1 contextRef="D2014-07-01_To_2015-06-30" unitRef="USD" decimals="-3">790000</us-gaap:OtherSignificantNoncashTransactionValueOfConsiderationGiven1>
    <us-gaap:OtherSignificantNoncashTransactionValueOfConsiderationGiven1 contextRef="From2015-07-01to2016-06-30" unitRef="USD" xsi:nil="true" />
    <psti:PropertyPlantAndEquipmentAnnualRateOfDepreciation contextRef="From2016-07-01to2017-06-30_us-gaap_OtherMachineryAndEquipmentMember_us-gaap_MinimumMember" unitRef="Pure" decimals="INF">0.10</psti:PropertyPlantAndEquipmentAnnualRateOfDepreciation>
    <psti:PropertyPlantAndEquipmentAnnualRateOfDepreciation contextRef="From2016-07-01to2017-06-30_us-gaap_OtherMachineryAndEquipmentMember_us-gaap_MaximumMember" unitRef="Pure" decimals="INF">0.15</psti:PropertyPlantAndEquipmentAnnualRateOfDepreciation>
    <psti:PropertyPlantAndEquipmentAnnualRateOfDepreciation contextRef="From2016-07-01to2017-06-30_us-gaap_ComputerEquipmentMember" unitRef="Pure" decimals="INF">0.33</psti:PropertyPlantAndEquipmentAnnualRateOfDepreciation>
    <psti:PropertyPlantAndEquipmentAnnualRateOfDepreciation contextRef="From2016-07-01to2017-06-30_us-gaap_OfficeEquipmentMember" unitRef="Pure" decimals="INF">0.15</psti:PropertyPlantAndEquipmentAnnualRateOfDepreciation>
    <psti:PropertyPlantAndEquipmentAnnualRateOfDepreciation contextRef="From2016-07-01to2017-06-30_us-gaap_VehiclesMember" unitRef="Pure" decimals="INF">0.15</psti:PropertyPlantAndEquipmentAnnualRateOfDepreciation>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue contextRef="D2016-07-01_To_2017-06-30" unitRef="usdpershare" decimals="INF">1.41</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue contextRef="D2014-07-01_To_2015-06-30" unitRef="usdpershare" decimals="INF">2.70</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue contextRef="From2015-07-01to2016-06-30" unitRef="usdpershare" decimals="INF">1.13</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:PostemploymentBenefitsPeriodExpense contextRef="D2016-07-01_To_2017-06-30" unitRef="USD" decimals="-3">524000</us-gaap:PostemploymentBenefitsPeriodExpense>
    <us-gaap:PostemploymentBenefitsPeriodExpense contextRef="D2014-07-01_To_2015-06-30" unitRef="USD" decimals="-3">441000</us-gaap:PostemploymentBenefitsPeriodExpense>
    <us-gaap:PostemploymentBenefitsPeriodExpense contextRef="From2015-07-01to2016-06-30" unitRef="USD" decimals="-3">556000</us-gaap:PostemploymentBenefitsPeriodExpense>
    <us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue contextRef="I2016-06-30" unitRef="USD" decimals="-3">65000</us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue>
    <us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue contextRef="AsOf2017-06-30" unitRef="USD" decimals="-3">295000</us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue>
    <psti:OtherthantemporaryImpairment contextRef="I2016-06-30" unitRef="USD" decimals="-3">38000</psti:OtherthantemporaryImpairment>
    <psti:OtherthantemporaryImpairment contextRef="AsOf2016-06-30_us-gaap_EquitySecuritiesMember_custom_AvailableForSaleSecuritiesMaturesWithinOneYearMember" unitRef="USD" decimals="-3">38000</psti:OtherthantemporaryImpairment>
    <psti:OtherthantemporaryImpairment contextRef="AsOf2016-06-30_custom_GovernmentDebtSecuritiesMember_custom_AvailableForSaleSecuritiesMaturesWithinOneYearMember" unitRef="USD" xsi:nil="true" />
    <psti:OtherthantemporaryImpairment contextRef="AsOf2016-06-30_us-gaap_CorporateDebtSecuritiesMember_custom_AvailableForSaleSecuritiesMaturesWithinOneYearMember" unitRef="USD" xsi:nil="true" />
    <psti:OtherthantemporaryImpairment contextRef="I2016-06-30_AvailableForSaleSecuritiesMaturesWithinOneYearMember" unitRef="USD" decimals="-3">38000</psti:OtherthantemporaryImpairment>
    <psti:OtherthantemporaryImpairment contextRef="AsOf2016-06-30_custom_GovernmentDebtSecuritiesMember_custom_AvailableForSaleSecuritiesMaturesAfterOneYearThroughFiveYearsMember" unitRef="USD" xsi:nil="true" />
    <psti:OtherthantemporaryImpairment contextRef="I2016-06-30_CorporateDebtSecuritiesMember_AvailableForSaleSecuritiesMaturesAfterOneYearThroughFiveYearsMember" unitRef="USD" xsi:nil="true" />
    <psti:OtherthantemporaryImpairment contextRef="I2016-06-30_AvailableForSaleSecuritiesMaturesAfterOneYearThroughFiveYearsMember" unitRef="USD" xsi:nil="true" />
    <psti:OtherthantemporaryImpairment contextRef="AsOf2016-06-30_us-gaap_CorporateDebtSecuritiesMember_custom_AvailableForSaleSecuritiesMaturesAfterFiveYearsThroughTenYearsMember" unitRef="USD" xsi:nil="true" />
    <psti:OtherthantemporaryImpairment contextRef="I2016-06-30_AvailableForSaleSecuritiesMaturesAfterFiveYearsThroughTenYearsMember" unitRef="USD" xsi:nil="true" />
    <psti:OtherthantemporaryImpairment contextRef="AsOf2017-06-30" unitRef="USD" decimals="-3">767000</psti:OtherthantemporaryImpairment>
    <psti:OtherthantemporaryImpairment contextRef="AsOf2017-06-30_custom_AvailableForSaleSecuritiesMaturesAfterFiveYearsThroughTenYearsMember" unitRef="USD" xsi:nil="true" />
    <psti:OtherthantemporaryImpairment contextRef="AsOf2017-06-30_custom_AvailableForSaleSecuritiesMaturesAfterFiveYearsThroughTenYearsMember_us-gaap_CorporateDebtSecuritiesMember" unitRef="USD" xsi:nil="true" />
    <psti:OtherthantemporaryImpairment contextRef="AsOf2017-06-30_custom_AvailableForSaleSecuritiesMaturesAfterOneYearThroughFiveYearsMember_us-gaap_CorporateDebtSecuritiesMember" unitRef="USD" xsi:nil="true" />
    <psti:OtherthantemporaryImpairment contextRef="AsOf2017-06-30_custom_AvailableForSaleSecuritiesMaturesAfterOneYearThroughFiveYearsMember_custom_GovernmentDebtSecuritiesMember" unitRef="USD" xsi:nil="true" />
    <psti:OtherthantemporaryImpairment contextRef="AsOf2017-06-30_custom_AvailableForSaleSecuritiesMaturesAfterOneYearThroughFiveYearsMember" unitRef="USD" xsi:nil="true" />
    <psti:OtherthantemporaryImpairment contextRef="AsOf2017-06-30_custom_AvailableForSaleSecuritiesMaturesWithinOneYearMember_us-gaap_CorporateDebtSecuritiesMember" unitRef="USD" xsi:nil="true" />
    <psti:OtherthantemporaryImpairment contextRef="AsOf2017-06-30_custom_AvailableForSaleSecuritiesMaturesWithinOneYearMember_custom_GovernmentDebtSecuritiesMember" unitRef="USD" xsi:nil="true" />
    <psti:OtherthantemporaryImpairment contextRef="AsOf2017-06-30_custom_AvailableForSaleSecuritiesMaturesWithinOneYearMember_us-gaap_EquitySecuritiesMember" unitRef="USD" decimals="-3">767000</psti:OtherthantemporaryImpairment>
    <psti:OtherthantemporaryImpairment contextRef="AsOf2017-06-30_custom_AvailableForSaleSecuritiesMaturesWithinOneYearMember" unitRef="USD" decimals="-3">767000</psti:OtherthantemporaryImpairment>
    <us-gaap:InterestReceivable contextRef="I2016-06-30" unitRef="USD" decimals="-3">28000</us-gaap:InterestReceivable>
    <us-gaap:InterestReceivable contextRef="AsOf2017-06-30" unitRef="USD" decimals="-3">11000</us-gaap:InterestReceivable>
    <us-gaap:PrepaidExpenseCurrent contextRef="I2016-06-30" unitRef="USD" decimals="-3">300000</us-gaap:PrepaidExpenseCurrent>
    <us-gaap:PrepaidExpenseCurrent contextRef="AsOf2017-06-30" unitRef="USD" decimals="-3">882000</us-gaap:PrepaidExpenseCurrent>
    <psti:AccountsReceivableFromMinistryOfEconomyCurrent contextRef="I2016-06-30" unitRef="USD" decimals="-3">23000</psti:AccountsReceivableFromMinistryOfEconomyCurrent>
    <psti:AccountsReceivableFromMinistryOfEconomyCurrent contextRef="AsOf2017-06-30" unitRef="USD" xsi:nil="true" />
    <us-gaap:ValueAddedTaxReceivableCurrent contextRef="I2016-06-30" unitRef="USD" decimals="-3">167000</us-gaap:ValueAddedTaxReceivableCurrent>
    <us-gaap:ValueAddedTaxReceivableCurrent contextRef="AsOf2017-06-30" unitRef="USD" decimals="-3">137000</us-gaap:ValueAddedTaxReceivableCurrent>
    <us-gaap:OtherReceivablesNetCurrent contextRef="I2016-06-30" unitRef="USD" decimals="-3">63000</us-gaap:OtherReceivablesNetCurrent>
    <us-gaap:OtherReceivablesNetCurrent contextRef="AsOf2017-06-30" unitRef="USD" decimals="-3">1000</us-gaap:OtherReceivablesNetCurrent>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="I2016-06-30" unitRef="USD" decimals="-3">17183000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="AsOf2016-06-30_us-gaap_OtherMachineryAndEquipmentMember" unitRef="USD" decimals="-3">6000000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="AsOf2016-06-30_us-gaap_ComputerEquipmentMember" unitRef="USD" decimals="-3">1024000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="AsOf2016-06-30_us-gaap_OfficeEquipmentMember" unitRef="USD" decimals="-3">715000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="AsOf2016-06-30_us-gaap_LeaseholdImprovementsMember" unitRef="USD" decimals="-3">9349000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="AsOf2016-06-30_us-gaap_VehiclesMember" unitRef="USD" decimals="-3">95000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="AsOf2017-06-30" unitRef="USD" decimals="-3">16507000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="AsOf2017-06-30_us-gaap_OtherMachineryAndEquipmentMember" unitRef="USD" decimals="-3">6097000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="AsOf2017-06-30_us-gaap_ComputerEquipmentMember" unitRef="USD" decimals="-3">1126000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="AsOf2017-06-30_us-gaap_OfficeEquipmentMember" unitRef="USD" decimals="-3">681000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="AsOf2017-06-30_us-gaap_LeaseholdImprovementsMember" unitRef="USD" decimals="-3">8603000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="AsOf2017-06-30_us-gaap_VehiclesMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment contextRef="I2016-06-30" unitRef="USD" decimals="-3">7967000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment contextRef="AsOf2016-06-30_us-gaap_OtherMachineryAndEquipmentMember" unitRef="USD" decimals="-3">3401000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment contextRef="AsOf2016-06-30_us-gaap_ComputerEquipmentMember" unitRef="USD" decimals="-3">802000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment contextRef="AsOf2016-06-30_us-gaap_OfficeEquipmentMember" unitRef="USD" decimals="-3">353000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment contextRef="AsOf2016-06-30_us-gaap_LeaseholdImprovementsMember" unitRef="USD" decimals="-3">3374000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment contextRef="AsOf2016-06-30_us-gaap_VehiclesMember" unitRef="USD" decimals="-3">37000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment contextRef="AsOf2017-06-30" unitRef="USD" decimals="-3">9230000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment contextRef="AsOf2017-06-30_us-gaap_OtherMachineryAndEquipmentMember" unitRef="USD" decimals="-3">4164000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment contextRef="AsOf2017-06-30_us-gaap_ComputerEquipmentMember" unitRef="USD" decimals="-3">951000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment contextRef="AsOf2017-06-30_us-gaap_OfficeEquipmentMember" unitRef="USD" decimals="-3">416000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment contextRef="AsOf2017-06-30_us-gaap_LeaseholdImprovementsMember" unitRef="USD" decimals="-3">3699000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment contextRef="AsOf2017-06-30_us-gaap_VehiclesMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:EmployeeRelatedLiabilitiesCurrent contextRef="I2016-06-30" unitRef="USD" decimals="-3">421000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent contextRef="AsOf2017-06-30" unitRef="USD" decimals="-3">505000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <psti:OtherAccountsPayablePayrollInstitutions contextRef="I2016-06-30" unitRef="USD" decimals="-3">309000</psti:OtherAccountsPayablePayrollInstitutions>
    <psti:OtherAccountsPayablePayrollInstitutions contextRef="AsOf2017-06-30" unitRef="USD" decimals="-3">345000</psti:OtherAccountsPayablePayrollInstitutions>
    <us-gaap:AccruedVacationCurrent contextRef="I2016-06-30" unitRef="USD" decimals="-3">720000</us-gaap:AccruedVacationCurrent>
    <us-gaap:AccruedVacationCurrent contextRef="AsOf2017-06-30" unitRef="USD" decimals="-3">791000</us-gaap:AccruedVacationCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent contextRef="I2016-06-30" unitRef="USD" decimals="-3">251000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent contextRef="AsOf2017-06-30" unitRef="USD" decimals="-3">342000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:GuaranteeObligationsCurrentCarryingValue contextRef="AsOf2017-06-30_us-gaap_LandAndBuildingMember" unitRef="USD" decimals="-3">399000</us-gaap:GuaranteeObligationsCurrentCarryingValue>
    <us-gaap:OperatingLeasesRentExpenseNet contextRef="From2015-07-01to2016-06-30_us-gaap_LandAndBuildingMember" unitRef="USD" decimals="-3">824000</us-gaap:OperatingLeasesRentExpenseNet>
    <us-gaap:OperatingLeasesRentExpenseNet contextRef="C920255" unitRef="USD" decimals="-3">704000</us-gaap:OperatingLeasesRentExpenseNet>
    <us-gaap:OperatingLeasesRentExpenseNet contextRef="From2016-07-01to2017-06-30_us-gaap_LandAndBuildingMember" unitRef="USD" decimals="-3">781000</us-gaap:OperatingLeasesRentExpenseNet>
    <us-gaap:OperatingLeasesRentExpenseNet contextRef="From2015-07-01to2016-06-30_us-gaap_AutomobilesMember" unitRef="USD" decimals="-3">210000</us-gaap:OperatingLeasesRentExpenseNet>
    <us-gaap:OperatingLeasesRentExpenseNet contextRef="C920256" unitRef="USD" decimals="-3">218000</us-gaap:OperatingLeasesRentExpenseNet>
    <us-gaap:OperatingLeasesRentExpenseNet contextRef="From2016-07-01to2017-06-30_us-gaap_AutomobilesMember" unitRef="USD" decimals="-3">233000</us-gaap:OperatingLeasesRentExpenseNet>
    <us-gaap:OperatingLeasesFutureMinimumPaymentsDueCurrent contextRef="AsOf2017-06-30_us-gaap_LandAndBuildingMember" unitRef="USD" decimals="-3">884000</us-gaap:OperatingLeasesFutureMinimumPaymentsDueCurrent>
    <us-gaap:OperatingLeasesFutureMinimumPaymentsDueCurrent contextRef="AsOf2017-06-30_us-gaap_AutomobilesMember" unitRef="USD" decimals="-3">225000</us-gaap:OperatingLeasesFutureMinimumPaymentsDueCurrent>
    <us-gaap:OperatingLeasesFutureMinimumPaymentsDueInTwoYears contextRef="AsOf2017-06-30_us-gaap_LandAndBuildingMember" unitRef="USD" decimals="-3">884000</us-gaap:OperatingLeasesFutureMinimumPaymentsDueInTwoYears>
    <us-gaap:OperatingLeasesFutureMinimumPaymentsDueInTwoYears contextRef="AsOf2017-06-30_us-gaap_AutomobilesMember" unitRef="USD" decimals="-3">142000</us-gaap:OperatingLeasesFutureMinimumPaymentsDueInTwoYears>
    <us-gaap:OperatingLeasesFutureMinimumPaymentsDueInThreeYears contextRef="AsOf2017-06-30_us-gaap_LandAndBuildingMember" unitRef="USD" decimals="-3">894000</us-gaap:OperatingLeasesFutureMinimumPaymentsDueInThreeYears>
    <us-gaap:OperatingLeasesFutureMinimumPaymentsDueInThreeYears contextRef="AsOf2017-06-30_us-gaap_AutomobilesMember" unitRef="USD" decimals="-3">77000</us-gaap:OperatingLeasesFutureMinimumPaymentsDueInThreeYears>
    <us-gaap:OperatingLeasesFutureMinimumPaymentsDueInFourYears contextRef="AsOf2017-06-30_us-gaap_LandAndBuildingMember" unitRef="USD" decimals="-3">904000</us-gaap:OperatingLeasesFutureMinimumPaymentsDueInFourYears>
    <us-gaap:OperatingLeasesFutureMinimumPaymentsDue contextRef="AsOf2017-06-30_us-gaap_LandAndBuildingMember" unitRef="USD" decimals="-3">4018000</us-gaap:OperatingLeasesFutureMinimumPaymentsDue>
    <us-gaap:OperatingLeasesFutureMinimumPaymentsDue contextRef="AsOf2017-06-30_us-gaap_AutomobilesMember" unitRef="USD" decimals="-3">444000</us-gaap:OperatingLeasesFutureMinimumPaymentsDue>
    <us-gaap:ForeignCurrencyTransactionGainLossBeforeTax contextRef="D2016-07-01_To_2017-06-30" unitRef="USD" decimals="-3">182000</us-gaap:ForeignCurrencyTransactionGainLossBeforeTax>
    <us-gaap:ForeignCurrencyTransactionGainLossBeforeTax contextRef="D2014-07-01_To_2015-06-30" unitRef="USD" decimals="-3">-1109000</us-gaap:ForeignCurrencyTransactionGainLossBeforeTax>
    <us-gaap:ForeignCurrencyTransactionGainLossBeforeTax contextRef="From2015-07-01to2016-06-30" unitRef="USD" decimals="-3">-174000</us-gaap:ForeignCurrencyTransactionGainLossBeforeTax>
    <psti:InterestOnShortTermBankCreditAndBankExpenses contextRef="D2016-07-01_To_2017-06-30" unitRef="USD" decimals="-3">67000</psti:InterestOnShortTermBankCreditAndBankExpenses>
    <psti:InterestOnShortTermBankCreditAndBankExpenses contextRef="D2014-07-01_To_2015-06-30" unitRef="USD" decimals="-3">37000</psti:InterestOnShortTermBankCreditAndBankExpenses>
    <psti:InterestOnShortTermBankCreditAndBankExpenses contextRef="From2015-07-01to2016-06-30" unitRef="USD" decimals="-3">85000</psti:InterestOnShortTermBankCreditAndBankExpenses>
    <us-gaap:InterestIncomeDepositsWithFinancialInstitutions contextRef="D2016-07-01_To_2017-06-30" unitRef="USD" decimals="-3">122000</us-gaap:InterestIncomeDepositsWithFinancialInstitutions>
    <us-gaap:InterestIncomeDepositsWithFinancialInstitutions contextRef="D2014-07-01_To_2015-06-30" unitRef="USD" decimals="-3">112000</us-gaap:InterestIncomeDepositsWithFinancialInstitutions>
    <us-gaap:InterestIncomeDepositsWithFinancialInstitutions contextRef="From2015-07-01to2016-06-30" unitRef="USD" decimals="-3">149000</us-gaap:InterestIncomeDepositsWithFinancialInstitutions>
    <us-gaap:MarketableSecuritiesGainLoss contextRef="D2016-07-01_To_2017-06-30" unitRef="USD" decimals="-3">-513000</us-gaap:MarketableSecuritiesGainLoss>
    <us-gaap:MarketableSecuritiesGainLoss contextRef="D2014-07-01_To_2015-06-30" unitRef="USD" decimals="-3">1229000</us-gaap:MarketableSecuritiesGainLoss>
    <us-gaap:MarketableSecuritiesGainLoss contextRef="From2015-07-01to2016-06-30" unitRef="USD" decimals="-3">190000</us-gaap:MarketableSecuritiesGainLoss>
    <us-gaap:GainLossOnDerivativeInstrumentsNetPretax contextRef="D2016-07-01_To_2017-06-30" unitRef="USD" decimals="-3">481000</us-gaap:GainLossOnDerivativeInstrumentsNetPretax>
    <us-gaap:GainLossOnDerivativeInstrumentsNetPretax contextRef="D2014-07-01_To_2015-06-30" unitRef="USD" decimals="-3">395000</us-gaap:GainLossOnDerivativeInstrumentsNetPretax>
    <us-gaap:GainLossOnDerivativeInstrumentsNetPretax contextRef="From2015-07-01to2016-06-30" unitRef="USD" decimals="-3">-30000</us-gaap:GainLossOnDerivativeInstrumentsNetPretax>
    <us-gaap:OtherNonoperatingIncome contextRef="D2016-07-01_To_2017-06-30" unitRef="USD" xsi:nil="true" />
    <us-gaap:OtherNonoperatingIncome contextRef="D2014-07-01_To_2015-06-30" unitRef="USD" xsi:nil="true" />
    <us-gaap:OtherNonoperatingIncome contextRef="From2015-07-01to2016-06-30" unitRef="USD" decimals="-3">23000</us-gaap:OtherNonoperatingIncome>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsDomestic contextRef="I2016-06-30" unitRef="USD" decimals="-3">10210000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsDomestic>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsDomestic contextRef="AsOf2017-06-30" unitRef="USD" decimals="-3">11382000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsDomestic>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsForeign contextRef="I2016-06-30" unitRef="USD" decimals="-3">22105000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsForeign>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsForeign contextRef="AsOf2017-06-30" unitRef="USD" decimals="-3">26275000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsForeign>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals contextRef="I2016-06-30" unitRef="USD" decimals="-3">216000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals contextRef="AsOf2017-06-30" unitRef="USD" decimals="-3">222000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals>
    <us-gaap:DeferredTaxAssetsGross contextRef="I2016-06-30" unitRef="USD" decimals="-3">32531000</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:DeferredTaxAssetsGross contextRef="AsOf2017-06-30" unitRef="USD" decimals="-3">37879000</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:DeferredTaxAssetsValuationAllowance contextRef="I2016-06-30" unitRef="USD" decimals="-3">32531000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsValuationAllowance contextRef="AsOf2017-06-30" unitRef="USD" decimals="-3">37879000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsNet contextRef="I2016-06-30" unitRef="USD" xsi:nil="true" />
    <us-gaap:DeferredTaxAssetsNet contextRef="AsOf2017-06-30" unitRef="USD" xsi:nil="true" />
    <us-gaap:PreferredStockSharesAuthorized contextRef="AsOf2017-06-30" unitRef="Shares" decimals="INF">10000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockParOrStatedValuePerShare contextRef="AsOf2017-06-30" unitRef="usdpershare" decimals="INF">0.00001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:ConversionOfStockSharesConverted1 contextRef="From2014-07-01to2015-06-30_custom_InvestorWarrantsMember" unitRef="Shares" decimals="INF">2081303</us-gaap:ConversionOfStockSharesConverted1>
    <us-gaap:ConversionOfStockSharesIssued1 contextRef="From2014-07-01to2015-06-30_custom_InvestorWarrantsMember" unitRef="Shares" decimals="INF">963876</us-gaap:ConversionOfStockSharesIssued1>
    <us-gaap:StockIssuedDuringPeriodSharesOther contextRef="From2014-07-01to2015-06-30_custom_InvestorWarrantsMember" unitRef="Shares" decimals="INF">170167</us-gaap:StockIssuedDuringPeriodSharesOther>
    <psti:SharebasedCompensationArrangementWarrantsExercised contextRef="From2014-07-01to2015-06-30_custom_InvestorWarrantsMember" unitRef="Shares" decimals="INF">170167</psti:SharebasedCompensationArrangementWarrantsExercised>
    <us-gaap:ProceedsFromWarrantExercises contextRef="From2014-07-01to2015-06-30_custom_InvestorWarrantsMember" unitRef="USD" decimals="-3">276000</us-gaap:ProceedsFromWarrantExercises>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts contextRef="D2016-07-01_To_2017-06-30" unitRef="USD" decimals="-3">1532000</us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts contextRef="D2014-07-01_To_2015-06-30" unitRef="USD" decimals="-3">1200000</us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts>
    <us-gaap:ClassOfWarrantOrRightOutstanding contextRef="I2015-06-30" unitRef="Shares" decimals="INF">4080000</us-gaap:ClassOfWarrantOrRightOutstanding>
    <psti:ExpirationPeriodOfWarrantsSoldInOffering contextRef="From2014-07-01to2015-06-30_us-gaap_WarrantMember">P5Y</psti:ExpirationPeriodOfWarrantsSoldInOffering>
    <us-gaap:SharesIssuedPricePerShare contextRef="I2015-06-30" unitRef="usdpershare" decimals="INF">2.50</us-gaap:SharesIssuedPricePerShare>
    <us-gaap:SharesIssuedPricePerShare contextRef="AsOf2017-09-05_us-gaap_SubsequentEventMember" unitRef="usdpershare" decimals="INF">1.20</us-gaap:SharesIssuedPricePerShare>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized contextRef="AsOf2017-06-30_custom_Plan2005Member" unitRef="Shares" decimals="INF">19166082</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized contextRef="AsOf2017-06-30_custom_Plan2016Member" unitRef="Shares" decimals="INF">2584147</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant contextRef="AsOf2017-06-30_custom_Plan2005Member" unitRef="Shares" decimals="INF">3305428</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant contextRef="AsOf2017-06-30_custom_Plan2016Member" unitRef="Shares" decimals="INF">343327</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions contextRef="AsOf2017-06-30_us-gaap_WarrantMember" unitRef="Shares" decimals="INF">15748964</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions contextRef="AsOf2017-06-30_us-gaap_EmployeeStockOptionMember" unitRef="Shares" decimals="INF">992850</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions contextRef="AsOf2017-06-30_us-gaap_WarrantMember_custom_ExercisePriceRangeOneMember" unitRef="Shares" decimals="INF">8448981</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions contextRef="AsOf2017-06-30_us-gaap_WarrantMember_custom_ExercisePriceRangeTwoMember" unitRef="Shares" decimals="INF">4080000</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions contextRef="AsOf2017-06-30_us-gaap_WarrantMember_custom_ExercisePriceRangeThreeMember" unitRef="Shares" decimals="INF">3219983</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions contextRef="AsOf2017-06-30_us-gaap_EmployeeStockOptionMember_custom_ExercisePriceRangeFourMember" unitRef="Shares" decimals="INF">137200</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions contextRef="AsOf2017-06-30_us-gaap_EmployeeStockOptionMember_custom_ExercisePriceRangeFiveMember" unitRef="Shares" decimals="INF">345500</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions contextRef="AsOf2017-06-30_us-gaap_EmployeeStockOptionMember_custom_ExercisePriceRangeSixMember" unitRef="Shares" decimals="INF">25000</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions contextRef="AsOf2017-06-30_us-gaap_EmployeeStockOptionMember_custom_ExercisePriceRangeSevenMember" unitRef="Shares" decimals="INF">20000</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions contextRef="AsOf2017-06-30_us-gaap_EmployeeStockOptionMember_custom_ExercisePriceRangeEightMember" unitRef="Shares" decimals="INF">30000</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions contextRef="AsOf2017-06-30_us-gaap_EmployeeStockOptionMember_custom_ExercisePriceRangeNineMember" unitRef="Shares" decimals="INF">1000</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions contextRef="AsOf2017-06-30_us-gaap_EmployeeStockOptionMember_custom_ExercisePriceRangeTenMember" unitRef="Shares" decimals="INF">372500</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions contextRef="AsOf2017-06-30_us-gaap_EmployeeStockOptionMember_custom_ExercisePriceRangeElevenMember" unitRef="Shares" decimals="INF">400</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions contextRef="AsOf2017-06-30_us-gaap_EmployeeStockOptionMember_custom_ExercisePriceRangeTwelveMember" unitRef="Shares" decimals="INF">36250</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions contextRef="AsOf2017-06-30_us-gaap_EmployeeStockOptionMember_custom_ExercisePriceRangeThirteenMember" unitRef="Shares" decimals="INF">20000</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions contextRef="AsOf2017-06-30_us-gaap_EmployeeStockOptionMember_custom_ExercisePriceRangeFourteenMember" unitRef="Shares" decimals="INF">5000</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions contextRef="AsOf2017-06-30" unitRef="Shares" decimals="INF">16741814</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions contextRef="AsOf2017-06-30_us-gaap_WarrantMember" unitRef="Shares" decimals="INF">7299983</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions contextRef="AsOf2017-06-30_us-gaap_EmployeeStockOptionMember" unitRef="Shares" decimals="INF">980475</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions contextRef="AsOf2017-06-30_us-gaap_WarrantMember_custom_ExercisePriceRangeOneMember" unitRef="Shares" xsi:nil="true" />
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions contextRef="AsOf2017-06-30_us-gaap_WarrantMember_custom_ExercisePriceRangeTwoMember" unitRef="Shares" decimals="INF">4080000</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions contextRef="AsOf2017-06-30_us-gaap_WarrantMember_custom_ExercisePriceRangeThreeMember" unitRef="Shares" decimals="INF">3219983</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions contextRef="AsOf2017-06-30_us-gaap_EmployeeStockOptionMember_custom_ExercisePriceRangeFourMember" unitRef="Shares" decimals="INF">124825</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions contextRef="AsOf2017-06-30_us-gaap_EmployeeStockOptionMember_custom_ExercisePriceRangeFiveMember" unitRef="Shares" decimals="INF">345500</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions contextRef="AsOf2017-06-30_us-gaap_EmployeeStockOptionMember_custom_ExercisePriceRangeSixMember" unitRef="Shares" decimals="INF">25000</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions contextRef="AsOf2017-06-30_us-gaap_EmployeeStockOptionMember_custom_ExercisePriceRangeSevenMember" unitRef="Shares" decimals="INF">20000</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions contextRef="AsOf2017-06-30_us-gaap_EmployeeStockOptionMember_custom_ExercisePriceRangeEightMember" unitRef="Shares" decimals="INF">30000</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions contextRef="AsOf2017-06-30_us-gaap_EmployeeStockOptionMember_custom_ExercisePriceRangeNineMember" unitRef="Shares" decimals="INF">1000</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions contextRef="AsOf2017-06-30_us-gaap_EmployeeStockOptionMember_custom_ExercisePriceRangeTenMember" unitRef="Shares" decimals="INF">372500</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions contextRef="AsOf2017-06-30_us-gaap_EmployeeStockOptionMember_custom_ExercisePriceRangeElevenMember" unitRef="Shares" decimals="INF">400</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions contextRef="AsOf2017-06-30_us-gaap_EmployeeStockOptionMember_custom_ExercisePriceRangeTwelveMember" unitRef="Shares" decimals="INF">36250</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions contextRef="AsOf2017-06-30_us-gaap_EmployeeStockOptionMember_custom_ExercisePriceRangeThirteenMember" unitRef="Shares" decimals="INF">20000</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions contextRef="AsOf2017-06-30_us-gaap_EmployeeStockOptionMember_custom_ExercisePriceRangeFourteenMember" unitRef="Shares" decimals="INF">5000</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions contextRef="AsOf2017-06-30" unitRef="Shares" decimals="INF">8280458</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations contextRef="D2016-07-01_To_2017-06-30" unitRef="Pure" decimals="INF">0.00</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations contextRef="D2014-07-01_To_2015-06-30" unitRef="Pure" decimals="INF">0.00</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations contextRef="From2015-07-01to2016-06-30" unitRef="Pure" decimals="INF">0.00</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate contextRef="D2016-07-01_To_2017-06-30" unitRef="Pure" decimals="INF">0.24</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate contextRef="D2014-07-01_To_2015-06-30" unitRef="Pure" decimals="INF">0.265</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate contextRef="D2015-07-01_To_2016-06-30_MaximumMember" unitRef="Pure" decimals="INF">0.35</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate contextRef="D2015-07-01_To_2016-06-30_MinimumMember" unitRef="Pure" decimals="INF">0.24</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate contextRef="From2014-07-01to2015-06-30_us-gaap_MinimumMember" unitRef="Pure" decimals="INF">0.24</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate contextRef="From2014-07-01to2015-06-30_us-gaap_MaximumMember" unitRef="Pure" decimals="INF">0.35</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate contextRef="From2015-07-01to2016-06-30" unitRef="Pure" decimals="INF">0.25</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate contextRef="From2016-07-01to2017-06-30_us-gaap_MinimumMember" unitRef="Pure" decimals="INF">0.24</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate contextRef="From2016-07-01to2017-06-30_us-gaap_MaximumMember" unitRef="Pure" decimals="INF">0.35</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:OperatingLossCarryforwardsExpirationDate contextRef="From2016-07-01to2017-06-30_us-gaap_InternalRevenueServiceIRSMember_us-gaap_EarliestTaxYearMember">2024-12-31</us-gaap:OperatingLossCarryforwardsExpirationDate>
    <us-gaap:OperatingLossCarryforwardsExpirationDate contextRef="From2016-07-01to2017-06-30_us-gaap_InternalRevenueServiceIRSMember_us-gaap_LatestTaxYearMember">2037-12-31</us-gaap:OperatingLossCarryforwardsExpirationDate>
    <us-gaap:OperatingLossCarryforwards contextRef="AsOf2017-06-30_us-gaap_IsraelTaxAuthorityMember" unitRef="USD" decimals="-3">109480000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:OperatingLossCarryforwards contextRef="AsOf2017-06-30_us-gaap_InternalRevenueServiceIRSMember" unitRef="USD" decimals="-3">32519000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:StockholdersEquity contextRef="I2016-06-30" unitRef="USD" decimals="-3">38156000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="I2015-06-30" unitRef="USD" decimals="-3">58143000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="I2014-06-30" unitRef="USD" decimals="-3">62123000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="I2016-06-30_CommonStockMember" unitRef="USD" decimals="-3">1000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="I2016-06-30_AdditionalPaidInCapitalMember" unitRef="USD" decimals="-3">198432000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="I2016-06-30_AccumulatedOtherComprehensiveIncomeMember" unitRef="USD" decimals="-3">1480000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="I2014-06-30_CommonStockMember" unitRef="USD" id="Foot-00-3" xsi:nil="true" />
    <us-gaap:StockholdersEquity contextRef="I2014-06-30_AdditionalPaidInCapitalMember" unitRef="USD" decimals="-3">172998000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="I2014-06-30_ReceivablesFromStockholderMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:StockholdersEquity contextRef="I2015-06-30_CommonStockMember" unitRef="USD" decimals="-3">1000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="I2015-06-30_AdditionalPaidInCapitalMember" unitRef="USD" decimals="-3">195303000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="I2015-06-30_AccumulatedOtherComprehensiveIncomeMember" unitRef="USD" decimals="-3">2140000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="I2015-06-30_RetainedEarningsMember" unitRef="USD" decimals="-3">-138511000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="I2014-06-30_AccumulatedOtherComprehensiveIncomeMember" unitRef="USD" decimals="-3">2959000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="I2014-06-30_RetainedEarningsMember" unitRef="USD" decimals="-3">-113834000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="I2016-06-30_ReceivablesFromStockholderMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:StockholdersEquity contextRef="I2016-06-30_RetainedEarningsMember" unitRef="USD" decimals="-3">-161757000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="I2015-06-30_ReceivablesFromStockholderMember" unitRef="USD" decimals="-3">-790000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2017-06-30" unitRef="USD" decimals="-3">30251000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2017-06-30_us-gaap_CommonStockMember" unitRef="USD" decimals="-3">1000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2017-06-30_us-gaap_AdditionalPaidInCapitalMember" unitRef="USD" decimals="-3">217822000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2017-06-30_us-gaap_ReceivablesFromStockholderMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:StockholdersEquity contextRef="AsOf2017-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember" unitRef="USD" decimals="-3">1999000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2017-06-30_us-gaap_RetainedEarningsMember" unitRef="USD" decimals="-3">-189571000</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="D2014-07-01_To_2015-06-30" unitRef="USD" decimals="-3">15800000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="D2014-07-01_To_2015-06-30_CommonStockMember" unitRef="USD" decimals="-3">1000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="D2014-07-01_To_2015-06-30_AdditionalPaidInCapitalMember" unitRef="USD" decimals="-3">15799000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="D2014-07-01_To_2015-06-30_AccumulatedOtherComprehensiveIncomeMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="D2014-07-01_To_2015-06-30_ReceivablesFromStockholderMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="D2014-07-01_To_2015-06-30_RetainedEarningsMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="D2014-07-01_To_2015-06-30" unitRef="Shares" decimals="INF">6800000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="D2014-07-01_To_2015-06-30_CommonStockMember" unitRef="Shares" decimals="INF">6800000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="From2017-07-01to2017-09-05_us-gaap_SubsequentEventMember_custom_AtMarketIssuanceSalesAgreementMember" unitRef="Shares" decimals="INF">455731</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="D2016-07-01_To_2017-06-30" unitRef="USD" decimals="-3">10000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="D2014-07-01_To_2015-06-30" unitRef="USD" decimals="-3">11000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="D2014-07-01_To_2015-06-30_CommonStockMember" unitRef="USD" id="Foot-00-4" xsi:nil="true" />
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="D2015-07-01_To_2016-06-30_AccumulatedOtherComprehensiveIncomeMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="D2015-07-01_To_2016-06-30_RetainedEarningsMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="D2015-07-01_To_2016-06-30_CommonStockMember" unitRef="USD" id="Foot-00-5" xsi:nil="true" />
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="D2015-07-01_To_2016-06-30_AdditionalPaidInCapitalMember" unitRef="USD" decimals="-3">17000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="D2014-07-01_To_2015-06-30_AdditionalPaidInCapitalMember" unitRef="USD" decimals="-3">11000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="D2014-07-01_To_2015-06-30_AccumulatedOtherComprehensiveIncomeMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="D2014-07-01_To_2015-06-30_ReceivablesFromStockholderMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="D2014-07-01_To_2015-06-30_RetainedEarningsMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="From2015-07-01to2016-06-30_us-gaap_ReceivablesFromStockholderMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="From2015-07-01to2016-06-30" unitRef="USD" decimals="-3">17000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="From2016-07-01to2017-06-30_us-gaap_CommonStockMember" unitRef="USD" id="Foot-00-6" xsi:nil="true" />
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="From2016-07-01to2017-06-30_us-gaap_AdditionalPaidInCapitalMember" unitRef="USD" decimals="-3">10000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="From2016-07-01to2017-06-30_us-gaap_ReceivablesFromStockholderMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="From2016-07-01to2017-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="From2016-07-01to2017-06-30_us-gaap_RetainedEarningsMember" unitRef="USD" xsi:nil="true" />
    <psti:StockIssuedDuringPeriodValueStockWarrantsExercised contextRef="D2014-07-01_To_2015-06-30" unitRef="USD" decimals="-3">276000</psti:StockIssuedDuringPeriodValueStockWarrantsExercised>
    <psti:StockIssuedDuringPeriodValueStockWarrantsExercised contextRef="D2014-07-01_To_2015-06-30_CommonStockMember" unitRef="USD" id="Foot-00-7" xsi:nil="true" />
    <psti:StockIssuedDuringPeriodValueStockWarrantsExercised contextRef="D2014-07-01_To_2015-06-30_AdditionalPaidInCapitalMember" unitRef="USD" decimals="-3">276000</psti:StockIssuedDuringPeriodValueStockWarrantsExercised>
    <psti:StockIssuedDuringPeriodValueStockWarrantsExercised contextRef="D2014-07-01_To_2015-06-30_AccumulatedOtherComprehensiveIncomeMember" unitRef="USD" xsi:nil="true" />
    <psti:StockIssuedDuringPeriodValueStockWarrantsExercised contextRef="D2014-07-01_To_2015-06-30_ReceivablesFromStockholderMember" unitRef="USD" xsi:nil="true" />
    <psti:StockIssuedDuringPeriodValueStockWarrantsExercised contextRef="D2014-07-01_To_2015-06-30_RetainedEarningsMember" unitRef="USD" xsi:nil="true" />
    <psti:StockIssuedDuringPeriodSharesStockWarrantsExercised contextRef="D2014-07-01_To_2015-06-30_CommonStockMember" unitRef="Shares" decimals="INF">1134043</psti:StockIssuedDuringPeriodSharesStockWarrantsExercised>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation contextRef="D2016-07-01_To_2017-06-30" unitRef="USD" decimals="-3">3662000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation contextRef="D2014-07-01_To_2015-06-30" unitRef="USD" decimals="-3">4052000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation contextRef="D2014-07-01_To_2015-06-30_CommonStockMember" unitRef="USD" id="Foot-00-8" xsi:nil="true" />
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation contextRef="D2015-07-01_To_2016-06-30_AccumulatedOtherComprehensiveIncomeMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation contextRef="D2015-07-01_To_2016-06-30_RetainedEarningsMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation contextRef="D2015-07-01_To_2016-06-30_CommonStockMember" unitRef="USD" id="Foot-00-9" xsi:nil="true" />
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation contextRef="D2015-07-01_To_2016-06-30_AdditionalPaidInCapitalMember" unitRef="USD" decimals="-3">3073000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation contextRef="D2014-07-01_To_2015-06-30_AdditionalPaidInCapitalMember" unitRef="USD" decimals="-3">4052000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation contextRef="D2014-07-01_To_2015-06-30_AccumulatedOtherComprehensiveIncomeMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation contextRef="D2014-07-01_To_2015-06-30_ReceivablesFromStockholderMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation contextRef="D2014-07-01_To_2015-06-30_RetainedEarningsMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation contextRef="From2015-07-01to2016-06-30_us-gaap_ReceivablesFromStockholderMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation contextRef="From2015-07-01to2016-06-30" unitRef="USD" decimals="-3">3073000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation contextRef="From2016-07-01to2017-06-30_us-gaap_CommonStockMember" unitRef="USD" id="Foot-00-10" xsi:nil="true" />
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation contextRef="From2016-07-01to2017-06-30_us-gaap_AdditionalPaidInCapitalMember" unitRef="USD" decimals="-3">3662000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation contextRef="From2016-07-01to2017-06-30_us-gaap_ReceivablesFromStockholderMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation contextRef="From2016-07-01to2017-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation contextRef="From2016-07-01to2017-06-30_us-gaap_RetainedEarningsMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation contextRef="D2014-07-01_To_2015-06-30_CommonStockMember" unitRef="Shares" decimals="INF">1397406</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation contextRef="D2015-07-01_To_2016-06-30_CommonStockMember" unitRef="Shares" decimals="INF">1379094</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation contextRef="From2016-07-01to2017-06-30_us-gaap_CommonStockMember" unitRef="Shares" decimals="INF">2570257</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:NetIncomeLoss contextRef="D2016-07-01_To_2017-06-30" unitRef="USD" decimals="-3">-27814000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="D2014-07-01_To_2015-06-30" unitRef="USD" decimals="-3">-24677000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="D2014-07-01_To_2015-06-30_CommonStockMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:NetIncomeLoss contextRef="D2015-07-01_To_2016-06-30_AccumulatedOtherComprehensiveIncomeMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:NetIncomeLoss contextRef="D2015-07-01_To_2016-06-30_RetainedEarningsMember" unitRef="USD" decimals="-3">-23246000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="D2015-07-01_To_2016-06-30_CommonStockMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:NetIncomeLoss contextRef="D2015-07-01_To_2016-06-30_AdditionalPaidInCapitalMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:NetIncomeLoss contextRef="D2014-07-01_To_2015-06-30_AdditionalPaidInCapitalMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:NetIncomeLoss contextRef="D2014-07-01_To_2015-06-30_AccumulatedOtherComprehensiveIncomeMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:NetIncomeLoss contextRef="D2014-07-01_To_2015-06-30_ReceivablesFromStockholderMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:NetIncomeLoss contextRef="D2014-07-01_To_2015-06-30_RetainedEarningsMember" unitRef="USD" decimals="-3">-24677000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="From2015-07-01to2016-06-30_us-gaap_ReceivablesFromStockholderMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:NetIncomeLoss contextRef="From2015-07-01to2016-06-30" unitRef="USD" decimals="-3">-23246000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="From2016-07-01to2017-06-30_us-gaap_CommonStockMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:NetIncomeLoss contextRef="From2016-07-01to2017-06-30_us-gaap_AdditionalPaidInCapitalMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:NetIncomeLoss contextRef="From2016-07-01to2017-06-30_us-gaap_ReceivablesFromStockholderMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:NetIncomeLoss contextRef="From2016-07-01to2017-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:NetIncomeLoss contextRef="From2016-07-01to2017-06-30_us-gaap_RetainedEarningsMember" unitRef="USD" decimals="-3">-27814000</us-gaap:NetIncomeLoss>
    <psti:OperatingLeasedAssetsParticipationFromLessor contextRef="From2015-10-01to2015-10-31_us-gaap_LandAndBuildingMember" unitRef="USD" decimals="-3">947000</psti:OperatingLeasedAssetsParticipationFromLessor>
    <psti:OperatingLeasedAssetsParticipationFromLessor contextRef="From2013-01-01to2013-01-31_us-gaap_LandAndBuildingMember" unitRef="USD" decimals="-3">816000</psti:OperatingLeasedAssetsParticipationFromLessor>
    <us-gaap:OtherConstructionCosts contextRef="From2015-05-01to2015-05-31_currency_ILS" unitRef="ils" decimals="-3">4000000</us-gaap:OtherConstructionCosts>
    <us-gaap:DeferredRevenueAdditions contextRef="D2016-07-01_To_2017-06-30" unitRef="USD" decimals="-3">5000000</us-gaap:DeferredRevenueAdditions>
    <psti:BusinessCombinationContingentConsiderationReceivableUponCertainRegulatoryMilestones contextRef="D2016-07-01_To_2017-06-30" unitRef="USD" decimals="-3">37500000</psti:BusinessCombinationContingentConsiderationReceivableUponCertainRegulatoryMilestones>
    <psti:AdvancePaymentForDeveplomentCosts contextRef="D2016-07-01_To_2017-06-30" unitRef="USD" decimals="-3">2000000</psti:AdvancePaymentForDeveplomentCosts>
    <psti:LeaseholdImprovementsAnnualRateOfDepreciationDescription contextRef="From2016-07-01to2017-06-30_us-gaap_LeaseholdImprovementsMember">&lt;p style="margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;The shorter&#13;of the expected useful life or the reasonable assumed term of the lease.&lt;/font&gt;&lt;/p&gt;</psti:LeaseholdImprovementsAnnualRateOfDepreciationDescription>
    <us-gaap:AccountsReceivableNetCurrent contextRef="I2016-06-30" unitRef="USD" decimals="-3">2228000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent contextRef="AsOf2017-06-30" unitRef="USD" decimals="-3">1036000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue contextRef="I2016-06-30" unitRef="USD" decimals="-3">542000</us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue>
    <us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue contextRef="AsOf2017-06-30" unitRef="USD" decimals="-3">559000</us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue>
    <us-gaap:ShortTermInvestments contextRef="I2016-06-30" unitRef="USD" decimals="-3">8570000</us-gaap:ShortTermInvestments>
    <us-gaap:ShortTermInvestments contextRef="AsOf2017-06-30" unitRef="USD" decimals="-3">6235000</us-gaap:ShortTermInvestments>
    <us-gaap:Assets contextRef="I2016-06-30" unitRef="USD" decimals="-3">45941000</us-gaap:Assets>
    <us-gaap:Assets contextRef="AsOf2017-06-30" unitRef="USD" decimals="-3">37534000</us-gaap:Assets>
    <us-gaap:AssetsNoncurrent contextRef="I2016-06-30" unitRef="USD" decimals="-3">10345000</us-gaap:AssetsNoncurrent>
    <us-gaap:AssetsNoncurrent contextRef="AsOf2017-06-30" unitRef="USD" decimals="-3">8518000</us-gaap:AssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent contextRef="I2016-06-30" unitRef="USD" xsi:nil="true" />
    <us-gaap:OtherAssetsNoncurrent contextRef="AsOf2017-06-30" unitRef="USD" decimals="-3">34000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="I2016-06-30" unitRef="USD" decimals="-3">9216000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="AsOf2017-06-30" unitRef="USD" decimals="-3">7277000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent contextRef="I2016-06-30" unitRef="USD" decimals="-3">766000</us-gaap:DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent>
    <us-gaap:DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent contextRef="AsOf2017-06-30" unitRef="USD" decimals="-3">804000</us-gaap:DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent>
    <us-gaap:LongTermInvestments contextRef="I2016-06-30" unitRef="USD" decimals="-3">363000</us-gaap:LongTermInvestments>
    <us-gaap:LongTermInvestments contextRef="AsOf2017-06-30" unitRef="USD" decimals="-3">403000</us-gaap:LongTermInvestments>
    <us-gaap:NonoperatingIncomeExpense contextRef="D2016-07-01_To_2017-06-30" unitRef="USD" decimals="-3">205000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense contextRef="D2014-07-01_To_2015-06-30" unitRef="USD" decimals="-3">590000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense contextRef="From2015-07-01to2016-06-30" unitRef="USD" decimals="-3">73000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:OperatingIncomeLoss contextRef="D2016-07-01_To_2017-06-30" unitRef="USD" decimals="-3">-28019000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="D2014-07-01_To_2015-06-30" unitRef="USD" decimals="-3">-25267000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="From2015-07-01to2016-06-30" unitRef="USD" decimals="-3">-23319000</us-gaap:OperatingIncomeLoss>
    <us-gaap:GeneralAndAdministrativeExpense contextRef="D2016-07-01_To_2017-06-30" unitRef="USD" decimals="-3">6927000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense contextRef="D2014-07-01_To_2015-06-30" unitRef="USD" decimals="-3">6460000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense contextRef="From2015-07-01to2016-06-30" unitRef="USD" decimals="-3">6486000</us-gaap:GeneralAndAdministrativeExpense>
    <psti:ResearchAndDevelopmentExpensesNet contextRef="D2016-07-01_To_2017-06-30" unitRef="USD" decimals="-3">21092000</psti:ResearchAndDevelopmentExpensesNet>
    <psti:ResearchAndDevelopmentExpensesNet contextRef="D2014-07-01_To_2015-06-30" unitRef="USD" decimals="-3">19173000</psti:ResearchAndDevelopmentExpensesNet>
    <psti:ResearchAndDevelopmentExpensesNet contextRef="From2015-07-01to2016-06-30" unitRef="USD" decimals="-3">19580000</psti:ResearchAndDevelopmentExpensesNet>
    <psti:GovernmentAndThirdPartyGrantsReceived contextRef="D2016-07-01_To_2017-06-30" unitRef="USD" decimals="-3">2909000</psti:GovernmentAndThirdPartyGrantsReceived>
    <psti:GovernmentAndThirdPartyGrantsReceived contextRef="D2014-07-01_To_2015-06-30" unitRef="USD" decimals="-3">4243000</psti:GovernmentAndThirdPartyGrantsReceived>
    <psti:GovernmentAndThirdPartyGrantsReceived contextRef="From2015-07-01to2016-06-30" unitRef="USD" decimals="-3">3276000</psti:GovernmentAndThirdPartyGrantsReceived>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="D2016-07-01_To_2017-06-30" unitRef="USD" decimals="-3">24001000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="D2014-07-01_To_2015-06-30" unitRef="USD" decimals="-3">23416000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="From2015-07-01to2016-06-30" unitRef="USD" decimals="-3">22856000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:GrossProfit contextRef="D2016-07-01_To_2017-06-30" unitRef="USD" xsi:nil="true" />
    <us-gaap:GrossProfit contextRef="D2014-07-01_To_2015-06-30" unitRef="USD" decimals="-3">366000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit contextRef="From2015-07-01to2016-06-30" unitRef="USD" decimals="-3">2747000</us-gaap:GrossProfit>
    <us-gaap:CostOfRevenue contextRef="D2016-07-01_To_2017-06-30" unitRef="USD" xsi:nil="true" />
    <us-gaap:CostOfRevenue contextRef="D2014-07-01_To_2015-06-30" unitRef="USD" decimals="-3">13000</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue contextRef="From2015-07-01to2016-06-30" unitRef="USD" decimals="-3">100000</us-gaap:CostOfRevenue>
    <us-gaap:Revenues contextRef="D2016-07-01_To_2017-06-30" unitRef="USD" xsi:nil="true" />
    <us-gaap:Revenues contextRef="D2014-07-01_To_2015-06-30" unitRef="USD" decimals="-3">379000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="From2015-07-01to2016-06-30" unitRef="USD" decimals="-3">2847000</us-gaap:Revenues>
    <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted contextRef="D2016-07-01_To_2017-06-30" unitRef="Shares" decimals="INF">87426208</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
    <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted contextRef="D2014-07-01_To_2015-06-30" unitRef="Shares" decimals="INF">70284337</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
    <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted contextRef="From2015-07-01to2016-06-30" unitRef="Shares" decimals="INF">79547989</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
    <us-gaap:CashCashEquivalentsAndShortTermInvestments contextRef="AsOf2017-06-30" unitRef="USD" decimals="-3">26106000</us-gaap:CashCashEquivalentsAndShortTermInvestments>
    <psti:TotalGrantsAwardedToCliProgram contextRef="From2016-08-01to2016-08-31_currency_EUR" unitRef="euro" decimals="-3">7600000</psti:TotalGrantsAwardedToCliProgram>
    <psti:TotalGrantsAwardedToCliProgram contextRef="From2016-08-01to2016-08-31" unitRef="USD" decimals="-3">8700000</psti:TotalGrantsAwardedToCliProgram>
    <psti:AmountOfGrantsAwardedToCliProgramAllocatedToCompany contextRef="From2016-08-01to2016-08-31_currency_EUR" unitRef="euro" decimals="-3">1900000</psti:AmountOfGrantsAwardedToCliProgramAllocatedToCompany>
    <psti:AmountOfGrantsAwardedToCliProgramAllocatedToCompany contextRef="From2016-08-01to2016-08-31" unitRef="USD" decimals="-3">2200000</psti:AmountOfGrantsAwardedToCliProgramAllocatedToCompany>
    <psti:AmountOfGrantsReceivedConditionalAward contextRef="From2016-07-01to2017-06-30_custom_BinationalIndustrialResearchAndDevelopmentFoundationMember" unitRef="USD" decimals="-3">900000</psti:AmountOfGrantsReceivedConditionalAward>
    <psti:AmountOfDirectGrantAllocatedToTheCompany contextRef="From2016-07-01to2017-06-30_custom_BinationalIndustrialResearchAndDevelopmentFoundationMember" unitRef="USD" decimals="-3">585000</psti:AmountOfDirectGrantAllocatedToTheCompany>
    <psti:TermOfRoyaltyGrantReceived contextRef="From2016-07-01to2017-06-30_custom_SmartMoneyGrantMember">P5Y</psti:TermOfRoyaltyGrantReceived>
    <psti:NumberOfSharesAgreedToBeSoldThroughUnderwriterAgreement contextRef="AsOf2017-01-25_custom_UnderwritingAgreementMember" unitRef="Shares" decimals="INF">14081633</psti:NumberOfSharesAgreedToBeSoldThroughUnderwriterAgreement>
    <psti:NumberOfWarrantsAgreedToBeSoldThroughUnderwriterAgreement contextRef="AsOf2017-01-25_custom_UnderwritingAgreementMember" unitRef="Shares" decimals="INF">8448980</psti:NumberOfWarrantsAgreedToBeSoldThroughUnderwriterAgreement>
    <psti:GrossProceedsFromIssuanceOfCommonStock contextRef="From2017-01-01to2017-01-25_custom_UnderwritingAgreementMember" unitRef="USD" decimals="-3">17250000</psti:GrossProceedsFromIssuanceOfCommonStock>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 contextRef="AsOf2015-06-30_us-gaap_WarrantMember" unitRef="usdpershare" decimals="INF">2.85</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 contextRef="AsOf2017-01-25_custom_UnderwritingAgreementMember" unitRef="usdpershare" decimals="INF">1.40</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber contextRef="AsOf2016-06-30_custom_EmployeesAndDirectorsMember" unitRef="Shares" decimals="INF">1771700</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber contextRef="AsOf2017-06-30_custom_EmployeesAndDirectorsMember" unitRef="Shares" decimals="INF">815650</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber contextRef="AsOf2016-06-30_custom_NonemployeesMember" unitRef="Shares" decimals="INF">237300</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber contextRef="AsOf2017-06-30_custom_NonemployeesMember" unitRef="Shares" decimals="INF">177200</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod contextRef="From2016-07-01to2017-06-30_custom_EmployeesAndDirectorsMember" unitRef="Shares" decimals="INF">940050</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod contextRef="From2016-07-01to2017-06-30_custom_NonemployeesMember" unitRef="Shares" decimals="INF">105000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber contextRef="AsOf2017-06-30_custom_EmployeesAndDirectorsMember" unitRef="Shares" decimals="INF">815650</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber contextRef="AsOf2017-06-30_custom_NonemployeesMember" unitRef="Shares" decimals="INF">164825</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber contextRef="AsOf2017-06-30_custom_EmployeesAndDirectorsMember" unitRef="Shares" decimals="INF">815650</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber contextRef="AsOf2017-06-30_custom_NonemployeesMember" unitRef="Shares" decimals="INF">177200</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice contextRef="From2016-07-01to2017-06-30_custom_EmployeesAndDirectorsMember" unitRef="usdpershare" decimals="INF">0.62</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice contextRef="From2016-07-01to2017-06-30_custom_NonemployeesMember" unitRef="usdpershare" decimals="INF">0.00</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice contextRef="From2016-07-01to2017-06-30_custom_EmployeesAndDirectorsMember" unitRef="usdpershare" decimals="INF">4.49</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice contextRef="From2016-07-01to2017-06-30_custom_NonemployeesMember" unitRef="usdpershare" decimals="INF">10.98</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice contextRef="AsOf2017-06-30_custom_EmployeesAndDirectorsMember" unitRef="usdpershare" decimals="INF">2.98</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice contextRef="AsOf2017-06-30_custom_NonemployeesMember" unitRef="usdpershare" decimals="INF">0.78</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice contextRef="AsOf2017-06-30_custom_EmployeesAndDirectorsMember" unitRef="usdpershare" decimals="INF">2.98</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice contextRef="AsOf2017-06-30_custom_NonemployeesMember" unitRef="usdpershare" decimals="INF">0.72</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1 contextRef="From2016-07-01to2017-06-30_custom_EmployeesAndDirectorsMember">P0Y9M25D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1 contextRef="From2016-07-01to2017-06-30_custom_NonemployeesMember">P3Y11M1D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1 contextRef="From2016-07-01to2017-06-30_custom_EmployeesAndDirectorsMember">P0Y9M25D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1 contextRef="From2016-07-01to2017-06-30_custom_NonemployeesMember">P4Y3M19D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue contextRef="AsOf2017-06-30_custom_EmployeesAndDirectorsMember" unitRef="USD" decimals="-3">231000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue contextRef="AsOf2017-06-30_custom_NonemployeesMember" unitRef="USD" decimals="-3">179000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 contextRef="AsOf2017-06-30_custom_EmployeesAndDirectorsMember" unitRef="USD" decimals="-3">231000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 contextRef="AsOf2017-06-30_custom_NonemployeesMember" unitRef="USD" decimals="-3">163000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue contextRef="AsOf2017-06-30_custom_EmployeesAndDirectorsMember" unitRef="USD" decimals="-3">231000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue contextRef="AsOf2017-06-30_custom_NonemployeesMember" unitRef="USD" decimals="-3">179000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross contextRef="From2016-07-01to2017-06-30_custom_NonemployeesMember" unitRef="Shares" decimals="INF">46800</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice contextRef="From2016-07-01to2017-06-30_custom_NonemployeesMember" unitRef="usdpershare" decimals="INF">0.00</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod contextRef="From2016-07-01to2017-06-30_custom_EmployeesAndDirectorsMember_us-gaap_RestrictedStockUnitsRSUMember" unitRef="Shares" decimals="INF">107953</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <psti:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVest contextRef="AsOf2017-06-30_us-gaap_RestrictedStockUnitsRSUMember_custom_EmployeesAndDirectorsMember" unitRef="Shares" decimals="INF">5978114</psti:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVest>
    <us-gaap:GrantsReceivable contextRef="AsOf2017-07-31_us-gaap_SubsequentEventMember_custom_SmartMoneyGrantMember" unitRef="USD" decimals="-3">229000</us-gaap:GrantsReceivable>
    <us-gaap:ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock contextRef="From2016-07-01to2017-06-30_us-gaap_LandAndBuildingMember">&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 35.45pt"&gt;As of June 30, 2017, aggregate minimum lease commitments under the active operating lease agreements are as follows:&lt;/div&gt;&#13;&#13;&lt;div style="line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div&gt;&#13;&lt;table id="za09af2fca2c7484d97018003bd3aaf5a" cellspacing="0" cellpadding="0" align="center" border="0" style="font: 10pt Times New Roman, Times, serif; width: 70%"&gt;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: top"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 6.95pt; text-indent: -6.95pt"&gt;Year ending June 30,&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="vertical-align: bottom; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: top; width: 88%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 6.95pt; text-indent: -6.95pt"&gt;2018&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;884&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: top; width: 88%; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 6.95pt; text-indent: -6.95pt"&gt;2019&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;884&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: top; width: 88%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 6.95pt; text-indent: -6.95pt"&gt;2020&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;894&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: top; width: 88%; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 6.95pt; text-indent: -6.95pt"&gt;2021&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;904&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: top; padding-bottom: 2px; width: 88%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 6.95pt; text-indent: -6.95pt"&gt;2022&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;452&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: top; padding-bottom: 4px; width: 88%; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 6.95pt; text-indent: -6.95pt"&gt;Total&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 4px; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;4,018&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;/div&gt;</us-gaap:ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock>
    <us-gaap:ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock contextRef="From2016-07-01to2017-06-30_us-gaap_AutomobilesMember">&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 35.45pt"&gt;As of June 30, 2017, future aggregate minimum lease commitments under non-cancelable operating lease agreements are as follows:&lt;/div&gt;&#13;&#13;&lt;div style="line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div&gt;&#13;&lt;table id="z4f5dd2bb987c46d5bc7bca52a9a11c62" cellspacing="0" cellpadding="0" align="center" border="0" style="font: 10pt Times New Roman, Times, serif; width: 70%"&gt;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: top"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left"&gt;Year ending June 30,&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="vertical-align: bottom; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: top; width: 88%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left"&gt;2018&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;225&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: top; width: 88%; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left"&gt;2019&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;142&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: top; padding-bottom: 2px; width: 88%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left"&gt;2020&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;77&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: top; padding-bottom: 4px; width: 88%; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left"&gt;Total&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 4px; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;444&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;/div&gt;</us-gaap:ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock>
    <psti:NonrefundableAdvanceUnderTermsOfLicenseAgreement contextRef="D2011-08-01_To_2011-08-31" unitRef="USD" decimals="-3">5000000</psti:NonrefundableAdvanceUnderTermsOfLicenseAgreement>
    <psti:ValueOfCommonStockCompanyCanPeriodicallyIssueThroughAgentsPerTermsOfAtmAgreement contextRef="From2017-07-01to2017-09-05_us-gaap_SubsequentEventMember_custom_AtMarketIssuanceSalesAgreementMember" unitRef="USD" decimals="-3">80000000</psti:ValueOfCommonStockCompanyCanPeriodicallyIssueThroughAgentsPerTermsOfAtmAgreement>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="D2016-07-01_To_2017-06-30" unitRef="USD" decimals="-3">-21611000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="D2014-07-01_To_2015-06-30" unitRef="USD" decimals="-3">-20605000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="From2015-07-01to2016-06-30" unitRef="USD" decimals="-3">-18522000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="D2016-07-01_To_2017-06-30" unitRef="USD" decimals="-3">4298000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="D2014-07-01_To_2015-06-30" unitRef="USD" decimals="-3">21537000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="From2015-07-01to2016-06-30" unitRef="USD" decimals="-3">1312000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="D2016-07-01_To_2017-06-30" unitRef="USD" decimals="-3">15797000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="D2014-07-01_To_2015-06-30" unitRef="USD" decimals="-3">17201000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="From2015-07-01to2016-06-30" unitRef="USD" decimals="-3">807000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <psti:IssuanceOfCommonStockAndWarrantsRelatedToJanuaryTwentySeventeenOfferingNetOfIssuanceCostsShares contextRef="From2016-07-01to2017-06-30_us-gaap_CommonStockMember" unitRef="Shares" decimals="INF">14081633</psti:IssuanceOfCommonStockAndWarrantsRelatedToJanuaryTwentySeventeenOfferingNetOfIssuanceCostsShares>
    <psti:IssuanceOfCommonStockAndWarrantsRelatedToJanuaryTwentySeventeenOfferingNetOfIssuanceCostsValue contextRef="D2016-07-01_To_2017-06-30" unitRef="USD" decimals="-3">15718000</psti:IssuanceOfCommonStockAndWarrantsRelatedToJanuaryTwentySeventeenOfferingNetOfIssuanceCostsValue>
    <psti:IssuanceOfCommonStockAndWarrantsRelatedToJanuaryTwentySeventeenOfferingNetOfIssuanceCostsValue contextRef="From2016-07-01to2017-06-30_us-gaap_CommonStockMember" unitRef="USD" id="Foot-00-11" xsi:nil="true" />
    <psti:IssuanceOfCommonStockAndWarrantsRelatedToJanuaryTwentySeventeenOfferingNetOfIssuanceCostsValue contextRef="From2016-07-01to2017-06-30_us-gaap_AdditionalPaidInCapitalMember" unitRef="USD" decimals="-3">15718000</psti:IssuanceOfCommonStockAndWarrantsRelatedToJanuaryTwentySeventeenOfferingNetOfIssuanceCostsValue>
    <psti:IssuanceOfCommonStockAndWarrantsRelatedToJanuaryTwentySeventeenOfferingNetOfIssuanceCostsValue contextRef="From2016-07-01to2017-06-30_us-gaap_ReceivablesFromStockholderMember" unitRef="USD" xsi:nil="true" />
    <psti:IssuanceOfCommonStockAndWarrantsRelatedToJanuaryTwentySeventeenOfferingNetOfIssuanceCostsValue contextRef="From2016-07-01to2017-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember" unitRef="USD" xsi:nil="true" />
    <psti:IssuanceOfCommonStockAndWarrantsRelatedToJanuaryTwentySeventeenOfferingNetOfIssuanceCostsValue contextRef="From2016-07-01to2017-06-30_us-gaap_RetainedEarningsMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:OperatingLeasesFutureMinimumPaymentsDueInFiveYears contextRef="AsOf2017-06-30_us-gaap_LandAndBuildingMember" unitRef="USD" decimals="-3">452000</us-gaap:OperatingLeasesFutureMinimumPaymentsDueInFiveYears>
    <us-gaap:ProceedsFromPaymentsForOtherFinancingActivities contextRef="D2016-07-01_To_2017-06-30" unitRef="USD" decimals="-3">69000</us-gaap:ProceedsFromPaymentsForOtherFinancingActivities>
    <us-gaap:ProceedsFromPaymentsForOtherFinancingActivities contextRef="D2014-07-01_To_2015-06-30" unitRef="USD" xsi:nil="true" />
    <us-gaap:ProceedsFromPaymentsForOtherFinancingActivities contextRef="From2015-07-01to2016-06-30" unitRef="USD" xsi:nil="true" />
    <psti:CorporateStatutoryTaxRateOn2018AndThereafter contextRef="D2016-07-01_To_2017-06-30" unitRef="Pure" decimals="INF">0.23</psti:CorporateStatutoryTaxRateOn2018AndThereafter>
    <psti:CorporateStatutoryTaxRateOn2017AndThereafter contextRef="From2016-07-01to2017-06-30_custom_TechnologicalPreferredEnterpriseMember" unitRef="Pure" decimals="INF">.12</psti:CorporateStatutoryTaxRateOn2017AndThereafter>
    <psti:CorporateStatutoryTaxRateOn2017AndThereafter contextRef="From2016-07-01to2017-06-30_custom_PreferredEnterpriseMember_custom_DevelopmentAreaMember" unitRef="Pure" decimals="INF">0.075</psti:CorporateStatutoryTaxRateOn2017AndThereafter>
    <psti:CorporateStatutoryTaxRateOn2017AndThereafter contextRef="From2016-07-01to2017-06-30_custom_TechnologicalPreferredEnterpriseMember_custom_DevelopmentAreaMember" unitRef="Pure" decimals="INF">.075</psti:CorporateStatutoryTaxRateOn2017AndThereafter>
    <psti:CorporateStatutoryTaxRateOn2016 contextRef="From2016-07-01to2017-06-30_custom_PreferredEnterpriseMember_custom_DevelopmentAreaMember" unitRef="Pure" decimals="INF">0.09</psti:CorporateStatutoryTaxRateOn2016>
    <psti:CorporateStatutoryTaxRateOn2016AndThereafter contextRef="From2016-07-01to2017-06-30_custom_PreferredEnterpriseMember_custom_RestOfCountryMember" unitRef="Pure" decimals="INF">0.16</psti:CorporateStatutoryTaxRateOn2016AndThereafter>
    <psti:CorporateStatutoryTaxRateOnProfitsDerivingFromIntellectualProperty contextRef="From2016-07-01to2017-06-30_custom_SpecialTechnologicalPreferredEnterpriseMember" unitRef="Pure" decimals="INF">.06</psti:CorporateStatutoryTaxRateOnProfitsDerivingFromIntellectualProperty>
    <psti:CorporateStatutoryTaxRateForDividendsDistributedToIndividualsOrForeignResidentsDistributedFromPreferredEnterpriseProfits contextRef="From2016-07-01to2017-06-30_custom_PreferredEnterpriseMember" unitRef="Pure" decimals="INF">.20</psti:CorporateStatutoryTaxRateForDividendsDistributedToIndividualsOrForeignResidentsDistributedFromPreferredEnterpriseProfits>
    <psti:CorporateStatutoryTaxRateForDividendsDistributedToForeignCompanies contextRef="From2016-07-01to2017-06-30_custom_TechnologicalEnterpriseMember" unitRef="Pure" decimals="INF">0.04</psti:CorporateStatutoryTaxRateForDividendsDistributedToForeignCompanies>
    <us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock contextRef="D2016-07-01_To_2017-06-30">&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: left"&gt;NOTE 3:- MARKETABLE SECURITIES&lt;/div&gt;&#13;&#13;&lt;div style="line-height: 1.25"&gt;&lt;br style="line-height: 1.25" /&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 35.45pt"&gt;As of June 30, 2017 and 2016, all of the Company&amp;#8217;s marketable securities were classified as available-for-sale.&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 35.45pt"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div&gt;&#13;&lt;table id="z17c89b572ecf496caa4468908301afa4" cellspacing="0" cellpadding="0" align="right" border="0" style="font: 10pt Times New Roman, Times, serif; width: 94%"&gt;&#13;&lt;tr style="height: 12px"&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="18" style="vertical-align: bottom; vertical-align: top; border-bottom: #000000 2px solid; font-weight: bold; text-align: center"&gt;June 30, 2017&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="18" style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid"&gt;&#13;&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center"&gt;June 30, 2016&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: center"&gt;&lt;font style="font: bold 10pt Times New Roman, Times, serif"&gt;Amortized cos&lt;/font&gt;t&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid"&gt;&#13;&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center"&gt;Gross&lt;/div&gt;&#13;&#13;&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center"&gt;unrealized&lt;/div&gt;&#13;&#13;&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center"&gt;gain&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid"&gt;&#13;&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center"&gt;Gross&lt;/div&gt;&#13;&#13;&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center"&gt;unrealized&lt;/div&gt;&#13;&#13;&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center"&gt;loss&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="vertical-align: bottom; vertical-align: top; border-bottom: #000000 2px solid"&gt;&#13;&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center"&gt;Other-than-temporary impairment&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid"&gt;&#13;&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center"&gt;Fair&lt;/div&gt;&#13;&#13;&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center"&gt;value&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid"&gt;&#13;&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center"&gt;Amortized cost&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid"&gt;&#13;&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center"&gt;Gross&lt;/div&gt;&#13;&#13;&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center"&gt;unrealized&lt;/div&gt;&#13;&#13;&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center"&gt;gain&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid"&gt;&#13;&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center"&gt;Gross&lt;/div&gt;&#13;&#13;&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center"&gt;unrealized&lt;/div&gt;&#13;&#13;&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center"&gt;loss&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="vertical-align: bottom; vertical-align: top; border-bottom: #000000 2px solid"&gt;&#13;&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center"&gt;Other-than-temporary impairment&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid"&gt;&#13;&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center"&gt;Fair&lt;/div&gt;&#13;&#13;&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center"&gt;value&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; background-color: #cceeff"&gt;&#13;&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 8.65pt; text-indent: 0.7pt"&gt;Available-for-sale - matures within one year:&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="vertical-align: bottom; vertical-align: bottom; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="vertical-align: bottom; vertical-align: bottom; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="vertical-align: bottom; vertical-align: bottom; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="vertical-align: bottom; vertical-align: top; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="vertical-align: bottom; vertical-align: bottom; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="vertical-align: bottom; vertical-align: bottom; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="vertical-align: bottom; vertical-align: bottom; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="vertical-align: bottom; vertical-align: bottom; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="vertical-align: bottom; vertical-align: top; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="vertical-align: bottom; vertical-align: bottom; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; width: 20%; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 8.65pt; text-indent: 0.7pt"&gt;Stock and index linked notes&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 5%; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;11,988&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 5%; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;2,014&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 5%; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;(47&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;)&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 5%; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;(767&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;)&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 5%; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;13,188&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 5%; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;11,599&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 5%; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;1,594&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 5%; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;(208&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;)&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 5%; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;(38&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;)&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 5%; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;12,947&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; width: 20%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 8.65pt; text-indent: 0.7pt"&gt;Government debentures &amp;#8211; fixed interest rate&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 5%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;157&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 5%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;1&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 5%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;-&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 5%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;-&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 5%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;158&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 5%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;786&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 5%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;12&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 5%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;-&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 5%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;-&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 5%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;798&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; width: 20%; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 8.65pt; text-indent: 0.7pt"&gt;Corporate debentures &amp;#8211; fixed interest rate&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 5%; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;47&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 5%; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;1&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 5%; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;-&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 5%; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;-&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 5%; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;48&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 5%; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;439&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 5%; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;7&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 5%; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;-&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 5%; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;-&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 5%; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;446&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; width: 20%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 5%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;12,192&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 5%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;2,016&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 5%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;(47&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;)&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 5%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;(767&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;)&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 5%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;13,394&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 5%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;12,824&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 5%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;1,613&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 5%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;(208&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;)&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 5%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;(38&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;)&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 5%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;14,191&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; width: 20%; background-color: #ffffff"&gt;&#13;&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 8.65pt"&gt;Available-for-sale - matures after one year through five years:&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 5%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 5%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 5%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 5%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 5%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 5%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 5%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 5%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 5%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 5%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; width: 20%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 8.65pt; text-indent: 0.7pt"&gt;Government debentures &amp;#8211; fixed interest rate&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 5%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;468&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 5%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;23&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 5%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;-&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 5%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;-&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 5%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;491&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 5%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;717&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 5%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;27&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 5%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;-&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 5%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;-&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 5%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;744&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; width: 20%; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 8.65pt"&gt;Corporate debentures &amp;#8211; fixed interest rate&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 5%; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;1,255&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 5%; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;7&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 5%; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;(1&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;)&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 5%; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;-&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 5%; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;1,261&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 5%; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;2,403&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 5%; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;47&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 5%; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;-&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 5%; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;-&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 5%; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;2,450&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; width: 20%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 5%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;1,723&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 5%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;30&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 5%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;(1&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;)&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 5%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;-&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 5%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;1,752&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 5%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;3,120&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 5%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;74&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 5%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;-&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 5%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;-&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 5%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;3,194&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; width: 20%; background-color: #ffffff"&gt;&#13;&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 8.65pt; text-indent: 0.7pt"&gt;Available-for-sale - matures after five years through ten years:&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 5%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 5%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 5%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 5%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 5%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 5%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 5%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 5%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 5%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 5%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; width: 20%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 8.65pt; text-indent: 0.7pt"&gt;Corporate debentures &amp;#8211; fixed interest rate&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 5%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;17&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 5%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;1&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 5%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;-&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 5%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;-&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 5%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;18&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 5%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;29&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 5%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;1&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 5%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;-&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 5%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;-&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 5%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;30&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; width: 20%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 5%; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;17&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 5%; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;1&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 5%; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;-&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 5%; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;-&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 5%; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;18&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 5%; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;29&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 5%; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;1&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 5%; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;-&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 5%; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;-&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 5%; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;30&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 4px; width: 20%; background-color: #cceeff"&gt;&#13;&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 8.65pt; text-indent: 0.7pt"&gt;Total&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 4px; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 5%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;13,932&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 4px; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 5%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;2,047&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 4px; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 5%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;(48&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;)&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 4px; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 5%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;(767&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;)&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 4px; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 5%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;15,164&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 4px; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 5%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;15,973&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 4px; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 5%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;1,688&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 4px; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 5%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;(208&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;)&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 4px; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 5%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;(38&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;)&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 4px; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 5%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;17,415&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="line-height: 1.25"&gt;&lt;br style="line-height: 1.25" /&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 34.1pt"&gt;The following table presents gross unrealized losses and fair values for those investments that were in an unrealized loss position as of June 30, 2017 and June 30, 2016, and the length of time that those investments have been in a continuous loss position:&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 7.1pt"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div&gt;&#13;&lt;table id="z2ddad5786c9049a9adbfbf0b1b61d13c" cellspacing="0" cellpadding="0" align="right" border="0" style="font: 10pt Times New Roman, Times, serif; width: 94%"&gt;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="6" style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid"&gt;&#13;&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center"&gt;12 months or less&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="6" style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid"&gt;&#13;&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center"&gt;Greater than 12 months&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid"&gt;&#13;&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center"&gt;Fair Value&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid"&gt;&#13;&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center"&gt;Gross&lt;font style="font: 10pt Times New Roman, Times, serif"&gt;&lt;br /&gt;&#13;&lt;/font&gt;unrealized loss&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid"&gt;&#13;&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center"&gt;Fair Value&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid"&gt;&#13;&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center"&gt;Gross&lt;font style="font: 10pt Times New Roman, Times, serif"&gt;&lt;br /&gt;&#13;&lt;/font&gt;unrealized loss&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; width: 52%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 8.65pt; text-indent: 0.7pt"&gt;As of June 30, 2017&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;869&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;(24&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;)&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;106&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;(&lt;font style="font: 10pt Times New Roman, Times, serif"&gt;2&lt;/font&gt;4&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;)&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; width: 52%; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 8.65pt"&gt;As of June 30, 2016&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;1,258&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;(143&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;)&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;563&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;(65&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;)&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="clear: both; line-height: 1.25"&gt;&lt;br style="line-height: 1.25" /&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 36pt"&gt;The Company typically invests in highly-rated securities. When evaluating the investments for other-than-temporary impairment, the Company reviews factors such as the length of time and extent to which fair value has been below cost basis, the financial condition of the issuer and any changes thereto, and the Company's intent to sell, or whether it is more likely than not it will be required to sell, the investment before recovery of the investment's amortized cost basis.&lt;/div&gt;&#13;&#13;&lt;div style="line-height: 1.25"&gt;&lt;br style="line-height: 1.25" /&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 36pt"&gt;Based on the above factors, the Company concluded that unrealized losses in the amount of $48 on all available-for-sale securities were not other-than-temporary and no credit loss was present for any of its investments. The Company recognized other-than-temporary impairment loss on outstanding securities during the year ended June 30, 2017 and 2016, of $767 and $38, respectively.&lt;/div&gt;&#13;&#13;&lt;div style="margin-left: 9pt; line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 27pt; text-indent: 7.1pt"&gt;As of June 30, 2017 and 2016, interest receivable amounted to $11 and $28, respectively.&lt;/div&gt;</us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock>
    <us-gaap:FairValueDisclosuresTextBlock contextRef="D2016-07-01_To_2017-06-30">&lt;div style="line-height: 1.25"&gt;&lt;/div&gt;&#13;&#13;&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: left"&gt;NOTE 4:- FAIR VALUE OF FINANCIAL INSTRUMENTS&lt;/div&gt;&#13;&#13;&lt;div style="line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div&gt;&#13;&lt;table id="z900a4c6ca5f447c0aafaf4e29e3bf035" cellspacing="0" cellpadding="0" align="right" border="0" style="font: 10pt Times New Roman, Times, serif; width: 94%"&gt;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="6" style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid"&gt;&#13;&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center"&gt;June 30, 2017&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="6" style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid"&gt;&#13;&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center"&gt;June 30, 2016&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid"&gt;&#13;&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center"&gt;Level 1&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid"&gt;&#13;&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center"&gt;Level 2&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid"&gt;&#13;&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center"&gt;Level 1&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid"&gt;&#13;&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center"&gt;Level 2&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; width: 52%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 8.65pt; text-indent: 0.7pt"&gt;Marketable securities&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;10,523&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;4,641&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;11,228&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;6,187&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; width: 52%; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 8.65pt; text-indent: 0.7pt"&gt;Foreign currency derivative instruments not designated as hedge instruments&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;-&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;295&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;-&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;65&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 4px; width: 52%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 8.65pt; text-indent: 0.7pt"&gt;Total financial assets&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 4px; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;10,523&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 4px; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;4,936&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 4px; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;11,228&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 4px; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;6,252&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:FairValueDisclosuresTextBlock>
    <us-gaap:OtherCurrentAssetsTextBlock contextRef="D2016-07-01_To_2017-06-30">&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 36pt; text-indent: -36pt"&gt;NOTE 5:-OTHER CURRENT ASSETS&lt;/div&gt;&#13;&#13;&lt;div style="line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div&gt;&#13;&lt;table id="zfa607ab951ff484e866f040412187dff" cellspacing="0" cellpadding="0" align="right" border="0" style="font: 10pt Times New Roman, Times, serif; width: 94%"&gt;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="6" style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid"&gt;&#13;&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center"&gt;June 30,&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid"&gt;&#13;&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center"&gt;2017&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid"&gt;&#13;&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center"&gt;2016&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: top; width: 76%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 8.65pt; text-indent: 0.7pt"&gt;Prepaid expenses&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;882&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;300&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: top; width: 76%; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 8.65pt; text-indent: 0.7pt"&gt;Accounts receivable from the Ministry of Economy&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;-&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;23&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: top; width: 76%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 8.65pt; text-indent: 0.7pt"&gt;Derivatives not designated as hedge instruments&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;295&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;65&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: top; width: 76%; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 8.65pt; text-indent: 0.7pt"&gt;VAT receivables&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;137&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;167&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: top; padding-bottom: 2px; width: 76%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 8.65pt; text-indent: 0.7pt"&gt;Other receivables&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;1&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;63&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: top; padding-bottom: 4px; width: 76%; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 8.65pt; text-indent: 0.7pt"&gt;Total&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 4px; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;1,315&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 4px; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;618&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;/div&gt;</us-gaap:OtherCurrentAssetsTextBlock>
    <us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock contextRef="D2016-07-01_To_2017-06-30">&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 36pt; text-indent: -36pt"&gt;NOTE 6:-PROPERTY AND EQUIPMENT, NET&lt;/div&gt;&#13;&#13;&lt;div style="line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div&gt;&#13;&lt;table id="zdc26d7b242f24d7cab1183be09ef8d89" cellspacing="0" cellpadding="0" align="right" border="0" style="font: 10pt Times New Roman, Times, serif; width: 94%"&gt;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: middle; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="6" style="vertical-align: bottom; vertical-align: top; border-bottom: #000000 2px solid"&gt;&#13;&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center"&gt;June 30,&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: top; padding-bottom: 2px"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left"&gt;&amp;#160;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="vertical-align: bottom; vertical-align: top; border-bottom: #000000 2px solid"&gt;&#13;&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center"&gt;2017&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="vertical-align: bottom; vertical-align: top; border-bottom: #000000 2px solid"&gt;&#13;&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center"&gt;2016&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: top; background-color: #cceeff"&gt;&#13;&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: left"&gt;Cost:&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="vertical-align: bottom; vertical-align: top; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="vertical-align: bottom; vertical-align: top; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: top; width: 76%; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left"&gt;Laboratory equipment&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;6,097&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;6,000&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: top; width: 76%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left"&gt;Computers and peripheral equipment&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;1,126&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;1,024&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: top; width: 76%; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left"&gt;Office furniture and equipment&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;681&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;715&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: top; width: 76%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left"&gt;Leasehold improvements&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;8,603&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;9,349&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: top; padding-bottom: 2px; width: 76%; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left"&gt;Vehicles&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #ffffff"&gt;&#13;&lt;div style="line-height: 1.25"&gt;&#13;&lt;div style="line-height: 1.25"&gt;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;-&lt;/div&gt;&#13;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #ffffff"&gt;&#13;&lt;div style="line-height: 1.25"&gt;&#13;&lt;div style="line-height: 1.25"&gt;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;95&lt;/div&gt;&#13;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr style="height: 21px"&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: top; padding-bottom: 2px; width: 76%; background-color: #cceeff"&gt;&#13;&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: left"&gt;&amp;#160;Total Cost&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #cceeff"&gt;&#13;&lt;div style="line-height: 1.25"&gt;&#13;&lt;div style="line-height: 1.25"&gt;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;16,507&lt;/div&gt;&#13;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #cceeff"&gt;&#13;&lt;div style="line-height: 1.25"&gt;&#13;&lt;div style="line-height: 1.25"&gt;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;17,183&lt;/div&gt;&#13;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: top; width: 76%; background-color: #ffffff"&gt;&#13;&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: left"&gt;Accumulated depreciation:&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: top; width: 76%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left"&gt;Laboratory equipment&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;4,164&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;3,401&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: top; width: 76%; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left"&gt;Computers and peripheral equipment&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;951&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;802&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: top; width: 76%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left"&gt;Office furniture and equipment&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;416&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;353&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: top; width: 76%; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left"&gt;Leasehold improvements&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;3,699&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;3,374&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: top; padding-bottom: 2px; width: 76%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left"&gt;Vehicles&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #cceeff"&gt;&#13;&lt;div style="line-height: 1.25"&gt;&#13;&lt;div style="line-height: 1.25"&gt;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;-&lt;/div&gt;&#13;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #cceeff"&gt;&#13;&lt;div style="line-height: 1.25"&gt;&#13;&lt;div style="line-height: 1.25"&gt;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;37&lt;/div&gt;&#13;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: top; padding-bottom: 2px; width: 76%; background-color: #ffffff"&gt;&#13;&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: left"&gt;Total accumulated depreciation&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #ffffff"&gt;&#13;&lt;div style="line-height: 1.25"&gt;&#13;&lt;div style="line-height: 1.25"&gt;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;9,230&lt;/div&gt;&#13;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #ffffff"&gt;&#13;&lt;div style="line-height: 1.25"&gt;&#13;&lt;div style="line-height: 1.25"&gt;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;7,967&lt;/div&gt;&#13;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: top; padding-bottom: 4px; width: 76%; background-color: #cceeff"&gt;&#13;&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: left"&gt;Property and equipment, net&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 4px; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;7,277&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 4px; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;9,216&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="clear: both; line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 34.1pt"&gt;Depreciation expenses amounted to $2,177, $2,150 and $2,074 for the years ended June 30, 2017, 2016 and 2015, respectively.&lt;/div&gt;</us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock contextRef="D2016-07-01_To_2017-06-30">&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 36pt; text-indent: -36pt"&gt;NOTE 7:-OTHER ACCOUNTS PAYABLE&lt;/div&gt;&#13;&#13;&lt;div style="line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div&gt;&#13;&lt;table id="z01e5cbd23ef84c7daf6df4bce26c373c" cellspacing="0" cellpadding="0" align="right" border="0" style="font: 10pt Times New Roman, Times, serif; width: 94%"&gt;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="6" style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid"&gt;&#13;&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center"&gt;June 30,&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid"&gt;&#13;&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center"&gt;2017&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid"&gt;&#13;&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center"&gt;2016&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: top; width: 76%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 8.65pt; text-indent: 0.7pt"&gt;Accrued payroll&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;505&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;421&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: top; width: 76%; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 8.65pt; text-indent: 0.7pt"&gt;Payroll institutions&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;345&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;309&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: top; width: 76%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 8.65pt; text-indent: 0.7pt"&gt;Accrued vacation&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;791&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;720&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: top; padding-bottom: 2px; width: 76%; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 8.65pt; text-indent: 0.7pt"&gt;Other payables&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;342&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;251&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: top; padding-bottom: 4px; width: 76%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 8.65pt; text-indent: 0.7pt"&gt;Total&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 4px; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;1,983&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 4px; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;1,701&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock>
    <us-gaap:OtherIncomeAndOtherExpenseDisclosureTextBlock contextRef="D2016-07-01_To_2017-06-30">&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 36pt; text-indent: -36pt"&gt;NOTE 10:-FINANCIAL INCOME, NET&lt;/div&gt;&#13;&#13;&lt;div style="line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div&gt;&#13;&lt;table id="za47e081f166149a880e695ce08148ece" cellspacing="0" cellpadding="0" align="right" border="0" style="font: 10pt Times New Roman, Times, serif; width: 94%"&gt;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: top; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="10" style="vertical-align: bottom; vertical-align: middle; border-bottom: #000000 2px solid"&gt;&#13;&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center"&gt;Year ended June 30,&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: top; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="vertical-align: bottom; vertical-align: top; border-bottom: #000000 2px solid"&gt;&#13;&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center"&gt;2017&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="vertical-align: bottom; vertical-align: top; border-bottom: #000000 2px solid"&gt;&#13;&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center"&gt;2016&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="vertical-align: bottom; vertical-align: top; border-bottom: #000000 2px solid"&gt;&#13;&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center"&gt;2015&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: middle; width: 64%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 8.65pt; text-indent: 0.7pt"&gt;Foreign currency translation differences, net&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;182&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;(174&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;)&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;(1,109&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;)&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: middle; width: 64%; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 8.65pt; text-indent: 0.7pt"&gt;Bank and broker commissions&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;(67&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;)&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;(85&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;)&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;(37&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;)&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: middle; width: 64%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 8.65pt; text-indent: 0.7pt"&gt;Interest income on deposits&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;122&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;149&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;112&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: middle; width: 64%; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 8.65pt"&gt;Gain (loss) related to marketable securities, net&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;(513&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;)&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;190&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;1,229&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: middle; width: 64%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 8.65pt; text-indent: 0.7pt"&gt;Gain (loss) from&amp;#160; derivatives and fair value hedge derivatives&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;481&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;(30&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;)&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;395&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: middle; padding-bottom: 2px; width: 64%; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 8.65pt; text-indent: 0.7pt"&gt;Other financial income&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;-&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;23&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;-&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 4px; width: 64%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 4px; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;205&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 4px; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;73&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 4px; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;590&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;/div&gt;</us-gaap:OtherIncomeAndOtherExpenseDisclosureTextBlock>
    <us-gaap:UseOfEstimates contextRef="D2016-07-01_To_2017-06-30">&lt;div style="text-align: justify; line-height: 1.25"&gt;&lt;table id="z1af1627d0e9e4dd3b8eac1b4ebf43a64" class="DSPFListTable" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, serif; width: 100%"&gt;&lt;tr&gt;&lt;td style="font: bold 10pt Times New Roman, Times, serif; vertical-align: top; width: 27pt"&gt;a.&lt;/td&gt;&#13;&lt;td style="vertical-align: top; text-align: justify; width: auto"&gt;&#13;&lt;div style="font: bold 10pt Times New Roman, Times, serif"&gt;Use of estimates&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 27pt; text-indent: 0pt"&gt;The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates, judgments, and assumptions that are reasonable based upon information available at the time they are made. These estimates, judgments and assumptions can affect the amounts reported in the financial statements and accompanying notes. Actual results could differ from those estimates.&lt;/div&gt;</us-gaap:UseOfEstimates>
    <us-gaap:ConsolidationPolicyTextBlock contextRef="D2016-07-01_To_2017-06-30">&lt;div style="text-align: justify; line-height: 1.25"&gt;&lt;table id="z1f93aca01e5e4ee6a8fdf1dd94b2f8af" class="DSPFListTable" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, serif; width: 100%"&gt;&lt;tr&gt;&lt;td style="font: bold 10pt Times New Roman, Times, serif; vertical-align: top; width: 27pt"&gt;c.&lt;/td&gt;&#13;&lt;td style="vertical-align: top; text-align: justify; width: auto"&gt;&#13;&lt;div style="font: bold 10pt Times New Roman, Times, serif"&gt;Principles of consolidation&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 27pt; text-indent: 0pt"&gt;The consolidated financial statements include the accounts of Pluristem Therapeutics Inc. and it&amp;#8217;s Subsidiary. Intercompany transactions and balances have been eliminated upon consolidation.&lt;/div&gt;</us-gaap:ConsolidationPolicyTextBlock>
    <us-gaap:CashAndCashEquivalentsPolicyTextBlock contextRef="D2016-07-01_To_2017-06-30">&lt;div style="text-align: justify; line-height: 1.25"&gt;&lt;table id="ze0f636e14c5d4c1e86c453d6849bbd2f" class="DSPFListTable" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, serif; width: 100%"&gt;&lt;tr&gt;&lt;td style="font: bold 10pt Times New Roman, Times, serif; vertical-align: top; width: 27pt"&gt;d.&lt;/td&gt;&#13;&lt;td style="vertical-align: top; text-align: justify; width: auto"&gt;&#13;&lt;div style="font: bold 10pt Times New Roman, Times, serif"&gt;Cash and cash equivalents&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 28.35pt; text-indent: -1.35pt"&gt;Cash equivalents are short-term highly liquid investments that are readily convertible to cash with maturities of three months or less at the date acquired.&lt;/div&gt;</us-gaap:CashAndCashEquivalentsPolicyTextBlock>
    <psti:ShortTermBankDepositPolicyTextBlock contextRef="D2016-07-01_To_2017-06-30">&lt;div style="text-align: justify; line-height: 1.25"&gt;&lt;table id="zbfbd29a4eb644edbb7c98dcc26a49d3f" class="DSPFListTable" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, serif; width: 100%"&gt;&lt;tr&gt;&lt;td style="font: bold 10pt Times New Roman, Times, serif; vertical-align: top; width: 28.35pt"&gt;e.&lt;/td&gt;&#13;&lt;td style="vertical-align: top; text-align: justify; width: auto"&gt;&#13;&lt;div style="font: bold 10pt Times New Roman, Times, serif"&gt;Short-term bank deposit&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 28.35pt"&gt;Bank deposits with original maturities of more than three months but less than one year are presented as part of short-term investments. Deposits are presented at their cost which approximates market values including accrued interest. Interest on deposits is recorded as financial income.&lt;/div&gt;&#13;&#13;&lt;div style="line-height: 1.25"&gt;&lt;br style="line-height: 1.25" /&gt;&#13;&lt;/div&gt;</psti:ShortTermBankDepositPolicyTextBlock>
    <us-gaap:CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy contextRef="D2016-07-01_To_2017-06-30">&lt;div style="text-align: justify; line-height: 1.25"&gt;&lt;table id="z978469e1fcb646049d8a05cb6166784c" class="DSPFListTable" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, serif; width: 100%"&gt;&lt;tr&gt;&lt;td style="font: bold 10pt Times New Roman, Times, serif; vertical-align: top; width: 27pt"&gt;f.&lt;/td&gt;&#13;&lt;td style="vertical-align: top; text-align: justify; width: auto"&gt;&#13;&lt;div style="font: bold 10pt Times New Roman, Times, serif"&gt;Restricted cash and short-term bank deposits&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 28.35pt"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 28.35pt"&gt;Short-term restricted bank deposits and restricted cash used to secure derivative and hedging transactions and the Company&amp;#8217;s credit line. The restricted cash and short-term bank deposits are presented at cost which approximates market values including accrued interest.&lt;/div&gt;</us-gaap:CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy>
    <psti:LongTermRestrictedBankDepositPolicyTextBlock contextRef="D2016-07-01_To_2017-06-30">&lt;div style="text-align: justify; line-height: 1.25"&gt;&lt;table id="zd17e0f5d149c4b0dad19bc2e378a5f58" class="DSPFListTable" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, serif; width: 100%"&gt;&lt;tr&gt;&lt;td style="font: bold 10pt Times New Roman, Times, serif; vertical-align: top; width: 27pt"&gt;g.&lt;/td&gt;&#13;&lt;td style="vertical-align: top; text-align: justify; width: auto"&gt;&#13;&lt;div style="font: bold 10pt Times New Roman, Times, serif"&gt;Long-term restricted bank deposits&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 27pt; text-indent: 0pt"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 27pt; text-indent: 0pt"&gt;Long-term restricted bank deposits with maturities of more than one year used to secure operating lease agreement are presented at cost which approximates market values including accrued interest.&lt;/div&gt;</psti:LongTermRestrictedBankDepositPolicyTextBlock>
    <us-gaap:PropertyPlantAndEquipmentPolicyTextBlock contextRef="D2016-07-01_To_2017-06-30">&lt;div style="text-align: justify; line-height: 1.25"&gt;&lt;table id="z18f60214b5e14ae396da878f15bb2f47" class="DSPFListTable" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, serif; width: 100%"&gt;&lt;tr&gt;&lt;td style="font: bold 10pt Times New Roman, Times, serif; vertical-align: top; width: 28.35pt"&gt;j.&lt;/td&gt;&#13;&lt;td style="vertical-align: top; text-align: justify; width: auto"&gt;&#13;&lt;div style="font: bold 10pt Times New Roman, Times, serif"&gt;Property and Equipment&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 27pt; text-indent: 0pt"&gt;Property and equipment are stated at cost, net of accumulated depreciation. Depreciation is calculated by the straight-line method over the estimated useful lives of the assets, at the following annual rates:&lt;/div&gt;&#13;&#13;&lt;div style="line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div&gt;&#13;&lt;table id="z4239811fa84e426982a3190298cf9636" cellspacing="0" cellpadding="0" align="center" border="0" style="font: 10pt Times New Roman, Times, serif; width: 60%"&gt;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: top; padding-bottom: 2px; width: 40%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="vertical-align: top; border-bottom: #000000 2px solid; vertical-align: bottom"&gt;&#13;&lt;div style="line-height: 1.25"&gt;&#13;&lt;div style="line-height: 1.25"&gt;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: center"&gt;%&lt;/div&gt;&#13;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: top; width: 40%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left"&gt;Laboratory equipment&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 40%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: center"&gt;10-15&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr style="height: 16px"&gt;&#13;&lt;td style="vertical-align: top; width: 40%; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left"&gt;Computers and peripheral equipment&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 40%; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: center"&gt;33&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: top; width: 40%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left"&gt;Office furniture and equipment&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 40%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: center"&gt;15&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: top; width: 40%; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left"&gt;Vehicles&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 40%; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: center"&gt;15&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr style="height: 15px"&gt;&#13;&lt;td style="vertical-align: top; width: 40%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left"&gt;Leasehold improvements&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="vertical-align: top; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left"&gt;The shorter of the expected useful life or the reasonable assumed term of the lease.&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:PropertyPlantAndEquipmentPolicyTextBlock>
    <us-gaap:EarningsPerSharePolicyTextBlock contextRef="D2016-07-01_To_2017-06-30">&lt;div style="text-align: justify; line-height: 1.25"&gt;&lt;table id="zf823a2550b6d46c591eaa4a91db1adeb" class="DSPFListTable" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, serif; width: 100%"&gt;&lt;tr&gt;&lt;td style="font: bold 10pt Times New Roman, Times, serif; vertical-align: top; width: 28.35pt"&gt;o.&lt;/td&gt;&#13;&lt;td style="vertical-align: top; text-align: justify; width: auto"&gt;&#13;&lt;div style="font: bold 10pt Times New Roman, Times, serif"&gt;Loss per share&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 28.35pt; text-indent: 0pt"&gt;Basic and diluted net loss per share is computed based on the weighted average number of shares of common stock outstanding during each year. All outstanding stock options and unvested restricted stock units have been excluded from the calculation of the diluted loss per common share because all such securities are anti-dilutive for each of the periods presented.&lt;/div&gt;</us-gaap:EarningsPerSharePolicyTextBlock>
    <us-gaap:IncomeTaxPolicyTextBlock contextRef="D2016-07-01_To_2017-06-30">&lt;div style="text-align: justify; line-height: 1.25"&gt;&lt;table id="z06d5f9bd8e3e4f4981c1f51ed93f04fe" class="DSPFListTable" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, serif; width: 100%"&gt;&lt;tr&gt;&lt;td style="font: bold 10pt Times New Roman, Times, serif; vertical-align: top; width: 28.35pt"&gt;p.&lt;/td&gt;&#13;&lt;td style="vertical-align: top; text-align: justify; width: auto"&gt;&#13;&lt;div style="font: bold 10pt Times New Roman, Times, serif"&gt;Income taxes&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 28.35pt; text-indent: 0pt"&gt;The Company accounts for income taxes in accordance with ASC 740, "Income Taxes" (&amp;#8220;ASC 740&amp;#8221;). This Topic prescribes the use of the liability method, whereby deferred tax assets and liability account balances are determined based on differences between financial reporting and tax bases of assets and liabilities and are measured using the enacted tax rates and laws that will be in effect when the differences are expected to reverse. The Company provides a valuation allowance, if necessary, to reduce deferred tax assets to their estimated realizable value.&lt;/div&gt;&#13;&#13;&lt;div style="line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 28.35pt; text-indent: -1.35pt"&gt;ASC 740 establishes a single model to address accounting for uncertain tax positions. ASC 740 clarified the accounting for income taxes by prescribing the minimum recognition threshold a tax position is required to meet before being recognized in the financial statements.&lt;/div&gt;</us-gaap:IncomeTaxPolicyTextBlock>
    <us-gaap:ConcentrationRiskCreditRisk contextRef="D2016-07-01_To_2017-06-30">&lt;div style="text-align: justify; line-height: 1.25"&gt;&lt;table id="z320736ccd85f45a8b8e69213c3f489d0" class="DSPFListTable" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, serif; width: 100%"&gt;&lt;tr&gt;&lt;td style="font: bold 10pt Times New Roman, Times, serif; vertical-align: top; width: 28.35pt"&gt;q.&lt;/td&gt;&#13;&lt;td style="vertical-align: top; text-align: justify; width: auto"&gt;&#13;&lt;div style="font: bold 10pt Times New Roman, Times, serif"&gt;Concentration of credit risk&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 28.35pt; text-indent: 0pt"&gt;Financial instruments that potentially subject the Company to concentrations of credit risk consist principally of cash and cash equivalents, short-term deposits, long-term deposits, restricted deposits and marketable securities.&lt;/div&gt;&#13;&#13;&lt;div style="line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 28.35pt; text-indent: 0pt"&gt;The majority of the Company&amp;#8217;s cash and cash equivalents and short-term and long-term deposits are mainly invested in dollar instruments of major banks in Israel and in the United States. Generally, these deposits may be redeemed upon demand and therefore bear minimal risk.&lt;/div&gt;&#13;&#13;&lt;div style="line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 27.35pt; text-indent: 0pt"&gt;The Company invests its surplus cash in cash deposits and marketable securities in financial institutions and has established guidelines, approved by the Company&amp;#8217;s Investment Committee, relating to diversification and maturities to maintain safety and liquidity of the investments.&lt;/div&gt;&#13;&#13;&lt;div style="line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 27.35pt; text-indent: 0pt"&gt;The Company holds an investment portfolio consisting of corporate bonds, government bonds, stocks and index linked notes. The Company intends, and has the ability, to hold such investments until recovery of temporary declines in market value or maturity. However, the Company can provide no assurance that it will recover declines in the market value of its investments.&lt;/div&gt;&#13;&#13;&lt;div style="line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 27.35pt; text-indent: -27pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &lt;/font&gt;The Company utilizes forward and options contracts to protect against the risk of overall changes in exchange rates. The derivative instruments hedge a portion of the Company&amp;#8217;s non-dollar currency exposure. Counterparties to the Company&amp;#8217;s derivative instruments are all major financial institutions.&lt;/div&gt;</us-gaap:ConcentrationRiskCreditRisk>
    <us-gaap:ComprehensiveIncomePolicyPolicyTextBlock contextRef="D2016-07-01_To_2017-06-30">&lt;div style="text-align: justify; line-height: 1.25"&gt;&lt;table id="z3defcc6bbc8f4d2eb779a57c2bdb4a38" class="DSPFListTable" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, serif; width: 100%"&gt;&lt;tr&gt;&lt;td style="font: bold 10pt Times New Roman, Times, serif; vertical-align: top; width: 28.35pt"&gt;u.&lt;/td&gt;&#13;&lt;td style="vertical-align: top; text-align: justify; width: auto"&gt;&#13;&lt;div style="font: bold 10pt Times New Roman, Times, serif"&gt;Comprehensive income (loss):&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 28.35pt"&gt;The Company accounts for comprehensive income (loss) in accordance with ASC 220, &amp;#8220;Comprehensive Income&amp;#8221;.&lt;/div&gt;&#13;&#13;&lt;div style="line-height: 1.25"&gt;&lt;br style="line-height: 1.25" /&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 28.35pt"&gt;Comprehensive income generally represents all changes in stockholders&amp;#8217; equity during the period except those resulting from investments by, or distributions to, stockholders&amp;#8217;. The Company determined that its items of other comprehensive income (loss) relate to unrealized gains and losses on available for sale marketable securities.&lt;/div&gt;&#13;&#13;&lt;div style="line-height: 1.25"&gt;&lt;br style="line-height: 1.25" /&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 28.35pt"&gt;The following table summarizes the changes in accumulated balances of other comprehensive income for the year ended June 30, 2017:&lt;/div&gt;&#13;&#13;&lt;div style="line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div&gt;&#13;&lt;table id="z1a49afcc7d73463897c1b4177687276d" cellspacing="0" cellpadding="0" align="right" border="0" style="font: 10pt Times New Roman, Times, serif; width: 95%"&gt;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="vertical-align: bottom; vertical-align: top; border-bottom: #000000 2px solid; text-align: center"&gt;Year ended June 30, 2017&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: center"&gt;Unrealized&lt;font style="font: 10pt Times New Roman, Times, serif"&gt;&lt;br /&gt;&#13;&lt;/font&gt;gains (losses)&lt;font style="font: 10pt Times New Roman, Times, serif"&gt;&lt;br /&gt;&#13;&lt;/font&gt;on marketable&lt;font style="font: 10pt Times New Roman, Times, serif"&gt;&lt;br /&gt;&#13;&lt;/font&gt;securities&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: top; width: 88%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 4.7pt; text-indent: 5.05pt"&gt;Beginning balance&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;1,480&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: top; width: 88%; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 9.75pt"&gt;Other comprehensive income before reclassifications&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;924&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: top; padding-bottom: 2px; width: 88%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 9.75pt"&gt;Amounts reclassified from accumulated other comprehensive loss, net&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;(405&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;)&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: top; padding-bottom: 2px; width: 88%; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 12pt; text-indent: -2.25pt"&gt;Net current-period other comprehensive income&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;519&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: top; padding-bottom: 4px; width: 88%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 4.7pt; text-indent: 5.05pt"&gt;Ending balance&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 4px; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;1,999&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ComprehensiveIncomePolicyPolicyTextBlock>
    <psti:PropertyPlantAndEquipmentEstimatedUsefulLivesRateTableTextBlock contextRef="D2016-07-01_To_2017-06-30">&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 27pt; text-indent: 0pt"&gt;Depreciation is calculated by the straight-line method over the estimated useful lives of the assets, at the following annual rates:&lt;/div&gt;&#13;&#13;&lt;div style="line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div&gt;&#13;&lt;table id="z4239811fa84e426982a3190298cf9636" cellspacing="0" cellpadding="0" align="center" border="0" style="font: 10pt Times New Roman, Times, serif; width: 60%"&gt;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: top; padding-bottom: 2px; width: 40%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="vertical-align: top; border-bottom: #000000 2px solid; vertical-align: bottom"&gt;&#13;&lt;div style="line-height: 1.25"&gt;&#13;&lt;div style="line-height: 1.25"&gt;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: center"&gt;%&lt;/div&gt;&#13;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: top; width: 40%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left"&gt;Laboratory equipment&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 40%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: center"&gt;10-15&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr style="height: 16px"&gt;&#13;&lt;td style="vertical-align: top; width: 40%; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left"&gt;Computers and peripheral equipment&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 40%; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: center"&gt;33&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: top; width: 40%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left"&gt;Office furniture and equipment&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 40%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: center"&gt;15&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: top; width: 40%; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left"&gt;Vehicles&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 40%; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: center"&gt;15&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr style="height: 15px"&gt;&#13;&lt;td style="vertical-align: top; width: 40%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left"&gt;Leasehold improvements&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="vertical-align: top; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left"&gt;The shorter of the expected useful life or the reasonable assumed term of the lease.&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</psti:PropertyPlantAndEquipmentEstimatedUsefulLivesRateTableTextBlock>
    <us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock contextRef="D2016-07-01_To_2017-06-30">&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 28.35pt"&gt;The following table summarizes the changes in accumulated balances of other comprehensive income for the year ended June 30, 2017:&lt;/div&gt;&#13;&#13;&lt;div style="line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div&gt;&#13;&lt;table id="z1a49afcc7d73463897c1b4177687276d" cellspacing="0" cellpadding="0" align="right" border="0" style="font: 10pt Times New Roman, Times, serif; width: 95%"&gt;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="vertical-align: top; border-bottom: #000000 2px solid; text-align: center; vertical-align: bottom"&gt;Year ended June 30, 2017&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: center"&gt;Unrealized&lt;font style="font: 10pt Times New Roman, Times, serif"&gt;&lt;br /&gt;&#13;&lt;/font&gt;gains (losses)&lt;font style="font: 10pt Times New Roman, Times, serif"&gt;&lt;br /&gt;&#13;&lt;/font&gt;on marketable&lt;font style="font: 10pt Times New Roman, Times, serif"&gt;&lt;br /&gt;&#13;&lt;/font&gt;securities&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: top; width: 88%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 4.7pt; text-indent: 5.05pt"&gt;Beginning balance&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;1,480&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: top; width: 88%; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 9.75pt"&gt;Other comprehensive income before reclassifications&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;924&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: top; padding-bottom: 2px; width: 88%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 9.75pt"&gt;Amounts reclassified from accumulated other comprehensive loss, net&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;(405&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;)&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: top; padding-bottom: 2px; width: 88%; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 12pt; text-indent: -2.25pt"&gt;Net current-period other comprehensive income&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;519&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: top; padding-bottom: 4px; width: 88%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 4.7pt; text-indent: 5.05pt"&gt;Ending balance&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 4px; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;1,999&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock>
    <us-gaap:AvailableForSaleSecuritiesTextBlock contextRef="D2016-07-01_To_2017-06-30">&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 35.45pt"&gt;As of June 30, 2017 and 2016, all of the Company&amp;#8217;s marketable securities were classified as available-for-sale.&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 35.45pt"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div&gt;&#13;&lt;table id="z17c89b572ecf496caa4468908301afa4" cellspacing="0" cellpadding="0" align="right" border="0" style="font: 10pt Times New Roman, Times, serif; width: 94%"&gt;&#13;&lt;tr style="height: 12px"&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="18" style="vertical-align: bottom; vertical-align: top; border-bottom: #000000 2px solid; font-weight: bold; text-align: center"&gt;June 30, 2017&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="18" style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid"&gt;&#13;&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center"&gt;June 30, 2016&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: center"&gt;&lt;font style="font: bold 10pt Times New Roman, Times, serif"&gt;Amortized cos&lt;/font&gt;t&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid"&gt;&#13;&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center"&gt;Gross&lt;/div&gt;&#13;&#13;&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center"&gt;unrealized&lt;/div&gt;&#13;&#13;&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center"&gt;gain&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid"&gt;&#13;&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center"&gt;Gross&lt;/div&gt;&#13;&#13;&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center"&gt;unrealized&lt;/div&gt;&#13;&#13;&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center"&gt;loss&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="vertical-align: bottom; vertical-align: top; border-bottom: #000000 2px solid"&gt;&#13;&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center"&gt;Other-than-temporary impairment&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid"&gt;&#13;&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center"&gt;Fair&lt;/div&gt;&#13;&#13;&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center"&gt;value&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid"&gt;&#13;&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center"&gt;Amortized cost&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid"&gt;&#13;&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center"&gt;Gross&lt;/div&gt;&#13;&#13;&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center"&gt;unrealized&lt;/div&gt;&#13;&#13;&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center"&gt;gain&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid"&gt;&#13;&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center"&gt;Gross&lt;/div&gt;&#13;&#13;&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center"&gt;unrealized&lt;/div&gt;&#13;&#13;&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center"&gt;loss&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="vertical-align: bottom; vertical-align: top; border-bottom: #000000 2px solid"&gt;&#13;&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center"&gt;Other-than-temporary impairment&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid"&gt;&#13;&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center"&gt;Fair&lt;/div&gt;&#13;&#13;&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center"&gt;value&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; background-color: #cceeff"&gt;&#13;&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 8.65pt; text-indent: 0.7pt"&gt;Available-for-sale - matures within one year:&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="vertical-align: bottom; vertical-align: bottom; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="vertical-align: bottom; vertical-align: bottom; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="vertical-align: bottom; vertical-align: bottom; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="vertical-align: bottom; vertical-align: top; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="vertical-align: bottom; vertical-align: bottom; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="vertical-align: bottom; vertical-align: bottom; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="vertical-align: bottom; vertical-align: bottom; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="vertical-align: bottom; vertical-align: bottom; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="vertical-align: bottom; vertical-align: top; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="vertical-align: bottom; vertical-align: bottom; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; width: 20%; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 8.65pt; text-indent: 0.7pt"&gt;Stock and index linked notes&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 5%; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;11,988&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 5%; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;2,014&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 5%; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;(47&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;)&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 5%; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;(767&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;)&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 5%; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;13,188&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 5%; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;11,599&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 5%; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;1,594&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 5%; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;(208&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;)&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 5%; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;(38&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;)&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 5%; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;12,947&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; width: 20%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 8.65pt; text-indent: 0.7pt"&gt;Government debentures &amp;#8211; fixed interest rate&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 5%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;157&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 5%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;1&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 5%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;-&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 5%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;-&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 5%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;158&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 5%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;786&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 5%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;12&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 5%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;-&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 5%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;-&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 5%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;798&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; width: 20%; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 8.65pt; text-indent: 0.7pt"&gt;Corporate debentures &amp;#8211; fixed interest rate&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 5%; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;47&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 5%; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;1&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 5%; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;-&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 5%; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;-&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 5%; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;48&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 5%; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;439&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 5%; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;7&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 5%; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;-&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 5%; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;-&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 5%; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;446&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; width: 20%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 5%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;12,192&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 5%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;2,016&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 5%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;(47&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;)&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 5%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;(767&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;)&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 5%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;13,394&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 5%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;12,824&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 5%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;1,613&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 5%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;(208&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;)&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 5%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;(38&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;)&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 5%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;14,191&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; width: 20%; background-color: #ffffff"&gt;&#13;&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 8.65pt"&gt;Available-for-sale - matures after one year through five years:&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 5%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 5%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 5%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 5%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 5%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 5%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 5%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 5%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 5%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 5%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; width: 20%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 8.65pt; text-indent: 0.7pt"&gt;Government debentures &amp;#8211; fixed interest rate&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 5%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;468&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 5%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;23&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 5%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;-&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 5%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;-&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 5%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;491&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 5%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;717&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 5%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;27&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 5%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;-&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 5%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;-&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 5%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;744&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; width: 20%; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 8.65pt"&gt;Corporate debentures &amp;#8211; fixed interest rate&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 5%; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;1,255&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 5%; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;7&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 5%; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;(1&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;)&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 5%; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;-&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 5%; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;1,261&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 5%; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;2,403&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 5%; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;47&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 5%; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;-&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 5%; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;-&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 5%; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;2,450&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; width: 20%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 5%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;1,723&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 5%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;30&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 5%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;(1&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;)&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 5%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;-&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 5%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;1,752&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 5%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;3,120&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 5%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;74&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 5%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;-&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 5%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;-&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 5%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;3,194&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; width: 20%; background-color: #ffffff"&gt;&#13;&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 8.65pt; text-indent: 0.7pt"&gt;Available-for-sale - matures after five years through ten years:&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 5%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 5%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 5%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 5%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 5%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 5%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 5%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 5%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 5%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 5%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; width: 20%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 8.65pt; text-indent: 0.7pt"&gt;Corporate debentures &amp;#8211; fixed interest rate&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 5%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;17&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 5%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;1&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 5%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;-&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 5%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;-&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 5%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;18&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 5%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;29&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 5%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;1&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 5%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;-&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 5%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;-&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 5%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;30&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; width: 20%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 5%; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;17&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 5%; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;1&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 5%; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;-&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 5%; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;-&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 5%; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;18&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 5%; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;29&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 5%; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;1&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 5%; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;-&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 5%; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;-&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 5%; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;30&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 4px; width: 20%; background-color: #cceeff"&gt;&#13;&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 8.65pt; text-indent: 0.7pt"&gt;Total&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 4px; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 5%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;13,932&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 4px; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 5%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;2,047&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 4px; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 5%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;(48&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;)&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 4px; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 5%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;(767&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;)&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 4px; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 5%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;15,164&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 4px; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 5%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;15,973&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 4px; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 5%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;1,688&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 4px; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 5%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;(208&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;)&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 4px; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 5%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;(38&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;)&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 4px; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 5%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;17,415&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:AvailableForSaleSecuritiesTextBlock>
    <us-gaap:AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValueTableTextBlock contextRef="D2016-07-01_To_2017-06-30">&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 34.1pt"&gt;The following table presents gross unrealized losses and fair values for those investments that were in an unrealized loss position as of June 30, 2017 and June 30, 2016, and the length of time that those investments have been in a continuous loss position:&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 7.1pt"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div&gt;&#13;&lt;table id="z2ddad5786c9049a9adbfbf0b1b61d13c" cellspacing="0" cellpadding="0" align="right" border="0" style="font: 10pt Times New Roman, Times, serif; width: 94%"&gt;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="6" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom"&gt;&#13;&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center"&gt;12 months or less&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="6" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom"&gt;&#13;&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center"&gt;Greater than 12 months&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom"&gt;&#13;&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center"&gt;Fair Value&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom"&gt;&#13;&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center"&gt;Gross&lt;font style="font: 10pt Times New Roman, Times, serif"&gt;&lt;br /&gt;&#13;&lt;/font&gt;unrealized loss&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom"&gt;&#13;&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center"&gt;Fair Value&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom"&gt;&#13;&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center"&gt;Gross&lt;font style="font: 10pt Times New Roman, Times, serif"&gt;&lt;br /&gt;&#13;&lt;/font&gt;unrealized loss&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; width: 52%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 8.65pt; text-indent: 0.7pt"&gt;As of June 30, 2017&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;869&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;(24&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;)&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;106&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;(&lt;font style="font: 10pt Times New Roman, Times, serif"&gt;2&lt;/font&gt;4&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;)&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; width: 52%; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 8.65pt"&gt;As of June 30, 2016&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;1,258&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;(143&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;)&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;563&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;(65&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;)&lt;/div&gt;&#13;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValueTableTextBlock>
    <us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock contextRef="D2016-07-01_To_2017-06-30">&lt;table id="z900a4c6ca5f447c0aafaf4e29e3bf035" cellspacing="0" cellpadding="0" align="right" border="0" style="font: 10pt Times New Roman, Times, serif; width: 94%"&gt;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="6" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom"&gt;&#13;&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center"&gt;June 30, 2017&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="6" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom"&gt;&#13;&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center"&gt;June 30, 2016&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom"&gt;&#13;&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center"&gt;Level 1&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom"&gt;&#13;&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center"&gt;Level 2&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom"&gt;&#13;&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center"&gt;Level 1&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom"&gt;&#13;&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center"&gt;Level 2&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; width: 52%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 8.65pt; text-indent: 0.7pt"&gt;Marketable securities&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;10,523&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;4,641&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;11,228&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;6,187&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; width: 52%; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 8.65pt; text-indent: 0.7pt"&gt;Foreign currency derivative instruments not designated as hedge instruments&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;-&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;295&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;-&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;65&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 4px; width: 52%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 8.65pt; text-indent: 0.7pt"&gt;Total financial assets&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 4px; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;10,523&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 4px; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;4,936&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 4px; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;11,228&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 4px; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;6,252&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&lt;/table&gt;</us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock>
    <us-gaap:ScheduleOfOtherCurrentAssetsTableTextBlock contextRef="D2016-07-01_To_2017-06-30">&lt;table id="zfa607ab951ff484e866f040412187dff" cellspacing="0" cellpadding="0" align="right" border="0" style="font: 10pt Times New Roman, Times, serif; width: 94%"&gt;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="6" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom"&gt;&#13;&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center"&gt;June 30,&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom"&gt;&#13;&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center"&gt;2017&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom"&gt;&#13;&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center"&gt;2016&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: top; width: 76%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 8.65pt; text-indent: 0.7pt"&gt;Prepaid expenses&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;882&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;300&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: top; width: 76%; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 8.65pt; text-indent: 0.7pt"&gt;Accounts receivable from the Ministry of Economy&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;-&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;23&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: top; width: 76%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 8.65pt; text-indent: 0.7pt"&gt;Derivatives not designated as hedge instruments&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;295&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;65&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: top; width: 76%; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 8.65pt; text-indent: 0.7pt"&gt;VAT receivables&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;137&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;167&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: top; padding-bottom: 2px; width: 76%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 8.65pt; text-indent: 0.7pt"&gt;Other receivables&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;1&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;63&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: top; padding-bottom: 4px; width: 76%; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 8.65pt; text-indent: 0.7pt"&gt;Total&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 4px; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;1,315&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 4px; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;618&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&lt;/table&gt;</us-gaap:ScheduleOfOtherCurrentAssetsTableTextBlock>
    <us-gaap:PropertyPlantAndEquipmentTextBlock contextRef="D2016-07-01_To_2017-06-30">&lt;table id="zdc26d7b242f24d7cab1183be09ef8d89" cellspacing="0" cellpadding="0" align="right" border="0" style="font: 10pt Times New Roman, Times, serif; width: 94%"&gt;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: middle; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="6" style="vertical-align: top; border-bottom: #000000 2px solid; vertical-align: bottom"&gt;&#13;&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center"&gt;June 30,&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: top; padding-bottom: 2px; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left"&gt;&amp;#160;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="vertical-align: top; border-bottom: #000000 2px solid; vertical-align: bottom"&gt;&#13;&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center"&gt;2017&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="vertical-align: top; border-bottom: #000000 2px solid; vertical-align: bottom"&gt;&#13;&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center"&gt;2016&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: top; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: left"&gt;Cost:&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="vertical-align: top; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="vertical-align: top; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: top; width: 76%; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left"&gt;Laboratory equipment&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;6,097&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;6,000&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: top; width: 76%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left"&gt;Computers and peripheral equipment&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;1,126&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;1,024&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: top; width: 76%; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left"&gt;Office furniture and equipment&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;681&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;715&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: top; width: 76%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left"&gt;Leasehold improvements&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;8,603&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;9,349&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: top; padding-bottom: 2px; width: 76%; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left"&gt;Vehicles&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="line-height: 1.25"&gt;&#13;&lt;div style="line-height: 1.25"&gt;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;-&lt;/div&gt;&#13;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="line-height: 1.25"&gt;&#13;&lt;div style="line-height: 1.25"&gt;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;95&lt;/div&gt;&#13;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr style="height: 21px"&gt;&#13;&lt;td style="vertical-align: top; padding-bottom: 2px; width: 76%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: left"&gt;&amp;#160;Total Cost&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="line-height: 1.25"&gt;&#13;&lt;div style="line-height: 1.25"&gt;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;16,507&lt;/div&gt;&#13;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="line-height: 1.25"&gt;&#13;&lt;div style="line-height: 1.25"&gt;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;17,183&lt;/div&gt;&#13;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: top; width: 76%; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: left"&gt;Accumulated depreciation:&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: top; width: 76%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left"&gt;Laboratory equipment&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;4,164&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;3,401&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: top; width: 76%; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left"&gt;Computers and peripheral equipment&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;951&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;802&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: top; width: 76%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left"&gt;Office furniture and equipment&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;416&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;353&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: top; width: 76%; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left"&gt;Leasehold improvements&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;3,699&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;3,374&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: top; padding-bottom: 2px; width: 76%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left"&gt;Vehicles&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="line-height: 1.25"&gt;&#13;&lt;div style="line-height: 1.25"&gt;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;-&lt;/div&gt;&#13;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="line-height: 1.25"&gt;&#13;&lt;div style="line-height: 1.25"&gt;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;37&lt;/div&gt;&#13;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: top; padding-bottom: 2px; width: 76%; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: left"&gt;Total accumulated depreciation&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="line-height: 1.25"&gt;&#13;&lt;div style="line-height: 1.25"&gt;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;9,230&lt;/div&gt;&#13;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="line-height: 1.25"&gt;&#13;&lt;div style="line-height: 1.25"&gt;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;7,967&lt;/div&gt;&#13;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: top; padding-bottom: 4px; width: 76%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: left"&gt;Property and equipment, net&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 4px; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;7,277&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 4px; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;9,216&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&lt;/table&gt;</us-gaap:PropertyPlantAndEquipmentTextBlock>
    <us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock contextRef="D2016-07-01_To_2017-06-30">&lt;table id="z01e5cbd23ef84c7daf6df4bce26c373c" cellspacing="0" cellpadding="0" align="right" border="0" style="font: 10pt Times New Roman, Times, serif; width: 94%"&gt;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="6" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom"&gt;&#13;&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center"&gt;June 30,&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom"&gt;&#13;&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center"&gt;2017&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom"&gt;&#13;&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center"&gt;2016&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: top; width: 76%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 8.65pt; text-indent: 0.7pt"&gt;Accrued payroll&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;505&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;421&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: top; width: 76%; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 8.65pt; text-indent: 0.7pt"&gt;Payroll institutions&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;345&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;309&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: top; width: 76%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 8.65pt; text-indent: 0.7pt"&gt;Accrued vacation&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;791&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;720&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: top; padding-bottom: 2px; width: 76%; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 8.65pt; text-indent: 0.7pt"&gt;Other payables&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;342&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;251&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: top; padding-bottom: 4px; width: 76%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 8.65pt; text-indent: 0.7pt"&gt;Total&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 4px; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;1,983&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 4px; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;1,701&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&lt;/table&gt;</us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock>
    <us-gaap:ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock contextRef="D2016-07-01_To_2017-06-30">&lt;table id="za47e081f166149a880e695ce08148ece" cellspacing="0" cellpadding="0" align="right" border="0" style="font: 10pt Times New Roman, Times, serif; width: 94%"&gt;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: top; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="10" style="vertical-align: middle; border-bottom: #000000 2px solid; vertical-align: bottom"&gt;&#13;&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center"&gt;Year ended June 30,&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: top; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="vertical-align: top; border-bottom: #000000 2px solid; vertical-align: bottom"&gt;&#13;&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center"&gt;2017&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="vertical-align: top; border-bottom: #000000 2px solid; vertical-align: bottom"&gt;&#13;&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center"&gt;2016&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="vertical-align: top; border-bottom: #000000 2px solid; vertical-align: bottom"&gt;&#13;&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center"&gt;2015&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: middle; width: 64%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 8.65pt; text-indent: 0.7pt"&gt;Foreign currency translation differences, net&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;182&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;(174&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;)&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;(1,109&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;)&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: middle; width: 64%; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 8.65pt; text-indent: 0.7pt"&gt;Bank and broker commissions&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;(67&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;)&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;(85&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;)&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;(37&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;)&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: middle; width: 64%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 8.65pt; text-indent: 0.7pt"&gt;Interest income on deposits&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;122&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;149&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;112&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: middle; width: 64%; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 8.65pt"&gt;Gain (loss) related to marketable securities, net&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;(513&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;)&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;190&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;1,229&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: middle; width: 64%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 8.65pt; text-indent: 0.7pt"&gt;Gain (loss) from&amp;#160; derivatives and fair value hedge derivatives&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;481&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;(30&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;)&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;395&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: middle; padding-bottom: 2px; width: 64%; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 8.65pt; text-indent: 0.7pt"&gt;Other financial income&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;-&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;23&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;-&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 4px; width: 64%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 4px; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;205&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 4px; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;73&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 4px; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;590&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&lt;/table&gt;</us-gaap:ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock>
    <psti:QualifyingPercentageOfValueOfProductiveAssetsTableTextBlock contextRef="D2016-07-01_To_2017-06-30">&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 42.55pt"&gt;The qualifying percentage of the value of the productive assets is as follows:&lt;/div&gt;&#13;&#13;&lt;div style="line-height: 1.25"&gt;&lt;br style="line-height: 1.25" /&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div&gt;&#13;&lt;table id="z7dd3f999d96e475daadaf09b843306b8" cellspacing="0" cellpadding="0" align="right" border="0" style="font: 10pt Times New Roman, Times, serif; border-collapse: collapse; width: 94%"&gt;&#13;&lt;tr&gt;&#13;&lt;td style="text-align: center; border-bottom: #000000 2px solid; width: 53.57%; vertical-align: bottom"&gt;&#13;&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif; margin-left: 42.55pt"&gt;The value of productive&lt;/div&gt;&#13;&#13;&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif; margin-left: 42.55pt"&gt;assets before the expansion&lt;/div&gt;&#13;&#13;&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif; margin-left: 42.55pt"&gt;(NIS in millions)&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: top; width: 3.58%"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: center; width: 42.85%"&gt;&#13;&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif"&gt;The new proportion that the required &lt;/div&gt;&#13;&#13;&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif"&gt;investment bears to the value of productive assets&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="border-top: #000000 2px solid; vertical-align: top; width: 53.57%"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: top; width: 3.58%"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: top; width: 42.85%"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: top; width: 53.57%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 42.55pt"&gt;Up to NIS&amp;#160;140&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: top; width: 3.58%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: top; width: 42.85%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: center; margin-left: 42.55pt"&gt;12%&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: top; width: 53.57%; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 42.55pt"&gt;NIS&amp;#160;140 - NIS&amp;#160;500&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: top; width: 3.58%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: top; width: 42.85%; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: center; margin-left: 42.55pt"&gt;7%&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: top; width: 53.57%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 42.55pt"&gt;More than NIS&amp;#160;500&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: top; width: 3.58%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: top; width: 42.85%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: center; margin-left: 42.55pt"&gt;5%&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</psti:QualifyingPercentageOfValueOfProductiveAssetsTableTextBlock>
    <us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock contextRef="D2016-07-01_To_2017-06-30">&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 42.55pt"&gt;Significant components of the Company's deferred tax assets are as follows:&lt;/div&gt;&#13;&#13;&lt;div style="line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div&gt;&#13;&lt;table id="z8c0d601e87a3487a842fe95c2270aaeb" cellspacing="0" cellpadding="0" align="right" border="0" style="font: 10pt Times New Roman, Times, serif; width: 94%"&gt;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: top; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="6" style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid"&gt;&#13;&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center; text-indent: 2pt"&gt;June 30,&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: top; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid"&gt;&#13;&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center"&gt;2017&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid"&gt;&#13;&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center"&gt;2016&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: top; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 8.5pt; text-indent: -8.5pt"&gt;Deferred tax assets:&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="vertical-align: bottom; vertical-align: bottom; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="vertical-align: bottom; vertical-align: bottom; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: top; width: 76%; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 17pt; text-indent: -8.5pt"&gt;U.S. net operating loss carryforward&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;11,382&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;10,210&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: top; width: 76%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 17pt; text-indent: -8.5pt"&gt;Israeli net operating loss carryforward&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;26,275&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;22,105&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: top; padding-bottom: 2px; width: 76%; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 17pt; text-indent: -8.5pt"&gt;Allowances and reserves&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;222&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;216&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: top; width: 76%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: top; width: 76%; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 8.5pt; text-indent: -8.5pt"&gt;Total deferred tax assets before valuation allowance&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;37,879&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;32,531&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: top; padding-bottom: 2px; width: 76%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 8.5pt; text-indent: -8.5pt"&gt;Valuation allowance&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;(37,879&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;)&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;(32,531&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;)&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: top; width: 76%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: top; padding-bottom: 4px; width: 76%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 8.5pt; text-indent: -8.5pt"&gt;Net deferred tax asset&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 4px; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;-&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 4px; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;-&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;/div&gt;</us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock>
    <us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock contextRef="From2016-07-01to2017-06-30_custom_EmployeesAndDirectorsMember">&lt;div style="line-height: 1.25"&gt;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 36pt"&gt;A summary of the Company&amp;#8217;s activity for options granted to employees and directors under the 2005 Plan is as follows:&lt;/div&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div&gt;&#13;&lt;table id="zc5d82afc4543485a9c7bd20b618b95e2" cellspacing="0" cellpadding="0" align="right" border="0" style="font: 10pt Times New Roman, Times, serif; width: 94%"&gt;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="14" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom"&gt;&#13;&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center; text-indent: 2pt"&gt;Year ended June 30, 2017&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom"&gt;&#13;&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center; text-indent: 2pt"&gt;Number&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom"&gt;&#13;&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center; text-indent: 2pt"&gt;Weighted Average Exercise Price&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom"&gt;&#13;&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center; text-indent: 2pt"&gt;Weighted Average Remaining Contractual Terms (in years)&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom"&gt;&#13;&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center; text-indent: 2pt"&gt;Aggregate Intrinsic Value Price&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 8.65pt; text-indent: 0.7pt"&gt;Options outstanding at beginning of period&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;1,771,700&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;3.76&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="vertical-align: bottom; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="vertical-align: bottom; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 8.65pt; text-indent: 0.7pt"&gt;Options exercised&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;(16,000&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;)&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;0.62&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="vertical-align: bottom; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="vertical-align: bottom; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 8.65pt; text-indent: 0.7pt"&gt;Options forfeited&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; text-align: right; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;(940,050&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;)&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; text-align: right; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;4.49&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="vertical-align: bottom; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="vertical-align: bottom; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 4px; width: 52%; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 8.65pt; text-indent: 0.7pt"&gt;Options outstanding at end of the period&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 4px; text-align: right; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;815,650&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 4px; text-align: right; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;2.98&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 4px; text-align: right; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;0.82&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 4px; text-align: right; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;231&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 4px; width: 52%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 8.65pt; text-indent: 0.7pt"&gt;Options exercisable at the end of the period&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 4px; text-align: right; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;815,650&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 4px; text-align: right; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;2.98&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 4px; text-align: right; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;0.82&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 4px; text-align: right; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;231&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 4px; width: 52%; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 8.65pt; text-indent: 0.7pt"&gt;Options vested at the end of the period&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 4px; text-align: right; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;815,650&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 4px; text-align: right; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;2.98&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 4px; text-align: right; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;0.82&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 4px; text-align: right; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;231&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;/div&gt;</us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock>
    <us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock contextRef="From2016-07-01to2017-06-30_custom_NonemployeesMember">&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 36pt; text-indent: 0pt"&gt;A summary of the options to non-employee consultants is as follows:&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 36pt; text-indent: 0pt"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div&gt;&#13;&lt;table id="zffa8b47d18a649d3a4152a165d92e716" cellspacing="0" cellpadding="0" align="right" border="0" style="font: 10pt Times New Roman, Times, serif; width: 94%"&gt;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="14" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom"&gt;&#13;&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center; text-indent: 2pt"&gt;Year ended June 30, 2017&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr style="height: 52px"&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom"&gt;&#13;&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center; text-indent: 2pt"&gt;Number&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom"&gt;&#13;&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center; text-indent: 2pt"&gt;Weighted Average Exercise Price&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom"&gt;&#13;&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center; text-indent: 2pt"&gt;Weighted Average Remaining Contractual Terms (in years)&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom"&gt;&#13;&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center; text-indent: 2pt"&gt;Aggregate Intrinsic Value Price&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 8.65pt; text-indent: 0.7pt"&gt;Options outstanding at beginning of period&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;237, 300&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;5.40&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="vertical-align: bottom; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="vertical-align: bottom; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 8.65pt; text-indent: 0.7pt"&gt;Options granted&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;46,800&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;0.00&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="vertical-align: bottom; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="vertical-align: bottom; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 8.65pt; text-indent: 0.7pt"&gt;Options exercised&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;(1,900&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;)&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;0.00&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="vertical-align: bottom; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="vertical-align: bottom; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 8.65pt; text-indent: 0.7pt"&gt;Options forfeited&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;(105,000&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;)&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;10.98&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="vertical-align: bottom; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="vertical-align: bottom; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 4px; width: 52%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 8.65pt; text-indent: 0.7pt"&gt;Options outstanding at end of the period&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 4px; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;177,200&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 4px; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;0.72&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 4px; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;4.30&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 4px; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;179&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 4px; width: 52%; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 8.65pt; text-indent: 0.7pt"&gt;Options exercisable at the end of the period&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 4px; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;164,825&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 4px; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;0.78&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 4px; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;3.92&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 4px; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;163&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 4px; width: 52%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 8.65pt; text-indent: 0.7pt"&gt;Options vested&amp;#160; and expected to vest at the end of the period&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 4px; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;177,200&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 4px; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;0.72&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 4px; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;4.30&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 4px; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;179&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;/div&gt;</us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock>
    <us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock contextRef="From2016-07-01to2017-06-30_custom_NonemployeesMember">&lt;div style="margin-left: 36pt; line-height: 1.25"&gt;Compensation expenses related to options granted to consultants were recorded as follows:&lt;/div&gt;&#13;&#13;&lt;div style="line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div&gt;&#13;&lt;table id="zd480bd2b1cb94e0484682e7fd7793ed9" cellspacing="0" cellpadding="0" align="right" border="0" style="font: 10pt Times New Roman, Times, serif; width: 94%"&gt;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: top; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="10" style="vertical-align: middle; border-bottom: #000000 2px solid; vertical-align: bottom"&gt;&#13;&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center; text-indent: 2pt"&gt;Year ended June 30,&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: top; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="vertical-align: top; border-bottom: #000000 2px solid; vertical-align: bottom"&gt;&#13;&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center"&gt;2017&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="vertical-align: top; border-bottom: #000000 2px solid; vertical-align: bottom"&gt;&#13;&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center"&gt;2016&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="vertical-align: top; border-bottom: #000000 2px solid; vertical-align: bottom"&gt;&#13;&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center"&gt;2015&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; width: 64%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 8.65pt; text-indent: 0.7pt"&gt;Research and development expenses&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;7&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;22&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;1&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; width: 64%; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 8.65pt; text-indent: 0.7pt"&gt;General and administrative expenses&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;39&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;2&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;1&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 4px; width: 64%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 4px; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;46&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 4px; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;24&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 4px; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;2&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="clear: both; line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;</us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock>
    <us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock contextRef="From2016-07-01to2017-06-30_custom_EmployeesAndDirectorsMember_us-gaap_RestrictedStockUnitsRSUMember">&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 36pt"&gt;Compensation expenses related to RS and RSUs granted to employees and directors were recorded as follows:&lt;/div&gt;&#13;&#13;&lt;div style="line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div&gt;&#13;&lt;table id="z89fbe625712c46c7854b12e39917d0a6" cellspacing="0" cellpadding="0" align="right" border="0" style="font: 10pt Times New Roman, Times, serif; width: 94%"&gt;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: top; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="10" style="vertical-align: middle; border-bottom: #000000 2px solid; vertical-align: bottom"&gt;&#13;&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center"&gt;Year ended June 30,&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: top; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="vertical-align: top; border-bottom: #000000 2px solid; vertical-align: bottom"&gt;&#13;&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center"&gt;2017&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="vertical-align: top; border-bottom: #000000 2px solid; vertical-align: bottom"&gt;&#13;&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center"&gt;2016&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="vertical-align: top; border-bottom: #000000 2px solid; vertical-align: bottom"&gt;&#13;&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center"&gt;2015&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; width: 64%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 8.65pt; text-indent: 0.7pt"&gt;Research and development expenses&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;1,558&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;960&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;1,469&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; width: 64%; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 8.65pt; text-indent: 0.7pt"&gt;General and administrative expenses&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;1,645&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;1,905&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;2,277&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 4px; width: 64%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 4px; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;3,203&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 4px; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;2,865&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 4px; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;3,746&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="clear: both; line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;</us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock>
    <us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock contextRef="From2016-07-01to2017-06-30_custom_NonemployeesMember_us-gaap_RestrictedStockUnitsRSUMember">&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 36pt"&gt;Compensation expenses related to RS and RSUs granted to consultants were recorded as follows:&lt;/div&gt;&#13;&#13;&lt;div style="line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div&gt;&#13;&lt;table id="z3f959cbd462043d1b0e75a38e85ac309" cellspacing="0" cellpadding="0" align="right" border="0" style="font: 10pt Times New Roman, Times, serif; width: 94%"&gt;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: top; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="10" style="vertical-align: middle; border-bottom: #000000 2px solid; vertical-align: bottom"&gt;&#13;&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center"&gt;Year ended June 30,&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: top; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="vertical-align: top; border-bottom: #000000 2px solid; vertical-align: bottom"&gt;&#13;&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center"&gt;2017&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="vertical-align: top; border-bottom: #000000 2px solid; vertical-align: bottom"&gt;&#13;&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center"&gt;2016&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="vertical-align: top; border-bottom: #000000 2px solid; vertical-align: bottom"&gt;&#13;&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center"&gt;2015&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; width: 64%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 8.65pt; text-indent: 0.7pt"&gt;Research and development expenses&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;19&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;39&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;131&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; width: 64%; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 8.65pt; text-indent: 0.7pt"&gt;General and administrative expenses&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;394&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;145&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;173&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 4px; width: 64%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 4px; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;413&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 4px; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;184&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 4px; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;304&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="clear: both; line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;</us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock>
    <us-gaap:ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock contextRef="From2016-07-01to2017-06-30_custom_EmployeesAndDirectorsMember_us-gaap_RestrictedStockUnitsRSUMember">&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 35.45pt"&gt;The following table summarizes the activity related to unvested RS and RSUs granted to employees and directors under the 2005 Plan&amp;#160; and 2016 Plan&amp;#160; for the year ended June 30, 2017:&lt;/div&gt;&#13;&#13;&lt;div style="line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div&gt;&#13;&lt;table id="zdd176e5c456a4b89a1f51858b7a2875c" cellspacing="0" cellpadding="0" align="right" border="0" style="font: 10pt Times New Roman, Times, serif; width: 94%"&gt;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom"&gt;&#13;&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center; text-indent: 2pt"&gt;Number&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; width: 88%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 8.65pt; text-indent: 0.7pt"&gt;Unvested at the beginning of period&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;1,906,619&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; width: 88%; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 8.65pt; text-indent: 0.7pt"&gt;Granted&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;6,579,435&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; width: 88%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 8.65pt; text-indent: 0.7pt"&gt;Forfeited&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;(107,953&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;)&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; width: 88%; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 8.65pt; text-indent: 0.7pt"&gt;Vested&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;(2,313,200&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;)&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 4px; width: 88%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 8.65pt; text-indent: 0.7pt"&gt;Unvested at the end of the period&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 4px; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;6,064,901&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 4px; width: 88%; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 8.65pt; text-indent: 0.7pt"&gt;Expected to vest after June 30, 2017&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 4px; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;5,978,114&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="clear: both; line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;</us-gaap:ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock>
    <us-gaap:ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock contextRef="From2016-07-01to2017-06-30_custom_NonemployeesMember_us-gaap_RestrictedStockUnitsRSUMember">&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 36pt"&gt;The following table summarizes the activity related to unvested RS and RSUs granted to consultants for the year ended June 30, 2017:&lt;br style="line-height: 1.25" /&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div&gt;&#13;&lt;table id="z8e0bf2d3eaa64c13b2ffaf539d67195a" cellspacing="0" cellpadding="0" align="right" border="0" style="font: 10pt Times New Roman, Times, serif; width: 94%"&gt;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom"&gt;&#13;&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center; text-indent: 2pt"&gt;Number&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; width: 88%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 8.65pt; text-indent: 0.7pt"&gt;Unvested at the beginning of period&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;26,000&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr style="height: 16px"&gt;&#13;&lt;td style="vertical-align: bottom; width: 88%; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 8.65pt; text-indent: 0.7pt"&gt;Granted&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;273,557&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; width: 88%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 8.65pt; text-indent: 0.7pt"&gt;Vested&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;(257,057&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;)&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 4px; width: 88%; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 8.65pt; text-indent: 0.7pt"&gt;Unvested at the end of the period&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 4px; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;42,500&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="clear: both; line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;</us-gaap:ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock>
    <us-gaap:ScheduleOfShareBasedCompensationActivityTableTextBlock contextRef="D2016-07-01_To_2017-06-30">&lt;div&gt;&lt;table id="z522be72775cb4488b2680c438abfc4d4" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, serif; width: 100%"&gt;&#13;&lt;tr style="height: 60px"&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom"&gt;&#13;&lt;div style="line-height: 1.25"&gt;&#13;&lt;div style="line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center"&gt;Warrants / Options&lt;/div&gt;&#13;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom"&gt;&#13;&lt;div style="line-height: 1.25"&gt;&#13;&lt;div style="line-height: 1.25"&gt;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: center"&gt;&lt;font style="font: bold 10pt Times New Roman, Times, serif"&gt;Exercise Price&lt;/font&gt; &lt;/div&gt;&#13;&#13;&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center"&gt;per Share&lt;/div&gt;&#13;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom"&gt;&#13;&lt;div style="line-height: 1.25"&gt;&#13;&lt;div style="line-height: 1.25"&gt;&lt;/div&gt;&#13;&#13;&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center"&gt;Options and Warrants &lt;/div&gt;&#13;&#13;&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center"&gt;for Common Stock&lt;/div&gt;&#13;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom"&gt;&#13;&lt;div style="line-height: 1.25"&gt;&#13;&lt;div style="line-height: 1.25"&gt;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: center"&gt;&lt;font style="font: bold 10pt Times New Roman, Times, serif"&gt;Options and Warrants&lt;/font&gt; &lt;font style="font: bold 10pt Times New Roman, Times, serif"&gt;Exercisable&lt;/font&gt;&lt;/div&gt;&#13;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; width: 18px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: center; width: 151px"&gt;&#13;&lt;div style="line-height: 1.25"&gt;&#13;&lt;div style="line-height: 1.25"&gt;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: center"&gt;&lt;font style="font: bold 10pt Times New Roman, Times, serif"&gt;Weighted Average Remaining Contractual Terms&lt;/font&gt; &lt;font style="font: bold 10pt Times New Roman, Times, serif"&gt;(in years)&lt;/font&gt;&lt;/div&gt;&#13;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: top; width: 52%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 18pt"&gt;Warrants:&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;1.40&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;8,448,981&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;-&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1.17%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;5.06&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: top; width: 52%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;2.85&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;4,080,000&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;4,080,000&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1.17%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;3.00&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: top; padding-bottom: 2px; width: 52%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;5.00&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;3,219,983&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;3,219,983&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; width: 1.17%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;0.22&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: top; padding-bottom: 2px; width: 52%; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 18pt"&gt;Total warrants&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif"&gt;15,748,964&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif"&gt;7,299,983&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; width: 1.17%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: top; width: 52%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1.17%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: top; width: 52%; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 18pt"&gt;Options:&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;0.00&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;137,200&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;124,825&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1.17%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;5.32&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: top; width: 52%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;0.62&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;345,500&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;345,500&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1.17%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;1.28&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: top; width: 52%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;1.04&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;25,000&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;25,000&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1.17%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;1.16&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: top; width: 52%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;2.97&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;20,000&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;20,000&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1.17%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;0.86&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: top; width: 52%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;3.50&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;30,000&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;30,000&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1.17%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;0.14&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: top; width: 52%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;3.80&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;1,000&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;1,000&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1.17%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;0.14&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: top; width: 52%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;4.38&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;372,500&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;372,500&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1.17%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;0.47&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: top; width: 52%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;4.40&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;400&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;400&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1.17%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;0.14&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: top; width: 52%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;6.80&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;36,250&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;36,250&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1.17%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;0.37&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: top; width: 52%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;8.20&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;20,000&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;20,000&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; width: 1.17%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;0.16&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: top; padding-bottom: 2px; width: 52%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;20.00&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;5,000&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;5,000&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; width: 1.17%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;2.62&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: top; padding-bottom: 2px; width: 52%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 18pt"&gt;Total options&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif"&gt;992,850&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif"&gt;980,475&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; width: 1.17%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td colspan="4" style="vertical-align: top; padding-bottom: 2px; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: left; text-indent: 18pt"&gt;Total warrants and options&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif"&gt;16,741,814&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif"&gt;8,280,458&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; width: 18px; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 12px; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; text-align: right; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;</us-gaap:ScheduleOfShareBasedCompensationActivityTableTextBlock>
    <us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock contextRef="D2016-07-01_To_2017-06-30">&lt;div id="DSPFPageHeader"&gt;&lt;/div&gt;&#13;&#13;&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 36pt; text-indent: -36pt"&gt;NOTE 1:-GENERAL&lt;/div&gt;&#13;&#13;&lt;div style="line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="text-align: justify; line-height: 1.25"&gt;&#13;&lt;table id="z03ca1ab620fc4716b2524dbd7f0ead3c" class="DSPFListTable" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, serif; width: 100%"&gt;&#13;&lt;tr&gt;&#13;&lt;td style="font: 10pt Times New Roman, Times, serif; width: 18pt; vertical-align: top"&gt;a.&lt;/td&gt;&#13;&lt;td style="width: auto; vertical-align: top; text-align: justify"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif"&gt;Pluristem Therapeutics Inc., a Nevada corporation, was incorporated on May 11, 2001. Pluristem Therapeutics Inc. has a wholly owned subsidiary, Pluristem Ltd. (the &amp;#8220;Subsidiary&amp;#8221;), which is incorporated under the laws of the State of Israel. Pluristem Therapeutics Inc. and the Subsidiary are referred to as the &amp;#8220;Company&amp;#8221; or &amp;#8220;Pluristem&amp;#8221;.&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif"&gt;The Company&amp;#8217;s shares of common stock are traded on the NASDAQ Capital Market under the symbol &amp;#8220;PSTI&amp;#8221; and on the Tel-Aviv Stock Exchange under the symbol &amp;#8220;PLTR&amp;#8221;.&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="text-align: justify; line-height: 1.25"&gt;&#13;&lt;table id="z1f2560ed545f45e4876be47fea69fb87" class="DSPFListTable" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, serif; width: 100%"&gt;&#13;&lt;tr&gt;&#13;&lt;td style="font: 10pt Times New Roman, Times, serif; width: 18pt; vertical-align: top"&gt;b.&lt;/td&gt;&#13;&lt;td style="width: auto; vertical-align: top; text-align: justify"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif"&gt;The Company is a bio-therapeutics company developing placenta-based cell therapy product candidates for the treatment of multiple ischemic and inflammatory conditions. The Company has incurred an accumulated deficit of approximately $189,571 and incurred recurring operating losses and negative cash flows from operating activities since inception. As of June 30, 2017, the Company&amp;#8217;s total stockholders&amp;#8217; equity amounted to $30,251.&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 18pt; margin-right: 5.9pt"&gt;During the year ended June 30, 2017, the Company incurred operating losses of $27,814 and its negative cash flow from operating activities was $21,611. The Company will be required to obtain additional liquidity resources in the near term in order to support the commercialization of its products and maintain its research and development and clinical trials activities.&lt;/div&gt;&#13;&#13;&lt;div style="line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 18pt; margin-right: 5.9pt"&gt;As of June 30, 2017, the Company&amp;#8217;s cash position (cash and cash equivalents, short-term bank deposits and marketable securities) totaled approximately $26,106. The Company is addressing its liquidity issues by implementing initiatives to allow the continuation of its activities. The Company&amp;#8217;s current operating plan includes various assumptions concerning the level and timing of cash outflows for operating activities and capital expenditures. The Company&amp;#8217;s ability to successfully carry out its business plan, which includes a cost-reduction plan should it be unable to raise sufficient additional capital, is primarily dependent upon its ability to (1) obtain sufficient additional capital, (2) enter into license agreements to use or commercialize the Company&amp;#8217;s products and (3) receive other sources of funding, including non-diluting sources such as the IIA grants, the &lt;font style="font: 10pt Times New Roman, Times, serif"&gt;European Union&amp;#8217;s Horizon 2020 program (&amp;#8220;Horizon 2020&amp;#8221;)&lt;/font&gt; grant and other grants. There are no assurances, however, that the Company will be successful in obtaining an adequate level of financing needed for the long-term development and commercialization of its products.&lt;/div&gt;&#13;&#13;&lt;div style="line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="text-align: justify; margin-left: 18pt; line-height: 1.25; margin-right: 5.9pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, serif"&gt;According to management estimates, liquidity resources as of June 30, 2017 &lt;/font&gt;&lt;font style="font: 10pt Times New Roman, Times, serif"&gt;will be sufficient to maintain the Company&amp;#8217;s operations into the first quarter of the Company&amp;#8217;s fiscal year 2019. The Company&amp;#8217;s inability to raise funds to carry out its business plan will have a severe negative impact on its ability to remain a viable company.&lt;/font&gt;&lt;/div&gt;&#13;&#13;&lt;div style="line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 18pt; margin-right: 5.9pt"&gt;These conditions raise substantial doubt about the Company&amp;#8217;s ability to continue as a going concern. The audited consolidated financial statements do not include any adjustments relating to the recoverability and classification of assets or liabilities that might be necessary should the Company be unable to continue as a going concern.&lt;/div&gt;&#13;&#13;&lt;div style="line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="text-align: left; line-height: 1.25"&gt;&#13;&lt;table id="z2fa9d6ed738141e6935b02c642d6877d" class="DSPFListTable" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, serif; width: 100%"&gt;&#13;&lt;tr&gt;&#13;&lt;td style="font: 10pt Times New Roman, Times, serif; width: 18pt; vertical-align: top"&gt;c.&lt;/td&gt;&#13;&lt;td style="width: auto; vertical-align: top; text-align: left"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif"&gt;License Agreements:&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="line-height: 1.25"&gt;&lt;br style="line-height: 1.25" /&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 18pt; margin-right: 5.9pt"&gt;&lt;u&gt;United Therapeutics Corporation (&amp;#8220;United&amp;#8221;) Agreement&lt;/u&gt;&lt;/div&gt;&#13;&#13;&lt;div style="line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 18pt; margin-right: 5.9pt"&gt;On June 19, 2011, the Company entered into an exclusive license agreement (the &amp;#8220;United Agreement&amp;#8221;) with United for the use of the Company&amp;#8217;s PLX cells to develop and commercialize a cell-based product for the treatment of Pulmonary Hypertension (&amp;#8220;PAH&amp;#8221;). The United Agreement provided that United would receive exclusive worldwide license rights for the development and commercialization of the Company&amp;#8217;s PLX cell-based product to treat PAH.&lt;/div&gt;&#13;&#13;&lt;div style="line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 18pt; margin-right: 5.9pt"&gt;Under the United Agreement the Company received an upfront payment of $7,000 paid in August 2011, which included a $5,000 non-refundable upfront payment and a $2,000 advance payment on development.&lt;/div&gt;&#13;&#13;&#13;&#13;&lt;div style="line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 18pt; margin-right: 5.9pt"&gt;On December 8, 2015, the Company received a notice from United terminating the United Agreement, effective immediately. Pursuant to the United Agreement termination clause, Pluristem regained full rights to PLX in the field of PAH, as well as all clinical data and regulatory submissions. As the Company has no further obligations towards United, the Company recognized the remaining upfront payment received in August 2011 as revenues during the year ended June 30, 2016.&lt;/div&gt;&#13;&#13;&lt;div style="line-height: 1.25"&gt;&lt;br style="line-height: 1.25" /&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 18pt; margin-right: 5.9pt"&gt;&lt;u&gt;CHA Biotech Co. Ltd. (&amp;#8220;CHA&amp;#8221;) Agreement&lt;/u&gt;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 18pt; margin-right: 5.9pt"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 18pt; margin-right: 5.9pt"&gt;On June 26, 2013, Pluristem entered into an exclusive license and commercialization agreement (the &amp;#8220;CHA Agreement&amp;#8221;) with CHA, for conducting clinical trials and commercialization of Pluristem&amp;#8217;s PLX-PAD product in South Korea in connection with two indications: the treatment of Critical Limb Ischemia (&amp;#8220;CLI&amp;#8221;), and Intermediate Claudication (the &amp;#8220;Indications&amp;#8221;). Under the terms of the CHA Agreement, CHA will receive exclusive rights in South Korea for conducting clinical trials with respect to the Indications, and the Company&amp;#160;will continue to retain rights to its proprietary manufacturing technology and cell-related intellectual property.&lt;br style="line-height: 1.25" /&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 18pt; margin-right: 5.9pt"&gt;The first clinical study as part of the CHA Agreement is a Phase II trial in Intermittent Claudication. South Korea&amp;#8217;s Ministry of Food and Drug Safety approved this study in November 2013.&lt;/div&gt;&#13;&#13;&lt;div style="line-height: 1.25"&gt;&lt;br style="line-height: 1.25" /&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 18pt; margin-right: 5.9pt"&gt;Upon the first regulatory approval for a PLX product in South Korea, for the specified indications, Pluristem and CHA will establish an equally owned joint venture. The purpose of the joint venture will be to commercialize PLX cell products in South Korea.&lt;/div&gt;&#13;&#13;&lt;div style="line-height: 1.25"&gt;&lt;br style="line-height: 1.25" /&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 18pt; margin-right: 5.9pt"&gt;Pluristem will be able to use the data generated by CHA to pursue the development of PLX product candidates outside of South Korea.&lt;/div&gt;&#13;&#13;&lt;div style="line-height: 1.25"&gt;&lt;br style="line-height: 1.25" /&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 18pt; margin-right: 5.9pt"&gt;The CHA Agreement contains customary termination provisions, including in the event the parties do not reach an agreement upon development plan for conducting the clinical trials. Upon termination of this CHA Agreement, the license granted thereunder will terminate and all rights included therein will revert to the Company, whereupon the Company will be free to enter into agreements with any other third parties for the granting of a license in or outside South Korea or to deal in any other manner with such rights as it shall see fit at its sole discretion.&lt;/div&gt;&#13;&#13;&lt;div style="line-height: 1.25"&gt;&lt;br style="line-height: 1.25" /&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 18pt; margin-right: 5.9pt"&gt;In addition, and as contemplated by the CHA Agreement, in December 2013, Pluristem and CHA executed the mutual investment pursuant to which Pluristem issued 2,500,000 shares of its common stock in consideration for 1,011,504 shares of CHA, which reflects total consideration to each of Pluristem and CHA of approximately $10,414. The parties also agreed to give an irrevocable proxy to the other party&amp;#8217;s management with respect to the voting power of the shares issued.&lt;/div&gt;&#13;&#13;&lt;div style="line-height: 1.25"&gt;&lt;br style="line-height: 1.25" /&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 18pt; margin-right: 5.9pt"&gt;During March 2015, the Company sold a portion of the CHA shares received in December 2013.&lt;/div&gt;&#13;&#13;&lt;div style="line-height: 1.25"&gt;&lt;br style="line-height: 1.25" /&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 18pt; margin-right: 5.9pt"&gt;The remaining investment in CHA shares is presented as &amp;#8220;Marketable Securities&amp;#8221; and classified as available-for-sale in accordance with Accounting Standards Codification (&amp;#8220;ASC&amp;#8221;) 320, &amp;#8220;Investments - Debt and Equity Securities&amp;#8221;. The fair value of the remaining investment in CHA&amp;#8217;s shares as of June 30, 2017, is approximately $4,358.&lt;/div&gt;</us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock>
    <us-gaap:SignificantAccountingPoliciesTextBlock contextRef="D2016-07-01_To_2017-06-30">&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 36pt; text-indent: -36pt"&gt;NOTE 2:-SIGNIFICANT ACCOUNTING POLICIES&lt;/div&gt;&#13;&#13;&lt;div style="line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify"&gt;The consolidated financial statements have been prepared in accordance with United States generally accepted accounting principles (&amp;#8220;U.S. GAAP&amp;#8221;) applied on consistent basis.&lt;/div&gt;&#13;&#13;&lt;div style="line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="text-align: justify; line-height: 1.25"&gt;&#13;&lt;table id="z1af1627d0e9e4dd3b8eac1b4ebf43a64" class="DSPFListTable" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, serif; width: 100%"&gt;&#13;&lt;tr&gt;&#13;&lt;td style="font: bold 10pt Times New Roman, Times, serif; width: 27pt; vertical-align: top"&gt;a.&lt;/td&gt;&#13;&lt;td style="width: auto; vertical-align: top; text-align: justify"&gt;&#13;&lt;div style="font: bold 10pt Times New Roman, Times, serif"&gt;Use of estimates&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 27pt; text-indent: 0pt"&gt;The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates, judgments, and assumptions that are reasonable based upon information available at the time they are made. These estimates, judgments and assumptions can affect the amounts reported in the financial statements and accompanying notes. Actual results could differ from those estimates.&lt;/div&gt;&#13;&#13;&lt;div style="line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="text-align: justify; line-height: 1.25"&gt;&#13;&lt;table id="za7bc05a3506840d5a83f52e5cf3b45b1" class="DSPFListTable" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, serif; width: 100%"&gt;&#13;&lt;tr&gt;&#13;&lt;td style="font: bold 10pt Times New Roman, Times, serif; width: 27pt; vertical-align: top"&gt;b.&lt;/td&gt;&#13;&lt;td style="width: auto; vertical-align: top; text-align: justify"&gt;&#13;&lt;div style="font: bold 10pt Times New Roman, Times, serif"&gt;Functional currency&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="line-height: 1.25"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 27pt; text-indent: 0pt"&gt;Most of the Pluristem Therapeutics Inc. costs are denominated in United States dollars (&amp;#8220;dollar&amp;#8221;). The Company&amp;#8217;s management believes that the dollar is the primary currency of the economic environment in which Pluristem Therapeutics Inc. and its subsidiary operate. Thus, the dollar is the Company&amp;#8217;s functional and reporting currency. Accordingly, non-dollar denominated transactions and balances have been re-measured into the functional currency in accordance with ASC No. 830, &amp;#8220;Foreign Currency Matters&amp;#8221;. All transaction gains and losses from the re-measured monetary balance sheet items are reflected in the statements of income as financial income or expenses, as appropriate.&lt;/div&gt;&#13;&#13;&lt;div style="line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="text-align: justify; line-height: 1.25"&gt;&#13;&lt;table id="z1f93aca01e5e4ee6a8fdf1dd94b2f8af" class="DSPFListTable" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, serif; width: 100%"&gt;&#13;&lt;tr&gt;&#13;&lt;td style="font: bold 10pt Times New Roman, Times, serif; width: 27pt; vertical-align: top"&gt;c.&lt;/td&gt;&#13;&lt;td style="width: auto; vertical-align: top; text-align: justify"&gt;&#13;&lt;div style="font: bold 10pt Times New Roman, Times, serif"&gt;Principles of consolidation&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 27pt; text-indent: 0pt"&gt;The consolidated financial statements include the accounts of Pluristem Therapeutics Inc. and it&amp;#8217;s Subsidiary. Intercompany transactions and balances have been eliminated upon consolidation.&lt;/div&gt;&#13;&#13;&lt;div style="line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="text-align: justify; line-height: 1.25"&gt;&#13;&lt;table id="ze0f636e14c5d4c1e86c453d6849bbd2f" class="DSPFListTable" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, serif; width: 100%"&gt;&#13;&lt;tr&gt;&#13;&lt;td style="font: bold 10pt Times New Roman, Times, serif; width: 27pt; vertical-align: top"&gt;d.&lt;/td&gt;&#13;&lt;td style="width: auto; vertical-align: top; text-align: justify"&gt;&#13;&lt;div style="font: bold 10pt Times New Roman, Times, serif"&gt;Cash and cash equivalents&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 28.35pt; text-indent: -1.35pt"&gt;Cash equivalents are short-term highly liquid investments that are readily convertible to cash with maturities of three months or less at the date acquired.&lt;/div&gt;&#13;&#13;&lt;div style="line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="text-align: justify; line-height: 1.25"&gt;&#13;&lt;table id="zbfbd29a4eb644edbb7c98dcc26a49d3f" class="DSPFListTable" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, serif; width: 100%"&gt;&#13;&lt;tr&gt;&#13;&lt;td style="font: bold 10pt Times New Roman, Times, serif; width: 28.35pt; vertical-align: top"&gt;e.&lt;/td&gt;&#13;&lt;td style="width: auto; vertical-align: top; text-align: justify"&gt;&#13;&lt;div style="font: bold 10pt Times New Roman, Times, serif"&gt;Short-term bank deposit&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 28.35pt"&gt;Bank deposits with original maturities of more than three months but less than one year are presented as part of short-term investments. Deposits are presented at their cost which approximates market values including accrued interest. Interest on deposits is recorded as financial income.&lt;/div&gt;&#13;&#13;&lt;div style="line-height: 1.25"&gt;&lt;br style="line-height: 1.25" /&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="text-align: justify; line-height: 1.25"&gt;&#13;&lt;table id="z978469e1fcb646049d8a05cb6166784c" class="DSPFListTable" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, serif; width: 100%"&gt;&#13;&lt;tr&gt;&#13;&lt;td style="font: bold 10pt Times New Roman, Times, serif; width: 27pt; vertical-align: top"&gt;f.&lt;/td&gt;&#13;&lt;td style="width: auto; vertical-align: top; text-align: justify"&gt;&#13;&lt;div style="font: bold 10pt Times New Roman, Times, serif"&gt;Restricted cash and short-term bank deposits&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 28.35pt"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 28.35pt"&gt;Short-term restricted bank deposits and restricted cash used to secure derivative and hedging transactions and the Company&amp;#8217;s credit line. The restricted cash and short-term bank deposits are presented at cost which approximates market values including accrued interest.&lt;/div&gt;&#13;&#13;&lt;div style="line-height: 1.25"&gt;&lt;br style="line-height: 1.25" /&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="text-align: justify; line-height: 1.25"&gt;&#13;&lt;table id="zd17e0f5d149c4b0dad19bc2e378a5f58" class="DSPFListTable" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, serif; width: 100%"&gt;&#13;&lt;tr&gt;&#13;&lt;td style="font: bold 10pt Times New Roman, Times, serif; width: 27pt; vertical-align: top"&gt;g.&lt;/td&gt;&#13;&lt;td style="width: auto; vertical-align: top; text-align: justify"&gt;&#13;&lt;div style="font: bold 10pt Times New Roman, Times, serif"&gt;Long-term restricted bank deposits&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 27pt; text-indent: 0pt"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 27pt; text-indent: 0pt"&gt;Long-term restricted bank deposits with maturities of more than one year used to secure operating lease agreement are presented at cost which approximates market values including accrued interest.&lt;/div&gt;&#13;&#13;&lt;div style="text-align: justify; margin-left: 27pt; line-height: 1.25; text-indent: -27pt"&gt;&lt;br style="line-height: 1.25" /&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="text-align: justify; line-height: 1.25"&gt;&#13;&lt;table id="zb5071478f8d54ec5a96c5c5ab6b8e7f5" class="DSPFListTable" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, serif; width: 100%"&gt;&#13;&lt;tr&gt;&#13;&lt;td style="font: bold 10pt Times New Roman, Times, serif; width: 27pt; vertical-align: top"&gt;h.&lt;/td&gt;&#13;&lt;td style="width: auto; vertical-align: top; text-align: justify"&gt;&#13;&lt;div style="font: bold 10pt Times New Roman, Times, serif"&gt;Investment in marketable securities&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 28.35pt"&gt;The Company accounts for its investments in marketable securities in accordance with ASC 320,&amp;#8220;Investments &amp;#8211; Debt and Equity Securities&amp;#8221;. The Company determines the classification of marketable securities at the time of purchase and re-evaluates such designations as of each balance sheet date. The Company classifies all of its marketable securities as available-for-sale. Available-for-sale marketable securities are carried at fair value, with the unrealized gain and loss reported at &amp;#8220;Accumulated other comprehensive income (loss)&amp;#8221; in the statement of changes in stockholders&amp;#8217; equity.&lt;/div&gt;&#13;&#13;&#13;&#13;&lt;div style="line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 28.35pt"&gt;Realized gain and loss on sales of marketable securities are included in the Company&amp;#8217;s &amp;#8220;Financial income, net&amp;#8221; and are derived using the specific identification basis for determining the cost of marketable securities sold. The amortized cost of available for sale debt marketable securities is adjusted for amortization of premiums and accretion of discount to maturity. Such amortization, together with coupon interest on available for sale marketable securities, is included in the &amp;#8220;Financial income, net&amp;#8221;.&lt;/div&gt;&#13;&#13;&lt;div style="line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 28.35pt"&gt;The Company recognizes an impairment charge when a decline in the fair value of its available-for-sale marketable securities below the cost basis is judged to be other-than-temporary. The Company considers various factors in determining whether to recognize an impairment charge, including the length of time the investment has been in a loss position, the extent to which the fair value has been less than the Company&amp;#8217;s cost basis, the reason for the decline in value, the potential recovery period and the Company&amp;#8217;s intent to sell, including whether it is more likely than not that the Company will be required to sell the investment before recovery of cost basis. ASC 320-10-35, &amp;#8220;Investments - Debt and Equity Securities&amp;#8221;, requires another-than-temporary impairment for debt securities to be separated into (a)&amp;#160;the amount representing the credit loss and (b)&amp;#160;the amount related to all other factors (provided that the Company does not intend to sell the security and it is not more likely than not that it will be required to sell it before recovery). For securities that are deemed other-than-temporarily impaired, the amount of impairment is recognized in &amp;#8220;financial income, net&amp;#8221;, in the statement of operations and is limited to the amount related to credit loss, while impairment related to other factors is recognized in &amp;#8220;other comprehensive income (loss)&amp;#8221;.&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 28.35pt"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 28.35pt"&gt;During the years ended June 30, 2017 and 2016, the Company recognized other-than-temporary impairment loss of $767 and $38, respectively. During the year ended June 30, 2015 no impairment losses were identified (see note 3).&lt;/div&gt;&#13;&#13;&lt;div style="line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="text-align: justify; line-height: 1.25"&gt;&#13;&lt;table id="zb4e567880d2a4c168bd77962c3661dd1" class="DSPFListTable" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, serif; width: 100%"&gt;&#13;&lt;tr&gt;&#13;&lt;td style="font: bold 10pt Times New Roman, Times, serif; width: 27pt; vertical-align: top"&gt;i.&lt;/td&gt;&#13;&lt;td style="width: auto; vertical-align: top; text-align: justify"&gt;&#13;&lt;div style="font: bold 10pt Times New Roman, Times, serif"&gt;Revenue Recognition from the license Agreement with United&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 28.35pt"&gt;The Company recognized revenue pursuant to the License Agreement with United in accordance with ASC 605-25, &amp;#8220;Revenue Recognition, Multiple-Element Arrangements&amp;#8221;.&lt;/div&gt;&#13;&#13;&lt;div style="line-height: 1.25"&gt;&lt;br style="line-height: 1.25" /&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 28.35pt"&gt;Pursuant to ASC 605-25, each deliverable is evaluated to determine whether it qualifies as a separate unit of accounting based on whether the deliverable has &amp;#8220;stand-alone value&amp;#8221; to the customer. The arrangement&amp;#8217;s consideration that is fixed or determinable is then allocated to each separate unit of accounting based on the relative selling price of each deliverable. In general, the consideration allocated to each unit of accounting is recognized as the related goods or services are delivered, limited to the consideration that is not contingent upon future deliverables.&lt;/div&gt;&#13;&#13;&lt;div style="line-height: 1.25"&gt;&lt;br style="line-height: 1.25" /&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 28.35pt"&gt;The Company received an up-front, non-refundable license payment of $5,000. Additional payments totaling $37,500 were subject to the achievement of certain regulatory milestones by United.&lt;/div&gt;&#13;&#13;&lt;div style="line-height: 1.25"&gt;&lt;br style="line-height: 1.25" /&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 28.35pt"&gt;Since the deliverables in the United Agreement did not have stand-alone value, none of them qualified as a separate unit of accounting. Accordingly, the non-refundable upfront license fee of $5,000 was deferred and recognized on a straight line basis over the related performance period which was the development period in accordance with Staff Accounting Bulletin (&amp;#8220;SAB&amp;#8221;) 104, &amp;#8220;Revenue Recognition&amp;#8221;.&lt;/div&gt;&#13;&#13;&lt;div style="line-height: 1.25"&gt;&lt;br style="line-height: 1.25" /&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 28.35pt"&gt;The Company also received an advanced payment for the development, of $2,000 that was deductible against development expenses as it was incurred. The upfront payment which was received was included in the balance sheet as advance payment. The Company deducted the payments from its research and development expenses in accordance with ASC 730-20, &amp;#8220;Research and Development Agreements&amp;#8221;.&lt;/div&gt;&#13;&#13;&#13;&#13;&lt;div style="line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 28.35pt"&gt;On December 8, 2015, the Company received a notice from United terminating the United Agreement, effective immediately. Pursuant to the United Agreement termination clause, Pluristem regained full rights to PLX in the field of PAH, as well as all clinical data and regulatory submissions. As the Company had no further obligations&lt;font style="font: bold 10pt Times New Roman, Times, serif"&gt;&amp;#160;&lt;/font&gt;towards United, the Company recognized the remaining upfront payment received in 2011 as revenues during the year ended June 30, 2016.&lt;/div&gt;&#13;&#13;&lt;div style="line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="text-align: justify; line-height: 1.25"&gt;&#13;&lt;table id="z18f60214b5e14ae396da878f15bb2f47" class="DSPFListTable" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, serif; width: 100%"&gt;&#13;&lt;tr&gt;&#13;&lt;td style="font: bold 10pt Times New Roman, Times, serif; width: 28.35pt; vertical-align: top"&gt;j.&lt;/td&gt;&#13;&lt;td style="width: auto; vertical-align: top; text-align: justify"&gt;&#13;&lt;div style="font: bold 10pt Times New Roman, Times, serif"&gt;Property and Equipment&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 27pt; text-indent: 0pt"&gt;Property and equipment are stated at cost, net of accumulated depreciation. Depreciation is calculated by the straight-line method over the estimated useful lives of the assets, at the following annual rates:&lt;/div&gt;&#13;&#13;&lt;div style="line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div&gt;&#13;&lt;table id="z4239811fa84e426982a3190298cf9636" cellspacing="0" cellpadding="0" align="center" border="0" style="font: 10pt Times New Roman, Times, serif; width: 60%"&gt;&#13;&lt;tr&gt;&#13;&lt;td style="width: 40%; vertical-align: top; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="vertical-align: top; border-bottom: #000000 2px solid; vertical-align: bottom"&gt;&#13;&lt;div style="line-height: 1.25"&gt;&#13;&lt;div style="line-height: 1.25"&gt;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: center"&gt;%&lt;/div&gt;&#13;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="width: 40%; vertical-align: top; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left"&gt;Laboratory equipment&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 40%; vertical-align: bottom; text-align: right; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: center"&gt;10-15&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr style="height: 16px"&gt;&#13;&lt;td style="width: 40%; vertical-align: top; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left"&gt;Computers and peripheral equipment&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 40%; vertical-align: bottom; text-align: right; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: center"&gt;33&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="width: 40%; vertical-align: top; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left"&gt;Office furniture and equipment&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 40%; vertical-align: bottom; text-align: right; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: center"&gt;15&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="width: 40%; vertical-align: top; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left"&gt;Vehicles&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 40%; vertical-align: bottom; text-align: right; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: center"&gt;15&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr style="height: 15px"&gt;&#13;&lt;td style="width: 40%; vertical-align: top; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left"&gt;Leasehold improvements&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="vertical-align: top; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left"&gt;The shorter of the expected useful life or the reasonable assumed term of the lease.&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="text-align: justify; line-height: 1.25"&gt;&#13;&lt;table id="z252d414105c7440bb6165d5bf6b4d15a" class="DSPFListTable" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, serif; width: 100%"&gt;&#13;&lt;tr&gt;&#13;&lt;td style="font: bold 10pt Times New Roman, Times, serif; width: 28.35pt; vertical-align: top"&gt;k.&lt;/td&gt;&#13;&lt;td style="width: auto; vertical-align: top; text-align: justify"&gt;&#13;&lt;div style="font: bold 10pt Times New Roman, Times, serif"&gt;Impairment of long-lived assets&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 27pt; text-indent: 0pt"&gt;The Company&amp;#8217;s long-lived assets are reviewed for impairment in accordance with ASC 360, &amp;#8220;Property, Plant and Equipment&amp;#8221;, whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of the assets to the future undiscounted cash flows expected to be generated by the assets. If such assets are considered to be impaired, the impairment to be recognized is measured by the amount by which the carrying amount of the assets exceeds the fair value of the assets. During fiscal years 2017, 2016 and 2015, no impairment losses have been identified.&lt;/div&gt;&#13;&#13;&lt;div style="line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 27pt"&gt;&#13;&lt;div id="DSPFPageHeader"&gt;&lt;/div&gt;&#13;&#13;&lt;div style="line-height: 1.25"&gt;As required by ASC 820, &amp;#8220;Fair Value Measurements&amp;#8221; (&amp;#8220;ASC 820&amp;#8221;), the Company applies assumptions that marketplace participants would consider in determining the fair value of long-lived assets.&lt;/div&gt;&#13;&#13;&lt;div style="line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="text-align: justify; line-height: 1.25"&gt;&#13;&lt;table id="zb79e5bb96e214148b3fac6f353132e61" class="DSPFListTable" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, serif; width: 100%"&gt;&#13;&lt;tr&gt;&#13;&lt;td style="font: bold 10pt Times New Roman, Times, serif; width: 27pt; vertical-align: top"&gt;l.&lt;/td&gt;&#13;&lt;td style="width: auto; vertical-align: top; text-align: justify"&gt;&#13;&lt;div style="font: bold 10pt Times New Roman, Times, serif"&gt;Accounting for stock-based compensation&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 27pt; text-indent: 0.05pt"&gt;The Company accounts for stock-based compensation in accordance with ASC 718, &amp;#8220;Compensation-Stock Compensation&amp;#8221; (&amp;#8220;ASC 718&amp;#8221;) and ASC 505-50, &amp;#8220;Equity-Based Payments to Non-Employees&amp;#8221; (&amp;#8220;ASC 505-50&amp;#8221;). ASC 718 requires companies to estimate the fair value of equity-based payment awards on the date of grant using an option-pricing model. The Company estimates the fair value of stock options granted using the Black-Scholes-Merton option-pricing model. The Company accounts for employee&amp;#8217;s share-based payment awards classified as equity awards (restricted stocks or restricted stock units) using the grant-date fair value method. The fair value of share-based payment transactions is recognized as an expense over the requisite service period, net of estimated forfeitures. The Company estimates forfeitures based on historical experience and anticipated future conditions. The Company elected to recognize compensation cost for an award with service conditions and goals achievement that has a graded vesting schedule using the accelerated method based on the multiple-option award approach.&lt;/div&gt;&#13;&#13;&lt;div style="line-height: 1.25"&gt;&lt;br style="line-height: 1.25" /&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 27.05pt; text-indent: 0.05pt"&gt;During fiscal years 2017, 2016 and 2015, there were no options granted to employees or directors.&lt;/div&gt;&#13;&#13;&lt;div style="line-height: 1.25"&gt;&lt;br style="line-height: 1.25" /&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 28.35pt"&gt;The assumptions below are relevant to restricted stock and restricted stock units granted in 2017, 2016 and 2015:&lt;/div&gt;&#13;&#13;&lt;div style="line-height: 1.25"&gt;&lt;br style="line-height: 1.25" /&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 28.35pt"&gt;In accordance with ASC 718, restricted stock and restricted stock units are measured at their fair value. All restricted stock and restricted stock units to employees, directors and non-employees granted in 2017, 2016 and 2015, were granted for no consideration; therefore, their fair value was equal to the share price at the date of grant.&lt;/div&gt;&#13;&#13;&#13;&#13;&lt;div style="line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 28.35pt"&gt;The fair value of all restricted stock and restricted stock units was determined based on the close trading price of the Company&amp;#8217;s shares known at the grant date. The weighted average grant date fair value of shares granted during 2017, 2016 and 2015, was $1.41, $1.13 and $2.70, respectively.&lt;/div&gt;&#13;&#13;&lt;div style="line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="text-align: justify; line-height: 1.25"&gt;&#13;&lt;table id="z7e07885053824892bd52a1a2cb6999f9" class="DSPFListTable" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, serif; width: 100%"&gt;&#13;&lt;tr&gt;&#13;&lt;td style="font: bold 10pt Times New Roman, Times, serif; width: 28.35pt; vertical-align: top"&gt;m.&lt;/td&gt;&#13;&lt;td style="width: auto; vertical-align: top; text-align: justify"&gt;&#13;&lt;div style="font: bold 10pt Times New Roman, Times, serif"&gt;Research and Development expenses and royalty bearing grants&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 28.35pt; text-indent: 0pt"&gt;Research and development expenses, net of participations grants, are charged to the statement of operations as incurred.&lt;/div&gt;&#13;&#13;&lt;div style="line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="line-height: 1.25"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 28.35pt; text-indent: 0pt"&gt;Pluristem receives grants from the IIA in the Ministry of Economy and Industry (formerly the Office of Chief Scientist&amp;#8217;s) for the purpose of partially funding approved research and development projects. The grants are not to be repaid, but instead Pluristem is obliged to pay royalties as a percentage of future sales if and when sales from the funded projects are generated. These grants are recognized as a deduction from research and development costs at the time the Company is entitled to such grants on the basis of the research and development costs incurred. Since the payment of royalties is not probable when the grants are received, the Company records a liability in the amount of the estimated royalties for each individual contract, when the related revenues are recognized, as part of Cost of revenues. For more information regarding such royalties commitments and regarding grants and participation received, see Note 8.&lt;/div&gt;&#13;&#13;&lt;div style="line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="text-align: justify; line-height: 1.25"&gt;&#13;&lt;table id="zf79edeb6b6264cdebcff1930c5704a4a" class="DSPFListTable" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, serif; width: 100%"&gt;&#13;&lt;tr&gt;&#13;&lt;td style="font: bold 10pt Times New Roman, Times, serif; width: 28.35pt; vertical-align: top"&gt;n.&lt;/td&gt;&#13;&lt;td style="width: auto; vertical-align: top; text-align: justify"&gt;&#13;&lt;div style="font: bold 10pt Times New Roman, Times, serif"&gt;Non-royalty bearing grant&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="line-height: 1.25"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 28.35pt; text-indent: -1.35pt"&gt;T&lt;font style="font: 10pt Times New Roman, Times, serif"&gt;he Company&amp;#8217;s CLI program participates in a European Union&amp;#160;research and development consortium under Horizon 2020.&amp;#160; In August 2016, the CLI program consortium was awarded a Euro 7,600 (approximately $8,700) non-royalty bearing grant. An amount of Euro 1,900 (approximately $2,200) is a direct grant allocated to the Company. &lt;/font&gt;The non-royalty bearing grant for funding the projects is recognized at the time the Company is entitled to such grant on the basis of the related costs incurred and recorded as a deduction from research and development expenses.&lt;/div&gt;&#13;&#13;&lt;div style="line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="text-align: justify; line-height: 1.25"&gt;&#13;&lt;table id="zf823a2550b6d46c591eaa4a91db1adeb" class="DSPFListTable" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, serif; width: 100%"&gt;&#13;&lt;tr&gt;&#13;&lt;td style="font: bold 10pt Times New Roman, Times, serif; width: 28.35pt; vertical-align: top"&gt;o.&lt;/td&gt;&#13;&lt;td style="width: auto; vertical-align: top; text-align: justify"&gt;&#13;&lt;div style="font: bold 10pt Times New Roman, Times, serif"&gt;Loss per share&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 28.35pt; text-indent: 0pt"&gt;Basic and diluted net loss per share is computed based on the weighted average number of shares of common stock outstanding during each year. All outstanding stock options and unvested restricted stock units have been excluded from the calculation of the diluted loss per common share because all such securities are anti-dilutive for each of the periods presented.&lt;/div&gt;&#13;&#13;&lt;div style="line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="text-align: justify; line-height: 1.25"&gt;&#13;&lt;table id="z06d5f9bd8e3e4f4981c1f51ed93f04fe" class="DSPFListTable" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, serif; width: 100%"&gt;&#13;&lt;tr&gt;&#13;&lt;td style="font: bold 10pt Times New Roman, Times, serif; width: 28.35pt; vertical-align: top"&gt;p.&lt;/td&gt;&#13;&lt;td style="width: auto; vertical-align: top; text-align: justify"&gt;&#13;&lt;div style="font: bold 10pt Times New Roman, Times, serif"&gt;Income taxes&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 28.35pt; text-indent: 0pt"&gt;The Company accounts for income taxes in accordance with ASC 740, &amp;#8220;Income Taxes&amp;#8221; (&amp;#8220;ASC 740&amp;#8221;). This Topic prescribes the use of the liability method, whereby deferred tax assets and liability account balances are determined based on differences between financial reporting and tax bases of assets and liabilities and are measured using the enacted tax rates and laws that will be in effect when the differences are expected to reverse. The Company provides a valuation allowance, if necessary, to reduce deferred tax assets to their estimated realizable value.&lt;/div&gt;&#13;&#13;&#13;&#13;&lt;div style="line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 28.35pt; text-indent: -1.35pt"&gt;ASC 740 establishes a single model to address accounting for uncertain tax positions. ASC 740 clarified the accounting for income taxes by prescribing the minimum recognition threshold a tax position is required to meet before being recognized in the financial statements.&lt;/div&gt;&#13;&#13;&lt;div style="line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="text-align: justify; line-height: 1.25"&gt;&#13;&lt;table id="z320736ccd85f45a8b8e69213c3f489d0" class="DSPFListTable" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, serif; width: 100%"&gt;&#13;&lt;tr&gt;&#13;&lt;td style="font: bold 10pt Times New Roman, Times, serif; width: 28.35pt; vertical-align: top"&gt;q.&lt;/td&gt;&#13;&lt;td style="width: auto; vertical-align: top; text-align: justify"&gt;&#13;&lt;div style="font: bold 10pt Times New Roman, Times, serif"&gt;Concentration of credit risk&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 28.35pt; text-indent: 0pt"&gt;Financial instruments that potentially subject the Company to concentrations of credit risk consist principally of cash and cash equivalents, short-term deposits, long-term deposits, restricted deposits and marketable securities.&lt;/div&gt;&#13;&#13;&lt;div style="line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 28.35pt; text-indent: 0pt"&gt;The majority of the Company&amp;#8217;s cash and cash equivalents and short-term and long-term deposits are mainly invested in dollar instruments of major banks in Israel and in the United States. Generally, these deposits may be redeemed upon demand and therefore bear minimal risk.&lt;/div&gt;&#13;&#13;&lt;div style="line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 27.35pt; text-indent: 0pt"&gt;The Company invests its surplus cash in cash deposits and marketable securities in financial institutions and has established guidelines, approved by the Company&amp;#8217;s Investment Committee, relating to diversification and maturities to maintain safety and liquidity of the investments.&lt;/div&gt;&#13;&#13;&lt;div style="line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 27.35pt; text-indent: 0pt"&gt;The Company holds an investment portfolio consisting of corporate bonds, government bonds, stocks and index linked notes. The Company intends, and has the ability, to hold such investments until recovery of temporary declines in market value or maturity. However, the Company can provide no assurance that it will recover declines in the market value of its investments.&lt;/div&gt;&#13;&#13;&lt;div style="line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 27.35pt; text-indent: -27pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &lt;/font&gt;The Company utilizes forward and options contracts to protect against the risk of overall changes in exchange rates. The derivative instruments hedge a portion of the Company&amp;#8217;s non-dollar currency exposure. Counterparties to the Company&amp;#8217;s derivative instruments are all major financial institutions.&lt;/div&gt;&#13;&#13;&lt;div style="line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="text-align: justify; line-height: 1.25"&gt;&#13;&lt;table id="zfcbc5e1a8b494fc7b89fd7aa0beaa363" class="DSPFListTable" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, serif; width: 100%"&gt;&#13;&lt;tr&gt;&#13;&lt;td style="font: bold 10pt Times New Roman, Times, serif; width: 28.35pt; vertical-align: top"&gt;r.&lt;/td&gt;&#13;&lt;td style="width: auto; vertical-align: top; text-align: justify"&gt;&#13;&lt;div style="font: bold 10pt Times New Roman, Times, serif"&gt;Severance pay&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 28.35pt; text-indent: -1.35pt"&gt;&amp;#160;A majority of the Company&amp;#8217;s agreements with employees in Israel are subject to Section 14 of the Israeli Severance Pay Law, 1963 (&amp;#8220;Severance Pay Law&amp;#8221;). The Company&amp;#8217;s contributions for severance pay have replaced its severance obligation. Upon contribution of the full amount of the employee&amp;#8217;s monthly salary for each year of employment, no additional calculations are conducted between the parties regarding the matter of severance pay and no additional payments are made by the Company to the employee. Further, the related obligation and amounts deposited on behalf of the employee for such obligation are not stated on the balance sheet, as the Company is legally released from the obligation to employees once the deposit amounts have been paid.&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 28.35pt; text-indent: -1.35pt"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 28.35pt; text-indent: -1.35pt"&gt;&amp;#160;For some employees, which their agreement is not subject to Section 14 of the Severance Pay Law, the Subsidiary&amp;#8217;s liability for severance pay is calculated pursuant to Israeli Severance Pay Law, based on the most recent salary of the employees multiplied by the number of years of employment, as of the balance sheet date. Employees are entitled to one month&amp;#8217;s salary for each year of employment or a portion thereof.&lt;/div&gt;&#13;&#13;&lt;div style="line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 28.35pt; text-indent: -1.35pt"&gt;The Company&amp;#8217;s liability for all of its employees is fully provided by monthly deposits with insurance policies and by an accrual. The value of these policies is recorded as an asset in the Company&amp;#8217;s balance sheet. The deposited funds include profits or losses accumulated up to the balance sheet date. The deposited funds may be withdrawn only upon the fulfillment of the obligation pursuant to the Severance Pay Law or labor agreements. The value of the deposited funds is based on the cash surrendered value of these policies, and includes immaterial profits or losses.&lt;/div&gt;&#13;&#13;&lt;div style="line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 28.35pt; text-indent: -1.35pt"&gt;Severance expenses for the years ended June 30, 2017, 2016 and 2015 were $524, $556 and $441, respectively.&lt;/div&gt;&#13;&#13;&#13;&#13;&lt;div style="line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="text-align: justify; line-height: 1.25"&gt;&#13;&lt;table id="zd2ea3862cd6c4798b79f39ca5827c19b" class="DSPFListTable" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, serif; width: 100%"&gt;&#13;&lt;tr&gt;&#13;&lt;td style="font: bold 10pt Times New Roman, Times, serif; width: 28.35pt; vertical-align: top"&gt;s.&lt;/td&gt;&#13;&lt;td style="width: auto; vertical-align: top; text-align: justify"&gt;&#13;&lt;div style="font: bold 10pt Times New Roman, Times, serif"&gt;Fair value of financial instruments&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 28.35pt; text-indent: -1.35pt"&gt;The carrying amounts of the Company&amp;#8217;s financial instruments, including cash and cash equivalents, short-term and restricted bank deposits, accounts receivable and other current assets, trade payable and other accounts payable and accrued liabilities, approximate fair value because of their generally short term maturities.&lt;/div&gt;&#13;&#13;&lt;div style="line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="line-height: 1.25"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 28.35pt; text-indent: -1.35pt"&gt;The Company measures its investments in marketable securities and derivative instruments at fair value under ASC 820. Fair value is an exit price, representing the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants. As such, fair value is a market-based measurement that should be determined based on assumptions that market participants would use in pricing an asset or a liability. As a basis for considering such assumptions, ASC 820 establishes a three-tier value hierarchy, which prioritizes the inputs used in the valuation methodologies in measuring fair value:&lt;/div&gt;&#13;&#13;&lt;div style="line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 28.35pt; text-indent: -1.35pt"&gt;&lt;font style="font: bold 10pt Times New Roman, Times, serif"&gt;&amp;#160;Level 1&lt;/font&gt; - Quoted prices (unadjusted) in active markets for identical assets or liabilities;&lt;/div&gt;&#13;&#13;&lt;div style="line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 28.35pt; text-indent: -1.35pt"&gt;&lt;font style="font: bold 10pt Times New Roman, Times, serif"&gt;&amp;#160;Level 2&lt;/font&gt; - Inputs other than Level 1 that are observable for the asset or liability, either directly or indirectly; and&lt;/div&gt;&#13;&#13;&lt;div style="line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 28.35pt; text-indent: -1.35pt"&gt;&lt;font style="font: bold 10pt Times New Roman, Times, serif"&gt;&amp;#160;Level 3 &lt;/font&gt;- Unobservable inputs for the asset or liability.&lt;/div&gt;&#13;&#13;&lt;div style="line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 28.35pt; text-indent: -1.35pt"&gt;The fair value hierarchy also requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. The Company categorized each of its fair value measurements in one of these three levels of hierarchy (see Note 4).&lt;/div&gt;&#13;&#13;&lt;div style="line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="text-align: justify; line-height: 1.25"&gt;&#13;&lt;table id="zcbe558bdfec34c1c9b3738ad0e5c22de" class="DSPFListTable" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, serif; width: 100%"&gt;&#13;&lt;tr&gt;&#13;&lt;td style="font: bold 10pt Times New Roman, Times, serif; width: 28.35pt; vertical-align: top"&gt;t.&lt;/td&gt;&#13;&lt;td style="width: auto; vertical-align: top; text-align: justify"&gt;&#13;&lt;div style="font: bold 10pt Times New Roman, Times, serif"&gt;Derivative financial instruments&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="line-height: 1.25"&gt;&#13;&lt;div&gt;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 28.35pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, serif"&gt;The Company accounts for derivatives and hedging based on ASC 815, &lt;/font&gt;&lt;font style="font: 10pt Times New Roman, Times, serif"&gt;&amp;#8220;Derivatives and hedging&amp;#8221; &lt;/font&gt;(&amp;#8220;ASC 815&amp;#8221;)&lt;font style="font: 10pt Times New Roman, Times, serif"&gt;, as amended and related interpretations. ASC 815 requires the Company to recognize all derivatives on the balance sheet at fair value. If a derivative meets the definition of a hedge and is so designated, depending on the nature of the hedge, changes in the fair value of the derivative will either be offset against the change in fair value of the hedged assets, liabilities, or firm commitments through earnings (for fair value hedge transactions) or recognized in other comprehensive income (loss) until the hedged item is recognized in earnings (for cash flow hedge transactions).&lt;/font&gt;&lt;/div&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 28.35pt"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 28.35pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, serif"&gt;The ineffective portion of a derivative&amp;#8217;s change in fair value is recognized in earnings. If a derivative does not meet the definition of a hedge, the changes in the fair value are included in earnings. Cash flows related to such hedges are classified as operating activities. The Company enters into forward exchange contracts and option contracts in order to limit the exposure to exchange rate fluctuation associated with expenses mainly incurred in &lt;/font&gt;New Israeli Shekels (&amp;#8220;&lt;font style="font: 10pt Times New Roman, Times, serif"&gt;NIS&lt;/font&gt;&amp;#8221;)&lt;font style="font: 10pt Times New Roman, Times, serif"&gt;. Since the derivative instruments that the Company holds do not meet the definition of hedging instruments under ASC 815, any gain or loss derived from such instruments is recognized immediately as &amp;#8220;financial income, net&amp;#8221;.&lt;/font&gt;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 28.35pt"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 28.35pt"&gt;The Company measured the fair value of the contracts in accordance with ASC 820. Foreign currency derivative contracts are classified within Level 2 as the valuation inputs are based on quoted prices and market observable data of similar instruments. As of June 30, 2017 and 2016, the fair value of the&lt;font style="font: 10pt Times New Roman, Times, serif"&gt;&amp;#160;&lt;/font&gt;options contracts was approximately$ 295&lt;font style="font: 10pt Times New Roman, Times, serif"&gt;&amp;#160;&lt;/font&gt;and $65, respectively, presented in &amp;#8220;other current assets&amp;#8221; (see Note 4). The net gains (losses) recognized in &amp;#8220;Financial income, net&amp;#8221; during the years ended June 30, 2017, 2016 and 2015, were $230, ($205) and $248, respectively.&lt;/div&gt;&#13;&#13;&lt;div style="text-align: justify; line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="text-align: justify; line-height: 1.25"&gt;&#13;&lt;table id="z3defcc6bbc8f4d2eb779a57c2bdb4a38" class="DSPFListTable" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, serif; width: 100%"&gt;&#13;&lt;tr&gt;&#13;&lt;td style="font: bold 10pt Times New Roman, Times, serif; width: 28.35pt; vertical-align: top"&gt;u.&lt;/td&gt;&#13;&lt;td style="width: auto; vertical-align: top; text-align: justify"&gt;&#13;&lt;div style="font: bold 10pt Times New Roman, Times, serif"&gt;Comprehensive income (loss):&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 28.35pt"&gt;The Company accounts for comprehensive income (loss) in accordance with ASC 220, &amp;#8220;Comprehensive Income&amp;#8221;.&lt;/div&gt;&#13;&#13;&#13;&#13;&lt;div style="line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 28.35pt"&gt;Comprehensive income generally represents all changes in stockholders&amp;#8217; equity during the period except those resulting from investments by, or distributions to, stockholders&amp;#8217;. The Company determined that its items of other comprehensive income (loss) relate to unrealized gains and losses on available for sale marketable securities.&lt;/div&gt;&#13;&#13;&lt;div style="line-height: 1.25"&gt;&lt;br style="line-height: 1.25" /&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 28.35pt"&gt;The following table summarizes the changes in accumulated balances of other comprehensive income for the year ended June 30, 2017:&lt;/div&gt;&#13;&#13;&lt;div style="line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div&gt;&#13;&lt;table id="z1a49afcc7d73463897c1b4177687276d" cellspacing="0" cellpadding="0" align="right" border="0" style="font: 10pt Times New Roman, Times, serif; width: 95%"&gt;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="vertical-align: top; border-bottom: #000000 2px solid; text-align: center; vertical-align: bottom"&gt;Year ended June 30, 2017&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: center"&gt;Unrealized&lt;font style="font: 10pt Times New Roman, Times, serif"&gt;&lt;br /&gt;&#13;&lt;/font&gt;gains (losses)&lt;font style="font: 10pt Times New Roman, Times, serif"&gt;&lt;br /&gt;&#13;&lt;/font&gt;on marketable&lt;font style="font: 10pt Times New Roman, Times, serif"&gt;&lt;br /&gt;&#13;&lt;/font&gt;securities&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="width: 88%; vertical-align: top; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 4.7pt; text-indent: 5.05pt"&gt;Beginning balance&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;1,480&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="width: 88%; vertical-align: top; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 9.75pt"&gt;Other comprehensive income before reclassifications&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;924&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="width: 88%; vertical-align: top; padding-bottom: 2px; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 9.75pt"&gt;Amounts reclassified from accumulated other comprehensive loss, net&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;(405&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;)&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="width: 88%; vertical-align: top; padding-bottom: 2px; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 12pt; text-indent: -2.25pt"&gt;Net current-period other comprehensive income&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;519&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="width: 88%; vertical-align: top; padding-bottom: 4px; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 4.7pt; text-indent: 5.05pt"&gt;Ending balance&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;1,999&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="clear: both; line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="text-align: justify; line-height: 1.25"&gt;&#13;&lt;table id="z6ca6aeb30c4f45c4aa701f0c34367182" class="DSPFListTable" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, serif; width: 100%"&gt;&#13;&lt;tr&gt;&#13;&lt;td style="font: bold 10pt Times New Roman, Times, serif; width: 28.35pt; vertical-align: top"&gt;v.&lt;/td&gt;&#13;&lt;td style="width: auto; vertical-align: top; text-align: justify"&gt;&#13;&lt;div style="font: bold 10pt Times New Roman, Times, serif"&gt;Recent Accounting Pronouncement&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 27pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, serif"&gt;&lt;u&gt;Accounting Standards Update (&amp;#8220;ASU&amp;#8221;) 2014-09 &amp;#8211; &amp;#8220;Revenue from Contracts with Customers (Topic 606)&amp;#8221;&lt;/u&gt;&lt;/font&gt;:&lt;/div&gt;&#13;&#13;&lt;div style="line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="line-height: 1.25"&gt;&#13;&lt;div&gt;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 28.35pt"&gt;In May 2014, the Financial Accounting Standards Board (&amp;#8220;FASB&amp;#8221;) issued ASU No. 2014-09 (Topic 606) &amp;#8220;Revenue from Contracts with Customers&amp;#8221; (&amp;#8220;Topic 606&amp;#8221;). Topic 606 supersedes the revenue recognition requirements in ASC Topic 605, &amp;#8220;Revenue Recognition&amp;#8221;, and requires entities to recognize revenue when they transfer control of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled to in exchange for those goods or services. We intend to adopt Topic 606 as of July 1, 2017, using the modified retrospective transition method. Prior periods will not be retrospectively adjusted. As the Company currently does not have any contracts with customers which are not completed, as of June 30, 2017, we do not expect the adoption of Topic 606 will have a material impact on our consolidated financial statements, including the presentation of revenues in our consolidated statements of income.&lt;/div&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 28.35pt"&gt;&lt;u&gt;ASU 2014-15 - Presentation of Financial Statements - Going Concern (Subtopic 205-40):&lt;/u&gt;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left"&gt;&#13;&lt;div&gt;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 28.35pt"&gt;In August 2014, the FASB issued guidance on disclosure of Uncertainties about an Entity&amp;#8217;s Ability to Continue as a Going Concern (&amp;#8220;ASU 2014-15&amp;#8221;), which defines management&amp;#8217;s responsibility to evaluate whether there is substantial doubt about a company&amp;#8217;s ability to continue as a going concern. ASU 2014-15 also provides principles and definitions that are intended to reduce diversity in the timing and content of disclosures in the financial statement footnotes. This guidance is effective for the annual period ending after December 15, 2016, and for annual periods and interim periods thereafter. The Company adopted the provisions of ASU 2014-15 for the year ended December 31, 2016. The adoption of ASU 2014-15 did not have a material impact on the consolidated financial statements.&lt;/div&gt;&#13;&lt;/div&gt;&#13;&#13;&#13;&#13;&lt;div style="line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="line-height: 1.25"&gt;&#13;&lt;div&gt;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 28.35pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, serif"&gt;&lt;u&gt;ASU 2016-13 - Financial Instruments &amp;#8211; Credit Losses (Topic 326), &lt;/u&gt;&lt;/font&gt;&lt;font style="font: 10pt Times New Roman, Times, serif"&gt;&lt;u&gt;&amp;#8220;Measurement of Credit Losses on Financial Instruments&amp;#8221;:&lt;/u&gt;&lt;/font&gt;&lt;/div&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 28.35pt"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 28.35pt"&gt;In June 2016, the FASB issued ASU 2016-13. This update requires an entity to utilize a new impairment model known as the current expected credit loss (&amp;#8220;CECL&amp;#8221;) model to estimate its lifetime &amp;#8220;expected credit loss&amp;#8221; on a financial asset and record an allowance that, when deducted from the amortized cost basis of the financial asset, presents the net amount expected to be collected on the financial asset. The CECL model is expected to result in more timely recognition of credit losses. The update also requires new disclosures for financial assets measured at amortized cost, loans and available-for-sale debt securities. The update is effective for the interim and annual periods beginning on or after December 15, 2019, or July 1, 2020, for the Company. Early adoption is permitted. The Company is currently evaluating the impact of the update on its consolidated financial statements.&lt;/div&gt;&#13;&#13;&lt;div style="line-height: 1.25"&gt;&lt;br style="line-height: 1.25" /&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 28.35pt"&gt;&lt;u&gt;ASU 2016-18 - Restricted Cash (Topic 230):&lt;/u&gt;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 28.35pt"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 28.35pt"&gt;In November 2016, the FASB issued ASU 2016-18, &amp;#8220;Statement of Cash Flows&amp;#8221;. This standard requires the presentation of the statement of cash flows to show the changes in the total of cash, cash equivalents, restricted cash and restricted cash equivalents. The standard is effective for the interim and annual periods beginning on or after December 15, 2017, or July 1, 2018 for the Company. Early adoption is permitted. The Company is currently evaluating the impact of the standard on its consolidated financial statements.&lt;/div&gt;&#13;&#13;&lt;div style="line-height: 1.25"&gt;&lt;br style="line-height: 1.25" /&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 28.35pt"&gt;&lt;u&gt;ASU 2016-02 - Leases (Topic 842):&lt;/u&gt;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left"&gt;&#13;&lt;div&gt;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 28.35pt"&gt;In February 2016, the FASB issued guidance on the recognition, measurement, presentation and disclosure of leases for both parties to a contract (i.e., lessees and lessors). The new standard requires lessees to apply a dual approach, classifying leases as either finance or operating leases based on the principle of whether or not the lease is effectively a financed purchase by the lessee. This classification will determine whether lease expense is recognized based on an effective interest method or on a straight-line basis over the term of the lease, respectively. A lessee is also required to record a right-of-use asset and a lease liability for all leases with a term of greater than 12 months regardless of their classification. Leases with a term of 12 months or less will be accounted for in a manner similar to the accounting under existing guidance for operating leases today. The new standard requires lessors to account for leases using an approach that is substantially equivalent to existing guidance for sales-type leases, direct financing leases and operating leases. Topic 842 supersedes the previous leases standard, ASC 840, &amp;#8220;Leases&amp;#8221;. The guidance is effective for the interim and annual periods beginning on or after December 15, 2018. Early adoption is permitted. The Company is currently evaluating the potential effect of the guidance on its consolidated financial statements.&lt;/div&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="line-height: 1.25"&gt;&lt;br style="line-height: 1.25" /&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; text-indent: 28.35pt"&gt;&lt;u&gt;ASU 2016-01 - Financial Instruments - Overall (Subtopic 825-10):&lt;/u&gt;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left"&gt;&#13;&lt;div&gt;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 28.35pt"&gt;In January 2016, the FASB issued guidance on financial instruments - recognition and measurement of financial assets and financial liabilities. The pronouncement revises the classification and measurement of investments in certain equity investments and the presentation of certain fair value changes for certain financial liabilities measured at fair value. ASU 2016-01 is effective for fiscal years, beginning after December 15, 2017 and interim periods within those years. The Company is currently evaluating the impact of adopting the new standard on its consolidated financial statements.&lt;br style="line-height: 1.25" /&gt;&#13;&lt;/div&gt;&#13;&lt;/div&gt;&#13;&#13;&#13;&#13;&lt;div style="line-height: 1.25"&gt;&lt;br style="line-height: 1.25" /&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; text-indent: 28.35pt"&gt;&lt;u&gt;ASU 2016-09 - Compensation - Stock Compensation (Topic 718):&lt;/u&gt;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; text-indent: 28.35pt"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left"&gt;&#13;&lt;div&gt;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 28.35pt"&gt;In March 2016, the FASB issued guidance on improvements to employee share-based payments. The standard requires among others, that excess tax benefits or deficiencies for share-based payments be recorded as income tax benefit or expense, rather then within additional paid in capital, in the period in which the shares vest. Cash flows related to excess tax benefits will be included in operating activities instead of separately classified as a financing activity. The new guidance is effective for fiscal years beginning after December 15, 2016. Early adoption is permitted. The Company does not expect this guidance to have a material effect on its consolidated financial statements at the time of adoption of this standard.&lt;/div&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 28.35pt"&gt;&lt;u&gt;ASU 2017-11 - Earnings Per Share (Topic 260); Distinguishing Liabilities from Equity (Topic 480); Derivatives and Hedging (Topic 815): (Part I) Accounting for Certain Financial Instruments with Down Round Features, (Part II) Replacement of the Indefinite Deferral for Mandatorily Redeemable Financial Instruments of Certain Nonpublic Entities and Certain Mandatorily Redeemable Noncontrolling Interests with a Scope Exception:&lt;/u&gt;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left"&gt;&#13;&lt;div&gt;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 28.35pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, serif"&gt;In July 2017, the FASB issued ASU No. 2017-11.&amp;#160;The ASU was issued to address the complexity associated with applying U.S. GAAP for certain financial instruments with characteristics of liabilities and equity. The ASU, among other things, eliminates the need to consider the effects of down round features when analyzing convertible debt, warrants and other financing instruments. As a result, a freestanding equity-linked financial instrument (or embedded conversion option) no longer would be accounted for as a derivative liability at fair value as a result of the existence of a down round feature. The amendments are effective for fiscal years beginning after December 15, 2018, and should be applied retrospectively. Early adoption is permitted, including adoption in an interim period. The Company plans to adopt ASU 2017-11 in the first quarter of the Company&amp;#8217;s fiscal year 2018. &lt;/font&gt;The Company does not expect the adoption of &lt;font style="font: 10pt Times New Roman, Times, serif"&gt;ASU 2017-11&lt;/font&gt; will have a material impact on its consolidated financial statements and related disclosures.&lt;/div&gt;&#13;&lt;/div&gt;</us-gaap:SignificantAccountingPoliciesTextBlock>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock contextRef="D2016-07-01_To_2017-06-30">&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 36pt; text-indent: -36pt"&gt;NOTE 8:-COMMITMENTS AND CONTINGENCIES&lt;/div&gt;&#13;&#13;&lt;div style="line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="text-align: justify; line-height: 1.25"&gt;&#13;&lt;table id="zf3dda851cb664819a696bb696ff3f6a6" class="DSPFListTable" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, serif; width: 100%"&gt;&#13;&lt;tr&gt;&#13;&lt;td style="width: 17.45pt"&gt;&lt;/td&gt;&#13;&lt;td style="font: 10pt Times New Roman, Times, serif; width: 18pt; vertical-align: top"&gt;a.&lt;/td&gt;&#13;&lt;td style="width: auto; vertical-align: top; text-align: justify"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif"&gt;In February 2015, the Company signed an addendum to its facility operating lease agreement (the &amp;#8220;Addendum&amp;#8221;) with the lessor, which extended the lease period to December 2021.&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 35.45pt"&gt;The lessor paid a non-refundable leasehold improvement participation payment, of approximately $947 in October 2015, in addition to the non-refundable payment of approximately $816 received in January 2013.&lt;/div&gt;&#13;&#13;&lt;div style="line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 35.45pt"&gt;The payments are deductible against lease expenses as they are incurred. The lessor upfront payment is included in the balance sheet as advance payment and recognized as a deduction from lease expenses over the lease term.&lt;/div&gt;&#13;&#13;&lt;div style="line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 35.45pt"&gt;In June 2017, the Company terminated its operating lease agreement for a facility of 1,280 square meters.&lt;/div&gt;&#13;&#13;&lt;div style="line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 35.45pt"&gt;The Company recognizes lease expense, net of lessor participation, under such arrangements, on a straight-line basis over the lease term.&lt;/div&gt;&#13;&#13;&lt;div style="line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 35.45pt"&gt;As of June 30, 2017, aggregate minimum lease commitments under the active operating lease agreements are as follows:&lt;/div&gt;&#13;&#13;&lt;div style="line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div&gt;&#13;&lt;table id="za09af2fca2c7484d97018003bd3aaf5a" cellspacing="0" cellpadding="0" align="center" border="0" style="font: 10pt Times New Roman, Times, serif; width: 70%"&gt;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: top; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 6.95pt; text-indent: -6.95pt"&gt;Year ending June 30,&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="vertical-align: bottom; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="width: 88%; vertical-align: top; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 6.95pt; text-indent: -6.95pt"&gt;2018&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;884&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="width: 88%; vertical-align: top; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 6.95pt; text-indent: -6.95pt"&gt;2019&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;884&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="width: 88%; vertical-align: top; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 6.95pt; text-indent: -6.95pt"&gt;2020&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;894&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="width: 88%; vertical-align: top; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 6.95pt; text-indent: -6.95pt"&gt;2021&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;904&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="width: 88%; vertical-align: top; padding-bottom: 2px; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 6.95pt; text-indent: -6.95pt"&gt;2022&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;452&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="width: 88%; vertical-align: top; padding-bottom: 4px; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 6.95pt; text-indent: -6.95pt"&gt;Total&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;4,018&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 35.45pt"&gt;&amp;#160;Lease expenses, net of lessor participation, amounted to $781, $824 and $704 for the years ended June 30, 2017, 2016 and 2015, respectively.&lt;/div&gt;&#13;&#13;&lt;div style="line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 35.45pt"&gt;&amp;#160;The Subsidiary issued a bank guarantee in favor of the lessors in the amount of approximately $399.&lt;/div&gt;&#13;&#13;&lt;div style="line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="text-align: justify; line-height: 1.25"&gt;&#13;&lt;table id="z2db9cf5235734212b65a01ac2b1964a1" class="DSPFListTable" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, serif; width: 100%"&gt;&#13;&lt;tr&gt;&#13;&lt;td style="width: 17.45pt"&gt;&lt;/td&gt;&#13;&lt;td style="font: 10pt Times New Roman, Times, serif; width: 18pt; vertical-align: top"&gt;b.&lt;/td&gt;&#13;&lt;td style="width: auto; vertical-align: top; text-align: justify"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif"&gt;The Subsidiary leases several motor vehicles under operating lease agreements, which expire in various dates during years 2017 through June 2019.&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 35.45pt"&gt;As of June 30, 2017, future aggregate minimum lease commitments under non-cancelable operating lease agreements are as follows:&lt;/div&gt;&#13;&#13;&lt;div style="line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div&gt;&#13;&lt;table id="z4f5dd2bb987c46d5bc7bca52a9a11c62" cellspacing="0" cellpadding="0" align="center" border="0" style="font: 10pt Times New Roman, Times, serif; width: 70%"&gt;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: top; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left"&gt;Year ending June 30,&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="vertical-align: bottom; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="width: 88%; vertical-align: top; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left"&gt;2018&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;225&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="width: 88%; vertical-align: top; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left"&gt;2019&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;142&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="width: 88%; vertical-align: top; padding-bottom: 2px; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left"&gt;2020&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;77&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="width: 88%; vertical-align: top; padding-bottom: 4px; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left"&gt;Total&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;444&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 37.35pt"&gt;Lease expenses amounted to $233, $210 and $218 for the years ended June 30, 2017, 2016 and 2015, respectively.&lt;/div&gt;&#13;&#13;&lt;div style="line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="text-align: justify; line-height: 1.25"&gt;&#13;&lt;table id="z021c6eda0cb942fc96000b93a8c74f76" class="DSPFListTable" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, serif; width: 100%"&gt;&#13;&lt;tr&gt;&#13;&lt;td style="width: 17.45pt"&gt;&lt;/td&gt;&#13;&lt;td style="font: 10pt Times New Roman, Times, serif; width: 18pt; vertical-align: top"&gt;c.&lt;/td&gt;&#13;&lt;td style="width: auto; vertical-align: top; text-align: justify"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif"&gt;An amount of $559 of cash and deposits was pledged by the Subsidiary to secure certain derivatives and hedging transactions, credit line and bank guarantees as of June 30, 2017.&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;/div&gt;&#13;&#13;&#13;&#13;&lt;div style="line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="text-align: justify; line-height: 1.25"&gt;&#13;&lt;table id="zd06be3656474465ca4dfb34832da286c" class="DSPFListTable" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, serif; width: 100%"&gt;&#13;&lt;tr&gt;&#13;&lt;td style="width: 17.45pt"&gt;&lt;/td&gt;&#13;&lt;td style="font: 10pt Times New Roman, Times, serif; width: 18pt; vertical-align: top"&gt;d.&lt;/td&gt;&#13;&lt;td style="width: auto; vertical-align: top; text-align: justify"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif"&gt;Under the Law for the Encouragement of Industrial Research and Development, 1984, (the &amp;#8220;Research Law&amp;#8221;), research and development programs that meet specified criteria and are approved by the IIA are eligible for grants of up to 50% of the project&amp;#8217;s expenditures, as determined by the research committee, in exchange for the payment of royalties from the sale of products developed under the program. Regulations under the Research Law generally provide for the payment of royalties to the IIA of 3%-4% on sales of products and services derived from a technology developed using these grants until 100% of the dollar-linked grant is repaid. The Company&amp;#8217;s obligation to pay these royalties is contingent on its actual sale of such products and services. In the absence of such sales, no payment is required. Outstanding balance of the grants will be subject to interest at a rate equal to the 12 month LIBOR applicable to dollar deposits that is published on the first business day of each calendar year. Following the full repayment of the grant, there is no further liability for royalties.&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 35.45pt"&gt;Through June 30, 2017, total grants obtained aggregated to approximately $24,461. Through June 30, 2017, total royalties paid and accrued amounted to $166. As of June 30, 2017, the Company&amp;#8217;s contingent liability in respect to royalties to the IIA amounted to $24,295, not including LIBOR interest as described above.&lt;/div&gt;&#13;&#13;&lt;div style="line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="text-align: justify; line-height: 1.25"&gt;&#13;&lt;table id="z5c8e462bca1044178dfdf963bc0b6f4e" class="DSPFListTable" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, serif; width: 100%"&gt;&#13;&lt;tr&gt;&#13;&lt;td style="width: 17.45pt"&gt;&lt;/td&gt;&#13;&lt;td style="font: 10pt Times New Roman, Times, serif; width: 18pt; vertical-align: top"&gt;e.&lt;/td&gt;&#13;&lt;td style="width: auto; vertical-align: top; text-align: justify"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify"&gt;The Company has been awarded a marketing grant under the &amp;#8220;Smart Money&amp;#8221; program of the Israeli Ministry of Economy and Industry. The program&amp;#8217;s aim is to assist companies to extend their activities in international markets. The goal market that was chosen was Japan. The Israeli government granted the Company budget resources that are intended to be used to advance the Company&amp;#8217;s product candidate towards marketing in Japan and for regulatory activities there. As part of the program, the Company will repay royalties of 5% from the Company&amp;#8217;s income in Japan during five years, starting the year in which the Company will not be entitled to reimbursement of expenses under the program and will be spread for a period of up to 5 years or until the amount of the grant is fully paid&lt;font style="font: 10pt Times New Roman, Times, serif"&gt;.&lt;/font&gt;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 35.45pt"&gt;Through June 30, 2017, total grants obtained under the Smart Money program amounted to approximately $112. No royalties were paid or accrued as of June 30, 2017.&lt;/div&gt;&#13;&#13;&lt;div style="line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="text-align: justify; line-height: 1.25"&gt;&#13;&lt;table id="z53e4cec222574e43af1e7d3c20564ad0" class="DSPFListTable" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, serif; width: 100%"&gt;&#13;&lt;tr&gt;&#13;&lt;td style="width: 17.45pt"&gt;&lt;/td&gt;&#13;&lt;td style="font: 10pt Times New Roman, Times, serif; width: 18pt; vertical-align: top"&gt;f.&lt;/td&gt;&#13;&lt;td style="width: auto; vertical-align: top; text-align: justify"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify"&gt;The Company announced that it will collaborate with the New York Blood Center (&amp;#8220;NYBC&amp;#8221;) on preclinical studies of its placental expanded R-18 cells (&amp;#8220;PLX-R18&amp;#8221;) to enhance the efficacy of umbilical cord blood transplantation. The project has been selected to receive a conditional award of $900 from Israel-United States Binational Industrial Research and Development Foundation (&amp;#8220;BIRD Foundation&amp;#8221;), of which an amount of $585 is a direct grant allocated to the Company. Per the terms of the project, The Company will provide the PLX-R18 cells and the NYBC will be responsible for conducting and supporting the studies. Amounts received in connection with this award are presented in &amp;#8220;Other long-term liabilities&amp;#8221; as the Company does not expect to repay the liability in the next 12 months.&lt;/div&gt;&#13;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 35.45pt"&gt;In accordance with the agreement between the Company and NYBC, if only one party elects to proceed with the development of the product, such party shall be responsible for all repayment obligations to the BIRD Foundation for both parties, if applicable. In addition, in case of conclusion of project development which will trigger the grant repayment to the BIRD Foundation, if the Company will elect to pursue the development of the product, and NYBC elects not to pursue the development of the product, then, unless otherwise agreed by the parties, the Company shall pay NYBC royalties in the amount of 2.5% from its revenues of the product, up to an aggregate royalty amount of approximately $550.&lt;/div&gt;&#13;&#13;&lt;div style="line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock contextRef="D2016-07-01_To_2017-06-30">&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 36pt; text-indent: -36pt"&gt;NOTE 9: - STOCKHOLDERS&amp;#8217; EQUITY&lt;/div&gt;&#13;&#13;&lt;div style="line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify"&gt;The Company&amp;#8217;s authorized common stock consists of 200,000,000 shares with a par value of $0.00001 per share.&amp;#160; All shares have equal voting rights and are entitled to one vote per share in all matters to be voted upon by stockholders. The shares have no pre-emptive, subscription, conversion or redemption rights and may be issued only as fully paid and non-assessable shares. Holders of the common stock are entitled to equal ratable rights to dividends and distributions with respect to the common stock, as may be declared by the Board of Directors out of funds legally available.&lt;/div&gt;&#13;&#13;&lt;div style="line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify"&gt;The Company&amp;#8217;s authorized preferred stock consists of 10,000,000 shares of preferred stock, par value $0.00001 per share, with series, rights, preferences, privileges and restrictions as may be designated from time to time by the Company&amp;#8217;s Board of Directors.&amp;#160; No shares of preferred stock have been issued.&lt;/div&gt;&#13;&#13;&lt;div style="line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="text-align: justify; line-height: 1.25"&gt;&#13;&lt;table id="z87d2780cdb124755b18b71a7b2347e8b" class="DSPFListTable" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, serif; width: 100%"&gt;&#13;&lt;tr&gt;&#13;&lt;td style="width: 18pt"&gt;&lt;/td&gt;&#13;&lt;td style="font: 10pt Times New Roman, Times, serif; width: 18pt; vertical-align: top"&gt;a.&lt;/td&gt;&#13;&lt;td style="width: auto; vertical-align: top; text-align: justify"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif"&gt;From July 2014 through June 2015, a total of 2,081,303 warrants were exercised via &amp;#8220;cashless&amp;#8221; exercise, resulting in the issuance of 963,876 shares of common stock to investors of the Company. &amp;#160;In addition, 170,167 warrants were exercised for cash and resulted in the issuance of 170,167 shares of common stock to investors of the Company. The aggregate cash consideration received was $276.&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="text-align: justify; line-height: 1.25"&gt;&#13;&lt;table id="z2b2818ce06104f87b76ea2231fa00945" class="DSPFListTable" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, serif; width: 100%"&gt;&#13;&lt;tr&gt;&#13;&lt;td style="width: 18pt"&gt;&lt;/td&gt;&#13;&lt;td style="width: 18pt; vertical-align: top"&gt;&lt;font style="font: 10pt Times New Roman, Times, serif"&gt;b&lt;/font&gt;&lt;font style="font: bold 10pt Times New Roman, Times, serif"&gt;.&lt;/font&gt;&lt;/td&gt;&#13;&lt;td style="width: auto; vertical-align: top; text-align: justify"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif"&gt;From October 2014 through May 2015, the Company issued shares of common stock in private placements to investors. In October 2014, the Company issued 200,000 shares of common stock to an investor for aggregate cash consideration of $528. In February 2015, the Company issued an additional 200,000 shares of common stock to an investor for aggregate cash consideration of $586. In May 2015, the Company issued an additional 300,000 shares of common stock to an investor, for which the consideration in the amount of $790 was received from the investor in September 2015.&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="text-align: justify; line-height: 1.25"&gt;&#13;&lt;table id="z491d71b4839c4ba9afe1eabeb698efe0" class="DSPFListTable" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, serif; width: 100%"&gt;&#13;&lt;tr&gt;&#13;&lt;td style="width: 18pt"&gt;&lt;/td&gt;&#13;&lt;td style="font: 10pt Times New Roman, Times, serif; width: 18pt; vertical-align: top"&gt;c.&lt;/td&gt;&#13;&lt;td style="width: auto; vertical-align: top; text-align: justify"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif"&gt;On June 25, 2015, the Company entered into definitive agreements to sell 6,800,000 shares of common stock and warrants to purchase up to 4,080,000 shares of common stock at a combined price of $2.50 per share and related warrants (the &amp;#8220;Offering&amp;#8221;). The gross proceeds from the Offering were $17,000. Issuance costs amounted to $1,200. The warrants have an exercise price of $2.85 per share of common stock, are immediately exercisable and expire 5 years from the closing of the Offering. The Offering was closed on June 30, 2015.&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="text-align: justify; line-height: 1.25"&gt;&#13;&lt;table id="zf73f74b46a0544509aace56c79dbe85b" class="DSPFListTable" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, serif; width: 100%"&gt;&#13;&lt;tr&gt;&#13;&lt;td style="width: 18pt"&gt;&lt;/td&gt;&#13;&lt;td style="font: 10pt Times New Roman, Times, serif; width: 18pt; vertical-align: top"&gt;d.&lt;/td&gt;&#13;&lt;td style="width: auto; vertical-align: top; text-align: justify"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif"&gt;In February 2015, the Subsidiary entered into an agreement with a contractor for the construction of its new laboratories facility for a consideration of approximately NIS 3.3 million (approximately $841). Under the terms of the agreement, the Subsidiary agreed to pay part of the NIS 3.3 million consideration using 100,004 restricted shares of common stock of the Company, linked to performance milestones with respect to the new laboratories construction and which serve as a guarantee. These restricted shares were released to the contractor in December 2014 upon the successful completion of the construction.&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="line-height: 1.25"&gt;&lt;br style="line-height: 1.25" /&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 36pt"&gt;In May 2015, the Subsidiary entered into an addendum to the agreement with the contractor for the design and construction of additional office space renovations in the Subsidiary leased facility for additional consideration of approximately NIS 4 million (approximately $1,032) which is comprised of NIS 3 million (approximately $774) in cash and 90,000 restricted shares which were issued to the contractor in February 2016.&lt;/div&gt;&#13;&#13;&lt;div style="line-height: 1.25"&gt;&lt;br style="line-height: 1.25" /&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 36pt"&gt;The Company accounted for the abovementioned stock-based payment awards to the contractor in accordance with ASC 505-50, &amp;#8220;Equity based payments to non-employees&amp;#8221;.&lt;/div&gt;&#13;&#13;&#13;&#13;&lt;div style="line-height: 1.25"&gt;&lt;br style="line-height: 1.25" /&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 36pt"&gt;As performance by the contractor was not deemed complete while the awards were forfeitable (or not issued), the Company measured the fair value of the awards at each reporting period through the performance completion date (until completion of the construction work).&lt;/div&gt;&#13;&#13;&lt;div style="line-height: 1.25"&gt;&lt;br style="line-height: 1.25" /&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 36pt"&gt;The construction work was initiated in June 2015. On October 30, 2015, the contractor completed the agreed construction milestones. As a result, the Company recognized the fair value of the stock-based payments awards, using the fair value of the Company&amp;#8217;s shares on October 30, 2015, totaling approximately $302 as stock-based payment to the contractor in &amp;#8220;Additional paid-in capital&amp;#8221; with a corresponding amount included in &amp;#8220;Property and equipment, net&amp;#8221;.&lt;/div&gt;&#13;&#13;&lt;div style="line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="text-align: justify; line-height: 1.25"&gt;&#13;&lt;table id="z521b28fde2ea495c878549854f5db083" class="DSPFListTable" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, serif; width: 100%"&gt;&#13;&lt;tr&gt;&#13;&lt;td style="width: 18pt"&gt;&lt;/td&gt;&#13;&lt;td style="font: 10pt Times New Roman, Times, serif; width: 18pt; vertical-align: top"&gt;e.&lt;/td&gt;&#13;&lt;td style="width: auto; vertical-align: top; text-align: justify"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif"&gt;&#13;&lt;div style="line-height: 1.25"&gt;On January 25, 2017, the Company issued, pursuant to an underwriting agreement relating to a firm commitment public offering, an aggregate of 14,081,633 shares of common stock and warrants to purchase an aggregate of 8,448,980 shares of common stock, inclusive of the underwriter&amp;#8217;s over-allotment option, which was exercised in full, for aggregate gross proceeds of $17,250. The net proceeds, after deducting underwriting commissions, discounts and other expenses related to the offering were approximately $15,718.&lt;/div&gt;&#13;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="line-height: 1.25"&gt;&lt;br style="line-height: 1.25" /&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 36pt"&gt;The warrants issued in the offering are exercisable for a period of five years commencing&amp;#160;six months following issuance and have an exercise price of $1.40 per share. As of June 30, 2017, all of the warrants are outstanding.&lt;/div&gt;&#13;&#13;&lt;div style="line-height: 1.25"&gt;&lt;br style="line-height: 1.25" /&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="text-align: justify; line-height: 1.25"&gt;&#13;&lt;table id="z934cc2e6e6574d19885e34f2bb8a716e" class="DSPFListTable" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, serif; width: 100%"&gt;&#13;&lt;tr&gt;&#13;&lt;td style="font: 10pt Times New Roman, Times, serif; width: 49px; vertical-align: top; text-align: center"&gt;&amp;#160;f.&lt;/td&gt;&#13;&lt;td style="width: auto; vertical-align: top; font-weight: normal; text-align: justify"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif"&gt;Options, warrants and restricted stock units to employees, directors and consultants:&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="line-height: 1.25"&gt;&lt;br style="line-height: 1.25" /&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 35.45pt"&gt;The Company has approved incentive option plan from 2005 (the &amp;#8220;2005 Plan&amp;#8221;). Under the Plan, options, restricted stock (&amp;#8220;RS&amp;#8221;) and restricted stock units (&amp;#8220;RSUs&amp;#8221;) (collectively, the &amp;#8220;Awards&amp;#8221;) may be granted to the Company&amp;#8217;s officers, directors, employees and consultants.&amp;#160; Any Awards that are cancelled or forfeited before expiration become available for future grants.&lt;/div&gt;&#13;&#13;&lt;div style="line-height: 1.25"&gt;&lt;br style="line-height: 1.25" /&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 35.45pt"&gt;In addition, at the Company&amp;#8217;s annual meeting of its stockholders, held on May 31, 2016, the Company&amp;#8217;s stockholders approved the 2016 Equity Compensation Plan (the &amp;#8220;2016 Plan&amp;#8221;). Under the 2016 Plan, options, RS and RSUs may be granted to the Company&amp;#8217;s officers, directors, employees and consultants or the officers, directors, employees and consultants of our subsidiary.&lt;/div&gt;&#13;&#13;&lt;div style="line-height: 1.25"&gt;&lt;br style="line-height: 1.25" /&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 36pt"&gt;As of June 30, 2017, the number of shares of common stock authorized for issuance under the 2005 Plan amounted to 19,166,082, of which 3,305,428 shares are available for future grant under the 2005 Plan.&lt;/div&gt;&#13;&#13;&lt;div style="line-height: 1.25"&gt;&lt;br style="line-height: 1.25" /&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 36pt"&gt;As of June 30, 2017, the number of shares of common stock authorized for issuance under the 2016 Plan amounted to 2,584,147 for calendar year 2017, of which 343,327 shares are available for future grant under the 2016 Plan.&lt;/div&gt;&#13;&#13;&#13;&#13;&lt;div style="line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="line-height: 1.25"&gt;&#13;&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 71.45pt; text-indent: -36pt"&gt;&lt;u&gt;(1) Options to employees and directors:&lt;/u&gt;&lt;/div&gt;&#13;&#13;&lt;div style="line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 36pt"&gt;The Company accounts for its options to employees and directors under the fair value method in accordance with ASC 718, &amp;#8220;Compensation&amp;#8212;Stock Compensation&amp;#8221;. A summary of the Company&amp;#8217;s activity for options granted to employees and directors under the 2005 Plan is as follows:&lt;/div&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div&gt;&#13;&lt;table id="zc5d82afc4543485a9c7bd20b618b95e2" cellspacing="0" cellpadding="0" align="right" border="0" style="font: 10pt Times New Roman, Times, serif; width: 94%"&gt;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="14" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom"&gt;&#13;&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center; text-indent: 2pt"&gt;Year ended June 30, 2017&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom"&gt;&#13;&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center; text-indent: 2pt"&gt;Number&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom"&gt;&#13;&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center; text-indent: 2pt"&gt;Weighted Average Exercise Price&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom"&gt;&#13;&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center; text-indent: 2pt"&gt;Weighted Average Remaining Contractual Terms (in years)&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom"&gt;&#13;&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center; text-indent: 2pt"&gt;Aggregate Intrinsic Value Price&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 8.65pt; text-indent: 0.7pt"&gt;Options outstanding at beginning of period&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;1,771,700&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;3.76&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="vertical-align: bottom; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="vertical-align: bottom; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 8.65pt; text-indent: 0.7pt"&gt;Options exercised&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;(16,000&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;)&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;0.62&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="vertical-align: bottom; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="vertical-align: bottom; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 8.65pt; text-indent: 0.7pt"&gt;Options forfeited&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; text-align: right; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;(940,050&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;)&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; text-align: right; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;4.49&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="vertical-align: bottom; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="vertical-align: bottom; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="width: 52%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 8.65pt; text-indent: 0.7pt"&gt;Options outstanding at end of the period&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: right; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;815,650&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: right; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;2.98&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: right; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;0.82&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: right; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;231&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="width: 52%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 8.65pt; text-indent: 0.7pt"&gt;Options exercisable at the end of the period&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: right; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;815,650&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: right; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;2.98&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: right; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;0.82&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: right; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;231&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="width: 52%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 8.65pt; text-indent: 0.7pt"&gt;Options vested at the end of the period&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: right; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;815,650&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: right; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;2.98&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: right; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;0.82&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: right; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;231&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="clear: both; line-height: 1.25"&gt;&lt;br style="line-height: 1.25" /&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 35.45pt"&gt;Intrinsic value of exercisable options (the difference between the Company&amp;#8217;s closing stock price on the last trading day in the period and the exercise price, multiplied by the number of in-the-money options) represents the amount that would have been received by the employees and directors option holders had all option holders exercised their options on June 30, 2017. This amount changes based on the fair market value of the Company&amp;#8217;s common stock.&lt;/div&gt;&#13;&#13;&lt;div style="line-height: 1.25"&gt;&lt;br style="line-height: 1.25" /&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 71.45pt; text-indent: -36pt"&gt;&lt;u&gt;(2) Options to non-employees:&lt;/u&gt;&lt;/div&gt;&#13;&#13;&lt;div style="line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 36pt; text-indent: 0pt"&gt;A summary of the options to non-employee consultants is as follows:&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 36pt; text-indent: 0pt"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div&gt;&#13;&lt;table id="zffa8b47d18a649d3a4152a165d92e716" cellspacing="0" cellpadding="0" align="right" border="0" style="font: 10pt Times New Roman, Times, serif; width: 94%"&gt;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="14" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom"&gt;&#13;&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center; text-indent: 2pt"&gt;Year ended June 30, 2017&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr style="height: 52px"&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom"&gt;&#13;&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center; text-indent: 2pt"&gt;Number&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom"&gt;&#13;&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center; text-indent: 2pt"&gt;Weighted Average Exercise Price&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom"&gt;&#13;&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center; text-indent: 2pt"&gt;Weighted Average Remaining Contractual Terms (in years)&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom"&gt;&#13;&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center; text-indent: 2pt"&gt;Aggregate Intrinsic Value Price&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 8.65pt; text-indent: 0.7pt"&gt;Options outstanding at beginning of period&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;237,300&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;5.40&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="vertical-align: bottom; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="vertical-align: bottom; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 8.65pt; text-indent: 0.7pt"&gt;Options granted&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;46,800&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;0.00&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="vertical-align: bottom; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="vertical-align: bottom; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 8.65pt; text-indent: 0.7pt"&gt;Options exercised&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;(1,900&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;)&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; text-align: right; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;0.00&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="vertical-align: bottom; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="vertical-align: bottom; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 8.65pt; text-indent: 0.7pt"&gt;Options forfeited&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;(105,000&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;)&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;10.98&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="vertical-align: bottom; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="vertical-align: bottom; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="width: 52%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 8.65pt; text-indent: 0.7pt"&gt;Options outstanding at end of the period&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;177,200&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;0.72&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;4.30&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;179&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="width: 52%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 8.65pt; text-indent: 0.7pt"&gt;Options exercisable at the end of the period&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;164,825&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;0.78&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;3.92&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;163&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="width: 52%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 8.65pt; text-indent: 0.7pt"&gt;Options vested&amp;#160; and expected to vest at the end of the period&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;177,200&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;0.72&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;4.30&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;179&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="clear: both; line-height: 1.25"&gt;&lt;br style="line-height: 1.25" /&gt;&#13;&lt;/div&gt;&#13;&#13;&#13;&#13;&lt;div style="line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="margin-left: 36pt; line-height: 1.25"&gt;Compensation expenses related to options granted to consultants were recorded as follows:&lt;/div&gt;&#13;&#13;&lt;div style="line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div&gt;&#13;&lt;table id="zd480bd2b1cb94e0484682e7fd7793ed9" cellspacing="0" cellpadding="0" align="right" border="0" style="font: 10pt Times New Roman, Times, serif; width: 94%"&gt;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: top; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="10" style="vertical-align: middle; border-bottom: #000000 2px solid; vertical-align: bottom"&gt;&#13;&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center; text-indent: 2pt"&gt;Year ended June 30,&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: top; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="vertical-align: top; border-bottom: #000000 2px solid; vertical-align: bottom"&gt;&#13;&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center"&gt;2017&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="vertical-align: top; border-bottom: #000000 2px solid; vertical-align: bottom"&gt;&#13;&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center"&gt;2016&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="vertical-align: top; border-bottom: #000000 2px solid; vertical-align: bottom"&gt;&#13;&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center"&gt;2015&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="width: 64%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 8.65pt; text-indent: 0.7pt"&gt;Research and development expenses&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;7&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;22&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;1&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="width: 64%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 8.65pt; text-indent: 0.7pt"&gt;General and administrative expenses&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;39&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;2&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;1&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="width: 64%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;46&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;24&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;2&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="clear: both; line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="line-height: 1.25"&gt;&#13;&lt;div id="DSPFPageHeader"&gt;&lt;/div&gt;&#13;&#13;&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 71.45pt; text-indent: -36pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, serif"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font: 10pt Times New Roman, Times, serif"&gt;&lt;u&gt;(3) RS and RSUs to employees and directors:&lt;/u&gt;&lt;/font&gt;&lt;/div&gt;&#13;&#13;&lt;div style="line-height: 1.25"&gt;&#13;&lt;div&gt;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 35.45pt"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 35.45pt"&gt;The following table summarizes the activity related to unvested RS and RSUs granted to employees and directors under the 2005 Plan and 2016 Plan for the year ended June 30, 2017:&lt;/div&gt;&#13;&#13;&lt;div style="line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;&#13;&lt;/div&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div&gt;&#13;&lt;table id="zdd176e5c456a4b89a1f51858b7a2875c" cellspacing="0" cellpadding="0" align="right" border="0" style="font: 10pt Times New Roman, Times, serif; width: 94%"&gt;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom"&gt;&#13;&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center; text-indent: 2pt"&gt;Number&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="width: 88%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 8.65pt; text-indent: 0.7pt"&gt;Unvested at the beginning of period&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;1,906,619&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="width: 88%; vertical-align: bottom; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 8.65pt; text-indent: 0.7pt"&gt;Granted&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;6,579,435&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="width: 88%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 8.65pt; text-indent: 0.7pt"&gt;Forfeited&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;(107,953&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;)&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="width: 88%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 8.65pt; text-indent: 0.7pt"&gt;Vested&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;(2,313,200&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;)&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="width: 88%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 8.65pt; text-indent: 0.7pt"&gt;Unvested at the end of the period&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;6,064,901&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="width: 88%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 8.65pt; text-indent: 0.7pt"&gt;Expected to vest after June 30, 2017&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;5,978,114&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="clear: both; line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 36pt"&gt;Compensation expenses related to RS and RSUs granted to employees and directors were recorded as follows:&lt;/div&gt;&#13;&#13;&lt;div style="line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div&gt;&#13;&lt;table id="z89fbe625712c46c7854b12e39917d0a6" cellspacing="0" cellpadding="0" align="right" border="0" style="font: 10pt Times New Roman, Times, serif; width: 94%"&gt;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: top; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="10" style="vertical-align: middle; border-bottom: #000000 2px solid; vertical-align: bottom"&gt;&#13;&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center"&gt;Year ended June 30,&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: top; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="vertical-align: top; border-bottom: #000000 2px solid; vertical-align: bottom"&gt;&#13;&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center"&gt;2017&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="vertical-align: top; border-bottom: #000000 2px solid; vertical-align: bottom"&gt;&#13;&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center"&gt;2016&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="vertical-align: top; border-bottom: #000000 2px solid; vertical-align: bottom"&gt;&#13;&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center"&gt;2015&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="width: 64%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 8.65pt; text-indent: 0.7pt"&gt;Research and development expenses&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;1,558&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;960&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;1,469&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="width: 64%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 8.65pt; text-indent: 0.7pt"&gt;General and administrative expenses&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;1,645&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;1,905&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;2,277&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="width: 64%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;3,203&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;2,865&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;3,746&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="clear: both; line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 35.45pt"&gt;Unamortized compensation expenses related to RS and RSUs granted to employees and directors to be recognized over an average time of approximately 4 years are approximately $6,886.&lt;/div&gt;&#13;&#13;&#13;&#13;&#13;&#13;&lt;div style="line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="line-height: 1.25"&gt;&#13;&lt;div&gt;&lt;/div&gt;&#13;&#13;&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 71.45pt; text-indent: -36pt"&gt;&lt;u&gt;&amp;#160;(4) RS and RSUs to consultants:&lt;/u&gt;&lt;/div&gt;&#13;&#13;&lt;div style="line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 36pt"&gt;The following table summarizes the activity related to unvested RS and RSUs granted to consultants for the year ended June 30, 2017:&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 36pt"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div&gt;&#13;&lt;table id="z8e0bf2d3eaa64c13b2ffaf539d67195a" cellspacing="0" cellpadding="0" align="right" border="0" style="font: 10pt Times New Roman, Times, serif; width: 94%"&gt;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom"&gt;&#13;&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center; text-indent: 2pt"&gt;Number&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="width: 88%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 8.65pt; text-indent: 0.7pt"&gt;Unvested at the beginning of period&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;26,000&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr style="height: 16px"&gt;&#13;&lt;td style="width: 88%; vertical-align: bottom; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 8.65pt; text-indent: 0.7pt"&gt;Granted&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;273,557&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="width: 88%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 8.65pt; text-indent: 0.7pt"&gt;Vested&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;(257,057&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;)&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="width: 88%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 8.65pt; text-indent: 0.7pt"&gt;Unvested at the end of the period&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;42,500&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="clear: both; line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 36pt"&gt;Compensation expenses related to RS and RSUs granted to consultants were recorded as follows:&lt;/div&gt;&#13;&#13;&lt;div style="line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div&gt;&#13;&lt;table id="z3f959cbd462043d1b0e75a38e85ac309" cellspacing="0" cellpadding="0" align="right" border="0" style="font: 10pt Times New Roman, Times, serif; width: 94%"&gt;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: top; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="10" style="vertical-align: middle; border-bottom: #000000 2px solid; vertical-align: bottom"&gt;&#13;&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center"&gt;Year ended June 30,&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: top; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="vertical-align: top; border-bottom: #000000 2px solid; vertical-align: bottom"&gt;&#13;&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center"&gt;2017&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="vertical-align: top; border-bottom: #000000 2px solid; vertical-align: bottom"&gt;&#13;&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center"&gt;2016&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="vertical-align: top; border-bottom: #000000 2px solid; vertical-align: bottom"&gt;&#13;&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center"&gt;2015&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="width: 64%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 8.65pt; text-indent: 0.7pt"&gt;Research and development expenses&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;19&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;39&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;131&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="width: 64%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 8.65pt; text-indent: 0.7pt"&gt;General and administrative expenses&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;394&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;145&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;173&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="width: 64%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;413&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;184&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;304&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="clear: both; line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&#13;&#13;&lt;div style="line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="text-align: justify; line-height: 1.25"&gt;&#13;&lt;table id="z6be9f75f757044cbae38753b21d4a708" class="DSPFListTable" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, serif; width: 100%"&gt;&#13;&lt;tr&gt;&#13;&lt;td style="width: 18pt"&gt;&lt;/td&gt;&#13;&lt;td style="font: 10pt Times New Roman, Times, serif; width: 18pt; vertical-align: top"&gt;a.&lt;/td&gt;&#13;&lt;td style="width: auto; vertical-align: top; text-align: justify"&gt;&#13;&lt;div style="font: bold 10pt Times New Roman, Times, serif"&gt;Summary of warrants and options:&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div&gt;&#13;&lt;table id="z522be72775cb4488b2680c438abfc4d4" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, serif; width: 100%"&gt;&#13;&lt;tr style="height: 60px"&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom"&gt;&#13;&lt;div style="line-height: 1.25"&gt;&#13;&lt;div style="line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center"&gt;Warrants / Options&lt;/div&gt;&#13;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom"&gt;&#13;&lt;div style="line-height: 1.25"&gt;&#13;&lt;div style="line-height: 1.25"&gt;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: center"&gt;&lt;font style="font: bold 10pt Times New Roman, Times, serif"&gt;Exercise Price&lt;/font&gt; &lt;/div&gt;&#13;&#13;&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center"&gt;per Share&lt;/div&gt;&#13;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom"&gt;&#13;&lt;div style="line-height: 1.25"&gt;&#13;&lt;div style="line-height: 1.25"&gt;&lt;/div&gt;&#13;&#13;&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center"&gt;Options and Warrants &lt;/div&gt;&#13;&#13;&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center"&gt;for Common Stock&lt;/div&gt;&#13;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom"&gt;&#13;&lt;div style="line-height: 1.25"&gt;&#13;&lt;div style="line-height: 1.25"&gt;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: center"&gt;&lt;font style="font: bold 10pt Times New Roman, Times, serif"&gt;Options and Warrants&lt;/font&gt; &lt;font style="font: bold 10pt Times New Roman, Times, serif"&gt;Exercisable&lt;/font&gt;&lt;/div&gt;&#13;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 18px; vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="width: 151px; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: center"&gt;&#13;&lt;div style="line-height: 1.25"&gt;&#13;&lt;div style="line-height: 1.25"&gt;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: center"&gt;&lt;font style="font: bold 10pt Times New Roman, Times, serif"&gt;Weighted Average Remaining Contractual Terms&lt;/font&gt; &lt;font style="font: bold 10pt Times New Roman, Times, serif"&gt;(in years)&lt;/font&gt;&lt;/div&gt;&#13;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="width: 52%; vertical-align: top; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 18pt"&gt;Warrants:&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;1.40&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;8,448,981&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;-&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1.17%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;5.06&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="width: 52%; vertical-align: top; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;2.85&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;4,080,000&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;4,080,000&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1.17%; vertical-align: bottom; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;3.00&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="width: 52%; vertical-align: top; padding-bottom: 2px; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;5.00&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;3,219,983&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;3,219,983&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1.17%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;0.22&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="width: 52%; vertical-align: top; padding-bottom: 2px; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 18pt"&gt;Total warrants&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 9%; vertical-align: bottom; padding-bottom: 2px; text-align: right; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif"&gt;15,748,964&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif"&gt;7,299,983&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1.17%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 9%; vertical-align: bottom; padding-bottom: 2px; text-align: right; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="width: 52%; vertical-align: top; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1.17%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="width: 52%; vertical-align: top; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 18pt"&gt;Options:&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;0.00&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;137,200&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;124,825&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1.17%; vertical-align: bottom; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;5.32&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="width: 52%; vertical-align: top; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;0.62&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;345,500&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;345,500&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1.17%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;1.28&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="width: 52%; vertical-align: top; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;1.04&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;25,000&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;25,000&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1.17%; vertical-align: bottom; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;1.16&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="width: 52%; vertical-align: top; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;2.97&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;20,000&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;20,000&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1.17%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;0.86&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="width: 52%; vertical-align: top; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;3.50&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;30,000&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;30,000&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1.17%; vertical-align: bottom; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;0.14&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="width: 52%; vertical-align: top; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;3.80&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;1,000&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;1,000&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1.17%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;0.14&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="width: 52%; vertical-align: top; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;4.38&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;372,500&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;372,500&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1.17%; vertical-align: bottom; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;0.47&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="width: 52%; vertical-align: top; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;4.40&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;400&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;400&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1.17%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;0.14&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="width: 52%; vertical-align: top; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;6.80&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;36,250&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;36,250&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1.17%; vertical-align: bottom; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;0.37&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="width: 52%; vertical-align: top; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;8.20&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;20,000&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;20,000&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1.17%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;0.16&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="width: 52%; vertical-align: top; padding-bottom: 2px; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;20.00&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;5,000&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;5,000&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1.17%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;2.62&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="width: 52%; vertical-align: top; padding-bottom: 2px; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 18pt"&gt;Total options&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 9%; vertical-align: bottom; padding-bottom: 2px; text-align: right; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif"&gt;992,850&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif"&gt;980,475&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1.17%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 9%; vertical-align: bottom; padding-bottom: 2px; text-align: right; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td colspan="4" style="vertical-align: top; padding-bottom: 2px; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: left; text-indent: 18pt"&gt;Total warrants and options&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif"&gt;16,741,814&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif"&gt;8,280,458&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 18px; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 12px; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; text-align: right; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left"&gt;This summary does not include 6,107,401 RS and RSUs that are not vested as of June 30, 2017.&lt;/div&gt;</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <us-gaap:IncomeTaxDisclosureTextBlock contextRef="D2016-07-01_To_2017-06-30">&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 36pt; text-indent: -36pt"&gt;NOTE 11:-TAXES ON INCOME&lt;/div&gt;&#13;&#13;&lt;div style="line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="text-align: justify; line-height: 1.25"&gt;&#13;&lt;table id="z7bcbacf0f42c4d5c93c73efec80a360c" class="DSPFListTable" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, serif; width: 100%"&gt;&#13;&lt;tr&gt;&#13;&lt;td style="font: 10pt Times New Roman, Times, serif; width: 27pt; vertical-align: top"&gt;A.&lt;/td&gt;&#13;&lt;td style="width: auto; vertical-align: top; text-align: justify"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif"&gt;Tax assessments:&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 42.55pt"&gt;The Subsidiary has not received final tax assessments since its incorporation; however, the assessments of the Subsidiary are deemed final through 2012.&lt;/div&gt;&#13;&#13;&lt;div style="line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="text-align: justify; line-height: 1.25"&gt;&#13;&lt;table id="z0924a5ec76744668a468bba09bab2c68" class="DSPFListTable" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, serif; width: 100%"&gt;&#13;&lt;tr&gt;&#13;&lt;td style="font: 10pt Times New Roman, Times, serif; width: 27pt; vertical-align: top"&gt;B.&lt;/td&gt;&#13;&lt;td style="width: auto; vertical-align: top; text-align: justify"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif"&gt;Tax rates applicable to the Company:-&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="line-height: 1.25"&gt;&lt;br style="line-height: 1.25" /&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="text-align: justify; line-height: 1.25"&gt;&#13;&lt;table id="z66f1373608f746e1aae92f11f2a25673" class="DSPFListTable" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, serif; width: 100%"&gt;&#13;&lt;tr&gt;&#13;&lt;td style="width: 28.35pt"&gt;&lt;/td&gt;&#13;&lt;td style="font: 10pt Times New Roman, Times, serif; width: 14.2pt; vertical-align: top"&gt;1.&lt;/td&gt;&#13;&lt;td style="width: auto; vertical-align: top; text-align: justify"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif"&gt;Pluristem Therapeutics Inc.:&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 42.55pt"&gt;The tax rates applicable to Pluristem Therapeutics Inc., a Nevada corporation, are corporate (progressive) tax at the rate of up to 35%, excluding state tax and local tax if any, which rates depend on the state and city in which Pluristem Therapeutics Inc. conducts its business.&lt;/div&gt;&#13;&#13;&lt;div style="line-height: 1.25"&gt;&lt;br style="line-height: 1.25" /&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="text-align: justify; line-height: 1.25"&gt;&#13;&lt;table id="z1fb4eba8f33d44ab8cf4d66bb28cbda2" class="DSPFListTable" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, serif; width: 100%"&gt;&#13;&lt;tr&gt;&#13;&lt;td style="width: 28.35pt"&gt;&lt;/td&gt;&#13;&lt;td style="font: 10pt Times New Roman, Times, serif; width: 14.2pt; vertical-align: top"&gt;2.&lt;/td&gt;&#13;&lt;td style="width: auto; vertical-align: top; text-align: justify"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif"&gt;The Subsidiary:&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 42.55pt"&gt;Taxable income of Israeli companies is subject to tax at the rate of 24% in year 2017, 25% in 2016 and 26.5% in 2015.&lt;/div&gt;&#13;&#13;&lt;div style="line-height: 1.25"&gt;&lt;br style="line-height: 1.25" /&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 42.55pt"&gt;In December 2016, the Israeli Parliament approved the Economic Efficiency Law (Legislative Amendments for Applying the Economic Policy for the 2017 and 2018 Budget Years), 2016, which reduces the corporate income tax rate to 23% effective from January 1, 2018.&lt;/div&gt;&#13;&#13;&lt;div style="line-height: 1.25"&gt;&lt;br style="line-height: 1.25" /&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 42.55pt"&gt;Under the Foreign Exchange Regulations, the Subsidiary calculates its tax liability in U.S. Dollars according to certain orders. The tax liability, as calculated in U.S. Dollars is translated into New Israeli Shekels according to the exchange rate as of June 30 of each year.&lt;/div&gt;&#13;&#13;&#13;&#13;&lt;div style="line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 42.55pt"&gt;Tax Benefits Under the Law for Encouragement of Capital Investments.&lt;/div&gt;&#13;&#13;&lt;div style="line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 42.55pt"&gt;According to the Law for Encouragement of Capital Investments, 1959 (the &amp;#8220;Encouragement Law&amp;#8221;), the Subsidiary is entitled to various tax benefits due to &amp;#8220;Beneficiary Enterprise&amp;#8221; status granted to its enterprise, as implied by the Encouragement Law. The principal benefits by virtue of the Encouragement Law are:&lt;/div&gt;&#13;&#13;&lt;div style="line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: italic 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 42.55pt"&gt;Tax benefits and reduced tax rates:&lt;/div&gt;&#13;&#13;&lt;div style="line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 42.55pt"&gt;On July 7, 2010, the Subsidiary has received a letter of approval (the &amp;#8220;Ruling&amp;#8221;) from the Israeli Tax Authority. According to the Ruling, the Subsidiary&amp;#8217;s expansion program of its plant was granted the status of a &amp;#8220;Beneficiary Enterprise&amp;#8221; under the &amp;#8220;Alternative Track&amp;#8221; (the &amp;#8220;2007 Program&amp;#8221;). The Subsidiary chose the year 2007 as the election year of the 2007 Program.&lt;/div&gt;&#13;&#13;&lt;div style="line-height: 1.25"&gt;&lt;br style="line-height: 1.25" /&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 42.55pt"&gt;Under the 2007 Program &amp;#8220;Alternative Track&amp;#8221;, the Subsidiary, which was located in a National Priority Zone &amp;#8220;B&amp;#8221; with respect to the year 2007, is tax exempt in the first six years of the benefit period and subject to tax at the reduced rate of 10%-25% for a period of one to four years for the remaining benefit period (dependent on the level of foreign investments).&lt;/div&gt;&#13;&#13;&lt;div style="line-height: 1.25"&gt;&lt;br style="line-height: 1.25" /&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 42.55pt"&gt;On June 6, 2013, the Subsidiary informed the Israeli Tax Authority that it has chosen the year 2012 as an election year to the expansion of its &amp;#8220;Beneficiary Enterprise&amp;#8221; program (the &amp;#8220;2012 Program&amp;#8221;).&lt;/div&gt;&#13;&#13;&lt;div style="line-height: 1.25"&gt;&lt;br style="line-height: 1.25" /&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 42.55pt"&gt;Under the 2012 Program, the Subsidiary, which was located in the &amp;#8220;Other National Priority Zone&amp;#8221; with respect to the year 2012, would be tax exempt in the first two years of the benefit period and subject to tax at the reduced rate of 10%-25% for a period of five to eight years for the remaining benefit period (dependent on the level of foreign investments).&lt;/div&gt;&#13;&#13;&lt;div style="line-height: 1.25"&gt;&lt;br style="line-height: 1.25" /&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 42.55pt"&gt;Following the enactment of Amendment No. 60 to the Encouragement&lt;font style="font: bold 10pt Times New Roman, Times, serif"&gt;&amp;#160;&lt;/font&gt;Law, subsequent to April 1, 2005, companies whose election year entitled them to a Beneficiary Enterprise status are required, among others, to make a minimum qualifying investment. This condition requires an investment in the acquisition of productive assets such as machinery and equipment, which must be carried out within three years. The minimum qualifying investment required for setting up a plant is NIS&amp;#160;300,000, linked to the Israeli CPI in accordance with the guidelines of the Israeli tax authorities. As for plant expansion, the minimum qualifying investment is the higher of NIS&amp;#160;300,000, linked to the Israeli CPI as stated above, and an amount equivalent to the &amp;#8220;qualifying percentage&amp;#8221; of the value of the productive assets. Productive assets that are used by the plant but not owned by it will also be viewed as productive assets.&lt;/div&gt;&#13;&#13;&lt;div style="line-height: 1.25"&gt;&lt;br style="line-height: 1.25" /&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 42.55pt"&gt;The qualifying percentage of the value of the productive assets is as follows:&lt;/div&gt;&#13;&#13;&lt;div style="line-height: 1.25"&gt;&lt;br style="line-height: 1.25" /&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div&gt;&#13;&lt;table id="z7dd3f999d96e475daadaf09b843306b8" cellspacing="0" cellpadding="0" align="right" border="0" style="font: 10pt Times New Roman, Times, serif; width: 94%; border-collapse: collapse"&gt;&#13;&lt;tr&gt;&#13;&lt;td style="width: 53.57%; vertical-align: top; border-bottom: #000000 2px solid"&gt;&#13;&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center; margin-left: 42.55pt"&gt;The value of productive&lt;/div&gt;&#13;&#13;&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center; margin-left: 42.55pt"&gt;assets before the expansion&lt;/div&gt;&#13;&#13;&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center; margin-left: 42.55pt"&gt;(NIS in millions)&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 3.58%; vertical-align: top"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 42.85%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: center"&gt;&#13;&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif"&gt;The new proportion that the required &lt;/div&gt;&#13;&#13;&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif"&gt;investment bears to the value of productive assets&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="border-top: #000000 2px solid; width: 53.57%; vertical-align: top"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 3.58%; vertical-align: top"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 42.85%; vertical-align: top"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="width: 53.57%; vertical-align: top; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 42.55pt"&gt;Up to NIS&amp;#160;140&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 3.58%; vertical-align: top; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 42.85%; vertical-align: top; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: center; margin-left: 42.55pt"&gt;12%&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="width: 53.57%; vertical-align: top; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 42.55pt"&gt;NIS&amp;#160;140 - NIS&amp;#160;500&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 3.58%; vertical-align: top; background-color: #ffffff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 42.85%; vertical-align: top; background-color: #ffffff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: center; margin-left: 42.55pt"&gt;7%&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="width: 53.57%; vertical-align: top; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 42.55pt"&gt;More than NIS&amp;#160;500&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 3.58%; vertical-align: top; background-color: #cceeff"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 42.85%; vertical-align: top; background-color: #cceeff"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: center; margin-left: 42.55pt"&gt;5%&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="clear: both; line-height: 1.25"&gt;&lt;br style="line-height: 1.25" /&gt;&#13;&lt;/div&gt;&#13;&#13;&#13;&#13;&#13;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 42.55pt"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 42.55pt"&gt;The income qualifying for tax benefits under the alternative track is the taxable income of a &amp;#8220;beneficiary company&amp;#8221; that has met certain conditions as determined by the Encouragement&lt;font style="font: bold 10pt Times New Roman, Times, serif"&gt;&amp;#160;&lt;/font&gt;Law, and which is derived from an industrial enterprise. The Encouragement&lt;font style="font: bold 10pt Times New Roman, Times, serif"&gt;&amp;#160;&lt;/font&gt;Law specifies the types of qualifying income that is entitled to tax benefits under the alternative track both in respect of an industrial enterprise and of a hotel, whereby income from an industrial enterprise includes, among others, revenues from the production and development of software products and revenues from industrial research and development activities performed for a foreign resident (and approved by the Head of the Administration of Industrial Research and Development).&lt;/div&gt;&#13;&#13;&lt;div style="line-height: 1.25"&gt;&lt;br style="line-height: 1.25" /&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 42.55pt"&gt;As stated above, the Subsidiary&amp;#8217;s 2007 Program and 2012 Program were granted the status of a &amp;#8220;Beneficiary Enterprise&amp;#8221;, in accordance with the Encouragement&lt;font style="font: bold 10pt Times New Roman, Times, serif"&gt;&amp;#160;&lt;/font&gt;Law, under the alternative benefits track. Accordingly, income derived from the Beneficiary Enterprise is subject to the benefits and conditions stated above.&lt;/div&gt;&#13;&#13;&lt;div style="line-height: 1.25"&gt;&lt;br style="line-height: 1.25" /&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 42.55pt"&gt;In respect of expansion&#13;programs pursuant to Amendment No. 60 to the Encouragement&lt;font style="font: bold 10pt Times New Roman, Times, serif"&gt;&amp;#160;&lt;/font&gt;Law,&#13;the benefit period starts at the later of the election year and the first year the Company earns taxable income provided that&#13;12 years have not passed since the beginning of the election year and for companies in National Priority Zone A - 14 years since the beginning of the election year. The benefit period for the Subsidiary&amp;#8217;s 2007 Program will expire in 2018 (12 years since the beginning of the election year&amp;#8211; 2007). The benefit period for the Subsidiary&amp;#8217;s 2012 Program would expire in 2023 (12 years since the beginning of the election year &amp;#8211; 2012).&lt;/div&gt;&#13;&#13;&lt;div style="line-height: 1.25"&gt;&lt;br style="line-height: 1.25" /&gt;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 42.55pt"&gt;If a dividend is distributed out of tax exempt profits, as detailed above, the Subsidiary will become liable for tax at the rate applicable to its profits from the Beneficiary Enterprise in the year in which the income was earned, (tax at the rate of 10-25%, dependent on the level of foreign investments) and to a withholding tax rate of 15% (or lower, under an applicable tax treaty).&lt;/div&gt;&#13;&#13;&lt;div style="line-height: 1.25"&gt;&lt;br style="line-height: 1.25" /&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 42.55pt"&gt;As for &amp;#8220;Beneficiary Enterprises&amp;#8221; pursuant to Amendment No. 60 to the Encouragement&lt;font style="font: bold 10pt Times New Roman, Times, serif"&gt;&amp;#160;&lt;/font&gt;Law, the basic condition for receiving the benefits under this track is that the enterprise contributes to Israeli economic growth and is a competitive factor for the gross domestic product. In order to comply with this condition, the Encouragement&lt;font style="font: bold 10pt Times New Roman, Times, serif"&gt;&amp;#160;&lt;/font&gt;Law prescribes various requirements regarding industrial enterprises.&lt;/div&gt;&#13;&#13;&lt;div style="line-height: 1.25"&gt;&lt;br style="line-height: 1.25" /&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 42.55pt"&gt;As for industrial enterprises, in each tax year during the benefit period, one of the following conditions must be met:&lt;/div&gt;&#13;&#13;&lt;div style="line-height: 1.25"&gt;&lt;br style="line-height: 1.25" /&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="text-align: justify; line-height: 1.25"&gt;&#13;&lt;table id="z1f4f26a25e074c2091e8e557c8bf5801" class="DSPFListTable" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, serif; width: 100%"&gt;&#13;&lt;tr&gt;&#13;&lt;td style="width: 27pt"&gt;&lt;/td&gt;&#13;&lt;td style="font: 10pt Times New Roman, Times, serif; width: 23px; vertical-align: top"&gt;1.&lt;/td&gt;&#13;&lt;td style="width: auto; vertical-align: top; text-align: justify"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif"&gt;The industrial enterprise&amp;#8217;s main field of activity is biotechnology or nanotechnology as approved by the Head of the Administration of Industrial Research and Development, prior to the approval of the relevant program.&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif"&gt;&amp;#160;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="text-align: justify; line-height: 1.25"&gt;&#13;&lt;table id="z6cfa32b48c57460eab06454be6b3102b" class="DSPFListTable" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, serif; width: 100%"&gt;&#13;&lt;tr&gt;&#13;&lt;td style="width: 27pt"&gt;&lt;/td&gt;&#13;&lt;td style="font: 10pt Times New Roman, Times, serif; width: 18pt; vertical-align: top"&gt;2.&lt;/td&gt;&#13;&lt;td style="width: auto; vertical-align: top; text-align: justify"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif"&gt;The industrial enterprise&amp;#8217;s sales revenues in a specific market during the tax year do not exceed 75% of its total sales for that tax year. A &amp;#8220;market&amp;#8221; is defined as a separate country or customs territory.&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif"&gt;&amp;#160;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="text-align: justify; line-height: 1.25"&gt;&#13;&lt;table id="z9a10c1ef0035427c96f45e1f3b721a24" class="DSPFListTable" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, serif; width: 100%"&gt;&#13;&lt;tr&gt;&#13;&lt;td style="width: 27pt"&gt;&lt;/td&gt;&#13;&lt;td style="font: 10pt Times New Roman, Times, serif; width: 18pt; vertical-align: top"&gt;3.&lt;/td&gt;&#13;&lt;td style="width: auto; vertical-align: top; text-align: justify"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif"&gt;At least 25% of the industrial enterprise&amp;#8217;s overall revenues during the tax year were generated from the enterprise&amp;#8217;s sales in a specific market with a population of at least 14 million.&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: italic 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 42.55pt"&gt;Accelerated depreciation:&lt;/div&gt;&#13;&#13;&lt;div style="line-height: 1.25"&gt;&lt;br style="line-height: 1.25" /&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 42.55pt"&gt;The Subsidiary is eligible for deduction of accelerated depreciation on buildings, machinery and equipment used by the &amp;#8220;Beneficiary Enterprise&amp;#8221; at a rate of 200% (or 400% for buildings) from the first year of the assets operation.&lt;/div&gt;&#13;&#13;&#13;&#13;&lt;div style="line-height: 1.25"&gt;&lt;br style="line-height: 1.25" /&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="font: italic 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 42.55pt"&gt;Conditions for the entitlement to the benefits:&lt;/div&gt;&#13;&#13;&lt;div style="line-height: 1.25"&gt;&lt;br style="line-height: 1.25" /&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 42.55pt"&gt;The abovementioned benefits are conditional upon the fulfillment of the conditions stipulated by the Encouragement&lt;font style="font: bold 10pt Times New Roman, Times, serif"&gt;&amp;#160;&lt;/font&gt;Law, regulations promulgated thereunder, and the Ruling with respect to the beneficiary enterprise. Non-compliance with the conditions may cancel all or part of the benefits and refund of the amount of the benefits, including interest. The management believes that the Subsidiary is meeting the aforementioned conditions.&lt;/div&gt;&#13;&#13;&lt;div style="line-height: 1.25"&gt;&lt;br style="line-height: 1.25" /&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="font: italic 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 42.55pt"&gt;Amendment to the Encouragement Law:&lt;/div&gt;&#13;&#13;&lt;div style="line-height: 1.25"&gt;&lt;br style="line-height: 1.25" /&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 42.55pt"&gt;Effective January 2011, the Knesset (Israeli parliament) enacted a reform to the Encouragement Law. According to the reform a flat rate tax would apply to companies eligible for the &amp;#8220;Preferred Enterprise&amp;#8221; status. In order to be eligible for a &amp;#8220;Preferred Enterprise&amp;#8221; status, a company must meet minimum requirements to establish that it contributes to the country&amp;#8217;s economic growth and is a competitive factor for the Gross Domestic Product (a competitive enterprise).&lt;/div&gt;&#13;&#13;&lt;div style="line-height: 1.25"&gt;&lt;br style="line-height: 1.25" /&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 42.55pt"&gt;Israeli companies which currently benefit from an Approved or Privileged Enterprise status and meet the criteria for qualification as a &amp;#8220;Preferred Enterprise&amp;#8221; can elect to apply the new &amp;#8220;Preferred Enterprise&amp;#8221; benefits by waiving their benefits under the &amp;#8220;Approved&amp;#8221; and &amp;#8220;Beneficiary Enterprise&amp;#8221; status.&lt;/div&gt;&#13;&#13;&lt;div style="line-height: 1.25"&gt;&lt;br style="line-height: 1.25" /&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 42.55pt"&gt;Benefits granted to a &amp;#8220;Preferred Enterprise&amp;#8221; include reduced tax rates. Following the enactment of the National Priorities Law, effective January 1, 2014, the reduced tax rate is 9% in the Development Area A regions and 16% in other regions. &amp;#8220;Preferred Enterprises&amp;#8221; in peripheral regions are also eligible for Israeli government Investment Center grants, as well as the applicable reduced tax rates.&lt;/div&gt;&#13;&#13;&lt;div style="line-height: 1.25"&gt;&lt;br style="line-height: 1.25" /&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 42.55pt"&gt;A distribution from a &amp;#8220;Preferred Enterprise&amp;#8221; out of the &amp;#8220;Preferred Income&amp;#8221; is&amp;#160; subject to 20% withholding tax for Israeli-resident individuals and non-Israeli residents (subject to applicable treaty rates).&lt;/div&gt;&#13;&#13;&lt;div style="line-height: 1.25"&gt;&lt;br style="line-height: 1.25" /&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 42.55pt"&gt;A distribution from a &amp;#8220;Preferred Enterprise&amp;#8221; out of the &amp;#8220;Preferred Income&amp;#8221; would be exempt from withholding tax for an Israeli-resident company.&lt;/div&gt;&#13;&#13;&lt;div style="line-height: 1.25"&gt;&lt;br style="line-height: 1.25" /&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 42.55pt"&gt;The Subsidiary did not apply the Amendment to the Encouragement Law with respect to the Privileged Enterprise status, but may choose to apply the Amendment in the future&lt;font style="font: 10pt Times New Roman, Times, serif"&gt;.&lt;/font&gt;&lt;/div&gt;&#13;&#13;&lt;div style="line-height: 1.25"&gt;&lt;br style="line-height: 1.25" /&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="font: italic 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 42.55pt"&gt;Amendment to the Law for the Encouragement of Capital Investments, 1959 (Amendment 71):&lt;/div&gt;&#13;&#13;&lt;div style="line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="line-height: 1.25"&gt;&#13;&lt;div id="DSPFPageHeader"&gt;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 42.55pt"&gt;In August 2013, the Law for Changing National Priorities (Legislative Amendments for Achieving Budget Targets for 2013 and 2014), 2013 which includes Amendment 71 to the Law for the Encouragement of Capital Investments (&amp;#8220;Amendment 71&amp;#8221;) was enacted. According to Amendment 71, the tax rate on preferred income from a preferred enterprise in 2014 and thereafter will be 16% (in development area A - 9%). As for changes in tax rates resulting from the enactment of Amendment 73 to the Law, see below.&lt;/div&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="line-height: 1.25"&gt;&#13;&lt;div&gt;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 42.55pt"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 42.55pt"&gt;Amendment 71 also prescribes that any dividends distributed to individuals or foreign residents from the preferred enterprise&amp;#8217;s earnings as above will be subject to tax at a rate of 20%.&lt;/div&gt;&#13;&lt;/div&gt;&#13;&#13;&#13;&#13;&lt;div style="line-height: 1.25"&gt;&lt;br style="line-height: 1.25" /&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="font: italic 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 42.55pt"&gt;Amendment to the Law for the Encouragement of Capital Investments, 1959 (Amendment 73):&lt;/div&gt;&#13;&#13;&lt;div style="line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="line-height: 1.25"&gt;&#13;&lt;div&gt;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 42.55pt"&gt;In December 2016, the Economic Efficiency Law (Legislative Amendments for Applying the Economic Policy for the 2017 and 2018 Budget Years), 2016 which includes Amendment 73 to the Law for the Encouragement of Capital Investments (&amp;#8220;Amendment 73&amp;#8221;) was published. According to Amendment 73, a preferred enterprise located in development area A will be subject to a tax rate of 7.5% instead of 9% effective from January 1, 2017 and thereafter (the tax rate applicable to preferred enterprises located in other areas remains at 16%).&lt;/div&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="line-height: 1.25"&gt;&#13;&lt;div&gt;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 42.55pt"&gt;Amendment 73 also prescribes special tax tracks for technological enterprises, which are subject to rules that are to be issued by the Minister of Finance on May 28, 2017, the regulations were approved by the Minister of Finance and the amendment came into effect on January 1, 2017.&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 42.55pt"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 42.55pt"&gt;The new tax tracks under Amendment 73 are as follows:&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 42.55pt"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 42.55pt"&gt;Technological preferred enterprise - an enterprise for which total consolidated revenues of its parent company and all subsidiaries are less than NIS&amp;#160;10 billion. A technological preferred enterprise, as defined in the Encouragement of Capital Investments Law, which is located in the center of Israel will be subject to tax at a rate of 12% on profits deriving from intellectual property (in development area A - a tax rate of 7.5%).&lt;/div&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 42.55pt"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 42.55pt"&gt;Special technological preferred enterprise - an enterprise for which total consolidated revenues of its parent company and all subsidiaries exceed NIS&amp;#160;10 billion. Such enterprise will be subject to tax at a rate of 6% on profits deriving from intellectual property, regardless of the enterprise&amp;#8217;s geographical location.&lt;/div&gt;&#13;&#13;&lt;div style="line-height: 1.25"&gt;&lt;br style="line-height: 1.25" /&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 42.55pt"&gt;Any dividends distributed to &amp;#8220;foreign companies&amp;#8221;, as defined in the Law, deriving from income from the technological enterprises will be subject to tax at a rate of 4%.&lt;/div&gt;&#13;&#13;&lt;div style="line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="text-align: justify; line-height: 1.25"&gt;&#13;&lt;table id="zb09b81bc113f46fc99d09e1082987950" class="DSPFListTable" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, serif; width: 100%"&gt;&#13;&lt;tr&gt;&#13;&lt;td style="width: 27pt"&gt;&lt;/td&gt;&#13;&lt;td style="font: 10pt Times New Roman, Times, serif; width: 18pt; vertical-align: top"&gt;C.&lt;/td&gt;&#13;&lt;td style="width: auto; vertical-align: top; text-align: justify"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif"&gt;Carryforward losses for tax purposes&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="line-height: 1.25"&gt;&lt;br style="line-height: 1.25" /&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 42.55pt"&gt;As of June 30, 2017, the Company had U.S. federal net operating loss carryforward for income tax purposes in the amount of approximately $32,519. Net operating loss carryforward arising in taxable years&lt;font style="font: 10pt Times New Roman, Times, serif"&gt;,&lt;/font&gt; can be carried forward and offset against taxable income for 20 years and expiring between &lt;font style="font: 10pt Times New Roman, Times, serif"&gt;202&lt;/font&gt;4 and 2037.&lt;/div&gt;&#13;&#13;&lt;div style="line-height: 1.25"&gt;&lt;br style="line-height: 1.25" /&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 42.55pt"&gt;Utilization of U.S. net operating losses may be subject to substantial annual limitations due to the &amp;#8220;change in ownership&amp;#8221; provisions of the Internal Revenue Code of 1986 and similar state provisions. The annual limitation may result in the expiration of net operating losses before utilization.&lt;/div&gt;&#13;&#13;&lt;div style="line-height: 1.25"&gt;&lt;br style="line-height: 1.25" /&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 42.55pt"&gt;The Subsidiary in Israel has accumulated losses for tax purposes as of June 30, 2017, in the amount of approximately $109,480, which may be carried forward and offset against taxable business income and business capital gain in the future for an indefinite period.&lt;/div&gt;&#13;&#13;&#13;&#13;&lt;div style="line-height: 1.25"&gt;&lt;br style="line-height: 1.25" /&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 42.55pt"&gt;Deferred income taxes:&lt;/div&gt;&#13;&#13;&lt;div style="line-height: 1.25"&gt;&lt;br style="line-height: 1.25" /&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 42.55pt"&gt;Deferred income taxes reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. Significant components of the Company&amp;#8217;s deferred tax assets are as follows:&lt;/div&gt;&#13;&#13;&lt;div style="line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div&gt;&#13;&lt;table id="z8c0d601e87a3487a842fe95c2270aaeb" cellspacing="0" cellpadding="0" align="right" border="0" style="font: 10pt Times New Roman, Times, serif; width: 94%"&gt;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: top; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="6" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom"&gt;&#13;&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center; text-indent: 2pt"&gt;June 30,&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: top; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom"&gt;&#13;&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center"&gt;2017&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom"&gt;&#13;&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center"&gt;2016&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="vertical-align: top; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 8.5pt; text-indent: -8.5pt"&gt;Deferred tax assets:&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="vertical-align: bottom; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="vertical-align: bottom; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td colspan="2" style="vertical-align: bottom; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="width: 76%; vertical-align: top; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 17pt; text-indent: -8.5pt"&gt;U.S. net operating loss carryforward&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;11,382&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;10,210&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="width: 76%; vertical-align: top; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 17pt; text-indent: -8.5pt"&gt;Israeli net operating loss carryforward&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;26,275&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;22,105&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="width: 76%; vertical-align: top; padding-bottom: 2px; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 17pt; text-indent: -8.5pt"&gt;Allowances and reserves&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;222&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;216&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="width: 76%; vertical-align: top; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="width: 76%; vertical-align: top; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 8.5pt; text-indent: -8.5pt"&gt;Total deferred tax assets before valuation allowance&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;37,879&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;32,531&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="width: 76%; vertical-align: top; padding-bottom: 2px; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 8.5pt; text-indent: -8.5pt"&gt;Valuation allowance&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;(37,879&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;)&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;(32,531&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;)&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="width: 76%; vertical-align: top; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&#13;&lt;tr&gt;&#13;&lt;td style="width: 76%; vertical-align: top; padding-bottom: 4px; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 8.5pt; text-indent: -8.5pt"&gt;Net deferred tax asset&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;-&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;td style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;$&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff; vertical-align: bottom"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif"&gt;-&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;td nowrap="nowrap" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="clear: both; line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 42.55pt"&gt;As of June 30, 2017 and 2016, the Company has provided full valuation allowances in respect of deferred tax assets resulting from tax loss carryforward and other temporary differences, since they have a history of operating losses and current uncertainty concerning its ability to realize these deferred tax assets in the future.&lt;/div&gt;&#13;&#13;&lt;div style="line-height: 1.25"&gt;&lt;br style="line-height: 1.25" /&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 42.55pt"&gt;The Company accounts for its income tax uncertainties in accordance with ASC&amp;#160;740 which clarifies the accounting for uncertainties in income taxes recognized in a Company&amp;#8217;s financial statements and prescribes a recognition threshold and measurement attribute for the financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return.&lt;/div&gt;&#13;&#13;&lt;div style="line-height: 1.25"&gt;&lt;br style="line-height: 1.25" /&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 42.55pt"&gt;As of June 30, 2017 and 2016, there were no unrecognized tax benefits that if recognized would affect the annual effective tax rate.&lt;/div&gt;&#13;&#13;&lt;div style="line-height: 1.25"&gt;&lt;br style="line-height: 1.25" /&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 70.9pt; text-indent: -28.35pt"&gt;Reconciliation of the theoretical tax expense (benefit) to the actual tax expense (benefit):&lt;/div&gt;&#13;&#13;&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 70.9pt; text-indent: -28.35pt"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 42.55pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, serif"&gt;In 2017, 2016 and 2015, the main reconciling item of the statutory tax rate of the Company (24% to 35% in 2017, 2016 and 2015) to the effective tax rate (0%) is tax loss carryforwards, &lt;/font&gt;stock-based compensation&lt;font style="font: 10pt Times New Roman, Times, serif"&gt; and other deferred tax assets for which a full valuation allowance was provided.&lt;/font&gt;&lt;/div&gt;</us-gaap:IncomeTaxDisclosureTextBlock>
    <us-gaap:SubsequentEventsTextBlock contextRef="D2016-07-01_To_2017-06-30">&lt;div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: justify"&gt;NOTE 12:-SUBSEQUENT EVENTS&lt;/div&gt;&#13;&#13;&lt;div style="line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="text-align: justify; line-height: 1.25"&gt;&#13;&lt;table id="z9d1d848799254f268142eae03288cd90" class="DSPFListTable" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, serif; width: 100%"&gt;&#13;&lt;tr&gt;&#13;&lt;td style="width: 36.2pt"&gt;&lt;/td&gt;&#13;&lt;td style="font: 10pt Times New Roman, Times, serif; width: 18pt; vertical-align: top"&gt;a.&lt;/td&gt;&#13;&lt;td style="width: auto; vertical-align: top; text-align: justify"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify"&gt;Pursuant to a shelf registration on Form S-3 declared effective by the Securities and Exchange Commission on June 23, 2017, in July 2017 the Company entered into an At Market Issuance Sales Agreement (&amp;#8220;ATM Agreement&amp;#8221;) with FBR Capital Markets &amp;#38; Co., MLV &amp;#38; Co. LLC and Oppenheimer &amp;#38; Co. Inc. (collectively, the &amp;#8220;Agents&amp;#8221;), which provides that, upon the terms and subject to the conditions and limitations in the ATM Agreement, the Company may elect, from time to time, to offer and sell shares of common stock having an aggregate offering price of up to $80,000 through the Agents acting as sales agent. As of September 5, 2017, the Company had sold 455,731 shares of common stock at an average price of $1.20 per share.&lt;/div&gt;&#13;&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="text-align: justify; line-height: 1.25"&gt;&#13;&lt;table id="z359d4ff499e3488294820b8b25a6d506" class="DSPFListTable" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, serif; width: 100%"&gt;&#13;&lt;tr&gt;&#13;&lt;td style="width: 36.2pt"&gt;&lt;/td&gt;&#13;&lt;td style="font: 10pt Times New Roman, Times, serif; width: 18pt; vertical-align: top"&gt;b.&lt;/td&gt;&#13;&lt;td style="width: auto; vertical-align: top; text-align: justify"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif"&gt;In July 2017, the Company was awarded an additional &amp;#8220;Smart Money&amp;#8221; grant of approximately $229 from Israel&amp;#8217;s Ministry of Economy and Industry to help penetrate the Chinese market, including Hong Kong, with its advanced cell therapy products.&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="line-height: 1.25"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 54.2pt"&gt;The Israeli government granted the Company budget resources that are intended to be used to advance the Company&amp;#8217;s product candidate towards marketing in the China-Hong Kong markets. The Company will also receive close support from Israel&amp;#8217;s trade representatives stationed in China, including Hong Kong, along with experts appointed by the Smart Money program.&lt;/div&gt;&#13;&#13;&lt;div style="line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="line-height: 1.25"&gt;&#13;&lt;table id="z78ce9a509dd14812a7a6cb3f689514b3" class="DSPFListTable" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, serif; width: 100%"&gt;&#13;&lt;tr&gt;&#13;&lt;td style="width: 36.2pt"&gt;&lt;/td&gt;&#13;&lt;td style="font: 10pt Times New Roman, Times, serif; width: 18pt; vertical-align: top"&gt;c.&lt;/td&gt;&#13;&lt;td style="width: auto; vertical-align: top; text-align: justify"&gt;&#13;&lt;div style="font: 10pt Times New Roman, Times, serif"&gt;&#13;&lt;div style="text-align: justify; line-height: 1.25"&gt;On September 5, 2017, the Company announced that its phase III study of PLX-PAD cells to support recovery following surgery for femoral neck fracture was awarded a Euro 7,400 (approximately $8,700) non-dilutive grant from the Horizon 2020 program. An amount of Euro 2,400 (approximately $2,800) is a direct grant allocated to the Company, and the Company also expects to benefit from cost savings resulting from grant amounts allocated to the other consortium members. Final approval of the grant is subject to the finalization of the consortium and Horizon 2020 grant agreements.&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:SubsequentEventsTextBlock>
    <us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock contextRef="D2016-07-01_To_2017-06-30">&lt;div style="text-align: justify; line-height: 1.25"&gt;&lt;table id="za7bc05a3506840d5a83f52e5cf3b45b1" class="DSPFListTable" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, serif; width: 100%"&gt;&#13;&lt;tr&gt;&#13;&lt;td style="font: bold 10pt Times New Roman, Times, serif; width: 27pt; vertical-align: top"&gt;b.&lt;/td&gt;&#13;&lt;td style="width: auto; vertical-align: top; text-align: justify"&gt;&#13;&lt;div style="font: bold 10pt Times New Roman, Times, serif"&gt;Functional currency&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="line-height: 1.25"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 27pt; text-indent: 0pt"&gt;Most of the Pluristem Therapeutics Inc. costs are denominated in United States dollars (&amp;#8220;dollar&amp;#8221;). The Company&amp;#8217;s management believes that the dollar is the primary currency of the economic environment in which Pluristem Therapeutics Inc. and its subsidiary operate. Thus, the dollar is the Company&amp;#8217;s functional and reporting currency. Accordingly, non-dollar denominated transactions and balances have been re-measured into the functional currency in accordance with ASC No. 830, &amp;#8220;Foreign Currency Matters&amp;#8221;. All transaction gains and losses from the re-measured monetary balance sheet items are reflected in the statements of income as financial income or expenses, as appropriate.&lt;/div&gt;&lt;/div&gt;</us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock>
    <us-gaap:MarketableSecuritiesPolicy contextRef="D2016-07-01_To_2017-06-30">&lt;div style="text-align: justify; line-height: 1.25"&gt;&lt;table id="zb5071478f8d54ec5a96c5c5ab6b8e7f5" class="DSPFListTable" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, serif; width: 100%"&gt;&#13;&lt;tr&gt;&#13;&lt;td style="font: bold 10pt Times New Roman, Times, serif; width: 27pt; vertical-align: top"&gt;h.&lt;/td&gt;&#13;&lt;td style="width: auto; vertical-align: top; text-align: justify"&gt;&#13;&lt;div style="font: bold 10pt Times New Roman, Times, serif"&gt;Investment in marketable securities&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 28.35pt"&gt;The Company accounts for its investments in marketable securities in accordance with ASC 320,&amp;#8220;Investments &amp;#8211; Debt and Equity Securities&amp;#8221;. The Company determines the classification of marketable securities at the time of purchase and re-evaluates such designations as of each balance sheet date. The Company classifies all of its marketable securities as available-for-sale. Available-for-sale marketable securities are carried at fair value, with the unrealized gain and loss reported at &amp;#8220;Accumulated other comprehensive income (loss)&amp;#8221; in the statement of changes in stockholders&amp;#8217; equity.&lt;/div&gt;&#13;&#13;&#13;&#13;&lt;div style="line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 28.35pt"&gt;Realized gain and loss on sales of marketable securities are included in the Company&amp;#8217;s &amp;#8220;Financial income, net&amp;#8221; and are derived using the specific identification basis for determining the cost of marketable securities sold. The amortized cost of available for sale debt marketable securities is adjusted for amortization of premiums and accretion of discount to maturity. Such amortization, together with coupon interest on available for sale marketable securities, is included in the &amp;#8220;Financial income, net&amp;#8221;.&lt;/div&gt;&#13;&#13;&lt;div style="line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 28.35pt"&gt;The Company recognizes an impairment charge when a decline in the fair value of its available-for-sale marketable securities below the cost basis is judged to be other-than-temporary. The Company considers various factors in determining whether to recognize an impairment charge, including the length of time the investment has been in a loss position, the extent to which the fair value has been less than the Company&amp;#8217;s cost basis, the reason for the decline in value, the potential recovery period and the Company&amp;#8217;s intent to sell, including whether it is more likely than not that the Company will be required to sell the investment before recovery of cost basis. ASC 320-10-35, &amp;#8220;Investments - Debt and Equity Securities&amp;#8221;, requires another-than-temporary impairment for debt securities to be separated into (a)&amp;#160;the amount representing the credit loss and (b)&amp;#160;the amount related to all other factors (provided that the Company does not intend to sell the security and it is not more likely than not that it will be required to sell it before recovery). For securities that are deemed other-than-temporarily impaired, the amount of impairment is recognized in &amp;#8220;financial income, net&amp;#8221;, in the statement of operations and is limited to the amount related to credit loss, while impairment related to other factors is recognized in &amp;#8220;other comprehensive income (loss)&amp;#8221;.&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 28.35pt"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 28.35pt"&gt;During the years ended June 30, 2017 and 2016, the Company recognized other-than-temporary impairment loss of $767 and $38, respectively. During the year ended June 30, 2015 no impairment losses were identified (see note 3).&lt;/div&gt;</us-gaap:MarketableSecuritiesPolicy>
    <us-gaap:RevenueRecognitionPolicyTextBlock contextRef="D2016-07-01_To_2017-06-30">&lt;div style="text-align: justify; line-height: 1.25"&gt;&lt;table id="zb4e567880d2a4c168bd77962c3661dd1" class="DSPFListTable" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, serif; width: 100%"&gt;&#13;&lt;tr&gt;&#13;&lt;td style="font: bold 10pt Times New Roman, Times, serif; width: 27pt; vertical-align: top"&gt;i.&lt;/td&gt;&#13;&lt;td style="width: auto; vertical-align: top; text-align: justify"&gt;&#13;&lt;div style="font: bold 10pt Times New Roman, Times, serif"&gt;Revenue Recognition from the license Agreement with United&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 28.35pt"&gt;The Company recognized revenue pursuant to the License Agreement with United in accordance with ASC 605-25, &amp;#8220;Revenue Recognition, Multiple-Element Arrangements&amp;#8221;.&lt;/div&gt;&#13;&#13;&lt;div style="line-height: 1.25"&gt;&lt;br style="line-height: 1.25" /&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 28.35pt"&gt;Pursuant to ASC 605-25, each deliverable is evaluated to determine whether it qualifies as a separate unit of accounting based on whether the deliverable has &amp;#8220;stand-alone value&amp;#8221; to the customer. The arrangement&amp;#8217;s consideration that is fixed or determinable is then allocated to each separate unit of accounting based on the relative selling price of each deliverable. In general, the consideration allocated to each unit of accounting is recognized as the related goods or services are delivered, limited to the consideration that is not contingent upon future deliverables.&lt;/div&gt;&#13;&#13;&lt;div style="line-height: 1.25"&gt;&lt;br style="line-height: 1.25" /&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 28.35pt"&gt;The Company received an up-front, non-refundable license payment of $5,000. Additional payments totaling $37,500 were subject to the achievement of certain regulatory milestones by United.&lt;/div&gt;&#13;&#13;&lt;div style="line-height: 1.25"&gt;&lt;br style="line-height: 1.25" /&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 28.35pt"&gt;Since the deliverables in the United Agreement did not have stand-alone value, none of them qualified as a separate unit of accounting. Accordingly, the non-refundable upfront license fee of $5,000 was deferred and recognized on a straight line basis over the related performance period which was the development period in accordance with Staff Accounting Bulletin (&amp;#8220;SAB&amp;#8221;) 104, &amp;#8220;Revenue Recognition&amp;#8221;.&lt;/div&gt;&#13;&#13;&lt;div style="line-height: 1.25"&gt;&lt;br style="line-height: 1.25" /&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 28.35pt"&gt;The Company also received an advanced payment for the development, of $2,000 that was deductible against development expenses as it was incurred. The upfront payment which was received was included in the balance sheet as advance payment. The Company deducted the payments from its research and development expenses in accordance with ASC 730-20, &amp;#8220;Research and Development Agreements&amp;#8221;.&lt;/div&gt;&#13;&#13;&#13;&#13;&lt;div style="line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 28.35pt"&gt;On December 8, 2015, the Company received a notice from United terminating the United Agreement, effective immediately. Pursuant to the United Agreement termination clause, Pluristem regained full rights to PLX in the field of PAH, as well as all clinical data and regulatory submissions. As the Company had no further obligations&lt;font style="font: bold 10pt Times New Roman, Times, serif"&gt;&amp;#160;&lt;/font&gt;towards United, the Company recognized the remaining upfront payment received in 2011 as revenues during the year ended June 30, 2016.&lt;/div&gt;</us-gaap:RevenueRecognitionPolicyTextBlock>
    <us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock contextRef="D2016-07-01_To_2017-06-30">&lt;div style="text-align: justify; line-height: 1.25"&gt;&lt;table id="z252d414105c7440bb6165d5bf6b4d15a" class="DSPFListTable" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, serif; width: 100%"&gt;&#13;&lt;tr&gt;&#13;&lt;td style="font: bold 10pt Times New Roman, Times, serif; width: 28.35pt; vertical-align: top"&gt;k.&lt;/td&gt;&#13;&lt;td style="width: auto; vertical-align: top; text-align: justify"&gt;&#13;&lt;div style="font: bold 10pt Times New Roman, Times, serif"&gt;Impairment of long-lived assets&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 27pt; text-indent: 0pt"&gt;The Company&amp;#8217;s long-lived assets are reviewed for impairment in accordance with ASC 360, &amp;#8220;Property, Plant and Equipment&amp;#8221;, whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of the assets to the future undiscounted cash flows expected to be generated by the assets. If such assets are considered to be impaired, the impairment to be recognized is measured by the amount by which the carrying amount of the assets exceeds the fair value of the assets. During fiscal years 2017, 2016 and 2015, no impairment losses have been identified.&lt;/div&gt;&#13;&#13;&lt;div style="line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 27pt"&gt;&#13;&lt;div id="DSPFPageHeader"&gt;&lt;/div&gt;&#13;&#13;&lt;div style="line-height: 1.25"&gt;As required by ASC 820, &amp;#8220;Fair Value Measurements&amp;#8221; (&amp;#8220;ASC 820&amp;#8221;), the Company applies assumptions that marketplace participants would consider in determining the fair value of long-lived assets.&lt;/div&gt;&lt;/div&gt;</us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock>
    <us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy contextRef="D2016-07-01_To_2017-06-30">&lt;div style="text-align: justify; line-height: 1.25"&gt;&lt;table id="zb79e5bb96e214148b3fac6f353132e61" class="DSPFListTable" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, serif; width: 100%"&gt;&#13;&lt;tr&gt;&#13;&lt;td style="font: bold 10pt Times New Roman, Times, serif; width: 27pt; vertical-align: top"&gt;l.&lt;/td&gt;&#13;&lt;td style="width: auto; vertical-align: top; text-align: justify"&gt;&#13;&lt;div style="font: bold 10pt Times New Roman, Times, serif"&gt;Accounting for stock-based compensation&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 27pt; text-indent: 0.05pt"&gt;The Company accounts for stock-based compensation in accordance with ASC 718, &amp;#8220;Compensation-Stock Compensation&amp;#8221; (&amp;#8220;ASC 718&amp;#8221;) and ASC 505-50, &amp;#8220;Equity-Based Payments to Non-Employees&amp;#8221; (&amp;#8220;ASC 505-50&amp;#8221;). ASC 718 requires companies to estimate the fair value of equity-based payment awards on the date of grant using an option-pricing model. The Company estimates the fair value of stock options granted using the Black-Scholes-Merton option-pricing model. The Company accounts for employee&amp;#8217;s share-based payment awards classified as equity awards (restricted stocks or restricted stock units) using the grant-date fair value method. The fair value of share-based payment transactions is recognized as an expense over the requisite service period, net of estimated forfeitures. The Company estimates forfeitures based on historical experience and anticipated future conditions. The Company elected to recognize compensation cost for an award with service conditions and goals achievement that has a graded vesting schedule using the accelerated method based on the multiple-option award approach.&lt;/div&gt;&#13;&#13;&lt;div style="line-height: 1.25"&gt;&lt;br style="line-height: 1.25" /&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 27.05pt; text-indent: 0.05pt"&gt;During fiscal years 2017, 2016 and 2015, there were no options granted to employees or directors.&lt;/div&gt;&#13;&#13;&lt;div style="line-height: 1.25"&gt;&lt;br style="line-height: 1.25" /&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 28.35pt"&gt;The assumptions below are relevant to restricted stock and restricted stock units granted in 2017, 2016 and 2015:&lt;/div&gt;&#13;&#13;&lt;div style="line-height: 1.25"&gt;&lt;br style="line-height: 1.25" /&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 28.35pt"&gt;In accordance with ASC 718, restricted stock and restricted stock units are measured at their fair value. All restricted stock and restricted stock units to employees, directors and non-employees granted in 2017, 2016 and 2015, were granted for no consideration; therefore, their fair value was equal to the share price at the date of grant.&lt;/div&gt;&#13;&#13;&#13;&#13;&lt;div style="line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 28.35pt"&gt;The fair value of all restricted stock and restricted stock units was determined based on the close trading price of the Company&amp;#8217;s shares known at the grant date. The weighted average grant date fair value of shares granted during 2017, 2016 and 2015, was $1.41, $1.13 and $2.70, respectively.&lt;/div&gt;</us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy>
    <psti:ResearchAndDevelopmentExpensesAndRoyaltyBearingGrantsPolicyTextBlock contextRef="D2016-07-01_To_2017-06-30">&lt;div style="text-align: justify; line-height: 1.25"&gt;&lt;table id="z7e07885053824892bd52a1a2cb6999f9" class="DSPFListTable" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, serif; width: 100%"&gt;&#13;&lt;tr&gt;&#13;&lt;td style="font: bold 10pt Times New Roman, Times, serif; width: 28.35pt; vertical-align: top"&gt;m.&lt;/td&gt;&#13;&lt;td style="width: auto; vertical-align: top; text-align: justify"&gt;&#13;&lt;div style="font: bold 10pt Times New Roman, Times, serif"&gt;Research and Development expenses and royalty bearing grants&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 28.35pt; text-indent: 0pt"&gt;Research and development expenses, net of participations grants, are charged to the statement of operations as incurred.&lt;/div&gt;&#13;&#13;&lt;div style="line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="line-height: 1.25"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 28.35pt; text-indent: 0pt"&gt;Pluristem receives grants from the IIA in the Ministry of Economy and Industry (formerly the Office of Chief Scientist&amp;#8217;s) for the purpose of partially funding approved research and development projects. The grants are not to be repaid, but instead Pluristem is obliged to pay royalties as a percentage of future sales if and when sales from the funded projects are generated. These grants are recognized as a deduction from research and development costs at the time the Company is entitled to such grants on the basis of the research and development costs incurred. Since the payment of royalties is not probable when the grants are received, the Company records a liability in the amount of the estimated royalties for each individual contract, when the related revenues are recognized, as part of Cost of revenues. For more information regarding such royalties commitments and regarding grants and participation received, see Note 8.&lt;/div&gt;&lt;/div&gt;</psti:ResearchAndDevelopmentExpensesAndRoyaltyBearingGrantsPolicyTextBlock>
    <psti:NonroyaltyBearingGrantsPolicyTextBlock contextRef="D2016-07-01_To_2017-06-30">&lt;div style="text-align: justify; line-height: 1.25"&gt;&lt;table id="zf79edeb6b6264cdebcff1930c5704a4a" class="DSPFListTable" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, serif; width: 100%"&gt;&#13;&lt;tr&gt;&#13;&lt;td style="font: bold 10pt Times New Roman, Times, serif; width: 28.35pt; vertical-align: top"&gt;n.&lt;/td&gt;&#13;&lt;td style="width: auto; vertical-align: top; text-align: justify"&gt;&#13;&lt;div style="font: bold 10pt Times New Roman, Times, serif"&gt;Non-royalty bearing grant&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="line-height: 1.25"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 28.35pt; text-indent: -1.35pt"&gt;T&lt;font style="font: 10pt Times New Roman, Times, serif"&gt;he Company&amp;#8217;s CLI program participates in a European Union&amp;#160;research and development consortium under Horizon 2020.&amp;#160; In August 2016, the CLI program consortium was awarded a Euro 7,600 (approximately $8,700) non-royalty bearing grant. An amount of Euro 1,900 (approximately $2,200) is a direct grant allocated to the Company. &lt;/font&gt;The non-royalty bearing grant for funding the projects is recognized at the time the Company is entitled to such grant on the basis of the related costs incurred and recorded as a deduction from research and development expenses.&lt;/div&gt;&lt;/div&gt;</psti:NonroyaltyBearingGrantsPolicyTextBlock>
    <psti:SeverancePayPolicyTextBlock contextRef="D2016-07-01_To_2017-06-30">&lt;div style="text-align: justify; line-height: 1.25"&gt;&lt;table id="zfcbc5e1a8b494fc7b89fd7aa0beaa363" class="DSPFListTable" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, serif; width: 100%"&gt;&#13;&lt;tr&gt;&#13;&lt;td style="font: bold 10pt Times New Roman, Times, serif; width: 28.35pt; vertical-align: top"&gt;r.&lt;/td&gt;&#13;&lt;td style="width: auto; vertical-align: top; text-align: justify"&gt;&#13;&lt;div style="font: bold 10pt Times New Roman, Times, serif"&gt;Severance pay&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 28.35pt; text-indent: -1.35pt"&gt;&amp;#160;A majority of the Company&amp;#8217;s agreements with employees in Israel are subject to Section 14 of the Israeli Severance Pay Law, 1963 (&amp;#8220;Severance Pay Law&amp;#8221;). The Company&amp;#8217;s contributions for severance pay have replaced its severance obligation. Upon contribution of the full amount of the employee&amp;#8217;s monthly salary for each year of employment, no additional calculations are conducted between the parties regarding the matter of severance pay and no additional payments are made by the Company to the employee. Further, the related obligation and amounts deposited on behalf of the employee for such obligation are not stated on the balance sheet, as the Company is legally released from the obligation to employees once the deposit amounts have been paid.&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 28.35pt; text-indent: -1.35pt"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 28.35pt; text-indent: -1.35pt"&gt;&amp;#160;For some employees, which their agreement is not subject to Section 14 of the Severance Pay Law, the Subsidiary&amp;#8217;s liability for severance pay is calculated pursuant to Israeli Severance Pay Law, based on the most recent salary of the employees multiplied by the number of years of employment, as of the balance sheet date. Employees are entitled to one month&amp;#8217;s salary for each year of employment or a portion thereof.&lt;/div&gt;&#13;&#13;&lt;div style="line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 28.35pt; text-indent: -1.35pt"&gt;The Company&amp;#8217;s liability for all of its employees is fully provided by monthly deposits with insurance policies and by an accrual. The value of these policies is recorded as an asset in the Company&amp;#8217;s balance sheet. The deposited funds include profits or losses accumulated up to the balance sheet date. The deposited funds may be withdrawn only upon the fulfillment of the obligation pursuant to the Severance Pay Law or labor agreements. The value of the deposited funds is based on the cash surrendered value of these policies, and includes immaterial profits or losses.&lt;/div&gt;&#13;&#13;&lt;div style="line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 28.35pt; text-indent: -1.35pt"&gt;Severance expenses for the years ended June 30, 2017, 2016 and 2015 were $524, $556 and $441, respectively.&lt;/div&gt;</psti:SeverancePayPolicyTextBlock>
    <us-gaap:FairValueOfFinancialInstrumentsPolicy contextRef="D2016-07-01_To_2017-06-30">&lt;div style="text-align: justify; line-height: 1.25"&gt;&lt;table id="zd2ea3862cd6c4798b79f39ca5827c19b" class="DSPFListTable" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, serif; width: 100%"&gt;&#13;&lt;tr&gt;&#13;&lt;td style="font: bold 10pt Times New Roman, Times, serif; width: 28.35pt; vertical-align: top"&gt;s.&lt;/td&gt;&#13;&lt;td style="width: auto; vertical-align: top; text-align: justify"&gt;&#13;&lt;div style="font: bold 10pt Times New Roman, Times, serif"&gt;Fair value of financial instruments&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 28.35pt; text-indent: -1.35pt"&gt;The carrying amounts of the Company&amp;#8217;s financial instruments, including cash and cash equivalents, short-term and restricted bank deposits, accounts receivable and other current assets, trade payable and other accounts payable and accrued liabilities, approximate fair value because of their generally short term maturities.&lt;/div&gt;&#13;&#13;&lt;div style="line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="line-height: 1.25"&gt;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 28.35pt; text-indent: -1.35pt"&gt;The Company measures its investments in marketable securities and derivative instruments at fair value under ASC 820. Fair value is an exit price, representing the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants. As such, fair value is a market-based measurement that should be determined based on assumptions that market participants would use in pricing an asset or a liability. As a basis for considering such assumptions, ASC 820 establishes a three-tier value hierarchy, which prioritizes the inputs used in the valuation methodologies in measuring fair value:&lt;/div&gt;&#13;&#13;&lt;div style="line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 28.35pt; text-indent: -1.35pt"&gt;&lt;font style="font: bold 10pt Times New Roman, Times, serif"&gt;&amp;#160;Level 1&lt;/font&gt; - Quoted prices (unadjusted) in active markets for identical assets or liabilities;&lt;/div&gt;&#13;&#13;&lt;div style="line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 28.35pt; text-indent: -1.35pt"&gt;&lt;font style="font: bold 10pt Times New Roman, Times, serif"&gt;&amp;#160;Level 2&lt;/font&gt; - Inputs other than Level 1 that are observable for the asset or liability, either directly or indirectly; and&lt;/div&gt;&#13;&#13;&lt;div style="line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 28.35pt; text-indent: -1.35pt"&gt;&lt;font style="font: bold 10pt Times New Roman, Times, serif"&gt;&amp;#160;Level 3 &lt;/font&gt;- Unobservable inputs for the asset or liability.&lt;/div&gt;&#13;&#13;&lt;div style="line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 28.35pt; text-indent: -1.35pt"&gt;The fair value hierarchy also requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. The Company categorized each of its fair value measurements in one of these three levels of hierarchy (see Note 4).&lt;/div&gt;</us-gaap:FairValueOfFinancialInstrumentsPolicy>
    <us-gaap:DerivativesPolicyTextBlock contextRef="D2016-07-01_To_2017-06-30">&lt;div style="text-align: justify; line-height: 1.25"&gt;&lt;table id="zcbe558bdfec34c1c9b3738ad0e5c22de" class="DSPFListTable" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, serif; width: 100%"&gt;&#13;&lt;tr&gt;&#13;&lt;td style="font: bold 10pt Times New Roman, Times, serif; width: 28.35pt; vertical-align: top"&gt;t.&lt;/td&gt;&#13;&lt;td style="width: auto; vertical-align: top; text-align: justify"&gt;&#13;&lt;div style="font: bold 10pt Times New Roman, Times, serif"&gt;Derivative financial instruments&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="line-height: 1.25"&gt;&#13;&lt;div id="DSPFPageHeader"&gt;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 28.35pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, serif"&gt;The Company accounts for derivatives and hedging based on ASC 815, &lt;/font&gt;&lt;font style="font: 10pt Times New Roman, Times, serif"&gt;&amp;#8220;Derivatives and hedging&amp;#8221; &lt;/font&gt;(&amp;#8220;ASC 815&amp;#8221;)&lt;font style="font: 10pt Times New Roman, Times, serif"&gt;, as amended and related interpretations. ASC 815 requires the Company to recognize all derivatives on the balance sheet at fair value. If a derivative meets the definition of a hedge and is so designated, depending on the nature of the hedge, changes in the fair value of the derivative will either be offset against the change in fair value of the hedged assets, liabilities, or firm commitments through earnings (for fair value hedge transactions) or recognized in other comprehensive income (loss) until the hedged item is recognized in earnings (for cash flow hedge transactions).&lt;/font&gt;&lt;/div&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 28.35pt"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 28.35pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, serif"&gt;The ineffective portion of a derivative&amp;#8217;s change in fair value is recognized in earnings. If a derivative does not meet the definition of a hedge, the changes in the fair value are included in earnings. Cash flows related to such hedges are classified as operating activities. The Company enters into forward exchange contracts and option contracts in order to limit the exposure to exchange rate fluctuation associated with expenses mainly incurred in &lt;/font&gt;New Israeli Shekels (&amp;#8220;&lt;font style="font: 10pt Times New Roman, Times, serif"&gt;NIS&lt;/font&gt;&amp;#8221;)&lt;font style="font: 10pt Times New Roman, Times, serif"&gt;. Since the derivative instruments that the Company holds do not meet the definition of hedging instruments under ASC 815, any gain or loss derived from such instruments is recognized immediately as &amp;#8220;financial income, net&amp;#8221;.&lt;/font&gt;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 28.35pt"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 28.35pt"&gt;The Company measured the fair value of the contracts in accordance with ASC 820. Foreign currency derivative contracts are classified within Level 2 as the valuation inputs are based on quoted prices and market observable data of similar instruments. As of June 30, 2017 and 2016, the fair value of the&lt;font style="font: 10pt Times New Roman, Times, serif"&gt;&amp;#160;&lt;/font&gt;options contracts was approximately$ 295&lt;font style="font: 10pt Times New Roman, Times, serif"&gt;&amp;#160;&lt;/font&gt;and $65, respectively, presented in &amp;#8220;other current assets&amp;#8221; (see Note 4). The net gains (losses) recognized in &amp;#8220;Financial income, net&amp;#8221; during the years ended June 30, 2017, 2016 and 2015, were $230, ($205) and $248, respectively.&lt;/div&gt;</us-gaap:DerivativesPolicyTextBlock>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock contextRef="D2016-07-01_To_2017-06-30">&lt;div style="text-align: justify; line-height: 1.25"&gt;&lt;table id="z6ca6aeb30c4f45c4aa701f0c34367182" class="DSPFListTable" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, serif; width: 100%"&gt;&#13;&lt;tr&gt;&#13;&lt;td style="font: bold 10pt Times New Roman, Times, serif; width: 28.35pt; vertical-align: top"&gt;v.&lt;/td&gt;&#13;&lt;td style="width: auto; vertical-align: top; text-align: justify"&gt;&#13;&lt;div style="font: bold 10pt Times New Roman, Times, serif"&gt;Recent Accounting Pronouncement&lt;/div&gt;&#13;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 27pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, serif"&gt;&lt;u&gt;Accounting Standards Update (&amp;#8220;ASU&amp;#8221;) 2014-09 &amp;#8211; &amp;#8220;Revenue from Contracts with Customers (Topic 606)&amp;#8221;&lt;/u&gt;&lt;/font&gt;:&lt;/div&gt;&#13;&#13;&lt;div style="line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="line-height: 1.25"&gt;&#13;&lt;div id="DSPFPageHeader"&gt;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 28.35pt"&gt;In May 2014, the Financial Accounting Standards Board (&amp;#8220;FASB&amp;#8221;) issued ASU No. 2014-09 (Topic 606) &amp;#8220;Revenue from Contracts with Customers&amp;#8221; (&amp;#8220;Topic 606&amp;#8221;). Topic 606 supersedes the revenue recognition requirements in ASC Topic 605, &amp;#8220;Revenue Recognition&amp;#8221;, and requires entities to recognize revenue when they transfer control of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled to in exchange for those goods or services. We intend to adopt Topic 606 as of July 1, 2017, using the modified retrospective transition method. Prior periods will not be retrospectively adjusted. As the Company currently does not have any contracts with customers which are not completed, as of June 30, 2017, we do not expect the adoption of Topic 606 will have a material impact on our consolidated financial statements, including the presentation of revenues in our consolidated statements of income.&lt;/div&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 28.35pt"&gt;&lt;u&gt;ASU 2014-15 - Presentation of Financial Statements - Going Concern (Subtopic 205-40):&lt;/u&gt;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left"&gt;&#13;&lt;div&gt;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 28.35pt"&gt;In August 2014, the FASB issued guidance on disclosure of Uncertainties about an Entity&amp;#8217;s Ability to Continue as a Going Concern (&amp;#8220;ASU 2014-15&amp;#8221;), which defines management&amp;#8217;s responsibility to evaluate whether there is substantial doubt about a company&amp;#8217;s ability to continue as a going concern. ASU 2014-15 also provides principles and definitions that are intended to reduce diversity in the timing and content of disclosures in the financial statement footnotes. This guidance is effective for the annual period ending after December 15, 2016, and for annual periods and interim periods thereafter. The Company adopted the provisions of ASU 2014-15 for the year ended December 31, 2016. The adoption of ASU 2014-15 did not have a material impact on the consolidated financial statements.&lt;/div&gt;&#13;&lt;/div&gt;&#13;&#13;&#13;&#13;&lt;div style="line-height: 1.25"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="line-height: 1.25"&gt;&#13;&lt;div&gt;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 28.35pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, serif"&gt;&lt;u&gt;ASU 2016-13 - Financial Instruments &amp;#8211; Credit Losses (Topic 326), &lt;/u&gt;&lt;/font&gt;&lt;font style="font: 10pt Times New Roman, Times, serif"&gt;&lt;u&gt;&amp;#8220;Measurement of Credit Losses on Financial Instruments&amp;#8221;:&lt;/u&gt;&lt;/font&gt;&lt;/div&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 28.35pt"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 28.35pt"&gt;In June 2016, the FASB issued ASU 2016-13. This update requires an entity to utilize a new impairment model known as the current expected credit loss (&amp;#8220;CECL&amp;#8221;) model to estimate its lifetime &amp;#8220;expected credit loss&amp;#8221; on a financial asset and record an allowance that, when deducted from the amortized cost basis of the financial asset, presents the net amount expected to be collected on the financial asset. The CECL model is expected to result in more timely recognition of credit losses. The update also requires new disclosures for financial assets measured at amortized cost, loans and available-for-sale debt securities. The update is effective for the interim and annual periods beginning on or after December 15, 2019, or July 1, 2020, for the Company. Early adoption is permitted. The Company is currently evaluating the impact of the update on its consolidated financial statements.&lt;/div&gt;&#13;&#13;&lt;div style="line-height: 1.25"&gt;&lt;br style="line-height: 1.25" /&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 28.35pt"&gt;&lt;u&gt;ASU 2016-18 - Restricted Cash (Topic 230):&lt;/u&gt;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 28.35pt"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 28.35pt"&gt;In November 2016, the FASB issued ASU 2016-18, &amp;#8220;Statement of Cash Flows&amp;#8221;. This standard requires the presentation of the statement of cash flows to show the changes in the total of cash, cash equivalents, restricted cash and restricted cash equivalents. The standard is effective for the interim and annual periods beginning on or after December 15, 2017, or July 1, 2018 for the Company. Early adoption is permitted. The Company is currently evaluating the impact of the standard on its consolidated financial statements.&lt;/div&gt;&#13;&#13;&lt;div style="line-height: 1.25"&gt;&lt;br style="line-height: 1.25" /&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 28.35pt"&gt;&lt;u&gt;ASU 2016-02 - Leases (Topic 842):&lt;/u&gt;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left"&gt;&#13;&lt;div&gt;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 28.35pt"&gt;In February 2016, the FASB issued guidance on the recognition, measurement, presentation and disclosure of leases for both parties to a contract (i.e., lessees and lessors). The new standard requires lessees to apply a dual approach, classifying leases as either finance or operating leases based on the principle of whether or not the lease is effectively a financed purchase by the lessee. This classification will determine whether lease expense is recognized based on an effective interest method or on a straight-line basis over the term of the lease, respectively. A lessee is also required to record a right-of-use asset and a lease liability for all leases with a term of greater than 12 months regardless of their classification. Leases with a term of 12 months or less will be accounted for in a manner similar to the accounting under existing guidance for operating leases today. The new standard requires lessors to account for leases using an approach that is substantially equivalent to existing guidance for sales-type leases, direct financing leases and operating leases. Topic 842 supersedes the previous leases standard, ASC 840, &amp;#8220;Leases&amp;#8221;. The guidance is effective for the interim and annual periods beginning on or after December 15, 2018. Early adoption is permitted. The Company is currently evaluating the potential effect of the guidance on its consolidated financial statements.&lt;/div&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="line-height: 1.25"&gt;&lt;br style="line-height: 1.25" /&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; text-indent: 28.35pt"&gt;&lt;u&gt;ASU 2016-01 - Financial Instruments - Overall (Subtopic 825-10):&lt;/u&gt;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left"&gt;&#13;&lt;div&gt;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 28.35pt"&gt;In January 2016, the FASB issued guidance on financial instruments - recognition and measurement of financial assets and financial liabilities. The pronouncement revises the classification and measurement of investments in certain equity investments and the presentation of certain fair value changes for certain financial liabilities measured at fair value. ASU 2016-01 is effective for fiscal years, beginning after December 15, 2017 and interim periods within those years. The Company is currently evaluating the impact of adopting the new standard on its consolidated financial statements.&lt;br style="line-height: 1.25" /&gt;&#13;&lt;/div&gt;&#13;&lt;/div&gt;&#13;&#13;&#13;&#13;&lt;div style="line-height: 1.25"&gt;&lt;br style="line-height: 1.25" /&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; text-indent: 28.35pt"&gt;&lt;u&gt;ASU 2016-09 - Compensation - Stock Compensation (Topic 718):&lt;/u&gt;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; text-indent: 28.35pt"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left"&gt;&#13;&lt;div&gt;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 28.35pt"&gt;In March 2016, the FASB issued guidance on improvements to employee share-based payments. The standard requires among others, that excess tax benefits or deficiencies for share-based payments be recorded as income tax benefit or expense, rather then within additional paid in capital, in the period in which the shares vest. Cash flows related to excess tax benefits will be included in operating activities instead of separately classified as a financing activity. The new guidance is effective for fiscal years beginning after December 15, 2016. Early adoption is permitted. The Company does not expect this guidance to have a material effect on its consolidated financial statements at the time of adoption of this standard.&lt;/div&gt;&#13;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 28.35pt"&gt;&lt;u&gt;ASU 2017-11 - Earnings Per Share (Topic 260); Distinguishing Liabilities from Equity (Topic 480); Derivatives and Hedging (Topic 815): (Part I) Accounting for Certain Financial Instruments with Down Round Features, (Part II) Replacement of the Indefinite Deferral for Mandatorily Redeemable Financial Instruments of Certain Nonpublic Entities and Certain Mandatorily Redeemable Noncontrolling Interests with a Scope Exception:&lt;/u&gt;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left"&gt;&amp;#160;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left"&gt;&#13;&lt;div&gt;&lt;/div&gt;&#13;&#13;&lt;div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 28.35pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, serif"&gt;In July 2017, the FASB issued ASU No. 2017-11.&amp;#160;The ASU was issued to address the complexity associated with applying U.S. GAAP for certain financial instruments with characteristics of liabilities and equity. The ASU, among other things, eliminates the need to consider the effects of down round features when analyzing convertible debt, warrants and other financing instruments. As a result, a freestanding equity-linked financial instrument (or embedded conversion option) no longer would be accounted for as a derivative liability at fair value as a result of the existence of a down round feature. The amendments are effective for fiscal years beginning after December 15, 2018, and should be applied retrospectively. Early adoption is permitted, including adoption in an interim period. The Company plans to adopt ASU 2017-11 in the first quarter of the Company&amp;#8217;s fiscal year 2018. &lt;/font&gt;The Company does not expect the adoption of &lt;font style="font: 10pt Times New Roman, Times, serif"&gt;ASU 2017-11&lt;/font&gt; will have a material impact on its consolidated financial statements and related disclosures.&lt;/div&gt;&lt;/div&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <psti:TotalNondilutiveGrantAwardedFromHorizon2020Program contextRef="From2017-09-04to2017-09-05_us-gaap_SubsequentEventMember" unitRef="USD" decimals="-3">8700000</psti:TotalNondilutiveGrantAwardedFromHorizon2020Program>
    <psti:TotalNondilutiveGrantAwardedFromHorizon2020Program contextRef="From2017-09-04to2017-09-05_us-gaap_SubsequentEventMember_currency_EUR" unitRef="USD" decimals="-3">7400000</psti:TotalNondilutiveGrantAwardedFromHorizon2020Program>
    <psti:AmountOfDirectGrantsAwardedAllocatedToCompany contextRef="From2017-09-04to2017-09-05_us-gaap_SubsequentEventMember" unitRef="USD" decimals="-3">2800000</psti:AmountOfDirectGrantsAwardedAllocatedToCompany>
    <psti:AmountOfDirectGrantsAwardedAllocatedToCompany contextRef="From2017-09-04to2017-09-05_us-gaap_SubsequentEventMember_currency_EUR" unitRef="USD" decimals="-3">2400000</psti:AmountOfDirectGrantsAwardedAllocatedToCompany>
    <dei:EntityCommonStockSharesOutstanding contextRef="AsOf2017-08-31" unitRef="Shares" decimals="INF">97473652</dei:EntityCommonStockSharesOutstanding>
    <dei:EntityPublicFloat contextRef="AsOf2016-12-31" unitRef="USD" decimals="0">107969302</dei:EntityPublicFloat>
    <link:footnoteLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="#Foot-00-0" xlink:label="Foot-00_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-00-1" xlink:label="Foot-00_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-00-2" xlink:label="Foot-00_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-00-3" xlink:label="Foot-00_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-00-4" xlink:label="Foot-00_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-00-5" xlink:label="Foot-00_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-00-6" xlink:label="Foot-00_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-00-7" xlink:label="Foot-00_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-00-8" xlink:label="Foot-00_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-00-9" xlink:label="Foot-00_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-00-10" xlink:label="Foot-00_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-00-11" xlink:label="Foot-00_loc" />
      <link:footnoteArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" xlink:from="Foot-00_loc" xlink:to="Footnote-01" order="1" />
      <link:footnote xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:label="Footnote-01" xml:lang="en-US">Less than $1</link:footnote>
    </link:footnoteLink>
</xbrli:xbrl>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>12
<FILENAME>psti-20170630.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoXBRL; Version: 4.19b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: http://www.novaworks.co -->
    <!-- Field: Doc-Info; Name: Source; Value: psti%2D0617 10K Steve Fix.xfr; Date: 2017%2D09%2D07T12:28:18Z -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x800B0001 -->
    <!-- Field: Doc-Info; Name: Misc; Value: /a4po7xRiXgen8uNbH1cSayMebPtypVx2Ykxu2J4fXmaXy8t5pu8tiwqLt7mwcMA -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2014-01-31" xmlns:us-gaap="http://fasb.org/us-gaap/2017-01-31" xmlns:us-roles="http://fasb.org/us-roles/2017-01-31" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:us-types="http://fasb.org/us-types/2017-01-31" xmlns:psti="http://pluristem.com/20170630" elementFormDefault="qualified" targetNamespace="http://pluristem.com/20170630">
    <annotation>
      <appinfo>
	<link:roleType roleURI="http://pluristem.com/role/DocumentAndEntityInformation" id="DocumentAndEntityInformation">
	  <link:definition>00000001 - Document - Document and Entity Information</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://pluristem.com/role/ConsolidatedBalanceSheets" id="ConsolidatedBalanceSheets">
	  <link:definition>00000002 - Statement - CONSOLIDATED BALANCE SHEETS</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://pluristem.com/role/ConsolidatedBalanceSheetsParenthetical" id="ConsolidatedBalanceSheetsParenthetical">
	  <link:definition>00000003 - Statement - CONSOLIDATED BALANCE SHEETS (PARENTHETICAL)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://pluristem.com/role/InterimCondensedConsolidatedStatementsOfOperations" id="InterimCondensedConsolidatedStatementsOfOperations">
	  <link:definition>00000004 - Statement - CONSOLIDATED STATEMENTS OF  OPERATIONS</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://pluristem.com/role/ConsolidatedStatementsOfComprehensiveLoss" id="ConsolidatedStatementsOfComprehensiveLoss">
	  <link:definition>00000005 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE  LOSS</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://pluristem.com/role/StatementsOfChangesInStockholdersEquity" id="StatementsOfChangesInStockholdersEquity">
	  <link:definition>00000006 - Statement - STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://pluristem.com/role/StatementsOfChangesInStockholdersEquityParenthetical" id="StatementsOfChangesInStockholdersEquityParenthetical">
	  <link:definition>00000007 - Statement - STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (Parenthetical)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://pluristem.com/role/ConsolidatedStatementsOfCashFlows" id="ConsolidatedStatementsOfCashFlows">
	  <link:definition>00000008 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://pluristem.com/role/psti-g1" id="psti-g1">
	  <link:definition>00000009 - Disclosure - GENERAL</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://pluristem.com/role/Disclosure-BASISOFPRESENTATIONANDSIGNIFICANTACCOUNTINGPOLICIES" id="Disclosure-BASISOFPRESENTATIONANDSIGNIFICANTACCOUNTINGPOLICIES">
	  <link:definition>00000010 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://pluristem.com/role/psti-ms" id="psti-ms">
	  <link:definition>00000011 - Disclosure - MARKETABLE SECURITIES</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://pluristem.com/role/psti-fvofi12" id="psti-fvofi12">
	  <link:definition>00000012 - Disclosure - FAIR VALUE OF FINANCIAL INSTRUMENTS</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://pluristem.com/role/OtherCurrentAssets" id="OtherCurrentAssets">
	  <link:definition>00000013 - Disclosure - OTHER CURRENT ASSETS</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://pluristem.com/role/PropertyAndEquipmentNet" id="PropertyAndEquipmentNet">
	  <link:definition>00000014 - Disclosure - PROPERTY AND EQUIPMENT, NET</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://pluristem.com/role/OtherAccountsPayable" id="OtherAccountsPayable">
	  <link:definition>00000015 - Disclosure - OTHER ACCOUNTS PAYABLE</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://pluristem.com/role/psti-cac1" id="psti-cac1">
	  <link:definition>00000016 - Disclosure - COMMITMENTS AND CONTINGENCIES</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://pluristem.com/role/psti-se12" id="psti-se12">
	  <link:definition>00000017 - Disclosure - STOCKHOLDERS' EQUITY</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://pluristem.com/role/FinancialIncomeNet" id="FinancialIncomeNet">
	  <link:definition>00000018 - Disclosure - FINANCIAL INCOME, NET</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://pluristem.com/role/TaxesOnIncome" id="TaxesOnIncome">
	  <link:definition>00000019 - Disclosure - TAXES ON INCOME</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://pluristem.com/role/SubsequentEvents" id="SubsequentEvents">
	  <link:definition>00000020 - Disclosure - SUBSEQUENT EVENTS</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://pluristem.com/role/SignificantAccountingPoliciesPolicies" id="SignificantAccountingPoliciesPolicies">
	  <link:definition>00000021 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Policies)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://pluristem.com/role/SignificantAccountingPoliciesTables" id="SignificantAccountingPoliciesTables">
	  <link:definition>00000022 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://pluristem.com/role/psti-mst1" id="psti-mst1">
	  <link:definition>00000023 - Disclosure - MARKETABLE SECURITIES (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://pluristem.com/role/psti-fvofit1" id="psti-fvofit1">
	  <link:definition>00000024 - Disclosure - FAIR VALUE OF FINANCIAL INSTRUMENTS (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://pluristem.com/role/OtherCurrentAssetsTables" id="OtherCurrentAssetsTables">
	  <link:definition>00000025 - Disclosure - OTHER CURRENT ASSETS (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://pluristem.com/role/PropertyAndEquipmentNetTables" id="PropertyAndEquipmentNetTables">
	  <link:definition>00000026 - Disclosure - PROPERTY AND EQUIPMENT, NET (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://pluristem.com/role/OtherAccountsPayableTables" id="OtherAccountsPayableTables">
	  <link:definition>00000027 - Disclosure - OTHER ACCOUNTS PAYABLE (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://pluristem.com/role/CommitmentsAndContingenciesTables" id="CommitmentsAndContingenciesTables">
	  <link:definition>00000028 - Disclosure - COMMITMENTS AND CONTINGENCIES (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://pluristem.com/role/Disclosure-STOCKHOLDERSEQUITYTables" id="Disclosure-STOCKHOLDERSEQUITYTables">
	  <link:definition>00000029 - Disclosure - STOCKHOLDERS' EQUITY (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://pluristem.com/role/FinancialIncomeNetTables" id="FinancialIncomeNetTables">
	  <link:definition>00000030 - Disclosure - FINANCIAL INCOME, NET (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://pluristem.com/role/TaxesOnIncomeTables" id="TaxesOnIncomeTables">
	  <link:definition>00000031 - Disclosure - TAXES ON INCOME (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://pluristem.com/role/psti-gd" id="psti-gd">
	  <link:definition>00000032 - Disclosure - GENERAL (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://pluristem.com/role/SignificantAccountingPoliciesNarrativeDetails" id="SignificantAccountingPoliciesNarrativeDetails">
	  <link:definition>00000033 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Narrative) (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://pluristem.com/role/SignificantAccountingPoliciesScheduleOfPropertyAndEquipmentDepreciationRateDetails" id="SignificantAccountingPoliciesScheduleOfPropertyAndEquipmentDepreciationRateDetails">
	  <link:definition>00000034 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Schedule of Property and Equipment Depreciation Rate) (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://pluristem.com/role/Disclosure-BASISOFPRESENTATIONANDSIGNIFICANTACCOUNTINGPOLICIESComprehensiveIncomeDetails" id="Disclosure-BASISOFPRESENTATIONANDSIGNIFICANTACCOUNTINGPOLICIESComprehensiveIncomeDetails">
	  <link:definition>00000035 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Comprehensive Income) (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://pluristem.com/role/psti-mssoamsd1" id="psti-mssoamsd1">
	  <link:definition>00000036 - Disclosure - MARKETABLE SECURITIES (Schedule of Available-for-sale Marketable Securities) (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://pluristem.com/role/psti-mssoiiuld" id="psti-mssoiiuld">
	  <link:definition>00000037 - Disclosure - MARKETABLE SECURITIES (Schedule of Investments in Unrealized Loss) (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://pluristem.com/role/psti-fvofisofvofid1" id="psti-fvofisofvofid1">
	  <link:definition>00000038 - Disclosure - FAIR VALUE OF FINANCIAL INSTRUMENTS (Schedule of Fair Value of Financial Instruments) (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://pluristem.com/role/OtherCurrentAssetsDetails" id="OtherCurrentAssetsDetails">
	  <link:definition>00000039 - Disclosure - OTHER CURRENT ASSETS (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://pluristem.com/role/PropertyAndEquipmentNetDetails" id="PropertyAndEquipmentNetDetails">
	  <link:definition>00000040 - Disclosure - PROPERTY AND EQUIPMENT, NET (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://pluristem.com/role/OtherAccountsPayableDetails" id="OtherAccountsPayableDetails">
	  <link:definition>00000041 - Disclosure - OTHER ACCOUNTS PAYABLE (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://pluristem.com/role/CommitmentsAndContingenciesOperatingLeaseDetails" id="CommitmentsAndContingenciesOperatingLeaseDetails">
	  <link:definition>00000042 - Disclosure - COMMITMENTS AND CONTINGENCIES (Operating Lease) (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://pluristem.com/role/CommitmentsAndContingenciesOtherDetails" id="CommitmentsAndContingenciesOtherDetails">
	  <link:definition>00000043 - Disclosure - COMMITMENTS AND CONTINGENCIES (Other) (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://pluristem.com/role/psti-send1" id="psti-send1">
	  <link:definition>00000044 - Disclosure - STOCKHOLDERS' EQUITY (Narrative) (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://pluristem.com/role/StockholdersEquitySummaryOfOptionActivityDetails" id="StockholdersEquitySummaryOfOptionActivityDetails">
	  <link:definition>00000045 - Disclosure - STOCKHOLDERS' EQUITY (Summary of Option Activity) (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://pluristem.com/role/StockholdersEquitySummaryOfOptionActivityToNon-employeeConsultantsDetails" id="StockholdersEquitySummaryOfOptionActivityToNon-employeeConsultantsDetails">
	  <link:definition>00000046 - Disclosure - STOCKHOLDERS' EQUITY (Summary of Option Activity to Non-employee Consultants) (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://pluristem.com/role/psti-sesoced1" id="psti-sesoced1">
	  <link:definition>00000047 - Disclosure - STOCKHOLDERS' EQUITY (Schedule of Compensation Expense) (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://pluristem.com/role/psti-sesorateadd1" id="psti-sesorateadd1">
	  <link:definition>00000048 - Disclosure - STOCKHOLDERS' EQUITY (Summary of RSU Activity to Employees and Directors) (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://pluristem.com/role/psti-sesoratcd1" id="psti-sesoratcd1">
	  <link:definition>00000049 - Disclosure - STOCKHOLDERS' EQUITY (Summary of RSU Activity to Consultants) (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://pluristem.com/role/StockholdersEquitySummaryOfWarrantsAndOptionsDetails" id="StockholdersEquitySummaryOfWarrantsAndOptionsDetails">
	  <link:definition>00000050 - Disclosure - STOCKHOLDERS' EQUITY (Summary of Warrants and Options) (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://pluristem.com/role/FinancialIncomeNetDetails" id="FinancialIncomeNetDetails">
	  <link:definition>00000051 - Disclosure - FINANCIAL INCOME, NET (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://pluristem.com/role/TaxesOnIncomeNarrativeDetails" id="TaxesOnIncomeNarrativeDetails">
	  <link:definition>00000052 - Disclosure - TAXES ON INCOME (Narrative) (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://pluristem.com/role/TaxesOnIncomeScheduleOfSignificantComponentsOfDeferredTaxAssetsDetails" id="TaxesOnIncomeScheduleOfSignificantComponentsOfDeferredTaxAssetsDetails">
	  <link:definition>00000053 - Disclosure - TAXES ON INCOME (Schedule of Significant Components of Deferred Tax Assets) (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://pluristem.com/role/SubsequentEventsNarrativeDetails" id="SubsequentEventsNarrativeDetails">
	  <link:definition>00000054 - Disclosure - SUBSEQUENT EVENTS (Narrative) (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:linkbaseRef xlink:type="simple" xlink:href="psti-20170630_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
	<link:linkbaseRef xlink:type="simple" xlink:href="psti-20170630_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
	<link:linkbaseRef xlink:type="simple" xlink:href="psti-20170630_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Calculation Links" />
	<link:linkbaseRef xlink:type="simple" xlink:href="psti-20170630_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Definition Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2014-01-31" schemaLocation="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd" />
    <import namespace="http://fasb.org/us-gaap/2017-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd" />
    <import namespace="http://fasb.org/us-types/2017-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2017/elts/us-types-2017-01-31.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/non-numeric" schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/numeric" schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd" />
    <import namespace="http://xbrl.sec.gov/currency/2017-01-31" schemaLocation="http://xbrl.sec.gov/currency/2017/currency-2017-01-31.xsd" />
    <import namespace="http://xbrl.sec.gov/invest/2013-01-31" schemaLocation="http://xbrl.sec.gov/invest/2013/invest-2013-01-31.xsd" />
    <element id="psti_StockIssuedDuringPeriodValuePrivatePlacement" name="StockIssuedDuringPeriodValuePrivatePlacement" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="psti_StockIssuedDuringPeriodSharesPrivatePlacement" name="StockIssuedDuringPeriodSharesPrivatePlacement" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="psti_ShareBasedGoodsAndNonemployeeServicesTransactionQuantityOfSecuritiesToBeIssued" name="ShareBasedGoodsAndNonemployeeServicesTransactionQuantityOfSecuritiesToBeIssued" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="psti_AvailableForSaleMarketableSecuritiesNumber" name="AvailableForSaleMarketableSecuritiesNumber" nillable="true" xbrli:periodType="instant" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="psti_AggregateGrantsReceived" name="AggregateGrantsReceived" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="psti_PercentageOfQualifiedExpenditures" name="PercentageOfQualifiedExpenditures" nillable="true" xbrli:periodType="duration" type="num:percentItemType" substitutionGroup="xbrli:item" />
    <element id="psti_RoyaltyRateSales" name="RoyaltyRateSales" nillable="true" xbrli:periodType="duration" type="num:percentItemType" substitutionGroup="xbrli:item" />
    <element id="psti_RoyaltyRatePayableOnGrantsReceived" name="RoyaltyRatePayableOnGrantsReceived" nillable="true" xbrli:periodType="duration" type="num:percentItemType" substitutionGroup="xbrli:item" />
    <element id="psti_RoyaltiesAmountPaidAndAccrued" name="RoyaltiesAmountPaidAndAccrued" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="psti_LinkageDifferencesAndInterestOnShortAndLongTermRestrictedLeaseDeposit" name="LinkageDifferencesAndInterestOnShortAndLongTermRestrictedLeaseDeposit" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="psti_AmortizationOfDiscountAndPremiumAndChangesInAccruedInterestFromMarketableSecurities" name="AmortizationOfDiscountAndPremiumAndChangesInAccruedInterestFromMarketableSecurities" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="psti_RepaymentOfInvestmentInLongtermDepositsAndRestrictedBankDeposits" name="RepaymentOfInvestmentInLongtermDepositsAndRestrictedBankDeposits" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="psti_PropertyPlantAndEquipmentAnnualRateOfDepreciation" name="PropertyPlantAndEquipmentAnnualRateOfDepreciation" nillable="true" xbrli:periodType="duration" type="num:percentItemType" substitutionGroup="xbrli:item" />
    <element id="psti_OtherthantemporaryImpairment" name="OtherthantemporaryImpairment" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="psti_AccountsReceivableFromMinistryOfEconomyCurrent" name="AccountsReceivableFromMinistryOfEconomyCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="psti_OtherAccountsPayablePayrollInstitutions" name="OtherAccountsPayablePayrollInstitutions" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="psti_InterestOnShortTermBankCreditAndBankExpenses" name="InterestOnShortTermBankCreditAndBankExpenses" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="psti_SharebasedCompensationArrangementWarrantsExercised" name="SharebasedCompensationArrangementWarrantsExercised" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="psti_ExpirationPeriodOfWarrantsSoldInOffering" name="ExpirationPeriodOfWarrantsSoldInOffering" nillable="true" xbrli:periodType="duration" type="xbrli:durationItemType" substitutionGroup="xbrli:item" />
    <element id="psti_StockIssuedDuringPeriodValueStockWarrantsExercised" name="StockIssuedDuringPeriodValueStockWarrantsExercised" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="psti_StockIssuedDuringPeriodSharesStockWarrantsExercised" name="StockIssuedDuringPeriodSharesStockWarrantsExercised" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="psti_OperatingLeasedAssetsParticipationFromLessor" name="OperatingLeasedAssetsParticipationFromLessor" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="psti_BusinessCombinationContingentConsiderationReceivableUponCertainRegulatoryMilestones" name="BusinessCombinationContingentConsiderationReceivableUponCertainRegulatoryMilestones" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="psti_AdvancePaymentForDeveplomentCosts" name="AdvancePaymentForDeveplomentCosts" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="psti_LeaseholdImprovementsAnnualRateOfDepreciationDescription" name="LeaseholdImprovementsAnnualRateOfDepreciationDescription" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="psti_ResearchAndDevelopmentExpensesNet" name="ResearchAndDevelopmentExpensesNet" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="psti_GovernmentAndThirdPartyGrantsReceived" name="GovernmentAndThirdPartyGrantsReceived" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="psti_TotalGrantsAwardedToCliProgram" name="TotalGrantsAwardedToCliProgram" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="psti_AmountOfGrantsAwardedToCliProgramAllocatedToCompany" name="AmountOfGrantsAwardedToCliProgramAllocatedToCompany" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="psti_AmountOfGrantsReceivedConditionalAward" name="AmountOfGrantsReceivedConditionalAward" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="psti_AmountOfDirectGrantAllocatedToTheCompany" name="AmountOfDirectGrantAllocatedToTheCompany" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="psti_TermOfRoyaltyGrantReceived" name="TermOfRoyaltyGrantReceived" nillable="true" xbrli:periodType="duration" type="xbrli:durationItemType" substitutionGroup="xbrli:item" />
    <element id="psti_NumberOfSharesAgreedToBeSoldThroughUnderwriterAgreement" name="NumberOfSharesAgreedToBeSoldThroughUnderwriterAgreement" nillable="true" xbrli:periodType="instant" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="psti_NumberOfWarrantsAgreedToBeSoldThroughUnderwriterAgreement" name="NumberOfWarrantsAgreedToBeSoldThroughUnderwriterAgreement" nillable="true" xbrli:periodType="instant" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="psti_GrossProceedsFromIssuanceOfCommonStock" name="GrossProceedsFromIssuanceOfCommonStock" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="psti_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVest" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVest" nillable="true" xbrli:periodType="instant" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="psti_NonrefundableAdvanceUnderTermsOfLicenseAgreement" name="NonrefundableAdvanceUnderTermsOfLicenseAgreement" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="psti_ValueOfCommonStockCompanyCanPeriodicallyIssueThroughAgentsPerTermsOfAtmAgreement" name="ValueOfCommonStockCompanyCanPeriodicallyIssueThroughAgentsPerTermsOfAtmAgreement" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="psti_IssuanceOfCommonStockAndWarrantsRelatedToJanuaryTwentySeventeenOfferingNetOfIssuanceCostsShares" name="IssuanceOfCommonStockAndWarrantsRelatedToJanuaryTwentySeventeenOfferingNetOfIssuanceCostsShares" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="psti_IssuanceOfCommonStockAndWarrantsRelatedToJanuaryTwentySeventeenOfferingNetOfIssuanceCostsValue" name="IssuanceOfCommonStockAndWarrantsRelatedToJanuaryTwentySeventeenOfferingNetOfIssuanceCostsValue" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="psti_CorporateStatutoryTaxRateOn2018AndThereafter" name="CorporateStatutoryTaxRateOn2018AndThereafter" nillable="true" xbrli:periodType="duration" type="num:percentItemType" substitutionGroup="xbrli:item" />
    <element id="psti_CorporateStatutoryTaxRateOn2017AndThereafter" name="CorporateStatutoryTaxRateOn2017AndThereafter" nillable="true" xbrli:periodType="duration" type="num:percentItemType" substitutionGroup="xbrli:item" />
    <element id="psti_CorporateStatutoryTaxRateOn2016" name="CorporateStatutoryTaxRateOn2016" nillable="true" xbrli:periodType="duration" type="num:percentItemType" substitutionGroup="xbrli:item" />
    <element id="psti_CorporateStatutoryTaxRateOn2016AndThereafter" name="CorporateStatutoryTaxRateOn2016AndThereafter" nillable="true" xbrli:periodType="duration" type="num:percentItemType" substitutionGroup="xbrli:item" />
    <element id="psti_CorporateStatutoryTaxRateOnProfitsDerivingFromIntellectualProperty" name="CorporateStatutoryTaxRateOnProfitsDerivingFromIntellectualProperty" nillable="true" xbrli:periodType="duration" type="num:percentItemType" substitutionGroup="xbrli:item" />
    <element id="psti_CorporateStatutoryTaxRateForDividendsDistributedToIndividualsOrForeignResidentsDistributedFromPreferredEnterpriseProfits" name="CorporateStatutoryTaxRateForDividendsDistributedToIndividualsOrForeignResidentsDistributedFromPreferredEnterpriseProfits" nillable="true" xbrli:periodType="duration" type="num:percentItemType" substitutionGroup="xbrli:item" />
    <element id="psti_CorporateStatutoryTaxRateForDividendsDistributedToForeignCompanies" name="CorporateStatutoryTaxRateForDividendsDistributedToForeignCompanies" nillable="true" xbrli:periodType="duration" type="num:percentItemType" substitutionGroup="xbrli:item" />
    <element id="psti_ShortTermBankDepositPolicyTextBlock" name="ShortTermBankDepositPolicyTextBlock" nillable="true" xbrli:periodType="duration" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="psti_LongTermRestrictedBankDepositPolicyTextBlock" name="LongTermRestrictedBankDepositPolicyTextBlock" nillable="true" xbrli:periodType="duration" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="psti_PropertyPlantAndEquipmentEstimatedUsefulLivesRateTableTextBlock" name="PropertyPlantAndEquipmentEstimatedUsefulLivesRateTableTextBlock" nillable="true" xbrli:periodType="duration" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="psti_QualifyingPercentageOfValueOfProductiveAssetsTableTextBlock" name="QualifyingPercentageOfValueOfProductiveAssetsTableTextBlock" nillable="true" xbrli:periodType="duration" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="psti_ResearchAndDevelopmentExpensesAndRoyaltyBearingGrantsPolicyTextBlock" name="ResearchAndDevelopmentExpensesAndRoyaltyBearingGrantsPolicyTextBlock" nillable="true" xbrli:periodType="duration" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="psti_NonroyaltyBearingGrantsPolicyTextBlock" name="NonroyaltyBearingGrantsPolicyTextBlock" nillable="true" xbrli:periodType="duration" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="psti_SeverancePayPolicyTextBlock" name="SeverancePayPolicyTextBlock" nillable="true" xbrli:periodType="duration" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="psti_TotalNondilutiveGrantAwardedFromHorizon2020Program" name="TotalNondilutiveGrantAwardedFromHorizon2020Program" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="psti_AmountOfDirectGrantsAwardedAllocatedToCompany" name="AmountOfDirectGrantsAwardedAllocatedToCompany" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="psti_OtherAccountReceivableMember" name="OtherAccountReceivableMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="psti_ConsultantsMember" name="ConsultantsMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="psti_ContractorMember" name="ContractorMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="psti_ConsultantRestrictedStockUnitsMember" name="ConsultantRestrictedStockUnitsMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="psti_AvailableForSaleSecuritiesMaturesWithinOneYearMember" name="AvailableForSaleSecuritiesMaturesWithinOneYearMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="psti_GovernmentDebtSecuritiesMember" name="GovernmentDebtSecuritiesMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="psti_AvailableForSaleSecuritiesMaturesAfterOneYearThroughFiveYearsMember" name="AvailableForSaleSecuritiesMaturesAfterOneYearThroughFiveYearsMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="psti_AvailableForSaleSecuritiesMaturesAfterFiveYearsThroughTenYearsMember" name="AvailableForSaleSecuritiesMaturesAfterFiveYearsThroughTenYearsMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="psti_EquityOptionsAndWarrantsMember" name="EquityOptionsAndWarrantsMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="psti_InvestorWarrantsMember" name="InvestorWarrantsMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="psti_ConsultantWarrantsMember" name="ConsultantWarrantsMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="psti_Plan2005Member" name="Plan2005Member" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="psti_Plan2016Member" name="Plan2016Member" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="psti_ExercisePriceRangeOneMember" name="ExercisePriceRangeOneMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="psti_ExercisePriceRangeTwoMember" name="ExercisePriceRangeTwoMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="psti_ExercisePriceRangeThreeMember" name="ExercisePriceRangeThreeMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="psti_ExercisePriceRangeFourMember" name="ExercisePriceRangeFourMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="psti_ExercisePriceRangeFiveMember" name="ExercisePriceRangeFiveMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="psti_ExercisePriceRangeSixMember" name="ExercisePriceRangeSixMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="psti_ExercisePriceRangeSevenMember" name="ExercisePriceRangeSevenMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="psti_ExercisePriceRangeEightMember" name="ExercisePriceRangeEightMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="psti_ExercisePriceRangeNineMember" name="ExercisePriceRangeNineMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="psti_ExercisePriceRangeTenMember" name="ExercisePriceRangeTenMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="psti_ExercisePriceRangeElevenMember" name="ExercisePriceRangeElevenMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="psti_ExercisePriceRangeTwelveMember" name="ExercisePriceRangeTwelveMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="psti_ExercisePriceRangeThirteenMember" name="ExercisePriceRangeThirteenMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="psti_ExercisePriceRangeFourteenMember" name="ExercisePriceRangeFourteenMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="psti_ExercisePriceRangeFifteenMember" name="ExercisePriceRangeFifteenMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="psti_ExercisePriceRangeSixteenMember" name="ExercisePriceRangeSixteenMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="psti_BinationalIndustrialResearchAndDevelopmentFoundationMember" name="BinationalIndustrialResearchAndDevelopmentFoundationMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="psti_SmartMoneyGrantMember" name="SmartMoneyGrantMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="psti_NewYorkBloodCenterIncMember" name="NewYorkBloodCenterIncMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="psti_UnderwritingAgreementMember" name="UnderwritingAgreementMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="psti_EmployeesAndDirectorsMember" name="EmployeesAndDirectorsMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="psti_NonemployeesMember" name="NonemployeesMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="psti_AtMarketIssuanceSalesAgreementMember" name="AtMarketIssuanceSalesAgreementMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="psti_TwoThousandsEighteenMember" name="TwoThousandsEighteenMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="psti_TechnologicalPreferredEnterpriseMember" name="TechnologicalPreferredEnterpriseMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="psti_SpecialTechnologicalPreferredEnterpriseMember" name="SpecialTechnologicalPreferredEnterpriseMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="psti_PreferredEnterpriseMember" name="PreferredEnterpriseMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="psti_DevelopmentAreaMember" name="DevelopmentAreaMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="psti_RestOfCountryMember" name="RestOfCountryMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="psti_TechnologicalEnterpriseMember" name="TechnologicalEnterpriseMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="psti_DocumentAndEntityInformationAbstract" name="DocumentAndEntityInformationAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="psti_ExerciseOfOptionsByEmployees" name="ExerciseOfOptionsByEmployees" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="psti_ExerciseOfOptionsByEmployeesShares" name="ExerciseOfOptionsByEmployeesShares" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="psti_GeneralAbstract" name="GeneralAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="psti_OtherAccountsPayableAbstract" name="OtherAccountsPayableAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="psti_SignificantAccountingPolicyPolicyTextBlock" name="SignificantAccountingPolicyPolicyTextBlock" nillable="true" xbrli:periodType="duration" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="psti_StockholdersEquityNoteTable" name="StockholdersEquityNoteTable" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrldt:hypercubeItem" />
    <element id="psti_StockholdersEquityNoteLineItems" name="StockholdersEquityNoteLineItems" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="psti_RecognizedRAndDPariticipationGrants" name="RecognizedRAndDPariticipationGrants" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="psti_MaturityDateRangeAxis" name="MaturityDateRangeAxis" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrldt:dimensionItem" />
    <element id="psti_MaturityDateRangeDomain" name="MaturityDateRangeDomain" abstract="true" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="psti_OperatingLeasedAssetsNumberOfUnits" name="OperatingLeasedAssetsNumberOfUnits" nillable="true" xbrli:periodType="instant" type="xbrli:decimalItemType" substitutionGroup="xbrli:item" />
    <element id="psti_CommonStockAggregateOfferingPriceAuthorized" name="CommonStockAggregateOfferingPriceAuthorized" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="psti_AggregateOfferingPriceUnderATMAgreement" name="AggregateOfferingPriceUnderATMAgreement" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="psti_PercentageOfConstructionMilestonesCompleted" name="PercentageOfConstructionMilestonesCompleted" nillable="true" xbrli:periodType="instant" type="num:percentItemType" substitutionGroup="xbrli:item" />
    <element id="psti_WeightedAverageRemainingContractualTermsAbstract" name="WeightedAverageRemainingContractualTermsAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="psti_AggregateIntrinsicValueAbstract" name="AggregateIntrinsicValueAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="psti_StockholdersEquitySummaryOfOptionActivityToNonemployeeConsultantsDetailsAbstract" name="StockholdersEquitySummaryOfOptionActivityToNonemployeeConsultantsDetailsAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>13
<FILENAME>psti-20170630_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoXBRL; Version: 4.19b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: http://www.novaworks.co -->
    <!-- Field: Doc-Info; Name: Source; Value: psti%2D0617 10K Steve Fix.xfr; Date: 2017%2D09%2D07T12:28:18Z -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x800B0001 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://pluristem.com/role/DocumentAndEntityInformation" xlink:href="psti-20170630.xsd#DocumentAndEntityInformation" xlink:type="simple" />
    <link:roleRef roleURI="http://pluristem.com/role/ConsolidatedBalanceSheets" xlink:href="psti-20170630.xsd#ConsolidatedBalanceSheets" xlink:type="simple" />
    <link:roleRef roleURI="http://pluristem.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:href="psti-20170630.xsd#ConsolidatedBalanceSheetsParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://pluristem.com/role/InterimCondensedConsolidatedStatementsOfOperations" xlink:href="psti-20170630.xsd#InterimCondensedConsolidatedStatementsOfOperations" xlink:type="simple" />
    <link:roleRef roleURI="http://pluristem.com/role/ConsolidatedStatementsOfComprehensiveLoss" xlink:href="psti-20170630.xsd#ConsolidatedStatementsOfComprehensiveLoss" xlink:type="simple" />
    <link:roleRef roleURI="http://pluristem.com/role/StatementsOfChangesInStockholdersEquity" xlink:href="psti-20170630.xsd#StatementsOfChangesInStockholdersEquity" xlink:type="simple" />
    <link:roleRef roleURI="http://pluristem.com/role/StatementsOfChangesInStockholdersEquityParenthetical" xlink:href="psti-20170630.xsd#StatementsOfChangesInStockholdersEquityParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://pluristem.com/role/ConsolidatedStatementsOfCashFlows" xlink:href="psti-20170630.xsd#ConsolidatedStatementsOfCashFlows" xlink:type="simple" />
    <link:roleRef roleURI="http://pluristem.com/role/psti-g1" xlink:href="psti-20170630.xsd#psti-g1" xlink:type="simple" />
    <link:roleRef roleURI="http://pluristem.com/role/Disclosure-BASISOFPRESENTATIONANDSIGNIFICANTACCOUNTINGPOLICIES" xlink:href="psti-20170630.xsd#Disclosure-BASISOFPRESENTATIONANDSIGNIFICANTACCOUNTINGPOLICIES" xlink:type="simple" />
    <link:roleRef roleURI="http://pluristem.com/role/psti-ms" xlink:href="psti-20170630.xsd#psti-ms" xlink:type="simple" />
    <link:roleRef roleURI="http://pluristem.com/role/psti-fvofi12" xlink:href="psti-20170630.xsd#psti-fvofi12" xlink:type="simple" />
    <link:roleRef roleURI="http://pluristem.com/role/OtherCurrentAssets" xlink:href="psti-20170630.xsd#OtherCurrentAssets" xlink:type="simple" />
    <link:roleRef roleURI="http://pluristem.com/role/PropertyAndEquipmentNet" xlink:href="psti-20170630.xsd#PropertyAndEquipmentNet" xlink:type="simple" />
    <link:roleRef roleURI="http://pluristem.com/role/OtherAccountsPayable" xlink:href="psti-20170630.xsd#OtherAccountsPayable" xlink:type="simple" />
    <link:roleRef roleURI="http://pluristem.com/role/psti-cac1" xlink:href="psti-20170630.xsd#psti-cac1" xlink:type="simple" />
    <link:roleRef roleURI="http://pluristem.com/role/psti-se12" xlink:href="psti-20170630.xsd#psti-se12" xlink:type="simple" />
    <link:roleRef roleURI="http://pluristem.com/role/FinancialIncomeNet" xlink:href="psti-20170630.xsd#FinancialIncomeNet" xlink:type="simple" />
    <link:roleRef roleURI="http://pluristem.com/role/TaxesOnIncome" xlink:href="psti-20170630.xsd#TaxesOnIncome" xlink:type="simple" />
    <link:roleRef roleURI="http://pluristem.com/role/SubsequentEvents" xlink:href="psti-20170630.xsd#SubsequentEvents" xlink:type="simple" />
    <link:roleRef roleURI="http://pluristem.com/role/SignificantAccountingPoliciesPolicies" xlink:href="psti-20170630.xsd#SignificantAccountingPoliciesPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://pluristem.com/role/SignificantAccountingPoliciesTables" xlink:href="psti-20170630.xsd#SignificantAccountingPoliciesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://pluristem.com/role/psti-mst1" xlink:href="psti-20170630.xsd#psti-mst1" xlink:type="simple" />
    <link:roleRef roleURI="http://pluristem.com/role/psti-fvofit1" xlink:href="psti-20170630.xsd#psti-fvofit1" xlink:type="simple" />
    <link:roleRef roleURI="http://pluristem.com/role/OtherCurrentAssetsTables" xlink:href="psti-20170630.xsd#OtherCurrentAssetsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://pluristem.com/role/PropertyAndEquipmentNetTables" xlink:href="psti-20170630.xsd#PropertyAndEquipmentNetTables" xlink:type="simple" />
    <link:roleRef roleURI="http://pluristem.com/role/OtherAccountsPayableTables" xlink:href="psti-20170630.xsd#OtherAccountsPayableTables" xlink:type="simple" />
    <link:roleRef roleURI="http://pluristem.com/role/CommitmentsAndContingenciesTables" xlink:href="psti-20170630.xsd#CommitmentsAndContingenciesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://pluristem.com/role/Disclosure-STOCKHOLDERSEQUITYTables" xlink:href="psti-20170630.xsd#Disclosure-STOCKHOLDERSEQUITYTables" xlink:type="simple" />
    <link:roleRef roleURI="http://pluristem.com/role/FinancialIncomeNetTables" xlink:href="psti-20170630.xsd#FinancialIncomeNetTables" xlink:type="simple" />
    <link:roleRef roleURI="http://pluristem.com/role/TaxesOnIncomeTables" xlink:href="psti-20170630.xsd#TaxesOnIncomeTables" xlink:type="simple" />
    <link:roleRef roleURI="http://pluristem.com/role/psti-gd" xlink:href="psti-20170630.xsd#psti-gd" xlink:type="simple" />
    <link:roleRef roleURI="http://pluristem.com/role/SignificantAccountingPoliciesNarrativeDetails" xlink:href="psti-20170630.xsd#SignificantAccountingPoliciesNarrativeDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://pluristem.com/role/SignificantAccountingPoliciesScheduleOfPropertyAndEquipmentDepreciationRateDetails" xlink:href="psti-20170630.xsd#SignificantAccountingPoliciesScheduleOfPropertyAndEquipmentDepreciationRateDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://pluristem.com/role/Disclosure-BASISOFPRESENTATIONANDSIGNIFICANTACCOUNTINGPOLICIESComprehensiveIncomeDetails" xlink:href="psti-20170630.xsd#Disclosure-BASISOFPRESENTATIONANDSIGNIFICANTACCOUNTINGPOLICIESComprehensiveIncomeDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://pluristem.com/role/psti-mssoamsd1" xlink:href="psti-20170630.xsd#psti-mssoamsd1" xlink:type="simple" />
    <link:roleRef roleURI="http://pluristem.com/role/psti-mssoiiuld" xlink:href="psti-20170630.xsd#psti-mssoiiuld" xlink:type="simple" />
    <link:roleRef roleURI="http://pluristem.com/role/psti-fvofisofvofid1" xlink:href="psti-20170630.xsd#psti-fvofisofvofid1" xlink:type="simple" />
    <link:roleRef roleURI="http://pluristem.com/role/OtherCurrentAssetsDetails" xlink:href="psti-20170630.xsd#OtherCurrentAssetsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://pluristem.com/role/PropertyAndEquipmentNetDetails" xlink:href="psti-20170630.xsd#PropertyAndEquipmentNetDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://pluristem.com/role/OtherAccountsPayableDetails" xlink:href="psti-20170630.xsd#OtherAccountsPayableDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://pluristem.com/role/CommitmentsAndContingenciesOperatingLeaseDetails" xlink:href="psti-20170630.xsd#CommitmentsAndContingenciesOperatingLeaseDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://pluristem.com/role/CommitmentsAndContingenciesOtherDetails" xlink:href="psti-20170630.xsd#CommitmentsAndContingenciesOtherDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://pluristem.com/role/psti-send1" xlink:href="psti-20170630.xsd#psti-send1" xlink:type="simple" />
    <link:roleRef roleURI="http://pluristem.com/role/StockholdersEquitySummaryOfOptionActivityDetails" xlink:href="psti-20170630.xsd#StockholdersEquitySummaryOfOptionActivityDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://pluristem.com/role/StockholdersEquitySummaryOfOptionActivityToNon-employeeConsultantsDetails" xlink:href="psti-20170630.xsd#StockholdersEquitySummaryOfOptionActivityToNon-employeeConsultantsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://pluristem.com/role/psti-sesoced1" xlink:href="psti-20170630.xsd#psti-sesoced1" xlink:type="simple" />
    <link:roleRef roleURI="http://pluristem.com/role/psti-sesorateadd1" xlink:href="psti-20170630.xsd#psti-sesorateadd1" xlink:type="simple" />
    <link:roleRef roleURI="http://pluristem.com/role/psti-sesoratcd1" xlink:href="psti-20170630.xsd#psti-sesoratcd1" xlink:type="simple" />
    <link:roleRef roleURI="http://pluristem.com/role/StockholdersEquitySummaryOfWarrantsAndOptionsDetails" xlink:href="psti-20170630.xsd#StockholdersEquitySummaryOfWarrantsAndOptionsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://pluristem.com/role/FinancialIncomeNetDetails" xlink:href="psti-20170630.xsd#FinancialIncomeNetDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://pluristem.com/role/TaxesOnIncomeNarrativeDetails" xlink:href="psti-20170630.xsd#TaxesOnIncomeNarrativeDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://pluristem.com/role/TaxesOnIncomeScheduleOfSignificantComponentsOfDeferredTaxAssetsDetails" xlink:href="psti-20170630.xsd#TaxesOnIncomeScheduleOfSignificantComponentsOfDeferredTaxAssetsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://pluristem.com/role/SubsequentEventsNarrativeDetails" xlink:href="psti-20170630.xsd#SubsequentEventsNarrativeDetails" xlink:type="simple" />
    <link:calculationLink xlink:type="extended" xlink:role="http://pluristem.com/role/DocumentAndEntityInformation" xlink:title="00000001 - Document - Document and Entity Information" />
    <link:calculationLink xlink:type="extended" xlink:role="http://pluristem.com/role/ConsolidatedBalanceSheets" xlink:title="00000002 - Statement - CONSOLIDATED BALANCE SHEETS">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaapAssetsCurrent" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="loc_us-gaapAccountsReceivableNetCurrent" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapAccountsReceivableNetCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherAssetsCurrent" xlink:label="loc_us-gaapOtherAssetsCurrent" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapOtherAssetsCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaapRestrictedCashAndCashEquivalentsAtCarryingValue" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapRestrictedCashAndCashEquivalentsAtCarryingValue" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShortTermInvestments" xlink:label="loc_us-gaapShortTermInvestments" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapShortTermInvestments" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_MarketableSecuritiesCurrent" xlink:label="loc_us-gaapMarketableSecuritiesCurrent" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapMarketableSecuritiesCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AssetsNoncurrent" xlink:label="loc_us-gaapAssetsNoncurrent" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LongTermInvestments" xlink:label="loc_us-gaapLongTermInvestments" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsNoncurrent" xlink:to="loc_us-gaapLongTermInvestments" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent" xlink:label="loc_us-gaapDefinedBenefitPlanAssetsForPlanBenefitsNoncurrent" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsNoncurrent" xlink:to="loc_us-gaapDefinedBenefitPlanAssetsForPlanBenefitsNoncurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherAssetsNoncurrent" xlink:label="loc_us-gaapOtherAssetsNoncurrent" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsNoncurrent" xlink:to="loc_us-gaapOtherAssetsNoncurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaapPropertyPlantAndEquipmentNet" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsNoncurrent" xlink:to="loc_us-gaapPropertyPlantAndEquipmentNet" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_Assets" xlink:label="loc_us-gaapAssets" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapAssetsCurrent" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapAssetsNoncurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaapLiabilitiesCurrent" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccountsPayableCurrent" xlink:label="loc_us-gaapAccountsPayableCurrent" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapAccountsPayableCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="loc_us-gaapAccruedLiabilitiesCurrent" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapAccruedLiabilitiesCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccountsPayableOtherCurrent" xlink:label="loc_us-gaapAccountsPayableOtherCurrent" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapAccountsPayableOtherCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LiabilitiesNoncurrent" xlink:label="loc_us-gaapLiabilitiesNoncurrent" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PostemploymentBenefitsLiabilityNoncurrent" xlink:label="loc_us-gaapPostemploymentBenefitsLiabilityNoncurrent" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesNoncurrent" xlink:to="loc_us-gaapPostemploymentBenefitsLiabilityNoncurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent" xlink:label="loc_us-gaapOtherLiabilitiesNoncurrent" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesNoncurrent" xlink:to="loc_us-gaapOtherLiabilitiesNoncurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaapCommonStockValue" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapCommonStockValue" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaapRetainedEarningsAccumulatedDeficit" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapRetainedEarningsAccumulatedDeficit" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="loc_us-gaapAdditionalPaidInCapital" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapAdditionalPaidInCapital" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:label="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossNetOfTax" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquity" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaapLiabilitiesCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="loc_us-gaapCommitmentsAndContingencies" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaapCommitmentsAndContingencies" xlink:type="arc" weight="1" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaapLiabilitiesNoncurrent" xlink:type="arc" weight="1" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaapStockholdersEquity" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://pluristem.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:title="00000003 - Statement - CONSOLIDATED BALANCE SHEETS (PARENTHETICAL)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://pluristem.com/role/InterimCondensedConsolidatedStatementsOfOperations" xlink:title="00000004 - Statement - CONSOLIDATED STATEMENTS OF  OPERATIONS">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_GrossProfit" xlink:label="loc_us-gaapGrossProfit" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_Revenues" xlink:label="loc_us-gaapRevenues" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapGrossProfit" xlink:to="loc_us-gaapRevenues" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CostOfRevenue" xlink:label="loc_us-gaapCostOfRevenue" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapGrossProfit" xlink:to="loc_us-gaapCostOfRevenue" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_ResearchAndDevelopmentExpensesNet" xlink:label="loc_pstiResearchAndDevelopmentExpensesNet" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="loc_us-gaapResearchAndDevelopmentExpense" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_pstiResearchAndDevelopmentExpensesNet" xlink:to="loc_us-gaapResearchAndDevelopmentExpense" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_GovernmentAndThirdPartyGrantsReceived" xlink:label="loc_pstiGovernmentAndThirdPartyGrantsReceived" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_pstiResearchAndDevelopmentExpensesNet" xlink:to="loc_pstiGovernmentAndThirdPartyGrantsReceived" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaapOperatingIncomeLoss" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingIncomeLoss" xlink:to="loc_us-gaapGrossProfit" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingIncomeLoss" xlink:to="loc_pstiResearchAndDevelopmentExpensesNet" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="loc_us-gaapGeneralAndAdministrativeExpense" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingIncomeLoss" xlink:to="loc_us-gaapGeneralAndAdministrativeExpense" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetIncomeLoss" xlink:to="loc_us-gaapOperatingIncomeLoss" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="loc_us-gaapNonoperatingIncomeExpense" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetIncomeLoss" xlink:to="loc_us-gaapNonoperatingIncomeExpense" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://pluristem.com/role/ConsolidatedStatementsOfComprehensiveLoss" xlink:title="00000005 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE  LOSS">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:label="loc_us-gaapOtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax" xlink:label="loc_us-gaapOtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:to="loc_us-gaapOtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:label="loc_us-gaapOtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:to="loc_us-gaapOtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax" xlink:label="loc_us-gaapOtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:to="loc_us-gaapOtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax" xlink:label="loc_us-gaapOtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:to="loc_us-gaapOtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax" xlink:label="loc_us-gaapComprehensiveIncomeNetOfTax" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapComprehensiveIncomeNetOfTax" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapComprehensiveIncomeNetOfTax" xlink:to="loc_us-gaapOtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://pluristem.com/role/StatementsOfChangesInStockholdersEquity" xlink:title="00000006 - Statement - STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY" />
    <link:calculationLink xlink:type="extended" xlink:role="http://pluristem.com/role/StatementsOfChangesInStockholdersEquityParenthetical" xlink:title="00000007 - Statement - STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (Parenthetical)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://pluristem.com/role/ConsolidatedStatementsOfCashFlows" xlink:title="00000008 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_Depreciation" xlink:label="loc_us-gaapDepreciation" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapDepreciation" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:label="loc_us-gaapGainLossOnSaleOfPropertyPlantEquipment" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapGainLossOnSaleOfPropertyPlantEquipment" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_AmortizationOfDiscountAndPremiumAndChangesInAccruedInterestFromMarketableSecurities" xlink:label="loc_pstiAmortizationOfDiscountAndPremiumAndChangesInAccruedInterestFromMarketableSecurities" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_pstiAmortizationOfDiscountAndPremiumAndChangesInAccruedInterestFromMarketableSecurities" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_MarketableSecuritiesRealizedGainLoss" xlink:label="loc_us-gaapMarketableSecuritiesRealizedGainLoss" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapMarketableSecuritiesRealizedGainLoss" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherThanTemporaryImpairmentLossesInvestmentsPortionRecognizedInEarningsNet" xlink:label="loc_us-gaapOtherThanTemporaryImpairmentLossesInvestmentsPortionRecognizedInEarningsNet" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapOtherThanTemporaryImpairmentLossesInvestmentsPortionRecognizedInEarningsNet" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaapShareBasedCompensation" />
      <link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapShareBasedCompensation" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncreaseDecreaseInOtherReceivables" xlink:label="loc_us-gaapIncreaseDecreaseInOtherReceivables" />
      <link:calculationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInOtherReceivables" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:label="loc_us-gaapIncreaseDecreaseInOtherOperatingAssets" />
      <link:calculationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInOtherOperatingAssets" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsPayable" />
      <link:calculationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsPayable" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities" xlink:label="loc_us-gaapIncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities" />
      <link:calculationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:label="loc_us-gaapIncreaseDecreaseInDeferredRevenue" />
      <link:calculationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInDeferredRevenue" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncreaseDecreaseInCustomerAdvances" xlink:label="loc_us-gaapIncreaseDecreaseInCustomerAdvances" />
      <link:calculationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInCustomerAdvances" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedInterestReceivableNet" xlink:label="loc_us-gaapIncreaseDecreaseInAccruedInterestReceivableNet" />
      <link:calculationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInAccruedInterestReceivableNet" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_LinkageDifferencesAndInterestOnShortAndLongTermRestrictedLeaseDeposit" xlink:label="loc_pstiLinkageDifferencesAndInterestOnShortAndLongTermRestrictedLeaseDeposit" />
      <link:calculationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_pstiLinkageDifferencesAndInterestOnShortAndLongTermRestrictedLeaseDeposit" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncreaseDecreaseInPensionAndPostretirementObligations" xlink:label="loc_us-gaapIncreaseDecreaseInPensionAndPostretirementObligations" />
      <link:calculationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInPensionAndPostretirementObligations" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="loc_us-gaapPaymentsToAcquirePropertyPlantAndEquipment" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:to="loc_us-gaapPaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:label="loc_us-gaapProceedsFromSaleOfPropertyPlantAndEquipment" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:to="loc_us-gaapProceedsFromSaleOfPropertyPlantAndEquipment" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PaymentsForProceedsFromShortTermInvestments" xlink:label="loc_us-gaapPaymentsForProceedsFromShortTermInvestments" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:to="loc_us-gaapPaymentsForProceedsFromShortTermInvestments" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_RepaymentOfInvestmentInLongtermDepositsAndRestrictedBankDeposits" xlink:label="loc_pstiRepaymentOfInvestmentInLongtermDepositsAndRestrictedBankDeposits" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:to="loc_pstiRepaymentOfInvestmentInLongtermDepositsAndRestrictedBankDeposits" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ProceedsFromSaleOfAvailableForSaleSecurities" xlink:label="loc_us-gaapProceedsFromSaleOfAvailableForSaleSecurities" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:to="loc_us-gaapProceedsFromSaleOfAvailableForSaleSecurities" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities" xlink:label="loc_us-gaapProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:to="loc_us-gaapProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PaymentsToAcquireAvailableForSaleSecurities" xlink:label="loc_us-gaapPaymentsToAcquireAvailableForSaleSecurities" />
      <link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:to="loc_us-gaapPaymentsToAcquireAvailableForSaleSecurities" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="loc_us-gaapProceedsFromIssuanceOfCommonStock" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapProceedsFromIssuanceOfCommonStock" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:label="loc_us-gaapProceedsFromPaymentsForOtherFinancingActivities" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapProceedsFromPaymentsForOtherFinancingActivities" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:label="loc_us-gaapProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:label="loc_us-gaapCashAndCashEquivalentsPeriodIncreaseDecrease" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashAndCashEquivalentsPeriodIncreaseDecrease" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashAndCashEquivalentsPeriodIncreaseDecrease" xlink:to="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:type="arc" weight="1" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashAndCashEquivalentsPeriodIncreaseDecrease" xlink:to="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://pluristem.com/role/psti-g1" xlink:title="00000009 - Disclosure - GENERAL" />
    <link:calculationLink xlink:type="extended" xlink:role="http://pluristem.com/role/Disclosure-BASISOFPRESENTATIONANDSIGNIFICANTACCOUNTINGPOLICIES" xlink:title="00000010 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES" />
    <link:calculationLink xlink:type="extended" xlink:role="http://pluristem.com/role/psti-ms" xlink:title="00000011 - Disclosure - MARKETABLE SECURITIES" />
    <link:calculationLink xlink:type="extended" xlink:role="http://pluristem.com/role/psti-fvofi12" xlink:title="00000012 - Disclosure - FAIR VALUE OF FINANCIAL INSTRUMENTS" />
    <link:calculationLink xlink:type="extended" xlink:role="http://pluristem.com/role/OtherCurrentAssets" xlink:title="00000013 - Disclosure - OTHER CURRENT ASSETS" />
    <link:calculationLink xlink:type="extended" xlink:role="http://pluristem.com/role/PropertyAndEquipmentNet" xlink:title="00000014 - Disclosure - PROPERTY AND EQUIPMENT, NET" />
    <link:calculationLink xlink:type="extended" xlink:role="http://pluristem.com/role/OtherAccountsPayable" xlink:title="00000015 - Disclosure - OTHER ACCOUNTS PAYABLE" />
    <link:calculationLink xlink:type="extended" xlink:role="http://pluristem.com/role/psti-cac1" xlink:title="00000016 - Disclosure - COMMITMENTS AND CONTINGENCIES" />
    <link:calculationLink xlink:type="extended" xlink:role="http://pluristem.com/role/psti-se12" xlink:title="00000017 - Disclosure - STOCKHOLDERS' EQUITY" />
    <link:calculationLink xlink:type="extended" xlink:role="http://pluristem.com/role/FinancialIncomeNet" xlink:title="00000018 - Disclosure - FINANCIAL INCOME, NET" />
    <link:calculationLink xlink:type="extended" xlink:role="http://pluristem.com/role/TaxesOnIncome" xlink:title="00000019 - Disclosure - TAXES ON INCOME" />
    <link:calculationLink xlink:type="extended" xlink:role="http://pluristem.com/role/SubsequentEvents" xlink:title="00000020 - Disclosure - SUBSEQUENT EVENTS" />
    <link:calculationLink xlink:type="extended" xlink:role="http://pluristem.com/role/SignificantAccountingPoliciesPolicies" xlink:title="00000021 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Policies)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://pluristem.com/role/SignificantAccountingPoliciesTables" xlink:title="00000022 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://pluristem.com/role/psti-mst1" xlink:title="00000023 - Disclosure - MARKETABLE SECURITIES (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://pluristem.com/role/psti-fvofit1" xlink:title="00000024 - Disclosure - FAIR VALUE OF FINANCIAL INSTRUMENTS (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://pluristem.com/role/OtherCurrentAssetsTables" xlink:title="00000025 - Disclosure - OTHER CURRENT ASSETS (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://pluristem.com/role/PropertyAndEquipmentNetTables" xlink:title="00000026 - Disclosure - PROPERTY AND EQUIPMENT, NET (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://pluristem.com/role/OtherAccountsPayableTables" xlink:title="00000027 - Disclosure - OTHER ACCOUNTS PAYABLE (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://pluristem.com/role/CommitmentsAndContingenciesTables" xlink:title="00000028 - Disclosure - COMMITMENTS AND CONTINGENCIES (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://pluristem.com/role/Disclosure-STOCKHOLDERSEQUITYTables" xlink:title="00000029 - Disclosure - STOCKHOLDERS' EQUITY (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://pluristem.com/role/FinancialIncomeNetTables" xlink:title="00000030 - Disclosure - FINANCIAL INCOME, NET (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://pluristem.com/role/TaxesOnIncomeTables" xlink:title="00000031 - Disclosure - TAXES ON INCOME (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://pluristem.com/role/psti-gd" xlink:title="00000032 - Disclosure - GENERAL (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://pluristem.com/role/SignificantAccountingPoliciesNarrativeDetails" xlink:title="00000033 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Narrative) (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://pluristem.com/role/SignificantAccountingPoliciesScheduleOfPropertyAndEquipmentDepreciationRateDetails" xlink:title="00000034 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Schedule of Property and Equipment Depreciation Rate) (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://pluristem.com/role/Disclosure-BASISOFPRESENTATIONANDSIGNIFICANTACCOUNTINGPOLICIESComprehensiveIncomeDetails" xlink:title="00000035 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Comprehensive Income) (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:label="loc_us-gaapOtherComprehensiveIncomeLossNetOfTax" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:label="loc_us-gaapOtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOtherComprehensiveIncomeLossNetOfTax" xlink:to="loc_us-gaapOtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:label="loc_us-gaapReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOtherComprehensiveIncomeLossNetOfTax" xlink:to="loc_us-gaapReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:type="arc" weight="-1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://pluristem.com/role/psti-mssoamsd1" xlink:title="00000036 - Disclosure - MARKETABLE SECURITIES (Schedule of Available-for-sale Marketable Securities) (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AvailableForSaleSecuritiesAmortizedCost" xlink:label="loc_us-gaapAvailableForSaleSecuritiesAmortizedCost" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AvailableForSaleSecurities" xlink:label="loc_us-gaapAvailableForSaleSecurities" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAvailableForSaleSecuritiesAmortizedCost" xlink:to="loc_us-gaapAvailableForSaleSecurities" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:label="loc_us-gaapAvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedGainBeforeTax" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAvailableForSaleSecuritiesAmortizedCost" xlink:to="loc_us-gaapAvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:label="loc_us-gaapAvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedLossBeforeTax" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAvailableForSaleSecuritiesAmortizedCost" xlink:to="loc_us-gaapAvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_OtherthantemporaryImpairment" xlink:label="loc_pstiOtherthantemporaryImpairment" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAvailableForSaleSecuritiesAmortizedCost" xlink:to="loc_pstiOtherthantemporaryImpairment" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://pluristem.com/role/psti-mssoiiuld" xlink:title="00000037 - Disclosure - MARKETABLE SECURITIES (Schedule of Investments in Unrealized Loss) (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://pluristem.com/role/psti-fvofisofvofid1" xlink:title="00000038 - Disclosure - FAIR VALUE OF FINANCIAL INSTRUMENTS (Schedule of Fair Value of Financial Instruments) (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueNetAssetLiability" xlink:label="loc_us-gaapFairValueNetAssetLiability" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_MarketableSecuritiesCurrent" xlink:label="loc_us-gaapMarketableSecuritiesCurrent" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapFairValueNetAssetLiability" xlink:to="loc_us-gaapMarketableSecuritiesCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet" xlink:label="loc_us-gaapDerivativeAssetsLiabilitiesAtFairValueNet" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapFairValueNetAssetLiability" xlink:to="loc_us-gaapDerivativeAssetsLiabilitiesAtFairValueNet" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://pluristem.com/role/OtherCurrentAssetsDetails" xlink:title="00000039 - Disclosure - OTHER CURRENT ASSETS (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherAssetsCurrent" xlink:label="loc_us-gaapOtherAssetsCurrent" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PrepaidExpenseCurrent" xlink:label="loc_us-gaapPrepaidExpenseCurrent" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOtherAssetsCurrent" xlink:to="loc_us-gaapPrepaidExpenseCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_AccountsReceivableFromMinistryOfEconomyCurrent" xlink:label="loc_pstiAccountsReceivableFromMinistryOfEconomyCurrent" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOtherAssetsCurrent" xlink:to="loc_pstiAccountsReceivableFromMinistryOfEconomyCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CashFlowHedgesDerivativeInstrumentsAtFairValueNet" xlink:label="loc_us-gaapCashFlowHedgesDerivativeInstrumentsAtFairValueNet" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOtherAssetsCurrent" xlink:to="loc_us-gaapCashFlowHedgesDerivativeInstrumentsAtFairValueNet" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue" xlink:label="loc_us-gaapDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOtherAssetsCurrent" xlink:to="loc_us-gaapDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ValueAddedTaxReceivableCurrent" xlink:label="loc_us-gaapValueAddedTaxReceivableCurrent" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOtherAssetsCurrent" xlink:to="loc_us-gaapValueAddedTaxReceivableCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherReceivablesNetCurrent" xlink:label="loc_us-gaapOtherReceivablesNetCurrent" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOtherAssetsCurrent" xlink:to="loc_us-gaapOtherReceivablesNetCurrent" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://pluristem.com/role/PropertyAndEquipmentNetDetails" xlink:title="00000040 - Disclosure - PROPERTY AND EQUIPMENT, NET (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaapPropertyPlantAndEquipmentNet" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="loc_us-gaapPropertyPlantAndEquipmentGross" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapPropertyPlantAndEquipmentNet" xlink:to="loc_us-gaapPropertyPlantAndEquipmentGross" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="loc_us-gaapAccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapPropertyPlantAndEquipmentNet" xlink:to="loc_us-gaapAccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:type="arc" weight="-1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://pluristem.com/role/OtherAccountsPayableDetails" xlink:title="00000041 - Disclosure - OTHER ACCOUNTS PAYABLE (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccountsPayableOtherCurrent" xlink:label="loc_us-gaapAccountsPayableOtherCurrent" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:label="loc_us-gaapEmployeeRelatedLiabilitiesCurrent" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAccountsPayableOtherCurrent" xlink:to="loc_us-gaapEmployeeRelatedLiabilitiesCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_OtherAccountsPayablePayrollInstitutions" xlink:label="loc_pstiOtherAccountsPayablePayrollInstitutions" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAccountsPayableOtherCurrent" xlink:to="loc_pstiOtherAccountsPayablePayrollInstitutions" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccruedVacationCurrent" xlink:label="loc_us-gaapAccruedVacationCurrent" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAccountsPayableOtherCurrent" xlink:to="loc_us-gaapAccruedVacationCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DerivativeLiabilitiesCurrent" xlink:label="loc_us-gaapDerivativeLiabilitiesCurrent" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAccountsPayableOtherCurrent" xlink:to="loc_us-gaapDerivativeLiabilitiesCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DeferredRentCreditCurrent" xlink:label="loc_us-gaapDeferredRentCreditCurrent" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAccountsPayableOtherCurrent" xlink:to="loc_us-gaapDeferredRentCreditCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent" xlink:label="loc_us-gaapOtherAccruedLiabilitiesCurrent" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAccountsPayableOtherCurrent" xlink:to="loc_us-gaapOtherAccruedLiabilitiesCurrent" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://pluristem.com/role/CommitmentsAndContingenciesOperatingLeaseDetails" xlink:title="00000042 - Disclosure - COMMITMENTS AND CONTINGENCIES (Operating Lease) (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDue" xlink:label="loc_us-gaapOperatingLeasesFutureMinimumPaymentsDue" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears" xlink:label="loc_us-gaapOperatingLeasesFutureMinimumPaymentsDueInTwoYears" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingLeasesFutureMinimumPaymentsDue" xlink:to="loc_us-gaapOperatingLeasesFutureMinimumPaymentsDueInTwoYears" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears" xlink:label="loc_us-gaapOperatingLeasesFutureMinimumPaymentsDueInThreeYears" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingLeasesFutureMinimumPaymentsDue" xlink:to="loc_us-gaapOperatingLeasesFutureMinimumPaymentsDueInThreeYears" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears" xlink:label="loc_us-gaapOperatingLeasesFutureMinimumPaymentsDueInFourYears" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingLeasesFutureMinimumPaymentsDue" xlink:to="loc_us-gaapOperatingLeasesFutureMinimumPaymentsDueInFourYears" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent" xlink:label="loc_us-gaapOperatingLeasesFutureMinimumPaymentsDueCurrent" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingLeasesFutureMinimumPaymentsDue" xlink:to="loc_us-gaapOperatingLeasesFutureMinimumPaymentsDueCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears" xlink:label="loc_us-gaapOperatingLeasesFutureMinimumPaymentsDueInFiveYears" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingLeasesFutureMinimumPaymentsDue" xlink:to="loc_us-gaapOperatingLeasesFutureMinimumPaymentsDueInFiveYears" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://pluristem.com/role/CommitmentsAndContingenciesOtherDetails" xlink:title="00000043 - Disclosure - COMMITMENTS AND CONTINGENCIES (Other) (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://pluristem.com/role/psti-send1" xlink:title="00000044 - Disclosure - STOCKHOLDERS' EQUITY (Narrative) (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://pluristem.com/role/StockholdersEquitySummaryOfOptionActivityDetails" xlink:title="00000045 - Disclosure - STOCKHOLDERS' EQUITY (Summary of Option Activity) (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://pluristem.com/role/StockholdersEquitySummaryOfOptionActivityToNon-employeeConsultantsDetails" xlink:title="00000046 - Disclosure - STOCKHOLDERS' EQUITY (Summary of Option Activity to Non-employee Consultants) (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://pluristem.com/role/psti-sesoced1" xlink:title="00000047 - Disclosure - STOCKHOLDERS' EQUITY (Schedule of Compensation Expense) (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://pluristem.com/role/psti-sesorateadd1" xlink:title="00000048 - Disclosure - STOCKHOLDERS' EQUITY (Summary of RSU Activity to Employees and Directors) (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://pluristem.com/role/psti-sesoratcd1" xlink:title="00000049 - Disclosure - STOCKHOLDERS' EQUITY (Summary of RSU Activity to Consultants) (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://pluristem.com/role/StockholdersEquitySummaryOfWarrantsAndOptionsDetails" xlink:title="00000050 - Disclosure - STOCKHOLDERS' EQUITY (Summary of Warrants and Options) (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://pluristem.com/role/FinancialIncomeNetDetails" xlink:title="00000051 - Disclosure - FINANCIAL INCOME, NET (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="loc_us-gaapNonoperatingIncomeExpense" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:label="loc_us-gaapForeignCurrencyTransactionGainLossBeforeTax" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNonoperatingIncomeExpense" xlink:to="loc_us-gaapForeignCurrencyTransactionGainLossBeforeTax" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_InterestOnShortTermBankCreditAndBankExpenses" xlink:label="loc_pstiInterestOnShortTermBankCreditAndBankExpenses" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNonoperatingIncomeExpense" xlink:to="loc_pstiInterestOnShortTermBankCreditAndBankExpenses" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_InterestIncomeDepositsWithFinancialInstitutions" xlink:label="loc_us-gaapInterestIncomeDepositsWithFinancialInstitutions" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNonoperatingIncomeExpense" xlink:to="loc_us-gaapInterestIncomeDepositsWithFinancialInstitutions" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_MarketableSecuritiesGainLoss" xlink:label="loc_us-gaapMarketableSecuritiesGainLoss" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNonoperatingIncomeExpense" xlink:to="loc_us-gaapMarketableSecuritiesGainLoss" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_GainLossOnDerivativeInstrumentsNetPretax" xlink:label="loc_us-gaapGainLossOnDerivativeInstrumentsNetPretax" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNonoperatingIncomeExpense" xlink:to="loc_us-gaapGainLossOnDerivativeInstrumentsNetPretax" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherNonoperatingIncome" xlink:label="loc_us-gaapOtherNonoperatingIncome" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNonoperatingIncomeExpense" xlink:to="loc_us-gaapOtherNonoperatingIncome" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://pluristem.com/role/TaxesOnIncomeNarrativeDetails" xlink:title="00000052 - Disclosure - TAXES ON INCOME (Narrative) (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://pluristem.com/role/TaxesOnIncomeScheduleOfSignificantComponentsOfDeferredTaxAssetsDetails" xlink:title="00000053 - Disclosure - TAXES ON INCOME (Schedule of Significant Components of Deferred Tax Assets) (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DeferredTaxAssetsGross" xlink:label="loc_us-gaapDeferredTaxAssetsGross" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic" xlink:label="loc_us-gaapDeferredTaxAssetsOperatingLossCarryforwardsDomestic" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredTaxAssetsGross" xlink:to="loc_us-gaapDeferredTaxAssetsOperatingLossCarryforwardsDomestic" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign" xlink:label="loc_us-gaapDeferredTaxAssetsOperatingLossCarryforwardsForeign" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredTaxAssetsGross" xlink:to="loc_us-gaapDeferredTaxAssetsOperatingLossCarryforwardsForeign" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals" xlink:label="loc_us-gaapDeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredTaxAssetsGross" xlink:to="loc_us-gaapDeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DeferredTaxAssetsNet" xlink:label="loc_us-gaapDeferredTaxAssetsNet" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredTaxAssetsNet" xlink:to="loc_us-gaapDeferredTaxAssetsGross" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="loc_us-gaapDeferredTaxAssetsValuationAllowance" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredTaxAssetsNet" xlink:to="loc_us-gaapDeferredTaxAssetsValuationAllowance" xlink:type="arc" weight="-1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://pluristem.com/role/SubsequentEventsNarrativeDetails" xlink:title="00000054 - Disclosure - SUBSEQUENT EVENTS (Narrative) (Details)" />
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>14
<FILENAME>psti-20170630_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoXBRL; Version: 4.19b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: http://www.novaworks.co -->
    <!-- Field: Doc-Info; Name: Source; Value: psti%2D0617 10K Steve Fix.xfr; Date: 2017%2D09%2D07T12:28:18Z -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x800B0001 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://pluristem.com/role/DocumentAndEntityInformation" xlink:href="psti-20170630.xsd#DocumentAndEntityInformation" xlink:type="simple" />
    <link:roleRef roleURI="http://pluristem.com/role/ConsolidatedBalanceSheets" xlink:href="psti-20170630.xsd#ConsolidatedBalanceSheets" xlink:type="simple" />
    <link:roleRef roleURI="http://pluristem.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:href="psti-20170630.xsd#ConsolidatedBalanceSheetsParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://pluristem.com/role/InterimCondensedConsolidatedStatementsOfOperations" xlink:href="psti-20170630.xsd#InterimCondensedConsolidatedStatementsOfOperations" xlink:type="simple" />
    <link:roleRef roleURI="http://pluristem.com/role/ConsolidatedStatementsOfComprehensiveLoss" xlink:href="psti-20170630.xsd#ConsolidatedStatementsOfComprehensiveLoss" xlink:type="simple" />
    <link:roleRef roleURI="http://pluristem.com/role/StatementsOfChangesInStockholdersEquity" xlink:href="psti-20170630.xsd#StatementsOfChangesInStockholdersEquity" xlink:type="simple" />
    <link:roleRef roleURI="http://pluristem.com/role/StatementsOfChangesInStockholdersEquityParenthetical" xlink:href="psti-20170630.xsd#StatementsOfChangesInStockholdersEquityParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://pluristem.com/role/ConsolidatedStatementsOfCashFlows" xlink:href="psti-20170630.xsd#ConsolidatedStatementsOfCashFlows" xlink:type="simple" />
    <link:roleRef roleURI="http://pluristem.com/role/psti-g1" xlink:href="psti-20170630.xsd#psti-g1" xlink:type="simple" />
    <link:roleRef roleURI="http://pluristem.com/role/Disclosure-BASISOFPRESENTATIONANDSIGNIFICANTACCOUNTINGPOLICIES" xlink:href="psti-20170630.xsd#Disclosure-BASISOFPRESENTATIONANDSIGNIFICANTACCOUNTINGPOLICIES" xlink:type="simple" />
    <link:roleRef roleURI="http://pluristem.com/role/psti-ms" xlink:href="psti-20170630.xsd#psti-ms" xlink:type="simple" />
    <link:roleRef roleURI="http://pluristem.com/role/psti-fvofi12" xlink:href="psti-20170630.xsd#psti-fvofi12" xlink:type="simple" />
    <link:roleRef roleURI="http://pluristem.com/role/OtherCurrentAssets" xlink:href="psti-20170630.xsd#OtherCurrentAssets" xlink:type="simple" />
    <link:roleRef roleURI="http://pluristem.com/role/PropertyAndEquipmentNet" xlink:href="psti-20170630.xsd#PropertyAndEquipmentNet" xlink:type="simple" />
    <link:roleRef roleURI="http://pluristem.com/role/OtherAccountsPayable" xlink:href="psti-20170630.xsd#OtherAccountsPayable" xlink:type="simple" />
    <link:roleRef roleURI="http://pluristem.com/role/psti-cac1" xlink:href="psti-20170630.xsd#psti-cac1" xlink:type="simple" />
    <link:roleRef roleURI="http://pluristem.com/role/psti-se12" xlink:href="psti-20170630.xsd#psti-se12" xlink:type="simple" />
    <link:roleRef roleURI="http://pluristem.com/role/FinancialIncomeNet" xlink:href="psti-20170630.xsd#FinancialIncomeNet" xlink:type="simple" />
    <link:roleRef roleURI="http://pluristem.com/role/TaxesOnIncome" xlink:href="psti-20170630.xsd#TaxesOnIncome" xlink:type="simple" />
    <link:roleRef roleURI="http://pluristem.com/role/SubsequentEvents" xlink:href="psti-20170630.xsd#SubsequentEvents" xlink:type="simple" />
    <link:roleRef roleURI="http://pluristem.com/role/SignificantAccountingPoliciesPolicies" xlink:href="psti-20170630.xsd#SignificantAccountingPoliciesPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://pluristem.com/role/SignificantAccountingPoliciesTables" xlink:href="psti-20170630.xsd#SignificantAccountingPoliciesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://pluristem.com/role/psti-mst1" xlink:href="psti-20170630.xsd#psti-mst1" xlink:type="simple" />
    <link:roleRef roleURI="http://pluristem.com/role/psti-fvofit1" xlink:href="psti-20170630.xsd#psti-fvofit1" xlink:type="simple" />
    <link:roleRef roleURI="http://pluristem.com/role/OtherCurrentAssetsTables" xlink:href="psti-20170630.xsd#OtherCurrentAssetsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://pluristem.com/role/PropertyAndEquipmentNetTables" xlink:href="psti-20170630.xsd#PropertyAndEquipmentNetTables" xlink:type="simple" />
    <link:roleRef roleURI="http://pluristem.com/role/OtherAccountsPayableTables" xlink:href="psti-20170630.xsd#OtherAccountsPayableTables" xlink:type="simple" />
    <link:roleRef roleURI="http://pluristem.com/role/CommitmentsAndContingenciesTables" xlink:href="psti-20170630.xsd#CommitmentsAndContingenciesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://pluristem.com/role/Disclosure-STOCKHOLDERSEQUITYTables" xlink:href="psti-20170630.xsd#Disclosure-STOCKHOLDERSEQUITYTables" xlink:type="simple" />
    <link:roleRef roleURI="http://pluristem.com/role/FinancialIncomeNetTables" xlink:href="psti-20170630.xsd#FinancialIncomeNetTables" xlink:type="simple" />
    <link:roleRef roleURI="http://pluristem.com/role/TaxesOnIncomeTables" xlink:href="psti-20170630.xsd#TaxesOnIncomeTables" xlink:type="simple" />
    <link:roleRef roleURI="http://pluristem.com/role/psti-gd" xlink:href="psti-20170630.xsd#psti-gd" xlink:type="simple" />
    <link:roleRef roleURI="http://pluristem.com/role/SignificantAccountingPoliciesNarrativeDetails" xlink:href="psti-20170630.xsd#SignificantAccountingPoliciesNarrativeDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://pluristem.com/role/SignificantAccountingPoliciesScheduleOfPropertyAndEquipmentDepreciationRateDetails" xlink:href="psti-20170630.xsd#SignificantAccountingPoliciesScheduleOfPropertyAndEquipmentDepreciationRateDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://pluristem.com/role/Disclosure-BASISOFPRESENTATIONANDSIGNIFICANTACCOUNTINGPOLICIESComprehensiveIncomeDetails" xlink:href="psti-20170630.xsd#Disclosure-BASISOFPRESENTATIONANDSIGNIFICANTACCOUNTINGPOLICIESComprehensiveIncomeDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://pluristem.com/role/psti-mssoamsd1" xlink:href="psti-20170630.xsd#psti-mssoamsd1" xlink:type="simple" />
    <link:roleRef roleURI="http://pluristem.com/role/psti-mssoiiuld" xlink:href="psti-20170630.xsd#psti-mssoiiuld" xlink:type="simple" />
    <link:roleRef roleURI="http://pluristem.com/role/psti-fvofisofvofid1" xlink:href="psti-20170630.xsd#psti-fvofisofvofid1" xlink:type="simple" />
    <link:roleRef roleURI="http://pluristem.com/role/OtherCurrentAssetsDetails" xlink:href="psti-20170630.xsd#OtherCurrentAssetsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://pluristem.com/role/PropertyAndEquipmentNetDetails" xlink:href="psti-20170630.xsd#PropertyAndEquipmentNetDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://pluristem.com/role/OtherAccountsPayableDetails" xlink:href="psti-20170630.xsd#OtherAccountsPayableDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://pluristem.com/role/CommitmentsAndContingenciesOperatingLeaseDetails" xlink:href="psti-20170630.xsd#CommitmentsAndContingenciesOperatingLeaseDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://pluristem.com/role/CommitmentsAndContingenciesOtherDetails" xlink:href="psti-20170630.xsd#CommitmentsAndContingenciesOtherDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://pluristem.com/role/psti-send1" xlink:href="psti-20170630.xsd#psti-send1" xlink:type="simple" />
    <link:roleRef roleURI="http://pluristem.com/role/StockholdersEquitySummaryOfOptionActivityDetails" xlink:href="psti-20170630.xsd#StockholdersEquitySummaryOfOptionActivityDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://pluristem.com/role/StockholdersEquitySummaryOfOptionActivityToNon-employeeConsultantsDetails" xlink:href="psti-20170630.xsd#StockholdersEquitySummaryOfOptionActivityToNon-employeeConsultantsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://pluristem.com/role/psti-sesoced1" xlink:href="psti-20170630.xsd#psti-sesoced1" xlink:type="simple" />
    <link:roleRef roleURI="http://pluristem.com/role/psti-sesorateadd1" xlink:href="psti-20170630.xsd#psti-sesorateadd1" xlink:type="simple" />
    <link:roleRef roleURI="http://pluristem.com/role/psti-sesoratcd1" xlink:href="psti-20170630.xsd#psti-sesoratcd1" xlink:type="simple" />
    <link:roleRef roleURI="http://pluristem.com/role/StockholdersEquitySummaryOfWarrantsAndOptionsDetails" xlink:href="psti-20170630.xsd#StockholdersEquitySummaryOfWarrantsAndOptionsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://pluristem.com/role/FinancialIncomeNetDetails" xlink:href="psti-20170630.xsd#FinancialIncomeNetDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://pluristem.com/role/TaxesOnIncomeNarrativeDetails" xlink:href="psti-20170630.xsd#TaxesOnIncomeNarrativeDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://pluristem.com/role/TaxesOnIncomeScheduleOfSignificantComponentsOfDeferredTaxAssetsDetails" xlink:href="psti-20170630.xsd#TaxesOnIncomeScheduleOfSignificantComponentsOfDeferredTaxAssetsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://pluristem.com/role/SubsequentEventsNarrativeDetails" xlink:href="psti-20170630.xsd#SubsequentEventsNarrativeDetails" xlink:type="simple" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" arcroleURI="http://xbrl.org/int/dim/arcrole/all" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#notAll" arcroleURI="http://xbrl.org/int/dim/arcrole/notAll" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" />
    <link:definitionLink xlink:type="extended" xlink:role="http://pluristem.com/role/DocumentAndEntityInformation" xlink:title="00000001 - Document - Document and Entity Information" />
    <link:definitionLink xlink:type="extended" xlink:role="http://pluristem.com/role/ConsolidatedBalanceSheets" xlink:title="00000002 - Statement - CONSOLIDATED BALANCE SHEETS" />
    <link:definitionLink xlink:type="extended" xlink:role="http://pluristem.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:title="00000003 - Statement - CONSOLIDATED BALANCE SHEETS (PARENTHETICAL)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://pluristem.com/role/InterimCondensedConsolidatedStatementsOfOperations" xlink:title="00000004 - Statement - CONSOLIDATED STATEMENTS OF  OPERATIONS" />
    <link:definitionLink xlink:type="extended" xlink:role="http://pluristem.com/role/ConsolidatedStatementsOfComprehensiveLoss" xlink:title="00000005 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE  LOSS" />
    <link:definitionLink xlink:type="extended" xlink:role="http://pluristem.com/role/StatementsOfChangesInStockholdersEquity" xlink:title="00000006 - Statement - STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapCommonStockMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="loc_us-gaapAdditionalPaidInCapitalMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapAdditionalPaidInCapitalMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ReceivablesFromStockholderMember" xlink:label="loc_us-gaapReceivablesFromStockholderMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapReceivablesFromStockholderMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:label="loc_us-gaapAccumulatedOtherComprehensiveIncomeMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapAccumulatedOtherComprehensiveIncomeMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RetainedEarningsMember" xlink:label="loc_us-gaapRetainedEarningsMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapRetainedEarningsMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockholdersEquity_70" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaapCommonStockSharesOutstanding_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockSharesOutstanding_70" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueNewIssues_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueNewIssues_70" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues_70" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_ExerciseOfOptionsByEmployees" xlink:label="loc_pstiExerciseOfOptionsByEmployees_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_pstiExerciseOfOptionsByEmployees_70" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_ExerciseOfOptionsByEmployeesShares" xlink:label="loc_pstiExerciseOfOptionsByEmployeesShares_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_pstiExerciseOfOptionsByEmployeesShares_70" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueStockOptionsExercised_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueStockOptionsExercised_70" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesStockOptionsExercised_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesStockOptionsExercised_70" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_StockIssuedDuringPeriodValueStockWarrantsExercised" xlink:label="loc_pstiStockIssuedDuringPeriodValueStockWarrantsExercised_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_pstiStockIssuedDuringPeriodValueStockWarrantsExercised_70" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_StockIssuedDuringPeriodSharesStockWarrantsExercised" xlink:label="loc_pstiStockIssuedDuringPeriodSharesStockWarrantsExercised_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_pstiStockIssuedDuringPeriodSharesStockWarrantsExercised_70" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueShareBasedCompensation_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueShareBasedCompensation_70" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesShareBasedCompensation_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesShareBasedCompensation_70" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_StockIssuedDuringPeriodValuePrivatePlacement" xlink:label="loc_pstiStockIssuedDuringPeriodValuePrivatePlacement_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_pstiStockIssuedDuringPeriodValuePrivatePlacement_70" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_StockIssuedDuringPeriodSharesPrivatePlacement" xlink:label="loc_pstiStockIssuedDuringPeriodSharesPrivatePlacement_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_pstiStockIssuedDuringPeriodSharesPrivatePlacement_70" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueIssuedForServices" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueIssuedForServices_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueIssuedForServices_70" xlink:type="arc" order="15" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesIssuedForServices_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesIssuedForServices_70" xlink:type="arc" order="16" />
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_IssuanceOfCommonStockAndWarrantsRelatedToJanuaryTwentySeventeenOfferingNetOfIssuanceCostsValue" xlink:label="loc_pstiIssuanceOfCommonStockAndWarrantsRelatedToJanuaryTwentySeventeenOfferingNetOfIssuanceCostsValue_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_pstiIssuanceOfCommonStockAndWarrantsRelatedToJanuaryTwentySeventeenOfferingNetOfIssuanceCostsValue_70" xlink:type="arc" order="17" />
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_IssuanceOfCommonStockAndWarrantsRelatedToJanuaryTwentySeventeenOfferingNetOfIssuanceCostsShares" xlink:label="loc_pstiIssuanceOfCommonStockAndWarrantsRelatedToJanuaryTwentySeventeenOfferingNetOfIssuanceCostsShares_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_pstiIssuanceOfCommonStockAndWarrantsRelatedToJanuaryTwentySeventeenOfferingNetOfIssuanceCostsShares_70" xlink:type="arc" order="18" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:label="loc_us-gaapOtherComprehensiveIncomeLossNetOfTax_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapOtherComprehensiveIncomeLossNetOfTax_70" xlink:type="arc" order="19" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNetIncomeLoss_70" xlink:type="arc" order="20" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://pluristem.com/role/StatementsOfChangesInStockholdersEquityParenthetical" xlink:title="00000007 - Statement - STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (Parenthetical)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://pluristem.com/role/ConsolidatedStatementsOfCashFlows" xlink:title="00000008 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS" />
    <link:definitionLink xlink:type="extended" xlink:role="http://pluristem.com/role/psti-g1" xlink:title="00000009 - Disclosure - GENERAL" />
    <link:definitionLink xlink:type="extended" xlink:role="http://pluristem.com/role/Disclosure-BASISOFPRESENTATIONANDSIGNIFICANTACCOUNTINGPOLICIES" xlink:title="00000010 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES" />
    <link:definitionLink xlink:type="extended" xlink:role="http://pluristem.com/role/psti-ms" xlink:title="00000011 - Disclosure - MARKETABLE SECURITIES" />
    <link:definitionLink xlink:type="extended" xlink:role="http://pluristem.com/role/psti-fvofi12" xlink:title="00000012 - Disclosure - FAIR VALUE OF FINANCIAL INSTRUMENTS" />
    <link:definitionLink xlink:type="extended" xlink:role="http://pluristem.com/role/OtherCurrentAssets" xlink:title="00000013 - Disclosure - OTHER CURRENT ASSETS" />
    <link:definitionLink xlink:type="extended" xlink:role="http://pluristem.com/role/PropertyAndEquipmentNet" xlink:title="00000014 - Disclosure - PROPERTY AND EQUIPMENT, NET" />
    <link:definitionLink xlink:type="extended" xlink:role="http://pluristem.com/role/OtherAccountsPayable" xlink:title="00000015 - Disclosure - OTHER ACCOUNTS PAYABLE" />
    <link:definitionLink xlink:type="extended" xlink:role="http://pluristem.com/role/psti-cac1" xlink:title="00000016 - Disclosure - COMMITMENTS AND CONTINGENCIES" />
    <link:definitionLink xlink:type="extended" xlink:role="http://pluristem.com/role/psti-se12" xlink:title="00000017 - Disclosure - STOCKHOLDERS' EQUITY" />
    <link:definitionLink xlink:type="extended" xlink:role="http://pluristem.com/role/FinancialIncomeNet" xlink:title="00000018 - Disclosure - FINANCIAL INCOME, NET" />
    <link:definitionLink xlink:type="extended" xlink:role="http://pluristem.com/role/TaxesOnIncome" xlink:title="00000019 - Disclosure - TAXES ON INCOME" />
    <link:definitionLink xlink:type="extended" xlink:role="http://pluristem.com/role/SubsequentEvents" xlink:title="00000020 - Disclosure - SUBSEQUENT EVENTS" />
    <link:definitionLink xlink:type="extended" xlink:role="http://pluristem.com/role/SignificantAccountingPoliciesPolicies" xlink:title="00000021 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Policies)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://pluristem.com/role/SignificantAccountingPoliciesTables" xlink:title="00000022 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://pluristem.com/role/psti-mst1" xlink:title="00000023 - Disclosure - MARKETABLE SECURITIES (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://pluristem.com/role/psti-fvofit1" xlink:title="00000024 - Disclosure - FAIR VALUE OF FINANCIAL INSTRUMENTS (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://pluristem.com/role/OtherCurrentAssetsTables" xlink:title="00000025 - Disclosure - OTHER CURRENT ASSETS (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://pluristem.com/role/PropertyAndEquipmentNetTables" xlink:title="00000026 - Disclosure - PROPERTY AND EQUIPMENT, NET (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://pluristem.com/role/OtherAccountsPayableTables" xlink:title="00000027 - Disclosure - OTHER ACCOUNTS PAYABLE (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://pluristem.com/role/CommitmentsAndContingenciesTables" xlink:title="00000028 - Disclosure - COMMITMENTS AND CONTINGENCIES (Tables)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LongTermPurchaseCommitmentLineItems" xlink:label="loc_us-gaapLongTermPurchaseCommitmentLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LongTermPurchaseCommitmentTable" xlink:label="loc_us-gaapLongTermPurchaseCommitmentTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapLongTermPurchaseCommitmentLineItems" xlink:to="loc_us-gaapLongTermPurchaseCommitmentTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapLongTermPurchaseCommitmentTable" xlink:to="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LandAndBuildingMember" xlink:label="loc_us-gaapLandAndBuildingMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapLandAndBuildingMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AutomobilesMember" xlink:label="loc_us-gaapAutomobilesMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapAutomobilesMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock" xlink:label="loc_us-gaapScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLongTermPurchaseCommitmentLineItems" xlink:to="loc_us-gaapScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock_30" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_UnrecordedUnconditionalPurchaseObligationsDisclosureTextBlock" xlink:label="loc_us-gaapUnrecordedUnconditionalPurchaseObligationsDisclosureTextBlock_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLongTermPurchaseCommitmentLineItems" xlink:to="loc_us-gaapUnrecordedUnconditionalPurchaseObligationsDisclosureTextBlock_30" xlink:type="arc" order="1" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://pluristem.com/role/Disclosure-STOCKHOLDERSEQUITYTables" xlink:title="00000029 - Disclosure - STOCKHOLDERS' EQUITY (Tables)">
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_StockholdersEquityNoteLineItems" xlink:label="loc_pstiStockholdersEquityNoteLineItems" />
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_StockholdersEquityNoteTable" xlink:label="loc_pstiStockholdersEquityNoteTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_pstiStockholdersEquityNoteLineItems" xlink:to="loc_pstiStockholdersEquityNoteTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TitleOfIndividualAxis" xlink:label="loc_us-gaapTitleOfIndividualAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_pstiStockholdersEquityNoteTable" xlink:to="loc_us-gaapTitleOfIndividualAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_us-gaapTitleOfIndividualWithRelationshipToEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapTitleOfIndividualAxis" xlink:to="loc_us-gaapTitleOfIndividualWithRelationshipToEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_us-gaapTitleOfIndividualWithRelationshipToEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapTitleOfIndividualAxis" xlink:to="loc_us-gaapTitleOfIndividualWithRelationshipToEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_EmployeesAndDirectorsMember" xlink:label="loc_pstiEmployeesAndDirectorsMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_pstiEmployeesAndDirectorsMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_NonemployeesMember" xlink:label="loc_pstiNonemployeesMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_pstiNonemployeesMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaapAwardTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_pstiStockholdersEquityNoteTable" xlink:to="loc_us-gaapAwardTypeAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="loc_us-gaapRestrictedStockUnitsRSUMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaapRestrictedStockUnitsRSUMember_10" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock" xlink:label="loc_us-gaapScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_pstiStockholdersEquityNoteLineItems" xlink:to="loc_us-gaapScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock_60" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:label="loc_us-gaapScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_pstiStockholdersEquityNoteLineItems" xlink:to="loc_us-gaapScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_60" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:label="loc_us-gaapScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_pstiStockholdersEquityNoteLineItems" xlink:to="loc_us-gaapScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_60" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock" xlink:label="loc_us-gaapScheduleOfShareBasedCompensationActivityTableTextBlock_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_pstiStockholdersEquityNoteLineItems" xlink:to="loc_us-gaapScheduleOfShareBasedCompensationActivityTableTextBlock_60" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock" xlink:label="loc_us-gaapScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_pstiStockholdersEquityNoteLineItems" xlink:to="loc_us-gaapScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock_60" xlink:type="arc" order="4" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://pluristem.com/role/FinancialIncomeNetTables" xlink:title="00000030 - Disclosure - FINANCIAL INCOME, NET (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://pluristem.com/role/TaxesOnIncomeTables" xlink:title="00000031 - Disclosure - TAXES ON INCOME (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://pluristem.com/role/psti-gd" xlink:title="00000032 - Disclosure - GENERAL (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://pluristem.com/role/SignificantAccountingPoliciesNarrativeDetails" xlink:title="00000033 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Narrative) (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CurrencyAxis" xlink:label="loc_us-gaapCurrencyAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapCurrencyAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/currency/2017/currency-2017-01-31.xsd#currency_AllCurrenciesDomain" xlink:label="loc_currencyAllCurrenciesDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapCurrencyAxis" xlink:to="loc_currencyAllCurrenciesDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/currency/2017/currency-2017-01-31.xsd#currency_AllCurrenciesDomain" xlink:label="loc_currencyAllCurrenciesDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapCurrencyAxis" xlink:to="loc_currencyAllCurrenciesDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/currency/2017/currency-2017-01-31.xsd#currency_EUR" xlink:label="loc_currencyEUR_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_currencyAllCurrenciesDomain" xlink:to="loc_currencyEUR_70" xlink:type="arc" order="71" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaapAwardTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapAwardTypeAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherThanTemporaryImpairmentLossesInvestmentsPortionRecognizedInEarningsNet" xlink:label="loc_us-gaapOtherThanTemporaryImpairmentLossesInvestmentsPortionRecognizedInEarningsNet_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapOtherThanTemporaryImpairmentLossesInvestmentsPortionRecognizedInEarningsNet_90" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_NonrefundableAdvanceUnderTermsOfLicenseAgreement" xlink:label="loc_pstiNonrefundableAdvanceUnderTermsOfLicenseAgreement_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_pstiNonrefundableAdvanceUnderTermsOfLicenseAgreement_90" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_BusinessCombinationContingentConsiderationReceivableUponCertainRegulatoryMilestones" xlink:label="loc_pstiBusinessCombinationContingentConsiderationReceivableUponCertainRegulatoryMilestones_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_pstiBusinessCombinationContingentConsiderationReceivableUponCertainRegulatoryMilestones_90" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DeferredRevenueAdditions" xlink:label="loc_us-gaapDeferredRevenueAdditions_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapDeferredRevenueAdditions_90" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_AdvancePaymentForDeveplomentCosts" xlink:label="loc_pstiAdvancePaymentForDeveplomentCosts_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_pstiAdvancePaymentForDeveplomentCosts_90" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_90" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PostemploymentBenefitsPeriodExpense" xlink:label="loc_us-gaapPostemploymentBenefitsPeriodExpense_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapPostemploymentBenefitsPeriodExpense_90" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DerivativeGainLossOnDerivativeNet" xlink:label="loc_us-gaapDerivativeGainLossOnDerivativeNet_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapDerivativeGainLossOnDerivativeNet_90" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue" xlink:label="loc_us-gaapDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue_90" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_TotalGrantsAwardedToCliProgram" xlink:label="loc_pstiTotalGrantsAwardedToCliProgram_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_pstiTotalGrantsAwardedToCliProgram_90" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_AmountOfGrantsAwardedToCliProgramAllocatedToCompany" xlink:label="loc_pstiAmountOfGrantsAwardedToCliProgramAllocatedToCompany_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_pstiAmountOfGrantsAwardedToCliProgramAllocatedToCompany_90" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RevenueFromGrants" xlink:label="loc_us-gaapRevenueFromGrants_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapRevenueFromGrants_90" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_RecognizedRAndDPariticipationGrants" xlink:label="loc_pstiRecognizedRAndDPariticipationGrants_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_pstiRecognizedRAndDPariticipationGrants_90" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherLiabilitiesCurrent" xlink:label="loc_us-gaapOtherLiabilitiesCurrent_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapOtherLiabilitiesCurrent_90" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_AmountOfGrantsReceivedConditionalAward" xlink:label="loc_pstiAmountOfGrantsReceivedConditionalAward_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_pstiAmountOfGrantsReceivedConditionalAward_90" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_AmountOfDirectGrantAllocatedToTheCompany" xlink:label="loc_pstiAmountOfDirectGrantAllocatedToTheCompany_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_pstiAmountOfDirectGrantAllocatedToTheCompany_90" xlink:type="arc" order="15" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://pluristem.com/role/SignificantAccountingPoliciesScheduleOfPropertyAndEquipmentDepreciationRateDetails" xlink:title="00000034 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Schedule of Property and Equipment Depreciation Rate) (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="loc_us-gaapPropertyPlantAndEquipmentLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:to="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherMachineryAndEquipmentMember" xlink:label="loc_us-gaapOtherMachineryAndEquipmentMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapOtherMachineryAndEquipmentMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ComputerEquipmentMember" xlink:label="loc_us-gaapComputerEquipmentMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapComputerEquipmentMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OfficeEquipmentMember" xlink:label="loc_us-gaapOfficeEquipmentMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapOfficeEquipmentMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_VehiclesMember" xlink:label="loc_us-gaapVehiclesMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapVehiclesMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LeaseholdImprovementsMember" xlink:label="loc_us-gaapLeaseholdImprovementsMember_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapLeaseholdImprovementsMember_50" xlink:type="arc" order="51" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RangeAxis" xlink:label="loc_us-gaapRangeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:to="loc_us-gaapRangeAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RangeMember" xlink:label="loc_us-gaapRangeMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapRangeAxis" xlink:to="loc_us-gaapRangeMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RangeMember" xlink:label="loc_us-gaapRangeMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapRangeAxis" xlink:to="loc_us-gaapRangeMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_MinimumMember" xlink:label="loc_us-gaapMinimumMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRangeMember" xlink:to="loc_us-gaapMinimumMember_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_MaximumMember" xlink:label="loc_us-gaapMaximumMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRangeMember" xlink:to="loc_us-gaapMaximumMember_10" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_PropertyPlantAndEquipmentAnnualRateOfDepreciation" xlink:label="loc_pstiPropertyPlantAndEquipmentAnnualRateOfDepreciation_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_pstiPropertyPlantAndEquipmentAnnualRateOfDepreciation_70" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_LeaseholdImprovementsAnnualRateOfDepreciationDescription" xlink:label="loc_pstiLeaseholdImprovementsAnnualRateOfDepreciationDescription_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_pstiLeaseholdImprovementsAnnualRateOfDepreciationDescription_70" xlink:type="arc" order="1" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://pluristem.com/role/Disclosure-BASISOFPRESENTATIONANDSIGNIFICANTACCOUNTINGPOLICIESComprehensiveIncomeDetails" xlink:title="00000035 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Comprehensive Income) (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:label="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:label="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember" xlink:label="loc_us-gaapAccumulatedNetUnrealizedInvestmentGainLossMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapAccumulatedNetUnrealizedInvestmentGainLossMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember" xlink:label="loc_us-gaapAccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapAccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:label="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossNetOfTax_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossNetOfTax_30" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:label="loc_us-gaapOtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapOtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_30" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:label="loc_us-gaapReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_30" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:label="loc_us-gaapOtherComprehensiveIncomeLossNetOfTax_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapOtherComprehensiveIncomeLossNetOfTax_30" xlink:type="arc" order="3" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://pluristem.com/role/psti-mssoamsd1" xlink:title="00000036 - Disclosure - MARKETABLE SECURITIES (Schedule of Available-for-sale Marketable Securities) (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:label="loc_us-gaapScheduleOfAvailableForSaleSecuritiesLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesTable" xlink:label="loc_us-gaapScheduleOfAvailableForSaleSecuritiesTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="loc_us-gaapScheduleOfAvailableForSaleSecuritiesTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis" xlink:label="loc_us-gaapMajorTypesOfDebtAndEquitySecuritiesAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfAvailableForSaleSecuritiesTable" xlink:to="loc_us-gaapMajorTypesOfDebtAndEquitySecuritiesAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_MajorTypesOfDebtAndEquitySecuritiesDomain" xlink:label="loc_us-gaapMajorTypesOfDebtAndEquitySecuritiesDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapMajorTypesOfDebtAndEquitySecuritiesAxis" xlink:to="loc_us-gaapMajorTypesOfDebtAndEquitySecuritiesDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_MajorTypesOfDebtAndEquitySecuritiesDomain" xlink:label="loc_us-gaapMajorTypesOfDebtAndEquitySecuritiesDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapMajorTypesOfDebtAndEquitySecuritiesAxis" xlink:to="loc_us-gaapMajorTypesOfDebtAndEquitySecuritiesDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EquitySecuritiesMember" xlink:label="loc_us-gaapEquitySecuritiesMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapMajorTypesOfDebtAndEquitySecuritiesDomain" xlink:to="loc_us-gaapEquitySecuritiesMember_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_GovernmentDebtSecuritiesMember" xlink:label="loc_pstiGovernmentDebtSecuritiesMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapMajorTypesOfDebtAndEquitySecuritiesDomain" xlink:to="loc_pstiGovernmentDebtSecuritiesMember_10" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CorporateDebtSecuritiesMember" xlink:label="loc_us-gaapCorporateDebtSecuritiesMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapMajorTypesOfDebtAndEquitySecuritiesDomain" xlink:to="loc_us-gaapCorporateDebtSecuritiesMember_20" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_MaturityDateRangeAxis" xlink:label="loc_pstiMaturityDateRangeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfAvailableForSaleSecuritiesTable" xlink:to="loc_pstiMaturityDateRangeAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_MaturityDateRangeDomain" xlink:label="loc_pstiMaturityDateRangeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_pstiMaturityDateRangeAxis" xlink:to="loc_pstiMaturityDateRangeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_MaturityDateRangeDomain" xlink:label="loc_pstiMaturityDateRangeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_pstiMaturityDateRangeAxis" xlink:to="loc_pstiMaturityDateRangeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_AvailableForSaleSecuritiesMaturesWithinOneYearMember" xlink:label="loc_pstiAvailableForSaleSecuritiesMaturesWithinOneYearMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_pstiMaturityDateRangeDomain" xlink:to="loc_pstiAvailableForSaleSecuritiesMaturesWithinOneYearMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_AvailableForSaleSecuritiesMaturesAfterOneYearThroughFiveYearsMember" xlink:label="loc_pstiAvailableForSaleSecuritiesMaturesAfterOneYearThroughFiveYearsMember_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_pstiMaturityDateRangeDomain" xlink:to="loc_pstiAvailableForSaleSecuritiesMaturesAfterOneYearThroughFiveYearsMember_80" xlink:type="arc" order="81" />
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_AvailableForSaleSecuritiesMaturesAfterFiveYearsThroughTenYearsMember" xlink:label="loc_pstiAvailableForSaleSecuritiesMaturesAfterFiveYearsThroughTenYearsMember_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_pstiMaturityDateRangeDomain" xlink:to="loc_pstiAvailableForSaleSecuritiesMaturesAfterFiveYearsThroughTenYearsMember_140" xlink:type="arc" order="141" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AvailableForSaleSecurities" xlink:label="loc_us-gaapAvailableForSaleSecurities_210" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="loc_us-gaapAvailableForSaleSecurities_210" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:label="loc_us-gaapAvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedGainBeforeTax_210" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="loc_us-gaapAvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedGainBeforeTax_210" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:label="loc_us-gaapAvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedLossBeforeTax_210" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="loc_us-gaapAvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedLossBeforeTax_210" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_OtherthantemporaryImpairment" xlink:label="loc_pstiOtherthantemporaryImpairment_210" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="loc_pstiOtherthantemporaryImpairment_210" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AvailableForSaleSecuritiesAmortizedCost" xlink:label="loc_us-gaapAvailableForSaleSecuritiesAmortizedCost_210" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="loc_us-gaapAvailableForSaleSecuritiesAmortizedCost_210" xlink:type="arc" order="4" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://pluristem.com/role/psti-mssoiiuld" xlink:title="00000037 - Disclosure - MARKETABLE SECURITIES (Schedule of Investments in Unrealized Loss) (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://pluristem.com/role/psti-fvofisofvofid1" xlink:title="00000038 - Disclosure - FAIR VALUE OF FINANCIAL INSTRUMENTS (Schedule of Fair Value of Financial Instruments) (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:label="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:label="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis" xlink:label="loc_us-gaapFairValueByMeasurementFrequencyAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="loc_us-gaapFairValueByMeasurementFrequencyAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain" xlink:label="loc_us-gaapFairValueMeasurementFrequencyDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapFairValueByMeasurementFrequencyAxis" xlink:to="loc_us-gaapFairValueMeasurementFrequencyDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain" xlink:label="loc_us-gaapFairValueMeasurementFrequencyDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapFairValueByMeasurementFrequencyAxis" xlink:to="loc_us-gaapFairValueMeasurementFrequencyDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember" xlink:label="loc_us-gaapFairValueMeasurementsRecurringMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFairValueMeasurementFrequencyDomain" xlink:to="loc_us-gaapFairValueMeasurementsRecurringMember_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" xlink:to="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" xlink:to="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueInputsLevel1Member" xlink:label="loc_us-gaapFairValueInputsLevel1Member_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" xlink:to="loc_us-gaapFairValueInputsLevel1Member_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueInputsLevel2Member" xlink:label="loc_us-gaapFairValueInputsLevel2Member_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" xlink:to="loc_us-gaapFairValueInputsLevel2Member_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_MarketableSecuritiesCurrent" xlink:label="loc_us-gaapMarketableSecuritiesCurrent_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="loc_us-gaapMarketableSecuritiesCurrent_50" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet" xlink:label="loc_us-gaapDerivativeAssetsLiabilitiesAtFairValueNet_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="loc_us-gaapDerivativeAssetsLiabilitiesAtFairValueNet_50" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueNetAssetLiability" xlink:label="loc_us-gaapFairValueNetAssetLiability_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="loc_us-gaapFairValueNetAssetLiability_50" xlink:type="arc" order="2" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://pluristem.com/role/OtherCurrentAssetsDetails" xlink:title="00000039 - Disclosure - OTHER CURRENT ASSETS (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://pluristem.com/role/PropertyAndEquipmentNetDetails" xlink:title="00000040 - Disclosure - PROPERTY AND EQUIPMENT, NET (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="loc_us-gaapPropertyPlantAndEquipmentLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:to="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherMachineryAndEquipmentMember" xlink:label="loc_us-gaapOtherMachineryAndEquipmentMember_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapOtherMachineryAndEquipmentMember_50" xlink:type="arc" order="51" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ComputerEquipmentMember" xlink:label="loc_us-gaapComputerEquipmentMember_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapComputerEquipmentMember_70" xlink:type="arc" order="71" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OfficeEquipmentMember" xlink:label="loc_us-gaapOfficeEquipmentMember_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapOfficeEquipmentMember_90" xlink:type="arc" order="91" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LeaseholdImprovementsMember" xlink:label="loc_us-gaapLeaseholdImprovementsMember_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapLeaseholdImprovementsMember_110" xlink:type="arc" order="111" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_VehiclesMember" xlink:label="loc_us-gaapVehiclesMember_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapVehiclesMember_130" xlink:type="arc" order="131" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="loc_us-gaapPropertyPlantAndEquipmentGross_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapPropertyPlantAndEquipmentGross_160" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="loc_us-gaapAccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapAccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_160" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaapPropertyPlantAndEquipmentNet_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapPropertyPlantAndEquipmentNet_160" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_Depreciation" xlink:label="loc_us-gaapDepreciation_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapDepreciation_160" xlink:type="arc" order="3" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://pluristem.com/role/OtherAccountsPayableDetails" xlink:title="00000041 - Disclosure - OTHER ACCOUNTS PAYABLE (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://pluristem.com/role/CommitmentsAndContingenciesOperatingLeaseDetails" xlink:title="00000042 - Disclosure - COMMITMENTS AND CONTINGENCIES (Operating Lease) (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OperatingLeasedAssetsLineItems" xlink:label="loc_us-gaapOperatingLeasedAssetsLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfOperatingLeasedAssetsTable" xlink:label="loc_us-gaapScheduleOfOperatingLeasedAssetsTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapOperatingLeasedAssetsLineItems" xlink:to="loc_us-gaapScheduleOfOperatingLeasedAssetsTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_GuaranteeObligationsByNatureAxis" xlink:label="loc_us-gaapGuaranteeObligationsByNatureAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfOperatingLeasedAssetsTable" xlink:to="loc_us-gaapGuaranteeObligationsByNatureAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_GuaranteeObligationsNatureDomain" xlink:label="loc_us-gaapGuaranteeObligationsNatureDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapGuaranteeObligationsByNatureAxis" xlink:to="loc_us-gaapGuaranteeObligationsNatureDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_GuaranteeObligationsNatureDomain" xlink:label="loc_us-gaapGuaranteeObligationsNatureDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapGuaranteeObligationsByNatureAxis" xlink:to="loc_us-gaapGuaranteeObligationsNatureDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfOperatingLeasedAssetsTable" xlink:to="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LandAndBuildingMember" xlink:label="loc_us-gaapLandAndBuildingMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapLandAndBuildingMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AutomobilesMember" xlink:label="loc_us-gaapAutomobilesMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapAutomobilesMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RangeAxis" xlink:label="loc_us-gaapRangeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfOperatingLeasedAssetsTable" xlink:to="loc_us-gaapRangeAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RangeMember" xlink:label="loc_us-gaapRangeMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapRangeAxis" xlink:to="loc_us-gaapRangeMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RangeMember" xlink:label="loc_us-gaapRangeMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapRangeAxis" xlink:to="loc_us-gaapRangeMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_OperatingLeasedAssetsNumberOfUnits" xlink:label="loc_pstiOperatingLeasedAssetsNumberOfUnits_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapOperatingLeasedAssetsLineItems" xlink:to="loc_pstiOperatingLeasedAssetsNumberOfUnits_110" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_OperatingLeasedAssetsParticipationFromLessor" xlink:label="loc_pstiOperatingLeasedAssetsParticipationFromLessor_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapOperatingLeasedAssetsLineItems" xlink:to="loc_pstiOperatingLeasedAssetsParticipationFromLessor_110" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_GuaranteeObligationsCurrentCarryingValue" xlink:label="loc_us-gaapGuaranteeObligationsCurrentCarryingValue_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapOperatingLeasedAssetsLineItems" xlink:to="loc_us-gaapGuaranteeObligationsCurrentCarryingValue_110" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OperatingLeasesRentExpenseNet" xlink:label="loc_us-gaapOperatingLeasesRentExpenseNet_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapOperatingLeasedAssetsLineItems" xlink:to="loc_us-gaapOperatingLeasesRentExpenseNet_110" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent" xlink:label="loc_us-gaapOperatingLeasesFutureMinimumPaymentsDueCurrent_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapOperatingLeasedAssetsLineItems" xlink:to="loc_us-gaapOperatingLeasesFutureMinimumPaymentsDueCurrent_110" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears" xlink:label="loc_us-gaapOperatingLeasesFutureMinimumPaymentsDueInTwoYears_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapOperatingLeasedAssetsLineItems" xlink:to="loc_us-gaapOperatingLeasesFutureMinimumPaymentsDueInTwoYears_110" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears" xlink:label="loc_us-gaapOperatingLeasesFutureMinimumPaymentsDueInThreeYears_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapOperatingLeasedAssetsLineItems" xlink:to="loc_us-gaapOperatingLeasesFutureMinimumPaymentsDueInThreeYears_110" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears" xlink:label="loc_us-gaapOperatingLeasesFutureMinimumPaymentsDueInFourYears_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapOperatingLeasedAssetsLineItems" xlink:to="loc_us-gaapOperatingLeasesFutureMinimumPaymentsDueInFourYears_110" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears" xlink:label="loc_us-gaapOperatingLeasesFutureMinimumPaymentsDueInFiveYears_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapOperatingLeasedAssetsLineItems" xlink:to="loc_us-gaapOperatingLeasesFutureMinimumPaymentsDueInFiveYears_110" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDue" xlink:label="loc_us-gaapOperatingLeasesFutureMinimumPaymentsDue_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapOperatingLeasedAssetsLineItems" xlink:to="loc_us-gaapOperatingLeasesFutureMinimumPaymentsDue_110" xlink:type="arc" order="9" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://pluristem.com/role/CommitmentsAndContingenciesOtherDetails" xlink:title="00000043 - Disclosure - COMMITMENTS AND CONTINGENCIES (Other) (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherCommitmentsLineItems" xlink:label="loc_us-gaapOtherCommitmentsLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherCommitmentsTable" xlink:label="loc_us-gaapOtherCommitmentsTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapOtherCommitmentsLineItems" xlink:to="loc_us-gaapOtherCommitmentsTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RangeAxis" xlink:label="loc_us-gaapRangeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapOtherCommitmentsTable" xlink:to="loc_us-gaapRangeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RangeMember" xlink:label="loc_us-gaapRangeMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapRangeAxis" xlink:to="loc_us-gaapRangeMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RangeMember" xlink:label="loc_us-gaapRangeMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapRangeAxis" xlink:to="loc_us-gaapRangeMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_MinimumMember" xlink:label="loc_us-gaapMinimumMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRangeMember" xlink:to="loc_us-gaapMinimumMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_MaximumMember" xlink:label="loc_us-gaapMaximumMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRangeMember" xlink:to="loc_us-gaapMaximumMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaapAwardTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapOtherCommitmentsTable" xlink:to="loc_us-gaapAwardTypeAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_SmartMoneyGrantMember" xlink:label="loc_pstiSmartMoneyGrantMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_pstiSmartMoneyGrantMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_BinationalIndustrialResearchAndDevelopmentFoundationMember" xlink:label="loc_pstiBinationalIndustrialResearchAndDevelopmentFoundationMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_pstiBinationalIndustrialResearchAndDevelopmentFoundationMember_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_NewYorkBloodCenterIncMember" xlink:label="loc_pstiNewYorkBloodCenterIncMember_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_pstiNewYorkBloodCenterIncMember_70" xlink:type="arc" order="71" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaapRestrictedCashAndCashEquivalentsAtCarryingValue_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapOtherCommitmentsLineItems" xlink:to="loc_us-gaapRestrictedCashAndCashEquivalentsAtCarryingValue_100" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncreaseDecreaseInSecurityDeposits" xlink:label="loc_us-gaapIncreaseDecreaseInSecurityDeposits_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapOtherCommitmentsLineItems" xlink:to="loc_us-gaapIncreaseDecreaseInSecurityDeposits_100" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_AggregateGrantsReceived" xlink:label="loc_pstiAggregateGrantsReceived_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapOtherCommitmentsLineItems" xlink:to="loc_pstiAggregateGrantsReceived_100" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_PercentageOfQualifiedExpenditures" xlink:label="loc_pstiPercentageOfQualifiedExpenditures_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapOtherCommitmentsLineItems" xlink:to="loc_pstiPercentageOfQualifiedExpenditures_100" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_RoyaltyRateSales" xlink:label="loc_pstiRoyaltyRateSales_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapOtherCommitmentsLineItems" xlink:to="loc_pstiRoyaltyRateSales_100" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_RoyaltyRatePayableOnGrantsReceived" xlink:label="loc_pstiRoyaltyRatePayableOnGrantsReceived_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapOtherCommitmentsLineItems" xlink:to="loc_pstiRoyaltyRatePayableOnGrantsReceived_100" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_TermOfRoyaltyGrantReceived" xlink:label="loc_pstiTermOfRoyaltyGrantReceived_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapOtherCommitmentsLineItems" xlink:to="loc_pstiTermOfRoyaltyGrantReceived_100" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_RoyaltiesAmountPaidAndAccrued" xlink:label="loc_pstiRoyaltiesAmountPaidAndAccrued_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapOtherCommitmentsLineItems" xlink:to="loc_pstiRoyaltiesAmountPaidAndAccrued_100" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RoyaltyGuaranteesCommitmentsAmount" xlink:label="loc_us-gaapRoyaltyGuaranteesCommitmentsAmount_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapOtherCommitmentsLineItems" xlink:to="loc_us-gaapRoyaltyGuaranteesCommitmentsAmount_100" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_AmountOfGrantsReceivedConditionalAward" xlink:label="loc_pstiAmountOfGrantsReceivedConditionalAward_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapOtherCommitmentsLineItems" xlink:to="loc_pstiAmountOfGrantsReceivedConditionalAward_100" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_AmountOfDirectGrantAllocatedToTheCompany" xlink:label="loc_pstiAmountOfDirectGrantAllocatedToTheCompany_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapOtherCommitmentsLineItems" xlink:to="loc_pstiAmountOfDirectGrantAllocatedToTheCompany_100" xlink:type="arc" order="10" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://pluristem.com/role/psti-send1" xlink:title="00000044 - Disclosure - STOCKHOLDERS' EQUITY (Narrative) (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ClassOfStockLineItems" xlink:label="loc_us-gaapClassOfStockLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfStockByClassTable" xlink:label="loc_us-gaapScheduleOfStockByClassTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapScheduleOfStockByClassTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="loc_us-gaapClassOfWarrantOrRightAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfStockByClassTable" xlink:to="loc_us-gaapClassOfWarrantOrRightAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="loc_us-gaapClassOfWarrantOrRightDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapClassOfWarrantOrRightAxis" xlink:to="loc_us-gaapClassOfWarrantOrRightDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="loc_us-gaapClassOfWarrantOrRightDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapClassOfWarrantOrRightAxis" xlink:to="loc_us-gaapClassOfWarrantOrRightDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_InvestorWarrantsMember" xlink:label="loc_pstiInvestorWarrantsMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfWarrantOrRightDomain" xlink:to="loc_pstiInvestorWarrantsMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_WarrantMember" xlink:label="loc_us-gaapWarrantMember_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfWarrantOrRightDomain" xlink:to="loc_us-gaapWarrantMember_70" xlink:type="arc" order="71" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CurrencyAxis" xlink:label="loc_us-gaapCurrencyAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfStockByClassTable" xlink:to="loc_us-gaapCurrencyAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/currency/2017/currency-2017-01-31.xsd#currency_AllCurrenciesDomain" xlink:label="loc_currencyAllCurrenciesDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapCurrencyAxis" xlink:to="loc_currencyAllCurrenciesDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/currency/2017/currency-2017-01-31.xsd#currency_AllCurrenciesDomain" xlink:label="loc_currencyAllCurrenciesDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapCurrencyAxis" xlink:to="loc_currencyAllCurrenciesDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/currency/2017/currency-2017-01-31.xsd#currency_ILS" xlink:label="loc_currencyILS_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_currencyAllCurrenciesDomain" xlink:to="loc_currencyILS_90" xlink:type="arc" order="91" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis" xlink:label="loc_us-gaapShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfStockByClassTable" xlink:to="loc_us-gaapShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionSupplierDomain" xlink:label="loc_us-gaapShareBasedGoodsAndNonemployeeServicesTransactionSupplierDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis" xlink:to="loc_us-gaapShareBasedGoodsAndNonemployeeServicesTransactionSupplierDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionSupplierDomain" xlink:label="loc_us-gaapShareBasedGoodsAndNonemployeeServicesTransactionSupplierDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis" xlink:to="loc_us-gaapShareBasedGoodsAndNonemployeeServicesTransactionSupplierDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_ContractorMember" xlink:label="loc_pstiContractorMember_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedGoodsAndNonemployeeServicesTransactionSupplierDomain" xlink:to="loc_pstiContractorMember_110" xlink:type="arc" order="111" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfStockByClassTable" xlink:to="loc_deiLegalEntityAxis" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_UnderwritingAgreementMember" xlink:label="loc_pstiUnderwritingAgreementMember_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityDomain" xlink:to="loc_pstiUnderwritingAgreementMember_130" xlink:type="arc" order="131" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PlanNameAxis" xlink:label="loc_us-gaapPlanNameAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfStockByClassTable" xlink:to="loc_us-gaapPlanNameAxis" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaapPlanNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapPlanNameAxis" xlink:to="loc_us-gaapPlanNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaapPlanNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapPlanNameAxis" xlink:to="loc_us-gaapPlanNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_Plan2005Member" xlink:label="loc_pstiPlan2005Member_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPlanNameDomain" xlink:to="loc_pstiPlan2005Member_150" xlink:type="arc" order="151" />
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_Plan2016Member" xlink:label="loc_pstiPlan2016Member_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPlanNameDomain" xlink:to="loc_pstiPlan2016Member_160" xlink:type="arc" order="161" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaapCommonStockParOrStatedValuePerShare_180" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapCommonStockParOrStatedValuePerShare_180" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="loc_us-gaapCommonStockSharesAuthorized_180" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapCommonStockSharesAuthorized_180" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="loc_us-gaapPreferredStockSharesAuthorized_180" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapPreferredStockSharesAuthorized_180" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="loc_us-gaapPreferredStockParOrStatedValuePerShare_180" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapPreferredStockParOrStatedValuePerShare_180" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" xlink:label="loc_us-gaapAdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_180" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapAdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_180" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ConversionOfStockSharesConverted1" xlink:label="loc_us-gaapConversionOfStockSharesConverted1_180" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapConversionOfStockSharesConverted1_180" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ConversionOfStockSharesIssued1" xlink:label="loc_us-gaapConversionOfStockSharesIssued1_180" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapConversionOfStockSharesIssued1_180" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesOther" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesOther_180" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesOther_180" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_CommonStockAggregateOfferingPriceAuthorized" xlink:label="loc_pstiCommonStockAggregateOfferingPriceAuthorized_180" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_pstiCommonStockAggregateOfferingPriceAuthorized_180" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ProceedsFromWarrantExercises" xlink:label="loc_us-gaapProceedsFromWarrantExercises_180" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapProceedsFromWarrantExercises_180" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_SharebasedCompensationArrangementWarrantsExercised" xlink:label="loc_pstiSharebasedCompensationArrangementWarrantsExercised_180" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_pstiSharebasedCompensationArrangementWarrantsExercised_180" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesPurchaseOfAssets" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesPurchaseOfAssets_180" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesPurchaseOfAssets_180" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_AvailableForSaleMarketableSecuritiesNumber" xlink:label="loc_pstiAvailableForSaleMarketableSecuritiesNumber_180" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_pstiAvailableForSaleMarketableSecuritiesNumber_180" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockIssuedDuringPeriodValuePurchaseOfAssets" xlink:label="loc_us-gaapStockIssuedDuringPeriodValuePurchaseOfAssets_180" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValuePurchaseOfAssets_180" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_AggregateOfferingPriceUnderATMAgreement" xlink:label="loc_pstiAggregateOfferingPriceUnderATMAgreement_180" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_pstiAggregateOfferingPriceUnderATMAgreement_180" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_ShareBasedGoodsAndNonemployeeServicesTransactionQuantityOfSecuritiesToBeIssued" xlink:label="loc_pstiShareBasedGoodsAndNonemployeeServicesTransactionQuantityOfSecuritiesToBeIssued_180" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_pstiShareBasedGoodsAndNonemployeeServicesTransactionQuantityOfSecuritiesToBeIssued_180" xlink:type="arc" order="15" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesIssuedForServices_180" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesIssuedForServices_180" xlink:type="arc" order="16" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues_180" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues_180" xlink:type="arc" order="17" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SharesIssuedPricePerShare" xlink:label="loc_us-gaapSharesIssuedPricePerShare_180" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapSharesIssuedPricePerShare_180" xlink:type="arc" order="18" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" xlink:label="loc_us-gaapClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_180" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_180" xlink:type="arc" order="19" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_180" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_180" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ClassOfWarrantOrRightOutstanding" xlink:label="loc_us-gaapClassOfWarrantOrRightOutstanding_180" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightOutstanding_180" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="loc_us-gaapProceedsFromIssuanceOfCommonStock_180" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapProceedsFromIssuanceOfCommonStock_180" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_StockIssuedDuringPeriodValuePrivatePlacement" xlink:label="loc_pstiStockIssuedDuringPeriodValuePrivatePlacement_180" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_pstiStockIssuedDuringPeriodValuePrivatePlacement_180" xlink:type="arc" order="23" />
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_StockIssuedDuringPeriodSharesPrivatePlacement" xlink:label="loc_pstiStockIssuedDuringPeriodSharesPrivatePlacement_180" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_pstiStockIssuedDuringPeriodSharesPrivatePlacement_180" xlink:type="arc" order="24" />
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_ExpirationPeriodOfWarrantsSoldInOffering" xlink:label="loc_pstiExpirationPeriodOfWarrantsSoldInOffering_180" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_pstiExpirationPeriodOfWarrantsSoldInOffering_180" xlink:type="arc" order="25" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueIssuedForServices" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueIssuedForServices_180" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueIssuedForServices_180" xlink:type="arc" order="26" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherConstructionCosts" xlink:label="loc_us-gaapOtherConstructionCosts_180" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapOtherConstructionCosts_180" xlink:type="arc" order="27" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ConstructionInProgressExpendituresIncurredButNotYetPaid" xlink:label="loc_us-gaapConstructionInProgressExpendituresIncurredButNotYetPaid_180" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapConstructionInProgressExpendituresIncurredButNotYetPaid_180" xlink:type="arc" order="28" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceSheetAmount" xlink:label="loc_us-gaapUnrecordedUnconditionalPurchaseObligationBalanceSheetAmount_180" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapUnrecordedUnconditionalPurchaseObligationBalanceSheetAmount_180" xlink:type="arc" order="29" />
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_PercentageOfConstructionMilestonesCompleted" xlink:label="loc_pstiPercentageOfConstructionMilestonesCompleted_180" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_pstiPercentageOfConstructionMilestonesCompleted_180" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionCapitalizedCost" xlink:label="loc_us-gaapShareBasedGoodsAndNonemployeeServicesTransactionCapitalizedCost_180" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapShareBasedGoodsAndNonemployeeServicesTransactionCapitalizedCost_180" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_180" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_180" xlink:type="arc" order="32" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_180" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_180" xlink:type="arc" order="33" />
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_NumberOfSharesAgreedToBeSoldThroughUnderwriterAgreement" xlink:label="loc_pstiNumberOfSharesAgreedToBeSoldThroughUnderwriterAgreement_180" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_pstiNumberOfSharesAgreedToBeSoldThroughUnderwriterAgreement_180" xlink:type="arc" order="34" />
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_NumberOfWarrantsAgreedToBeSoldThroughUnderwriterAgreement" xlink:label="loc_pstiNumberOfWarrantsAgreedToBeSoldThroughUnderwriterAgreement_180" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_pstiNumberOfWarrantsAgreedToBeSoldThroughUnderwriterAgreement_180" xlink:type="arc" order="35" />
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_GrossProceedsFromIssuanceOfCommonStock" xlink:label="loc_pstiGrossProceedsFromIssuanceOfCommonStock_180" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_pstiGrossProceedsFromIssuanceOfCommonStock_180" xlink:type="arc" order="36" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://pluristem.com/role/StockholdersEquitySummaryOfOptionActivityDetails" xlink:title="00000045 - Disclosure - STOCKHOLDERS' EQUITY (Summary of Option Activity) (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TitleOfIndividualAxis" xlink:label="loc_us-gaapTitleOfIndividualAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapTitleOfIndividualAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_us-gaapTitleOfIndividualWithRelationshipToEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapTitleOfIndividualAxis" xlink:to="loc_us-gaapTitleOfIndividualWithRelationshipToEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_us-gaapTitleOfIndividualWithRelationshipToEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapTitleOfIndividualAxis" xlink:to="loc_us-gaapTitleOfIndividualWithRelationshipToEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_EmployeesAndDirectorsMember" xlink:label="loc_pstiEmployeesAndDirectorsMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_pstiEmployeesAndDirectorsMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_20" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_20" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_20" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesStockOptionsExercised_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_20" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesStockOptionsExercised_20" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_20" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_20" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_20" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_20" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_20" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_20" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_20" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_20" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_20" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_20" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_20" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_20" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_20" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_20" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_20" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_20" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_20" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_WeightedAverageRemainingContractualTermsAbstract" xlink:label="loc_pstiWeightedAverageRemainingContractualTermsAbstract_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_pstiWeightedAverageRemainingContractualTermsAbstract_20" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_pstiWeightedAverageRemainingContractualTermsAbstract_20" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_20" xlink:type="arc" order="15" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_pstiWeightedAverageRemainingContractualTermsAbstract_20" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_20" xlink:type="arc" order="16" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_pstiWeightedAverageRemainingContractualTermsAbstract_20" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1_20" xlink:type="arc" order="17" />
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_AggregateIntrinsicValueAbstract" xlink:label="loc_pstiAggregateIntrinsicValueAbstract_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_pstiAggregateIntrinsicValueAbstract_20" xlink:type="arc" order="18" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_pstiAggregateIntrinsicValueAbstract_20" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_20" xlink:type="arc" order="19" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_pstiAggregateIntrinsicValueAbstract_20" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_20" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_pstiAggregateIntrinsicValueAbstract_20" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_20" xlink:type="arc" order="21" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://pluristem.com/role/StockholdersEquitySummaryOfOptionActivityToNon-employeeConsultantsDetails" xlink:title="00000046 - Disclosure - STOCKHOLDERS' EQUITY (Summary of Option Activity to Non-employee Consultants) (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TitleOfIndividualAxis" xlink:label="loc_us-gaapTitleOfIndividualAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapTitleOfIndividualAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_us-gaapTitleOfIndividualWithRelationshipToEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapTitleOfIndividualAxis" xlink:to="loc_us-gaapTitleOfIndividualWithRelationshipToEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_us-gaapTitleOfIndividualWithRelationshipToEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapTitleOfIndividualAxis" xlink:to="loc_us-gaapTitleOfIndividualWithRelationshipToEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_NonemployeesMember" xlink:label="loc_pstiNonemployeesMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_pstiNonemployeesMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_20" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_20" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_20" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_20" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_20" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesStockOptionsExercised_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_20" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesStockOptionsExercised_20" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_20" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_20" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_20" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_20" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_20" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_20" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_20" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_20" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_20" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_20" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_20" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_20" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_20" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_20" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_20" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_20" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_20" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_20" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_20" xlink:type="arc" order="15" />
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_WeightedAverageRemainingContractualTermsAbstract" xlink:label="loc_pstiWeightedAverageRemainingContractualTermsAbstract_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_pstiWeightedAverageRemainingContractualTermsAbstract_20" xlink:type="arc" order="16" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_pstiWeightedAverageRemainingContractualTermsAbstract_20" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_20" xlink:type="arc" order="17" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_pstiWeightedAverageRemainingContractualTermsAbstract_20" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_20" xlink:type="arc" order="18" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_pstiWeightedAverageRemainingContractualTermsAbstract_20" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1_20" xlink:type="arc" order="19" />
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_AggregateIntrinsicValueAbstract" xlink:label="loc_pstiAggregateIntrinsicValueAbstract_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_pstiAggregateIntrinsicValueAbstract_20" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_pstiAggregateIntrinsicValueAbstract_20" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_pstiAggregateIntrinsicValueAbstract_20" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_20" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_pstiAggregateIntrinsicValueAbstract_20" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_20" xlink:type="arc" order="23" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://pluristem.com/role/psti-sesoced1" xlink:title="00000047 - Disclosure - STOCKHOLDERS' EQUITY (Schedule of Compensation Expense) (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:label="loc_us-gaapEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:label="loc_us-gaapScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:to="loc_us-gaapScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaapAwardTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:to="loc_us-gaapAwardTypeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="loc_us-gaapEmployeeStockOptionMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaapEmployeeStockOptionMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="loc_us-gaapRestrictedStockUnitsRSUMember_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaapRestrictedStockUnitsRSUMember_90" xlink:type="arc" order="91" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="loc_us-gaapIncomeStatementLocationAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:to="loc_us-gaapIncomeStatementLocationAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="loc_us-gaapIncomeStatementLocationDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapIncomeStatementLocationAxis" xlink:to="loc_us-gaapIncomeStatementLocationDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="loc_us-gaapIncomeStatementLocationDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapIncomeStatementLocationAxis" xlink:to="loc_us-gaapIncomeStatementLocationDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember" xlink:label="loc_us-gaapResearchAndDevelopmentExpenseMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapIncomeStatementLocationDomain" xlink:to="loc_us-gaapResearchAndDevelopmentExpenseMember_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_GeneralAndAdministrativeExpenseMember" xlink:label="loc_us-gaapGeneralAndAdministrativeExpenseMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapIncomeStatementLocationDomain" xlink:to="loc_us-gaapGeneralAndAdministrativeExpenseMember_30" xlink:type="arc" order="32" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis" xlink:label="loc_us-gaapShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:to="loc_us-gaapShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionSupplierDomain" xlink:label="loc_us-gaapShareBasedGoodsAndNonemployeeServicesTransactionSupplierDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis" xlink:to="loc_us-gaapShareBasedGoodsAndNonemployeeServicesTransactionSupplierDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionSupplierDomain" xlink:label="loc_us-gaapShareBasedGoodsAndNonemployeeServicesTransactionSupplierDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis" xlink:to="loc_us-gaapShareBasedGoodsAndNonemployeeServicesTransactionSupplierDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_ConsultantsMember" xlink:label="loc_pstiConsultantsMember_180" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedGoodsAndNonemployeeServicesTransactionSupplierDomain" xlink:to="loc_pstiConsultantsMember_180" xlink:type="arc" order="183" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="loc_us-gaapAllocatedShareBasedCompensationExpense_290" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:to="loc_us-gaapAllocatedShareBasedCompensationExpense_290" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:label="loc_us-gaapEmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_290" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:to="loc_us-gaapEmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_290" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:label="loc_us-gaapEmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_290" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:to="loc_us-gaapEmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_290" xlink:type="arc" order="2" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://pluristem.com/role/psti-sesorateadd1" xlink:title="00000048 - Disclosure - STOCKHOLDERS' EQUITY (Summary of RSU Activity to Employees and Directors) (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaapAwardTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapAwardTypeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="loc_us-gaapRestrictedStockUnitsRSUMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaapRestrictedStockUnitsRSUMember_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TitleOfIndividualAxis" xlink:label="loc_us-gaapTitleOfIndividualAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapTitleOfIndividualAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_us-gaapTitleOfIndividualWithRelationshipToEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapTitleOfIndividualAxis" xlink:to="loc_us-gaapTitleOfIndividualWithRelationshipToEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_us-gaapTitleOfIndividualWithRelationshipToEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapTitleOfIndividualAxis" xlink:to="loc_us-gaapTitleOfIndividualWithRelationshipToEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_EmployeesAndDirectorsMember" xlink:label="loc_pstiEmployeesAndDirectorsMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_pstiEmployeesAndDirectorsMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_20" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_20" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_20" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_20" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVest" xlink:label="loc_pstiShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVest_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_pstiShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVest_20" xlink:type="arc" order="5" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://pluristem.com/role/psti-sesoratcd1" xlink:title="00000049 - Disclosure - STOCKHOLDERS' EQUITY (Summary of RSU Activity to Consultants) (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis" xlink:label="loc_us-gaapShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionSupplierDomain" xlink:label="loc_us-gaapShareBasedGoodsAndNonemployeeServicesTransactionSupplierDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis" xlink:to="loc_us-gaapShareBasedGoodsAndNonemployeeServicesTransactionSupplierDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionSupplierDomain" xlink:label="loc_us-gaapShareBasedGoodsAndNonemployeeServicesTransactionSupplierDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis" xlink:to="loc_us-gaapShareBasedGoodsAndNonemployeeServicesTransactionSupplierDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_ConsultantsMember" xlink:label="loc_pstiConsultantsMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedGoodsAndNonemployeeServicesTransactionSupplierDomain" xlink:to="loc_pstiConsultantsMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TitleOfIndividualAxis" xlink:label="loc_us-gaapTitleOfIndividualAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapTitleOfIndividualAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_us-gaapTitleOfIndividualWithRelationshipToEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapTitleOfIndividualAxis" xlink:to="loc_us-gaapTitleOfIndividualWithRelationshipToEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_us-gaapTitleOfIndividualWithRelationshipToEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapTitleOfIndividualAxis" xlink:to="loc_us-gaapTitleOfIndividualWithRelationshipToEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_20" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_20" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_20" xlink:type="arc" order="2" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://pluristem.com/role/StockholdersEquitySummaryOfWarrantsAndOptionsDetails" xlink:title="00000050 - Disclosure - STOCKHOLDERS' EQUITY (Summary of Warrants and Options) (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="loc_us-gaapClassOfWarrantOrRightAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapClassOfWarrantOrRightAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="loc_us-gaapClassOfWarrantOrRightDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapClassOfWarrantOrRightAxis" xlink:to="loc_us-gaapClassOfWarrantOrRightDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="loc_us-gaapClassOfWarrantOrRightDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapClassOfWarrantOrRightAxis" xlink:to="loc_us-gaapClassOfWarrantOrRightDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_WarrantMember" xlink:label="loc_us-gaapWarrantMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfWarrantOrRightDomain" xlink:to="loc_us-gaapWarrantMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaapAwardTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapAwardTypeAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="loc_us-gaapEmployeeStockOptionMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaapEmployeeStockOptionMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:label="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:label="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:to="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:label="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:to="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_ExercisePriceRangeOneMember" xlink:label="loc_pstiExercisePriceRangeOneMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="loc_pstiExercisePriceRangeOneMember_30" xlink:type="arc" order="32" />
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_ExercisePriceRangeTwoMember" xlink:label="loc_pstiExercisePriceRangeTwoMember_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="loc_pstiExercisePriceRangeTwoMember_50" xlink:type="arc" order="52" />
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_ExercisePriceRangeThreeMember" xlink:label="loc_pstiExercisePriceRangeThreeMember_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="loc_pstiExercisePriceRangeThreeMember_70" xlink:type="arc" order="72" />
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_ExercisePriceRangeFourMember" xlink:label="loc_pstiExercisePriceRangeFourMember_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="loc_pstiExercisePriceRangeFourMember_90" xlink:type="arc" order="92" />
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_ExercisePriceRangeFiveMember" xlink:label="loc_pstiExercisePriceRangeFiveMember_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="loc_pstiExercisePriceRangeFiveMember_110" xlink:type="arc" order="112" />
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_ExercisePriceRangeSixMember" xlink:label="loc_pstiExercisePriceRangeSixMember_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="loc_pstiExercisePriceRangeSixMember_130" xlink:type="arc" order="132" />
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_ExercisePriceRangeSevenMember" xlink:label="loc_pstiExercisePriceRangeSevenMember_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="loc_pstiExercisePriceRangeSevenMember_150" xlink:type="arc" order="152" />
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_ExercisePriceRangeEightMember" xlink:label="loc_pstiExercisePriceRangeEightMember_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="loc_pstiExercisePriceRangeEightMember_170" xlink:type="arc" order="172" />
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_ExercisePriceRangeNineMember" xlink:label="loc_pstiExercisePriceRangeNineMember_190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="loc_pstiExercisePriceRangeNineMember_190" xlink:type="arc" order="192" />
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_ExercisePriceRangeTenMember" xlink:label="loc_pstiExercisePriceRangeTenMember_210" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="loc_pstiExercisePriceRangeTenMember_210" xlink:type="arc" order="212" />
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_ExercisePriceRangeElevenMember" xlink:label="loc_pstiExercisePriceRangeElevenMember_230" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="loc_pstiExercisePriceRangeElevenMember_230" xlink:type="arc" order="232" />
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_ExercisePriceRangeTwelveMember" xlink:label="loc_pstiExercisePriceRangeTwelveMember_250" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="loc_pstiExercisePriceRangeTwelveMember_250" xlink:type="arc" order="252" />
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_ExercisePriceRangeThirteenMember" xlink:label="loc_pstiExercisePriceRangeThirteenMember_270" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="loc_pstiExercisePriceRangeThirteenMember_270" xlink:type="arc" order="272" />
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_ExercisePriceRangeFourteenMember" xlink:label="loc_pstiExercisePriceRangeFourteenMember_290" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="loc_pstiExercisePriceRangeFourteenMember_290" xlink:type="arc" order="292" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_320" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_320" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" xlink:label="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_320" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_320" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" xlink:label="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_320" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_320" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_320" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_320" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_320" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_320" xlink:type="arc" order="4" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://pluristem.com/role/FinancialIncomeNetDetails" xlink:title="00000051 - Disclosure - FINANCIAL INCOME, NET (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://pluristem.com/role/TaxesOnIncomeNarrativeDetails" xlink:title="00000052 - Disclosure - TAXES ON INCOME (Narrative) (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RangeAxis" xlink:label="loc_us-gaapRangeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapRangeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RangeMember" xlink:label="loc_us-gaapRangeMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapRangeAxis" xlink:to="loc_us-gaapRangeMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RangeMember" xlink:label="loc_us-gaapRangeMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapRangeAxis" xlink:to="loc_us-gaapRangeMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_MaximumMember" xlink:label="loc_us-gaapMaximumMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRangeMember" xlink:to="loc_us-gaapMaximumMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_MinimumMember" xlink:label="loc_us-gaapMinimumMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRangeMember" xlink:to="loc_us-gaapMinimumMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeTaxAuthorityAxis" xlink:label="loc_us-gaapIncomeTaxAuthorityAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapIncomeTaxAuthorityAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain" xlink:label="loc_us-gaapIncomeTaxAuthorityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapIncomeTaxAuthorityAxis" xlink:to="loc_us-gaapIncomeTaxAuthorityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain" xlink:label="loc_us-gaapIncomeTaxAuthorityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapIncomeTaxAuthorityAxis" xlink:to="loc_us-gaapIncomeTaxAuthorityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_InternalRevenueServiceIRSMember" xlink:label="loc_us-gaapInternalRevenueServiceIRSMember_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapIncomeTaxAuthorityDomain" xlink:to="loc_us-gaapInternalRevenueServiceIRSMember_70" xlink:type="arc" order="71" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IsraelTaxAuthorityMember" xlink:label="loc_us-gaapIsraelTaxAuthorityMember_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapIncomeTaxAuthorityDomain" xlink:to="loc_us-gaapIsraelTaxAuthorityMember_100" xlink:type="arc" order="101" />
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_TechnologicalPreferredEnterpriseMember" xlink:label="loc_pstiTechnologicalPreferredEnterpriseMember_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapIncomeTaxAuthorityDomain" xlink:to="loc_pstiTechnologicalPreferredEnterpriseMember_130" xlink:type="arc" order="131" />
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_TechnologicalEnterpriseMember" xlink:label="loc_pstiTechnologicalEnterpriseMember_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapIncomeTaxAuthorityDomain" xlink:to="loc_pstiTechnologicalEnterpriseMember_140" xlink:type="arc" order="141" />
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_SpecialTechnologicalPreferredEnterpriseMember" xlink:label="loc_pstiSpecialTechnologicalPreferredEnterpriseMember_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapIncomeTaxAuthorityDomain" xlink:to="loc_pstiSpecialTechnologicalPreferredEnterpriseMember_160" xlink:type="arc" order="161" />
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_PreferredEnterpriseMember" xlink:label="loc_pstiPreferredEnterpriseMember_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapIncomeTaxAuthorityDomain" xlink:to="loc_pstiPreferredEnterpriseMember_170" xlink:type="arc" order="171" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TaxPeriodAxis" xlink:label="loc_us-gaapTaxPeriodAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapTaxPeriodAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TaxPeriodDomain" xlink:label="loc_us-gaapTaxPeriodDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapTaxPeriodAxis" xlink:to="loc_us-gaapTaxPeriodDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TaxPeriodDomain" xlink:label="loc_us-gaapTaxPeriodDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapTaxPeriodAxis" xlink:to="loc_us-gaapTaxPeriodDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EarliestTaxYearMember" xlink:label="loc_us-gaapEarliestTaxYearMember_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapTaxPeriodDomain" xlink:to="loc_us-gaapEarliestTaxYearMember_80" xlink:type="arc" order="82" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LatestTaxYearMember" xlink:label="loc_us-gaapLatestTaxYearMember_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapTaxPeriodDomain" xlink:to="loc_us-gaapLatestTaxYearMember_90" xlink:type="arc" order="92" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementGeographicalAxis" xlink:label="loc_us-gaapStatementGeographicalAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementGeographicalAxis" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SegmentGeographicalDomain" xlink:label="loc_us-gaapSegmentGeographicalDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementGeographicalAxis" xlink:to="loc_us-gaapSegmentGeographicalDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SegmentGeographicalDomain" xlink:label="loc_us-gaapSegmentGeographicalDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementGeographicalAxis" xlink:to="loc_us-gaapSegmentGeographicalDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_DevelopmentAreaMember" xlink:label="loc_pstiDevelopmentAreaMember_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSegmentGeographicalDomain" xlink:to="loc_pstiDevelopmentAreaMember_150" xlink:type="arc" order="152" />
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_RestOfCountryMember" xlink:label="loc_pstiRestOfCountryMember_190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSegmentGeographicalDomain" xlink:to="loc_pstiRestOfCountryMember_190" xlink:type="arc" order="192" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:label="loc_us-gaapEffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_210" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapEffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_210" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:label="loc_us-gaapEffectiveIncomeTaxRateContinuingOperations_210" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapEffectiveIncomeTaxRateContinuingOperations_210" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OperatingLossCarryforwards" xlink:label="loc_us-gaapOperatingLossCarryforwards_210" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapOperatingLossCarryforwards_210" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OperatingLossCarryforwardsExpirationDate" xlink:label="loc_us-gaapOperatingLossCarryforwardsExpirationDate_210" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapOperatingLossCarryforwardsExpirationDate_210" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_Revenues" xlink:label="loc_us-gaapRevenues_210" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapRevenues_210" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_CorporateStatutoryTaxRateOn2018AndThereafter" xlink:label="loc_pstiCorporateStatutoryTaxRateOn2018AndThereafter_210" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_pstiCorporateStatutoryTaxRateOn2018AndThereafter_210" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_CorporateStatutoryTaxRateOn2017AndThereafter" xlink:label="loc_pstiCorporateStatutoryTaxRateOn2017AndThereafter_210" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_pstiCorporateStatutoryTaxRateOn2017AndThereafter_210" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_CorporateStatutoryTaxRateForDividendsDistributedToIndividualsOrForeignResidentsDistributedFromPreferredEnterpriseProfits" xlink:label="loc_pstiCorporateStatutoryTaxRateForDividendsDistributedToIndividualsOrForeignResidentsDistributedFromPreferredEnterpriseProfits_210" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_pstiCorporateStatutoryTaxRateForDividendsDistributedToIndividualsOrForeignResidentsDistributedFromPreferredEnterpriseProfits_210" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_CorporateStatutoryTaxRateOnProfitsDerivingFromIntellectualProperty" xlink:label="loc_pstiCorporateStatutoryTaxRateOnProfitsDerivingFromIntellectualProperty_210" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_pstiCorporateStatutoryTaxRateOnProfitsDerivingFromIntellectualProperty_210" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_CorporateStatutoryTaxRateForDividendsDistributedToForeignCompanies" xlink:label="loc_pstiCorporateStatutoryTaxRateForDividendsDistributedToForeignCompanies_210" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_pstiCorporateStatutoryTaxRateForDividendsDistributedToForeignCompanies_210" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_CorporateStatutoryTaxRateOn2016" xlink:label="loc_pstiCorporateStatutoryTaxRateOn2016_210" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_pstiCorporateStatutoryTaxRateOn2016_210" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_CorporateStatutoryTaxRateOn2016AndThereafter" xlink:label="loc_pstiCorporateStatutoryTaxRateOn2016AndThereafter_210" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_pstiCorporateStatutoryTaxRateOn2016AndThereafter_210" xlink:type="arc" order="11" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://pluristem.com/role/TaxesOnIncomeScheduleOfSignificantComponentsOfDeferredTaxAssetsDetails" xlink:title="00000053 - Disclosure - TAXES ON INCOME (Schedule of Significant Components of Deferred Tax Assets) (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://pluristem.com/role/SubsequentEventsNarrativeDetails" xlink:title="00000054 - Disclosure - SUBSEQUENT EVENTS (Narrative) (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SubsequentEventLineItems" xlink:label="loc_us-gaapSubsequentEventLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SubsequentEventTable" xlink:label="loc_us-gaapSubsequentEventTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapSubsequentEventTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_us-gaapSubsequentEventTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapSubsequentEventTable" xlink:to="loc_us-gaapSubsequentEventTypeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaapSubsequentEventTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapSubsequentEventTypeAxis" xlink:to="loc_us-gaapSubsequentEventTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaapSubsequentEventTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapSubsequentEventTypeAxis" xlink:to="loc_us-gaapSubsequentEventTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SubsequentEventMember" xlink:label="loc_us-gaapSubsequentEventMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventTypeDomain" xlink:to="loc_us-gaapSubsequentEventMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaapAwardTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapSubsequentEventTable" xlink:to="loc_us-gaapAwardTypeAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_SmartMoneyGrantMember" xlink:label="loc_pstiSmartMoneyGrantMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_pstiSmartMoneyGrantMember_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RelatedPartyTransactionAxis" xlink:label="loc_us-gaapRelatedPartyTransactionAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapSubsequentEventTable" xlink:to="loc_us-gaapRelatedPartyTransactionAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RelatedPartyTransactionDomain" xlink:label="loc_us-gaapRelatedPartyTransactionDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapRelatedPartyTransactionAxis" xlink:to="loc_us-gaapRelatedPartyTransactionDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RelatedPartyTransactionDomain" xlink:label="loc_us-gaapRelatedPartyTransactionDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapRelatedPartyTransactionAxis" xlink:to="loc_us-gaapRelatedPartyTransactionDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_AtMarketIssuanceSalesAgreementMember" xlink:label="loc_pstiAtMarketIssuanceSalesAgreementMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyTransactionDomain" xlink:to="loc_pstiAtMarketIssuanceSalesAgreementMember_10" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CurrencyAxis" xlink:label="loc_us-gaapCurrencyAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapSubsequentEventTable" xlink:to="loc_us-gaapCurrencyAxis" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/currency/2017/currency-2017-01-31.xsd#currency_AllCurrenciesDomain" xlink:label="loc_currencyAllCurrenciesDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapCurrencyAxis" xlink:to="loc_currencyAllCurrenciesDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/currency/2017/currency-2017-01-31.xsd#currency_AllCurrenciesDomain" xlink:label="loc_currencyAllCurrenciesDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapCurrencyAxis" xlink:to="loc_currencyAllCurrenciesDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/currency/2017/currency-2017-01-31.xsd#currency_EUR" xlink:label="loc_currencyEUR_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_currencyAllCurrenciesDomain" xlink:to="loc_currencyEUR_40" xlink:type="arc" order="42" />
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_ValueOfCommonStockCompanyCanPeriodicallyIssueThroughAgentsPerTermsOfAtmAgreement" xlink:label="loc_pstiValueOfCommonStockCompanyCanPeriodicallyIssueThroughAgentsPerTermsOfAtmAgreement_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_pstiValueOfCommonStockCompanyCanPeriodicallyIssueThroughAgentsPerTermsOfAtmAgreement_60" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_GrantsReceivable" xlink:label="loc_us-gaapGrantsReceivable_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapGrantsReceivable_60" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues_60" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SharesIssuedPricePerShare" xlink:label="loc_us-gaapSharesIssuedPricePerShare_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapSharesIssuedPricePerShare_60" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_TotalNondilutiveGrantAwardedFromHorizon2020Program" xlink:label="loc_pstiTotalNondilutiveGrantAwardedFromHorizon2020Program_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_pstiTotalNondilutiveGrantAwardedFromHorizon2020Program_60" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_AmountOfDirectGrantsAwardedAllocatedToCompany" xlink:label="loc_pstiAmountOfDirectGrantsAwardedAllocatedToCompany_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_pstiAmountOfDirectGrantsAwardedAllocatedToCompany_60" xlink:type="arc" order="5" />
    </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>15
<FILENAME>psti-20170630_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoXBRL; Version: 4.19b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: http://www.novaworks.co -->
    <!-- Field: Doc-Info; Name: Source; Value: psti%2D0617 10K Steve Fix.xfr; Date: 2017%2D09%2D07T12:28:18Z -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x800B0001 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueByFairValueHierarchyLevelAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis_lbl" xml:lang="en-US">Fair Value, Hierarchy [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueInputsLevel1Member" xlink:label="us-gaap_FairValueInputsLevel1Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueInputsLevel1Member" xlink:to="us-gaap_FairValueInputsLevel1Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueInputsLevel1Member_lbl" xml:lang="en-US">Level 1 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis" xlink:label="us-gaap_FairValueByMeasurementFrequencyAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueByMeasurementFrequencyAxis" xlink:to="us-gaap_FairValueByMeasurementFrequencyAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueByMeasurementFrequencyAxis_lbl" xml:lang="en-US">Measurement Frequency [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember" xlink:label="us-gaap_FairValueMeasurementsRecurringMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueMeasurementsRecurringMember" xlink:to="us-gaap_FairValueMeasurementsRecurringMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueMeasurementsRecurringMember_lbl" xml:lang="en-US">Fair Value, Measurements, Recurring [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueInputsLevel2Member" xlink:label="us-gaap_FairValueInputsLevel2Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueInputsLevel2Member" xlink:to="us-gaap_FairValueInputsLevel2Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueInputsLevel2Member_lbl" xml:lang="en-US">Level 2 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_StatementEquityComponentsAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementEquityComponentsAxis_lbl" xml:lang="en-US">Equity Components [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockMember" xlink:to="us-gaap_CommonStockMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockMember_lbl" xml:lang="en-US">Common Stock [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeMember_lbl" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RetainedEarningsMember" xlink:label="us-gaap_RetainedEarningsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsMember" xlink:to="us-gaap_RetainedEarningsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RetainedEarningsMember_lbl" xml:lang="en-US">Accumulated Deficit [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="us-gaap_AdditionalPaidInCapitalMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapitalMember" xlink:to="us-gaap_AdditionalPaidInCapitalMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdditionalPaidInCapitalMember_lbl" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ReceivablesFromStockholderMember" xlink:label="us-gaap_ReceivablesFromStockholderMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ReceivablesFromStockholderMember" xlink:to="us-gaap_ReceivablesFromStockholderMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ReceivablesFromStockholderMember_lbl" xml:lang="en-US">Receivables on account of shares [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis" xlink:label="us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis" xlink:to="us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis_lbl" xml:lang="en-US">Share-based Goods and Nonemployee Services Transaction, by Supplier [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_ConsultantsMember" xlink:label="psti_ConsultantsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="psti_ConsultantsMember" xlink:to="psti_ConsultantsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="psti_ConsultantsMember_lbl" xml:lang="en-US">Consultants [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_AwardTypeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AwardTypeAxis_lbl" xml:lang="en-US">Award Type [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="us-gaap_RestrictedStockUnitsRSUMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RestrictedStockUnitsRSUMember" xlink:to="us-gaap_RestrictedStockUnitsRSUMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RestrictedStockUnitsRSUMember_lbl" xml:lang="en-US">Restricted stock units [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="us-gaap_EmployeeStockOptionMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeStockOptionMember" xlink:to="us-gaap_EmployeeStockOptionMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EmployeeStockOptionMember_lbl" xml:lang="en-US">Option [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember" xlink:label="us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember" xlink:to="us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember_lbl" xml:lang="en-US">Unrealized gains (losses) on marketable securities [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_MaturityDateRangeAxis" xlink:label="psti_MaturityDateRangeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="psti_MaturityDateRangeAxis" xlink:to="psti_MaturityDateRangeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="psti_MaturityDateRangeAxis_lbl" xml:lang="en-US">Maturity Date Range [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_AvailableForSaleSecuritiesMaturesWithinOneYearMember" xlink:label="psti_AvailableForSaleSecuritiesMaturesWithinOneYearMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="psti_AvailableForSaleSecuritiesMaturesWithinOneYearMember" xlink:to="psti_AvailableForSaleSecuritiesMaturesWithinOneYearMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="psti_AvailableForSaleSecuritiesMaturesWithinOneYearMember_lbl" xml:lang="en-US">Within One Year [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis" xlink:label="us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis" xlink:to="us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis_lbl" xml:lang="en-US">Major Types of Debt and Equity Securities [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EquitySecuritiesMember" xlink:label="us-gaap_EquitySecuritiesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquitySecuritiesMember" xlink:to="us-gaap_EquitySecuritiesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EquitySecuritiesMember_lbl" xml:lang="en-US">Stock and Index Linked Notes [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_GovernmentDebtSecuritiesMember" xlink:label="psti_GovernmentDebtSecuritiesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="psti_GovernmentDebtSecuritiesMember" xlink:to="psti_GovernmentDebtSecuritiesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="psti_GovernmentDebtSecuritiesMember_lbl" xml:lang="en-US">Government Debentures [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CorporateDebtSecuritiesMember" xlink:label="us-gaap_CorporateDebtSecuritiesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CorporateDebtSecuritiesMember" xlink:to="us-gaap_CorporateDebtSecuritiesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CorporateDebtSecuritiesMember_lbl" xml:lang="en-US">Corporate Debentures [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_AvailableForSaleSecuritiesMaturesAfterOneYearThroughFiveYearsMember" xlink:label="psti_AvailableForSaleSecuritiesMaturesAfterOneYearThroughFiveYearsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="psti_AvailableForSaleSecuritiesMaturesAfterOneYearThroughFiveYearsMember" xlink:to="psti_AvailableForSaleSecuritiesMaturesAfterOneYearThroughFiveYearsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="psti_AvailableForSaleSecuritiesMaturesAfterOneYearThroughFiveYearsMember_lbl" xml:lang="en-US">One to Five Years [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_AvailableForSaleSecuritiesMaturesAfterFiveYearsThroughTenYearsMember" xlink:label="psti_AvailableForSaleSecuritiesMaturesAfterFiveYearsThroughTenYearsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="psti_AvailableForSaleSecuritiesMaturesAfterFiveYearsThroughTenYearsMember" xlink:to="psti_AvailableForSaleSecuritiesMaturesAfterFiveYearsThroughTenYearsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="psti_AvailableForSaleSecuritiesMaturesAfterFiveYearsThroughTenYearsMember_lbl" xml:lang="en-US">After Five Years through Ten Years [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RangeAxis" xlink:label="us-gaap_RangeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RangeAxis" xlink:to="us-gaap_RangeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RangeAxis_lbl" xml:lang="en-US">Range [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_MaximumMember" xlink:label="us-gaap_MaximumMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MaximumMember" xlink:to="us-gaap_MaximumMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MaximumMember_lbl" xml:lang="en-US">Maximum [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_MinimumMember" xlink:label="us-gaap_MinimumMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MinimumMember" xlink:to="us-gaap_MinimumMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MinimumMember_lbl" xml:lang="en-US">Minimum [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="us-gaap_IncomeStatementLocationAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeStatementLocationAxis_lbl" xml:lang="en-US">Income Statement Location [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember" xlink:label="us-gaap_ResearchAndDevelopmentExpenseMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentExpenseMember" xlink:to="us-gaap_ResearchAndDevelopmentExpenseMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ResearchAndDevelopmentExpenseMember_lbl" xml:lang="en-US">Research and development expenses [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_GeneralAndAdministrativeExpenseMember" xlink:label="us-gaap_GeneralAndAdministrativeExpenseMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GeneralAndAdministrativeExpenseMember" xlink:to="us-gaap_GeneralAndAdministrativeExpenseMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GeneralAndAdministrativeExpenseMember_lbl" xml:lang="en-US">General and administrative expenses [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis_lbl" xml:lang="en-US">Property, Plant and Equipment by Type [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherMachineryAndEquipmentMember" xlink:label="us-gaap_OtherMachineryAndEquipmentMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherMachineryAndEquipmentMember" xlink:to="us-gaap_OtherMachineryAndEquipmentMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherMachineryAndEquipmentMember_lbl" xml:lang="en-US">Laboratory equipment [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ComputerEquipmentMember" xlink:label="us-gaap_ComputerEquipmentMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ComputerEquipmentMember" xlink:to="us-gaap_ComputerEquipmentMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ComputerEquipmentMember_lbl" xml:lang="en-US">Computers and peripheral equipment [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OfficeEquipmentMember" xlink:label="us-gaap_OfficeEquipmentMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OfficeEquipmentMember" xlink:to="us-gaap_OfficeEquipmentMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OfficeEquipmentMember_lbl" xml:lang="en-US">Office furniture and equipment [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LeaseholdImprovementsMember" xlink:label="us-gaap_LeaseholdImprovementsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeaseholdImprovementsMember" xlink:to="us-gaap_LeaseholdImprovementsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LeaseholdImprovementsMember_lbl" xml:lang="en-US">Leasehold Improvements [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_VehiclesMember" xlink:label="us-gaap_VehiclesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_VehiclesMember" xlink:to="us-gaap_VehiclesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_VehiclesMember_lbl" xml:lang="en-US">Vehicles [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LandAndBuildingMember" xlink:label="us-gaap_LandAndBuildingMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LandAndBuildingMember" xlink:to="us-gaap_LandAndBuildingMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LandAndBuildingMember_lbl" xml:lang="en-US">Leased Facilities [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AutomobilesMember" xlink:label="us-gaap_AutomobilesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AutomobilesMember" xlink:to="us-gaap_AutomobilesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AutomobilesMember_lbl" xml:lang="en-US">Automobiles [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="us-gaap_ClassOfWarrantOrRightAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightAxis" xlink:to="us-gaap_ClassOfWarrantOrRightAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ClassOfWarrantOrRightAxis_lbl" xml:lang="en-US">Class of Warrant or Right [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_InvestorWarrantsMember" xlink:label="psti_InvestorWarrantsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="psti_InvestorWarrantsMember" xlink:to="psti_InvestorWarrantsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="psti_InvestorWarrantsMember_lbl" xml:lang="en-US">Investor Warrants [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_WarrantMember" xlink:label="us-gaap_WarrantMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WarrantMember" xlink:to="us-gaap_WarrantMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WarrantMember_lbl" xml:lang="en-US">Warrant [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PlanNameAxis" xlink:label="us-gaap_PlanNameAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PlanNameAxis_lbl" xml:lang="en-US">Plan Name [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_Plan2005Member" xlink:label="psti_Plan2005Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="psti_Plan2005Member" xlink:to="psti_Plan2005Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="psti_Plan2005Member_lbl" xml:lang="en-US">2005 Plan [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_Plan2016Member" xlink:label="psti_Plan2016Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="psti_Plan2016Member" xlink:to="psti_Plan2016Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="psti_Plan2016Member_lbl" xml:lang="en-US">2016 Plan [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:to="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_lbl" xml:lang="en-US">Exercise Price Range [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_ExercisePriceRangeOneMember" xlink:label="psti_ExercisePriceRangeOneMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="psti_ExercisePriceRangeOneMember" xlink:to="psti_ExercisePriceRangeOneMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="psti_ExercisePriceRangeOneMember_lbl" xml:lang="en-US">$1.4 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_ExercisePriceRangeTwoMember" xlink:label="psti_ExercisePriceRangeTwoMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="psti_ExercisePriceRangeTwoMember" xlink:to="psti_ExercisePriceRangeTwoMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="psti_ExercisePriceRangeTwoMember_lbl" xml:lang="en-US">$2.85 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_ExercisePriceRangeThreeMember" xlink:label="psti_ExercisePriceRangeThreeMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="psti_ExercisePriceRangeThreeMember" xlink:to="psti_ExercisePriceRangeThreeMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="psti_ExercisePriceRangeThreeMember_lbl" xml:lang="en-US">$5.00 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_ExercisePriceRangeFourMember" xlink:label="psti_ExercisePriceRangeFourMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="psti_ExercisePriceRangeFourMember" xlink:to="psti_ExercisePriceRangeFourMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="psti_ExercisePriceRangeFourMember_lbl" xml:lang="en-US">$0.00 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_ExercisePriceRangeFiveMember" xlink:label="psti_ExercisePriceRangeFiveMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="psti_ExercisePriceRangeFiveMember" xlink:to="psti_ExercisePriceRangeFiveMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="psti_ExercisePriceRangeFiveMember_lbl" xml:lang="en-US">$0.62 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_ExercisePriceRangeSixMember" xlink:label="psti_ExercisePriceRangeSixMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="psti_ExercisePriceRangeSixMember" xlink:to="psti_ExercisePriceRangeSixMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="psti_ExercisePriceRangeSixMember_lbl" xml:lang="en-US">$1.04 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_ExercisePriceRangeSevenMember" xlink:label="psti_ExercisePriceRangeSevenMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="psti_ExercisePriceRangeSevenMember" xlink:to="psti_ExercisePriceRangeSevenMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="psti_ExercisePriceRangeSevenMember_lbl" xml:lang="en-US">$2.97 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_ExercisePriceRangeEightMember" xlink:label="psti_ExercisePriceRangeEightMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="psti_ExercisePriceRangeEightMember" xlink:to="psti_ExercisePriceRangeEightMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="psti_ExercisePriceRangeEightMember_lbl" xml:lang="en-US">$3.50 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_ExercisePriceRangeNineMember" xlink:label="psti_ExercisePriceRangeNineMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="psti_ExercisePriceRangeNineMember" xlink:to="psti_ExercisePriceRangeNineMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="psti_ExercisePriceRangeNineMember_lbl" xml:lang="en-US">$3.80 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_ExercisePriceRangeTenMember" xlink:label="psti_ExercisePriceRangeTenMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="psti_ExercisePriceRangeTenMember" xlink:to="psti_ExercisePriceRangeTenMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="psti_ExercisePriceRangeTenMember_lbl" xml:lang="en-US">$4.38 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_ExercisePriceRangeElevenMember" xlink:label="psti_ExercisePriceRangeElevenMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="psti_ExercisePriceRangeElevenMember" xlink:to="psti_ExercisePriceRangeElevenMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="psti_ExercisePriceRangeElevenMember_lbl" xml:lang="en-US">$4.40 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_ExercisePriceRangeTwelveMember" xlink:label="psti_ExercisePriceRangeTwelveMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="psti_ExercisePriceRangeTwelveMember" xlink:to="psti_ExercisePriceRangeTwelveMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="psti_ExercisePriceRangeTwelveMember_lbl" xml:lang="en-US">$6.80 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_ExercisePriceRangeThirteenMember" xlink:label="psti_ExercisePriceRangeThirteenMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="psti_ExercisePriceRangeThirteenMember" xlink:to="psti_ExercisePriceRangeThirteenMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="psti_ExercisePriceRangeThirteenMember_lbl" xml:lang="en-US">$8.20 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_ExercisePriceRangeFourteenMember" xlink:label="psti_ExercisePriceRangeFourteenMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="psti_ExercisePriceRangeFourteenMember" xlink:to="psti_ExercisePriceRangeFourteenMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="psti_ExercisePriceRangeFourteenMember_lbl" xml:lang="en-US">$20.00 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeTaxAuthorityAxis" xlink:label="us-gaap_IncomeTaxAuthorityAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxAuthorityAxis" xlink:to="us-gaap_IncomeTaxAuthorityAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxAuthorityAxis_lbl" xml:lang="en-US">Income Tax Authority [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_InternalRevenueServiceIRSMember" xlink:label="us-gaap_InternalRevenueServiceIRSMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InternalRevenueServiceIRSMember" xlink:to="us-gaap_InternalRevenueServiceIRSMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InternalRevenueServiceIRSMember_lbl" xml:lang="en-US">Internal Revenue Service (IRS) [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TaxPeriodAxis" xlink:label="us-gaap_TaxPeriodAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TaxPeriodAxis" xlink:to="us-gaap_TaxPeriodAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TaxPeriodAxis_lbl" xml:lang="en-US">Tax Period [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EarliestTaxYearMember" xlink:label="us-gaap_EarliestTaxYearMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarliestTaxYearMember" xlink:to="us-gaap_EarliestTaxYearMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarliestTaxYearMember_lbl" xml:lang="en-US">Earliest Tax Year [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LatestTaxYearMember" xlink:label="us-gaap_LatestTaxYearMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LatestTaxYearMember" xlink:to="us-gaap_LatestTaxYearMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LatestTaxYearMember_lbl" xml:lang="en-US">Latest Tax Year [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IsraelTaxAuthorityMember" xlink:label="us-gaap_IsraelTaxAuthorityMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IsraelTaxAuthorityMember" xlink:to="us-gaap_IsraelTaxAuthorityMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IsraelTaxAuthorityMember_lbl" xml:lang="en-US">Israel Tax Authority [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CurrencyAxis" xlink:label="us-gaap_CurrencyAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CurrencyAxis" xlink:to="us-gaap_CurrencyAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CurrencyAxis_lbl" xml:lang="en-US">Currency [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/currency/2017/currency-2017-01-31.xsd#currency_ILS" xlink:label="currency_ILS" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="currency_ILS" xlink:to="currency_ILS_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="currency_ILS_lbl" xml:lang="en-US">Israel, New Shekels [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapitalMember" xlink:to="us-gaap_AdditionalPaidInCapitalMember_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_AdditionalPaidInCapitalMember_2_lbl" xml:lang="en-US">Additional Paid-In Capital [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/currency/2017/currency-2017-01-31.xsd#currency_EUR" xlink:label="currency_EUR" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="currency_EUR" xlink:to="currency_EUR_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="currency_EUR_lbl" xml:lang="en-US">Euro [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_BinationalIndustrialResearchAndDevelopmentFoundationMember" xlink:label="psti_BinationalIndustrialResearchAndDevelopmentFoundationMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="psti_BinationalIndustrialResearchAndDevelopmentFoundationMember" xlink:to="psti_BinationalIndustrialResearchAndDevelopmentFoundationMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="psti_BinationalIndustrialResearchAndDevelopmentFoundationMember_lbl" xml:lang="en-US">BIRD [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_SmartMoneyGrantMember" xlink:label="psti_SmartMoneyGrantMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="psti_SmartMoneyGrantMember" xlink:to="psti_SmartMoneyGrantMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="psti_SmartMoneyGrantMember_lbl" xml:lang="en-US">Smart Money Grant [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_NewYorkBloodCenterIncMember" xlink:label="psti_NewYorkBloodCenterIncMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="psti_NewYorkBloodCenterIncMember" xlink:to="psti_NewYorkBloodCenterIncMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="psti_NewYorkBloodCenterIncMember_lbl" xml:lang="en-US">NYBC [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_ContractorMember" xlink:label="psti_ContractorMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="psti_ContractorMember" xlink:to="psti_ContractorMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="psti_ContractorMember_lbl" xml:lang="en-US">Contractor [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LegalEntityAxis" xlink:to="dei_LegalEntityAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LegalEntityAxis_lbl" xml:lang="en-US">Legal Entity [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_UnderwritingAgreementMember" xlink:label="psti_UnderwritingAgreementMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="psti_UnderwritingAgreementMember" xlink:to="psti_UnderwritingAgreementMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="psti_UnderwritingAgreementMember_lbl" xml:lang="en-US">Underwriting Agreement [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TitleOfIndividualAxis" xlink:label="us-gaap_TitleOfIndividualAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TitleOfIndividualAxis" xlink:to="us-gaap_TitleOfIndividualAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TitleOfIndividualAxis_lbl" xml:lang="en-US">Title Of Individual [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_EmployeesAndDirectorsMember" xlink:label="psti_EmployeesAndDirectorsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="psti_EmployeesAndDirectorsMember" xlink:to="psti_EmployeesAndDirectorsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="psti_EmployeesAndDirectorsMember_lbl" xml:lang="en-US">Employees and Directors [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_NonemployeesMember" xlink:label="psti_NonemployeesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="psti_NonemployeesMember" xlink:to="psti_NonemployeesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="psti_NonemployeesMember_lbl" xml:lang="en-US">Non-employee Consultants [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="us-gaap_SubsequentEventTypeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventTypeAxis_lbl" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SubsequentEventMember" xlink:label="us-gaap_SubsequentEventMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventMember" xlink:to="us-gaap_SubsequentEventMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventMember_lbl" xml:lang="en-US">Subsequent Event [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RelatedPartyTransactionAxis" xlink:label="us-gaap_RelatedPartyTransactionAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionAxis" xlink:to="us-gaap_RelatedPartyTransactionAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyTransactionAxis_lbl" xml:lang="en-US">Related Party Transaction [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_AtMarketIssuanceSalesAgreementMember" xlink:label="psti_AtMarketIssuanceSalesAgreementMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="psti_AtMarketIssuanceSalesAgreementMember" xlink:to="psti_AtMarketIssuanceSalesAgreementMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="psti_AtMarketIssuanceSalesAgreementMember_lbl" xml:lang="en-US">ATM Agreement [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_TechnologicalPreferredEnterpriseMember" xlink:label="psti_TechnologicalPreferredEnterpriseMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="psti_TechnologicalPreferredEnterpriseMember" xlink:to="psti_TechnologicalPreferredEnterpriseMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="psti_TechnologicalPreferredEnterpriseMember_lbl" xml:lang="en-US">Technological Preferred Enterprise [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_SpecialTechnologicalPreferredEnterpriseMember" xlink:label="psti_SpecialTechnologicalPreferredEnterpriseMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="psti_SpecialTechnologicalPreferredEnterpriseMember" xlink:to="psti_SpecialTechnologicalPreferredEnterpriseMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="psti_SpecialTechnologicalPreferredEnterpriseMember_lbl" xml:lang="en-US">Special Technological Preferred Enterprise [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_PreferredEnterpriseMember" xlink:label="psti_PreferredEnterpriseMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="psti_PreferredEnterpriseMember" xlink:to="psti_PreferredEnterpriseMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="psti_PreferredEnterpriseMember_lbl" xml:lang="en-US">Preferred Enterprise [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementGeographicalAxis" xlink:label="us-gaap_StatementGeographicalAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementGeographicalAxis" xlink:to="us-gaap_StatementGeographicalAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementGeographicalAxis_lbl" xml:lang="en-US">Statement, Geographical [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_DevelopmentAreaMember" xlink:label="psti_DevelopmentAreaMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="psti_DevelopmentAreaMember" xlink:to="psti_DevelopmentAreaMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="psti_DevelopmentAreaMember_lbl" xml:lang="en-US">Development Area A [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_RestOfCountryMember" xlink:label="psti_RestOfCountryMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="psti_RestOfCountryMember" xlink:to="psti_RestOfCountryMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="psti_RestOfCountryMember_lbl" xml:lang="en-US">Rest Of Country [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_TechnologicalEnterpriseMember" xlink:label="psti_TechnologicalEnterpriseMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="psti_TechnologicalEnterpriseMember" xlink:to="psti_TechnologicalEnterpriseMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="psti_TechnologicalEnterpriseMember_lbl" xml:lang="en-US">Technological Enterprise [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_DocumentAndEntityInformationAbstract" xlink:label="psti_DocumentAndEntityInformationAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="psti_DocumentAndEntityInformationAbstract" xlink:to="psti_DocumentAndEntityInformationAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="psti_DocumentAndEntityInformationAbstract_lbl" xml:lang="en-US">Document and Entity Information [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US">Entity Public Float</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity Voluntary Filers</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="us-gaap_StatementOfFinancialPositionAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_StatementOfFinancialPositionAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementOfFinancialPositionAbstract_lbl" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AssetsAbstract" xlink:label="us-gaap_AssetsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_AssetsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AssetsAbstract_lbl" xml:lang="en-US">ASSETS</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="us-gaap_AssetsCurrentAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AssetsCurrentAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsCurrentAbstract_lbl" xml:lang="en-US">CURRENT ASSETS:</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" xml:lang="en-US">Cash and cash equivalents</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShortTermInvestments" xlink:label="us-gaap_ShortTermInvestments" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShortTermInvestments" xlink:to="us-gaap_ShortTermInvestments_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShortTermInvestments_lbl" xml:lang="en-US">Short-term bank deposits</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue" xlink:label="us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue" xlink:to="us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_lbl" xml:lang="en-US">Restricted cash and short-term-bank deposits</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_MarketableSecuritiesCurrent" xlink:label="us-gaap_MarketableSecuritiesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MarketableSecuritiesCurrent" xlink:to="us-gaap_MarketableSecuritiesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MarketableSecuritiesCurrent_lbl" xml:lang="en-US">Marketable securities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="us-gaap_AccountsReceivableNetCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsReceivableNetCurrent" xlink:to="us-gaap_AccountsReceivableNetCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsReceivableNetCurrent_lbl" xml:lang="en-US">Accounts receivable from the Israeli Innovation Authority ("IIA")</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherAssetsCurrent" xlink:label="us-gaap_OtherAssetsCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherAssetsCurrent" xlink:to="us-gaap_OtherAssetsCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OtherAssetsCurrent_lbl" xml:lang="en-US">Other current assets</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="us-gaap_AssetsCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_AssetsCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_AssetsCurrent_lbl" xml:lang="en-US">Total current assets</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AssetsNoncurrentAbstract" xlink:label="us-gaap_AssetsNoncurrentAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsNoncurrentAbstract" xlink:to="us-gaap_AssetsNoncurrentAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsNoncurrentAbstract_lbl" xml:lang="en-US">LONG-TERM ASSETS:</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LongTermInvestments" xlink:label="us-gaap_LongTermInvestments" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermInvestments" xlink:to="us-gaap_LongTermInvestments_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LongTermInvestments_lbl" xml:lang="en-US">Long-term deposits and restricted bank deposits</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent" xlink:label="us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent" xlink:to="us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent_lbl" xml:lang="en-US">Severance pay fund</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="us-gaap_PropertyPlantAndEquipmentNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentNet" xlink:to="us-gaap_PropertyPlantAndEquipmentNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentNet_lbl" xml:lang="en-US">Property and equipment, net</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherAssetsNoncurrent" xlink:label="us-gaap_OtherAssetsNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherAssetsNoncurrent" xlink:to="us-gaap_OtherAssetsNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherAssetsNoncurrent_lbl" xml:lang="en-US">Other long term assets</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AssetsNoncurrent" xlink:label="us-gaap_AssetsNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsNoncurrent" xlink:to="us-gaap_AssetsNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_AssetsNoncurrent_lbl" xml:lang="en-US">Total long-term assets</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_Assets" xlink:label="us-gaap_Assets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Assets" xlink:to="us-gaap_Assets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_Assets_lbl" xml:lang="en-US">Total assets</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl" xml:lang="en-US">LIABILITIES AND STOCKHOLDERS' EQUITY</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="us-gaap_LiabilitiesCurrentAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_LiabilitiesCurrentAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesCurrentAbstract_lbl" xml:lang="en-US">CURRENT LIABILITIES</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccountsPayableCurrent" xlink:label="us-gaap_AccountsPayableCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableCurrent" xlink:to="us-gaap_AccountsPayableCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AccountsPayableCurrent_lbl" xml:lang="en-US">Trade payables</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="us-gaap_AccruedLiabilitiesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccruedLiabilitiesCurrent" xlink:to="us-gaap_AccruedLiabilitiesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccruedLiabilitiesCurrent_lbl" xml:lang="en-US">Accrued expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccountsPayableOtherCurrent" xlink:label="us-gaap_AccountsPayableOtherCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableOtherCurrent" xlink:to="us-gaap_AccountsPayableOtherCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AccountsPayableOtherCurrent_lbl" xml:lang="en-US">Other accounts payable</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="us-gaap_LiabilitiesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_LiabilitiesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_LiabilitiesCurrent_lbl" xml:lang="en-US">Total current liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LiabilitiesNoncurrentAbstract" xlink:label="us-gaap_LiabilitiesNoncurrentAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesNoncurrentAbstract" xlink:to="us-gaap_LiabilitiesNoncurrentAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesNoncurrentAbstract_lbl" xml:lang="en-US">LONG-TERM LIABILITIES</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PostemploymentBenefitsLiabilityNoncurrent" xlink:label="us-gaap_PostemploymentBenefitsLiabilityNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PostemploymentBenefitsLiabilityNoncurrent" xlink:to="us-gaap_PostemploymentBenefitsLiabilityNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PostemploymentBenefitsLiabilityNoncurrent_lbl" xml:lang="en-US">Accrued severance pay</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent" xlink:label="us-gaap_OtherLiabilitiesNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherLiabilitiesNoncurrent" xlink:to="us-gaap_OtherLiabilitiesNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherLiabilitiesNoncurrent_lbl" xml:lang="en-US">Other long-term liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LiabilitiesNoncurrent" xlink:label="us-gaap_LiabilitiesNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesNoncurrent" xlink:to="us-gaap_LiabilitiesNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_LiabilitiesNoncurrent_lbl" xml:lang="en-US">Total long-term liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="us-gaap_CommitmentsAndContingencies" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingencies" xlink:to="us-gaap_CommitmentsAndContingencies_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommitmentsAndContingencies_lbl" xml:lang="en-US">COMMITMENTS AND CONTINGENCIES</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EquityAbstract" xlink:label="us-gaap_EquityAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityAbstract" xlink:to="us-gaap_EquityAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EquityAbstract_lbl" xml:lang="en-US">STOCKHOLDERS' EQUITY</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CommonStockValue" xlink:label="us-gaap_CommonStockValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockValue" xlink:to="us-gaap_CommonStockValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockValue_lbl" xml:lang="en-US">Common stock $0.00001 par value per share: Authorized: 200,000,000 shares Issued and outstanding: 96,938,789 shares as of June 30, 2017; 80,268,999 shares as of June 30, 2016</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="us-gaap_AdditionalPaidInCapital" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapital" xlink:to="us-gaap_AdditionalPaidInCapital_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdditionalPaidInCapital_lbl" xml:lang="en-US">Additional paid-in capital</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xml:lang="en-US">Accumulated deficit</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_lbl" xml:lang="en-US">Other comprehensive income</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_StockholdersEquity_lbl" xml:lang="en-US">Total stockholders' equity</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_lbl" xml:lang="en-US">Total liabilities and stockholders' equity</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare_lbl" xml:lang="en-US">Common stock, par value per share</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="us-gaap_CommonStockSharesAuthorized" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesAuthorized" xlink:to="us-gaap_CommonStockSharesAuthorized_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesAuthorized_lbl" xml:lang="en-US">Common stock, shares authorized</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:label="us-gaap_CommonStockSharesIssued" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesIssued" xlink:to="us-gaap_CommonStockSharesIssued_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesIssued_lbl" xml:lang="en-US">Common stock, shares issued</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="us-gaap_CommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesOutstanding" xlink:to="us-gaap_CommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesOutstanding_lbl" xml:lang="en-US">Common stock, shares outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeStatementAbstract" xlink:label="us-gaap_IncomeStatementAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_IncomeStatementAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeStatementAbstract_lbl" xml:lang="en-US">Income Statement [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_Revenues" xlink:label="us-gaap_Revenues" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Revenues" xlink:to="us-gaap_Revenues_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Revenues_lbl" xml:lang="en-US">Revenues</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CostOfRevenue" xlink:label="us-gaap_CostOfRevenue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CostOfRevenue" xlink:to="us-gaap_CostOfRevenue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_CostOfRevenue_lbl" xml:lang="en-US">Cost of revenues</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_GrossProfit" xlink:label="us-gaap_GrossProfit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GrossProfit" xlink:to="us-gaap_GrossProfit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_GrossProfit_lbl" xml:lang="en-US">Gross profit</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="us-gaap_ResearchAndDevelopmentExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentExpense" xlink:to="us-gaap_ResearchAndDevelopmentExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_ResearchAndDevelopmentExpense_lbl" xml:lang="en-US">Research and development expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_GovernmentAndThirdPartyGrantsReceived" xlink:label="psti_GovernmentAndThirdPartyGrantsReceived" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="psti_GovernmentAndThirdPartyGrantsReceived" xlink:to="psti_GovernmentAndThirdPartyGrantsReceived_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="psti_GovernmentAndThirdPartyGrantsReceived_lbl" xml:lang="en-US">Less R&amp;D participation grants</link:label>
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_ResearchAndDevelopmentExpensesNet" xlink:label="psti_ResearchAndDevelopmentExpensesNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="psti_ResearchAndDevelopmentExpensesNet" xlink:to="psti_ResearchAndDevelopmentExpensesNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:label="psti_ResearchAndDevelopmentExpensesNet_lbl" xml:lang="en-US">Research and development expenses, net</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="us-gaap_GeneralAndAdministrativeExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GeneralAndAdministrativeExpense" xlink:to="us-gaap_GeneralAndAdministrativeExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_GeneralAndAdministrativeExpense_lbl" xml:lang="en-US">General and administrative expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="us-gaap_OperatingIncomeLoss" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_OperatingIncomeLoss_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_OperatingIncomeLoss_lbl" xml:lang="en-US">Operating loss</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="us-gaap_NonoperatingIncomeExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NonoperatingIncomeExpense" xlink:to="us-gaap_NonoperatingIncomeExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NonoperatingIncomeExpense_lbl" xml:lang="en-US">Financial income, net</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetIncomeLoss_lbl" xml:lang="en-US">Net loss for the period</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="us-gaap_EarningsPerShareAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_EarningsPerShareAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerShareAbstract_lbl" xml:lang="en-US">Loss per share:</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EarningsPerShareBasicAndDiluted" xlink:label="us-gaap_EarningsPerShareBasicAndDiluted" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareBasicAndDiluted" xlink:to="us-gaap_EarningsPerShareBasicAndDiluted_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerShareBasicAndDiluted_lbl" xml:lang="en-US">Basic and diluted net loss per share</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:label="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:to="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_lbl" xml:lang="en-US">Weighted average number of shares used in computing basic and diluted net loss per share</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:label="us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:to="us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_lbl" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetIncomeLoss_2_lbl" xml:lang="en-US">Net loss</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParentAbstract" xlink:label="us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParentAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParentAbstract" xlink:to="us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParentAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParentAbstract_lbl" xml:lang="en-US">Other comprehensive income (loss), net:</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax" xlink:label="us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax" xlink:to="us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax_lbl" xml:lang="en-US">Unrealized gain on derivative instruments</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:label="us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:to="us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_lbl" xml:lang="en-US">Unrealized gain (loss) on available-for-sale marketable securities, net</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax" xlink:label="us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax" xlink:to="us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax_lbl" xml:lang="en-US">Reclassification adjustment of derivative instruments losses realized in net loss, net</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax" xlink:label="us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax" xlink:to="us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax_lbl" xml:lang="en-US">Reclassification adjustment of available-for-sale marketable securities gains (losses) realized in net loss, net</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:to="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_lbl" xml:lang="en-US">Other comprehensive income (loss)</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax" xlink:label="us-gaap_ComprehensiveIncomeNetOfTax" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="us-gaap_ComprehensiveIncomeNetOfTax_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_ComprehensiveIncomeNetOfTax_lbl" xml:lang="en-US">Total comprehensive loss</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementTable_lbl" xml:lang="en-US">Statement [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementLineItems_lbl" xml:lang="en-US">Statement [Line Items]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_StockholdersEquity_2_lbl" xml:lang="en-US">Balance</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesOutstanding" xlink:to="us-gaap_CommonStockSharesOutstanding_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_CommonStockSharesOutstanding_2_lbl" xml:lang="en-US">Balance, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues_lbl" xml:lang="en-US">Issuance of common stock and warrants related to June 2015 offering, net of issuance costs of $1,200 (Note 9c)</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl" xml:lang="en-US">Issuance of common stock and warrants related to June 2015 offering, net of issuance costs of $1,200 (Note 9c), shares</link:label>
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_ExerciseOfOptionsByEmployees" xlink:label="psti_ExerciseOfOptionsByEmployees" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="psti_ExerciseOfOptionsByEmployees" xlink:to="psti_ExerciseOfOptionsByEmployees_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="psti_ExerciseOfOptionsByEmployees_lbl" xml:lang="en-US">Exercise of options by employees</link:label>
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_ExerciseOfOptionsByEmployeesShares" xlink:label="psti_ExerciseOfOptionsByEmployeesShares" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="psti_ExerciseOfOptionsByEmployeesShares" xlink:to="psti_ExerciseOfOptionsByEmployeesShares_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="psti_ExerciseOfOptionsByEmployeesShares_lbl" xml:lang="en-US">Exercise of options by employees, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:to="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_lbl" xml:lang="en-US">Exercise of options by employees and non-employee consultants</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl" xml:lang="en-US">Exercise of options by employees and non-employee consultants, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_StockIssuedDuringPeriodValueStockWarrantsExercised" xlink:label="psti_StockIssuedDuringPeriodValueStockWarrantsExercised" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="psti_StockIssuedDuringPeriodValueStockWarrantsExercised" xlink:to="psti_StockIssuedDuringPeriodValueStockWarrantsExercised_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="psti_StockIssuedDuringPeriodValueStockWarrantsExercised_lbl" xml:lang="en-US">Exercise of warrants by investors and finders</link:label>
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_StockIssuedDuringPeriodSharesStockWarrantsExercised" xlink:label="psti_StockIssuedDuringPeriodSharesStockWarrantsExercised" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="psti_StockIssuedDuringPeriodSharesStockWarrantsExercised" xlink:to="psti_StockIssuedDuringPeriodSharesStockWarrantsExercised_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="psti_StockIssuedDuringPeriodSharesStockWarrantsExercised_lbl" xml:lang="en-US">Exercise of warrants by investors and finders, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:label="us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:to="us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_lbl" xml:lang="en-US">Stock based compensation to employees, directors and non-employee consultants</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:label="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:to="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_lbl" xml:lang="en-US">Stock based compensation to employees, directors and non-employee consultants, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_StockIssuedDuringPeriodValuePrivatePlacement" xlink:label="psti_StockIssuedDuringPeriodValuePrivatePlacement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="psti_StockIssuedDuringPeriodValuePrivatePlacement" xlink:to="psti_StockIssuedDuringPeriodValuePrivatePlacement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="psti_StockIssuedDuringPeriodValuePrivatePlacement_lbl" xml:lang="en-US">Proceeds related to issuance of common stock in a private placement (Note 9b)</link:label>
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_StockIssuedDuringPeriodSharesPrivatePlacement" xlink:label="psti_StockIssuedDuringPeriodSharesPrivatePlacement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="psti_StockIssuedDuringPeriodSharesPrivatePlacement" xlink:to="psti_StockIssuedDuringPeriodSharesPrivatePlacement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="psti_StockIssuedDuringPeriodSharesPrivatePlacement_lbl" xml:lang="en-US">Proceeds related to issuance of common stock in a private placement (Note 9b), shares</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueIssuedForServices" xlink:label="us-gaap_StockIssuedDuringPeriodValueIssuedForServices" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueIssuedForServices" xlink:to="us-gaap_StockIssuedDuringPeriodValueIssuedForServices_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueIssuedForServices_lbl" xml:lang="en-US">Stock-based compensation to contractor (Note 9d)</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:label="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:to="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_lbl" xml:lang="en-US">Stock-based compensation to contractor, shares (Note 9d)</link:label>
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_IssuanceOfCommonStockAndWarrantsRelatedToJanuaryTwentySeventeenOfferingNetOfIssuanceCostsValue" xlink:label="psti_IssuanceOfCommonStockAndWarrantsRelatedToJanuaryTwentySeventeenOfferingNetOfIssuanceCostsValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="psti_IssuanceOfCommonStockAndWarrantsRelatedToJanuaryTwentySeventeenOfferingNetOfIssuanceCostsValue" xlink:to="psti_IssuanceOfCommonStockAndWarrantsRelatedToJanuaryTwentySeventeenOfferingNetOfIssuanceCostsValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="psti_IssuanceOfCommonStockAndWarrantsRelatedToJanuaryTwentySeventeenOfferingNetOfIssuanceCostsValue_lbl" xml:lang="en-US">Issuance of common stock and warrants related to January 2017 offering, net of issuance costs of $1,532 (Note 9e)</link:label>
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_IssuanceOfCommonStockAndWarrantsRelatedToJanuaryTwentySeventeenOfferingNetOfIssuanceCostsShares" xlink:label="psti_IssuanceOfCommonStockAndWarrantsRelatedToJanuaryTwentySeventeenOfferingNetOfIssuanceCostsShares" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="psti_IssuanceOfCommonStockAndWarrantsRelatedToJanuaryTwentySeventeenOfferingNetOfIssuanceCostsShares" xlink:to="psti_IssuanceOfCommonStockAndWarrantsRelatedToJanuaryTwentySeventeenOfferingNetOfIssuanceCostsShares_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="psti_IssuanceOfCommonStockAndWarrantsRelatedToJanuaryTwentySeventeenOfferingNetOfIssuanceCostsShares_lbl" xml:lang="en-US">Issuance of common stock and warrants related to January 2017 offering, net of issuance costs of $1,532 (Note 9e), shares</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTax" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:to="us-gaap_OtherComprehensiveIncomeLossNetOfTax_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTax_lbl" xml:lang="en-US">Other comprehensive income (loss), net</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_StockholdersEquity_3_lbl" xml:lang="en-US">Balance</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesOutstanding" xlink:to="us-gaap_CommonStockSharesOutstanding_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_CommonStockSharesOutstanding_3_lbl" xml:lang="en-US">Balance, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract" xlink:label="us-gaap_StatementOfStockholdersEquityAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="us-gaap_StatementOfStockholdersEquityAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementOfStockholdersEquityAbstract_lbl" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_lbl" xml:lang="en-US">Issuance of common stock and warrants, issuance costs</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="us-gaap_StatementOfCashFlowsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_StatementOfCashFlowsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementOfCashFlowsAbstract_lbl" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xml:lang="en-US">CASH FLOWS FROM OPERATING ACTIVITIES:</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xml:lang="en-US">Adjustments to reconcile net loss to net cash used in operating activities:</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_Depreciation" xlink:label="us-gaap_Depreciation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Depreciation" xlink:to="us-gaap_Depreciation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Depreciation_lbl" xml:lang="en-US">Depreciation</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:label="us-gaap_GainLossOnSaleOfPropertyPlantEquipment" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:to="us-gaap_GainLossOnSaleOfPropertyPlantEquipment_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_GainLossOnSaleOfPropertyPlantEquipment_lbl" xml:lang="en-US">Loss from sale of property and equipment, net</link:label>
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_AmortizationOfDiscountAndPremiumAndChangesInAccruedInterestFromMarketableSecurities" xlink:label="psti_AmortizationOfDiscountAndPremiumAndChangesInAccruedInterestFromMarketableSecurities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="psti_AmortizationOfDiscountAndPremiumAndChangesInAccruedInterestFromMarketableSecurities" xlink:to="psti_AmortizationOfDiscountAndPremiumAndChangesInAccruedInterestFromMarketableSecurities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="psti_AmortizationOfDiscountAndPremiumAndChangesInAccruedInterestFromMarketableSecurities_lbl" xml:lang="en-US">Accretion of discount, amortization of premium and changes in accrued interest of marketable securities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_MarketableSecuritiesRealizedGainLoss" xlink:label="us-gaap_MarketableSecuritiesRealizedGainLoss" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MarketableSecuritiesRealizedGainLoss" xlink:to="us-gaap_MarketableSecuritiesRealizedGainLoss_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_MarketableSecuritiesRealizedGainLoss_lbl" xml:lang="en-US">Loss (gain) from sale of investments of available-for-sale marketable securities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherThanTemporaryImpairmentLossesInvestmentsPortionRecognizedInEarningsNet" xlink:label="us-gaap_OtherThanTemporaryImpairmentLossesInvestmentsPortionRecognizedInEarningsNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherThanTemporaryImpairmentLossesInvestmentsPortionRecognizedInEarningsNet" xlink:to="us-gaap_OtherThanTemporaryImpairmentLossesInvestmentsPortionRecognizedInEarningsNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherThanTemporaryImpairmentLossesInvestmentsPortionRecognizedInEarningsNet_lbl" xml:lang="en-US">Other-than-temporary loss of available-for-sale marketable securities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="us-gaap_ShareBasedCompensation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensation" xlink:to="us-gaap_ShareBasedCompensation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensation_lbl" xml:lang="en-US">Stock-based compensation to employees, directors and non-employees consultants</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncreaseDecreaseInOtherReceivables" xlink:label="us-gaap_IncreaseDecreaseInOtherReceivables" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOtherReceivables" xlink:to="us-gaap_IncreaseDecreaseInOtherReceivables_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncreaseDecreaseInOtherReceivables_lbl" xml:lang="en-US">Decrease (increase) in Accounts receivable from the IIA</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:label="us-gaap_IncreaseDecreaseInOtherOperatingAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:to="us-gaap_IncreaseDecreaseInOtherOperatingAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncreaseDecreaseInOtherOperatingAssets_lbl" xml:lang="en-US">Decrease (increase) in other current assets and other long-term assets</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsPayable" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable_lbl" xml:lang="en-US">Decrease in trade payables</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities" xlink:label="us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities" xlink:to="us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities_lbl" xml:lang="en-US">Increase (decrease) in other accounts payable, accrued expenses, other long-term liabilities and other current liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:label="us-gaap_IncreaseDecreaseInDeferredRevenue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:to="us-gaap_IncreaseDecreaseInDeferredRevenue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInDeferredRevenue_lbl" xml:lang="en-US">Decrease in deferred revenues</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncreaseDecreaseInCustomerAdvances" xlink:label="us-gaap_IncreaseDecreaseInCustomerAdvances" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInCustomerAdvances" xlink:to="us-gaap_IncreaseDecreaseInCustomerAdvances_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInCustomerAdvances_lbl" xml:lang="en-US">Decrease in advance payment from United</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedInterestReceivableNet" xlink:label="us-gaap_IncreaseDecreaseInAccruedInterestReceivableNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccruedInterestReceivableNet" xlink:to="us-gaap_IncreaseDecreaseInAccruedInterestReceivableNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncreaseDecreaseInAccruedInterestReceivableNet_lbl" xml:lang="en-US">Increase (decrease) in interest receivable on short-term deposits</link:label>
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_LinkageDifferencesAndInterestOnShortAndLongTermRestrictedLeaseDeposit" xlink:label="psti_LinkageDifferencesAndInterestOnShortAndLongTermRestrictedLeaseDeposit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="psti_LinkageDifferencesAndInterestOnShortAndLongTermRestrictedLeaseDeposit" xlink:to="psti_LinkageDifferencesAndInterestOnShortAndLongTermRestrictedLeaseDeposit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="psti_LinkageDifferencesAndInterestOnShortAndLongTermRestrictedLeaseDeposit_lbl" xml:lang="en-US">Linkage differences and interest on short and long-term deposits and restricted bank deposits</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncreaseDecreaseInPensionAndPostretirementObligations" xlink:label="us-gaap_IncreaseDecreaseInPensionAndPostretirementObligations" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInPensionAndPostretirementObligations" xlink:to="us-gaap_IncreaseDecreaseInPensionAndPostretirementObligations_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInPensionAndPostretirementObligations_lbl" xml:lang="en-US">Accrued severance pay, net</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl" xml:lang="en-US">Net cash used in operating activities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl" xml:lang="en-US">CASH FLOWS FROM INVESTING ACTIVITIES:</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl" xml:lang="en-US">Purchase of property and equipment</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:label="us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:to="us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_lbl" xml:lang="en-US">Proceeds from sale of property and equipment</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PaymentsForProceedsFromShortTermInvestments" xlink:label="us-gaap_PaymentsForProceedsFromShortTermInvestments" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsForProceedsFromShortTermInvestments" xlink:to="us-gaap_PaymentsForProceedsFromShortTermInvestments_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_PaymentsForProceedsFromShortTermInvestments_lbl" xml:lang="en-US">Repayment of (investment in) short-term deposits</link:label>
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_RepaymentOfInvestmentInLongtermDepositsAndRestrictedBankDeposits" xlink:label="psti_RepaymentOfInvestmentInLongtermDepositsAndRestrictedBankDeposits" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="psti_RepaymentOfInvestmentInLongtermDepositsAndRestrictedBankDeposits" xlink:to="psti_RepaymentOfInvestmentInLongtermDepositsAndRestrictedBankDeposits_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="psti_RepaymentOfInvestmentInLongtermDepositsAndRestrictedBankDeposits_lbl" xml:lang="en-US">Repayment of (investment in) long-term deposits and restricted bank deposits</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ProceedsFromSaleOfAvailableForSaleSecurities" xlink:label="us-gaap_ProceedsFromSaleOfAvailableForSaleSecurities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromSaleOfAvailableForSaleSecurities" xlink:to="us-gaap_ProceedsFromSaleOfAvailableForSaleSecurities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromSaleOfAvailableForSaleSecurities_lbl" xml:lang="en-US">Proceeds from sale of available-for-sale marketable securities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities" xlink:label="us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities" xlink:to="us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities_lbl" xml:lang="en-US">Proceeds from redemption of available-for-sale marketable securities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PaymentsToAcquireAvailableForSaleSecurities" xlink:label="us-gaap_PaymentsToAcquireAvailableForSaleSecurities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquireAvailableForSaleSecurities" xlink:to="us-gaap_PaymentsToAcquireAvailableForSaleSecurities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_PaymentsToAcquireAvailableForSaleSecurities_lbl" xml:lang="en-US">Investment in available-for-sale marketable securities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl" xml:lang="en-US">Net cash provided by investing activities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl" xml:lang="en-US">CASH FLOWS FROM FINANCING ACTIVITIES:</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl" xml:lang="en-US">Proceeds related to issuance of common stock and warrants, net of issuance costs</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:label="us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:to="us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_lbl" xml:lang="en-US">Proceeds in respect of BIRD liability</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:label="us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:to="us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_lbl" xml:lang="en-US">Exercise of warrants and options</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl" xml:lang="en-US">Net cash provided by financing activities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:label="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:to="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease_lbl" xml:lang="en-US">Increase (decrease) in cash and cash equivalents</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_2_lbl" xml:lang="en-US">Cash and cash equivalents at the beginning of the period</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_3_lbl" xml:lang="en-US">Cash and cash equivalents at the end of the period</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract" xlink:label="us-gaap_SupplementalCashFlowInformationAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="us-gaap_SupplementalCashFlowInformationAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SupplementalCashFlowInformationAbstract_lbl" xml:lang="en-US">(a) Supplemental disclosure of cash flow activities:</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeTaxesPaid" xlink:label="us-gaap_IncomeTaxesPaid" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxesPaid" xlink:to="us-gaap_IncomeTaxesPaid_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxesPaid_lbl" xml:lang="en-US">Cash paid during the period for: Taxes paid due to non-deductible expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherNoncashInvestingAndFinancingItemsAbstract" xlink:label="us-gaap_OtherNoncashInvestingAndFinancingItemsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherNoncashInvestingAndFinancingItemsAbstract" xlink:to="us-gaap_OtherNoncashInvestingAndFinancingItemsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherNoncashInvestingAndFinancingItemsAbstract_lbl" xml:lang="en-US">(b) Supplemental disclosure of non-cash activities:</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:label="us-gaap_CapitalExpendituresIncurredButNotYetPaid" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:to="us-gaap_CapitalExpendituresIncurredButNotYetPaid_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CapitalExpendituresIncurredButNotYetPaid_lbl" xml:lang="en-US">Purchase of property and equipment on credit</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockIssued1" xlink:label="us-gaap_StockIssued1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssued1" xlink:to="us-gaap_StockIssued1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssued1_lbl" xml:lang="en-US">Share consideration to constructor</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherSignificantNoncashTransactionValueOfConsiderationGiven1" xlink:label="us-gaap_OtherSignificantNoncashTransactionValueOfConsiderationGiven1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherSignificantNoncashTransactionValueOfConsiderationGiven1" xlink:to="us-gaap_OtherSignificantNoncashTransactionValueOfConsiderationGiven1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherSignificantNoncashTransactionValueOfConsiderationGiven1_lbl" xml:lang="en-US">Receivables on account of shares</link:label>
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_GeneralAbstract" xlink:label="psti_GeneralAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="psti_GeneralAbstract" xlink:to="psti_GeneralAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="psti_GeneralAbstract_lbl" xml:lang="en-US">GENERAL [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:to="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_lbl" xml:lang="en-US">GENERAL</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="us-gaap_AccountingPoliciesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_AccountingPoliciesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountingPoliciesAbstract_lbl" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SignificantAccountingPoliciesTextBlock" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SignificantAccountingPoliciesTextBlock" xlink:to="us-gaap_SignificantAccountingPoliciesTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock_lbl" xml:lang="en-US">SIGNIFICANT ACCOUNTING POLICIES</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_MarketableSecuritiesAbstract" xlink:label="us-gaap_MarketableSecuritiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MarketableSecuritiesAbstract" xlink:to="us-gaap_MarketableSecuritiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MarketableSecuritiesAbstract_lbl" xml:lang="en-US">Marketable Securities [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:label="us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:to="us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_lbl" xml:lang="en-US">MARKETABLE SECURITIES</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="us-gaap_FairValueDisclosuresAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueDisclosuresAbstract" xlink:to="us-gaap_FairValueDisclosuresAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueDisclosuresAbstract_lbl" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueDisclosuresTextBlock" xlink:label="us-gaap_FairValueDisclosuresTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueDisclosuresTextBlock" xlink:to="us-gaap_FairValueDisclosuresTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_FairValueDisclosuresTextBlock_lbl" xml:lang="en-US">FAIR VALUE OF FINANCIAL INSTRUMENTS</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract" xlink:label="us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract" xlink:to="us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract_lbl" xml:lang="en-US">Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherCurrentAssetsTextBlock" xlink:label="us-gaap_OtherCurrentAssetsTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherCurrentAssetsTextBlock" xlink:to="us-gaap_OtherCurrentAssetsTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherCurrentAssetsTextBlock_lbl" xml:lang="en-US">OTHER CURRENT ASSETS</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="us-gaap_PropertyPlantAndEquipmentAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentAbstract_lbl" xml:lang="en-US">Property, Plant and Equipment [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:label="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:to="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_lbl" xml:lang="en-US">PROPERTY AND EQUIPMENT, NET</link:label>
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_OtherAccountsPayableAbstract" xlink:label="psti_OtherAccountsPayableAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="psti_OtherAccountsPayableAbstract" xlink:to="psti_OtherAccountsPayableAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="psti_OtherAccountsPayableAbstract_lbl" xml:lang="en-US">OTHER ACCOUNTS PAYABLE [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:to="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_lbl" xml:lang="en-US">OTHER ACCOUNTS PAYABLE</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract_lbl" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl" xml:lang="en-US">COMMITMENTS AND CONTINGENCIES</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract" xlink:label="us-gaap_StockholdersEquityNoteAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityNoteAbstract" xlink:to="us-gaap_StockholdersEquityNoteAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquityNoteAbstract_lbl" xml:lang="en-US">Stockholders' Equity Note [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:to="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl" xml:lang="en-US">STOCKHOLDERS' EQUITY</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherIncomeAndExpensesAbstract" xlink:label="us-gaap_OtherIncomeAndExpensesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherIncomeAndExpensesAbstract" xlink:to="us-gaap_OtherIncomeAndExpensesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherIncomeAndExpensesAbstract_lbl" xml:lang="en-US">Other Income and Expenses [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherIncomeAndOtherExpenseDisclosureTextBlock" xlink:label="us-gaap_OtherIncomeAndOtherExpenseDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherIncomeAndOtherExpenseDisclosureTextBlock" xlink:to="us-gaap_OtherIncomeAndOtherExpenseDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OtherIncomeAndOtherExpenseDisclosureTextBlock_lbl" xml:lang="en-US">FINANCIAL INCOME, NET</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="us-gaap_IncomeTaxDisclosureAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_IncomeTaxDisclosureAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxDisclosureAbstract_lbl" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="us-gaap_IncomeTaxDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock_lbl" xml:lang="en-US">TAXES ON INCOME</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="us-gaap_SubsequentEventsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventsAbstract" xlink:to="us-gaap_SubsequentEventsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventsAbstract_lbl" xml:lang="en-US">Subsequent Events [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SubsequentEventsTextBlock" xlink:label="us-gaap_SubsequentEventsTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventsTextBlock" xlink:to="us-gaap_SubsequentEventsTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventsTextBlock_lbl" xml:lang="en-US">SUBSEQUENT EVENTS</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:label="us-gaap_BasisOfAccountingPolicyPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:to="us-gaap_BasisOfAccountingPolicyPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BasisOfAccountingPolicyPolicyTextBlock_lbl" xml:lang="en-US">Unaudited Interim Financial Information</link:label>
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_SignificantAccountingPolicyPolicyTextBlock" xlink:label="psti_SignificantAccountingPolicyPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="psti_SignificantAccountingPolicyPolicyTextBlock" xlink:to="psti_SignificantAccountingPolicyPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="psti_SignificantAccountingPolicyPolicyTextBlock_lbl" xml:lang="en-US">Significant Accounting Policies</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_UseOfEstimates" xlink:label="us-gaap_UseOfEstimates" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UseOfEstimates" xlink:to="us-gaap_UseOfEstimates_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_UseOfEstimates_lbl" xml:lang="en-US">Use of estimates</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:label="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:to="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_lbl" xml:lang="en-US">Functional currency</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ConsolidationPolicyTextBlock" xlink:label="us-gaap_ConsolidationPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConsolidationPolicyTextBlock" xlink:to="us-gaap_ConsolidationPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConsolidationPolicyTextBlock_lbl" xml:lang="en-US">Principles of consolidation</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:to="us-gaap_CashAndCashEquivalentsPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock_lbl" xml:lang="en-US">Cash and cash equivalents</link:label>
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_ShortTermBankDepositPolicyTextBlock" xlink:label="psti_ShortTermBankDepositPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="psti_ShortTermBankDepositPolicyTextBlock" xlink:to="psti_ShortTermBankDepositPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="psti_ShortTermBankDepositPolicyTextBlock_lbl" xml:lang="en-US">Short-term bank deposit</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:label="us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:to="us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_lbl" xml:lang="en-US">Restricted cash and short-term bank deposits</link:label>
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_LongTermRestrictedBankDepositPolicyTextBlock" xlink:label="psti_LongTermRestrictedBankDepositPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="psti_LongTermRestrictedBankDepositPolicyTextBlock" xlink:to="psti_LongTermRestrictedBankDepositPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="psti_LongTermRestrictedBankDepositPolicyTextBlock_lbl" xml:lang="en-US">Long-term restricted bank deposits</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_MarketableSecuritiesPolicy" xlink:label="us-gaap_MarketableSecuritiesPolicy" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MarketableSecuritiesPolicy" xlink:to="us-gaap_MarketableSecuritiesPolicy_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_MarketableSecuritiesPolicy_lbl" xml:lang="en-US">Investment in marketable securities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RevenueRecognitionPolicyTextBlock" xlink:label="us-gaap_RevenueRecognitionPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueRecognitionPolicyTextBlock" xlink:to="us-gaap_RevenueRecognitionPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RevenueRecognitionPolicyTextBlock_lbl" xml:lang="en-US">Revenue Recognition from the license Agreement with United</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:label="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:to="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_lbl" xml:lang="en-US">Property and Equipment</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:label="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:to="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_lbl" xml:lang="en-US">Impairment of long-lived assets</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:label="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:to="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_lbl" xml:lang="en-US">Accounting for stock-based compensation</link:label>
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_ResearchAndDevelopmentExpensesAndRoyaltyBearingGrantsPolicyTextBlock" xlink:label="psti_ResearchAndDevelopmentExpensesAndRoyaltyBearingGrantsPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="psti_ResearchAndDevelopmentExpensesAndRoyaltyBearingGrantsPolicyTextBlock" xlink:to="psti_ResearchAndDevelopmentExpensesAndRoyaltyBearingGrantsPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="psti_ResearchAndDevelopmentExpensesAndRoyaltyBearingGrantsPolicyTextBlock_lbl" xml:lang="en-US">Research and Development expenses and royalty bearing grants</link:label>
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_NonroyaltyBearingGrantsPolicyTextBlock" xlink:label="psti_NonroyaltyBearingGrantsPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="psti_NonroyaltyBearingGrantsPolicyTextBlock" xlink:to="psti_NonroyaltyBearingGrantsPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="psti_NonroyaltyBearingGrantsPolicyTextBlock_lbl" xml:lang="en-US">Non-royalty bearing grant</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EarningsPerSharePolicyTextBlock" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerSharePolicyTextBlock" xlink:to="us-gaap_EarningsPerSharePolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock_lbl" xml:lang="en-US">Loss per share</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeTaxPolicyTextBlock" xlink:label="us-gaap_IncomeTaxPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxPolicyTextBlock" xlink:to="us-gaap_IncomeTaxPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxPolicyTextBlock_lbl" xml:lang="en-US">Income taxes</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ConcentrationRiskCreditRisk" xlink:label="us-gaap_ConcentrationRiskCreditRisk" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskCreditRisk" xlink:to="us-gaap_ConcentrationRiskCreditRisk_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConcentrationRiskCreditRisk_lbl" xml:lang="en-US">Concentration of credit risk</link:label>
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_SeverancePayPolicyTextBlock" xlink:label="psti_SeverancePayPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="psti_SeverancePayPolicyTextBlock" xlink:to="psti_SeverancePayPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="psti_SeverancePayPolicyTextBlock_lbl" xml:lang="en-US">Severance pay</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:label="us-gaap_FairValueOfFinancialInstrumentsPolicy" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:to="us-gaap_FairValueOfFinancialInstrumentsPolicy_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueOfFinancialInstrumentsPolicy_lbl" xml:lang="en-US">Fair value of financial instruments</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DerivativesPolicyTextBlock" xlink:label="us-gaap_DerivativesPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DerivativesPolicyTextBlock" xlink:to="us-gaap_DerivativesPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DerivativesPolicyTextBlock_lbl" xml:lang="en-US">Derivative financial instruments</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:label="us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:to="us-gaap_ComprehensiveIncomePolicyPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ComprehensiveIncomePolicyPolicyTextBlock_lbl" xml:lang="en-US">Comprehensive income (loss)</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl" xml:lang="en-US">Recent Accounting Pronouncement</link:label>
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_PropertyPlantAndEquipmentEstimatedUsefulLivesRateTableTextBlock" xlink:label="psti_PropertyPlantAndEquipmentEstimatedUsefulLivesRateTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="psti_PropertyPlantAndEquipmentEstimatedUsefulLivesRateTableTextBlock" xlink:to="psti_PropertyPlantAndEquipmentEstimatedUsefulLivesRateTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="psti_PropertyPlantAndEquipmentEstimatedUsefulLivesRateTableTextBlock_lbl" xml:lang="en-US">Schedule of Property and Equipment, Estimated Useful Lives, Annual Rate</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:label="us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:to="us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_lbl" xml:lang="en-US">Schedule of Accumulated Other Comprehensive Income (Loss)</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AvailableForSaleSecuritiesTextBlock" xlink:label="us-gaap_AvailableForSaleSecuritiesTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AvailableForSaleSecuritiesTextBlock" xlink:to="us-gaap_AvailableForSaleSecuritiesTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AvailableForSaleSecuritiesTextBlock_lbl" xml:lang="en-US">Schedule of Available-for-sale Marketable Securities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValueTableTextBlock" xlink:label="us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValueTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValueTableTextBlock" xlink:to="us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValueTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValueTableTextBlock_lbl" xml:lang="en-US">Schedule of Investments in Continuous Unrealized Loss Position</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock_lbl" xml:lang="en-US">Schedule of Fair Value of Financial Instruments</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:label="us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:to="us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_lbl" xml:lang="en-US">Schedule of Derivative Hedging Activity and Balance Sheet Location</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock" xlink:label="us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock" xlink:to="us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock_lbl" xml:lang="en-US">Schedule of Other Current Assets</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:label="us-gaap_PropertyPlantAndEquipmentTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:to="us-gaap_PropertyPlantAndEquipmentTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentTextBlock_lbl" xml:lang="en-US">Schedule of Property and Equipment, Net</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:label="us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:to="us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_lbl" xml:lang="en-US">Schedule of Other Accounts Payable</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LongTermPurchaseCommitmentTable" xlink:label="us-gaap_LongTermPurchaseCommitmentTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermPurchaseCommitmentTable" xlink:to="us-gaap_LongTermPurchaseCommitmentTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LongTermPurchaseCommitmentTable_lbl" xml:lang="en-US">Long-term Purchase Commitment [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LongTermPurchaseCommitmentLineItems" xlink:label="us-gaap_LongTermPurchaseCommitmentLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermPurchaseCommitmentLineItems" xlink:to="us-gaap_LongTermPurchaseCommitmentLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LongTermPurchaseCommitmentLineItems_lbl" xml:lang="en-US">Long-term Purchase Commitment [Line Items]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis_2_lbl" xml:lang="en-US">Property, Plant and Equipment, Type [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock" xlink:label="us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock" xlink:to="us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock_lbl" xml:lang="en-US">Schedule of Future Minimum Rental Commitments</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_UnrecordedUnconditionalPurchaseObligationsDisclosureTextBlock" xlink:label="us-gaap_UnrecordedUnconditionalPurchaseObligationsDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UnrecordedUnconditionalPurchaseObligationsDisclosureTextBlock" xlink:to="us-gaap_UnrecordedUnconditionalPurchaseObligationsDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_UnrecordedUnconditionalPurchaseObligationsDisclosureTextBlock_lbl" xml:lang="en-US">Commitment to Suppliers and Contractor</link:label>
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_StockholdersEquityNoteTable" xlink:label="psti_StockholdersEquityNoteTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="psti_StockholdersEquityNoteTable" xlink:to="psti_StockholdersEquityNoteTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="psti_StockholdersEquityNoteTable_lbl" xml:lang="en-US">Stockholders Equity Note [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_StockholdersEquityNoteLineItems" xlink:label="psti_StockholdersEquityNoteLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="psti_StockholdersEquityNoteLineItems" xlink:to="psti_StockholdersEquityNoteLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="psti_StockholdersEquityNoteLineItems_lbl" xml:lang="en-US">Stockholders Equity Note [Line Items]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TitleOfIndividualAxis" xlink:to="us-gaap_TitleOfIndividualAxis_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_TitleOfIndividualAxis_2_lbl" xml:lang="en-US">Title of Individual [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock" xlink:label="us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock" xlink:to="us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock_lbl" xml:lang="en-US">Schedule of Unvested Restricted Stock Units</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:label="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:to="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_lbl" xml:lang="en-US">Schedule of Stock Option Activity</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:to="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_lbl" xml:lang="en-US">Schedule of Stock-based Compensation Expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock" xlink:label="us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock" xlink:to="us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock_lbl" xml:lang="en-US">Schedule of Stock Option and Warrant Activity</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock" xlink:label="us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock" xlink:to="us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock_lbl" xml:lang="en-US">Summary of Options and Warrants Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock" xlink:label="us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock" xlink:to="us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock_lbl" xml:lang="en-US">Schedule of Financial Expenses (Income), Net</link:label>
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_QualifyingPercentageOfValueOfProductiveAssetsTableTextBlock" xlink:label="psti_QualifyingPercentageOfValueOfProductiveAssetsTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="psti_QualifyingPercentageOfValueOfProductiveAssetsTableTextBlock" xlink:to="psti_QualifyingPercentageOfValueOfProductiveAssetsTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="psti_QualifyingPercentageOfValueOfProductiveAssetsTableTextBlock_lbl" xml:lang="en-US">Qualifying Percentage of Value of Productive Assets</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:label="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:to="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_lbl" xml:lang="en-US">Schedule of Deferred Tax Assets</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_2_lbl" xml:lang="en-US">Accumulated deficit</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_4_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquity_4_lbl" xml:lang="en-US">Total stockholders' equity</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_NetIncomeLoss_3_lbl" xml:lang="en-US">Net loss</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_2_lbl" xml:lang="en-US">Cash flow operating activities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CashCashEquivalentsAndShortTermInvestments" xlink:label="us-gaap_CashCashEquivalentsAndShortTermInvestments" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsAndShortTermInvestments" xlink:to="us-gaap_CashCashEquivalentsAndShortTermInvestments_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashCashEquivalentsAndShortTermInvestments_lbl" xml:lang="en-US">Cash and cash equivalents, short-term bank deposits and marketable securities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LicensesRevenue" xlink:label="us-gaap_LicensesRevenue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LicensesRevenue" xlink:to="us-gaap_LicensesRevenue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LicensesRevenue_lbl" xml:lang="en-US">Upfront payment received</link:label>
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_NonrefundableAdvanceUnderTermsOfLicenseAgreement" xlink:label="psti_NonrefundableAdvanceUnderTermsOfLicenseAgreement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="psti_NonrefundableAdvanceUnderTermsOfLicenseAgreement" xlink:to="psti_NonrefundableAdvanceUnderTermsOfLicenseAgreement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="psti_NonrefundableAdvanceUnderTermsOfLicenseAgreement_lbl" xml:lang="en-US">Nonrefundable upfront payments received</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ProceedsFromCustomers" xlink:label="us-gaap_ProceedsFromCustomers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromCustomers" xlink:to="us-gaap_ProceedsFromCustomers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromCustomers_lbl" xml:lang="en-US">Advance payment on the development</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesPurchaseOfAssets" xlink:label="us-gaap_StockIssuedDuringPeriodSharesPurchaseOfAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesPurchaseOfAssets" xlink:to="us-gaap_StockIssuedDuringPeriodSharesPurchaseOfAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesPurchaseOfAssets_lbl" xml:lang="en-US">Issuance of common stock under CHA agreement</link:label>
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_AvailableForSaleMarketableSecuritiesNumber" xlink:label="psti_AvailableForSaleMarketableSecuritiesNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="psti_AvailableForSaleMarketableSecuritiesNumber" xlink:to="psti_AvailableForSaleMarketableSecuritiesNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="psti_AvailableForSaleMarketableSecuritiesNumber_lbl" xml:lang="en-US">CHA shares classified as marketable securities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockIssuedDuringPeriodValuePurchaseOfAssets" xlink:label="us-gaap_StockIssuedDuringPeriodValuePurchaseOfAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValuePurchaseOfAssets" xlink:to="us-gaap_StockIssuedDuringPeriodValuePurchaseOfAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValuePurchaseOfAssets_lbl" xml:lang="en-US">Total consideration reflected under the CHA agreement</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AvailableForSaleSecuritiesCurrent" xlink:label="us-gaap_AvailableForSaleSecuritiesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AvailableForSaleSecuritiesCurrent" xlink:to="us-gaap_AvailableForSaleSecuritiesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AvailableForSaleSecuritiesCurrent_lbl" xml:lang="en-US">Fair value of the remaining investment in CHA shares</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_lbl" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_lbl" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherThanTemporaryImpairmentLossesInvestmentsPortionRecognizedInEarningsNet" xlink:to="us-gaap_OtherThanTemporaryImpairmentLossesInvestmentsPortionRecognizedInEarningsNet_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_OtherThanTemporaryImpairmentLossesInvestmentsPortionRecognizedInEarningsNet_2_lbl" xml:lang="en-US">Other-than-temporary impairment loss</link:label>
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_BusinessCombinationContingentConsiderationReceivableUponCertainRegulatoryMilestones" xlink:label="psti_BusinessCombinationContingentConsiderationReceivableUponCertainRegulatoryMilestones" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="psti_BusinessCombinationContingentConsiderationReceivableUponCertainRegulatoryMilestones" xlink:to="psti_BusinessCombinationContingentConsiderationReceivableUponCertainRegulatoryMilestones_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="psti_BusinessCombinationContingentConsiderationReceivableUponCertainRegulatoryMilestones_lbl" xml:lang="en-US">Contingent consideration receivable if certain regulatory milestones are reached</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DeferredRevenueAdditions" xlink:label="us-gaap_DeferredRevenueAdditions" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredRevenueAdditions" xlink:to="us-gaap_DeferredRevenueAdditions_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredRevenueAdditions_lbl" xml:lang="en-US">Deferred revenue</link:label>
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_AdvancePaymentForDeveplomentCosts" xlink:label="psti_AdvancePaymentForDeveplomentCosts" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="psti_AdvancePaymentForDeveplomentCosts" xlink:to="psti_AdvancePaymentForDeveplomentCosts_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="psti_AdvancePaymentForDeveplomentCosts_lbl" xml:lang="en-US">Advance payment for development costs</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl" xml:lang="en-US">Granted, weighted-average grant date fair value</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PostemploymentBenefitsPeriodExpense" xlink:label="us-gaap_PostemploymentBenefitsPeriodExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PostemploymentBenefitsPeriodExpense" xlink:to="us-gaap_PostemploymentBenefitsPeriodExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PostemploymentBenefitsPeriodExpense_lbl" xml:lang="en-US">Severance expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DerivativeGainLossOnDerivativeNet" xlink:label="us-gaap_DerivativeGainLossOnDerivativeNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DerivativeGainLossOnDerivativeNet" xlink:to="us-gaap_DerivativeGainLossOnDerivativeNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DerivativeGainLossOnDerivativeNet_lbl" xml:lang="en-US">Net gain (loss) realized on derivatives</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue" xlink:label="us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue" xlink:to="us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue_lbl" xml:lang="en-US">Fair value of other derivatives</link:label>
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_TotalGrantsAwardedToCliProgram" xlink:label="psti_TotalGrantsAwardedToCliProgram" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="psti_TotalGrantsAwardedToCliProgram" xlink:to="psti_TotalGrantsAwardedToCliProgram_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="psti_TotalGrantsAwardedToCliProgram_lbl" xml:lang="en-US">Total grants awared to CLI program consortium under the European Union's Horizon 2020 program</link:label>
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_AmountOfGrantsAwardedToCliProgramAllocatedToCompany" xlink:label="psti_AmountOfGrantsAwardedToCliProgramAllocatedToCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="psti_AmountOfGrantsAwardedToCliProgramAllocatedToCompany" xlink:to="psti_AmountOfGrantsAwardedToCliProgramAllocatedToCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="psti_AmountOfGrantsAwardedToCliProgramAllocatedToCompany_lbl" xml:lang="en-US">Amount of grants awared under CLI program allocated to Company</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RevenueFromGrants" xlink:label="us-gaap_RevenueFromGrants" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueFromGrants" xlink:to="us-gaap_RevenueFromGrants_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RevenueFromGrants_lbl" xml:lang="en-US">Grants received from the Horizon 2020 program</link:label>
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_RecognizedRAndDPariticipationGrants" xlink:label="psti_RecognizedRAndDPariticipationGrants" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="psti_RecognizedRAndDPariticipationGrants" xlink:to="psti_RecognizedRAndDPariticipationGrants_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="psti_RecognizedRAndDPariticipationGrants_lbl" xml:lang="en-US">Recognized R&amp;D participation grants</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherLiabilitiesCurrent" xlink:label="us-gaap_OtherLiabilitiesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherLiabilitiesCurrent" xlink:to="us-gaap_OtherLiabilitiesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherLiabilitiesCurrent_lbl" xml:lang="en-US">Other current liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_AmountOfGrantsReceivedConditionalAward" xlink:label="psti_AmountOfGrantsReceivedConditionalAward" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="psti_AmountOfGrantsReceivedConditionalAward" xlink:to="psti_AmountOfGrantsReceivedConditionalAward_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="psti_AmountOfGrantsReceivedConditionalAward_lbl" xml:lang="en-US">Amount of grants received conditional award</link:label>
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_AmountOfDirectGrantAllocatedToTheCompany" xlink:label="psti_AmountOfDirectGrantAllocatedToTheCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="psti_AmountOfDirectGrantAllocatedToTheCompany" xlink:to="psti_AmountOfDirectGrantAllocatedToTheCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="psti_AmountOfDirectGrantAllocatedToTheCompany_lbl" xml:lang="en-US">Amount of direct grant allocated to the Company</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_lbl" xml:lang="en-US">Property, Plant and Equipment [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems_lbl" xml:lang="en-US">Property, Plant and Equipment [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_PropertyPlantAndEquipmentAnnualRateOfDepreciation" xlink:label="psti_PropertyPlantAndEquipmentAnnualRateOfDepreciation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="psti_PropertyPlantAndEquipmentAnnualRateOfDepreciation" xlink:to="psti_PropertyPlantAndEquipmentAnnualRateOfDepreciation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="psti_PropertyPlantAndEquipmentAnnualRateOfDepreciation_lbl" xml:lang="en-US">Depreciation rate</link:label>
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_LeaseholdImprovementsAnnualRateOfDepreciationDescription" xlink:label="psti_LeaseholdImprovementsAnnualRateOfDepreciationDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="psti_LeaseholdImprovementsAnnualRateOfDepreciationDescription" xlink:to="psti_LeaseholdImprovementsAnnualRateOfDepreciationDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="psti_LeaseholdImprovementsAnnualRateOfDepreciationDescription_lbl" xml:lang="en-US">Depreciation, leasehold</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_lbl" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_lbl" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember" xlink:label="us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember" xlink:to="us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember_lbl" xml:lang="en-US">Unrealized gains (losses) on cash flow hedges [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_2_lbl" xml:lang="en-US">Beginning balance</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:label="us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:to="us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_lbl" xml:lang="en-US">Other comprehensive income before reclassifications</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:label="us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:to="us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_lbl" xml:lang="en-US">Amounts reclassified from accumulated other comprehensive loss, net</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:to="us-gaap_OtherComprehensiveIncomeLossNetOfTax_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTax_2_lbl" xml:lang="en-US">Net current-period other comprehensive income</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_3_lbl" xml:lang="en-US">Ending balance</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesTable" xlink:label="us-gaap_ScheduleOfAvailableForSaleSecuritiesTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesTable" xlink:to="us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_lbl" xml:lang="en-US">Schedule of Available-for-sale Securities [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:label="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_lbl" xml:lang="en-US">Schedule of Available-for-sale Securities [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AvailableForSaleSecurities" xlink:label="us-gaap_AvailableForSaleSecurities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AvailableForSaleSecurities" xlink:to="us-gaap_AvailableForSaleSecurities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AvailableForSaleSecurities_lbl" xml:lang="en-US">Fair value</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:label="us-gaap_AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedGainBeforeTax" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:to="us-gaap_AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedGainBeforeTax_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedGainBeforeTax_lbl" xml:lang="en-US">Gross unrealized gain</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:label="us-gaap_AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedLossBeforeTax" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:to="us-gaap_AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedLossBeforeTax_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedLossBeforeTax_lbl" xml:lang="en-US">Gross unrealized loss</link:label>
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_OtherthantemporaryImpairment" xlink:label="psti_OtherthantemporaryImpairment" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="psti_OtherthantemporaryImpairment" xlink:to="psti_OtherthantemporaryImpairment_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="psti_OtherthantemporaryImpairment_lbl" xml:lang="en-US">Other-than-temporary impairment</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AvailableForSaleSecuritiesAmortizedCost" xlink:label="us-gaap_AvailableForSaleSecuritiesAmortizedCost" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AvailableForSaleSecuritiesAmortizedCost" xlink:to="us-gaap_AvailableForSaleSecuritiesAmortizedCost_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_AvailableForSaleSecuritiesAmortizedCost_lbl" xml:lang="en-US">Amortized cost</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue" xlink:label="us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue" xlink:to="us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue_lbl" xml:lang="en-US">Less than 12 months, fair value</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" xlink:label="us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" xlink:to="us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss_lbl" xml:lang="en-US">Less than 12 months, gross unrealized loss</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValue" xlink:label="us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValue" xlink:to="us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValue_lbl" xml:lang="en-US">12 months or greater, fair value</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" xlink:label="us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" xlink:to="us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss_lbl" xml:lang="en-US">12 months or greater, gross unrealized loss</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_InterestReceivable" xlink:label="us-gaap_InterestReceivable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestReceivable" xlink:to="us-gaap_InterestReceivable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InterestReceivable_lbl" xml:lang="en-US">Interest receivable</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_lbl" xml:lang="en-US">Fair Value Measurements, Recurring and Nonrecurring [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_lbl" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MarketableSecuritiesCurrent" xlink:to="us-gaap_MarketableSecuritiesCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_MarketableSecuritiesCurrent_2_lbl" xml:lang="en-US">Marketable securities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet" xlink:label="us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet" xlink:to="us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet_lbl" xml:lang="en-US">Foreign currency derivative instruments not designated as hedge instruments</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueNetAssetLiability" xlink:label="us-gaap_FairValueNetAssetLiability" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueNetAssetLiability" xlink:to="us-gaap_FairValueNetAssetLiability_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_FairValueNetAssetLiability_lbl" xml:lang="en-US">Total financial assets</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PrepaidExpenseCurrent" xlink:label="us-gaap_PrepaidExpenseCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrepaidExpenseCurrent" xlink:to="us-gaap_PrepaidExpenseCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PrepaidExpenseCurrent_lbl" xml:lang="en-US">Prepaid expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_AccountsReceivableFromMinistryOfEconomyCurrent" xlink:label="psti_AccountsReceivableFromMinistryOfEconomyCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="psti_AccountsReceivableFromMinistryOfEconomyCurrent" xlink:to="psti_AccountsReceivableFromMinistryOfEconomyCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="psti_AccountsReceivableFromMinistryOfEconomyCurrent_lbl" xml:lang="en-US">Accounts receivable from the Ministry of Economy</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CashFlowHedgesDerivativeInstrumentsAtFairValueNet" xlink:label="us-gaap_CashFlowHedgesDerivativeInstrumentsAtFairValueNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashFlowHedgesDerivativeInstrumentsAtFairValueNet" xlink:to="us-gaap_CashFlowHedgesDerivativeInstrumentsAtFairValueNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashFlowHedgesDerivativeInstrumentsAtFairValueNet_lbl" xml:lang="en-US">Derivatives designated as cash flow hedge instruments</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue" xlink:to="us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue_2_lbl" xml:lang="en-US">Derivatives not designated as hedge instruments</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ValueAddedTaxReceivableCurrent" xlink:label="us-gaap_ValueAddedTaxReceivableCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ValueAddedTaxReceivableCurrent" xlink:to="us-gaap_ValueAddedTaxReceivableCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ValueAddedTaxReceivableCurrent_lbl" xml:lang="en-US">VAT receivables</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherReceivablesNetCurrent" xlink:label="us-gaap_OtherReceivablesNetCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherReceivablesNetCurrent" xlink:to="us-gaap_OtherReceivablesNetCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherReceivablesNetCurrent_lbl" xml:lang="en-US">Other receivables</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherAssetsCurrent" xlink:to="us-gaap_OtherAssetsCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_OtherAssetsCurrent_2_lbl" xml:lang="en-US">Total</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="us-gaap_PropertyPlantAndEquipmentGross" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentGross" xlink:to="us-gaap_PropertyPlantAndEquipmentGross_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentGross_lbl" xml:lang="en-US">Property and equipment, cost</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:to="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl" xml:lang="en-US">Property and equipment, accumulated depreciation</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentNet" xlink:to="us-gaap_PropertyPlantAndEquipmentNet_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_PropertyPlantAndEquipmentNet_2_lbl" xml:lang="en-US">Property and equipment, net</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:label="us-gaap_EmployeeRelatedLiabilitiesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:to="us-gaap_EmployeeRelatedLiabilitiesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EmployeeRelatedLiabilitiesCurrent_lbl" xml:lang="en-US">Accrued payroll</link:label>
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_OtherAccountsPayablePayrollInstitutions" xlink:label="psti_OtherAccountsPayablePayrollInstitutions" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="psti_OtherAccountsPayablePayrollInstitutions" xlink:to="psti_OtherAccountsPayablePayrollInstitutions_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="psti_OtherAccountsPayablePayrollInstitutions_lbl" xml:lang="en-US">Payroll institutions</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccruedVacationCurrent" xlink:label="us-gaap_AccruedVacationCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccruedVacationCurrent" xlink:to="us-gaap_AccruedVacationCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccruedVacationCurrent_lbl" xml:lang="en-US">Accrued vacation</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DeferredRentCreditCurrent" xlink:label="us-gaap_DeferredRentCreditCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredRentCreditCurrent" xlink:to="us-gaap_DeferredRentCreditCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredRentCreditCurrent_lbl" xml:lang="en-US">Advanced payment from lessor</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DerivativeLiabilitiesCurrent" xlink:label="us-gaap_DerivativeLiabilitiesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DerivativeLiabilitiesCurrent" xlink:to="us-gaap_DerivativeLiabilitiesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DerivativeLiabilitiesCurrent_lbl" xml:lang="en-US">Derivatives designated as a fair value hedge instruments</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent" xlink:label="us-gaap_OtherAccruedLiabilitiesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherAccruedLiabilitiesCurrent" xlink:to="us-gaap_OtherAccruedLiabilitiesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherAccruedLiabilitiesCurrent_lbl" xml:lang="en-US">Other payables</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableOtherCurrent" xlink:to="us-gaap_AccountsPayableOtherCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_AccountsPayableOtherCurrent_2_lbl" xml:lang="en-US">Total</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfOperatingLeasedAssetsTable" xlink:label="us-gaap_ScheduleOfOperatingLeasedAssetsTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfOperatingLeasedAssetsTable" xlink:to="us-gaap_ScheduleOfOperatingLeasedAssetsTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfOperatingLeasedAssetsTable_lbl" xml:lang="en-US">Schedule of Operating Leased Assets [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OperatingLeasedAssetsLineItems" xlink:label="us-gaap_OperatingLeasedAssetsLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasedAssetsLineItems" xlink:to="us-gaap_OperatingLeasedAssetsLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeasedAssetsLineItems_lbl" xml:lang="en-US">Operating Leased Assets [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_GuaranteeObligationsByNatureAxis" xlink:label="us-gaap_GuaranteeObligationsByNatureAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GuaranteeObligationsByNatureAxis" xlink:to="us-gaap_GuaranteeObligationsByNatureAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GuaranteeObligationsByNatureAxis_lbl" xml:lang="en-US">Guarantor Obligations, Nature [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_OperatingLeasedAssetsNumberOfUnits" xlink:label="psti_OperatingLeasedAssetsNumberOfUnits" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="psti_OperatingLeasedAssetsNumberOfUnits" xlink:to="psti_OperatingLeasedAssetsNumberOfUnits_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="psti_OperatingLeasedAssetsNumberOfUnits_lbl" xml:lang="en-US">Number of vehicles leased under operating lease agreements</link:label>
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_OperatingLeasedAssetsParticipationFromLessor" xlink:label="psti_OperatingLeasedAssetsParticipationFromLessor" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="psti_OperatingLeasedAssetsParticipationFromLessor" xlink:to="psti_OperatingLeasedAssetsParticipationFromLessor_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="psti_OperatingLeasedAssetsParticipationFromLessor_lbl" xml:lang="en-US">Participation from lessor</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_GuaranteeObligationsCurrentCarryingValue" xlink:label="us-gaap_GuaranteeObligationsCurrentCarryingValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GuaranteeObligationsCurrentCarryingValue" xlink:to="us-gaap_GuaranteeObligationsCurrentCarryingValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GuaranteeObligationsCurrentCarryingValue_lbl" xml:lang="en-US">Lessor favored bank guarantee</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OperatingLeasesRentExpenseNet" xlink:label="us-gaap_OperatingLeasesRentExpenseNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasesRentExpenseNet" xlink:to="us-gaap_OperatingLeasesRentExpenseNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeasesRentExpenseNet_lbl" xml:lang="en-US">Lease expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent_lbl" xml:lang="en-US">Year ending June 30, 2018</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears_lbl" xml:lang="en-US">Year ending June 30, 2019</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears_lbl" xml:lang="en-US">Year ending June 30, 2020</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears_lbl" xml:lang="en-US">Year ending June 30, 2021</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears_lbl" xml:lang="en-US">Year ending June 30, 2022</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDue" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDue" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDue_lbl" xml:lang="en-US">Total</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherCommitmentsTable" xlink:label="us-gaap_OtherCommitmentsTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherCommitmentsTable" xlink:to="us-gaap_OtherCommitmentsTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherCommitmentsTable_lbl" xml:lang="en-US">Other Commitments [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherCommitmentsLineItems" xlink:label="us-gaap_OtherCommitmentsLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherCommitmentsLineItems" xlink:to="us-gaap_OtherCommitmentsLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherCommitmentsLineItems_lbl" xml:lang="en-US">Other Commitments [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncreaseDecreaseInSecurityDeposits" xlink:label="us-gaap_IncreaseDecreaseInSecurityDeposits" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInSecurityDeposits" xlink:to="us-gaap_IncreaseDecreaseInSecurityDeposits_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInSecurityDeposits_lbl" xml:lang="en-US">Security deposits increase</link:label>
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_AggregateGrantsReceived" xlink:label="psti_AggregateGrantsReceived" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="psti_AggregateGrantsReceived" xlink:to="psti_AggregateGrantsReceived_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="psti_AggregateGrantsReceived_lbl" xml:lang="en-US">Grants received</link:label>
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_PercentageOfQualifiedExpenditures" xlink:label="psti_PercentageOfQualifiedExpenditures" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="psti_PercentageOfQualifiedExpenditures" xlink:to="psti_PercentageOfQualifiedExpenditures_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="psti_PercentageOfQualifiedExpenditures_lbl" xml:lang="en-US">Percentage of qualified expenditures eligible for grant</link:label>
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_RoyaltyRateSales" xlink:label="psti_RoyaltyRateSales" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="psti_RoyaltyRateSales" xlink:to="psti_RoyaltyRateSales_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="psti_RoyaltyRateSales_lbl" xml:lang="en-US">Royalty rate</link:label>
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_RoyaltyRatePayableOnGrantsReceived" xlink:label="psti_RoyaltyRatePayableOnGrantsReceived" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="psti_RoyaltyRatePayableOnGrantsReceived" xlink:to="psti_RoyaltyRatePayableOnGrantsReceived_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="psti_RoyaltyRatePayableOnGrantsReceived_lbl" xml:lang="en-US">Royalty payable based on grants received</link:label>
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_TermOfRoyaltyGrantReceived" xlink:label="psti_TermOfRoyaltyGrantReceived" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="psti_TermOfRoyaltyGrantReceived" xlink:to="psti_TermOfRoyaltyGrantReceived_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="psti_TermOfRoyaltyGrantReceived_lbl" xml:lang="en-US">Term of royalty grant received</link:label>
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_RoyaltiesAmountPaidAndAccrued" xlink:label="psti_RoyaltiesAmountPaidAndAccrued" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="psti_RoyaltiesAmountPaidAndAccrued" xlink:to="psti_RoyaltiesAmountPaidAndAccrued_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="psti_RoyaltiesAmountPaidAndAccrued_lbl" xml:lang="en-US">Accrued and paid royalties</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RoyaltyGuaranteesCommitmentsAmount" xlink:label="us-gaap_RoyaltyGuaranteesCommitmentsAmount" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RoyaltyGuaranteesCommitmentsAmount" xlink:to="us-gaap_RoyaltyGuaranteesCommitmentsAmount_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RoyaltyGuaranteesCommitmentsAmount_lbl" xml:lang="en-US">Contingent liability amount</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfStockByClassTable" xlink:label="us-gaap_ScheduleOfStockByClassTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfStockByClassTable" xlink:to="us-gaap_ScheduleOfStockByClassTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfStockByClassTable_lbl" xml:lang="en-US">Schedule of Stock by Class [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ClassOfStockLineItems" xlink:label="us-gaap_ClassOfStockLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_ClassOfStockLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ClassOfStockLineItems_lbl" xml:lang="en-US">Class of Stock [Line Items]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis" xlink:to="us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis_2_lbl" xml:lang="en-US">Supplier [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="us-gaap_PreferredStockSharesAuthorized" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesAuthorized" xlink:to="us-gaap_PreferredStockSharesAuthorized_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockSharesAuthorized_lbl" xml:lang="en-US">Preferred stock, shares authorized</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare_lbl" xml:lang="en-US">Preferred stock, par value per share</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_2_lbl" xml:lang="en-US">Issuance of common stock and warrants, issuance costs</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ConversionOfStockSharesConverted1" xlink:label="us-gaap_ConversionOfStockSharesConverted1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConversionOfStockSharesConverted1" xlink:to="us-gaap_ConversionOfStockSharesConverted1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConversionOfStockSharesConverted1_lbl" xml:lang="en-US">Warrants exercised via cashless exercise</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ConversionOfStockSharesIssued1" xlink:label="us-gaap_ConversionOfStockSharesIssued1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConversionOfStockSharesIssued1" xlink:to="us-gaap_ConversionOfStockSharesIssued1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConversionOfStockSharesIssued1_lbl" xml:lang="en-US">Warrants exercised via cashless exercise, shares issued</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesOther" xlink:label="us-gaap_StockIssuedDuringPeriodSharesOther" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesOther" xlink:to="us-gaap_StockIssuedDuringPeriodSharesOther_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesOther_lbl" xml:lang="en-US">Warrants exercised for cash</link:label>
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_CommonStockAggregateOfferingPriceAuthorized" xlink:label="psti_CommonStockAggregateOfferingPriceAuthorized" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="psti_CommonStockAggregateOfferingPriceAuthorized" xlink:to="psti_CommonStockAggregateOfferingPriceAuthorized_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="psti_CommonStockAggregateOfferingPriceAuthorized_lbl" xml:lang="en-US">Aggregate offering price authorized</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ProceedsFromWarrantExercises" xlink:label="us-gaap_ProceedsFromWarrantExercises" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromWarrantExercises" xlink:to="us-gaap_ProceedsFromWarrantExercises_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromWarrantExercises_lbl" xml:lang="en-US">Aggregate cash consideration received</link:label>
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_SharebasedCompensationArrangementWarrantsExercised" xlink:label="psti_SharebasedCompensationArrangementWarrantsExercised" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="psti_SharebasedCompensationArrangementWarrantsExercised" xlink:to="psti_SharebasedCompensationArrangementWarrantsExercised_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="psti_SharebasedCompensationArrangementWarrantsExercised_lbl" xml:lang="en-US">Number of warrants exercised</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValuePurchaseOfAssets" xlink:to="us-gaap_StockIssuedDuringPeriodValuePurchaseOfAssets_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodValuePurchaseOfAssets_2_lbl" xml:lang="en-US">Issuance of common stock under CHA Agreement (Note 1c)</link:label>
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_AggregateOfferingPriceUnderATMAgreement" xlink:label="psti_AggregateOfferingPriceUnderATMAgreement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="psti_AggregateOfferingPriceUnderATMAgreement" xlink:to="psti_AggregateOfferingPriceUnderATMAgreement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="psti_AggregateOfferingPriceUnderATMAgreement_lbl" xml:lang="en-US">Aggregate offering price under ATM agreement</link:label>
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_ShareBasedGoodsAndNonemployeeServicesTransactionQuantityOfSecuritiesToBeIssued" xlink:label="psti_ShareBasedGoodsAndNonemployeeServicesTransactionQuantityOfSecuritiesToBeIssued" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="psti_ShareBasedGoodsAndNonemployeeServicesTransactionQuantityOfSecuritiesToBeIssued" xlink:to="psti_ShareBasedGoodsAndNonemployeeServicesTransactionQuantityOfSecuritiesToBeIssued_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="psti_ShareBasedGoodsAndNonemployeeServicesTransactionQuantityOfSecuritiesToBeIssued_lbl" xml:lang="en-US">Stock-based compensation to contractor, shares to be issued</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:to="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_2_lbl" xml:lang="en-US">Stock-based compensation to contractor, shares</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues_2_lbl" xml:lang="en-US">Issuance of common stock and warrants, net of issuance costs, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SharesIssuedPricePerShare" xlink:label="us-gaap_SharesIssuedPricePerShare" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesIssuedPricePerShare" xlink:to="us-gaap_SharesIssuedPricePerShare_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharesIssuedPricePerShare_lbl" xml:lang="en-US">Offering price per unit</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" xlink:to="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_lbl" xml:lang="en-US">Shares covered by each warrant</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_lbl" xml:lang="en-US">Warrant exercise price</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ClassOfWarrantOrRightOutstanding" xlink:label="us-gaap_ClassOfWarrantOrRightOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightOutstanding" xlink:to="us-gaap_ClassOfWarrantOrRightOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ClassOfWarrantOrRightOutstanding_lbl" xml:lang="en-US">Warrants for common stock</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock_2_lbl" xml:lang="en-US">Proceeds from issuance of stock</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="psti_StockIssuedDuringPeriodValuePrivatePlacement" xlink:to="psti_StockIssuedDuringPeriodValuePrivatePlacement_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="psti_StockIssuedDuringPeriodValuePrivatePlacement_2_lbl" xml:lang="en-US">Issuance of common stock in a private placement</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="psti_StockIssuedDuringPeriodSharesPrivatePlacement" xlink:to="psti_StockIssuedDuringPeriodSharesPrivatePlacement_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="psti_StockIssuedDuringPeriodSharesPrivatePlacement_2_lbl" xml:lang="en-US">Issuance of common stock in a private placement, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_ExpirationPeriodOfWarrantsSoldInOffering" xlink:label="psti_ExpirationPeriodOfWarrantsSoldInOffering" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="psti_ExpirationPeriodOfWarrantsSoldInOffering" xlink:to="psti_ExpirationPeriodOfWarrantsSoldInOffering_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="psti_ExpirationPeriodOfWarrantsSoldInOffering_lbl" xml:lang="en-US">Expiration period of warrants</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueIssuedForServices" xlink:to="us-gaap_StockIssuedDuringPeriodValueIssuedForServices_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodValueIssuedForServices_2_lbl" xml:lang="en-US">Stock based compensation to contractor</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherConstructionCosts" xlink:label="us-gaap_OtherConstructionCosts" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherConstructionCosts" xlink:to="us-gaap_OtherConstructionCosts_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherConstructionCosts_lbl" xml:lang="en-US">Costs paid to construction contractor</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ConstructionInProgressExpendituresIncurredButNotYetPaid" xlink:label="us-gaap_ConstructionInProgressExpendituresIncurredButNotYetPaid" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConstructionInProgressExpendituresIncurredButNotYetPaid" xlink:to="us-gaap_ConstructionInProgressExpendituresIncurredButNotYetPaid_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConstructionInProgressExpendituresIncurredButNotYetPaid_lbl" xml:lang="en-US">Cash paid to construction contractor</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceSheetAmount" xlink:label="us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceSheetAmount" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceSheetAmount" xlink:to="us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceSheetAmount_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceSheetAmount_lbl" xml:lang="en-US">Unrecorded Unconditional Purchase Obligation</link:label>
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_PercentageOfConstructionMilestonesCompleted" xlink:label="psti_PercentageOfConstructionMilestonesCompleted" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="psti_PercentageOfConstructionMilestonesCompleted" xlink:to="psti_PercentageOfConstructionMilestonesCompleted_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="psti_PercentageOfConstructionMilestonesCompleted_lbl" xml:lang="en-US">Percentage of construction milestones completed</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionCapitalizedCost" xlink:label="us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionCapitalizedCost" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionCapitalizedCost" xlink:to="us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionCapitalizedCost_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionCapitalizedCost_lbl" xml:lang="en-US">Amount of share-based compensation included in additional paid-in capital and property and equipment</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_lbl" xml:lang="en-US">Options authorized</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_lbl" xml:lang="en-US">Options available for future grant</link:label>
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_NumberOfSharesAgreedToBeSoldThroughUnderwriterAgreement" xlink:label="psti_NumberOfSharesAgreedToBeSoldThroughUnderwriterAgreement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="psti_NumberOfSharesAgreedToBeSoldThroughUnderwriterAgreement" xlink:to="psti_NumberOfSharesAgreedToBeSoldThroughUnderwriterAgreement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="psti_NumberOfSharesAgreedToBeSoldThroughUnderwriterAgreement_lbl" xml:lang="en-US">Number of shares agreed to be sold through Underwriter Agreement</link:label>
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_NumberOfWarrantsAgreedToBeSoldThroughUnderwriterAgreement" xlink:label="psti_NumberOfWarrantsAgreedToBeSoldThroughUnderwriterAgreement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="psti_NumberOfWarrantsAgreedToBeSoldThroughUnderwriterAgreement" xlink:to="psti_NumberOfWarrantsAgreedToBeSoldThroughUnderwriterAgreement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="psti_NumberOfWarrantsAgreedToBeSoldThroughUnderwriterAgreement_lbl" xml:lang="en-US">Number of warrants agreed to be sold through Underwriter Agreement</link:label>
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_GrossProceedsFromIssuanceOfCommonStock" xlink:label="psti_GrossProceedsFromIssuanceOfCommonStock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="psti_GrossProceedsFromIssuanceOfCommonStock" xlink:to="psti_GrossProceedsFromIssuanceOfCommonStock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="psti_GrossProceedsFromIssuanceOfCommonStock_lbl" xml:lang="en-US">Proceeds from public offering, gross</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_lbl" xml:lang="en-US">Number</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl" xml:lang="en-US">Options outstanding at beginning of period</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_2_lbl" xml:lang="en-US">Options exercised</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_lbl" xml:lang="en-US">Options forfeited</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_2_lbl" xml:lang="en-US">Options outstanding at end of the period</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_lbl" xml:lang="en-US">Options exercisable at the end of the period</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_lbl" xml:lang="en-US">Options vested at the end of the period</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_lbl" xml:lang="en-US">Weighted average exercise price</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl" xml:lang="en-US">Options outstanding at beginning of period</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_lbl" xml:lang="en-US">Options exercised</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_lbl" xml:lang="en-US">Options forfeited</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_2_lbl" xml:lang="en-US">Options outstanding at end of the period</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_lbl" xml:lang="en-US">Options exercisable at the end of the period</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_lbl" xml:lang="en-US">Options vested at the end of the period</link:label>
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_WeightedAverageRemainingContractualTermsAbstract" xlink:label="psti_WeightedAverageRemainingContractualTermsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="psti_WeightedAverageRemainingContractualTermsAbstract" xlink:to="psti_WeightedAverageRemainingContractualTermsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="psti_WeightedAverageRemainingContractualTermsAbstract_lbl" xml:lang="en-US">Weighted average remaining contractual term</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_lbl" xml:lang="en-US">Weighted Average Remaining Contractual Terms (in years)</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_lbl" xml:lang="en-US">Options exercisable at the end of the period</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1_lbl" xml:lang="en-US">Options vested at the end of the period</link:label>
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_AggregateIntrinsicValueAbstract" xlink:label="psti_AggregateIntrinsicValueAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="psti_AggregateIntrinsicValueAbstract" xlink:to="psti_AggregateIntrinsicValueAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="psti_AggregateIntrinsicValueAbstract_lbl" xml:lang="en-US">Aggregate intrinsic value price</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_lbl" xml:lang="en-US">Options outstanding at end of the period</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_lbl" xml:lang="en-US">Options exercisable at the end of the period</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_lbl" xml:lang="en-US">Options vested at the end of the period</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl" xml:lang="en-US">Option granted</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_2_lbl" xml:lang="en-US">Options vested and expected to vest at the end of the period</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl" xml:lang="en-US">Options granted</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_2_lbl" xml:lang="en-US">Options vested and expected to vest at the end of the period</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1_2_lbl" xml:lang="en-US">Options vested and expected to vest at the end of the period</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_2_lbl" xml:lang="en-US">Options vested and expected to vest at the end of the period</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:to="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_lbl" xml:lang="en-US">Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_lbl" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AllocatedShareBasedCompensationExpense" xlink:to="us-gaap_AllocatedShareBasedCompensationExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense_lbl" xml:lang="en-US">Compensation expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_lbl" xml:lang="en-US">Unrecognized compensation expense</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_lbl" xml:lang="en-US">Unrecognized compensation expense, recognition period</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_lbl" xml:lang="en-US">Unvested at the beginning of period</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_lbl" xml:lang="en-US">Granted</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_lbl" xml:lang="en-US">Forfeited</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_lbl" xml:lang="en-US">Vested</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_2_lbl" xml:lang="en-US">Unvested at the end of the period</link:label>
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVest" xlink:label="psti_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVest" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="psti_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVest" xlink:to="psti_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVest_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="psti_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVest_lbl" xml:lang="en-US">Expected to vest after June 30, 2017</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_3_lbl" xml:lang="en-US">Exercise Price per Share</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" xlink:to="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_lbl" xml:lang="en-US">Options and Warrants for Common Stock</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" xlink:to="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_lbl" xml:lang="en-US">Options and Warrants Exercisable</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_3_lbl" xml:lang="en-US">Restricted stock not included in summary of options and warrants</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:label="us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:to="us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_lbl" xml:lang="en-US">Foreign currency translation differences, net</link:label>
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_InterestOnShortTermBankCreditAndBankExpenses" xlink:label="psti_InterestOnShortTermBankCreditAndBankExpenses" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="psti_InterestOnShortTermBankCreditAndBankExpenses" xlink:to="psti_InterestOnShortTermBankCreditAndBankExpenses_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="psti_InterestOnShortTermBankCreditAndBankExpenses_lbl" xml:lang="en-US">Bank and broker commissions</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_InterestIncomeDepositsWithFinancialInstitutions" xlink:label="us-gaap_InterestIncomeDepositsWithFinancialInstitutions" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestIncomeDepositsWithFinancialInstitutions" xlink:to="us-gaap_InterestIncomeDepositsWithFinancialInstitutions_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InterestIncomeDepositsWithFinancialInstitutions_lbl" xml:lang="en-US">Interest income on deposits</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_MarketableSecuritiesGainLoss" xlink:label="us-gaap_MarketableSecuritiesGainLoss" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MarketableSecuritiesGainLoss" xlink:to="us-gaap_MarketableSecuritiesGainLoss_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MarketableSecuritiesGainLoss_lbl" xml:lang="en-US">Gain (loss) related to marketable securities, net</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_GainLossOnDerivativeInstrumentsNetPretax" xlink:label="us-gaap_GainLossOnDerivativeInstrumentsNetPretax" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GainLossOnDerivativeInstrumentsNetPretax" xlink:to="us-gaap_GainLossOnDerivativeInstrumentsNetPretax_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GainLossOnDerivativeInstrumentsNetPretax_lbl" xml:lang="en-US">Gain (loss) from derivatives and fair value hedge derivatives</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherNonoperatingIncome" xlink:label="us-gaap_OtherNonoperatingIncome" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherNonoperatingIncome" xlink:to="us-gaap_OtherNonoperatingIncome_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherNonoperatingIncome_lbl" xml:lang="en-US">Other financial income</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NonoperatingIncomeExpense" xlink:to="us-gaap_NonoperatingIncomeExpense_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NonoperatingIncomeExpense_2_lbl" xml:lang="en-US">Financial income, net</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementGeographicalAxis" xlink:to="us-gaap_StatementGeographicalAxis_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_StatementGeographicalAxis_2_lbl" xml:lang="en-US">Geographical [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_lbl" xml:lang="en-US">Statutory tax rate</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:label="us-gaap_EffectiveIncomeTaxRateContinuingOperations" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="us-gaap_EffectiveIncomeTaxRateContinuingOperations_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EffectiveIncomeTaxRateContinuingOperations_lbl" xml:lang="en-US">Effective income tax rate</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OperatingLossCarryforwards" xlink:label="us-gaap_OperatingLossCarryforwards" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLossCarryforwards" xlink:to="us-gaap_OperatingLossCarryforwards_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLossCarryforwards_lbl" xml:lang="en-US">Net operating loss carryforwards</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OperatingLossCarryforwardsExpirationDate" xlink:label="us-gaap_OperatingLossCarryforwardsExpirationDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLossCarryforwardsExpirationDate" xlink:to="us-gaap_OperatingLossCarryforwardsExpirationDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLossCarryforwardsExpirationDate_lbl" xml:lang="en-US">Net federal operating loss carry forward expiration date</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Revenues" xlink:to="us-gaap_Revenues_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_Revenues_2_lbl" xml:lang="en-US">Total consolidated revenues of its parent company and all subsidiaries</link:label>
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_CorporateStatutoryTaxRateOn2018AndThereafter" xlink:label="psti_CorporateStatutoryTaxRateOn2018AndThereafter" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="psti_CorporateStatutoryTaxRateOn2018AndThereafter" xlink:to="psti_CorporateStatutoryTaxRateOn2018AndThereafter_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="psti_CorporateStatutoryTaxRateOn2018AndThereafter_lbl" xml:lang="en-US">Corporate statutory tax rate on 2018 and thereafter</link:label>
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_CorporateStatutoryTaxRateOn2017AndThereafter" xlink:label="psti_CorporateStatutoryTaxRateOn2017AndThereafter" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="psti_CorporateStatutoryTaxRateOn2017AndThereafter" xlink:to="psti_CorporateStatutoryTaxRateOn2017AndThereafter_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="psti_CorporateStatutoryTaxRateOn2017AndThereafter_lbl" xml:lang="en-US">Corporate statutory tax rate on 2017 and thereafter</link:label>
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_CorporateStatutoryTaxRateForDividendsDistributedToIndividualsOrForeignResidentsDistributedFromPreferredEnterpriseProfits" xlink:label="psti_CorporateStatutoryTaxRateForDividendsDistributedToIndividualsOrForeignResidentsDistributedFromPreferredEnterpriseProfits" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="psti_CorporateStatutoryTaxRateForDividendsDistributedToIndividualsOrForeignResidentsDistributedFromPreferredEnterpriseProfits" xlink:to="psti_CorporateStatutoryTaxRateForDividendsDistributedToIndividualsOrForeignResidentsDistributedFromPreferredEnterpriseProfits_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="psti_CorporateStatutoryTaxRateForDividendsDistributedToIndividualsOrForeignResidentsDistributedFromPreferredEnterpriseProfits_lbl" xml:lang="en-US">Corporate statutory tax rate for any dividends distributed to individuals or foreign residents from the preferred enterprise's earnings</link:label>
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_CorporateStatutoryTaxRateOnProfitsDerivingFromIntellectualProperty" xlink:label="psti_CorporateStatutoryTaxRateOnProfitsDerivingFromIntellectualProperty" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="psti_CorporateStatutoryTaxRateOnProfitsDerivingFromIntellectualProperty" xlink:to="psti_CorporateStatutoryTaxRateOnProfitsDerivingFromIntellectualProperty_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="psti_CorporateStatutoryTaxRateOnProfitsDerivingFromIntellectualProperty_lbl" xml:lang="en-US">Corporate statutory tax rate on profits deriving from intellectual property</link:label>
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_CorporateStatutoryTaxRateForDividendsDistributedToForeignCompanies" xlink:label="psti_CorporateStatutoryTaxRateForDividendsDistributedToForeignCompanies" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="psti_CorporateStatutoryTaxRateForDividendsDistributedToForeignCompanies" xlink:to="psti_CorporateStatutoryTaxRateForDividendsDistributedToForeignCompanies_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="psti_CorporateStatutoryTaxRateForDividendsDistributedToForeignCompanies_lbl" xml:lang="en-US">Corporate statutory tax rate for dividends distributed to foreign companies</link:label>
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_CorporateStatutoryTaxRateOn2016" xlink:label="psti_CorporateStatutoryTaxRateOn2016" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="psti_CorporateStatutoryTaxRateOn2016" xlink:to="psti_CorporateStatutoryTaxRateOn2016_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="psti_CorporateStatutoryTaxRateOn2016_lbl" xml:lang="en-US">Corporate statutory tax rate on 2016</link:label>
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_CorporateStatutoryTaxRateOn2016AndThereafter" xlink:label="psti_CorporateStatutoryTaxRateOn2016AndThereafter" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="psti_CorporateStatutoryTaxRateOn2016AndThereafter" xlink:to="psti_CorporateStatutoryTaxRateOn2016AndThereafter_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="psti_CorporateStatutoryTaxRateOn2016AndThereafter_lbl" xml:lang="en-US">Corporate statutory tax rate on 2016 and thereafter</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic_lbl" xml:lang="en-US">U.S. net operating loss carryforward</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign_lbl" xml:lang="en-US">Israeli net operating loss carryforward</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals" xlink:to="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals_lbl" xml:lang="en-US">Allowances and reserves</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DeferredTaxAssetsGross" xlink:label="us-gaap_DeferredTaxAssetsGross" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="us-gaap_DeferredTaxAssetsGross_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_DeferredTaxAssetsGross_lbl" xml:lang="en-US">Total deferred tax assets before valuation allowance</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsValuationAllowance" xlink:to="us-gaap_DeferredTaxAssetsValuationAllowance_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance_lbl" xml:lang="en-US">Valuation allowance</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DeferredTaxAssetsNet" xlink:label="us-gaap_DeferredTaxAssetsNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsNet" xlink:to="us-gaap_DeferredTaxAssetsNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_DeferredTaxAssetsNet_lbl" xml:lang="en-US">Net deferred tax asset</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SubsequentEventTable" xlink:label="us-gaap_SubsequentEventTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventTable" xlink:to="us-gaap_SubsequentEventTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventTable_lbl" xml:lang="en-US">Subsequent Event [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SubsequentEventLineItems" xlink:label="us-gaap_SubsequentEventLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_SubsequentEventLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventLineItems_lbl" xml:lang="en-US">Subsequent Event [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_ValueOfCommonStockCompanyCanPeriodicallyIssueThroughAgentsPerTermsOfAtmAgreement" xlink:label="psti_ValueOfCommonStockCompanyCanPeriodicallyIssueThroughAgentsPerTermsOfAtmAgreement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="psti_ValueOfCommonStockCompanyCanPeriodicallyIssueThroughAgentsPerTermsOfAtmAgreement" xlink:to="psti_ValueOfCommonStockCompanyCanPeriodicallyIssueThroughAgentsPerTermsOfAtmAgreement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="psti_ValueOfCommonStockCompanyCanPeriodicallyIssueThroughAgentsPerTermsOfAtmAgreement_lbl" xml:lang="en-US">Value of common stock company can periodically issue through Agents, per terms of ATM Agreement</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_GrantsReceivable" xlink:label="us-gaap_GrantsReceivable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GrantsReceivable" xlink:to="us-gaap_GrantsReceivable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GrantsReceivable_lbl" xml:lang="en-US">Additonal grant awarded</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues_3_lbl" xml:lang="en-US">Stock issued</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesIssuedPricePerShare" xlink:to="us-gaap_SharesIssuedPricePerShare_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_SharesIssuedPricePerShare_2_lbl" xml:lang="en-US">Equity issuance, price per share</link:label>
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_TotalNondilutiveGrantAwardedFromHorizon2020Program" xlink:label="psti_TotalNondilutiveGrantAwardedFromHorizon2020Program" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="psti_TotalNondilutiveGrantAwardedFromHorizon2020Program" xlink:to="psti_TotalNondilutiveGrantAwardedFromHorizon2020Program_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="psti_TotalNondilutiveGrantAwardedFromHorizon2020Program_lbl" xml:lang="en-US">Total non-dilutive grants awarded under the European Union's Horizon 2020 program</link:label>
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_AmountOfDirectGrantsAwardedAllocatedToCompany" xlink:label="psti_AmountOfDirectGrantsAwardedAllocatedToCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="psti_AmountOfDirectGrantsAwardedAllocatedToCompany" xlink:to="psti_AmountOfDirectGrantsAwardedAllocatedToCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="psti_AmountOfDirectGrantsAwardedAllocatedToCompany_lbl" xml:lang="en-US">Amount of direct grants awarded allocated to Company</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="psti_AccountsReceivableFromMinistryOfEconomyCurrent" xlink:to="psti_AccountsReceivableFromMinistryOfEconomyCurrent_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="psti_AccountsReceivableFromMinistryOfEconomyCurrent_doc" xml:lang="en-US">The carrying amount of accounts receivable from the Ministry of Economy due within one year of the balance sheet date (or one operating cycle, if longer).</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="psti_AdvancePaymentForDeveplomentCosts" xlink:to="psti_AdvancePaymentForDeveplomentCosts_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="psti_AdvancePaymentForDeveplomentCosts_doc" xml:lang="en-US">The advance payment for any development costs.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="psti_AggregateGrantsReceived" xlink:to="psti_AggregateGrantsReceived_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="psti_AggregateGrantsReceived_doc" xml:lang="en-US">Aggregate revenue received from grants as of the balance sheet date.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="psti_AggregateIntrinsicValueAbstract" xlink:to="psti_AggregateIntrinsicValueAbstract_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="psti_AggregateIntrinsicValueAbstract_doc" xml:lang="en-US">Aggregate Intrinsic Value [Abstract].</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="psti_AggregateOfferingPriceUnderATMAgreement" xlink:to="psti_AggregateOfferingPriceUnderATMAgreement_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="psti_AggregateOfferingPriceUnderATMAgreement_doc" xml:lang="en-US">The maximum aggregate offering price under the At Market Issuance Sales Agreement.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="psti_AmortizationOfDiscountAndPremiumAndChangesInAccruedInterestFromMarketableSecurities" xlink:to="psti_AmortizationOfDiscountAndPremiumAndChangesInAccruedInterestFromMarketableSecurities_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="psti_AmortizationOfDiscountAndPremiumAndChangesInAccruedInterestFromMarketableSecurities_doc" xml:lang="en-US">Amortization of discount and premium and changes in accrued interest from marketable securities.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="psti_AvailableForSaleMarketableSecuritiesNumber" xlink:to="psti_AvailableForSaleMarketableSecuritiesNumber_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="psti_AvailableForSaleMarketableSecuritiesNumber_doc" xml:lang="en-US">Number of equity financial securities classified as available-for-sale.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="psti_AvailableForSaleSecuritiesMaturesAfterFiveYearsThroughTenYearsMember" xlink:to="psti_AvailableForSaleSecuritiesMaturesAfterFiveYearsThroughTenYearsMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="psti_AvailableForSaleSecuritiesMaturesAfterFiveYearsThroughTenYearsMember_doc" xml:lang="en-US">Available-for-sale securities with maturities after five years and within ten years.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="psti_AvailableForSaleSecuritiesMaturesAfterOneYearThroughFiveYearsMember" xlink:to="psti_AvailableForSaleSecuritiesMaturesAfterOneYearThroughFiveYearsMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="psti_AvailableForSaleSecuritiesMaturesAfterOneYearThroughFiveYearsMember_doc" xml:lang="en-US">Available-for sale securities with maturities between one and five years.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="psti_AvailableForSaleSecuritiesMaturesWithinOneYearMember" xlink:to="psti_AvailableForSaleSecuritiesMaturesWithinOneYearMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="psti_AvailableForSaleSecuritiesMaturesWithinOneYearMember_doc" xml:lang="en-US">Available-for-sale securities with maturites within the nex year.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="psti_BusinessCombinationContingentConsiderationReceivableUponCertainRegulatoryMilestones" xlink:to="psti_BusinessCombinationContingentConsiderationReceivableUponCertainRegulatoryMilestones_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="psti_BusinessCombinationContingentConsiderationReceivableUponCertainRegulatoryMilestones_doc" xml:lang="en-US">Business combination contingent consideration receivable upon certain regulatory milestones.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="psti_CommonStockAggregateOfferingPriceAuthorized" xlink:to="psti_CommonStockAggregateOfferingPriceAuthorized_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="psti_CommonStockAggregateOfferingPriceAuthorized_doc" xml:lang="en-US">The maximum aggregate offering price of common shares permitted to be issued.</link:label>
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_ConsultantRestrictedStockUnitsMember" xlink:label="psti_ConsultantRestrictedStockUnitsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="psti_ConsultantRestrictedStockUnitsMember" xlink:to="psti_ConsultantRestrictedStockUnitsMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="psti_ConsultantRestrictedStockUnitsMember_doc" xml:lang="en-US">Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met, issued to consultants.</link:label>
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_ConsultantWarrantsMember" xlink:label="psti_ConsultantWarrantsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="psti_ConsultantWarrantsMember" xlink:to="psti_ConsultantWarrantsMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="psti_ConsultantWarrantsMember_doc" xml:lang="en-US">Consultant Warrants [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="psti_ConsultantsMember" xlink:to="psti_ConsultantsMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="psti_ConsultantsMember_doc" xml:lang="en-US">Non-employee consultants providing a serivce to the company.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="psti_ContractorMember" xlink:to="psti_ContractorMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="psti_ContractorMember_doc" xml:lang="en-US">Contractor member.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="psti_DocumentAndEntityInformationAbstract" xlink:to="psti_DocumentAndEntityInformationAbstract_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="psti_DocumentAndEntityInformationAbstract_doc" xml:lang="en-US">Document And Entity Information Abstract</link:label>
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_EquityOptionsAndWarrantsMember" xlink:label="psti_EquityOptionsAndWarrantsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="psti_EquityOptionsAndWarrantsMember" xlink:to="psti_EquityOptionsAndWarrantsMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="psti_EquityOptionsAndWarrantsMember_doc" xml:lang="en-US">Options and warrants issued as equity award compensation.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="psti_ExerciseOfOptionsByEmployees" xlink:to="psti_ExerciseOfOptionsByEmployees_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="psti_ExerciseOfOptionsByEmployees_doc" xml:lang="en-US">Exercise of options by employees.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="psti_ExerciseOfOptionsByEmployeesShares" xlink:to="psti_ExerciseOfOptionsByEmployeesShares_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="psti_ExerciseOfOptionsByEmployeesShares_doc" xml:lang="en-US">Exercise of options by employees, shares.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="psti_ExercisePriceRangeEightMember" xlink:to="psti_ExercisePriceRangeEightMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="psti_ExercisePriceRangeEightMember_doc" xml:lang="en-US">$ 3.50.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="psti_ExercisePriceRangeElevenMember" xlink:to="psti_ExercisePriceRangeElevenMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="psti_ExercisePriceRangeElevenMember_doc" xml:lang="en-US">$ 4.00.</link:label>
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_ExercisePriceRangeFifteenMember" xlink:label="psti_ExercisePriceRangeFifteenMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="psti_ExercisePriceRangeFifteenMember" xlink:to="psti_ExercisePriceRangeFifteenMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="psti_ExercisePriceRangeFifteenMember_doc" xml:lang="en-US">$ 8.20.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="psti_ExercisePriceRangeFiveMember" xlink:to="psti_ExercisePriceRangeFiveMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="psti_ExercisePriceRangeFiveMember_doc" xml:lang="en-US">$ 0.62.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="psti_ExercisePriceRangeFourMember" xlink:to="psti_ExercisePriceRangeFourMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="psti_ExercisePriceRangeFourMember_doc" xml:lang="en-US">$ 0.00.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="psti_ExercisePriceRangeFourteenMember" xlink:to="psti_ExercisePriceRangeFourteenMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="psti_ExercisePriceRangeFourteenMember_doc" xml:lang="en-US">$ 6.80.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="psti_ExercisePriceRangeNineMember" xlink:to="psti_ExercisePriceRangeNineMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="psti_ExercisePriceRangeNineMember_doc" xml:lang="en-US">$ 3.72.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="psti_ExercisePriceRangeOneMember" xlink:to="psti_ExercisePriceRangeOneMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="psti_ExercisePriceRangeOneMember_doc" xml:lang="en-US">$ 2.85.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="psti_ExercisePriceRangeSevenMember" xlink:to="psti_ExercisePriceRangeSevenMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="psti_ExercisePriceRangeSevenMember_doc" xml:lang="en-US">$ 2.97.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="psti_ExercisePriceRangeSixMember" xlink:to="psti_ExercisePriceRangeSixMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="psti_ExercisePriceRangeSixMember_doc" xml:lang="en-US">$ 1.04.</link:label>
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_ExercisePriceRangeSixteenMember" xlink:label="psti_ExercisePriceRangeSixteenMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="psti_ExercisePriceRangeSixteenMember" xlink:to="psti_ExercisePriceRangeSixteenMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="psti_ExercisePriceRangeSixteenMember_doc" xml:lang="en-US">$ 20.00.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="psti_ExercisePriceRangeTenMember" xlink:to="psti_ExercisePriceRangeTenMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="psti_ExercisePriceRangeTenMember_doc" xml:lang="en-US">$ 3.80.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="psti_ExercisePriceRangeThirteenMember" xlink:to="psti_ExercisePriceRangeThirteenMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="psti_ExercisePriceRangeThirteenMember_doc" xml:lang="en-US">$ 4.40.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="psti_ExercisePriceRangeThreeMember" xlink:to="psti_ExercisePriceRangeThreeMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="psti_ExercisePriceRangeThreeMember_doc" xml:lang="en-US">$ 5.00.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="psti_ExercisePriceRangeTwelveMember" xlink:to="psti_ExercisePriceRangeTwelveMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="psti_ExercisePriceRangeTwelveMember_doc" xml:lang="en-US">$ 4.38.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="psti_ExercisePriceRangeTwoMember" xlink:to="psti_ExercisePriceRangeTwoMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="psti_ExercisePriceRangeTwoMember_doc" xml:lang="en-US">$ 4.20.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="psti_ExpirationPeriodOfWarrantsSoldInOffering" xlink:to="psti_ExpirationPeriodOfWarrantsSoldInOffering_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="psti_ExpirationPeriodOfWarrantsSoldInOffering_doc" xml:lang="en-US">Expiration period of the warrants sold in the offering.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="psti_GeneralAbstract" xlink:to="psti_GeneralAbstract_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="psti_GeneralAbstract_doc" xml:lang="en-US">General Disclosure Abstract</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="psti_GovernmentAndThirdPartyGrantsReceived" xlink:to="psti_GovernmentAndThirdPartyGrantsReceived_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="psti_GovernmentAndThirdPartyGrantsReceived_doc" xml:lang="en-US">Grants received from the government and third parties for research and development programs.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="psti_GovernmentDebtSecuritiesMember" xlink:to="psti_GovernmentDebtSecuritiesMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="psti_GovernmentDebtSecuritiesMember_doc" xml:lang="en-US">Debt securities issued by a national, local, or municipal government.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="psti_InterestOnShortTermBankCreditAndBankExpenses" xlink:to="psti_InterestOnShortTermBankCreditAndBankExpenses_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="psti_InterestOnShortTermBankCreditAndBankExpenses_doc" xml:lang="en-US">Interest on short-term bank credit and bank expenses.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="psti_InvestorWarrantsMember" xlink:to="psti_InvestorWarrantsMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="psti_InvestorWarrantsMember_doc" xml:lang="en-US">Investor Warrants [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="psti_LeaseholdImprovementsAnnualRateOfDepreciationDescription" xlink:to="psti_LeaseholdImprovementsAnnualRateOfDepreciationDescription_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="psti_LeaseholdImprovementsAnnualRateOfDepreciationDescription_doc" xml:lang="en-US">The depreciation description for leasehold improvements.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="psti_LinkageDifferencesAndInterestOnShortAndLongTermRestrictedLeaseDeposit" xlink:to="psti_LinkageDifferencesAndInterestOnShortAndLongTermRestrictedLeaseDeposit_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="psti_LinkageDifferencesAndInterestOnShortAndLongTermRestrictedLeaseDeposit_doc" xml:lang="en-US">Linkage differences and interest on short and long term restricted lease deposit.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="psti_MaturityDateRangeAxis" xlink:to="psti_MaturityDateRangeAxis_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="psti_MaturityDateRangeAxis_doc" xml:lang="en-US">Information by maturity date range.</link:label>
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_MaturityDateRangeDomain" xlink:label="psti_MaturityDateRangeDomain" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="psti_MaturityDateRangeDomain" xlink:to="psti_MaturityDateRangeDomain_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="psti_MaturityDateRangeDomain_doc" xml:lang="en-US">Extent of variation of maturity date ranges.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="psti_OperatingLeasedAssetsNumberOfUnits" xlink:to="psti_OperatingLeasedAssetsNumberOfUnits_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="psti_OperatingLeasedAssetsNumberOfUnits_doc" xml:lang="en-US">The number of units (items of property) under operating lease arrangements.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="psti_OperatingLeasedAssetsParticipationFromLessor" xlink:to="psti_OperatingLeasedAssetsParticipationFromLessor_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="psti_OperatingLeasedAssetsParticipationFromLessor_doc" xml:lang="en-US">Operating Leased Assets, Participation From Lessor.</link:label>
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_OtherAccountReceivableMember" xlink:label="psti_OtherAccountReceivableMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="psti_OtherAccountReceivableMember" xlink:to="psti_OtherAccountReceivableMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="psti_OtherAccountReceivableMember_doc" xml:lang="en-US">Other Account Receivable [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="psti_OtherAccountsPayableAbstract" xlink:to="psti_OtherAccountsPayableAbstract_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="psti_OtherAccountsPayableAbstract_doc" xml:lang="en-US">Other Accounts Payable [Abstract].</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="psti_OtherAccountsPayablePayrollInstitutions" xlink:to="psti_OtherAccountsPayablePayrollInstitutions_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="psti_OtherAccountsPayablePayrollInstitutions_doc" xml:lang="en-US">Other accounts payable related to payroll institutions.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="psti_OtherthantemporaryImpairment" xlink:to="psti_OtherthantemporaryImpairment_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="psti_OtherthantemporaryImpairment_doc" xml:lang="en-US">Other-than-temporary impairment.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="psti_PercentageOfConstructionMilestonesCompleted" xlink:to="psti_PercentageOfConstructionMilestonesCompleted_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="psti_PercentageOfConstructionMilestonesCompleted_doc" xml:lang="en-US">Percentage of construction milestones completed.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="psti_PercentageOfQualifiedExpenditures" xlink:to="psti_PercentageOfQualifiedExpenditures_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="psti_PercentageOfQualifiedExpenditures_doc" xml:lang="en-US">Percentage Of Qualified Expenditures.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="psti_Plan2005Member" xlink:to="psti_Plan2005Member_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="psti_Plan2005Member_doc" xml:lang="en-US">Plan 2005 [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="psti_Plan2016Member" xlink:to="psti_Plan2016Member_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="psti_Plan2016Member_doc" xml:lang="en-US">Plan 2016 [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="psti_PropertyPlantAndEquipmentAnnualRateOfDepreciation" xlink:to="psti_PropertyPlantAndEquipmentAnnualRateOfDepreciation_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="psti_PropertyPlantAndEquipmentAnnualRateOfDepreciation_doc" xml:lang="en-US">The depreciation rate applied annually using the straight-line method.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="psti_PropertyPlantAndEquipmentEstimatedUsefulLivesRateTableTextBlock" xlink:to="psti_PropertyPlantAndEquipmentEstimatedUsefulLivesRateTableTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="psti_PropertyPlantAndEquipmentEstimatedUsefulLivesRateTableTextBlock_doc" xml:lang="en-US">Property Plant And Equipment Estimated Useful Lives Rate [Table Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="psti_QualifyingPercentageOfValueOfProductiveAssetsTableTextBlock" xlink:to="psti_QualifyingPercentageOfValueOfProductiveAssetsTableTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="psti_QualifyingPercentageOfValueOfProductiveAssetsTableTextBlock_doc" xml:lang="en-US">Qualifying Percentage Of Value Of Productive Assets [Table Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="psti_RepaymentOfInvestmentInLongtermDepositsAndRestrictedBankDeposits" xlink:to="psti_RepaymentOfInvestmentInLongtermDepositsAndRestrictedBankDeposits_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="psti_RepaymentOfInvestmentInLongtermDepositsAndRestrictedBankDeposits_doc" xml:lang="en-US">Repayment of (investment in) long-term deposits and restricted bank deposits.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="psti_ResearchAndDevelopmentExpensesNet" xlink:to="psti_ResearchAndDevelopmentExpensesNet_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="psti_ResearchAndDevelopmentExpensesNet_doc" xml:lang="en-US">Research and development expenses, net.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="psti_RoyaltiesAmountPaidAndAccrued" xlink:to="psti_RoyaltiesAmountPaidAndAccrued_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="psti_RoyaltiesAmountPaidAndAccrued_doc" xml:lang="en-US">Amount of royalty paid or accrued.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="psti_RoyaltyRatePayableOnGrantsReceived" xlink:to="psti_RoyaltyRatePayableOnGrantsReceived_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="psti_RoyaltyRatePayableOnGrantsReceived_doc" xml:lang="en-US">Maximum royalty payable based on a percentage of grants received.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="psti_RoyaltyRateSales" xlink:to="psti_RoyaltyRateSales_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="psti_RoyaltyRateSales_doc" xml:lang="en-US">Royalty rate payable calculated as a percentage of the sale of products and other related revenues generated from such projects.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="psti_SeverancePayPolicyTextBlock" xlink:to="psti_SeverancePayPolicyTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="psti_SeverancePayPolicyTextBlock_doc" xml:lang="en-US">Disclosure of accounting policy related to severance pay.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="psti_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVest" xlink:to="psti_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVest_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="psti_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVest_doc" xml:lang="en-US">Share based compensation arrangement by share based payment award equity instruments other than options expected to vest.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="psti_ShareBasedGoodsAndNonemployeeServicesTransactionQuantityOfSecuritiesToBeIssued" xlink:to="psti_ShareBasedGoodsAndNonemployeeServicesTransactionQuantityOfSecuritiesToBeIssued_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="psti_ShareBasedGoodsAndNonemployeeServicesTransactionQuantityOfSecuritiesToBeIssued_doc" xml:lang="en-US">The number of shares or units of entity securities to be issued in the transaction in which equity securities will be issued to pay for goods or nonemployee services.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="psti_SharebasedCompensationArrangementWarrantsExercised" xlink:to="psti_SharebasedCompensationArrangementWarrantsExercised_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="psti_SharebasedCompensationArrangementWarrantsExercised_doc" xml:lang="en-US">Number of warrants exercised during the period.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="psti_ShortTermBankDepositPolicyTextBlock" xlink:to="psti_ShortTermBankDepositPolicyTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="psti_ShortTermBankDepositPolicyTextBlock_doc" xml:lang="en-US">The policy disclosure regarding short-term bank deposits for the entity.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="psti_SignificantAccountingPolicyPolicyTextBlock" xlink:to="psti_SignificantAccountingPolicyPolicyTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="psti_SignificantAccountingPolicyPolicyTextBlock_doc" xml:lang="en-US">Disclosure of accounting policy for significant accounting policies.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="psti_StockIssuedDuringPeriodSharesPrivatePlacement" xlink:to="psti_StockIssuedDuringPeriodSharesPrivatePlacement_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="psti_StockIssuedDuringPeriodSharesPrivatePlacement_doc" xml:lang="en-US">Represents the number of stock issued during the period under the private placement.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="psti_StockIssuedDuringPeriodSharesStockWarrantsExercised" xlink:to="psti_StockIssuedDuringPeriodSharesStockWarrantsExercised_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="psti_StockIssuedDuringPeriodSharesStockWarrantsExercised_doc" xml:lang="en-US">Number of shares of stock issued as a result of the exercise of stock warrants.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="psti_StockIssuedDuringPeriodValuePrivatePlacement" xlink:to="psti_StockIssuedDuringPeriodValuePrivatePlacement_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="psti_StockIssuedDuringPeriodValuePrivatePlacement_doc" xml:lang="en-US">Represents the equity impact of the value of private placement issued during the period.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="psti_StockIssuedDuringPeriodValueStockWarrantsExercised" xlink:to="psti_StockIssuedDuringPeriodValueStockWarrantsExercised_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="psti_StockIssuedDuringPeriodValueStockWarrantsExercised_doc" xml:lang="en-US">Value of stock issued as a result of the exercise of stock warrants.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="psti_StockholdersEquityNoteLineItems" xlink:to="psti_StockholdersEquityNoteLineItems_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="psti_StockholdersEquityNoteLineItems_doc" xml:lang="en-US">Stockholders' Equity Note [Line Items].</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="psti_StockholdersEquityNoteTable" xlink:to="psti_StockholdersEquityNoteTable_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="psti_StockholdersEquityNoteTable_doc" xml:lang="en-US">Stockholders' Equity Note [Table].</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="psti_WeightedAverageRemainingContractualTermsAbstract" xlink:to="psti_WeightedAverageRemainingContractualTermsAbstract_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="psti_WeightedAverageRemainingContractualTermsAbstract_doc" xml:lang="en-US">Weighted Average Remaining Contractual Terms [Abstract].</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="psti_TotalGrantsAwardedToCliProgram" xlink:to="psti_TotalGrantsAwardedToCliProgram_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="psti_TotalGrantsAwardedToCliProgram_doc" xml:lang="en-US">Total grants awarded to CLI program under the European Union's Horizon 2020 program.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="psti_AmountOfGrantsAwardedToCliProgramAllocatedToCompany" xlink:to="psti_AmountOfGrantsAwardedToCliProgramAllocatedToCompany_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="psti_AmountOfGrantsAwardedToCliProgramAllocatedToCompany_doc" xml:lang="en-US">Amount of grants awared under CLI program allocated to Company.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="psti_RecognizedRAndDPariticipationGrants" xlink:to="psti_RecognizedRAndDPariticipationGrants_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="psti_RecognizedRAndDPariticipationGrants_doc" xml:lang="en-US">Recognized research and development participation grants.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="psti_AmountOfGrantsReceivedConditionalAward" xlink:to="psti_AmountOfGrantsReceivedConditionalAward_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="psti_AmountOfGrantsReceivedConditionalAward_doc" xml:lang="en-US">Amount of grants awared received conditional award.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="psti_BinationalIndustrialResearchAndDevelopmentFoundationMember" xlink:to="psti_BinationalIndustrialResearchAndDevelopmentFoundationMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="psti_BinationalIndustrialResearchAndDevelopmentFoundationMember_doc" xml:lang="en-US">BIRD [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="psti_AmountOfDirectGrantAllocatedToTheCompany" xlink:to="psti_AmountOfDirectGrantAllocatedToTheCompany_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="psti_AmountOfDirectGrantAllocatedToTheCompany_doc" xml:lang="en-US">Amount of grants awared allocated to Company.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="psti_SmartMoneyGrantMember" xlink:to="psti_SmartMoneyGrantMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="psti_SmartMoneyGrantMember_doc" xml:lang="en-US">Smart Money Grant [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="psti_TermOfRoyaltyGrantReceived" xlink:to="psti_TermOfRoyaltyGrantReceived_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="psti_TermOfRoyaltyGrantReceived_doc" xml:lang="en-US">Term of royalty grant received.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="psti_NewYorkBloodCenterIncMember" xlink:to="psti_NewYorkBloodCenterIncMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="psti_NewYorkBloodCenterIncMember_doc" xml:lang="en-US">NYBC [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="psti_UnderwritingAgreementMember" xlink:to="psti_UnderwritingAgreementMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="psti_UnderwritingAgreementMember_doc" xml:lang="en-US">Underwriting Agreement [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="psti_NumberOfSharesAgreedToBeSoldThroughUnderwriterAgreement" xlink:to="psti_NumberOfSharesAgreedToBeSoldThroughUnderwriterAgreement_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="psti_NumberOfSharesAgreedToBeSoldThroughUnderwriterAgreement_doc" xml:lang="en-US">Number of shares agreed to be sold through Underwriter Agreement.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="psti_NumberOfWarrantsAgreedToBeSoldThroughUnderwriterAgreement" xlink:to="psti_NumberOfWarrantsAgreedToBeSoldThroughUnderwriterAgreement_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="psti_NumberOfWarrantsAgreedToBeSoldThroughUnderwriterAgreement_doc" xml:lang="en-US">Number of warrants agreed to be sold through Underwriter Agreement.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="psti_GrossProceedsFromIssuanceOfCommonStock" xlink:to="psti_GrossProceedsFromIssuanceOfCommonStock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="psti_GrossProceedsFromIssuanceOfCommonStock_doc" xml:lang="en-US">Gross proceeds from the additional capital contribution to the entity.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="psti_EmployeesAndDirectorsMember" xlink:to="psti_EmployeesAndDirectorsMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="psti_EmployeesAndDirectorsMember_doc" xml:lang="en-US">Employees and Directors [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="psti_NonemployeesMember" xlink:to="psti_NonemployeesMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="psti_NonemployeesMember_doc" xml:lang="en-US">Non-employee Consultants [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="psti_AtMarketIssuanceSalesAgreementMember" xlink:to="psti_AtMarketIssuanceSalesAgreementMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="psti_AtMarketIssuanceSalesAgreementMember_doc" xml:lang="en-US">ATM Agreement [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="psti_NonrefundableAdvanceUnderTermsOfLicenseAgreement" xlink:to="psti_NonrefundableAdvanceUnderTermsOfLicenseAgreement_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="psti_NonrefundableAdvanceUnderTermsOfLicenseAgreement_doc" xml:lang="en-US">Nonrefundable upfront payment received from customer.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="psti_ValueOfCommonStockCompanyCanPeriodicallyIssueThroughAgentsPerTermsOfAtmAgreement" xlink:to="psti_ValueOfCommonStockCompanyCanPeriodicallyIssueThroughAgentsPerTermsOfAtmAgreement_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="psti_ValueOfCommonStockCompanyCanPeriodicallyIssueThroughAgentsPerTermsOfAtmAgreement_doc" xml:lang="en-US">Value of common stock company can periodically issue through Agents, per terms of ATM Agreement.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="psti_IssuanceOfCommonStockAndWarrantsRelatedToJanuaryTwentySeventeenOfferingNetOfIssuanceCostsShares" xlink:to="psti_IssuanceOfCommonStockAndWarrantsRelatedToJanuaryTwentySeventeenOfferingNetOfIssuanceCostsShares_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="psti_IssuanceOfCommonStockAndWarrantsRelatedToJanuaryTwentySeventeenOfferingNetOfIssuanceCostsShares_doc" xml:lang="en-US">Issuance of common stock and warrants related to January 2017 offering, net of issuance costs, number of shares issued.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="psti_IssuanceOfCommonStockAndWarrantsRelatedToJanuaryTwentySeventeenOfferingNetOfIssuanceCostsValue" xlink:to="psti_IssuanceOfCommonStockAndWarrantsRelatedToJanuaryTwentySeventeenOfferingNetOfIssuanceCostsValue_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="psti_IssuanceOfCommonStockAndWarrantsRelatedToJanuaryTwentySeventeenOfferingNetOfIssuanceCostsValue_doc" xml:lang="en-US">Issuance of common stock and warrants related to January 2017 offering, net of issuance costs, value.</link:label>
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_TwoThousandsEighteenMember" xlink:label="psti_TwoThousandsEighteenMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="psti_TwoThousandsEighteenMember" xlink:to="psti_TwoThousandsEighteenMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="psti_TwoThousandsEighteenMember_doc" xml:lang="en-US">2018 Budget years [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="psti_TechnologicalPreferredEnterpriseMember" xlink:to="psti_TechnologicalPreferredEnterpriseMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="psti_TechnologicalPreferredEnterpriseMember_doc" xml:lang="en-US">Technological Preferred Enterprise [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="psti_SpecialTechnologicalPreferredEnterpriseMember" xlink:to="psti_SpecialTechnologicalPreferredEnterpriseMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="psti_SpecialTechnologicalPreferredEnterpriseMember_doc" xml:lang="en-US">Special Technological Preferred Enterprise [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="psti_LongTermRestrictedBankDepositPolicyTextBlock" xlink:to="psti_LongTermRestrictedBankDepositPolicyTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="psti_LongTermRestrictedBankDepositPolicyTextBlock_doc" xml:lang="en-US">The policy disclosure regarding long-term restricted bank deposits for the entity.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="psti_ResearchAndDevelopmentExpensesAndRoyaltyBearingGrantsPolicyTextBlock" xlink:to="psti_ResearchAndDevelopmentExpensesAndRoyaltyBearingGrantsPolicyTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="psti_ResearchAndDevelopmentExpensesAndRoyaltyBearingGrantsPolicyTextBlock_doc" xml:lang="en-US">Disclosure of accounting policy for research and development expenses and royalty bearing grants.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="psti_NonroyaltyBearingGrantsPolicyTextBlock" xlink:to="psti_NonroyaltyBearingGrantsPolicyTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="psti_NonroyaltyBearingGrantsPolicyTextBlock_doc" xml:lang="en-US">Disclosure of accounting policy for non-royalty bearing grants.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="psti_CorporateStatutoryTaxRateOn2018AndThereafter" xlink:to="psti_CorporateStatutoryTaxRateOn2018AndThereafter_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="psti_CorporateStatutoryTaxRateOn2018AndThereafter_doc" xml:lang="en-US">Corporate statutory tax rate on 2018 and thereafter.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="psti_CorporateStatutoryTaxRateOn2017AndThereafter" xlink:to="psti_CorporateStatutoryTaxRateOn2017AndThereafter_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="psti_CorporateStatutoryTaxRateOn2017AndThereafter_doc" xml:lang="en-US">Corporate statutory tax rate on 2017 and thereafter.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="psti_CorporateStatutoryTaxRateOn2016" xlink:to="psti_CorporateStatutoryTaxRateOn2016_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="psti_CorporateStatutoryTaxRateOn2016_doc" xml:lang="en-US">Corporate statutory tax rate on 2016.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="psti_CorporateStatutoryTaxRateOn2016AndThereafter" xlink:to="psti_CorporateStatutoryTaxRateOn2016AndThereafter_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="psti_CorporateStatutoryTaxRateOn2016AndThereafter_doc" xml:lang="en-US">Corporate statutory tax rate on 2016 and thereafter.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="psti_PreferredEnterpriseMember" xlink:to="psti_PreferredEnterpriseMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="psti_PreferredEnterpriseMember_doc" xml:lang="en-US">Preferred Enterprise [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="psti_DevelopmentAreaMember" xlink:to="psti_DevelopmentAreaMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="psti_DevelopmentAreaMember_doc" xml:lang="en-US">Development Area A [Member[</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="psti_RestOfCountryMember" xlink:to="psti_RestOfCountryMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="psti_RestOfCountryMember_doc" xml:lang="en-US">Rest of Country [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="psti_CorporateStatutoryTaxRateOnProfitsDerivingFromIntellectualProperty" xlink:to="psti_CorporateStatutoryTaxRateOnProfitsDerivingFromIntellectualProperty_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="psti_CorporateStatutoryTaxRateOnProfitsDerivingFromIntellectualProperty_doc" xml:lang="en-US">Corporate statutory tax rate on profits deriving from intellectual property for an enterprise which total consolidated revenues of its parent company and all subsidiaries exceed NIS 10 billion.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="psti_CorporateStatutoryTaxRateForDividendsDistributedToForeignCompanies" xlink:to="psti_CorporateStatutoryTaxRateForDividendsDistributedToForeignCompanies_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="psti_CorporateStatutoryTaxRateForDividendsDistributedToForeignCompanies_doc" xml:lang="en-US">Corporate statutory tax rate for dividends distributed to foreign companies.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="psti_CorporateStatutoryTaxRateForDividendsDistributedToIndividualsOrForeignResidentsDistributedFromPreferredEnterpriseProfits" xlink:to="psti_CorporateStatutoryTaxRateForDividendsDistributedToIndividualsOrForeignResidentsDistributedFromPreferredEnterpriseProfits_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="psti_CorporateStatutoryTaxRateForDividendsDistributedToIndividualsOrForeignResidentsDistributedFromPreferredEnterpriseProfits_doc" xml:lang="en-US">Corporate statutory tax rate for any dividends distributed to individuals or foreign residents from the preferred enterprise's earnings.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="psti_TechnologicalEnterpriseMember" xlink:to="psti_TechnologicalEnterpriseMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="psti_TechnologicalEnterpriseMember_doc" xml:lang="en-US">Technological Enterprise [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="psti_TotalNondilutiveGrantAwardedFromHorizon2020Program" xlink:to="psti_TotalNondilutiveGrantAwardedFromHorizon2020Program_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="psti_TotalNondilutiveGrantAwardedFromHorizon2020Program_doc" xml:lang="en-US">Total non-dilutive grants awarded under the European Union's Horizon 2020 program.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="psti_AmountOfDirectGrantsAwardedAllocatedToCompany" xlink:to="psti_AmountOfDirectGrantsAwardedAllocatedToCompany_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="psti_AmountOfDirectGrantsAwardedAllocatedToCompany_doc" xml:lang="en-US">Amount of direct grants awarded allocated to Company.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherAssetsCurrent" xlink:to="us-gaap_OtherAssetsCurrent_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherAssetsCurrent_3_lbl" xml:lang="en-US">Other Assets, Current</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_AssetsCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsCurrent_2_lbl" xml:lang="en-US">Assets, Current</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsNoncurrent" xlink:to="us-gaap_AssetsNoncurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsNoncurrent_2_lbl" xml:lang="en-US">Assets, Noncurrent</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Assets" xlink:to="us-gaap_Assets_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Assets_2_lbl" xml:lang="en-US">Assets</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableCurrent" xlink:to="us-gaap_AccountsPayableCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsPayableCurrent_2_lbl" xml:lang="en-US">Accounts Payable, Current</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableOtherCurrent" xlink:to="us-gaap_AccountsPayableOtherCurrent_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsPayableOtherCurrent_3_lbl" xml:lang="en-US">Accounts Payable, Other, Current</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_LiabilitiesCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesCurrent_2_lbl" xml:lang="en-US">Liabilities, Current</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesNoncurrent" xlink:to="us-gaap_LiabilitiesNoncurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesNoncurrent_2_lbl" xml:lang="en-US">Liabilities, Noncurrent</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_2_lbl" xml:lang="en-US">Liabilities and Equity</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CostOfRevenue" xlink:to="us-gaap_CostOfRevenue_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CostOfRevenue_2_lbl" xml:lang="en-US">Cost of Revenue</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GrossProfit" xlink:to="us-gaap_GrossProfit_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GrossProfit_2_lbl" xml:lang="en-US">Gross Profit</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentExpense" xlink:to="us-gaap_ResearchAndDevelopmentExpense_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ResearchAndDevelopmentExpense_2_lbl" xml:lang="en-US">Research and Development Expense</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="psti_ResearchAndDevelopmentExpensesNet" xlink:to="psti_ResearchAndDevelopmentExpensesNet_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="psti_ResearchAndDevelopmentExpensesNet_3_lbl" xml:lang="en-US">ResearchAndDevelopmentExpensesNet</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GeneralAndAdministrativeExpense" xlink:to="us-gaap_GeneralAndAdministrativeExpense_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GeneralAndAdministrativeExpense_2_lbl" xml:lang="en-US">General and Administrative Expense</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_OperatingIncomeLoss_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingIncomeLoss_2_lbl" xml:lang="en-US">Operating Income (Loss)</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax" xlink:to="us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax_2_lbl" xml:lang="en-US">Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI on Derivatives, Net of Tax</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax" xlink:to="us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax_2_lbl" xml:lang="en-US">Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI for Sale of Securities, Net of Tax</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:to="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_2_lbl" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="us-gaap_ComprehensiveIncomeNetOfTax_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ComprehensiveIncomeNetOfTax_2_lbl" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Parent</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:to="us-gaap_GainLossOnSaleOfPropertyPlantEquipment_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GainLossOnSaleOfPropertyPlantEquipment_2_lbl" xml:lang="en-US">Gain (Loss) on Disposition of Property Plant Equipment</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MarketableSecuritiesRealizedGainLoss" xlink:to="us-gaap_MarketableSecuritiesRealizedGainLoss_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MarketableSecuritiesRealizedGainLoss_2_lbl" xml:lang="en-US">Marketable Securities, Realized Gain (Loss)</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOtherReceivables" xlink:to="us-gaap_IncreaseDecreaseInOtherReceivables_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInOtherReceivables_2_lbl" xml:lang="en-US">Increase (Decrease) in Other Receivables</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:to="us-gaap_IncreaseDecreaseInOtherOperatingAssets_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInOtherOperatingAssets_2_lbl" xml:lang="en-US">Increase (Decrease) in Other Operating Assets</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccruedInterestReceivableNet" xlink:to="us-gaap_IncreaseDecreaseInAccruedInterestReceivableNet_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInAccruedInterestReceivableNet_2_lbl" xml:lang="en-US">Increase (Decrease) in Accrued Interest Receivable, Net</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_3_lbl" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_2_lbl" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsForProceedsFromShortTermInvestments" xlink:to="us-gaap_PaymentsForProceedsFromShortTermInvestments_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsForProceedsFromShortTermInvestments_2_lbl" xml:lang="en-US">Payments for (Proceeds from) Short-term Investments</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="psti_RepaymentOfInvestmentInLongtermDepositsAndRestrictedBankDeposits" xlink:to="psti_RepaymentOfInvestmentInLongtermDepositsAndRestrictedBankDeposits_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="psti_RepaymentOfInvestmentInLongtermDepositsAndRestrictedBankDeposits_3_lbl" xml:lang="en-US">Options and warrants exercisable at the end of the period</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquireAvailableForSaleSecurities" xlink:to="us-gaap_PaymentsToAcquireAvailableForSaleSecurities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsToAcquireAvailableForSaleSecurities_2_lbl" xml:lang="en-US">Payments to Acquire Available-for-sale Securities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities_2_lbl" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_2_lbl" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:to="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease_2_lbl" xml:lang="en-US">Cash and Cash Equivalents, Period Increase (Decrease)</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:to="us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_2_lbl" xml:lang="en-US">Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure [Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueDisclosuresTextBlock" xlink:to="us-gaap_FairValueDisclosuresTextBlock_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueDisclosuresTextBlock_2_lbl" xml:lang="en-US">Fair Value Disclosures [Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:to="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_2_lbl" xml:lang="en-US">Property, Plant and Equipment Disclosure [Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:to="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_2_lbl" xml:lang="en-US">Accounts Payable and Accrued Liabilities Disclosure [Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_2_lbl" xml:lang="en-US">Commitments and Contingencies Disclosure [Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:to="us-gaap_StockholdersEquityNoteDisclosureTextBlock_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock_2_lbl" xml:lang="en-US">Stockholders' Equity Note Disclosure [Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherIncomeAndOtherExpenseDisclosureTextBlock" xlink:to="us-gaap_OtherIncomeAndOtherExpenseDisclosureTextBlock_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherIncomeAndOtherExpenseDisclosureTextBlock_2_lbl" xml:lang="en-US">Other Income and Other Expense Disclosure [Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:to="us-gaap_CashAndCashEquivalentsPolicyTextBlock_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock_2_lbl" xml:lang="en-US">Cash and Cash Equivalents, Policy [Policy Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MarketableSecuritiesPolicy" xlink:to="us-gaap_MarketableSecuritiesPolicy_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MarketableSecuritiesPolicy_2_lbl" xml:lang="en-US">Marketable Securities, Policy [Policy Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:to="us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_2_lbl" xml:lang="en-US">Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:to="us-gaap_AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedLossBeforeTax_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedLossBeforeTax_2_lbl" xml:lang="en-US">Available-for-sale Equity Securities, Accumulated Gross Unrealized Loss, before Tax</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="psti_OtherthantemporaryImpairment" xlink:to="psti_OtherthantemporaryImpairment_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="psti_OtherthantemporaryImpairment_3_lbl" xml:lang="en-US">Options and warrants exercised</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AvailableForSaleSecuritiesAmortizedCost" xlink:to="us-gaap_AvailableForSaleSecuritiesAmortizedCost_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AvailableForSaleSecuritiesAmortizedCost_2_lbl" xml:lang="en-US">Available-for-sale Securities, Amortized Cost Basis</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" xlink:to="us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss_2_lbl" xml:lang="en-US">Available-for-sale Securities, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" xlink:to="us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss_2_lbl" xml:lang="en-US">Available-for-sale Securities, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueNetAssetLiability" xlink:to="us-gaap_FairValueNetAssetLiability_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueNetAssetLiability_2_lbl" xml:lang="en-US">Fair Value, Net Asset (Liability)</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDue" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDue_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDue_2_lbl" xml:lang="en-US">Operating Leases, Future Minimum Payments Due</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_3_lbl" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_2_lbl" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_2_lbl" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_2_lbl" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_3_lbl" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1_3_lbl" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Remaining Contractual Term</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_2_lbl" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_2_lbl" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_3_lbl" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_2_lbl" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_2_lbl" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="psti_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVest" xlink:to="psti_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVest_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="psti_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVest_3_lbl" xml:lang="en-US">ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVest</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="psti_InterestOnShortTermBankCreditAndBankExpenses" xlink:to="psti_InterestOnShortTermBankCreditAndBankExpenses_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="psti_InterestOnShortTermBankCreditAndBankExpenses_3_lbl" xml:lang="en-US">Interest On Short Term Bank Credit And Bank Expenses</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="us-gaap_DeferredTaxAssetsGross_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsGross_2_lbl" xml:lang="en-US">Deferred Tax Assets, Gross</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsValuationAllowance" xlink:to="us-gaap_DeferredTaxAssetsValuationAllowance_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance_2_lbl" xml:lang="en-US">Deferred Tax Assets, Valuation Allowance</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsNet" xlink:to="us-gaap_DeferredTaxAssetsNet_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsNet_2_lbl" xml:lang="en-US">Deferred Tax Assets, Net of Valuation Allowance</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>16
<FILENAME>psti-20170630_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoXBRL; Version: 4.19b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: http://www.novaworks.co -->
    <!-- Field: Doc-Info; Name: Source; Value: psti%2D0617 10K Steve Fix.xfr; Date: 2017%2D09%2D07T12:28:18Z -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x800B0001 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://pluristem.com/role/DocumentAndEntityInformation" xlink:href="psti-20170630.xsd#DocumentAndEntityInformation" xlink:type="simple" />
    <link:roleRef roleURI="http://pluristem.com/role/ConsolidatedBalanceSheets" xlink:href="psti-20170630.xsd#ConsolidatedBalanceSheets" xlink:type="simple" />
    <link:roleRef roleURI="http://pluristem.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:href="psti-20170630.xsd#ConsolidatedBalanceSheetsParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://pluristem.com/role/InterimCondensedConsolidatedStatementsOfOperations" xlink:href="psti-20170630.xsd#InterimCondensedConsolidatedStatementsOfOperations" xlink:type="simple" />
    <link:roleRef roleURI="http://pluristem.com/role/ConsolidatedStatementsOfComprehensiveLoss" xlink:href="psti-20170630.xsd#ConsolidatedStatementsOfComprehensiveLoss" xlink:type="simple" />
    <link:roleRef roleURI="http://pluristem.com/role/StatementsOfChangesInStockholdersEquity" xlink:href="psti-20170630.xsd#StatementsOfChangesInStockholdersEquity" xlink:type="simple" />
    <link:roleRef roleURI="http://pluristem.com/role/StatementsOfChangesInStockholdersEquityParenthetical" xlink:href="psti-20170630.xsd#StatementsOfChangesInStockholdersEquityParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://pluristem.com/role/ConsolidatedStatementsOfCashFlows" xlink:href="psti-20170630.xsd#ConsolidatedStatementsOfCashFlows" xlink:type="simple" />
    <link:roleRef roleURI="http://pluristem.com/role/psti-g1" xlink:href="psti-20170630.xsd#psti-g1" xlink:type="simple" />
    <link:roleRef roleURI="http://pluristem.com/role/Disclosure-BASISOFPRESENTATIONANDSIGNIFICANTACCOUNTINGPOLICIES" xlink:href="psti-20170630.xsd#Disclosure-BASISOFPRESENTATIONANDSIGNIFICANTACCOUNTINGPOLICIES" xlink:type="simple" />
    <link:roleRef roleURI="http://pluristem.com/role/psti-ms" xlink:href="psti-20170630.xsd#psti-ms" xlink:type="simple" />
    <link:roleRef roleURI="http://pluristem.com/role/psti-fvofi12" xlink:href="psti-20170630.xsd#psti-fvofi12" xlink:type="simple" />
    <link:roleRef roleURI="http://pluristem.com/role/OtherCurrentAssets" xlink:href="psti-20170630.xsd#OtherCurrentAssets" xlink:type="simple" />
    <link:roleRef roleURI="http://pluristem.com/role/PropertyAndEquipmentNet" xlink:href="psti-20170630.xsd#PropertyAndEquipmentNet" xlink:type="simple" />
    <link:roleRef roleURI="http://pluristem.com/role/OtherAccountsPayable" xlink:href="psti-20170630.xsd#OtherAccountsPayable" xlink:type="simple" />
    <link:roleRef roleURI="http://pluristem.com/role/psti-cac1" xlink:href="psti-20170630.xsd#psti-cac1" xlink:type="simple" />
    <link:roleRef roleURI="http://pluristem.com/role/psti-se12" xlink:href="psti-20170630.xsd#psti-se12" xlink:type="simple" />
    <link:roleRef roleURI="http://pluristem.com/role/FinancialIncomeNet" xlink:href="psti-20170630.xsd#FinancialIncomeNet" xlink:type="simple" />
    <link:roleRef roleURI="http://pluristem.com/role/TaxesOnIncome" xlink:href="psti-20170630.xsd#TaxesOnIncome" xlink:type="simple" />
    <link:roleRef roleURI="http://pluristem.com/role/SubsequentEvents" xlink:href="psti-20170630.xsd#SubsequentEvents" xlink:type="simple" />
    <link:roleRef roleURI="http://pluristem.com/role/SignificantAccountingPoliciesPolicies" xlink:href="psti-20170630.xsd#SignificantAccountingPoliciesPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://pluristem.com/role/SignificantAccountingPoliciesTables" xlink:href="psti-20170630.xsd#SignificantAccountingPoliciesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://pluristem.com/role/psti-mst1" xlink:href="psti-20170630.xsd#psti-mst1" xlink:type="simple" />
    <link:roleRef roleURI="http://pluristem.com/role/psti-fvofit1" xlink:href="psti-20170630.xsd#psti-fvofit1" xlink:type="simple" />
    <link:roleRef roleURI="http://pluristem.com/role/OtherCurrentAssetsTables" xlink:href="psti-20170630.xsd#OtherCurrentAssetsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://pluristem.com/role/PropertyAndEquipmentNetTables" xlink:href="psti-20170630.xsd#PropertyAndEquipmentNetTables" xlink:type="simple" />
    <link:roleRef roleURI="http://pluristem.com/role/OtherAccountsPayableTables" xlink:href="psti-20170630.xsd#OtherAccountsPayableTables" xlink:type="simple" />
    <link:roleRef roleURI="http://pluristem.com/role/CommitmentsAndContingenciesTables" xlink:href="psti-20170630.xsd#CommitmentsAndContingenciesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://pluristem.com/role/Disclosure-STOCKHOLDERSEQUITYTables" xlink:href="psti-20170630.xsd#Disclosure-STOCKHOLDERSEQUITYTables" xlink:type="simple" />
    <link:roleRef roleURI="http://pluristem.com/role/FinancialIncomeNetTables" xlink:href="psti-20170630.xsd#FinancialIncomeNetTables" xlink:type="simple" />
    <link:roleRef roleURI="http://pluristem.com/role/TaxesOnIncomeTables" xlink:href="psti-20170630.xsd#TaxesOnIncomeTables" xlink:type="simple" />
    <link:roleRef roleURI="http://pluristem.com/role/psti-gd" xlink:href="psti-20170630.xsd#psti-gd" xlink:type="simple" />
    <link:roleRef roleURI="http://pluristem.com/role/SignificantAccountingPoliciesNarrativeDetails" xlink:href="psti-20170630.xsd#SignificantAccountingPoliciesNarrativeDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://pluristem.com/role/SignificantAccountingPoliciesScheduleOfPropertyAndEquipmentDepreciationRateDetails" xlink:href="psti-20170630.xsd#SignificantAccountingPoliciesScheduleOfPropertyAndEquipmentDepreciationRateDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://pluristem.com/role/Disclosure-BASISOFPRESENTATIONANDSIGNIFICANTACCOUNTINGPOLICIESComprehensiveIncomeDetails" xlink:href="psti-20170630.xsd#Disclosure-BASISOFPRESENTATIONANDSIGNIFICANTACCOUNTINGPOLICIESComprehensiveIncomeDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://pluristem.com/role/psti-mssoamsd1" xlink:href="psti-20170630.xsd#psti-mssoamsd1" xlink:type="simple" />
    <link:roleRef roleURI="http://pluristem.com/role/psti-mssoiiuld" xlink:href="psti-20170630.xsd#psti-mssoiiuld" xlink:type="simple" />
    <link:roleRef roleURI="http://pluristem.com/role/psti-fvofisofvofid1" xlink:href="psti-20170630.xsd#psti-fvofisofvofid1" xlink:type="simple" />
    <link:roleRef roleURI="http://pluristem.com/role/OtherCurrentAssetsDetails" xlink:href="psti-20170630.xsd#OtherCurrentAssetsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://pluristem.com/role/PropertyAndEquipmentNetDetails" xlink:href="psti-20170630.xsd#PropertyAndEquipmentNetDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://pluristem.com/role/OtherAccountsPayableDetails" xlink:href="psti-20170630.xsd#OtherAccountsPayableDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://pluristem.com/role/CommitmentsAndContingenciesOperatingLeaseDetails" xlink:href="psti-20170630.xsd#CommitmentsAndContingenciesOperatingLeaseDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://pluristem.com/role/CommitmentsAndContingenciesOtherDetails" xlink:href="psti-20170630.xsd#CommitmentsAndContingenciesOtherDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://pluristem.com/role/psti-send1" xlink:href="psti-20170630.xsd#psti-send1" xlink:type="simple" />
    <link:roleRef roleURI="http://pluristem.com/role/StockholdersEquitySummaryOfOptionActivityDetails" xlink:href="psti-20170630.xsd#StockholdersEquitySummaryOfOptionActivityDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://pluristem.com/role/StockholdersEquitySummaryOfOptionActivityToNon-employeeConsultantsDetails" xlink:href="psti-20170630.xsd#StockholdersEquitySummaryOfOptionActivityToNon-employeeConsultantsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://pluristem.com/role/psti-sesoced1" xlink:href="psti-20170630.xsd#psti-sesoced1" xlink:type="simple" />
    <link:roleRef roleURI="http://pluristem.com/role/psti-sesorateadd1" xlink:href="psti-20170630.xsd#psti-sesorateadd1" xlink:type="simple" />
    <link:roleRef roleURI="http://pluristem.com/role/psti-sesoratcd1" xlink:href="psti-20170630.xsd#psti-sesoratcd1" xlink:type="simple" />
    <link:roleRef roleURI="http://pluristem.com/role/StockholdersEquitySummaryOfWarrantsAndOptionsDetails" xlink:href="psti-20170630.xsd#StockholdersEquitySummaryOfWarrantsAndOptionsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://pluristem.com/role/FinancialIncomeNetDetails" xlink:href="psti-20170630.xsd#FinancialIncomeNetDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://pluristem.com/role/TaxesOnIncomeNarrativeDetails" xlink:href="psti-20170630.xsd#TaxesOnIncomeNarrativeDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://pluristem.com/role/TaxesOnIncomeScheduleOfSignificantComponentsOfDeferredTaxAssetsDetails" xlink:href="psti-20170630.xsd#TaxesOnIncomeScheduleOfSignificantComponentsOfDeferredTaxAssetsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://pluristem.com/role/SubsequentEventsNarrativeDetails" xlink:href="psti-20170630.xsd#SubsequentEventsNarrativeDetails" xlink:type="simple" />
    <link:presentationLink xlink:type="extended" xlink:role="http://pluristem.com/role/DocumentAndEntityInformation" xlink:title="00000001 - Document - Document and Entity Information">
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_DocumentAndEntityInformationAbstract" xlink:label="loc_pstiDocumentAndEntityInformationAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_pstiDocumentAndEntityInformationAbstract" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_pstiDocumentAndEntityInformationAbstract" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_pstiDocumentAndEntityInformationAbstract" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_pstiDocumentAndEntityInformationAbstract" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_pstiDocumentAndEntityInformationAbstract" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_pstiDocumentAndEntityInformationAbstract" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_pstiDocumentAndEntityInformationAbstract" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_pstiDocumentAndEntityInformationAbstract" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_pstiDocumentAndEntityInformationAbstract" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_pstiDocumentAndEntityInformationAbstract" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_pstiDocumentAndEntityInformationAbstract" xlink:to="loc_deiEntityPublicFloat" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_pstiDocumentAndEntityInformationAbstract" xlink:to="loc_deiEntityVoluntaryFilers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_pstiDocumentAndEntityInformationAbstract" xlink:to="loc_deiEntityWellKnownSeasonedIssuer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_pstiDocumentAndEntityInformationAbstract" xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://pluristem.com/role/ConsolidatedBalanceSheets" xlink:title="00000002 - Statement - CONSOLIDATED BALANCE SHEETS">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="loc_us-gaapStatementOfFinancialPositionAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AssetsAbstract" xlink:label="loc_us-gaapAssetsAbstract" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapAssetsAbstract" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="loc_us-gaapAssetsCurrentAbstract" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsAbstract" xlink:to="loc_us-gaapAssetsCurrentAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShortTermInvestments" xlink:label="loc_us-gaapShortTermInvestments" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapShortTermInvestments" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaapRestrictedCashAndCashEquivalentsAtCarryingValue" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapRestrictedCashAndCashEquivalentsAtCarryingValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_MarketableSecuritiesCurrent" xlink:label="loc_us-gaapMarketableSecuritiesCurrent" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapMarketableSecuritiesCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="loc_us-gaapAccountsReceivableNetCurrent" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapAccountsReceivableNetCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherAssetsCurrent" xlink:label="loc_us-gaapOtherAssetsCurrent" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapOtherAssetsCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaapAssetsCurrent" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapAssetsCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AssetsNoncurrentAbstract" xlink:label="loc_us-gaapAssetsNoncurrentAbstract" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsAbstract" xlink:to="loc_us-gaapAssetsNoncurrentAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LongTermInvestments" xlink:label="loc_us-gaapLongTermInvestments" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsNoncurrentAbstract" xlink:to="loc_us-gaapLongTermInvestments" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent" xlink:label="loc_us-gaapDefinedBenefitPlanAssetsForPlanBenefitsNoncurrent" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsNoncurrentAbstract" xlink:to="loc_us-gaapDefinedBenefitPlanAssetsForPlanBenefitsNoncurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaapPropertyPlantAndEquipmentNet" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsNoncurrentAbstract" xlink:to="loc_us-gaapPropertyPlantAndEquipmentNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherAssetsNoncurrent" xlink:label="loc_us-gaapOtherAssetsNoncurrent" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsNoncurrentAbstract" xlink:to="loc_us-gaapOtherAssetsNoncurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AssetsNoncurrent" xlink:label="loc_us-gaapAssetsNoncurrent" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsNoncurrentAbstract" xlink:to="loc_us-gaapAssetsNoncurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_Assets" xlink:label="loc_us-gaapAssets" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsAbstract" xlink:to="loc_us-gaapAssets" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="loc_us-gaapLiabilitiesCurrentAbstract" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapLiabilitiesCurrentAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccountsPayableCurrent" xlink:label="loc_us-gaapAccountsPayableCurrent" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapAccountsPayableCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="loc_us-gaapAccruedLiabilitiesCurrent" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapAccruedLiabilitiesCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccountsPayableOtherCurrent" xlink:label="loc_us-gaapAccountsPayableOtherCurrent" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapAccountsPayableOtherCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaapLiabilitiesCurrent" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapLiabilitiesCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LiabilitiesNoncurrentAbstract" xlink:label="loc_us-gaapLiabilitiesNoncurrentAbstract" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapLiabilitiesNoncurrentAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PostemploymentBenefitsLiabilityNoncurrent" xlink:label="loc_us-gaapPostemploymentBenefitsLiabilityNoncurrent" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesNoncurrentAbstract" xlink:to="loc_us-gaapPostemploymentBenefitsLiabilityNoncurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent" xlink:label="loc_us-gaapOtherLiabilitiesNoncurrent" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesNoncurrentAbstract" xlink:to="loc_us-gaapOtherLiabilitiesNoncurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LiabilitiesNoncurrent" xlink:label="loc_us-gaapLiabilitiesNoncurrent" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesNoncurrentAbstract" xlink:to="loc_us-gaapLiabilitiesNoncurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="loc_us-gaapCommitmentsAndContingencies" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapCommitmentsAndContingencies" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaapEquityAbstract" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapEquityAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaapCommonStockValue" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapCommonStockValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="loc_us-gaapAdditionalPaidInCapital" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapAdditionalPaidInCapital" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaapRetainedEarningsAccumulatedDeficit" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapRetainedEarningsAccumulatedDeficit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:label="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossNetOfTax" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapStockholdersEquity" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquity" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://pluristem.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:title="00000003 - Statement - CONSOLIDATED BALANCE SHEETS (PARENTHETICAL)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="loc_us-gaapStatementOfFinancialPositionAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaapCommonStockParOrStatedValuePerShare" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapCommonStockParOrStatedValuePerShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="loc_us-gaapCommonStockSharesAuthorized" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapCommonStockSharesAuthorized" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:label="loc_us-gaapCommonStockSharesIssued" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapCommonStockSharesIssued" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaapCommonStockSharesOutstanding" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapCommonStockSharesOutstanding" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://pluristem.com/role/InterimCondensedConsolidatedStatementsOfOperations" xlink:title="00000004 - Statement - CONSOLIDATED STATEMENTS OF  OPERATIONS">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeStatementAbstract" xlink:label="loc_us-gaapIncomeStatementAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_Revenues" xlink:label="loc_us-gaapRevenues" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapRevenues" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CostOfRevenue" xlink:label="loc_us-gaapCostOfRevenue" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapCostOfRevenue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_GrossProfit" xlink:label="loc_us-gaapGrossProfit" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapGrossProfit" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="loc_us-gaapResearchAndDevelopmentExpense" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapResearchAndDevelopmentExpense" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_GovernmentAndThirdPartyGrantsReceived" xlink:label="loc_pstiGovernmentAndThirdPartyGrantsReceived" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_pstiGovernmentAndThirdPartyGrantsReceived" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_ResearchAndDevelopmentExpensesNet" xlink:label="loc_pstiResearchAndDevelopmentExpensesNet" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_pstiResearchAndDevelopmentExpensesNet" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="loc_us-gaapGeneralAndAdministrativeExpense" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapGeneralAndAdministrativeExpense" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaapOperatingIncomeLoss" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapOperatingIncomeLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="loc_us-gaapNonoperatingIncomeExpense" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapNonoperatingIncomeExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="loc_us-gaapEarningsPerShareAbstract" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapEarningsPerShareAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EarningsPerShareBasicAndDiluted" xlink:label="loc_us-gaapEarningsPerShareBasicAndDiluted" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEarningsPerShareAbstract" xlink:to="loc_us-gaapEarningsPerShareBasicAndDiluted" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:label="loc_us-gaapWeightedAverageNumberOfShareOutstandingBasicAndDiluted" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEarningsPerShareAbstract" xlink:to="loc_us-gaapWeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://pluristem.com/role/ConsolidatedStatementsOfComprehensiveLoss" xlink:title="00000005 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE  LOSS">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:label="loc_us-gaapStatementOfIncomeAndComprehensiveIncomeAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfIncomeAndComprehensiveIncomeAbstract" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParentAbstract" xlink:label="loc_us-gaapOtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParentAbstract" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfIncomeAndComprehensiveIncomeAbstract" xlink:to="loc_us-gaapOtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParentAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax" xlink:label="loc_us-gaapOtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParentAbstract" xlink:to="loc_us-gaapOtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:label="loc_us-gaapOtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParentAbstract" xlink:to="loc_us-gaapOtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax" xlink:label="loc_us-gaapOtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParentAbstract" xlink:to="loc_us-gaapOtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax" xlink:label="loc_us-gaapOtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParentAbstract" xlink:to="loc_us-gaapOtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:label="loc_us-gaapOtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParentAbstract" xlink:to="loc_us-gaapOtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax" xlink:label="loc_us-gaapComprehensiveIncomeNetOfTax" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfIncomeAndComprehensiveIncomeAbstract" xlink:to="loc_us-gaapComprehensiveIncomeNetOfTax" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://pluristem.com/role/StatementsOfChangesInStockholdersEquity" xlink:title="00000006 - Statement - STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract" xlink:label="loc_us-gaapStatementOfStockholdersEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfStockholdersEquityAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" order="60" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapCommonStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="loc_us-gaapAdditionalPaidInCapitalMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapAdditionalPaidInCapitalMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ReceivablesFromStockholderMember" xlink:label="loc_us-gaapReceivablesFromStockholderMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapReceivablesFromStockholderMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:label="loc_us-gaapAccumulatedOtherComprehensiveIncomeMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapAccumulatedOtherComprehensiveIncomeMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RetainedEarningsMember" xlink:label="loc_us-gaapRetainedEarningsMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapRetainedEarningsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockholdersEquity" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaapCommonStockSharesOutstanding" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockSharesOutstanding" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueNewIssues" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueNewIssues" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_ExerciseOfOptionsByEmployees" xlink:label="loc_pstiExerciseOfOptionsByEmployees" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_pstiExerciseOfOptionsByEmployees" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_ExerciseOfOptionsByEmployeesShares" xlink:label="loc_pstiExerciseOfOptionsByEmployeesShares" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_pstiExerciseOfOptionsByEmployeesShares" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueStockOptionsExercised" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueStockOptionsExercised" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesStockOptionsExercised" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_StockIssuedDuringPeriodValueStockWarrantsExercised" xlink:label="loc_pstiStockIssuedDuringPeriodValueStockWarrantsExercised" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_pstiStockIssuedDuringPeriodValueStockWarrantsExercised" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_StockIssuedDuringPeriodSharesStockWarrantsExercised" xlink:label="loc_pstiStockIssuedDuringPeriodSharesStockWarrantsExercised" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_pstiStockIssuedDuringPeriodSharesStockWarrantsExercised" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueShareBasedCompensation" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueShareBasedCompensation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesShareBasedCompensation" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesShareBasedCompensation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_StockIssuedDuringPeriodValuePrivatePlacement" xlink:label="loc_pstiStockIssuedDuringPeriodValuePrivatePlacement" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_pstiStockIssuedDuringPeriodValuePrivatePlacement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_StockIssuedDuringPeriodSharesPrivatePlacement" xlink:label="loc_pstiStockIssuedDuringPeriodSharesPrivatePlacement" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_pstiStockIssuedDuringPeriodSharesPrivatePlacement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueIssuedForServices" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueIssuedForServices" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueIssuedForServices" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesIssuedForServices" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesIssuedForServices" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_IssuanceOfCommonStockAndWarrantsRelatedToJanuaryTwentySeventeenOfferingNetOfIssuanceCostsValue" xlink:label="loc_pstiIssuanceOfCommonStockAndWarrantsRelatedToJanuaryTwentySeventeenOfferingNetOfIssuanceCostsValue" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_pstiIssuanceOfCommonStockAndWarrantsRelatedToJanuaryTwentySeventeenOfferingNetOfIssuanceCostsValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_IssuanceOfCommonStockAndWarrantsRelatedToJanuaryTwentySeventeenOfferingNetOfIssuanceCostsShares" xlink:label="loc_pstiIssuanceOfCommonStockAndWarrantsRelatedToJanuaryTwentySeventeenOfferingNetOfIssuanceCostsShares" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_pstiIssuanceOfCommonStockAndWarrantsRelatedToJanuaryTwentySeventeenOfferingNetOfIssuanceCostsShares" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:label="loc_us-gaapOtherComprehensiveIncomeLossNetOfTax" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity_2" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockholdersEquity_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaapCommonStockSharesOutstanding_2" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockSharesOutstanding_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://pluristem.com/role/StatementsOfChangesInStockholdersEquityParenthetical" xlink:title="00000007 - Statement - STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (Parenthetical)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract" xlink:label="loc_us-gaapStatementOfStockholdersEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" xlink:label="loc_us-gaapAdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfStockholdersEquityAbstract" xlink:to="loc_us-gaapAdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://pluristem.com/role/ConsolidatedStatementsOfCashFlows" xlink:title="00000008 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="loc_us-gaapStatementOfCashFlowsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_Depreciation" xlink:label="loc_us-gaapDepreciation" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapDepreciation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:label="loc_us-gaapGainLossOnSaleOfPropertyPlantEquipment" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapGainLossOnSaleOfPropertyPlantEquipment" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_AmortizationOfDiscountAndPremiumAndChangesInAccruedInterestFromMarketableSecurities" xlink:label="loc_pstiAmortizationOfDiscountAndPremiumAndChangesInAccruedInterestFromMarketableSecurities" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_pstiAmortizationOfDiscountAndPremiumAndChangesInAccruedInterestFromMarketableSecurities" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_MarketableSecuritiesRealizedGainLoss" xlink:label="loc_us-gaapMarketableSecuritiesRealizedGainLoss" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapMarketableSecuritiesRealizedGainLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherThanTemporaryImpairmentLossesInvestmentsPortionRecognizedInEarningsNet" xlink:label="loc_us-gaapOtherThanTemporaryImpairmentLossesInvestmentsPortionRecognizedInEarningsNet" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapOtherThanTemporaryImpairmentLossesInvestmentsPortionRecognizedInEarningsNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaapShareBasedCompensation" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapShareBasedCompensation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncreaseDecreaseInOtherReceivables" xlink:label="loc_us-gaapIncreaseDecreaseInOtherReceivables" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInOtherReceivables" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:label="loc_us-gaapIncreaseDecreaseInOtherOperatingAssets" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInOtherOperatingAssets" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsPayable" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsPayable" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities" xlink:label="loc_us-gaapIncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:label="loc_us-gaapIncreaseDecreaseInDeferredRevenue" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInDeferredRevenue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncreaseDecreaseInCustomerAdvances" xlink:label="loc_us-gaapIncreaseDecreaseInCustomerAdvances" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInCustomerAdvances" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedInterestReceivableNet" xlink:label="loc_us-gaapIncreaseDecreaseInAccruedInterestReceivableNet" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInAccruedInterestReceivableNet" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_LinkageDifferencesAndInterestOnShortAndLongTermRestrictedLeaseDeposit" xlink:label="loc_pstiLinkageDifferencesAndInterestOnShortAndLongTermRestrictedLeaseDeposit" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_pstiLinkageDifferencesAndInterestOnShortAndLongTermRestrictedLeaseDeposit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncreaseDecreaseInPensionAndPostretirementObligations" xlink:label="loc_us-gaapIncreaseDecreaseInPensionAndPostretirementObligations" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInPensionAndPostretirementObligations" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="loc_us-gaapPaymentsToAcquirePropertyPlantAndEquipment" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="loc_us-gaapPaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:label="loc_us-gaapProceedsFromSaleOfPropertyPlantAndEquipment" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="loc_us-gaapProceedsFromSaleOfPropertyPlantAndEquipment" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PaymentsForProceedsFromShortTermInvestments" xlink:label="loc_us-gaapPaymentsForProceedsFromShortTermInvestments" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="loc_us-gaapPaymentsForProceedsFromShortTermInvestments" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_RepaymentOfInvestmentInLongtermDepositsAndRestrictedBankDeposits" xlink:label="loc_pstiRepaymentOfInvestmentInLongtermDepositsAndRestrictedBankDeposits" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="loc_pstiRepaymentOfInvestmentInLongtermDepositsAndRestrictedBankDeposits" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ProceedsFromSaleOfAvailableForSaleSecurities" xlink:label="loc_us-gaapProceedsFromSaleOfAvailableForSaleSecurities" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="loc_us-gaapProceedsFromSaleOfAvailableForSaleSecurities" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities" xlink:label="loc_us-gaapProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="loc_us-gaapProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PaymentsToAcquireAvailableForSaleSecurities" xlink:label="loc_us-gaapPaymentsToAcquireAvailableForSaleSecurities" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="loc_us-gaapPaymentsToAcquireAvailableForSaleSecurities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="loc_us-gaapProceedsFromIssuanceOfCommonStock" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapProceedsFromIssuanceOfCommonStock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:label="loc_us-gaapProceedsFromPaymentsForOtherFinancingActivities" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapProceedsFromPaymentsForOtherFinancingActivities" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:label="loc_us-gaapProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:label="loc_us-gaapCashAndCashEquivalentsPeriodIncreaseDecrease" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapCashAndCashEquivalentsPeriodIncreaseDecrease" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaapCashAndCashEquivalentsAtCarryingValue_2" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapCashAndCashEquivalentsAtCarryingValue_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract" xlink:label="loc_us-gaapSupplementalCashFlowInformationAbstract" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapSupplementalCashFlowInformationAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeTaxesPaid" xlink:label="loc_us-gaapIncomeTaxesPaid" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSupplementalCashFlowInformationAbstract" xlink:to="loc_us-gaapIncomeTaxesPaid" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherNoncashInvestingAndFinancingItemsAbstract" xlink:label="loc_us-gaapOtherNoncashInvestingAndFinancingItemsAbstract" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapOtherNoncashInvestingAndFinancingItemsAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:label="loc_us-gaapCapitalExpendituresIncurredButNotYetPaid" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherNoncashInvestingAndFinancingItemsAbstract" xlink:to="loc_us-gaapCapitalExpendituresIncurredButNotYetPaid" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockIssued1" xlink:label="loc_us-gaapStockIssued1" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherNoncashInvestingAndFinancingItemsAbstract" xlink:to="loc_us-gaapStockIssued1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherSignificantNoncashTransactionValueOfConsiderationGiven1" xlink:label="loc_us-gaapOtherSignificantNoncashTransactionValueOfConsiderationGiven1" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherNoncashInvestingAndFinancingItemsAbstract" xlink:to="loc_us-gaapOtherSignificantNoncashTransactionValueOfConsiderationGiven1" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://pluristem.com/role/psti-g1" xlink:title="00000009 - Disclosure - GENERAL">
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_GeneralAbstract" xlink:label="loc_pstiGeneralAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:label="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_pstiGeneralAbstract" xlink:to="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://pluristem.com/role/Disclosure-BASISOFPRESENTATIONANDSIGNIFICANTACCOUNTINGPOLICIES" xlink:title="00000010 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SignificantAccountingPoliciesTextBlock" xlink:label="loc_us-gaapSignificantAccountingPoliciesTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapSignificantAccountingPoliciesTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://pluristem.com/role/psti-ms" xlink:title="00000011 - Disclosure - MARKETABLE SECURITIES">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_MarketableSecuritiesAbstract" xlink:label="loc_us-gaapMarketableSecuritiesAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:label="loc_us-gaapInvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapMarketableSecuritiesAbstract" xlink:to="loc_us-gaapInvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://pluristem.com/role/psti-fvofi12" xlink:title="00000012 - Disclosure - FAIR VALUE OF FINANCIAL INSTRUMENTS">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="loc_us-gaapFairValueDisclosuresAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueDisclosuresTextBlock" xlink:label="loc_us-gaapFairValueDisclosuresTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueDisclosuresAbstract" xlink:to="loc_us-gaapFairValueDisclosuresTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://pluristem.com/role/OtherCurrentAssets" xlink:title="00000013 - Disclosure - OTHER CURRENT ASSETS">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract" xlink:label="loc_us-gaapDeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherCurrentAssetsTextBlock" xlink:label="loc_us-gaapOtherCurrentAssetsTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract" xlink:to="loc_us-gaapOtherCurrentAssetsTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://pluristem.com/role/PropertyAndEquipmentNet" xlink:title="00000014 - Disclosure - PROPERTY AND EQUIPMENT, NET">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="loc_us-gaapPropertyPlantAndEquipmentAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:label="loc_us-gaapPropertyPlantAndEquipmentDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentAbstract" xlink:to="loc_us-gaapPropertyPlantAndEquipmentDisclosureTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://pluristem.com/role/OtherAccountsPayable" xlink:title="00000015 - Disclosure - OTHER ACCOUNTS PAYABLE">
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_OtherAccountsPayableAbstract" xlink:label="loc_pstiOtherAccountsPayableAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:label="loc_us-gaapAccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_pstiOtherAccountsPayableAbstract" xlink:to="loc_us-gaapAccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://pluristem.com/role/psti-cac1" xlink:title="00000016 - Disclosure - COMMITMENTS AND CONTINGENCIES">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:label="loc_us-gaapCommitmentsAndContingenciesDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_us-gaapCommitmentsAndContingenciesDisclosureTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://pluristem.com/role/psti-se12" xlink:title="00000017 - Disclosure - STOCKHOLDERS' EQUITY">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract" xlink:label="loc_us-gaapStockholdersEquityNoteAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:label="loc_us-gaapStockholdersEquityNoteDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityNoteAbstract" xlink:to="loc_us-gaapStockholdersEquityNoteDisclosureTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://pluristem.com/role/FinancialIncomeNet" xlink:title="00000018 - Disclosure - FINANCIAL INCOME, NET">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherIncomeAndExpensesAbstract" xlink:label="loc_us-gaapOtherIncomeAndExpensesAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherIncomeAndOtherExpenseDisclosureTextBlock" xlink:label="loc_us-gaapOtherIncomeAndOtherExpenseDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherIncomeAndExpensesAbstract" xlink:to="loc_us-gaapOtherIncomeAndOtherExpenseDisclosureTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://pluristem.com/role/TaxesOnIncome" xlink:title="00000019 - Disclosure - TAXES ON INCOME">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaapIncomeTaxDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock" xlink:label="loc_us-gaapIncomeTaxDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapIncomeTaxDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://pluristem.com/role/SubsequentEvents" xlink:title="00000020 - Disclosure - SUBSEQUENT EVENTS">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="loc_us-gaapSubsequentEventsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SubsequentEventsTextBlock" xlink:label="loc_us-gaapSubsequentEventsTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventsAbstract" xlink:to="loc_us-gaapSubsequentEventsTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://pluristem.com/role/SignificantAccountingPoliciesPolicies" xlink:title="00000021 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Policies)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:label="loc_us-gaapBasisOfAccountingPolicyPolicyTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapBasisOfAccountingPolicyPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_SignificantAccountingPolicyPolicyTextBlock" xlink:label="loc_pstiSignificantAccountingPolicyPolicyTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_pstiSignificantAccountingPolicyPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_UseOfEstimates" xlink:label="loc_us-gaapUseOfEstimates" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapUseOfEstimates" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:label="loc_us-gaapForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ConsolidationPolicyTextBlock" xlink:label="loc_us-gaapConsolidationPolicyTextBlock" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapConsolidationPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:label="loc_us-gaapCashAndCashEquivalentsPolicyTextBlock" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapCashAndCashEquivalentsPolicyTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_ShortTermBankDepositPolicyTextBlock" xlink:label="loc_pstiShortTermBankDepositPolicyTextBlock" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_pstiShortTermBankDepositPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:label="loc_us-gaapCashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapCashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_LongTermRestrictedBankDepositPolicyTextBlock" xlink:label="loc_pstiLongTermRestrictedBankDepositPolicyTextBlock" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_pstiLongTermRestrictedBankDepositPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_MarketableSecuritiesPolicy" xlink:label="loc_us-gaapMarketableSecuritiesPolicy" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapMarketableSecuritiesPolicy" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RevenueRecognitionPolicyTextBlock" xlink:label="loc_us-gaapRevenueRecognitionPolicyTextBlock" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapRevenueRecognitionPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:label="loc_us-gaapPropertyPlantAndEquipmentPolicyTextBlock" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapPropertyPlantAndEquipmentPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:label="loc_us-gaapImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:label="loc_us-gaapShareBasedCompensationOptionAndIncentivePlansPolicy" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_ResearchAndDevelopmentExpensesAndRoyaltyBearingGrantsPolicyTextBlock" xlink:label="loc_pstiResearchAndDevelopmentExpensesAndRoyaltyBearingGrantsPolicyTextBlock" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_pstiResearchAndDevelopmentExpensesAndRoyaltyBearingGrantsPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_NonroyaltyBearingGrantsPolicyTextBlock" xlink:label="loc_pstiNonroyaltyBearingGrantsPolicyTextBlock" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_pstiNonroyaltyBearingGrantsPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EarningsPerSharePolicyTextBlock" xlink:label="loc_us-gaapEarningsPerSharePolicyTextBlock" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapEarningsPerSharePolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeTaxPolicyTextBlock" xlink:label="loc_us-gaapIncomeTaxPolicyTextBlock" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapIncomeTaxPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ConcentrationRiskCreditRisk" xlink:label="loc_us-gaapConcentrationRiskCreditRisk" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapConcentrationRiskCreditRisk" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_SeverancePayPolicyTextBlock" xlink:label="loc_pstiSeverancePayPolicyTextBlock" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_pstiSeverancePayPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:label="loc_us-gaapFairValueOfFinancialInstrumentsPolicy" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapFairValueOfFinancialInstrumentsPolicy" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DerivativesPolicyTextBlock" xlink:label="loc_us-gaapDerivativesPolicyTextBlock" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapDerivativesPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:label="loc_us-gaapComprehensiveIncomePolicyPolicyTextBlock" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapComprehensiveIncomePolicyPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="loc_us-gaapNewAccountingPronouncementsPolicyPolicyTextBlock" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapNewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://pluristem.com/role/SignificantAccountingPoliciesTables" xlink:title="00000022 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Tables)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_PropertyPlantAndEquipmentEstimatedUsefulLivesRateTableTextBlock" xlink:label="loc_pstiPropertyPlantAndEquipmentEstimatedUsefulLivesRateTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_pstiPropertyPlantAndEquipmentEstimatedUsefulLivesRateTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:label="loc_us-gaapScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://pluristem.com/role/psti-mst1" xlink:title="00000023 - Disclosure - MARKETABLE SECURITIES (Tables)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_MarketableSecuritiesAbstract" xlink:label="loc_us-gaapMarketableSecuritiesAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AvailableForSaleSecuritiesTextBlock" xlink:label="loc_us-gaapAvailableForSaleSecuritiesTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapMarketableSecuritiesAbstract" xlink:to="loc_us-gaapAvailableForSaleSecuritiesTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValueTableTextBlock" xlink:label="loc_us-gaapAvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValueTableTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapMarketableSecuritiesAbstract" xlink:to="loc_us-gaapAvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValueTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://pluristem.com/role/psti-fvofit1" xlink:title="00000024 - Disclosure - FAIR VALUE OF FINANCIAL INSTRUMENTS (Tables)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="loc_us-gaapFairValueDisclosuresAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock" xlink:label="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueDisclosuresAbstract" xlink:to="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:label="loc_us-gaapScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueDisclosuresAbstract" xlink:to="loc_us-gaapScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://pluristem.com/role/OtherCurrentAssetsTables" xlink:title="00000025 - Disclosure - OTHER CURRENT ASSETS (Tables)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract" xlink:label="loc_us-gaapDeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock" xlink:label="loc_us-gaapScheduleOfOtherCurrentAssetsTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfOtherCurrentAssetsTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://pluristem.com/role/PropertyAndEquipmentNetTables" xlink:title="00000026 - Disclosure - PROPERTY AND EQUIPMENT, NET (Tables)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="loc_us-gaapPropertyPlantAndEquipmentAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentAbstract" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://pluristem.com/role/OtherAccountsPayableTables" xlink:title="00000027 - Disclosure - OTHER ACCOUNTS PAYABLE (Tables)">
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_OtherAccountsPayableAbstract" xlink:label="loc_pstiOtherAccountsPayableAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:label="loc_us-gaapScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_pstiOtherAccountsPayableAbstract" xlink:to="loc_us-gaapScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://pluristem.com/role/CommitmentsAndContingenciesTables" xlink:title="00000028 - Disclosure - COMMITMENTS AND CONTINGENCIES (Tables)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LongTermPurchaseCommitmentTable" xlink:label="loc_us-gaapLongTermPurchaseCommitmentTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_us-gaapLongTermPurchaseCommitmentTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LongTermPurchaseCommitmentLineItems" xlink:label="loc_us-gaapLongTermPurchaseCommitmentLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLongTermPurchaseCommitmentTable" xlink:to="loc_us-gaapLongTermPurchaseCommitmentLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLongTermPurchaseCommitmentTable" xlink:to="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LandAndBuildingMember" xlink:label="loc_us-gaapLandAndBuildingMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapLandAndBuildingMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AutomobilesMember" xlink:label="loc_us-gaapAutomobilesMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapAutomobilesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock" xlink:label="loc_us-gaapScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLongTermPurchaseCommitmentLineItems" xlink:to="loc_us-gaapScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_UnrecordedUnconditionalPurchaseObligationsDisclosureTextBlock" xlink:label="loc_us-gaapUnrecordedUnconditionalPurchaseObligationsDisclosureTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLongTermPurchaseCommitmentLineItems" xlink:to="loc_us-gaapUnrecordedUnconditionalPurchaseObligationsDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://pluristem.com/role/Disclosure-STOCKHOLDERSEQUITYTables" xlink:title="00000029 - Disclosure - STOCKHOLDERS' EQUITY (Tables)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract" xlink:label="loc_us-gaapStockholdersEquityNoteAbstract" />
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_StockholdersEquityNoteTable" xlink:label="loc_pstiStockholdersEquityNoteTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityNoteAbstract" xlink:to="loc_pstiStockholdersEquityNoteTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_StockholdersEquityNoteLineItems" xlink:label="loc_pstiStockholdersEquityNoteLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_pstiStockholdersEquityNoteTable" xlink:to="loc_pstiStockholdersEquityNoteLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TitleOfIndividualAxis" xlink:label="loc_us-gaapTitleOfIndividualAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_pstiStockholdersEquityNoteTable" xlink:to="loc_us-gaapTitleOfIndividualAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_us-gaapTitleOfIndividualWithRelationshipToEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTitleOfIndividualAxis" xlink:to="loc_us-gaapTitleOfIndividualWithRelationshipToEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_EmployeesAndDirectorsMember" xlink:label="loc_pstiEmployeesAndDirectorsMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_pstiEmployeesAndDirectorsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_NonemployeesMember" xlink:label="loc_pstiNonemployeesMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_pstiNonemployeesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaapAwardTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_pstiStockholdersEquityNoteTable" xlink:to="loc_us-gaapAwardTypeAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="loc_us-gaapRestrictedStockUnitsRSUMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaapRestrictedStockUnitsRSUMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock" xlink:label="loc_us-gaapScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_pstiStockholdersEquityNoteLineItems" xlink:to="loc_us-gaapScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:label="loc_us-gaapScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_pstiStockholdersEquityNoteLineItems" xlink:to="loc_us-gaapScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:label="loc_us-gaapScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_pstiStockholdersEquityNoteLineItems" xlink:to="loc_us-gaapScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock" xlink:label="loc_us-gaapScheduleOfShareBasedCompensationActivityTableTextBlock" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_pstiStockholdersEquityNoteLineItems" xlink:to="loc_us-gaapScheduleOfShareBasedCompensationActivityTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock" xlink:label="loc_us-gaapScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_pstiStockholdersEquityNoteLineItems" xlink:to="loc_us-gaapScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://pluristem.com/role/FinancialIncomeNetTables" xlink:title="00000030 - Disclosure - FINANCIAL INCOME, NET (Tables)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherIncomeAndExpensesAbstract" xlink:label="loc_us-gaapOtherIncomeAndExpensesAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock" xlink:label="loc_us-gaapScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherIncomeAndExpensesAbstract" xlink:to="loc_us-gaapScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://pluristem.com/role/TaxesOnIncomeTables" xlink:title="00000031 - Disclosure - TAXES ON INCOME (Tables)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaapIncomeTaxDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_QualifyingPercentageOfValueOfProductiveAssetsTableTextBlock" xlink:label="loc_pstiQualifyingPercentageOfValueOfProductiveAssetsTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_pstiQualifyingPercentageOfValueOfProductiveAssetsTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:label="loc_us-gaapScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://pluristem.com/role/psti-gd" xlink:title="00000032 - Disclosure - GENERAL (Details)">
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_GeneralAbstract" xlink:label="loc_pstiGeneralAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaapRetainedEarningsAccumulatedDeficit" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_pstiGeneralAbstract" xlink:to="loc_us-gaapRetainedEarningsAccumulatedDeficit" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_pstiGeneralAbstract" xlink:to="loc_us-gaapStockholdersEquity" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_pstiGeneralAbstract" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_pstiGeneralAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CashCashEquivalentsAndShortTermInvestments" xlink:label="loc_us-gaapCashCashEquivalentsAndShortTermInvestments" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_pstiGeneralAbstract" xlink:to="loc_us-gaapCashCashEquivalentsAndShortTermInvestments" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LicensesRevenue" xlink:label="loc_us-gaapLicensesRevenue" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_pstiGeneralAbstract" xlink:to="loc_us-gaapLicensesRevenue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_NonrefundableAdvanceUnderTermsOfLicenseAgreement" xlink:label="loc_pstiNonrefundableAdvanceUnderTermsOfLicenseAgreement" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_pstiGeneralAbstract" xlink:to="loc_pstiNonrefundableAdvanceUnderTermsOfLicenseAgreement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ProceedsFromCustomers" xlink:label="loc_us-gaapProceedsFromCustomers" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_pstiGeneralAbstract" xlink:to="loc_us-gaapProceedsFromCustomers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesPurchaseOfAssets" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesPurchaseOfAssets" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_pstiGeneralAbstract" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesPurchaseOfAssets" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_AvailableForSaleMarketableSecuritiesNumber" xlink:label="loc_pstiAvailableForSaleMarketableSecuritiesNumber" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_pstiGeneralAbstract" xlink:to="loc_pstiAvailableForSaleMarketableSecuritiesNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockIssuedDuringPeriodValuePurchaseOfAssets" xlink:label="loc_us-gaapStockIssuedDuringPeriodValuePurchaseOfAssets" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_pstiGeneralAbstract" xlink:to="loc_us-gaapStockIssuedDuringPeriodValuePurchaseOfAssets" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AvailableForSaleSecuritiesCurrent" xlink:label="loc_us-gaapAvailableForSaleSecuritiesCurrent" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_pstiGeneralAbstract" xlink:to="loc_us-gaapAvailableForSaleSecuritiesCurrent" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://pluristem.com/role/SignificantAccountingPoliciesNarrativeDetails" xlink:title="00000033 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Narrative) (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CurrencyAxis" xlink:label="loc_us-gaapCurrencyAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapCurrencyAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/currency/2017/currency-2017-01-31.xsd#currency_AllCurrenciesDomain" xlink:label="loc_currencyAllCurrenciesDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCurrencyAxis" xlink:to="loc_currencyAllCurrenciesDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/currency/2017/currency-2017-01-31.xsd#currency_EUR" xlink:label="loc_currencyEUR" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_currencyAllCurrenciesDomain" xlink:to="loc_currencyEUR" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaapAwardTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapAwardTypeAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherThanTemporaryImpairmentLossesInvestmentsPortionRecognizedInEarningsNet" xlink:label="loc_us-gaapOtherThanTemporaryImpairmentLossesInvestmentsPortionRecognizedInEarningsNet" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapOtherThanTemporaryImpairmentLossesInvestmentsPortionRecognizedInEarningsNet" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_NonrefundableAdvanceUnderTermsOfLicenseAgreement" xlink:label="loc_pstiNonrefundableAdvanceUnderTermsOfLicenseAgreement" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_pstiNonrefundableAdvanceUnderTermsOfLicenseAgreement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_BusinessCombinationContingentConsiderationReceivableUponCertainRegulatoryMilestones" xlink:label="loc_pstiBusinessCombinationContingentConsiderationReceivableUponCertainRegulatoryMilestones" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_pstiBusinessCombinationContingentConsiderationReceivableUponCertainRegulatoryMilestones" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DeferredRevenueAdditions" xlink:label="loc_us-gaapDeferredRevenueAdditions" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapDeferredRevenueAdditions" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_AdvancePaymentForDeveplomentCosts" xlink:label="loc_pstiAdvancePaymentForDeveplomentCosts" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_pstiAdvancePaymentForDeveplomentCosts" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PostemploymentBenefitsPeriodExpense" xlink:label="loc_us-gaapPostemploymentBenefitsPeriodExpense" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapPostemploymentBenefitsPeriodExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DerivativeGainLossOnDerivativeNet" xlink:label="loc_us-gaapDerivativeGainLossOnDerivativeNet" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapDerivativeGainLossOnDerivativeNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue" xlink:label="loc_us-gaapDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_TotalGrantsAwardedToCliProgram" xlink:label="loc_pstiTotalGrantsAwardedToCliProgram" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_pstiTotalGrantsAwardedToCliProgram" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_AmountOfGrantsAwardedToCliProgramAllocatedToCompany" xlink:label="loc_pstiAmountOfGrantsAwardedToCliProgramAllocatedToCompany" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_pstiAmountOfGrantsAwardedToCliProgramAllocatedToCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RevenueFromGrants" xlink:label="loc_us-gaapRevenueFromGrants" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapRevenueFromGrants" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_RecognizedRAndDPariticipationGrants" xlink:label="loc_pstiRecognizedRAndDPariticipationGrants" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_pstiRecognizedRAndDPariticipationGrants" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherLiabilitiesCurrent" xlink:label="loc_us-gaapOtherLiabilitiesCurrent" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapOtherLiabilitiesCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_AmountOfGrantsReceivedConditionalAward" xlink:label="loc_pstiAmountOfGrantsReceivedConditionalAward" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_pstiAmountOfGrantsReceivedConditionalAward" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_AmountOfDirectGrantAllocatedToTheCompany" xlink:label="loc_pstiAmountOfDirectGrantAllocatedToTheCompany" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_pstiAmountOfDirectGrantAllocatedToTheCompany" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://pluristem.com/role/SignificantAccountingPoliciesScheduleOfPropertyAndEquipmentDepreciationRateDetails" xlink:title="00000034 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Schedule of Property and Equipment Depreciation Rate) (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="loc_us-gaapPropertyPlantAndEquipmentLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:to="loc_us-gaapPropertyPlantAndEquipmentLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:to="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherMachineryAndEquipmentMember" xlink:label="loc_us-gaapOtherMachineryAndEquipmentMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapOtherMachineryAndEquipmentMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ComputerEquipmentMember" xlink:label="loc_us-gaapComputerEquipmentMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapComputerEquipmentMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OfficeEquipmentMember" xlink:label="loc_us-gaapOfficeEquipmentMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapOfficeEquipmentMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_VehiclesMember" xlink:label="loc_us-gaapVehiclesMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapVehiclesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LeaseholdImprovementsMember" xlink:label="loc_us-gaapLeaseholdImprovementsMember" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapLeaseholdImprovementsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RangeAxis" xlink:label="loc_us-gaapRangeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:to="loc_us-gaapRangeAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RangeMember" xlink:label="loc_us-gaapRangeMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRangeAxis" xlink:to="loc_us-gaapRangeMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_MinimumMember" xlink:label="loc_us-gaapMinimumMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRangeMember" xlink:to="loc_us-gaapMinimumMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_MaximumMember" xlink:label="loc_us-gaapMaximumMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRangeMember" xlink:to="loc_us-gaapMaximumMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_PropertyPlantAndEquipmentAnnualRateOfDepreciation" xlink:label="loc_pstiPropertyPlantAndEquipmentAnnualRateOfDepreciation" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_pstiPropertyPlantAndEquipmentAnnualRateOfDepreciation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_LeaseholdImprovementsAnnualRateOfDepreciationDescription" xlink:label="loc_pstiLeaseholdImprovementsAnnualRateOfDepreciationDescription" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_pstiLeaseholdImprovementsAnnualRateOfDepreciationDescription" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://pluristem.com/role/Disclosure-BASISOFPRESENTATIONANDSIGNIFICANTACCOUNTINGPOLICIESComprehensiveIncomeDetails" xlink:title="00000035 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Comprehensive Income) (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:label="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:label="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossTable" xlink:to="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember" xlink:label="loc_us-gaapAccumulatedNetUnrealizedInvestmentGainLossMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapAccumulatedNetUnrealizedInvestmentGainLossMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember" xlink:label="loc_us-gaapAccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapAccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:label="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossNetOfTax" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:label="loc_us-gaapOtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapOtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:label="loc_us-gaapReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:label="loc_us-gaapOtherComprehensiveIncomeLossNetOfTax" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:label="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossNetOfTax_2" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossNetOfTax_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://pluristem.com/role/psti-mssoamsd1" xlink:title="00000036 - Disclosure - MARKETABLE SECURITIES (Schedule of Available-for-sale Marketable Securities) (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_MarketableSecuritiesAbstract" xlink:label="loc_us-gaapMarketableSecuritiesAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesTable" xlink:label="loc_us-gaapScheduleOfAvailableForSaleSecuritiesTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapMarketableSecuritiesAbstract" xlink:to="loc_us-gaapScheduleOfAvailableForSaleSecuritiesTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:label="loc_us-gaapScheduleOfAvailableForSaleSecuritiesLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfAvailableForSaleSecuritiesTable" xlink:to="loc_us-gaapScheduleOfAvailableForSaleSecuritiesLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis" xlink:label="loc_us-gaapMajorTypesOfDebtAndEquitySecuritiesAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfAvailableForSaleSecuritiesTable" xlink:to="loc_us-gaapMajorTypesOfDebtAndEquitySecuritiesAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_MajorTypesOfDebtAndEquitySecuritiesDomain" xlink:label="loc_us-gaapMajorTypesOfDebtAndEquitySecuritiesDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapMajorTypesOfDebtAndEquitySecuritiesAxis" xlink:to="loc_us-gaapMajorTypesOfDebtAndEquitySecuritiesDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EquitySecuritiesMember" xlink:label="loc_us-gaapEquitySecuritiesMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapMajorTypesOfDebtAndEquitySecuritiesDomain" xlink:to="loc_us-gaapEquitySecuritiesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_GovernmentDebtSecuritiesMember" xlink:label="loc_pstiGovernmentDebtSecuritiesMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapMajorTypesOfDebtAndEquitySecuritiesDomain" xlink:to="loc_pstiGovernmentDebtSecuritiesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CorporateDebtSecuritiesMember" xlink:label="loc_us-gaapCorporateDebtSecuritiesMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapMajorTypesOfDebtAndEquitySecuritiesDomain" xlink:to="loc_us-gaapCorporateDebtSecuritiesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_MaturityDateRangeAxis" xlink:label="loc_pstiMaturityDateRangeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfAvailableForSaleSecuritiesTable" xlink:to="loc_pstiMaturityDateRangeAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_MaturityDateRangeDomain" xlink:label="loc_pstiMaturityDateRangeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_pstiMaturityDateRangeAxis" xlink:to="loc_pstiMaturityDateRangeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_AvailableForSaleSecuritiesMaturesWithinOneYearMember" xlink:label="loc_pstiAvailableForSaleSecuritiesMaturesWithinOneYearMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_pstiMaturityDateRangeDomain" xlink:to="loc_pstiAvailableForSaleSecuritiesMaturesWithinOneYearMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_AvailableForSaleSecuritiesMaturesAfterOneYearThroughFiveYearsMember" xlink:label="loc_pstiAvailableForSaleSecuritiesMaturesAfterOneYearThroughFiveYearsMember" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_pstiMaturityDateRangeDomain" xlink:to="loc_pstiAvailableForSaleSecuritiesMaturesAfterOneYearThroughFiveYearsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_AvailableForSaleSecuritiesMaturesAfterFiveYearsThroughTenYearsMember" xlink:label="loc_pstiAvailableForSaleSecuritiesMaturesAfterFiveYearsThroughTenYearsMember" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_pstiMaturityDateRangeDomain" xlink:to="loc_pstiAvailableForSaleSecuritiesMaturesAfterFiveYearsThroughTenYearsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AvailableForSaleSecurities" xlink:label="loc_us-gaapAvailableForSaleSecurities" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="loc_us-gaapAvailableForSaleSecurities" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:label="loc_us-gaapAvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedGainBeforeTax" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="loc_us-gaapAvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:label="loc_us-gaapAvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedLossBeforeTax" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="loc_us-gaapAvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_OtherthantemporaryImpairment" xlink:label="loc_pstiOtherthantemporaryImpairment" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="loc_pstiOtherthantemporaryImpairment" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AvailableForSaleSecuritiesAmortizedCost" xlink:label="loc_us-gaapAvailableForSaleSecuritiesAmortizedCost" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="loc_us-gaapAvailableForSaleSecuritiesAmortizedCost" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://pluristem.com/role/psti-mssoiiuld" xlink:title="00000037 - Disclosure - MARKETABLE SECURITIES (Schedule of Investments in Unrealized Loss) (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_MarketableSecuritiesAbstract" xlink:label="loc_us-gaapMarketableSecuritiesAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue" xlink:label="loc_us-gaapAvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapMarketableSecuritiesAbstract" xlink:to="loc_us-gaapAvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" xlink:label="loc_us-gaapAvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapMarketableSecuritiesAbstract" xlink:to="loc_us-gaapAvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValue" xlink:label="loc_us-gaapAvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValue" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapMarketableSecuritiesAbstract" xlink:to="loc_us-gaapAvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" xlink:label="loc_us-gaapAvailableForSaleSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapMarketableSecuritiesAbstract" xlink:to="loc_us-gaapAvailableForSaleSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_InterestReceivable" xlink:label="loc_us-gaapInterestReceivable" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapMarketableSecuritiesAbstract" xlink:to="loc_us-gaapInterestReceivable" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://pluristem.com/role/psti-fvofisofvofid1" xlink:title="00000038 - Disclosure - FAIR VALUE OF FINANCIAL INSTRUMENTS (Schedule of Fair Value of Financial Instruments) (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="loc_us-gaapFairValueDisclosuresAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:label="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueDisclosuresAbstract" xlink:to="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:label="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis" xlink:label="loc_us-gaapFairValueByMeasurementFrequencyAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="loc_us-gaapFairValueByMeasurementFrequencyAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain" xlink:label="loc_us-gaapFairValueMeasurementFrequencyDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueByMeasurementFrequencyAxis" xlink:to="loc_us-gaapFairValueMeasurementFrequencyDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember" xlink:label="loc_us-gaapFairValueMeasurementsRecurringMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueMeasurementFrequencyDomain" xlink:to="loc_us-gaapFairValueMeasurementsRecurringMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" xlink:to="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueInputsLevel1Member" xlink:label="loc_us-gaapFairValueInputsLevel1Member" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" xlink:to="loc_us-gaapFairValueInputsLevel1Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueInputsLevel2Member" xlink:label="loc_us-gaapFairValueInputsLevel2Member" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" xlink:to="loc_us-gaapFairValueInputsLevel2Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_MarketableSecuritiesCurrent" xlink:label="loc_us-gaapMarketableSecuritiesCurrent" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="loc_us-gaapMarketableSecuritiesCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet" xlink:label="loc_us-gaapDerivativeAssetsLiabilitiesAtFairValueNet" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="loc_us-gaapDerivativeAssetsLiabilitiesAtFairValueNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueNetAssetLiability" xlink:label="loc_us-gaapFairValueNetAssetLiability" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="loc_us-gaapFairValueNetAssetLiability" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://pluristem.com/role/OtherCurrentAssetsDetails" xlink:title="00000039 - Disclosure - OTHER CURRENT ASSETS (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract" xlink:label="loc_us-gaapDeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PrepaidExpenseCurrent" xlink:label="loc_us-gaapPrepaidExpenseCurrent" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract" xlink:to="loc_us-gaapPrepaidExpenseCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_AccountsReceivableFromMinistryOfEconomyCurrent" xlink:label="loc_pstiAccountsReceivableFromMinistryOfEconomyCurrent" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract" xlink:to="loc_pstiAccountsReceivableFromMinistryOfEconomyCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CashFlowHedgesDerivativeInstrumentsAtFairValueNet" xlink:label="loc_us-gaapCashFlowHedgesDerivativeInstrumentsAtFairValueNet" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract" xlink:to="loc_us-gaapCashFlowHedgesDerivativeInstrumentsAtFairValueNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue" xlink:label="loc_us-gaapDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract" xlink:to="loc_us-gaapDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ValueAddedTaxReceivableCurrent" xlink:label="loc_us-gaapValueAddedTaxReceivableCurrent" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract" xlink:to="loc_us-gaapValueAddedTaxReceivableCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherReceivablesNetCurrent" xlink:label="loc_us-gaapOtherReceivablesNetCurrent" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract" xlink:to="loc_us-gaapOtherReceivablesNetCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherAssetsCurrent" xlink:label="loc_us-gaapOtherAssetsCurrent" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract" xlink:to="loc_us-gaapOtherAssetsCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://pluristem.com/role/PropertyAndEquipmentNetDetails" xlink:title="00000040 - Disclosure - PROPERTY AND EQUIPMENT, NET (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="loc_us-gaapPropertyPlantAndEquipmentAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentAbstract" xlink:to="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="loc_us-gaapPropertyPlantAndEquipmentLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:to="loc_us-gaapPropertyPlantAndEquipmentLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:to="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherMachineryAndEquipmentMember" xlink:label="loc_us-gaapOtherMachineryAndEquipmentMember" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapOtherMachineryAndEquipmentMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ComputerEquipmentMember" xlink:label="loc_us-gaapComputerEquipmentMember" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapComputerEquipmentMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OfficeEquipmentMember" xlink:label="loc_us-gaapOfficeEquipmentMember" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapOfficeEquipmentMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LeaseholdImprovementsMember" xlink:label="loc_us-gaapLeaseholdImprovementsMember" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapLeaseholdImprovementsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_VehiclesMember" xlink:label="loc_us-gaapVehiclesMember" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapVehiclesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="loc_us-gaapPropertyPlantAndEquipmentGross" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapPropertyPlantAndEquipmentGross" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="loc_us-gaapAccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapAccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaapPropertyPlantAndEquipmentNet" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapPropertyPlantAndEquipmentNet" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_Depreciation" xlink:label="loc_us-gaapDepreciation" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapDepreciation" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://pluristem.com/role/OtherAccountsPayableDetails" xlink:title="00000041 - Disclosure - OTHER ACCOUNTS PAYABLE (Details)">
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_OtherAccountsPayableAbstract" xlink:label="loc_pstiOtherAccountsPayableAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:label="loc_us-gaapEmployeeRelatedLiabilitiesCurrent" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_pstiOtherAccountsPayableAbstract" xlink:to="loc_us-gaapEmployeeRelatedLiabilitiesCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_OtherAccountsPayablePayrollInstitutions" xlink:label="loc_pstiOtherAccountsPayablePayrollInstitutions" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_pstiOtherAccountsPayableAbstract" xlink:to="loc_pstiOtherAccountsPayablePayrollInstitutions" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccruedVacationCurrent" xlink:label="loc_us-gaapAccruedVacationCurrent" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_pstiOtherAccountsPayableAbstract" xlink:to="loc_us-gaapAccruedVacationCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DeferredRentCreditCurrent" xlink:label="loc_us-gaapDeferredRentCreditCurrent" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_pstiOtherAccountsPayableAbstract" xlink:to="loc_us-gaapDeferredRentCreditCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DerivativeLiabilitiesCurrent" xlink:label="loc_us-gaapDerivativeLiabilitiesCurrent" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_pstiOtherAccountsPayableAbstract" xlink:to="loc_us-gaapDerivativeLiabilitiesCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent" xlink:label="loc_us-gaapOtherAccruedLiabilitiesCurrent" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_pstiOtherAccountsPayableAbstract" xlink:to="loc_us-gaapOtherAccruedLiabilitiesCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccountsPayableOtherCurrent" xlink:label="loc_us-gaapAccountsPayableOtherCurrent" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_pstiOtherAccountsPayableAbstract" xlink:to="loc_us-gaapAccountsPayableOtherCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://pluristem.com/role/CommitmentsAndContingenciesOperatingLeaseDetails" xlink:title="00000042 - Disclosure - COMMITMENTS AND CONTINGENCIES (Operating Lease) (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfOperatingLeasedAssetsTable" xlink:label="loc_us-gaapScheduleOfOperatingLeasedAssetsTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfOperatingLeasedAssetsTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OperatingLeasedAssetsLineItems" xlink:label="loc_us-gaapOperatingLeasedAssetsLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfOperatingLeasedAssetsTable" xlink:to="loc_us-gaapOperatingLeasedAssetsLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_GuaranteeObligationsByNatureAxis" xlink:label="loc_us-gaapGuaranteeObligationsByNatureAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfOperatingLeasedAssetsTable" xlink:to="loc_us-gaapGuaranteeObligationsByNatureAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_GuaranteeObligationsNatureDomain" xlink:label="loc_us-gaapGuaranteeObligationsNatureDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapGuaranteeObligationsByNatureAxis" xlink:to="loc_us-gaapGuaranteeObligationsNatureDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfOperatingLeasedAssetsTable" xlink:to="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LandAndBuildingMember" xlink:label="loc_us-gaapLandAndBuildingMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapLandAndBuildingMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AutomobilesMember" xlink:label="loc_us-gaapAutomobilesMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapAutomobilesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RangeAxis" xlink:label="loc_us-gaapRangeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfOperatingLeasedAssetsTable" xlink:to="loc_us-gaapRangeAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RangeMember" xlink:label="loc_us-gaapRangeMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRangeAxis" xlink:to="loc_us-gaapRangeMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_OperatingLeasedAssetsNumberOfUnits" xlink:label="loc_pstiOperatingLeasedAssetsNumberOfUnits" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingLeasedAssetsLineItems" xlink:to="loc_pstiOperatingLeasedAssetsNumberOfUnits" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_OperatingLeasedAssetsParticipationFromLessor" xlink:label="loc_pstiOperatingLeasedAssetsParticipationFromLessor" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingLeasedAssetsLineItems" xlink:to="loc_pstiOperatingLeasedAssetsParticipationFromLessor" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_GuaranteeObligationsCurrentCarryingValue" xlink:label="loc_us-gaapGuaranteeObligationsCurrentCarryingValue" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingLeasedAssetsLineItems" xlink:to="loc_us-gaapGuaranteeObligationsCurrentCarryingValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OperatingLeasesRentExpenseNet" xlink:label="loc_us-gaapOperatingLeasesRentExpenseNet" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingLeasedAssetsLineItems" xlink:to="loc_us-gaapOperatingLeasesRentExpenseNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent" xlink:label="loc_us-gaapOperatingLeasesFutureMinimumPaymentsDueCurrent" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingLeasedAssetsLineItems" xlink:to="loc_us-gaapOperatingLeasesFutureMinimumPaymentsDueCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears" xlink:label="loc_us-gaapOperatingLeasesFutureMinimumPaymentsDueInTwoYears" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingLeasedAssetsLineItems" xlink:to="loc_us-gaapOperatingLeasesFutureMinimumPaymentsDueInTwoYears" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears" xlink:label="loc_us-gaapOperatingLeasesFutureMinimumPaymentsDueInThreeYears" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingLeasedAssetsLineItems" xlink:to="loc_us-gaapOperatingLeasesFutureMinimumPaymentsDueInThreeYears" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears" xlink:label="loc_us-gaapOperatingLeasesFutureMinimumPaymentsDueInFourYears" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingLeasedAssetsLineItems" xlink:to="loc_us-gaapOperatingLeasesFutureMinimumPaymentsDueInFourYears" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears" xlink:label="loc_us-gaapOperatingLeasesFutureMinimumPaymentsDueInFiveYears" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingLeasedAssetsLineItems" xlink:to="loc_us-gaapOperatingLeasesFutureMinimumPaymentsDueInFiveYears" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDue" xlink:label="loc_us-gaapOperatingLeasesFutureMinimumPaymentsDue" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingLeasedAssetsLineItems" xlink:to="loc_us-gaapOperatingLeasesFutureMinimumPaymentsDue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://pluristem.com/role/CommitmentsAndContingenciesOtherDetails" xlink:title="00000043 - Disclosure - COMMITMENTS AND CONTINGENCIES (Other) (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherCommitmentsTable" xlink:label="loc_us-gaapOtherCommitmentsTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_us-gaapOtherCommitmentsTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherCommitmentsLineItems" xlink:label="loc_us-gaapOtherCommitmentsLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherCommitmentsTable" xlink:to="loc_us-gaapOtherCommitmentsLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RangeAxis" xlink:label="loc_us-gaapRangeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherCommitmentsTable" xlink:to="loc_us-gaapRangeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RangeMember" xlink:label="loc_us-gaapRangeMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRangeAxis" xlink:to="loc_us-gaapRangeMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_MinimumMember" xlink:label="loc_us-gaapMinimumMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRangeMember" xlink:to="loc_us-gaapMinimumMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_MaximumMember" xlink:label="loc_us-gaapMaximumMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRangeMember" xlink:to="loc_us-gaapMaximumMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaapAwardTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherCommitmentsTable" xlink:to="loc_us-gaapAwardTypeAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_SmartMoneyGrantMember" xlink:label="loc_pstiSmartMoneyGrantMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_pstiSmartMoneyGrantMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_BinationalIndustrialResearchAndDevelopmentFoundationMember" xlink:label="loc_pstiBinationalIndustrialResearchAndDevelopmentFoundationMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_pstiBinationalIndustrialResearchAndDevelopmentFoundationMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_NewYorkBloodCenterIncMember" xlink:label="loc_pstiNewYorkBloodCenterIncMember" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_pstiNewYorkBloodCenterIncMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaapRestrictedCashAndCashEquivalentsAtCarryingValue" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherCommitmentsLineItems" xlink:to="loc_us-gaapRestrictedCashAndCashEquivalentsAtCarryingValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncreaseDecreaseInSecurityDeposits" xlink:label="loc_us-gaapIncreaseDecreaseInSecurityDeposits" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherCommitmentsLineItems" xlink:to="loc_us-gaapIncreaseDecreaseInSecurityDeposits" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_AggregateGrantsReceived" xlink:label="loc_pstiAggregateGrantsReceived" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherCommitmentsLineItems" xlink:to="loc_pstiAggregateGrantsReceived" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_PercentageOfQualifiedExpenditures" xlink:label="loc_pstiPercentageOfQualifiedExpenditures" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherCommitmentsLineItems" xlink:to="loc_pstiPercentageOfQualifiedExpenditures" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_RoyaltyRateSales" xlink:label="loc_pstiRoyaltyRateSales" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherCommitmentsLineItems" xlink:to="loc_pstiRoyaltyRateSales" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_RoyaltyRatePayableOnGrantsReceived" xlink:label="loc_pstiRoyaltyRatePayableOnGrantsReceived" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherCommitmentsLineItems" xlink:to="loc_pstiRoyaltyRatePayableOnGrantsReceived" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_TermOfRoyaltyGrantReceived" xlink:label="loc_pstiTermOfRoyaltyGrantReceived" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherCommitmentsLineItems" xlink:to="loc_pstiTermOfRoyaltyGrantReceived" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_RoyaltiesAmountPaidAndAccrued" xlink:label="loc_pstiRoyaltiesAmountPaidAndAccrued" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherCommitmentsLineItems" xlink:to="loc_pstiRoyaltiesAmountPaidAndAccrued" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RoyaltyGuaranteesCommitmentsAmount" xlink:label="loc_us-gaapRoyaltyGuaranteesCommitmentsAmount" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherCommitmentsLineItems" xlink:to="loc_us-gaapRoyaltyGuaranteesCommitmentsAmount" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_AmountOfGrantsReceivedConditionalAward" xlink:label="loc_pstiAmountOfGrantsReceivedConditionalAward" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherCommitmentsLineItems" xlink:to="loc_pstiAmountOfGrantsReceivedConditionalAward" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_AmountOfDirectGrantAllocatedToTheCompany" xlink:label="loc_pstiAmountOfDirectGrantAllocatedToTheCompany" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherCommitmentsLineItems" xlink:to="loc_pstiAmountOfDirectGrantAllocatedToTheCompany" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://pluristem.com/role/psti-send1" xlink:title="00000044 - Disclosure - STOCKHOLDERS' EQUITY (Narrative) (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract" xlink:label="loc_us-gaapStockholdersEquityNoteAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfStockByClassTable" xlink:label="loc_us-gaapScheduleOfStockByClassTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityNoteAbstract" xlink:to="loc_us-gaapScheduleOfStockByClassTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ClassOfStockLineItems" xlink:label="loc_us-gaapClassOfStockLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfStockByClassTable" xlink:to="loc_us-gaapClassOfStockLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="loc_us-gaapClassOfWarrantOrRightAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfStockByClassTable" xlink:to="loc_us-gaapClassOfWarrantOrRightAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="loc_us-gaapClassOfWarrantOrRightDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfWarrantOrRightAxis" xlink:to="loc_us-gaapClassOfWarrantOrRightDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_InvestorWarrantsMember" xlink:label="loc_pstiInvestorWarrantsMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfWarrantOrRightDomain" xlink:to="loc_pstiInvestorWarrantsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_WarrantMember" xlink:label="loc_us-gaapWarrantMember" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfWarrantOrRightDomain" xlink:to="loc_us-gaapWarrantMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CurrencyAxis" xlink:label="loc_us-gaapCurrencyAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfStockByClassTable" xlink:to="loc_us-gaapCurrencyAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/currency/2017/currency-2017-01-31.xsd#currency_AllCurrenciesDomain" xlink:label="loc_currencyAllCurrenciesDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCurrencyAxis" xlink:to="loc_currencyAllCurrenciesDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/currency/2017/currency-2017-01-31.xsd#currency_ILS" xlink:label="loc_currencyILS" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_currencyAllCurrenciesDomain" xlink:to="loc_currencyILS" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis" xlink:label="loc_us-gaapShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfStockByClassTable" xlink:to="loc_us-gaapShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionSupplierDomain" xlink:label="loc_us-gaapShareBasedGoodsAndNonemployeeServicesTransactionSupplierDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis" xlink:to="loc_us-gaapShareBasedGoodsAndNonemployeeServicesTransactionSupplierDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_ContractorMember" xlink:label="loc_pstiContractorMember" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedGoodsAndNonemployeeServicesTransactionSupplierDomain" xlink:to="loc_pstiContractorMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfStockByClassTable" xlink:to="loc_deiLegalEntityAxis" order="40" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_UnderwritingAgreementMember" xlink:label="loc_pstiUnderwritingAgreementMember" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityDomain" xlink:to="loc_pstiUnderwritingAgreementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PlanNameAxis" xlink:label="loc_us-gaapPlanNameAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfStockByClassTable" xlink:to="loc_us-gaapPlanNameAxis" order="50" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaapPlanNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPlanNameAxis" xlink:to="loc_us-gaapPlanNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_Plan2005Member" xlink:label="loc_pstiPlan2005Member" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPlanNameDomain" xlink:to="loc_pstiPlan2005Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_Plan2016Member" xlink:label="loc_pstiPlan2016Member" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPlanNameDomain" xlink:to="loc_pstiPlan2016Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaapCommonStockParOrStatedValuePerShare" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapCommonStockParOrStatedValuePerShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="loc_us-gaapCommonStockSharesAuthorized" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapCommonStockSharesAuthorized" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="loc_us-gaapPreferredStockSharesAuthorized" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapPreferredStockSharesAuthorized" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="loc_us-gaapPreferredStockParOrStatedValuePerShare" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapPreferredStockParOrStatedValuePerShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" xlink:label="loc_us-gaapAdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapAdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ConversionOfStockSharesConverted1" xlink:label="loc_us-gaapConversionOfStockSharesConverted1" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapConversionOfStockSharesConverted1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ConversionOfStockSharesIssued1" xlink:label="loc_us-gaapConversionOfStockSharesIssued1" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapConversionOfStockSharesIssued1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesOther" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesOther" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesOther" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_CommonStockAggregateOfferingPriceAuthorized" xlink:label="loc_pstiCommonStockAggregateOfferingPriceAuthorized" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_pstiCommonStockAggregateOfferingPriceAuthorized" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ProceedsFromWarrantExercises" xlink:label="loc_us-gaapProceedsFromWarrantExercises" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapProceedsFromWarrantExercises" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_SharebasedCompensationArrangementWarrantsExercised" xlink:label="loc_pstiSharebasedCompensationArrangementWarrantsExercised" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_pstiSharebasedCompensationArrangementWarrantsExercised" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesPurchaseOfAssets" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesPurchaseOfAssets" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesPurchaseOfAssets" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_AvailableForSaleMarketableSecuritiesNumber" xlink:label="loc_pstiAvailableForSaleMarketableSecuritiesNumber" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_pstiAvailableForSaleMarketableSecuritiesNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockIssuedDuringPeriodValuePurchaseOfAssets" xlink:label="loc_us-gaapStockIssuedDuringPeriodValuePurchaseOfAssets" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValuePurchaseOfAssets" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_AggregateOfferingPriceUnderATMAgreement" xlink:label="loc_pstiAggregateOfferingPriceUnderATMAgreement" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_pstiAggregateOfferingPriceUnderATMAgreement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_ShareBasedGoodsAndNonemployeeServicesTransactionQuantityOfSecuritiesToBeIssued" xlink:label="loc_pstiShareBasedGoodsAndNonemployeeServicesTransactionQuantityOfSecuritiesToBeIssued" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_pstiShareBasedGoodsAndNonemployeeServicesTransactionQuantityOfSecuritiesToBeIssued" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesIssuedForServices" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesIssuedForServices" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SharesIssuedPricePerShare" xlink:label="loc_us-gaapSharesIssuedPricePerShare" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapSharesIssuedPricePerShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" xlink:label="loc_us-gaapClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ClassOfWarrantOrRightOutstanding" xlink:label="loc_us-gaapClassOfWarrantOrRightOutstanding" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="loc_us-gaapProceedsFromIssuanceOfCommonStock" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapProceedsFromIssuanceOfCommonStock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_StockIssuedDuringPeriodValuePrivatePlacement" xlink:label="loc_pstiStockIssuedDuringPeriodValuePrivatePlacement" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_pstiStockIssuedDuringPeriodValuePrivatePlacement" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_StockIssuedDuringPeriodSharesPrivatePlacement" xlink:label="loc_pstiStockIssuedDuringPeriodSharesPrivatePlacement" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_pstiStockIssuedDuringPeriodSharesPrivatePlacement" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_ExpirationPeriodOfWarrantsSoldInOffering" xlink:label="loc_pstiExpirationPeriodOfWarrantsSoldInOffering" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_pstiExpirationPeriodOfWarrantsSoldInOffering" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueIssuedForServices" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueIssuedForServices" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueIssuedForServices" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherConstructionCosts" xlink:label="loc_us-gaapOtherConstructionCosts" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapOtherConstructionCosts" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ConstructionInProgressExpendituresIncurredButNotYetPaid" xlink:label="loc_us-gaapConstructionInProgressExpendituresIncurredButNotYetPaid" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapConstructionInProgressExpendituresIncurredButNotYetPaid" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceSheetAmount" xlink:label="loc_us-gaapUnrecordedUnconditionalPurchaseObligationBalanceSheetAmount" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapUnrecordedUnconditionalPurchaseObligationBalanceSheetAmount" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_PercentageOfConstructionMilestonesCompleted" xlink:label="loc_pstiPercentageOfConstructionMilestonesCompleted" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_pstiPercentageOfConstructionMilestonesCompleted" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionCapitalizedCost" xlink:label="loc_us-gaapShareBasedGoodsAndNonemployeeServicesTransactionCapitalizedCost" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapShareBasedGoodsAndNonemployeeServicesTransactionCapitalizedCost" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_NumberOfSharesAgreedToBeSoldThroughUnderwriterAgreement" xlink:label="loc_pstiNumberOfSharesAgreedToBeSoldThroughUnderwriterAgreement" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_pstiNumberOfSharesAgreedToBeSoldThroughUnderwriterAgreement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_NumberOfWarrantsAgreedToBeSoldThroughUnderwriterAgreement" xlink:label="loc_pstiNumberOfWarrantsAgreedToBeSoldThroughUnderwriterAgreement" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_pstiNumberOfWarrantsAgreedToBeSoldThroughUnderwriterAgreement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_GrossProceedsFromIssuanceOfCommonStock" xlink:label="loc_pstiGrossProceedsFromIssuanceOfCommonStock" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_pstiGrossProceedsFromIssuanceOfCommonStock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://pluristem.com/role/StockholdersEquitySummaryOfOptionActivityDetails" xlink:title="00000045 - Disclosure - STOCKHOLDERS' EQUITY (Summary of Option Activity) (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract" xlink:label="loc_us-gaapStockholdersEquityNoteAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityNoteAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TitleOfIndividualAxis" xlink:label="loc_us-gaapTitleOfIndividualAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapTitleOfIndividualAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_us-gaapTitleOfIndividualWithRelationshipToEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTitleOfIndividualAxis" xlink:to="loc_us-gaapTitleOfIndividualWithRelationshipToEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_EmployeesAndDirectorsMember" xlink:label="loc_pstiEmployeesAndDirectorsMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_pstiEmployeesAndDirectorsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesStockOptionsExercised" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_2" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_2" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_WeightedAverageRemainingContractualTermsAbstract" xlink:label="loc_pstiWeightedAverageRemainingContractualTermsAbstract" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_pstiWeightedAverageRemainingContractualTermsAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_pstiWeightedAverageRemainingContractualTermsAbstract" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_pstiWeightedAverageRemainingContractualTermsAbstract" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_pstiWeightedAverageRemainingContractualTermsAbstract" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_AggregateIntrinsicValueAbstract" xlink:label="loc_pstiAggregateIntrinsicValueAbstract" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_pstiAggregateIntrinsicValueAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_pstiAggregateIntrinsicValueAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_pstiAggregateIntrinsicValueAbstract" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_pstiAggregateIntrinsicValueAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://pluristem.com/role/StockholdersEquitySummaryOfOptionActivityToNon-employeeConsultantsDetails" xlink:title="00000046 - Disclosure - STOCKHOLDERS' EQUITY (Summary of Option Activity to Non-employee Consultants) (Details)">
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_StockholdersEquitySummaryOfOptionActivityToNonemployeeConsultantsDetailsAbstract" xlink:label="loc_pstiStockholdersEquitySummaryOfOptionActivityToNonemployeeConsultantsDetailsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_pstiStockholdersEquitySummaryOfOptionActivityToNonemployeeConsultantsDetailsAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TitleOfIndividualAxis" xlink:label="loc_us-gaapTitleOfIndividualAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapTitleOfIndividualAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_us-gaapTitleOfIndividualWithRelationshipToEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTitleOfIndividualAxis" xlink:to="loc_us-gaapTitleOfIndividualWithRelationshipToEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_NonemployeesMember" xlink:label="loc_pstiNonemployeesMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_pstiNonemployeesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesStockOptionsExercised" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_2" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_2" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_WeightedAverageRemainingContractualTermsAbstract" xlink:label="loc_pstiWeightedAverageRemainingContractualTermsAbstract" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_pstiWeightedAverageRemainingContractualTermsAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_pstiWeightedAverageRemainingContractualTermsAbstract" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_pstiWeightedAverageRemainingContractualTermsAbstract" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_pstiWeightedAverageRemainingContractualTermsAbstract" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_AggregateIntrinsicValueAbstract" xlink:label="loc_pstiAggregateIntrinsicValueAbstract" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_pstiAggregateIntrinsicValueAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_pstiAggregateIntrinsicValueAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_pstiAggregateIntrinsicValueAbstract" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_pstiAggregateIntrinsicValueAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://pluristem.com/role/psti-sesoced1" xlink:title="00000047 - Disclosure - STOCKHOLDERS' EQUITY (Schedule of Compensation Expense) (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract" xlink:label="loc_us-gaapStockholdersEquityNoteAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:label="loc_us-gaapScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityNoteAbstract" xlink:to="loc_us-gaapScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:label="loc_us-gaapEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:to="loc_us-gaapEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaapAwardTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:to="loc_us-gaapAwardTypeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="loc_us-gaapEmployeeStockOptionMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaapEmployeeStockOptionMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="loc_us-gaapRestrictedStockUnitsRSUMember" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaapRestrictedStockUnitsRSUMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="loc_us-gaapIncomeStatementLocationAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:to="loc_us-gaapIncomeStatementLocationAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="loc_us-gaapIncomeStatementLocationDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementLocationAxis" xlink:to="loc_us-gaapIncomeStatementLocationDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember" xlink:label="loc_us-gaapResearchAndDevelopmentExpenseMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementLocationDomain" xlink:to="loc_us-gaapResearchAndDevelopmentExpenseMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_GeneralAndAdministrativeExpenseMember" xlink:label="loc_us-gaapGeneralAndAdministrativeExpenseMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementLocationDomain" xlink:to="loc_us-gaapGeneralAndAdministrativeExpenseMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis" xlink:label="loc_us-gaapShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:to="loc_us-gaapShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionSupplierDomain" xlink:label="loc_us-gaapShareBasedGoodsAndNonemployeeServicesTransactionSupplierDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis" xlink:to="loc_us-gaapShareBasedGoodsAndNonemployeeServicesTransactionSupplierDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_ConsultantsMember" xlink:label="loc_pstiConsultantsMember" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedGoodsAndNonemployeeServicesTransactionSupplierDomain" xlink:to="loc_pstiConsultantsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="loc_us-gaapAllocatedShareBasedCompensationExpense" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:to="loc_us-gaapAllocatedShareBasedCompensationExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:label="loc_us-gaapEmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:to="loc_us-gaapEmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:label="loc_us-gaapEmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:to="loc_us-gaapEmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://pluristem.com/role/psti-sesorateadd1" xlink:title="00000048 - Disclosure - STOCKHOLDERS' EQUITY (Summary of RSU Activity to Employees and Directors) (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract" xlink:label="loc_us-gaapStockholdersEquityNoteAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityNoteAbstract" xlink:to="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaapAwardTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapAwardTypeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="loc_us-gaapRestrictedStockUnitsRSUMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaapRestrictedStockUnitsRSUMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TitleOfIndividualAxis" xlink:label="loc_us-gaapTitleOfIndividualAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapTitleOfIndividualAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_us-gaapTitleOfIndividualWithRelationshipToEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTitleOfIndividualAxis" xlink:to="loc_us-gaapTitleOfIndividualWithRelationshipToEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_EmployeesAndDirectorsMember" xlink:label="loc_pstiEmployeesAndDirectorsMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_pstiEmployeesAndDirectorsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_2" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVest" xlink:label="loc_pstiShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVest" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_pstiShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVest" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://pluristem.com/role/psti-sesoratcd1" xlink:title="00000049 - Disclosure - STOCKHOLDERS' EQUITY (Summary of RSU Activity to Consultants) (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract" xlink:label="loc_us-gaapStockholdersEquityNoteAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityNoteAbstract" xlink:to="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis" xlink:label="loc_us-gaapShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionSupplierDomain" xlink:label="loc_us-gaapShareBasedGoodsAndNonemployeeServicesTransactionSupplierDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis" xlink:to="loc_us-gaapShareBasedGoodsAndNonemployeeServicesTransactionSupplierDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_ConsultantsMember" xlink:label="loc_pstiConsultantsMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedGoodsAndNonemployeeServicesTransactionSupplierDomain" xlink:to="loc_pstiConsultantsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TitleOfIndividualAxis" xlink:label="loc_us-gaapTitleOfIndividualAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapTitleOfIndividualAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_us-gaapTitleOfIndividualWithRelationshipToEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTitleOfIndividualAxis" xlink:to="loc_us-gaapTitleOfIndividualWithRelationshipToEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_2" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://pluristem.com/role/StockholdersEquitySummaryOfWarrantsAndOptionsDetails" xlink:title="00000050 - Disclosure - STOCKHOLDERS' EQUITY (Summary of Warrants and Options) (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract" xlink:label="loc_us-gaapStockholdersEquityNoteAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityNoteAbstract" xlink:to="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="loc_us-gaapClassOfWarrantOrRightAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapClassOfWarrantOrRightAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="loc_us-gaapClassOfWarrantOrRightDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfWarrantOrRightAxis" xlink:to="loc_us-gaapClassOfWarrantOrRightDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_WarrantMember" xlink:label="loc_us-gaapWarrantMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfWarrantOrRightDomain" xlink:to="loc_us-gaapWarrantMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaapAwardTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapAwardTypeAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="loc_us-gaapEmployeeStockOptionMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaapEmployeeStockOptionMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:label="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:label="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:to="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_ExercisePriceRangeOneMember" xlink:label="loc_pstiExercisePriceRangeOneMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="loc_pstiExercisePriceRangeOneMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_ExercisePriceRangeTwoMember" xlink:label="loc_pstiExercisePriceRangeTwoMember" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="loc_pstiExercisePriceRangeTwoMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_ExercisePriceRangeThreeMember" xlink:label="loc_pstiExercisePriceRangeThreeMember" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="loc_pstiExercisePriceRangeThreeMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_ExercisePriceRangeFourMember" xlink:label="loc_pstiExercisePriceRangeFourMember" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="loc_pstiExercisePriceRangeFourMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_ExercisePriceRangeFiveMember" xlink:label="loc_pstiExercisePriceRangeFiveMember" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="loc_pstiExercisePriceRangeFiveMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_ExercisePriceRangeSixMember" xlink:label="loc_pstiExercisePriceRangeSixMember" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="loc_pstiExercisePriceRangeSixMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_ExercisePriceRangeSevenMember" xlink:label="loc_pstiExercisePriceRangeSevenMember" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="loc_pstiExercisePriceRangeSevenMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_ExercisePriceRangeEightMember" xlink:label="loc_pstiExercisePriceRangeEightMember" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="loc_pstiExercisePriceRangeEightMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_ExercisePriceRangeNineMember" xlink:label="loc_pstiExercisePriceRangeNineMember" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="loc_pstiExercisePriceRangeNineMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_ExercisePriceRangeTenMember" xlink:label="loc_pstiExercisePriceRangeTenMember" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="loc_pstiExercisePriceRangeTenMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_ExercisePriceRangeElevenMember" xlink:label="loc_pstiExercisePriceRangeElevenMember" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="loc_pstiExercisePriceRangeElevenMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_ExercisePriceRangeTwelveMember" xlink:label="loc_pstiExercisePriceRangeTwelveMember" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="loc_pstiExercisePriceRangeTwelveMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_ExercisePriceRangeThirteenMember" xlink:label="loc_pstiExercisePriceRangeThirteenMember" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="loc_pstiExercisePriceRangeThirteenMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_ExercisePriceRangeFourteenMember" xlink:label="loc_pstiExercisePriceRangeFourteenMember" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="loc_pstiExercisePriceRangeFourteenMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" xlink:label="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" xlink:label="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://pluristem.com/role/FinancialIncomeNetDetails" xlink:title="00000051 - Disclosure - FINANCIAL INCOME, NET (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherIncomeAndExpensesAbstract" xlink:label="loc_us-gaapOtherIncomeAndExpensesAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:label="loc_us-gaapForeignCurrencyTransactionGainLossBeforeTax" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherIncomeAndExpensesAbstract" xlink:to="loc_us-gaapForeignCurrencyTransactionGainLossBeforeTax" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_InterestOnShortTermBankCreditAndBankExpenses" xlink:label="loc_pstiInterestOnShortTermBankCreditAndBankExpenses" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherIncomeAndExpensesAbstract" xlink:to="loc_pstiInterestOnShortTermBankCreditAndBankExpenses" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_InterestIncomeDepositsWithFinancialInstitutions" xlink:label="loc_us-gaapInterestIncomeDepositsWithFinancialInstitutions" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherIncomeAndExpensesAbstract" xlink:to="loc_us-gaapInterestIncomeDepositsWithFinancialInstitutions" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_MarketableSecuritiesGainLoss" xlink:label="loc_us-gaapMarketableSecuritiesGainLoss" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherIncomeAndExpensesAbstract" xlink:to="loc_us-gaapMarketableSecuritiesGainLoss" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_GainLossOnDerivativeInstrumentsNetPretax" xlink:label="loc_us-gaapGainLossOnDerivativeInstrumentsNetPretax" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherIncomeAndExpensesAbstract" xlink:to="loc_us-gaapGainLossOnDerivativeInstrumentsNetPretax" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherNonoperatingIncome" xlink:label="loc_us-gaapOtherNonoperatingIncome" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherIncomeAndExpensesAbstract" xlink:to="loc_us-gaapOtherNonoperatingIncome" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="loc_us-gaapNonoperatingIncomeExpense" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherIncomeAndExpensesAbstract" xlink:to="loc_us-gaapNonoperatingIncomeExpense" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://pluristem.com/role/TaxesOnIncomeNarrativeDetails" xlink:title="00000052 - Disclosure - TAXES ON INCOME (Narrative) (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaapIncomeTaxDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RangeAxis" xlink:label="loc_us-gaapRangeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapRangeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RangeMember" xlink:label="loc_us-gaapRangeMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRangeAxis" xlink:to="loc_us-gaapRangeMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_MaximumMember" xlink:label="loc_us-gaapMaximumMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRangeMember" xlink:to="loc_us-gaapMaximumMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_MinimumMember" xlink:label="loc_us-gaapMinimumMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRangeMember" xlink:to="loc_us-gaapMinimumMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeTaxAuthorityAxis" xlink:label="loc_us-gaapIncomeTaxAuthorityAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapIncomeTaxAuthorityAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain" xlink:label="loc_us-gaapIncomeTaxAuthorityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxAuthorityAxis" xlink:to="loc_us-gaapIncomeTaxAuthorityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_InternalRevenueServiceIRSMember" xlink:label="loc_us-gaapInternalRevenueServiceIRSMember" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxAuthorityDomain" xlink:to="loc_us-gaapInternalRevenueServiceIRSMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IsraelTaxAuthorityMember" xlink:label="loc_us-gaapIsraelTaxAuthorityMember" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxAuthorityDomain" xlink:to="loc_us-gaapIsraelTaxAuthorityMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_TechnologicalPreferredEnterpriseMember" xlink:label="loc_pstiTechnologicalPreferredEnterpriseMember" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxAuthorityDomain" xlink:to="loc_pstiTechnologicalPreferredEnterpriseMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_TechnologicalEnterpriseMember" xlink:label="loc_pstiTechnologicalEnterpriseMember" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxAuthorityDomain" xlink:to="loc_pstiTechnologicalEnterpriseMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_SpecialTechnologicalPreferredEnterpriseMember" xlink:label="loc_pstiSpecialTechnologicalPreferredEnterpriseMember" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxAuthorityDomain" xlink:to="loc_pstiSpecialTechnologicalPreferredEnterpriseMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_PreferredEnterpriseMember" xlink:label="loc_pstiPreferredEnterpriseMember" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxAuthorityDomain" xlink:to="loc_pstiPreferredEnterpriseMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TaxPeriodAxis" xlink:label="loc_us-gaapTaxPeriodAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapTaxPeriodAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TaxPeriodDomain" xlink:label="loc_us-gaapTaxPeriodDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTaxPeriodAxis" xlink:to="loc_us-gaapTaxPeriodDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EarliestTaxYearMember" xlink:label="loc_us-gaapEarliestTaxYearMember" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTaxPeriodDomain" xlink:to="loc_us-gaapEarliestTaxYearMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LatestTaxYearMember" xlink:label="loc_us-gaapLatestTaxYearMember" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTaxPeriodDomain" xlink:to="loc_us-gaapLatestTaxYearMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementGeographicalAxis" xlink:label="loc_us-gaapStatementGeographicalAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementGeographicalAxis" order="40" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SegmentGeographicalDomain" xlink:label="loc_us-gaapSegmentGeographicalDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementGeographicalAxis" xlink:to="loc_us-gaapSegmentGeographicalDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_DevelopmentAreaMember" xlink:label="loc_pstiDevelopmentAreaMember" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSegmentGeographicalDomain" xlink:to="loc_pstiDevelopmentAreaMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_RestOfCountryMember" xlink:label="loc_pstiRestOfCountryMember" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSegmentGeographicalDomain" xlink:to="loc_pstiRestOfCountryMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:label="loc_us-gaapEffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapEffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:label="loc_us-gaapEffectiveIncomeTaxRateContinuingOperations" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapEffectiveIncomeTaxRateContinuingOperations" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OperatingLossCarryforwards" xlink:label="loc_us-gaapOperatingLossCarryforwards" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapOperatingLossCarryforwards" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OperatingLossCarryforwardsExpirationDate" xlink:label="loc_us-gaapOperatingLossCarryforwardsExpirationDate" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapOperatingLossCarryforwardsExpirationDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_Revenues" xlink:label="loc_us-gaapRevenues" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapRevenues" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_CorporateStatutoryTaxRateOn2018AndThereafter" xlink:label="loc_pstiCorporateStatutoryTaxRateOn2018AndThereafter" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_pstiCorporateStatutoryTaxRateOn2018AndThereafter" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_CorporateStatutoryTaxRateOn2017AndThereafter" xlink:label="loc_pstiCorporateStatutoryTaxRateOn2017AndThereafter" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_pstiCorporateStatutoryTaxRateOn2017AndThereafter" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_CorporateStatutoryTaxRateForDividendsDistributedToIndividualsOrForeignResidentsDistributedFromPreferredEnterpriseProfits" xlink:label="loc_pstiCorporateStatutoryTaxRateForDividendsDistributedToIndividualsOrForeignResidentsDistributedFromPreferredEnterpriseProfits" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_pstiCorporateStatutoryTaxRateForDividendsDistributedToIndividualsOrForeignResidentsDistributedFromPreferredEnterpriseProfits" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_CorporateStatutoryTaxRateOnProfitsDerivingFromIntellectualProperty" xlink:label="loc_pstiCorporateStatutoryTaxRateOnProfitsDerivingFromIntellectualProperty" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_pstiCorporateStatutoryTaxRateOnProfitsDerivingFromIntellectualProperty" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_CorporateStatutoryTaxRateForDividendsDistributedToForeignCompanies" xlink:label="loc_pstiCorporateStatutoryTaxRateForDividendsDistributedToForeignCompanies" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_pstiCorporateStatutoryTaxRateForDividendsDistributedToForeignCompanies" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_CorporateStatutoryTaxRateOn2016" xlink:label="loc_pstiCorporateStatutoryTaxRateOn2016" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_pstiCorporateStatutoryTaxRateOn2016" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_CorporateStatutoryTaxRateOn2016AndThereafter" xlink:label="loc_pstiCorporateStatutoryTaxRateOn2016AndThereafter" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_pstiCorporateStatutoryTaxRateOn2016AndThereafter" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://pluristem.com/role/TaxesOnIncomeScheduleOfSignificantComponentsOfDeferredTaxAssetsDetails" xlink:title="00000053 - Disclosure - TAXES ON INCOME (Schedule of Significant Components of Deferred Tax Assets) (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaapIncomeTaxDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic" xlink:label="loc_us-gaapDeferredTaxAssetsOperatingLossCarryforwardsDomestic" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredTaxAssetsOperatingLossCarryforwardsDomestic" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign" xlink:label="loc_us-gaapDeferredTaxAssetsOperatingLossCarryforwardsForeign" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredTaxAssetsOperatingLossCarryforwardsForeign" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals" xlink:label="loc_us-gaapDeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DeferredTaxAssetsGross" xlink:label="loc_us-gaapDeferredTaxAssetsGross" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredTaxAssetsGross" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="loc_us-gaapDeferredTaxAssetsValuationAllowance" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredTaxAssetsValuationAllowance" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DeferredTaxAssetsNet" xlink:label="loc_us-gaapDeferredTaxAssetsNet" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredTaxAssetsNet" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://pluristem.com/role/SubsequentEventsNarrativeDetails" xlink:title="00000054 - Disclosure - SUBSEQUENT EVENTS (Narrative) (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="loc_us-gaapSubsequentEventsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SubsequentEventTable" xlink:label="loc_us-gaapSubsequentEventTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventsAbstract" xlink:to="loc_us-gaapSubsequentEventTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SubsequentEventLineItems" xlink:label="loc_us-gaapSubsequentEventLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTable" xlink:to="loc_us-gaapSubsequentEventLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_us-gaapSubsequentEventTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTable" xlink:to="loc_us-gaapSubsequentEventTypeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaapSubsequentEventTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTypeAxis" xlink:to="loc_us-gaapSubsequentEventTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SubsequentEventMember" xlink:label="loc_us-gaapSubsequentEventMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTypeDomain" xlink:to="loc_us-gaapSubsequentEventMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaapAwardTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTable" xlink:to="loc_us-gaapAwardTypeAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_SmartMoneyGrantMember" xlink:label="loc_pstiSmartMoneyGrantMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_pstiSmartMoneyGrantMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RelatedPartyTransactionAxis" xlink:label="loc_us-gaapRelatedPartyTransactionAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTable" xlink:to="loc_us-gaapRelatedPartyTransactionAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RelatedPartyTransactionDomain" xlink:label="loc_us-gaapRelatedPartyTransactionDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionAxis" xlink:to="loc_us-gaapRelatedPartyTransactionDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_AtMarketIssuanceSalesAgreementMember" xlink:label="loc_pstiAtMarketIssuanceSalesAgreementMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionDomain" xlink:to="loc_pstiAtMarketIssuanceSalesAgreementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CurrencyAxis" xlink:label="loc_us-gaapCurrencyAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTable" xlink:to="loc_us-gaapCurrencyAxis" order="40" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/currency/2017/currency-2017-01-31.xsd#currency_AllCurrenciesDomain" xlink:label="loc_currencyAllCurrenciesDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCurrencyAxis" xlink:to="loc_currencyAllCurrenciesDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/currency/2017/currency-2017-01-31.xsd#currency_EUR" xlink:label="loc_currencyEUR" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_currencyAllCurrenciesDomain" xlink:to="loc_currencyEUR" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_ValueOfCommonStockCompanyCanPeriodicallyIssueThroughAgentsPerTermsOfAtmAgreement" xlink:label="loc_pstiValueOfCommonStockCompanyCanPeriodicallyIssueThroughAgentsPerTermsOfAtmAgreement" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_pstiValueOfCommonStockCompanyCanPeriodicallyIssueThroughAgentsPerTermsOfAtmAgreement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_GrantsReceivable" xlink:label="loc_us-gaapGrantsReceivable" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapGrantsReceivable" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SharesIssuedPricePerShare" xlink:label="loc_us-gaapSharesIssuedPricePerShare" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapSharesIssuedPricePerShare" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_TotalNondilutiveGrantAwardedFromHorizon2020Program" xlink:label="loc_pstiTotalNondilutiveGrantAwardedFromHorizon2020Program" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_pstiTotalNondilutiveGrantAwardedFromHorizon2020Program" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="psti-20170630.xsd#psti_AmountOfDirectGrantsAwardedAllocatedToCompany" xlink:label="loc_pstiAmountOfDirectGrantsAwardedAllocatedToCompany" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_pstiAmountOfDirectGrantsAwardedAllocatedToCompany" xlink:type="arc" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>17
<FILENAME>image0.jpg
<TEXT>
begin 644 image0.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" RG"P,# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHIDLT4(S(ZKZ9/6IG.,(\TG9#2;T0^BLV?6(E!$*EV[$
M\#_&L^74;F4_ZPH,]$X_^O7A8OB3!4-(OG?EM]^WW7-X8:I+?0W);N" XDE4
M'/3J?RK/FUGH((_J7_P%9-%?,8OB?&5M*5H+RU?WO]$CJAA81WU)9KJ:XQYL
MA8#MT'Y5%117S]2K.K+FJ-M]WJ=*22L@HHHK,84444 =#IG_ "#XOQ_F:*-,
M_P"0?%^/\S17Z[EO^Y4?\,?R1XU7XWZENBBBNT@**** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M%%%%<984444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% '0Z9_R#XOQ_F:*-,_Y!\7X_S-%?KN6_[E1_
MPQ_)'C5?C?J6Z***[2 HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%(2%!)( '))[52FU
M6WCR%)D;G[HX_.N;$8RAAH\U::CZ_P"1482E\*+U,DE2%-\CA5]36+/JL\IQ
M'B)?0<G\ZHLS.Q9V+,>I)R:^;Q?%E&%XX>+D^[T7^?Y'5#"2?Q.QM2ZQ"AQ$
MC2<]>@K.EU&YE/\ K"@ST3C_ .O56BOF<7GF.Q6DIV79:?\ !?S9U0H4X;(*
M***\@V"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#H=,_Y!\7X_S-%&F?\@^+
M\?YFBOUW+?\ <J/^&/Y(\:K\;]2W1117:0%%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 445
M%+<0P#][(J]\9Y_*HJ5(4X\TVDO,:3;LB6BLJ761C$,1^K_X#_&L^>\GN"=\
MAVG^$<#\J^?Q?$^#HZ4KS?EHOO?Z)G1#"SEOH;D]_;P#YG#,#C:O)K/FUB0Y
M$,84<\MR?\_G6917S.+XEQM?2F^1>6_W_P"5CJAA81WU'RS2S',CLW/&3TIE
M%%>!.<IRYI.[.A)+1!1114C"BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** .ATS_ )!\7X_S-%&F?\@^+\?YFBOUW+?]RH_X8_DCQJOQOU+=%%%=
MI 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@#H=,_Y!\7X_S-%&F?\@^+\?YFBOUW
M+?\ <J/^&/Y(\:K\;]2W1117:0%%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%12W$, _>R*O?&>?RK/GU@ D01[O1FZ?E7!B\
MTPF$_C32?;=_<C2%*<]D:M5YKZW@R&D!89^5>3QV]JPY[V>X&))#MS]T<"J]
M?,XOBWIAH?.7^2_S.J&#_F9IS:Q(<B&,*.>6Y/\ G\ZH33RSMNE<L>V>@J.B
MOF,5F6+Q>E:;:[;+[EH=4*4(?"@HHHKA- HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#H=,_Y!\7X_
MS-%&F?\ (/B_'^9HK]=RW_<J/^&/Y(\:K\;]2W1117:0%%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%(2%!)( '))[54EU.VB.-Y<YZ(,_KTK"OBJ
M&'7-6FH^K*C"4MD7*:\B1C+NJC.,L<5BRZO.Y_=A8QGTR?UJB\CR'+NS'IEC
MFOF\7Q7AX:8>+D^[T7^?Y'3#"2?Q.QM2ZO @_=AI#],"L^74[F48WA!Z(,?K
MUJG17S&+SW'8G1SY5VCI_P '\3JAAZ<>@I)8DDDDG))[TE%%>0W?5FP4444A
MA1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 =#IG_ "#XOQ_F:*-,_P"0?%^/\S17Z[EO
M^Y4?\,?R1XU7XWZENBBBNT@**** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** .ATS_D'Q?C_,T4:9_R#XOQ_F:*_7<M_P!RH_X8
M_DCQJOQOU+=%%%=I 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%,EFBA&9'5?3)ZUGS:P@R(8RQYY;@?Y_*N'%YEA<)_&FD
M^V[^Y:FD*4Y_"C3J">\@MP=\@W#^$<G\JPY[^XG/S.54\;5X%5J^9Q?%JUCA
MH?-_Y+_,Z88/^9FK+K)SB&(=>K_X#_&L^6XFG/[V1FYSC/'Y5%17S.+S3%XO
M2M-M=ME]R.J%*$-D%%%%>>:A1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 =#IG_(/B_'^9HHTS_D'Q?C
M_,T5^NY;_N5'_#'\D>-5^-^I;HHHKM("BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHJK+J-M$/]8'/HG/\ ]:L:^(HT(\U62BO-E1C*3LD6J1F5
M%+.P51U).!6++K$SC$2+'[]35&2629]\CEF]37S>+XKPU/2A%S?W+_/\#IAA
M)/XM#:GU:",E4!D8>G _.L^?5+B884B-<_P]?SJE17S&+S['8FZ<N5/HM/QW
M_$ZH8>G'H*26)))))R2>])117CMWU9L%%%%(84444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 =#IG_(/B_'^9HHTS_D'Q?C_,T5^NY;_N5'_#'\D>-5^-^I;HHHKM("BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHIDLT4(S(ZKZ9/6IG.,(\TG9#2;T0^BLR?6(U.
M(4+_ .T>!5"?4+B<$,^U3_"O KP<7Q)@J%U!\[\MOOV^ZYO##3EOH;DMW! <
M22J#GIU/Y5G2ZR<XAB'7J_\ @/\ &LJBOF<7Q/C*VE*T%Y:O[W^B1U0PL([Z
MDLUU-<8\V0L!VZ#\JBHHKY^I5G5ES5&V^[U.E))604445F,**** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** .ATS_D'Q?C_,T4:9_P @^+\?YFBOUW+?
M]RH_X8_DCQJOQOU+=%%%=I 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !15674;:(?ZP.?1.?\ ZU9\
M^L2L2(5"+V)Y/^%>3B\[P6%^*=WV6K_R^]FT*%2>R-EF5%+.P51U).!5*;5;
M>/(4F1N?NCC\ZQ)9I9CF1V;GC)Z4ROF<7Q96EIAH**[O5_Y?F=4,)%?$R]-J
MMQ)D*1&O/W1S^=4F9G8L[%F/4DY-)17S6(QF(Q+O6FY>O^6QTQA&/PH****Y
MBPHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH Z
M'3/^0?%^/\S11IG_ "#XOQ_F:*_7<M_W*C_AC^2/&J_&_4MT445VD!1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH Z'3/^0?%^/\S11IG_ "#XOQ_F:*_7<M_W*C_AC^2/&J_&_4MT
M445VD!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#H=,_Y!\7X_P S11IG_(/B
M_'^9HK]=RW_<J/\ AC^2/&J_&_4MT445VD!1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%->1(QEW51G&6.*4I**NW9 .HK.EUB%#B)&DYZ]!6?-J5S-CY]@'9.*\+
M%\1X&AI&7._+_/;[KG1##5);Z&Y+<0P#][(J]\9Y_*L^761C$,1^K_X#_&LB
MBOF,7Q1BZVE%*"^]_>_\CJAA8+?4GGO)[@G?(=I_A' _*H***^>JUJE:7/4D
MV_,Z$DE9!1116904444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!T.F?\
M@^+\?YFBC3/^0?%^/\S17Z[EO^Y4?\,?R1XU7XWZENBBBNT@**** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH Z'3/^0?%^/\S11IG_ "#XOQ_F:*_7<M_W
M*C_AC^2/&J_&_4MT445VD!1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !137D2,9=U49QECBJ$VKPI@1*9#^0KDQ6/PV%5Z
MTTOS^[<N-.4_A1HU%+<0P#][(J]\9Y_*L274[F48WA!Z(,?KUJG7S.+XMA'3
M#0OYO3\%_FCJA@W]IFO/K !(@CW>C-T_*J$][/<#$DAVY^Z.!5>BOF<7F^,Q
M=U4F[/HM%_P?G<ZH480V04445YAJ%%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 =#IG_(/B_'^9HHTS_D'Q
M?C_,T5^NY;_N5'_#'\D>-5^-^I;HHHKM("BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBJ\U];P9#2 L,_*O)X[>U95J]*C'FJR45YNPU%R=D
M6*0D*"20 .23VK(GUAB<0(%']YNM4);B:<_O9&;G.,\?E7SV+XIPM*\:*<W]
MR^_?\#IAA)OXM#;EU.VB.-Y<YZ(,_KTK/EU>=S^["QC/ID_K6?17S&+XBQV(
MT4N1?W=/QW.J&&IQ\QSR/(<N[,>F6.:;117ARDY.[=V;A1112&%%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110!T.F?\@^+\?YFBC3/^0?%^/\S17Z[EO^Y4?\,?R1XU7XWZEN
MBBBNT@**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH ***1F5%+.P51U).!2;25V M%9\
MNKP(/W8:0_3 K/GU.XE)"MY:GLO7\Z\/%\18'#Z*7._[NOX[&\,-4ETL;<MQ
M# /WLBKWQGG\JH3ZPH&($+'/WFZ5D$EB2222<DGO25\SB^*<55O&BE!?>_OV
M_ ZX82"^+4L37UQ/D-(0IS\J\#GM[U7HHKYVM7JUI<U63D_-W.A1459!1116
M104444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% '0Z9_P @^+\?YFBC3/\
MD'Q?C_,T5^NY;_N5'_#'\D>-5^-^I;HHHKM("BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HJ">]@
MMSB20;O[HY-9\^L$@B"/;Z,W7\J\S%YO@\)=5)JZZ+5_\#YV-849SV1KU3EU
M.VB.-Y<YZ(,_KTK$EN)IS^]D9N<XSQ^515\SB^+9RTPT+>;U_!?YLZH8-?:9
MHS:O,^!$HC'YFJ#R/(<N[,>F6.:;17S.*Q^)Q3O6FW^7W;'5&G&'PH****Y"
MPHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBI5M;A]NV&0ANAVG'YUI"E.H[03?H)M+<BH
MJZFE73'!54]V;_"K"Z*Q4;YP&[@+D5Z%+),PJ_#2?ST_.QDZ]-;LRJ*W5TBV
M5@29&'H3Q^E6$LK:,8$"'G/S#/\ .O3I<*8R7QRC'\?T_4R>+@MCFP"Q  ))
M. !WJ=+&ZDSM@88_O?+_ #KHP H    X ':EKTZ/"-)?Q:K?HK?G<R>,?1&$
MND7+*"3&I]">?TJRFBH#\\S,/15Q_C6I17IT>&\OI[Q<O5O]+(SEB:CZE)-*
MM5&"K/SU9O\ "K$=M!$04B12O (7G\ZEHKTJ. PM'^'32^2O]YDZDY;L****
MZR HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHJ&6[@@.))5!STZG\JSJ5
M:=*/-4DDO-V&DV[(FHK(EUDYQ#$.O5_\!_C6?-=37&/-D+ =N@_*OGL7Q1@Z
M.E*\W]R^]_HF=,,+-[Z&Y-J5M#CY]Y/9.:SY=8F<8B18_?J:SJ*^8Q?$>.KZ
M1ER+R_SW^ZQU0PU..^HYY'D.7=F/3+'--HHKPI2<G=N[-PHHHI#"BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **>D4DN?+C9\==HSBI
MUTZ[=0PA.#ZD _K712PM>M_#@Y>B;)<XK=E6BM--&E)^>5%'JN3_ (5,FC1
M?/*['/5<#_&O3I</9C4_Y=V]6O\ AS)XFFNIC45T4>G6L9!$08CNQSG\.E3I
M%'%GRXU3/7:,9KTJ7".(?\6HEZ7?^1D\9'HCFUM;A]NV&0ANAVG'YU832KIC
M@JJ>[-_A6_17ITN$\+'6I.3^Y?Y_F9/&3Z(R%T5BHWS@-W 7(JPND6RL"3(P
M]">/TJ_17ITLAR^EM33];O\ /0R>(J/J0)96T8P($/.?F&?YU, %    '  [
M4M%>E2H4J2M3BEZ*QDY-[L****U$%%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M\[6Q%6O+GJR<GYG3&*BK)!1116)04444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MDOFK_G<S=:H]V,2*.+/EQJF>NT8S3Z**[XQC%6BK(R;N%%%%4 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%(2%
M!)( '))[52FU6WCR%)D;G[HX_.N;$8RAAH\U::CZ_P"1482E\*+U,DE2%-\C
MA5]36+/JL\IQ'B)?0<G\ZHLS.Q9V+,>I)R:^;Q?%E&%XX>+D^[T7^?Y'5#"2
M?Q.QLSZQ$H(A4NW8G@?XUGRZC<RG_6%!GHG'_P!>JM%?,8O.\;BOBG9=EHO\
M_O9U0H4X;(****\DV"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%(2%!)(
M '))[4-VU8"T52GU2WA.%)D;_9Z?G6?/JT\@*H!&I].3^=>-B\^P.&NG+F:Z
M+7\=OQ-X8>I+H;;R)&,NZJ,XRQQ5"76(4.(D:3GKT%8K,SL6=BS'J2<FDKYC
M%\5XBIIAXJ"[[O\ R_!G5#"17Q:EN;4KF;'S[ .R<54HHKYROB:V(ES5I.3\
MSIC&,59(****P*"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BHI;B& ?O9%7OC//Y5GSZP 2((]WHS=/RK@Q>:8
M3"?QII/MN_N1I"E.>R-6JT]_;P#YG#,#C:O)K$GO9[@8DD.W/W1P*KU\QC.+
M7K'"P^;_ ,E_G\CJA@_YV:<VL2'(AC"CGEN3_G\ZSY9I9CF1V;GC)Z4RBOF<
M7F6*Q?\ &FVNVR^Y:'5"E"'PH****X30**** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MFX4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M=L,8*]#M&?SJ6BO2HY?A:/\ #II?)?F9.I.6["BBBNP@**** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **IRZG;1'&\N<]$&?UZ50FU>9\"
M)1&/S->/B\]P.&TE/F?9:_\  ^]FT,/4ET-IF5%+.P51U).!5"75X$'[L-(?
MI@5BO(\AR[LQZ98YIM?,XOBNO/3#Q45W>K_R_,ZH82*^)W+DNIW,HQO"#T08
M_7K50DL22223DD]Z2BOFZ^*KXA\U:;EZLZHPC'9!1117.4%%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%.2-Y#A$9CUPHS4Z6%U(,B%ASCYN/YUO2PU>M_#@Y
M>B;)<HK=E:BM)=&F+#?)&%[D9)J=-&C&?,F9O3:,?XUZ=+A_,:G_ "[MZM+]
M;F3Q%-=3&HKH5TVT7;^ZR1W)/-6$ABC.4B13TRJ@5Z5+A+$/^)42]+O_ ",G
MC(]$<TMO,ZADAD93T(4D5872[MF *!1ZEAC]*Z"BO3I<)8:/\2;?I9?YF3QD
MNB,=-%<CYYE4YZ*N?\*G71[<;2SR,1UY !K1HKTZ609=3VIW]6W_ , R>(J/
MJ5TL;6/.V!3G^]\W\ZG5510J*%4= !@4M%>E2P]&C_#@H^B2,W*3W84445L2
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHJ1;>9U#)#(RGH0I(JX0E-V@KB;2W(Z*N+I
M=VS % H]2PQ^E6$T5R/GF53GHJY_PKT:62YA5^&D_GI^=C-UZ:W9ET5MKH]N
M-I9Y&(Z\@ U92QM8\[8%.?[WS?SKTJ/"N-G\;4?G?\O\S)XN"V.;JPEE<R'
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1152;4K:''S[R>R<UA7Q-'#QYJTE%>948RD[)%ND9E12SL%4=23@5
MBRZQ,XQ$BQ^_4U0>1Y#EW9CTRQS7SF+XKP]/3#Q<WWV7^?X(Z8823^+0VY]6
M@C)5 9&'IP/SK/GU2XF&%(C7/\/7\ZI45\QB\^QV)NG+E3Z+3\=_Q.J&'IQZ
M"DEB2222<DGO2445X[=]6;!1112&%%%% !1110 4444 %%%% !1110 4444
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MP%+X:2^>OYW,G6J/=C$ABC.4B13TRJ@4^BBO0C",%:*LC-MO<****H04444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 444R6:*$9D=5],GK4SG&$>:3LAI-Z(?169/K$:G$*
M%_\ :/ JA/J%Q."&?:I_A7@5X.+XDP5"Z@^=^6WW[?=<WAAIRWT-N>\@MP=\
M@W#^$<G\JSY=9.<0Q#KU?_ ?XUE45\QB^)\96TI6@O+5_>_T2.J&%A'?4EEN
M)IS^]D9N<XSQ^51445\_4J3J2YIMM^9TI)*R"BBBH&%%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%.2-Y#A$9CUPHS4Z6%U(,B%ASCYN/YUO2
MPU>M_#@Y>B;)<HK=E:BM&/1YV(WNB@]<<D5831HQGS)F;TVC'^->E2X?S&K_
M ,N[+S:7_!_ R>(IKJ8U%="NFVB[?W62.Y)YJPD,49RD2*>F54"O3I<)8A_Q
M*B7I=_Y&3QD>B.:6WF=0R0R,IZ$*2*L+I=VS % H]2PQ^E=!17ITN$L-'^)-
MOTLO\S)XR71&.FBN1\\RJ<]%7/\ A4ZZ/;C:6>1B.O( -:-%>G2R#+J>U._J
MV_\ @&3Q%1]2NEC:QYVP*<_WOF_G4ZJJ*%10JCH ,"EHKTJ6'HT?X<%'T21F
MY2>["BBBMB0HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M_P"1TQA&/PH****YBPHHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%->1(QEW51G&6.*H3:O"F!$ID/Y"N3%8_#857K32_/[MRXTY
M3^%&C44MQ# /WLBKWQGG\JQ)=3N91C>$'H@Q^O6J=?,XOBV$=,-"_F]/P7^:
M.J&#?VF:\NLC&(8C]7_P'^-9\]Y/<$[Y#M/\(X'Y5!17S&+S?&8O2K-V[+1?
MA^IU0HPAL@HHHKS34**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MDP'/(5?Z_P#UJUZ*]*EPSE]/XDY>K_RL9/%5&44TFV4Y.]_9F_PJ=+*VC&!
MAYS\PS_.IZ*].EEN#I?!2BODOS,G5F]V%%%%=I 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 444C,J*6=@JCJ2<"DVDKL!:*HSZK!$,1YE;/0<#\ZSYM5N),A
M2(UY^Z.?SKQ<7Q!@<-IS<S[1U_';\3>&'J2Z6-N6:*$9D=5],GK6?-K"#(AC
M+'GEN!_G\JQR2Q)))).23WI*^8Q?%.*JZ4$H+[W_ )?@=4,)!?%J69[^XG/S
M.54\;5X%5J**^=K5ZM>7/5DY/S.F,5%604445B4%%%% !1110 4444 %%%%
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M "@   #@ =J].CPC4?\ %JI>BO\ G8R>,71'.)8W4F=L##'][Y?YU8CTBX8
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M=3_Y=W]6W_P#)XBH^I573K1&#"$9'J21^M6$C2,81%49SA1BG45Z=+"T*/\
M"@H^B2,G.4MV%%%%;DA1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M3'9EP%C+D^X 'U_R:KR1WLS$>;'"F/X/F/ZX_2N>MB'3TC!R?9+]79?B5&-]
MW8L22I"F^1PJ^IJC+K$*'$2-)SUZ"C^R8W^:6:5W/5L]:G73K1&#"$9'J21^
MM>76>;U]*2C37F^9_E;^MS5>QCO=F/+J-S*?]84&>B<?_7J);6X?;MAD(;H=
MIQ^==*D:1C"(JC.<*,4ZO.?#-2O+GQ5=R?\ 7=O\C7ZTHZ0C8P4TFZ?.X*F/
M[S=?RJ==%8J-\X#=P%R*UZ*[:7#.7P^).7J_\K&;Q51E%-)ME.3O?V9O\*G2
MRMHQ@0(><_,,_P ZGHKTZ66X.E\%**^2_,R=6;W8@ 4    < #M2T45VI6T1
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 45CWOBG
M1M.O)+2[O/+GCQN7RG.,@$<@8Z$57_X3;P[_ -!#_P @R?\ Q- '045S_P#P
MFWAW_H(?^09/_B:/^$V\._\ 00_\@R?_ !- '045S_\ PFWAW_H(?^09/_B:
M/^$V\._]!#_R#)_\30!T%%<__P )MX=_Z"'_ )!D_P#B:/\ A-O#O_00_P#(
M,G_Q- '045S_ /PFWAW_ *"'_D&3_P")H_X3;P[_ -!#_P @R?\ Q- '045S
M_P#PFWAW_H(?^09/_B:/^$V\._\ 00_\@R?_ !- '045S_\ PFWAW_H(?^09
M/_B:/^$V\._]!#_R#)_\30!T%%<__P )MX=_Z"'_ )!D_P#B:/\ A-O#O_00
M_P#(,G_Q- '045S_ /PFWAW_ *"'_D&3_P")H_X3;P[_ -!#_P @R?\ Q- '
M045S_P#PFWAW_H(?^09/_B:/^$V\._\ 00_\@R?_ !- '045S_\ PFWAW_H(
M?^09/_B:/^$V\._]!#_R#)_\30!T%%<__P )MX=_Z"'_ )!D_P#B:/\ A-O#
MO_00_P#(,G_Q- '045S_ /PFWAW_ *"'_D&3_P")H_X3;P[_ -!#_P @R?\
MQ- '045S_P#PFWAW_H(?^09/_B:/^$V\._\ 00_\@R?_ !- '045S_\ PFWA
MW_H(?^09/_B:/^$V\._]!#_R#)_\30!T%%<__P )MX=_Z"'_ )!D_P#B:/\
MA-O#O_00_P#(,G_Q- '045S_ /PFWAW_ *"'_D&3_P")H_X3;P[_ -!#_P @
MR?\ Q- '045S_P#PFWAW_H(?^09/_B:/^$V\._\ 00_\@R?_ !- '045S_\
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M -!#_P @R?\ Q- '045S_P#PFWAW_H(?^09/_B:/^$V\._\ 00_\@R?_ !-
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M-'_";>'?^@A_Y!D_^)H Z"BN?_X3;P[_ -!#_P @R?\ Q-'_  FWAW_H(?\
MD&3_ .)H Z"BN?\ ^$V\._\ 00_\@R?_ !-'_";>'?\ H(?^09/_ (F@#H**
MY_\ X3;P[_T$/_(,G_Q-'_";>'?^@A_Y!D_^)H Z"BN?_P"$V\._]!#_ ,@R
M?_$T?\)MX=_Z"'_D&3_XF@#H**Y__A-O#O\ T$/_ "#)_P#$T?\ ";>'?^@A
M_P"09/\ XF@#H**Y_P#X3;P[_P!!#_R#)_\ $T?\)MX=_P"@A_Y!D_\ B: .
M@HKG_P#A-O#O_00_\@R?_$T?\)MX=_Z"'_D&3_XF@#H**Y__ (3;P[_T$/\
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M (F@#H**Y_\ X3;P[_T$/_(,G_Q-;5K=07UK'<VTJRPR#*NO?_/I0!-1110
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M^)H Z"BN?_X3;P[_ -!#_P @R?\ Q-'_  FWAW_H(?\ D&3_ .)H Z"BN?\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M[N'C^,]#T(X&3SUQCO7C% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 445I:#I3ZUK$%FNX(QW2L/X4'4YP<>@SW(H [3X>Z(B6KZO/&IDD)2W)
M&=JCAB.>YR.F>/0UW--CC2*-8XT5$0!551@ #H *=0 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110!Y!XV_Y&^^_P"V?_HM:Y^N@\;?\C???]L__1:US] !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 .CD>*1
M9(W9'0AE93@@CH0:]G\.:R-=T>.[*JDH)25%SA6'IGU!![]<9KQ:NB\':X='
MUA4D95M+DA)B0/EZ[6R<8P3S[$^U 'KM%%% !1110 4444 %%%% !1110!7O
MK.'4;&:SN%S%,A5N!D>XSW'4>XKQ"^LYM.OIK.X7$L+E6X.#[C/8]1[&O=ZX
MGX@Z(]U:Q:I;QL\EN-DP49_=\G/7L<]!_%GH* /-J*** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@#N/AWJ_DWDNE2'Y)\R1<?Q@<CIW49Y/\/O
M7H]>"03R6UQ%<0MMEB<.C8S@@Y!YKV_2M0CU72[>^B&%F3)7^Z>A'09P01GV
MH N4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 445S_ (PUG^R-#D\M]MU<
M?NHL'!&>K=0>!W'0D4 <-XVUM-6U@16\BO:VHV(RG(9C]X@X]@.X^7(ZUS-%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5ZWX,T)M&TGS)ABZ
MNMLD@P04&/E4@]QDYXZG':N(\&:$NLZMYDPS:VNV208!#G/RJ0>QP<\=!CO7
MK= !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110!Y!XV_Y&^^_[9_\ HM:Y^N@\;?\
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M0=536='@O%VAV&V51_"XZC&3CU&>Q%:5 !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %>0>,-9_M?7)/+?=:V_[J+!R#CJW4CD]QU %=_XPUG^R-#D\M]MU<?NH
ML'!&>K=0>!W'0D5Y!0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%.CC>618XT9W<A551DDGH *;7<> -!\^X;5;J#,,7%OO7AGSRPY_AQCIU/J*
M .S\/Z/'H>DQVB<R'YYFW9#2$#)'MQ@<=!ZUJ444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% 'D'C;_ )&^^_[9_P#HM:Y^N@\;?\C???\ ;/\ ]%K7/T %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %>B?#[75>$Z+,<.FZ2!B0 1U*^N<DGOQGIBO.ZL6-Y-IU]#>6[8EA
M<,O)P?8X['H?8T >[T53TK4(]5TNWOHAA9DR5_NGH1T&<$$9]JN4 %%%% !1
M110 4444 %%%% !7DWC;1$TG6!+;QJEK=#>BJ,!6'W@!GW![#YL#I7K-9NO:
M4FM://9MM#L-T3'^%QT.<''H<=B: /$J*DG@DMKB6WF7;+$Y1USG!!P1Q4=
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /(
M/&W_ "-]]_VS_P#1:US]=!XV_P"1OOO^V?\ Z+6N?H **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@#R#QM_R-]]_VS_]%K7/UT'C;_D;[[_MG_Z+6N?H **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "M
M[PGK@T/6%>9F%I,-DP )QZ-CV/UX)Q6#10![_17)^!==74=+%A*<7-F@49(^
M>/H"![< _ASS764 %%%% !1110 4444 %%%% !7&^/M#%YI_]J0HQN+8 . 2
M=T63V]B<YXXSGM7944 > 45M>)]$?1-8EB6-A:R$O;MC@KZ9R>F<<\]#WK%H
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** .H\"ZO_9VN"VD.(+S$
M9XZ/_ >F>I(_X%D]*]7KP"O9_#&K_P!M:'#<N<SK^[FX_C'4] .1@\=,X[4
M;%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4V21(HVDD=41 69F.  .I)IU<?X_UG[%I:Z?"^)[K[^#
MRL8Z]#D9/'H1NH X+7M5?6=8GO&W!&.V)3_"@Z#&3CU..Y-9M%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !114D$$ES<16\*[I97"(N<9). .: .H\
M"Z$VHZH+^48MK-PPR#\\G4 'VX)_#CFO4ZS]%TF'1-+BLH3OVY+R%0"['J3C
M\OH *T* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /(/&W_(WWW_;
M/_T6M<_70>-O^1OOO^V?_HM:Y^@ HHHH **** "BBB@ HHHH **** "BBB@
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% 'D'C;_ )&^
M^_[9_P#HM:Y^N@\;?\C???\ ;/\ ]%K7/T %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M@CBHZ] ^(FC?ZK5X4](KC _[Y8X'X$D_W17G] !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110!T'@_6?[(UR/S'VVMQ^ZER< 9Z-U X/<] 37K]> 5
MZSX)UM]6T<Q7$C/=6IV.S')93]TDX]B.Y^7)ZT =-1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !4<\\=M;RW$S;8HD
M+NV,X &2>*DKA/B#KJI"-%A.7?;).P(( ZA?7.0#VXQUS0!P^JZA)JNJ7%]*
M,-,^0O\ ='0#H,X  S[53HHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M ***W/"VA-KNK+&XQ:PXDG)!P1G[N1T)^O3)[4 =KX#T,Z?IK7\Z+Y]V 4Y!
MVQ8R/IGJ1GLO<5UU%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110!Y!XV_Y&^^_[9_\ HM:Y^N@\;?\ (WWW_;/_ -%K7/T %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 >G^ -9^VZ6VGS/F>U^YD\M&>G4Y.#QZ ;:["O#-*U"32M4M[Z(9:
M%\E?[PZ$=#C()&?>O:[&\AU&QAO+=LQ3(&7D9'L<=QT/N* +%%%% !1110 4
M444 %%%% !1110!X]XLT,:'K#)"C"TF&^$DDX]5S['Z\$9K!KV7Q/HB:WH\L
M2QJ;J,%[=L<AO3.1UQCGCH>U>.21O%(T<B,CH2K*PP01U!% #:*** "BBB@
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#R#QM_P C
M???]L_\ T6M<_70>-O\ D;[[_MG_ .BUKGZ "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% %S2M0DTK5+>^B&6A?)7^\.A'0XR"1GWKV^
M">.YMXKB%MT4J!T;&,@C(/->"5Z1\.]7\ZSETJ0_/!F2+C^ GD=.S'/)_B]J
M .WHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "LW7M531M'GO&VE
MU&V)3_$YZ#&1GU..P-:5>8>/]9^VZHNGPOF"U^_@\-(>O0X.!QZ@[J .1DD>
M61I)'9W<EF9CDDGJ2:;110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5
MT7@[0SK&L*\B*UI:D/,"1\W7:N#G.2.?8'VKGXXWED6.-&=W(5549))Z "O:
M?#^CQZ'I,=HG,A^>9MV0TA R1[<8''0>M &I1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110!Y!XV_Y&^^_[9_\ HM:Y^N@\
M;?\ (WWW_;/_ -%K7/T %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5
MK>'-9.A:Q'=E6>(@I*BXRRGTSZ$ ]NF,UDT4 >^QR)+&LD;JZ. RLIR"#T(-
M.KB_ &NM>6;:5.<RVR;HF))+1YZ'_=R!]"..*[2@ HHHH **** "BBB@ HHH
MH *YGQMHCZMHXEMXV>ZM3O15&2RG[P S[ ]S\N!UKIJ* / **Z+QCH9T?6&>
M-%6TNB7A (^7IN7 QC!/'L1[USM !1110 4444 %%%% !1110 4444 %%%%
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MPH Z[X?:(EU=2ZI<1J\=N=D(89_><'/7L,=1_%GJ*])JO8V<.G6,-G;KB*%
MJ\#)]SCN>I]S5B@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH \@\;?\ (WWW_;/_ -%K7/UT'C;_ )&^^_[9_P#HM:Y^
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@"UIVH3Z7J$-[;%1
M+$<C<,@Y&"#]02*]ML;R'4;&&\MVS%,@9>1D>QQW'0^XKPBNV^'VMI:W4NEW
M$BI'<'?"6./WG QT[C'4_P ..IH ])HHHH **** "BBB@ HHHH **** ,OQ!
MH\>N:3):/Q(/GA;=@+( <$^W.#QT/K7BTD;Q2-'(C(Z$JRL,$$=017OM>;?$
M'1$M;J+5+>-4CN#LF"C'[SDYZ]QGH/X<]30!Q-%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% %BQO)M.OH;RW;$L+AEY.#[''8]#[&O;[&\AU&QAO+=
MLQ3(&7D9'L<=QT/N*\(KT#X=ZS_K=(F?UEM\G_OI1D_B !_>- '?T444 %%%
M% !1110 4444 %%%% !1110 5C^)]7_L70YKE#B=OW</'\9Z'H1P,GGKC'>M
MBO*/'6K_ -HZX;:,Y@L\QCCJ_P#&>F>H _X#D=: .7HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH *]+\ :$UG9MJLXQ+<IMB4@@K'GJ?][ /T YYK
MBO#FC'7=8CM"S)$ 7E=<951Z9]20._7.*]GCC2*-8XT5$0!551@ #H * '44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% 'D'C;_D;[[_MG_Z+6N?KH/&W_(WWW_;/_P!%K7/T %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 5-:6SWEY!:QE0\TBQJ6Z DX&?SJ&M#0O^1ATS_K[B_\
M0Q0!T'_"N-8_Y^;'_OM__B:/^%<:Q_S\V/\ WV__ ,37I]% 'F'_  KC6/\
MGYL?^^W_ /B:/^%<:Q_S\V/_ 'V__P 37I]% 'F'_"N-8_Y^;'_OM_\ XFC_
M (5QK'_/S8_]]O\ _$UZ?10!YA_PKC6/^?FQ_P"^W_\ B:/^%<:Q_P _-C_W
MV_\ \37I]% 'F'_"N-8_Y^;'_OM__B:/^%<:Q_S\V/\ WV__ ,37I]% 'F'_
M  KC6/\ GYL?^^W_ /B:/^%<:Q_S\V/_ 'V__P 37I]% 'F'_"N-8_Y^;'_O
MM_\ XFC_ (5QK'_/S8_]]O\ _$UZ?10!YA_PKC6/^?FQ_P"^W_\ B:/^%<:Q
M_P _-C_WV_\ \37I]% 'F'_"N-8_Y^;'_OM__B:/^%<:Q_S\V/\ WV__ ,37
MI]% 'F'_  KC6/\ GYL?^^W_ /B:/^%<:Q_S\V/_ 'V__P 37I]% 'F'_"N-
M8_Y^;'_OM_\ XFC_ (5QK'_/S8_]]O\ _$UZ?10!YA_PKC6/^?FQ_P"^W_\
MB:/^%<:Q_P _-C_WV_\ \37I]% 'F'_"N-8_Y^;'_OM__B:/^%<:Q_S\V/\
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M;*H!)://4?[N2?H3SQ7FE !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !5
MBQO)M.OH;RW;$L+AEY.#[''8]#[&J]% 'N>E:A'JNEV]]$,+,F2O]T]".@S@
M@C/M5RO./AWJ_DWDNE2'Y)\R1<?Q@<CIW49Y/\/O7H] !1110 4444 %%%%
M!1110 4444 8/BS7#H>CL\+*+N8[(00#CU;'L/KR1FO'JZ#QAK/]KZY)Y;[K
M6W_=18.0<=6ZD<GN.H KGZ "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBNJ\#:(^H:PE[+&WV6T._=CAI!]T9SV^]WZ 'K0!V?@[0QH^CJ\B,MW= /,
M"3\O7:N#C& >?<GVKHJ** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH \@\;?\ (WWW_;/_ -%K7/UT'C;_ )&^
M^_[9_P#HM:Y^@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "M#0O^1ATS_K[B_]
M#%9]:&A?\C#IG_7W%_Z&* /;Z*** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MW'0D5T%>.>*==;7=6:1#BUAS'  3@C/WL'H3].F!VH PZ*** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** )(()+FXBMX5W2RN$1<XR2< <U[3H.E)HNCP
M6:[2ZC=*P_B<]3G SZ#/8"N0^'NAAF?69T;*$I;<D=L,WOUP.?[WH*]!H **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH \@\;?\C???]L__ $6M<_70>-O^1OOO^V?_ *+6N?H **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ K0T+_ )&'3/\ K[B_]#%9]:&A?\C#IG_7W%_Z
M&* /;Z*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#RCQK
MH/\ 96J?:;:#98W'*[5PJ/W7K[9'3K@=*Y>O;=>TI-:T>>S;:'8;HF/\+CH<
MX./0X[$UXM/!);7$MO,NV6)RCKG."#@CB@".BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "G1R/%(LD;LCH0RLIP01T(--HH ]MT'54UG1X+Q=H=AME4?PN
M.HQDX]1GL16E7F'@#6?L6J-I\SX@NON9/"R#IU.!D<>I.VO3Z "BBB@ HHHH
M **** .7\=:O_9VAFVC.)[S,8XZ)_&>F.A _X%D=*\HK8\3ZO_;6N37*',"_
MNX>/X!T/0'DY//3..U8] !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !5S
M2M/DU75+>QB.&F?!;^Z.I/49P 3CVJG7J/@/0SI^FM?SHOGW8!3D';%C(^F>
MI&>R]Q0!U%K:P6-K';6T2Q0QC"HO;_/K4U%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% 'D'C;_D;[[_
M +9_^BUKGZZ#QM_R-]]_VS_]%K7/T %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 5H:%_R,.F?]?<7_ *&*SZT-"_Y&'3/^ON+_ -#% 'M]%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 5YY\0="9)AK4(RC[8YU )(/0-Z
M8P .W..N:]#JO?6<.HV,UG<+F*9"K<#(]QGN.H]Q0!X115S5=/DTK5+BQE.6
MA? ;^\.H/4XR"#CWJG0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 Z.1X
MI%DC=D="&5E."".A!KVO0=536='@O%VAV&V51_"XZC&3CU&>Q%>)5U7@;6WT
M_6$LI9&^RW9V;<\+(?NG&._W>W4$]* /5:*** "BBB@ KD_'6NKIVEFPB.;F
M\0J<$?)'T)(]^0/QYXKJI)$BC:21U1$!9F8X  ZDFO%->U5]9UB>\;<$8[8E
M/\*#H,9./4X[DT 9M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% &YX
M6T)M=U98W&+6'$DY(.",_=R.A/UZ9/:O8ZP_"VA+H6DK&XS=38DG) R#C[N1
MU ^O7)[UN4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% 'D'C;_D;[[_MG_Z+6N?KH/&W_(WWW_;/
M_P!%K7/T %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 5H:%_P C#IG_ %]Q?^AB
ML^M#0O\ D8=,_P"ON+_T,4 >WT444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110!Q_C_1OMNEKJ$*9GM?OX'+1GKT&3@\^@&ZO,*]_K
MQKQ/HCZ)K$L2QL+60E[=L<%?3.3TSCGGH>] &+1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110![/X8U?^VM#AN7.9U_=S<?QCJ>@'(P>.F<=JV*\H\"
MZO\ V=K@MI#B"\Q&>.C_ ,!Z9ZDC_@63TKU>@ HHJ.>>.VMY;B9ML42%W;&<
M #)/% ')^/\ 6?L6EKI\+XGNOOX/*QCKT.1D\>A&ZO,*TM>U5]9UB>\;<$8[
M8E/\*#H,9./4X[DUFT %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %==X#
MT,:AJ37\Z-Y%H04Y(W2YR/KCJ1GNO8UR]K:SWUU';6T32S2'"HO?_/K7MNE:
M?'I6EV]C$<K"F"W]X]2>IQDDG'O0!<HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M(/?#-[=,#G^]ZBN]J."".VMXK>%=L42!$7.< # '-24 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110!Y!XV_Y&^^_P"V?_HM:Y^N@\;?\C???]L__1:US] !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %:&A?\C#IG_7W%_P"ABL^M#0O^1ATS_K[B_P#0Q0![
M?1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0!1U?2X-8TV:SG5<./D<C/EMCAA]/UZ=Z\2G@DMKB6WF7;+$Y1USG!!P1Q7O
M=<%\0M#+*FLP(N$ 2YY [X5O?K@\_P!WT- 'GM%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% '5:KXL?4/"=IIQ9C<D[;EC_$J8VG)SG/!)R#E3V-<K
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 5ZKX&T1-/T=+V6-?M5V-
M^['*QG[HSGO][MU /2N,\':&=8UA7D16M+4AY@2/FZ[5P<YR1S[ ^U>NT %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 >0>-O^1OOO^V?_ *+6N?KH/&W_ "-]]_VS
M_P#1:US] !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %:&A?\C#IG_7W%_Z&*SZ
MT-"_Y&'3/^ON+_T,4 >WT444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %1SP1W-O+;S+NBE0HZYQD$8(XJ2B@#Q#6M)FT35
M);*8[]N"D@4@.IZ$9_+Z@BL^O4_'6A+J.EF_B&+FS0L< ?/'U()]N2/QXYKR
MR@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ IT<;RR+'&C.[D*JJ,DD] !3:[3P!H2WEXVJSC,5L^V)2
M0TF.I_W<@_4CGB@#M?#FC#0M'CM"RO*27E=<X9CZ9]  .W3.*UJ** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** /(/&W_ "-]]_VS_P#1:US]=!XV_P"1OOO^V?\
MZ+6N?H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ K0T+_D8=,_Z^XO_0Q6?6AH
M7_(PZ9_U]Q?^AB@#V^BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH *\>\6:&-#UADA1A:3#?"22<>JY]C]>",U[#6
M/XGTC^VM#FMD&9U_>0\_QCH.H'(R.>F<]J /&**=)&\4C1R(R.A*LK#!!'4$
M4V@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** +%C9S:C?0V=NN99G"KP<#W..PZGV%>WV-G#IUC#9VZXBA0*O R
M?<X[GJ?<UR/P^T1[6UEU2XC9)+@;(0PQ^[X.>O<XZC^'/0UVU !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110!Y!XV_P"1OOO^V?\ Z+6N?KH/&W_(WWW_ &S_
M /1:US] !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %:&A?\C#IG_7W%_Z&*SZT
M-"_Y&'3/^ON+_P!#% 'M]%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 >9>/M#-GJ']J0HHM[D@. 0-LN#V]
MP,YYYSGM7&U[GJNGQZKI=Q8RG"S)@-_=/4'J,X(!Q[5XI?6<VG7TUG<+B6%R
MK<'!]QGL>H]C0!7HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH *U/#^CR:YJT=HG$8^>9MV"L8(R1[\X''4^E9=>N^#M#&
MCZ.KR(RW=T \P)/R]=JX.,8!Y]R?:@#H(XTBC6.-%1$ 5548  Z "G444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% 'D'C;_D;[[_MG_P"BUKGZZ#QM_P C
M???]L_\ T6M<_0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !6AH7_(PZ9_U]Q?
M^ABL^IK2Y>SO(+J,*7AD610W0D'(S^5 'O-%>8?\+'UC_GVL?^^'_P#BJ/\
MA8^L?\^UC_WP_P#\50!Z?17F'_"Q]8_Y]K'_ +X?_P"*H_X6/K'_ #[6/_?#
M_P#Q5 'I]%>8?\+'UC_GVL?^^'_^*H_X6/K'_/M8_P#?#_\ Q5 'I]%>8?\
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MU[2GT76)[-MQ13NB8_Q(>AS@9]#CN#6;0 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !114D$$ES<16\*[I97"(N<9). .: .B\$Z(F
MK:P9;B-7M;4;W5AD,Q^Z",^Q/<?+@]:]9K-T'2DT71X+-=I=1NE8?Q.>IS@9
M]!GL!6E0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% 'D'C;_D;[[_MG
M_P"BUKGZZ#QM_P C???]L_\ T6M<_0 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %>G_  X_Y%ZX_P"OMO\ T!*\PKT_X<?\B]<?]?;?^@)0!V%%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110!S/C;1'U;1Q+;QL]U:G>BJ,EE/W@!GV![GY<#K7DU>_UY)XST)=&U;S(
M1BUNMTD8P $.?F4 =AD8XZ'':@#FZ*** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ KO/A]H3/,=:F&$3=' I!!)Z%O3&"1WYSTQ7'Z5I\F
MJZI;V,1PTSX+?W1U)ZC. "<>U>UV-G#IUC#9VZXBA0*O R?<X[GJ?<T 6***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH \@\;?\ (WWW_;/_ -%K
M7/UT'C;_ )&^^_[9_P#HM:Y^@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH \@\;?\ (WWW_;/_ -%K7/UT'C;_ )&^^_[9
M_P#HM:Y^@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110!Y!XV_Y&^^_[9_^BUKGZZ#QM_R-]]_VS_\ 1:US] !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 5Z?\./\ D7KC_K[;_P! 2O,*]/\ AQ_R+UQ_
MU]M_Z E '84444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4V2-)8VCD171P596&00>H(IU% 'BWB
M/1CH6L26@9GB(#Q.V,LI]<>A!';IG%9->O\ C#1O[7T.3RTW75O^]BP,DXZK
MT)Y'8=2!7D% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5)!!)<W$5O"NZ65PB+
MG&23@#FHZ]"^'NAE5?69T7#@I;<@]\,WMTP.?[WJ* .OTC2X-'TV&S@5<(/G
M<#'F-CEC]?TZ=JO444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% 'D'C;_D;[[_MG_Z+6N?KH/&W_(WWW_;/_P!%K7/T %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !7I_PX_P"1>N/^OMO_ $!*\PKT_P"''_(O7'_7
MVW_H"4 =A1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 5Y5XYT1]/UA[V*-OLMV=^['"R'
M[PSGO][MU('2O5:S=>TI-:T>>S;:'8;HF/\ "XZ'.#CT..Q- 'B5%23P26UQ
M+;S+MEB<HZYS@@X(XJ.@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#0T729M;U2*RA.S=
MDO(5)"*.I./R^I KVN"".VMXK>%=L42!$7.< # '-<OX%T)=.TL7\HS<WB!A
MD#Y(^H /OP3^''%=90 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% 'D'C;_D;[[_ +9_^BUKGZZ#QM_R-]]_VS_]%K7/T %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !7I_PX_Y%ZX_Z^V_] 2O,*]/^''_(O7'_
M %]M_P"@)0!V%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110!Y]\0M#"LFLP(V7(2Y
MY)[85O;I@\_W?4UP->\W5K!?6LEM<Q++#(,,C=_\^M>):KI\FE:I<6,IRT+X
M#?WAU!ZG&00<>] %.BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH *Z#P?HW]KZY'YB;K6W_>RY&0<
M=%Z$<GL>H!K!CC>618XT9W<A551DDGH *]E\,:1_8NAPVSC$[?O)N?XSU'4C
M@8''7&>] &Q1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% 'D'C;_ )&^^_[9_P#HM:Y^N@\;?\C???\ ;/\ ]%K7/T %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !7I_PX_Y%ZX_Z^V_] 2O,*]/^''_ "+U
MQ_U]M_Z E '84444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7'^/]&^VZ6NH0IF>U
M^_@<M&>O09.#SZ ;J["B@#P"BMSQ3H3:%JS1H,VLV9(" < 9^[D]2/KTP>]8
M= !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !115BQLYM1OH;.W7,LSA5X.![G'8=3["@#K/ &A+>7C:K.,Q6S
M[8E(!#28ZG_=R#]2.>*]+JKIVGP:7I\-E;!A%$,#<<DY.23]22:M4 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 >0>-O^
M1OOO^V?_ *+6N?KH/&W_ "-]]_VS_P#1:US] !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 5Z?\ #C_D7KC_ *^V_P#0$KS"O3_AQ_R+UQ_U]M_Z E '8444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110!A^*="77=):-!BZAS) 0!DG'W<GH
M#]>N#VKQRO?Z\N\>:&-/U);^!&\B[)+\D[9<Y/TSU SV;L* .1HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KT
MCP!H/D6[:K=08FEXM]Z\JF.6'/\ %G'3H/0UQ?A_1Y-<U:.T3B,?/,V[!6,$
M9(]^<#CJ?2O:8XTBC6.-%1$ 5548  Z "@!U%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% 'D'C;_D;[[_MG_Z+6N?K
MH/&W_(WWW_;/_P!%K7/T %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7I_PX
M_P"1>N/^OMO_ $!*\PKT_P"''_(O7'_7VW_H"4 =A1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110!Y!XV_P"1OOO^V?\ Z+6N?KH/&W_(WWW_ &S_
M /1:US] !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5Z?\./^1>N/^OMO_0$
MKS"O3_AQ_P B]<?]?;?^@)0!V%%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% $<\$=S;RV\R[HI4*.N<9!&".*\4UK29M$U26RF._;@I(%(#J>A&?R^
MH(KV^N3\=:$NHZ6;^(8N;-"QP!\\?4@GVY(_'CF@#RRBBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@!T<;RR+'&C.[D*JJ,DD]
M!7M>@Z4FBZ/!9KM+J-TK#^)SU.<#/H,]@*XSX>Z([W3ZO/&PCC!2W)&-S'AB
M.>PR.F.?45Z+0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% 'D'C;_D;[[_MG_Z+6N?KH/&W_(WWW_;/_P!%
MK7/T %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !7I_PX_P"1>N/^OMO_ $!*
M\PKT_P"''_(O7'_7VW_H"4 =A1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH \@\;?\C???\ ;/\ ]%K7/UT'C;_D
M;[[_ +9_^BUKGZ "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KT_X<?\B]<?
M]?;?^@)7F%>G_#C_ )%ZX_Z^V_\ 0$H ["BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH *\R\?:&;/4/[4A11;W) < @;9<'M[@9SSSG/:O3:
MJZCI\&J:?-97(8Q2C!VG!&#D$?0@&@#PJBK%]9S:=?36=PN)87*MP<'W&>QZ
MCV-5Z "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#:\,:(^MZQ%$T
M;&UC(>X;' 7TSD=<8XYZGM7L<<:11K'&BHB *JJ,  = !6'X3T,Z'HZI,BB[
MF.^8@@X]%S[#Z\DXK>H **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M^(O^@?\ ^1H__BJ/^$)\1?\ 0/\ _(T?_P 50!S]%=!_PA/B+_H'_P#D:/\
M^*H_X0GQ%_T#_P#R-'_\50!S]>G_  X_Y%ZX_P"OMO\ T!*Y#_A"?$7_ $#_
M /R-'_\ %5W?@K2[W2-&FM[Z'RI6N&<+N#<;5&>"?0T =)1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% '#?$+1$>U35X(U$D9"7! QN
M4\*3SV.!TSSZ"O.:]]DC26-HY$5T<%65AD$'J"*\2US3?[(UJZL0VY8G^0YR
M=I *YX'.",^] &?1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !76>!=";4=
M4%_*,6UFX89!^>3J #[<$_AQS7+P027-Q%;PKNEE<(BYQDDX YKVO1=)AT32
MXK*$[]N2\A4 NQZDX_+Z "@#0HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH \@\;?\C???]L__
M $6M<_70>-O^1OOO^V?_ *+6N?H **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ K
M0T+_ )&'3/\ K[B_]#%9]:&A?\C#IG_7W%_Z&* /;Z*** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ KR#QM_R-]]_VS_\ 1:UZ_7D'
MC;_D;[[_ +9_^BUH Y^BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** -#0O\
MD8=,_P"ON+_T,5[?7B&A?\C#IG_7W%_Z&*]OH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /
M(/&W_(WWW_;/_P!%K7/UT'C;_D;[[_MG_P"BUKGZ "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH *T-"_P"1ATS_ *^XO_0Q6?6AH7_(PZ9_U]Q?^AB@#V^BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *\@\;?\C???
M]L__ $6M>OUY!XV_Y&^^_P"V?_HM: .?HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@#0T+_ )&'3/\ K[B_]#%>WUXAH7_(PZ9_U]Q?^ABO;Z "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@#R#QM_R-]]_VS_\ 1:US]=!XV_Y&^^_[9_\ HM:Y^@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "M#0O\ D8=,_P"ON+_T,5GUH:%_R,.F?]?<
M7_H8H ]OHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "O(/&W_(WWW_;/_P!%K7K]>0>-O^1OOO\ MG_Z+6@#GZ*** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH T-"_P"1ATS_ *^XO_0Q7M]>(:%_R,.F?]?<7_H8
MKV^@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH \@\;?\C???]L__ $6M<_70>-O^1OOO^V?_
M *+6N?H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ K0T+_ )&'3/\ K[B_]#%9
M]:&A?\C#IG_7W%_Z&* /;Z*** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ KR#QM_R-]]_VS_\ 1:UZ_7D'C;_D;[[_ +9_^BUH Y^B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** -#0O\ D8=,_P"ON+_T,5[?7B&A
M?\C#IG_7W%_Z&*]OH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** /(/&W_(WWW_;/_P!%K7/U
MT'C;_D;[[_MG_P"BUKGZ "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *T-"_P"1
MATS_ *^XO_0Q6?6AH7_(PZ9_U]Q?^AB@#V^BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH *\@\;?\C???]L__ $6M>OUY!XV_Y&^^
M_P"V?_HM: .?HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#0T+_ )&'3/\
MK[B_]#%>WUXAH7_(PZ9_U]Q?^ABO;Z "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#R#QM_R-
M]]_VS_\ 1:US]=!XV_Y&^^_[9_\ HM:Y^@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "M#0O\ D8=,_P"ON+_T,5GUH:%_R,.F?]?<7_H8H ]OHHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "O(/&W_(WWW_;/_P!%
MK7K]>0>-O^1OOO\ MG_Z+6@#GZ*** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M T-"_P"1ATS_ *^XO_0Q7M]>(:%_R,.F?]?<7_H8KV^@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH \@\;?\C???]L__ $6M<_70>-O^1OOO^V?_ *+6N?H **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ K0T+_ )&'3/\ K[B_]#%9]:&A?\C#IG_7W%_Z&* /
M;Z*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KR#Q
MM_R-]]_VS_\ 1:UZ_7D'C;_D;[[_ +9_^BUH Y^BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** -#0O\ D8=,_P"ON+_T,5[?7B&A?\C#IG_7W%_Z&*]OH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** /(/&W_(WWW_;/_P!%K7/UT'C;_D;[[_MG_P"BUKGZ
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH *T-"_P"1ATS_ *^XO_0Q6?6AH7_(
MPZ9_U]Q?^AB@#V^BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH *\@\;?\C???]L__ $6M>OUY!XV_Y&^^_P"V?_HM: .?HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@#0T+_ )&'3/\ K[B_]#%>WUXAH7_(PZ9_
MU]Q?^ABO;Z "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@#R#QM_R-]]_VS_\ 1:US]=!XV_Y&
M^^_[9_\ HM:Y^@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "M#0O\ D8=,_P"O
MN+_T,5GUH:%_R,.F?]?<7_H8H ]OHHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "O(/&W_(WWW_;/_P!%K7K]>0>-O^1OOO\ MG_Z
M+6@#GZ*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH T-"_P"1ATS_ *^XO_0Q
M7M]>(:%_R,.F?]?<7_H8KV^@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH \@\;?\C???]L__
M $6M<_70>-O^1OOO^V?_ *+6N?H **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ K
M0T+_ )&'3/\ K[B_]#%9]:&A?\C#IG_7W%_Z&* /;Z*** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ KR#QM_R-]]_VS_\ 1:UZ_7D'
MC;_D;[[_ +9_^BUH Y^BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** -#0O\
MD8=,_P"ON+_T,5[?7B&A?\C#IG_7W%_Z&*]OH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /
M(/&W_(WWW_;/_P!%K7/UT'C;_D;[[_MG_P"BUKGZ "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH *L6%U]BU&VN]F_R)5DVYQNVD'&?PJO10!Z!_PLW_ *A'_DS_
M /84?\+-_P"H1_Y,_P#V%>?T4 >@?\+-_P"H1_Y,_P#V%'_"S?\ J$?^3/\
M]A7G]% 'H'_"S?\ J$?^3/\ ]A1_PLW_ *A'_DS_ /85Y_10!Z!_PLW_ *A'
M_DS_ /84?\+-_P"H1_Y,_P#V%>?T4 >@?\+-_P"H1_Y,_P#V%'_"S?\ J$?^
M3/\ ]A7G]% 'H'_"S?\ J$?^3/\ ]A1_PLW_ *A'_DS_ /85Y_10!Z!_PLW_
M *A'_DS_ /84?\+-_P"H1_Y,_P#V%>?T4 >@?\+-_P"H1_Y,_P#V%'_"S?\
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M4 >@?\+-_P"H1_Y,_P#V%'_"S?\ J$?^3/\ ]A7G]% 'H'_"S?\ J$?^3/\
M]A1_PLW_ *A'_DS_ /85Y_10!Z!_PLW_ *A'_DS_ /84?\+-_P"H1_Y,_P#V
M%>?T4 >GZ)XY_MC5X+#^SO)\W=\_G[L84GIM'I785Y!X)_Y&^Q_[:?\ HMJ]
M?H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH *\@\;?\C???\ ;/\ ]%K7K]>0>-O^1OOO^V?_ *+6@#GZ*** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH T-"_Y&'3/^ON+_P!#%>WUXAH7_(PZ9_U]
MQ?\ H8KV^@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH \@\;?\C???\ ;/\ ]%K7/UT'C;_D
M;[[_ +9_^BUKGZ "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@#H/!/_(WV/\ VT_]%M7K]>0>
M"?\ D;['_MI_Z+:O7Z "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "O(/&W_(WWW_;/_T6M>OUY!XV_P"1OOO^V?\
MZ+6@#GZ*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH T-"_Y&'3/^ON+_ -#%
M>WUXAH7_ ",.F?\ 7W%_Z&*]OH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /(/&W_(WWW_;
M/_T6M<_70>-O^1OOO^V?_HM:Y^@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH Z#P3_R-]C_V
MT_\ 1;5Z_7D'@G_D;['_ +:?^BVKU^@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ KR#QM_R-]]_VS_\ 1:UZ_7D'
MC;_D;[[_ +9_^BUH Y^BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** -#0O\
MD8=,_P"ON+_T,5[?7B&A?\C#IG_7W%_Z&*]OH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /
M(/&W_(WWW_;/_P!%K7/UT'C;_D;[[_MG_P"BUKGZ "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@#H/!/_ "-]C_VT_P#1;5Z_7D'@G_D;['_MI_Z+:O7Z "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "O(/&W_ "-]
M]_VS_P#1:UZ_7D'C;_D;[[_MG_Z+6@#GZ*** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH T-"_Y&'3/^ON+_T,5[?7B&A?\C#IG_7W%_Z&*]OH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** /(/&W_ "-]]_VS_P#1:US]=!XV_P"1OOO^V?\ Z+6N?H ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** .@\$_P#(WV/_ &T_]%M7K]>0>"?^1OL?^VG_ *+:O7Z
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "O(/&W_(WWW_ &S_ /1:UZ_7D'C;_D;[[_MG_P"BUH Y^BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** -#0O^1ATS_K[B_\ 0Q7M]>(:%_R,.F?]?<7_
M *&*]OH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** /(/&W_(WWW_ &S_ /1:US]=!XV_Y&^^
M_P"V?_HM:Y^@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH Z#P3_R-]C_ -M/_1;5Z_7D'@G_
M )&^Q_[:?^BVKU^@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ KR#QM_R-]]_VS_]%K7K]>0>-O\ D;[[_MG_ .BU
MH Y^BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** -#0O^1ATS_K[B_P#0Q7M]
M>(:%_P C#IG_ %]Q?^ABO;Z "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#R#QM_R-]]_VS_]
M%K7/UT'C;_D;[[_MG_Z+6N?H **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** .@\$_\C?8_]M/_
M $6U>OUY!X)_Y&^Q_P"VG_HMJ]?H **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH *\@\;?\C???]L__ $6M>OUY!XV_
MY&^^_P"V?_HM: .?HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#0T+_ )&'
M3/\ K[B_]#%>WUXAH7_(PZ9_U]Q?^ABO;Z "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#R#Q
MM_R-]]_VS_\ 1:US]=!XV_Y&^^_[9_\ HM:Y^@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
MZ#P3_P C?8_]M/\ T6U>OUY!X)_Y&^Q_[:?^BVKU^@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KR#QM_P C???]
ML_\ T6M>OUY!XV_Y&^^_[9_^BUH Y^BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** -#0O^1ATS_K[B_]#%>WUXAH7_(PZ9_U]Q?^ABO;Z "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@#R#QM_P C???]L_\ T6M<_70>-O\ D;[[_MG_ .BUKGZ "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@#H/!/\ R-]C_P!M/_1;5Z_7D'@G_D;['_MI_P"BVKU^@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ KR#QM_R-]]_P!L_P#T6M>OUY!XV_Y&^^_[9_\ HM: .?HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@#0T+_D8=,_Z^XO_ $,5[?7B&A?\C#IG_7W%_P"A
MBO;Z "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@#R#QM_R-]]_P!L_P#T6M<_70>-O^1OOO\
MMG_Z+6N?H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** .@\$_\C?8_P#;3_T6U>OUY!X)_P"1
MOL?^VG_HMJ]?H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH *\@\;?\C???]L__1:UZ_7D'C;_ )&^^_[9_P#HM: .
M?HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@#0T+_D8=,_Z^XO\ T,5[?7B&
MA?\ (PZ9_P!?<7_H8KV^@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH \@\;?\C???]L__1:U
MS]=!XV_Y&^^_[9_^BUKGZ "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#H/!/_(WV/_;3_P!%
MM7K]>0>"?^1OL?\ MI_Z+:O7Z "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "O(/&W_(WWW_;/_P!%K7K]>0>-O^1O
MOO\ MG_Z+6@#GZ*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH T-"_P"1ATS_
M *^XO_0Q7M]>(:%_R,.F?]?<7_H8KV^@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH \@\;?\
MC???]L__ $6M<_70>-O^1OOO^V?_ *+6N?H **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** .@\
M$_\ (WV/_;3_ -%M7K]>0>"?^1OL?^VG_HMJ]?H **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *\@\;?\ (WWW_;/_
M -%K7K]>0>-O^1OOO^V?_HM: .?HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@#0T+_D8=,_Z^XO_0Q7M]>(:%_R,.F?]?<7_H8KV^@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH \@\;?\ (WWW_;/_ -%K7/UT'C;_ )&^^_[9_P#HM:Y^@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH Z#P3_ ,C?8_\ ;3_T6U>OUY!X)_Y&^Q_[:?\ HMJ]?H ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M\@\;?\C???\ ;/\ ]%K7K]>0>-O^1OOO^V?_ *+6@#GZ*** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH T-"_Y&'3/^ON+_P!#%>WUXAH7_(PZ9_U]Q?\ H8KV
M^@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH \@\;?\C???\ ;/\ ]%K7/UT'C;_D;[[_ +9_
M^BUKGZ "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@#H/!/_(WV/\ VT_]%M7K]>0>"?\ D;['
M_MI_Z+:O7Z "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "O(/&W_(WWW_;/_T6M>OUY!XV_P"1OOO^V?\ Z+6@#GZ*
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH T-"_Y&'3/^ON+_ -#%>WUXAH7_
M ",.F?\ 7W%_Z&*]OH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M1_\ GYOO^^T_^)H_X5QH_P#S\WW_ 'VG_P 30!YA17I__"N-'_Y^;[_OM/\
MXFC_ (5QH_\ S\WW_?:?_$T >845Z?\ \*XT?_GYOO\ OM/_ (FC_A7&C_\
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M_P 30!YA17I__"N-'_Y^;[_OM/\ XFC_ (5QH_\ S\WW_?:?_$T >845Z?\
M\*XT?_GYOO\ OM/_ (FC_A7&C_\ /S??]]I_\30!YA17I_\ PKC1_P#GYOO^
M^T_^)H_X5QH__/S??]]I_P#$T >845Z?_P *XT?_ )^;[_OM/_B:/^%<:/\
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M%%>G_P#"N-'_ .?F^_[[3_XFC_A7&C_\_-]_WVG_ ,30!YA17I__  KC1_\
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MQH__ #\WW_?:?_$T >845Z?_ ,*XT?\ Y^;[_OM/_B:/^%<:/_S\WW_?:?\
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M%>G_ /"N-'_Y^;[_ +[3_P")H_X5QH__ #\WW_?:?_$T >845Z?_ ,*XT?\
MY^;[_OM/_B:/^%<:/_S\WW_?:?\ Q- '(>"?^1OL?^VG_HMJ]?KF]+\%:;I&
MI17UO/=M+%G:)'4KR".RCUKI* "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "O(/&W_(WWW_;/_P!%K7K]<WJG@K3=
M7U*6^N)[M99<;A&ZA> !W4^E 'DE%>G_ /"N-'_Y^;[_ +[3_P")H_X5QH__
M #\WW_?:?_$T >845Z?_ ,*XT?\ Y^;[_OM/_B:/^%<:/_S\WW_?:?\ Q- '
MF%%>G_\ "N-'_P"?F^_[[3_XFC_A7&C_ //S??\ ?:?_ !- 'F%%>G_\*XT?
M_GYOO^^T_P#B:/\ A7&C_P#/S??]]I_\30!YA17I_P#PKC1_^?F^_P"^T_\
MB:/^%<:/_P _-]_WVG_Q- 'F%%>G_P#"N-'_ .?F^_[[3_XFC_A7&C_\_-]_
MWVG_ ,30!YA17I__  KC1_\ GYOO^^T_^)H_X5QH_P#S\WW_ 'VG_P 30!YA
M17I__"N-'_Y^;[_OM/\ XFC_ (5QH_\ S\WW_?:?_$T >845Z?\ \*XT?_GY
MOO\ OM/_ (FC_A7&C_\ /S??]]I_\30!YA17I_\ PKC1_P#GYOO^^T_^)H_X
M5QH__/S??]]I_P#$T >845Z?_P *XT?_ )^;[_OM/_B:/^%<:/\ \_-]_P!]
MI_\ $T >845Z?_PKC1_^?F^_[[3_ .)H_P"%<:/_ ,_-]_WVG_Q- 'F%%>G_
M /"N-'_Y^;[_ +[3_P")H_X5QH__ #\WW_?:?_$T >845Z?_ ,*XT?\ Y^;[
M_OM/_B:/^%<:/_S\WW_?:?\ Q- 'F%%>G_\ "N-'_P"?F^_[[3_XFC_A7&C_
M //S??\ ?:?_ !- 'F%%>G_\*XT?_GYOO^^T_P#B:/\ A7&C_P#/S??]]I_\
M30!YA17I_P#PKC1_^?F^_P"^T_\ B:/^%<:/_P _-]_WVG_Q- 'F%%>G_P#"
MN-'_ .?F^_[[3_XFC_A7&C_\_-]_WVG_ ,30!P&A?\C#IG_7W%_Z&*]OKE;3
MP#I5G>074=Q>%X9%D4,ZX)!R,_+[5U5 !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%8^K^)]
M+T7*7,^^<?\ +"+YG[=1T'!SR1GM6Q0 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%-21)%W(ZL 2I*G/(."/P((H =111
M0 4444 %%%% !1110 4444 %%%% !1110 44V21(HVDD=41 69F.  .I)HCD
M26-9(W5T<!E93D$'H0: '4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110!Y9XOU;4K;Q3>0V^H7<42[-J1S,JCY%/0&L/^W=8
M_P"@K??^!#_XUH>-O^1OOO\ MG_Z+6N?H T/[=UC_H*WW_@0_P#C1_;NL?\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 >
M4444 %%%% !7H'PR_P"8I_VR_P#9Z\_KT#X9?\Q3_ME_[/0!W]%%% !1110!
MYA\1_P#D8;?_ *]%_P#0WKCZ[#XC_P#(PV__ %Z+_P"AO7'T %%%% !1110!
M[_1110 4444 %%%% !1110 4444 %%%% !1110 4444 %<!\3?\ F%_]M?\
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M *!__D:3_P"*H \@HKU__A"?#O\ T#__ "-)_P#%4?\ "$^'?^@?_P"1I/\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 5P'Q-_P"87_VU_P#9*[^N ^)O_,+_ .VO_LE 'G]%%% !
M1110 5[_ %X!7O\ 0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M<_XV_P"10OO^V?\ Z,6N@KG_ !M_R*%]_P!L_P#T8M 'D%%%% !1110 5Z_X
M)_Y%"Q_[:?\ HQJ\@KU_P3_R*%C_ -M/_1C4 =!1110 4444 %%%% !1110
M5Q_Q'_Y%ZW_Z^U_] >NPKC_B/_R+UO\ ]?:_^@/0!YA1110 4444 %>WZ%_R
M+VF?]>D7_H KQ"O;]"_Y%[3/^O2+_P! % &A1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% 'D'C;_D;[[_MG_P"BUKGZZ#QM
M_P C???]L_\ T6M<_0 4444 %:&A?\C#IG_7W%_Z&*SZT-"_Y&'3/^ON+_T,
M4 >WT444 %%%% !1110 4444 %-DC26-HY$5T<%65AD$'J"*=10!XYXIT)M"
MU9HT&;6;,D! . ,_=R>I'UZ8/>L.O6?'ELD_A6:1BP,$B2+CN2=O/X,:\FH
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MS&[RI VW/3./H:L4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4455N=2L+.01W5[;0.1N"RRJI(]<$^U %JBL_P#MW1_^@K8_^!"?XU>CD26-
M9(W5T<!E93D$'H0: '4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 45#<W=M9QB2ZN(H$)VAI7"
M@GTR?I57^W='_P"@K8_^!"?XT :%%9_]NZ/_ -!6Q_\  A/\:M6UW;7D9DM;
MB*= =I:)PP!],CZT 34444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MO:9_UZ1?^@"O$*]OT+_D7M,_Z](O_0!0!H4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%-DD2*-I)'5$0%F9C@ #J2: '45G_V[H_\ T%;'_P "$_QJ
MQ:W]G>[OLEW!<;,;O*D#;<],X^AH L4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%4Y]6TVVF:&XU"TBE7[R23*K#OT)H N45G_
M -NZ/_T%;'_P(3_&KT<B2QK)&ZNC@,K*<@@]"#0 ZBBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /(/&W_(WWW_;
M/_T6M<_70>-O^1OOO^V?_HM:Y^@ HHHH *T-"_Y&'3/^ON+_ -#%9]:&A?\
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M>0?05S?_  FWB+_H(?\ D&/_ .)K0^(__(PV_P#UZ+_Z&]<?0!T'_";>(O\
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MS@<=3Z4 >C^"-,73_#L,K1[9[K]\Y."2#]WD=MN#@]"372444 %%%% !7/\
MC;_D4+[_ +9_^C%KH*Y_QM_R*%]_VS_]&+0!Y!1110 4444 %>O^"?\ D4+'
M_MI_Z,:O(*]?\$_\BA8_]M/_ $8U '04444 %%%% !1110 5P'Q-_P"87_VU
M_P#9*[^N ^)O_,+_ .VO_LE 'G]%%% !1110 5[_ %X!7O\ 0 4444 %%%%
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M 4444 %%%% !1110!Y!XV_Y&^^_[9_\ HM:Y^N@\;?\ (WWW_;/_ -%K7/T
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 445>TO2+W6+I8+.%G
M.0&?!V1Y[L>W0_7'&: *]K:SWUU';6T32S2'"HO?_/K7L/AO0H]!TM8,1M<O
M\T\JC[Y[#GL.@_/ R:A\/^%;+0H]V%N+LDDW#H 1U&%'.W@^O/Y ;U !1110
M 4444 %<_P"-O^10OO\ MG_Z,6N@KG_&W_(H7W_;/_T8M 'D%%%% !1110 5
MZ_X)_P"10L?^VG_HQJ\@KU_P3_R*%C_VT_\ 1C4 =!1110 4444 %%%% !7
M?$W_ )A?_;7_ -DKOZX#XF_\PO\ [:_^R4 >?T444 %%%% !7O\ 7@%>_P!
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M0/AE_P Q3_ME_P"ST =_1110 4444 >8?$?_ )&&W_Z]%_\ 0WKCZ[#XC_\
M(PV__7HO_H;UQ] !1110 4444 %%%;6@>&;W7Y&,.V*WC(#S.#CZ#U..<?F1
MD4 8M20037,RPV\4DLK?=2-2S'OT%>NZ?X.T33U&+-;A\$%[GY\\YZ?=_$"M
MZ@#PJYTV_LXQ)=65S A.T-+$R@GTR1[55KW^J=YI6GZCDWEE!,Q39O= 6 ]
MW4=3TH \,HKNO$'@%X%>ZT<M)&H+-;L<N.>B<<\=CSQW)KA: "BBB@ HHHH
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M -=_I?AO2M'97M;5?.  \Z0[GZ8R">F<G.,4 >.6UI<WDACM;>6=P-Q6)"Q
M]<#ZTV>":VF:&XBDBE7[R2*58=^AKWNFR1I+&T<B*Z."K*PR"#U!% '@5%>K
MZOX%TO4<R6P^PSGO$OR'IU3IT';'7)S7FFIZ9=:1?/:7<>V1>01]UQV8'N/\
M]: *=%%% !1110 5ZOX%U?\ M'0Q;2',]GB,\=4_@/3'0$?\!R>M>45T7@G4
M!8>)H Y4)<@P,2">N"N,>K!1^- 'KM%%% !1110 5YAX[U_[???V;;MFVM7_
M 'F4P6E&0>?0=.W.>O%=OXGU?^Q=#FN4.)V_=P\?QGH>A' R>>N,=Z\8H **
M** "BBB@ J:VM+F\D,=K;RSN!N*Q(6('K@?6MKPUX6N->F$K'RK%'*R2@C=D
M8.T#UY')X^O2O5=/TZTTNU%M90+#$"6P"3DGN2>3^- 'FEM\/M;GC+2"VMR#
MC9++DGW^4$?K4W_"N-8_Y^;'_OM__B:]/HH \BU#P3K=@I<6ZW*  EK9MW4X
MQMX8_@*Y^2-XI&CD1D="596&"".H(KWVL?7?#=CKT)\]-ERJ%8YU^\G?D?Q#
MV/J<8SF@#QBBKFIZ9=:1?/:7<>V1>01]UQV8'N/\]:IT %%%% !7L/A/7#KF
MCJ\S*;N$[)@ !GT;'N/IR#BO'JZ;P-J@T_Q D4C,(KL>21DX#$_*<#KSQ[;C
M0!ZS1110!YA\1_\ D8;?_KT7_P!#>N/KU?Q'X/\ ^$@U&.[^W?9]D0CV^3NS
M@DYSN'K61_PK+_J+_P#DM_\ 9T >?T5Z!_PK+_J+_P#DM_\ 9UGZWX&_L;2)
M[_\ M'SO*V_)Y&W.6 Z[CZT <?1110 4444 %%%=AHG@;^V=(@O_ .T?)\W=
M\GD;L88CKN'I0!Q]%>@?\*R_ZB__ )+?_9T?\*R_ZB__ )+?_9T >?T5Z!_P
MK+_J+_\ DM_]G1_PK+_J+_\ DM_]G0!W]%%% 'B&N_\ (PZG_P!?<O\ Z&:S
MZ](O_AY]MU&YN_[4V>?*TFW[/G;N).,[O>J__"LO^HO_ .2W_P!G0!Y_17H'
M_"LO^HO_ .2W_P!G6/XC\'_\(_IT=W]N^T;Y1'M\G;C()SG<?2@#EZ*** "B
MBB@ HHKN+#X>?;=.MKO^U-GGQ+)M^SYV[@#C.[WH X>BO0/^%9?]1?\ \EO_
M +.C_A67_47_ /);_P"SH \_HKT#_A67_47_ /);_P"SH_X5E_U%_P#R6_\
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MGY6DW5XRR!IY=HW#Y2JC@C\68?A7FE>U^'+/[!X=L+<K(K"(,ZR##*S?,P_
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M "*%C_VT_P#1C5Y!7K_@G_D4+'_MI_Z,:@#H**** "BBB@ HHHH *X#XF_\
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M* //Z*** "BBB@"2">2VN(KB%MLL3AT;&<$'(/->]UX!7O\ 0 4444 %%%%
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M>UM8+&UCMK:)8H8QA47M_GUJ:BB@ HHHH **** ,'Q9H9US1V2%%-W"=\))
MSZKGW'TY S7CU>_UXQXILX;#Q-?6]NNV(.&5< !=RAL#'89X]J ,>BBB@ IT
M<CQ2+)&[(Z$,K*<$$="#3:* /<='U :IH]I>@J3+&"^T$ ,.& SZ$$5>KD?A
MY=&;P_) TJL8)V"IQE5(!'YDMR??TKKJ "BBB@ KG_&W_(H7W_;/_P!&+705
MS_C;_D4+[_MG_P"C%H \@HHHH **** "O7_!/_(H6/\ VT_]&-7D%>O^"?\
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M*U2XL93EH7P&_O#J#U.,@@X]ZIUZ!\2K+_CQOUC_ +T,C[OQ48_[[_SBO/Z
M"BBB@ KU/P!J;7NAM:RR;I;1]@SG/EGE<D_\"''0 5Y979?#FZ,6MW%L955)
MH,A#CYF4C&._ +<#^E 'IM%%% !7'_$?_D7K?_K[7_T!Z["N/^(__(O6_P#U
M]K_Z ] 'F%%%% !1110 445TW@;2QJ'B!)9%8Q6@\XG!P6!^49'3GGWVF@#K
M?!_A:/2K>._NEW7TJ9 9<>2".F#_ !>I_#USUE%% !1110 4V2-)8VCD171P
M596&00>H(IU% ')ZCX#TVYNXKBU3R,2JTL.X^6Z;LL!W4X/&..,8'6NLHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@#R#QM_R-]]_P!L_P#T6M<_70>-O^1OOO\ MG_Z+6N?H **** "I(()+FXB
MMX5W2RN$1<XR2< <U'6AH7_(PZ9_U]Q?^AB@#0_X0GQ%_P! _P#\C1__ !5'
M_"$^(O\ H'_^1H__ (JO7Z* /(/^$)\1?] __P C1_\ Q5'_  A/B+_H'_\
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M!VSS^*H9%*@01O(V>X(V\?BPKF:[SX:01M<:C<%?WJ)&BMGH&+$C_P ='Y4
M>AT444 %%%% !1110 5P'Q-_YA?_ &U_]DKOZX#XF_\ ,+_[:_\ LE 'G]%%
M% !1110 5[_7@%>_T %%%% !6?KO_(O:G_UZ2_\ H!K0K/UW_D7M3_Z])?\
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M&PLUPJ.,=1AFQ^:C\JZRN$^)<\BV^G6X;]T[R.RXZE0H!_\ 'C^= 'G=%%%
M!1110 5ZK\/K9X/#/F,5(GG>1<=@,+S^*FO*J]K\.01V_AK34B7:IMT<C.>6
M&XG\R: -2BBB@ HHHH **** "O$-=_Y&'4_^ON7_ -#->WUXAKO_ ",.I_\
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M?_0'H \PHHHH **** "O2_AO!&NC7=P%_>O<;&;/4*H('_CQ_.O-*]?\$_\
M(H6/_;3_ -&-0!T%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 >0>-O^1OOO^V?_HM:Y^N@
M\;?\C???]L__ $6M<_0 4444 %:&A?\ (PZ9_P!?<7_H8K/K0T+_ )&'3/\
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MO_9Z ._HHHH **** /,/B/\ \C#;_P#7HO\ Z&]<?78?$?\ Y&&W_P"O1?\
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MAM_^O1?_ $-ZX^NP^(__ ",-O_UZ+_Z&]<?0 4444 %%%% 'O]%%% !1110
M4444 %%%% 'D'C;_ )&^^_[9_P#HM:Y^N@\;?\C???\ ;/\ ]%K7/T %%%%
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 >0>-O\
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M"=WXYKS"NR^'6H"WUB>R8J!=1Y7@Y+)D@>W!8\^@H ]-HHHH **** "BBB@
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M@ HHHH **** "BBB@ KC_B/_ ,B];_\ 7VO_ * ]=A7'_$?_ )%ZW_Z^U_\
M0'H \PHHHH **** "O;]"_Y%[3/^O2+_ - %>(5[?H7_ "+VF?\ 7I%_Z *
M-"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** /(/&W_(WWW_ &S_ /1:US]=!XV_Y&^^_P"V
M?_HM:Y^@ HHHH *T-"_Y&'3/^ON+_P!#%9]6+"Z^Q:C;7>S?Y$JR;<XW;2#C
M/X4 >[T5P'_"S?\ J$?^3/\ ]A1_PLW_ *A'_DS_ /84 =_17 ?\+-_ZA'_D
MS_\ 84?\+-_ZA'_DS_\ 84 =_17 ?\+-_P"H1_Y,_P#V%'_"S?\ J$?^3/\
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M0 4444 >8?$?_D8;?_KT7_T-ZX^NP^(__(PV_P#UZ+_Z&]<?0 4444 %%%%
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M5 MK<$X$B@^4W(QW)7KWXXSGM0!V5%0VUW;7D9DM;B*= =I:)PP!],CZU-0
M45FW7B#2+)9#/J-LIC.UT60,X.<8VC)Z^U<1K?Q!GNHWM]+B:WC88,SG]YVZ
M8X7N,\^HP: -OQGXG33;5]/LY6%_(!N:,_ZE3ZGU(Z=QG/'&?+J** "BBB@
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M2(UM8W!WR)EI<=>#T4_GQU'2N9U77M1UF3=>7#,@.5B7A%ZXP/;)&3D^]9M
M'M>A:[:Z]8BXMSMD7 EA)^:,_P!1Z'O]<@:E>&:9J=UI%\EW:2;9%X(/W7'=
M2.X_SUKU_0M=M=>L1<6YVR+@2PD_-&?ZCT/?ZY  -2BBB@ HHHH *X_XC_\
M(O6__7VO_H#UV%<?\1_^1>M_^OM?_0'H \PHHHH **** "O;]"_Y%[3/^O2+
M_P! %>(5[?H7_(O:9_UZ1?\ H H T**** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH \@\;?\
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M%% '@%%%% !1110 5Z!\,O\ F*?]LO\ V>O/Z] ^&7_,4_[9?^ST =_1110
M4444 >8?$?\ Y&&W_P"O1?\ T-ZX^NP^(_\ R,-O_P!>B_\ H;UQ] !1110
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MTS_KTB_] % &A1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M 5[_ $ %%%% !1110 4444 %%%% !1110 4444 %<!\3?^87_P!M?_9*[^N
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** .$\1>"M2U?7;F^MY[18I=NT2.P;A
M0.RGTK+_ .%<:Q_S\V/_ 'V__P 37I]% 'F'_"N-8_Y^;'_OM_\ XFC_ (5Q
MK'_/S8_]]O\ _$UZ?10!YA_PKC6/^?FQ_P"^W_\ B:/^%<:Q_P _-C_WV_\
M\37I]% 'F'_"N-8_Y^;'_OM__B:/^%<:Q_S\V/\ WV__ ,37I]% 'F'_  KC
M6/\ GYL?^^W_ /B:/^%<:Q_S\V/_ 'V__P 37I]% 'F'_"N-8_Y^;'_OM_\
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M;_\ Q->GT4 >8?\ "N-8_P"?FQ_[[?\ ^)H_X5QK'_/S8_\ ?;__ !->GT4
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M^,/#EYX@^Q?9)($\C?N\UB,[MN,8!]#7444 >8?\*XUC_GYL?^^W_P#B:/\
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M31_PKC6/^?FQ_P"^W_\ B:]/HH \P_X5QK'_ #\V/_?;_P#Q->GT44 %%%%
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MQVPQ@YX^9ASQ[#_'O:* *NGZ=::7:BVLH%AB!+8!)R3W)/)_&K5%% !1110
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !115/4]3M=(L7N[N3;&O  ^\Y[*!W/\ GI0!D^--533?#\T?RF:[!A13
MZ$?,<9SP._J17D5;'B379->U1I\R+;)\L$3'[@[GCN>I_+)P*QZ "BBB@ HH
MJ:TMGO+R"UC*AYI%C4MT!)P,_G0!ZWX-M3:>%;(/$J/(#*V,?-N)*DX_V=O\
MJWJC@@CMK>*WA7;%$@1%SG  P!S4E !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110!Y!XPT;^R-<D\M-MK<?O8L# &>J] .#V'0
M$5S]>K^.M(_M'0S<QC,]GF0<]4_C'7'0 _\  <#K7E% !1110 4444 %%%%
M!14UK:SWUU';6T32S2'"HO?_ #ZUZ7X8\&0:;'%>:A&LM^"'5<Y6'T'H3[]C
MC'3) '>"O#?]E6?V^Y21;ZX3!1N/+3.<8]3@$YZ=..<]9110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 445FZKKVG:-'NO+A5<C*Q+R[=<8'O@C)P/>@#2K-U77M.T:/=>7"JY&
M5B7EVZXP/?!&3@>]<%K/C^^O=\.GK]C@.1OZR,.1UZ+P1TY!'6N1DD>61I)'
M9W<EF9CDDGJ2: .NUGQ_?7N^'3U^QP'(W]9&'(Z]%X(Z<@CK7H.BR/+H6GR2
M.SN]M&S,QR22HR2:\.KV_0O^1>TS_KTB_P#0!0!H4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% '-ZIXUTW2-2EL;B"[:6+&XQHI7D ]V'K5/_A8^
MC_\ /M??]\)_\57(>-O^1OOO^V?_ *+6N?H ]/\ ^%CZ/_S[7W_?"?\ Q5'_
M  L?1_\ GVOO^^$_^*KS"B@#T_\ X6/H_P#S[7W_ 'PG_P 55S2_&NFZOJ45
MC;P7:RRYVF1%"\ GLQ]*\DKH/!/_ "-]C_VT_P#1;4 >OT444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %>):]I3Z+K$]FVXHIW1,?XD/0YP,^AQW!K
MVVN1\;^';K6([6>PA62XB)1U^52RGD'<2.A'3_:- 'EU%=%'X'\0/(JM9*@8
M@%VF3"^YP2?R%7O^%<:Q_P _-C_WV_\ \30!Q]%=Q:_#6\?=]KU""+&-OE(9
M,^N<[<=O6M^U\ :%!N\R.>YW8QYLI&WZ;<?KZ4 >51QO+(L<:,[N0JJHR23T
M %==HW@"^O=DVH-]C@.#LZR,.#TZ+P3UY!'2O1[6PL[+=]DM(+??C=Y487=C
MIG'U-6* ,W2M!T[18]MG;JKD8:5N7;IG)]\ X&![5I444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%-DD2*-I)'5$0%F9C@ #J2: '4V2
M1(HVDD=41 69F.  .I)KD=9\?V-EOAT]?MDXR-_2-3R.O5N0.G!!ZUP6JZ]J
M.LR;KRX9D!RL2\(O7&![9(R<GWH [W6?']C9;X=/7[9.,C?TC4\CKU;D#IP0
M>M'@C6K[6[C4YKV;=M\O8BC"H"7. /ZGG@<UYA7H'PR_YBG_ &R_]GH [^BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBN7U?QUI>G9CM
MC]NG':)OD'3J_3H>V>F#B@#J*Y?5_'6EZ=F.V/VZ<=HF^0=.K].A[9Z8.*X#
M5_$^J:UE+F?9 ?\ EA%\J=NHZGD9Y)QVK'H ]&\(^(]1UWQ',+N51$MLS+#&
M,(IW(,^I_$GJ<5W->8?#C_D8;C_KT;_T-*]/H **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *HZKJUIHUG
M]JO'94)VJ%4DLV"0!]<'K@5>KC_B/_R+UO\ ]?:_^@/0!@:SX_OKW?#IZ_8X
M#D;^LC#D=>B\$=.01UKD9)'ED:21V=W)9F8Y))ZDFFT4 %%%% !7M^A?\B]I
MG_7I%_Z *\0KV_0O^1>TS_KTB_\ 0!0!H4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% 'D'C;_D;[[_MG_P"BUKGZZ#QM_P C???]L_\ T6M<_0 4
M444 %=!X)_Y&^Q_[:?\ HMJY^N@\$_\ (WV/_;3_ -%M0!Z_1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% ''ZSX_L;+?#IZ_;)QD;^D
M:GD=>K<@=."#UK@M5U[4=9DW7EPS(#E8EX1>N,#VR1DY/O6;10 4444 %>@?
M#+_F*?\ ;+_V>O/Z] ^&7_,4_P"V7_L] '?T444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !7,ZWXVT[29'MX@UW=(=K1H<*IXR"WXGIGD8.*Z:O$-
M=_Y&'4_^ON7_ -#- %C5_$^J:UE+F?9 ?^6$7RIVZCJ>1GDG':L>BB@ HHHH
M [#X<?\ (PW'_7HW_H:5Z?7F'PX_Y&&X_P"O1O\ T-*]/H **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** / **** "BBB
M@ KT#X9?\Q3_ +9?^SUY_7H'PR_YBG_;+_V>@#OZ*** "BBB@ HHHH ****
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MM]YY(59CVZD5'_86C_\ 0*L?_ =/\*T** ,_^PM'_P"@58_^ Z?X4?V%H_\
MT"K'_P !T_PK0HH S_["T?\ Z!5C_P" Z?X5)!I.FVTRS6^GVD4J_=>.%58=
MNH%7** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /
M **** "BBB@ KT#X9?\ ,4_[9?\ L]>?UZ!\,O\ F*?]LO\ V>@#OZ*** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ KQ#7?^1AU/\ Z^Y?_0S7M]>(
M:[_R,.I_]?<O_H9H SZ*** "BBB@#L/AQ_R,-Q_UZ-_Z&E>GUYA\./\ D8;C
M_KT;_P!#2O3Z "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M 2$RJQ.2S#L1Z5A?\+'UC_GVL?\ OA__ (J@#T^BO,/^%CZQ_P ^UC_WP_\
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MWSR9*)_LC!&3Z^G3KG !V5%>8?\ "Q]8_P"?:Q_[X?\ ^*H_X6/K'_/M8_\
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M =I138Y$EC62-U=' 964Y!!Z$&N/\6>++_0=5BM;6&V='@$A,JL3DLP[$>E
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M#_\ Q5:WAOQM?ZMKD-C=6]L$E#8:(,I4A2W<G/3'XT =S1110 4444 %%%%
M!17)^+O%5QH-Q:V]FL$DLB%Y%E1C@9PI&".N&_*N<_X6/K'_ #[6/_?#_P#Q
M5 'I]%>8?\+'UC_GVL?^^'_^*H_X6/K'_/M8_P#?#_\ Q5 'I]%>8?\ "Q]8
M_P"?:Q_[X?\ ^*JQ8>/=8O=1MK3R;%//E6/=Y3G;N(&<;_>@#T>BBB@ HHHH
M **** "BFR2)%&TDCJB("S,QP !U)-<GJ'Q"TJV4BS26\? ((&Q.O()//3GH
M: .NHKRC4?'FL7NY('CM(CN&(ERQ!Z98]QZC%8-SJ5_>1B.ZO;F= =P665F
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M !1110!X!1110 4444 %>@?#+_F*?]LO_9Z\_KT#X9?\Q3_ME_[/0!W]%%%
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M#_M8[#L/Q],<O0!)//-<S--<2R2RM]YY&+,>W4U'110 4444 %%%% !1110
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MVO\ Z ]=A7'_ !'_ .1>M_\ K[7_ - >@#S"BBB@ HHHH *]OT+_ )%[3/\
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MD:2QM'(BNC@JRL,@@]017A%W;/9WD]K(5+PR-&Q7H2#@X_*@"&BBB@ HHHH
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M *,6O(*]?\;?\BA??]L__1BUY!0 4444 %%%% 'J?AS4[72/ 5I=W<FV-?,
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M1RKYC;<X0\-Q_NDU[?7@%>WZ'>_VCH=E=F3S'DB7S&VXRXX;C_>!H T****
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MZ&E>GT %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M\.2\?F:M<LA8<0VY&5Z=6((]1@#\:Z/PSX9@T"UR=LM[(/WLN.G^ROM_/KZ
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MLSYL2R;L]-IQC'OO_2@#T>BBB@#S#XB7OGZY%:+)N2VB&Y=N-KMR>>_R[/\
M.:X^M#7+W^T=<O;L2>8DDK>6VW&4'"\?[H%9] !1110 5VGPXL_-U:ZO&6,K
M!%M&X?,&8\$?@K#\:XNO6? ED]GX9C=]P-S(TP5EQM!PH^N0H.?>@#IJ***
M"O)/'-Y]K\43J&C9+=%A4H<]!DY]PS$?A7K,DB11M)(ZHB LS,<  =237A%W
M<O>7D]U(%#S2-(P7H"3DX_.@"&BBB@ HHHH *]G\,:1_8NAPVSC$[?O)N?XS
MU'4C@8''7&>]>;>#M/.H>)K48;9 ?/<J0,;>1U_VMH_&O8: "BBB@ HHHH *
M*** . ^(FC?ZK5X4](KC _[Y8X'X$D_W17G]>XZQIXU31[NR(4F6,A-Q( 8<
MJ3CT(!KPZ@ HHHH **** /2_AQ>>;I-U9LTA:"7<-Q^4*PX _%6/XUVE>5>
M+U[?Q(ML-Q2ZC9"-V "!N!QWZ$?\"->JT %%%% 'F'Q'_P"1AM_^O1?_ $-Z
MX^NP^(__ ",-O_UZ+_Z&]<?0 4444 %%%% 'HWPYTL1VMQJCJP>0^3'D$?*,
M$D=CDX'MM^M=S67X<@CM_#6FI$NU3;HY&<\L-Q/YDUJ4 %%%% !1110 4444
M %%%% !7'_$?_D7K?_K[7_T!Z["N/^(__(O6_P#U]K_Z ] 'F%%%% !1110
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M* "O,/B/_P C#;_]>B_^AO7I]>8?$?\ Y&&W_P"O1?\ T-Z ./HHHH ****
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MC=M(.,_A7N] !1110!YA\1_^1AM_^O1?_0WKCZ[#XC_\C#;_ /7HO_H;UQ]
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M_D4+'_MI_P"C&H Z"BBB@#G_ !M_R*%]_P!L_P#T8M>05Z_XV_Y%"^_[9_\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "N?\:67VWPO=;8]\D&)D^;&W:?F/\ WR6_
M_7704V2-)8VCD171P596&00>H(H \"HJ:[MGL[R>UD*EX9&C8KT)!P<?E4-
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M]2O4TW3;F\?:1#&7 9MNX@<#/N<#\:\,DD>61I)'9W<EF9CDDGJ2: &T444
M%%%% &AH7_(PZ9_U]Q?^ABO;Z\H\ VWG^*$DW[?L\3R8QG=D;<>WWL_A7J]
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M/F+*>2?P91^%<70 4444 %=!XBU+[;INA0HN(H;(8)'S%LE&[]/W?'UKGZ*
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M(-OH_P P_0BO::\L^(-G]G\1"X59-MS$K%F'R[A\I _ +^= ')T444 %%%%
M&MX8N7M?$VG2(%):=8SN]'^4_H37M-> 5[KIMZFI:;;7B;0)HPY"MNVDCD9]
MCD?A0!:HHHH **** "BBB@ KAOB5<NMGI]J NR21Y">^5  _]#/Z5W->3>.[
MU+SQ-(B;2+:-82RMG<1EC],%B,>U ',T444 %%%% !7LOA*V>U\*Z?&Y4EH_
M,&WT<EA^A%>.1QO+(L<:,[N0JJHR23T %>[VELEG9P6L98I#&L:ENI &!G\J
M )J*** .?\;?\BA??]L__1BUY!7K_C;_ )%"^_[9_P#HQ:\@H **** "BBB@
M#U_P3_R*%C_VT_\ 1C5T%<_X)_Y%"Q_[:?\ HQJZ"@ HHHH **** "BBB@ H
MHHH **** / **** "BBB@ KT#X9?\Q3_ +9?^SUY_7H'PR_YBG_;+_V>@#OZ
M*** "N ^)O\ S"_^VO\ [)7?UR/Q#M3-X?CG6)6,$ZEGXRJD$'\R5X'MZ4 >
M74444 %%%% !7L?@^>2X\*6#RMN8(R XQPK%0/R KQRO2?AM<HVE7EJ V^.<
M2$]L,H _] /Z4 =M1110 4444 %%%% !7B&N_P#(PZG_ -?<O_H9KV^O$-=_
MY&'4_P#K[E_]#- &?1110 4444 =A\./^1AN/^O1O_0TKT^O,/AQ_P C#<?]
M>C?^AI7I] !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% 'E7C^R>W\2-<G<4NHU<';@ @;2,]^@/_ A
M7*UZ7\1[/S=)M;Q5D+02[3M'RA6')/XJH_&O-* "BBB@ HHHH **** "O=["
MV^Q:=;6F_?Y$2Q[L8W;0!G'X5Y!X5MOM?BC3X]^S;*),XS]P;L?CMQ^->ST
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MR;4;Z:\N&S+,Y9N3@>PSV'0>PJO0 4444 %%%.CC>618XT9W<A551DDGH *
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MHHH **** . ^)O\ S"_^VO\ [)7G]>@?$W_F%_\ ;7_V2O/Z "BBB@ HHHH
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M?]>C?^AI7I]>8?#C_D8;C_KT;_T-*]/H **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH S]<LO[1T.]M
M!'YCR1-Y:[L9<<KS_O 5XA7O]>*>([/[!XBO[<+&JB4LBQC"JK?,H_ $4 9=
M%%% !1110 4444 =Y\-;/-Q?7S+(-J+"AQ\IR<M^(VK^?O7H=<[X)T\V'AF
MN&#W),[ D'K@+C'JH4_C714 %%%% !7B6OZ>-+UZ\LU"A$DR@4DX4_,HR>>
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M^BVH ]?HHHH **** .?\;?\ (H7W_;/_ -&+7D%>O^-O^10OO^V?_HQ:\@H
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MZ#?_ *J]?KA/B59YM[&^58QM=H7./F.1E?P&UOS]Z /.Z*** "BBB@ HHHH
MN:59_P!HZM:6960K-*JOY8^8+GYC^ R?PKW.O+OA[IYN=>>\(;9:1D@@C[S?
M* 1UZ;NGI7J- !1110 5P7Q)T\>79ZDH4$$P.<G)SEEXZ<8;\Q^'>UA^+[/[
M;X7O5"QEXD\Y2X^[M.3CWV@C\: /'**** "BBB@ HHHH *]OT.R_L[0[*T,?
MEO'$OF+NSASRW/\ O$UY)X<L_M_B*PMRL;*90SK(,JRK\S#\0#7M= !1110
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M "BBB@ HHHH \ HHHH **** "O0/AE_S%/\ ME_[/7G]>@?#+_F*?]LO_9Z
M._HHHH **** /,OB+IXM]8@O5"@74>&Y.2R8!/MP5''H:XVO9_$^D?VUH<UL
M@S.O[R'G^,=!U Y&1STSGM7C% !1110 4444 36MU/8W4=S;2M%-&<JZ]O\
M/I7I^B>.=.U"-(KUUL[K'S;^(V/.<-VZ=\=<<UY510![['(DL:R1NKHX#*RG
M((/0@TZO!()YK:99K>62*5?NO&Q5AVZBI+J_O+W;]KNY[C9G;YLA;;GKC/T%
M 'M.H:SIVEJ3>WD4) #;"V7()QD*.3SZ"N*\0>/_ #X9+32%DC#?*;IN&QSG
M:.V>.3SR> >:X.B@ HHHH **** "BBB@#L/AQ_R,-Q_UZ-_Z&E>GUYA\./\
MD8;C_KT;_P!#2O3Z "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M?^VG_HMJ /7Z*** "BBB@#G_ !M_R*%]_P!L_P#T8M>05Z_XV_Y%"^_[9_\
MHQ:\@H **** "BBB@#U_P3_R*%C_ -M/_1C5T%<_X)_Y%"Q_[:?^C&KH* "B
MBB@ HHHH **** . ^)O_ #"_^VO_ +)7G]>@?$W_ )A?_;7_ -DKS^@ HHHH
M **** /?Z*** "BBB@ KF_&>A-K.D^9",W5KNDC&"2XQ\R@#N<#''48[UTE%
M '@%%=QXP\'_ &3S-3TR/_1_O30*/]7ZLH_N^H[?3IP] !1110 4444 %%%%
M !1110 4444 %%%% !1110 5[_7@%>_T %%%% !1110 4444 %%%% !1110
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M_P#D:/\ ^*H_X0GQ%_T#_P#R-'_\50!S]%=!_P (3XB_Z!__ )&C_P#BJ/\
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MC(+ $<5[G7B&A?\ (PZ9_P!?<7_H8KV^@ HHHH **** "BBB@ HHHH ****
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MXB_Z!_\ Y&C_ /BJ/^$)\1?] _\ \C1__%4 <_170?\ "$^(O^@?_P"1H_\
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MW5=(UF:XOK7RHFMV0-YBMSN4XX)]#7=T %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 53GTG3;F9IKC3[265OO/)"K,>W4BKE% &/=>%="N
M]OF:9 NW./*!CZ^NW&?QJ2#PYHMO"L2:7:%5Z&2(.WYMDFM2B@"&VM+:SC,=
MK;Q0(3N*Q(%!/K@?2IJ** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@"O=6%G>
M[?M=I!<;,[?-C#;<]<9^@JG/X<T6XA:)]+M K=3'$$;\UP16I10!CVOA70K3
M=Y>F0-NQGS09.GINSC\*T+6PL[+=]DM(+??C=Y487=CIG'U-6** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M** "BBB@ K-U[2DUK1Y[-MH=ANB8_P +CH<X./0X[$T44 >9?\(3XB_Z!_\
MY&C_ /BJFMO >O3R%9((K< 9WRR@@^WRY/Z444 7(_AOJID427=FJ$C<59B0
M.^!M&?S%;-G\.-/BPUY=SW#!\X0"-2/0CD^O((HHH WK+PSHNGR>9;:?$'R&
M#/ERI'0@L3C\*UJ** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
C **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>18
<FILENAME>image00002.jpg
<TEXT>
begin 644 image00002.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  8$!08%! 8&!08'!P8("A *"@D)
M"A0.#PP0%Q08&!<4%A8:'24?&ALC'!86("P@(R8G*2HI&1\M,"TH,"4H*2C_
MVP!# 0<'!PH("A,*"A,H&A8:*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H
M*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"C_P  1" %9 C # 2(  A$! Q$!_\0
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M1_PC6B?] BP_\!U_PK6HH R?^$:T3_H$6'_@.O\ A1_PC6B?] BP_P# =?\
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M (#K_A1_PC6B?] BP_\  =?\*UJ* ,G_ (1K1/\ H$6'_@.O^%'_  C6B?\
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M#K_A1_PC6B?] BP_\!U_PK6HH R?^$:T3_H$6'_@.O\ A1_PC6B?] BP_P#
M=?\ "M:B@#)_X1K1/^@18?\ @.O^%'_"-:)_T"+#_P !U_PK6HH R?\ A&M$
M_P"@18?^ Z_X4?\ "-:)_P! BP_\!U_PK6HH R?^$:T3_H$6'_@.O^%'_"-:
M)_T"+#_P'7_"M:B@#)_X1K1/^@18?^ Z_P"%'_"-:)_T"+#_ ,!U_P *UJ*
M,G_A&M$_Z!%A_P" Z_X5C>,M"TFU\+:G/;:;9Q31P,R2)"JLI]0<5U]87CO_
M )$[5_\ KW:@ \"?\B=I'_7NM;M87@3_ )$[2/\ KW6MV@ HHHH **** *.N
M?\@6_P#^O>3_ -!-75^Z/I5+7/\ D"W_ /U[R?\ H)JZOW1]* %HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ K"\=_\B=J_P#U[M6[6%X[_P"1.U?_
M *]VH / G_(G:1_U[K6[6%X$_P"1.TC_ *]UK=H **** "BBB@"CKG_(%O\
M_KWD_P#035U?NCZ52US_ ) M_P#]>\G_ *":NK]T?2@!:*** "BBB@ HHHH
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M_P#7NU !X$_Y$[2/^O=:W:PO G_(G:1_U[K6[0 4444 %%%% %'7/^0+?_\
M7O)_Z":NK]T?2J6N?\@6_P#^O>3_ -!-75^Z/I0 M%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MX$_Y$[2/^O=:W: "BBB@ HHHH HZY_R!;_\ Z]Y/_035U?NCZ52US_D"W_\
MU[R?^@FKJ_='TH 6BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BH+J\MK1=US<10C_ &W K&F\6Z8'V6K37DG]VWB+
M_KTK.=:$/B=A71T%%<Y_:NN7?_'CHP@7^_=RX_\ '1S1_9>N7?\ Q_:R(%_N
M6D6/_'CS4>WO\$6_P_.P7['0331PKNFD2-?5F %8UUXJTBW8H+H3R=-D"F0_
MI4</A+3 V^Z$]Y)_>N)2WZ=*V;6SMK1=MK;Q0C_80"C]]+LOQ_R#4P_[=U*Z
MXTW1+@@])+EA$/RZT?9/$=Y_Q\:A:V*'JMO'O8?B:Z.BCV#E\<F_P_(+=SE[
MGPA%<V[BYO[RXN&&%DF<LJGUVC K,_X5\,8_M(_]^/\ [*N[HK.6!H2U<?S%
MRHQHO#6E^1&MQ8VLL@4!G$07<?7%,;PGH;?\P^('_9+#^M;E%:_5Z76*^X=D
M<^WA#2/X(ID_W)W']:3_ (1.S7_5W>HQ_P"[<M70T4OJU'^5!RHY[_A&G7_4
MZUJJ?6;/]*0:#J*_ZOQ#>_\  T5JZ*BCZM3Z+\7_ )ARHY[^RM=3_5Z]N_W[
M9:3[)XF7IJ=B_P#O6Y'\JZ*BCZO'HW][_P PL<]M\4)_'I4OX.M)]I\3KUL-
M.D_W9B/YUT5%'L'TD_O"QPGB3Q)JMG;M:7%G%:W$R_+)'/O*CN<=J@\.^?XI
M5H-4U*7RK< &WC^4RC^\Q[UVEWI.GWDWFW5G!-*1C<Z G%+::386<WFVEG!#
M)C&Y$ .*YGA:LJG-.5X]O^&L3RN^I+8V5M80"&SA2&,=E&,_7UJQ117>DHJR
M+"BBBF 4444 %%%% !1110 4444 %%%% !6%X[_Y$[5_^O=JW:PO'?\ R)VK
M_P#7NU %?PH;D?#^Q_L_ROMGV+]QYV=F_:=N['.,XSBLCP)JMXNL/I?B&XU6
M/7)K474EI>)$8CM(1W@>/C9G'RDY^8$C)-;?@N&.X\#Z9#.BR126H5T89# C
MD&K'AWPUIN@(_P!@A)E<MNGE;?*5+%@NX\[1G '0 "@#&UK4]9LOB-X<LA=6
MXT?4!<JUNL/SDQQ;@S.3_>Z  <=<U5U#6-7T'5[N[\0R7:Z-)?QP6;6H@:,(
MX15$@(\S)D)&1GJ.V:Z:^\.:1?ZE'J%Y80S7L1S',PRR<8X/;CTI_P#8&E'4
M?MYL+<W>_P T2%<D/_>'8-[]: .$TCQ1K4VE>#];EO(YEUR_%M-8")0D2.)"
M-C ;MR;!DDD'YN!QCTZLNS\/Z19WYO;73K6*Z)9O,2, @M]XCT)[D=:U* ,O
MQ%.R:5>H()G#6[_,H&!\IZY-::_='TJEKG_(%O\ _KWD_P#035U?NCZ4 +11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !15:^O[6PB\R\N(
MX4]7;&?IZUA-XBNM0)30-.DG'3[1/^[C']364ZT(.S>O;J)M(Z5B%4EB !R2
M:Y'Q;XJ@M[1[;2[A9+MCM+QG(C'<YZ9JROAVZU A]?U"2X'7[/#^[B']35QO
M"VBG&=/BX&."1_6L*OMZL6H+E]=_P$[O8Q-$US6]:M_+L8[%'B 6665B23Z[
M1ZUI?V%J5U_R$M;N"#UCME$0_/K6GIVBZ?ILS2V-LL,C+M)4GD?G6A3I8>7+
M^^=WZNWZ H]S#M?"ND0-O:U$\G]^=C(?UK9AACA7;#&D:^B* *?171"E"'PJ
MPTDM@HHHJQA1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 5A>._P#D3M7_ .O=JW:PO'?_
M ")VK_\ 7NU !X$_Y$[2/^O=:W:PO G_ ")VD?\ 7NM;M !1110 4444 4=<
M_P"0+?\ _7O)_P"@FKJ_='TJEKG_ "!;_P#Z]Y/_ $$U=7[H^E "T444 %%%
M% !1110 4444 %%%9FOZY8:%8RW.H3H@12PCW#>_LH)Y-.,7)V0FTE=FG17A
MW_"U=6;7!=)#%_9V=HL^I(]=W7=^GM7?+XVN74-'X5U\@C(/D 9_6NF>#JPM
M=&$,53GL=G17&?\ "8ZF?N>$-:)]PH_K4=QXTU6")I9/".I)$O5I)HUQ^9K-
MT)K5V^]?YE^VA_29V]%</IOC74=41OL7AZ;>!QF8,!]<#'ZUDZA+XPU&X(N=
M'NGM.\,5RD ;\<DURJ;F^6DN;YJWW[?=<;JJU_T9VNI>)-.L'\HRF>XZ"& ;
MV)_"J/F^(=6_U,4>DVQ_CD^>4CZ=!6-ILWB'3DQI_@JVA!_B-^FX_4XS5[^U
M?&IZ>&[!?=KX'^E5]4K3_B32\DU^=[_D3[5/O]S-6Q\+V$$WGW?F7UUU,MRV
M_GV'2MU0% "@ #@ 5QG]H^.3TT/2E]FNR?Y"@7?CP_\ ,,T)?<W#G'Z5K#"*
MFK1LOF@51+9/[CLZ1F"J68@*.22< 5QWF^/&_P"7;0$_[:2'-<9\2H_&;Z8K
M:K]G.FC_ %JV&[:#V\S/)'Z5M3PW/)1<E]XIU^6+?*SV7K17C_@/Q-J?ARWB
MB\4QWD6C2H#;7$L+-L/H6ZA<>O\ *O5].U"TU*W6?3[F*YA;H\;!A4UJ$J3U
MU7<JE6C47GV+-%%%8&H4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !6%X[_Y$[5_
M^O=JW:PO'?\ R)VK_P#7NU !X$_Y$[2/^O=:W:PO G_(G:1_U[K6[0 4444
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MN-%OCSYEHV$;_>3H?TKL**N%24/A9,H1G\2.%_MGQ3X>XUW3EU>R7K>:>,2
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M/^0+?_\ 7O)_Z":NK]T?2@!:*** "BBB@ HHHH **** "BBB@ HHHH ****
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M9NFM6OXDC^E2+XX\,L,C6[+\9,4>QJ?RO[@]K#^9'1T5@KXQ\.,<+K>GD_\
M7=:E7Q3H+C*ZSIY_[;K_ (U/LI]F/VD>YLT5F+X@T9L;=6L#GI_I"?XU(NLZ
M6WW=2LC])U_QI<DNP^:/<OUE>)]#MO$>CRZ=>O+'#(RL6B(# J01U!]*M+J=
M@PRM[:D>TJ_XT\WUH 2;F# &2?,' I.+:LT7"HX24HO5'GW_  I_0_\ G]U+
M_OXG_P 37=:#I<.B:/:Z;:M(\-NFQ&D(+$9[XK L/B%H%[K3:='<,ISMCG<8
MBD;T!_QZUUU)T/8O6-C2>-J8F-I3ND%%%%!D%87CO_D3M7_Z]VK=K"\=_P#(
MG:O_ ->[4 '@3_D3M(_Z]UJYXDA6X\/ZC#)<W-HDENZ&XM03+$""-R8!.1UX
M%4_ G_(G:1_U[K6[0!YO\+95CU&ZM+&TTZZTY;5"-9TZ!H(YW5BI1U)(:0=2
MRD^^.!4-[;C2?%EQ=Z2D>KZA>:I$TMK<6+^9 A"([)-T554;\D8/(ZD5Z5;P
M16T*Q6\4<42_=2-0JCOT%24 >-_9;R2T,?D7@\9C7_,\\QN"(!<9SO\ N^3]
MGXQG'.,;J]DHHH R_$)N!I5Z(DB,?V=]Q9R"/E/08K37[H^E4M<_Y M__P!>
M\G_H)JZOW1]* %HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MB=J__7NU !X$_P"1.TC_ *]UK=K"\"?\B=I'_7NM;M !1110 4444 4=<_Y
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M_?.. PP.ISTKH_"FEKHVA6]A':I;+#GY%F,Q8DDEV<J"68DDG'4F@#7HHHH
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M197C$>W#-E2 =PX(XXY .LNO$5M;ZY-I@AN9I8+474S0Q[Q&&;:BX'S%F(;
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "L+QW_ ,B=J_\ U[M6[6%X[_Y$[5_^O=J #P)_R)VD?]>ZUNUA
M>!/^1.TC_KW6MV@ HHHH **** "BBB@ HHHH **** "H;NZ@L[=I[N:."%/O
M22,%4?B:FJ&\M;>]MV@O((IX6^]'*H93^!IJU]1.]M#,_P"$JT#_ *#6G?\
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M=*KP>"K&VUZZU*V=4%U<B[FB>WBDS+@ E792RYVKP#UY&,TS1? UAHTSBRD
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M='F)_?7\Z^8:* /I[S$_OK^='F)_?7\Z^8:* /I[S$_OK^='F)_?7\Z^8:*
M/I[S$_OK^='F)_?7\Z^8:* /I[S$_OK^='F)_?7\Z^8:* /I[S$_OK^='F)_
M?7\Z^8:* /I[S$_OK^='F)_?7\Z^8:* /I[S$_OK^='F)_?7\Z^8:* /I[S$
L_OK^='F)_?7\Z^8:* /I[S$_OK^=87CIU/@_5P&4G[.W>OGZE7[P^M '_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>19
<FILENAME>image2.jpg
<TEXT>
begin 644 image2.jpg
M_]C_X  02D9)1@ ! 0$ E@"6  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" !2!"T# 2(  A$! Q$!_\0
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ME>M?]"Q=?F?\*/K=+S^Y_P"0?V?7\O\ P*/^9UU%<C_PE>M?]"Q=?F?\*/\
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M_P"_8_QH_P"%@6/_ $#M0_[]C_&CZW0_F#^SL5_(SKJ*Y'_A8%C_ - [4/\
MOV/\:/\ A8-@/O:?J _[9#_&CZW0_F#^SL5_(SKJ*Y#_ (6'IO\ SXZA_P!^
MA_C1_P +#TW_ )\=0_[]#_&CZW0_F#^SL5_(SKZ*Y#_A8>F_\^.H?]^A_C1_
MPL/3?^?'4/\ OT/\:/K=#^8/[.Q7\C.OHKD?^%A:;WLK\?\ ;(?XTO\ PL+2
M_P#GTO\ _OT/\:/K=#^8/[.Q7\C.MHKDO^%A:7_SZ7__ 'Z'^-'_  L+2_\
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M!_YZ7'_?DT?6J'\Z%]0Q7_/M_<=317+?\+ T'_GI<?\ ?DT?\+ T'_GI<?\
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M]0N!P#[4 <+X*_Y*S\0/^NEK_P"BZK_!;3[(>'=7O!:P_:9M5N$DEV LR@C
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M#H-O2@!=-_Y!=I_UQ3_T$59J*VFMYH0UK+%)$OR@Q,"HQQCCTJ6@#S3XT_\
M(NZ-_P!ABW_F:K?&=+D'PO<&=+?38=1!N9Y8/.BA./D:1,@%0<]37I=YI]EJ
M,:1WMI!<I&XD19HPX5AT89[CUJ:6*.>)HIHTDC<89'4$$>X- 'E.KZ)<:^=+
M&J?$71)$@NXI[8P6,:2%P> C>:3STXK5UW_DN/A3_L'75=99>$_#FG7/VFRT
M'3+:?.?-AM$5L_4#-:#V%G+?17TEK"]W"I2.=HP713U ;J : ,B._P##)\:S
M649M/^$D%L&DQ%B4P]OGQR.G&:V+V![JRFMXKF2VDD0JLT6-T9/<9!&1[BFK
MIUBNHMJ*V=N+UT\MK@1CS"O]TMUQ[5!K>L6OA_1+O5KW?]FM8S))Y:Y;'L*
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M.LM4MOLVH6D%W!N#>5/&'7(Z'!XH XGX7:-=KI]WXJUA/^)QKTGVAP>L4/\
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M\O\ ZU'E^.?^>VG_ )?_ %JZ^BCZM_?E]X?7?^G<?N.0\OQS_P ]M/\ R_\
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M_P!>CS?'/_/OI_Y__7KKZ*/J_P#?E]X?75_S[C]W_!.0\[QR/^773V_X%_\
M7H^T>.?^?/3_ /OK_P"RKKZ*/J[_ )Y??_P ^N+_ )]1^[_@G(?:/'/_ #YZ
M?_WU_P#94?:/'/\ SYZ?_P!]?_95U]%'U=_SR^__ ( ?7%_SZC]S_P SCS+X
MW8Y-CII/N1_C2_:?'(_Y<=//MN_^RKKZ*/J[_GE]_P#P ^N+_GU'[G_F<)J=
MIXIUJR-GJ>A:3=VQ8,8I3E<@Y!^]5S[7XY_Z!VG_ /??_P!E77T4?5W_ #R^
M_P#X ?7%_P ^H_<_\SD/M?CG_H':?_WW_P#94?:_'/\ T#M/_P"^_P#[*NOH
MH^KO^>7W_P# #ZXO^?4?N?\ F<A]K\<CKIVGG_@?_P!E2_;?''_0,L/^_G_V
M5==11]7?\\OP_P @^N1_Y]1^Y_YG(_;?''_0,L/^_G_V5'VWQQ_T#+#_ +^?
M_95UU%'U=_SR_#_(/KD?^?4?N?\ F<C]M\<?] RP_P"_G_V5'VWQO_T"['_O
MY_\ 95UU%'U=_P \OP_R#ZY'_GU'[G_F<C_:'C7_ *!%G_W\_P#LJ/[0\:_]
M BS_ ._G_P!E7744?5W_ #O\/\@^N1_Y]1^Y_P"9R/\ :'C7_H$6?_?S_P"R
MH_M#QK_T"+/_ +^?_95UU%'U=_SO\/\ (/KD?^?4?N?^9R/]H>-?^@19_P#?
MS_[*C^T_&?\ T!K7_OY_]>NNHH^KR_G?X?Y!];A_SZC^/^9R/]I^,_\ H#6O
M_?S_ .O1_:?C/_H#6O\ W\_^O7744?5Y?SO\/\@^MP_Y]1_'_,Y'^T_&?_0&
MM?\ OY_]>C^T_&?_ $!K7_OY_P#7KKJ*/J\OYW^'^0?6X?\ /J/X_P"9R/\
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E** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH __V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>20
<FILENAME>plu.jpg
<TEXT>
begin 644 plu.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  0" P,# @0# P,$! 0$!0D&!04%
M!0L(" 8)#0L-#0T+# P.$!01#@\3#PP,$A@2$Q46%Q<7#A$9&QD6&A06%Q;_
MVP!# 00$! 4%!0H&!@H6#PP/%A86%A86%A86%A86%A86%A86%A86%A86%A86
M%A86%A86%A86%A86%A86%A86%A86%A;_P  1" "5 L8# 2(  A$! Q$!_\0
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M'ARA*$G&2LT%%%%,D**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBN9^*FLWNC^'HSIS21W5W<)
MDRQ>9Y )RSD$$< 'J,<T =-17%2:GXBEU;2],BO&22\7S)9/)3B/(+,,J00J
MX7/]Z1<C%=K0 445C^//$NF>$O"]SKFK2[(+=?E4?>E<_=11W)-3.<:<7.3L
MD:4J52M4C3IJ\F[)=V+XV\3Z+X3T.35M<O%M[=.%'5Y6[*B]6-?-'Q2^-_B;
MQ-))::-))HNF'@+"_P"_E'^VXZ?1?S-<?\2O&6L>-_$DFJZM*=H)%M;*?W=L
MG]U1Z^I[US]?G>;<0UL3)TZ#Y8?B_P#)>7WG[1P]P;A<#"-;%I3J^>JCZ+J_
M/[@8EG9V8LS'+,QR2?<]Z2EHKYL^V$HHI:0%S0-7U30]06^T?4+BQN%/$D$A
M4GZCH1[&O>O@]\?H[J:+2?' C@D;"QZG&NV-C_TU7^'_ 'AQ["OGBBO0P.9X
MG!3O2EIVZ,\C-LCP.:4W'$0UZ27Q+Y_H]#[]B=)8EDC=71P&5E.0P/0@]Z=7
MS1^RW\3-0TW6[7P7JGG7FGWDGEV3 %WM7/\ #[QG_P =Z]*^EZ_2\MS"ECZ"
MJPT?5=F?AF>9+7RG%NA5=T]4^Z_3S04445Z!XX4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5YE\7_ !Z-
M#\5VFBK;_:(DB6XN1"-TZ,7VQ!!W+8;CKQ7I-U,D%N\TAPD:EF/H ,FO#_V?
MKB3XC^-M;\97=E$^E6NK2?8+AAEKAUPJ8_V44#ZGFNS"0I^]4J*\8K\7L<6,
MG57+"D[2;^Y=3V#1=-MTNAJQ$QNI[9(\RC!C3)8J%_AR3SZX'H*U*,45QG:%
M?)O[47CA_%/CE]*LYBVEZ,[11@'Y99NCO[X/RCZ'UKZ*^-'B(^%OAGJVL1OM
MN(X#';'_ *:O\J_D3G\*^)VD7<2\H+9^8D\D^]?'<68YPA'"Q>^K].GX_D?I
MGA[E,:E2ICYJ_+[L?7J_NLOFQ:*171C@.I^AH9E7[S ?4U\*?JUF+11VR**8
M!1112 *,X&:N^']'U77-273]&T^XOKIU+"*!-S8'4GT'N:Z3X8>"[W5_BY8>
M%]7L9K9HY_,OH)E*LL:#<P/UX'_ JWHX>K5E%17Q.R?2YRXC&4,/"<IR7NIR
M:ZV76Q[?^RG\/8]!\.+XIU.#_B::I'F .O-M >0!Z%NI]L#UKU^DC54C5$4*
MJC  ' %+7ZU@\)3PE"-&FM%^/F?SMFF8ULQQ<\35>LOP71+T"BBBNHX HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MT^[M;^QBO;*XCN+>= \4L;!E=3T((J:O-_V6YHX/@KH<5Q<(DEP]QY$;OAG
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M]#?XR_\ !V_^%(WPFTX_\SAXT'TUM_\ "CVV+_Y\K_P+_@!]5R__ *"'_P"
M/_,] HKS]?A-8CIXT\;#Z:XW_P 31_PJBR_Z'7QM_P"#QO\ XFG[;%_\^?\
MR9?Y!]5R_P#Z"'_X _\ ,] HKS[_ (5-:#D>.?'/_@\;_P")I?\ A5-O_P!#
MYX[_ /!ZW_Q-+V^+_P"?/_DR_P @^JY?_P!!/_DC_P ST"BO/_\ A5-O_P!#
MYXZ_\'K?_$TX?"N$# \>>.?_  =G_P")H]OBO^?/_DR_R#ZK@/\ H)_\D?\
MF=]17 _\*LB_Z'WQS_X.S_\ $TB_"Q0<CQ_XW_\ !P?_ (FG[?%?\^?_ "9!
M]5P'_03_ .2/_,[^BN!_X5</^A_\;?\ @W_^QIK?"YL\?$#QJ/\ N+'_ .)H
M]OBO^?/_ ),@^JX#_H)_\D9Z!17 _P#"L)/^B@^,_P#P9_\ V-(?AA+CCX@^
M,O\ P9__ &-+V^*_Y\_^3(/JF!_Z"?\ R61W]%< OPQN1T^(?C#\=0'_ ,32
M_P#"L[G_ **'XP_\& _^)H^L8G_GS_Y,@^J8'_H)_P#)9'?45Y__ ,*RO-V1
M\1?%WXWP/]*=_P *UOO^BB>+/_ Q?_B:?UC$_P#/G_R9!]4P/_02O_ 9'?45
MP#?#2_QQ\1?%@_[>Q_A0/AOJ8&!\1_%/_@0O^%'UC$_\^7]Z#ZG@O^@E?^ R
M_P COZ*X'_A6^I_]%'\4_P#@0O\ A31\.-7!R/B3XG_&9#_2CZQB?^?+^^/^
M8?4\%_T$K_P&7^1Z!17 _P#"NM8_Z*3XF_[^)_A36^'.M?P_$KQ,/^VB?X4?
M6,3_ ,^7]\?\P^IX+_H*7_@,O\CT"BN _P"%>:[_ -%+\1_G'_A1_P *\U[_
M **7XC_./_"CZQB/^?+^^/\ F'U/!_\ 04O_  &?^1W]%>?K\/?$0X'Q-\0?
MBL?^%+_PK[Q%_P!%-\0?]\1_X4OK.(_Y\/[X_P"8?4L'_P!!4?\ P&?_ ,B=
M_17G_P#PK[Q*&ROQ.UX?6*,_TI?^$ \3_P#13]=_[\1?X4?6<1_SX?WQ_P P
M^I8/_H*C_P" S_\ D3OZ*X#_ (0#Q1V^*&N?]^(O\*!X"\6#C_A:6M?^ L/^
M%/ZSB/\ GP_OC_F'U'!_]!4?_ 9__(G?T5P'_"!^+?\ HJ6M?^ D/^%)_P (
M'XP!^7XIZQ^-E":/K-?_ )\/[X__ "0?4<)_T%1_\!G_ /(GH%%<!_P@OC'_
M **GJW_@##2'P)XR[?%35L^]A#2^LU_^?$OOC_\ )!]1PG_05'_P&I_\@>@4
M5P'_  @_C?\ Z*MJ?_@M@H_X0?QO_P!%6U/_ ,%L%'UJO_SXE]\/_D@^HX7_
M *"X?=4_^0._HKS_ /X0CQV/N_%?4,>^E0&E_P"$)\>?]%8U#_P4V]'UJO\
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M)7(*L>W4$9XZUTE[HGP/\->+E\6?\)!%=3?:Q-!807J31+*S9#;5Y"@G/S'
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M5Z%&G[*G&G>]E8\3%XCZQ7G6M;F=_F]PHHHK4YPHHHH **** "BBB@ HHHH
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
+ **** "BBB@#_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6809981936">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Document and Entity Information - USD ($)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2017</div></th>
<th class="th"><div>Aug. 31, 2017</div></th>
<th class="th"><div>Dec. 31, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_psti_DocumentAndEntityInformationAbstract', window );"><strong>Document and Entity Information [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-K<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Jun. 30,  2017<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">PLURISTEM THERAPEUTICS INC<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001158780<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--06-30<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2017<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">FY<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">97,473,652<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityPublicFloat', window );">Entity Public Float</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 107,969,302<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityVoluntaryFilers', window );">Entity Voluntary Filers</a></td>
<td class="text">No<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityWellKnownSeasonedIssuer', window );">Entity Well-known Seasoned Issuer</a></td>
<td class="text">No<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>If the value is true, then the document is an amendment to previously-filed/accepted document.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal period of the document report. For a first quarter 2006 quarterly report, which may also provide financial information from prior periods, the first fiscal quarter should be given as the fiscal period focus. Values: FY, Q1, Q2, Q3, Q4, H1, H2, M9, T1, T2, T3, M8, CY.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in CCYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word "Other".</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12b<br> -Subsection 1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate "Yes" or "No" whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: (1) Large Accelerated Filer, (2) Accelerated Filer, (3) Non-accelerated Filer, (4) Smaller Reporting Company (Non-accelerated) or (5) Smaller Reporting Accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityPublicFloat">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>State aggregate market value of voting and non-voting common equity held by non-affiliates computed by reference to price at which the common equity was last sold, or average bid and asked price of such common equity, as of the last business day of registrant's most recently completed second fiscal quarter. The public float should be reported on the cover page of the registrants form 10K.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityPublicFloat</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12b<br> -Subsection 1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityVoluntaryFilers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate "Yes" or "No" if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityVoluntaryFilers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityWellKnownSeasonedIssuer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate "Yes" or "No" if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityWellKnownSeasonedIssuer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_psti_DocumentAndEntityInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Document And Entity Information Abstract</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">psti_DocumentAndEntityInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>psti_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6816029120">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONSOLIDATED BALANCE SHEETS - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Jun. 30, 2017</div></th>
<th class="th"><div>Jun. 30, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>CURRENT ASSETS:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 4,707<span></span>
</td>
<td class="nump">$ 6,223<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermInvestments', window );">Short-term bank deposits</a></td>
<td class="nump">6,235<span></span>
</td>
<td class="nump">8,570<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue', window );">Restricted cash and short-term-bank deposits</a></td>
<td class="nump">559<span></span>
</td>
<td class="nump">542<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesCurrent', window );">Marketable securities</a></td>
<td class="nump">15,164<span></span>
</td>
<td class="nump">17,415<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts receivable from the Israeli Innovation Authority ("IIA")</a></td>
<td class="nump">1,036<span></span>
</td>
<td class="nump">2,228<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsCurrent', window );">Other current assets</a></td>
<td class="nump">1,315<span></span>
</td>
<td class="nump">618<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">29,016<span></span>
</td>
<td class="nump">35,596<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsNoncurrentAbstract', window );"><strong>LONG-TERM ASSETS:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermInvestments', window );">Long-term deposits and restricted bank deposits</a></td>
<td class="nump">403<span></span>
</td>
<td class="nump">363<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent', window );">Severance pay fund</a></td>
<td class="nump">804<span></span>
</td>
<td class="nump">766<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="nump">7,277<span></span>
</td>
<td class="nump">9,216<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other long term assets</a></td>
<td class="nump">34<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsNoncurrent', window );">Total long-term assets</a></td>
<td class="nump">8,518<span></span>
</td>
<td class="nump">10,345<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">37,534<span></span>
</td>
<td class="nump">45,941<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>CURRENT LIABILITIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Trade payables</a></td>
<td class="nump">1,966<span></span>
</td>
<td class="nump">2,705<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued expenses</a></td>
<td class="nump">1,465<span></span>
</td>
<td class="nump">1,369<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableOtherCurrent', window );">Other accounts payable</a></td>
<td class="nump">1,983<span></span>
</td>
<td class="nump">1,701<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">5,414<span></span>
</td>
<td class="nump">5,775<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesNoncurrentAbstract', window );"><strong>LONG-TERM LIABILITIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PostemploymentBenefitsLiabilityNoncurrent', window );">Accrued severance pay</a></td>
<td class="nump">940<span></span>
</td>
<td class="nump">910<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other long-term liabilities</a></td>
<td class="nump">929<span></span>
</td>
<td class="nump">1,100<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesNoncurrent', window );">Total long-term liabilities</a></td>
<td class="nump">1,869<span></span>
</td>
<td class="nump">2,010<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">COMMITMENTS AND CONTINGENCIES</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>STOCKHOLDERS' EQUITY</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock $0.00001 par value per share: Authorized: 200,000,000 shares Issued and outstanding: 96,938,789 shares as of June 30, 2017; 80,268,999 shares as of June 30, 2016</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional paid-in capital</a></td>
<td class="nump">217,822<span></span>
</td>
<td class="nump">198,432<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="num">(189,571)<span></span>
</td>
<td class="num">(161,757)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income</a></td>
<td class="nump">1,999<span></span>
</td>
<td class="nump">1,480<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total stockholders' equity</a></td>
<td class="nump">30,251<span></span>
</td>
<td class="nump">38,156<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities and stockholders' equity</a></td>
<td class="nump">$ 37,534<span></span>
</td>
<td class="nump">$ 45,941<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableOtherCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of obligations incurred classified as other, payable within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=82887183&amp;loc=d3e6935-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableOtherCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount due from customers or clients, within one year of the balance sheet date (or the normal operating cycle, whichever is longer), for goods or services (including trade receivables) that have been delivered or sold in the normal course of business, reduced to the estimated net realizable fair value by an allowance established by the entity of the amount it deems uncertain of collection.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=84228862&amp;loc=d3e637-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=84228862&amp;loc=d3e681-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=84228862&amp;loc=SL7669686-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders. Includes adjustments to additional paid in capital. Some examples of such adjustments include recording the issuance of debt with a beneficial conversion feature and certain tax consequences of equity instruments awarded to employees. Use this element for the aggregate amount of additional paid-in capital associated with common and preferred stock. For additional paid-in capital associated with only common stock, use the element additional paid in capital, common stock. For additional paid-in capital associated with only preferred stock, use the element additional paid in capital, preferred stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=82887183&amp;loc=d3e6801-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=82887183&amp;loc=d3e6676-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold or consumed after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 8: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsNoncurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsNoncurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=82887183&amp;loc=d3e6676-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3044-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.(a),19)<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=82911808&amp;loc=d3e14326-108349<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset, recognized in statement of financial position, for overfunded defined benefit pension and other postretirement plans.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=82843861&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=64852052&amp;loc=d3e1731-114919<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=64852052&amp;loc=d3e1703-114919<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation due after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 201.5-02(26))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 201.5-02(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 201.5-02(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesNoncurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesNoncurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The total amount of investments that are intended to be held for an extended period of time (longer than one operating cycle).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.12)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecuritiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investments in debt and equity securities, including, but not limited to, held-to-maturity, trading and available-for-sale expected to be converted to cash, sold or exchanged within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=82887183&amp;loc=d3e6676-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=82896770&amp;loc=d3e26626-111562<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketableSecuritiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.8)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PostemploymentBenefitsLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For a classified balance sheet, the carrying amount as of the balance sheet date of the portion of the obligations recognized for the various benefits provided to former or inactive employees, their beneficiaries, and covered dependents after employment but before retirement that is payable after one year (or beyond the operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 712<br> -SubTopic 10<br> -Section 25<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=6410138&amp;loc=d3e79691-111665<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PostemploymentBenefitsLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents restricted as to withdrawal or usage, classified as current. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=98513485&amp;loc=SL98516268-108586<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3044-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=82887183&amp;loc=d3e6676-107765<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investments including trading securities, available-for-sale securities, held-to-maturity securities, and short-term investments classified as other and current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(1)(g))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(6))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=27010918&amp;loc=d3e74512-122707<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6801782720">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONSOLIDATED BALANCE SHEETS (PARENTHETICAL) - $ / shares<br></strong></div></th>
<th class="th"><div>Jun. 30, 2017</div></th>
<th class="th"><div>Jun. 30, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfFinancialPositionAbstract', window );"><strong>Statement of Financial Position [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value per share</a></td>
<td class="nump">$ 0.00001<span></span>
</td>
<td class="nump">$ 0.00001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized</a></td>
<td class="nump">200,000,000<span></span>
</td>
<td class="nump">200,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued</a></td>
<td class="nump">96,938,789<span></span>
</td>
<td class="nump">80,268,999<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding</a></td>
<td class="nump">96,938,789<span></span>
</td>
<td class="nump">80,268,999<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=84159872&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfFinancialPositionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfFinancialPositionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6810128640">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF  OPERATIONS - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2017</div></th>
<th class="th"><div>Jun. 30, 2016</div></th>
<th class="th"><div>Jun. 30, 2015</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementAbstract', window );"><strong>Income Statement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 2,847<span></span>
</td>
<td class="nump">$ 379<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfRevenue', window );">Cost of revenues</a></td>
<td class="text"> <span></span>
</td>
<td class="num">(100)<span></span>
</td>
<td class="num">(13)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Gross profit</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">2,747<span></span>
</td>
<td class="nump">366<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development expenses</a></td>
<td class="num">(24,001)<span></span>
</td>
<td class="num">(22,856)<span></span>
</td>
<td class="num">(23,416)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_psti_GovernmentAndThirdPartyGrantsReceived', window );">Less R&amp;D participation grants</a></td>
<td class="nump">2,909<span></span>
</td>
<td class="nump">3,276<span></span>
</td>
<td class="nump">4,243<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_psti_ResearchAndDevelopmentExpensesNet', window );">Research and development expenses, net</a></td>
<td class="num">(21,092)<span></span>
</td>
<td class="num">(19,580)<span></span>
</td>
<td class="num">(19,173)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General and administrative expenses</a></td>
<td class="num">(6,927)<span></span>
</td>
<td class="num">(6,486)<span></span>
</td>
<td class="num">(6,460)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating loss</a></td>
<td class="num">(28,019)<span></span>
</td>
<td class="num">(23,319)<span></span>
</td>
<td class="num">(25,267)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpense', window );">Financial income, net</a></td>
<td class="nump">205<span></span>
</td>
<td class="nump">73<span></span>
</td>
<td class="nump">590<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss for the period</a></td>
<td class="num">$ (27,814)<span></span>
</td>
<td class="num">$ (23,246)<span></span>
</td>
<td class="num">$ (24,677)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Loss per share:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAndDiluted', window );">Basic and diluted net loss per share</a></td>
<td class="num">$ (0.32)<span></span>
</td>
<td class="num">$ (0.29)<span></span>
</td>
<td class="num">$ (0.35)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted', window );">Weighted average number of shares used in computing basic and diluted net loss per share</a></td>
<td class="nump">87,426,208<span></span>
</td>
<td class="nump">79,547,989<span></span>
</td>
<td class="nump">70,284,337<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_psti_GovernmentAndThirdPartyGrantsReceived">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Grants received from the government and third parties for research and development programs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">psti_GovernmentAndThirdPartyGrantsReceived</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>psti_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_psti_ResearchAndDevelopmentExpensesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Research and development expenses, net.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">psti_ResearchAndDevelopmentExpensesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>psti_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate cost of goods produced and sold and services rendered during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAndDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements.  Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period.  Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicAndDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GrossProfit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1,2)<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GrossProfit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879574&amp;loc=d3e536633-122882<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879464&amp;loc=d3e573970-122913<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Average number of shares or units issued and outstanding that are used in calculating basic and diluted earnings per share (EPS).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6809843952">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF COMPREHENSIVE  LOSS - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2017</div></th>
<th class="th"><div>Jun. 30, 2016</div></th>
<th class="th"><div>Jun. 30, 2015</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract', window );"><strong>Statement of Comprehensive Income [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (27,814)<span></span>
</td>
<td class="num">$ (23,246)<span></span>
</td>
<td class="num">$ (24,677)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParentAbstract', window );"><strong>Other comprehensive income (loss), net:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax', window );">Unrealized gain on derivative instruments</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">285<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax', window );">Unrealized gain (loss) on available-for-sale marketable securities, net</a></td>
<td class="nump">924<span></span>
</td>
<td class="num">(1,071)<span></span>
</td>
<td class="num">(1,132)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax', window );">Reclassification adjustment of derivative instruments losses realized in net loss, net</a></td>
<td class="text"> <span></span>
</td>
<td class="num">(46)<span></span>
</td>
<td class="num">(262)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax', window );">Reclassification adjustment of available-for-sale marketable securities gains (losses) realized in net loss, net</a></td>
<td class="num">(405)<span></span>
</td>
<td class="nump">457<span></span>
</td>
<td class="nump">290<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive income (loss)</a></td>
<td class="nump">519<span></span>
</td>
<td class="num">(660)<span></span>
</td>
<td class="num">(819)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Total comprehensive loss</a></td>
<td class="num">$ (27,295)<span></span>
</td>
<td class="num">$ (23,906)<span></span>
</td>
<td class="num">$ (25,496)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=84228862&amp;loc=d3e557-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879574&amp;loc=d3e536633-122882<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879464&amp;loc=d3e573970-122913<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of other comprehensive income (loss) attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=84161450&amp;loc=SL4573702-111684<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=96868048&amp;loc=SL4569616-111683<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=96868048&amp;loc=SL4569643-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of reclassification adjustment from accumulated other comprehensive income for unrealized gain (loss) realized upon the sale of available-for-sale securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=82897076&amp;loc=d3e27357-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=84228862&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=84228862&amp;loc=d3e689-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of reclassification adjustment from accumulated other comprehensive income of accumulated gain (loss) realized from derivative instruments designated and qualifying as the effective portion of cash flow hedges and an entity's share of an equity investee's deferred hedging gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=84228862&amp;loc=d3e689-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph c<br> -URI http://asc.fasb.org/extlink&amp;oid=84234895&amp;loc=d3e41638-113959<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=84228862&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in accumulated gain (loss) from derivative instruments designated and qualifying as the effective portion of cash flow hedges and an entity's share of an equity investee's increase (decrease) in deferred hedging gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=84228862&amp;loc=SL7669646-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=84228862&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6441202&amp;loc=d3e80720-113993<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84234895&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax, before reclassification adjustments, of unrealized holding gain (loss) on available-for-sale securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=84228862&amp;loc=SL7669646-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=84228862&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6817128016">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2"><div>Common Stock [Member]</div></th>
<th class="th"><div>Additional Paid-In Capital [Member]</div></th>
<th class="th"><div>Receivables on account of shares [Member]</div></th>
<th class="th"><div>Accumulated Other Comprehensive Income (Loss) [Member]</div></th>
<th class="th"><div>Accumulated Deficit [Member]</div></th>
<th class="th"><div>Total</div></th>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Jun. 30, 2014</a></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">$ 172,998<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 2,959<span></span>
</td>
<td class="num">$ (113,834)<span></span>
</td>
<td class="nump">$ 62,123<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance, shares at Jun. 30, 2014</a></td>
<td class="nump">68,601,452<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Issuance of common stock and warrants related to June 2015 offering, net of issuance costs of $1,200 (Note 9c)</a></td>
<td class="nump">$ 1<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">15,799<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 15,800<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of common stock and warrants related to June 2015 offering, net of issuance costs of $1,200 (Note 9c), shares</a></td>
<td class="nump">6,800,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,800,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Exercise of options by employees and non-employee consultants</a></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">11<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 11<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercise of options by employees and non-employee consultants, shares</a></td>
<td class="nump">39,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_psti_StockIssuedDuringPeriodValueStockWarrantsExercised', window );">Exercise of warrants by investors and finders</a></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">276<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">276<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_psti_StockIssuedDuringPeriodSharesStockWarrantsExercised', window );">Exercise of warrants by investors and finders, shares</a></td>
<td class="nump">1,134,043<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Stock based compensation to employees, directors and non-employee consultants</a></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">4,052<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">4,052<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Stock based compensation to employees, directors and non-employee consultants, shares</a></td>
<td class="nump">1,397,406<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_psti_StockIssuedDuringPeriodValuePrivatePlacement', window );">Proceeds related to issuance of common stock in a private placement (Note 9b)</a></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">1,904<span></span>
</td>
<td class="num">(790)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">1,114<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_psti_StockIssuedDuringPeriodSharesPrivatePlacement', window );">Proceeds related to issuance of common stock in a private placement (Note 9b), shares</a></td>
<td class="nump">700,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueIssuedForServices', window );">Stock-based compensation to contractor (Note 9d)</a></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">263<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">263<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices', window );">Stock-based compensation to contractor, shares (Note 9d)</a></td>
<td class="nump">100,004<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss), net</a></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(819)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(819)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(24,677)<span></span>
</td>
<td class="num">(24,677)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Jun. 30, 2015</a></td>
<td class="nump">$ 1<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">195,303<span></span>
</td>
<td class="num">(790)<span></span>
</td>
<td class="nump">2,140<span></span>
</td>
<td class="num">(138,511)<span></span>
</td>
<td class="nump">$ 58,143<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance, shares at Jun. 30, 2015</a></td>
<td class="nump">78,771,905<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">78,771,905<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Exercise of options by employees and non-employee consultants</a></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">17<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 17<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercise of options by employees and non-employee consultants, shares</a></td>
<td class="nump">28,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Stock based compensation to employees, directors and non-employee consultants</a></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">3,073<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">3,073<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Stock based compensation to employees, directors and non-employee consultants, shares</a></td>
<td class="nump">1,379,094<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_psti_StockIssuedDuringPeriodValuePrivatePlacement', window );">Proceeds related to issuance of common stock in a private placement (Note 9b)</a></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="nump">790<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">790<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueIssuedForServices', window );">Stock-based compensation to contractor (Note 9d)</a></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">39<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">39<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices', window );">Stock-based compensation to contractor, shares (Note 9d)</a></td>
<td class="nump">90,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss), net</a></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(660)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(660)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(23,246)<span></span>
</td>
<td class="num">(23,246)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Jun. 30, 2016</a></td>
<td class="nump">$ 1<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">198,432<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">1,480<span></span>
</td>
<td class="num">(161,757)<span></span>
</td>
<td class="nump">$ 38,156<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance, shares at Jun. 30, 2016</a></td>
<td class="nump">80,268,999<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">80,268,999<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Exercise of options by employees and non-employee consultants</a></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">10<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 10<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercise of options by employees and non-employee consultants, shares</a></td>
<td class="nump">17,900<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Stock based compensation to employees, directors and non-employee consultants</a></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">3,662<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">3,662<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Stock based compensation to employees, directors and non-employee consultants, shares</a></td>
<td class="nump">2,570,257<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_psti_IssuanceOfCommonStockAndWarrantsRelatedToJanuaryTwentySeventeenOfferingNetOfIssuanceCostsValue', window );">Issuance of common stock and warrants related to January 2017 offering, net of issuance costs of $1,532 (Note 9e)</a></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">15,718<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">15,718<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_psti_IssuanceOfCommonStockAndWarrantsRelatedToJanuaryTwentySeventeenOfferingNetOfIssuanceCostsShares', window );">Issuance of common stock and warrants related to January 2017 offering, net of issuance costs of $1,532 (Note 9e), shares</a></td>
<td class="nump">14,081,633<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss), net</a></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">519<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">519<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(27,814)<span></span>
</td>
<td class="num">(27,814)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Jun. 30, 2017</a></td>
<td class="nump">$ 1<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 217,822<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 1,999<span></span>
</td>
<td class="num">$ (189,571)<span></span>
</td>
<td class="nump">$ 30,251<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance, shares at Jun. 30, 2017</a></td>
<td class="nump">96,938,789<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">96,938,789<span></span>
</td>
</tr>
<tr><td colspan="8"></td></tr>
<tr><td colspan="8"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Less than $1</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_psti_IssuanceOfCommonStockAndWarrantsRelatedToJanuaryTwentySeventeenOfferingNetOfIssuanceCostsShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Issuance of common stock and warrants related to January 2017 offering, net of issuance costs, number of shares issued.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">psti_IssuanceOfCommonStockAndWarrantsRelatedToJanuaryTwentySeventeenOfferingNetOfIssuanceCostsShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>psti_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_psti_IssuanceOfCommonStockAndWarrantsRelatedToJanuaryTwentySeventeenOfferingNetOfIssuanceCostsValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Issuance of common stock and warrants related to January 2017 offering, net of issuance costs, value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">psti_IssuanceOfCommonStockAndWarrantsRelatedToJanuaryTwentySeventeenOfferingNetOfIssuanceCostsValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>psti_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_psti_StockIssuedDuringPeriodSharesPrivatePlacement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the number of stock issued during the period under the private placement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">psti_StockIssuedDuringPeriodSharesPrivatePlacement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>psti_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_psti_StockIssuedDuringPeriodSharesStockWarrantsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of stock issued as a result of the exercise of stock warrants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">psti_StockIssuedDuringPeriodSharesStockWarrantsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>psti_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_psti_StockIssuedDuringPeriodValuePrivatePlacement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the equity impact of the value of private placement issued during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">psti_StockIssuedDuringPeriodValuePrivatePlacement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>psti_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_psti_StockIssuedDuringPeriodValueStockWarrantsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued as a result of the exercise of stock warrants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">psti_StockIssuedDuringPeriodValueStockWarrantsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>psti_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=84159872&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879574&amp;loc=d3e536633-122882<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879464&amp;loc=d3e573970-122913<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=84159872&amp;loc=d3e21463-112644<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=84228862&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -URI http://asc.fasb.org/extlink&amp;oid=84228862&amp;loc=SL7669625-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=84158357&amp;loc=d3e1436-108581<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued in lieu of cash for services contributed to the entity. Number of shares includes, but is not limited to, shares issued for services contributed by vendors and founders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesIssuedForServices</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=84159872&amp;loc=d3e21463-112644<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares (or other type of equity) issued during the period as a result of any equity-based compensation plan other than an employee stock ownership plan (ESOP), net of any shares forfeited. Shares issued could result from the issuance of restricted stock, the exercise of stock options, stock issued under employee stock purchase plans, and/or other employee benefit plans.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=84159872&amp;loc=d3e21463-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=84159872&amp;loc=d3e21463-112644<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=96867065&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueIssuedForServices">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued in lieu of cash for services contributed to the entity. Value of the stock issued includes, but is not limited to, services contributed by vendors and founders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueIssuedForServices</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=84159872&amp;loc=d3e21463-112644<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of stock (or other type of equity) issued during the period as a result of any equity-based compensation plan other than an employee stock ownership plan (ESOP), net of stock value of such awards forfeited. Stock issued could result from the issuance of restricted stock, the exercise of stock options, stock issued under employee stock purchase plans, and/or other employee benefit plans.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=96867065&amp;loc=d3e5047-113901<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=96867065&amp;loc=d3e5070-113901<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued as a result of the exercise of stock options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=84159872&amp;loc=d3e21463-112644<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=27010918&amp;loc=d3e74512-122707<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AdditionalPaidInCapitalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AdditionalPaidInCapitalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_ReceivablesFromStockholderMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_ReceivablesFromStockholderMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_RetainedEarningsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_RetainedEarningsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6791400800">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (Parenthetical) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2017</div></th>
<th class="th"><div>Jun. 30, 2015</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfStockholdersEquityAbstract', window );"><strong>Statement of Stockholders' Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts', window );">Issuance of common stock and warrants, issuance costs</a></td>
<td class="nump">$ 1,532<span></span>
</td>
<td class="nump">$ 1,200<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in additional paid in capital (APIC) resulting from direct costs associated with issuing stock. Includes, but is not limited to, legal and accounting fees and direct costs associated with stock issues under a shelf registration.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=84159872&amp;loc=d3e21463-112644<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfStockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfStockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6816757424">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2017</div></th>
<th class="th"><div>Jun. 30, 2016</div></th>
<th class="th"><div>Jun. 30, 2015</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>CASH FLOWS FROM OPERATING ACTIVITIES:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (27,814)<span></span>
</td>
<td class="num">$ (23,246)<span></span>
</td>
<td class="num">$ (24,677)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net loss to net cash used in operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation</a></td>
<td class="nump">2,177<span></span>
</td>
<td class="nump">2,150<span></span>
</td>
<td class="nump">2,074<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfPropertyPlantEquipment', window );">Loss from sale of property and equipment, net</a></td>
<td class="nump">72<span></span>
</td>
<td class="nump">82<span></span>
</td>
<td class="nump">20<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_psti_AmortizationOfDiscountAndPremiumAndChangesInAccruedInterestFromMarketableSecurities', window );">Accretion of discount, amortization of premium and changes in accrued interest of marketable securities</a></td>
<td class="nump">35<span></span>
</td>
<td class="num">(114)<span></span>
</td>
<td class="nump">213<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesRealizedGainLoss', window );">Loss (gain) from sale of investments of available-for-sale marketable securities</a></td>
<td class="num">(362)<span></span>
</td>
<td class="nump">419<span></span>
</td>
<td class="nump">290<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherThanTemporaryImpairmentLossesInvestmentsPortionRecognizedInEarningsNet', window );">Other-than-temporary loss of available-for-sale marketable securities</a></td>
<td class="nump">767<span></span>
</td>
<td class="nump">38<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation to employees, directors and non-employees consultants</a></td>
<td class="nump">3,662<span></span>
</td>
<td class="nump">3,073<span></span>
</td>
<td class="nump">4,052<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherReceivables', window );">Decrease (increase) in Accounts receivable from the IIA</a></td>
<td class="nump">1,192<span></span>
</td>
<td class="num">(537)<span></span>
</td>
<td class="nump">572<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherOperatingAssets', window );">Decrease (increase) in other current assets and other long-term assets</a></td>
<td class="num">(731)<span></span>
</td>
<td class="nump">1,395<span></span>
</td>
<td class="num">(1,129)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayable', window );">Decrease in trade payables</a></td>
<td class="num">(701)<span></span>
</td>
<td class="num">(77)<span></span>
</td>
<td class="num">(566)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities', window );">Increase (decrease) in other accounts payable, accrued expenses, other long-term liabilities and other current liabilities</a></td>
<td class="nump">138<span></span>
</td>
<td class="nump">1,225<span></span>
</td>
<td class="num">(949)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInDeferredRevenue', window );">Decrease in deferred revenues</a></td>
<td class="text"> <span></span>
</td>
<td class="num">(2,847)<span></span>
</td>
<td class="num">(379)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInCustomerAdvances', window );">Decrease in advance payment from United</a></td>
<td class="text"> <span></span>
</td>
<td class="num">(93)<span></span>
</td>
<td class="num">(154)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccruedInterestReceivableNet', window );">Increase (decrease) in interest receivable on short-term deposits</a></td>
<td class="num">(24)<span></span>
</td>
<td class="num">(25)<span></span>
</td>
<td class="nump">35<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_psti_LinkageDifferencesAndInterestOnShortAndLongTermRestrictedLeaseDeposit', window );">Linkage differences and interest on short and long-term deposits and restricted bank deposits</a></td>
<td class="num">(14)<span></span>
</td>
<td class="num">(3)<span></span>
</td>
<td class="nump">54<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPensionAndPostretirementObligations', window );">Accrued severance pay, net</a></td>
<td class="num">(8)<span></span>
</td>
<td class="nump">38<span></span>
</td>
<td class="num">(61)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash used in operating activities</a></td>
<td class="num">(21,611)<span></span>
</td>
<td class="num">(18,522)<span></span>
</td>
<td class="num">(20,605)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>CASH FLOWS FROM INVESTING ACTIVITIES:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Purchase of property and equipment</a></td>
<td class="num">(378)<span></span>
</td>
<td class="num">(1,750)<span></span>
</td>
<td class="num">(831)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment', window );">Proceeds from sale of property and equipment</a></td>
<td class="nump">30<span></span>
</td>
<td class="nump">28<span></span>
</td>
<td class="nump">19<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForProceedsFromShortTermInvestments', window );">Repayment of (investment in) short-term deposits</a></td>
<td class="nump">2,316<span></span>
</td>
<td class="num">(849)<span></span>
</td>
<td class="nump">16,061<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_psti_RepaymentOfInvestmentInLongtermDepositsAndRestrictedBankDeposits', window );">Repayment of (investment in) long-term deposits and restricted bank deposits</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="num">(78)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfAvailableForSaleSecurities', window );">Proceeds from sale of available-for-sale marketable securities</a></td>
<td class="nump">5,527<span></span>
</td>
<td class="nump">6,999<span></span>
</td>
<td class="nump">10,635<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities', window );">Proceeds from redemption of available-for-sale marketable securities</a></td>
<td class="nump">410<span></span>
</td>
<td class="nump">1,094<span></span>
</td>
<td class="nump">634<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireAvailableForSaleSecurities', window );">Investment in available-for-sale marketable securities</a></td>
<td class="num">(3,607)<span></span>
</td>
<td class="num">(4,215)<span></span>
</td>
<td class="num">(4,903)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash provided by investing activities</a></td>
<td class="nump">4,298<span></span>
</td>
<td class="nump">1,312<span></span>
</td>
<td class="nump">21,537<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>CASH FLOWS FROM FINANCING ACTIVITIES:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Proceeds related to issuance of common stock and warrants, net of issuance costs</a></td>
<td class="nump">15,718<span></span>
</td>
<td class="nump">790<span></span>
</td>
<td class="nump">16,914<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities', window );">Proceeds in respect of BIRD liability</a></td>
<td class="nump">69<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions', window );">Exercise of warrants and options</a></td>
<td class="nump">10<span></span>
</td>
<td class="nump">17<span></span>
</td>
<td class="nump">287<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash provided by financing activities</a></td>
<td class="nump">15,797<span></span>
</td>
<td class="nump">807<span></span>
</td>
<td class="nump">17,201<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease', window );">Increase (decrease) in cash and cash equivalents</a></td>
<td class="num">(1,516)<span></span>
</td>
<td class="num">(16,403)<span></span>
</td>
<td class="nump">18,133<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents at the beginning of the period</a></td>
<td class="nump">6,223<span></span>
</td>
<td class="nump">22,626<span></span>
</td>
<td class="nump">4,493<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents at the end of the period</a></td>
<td class="nump">4,707<span></span>
</td>
<td class="nump">6,223<span></span>
</td>
<td class="nump">22,626<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowInformationAbstract', window );"><strong>(a) Supplemental disclosure of cash flow activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxesPaid', window );">Cash paid during the period for: Taxes paid due to non-deductible expenses</a></td>
<td class="nump">28<span></span>
</td>
<td class="nump">66<span></span>
</td>
<td class="nump">54<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNoncashInvestingAndFinancingItemsAbstract', window );"><strong>(b) Supplemental disclosure of non-cash activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CapitalExpendituresIncurredButNotYetPaid', window );">Purchase of property and equipment on credit</a></td>
<td class="nump">88<span></span>
</td>
<td class="nump">126<span></span>
</td>
<td class="nump">612<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssued1', window );">Share consideration to constructor</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">39<span></span>
</td>
<td class="nump">263<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherSignificantNoncashTransactionValueOfConsiderationGiven1', window );">Receivables on account of shares</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 790<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_psti_AmortizationOfDiscountAndPremiumAndChangesInAccruedInterestFromMarketableSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amortization of discount and premium and changes in accrued interest from marketable securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">psti_AmortizationOfDiscountAndPremiumAndChangesInAccruedInterestFromMarketableSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>psti_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_psti_LinkageDifferencesAndInterestOnShortAndLongTermRestrictedLeaseDeposit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Linkage differences and interest on short and long term restricted lease deposit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">psti_LinkageDifferencesAndInterestOnShortAndLongTermRestrictedLeaseDeposit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>psti_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_psti_RepaymentOfInvestmentInLongtermDepositsAndRestrictedBankDeposits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Repayment of (investment in) long-term deposits and restricted bank deposits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">psti_RepaymentOfInvestmentInLongtermDepositsAndRestrictedBankDeposits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>psti_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalExpendituresIncurredButNotYetPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Future cash outflow to pay for purchases of fixed assets that have occurred.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=98513485&amp;loc=d3e4332-108586<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=98513485&amp;loc=d3e4313-108586<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=98513485&amp;loc=d3e4304-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalExpendituresIncurredButNotYetPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=82887183&amp;loc=d3e6676-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3044-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash and cash equivalents. Cash and cash equivalents are the amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Includes effect from exchange rate changes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3521-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=98513438&amp;loc=d3e33268-110906<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Depreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Depreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnSaleOfPropertyPlantEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) on sale or disposal of property, plant and equipment assets, including oil and gas property and timber property.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnSaleOfPropertyPlantEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=98513485&amp;loc=d3e4297-108586<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxesPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccruedInterestReceivableNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the amount due from borrowers for interest payments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccruedInterestReceivableNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInCustomerAdvances">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the amount of prepayments by customers for goods or services to be provided at a later date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInCustomerAdvances</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInDeferredRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period, excluding the portion taken into income, in the liability reflecting revenue yet to be earned for which cash or other forms of consideration was received or recorded as a receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInDeferredRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in other obligations or expenses incurred but not yet paid.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherOperatingAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in operating assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherOperatingAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in receivables classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPensionAndPostretirementObligations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in obligation for pension and other postretirement benefits. Includes, but is not limited to, defined benefit and defined contribution plans.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPensionAndPostretirementObligations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecuritiesRealizedGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This item represents the total realized gain (loss) included in earnings for the period as a result of selling marketable securities categorized as trading, available-for-sale, or held-to-maturity. Additionally, this item would include any losses recognized for other than temporary impairments (OTTI) of the subject investments in debt and equity securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=82897076&amp;loc=d3e27357-111563<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=82897076&amp;loc=d3e27405-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketableSecuritiesRealizedGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3521-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 26<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3574-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3521-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 26<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3574-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3521-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3602-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879574&amp;loc=d3e536633-122882<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879464&amp;loc=d3e573970-122913<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNoncashInvestingAndFinancingItemsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNoncashInvestingAndFinancingItemsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherSignificantNoncashTransactionValueOfConsiderationGiven1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The value of the noncash (or part noncash) consideration given (for example, liability, equity) in a transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of a transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=98513485&amp;loc=d3e4304-108586<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=98513485&amp;loc=d3e4332-108586<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=98513485&amp;loc=d3e4313-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherSignificantNoncashTransactionValueOfConsiderationGiven1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherThanTemporaryImpairmentLossesInvestmentsPortionRecognizedInEarningsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of other than temporary impairment (OTTI) losses on equity securities, OTTI related to credit losses on debt securities, and OTTI losses on debt securities when the entity intends to sell the securities or it is more likely than not that the entity will be required to sell the securities before recovery of its amortized cost basis. Additionally, this item includes OTTI losses recognized during the period on investments accounted for under the cost method of accounting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8B<br> -URI http://asc.fasb.org/extlink&amp;oid=82897076&amp;loc=SL6284393-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherThanTemporaryImpairmentLossesInvestmentsPortionRecognizedInEarningsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForProceedsFromShortTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net amount paid (received) by the reporting entity through acquisition or sale and maturities of short-term investments with an original maturity that is three months or less which qualify for treatment as an investing activity based on management's intention and intended by management to be liquidated, if necessary, within the current operating cycle. Includes cash flows from securities classified as trading securities that were acquired for reasons other than sale in the short-term.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3098-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3095-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForProceedsFromShortTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireAvailableForSaleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to acquire debt and equity securities not classified as either held-to-maturity securities or trading securities which would be classified as available-for-sale securities and reported at fair value, with unrealized gains and losses excluded from earnings and reported in a separate component of shareholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (a),(b)<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3213-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=82896770&amp;loc=d3e26853-111562<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireAvailableForSaleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the additional capital contribution to the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from issuance of shares under share-based compensation arrangement. Issuance includes, but is not limited to, exercise of stock options and similar instruments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3255-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=96867065&amp;loc=SL79508275-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with maturities (principal being due), prepayments and calls (requests of early payments) on securities not classified as either held-to-maturity securities or trading securities which are classified as available-for-sale securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (a),(b)<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3179-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=82896770&amp;loc=d3e26853-111562<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3095-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3098-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromPaymentsForOtherFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleOfAvailableForSaleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the sale of debt and equity securities classified as available-for-sale securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=82896770&amp;loc=d3e26853-111562<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (a),(b)<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleOfAvailableForSaleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the sale of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of noncash, equity-based employee remuneration. This may include the value of stock or unit options, amortization of restricted stock or units, and adjustment for officers' compensation. As noncash, this element is an add back when calculating net cash generated by operating activities using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssued1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The fair value of stock issued in noncash financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=98513485&amp;loc=d3e4332-108586<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=98513485&amp;loc=d3e4304-108586<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=98513485&amp;loc=d3e4313-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssued1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6806710912">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>GENERAL<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_psti_GeneralAbstract', window );"><strong>GENERAL [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock', window );">GENERAL</a></td>
<td class="text"><div id="DSPFPageHeader"></div>

<div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 36pt; text-indent: -36pt">NOTE 1:-GENERAL</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">
<table id="z03ca1ab620fc4716b2524dbd7f0ead3c" class="DSPFListTable" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, serif; width: 100%">
<tr>
<td style="font: 10pt Times New Roman, Times, serif; width: 18pt; vertical-align: top">a.</td>
<td style="width: auto; vertical-align: top; text-align: justify">
<div style="font: 10pt Times New Roman, Times, serif">Pluristem Therapeutics Inc., a Nevada corporation, was incorporated on May 11, 2001. Pluristem Therapeutics Inc. has a wholly owned subsidiary, Pluristem Ltd. (the &#8220;Subsidiary&#8221;), which is incorporated under the laws of the State of Israel. Pluristem Therapeutics Inc. and the Subsidiary are referred to as the &#8220;Company&#8221; or &#8220;Pluristem&#8221;.</div>

<div style="font: 10pt Times New Roman, Times, serif">&#160;</div>

<div style="font: 10pt Times New Roman, Times, serif">The Company&#8217;s shares of common stock are traded on the NASDAQ Capital Market under the symbol &#8220;PSTI&#8221; and on the Tel-Aviv Stock Exchange under the symbol &#8220;PLTR&#8221;.</div>
</td>
</tr>
</table>
</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">
<table id="z1f2560ed545f45e4876be47fea69fb87" class="DSPFListTable" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, serif; width: 100%">
<tr>
<td style="font: 10pt Times New Roman, Times, serif; width: 18pt; vertical-align: top">b.</td>
<td style="width: auto; vertical-align: top; text-align: justify">
<div style="font: 10pt Times New Roman, Times, serif">The Company is a bio-therapeutics company developing placenta-based cell therapy product candidates for the treatment of multiple ischemic and inflammatory conditions. The Company has incurred an accumulated deficit of approximately $189,571 and incurred recurring operating losses and negative cash flows from operating activities since inception. As of June 30, 2017, the Company&#8217;s total stockholders&#8217; equity amounted to $30,251.</div>
</td>
</tr>
</table>
</div>

<div style="line-height: 1.25">&#160;</div>

<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 18pt; margin-right: 5.9pt">During the year ended June 30, 2017, the Company incurred operating losses of $27,814 and its negative cash flow from operating activities was $21,611. The Company will be required to obtain additional liquidity resources in the near term in order to support the commercialization of its products and maintain its research and development and clinical trials activities.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 18pt; margin-right: 5.9pt">As of June 30, 2017, the Company&#8217;s cash position (cash and cash equivalents, short-term bank deposits and marketable securities) totaled approximately $26,106. The Company is addressing its liquidity issues by implementing initiatives to allow the continuation of its activities. The Company&#8217;s current operating plan includes various assumptions concerning the level and timing of cash outflows for operating activities and capital expenditures. The Company&#8217;s ability to successfully carry out its business plan, which includes a cost-reduction plan should it be unable to raise sufficient additional capital, is primarily dependent upon its ability to (1) obtain sufficient additional capital, (2) enter into license agreements to use or commercialize the Company&#8217;s products and (3) receive other sources of funding, including non-diluting sources such as the IIA grants, the <font style="font: 10pt Times New Roman, Times, serif">European Union&#8217;s Horizon 2020 program (&#8220;Horizon 2020&#8221;)</font> grant and other grants. There are no assurances, however, that the Company will be successful in obtaining an adequate level of financing needed for the long-term development and commercialization of its products.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; margin-left: 18pt; line-height: 1.25; margin-right: 5.9pt"><font style="font: 10pt Times New Roman, Times, serif">According to management estimates, liquidity resources as of June 30, 2017 </font><font style="font: 10pt Times New Roman, Times, serif">will be sufficient to maintain the Company&#8217;s operations into the first quarter of the Company&#8217;s fiscal year 2019. The Company&#8217;s inability to raise funds to carry out its business plan will have a severe negative impact on its ability to remain a viable company.</font></div>

<div style="line-height: 1.25">&#160;</div>

<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 18pt; margin-right: 5.9pt">These conditions raise substantial doubt about the Company&#8217;s ability to continue as a going concern. The audited consolidated financial statements do not include any adjustments relating to the recoverability and classification of assets or liabilities that might be necessary should the Company be unable to continue as a going concern.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: left; line-height: 1.25">
<table id="z2fa9d6ed738141e6935b02c642d6877d" class="DSPFListTable" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, serif; width: 100%">
<tr>
<td style="font: 10pt Times New Roman, Times, serif; width: 18pt; vertical-align: top">c.</td>
<td style="width: auto; vertical-align: top; text-align: left">
<div style="font: 10pt Times New Roman, Times, serif">License Agreements:</div>
</td>
</tr>
</table>
</div>

<div style="line-height: 1.25"><br style="line-height: 1.25" />
</div>

<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 18pt; margin-right: 5.9pt"><u>United Therapeutics Corporation (&#8220;United&#8221;) Agreement</u></div>

<div style="line-height: 1.25">&#160;</div>

<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 18pt; margin-right: 5.9pt">On June 19, 2011, the Company entered into an exclusive license agreement (the &#8220;United Agreement&#8221;) with United for the use of the Company&#8217;s PLX cells to develop and commercialize a cell-based product for the treatment of Pulmonary Hypertension (&#8220;PAH&#8221;). The United Agreement provided that United would receive exclusive worldwide license rights for the development and commercialization of the Company&#8217;s PLX cell-based product to treat PAH.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 18pt; margin-right: 5.9pt">Under the United Agreement the Company received an upfront payment of $7,000 paid in August 2011, which included a $5,000 non-refundable upfront payment and a $2,000 advance payment on development.</div>



<div style="line-height: 1.25">&#160;</div>

<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 18pt; margin-right: 5.9pt">On December 8, 2015, the Company received a notice from United terminating the United Agreement, effective immediately. Pursuant to the United Agreement termination clause, Pluristem regained full rights to PLX in the field of PAH, as well as all clinical data and regulatory submissions. As the Company has no further obligations towards United, the Company recognized the remaining upfront payment received in August 2011 as revenues during the year ended June 30, 2016.</div>

<div style="line-height: 1.25"><br style="line-height: 1.25" />
</div>

<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 18pt; margin-right: 5.9pt"><u>CHA Biotech Co. Ltd. (&#8220;CHA&#8221;) Agreement</u></div>

<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 18pt; margin-right: 5.9pt">&#160;</div>

<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 18pt; margin-right: 5.9pt">On June 26, 2013, Pluristem entered into an exclusive license and commercialization agreement (the &#8220;CHA Agreement&#8221;) with CHA, for conducting clinical trials and commercialization of Pluristem&#8217;s PLX-PAD product in South Korea in connection with two indications: the treatment of Critical Limb Ischemia (&#8220;CLI&#8221;), and Intermediate Claudication (the &#8220;Indications&#8221;). Under the terms of the CHA Agreement, CHA will receive exclusive rights in South Korea for conducting clinical trials with respect to the Indications, and the Company&#160;will continue to retain rights to its proprietary manufacturing technology and cell-related intellectual property.<br style="line-height: 1.25" />
</div>

<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 18pt; margin-right: 5.9pt">The first clinical study as part of the CHA Agreement is a Phase II trial in Intermittent Claudication. South Korea&#8217;s Ministry of Food and Drug Safety approved this study in November 2013.</div>

<div style="line-height: 1.25"><br style="line-height: 1.25" />
</div>

<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 18pt; margin-right: 5.9pt">Upon the first regulatory approval for a PLX product in South Korea, for the specified indications, Pluristem and CHA will establish an equally owned joint venture. The purpose of the joint venture will be to commercialize PLX cell products in South Korea.</div>

<div style="line-height: 1.25"><br style="line-height: 1.25" />
</div>

<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 18pt; margin-right: 5.9pt">Pluristem will be able to use the data generated by CHA to pursue the development of PLX product candidates outside of South Korea.</div>

<div style="line-height: 1.25"><br style="line-height: 1.25" />
</div>

<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 18pt; margin-right: 5.9pt">The CHA Agreement contains customary termination provisions, including in the event the parties do not reach an agreement upon development plan for conducting the clinical trials. Upon termination of this CHA Agreement, the license granted thereunder will terminate and all rights included therein will revert to the Company, whereupon the Company will be free to enter into agreements with any other third parties for the granting of a license in or outside South Korea or to deal in any other manner with such rights as it shall see fit at its sole discretion.</div>

<div style="line-height: 1.25"><br style="line-height: 1.25" />
</div>

<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 18pt; margin-right: 5.9pt">In addition, and as contemplated by the CHA Agreement, in December 2013, Pluristem and CHA executed the mutual investment pursuant to which Pluristem issued 2,500,000 shares of its common stock in consideration for 1,011,504 shares of CHA, which reflects total consideration to each of Pluristem and CHA of approximately $10,414. The parties also agreed to give an irrevocable proxy to the other party&#8217;s management with respect to the voting power of the shares issued.</div>

<div style="line-height: 1.25"><br style="line-height: 1.25" />
</div>

<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 18pt; margin-right: 5.9pt">During March 2015, the Company sold a portion of the CHA shares received in December 2013.</div>

<div style="line-height: 1.25"><br style="line-height: 1.25" />
</div>

<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 18pt; margin-right: 5.9pt">The remaining investment in CHA shares is presented as &#8220;Marketable Securities&#8221; and classified as available-for-sale in accordance with Accounting Standards Codification (&#8220;ASC&#8221;) 320, &#8220;Investments - Debt and Equity Securities&#8221;. The fair value of the remaining investment in CHA&#8217;s shares as of June 30, 2017, is approximately $4,358.</div><span></span></td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_psti_GeneralAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>General Disclosure Abstract</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">psti_GeneralAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>psti_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -URI http://asc.fasb.org/topic&amp;trid=2122149<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -URI http://asc.fasb.org/topic&amp;trid=2197479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6783574528">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SIGNIFICANT ACCOUNTING POLICIES<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SignificantAccountingPoliciesTextBlock', window );">SIGNIFICANT ACCOUNTING POLICIES</a></td>
<td class="text"><div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 36pt; text-indent: -36pt">NOTE 2:-SIGNIFICANT ACCOUNTING POLICIES</div>

<div style="line-height: 1.25">&#160;</div>

<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify">The consolidated financial statements have been prepared in accordance with United States generally accepted accounting principles (&#8220;U.S. GAAP&#8221;) applied on consistent basis.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">
<table id="z1af1627d0e9e4dd3b8eac1b4ebf43a64" class="DSPFListTable" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, serif; width: 100%">
<tr>
<td style="font: bold 10pt Times New Roman, Times, serif; width: 27pt; vertical-align: top">a.</td>
<td style="width: auto; vertical-align: top; text-align: justify">
<div style="font: bold 10pt Times New Roman, Times, serif">Use of estimates</div>
</td>
</tr>
</table>
</div>

<div style="line-height: 1.25">&#160;</div>

<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 27pt; text-indent: 0pt">The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates, judgments, and assumptions that are reasonable based upon information available at the time they are made. These estimates, judgments and assumptions can affect the amounts reported in the financial statements and accompanying notes. Actual results could differ from those estimates.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">
<table id="za7bc05a3506840d5a83f52e5cf3b45b1" class="DSPFListTable" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, serif; width: 100%">
<tr>
<td style="font: bold 10pt Times New Roman, Times, serif; width: 27pt; vertical-align: top">b.</td>
<td style="width: auto; vertical-align: top; text-align: justify">
<div style="font: bold 10pt Times New Roman, Times, serif">Functional currency</div>
</td>
</tr>
</table>
</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25">
<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 27pt; text-indent: 0pt">Most of the Pluristem Therapeutics Inc. costs are denominated in United States dollars (&#8220;dollar&#8221;). The Company&#8217;s management believes that the dollar is the primary currency of the economic environment in which Pluristem Therapeutics Inc. and its subsidiary operate. Thus, the dollar is the Company&#8217;s functional and reporting currency. Accordingly, non-dollar denominated transactions and balances have been re-measured into the functional currency in accordance with ASC No. 830, &#8220;Foreign Currency Matters&#8221;. All transaction gains and losses from the re-measured monetary balance sheet items are reflected in the statements of income as financial income or expenses, as appropriate.</div>

<div style="line-height: 1.25">&#160;</div>
</div>

<div style="text-align: justify; line-height: 1.25">
<table id="z1f93aca01e5e4ee6a8fdf1dd94b2f8af" class="DSPFListTable" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, serif; width: 100%">
<tr>
<td style="font: bold 10pt Times New Roman, Times, serif; width: 27pt; vertical-align: top">c.</td>
<td style="width: auto; vertical-align: top; text-align: justify">
<div style="font: bold 10pt Times New Roman, Times, serif">Principles of consolidation</div>
</td>
</tr>
</table>
</div>

<div style="line-height: 1.25">&#160;</div>

<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 27pt; text-indent: 0pt">The consolidated financial statements include the accounts of Pluristem Therapeutics Inc. and it&#8217;s Subsidiary. Intercompany transactions and balances have been eliminated upon consolidation.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">
<table id="ze0f636e14c5d4c1e86c453d6849bbd2f" class="DSPFListTable" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, serif; width: 100%">
<tr>
<td style="font: bold 10pt Times New Roman, Times, serif; width: 27pt; vertical-align: top">d.</td>
<td style="width: auto; vertical-align: top; text-align: justify">
<div style="font: bold 10pt Times New Roman, Times, serif">Cash and cash equivalents</div>
</td>
</tr>
</table>
</div>

<div style="line-height: 1.25">&#160;</div>

<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 28.35pt; text-indent: -1.35pt">Cash equivalents are short-term highly liquid investments that are readily convertible to cash with maturities of three months or less at the date acquired.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">
<table id="zbfbd29a4eb644edbb7c98dcc26a49d3f" class="DSPFListTable" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, serif; width: 100%">
<tr>
<td style="font: bold 10pt Times New Roman, Times, serif; width: 28.35pt; vertical-align: top">e.</td>
<td style="width: auto; vertical-align: top; text-align: justify">
<div style="font: bold 10pt Times New Roman, Times, serif">Short-term bank deposit</div>
</td>
</tr>
</table>
</div>

<div style="line-height: 1.25">&#160;</div>

<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 28.35pt">Bank deposits with original maturities of more than three months but less than one year are presented as part of short-term investments. Deposits are presented at their cost which approximates market values including accrued interest. Interest on deposits is recorded as financial income.</div>

<div style="line-height: 1.25"><br style="line-height: 1.25" />
</div>

<div style="text-align: justify; line-height: 1.25">
<table id="z978469e1fcb646049d8a05cb6166784c" class="DSPFListTable" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, serif; width: 100%">
<tr>
<td style="font: bold 10pt Times New Roman, Times, serif; width: 27pt; vertical-align: top">f.</td>
<td style="width: auto; vertical-align: top; text-align: justify">
<div style="font: bold 10pt Times New Roman, Times, serif">Restricted cash and short-term bank deposits</div>
</td>
</tr>
</table>
</div>

<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 28.35pt">&#160;</div>

<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 28.35pt">Short-term restricted bank deposits and restricted cash used to secure derivative and hedging transactions and the Company&#8217;s credit line. The restricted cash and short-term bank deposits are presented at cost which approximates market values including accrued interest.</div>

<div style="line-height: 1.25"><br style="line-height: 1.25" />
</div>

<div style="text-align: justify; line-height: 1.25">
<table id="zd17e0f5d149c4b0dad19bc2e378a5f58" class="DSPFListTable" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, serif; width: 100%">
<tr>
<td style="font: bold 10pt Times New Roman, Times, serif; width: 27pt; vertical-align: top">g.</td>
<td style="width: auto; vertical-align: top; text-align: justify">
<div style="font: bold 10pt Times New Roman, Times, serif">Long-term restricted bank deposits</div>
</td>
</tr>
</table>
</div>

<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 27pt; text-indent: 0pt">&#160;</div>

<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 27pt; text-indent: 0pt">Long-term restricted bank deposits with maturities of more than one year used to secure operating lease agreement are presented at cost which approximates market values including accrued interest.</div>

<div style="text-align: justify; margin-left: 27pt; line-height: 1.25; text-indent: -27pt"><br style="line-height: 1.25" />
</div>

<div style="text-align: justify; line-height: 1.25">
<table id="zb5071478f8d54ec5a96c5c5ab6b8e7f5" class="DSPFListTable" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, serif; width: 100%">
<tr>
<td style="font: bold 10pt Times New Roman, Times, serif; width: 27pt; vertical-align: top">h.</td>
<td style="width: auto; vertical-align: top; text-align: justify">
<div style="font: bold 10pt Times New Roman, Times, serif">Investment in marketable securities</div>
</td>
</tr>
</table>
</div>

<div style="line-height: 1.25">&#160;</div>

<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 28.35pt">The Company accounts for its investments in marketable securities in accordance with ASC 320,&#8220;Investments &#8211; Debt and Equity Securities&#8221;. The Company determines the classification of marketable securities at the time of purchase and re-evaluates such designations as of each balance sheet date. The Company classifies all of its marketable securities as available-for-sale. Available-for-sale marketable securities are carried at fair value, with the unrealized gain and loss reported at &#8220;Accumulated other comprehensive income (loss)&#8221; in the statement of changes in stockholders&#8217; equity.</div>



<div style="line-height: 1.25">&#160;</div>

<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 28.35pt">Realized gain and loss on sales of marketable securities are included in the Company&#8217;s &#8220;Financial income, net&#8221; and are derived using the specific identification basis for determining the cost of marketable securities sold. The amortized cost of available for sale debt marketable securities is adjusted for amortization of premiums and accretion of discount to maturity. Such amortization, together with coupon interest on available for sale marketable securities, is included in the &#8220;Financial income, net&#8221;.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 28.35pt">The Company recognizes an impairment charge when a decline in the fair value of its available-for-sale marketable securities below the cost basis is judged to be other-than-temporary. The Company considers various factors in determining whether to recognize an impairment charge, including the length of time the investment has been in a loss position, the extent to which the fair value has been less than the Company&#8217;s cost basis, the reason for the decline in value, the potential recovery period and the Company&#8217;s intent to sell, including whether it is more likely than not that the Company will be required to sell the investment before recovery of cost basis. ASC 320-10-35, &#8220;Investments - Debt and Equity Securities&#8221;, requires another-than-temporary impairment for debt securities to be separated into (a)&#160;the amount representing the credit loss and (b)&#160;the amount related to all other factors (provided that the Company does not intend to sell the security and it is not more likely than not that it will be required to sell it before recovery). For securities that are deemed other-than-temporarily impaired, the amount of impairment is recognized in &#8220;financial income, net&#8221;, in the statement of operations and is limited to the amount related to credit loss, while impairment related to other factors is recognized in &#8220;other comprehensive income (loss)&#8221;.</div>

<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 28.35pt">&#160;</div>

<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 28.35pt">During the years ended June 30, 2017 and 2016, the Company recognized other-than-temporary impairment loss of $767 and $38, respectively. During the year ended June 30, 2015 no impairment losses were identified (see note 3).</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">
<table id="zb4e567880d2a4c168bd77962c3661dd1" class="DSPFListTable" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, serif; width: 100%">
<tr>
<td style="font: bold 10pt Times New Roman, Times, serif; width: 27pt; vertical-align: top">i.</td>
<td style="width: auto; vertical-align: top; text-align: justify">
<div style="font: bold 10pt Times New Roman, Times, serif">Revenue Recognition from the license Agreement with United</div>
</td>
</tr>
</table>
</div>

<div style="line-height: 1.25">&#160;</div>

<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 28.35pt">The Company recognized revenue pursuant to the License Agreement with United in accordance with ASC 605-25, &#8220;Revenue Recognition, Multiple-Element Arrangements&#8221;.</div>

<div style="line-height: 1.25"><br style="line-height: 1.25" />
</div>

<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 28.35pt">Pursuant to ASC 605-25, each deliverable is evaluated to determine whether it qualifies as a separate unit of accounting based on whether the deliverable has &#8220;stand-alone value&#8221; to the customer. The arrangement&#8217;s consideration that is fixed or determinable is then allocated to each separate unit of accounting based on the relative selling price of each deliverable. In general, the consideration allocated to each unit of accounting is recognized as the related goods or services are delivered, limited to the consideration that is not contingent upon future deliverables.</div>

<div style="line-height: 1.25"><br style="line-height: 1.25" />
</div>

<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 28.35pt">The Company received an up-front, non-refundable license payment of $5,000. Additional payments totaling $37,500 were subject to the achievement of certain regulatory milestones by United.</div>

<div style="line-height: 1.25"><br style="line-height: 1.25" />
</div>

<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 28.35pt">Since the deliverables in the United Agreement did not have stand-alone value, none of them qualified as a separate unit of accounting. Accordingly, the non-refundable upfront license fee of $5,000 was deferred and recognized on a straight line basis over the related performance period which was the development period in accordance with Staff Accounting Bulletin (&#8220;SAB&#8221;) 104, &#8220;Revenue Recognition&#8221;.</div>

<div style="line-height: 1.25"><br style="line-height: 1.25" />
</div>

<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 28.35pt">The Company also received an advanced payment for the development, of $2,000 that was deductible against development expenses as it was incurred. The upfront payment which was received was included in the balance sheet as advance payment. The Company deducted the payments from its research and development expenses in accordance with ASC 730-20, &#8220;Research and Development Agreements&#8221;.</div>



<div style="line-height: 1.25">&#160;</div>

<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 28.35pt">On December 8, 2015, the Company received a notice from United terminating the United Agreement, effective immediately. Pursuant to the United Agreement termination clause, Pluristem regained full rights to PLX in the field of PAH, as well as all clinical data and regulatory submissions. As the Company had no further obligations<font style="font: bold 10pt Times New Roman, Times, serif">&#160;</font>towards United, the Company recognized the remaining upfront payment received in 2011 as revenues during the year ended June 30, 2016.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">
<table id="z18f60214b5e14ae396da878f15bb2f47" class="DSPFListTable" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, serif; width: 100%">
<tr>
<td style="font: bold 10pt Times New Roman, Times, serif; width: 28.35pt; vertical-align: top">j.</td>
<td style="width: auto; vertical-align: top; text-align: justify">
<div style="font: bold 10pt Times New Roman, Times, serif">Property and Equipment</div>
</td>
</tr>
</table>
</div>

<div style="line-height: 1.25">&#160;</div>

<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 27pt; text-indent: 0pt">Property and equipment are stated at cost, net of accumulated depreciation. Depreciation is calculated by the straight-line method over the estimated useful lives of the assets, at the following annual rates:</div>

<div style="line-height: 1.25">&#160;</div>

<div>
<table id="z4239811fa84e426982a3190298cf9636" cellspacing="0" cellpadding="0" align="center" border="0" style="font: 10pt Times New Roman, Times, serif; width: 60%">
<tr>
<td style="width: 40%; vertical-align: top; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td colspan="2" style="vertical-align: top; border-bottom: #000000 2px solid; vertical-align: bottom">
<div style="line-height: 1.25">
<div style="line-height: 1.25"></div>

<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: center">%</div>
</div>
</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="width: 40%; vertical-align: top; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left">Laboratory equipment</div>
</td>
<td style="width: 1%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 40%; vertical-align: bottom; text-align: right; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: center">10-15</div>
</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
</tr>

<tr style="height: 16px">
<td style="width: 40%; vertical-align: top; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left">Computers and peripheral equipment</div>
</td>
<td style="width: 1%; vertical-align: bottom; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 40%; vertical-align: bottom; text-align: right; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: center">33</div>
</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="width: 40%; vertical-align: top; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left">Office furniture and equipment</div>
</td>
<td style="width: 1%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 40%; vertical-align: bottom; text-align: right; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: center">15</div>
</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="width: 40%; vertical-align: top; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left">Vehicles</div>
</td>
<td style="width: 1%; vertical-align: bottom; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 40%; vertical-align: bottom; text-align: right; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: center">15</div>
</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom">&#160;</td>
</tr>

<tr style="height: 15px">
<td style="width: 40%; vertical-align: top; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left">Leasehold improvements</div>
</td>
<td style="width: 1%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td colspan="2" style="vertical-align: top; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left">The shorter of the expected useful life or the reasonable assumed term of the lease.</div>
</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
</tr>
</table>
</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">
<table id="z252d414105c7440bb6165d5bf6b4d15a" class="DSPFListTable" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, serif; width: 100%">
<tr>
<td style="font: bold 10pt Times New Roman, Times, serif; width: 28.35pt; vertical-align: top">k.</td>
<td style="width: auto; vertical-align: top; text-align: justify">
<div style="font: bold 10pt Times New Roman, Times, serif">Impairment of long-lived assets</div>
</td>
</tr>
</table>
</div>

<div style="line-height: 1.25">&#160;</div>

<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 27pt; text-indent: 0pt">The Company&#8217;s long-lived assets are reviewed for impairment in accordance with ASC 360, &#8220;Property, Plant and Equipment&#8221;, whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of the assets to the future undiscounted cash flows expected to be generated by the assets. If such assets are considered to be impaired, the impairment to be recognized is measured by the amount by which the carrying amount of the assets exceeds the fair value of the assets. During fiscal years 2017, 2016 and 2015, no impairment losses have been identified.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 27pt">
<div id="DSPFPageHeader"></div>

<div style="line-height: 1.25">As required by ASC 820, &#8220;Fair Value Measurements&#8221; (&#8220;ASC 820&#8221;), the Company applies assumptions that marketplace participants would consider in determining the fair value of long-lived assets.</div>

<div style="line-height: 1.25">&#160;</div>
</div>

<div style="text-align: justify; line-height: 1.25">
<table id="zb79e5bb96e214148b3fac6f353132e61" class="DSPFListTable" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, serif; width: 100%">
<tr>
<td style="font: bold 10pt Times New Roman, Times, serif; width: 27pt; vertical-align: top">l.</td>
<td style="width: auto; vertical-align: top; text-align: justify">
<div style="font: bold 10pt Times New Roman, Times, serif">Accounting for stock-based compensation</div>
</td>
</tr>
</table>
</div>

<div style="line-height: 1.25">&#160;</div>

<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 27pt; text-indent: 0.05pt">The Company accounts for stock-based compensation in accordance with ASC 718, &#8220;Compensation-Stock Compensation&#8221; (&#8220;ASC 718&#8221;) and ASC 505-50, &#8220;Equity-Based Payments to Non-Employees&#8221; (&#8220;ASC 505-50&#8221;). ASC 718 requires companies to estimate the fair value of equity-based payment awards on the date of grant using an option-pricing model. The Company estimates the fair value of stock options granted using the Black-Scholes-Merton option-pricing model. The Company accounts for employee&#8217;s share-based payment awards classified as equity awards (restricted stocks or restricted stock units) using the grant-date fair value method. The fair value of share-based payment transactions is recognized as an expense over the requisite service period, net of estimated forfeitures. The Company estimates forfeitures based on historical experience and anticipated future conditions. The Company elected to recognize compensation cost for an award with service conditions and goals achievement that has a graded vesting schedule using the accelerated method based on the multiple-option award approach.</div>

<div style="line-height: 1.25"><br style="line-height: 1.25" />
</div>

<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 27.05pt; text-indent: 0.05pt">During fiscal years 2017, 2016 and 2015, there were no options granted to employees or directors.</div>

<div style="line-height: 1.25"><br style="line-height: 1.25" />
</div>

<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 28.35pt">The assumptions below are relevant to restricted stock and restricted stock units granted in 2017, 2016 and 2015:</div>

<div style="line-height: 1.25"><br style="line-height: 1.25" />
</div>

<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 28.35pt">In accordance with ASC 718, restricted stock and restricted stock units are measured at their fair value. All restricted stock and restricted stock units to employees, directors and non-employees granted in 2017, 2016 and 2015, were granted for no consideration; therefore, their fair value was equal to the share price at the date of grant.</div>



<div style="line-height: 1.25">&#160;</div>

<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 28.35pt">The fair value of all restricted stock and restricted stock units was determined based on the close trading price of the Company&#8217;s shares known at the grant date. The weighted average grant date fair value of shares granted during 2017, 2016 and 2015, was $1.41, $1.13 and $2.70, respectively.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">
<table id="z7e07885053824892bd52a1a2cb6999f9" class="DSPFListTable" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, serif; width: 100%">
<tr>
<td style="font: bold 10pt Times New Roman, Times, serif; width: 28.35pt; vertical-align: top">m.</td>
<td style="width: auto; vertical-align: top; text-align: justify">
<div style="font: bold 10pt Times New Roman, Times, serif">Research and Development expenses and royalty bearing grants</div>
</td>
</tr>
</table>
</div>

<div style="line-height: 1.25">&#160;</div>

<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 28.35pt; text-indent: 0pt">Research and development expenses, net of participations grants, are charged to the statement of operations as incurred.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25">
<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 28.35pt; text-indent: 0pt">Pluristem receives grants from the IIA in the Ministry of Economy and Industry (formerly the Office of Chief Scientist&#8217;s) for the purpose of partially funding approved research and development projects. The grants are not to be repaid, but instead Pluristem is obliged to pay royalties as a percentage of future sales if and when sales from the funded projects are generated. These grants are recognized as a deduction from research and development costs at the time the Company is entitled to such grants on the basis of the research and development costs incurred. Since the payment of royalties is not probable when the grants are received, the Company records a liability in the amount of the estimated royalties for each individual contract, when the related revenues are recognized, as part of Cost of revenues. For more information regarding such royalties commitments and regarding grants and participation received, see Note 8.</div>

<div style="line-height: 1.25">&#160;</div>
</div>

<div style="text-align: justify; line-height: 1.25">
<table id="zf79edeb6b6264cdebcff1930c5704a4a" class="DSPFListTable" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, serif; width: 100%">
<tr>
<td style="font: bold 10pt Times New Roman, Times, serif; width: 28.35pt; vertical-align: top">n.</td>
<td style="width: auto; vertical-align: top; text-align: justify">
<div style="font: bold 10pt Times New Roman, Times, serif">Non-royalty bearing grant</div>
</td>
</tr>
</table>
</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25">
<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 28.35pt; text-indent: -1.35pt">T<font style="font: 10pt Times New Roman, Times, serif">he Company&#8217;s CLI program participates in a European Union&#160;research and development consortium under Horizon 2020.&#160; In August 2016, the CLI program consortium was awarded a Euro 7,600 (approximately $8,700) non-royalty bearing grant. An amount of Euro 1,900 (approximately $2,200) is a direct grant allocated to the Company. </font>The non-royalty bearing grant for funding the projects is recognized at the time the Company is entitled to such grant on the basis of the related costs incurred and recorded as a deduction from research and development expenses.</div>

<div style="line-height: 1.25">&#160;</div>
</div>

<div style="text-align: justify; line-height: 1.25">
<table id="zf823a2550b6d46c591eaa4a91db1adeb" class="DSPFListTable" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, serif; width: 100%">
<tr>
<td style="font: bold 10pt Times New Roman, Times, serif; width: 28.35pt; vertical-align: top">o.</td>
<td style="width: auto; vertical-align: top; text-align: justify">
<div style="font: bold 10pt Times New Roman, Times, serif">Loss per share</div>
</td>
</tr>
</table>
</div>

<div style="line-height: 1.25">&#160;</div>

<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 28.35pt; text-indent: 0pt">Basic and diluted net loss per share is computed based on the weighted average number of shares of common stock outstanding during each year. All outstanding stock options and unvested restricted stock units have been excluded from the calculation of the diluted loss per common share because all such securities are anti-dilutive for each of the periods presented.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">
<table id="z06d5f9bd8e3e4f4981c1f51ed93f04fe" class="DSPFListTable" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, serif; width: 100%">
<tr>
<td style="font: bold 10pt Times New Roman, Times, serif; width: 28.35pt; vertical-align: top">p.</td>
<td style="width: auto; vertical-align: top; text-align: justify">
<div style="font: bold 10pt Times New Roman, Times, serif">Income taxes</div>
</td>
</tr>
</table>
</div>

<div style="line-height: 1.25">&#160;</div>

<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 28.35pt; text-indent: 0pt">The Company accounts for income taxes in accordance with ASC 740, &#8220;Income Taxes&#8221; (&#8220;ASC 740&#8221;). This Topic prescribes the use of the liability method, whereby deferred tax assets and liability account balances are determined based on differences between financial reporting and tax bases of assets and liabilities and are measured using the enacted tax rates and laws that will be in effect when the differences are expected to reverse. The Company provides a valuation allowance, if necessary, to reduce deferred tax assets to their estimated realizable value.</div>



<div style="line-height: 1.25">&#160;</div>

<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 28.35pt; text-indent: -1.35pt">ASC 740 establishes a single model to address accounting for uncertain tax positions. ASC 740 clarified the accounting for income taxes by prescribing the minimum recognition threshold a tax position is required to meet before being recognized in the financial statements.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">
<table id="z320736ccd85f45a8b8e69213c3f489d0" class="DSPFListTable" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, serif; width: 100%">
<tr>
<td style="font: bold 10pt Times New Roman, Times, serif; width: 28.35pt; vertical-align: top">q.</td>
<td style="width: auto; vertical-align: top; text-align: justify">
<div style="font: bold 10pt Times New Roman, Times, serif">Concentration of credit risk</div>
</td>
</tr>
</table>
</div>

<div style="line-height: 1.25">&#160;</div>

<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 28.35pt; text-indent: 0pt">Financial instruments that potentially subject the Company to concentrations of credit risk consist principally of cash and cash equivalents, short-term deposits, long-term deposits, restricted deposits and marketable securities.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 28.35pt; text-indent: 0pt">The majority of the Company&#8217;s cash and cash equivalents and short-term and long-term deposits are mainly invested in dollar instruments of major banks in Israel and in the United States. Generally, these deposits may be redeemed upon demand and therefore bear minimal risk.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 27.35pt; text-indent: 0pt">The Company invests its surplus cash in cash deposits and marketable securities in financial institutions and has established guidelines, approved by the Company&#8217;s Investment Committee, relating to diversification and maturities to maintain safety and liquidity of the investments.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 27.35pt; text-indent: 0pt">The Company holds an investment portfolio consisting of corporate bonds, government bonds, stocks and index linked notes. The Company intends, and has the ability, to hold such investments until recovery of temporary declines in market value or maturity. However, the Company can provide no assurance that it will recover declines in the market value of its investments.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 27.35pt; text-indent: -27pt"><font style="font: 10pt Times New Roman, Times, serif">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>The Company utilizes forward and options contracts to protect against the risk of overall changes in exchange rates. The derivative instruments hedge a portion of the Company&#8217;s non-dollar currency exposure. Counterparties to the Company&#8217;s derivative instruments are all major financial institutions.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">
<table id="zfcbc5e1a8b494fc7b89fd7aa0beaa363" class="DSPFListTable" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, serif; width: 100%">
<tr>
<td style="font: bold 10pt Times New Roman, Times, serif; width: 28.35pt; vertical-align: top">r.</td>
<td style="width: auto; vertical-align: top; text-align: justify">
<div style="font: bold 10pt Times New Roman, Times, serif">Severance pay</div>
</td>
</tr>
</table>
</div>

<div style="line-height: 1.25">&#160;</div>

<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 28.35pt; text-indent: -1.35pt">&#160;A majority of the Company&#8217;s agreements with employees in Israel are subject to Section 14 of the Israeli Severance Pay Law, 1963 (&#8220;Severance Pay Law&#8221;). The Company&#8217;s contributions for severance pay have replaced its severance obligation. Upon contribution of the full amount of the employee&#8217;s monthly salary for each year of employment, no additional calculations are conducted between the parties regarding the matter of severance pay and no additional payments are made by the Company to the employee. Further, the related obligation and amounts deposited on behalf of the employee for such obligation are not stated on the balance sheet, as the Company is legally released from the obligation to employees once the deposit amounts have been paid.</div>

<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 28.35pt; text-indent: -1.35pt">&#160;</div>

<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 28.35pt; text-indent: -1.35pt">&#160;For some employees, which their agreement is not subject to Section 14 of the Severance Pay Law, the Subsidiary&#8217;s liability for severance pay is calculated pursuant to Israeli Severance Pay Law, based on the most recent salary of the employees multiplied by the number of years of employment, as of the balance sheet date. Employees are entitled to one month&#8217;s salary for each year of employment or a portion thereof.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 28.35pt; text-indent: -1.35pt">The Company&#8217;s liability for all of its employees is fully provided by monthly deposits with insurance policies and by an accrual. The value of these policies is recorded as an asset in the Company&#8217;s balance sheet. The deposited funds include profits or losses accumulated up to the balance sheet date. The deposited funds may be withdrawn only upon the fulfillment of the obligation pursuant to the Severance Pay Law or labor agreements. The value of the deposited funds is based on the cash surrendered value of these policies, and includes immaterial profits or losses.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 28.35pt; text-indent: -1.35pt">Severance expenses for the years ended June 30, 2017, 2016 and 2015 were $524, $556 and $441, respectively.</div>



<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">
<table id="zd2ea3862cd6c4798b79f39ca5827c19b" class="DSPFListTable" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, serif; width: 100%">
<tr>
<td style="font: bold 10pt Times New Roman, Times, serif; width: 28.35pt; vertical-align: top">s.</td>
<td style="width: auto; vertical-align: top; text-align: justify">
<div style="font: bold 10pt Times New Roman, Times, serif">Fair value of financial instruments</div>
</td>
</tr>
</table>
</div>

<div style="line-height: 1.25">&#160;</div>

<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 28.35pt; text-indent: -1.35pt">The carrying amounts of the Company&#8217;s financial instruments, including cash and cash equivalents, short-term and restricted bank deposits, accounts receivable and other current assets, trade payable and other accounts payable and accrued liabilities, approximate fair value because of their generally short term maturities.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25">
<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 28.35pt; text-indent: -1.35pt">The Company measures its investments in marketable securities and derivative instruments at fair value under ASC 820. Fair value is an exit price, representing the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants. As such, fair value is a market-based measurement that should be determined based on assumptions that market participants would use in pricing an asset or a liability. As a basis for considering such assumptions, ASC 820 establishes a three-tier value hierarchy, which prioritizes the inputs used in the valuation methodologies in measuring fair value:</div>

<div style="line-height: 1.25">&#160;</div>
</div>

<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 28.35pt; text-indent: -1.35pt"><font style="font: bold 10pt Times New Roman, Times, serif">&#160;Level 1</font> - Quoted prices (unadjusted) in active markets for identical assets or liabilities;</div>

<div style="line-height: 1.25">&#160;</div>

<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 28.35pt; text-indent: -1.35pt"><font style="font: bold 10pt Times New Roman, Times, serif">&#160;Level 2</font> - Inputs other than Level 1 that are observable for the asset or liability, either directly or indirectly; and</div>

<div style="line-height: 1.25">&#160;</div>

<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 28.35pt; text-indent: -1.35pt"><font style="font: bold 10pt Times New Roman, Times, serif">&#160;Level 3 </font>- Unobservable inputs for the asset or liability.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 28.35pt; text-indent: -1.35pt">The fair value hierarchy also requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. The Company categorized each of its fair value measurements in one of these three levels of hierarchy (see Note 4).</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">
<table id="zcbe558bdfec34c1c9b3738ad0e5c22de" class="DSPFListTable" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, serif; width: 100%">
<tr>
<td style="font: bold 10pt Times New Roman, Times, serif; width: 28.35pt; vertical-align: top">t.</td>
<td style="width: auto; vertical-align: top; text-align: justify">
<div style="font: bold 10pt Times New Roman, Times, serif">Derivative financial instruments</div>
</td>
</tr>
</table>
</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25">
<div></div>

<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 28.35pt"><font style="font: 10pt Times New Roman, Times, serif">The Company accounts for derivatives and hedging based on ASC 815, </font><font style="font: 10pt Times New Roman, Times, serif">&#8220;Derivatives and hedging&#8221; </font>(&#8220;ASC 815&#8221;)<font style="font: 10pt Times New Roman, Times, serif">, as amended and related interpretations. ASC 815 requires the Company to recognize all derivatives on the balance sheet at fair value. If a derivative meets the definition of a hedge and is so designated, depending on the nature of the hedge, changes in the fair value of the derivative will either be offset against the change in fair value of the hedged assets, liabilities, or firm commitments through earnings (for fair value hedge transactions) or recognized in other comprehensive income (loss) until the hedged item is recognized in earnings (for cash flow hedge transactions).</font></div>
</div>

<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 28.35pt">&#160;</div>

<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 28.35pt"><font style="font: 10pt Times New Roman, Times, serif">The ineffective portion of a derivative&#8217;s change in fair value is recognized in earnings. If a derivative does not meet the definition of a hedge, the changes in the fair value are included in earnings. Cash flows related to such hedges are classified as operating activities. The Company enters into forward exchange contracts and option contracts in order to limit the exposure to exchange rate fluctuation associated with expenses mainly incurred in </font>New Israeli Shekels (&#8220;<font style="font: 10pt Times New Roman, Times, serif">NIS</font>&#8221;)<font style="font: 10pt Times New Roman, Times, serif">. Since the derivative instruments that the Company holds do not meet the definition of hedging instruments under ASC 815, any gain or loss derived from such instruments is recognized immediately as &#8220;financial income, net&#8221;.</font></div>

<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 28.35pt">&#160;</div>

<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 28.35pt">The Company measured the fair value of the contracts in accordance with ASC 820. Foreign currency derivative contracts are classified within Level 2 as the valuation inputs are based on quoted prices and market observable data of similar instruments. As of June 30, 2017 and 2016, the fair value of the<font style="font: 10pt Times New Roman, Times, serif">&#160;</font>options contracts was approximately$ 295<font style="font: 10pt Times New Roman, Times, serif">&#160;</font>and $65, respectively, presented in &#8220;other current assets&#8221; (see Note 4). The net gains (losses) recognized in &#8220;Financial income, net&#8221; during the years ended June 30, 2017, 2016 and 2015, were $230, ($205) and $248, respectively.</div>

<div style="text-align: justify; line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">
<table id="z3defcc6bbc8f4d2eb779a57c2bdb4a38" class="DSPFListTable" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, serif; width: 100%">
<tr>
<td style="font: bold 10pt Times New Roman, Times, serif; width: 28.35pt; vertical-align: top">u.</td>
<td style="width: auto; vertical-align: top; text-align: justify">
<div style="font: bold 10pt Times New Roman, Times, serif">Comprehensive income (loss):</div>
</td>
</tr>
</table>
</div>

<div style="line-height: 1.25">&#160;</div>

<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 28.35pt">The Company accounts for comprehensive income (loss) in accordance with ASC 220, &#8220;Comprehensive Income&#8221;.</div>



<div style="line-height: 1.25">&#160;</div>

<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 28.35pt">Comprehensive income generally represents all changes in stockholders&#8217; equity during the period except those resulting from investments by, or distributions to, stockholders&#8217;. The Company determined that its items of other comprehensive income (loss) relate to unrealized gains and losses on available for sale marketable securities.</div>

<div style="line-height: 1.25"><br style="line-height: 1.25" />
</div>

<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 28.35pt">The following table summarizes the changes in accumulated balances of other comprehensive income for the year ended June 30, 2017:</div>

<div style="line-height: 1.25">&#160;</div>

<div>
<table id="z1a49afcc7d73463897c1b4177687276d" cellspacing="0" cellpadding="0" align="right" border="0" style="font: 10pt Times New Roman, Times, serif; width: 95%">
<tr>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td colspan="2" style="vertical-align: top; border-bottom: #000000 2px solid; text-align: center; vertical-align: bottom">Year ended June 30, 2017</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: center">Unrealized<font style="font: 10pt Times New Roman, Times, serif"><br />
</font>gains (losses)<font style="font: 10pt Times New Roman, Times, serif"><br />
</font>on marketable<font style="font: 10pt Times New Roman, Times, serif"><br />
</font>securities</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="width: 88%; vertical-align: top; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 4.7pt; text-indent: 5.05pt">Beginning balance</div>
</td>
<td style="width: 1%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">$</div>
</td>
<td style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">1,480</div>
</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="width: 88%; vertical-align: top; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 9.75pt">Other comprehensive income before reclassifications</div>
</td>
<td style="width: 1%; vertical-align: bottom; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">924</div>
</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="width: 88%; vertical-align: top; padding-bottom: 2px; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 9.75pt">Amounts reclassified from accumulated other comprehensive loss, net</div>
</td>
<td style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">(405</div>
</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">)</div>
</td>
</tr>

<tr>
<td style="width: 88%; vertical-align: top; padding-bottom: 2px; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 12pt; text-indent: -2.25pt">Net current-period other comprehensive income</div>
</td>
<td style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">519</div>
</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="width: 88%; vertical-align: top; padding-bottom: 4px; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 4.7pt; text-indent: 5.05pt">Ending balance</div>
</td>
<td style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">$</div>
</td>
<td style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">1,999</div>
</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
</tr>
</table>
</div>

<div style="clear: both; line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">
<table id="z6ca6aeb30c4f45c4aa701f0c34367182" class="DSPFListTable" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, serif; width: 100%">
<tr>
<td style="font: bold 10pt Times New Roman, Times, serif; width: 28.35pt; vertical-align: top">v.</td>
<td style="width: auto; vertical-align: top; text-align: justify">
<div style="font: bold 10pt Times New Roman, Times, serif">Recent Accounting Pronouncement</div>
</td>
</tr>
</table>
</div>

<div style="line-height: 1.25">&#160;</div>

<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 27pt"><font style="font: 10pt Times New Roman, Times, serif"><u>Accounting Standards Update (&#8220;ASU&#8221;) 2014-09 &#8211; &#8220;Revenue from Contracts with Customers (Topic 606)&#8221;</u></font>:</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25">
<div></div>

<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 28.35pt">In May 2014, the Financial Accounting Standards Board (&#8220;FASB&#8221;) issued ASU No. 2014-09 (Topic 606) &#8220;Revenue from Contracts with Customers&#8221; (&#8220;Topic 606&#8221;). Topic 606 supersedes the revenue recognition requirements in ASC Topic 605, &#8220;Revenue Recognition&#8221;, and requires entities to recognize revenue when they transfer control of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled to in exchange for those goods or services. We intend to adopt Topic 606 as of July 1, 2017, using the modified retrospective transition method. Prior periods will not be retrospectively adjusted. As the Company currently does not have any contracts with customers which are not completed, as of June 30, 2017, we do not expect the adoption of Topic 606 will have a material impact on our consolidated financial statements, including the presentation of revenues in our consolidated statements of income.</div>
</div>

<div style="line-height: 1.25">&#160;</div>

<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 28.35pt"><u>ASU 2014-15 - Presentation of Financial Statements - Going Concern (Subtopic 205-40):</u></div>

<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left">&#160;</div>

<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left">
<div></div>

<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 28.35pt">In August 2014, the FASB issued guidance on disclosure of Uncertainties about an Entity&#8217;s Ability to Continue as a Going Concern (&#8220;ASU 2014-15&#8221;), which defines management&#8217;s responsibility to evaluate whether there is substantial doubt about a company&#8217;s ability to continue as a going concern. ASU 2014-15 also provides principles and definitions that are intended to reduce diversity in the timing and content of disclosures in the financial statement footnotes. This guidance is effective for the annual period ending after December 15, 2016, and for annual periods and interim periods thereafter. The Company adopted the provisions of ASU 2014-15 for the year ended December 31, 2016. The adoption of ASU 2014-15 did not have a material impact on the consolidated financial statements.</div>
</div>



<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25">
<div></div>

<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 28.35pt"><font style="font: 10pt Times New Roman, Times, serif"><u>ASU 2016-13 - Financial Instruments &#8211; Credit Losses (Topic 326), </u></font><font style="font: 10pt Times New Roman, Times, serif"><u>&#8220;Measurement of Credit Losses on Financial Instruments&#8221;:</u></font></div>
</div>

<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 28.35pt">&#160;</div>

<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 28.35pt">In June 2016, the FASB issued ASU 2016-13. This update requires an entity to utilize a new impairment model known as the current expected credit loss (&#8220;CECL&#8221;) model to estimate its lifetime &#8220;expected credit loss&#8221; on a financial asset and record an allowance that, when deducted from the amortized cost basis of the financial asset, presents the net amount expected to be collected on the financial asset. The CECL model is expected to result in more timely recognition of credit losses. The update also requires new disclosures for financial assets measured at amortized cost, loans and available-for-sale debt securities. The update is effective for the interim and annual periods beginning on or after December 15, 2019, or July 1, 2020, for the Company. Early adoption is permitted. The Company is currently evaluating the impact of the update on its consolidated financial statements.</div>

<div style="line-height: 1.25"><br style="line-height: 1.25" />
</div>

<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 28.35pt"><u>ASU 2016-18 - Restricted Cash (Topic 230):</u></div>

<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 28.35pt">&#160;</div>

<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 28.35pt">In November 2016, the FASB issued ASU 2016-18, &#8220;Statement of Cash Flows&#8221;. This standard requires the presentation of the statement of cash flows to show the changes in the total of cash, cash equivalents, restricted cash and restricted cash equivalents. The standard is effective for the interim and annual periods beginning on or after December 15, 2017, or July 1, 2018 for the Company. Early adoption is permitted. The Company is currently evaluating the impact of the standard on its consolidated financial statements.</div>

<div style="line-height: 1.25"><br style="line-height: 1.25" />
</div>

<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 28.35pt"><u>ASU 2016-02 - Leases (Topic 842):</u></div>

<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left">&#160;</div>

<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left">
<div></div>

<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 28.35pt">In February 2016, the FASB issued guidance on the recognition, measurement, presentation and disclosure of leases for both parties to a contract (i.e., lessees and lessors). The new standard requires lessees to apply a dual approach, classifying leases as either finance or operating leases based on the principle of whether or not the lease is effectively a financed purchase by the lessee. This classification will determine whether lease expense is recognized based on an effective interest method or on a straight-line basis over the term of the lease, respectively. A lessee is also required to record a right-of-use asset and a lease liability for all leases with a term of greater than 12 months regardless of their classification. Leases with a term of 12 months or less will be accounted for in a manner similar to the accounting under existing guidance for operating leases today. The new standard requires lessors to account for leases using an approach that is substantially equivalent to existing guidance for sales-type leases, direct financing leases and operating leases. Topic 842 supersedes the previous leases standard, ASC 840, &#8220;Leases&#8221;. The guidance is effective for the interim and annual periods beginning on or after December 15, 2018. Early adoption is permitted. The Company is currently evaluating the potential effect of the guidance on its consolidated financial statements.</div>
</div>

<div style="line-height: 1.25"><br style="line-height: 1.25" />
</div>

<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; text-indent: 28.35pt"><u>ASU 2016-01 - Financial Instruments - Overall (Subtopic 825-10):</u></div>

<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left">&#160;</div>

<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left">
<div></div>

<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 28.35pt">In January 2016, the FASB issued guidance on financial instruments - recognition and measurement of financial assets and financial liabilities. The pronouncement revises the classification and measurement of investments in certain equity investments and the presentation of certain fair value changes for certain financial liabilities measured at fair value. ASU 2016-01 is effective for fiscal years, beginning after December 15, 2017 and interim periods within those years. The Company is currently evaluating the impact of adopting the new standard on its consolidated financial statements.<br style="line-height: 1.25" />
</div>
</div>



<div style="line-height: 1.25"><br style="line-height: 1.25" />
</div>

<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; text-indent: 28.35pt"><u>ASU 2016-09 - Compensation - Stock Compensation (Topic 718):</u></div>

<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; text-indent: 28.35pt">&#160;</div>

<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left">
<div></div>

<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 28.35pt">In March 2016, the FASB issued guidance on improvements to employee share-based payments. The standard requires among others, that excess tax benefits or deficiencies for share-based payments be recorded as income tax benefit or expense, rather then within additional paid in capital, in the period in which the shares vest. Cash flows related to excess tax benefits will be included in operating activities instead of separately classified as a financing activity. The new guidance is effective for fiscal years beginning after December 15, 2016. Early adoption is permitted. The Company does not expect this guidance to have a material effect on its consolidated financial statements at the time of adoption of this standard.</div>
</div>

<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left">&#160;</div>

<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 28.35pt"><u>ASU 2017-11 - Earnings Per Share (Topic 260); Distinguishing Liabilities from Equity (Topic 480); Derivatives and Hedging (Topic 815): (Part I) Accounting for Certain Financial Instruments with Down Round Features, (Part II) Replacement of the Indefinite Deferral for Mandatorily Redeemable Financial Instruments of Certain Nonpublic Entities and Certain Mandatorily Redeemable Noncontrolling Interests with a Scope Exception:</u></div>

<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left">&#160;</div>

<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left">
<div></div>

<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 28.35pt"><font style="font: 10pt Times New Roman, Times, serif">In July 2017, the FASB issued ASU No. 2017-11.&#160;The ASU was issued to address the complexity associated with applying U.S. GAAP for certain financial instruments with characteristics of liabilities and equity. The ASU, among other things, eliminates the need to consider the effects of down round features when analyzing convertible debt, warrants and other financing instruments. As a result, a freestanding equity-linked financial instrument (or embedded conversion option) no longer would be accounted for as a derivative liability at fair value as a result of the existence of a down round feature. The amendments are effective for fiscal years beginning after December 15, 2018, and should be applied retrospectively. Early adoption is permitted, including adoption in an interim period. The Company plans to adopt ASU 2017-11 in the first quarter of the Company&#8217;s fiscal year 2018. </font>The Company does not expect the adoption of <font style="font: 10pt Times New Roman, Times, serif">ASU 2017-11</font> will have a material impact on its consolidated financial statements and related disclosures.</div>
</div><span></span></td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI http://asc.fasb.org/topic&amp;trid=2122369<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6806635936">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>MARKETABLE SECURITIES<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesAbstract', window );"><strong>Marketable Securities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock', window );">MARKETABLE SECURITIES</a></td>
<td class="text"><div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: left">NOTE 3:- MARKETABLE SECURITIES</div>

<div style="line-height: 1.25"><br style="line-height: 1.25" />
</div>

<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 35.45pt">As of June 30, 2017 and 2016, all of the Company&#8217;s marketable securities were classified as available-for-sale.</div>

<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 35.45pt">&#160;</div>

<div>
<table id="z17c89b572ecf496caa4468908301afa4" cellspacing="0" cellpadding="0" align="right" border="0" style="font: 10pt Times New Roman, Times, serif; width: 94%">
<tr style="height: 12px">
<td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
<td colspan="18" style="vertical-align: bottom; vertical-align: top; border-bottom: #000000 2px solid; font-weight: bold; text-align: center">June 30, 2017</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; text-align: left">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
<td colspan="18" style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid">
<div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center">June 30, 2016</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; text-align: left">&#160;</td>
</tr>

<tr>
<td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
<td colspan="2" style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid">
<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: center"><font style="font: bold 10pt Times New Roman, Times, serif">Amortized cos</font>t</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; text-align: left">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
<td colspan="2" style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid">
<div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center">Gross</div>

<div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center">unrealized</div>

<div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center">gain</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; text-align: left">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
<td colspan="2" style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid">
<div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center">Gross</div>

<div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center">unrealized</div>

<div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center">loss</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; text-align: left">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
<td colspan="2" style="vertical-align: bottom; vertical-align: top; border-bottom: #000000 2px solid">
<div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center">Other-than-temporary impairment</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; text-align: left">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
<td colspan="2" style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid">
<div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center">Fair</div>

<div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center">value</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; text-align: left">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
<td colspan="2" style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid">
<div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center">Amortized cost</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; text-align: left">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
<td colspan="2" style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid">
<div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center">Gross</div>

<div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center">unrealized</div>

<div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center">gain</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; text-align: left">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
<td colspan="2" style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid">
<div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center">Gross</div>

<div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center">unrealized</div>

<div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center">loss</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; text-align: left">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
<td colspan="2" style="vertical-align: bottom; vertical-align: top; border-bottom: #000000 2px solid">
<div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center">Other-than-temporary impairment</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; text-align: left">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
<td colspan="2" style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid">
<div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center">Fair</div>

<div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center">value</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; text-align: left">&#160;</td>
</tr>

<tr>
<td style="vertical-align: bottom; vertical-align: bottom; background-color: #cceeff">
<div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 8.65pt; text-indent: 0.7pt">Available-for-sale - matures within one year:</div>
</td>
<td style="vertical-align: bottom; vertical-align: bottom; background-color: #cceeff">&#160;</td>
<td colspan="2" style="vertical-align: bottom; vertical-align: bottom; background-color: #cceeff">&#160;</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; background-color: #cceeff">&#160;</td>
<td colspan="2" style="vertical-align: bottom; vertical-align: bottom; background-color: #cceeff">&#160;</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; background-color: #cceeff">&#160;</td>
<td colspan="2" style="vertical-align: bottom; vertical-align: bottom; background-color: #cceeff">&#160;</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; background-color: #cceeff">&#160;</td>
<td colspan="2" style="vertical-align: bottom; vertical-align: top; background-color: #cceeff">&#160;</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; background-color: #cceeff">&#160;</td>
<td colspan="2" style="vertical-align: bottom; vertical-align: bottom; background-color: #cceeff">&#160;</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; background-color: #cceeff">&#160;</td>
<td colspan="2" style="vertical-align: bottom; vertical-align: bottom; background-color: #cceeff">&#160;</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; background-color: #cceeff">&#160;</td>
<td colspan="2" style="vertical-align: bottom; vertical-align: bottom; background-color: #cceeff">&#160;</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; background-color: #cceeff">&#160;</td>
<td colspan="2" style="vertical-align: bottom; vertical-align: bottom; background-color: #cceeff">&#160;</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; background-color: #cceeff">&#160;</td>
<td colspan="2" style="vertical-align: bottom; vertical-align: top; background-color: #cceeff">&#160;</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; background-color: #cceeff">&#160;</td>
<td colspan="2" style="vertical-align: bottom; vertical-align: bottom; background-color: #cceeff">&#160;</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; background-color: #cceeff">&#160;</td>
</tr>

<tr>
<td style="vertical-align: bottom; vertical-align: bottom; width: 20%; background-color: #ffffff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 8.65pt; text-indent: 0.7pt">Stock and index linked notes</div>
</td>
<td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">$</div>
</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 5%; background-color: #ffffff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">11,988</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">$</div>
</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 5%; background-color: #ffffff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">2,014</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">$</div>
</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 5%; background-color: #ffffff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">(47</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">)</div>
</td>
<td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">$</div>
</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 5%; background-color: #ffffff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">(767</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">)</div>
</td>
<td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">$</div>
</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 5%; background-color: #ffffff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">13,188</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">$</div>
</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 5%; background-color: #ffffff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">11,599</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">$</div>
</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 5%; background-color: #ffffff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">1,594</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">$</div>
</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 5%; background-color: #ffffff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">(208</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">)</div>
</td>
<td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">$</div>
</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 5%; background-color: #ffffff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">(38</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">)</div>
</td>
<td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">$</div>
</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 5%; background-color: #ffffff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">12,947</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff">&#160;</td>
</tr>

<tr>
<td style="vertical-align: bottom; vertical-align: bottom; width: 20%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 8.65pt; text-indent: 0.7pt">Government debentures &#8211; fixed interest rate</div>
</td>
<td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 5%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">157</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 5%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">1</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 5%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">-</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 5%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">-</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 5%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">158</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 5%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">786</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 5%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">12</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 5%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">-</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 5%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">-</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 5%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">798</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff">&#160;</td>
</tr>

<tr>
<td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; width: 20%; background-color: #ffffff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 8.65pt; text-indent: 0.7pt">Corporate debentures &#8211; fixed interest rate</div>
</td>
<td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 5%; background-color: #ffffff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">47</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 5%; background-color: #ffffff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">1</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 5%; background-color: #ffffff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">-</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 5%; background-color: #ffffff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">-</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 5%; background-color: #ffffff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">48</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 5%; background-color: #ffffff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">439</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 5%; background-color: #ffffff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">7</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 5%; background-color: #ffffff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">-</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 5%; background-color: #ffffff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">-</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 5%; background-color: #ffffff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">446</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff">&#160;</td>
</tr>

<tr>
<td style="vertical-align: bottom; vertical-align: bottom; width: 20%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">$</div>
</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 5%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">12,192</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">$</div>
</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 5%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">2,016</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">$</div>
</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 5%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">(47</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">)</div>
</td>
<td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">$</div>
</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 5%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">(767</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">)</div>
</td>
<td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">$</div>
</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 5%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">13,394</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">$</div>
</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 5%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">12,824</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">$</div>
</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 5%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">1,613</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">$</div>
</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 5%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">(208</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">)</div>
</td>
<td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">$</div>
</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 5%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">(38</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">)</div>
</td>
<td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">$</div>
</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 5%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">14,191</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff">&#160;</td>
</tr>

<tr>
<td style="vertical-align: bottom; vertical-align: bottom; width: 20%; background-color: #ffffff">
<div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 8.65pt">Available-for-sale - matures after one year through five years:</div>
</td>
<td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 5%; background-color: #ffffff">&#160;</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 5%; background-color: #ffffff">&#160;</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 5%; background-color: #ffffff">&#160;</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 5%; background-color: #ffffff">&#160;</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 5%; background-color: #ffffff">&#160;</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 5%; background-color: #ffffff">&#160;</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 5%; background-color: #ffffff">&#160;</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 5%; background-color: #ffffff">&#160;</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 5%; background-color: #ffffff">&#160;</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 5%; background-color: #ffffff">&#160;</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff">&#160;</td>
</tr>

<tr>
<td style="vertical-align: bottom; vertical-align: bottom; width: 20%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 8.65pt; text-indent: 0.7pt">Government debentures &#8211; fixed interest rate</div>
</td>
<td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 5%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">468</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 5%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">23</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 5%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">-</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 5%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">-</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 5%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">491</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 5%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">717</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 5%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">27</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 5%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">-</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 5%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">-</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 5%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">744</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff">&#160;</td>
</tr>

<tr>
<td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; width: 20%; background-color: #ffffff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 8.65pt">Corporate debentures &#8211; fixed interest rate</div>
</td>
<td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 5%; background-color: #ffffff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">1,255</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 5%; background-color: #ffffff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">7</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 5%; background-color: #ffffff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">(1</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">)</div>
</td>
<td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 5%; background-color: #ffffff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">-</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 5%; background-color: #ffffff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">1,261</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 5%; background-color: #ffffff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">2,403</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 5%; background-color: #ffffff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">47</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 5%; background-color: #ffffff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">-</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 5%; background-color: #ffffff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">-</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 5%; background-color: #ffffff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">2,450</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff">&#160;</td>
</tr>

<tr>
<td style="vertical-align: bottom; vertical-align: bottom; width: 20%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">$</div>
</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 5%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">1,723</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">$</div>
</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 5%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">30</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">$</div>
</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 5%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">(1</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">)</div>
</td>
<td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">$</div>
</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 5%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">-</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">$</div>
</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 5%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">1,752</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">$</div>
</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 5%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">3,120</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">$</div>
</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 5%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">74</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">$</div>
</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 5%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">-</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">$</div>
</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 5%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">-</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">$</div>
</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 5%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">3,194</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff">&#160;</td>
</tr>

<tr>
<td style="vertical-align: bottom; vertical-align: bottom; width: 20%; background-color: #ffffff">
<div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 8.65pt; text-indent: 0.7pt">Available-for-sale - matures after five years through ten years:</div>
</td>
<td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 5%; background-color: #ffffff">&#160;</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 5%; background-color: #ffffff">&#160;</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 5%; background-color: #ffffff">&#160;</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 5%; background-color: #ffffff">&#160;</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 5%; background-color: #ffffff">&#160;</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 5%; background-color: #ffffff">&#160;</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 5%; background-color: #ffffff">&#160;</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 5%; background-color: #ffffff">&#160;</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 5%; background-color: #ffffff">&#160;</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 5%; background-color: #ffffff">&#160;</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff">&#160;</td>
</tr>

<tr>
<td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; width: 20%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 8.65pt; text-indent: 0.7pt">Corporate debentures &#8211; fixed interest rate</div>
</td>
<td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 5%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">17</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 5%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">1</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 5%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">-</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 5%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">-</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 5%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">18</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 5%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">29</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 5%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">1</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 5%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">-</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 5%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">-</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 5%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">30</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #cceeff">&#160;</td>
</tr>

<tr>
<td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; width: 20%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #ffffff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">$</div>
</td>
<td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 5%; background-color: #ffffff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">17</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #ffffff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">$</div>
</td>
<td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 5%; background-color: #ffffff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">1</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #ffffff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">$</div>
</td>
<td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 5%; background-color: #ffffff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">-</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #ffffff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">$</div>
</td>
<td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 5%; background-color: #ffffff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">-</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #ffffff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">$</div>
</td>
<td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 5%; background-color: #ffffff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">18</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #ffffff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">$</div>
</td>
<td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 5%; background-color: #ffffff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">29</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #ffffff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">$</div>
</td>
<td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 5%; background-color: #ffffff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">1</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #ffffff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">$</div>
</td>
<td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 5%; background-color: #ffffff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">-</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #ffffff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">$</div>
</td>
<td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 5%; background-color: #ffffff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">-</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #ffffff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">$</div>
</td>
<td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 5%; background-color: #ffffff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">30</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff">&#160;</td>
</tr>

<tr>
<td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 4px; width: 20%; background-color: #cceeff">
<div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 8.65pt; text-indent: 0.7pt">Total</div>
</td>
<td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 4px; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">$</div>
</td>
<td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 5%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">13,932</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 4px; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">$</div>
</td>
<td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 5%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">2,047</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 4px; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">$</div>
</td>
<td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 5%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">(48</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">)</div>
</td>
<td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 4px; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">$</div>
</td>
<td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 5%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">(767</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">)</div>
</td>
<td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 4px; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">$</div>
</td>
<td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 5%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">15,164</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 4px; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">$</div>
</td>
<td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 5%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">15,973</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 4px; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">$</div>
</td>
<td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 5%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">1,688</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 4px; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">$</div>
</td>
<td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 5%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">(208</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">)</div>
</td>
<td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 4px; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">$</div>
</td>
<td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 5%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">(38</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">)</div>
</td>
<td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 4px; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">$</div>
</td>
<td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 5%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">17,415</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #cceeff">&#160;</td>
</tr>
</table>
</div>

<div style="line-height: 1.25"><br style="line-height: 1.25" />
</div>

<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 34.1pt">The following table presents gross unrealized losses and fair values for those investments that were in an unrealized loss position as of June 30, 2017 and June 30, 2016, and the length of time that those investments have been in a continuous loss position:</div>

<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 7.1pt">&#160;</div>

<div>
<table id="z2ddad5786c9049a9adbfbf0b1b61d13c" cellspacing="0" cellpadding="0" align="right" border="0" style="font: 10pt Times New Roman, Times, serif; width: 94%">
<tr>
<td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
<td colspan="6" style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid">
<div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center">12 months or less</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; text-align: left">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
<td colspan="6" style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid">
<div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center">Greater than 12 months</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; text-align: left">&#160;</td>
</tr>

<tr>
<td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
<td colspan="2" style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid">
<div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center">Fair Value</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; text-align: left">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
<td colspan="2" style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid">
<div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center">Gross<font style="font: 10pt Times New Roman, Times, serif"><br />
</font>unrealized loss</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; text-align: left">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
<td colspan="2" style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid">
<div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center">Fair Value</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; text-align: left">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
<td colspan="2" style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid">
<div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center">Gross<font style="font: 10pt Times New Roman, Times, serif"><br />
</font>unrealized loss</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; text-align: left">&#160;</td>
</tr>

<tr>
<td style="vertical-align: bottom; vertical-align: bottom; width: 52%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 8.65pt; text-indent: 0.7pt">As of June 30, 2017</div>
</td>
<td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">$</div>
</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">869</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">$</div>
</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">(24</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">)</div>
</td>
<td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">$</div>
</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">106</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">$</div>
</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">(<font style="font: 10pt Times New Roman, Times, serif">2</font>4</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">)</div>
</td>
</tr>

<tr>
<td style="vertical-align: bottom; vertical-align: bottom; width: 52%; background-color: #ffffff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 8.65pt">As of June 30, 2016</div>
</td>
<td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">$</div>
</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">1,258</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">$</div>
</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">(143</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">)</div>
</td>
<td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">$</div>
</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">563</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">$</div>
</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">(65</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">)</div>
</td>
</tr>
</table>
</div>

<div style="clear: both; line-height: 1.25"><br style="line-height: 1.25" />
</div>

<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 36pt">The Company typically invests in highly-rated securities. When evaluating the investments for other-than-temporary impairment, the Company reviews factors such as the length of time and extent to which fair value has been below cost basis, the financial condition of the issuer and any changes thereto, and the Company's intent to sell, or whether it is more likely than not it will be required to sell, the investment before recovery of the investment's amortized cost basis.</div>

<div style="line-height: 1.25"><br style="line-height: 1.25" />
</div>

<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 36pt">Based on the above factors, the Company concluded that unrealized losses in the amount of $48 on all available-for-sale securities were not other-than-temporary and no credit loss was present for any of its investments. The Company recognized other-than-temporary impairment loss on outstanding securities during the year ended June 30, 2017 and 2016, of $767 and $38, respectively.</div>

<div style="margin-left: 9pt; line-height: 1.25">&#160;</div>

<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 27pt; text-indent: 7.1pt">As of June 30, 2017 and 2016, interest receivable amounted to $11 and $28, respectively.</div><span></span></td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for  investments in certain debt and equity securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -URI http://asc.fasb.org/topic&amp;trid=2196928<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 320<br> -URI http://asc.fasb.org/subtopic&amp;trid=4738149<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 320<br> -URI http://asc.fasb.org/subtopic&amp;trid=2176304<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 320<br> -URI http://asc.fasb.org/subtopic&amp;trid=2324412<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -URI http://asc.fasb.org/subtopic&amp;trid=2209399<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 320<br> -URI http://asc.fasb.org/subtopic&amp;trid=2289146<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecuritiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketableSecuritiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6796497248">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FAIR VALUE OF FINANCIAL INSTRUMENTS<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresTextBlock', window );">FAIR VALUE OF FINANCIAL INSTRUMENTS</a></td>
<td class="text"><div style="line-height: 1.25"></div>

<div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: left">NOTE 4:- FAIR VALUE OF FINANCIAL INSTRUMENTS</div>

<div style="line-height: 1.25">&#160;</div>

<div>
<table id="z900a4c6ca5f447c0aafaf4e29e3bf035" cellspacing="0" cellpadding="0" align="right" border="0" style="font: 10pt Times New Roman, Times, serif; width: 94%">
<tr>
<td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
<td colspan="6" style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid">
<div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center">June 30, 2017</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; text-align: left">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
<td colspan="6" style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid">
<div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center">June 30, 2016</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; text-align: left">&#160;</td>
</tr>

<tr>
<td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
<td colspan="2" style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid">
<div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center">Level 1</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; text-align: left">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
<td colspan="2" style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid">
<div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center">Level 2</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; text-align: left">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
<td colspan="2" style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid">
<div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center">Level 1</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; text-align: left">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
<td colspan="2" style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid">
<div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center">Level 2</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; text-align: left">&#160;</td>
</tr>

<tr>
<td style="vertical-align: bottom; vertical-align: bottom; width: 52%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 8.65pt; text-indent: 0.7pt">Marketable securities</div>
</td>
<td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">$</div>
</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">10,523</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">$</div>
</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">4,641</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">$</div>
</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">11,228</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">$</div>
</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">6,187</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff">&#160;</td>
</tr>

<tr>
<td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; width: 52%; background-color: #ffffff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 8.65pt; text-indent: 0.7pt">Foreign currency derivative instruments not designated as hedge instruments</div>
</td>
<td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #ffffff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">-</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #ffffff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">295</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #ffffff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">-</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #ffffff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">65</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff">&#160;</td>
</tr>

<tr>
<td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 4px; width: 52%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 8.65pt; text-indent: 0.7pt">Total financial assets</div>
</td>
<td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 4px; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">$</div>
</td>
<td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">10,523</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 4px; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">$</div>
</td>
<td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">4,936</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 4px; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">$</div>
</td>
<td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">11,228</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 4px; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">$</div>
</td>
<td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">6,252</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #cceeff">&#160;</td></tr></table></div><span></span></td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -URI http://asc.fasb.org/topic&amp;trid=2155941<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6644146080">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>OTHER CURRENT ASSETS<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract', window );"><strong>Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherCurrentAssetsTextBlock', window );">OTHER CURRENT ASSETS</a></td>
<td class="text"><div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 36pt; text-indent: -36pt">NOTE 5:-OTHER CURRENT ASSETS</div>

<div style="line-height: 1.25">&#160;</div>

<div>
<table id="zfa607ab951ff484e866f040412187dff" cellspacing="0" cellpadding="0" align="right" border="0" style="font: 10pt Times New Roman, Times, serif; width: 94%">
<tr>
<td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
<td colspan="6" style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid">
<div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center">June 30,</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; text-align: left">&#160;</td>
</tr>

<tr>
<td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
<td colspan="2" style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid">
<div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center">2017</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; text-align: left">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
<td colspan="2" style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid">
<div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center">2016</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; text-align: left">&#160;</td>
</tr>

<tr>
<td style="vertical-align: bottom; vertical-align: top; width: 76%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 8.65pt; text-indent: 0.7pt">Prepaid expenses</div>
</td>
<td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">$</div>
</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">882</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">$</div>
</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">300</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff">&#160;</td>
</tr>

<tr>
<td style="vertical-align: bottom; vertical-align: top; width: 76%; background-color: #ffffff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 8.65pt; text-indent: 0.7pt">Accounts receivable from the Ministry of Economy</div>
</td>
<td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">-</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">23</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff">&#160;</td>
</tr>

<tr>
<td style="vertical-align: bottom; vertical-align: top; width: 76%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 8.65pt; text-indent: 0.7pt">Derivatives not designated as hedge instruments</div>
</td>
<td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">295</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">65</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff">&#160;</td>
</tr>

<tr>
<td style="vertical-align: bottom; vertical-align: top; width: 76%; background-color: #ffffff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 8.65pt; text-indent: 0.7pt">VAT receivables</div>
</td>
<td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">137</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">167</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff">&#160;</td>
</tr>

<tr>
<td style="vertical-align: bottom; vertical-align: top; padding-bottom: 2px; width: 76%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 8.65pt; text-indent: 0.7pt">Other receivables</div>
</td>
<td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">1</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">63</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #cceeff">&#160;</td>
</tr>

<tr>
<td style="vertical-align: bottom; vertical-align: top; padding-bottom: 4px; width: 76%; background-color: #ffffff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 8.65pt; text-indent: 0.7pt">Total</div>
</td>
<td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 4px; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #ffffff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">$</div>
</td>
<td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; background-color: #ffffff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">1,315</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 4px; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #ffffff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">$</div>
</td>
<td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; background-color: #ffffff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">618</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #ffffff">&#160;</td>
</tr>
</table>
</div><span></span></td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherCurrentAssetsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for other current assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherCurrentAssetsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6798838112">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>PROPERTY AND EQUIPMENT, NET<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock', window );">PROPERTY AND EQUIPMENT, NET</a></td>
<td class="text"><div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 36pt; text-indent: -36pt">NOTE 6:-PROPERTY AND EQUIPMENT, NET</div>

<div style="line-height: 1.25">&#160;</div>

<div>
<table id="zdc26d7b242f24d7cab1183be09ef8d89" cellspacing="0" cellpadding="0" align="right" border="0" style="font: 10pt Times New Roman, Times, serif; width: 94%">
<tr>
<td style="vertical-align: bottom; vertical-align: middle; padding-bottom: 2px">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
<td colspan="6" style="vertical-align: bottom; vertical-align: top; border-bottom: #000000 2px solid">
<div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center">June 30,</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; text-align: left">&#160;</td>
</tr>

<tr>
<td style="vertical-align: bottom; vertical-align: top; padding-bottom: 2px">
<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left">&#160;</div>
</td>
<td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
<td colspan="2" style="vertical-align: bottom; vertical-align: top; border-bottom: #000000 2px solid">
<div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center">2017</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; text-align: left">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
<td colspan="2" style="vertical-align: bottom; vertical-align: top; border-bottom: #000000 2px solid">
<div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center">2016</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; text-align: left">&#160;</td>
</tr>

<tr>
<td style="vertical-align: bottom; vertical-align: top; background-color: #cceeff">
<div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: left">Cost:</div>
</td>
<td style="vertical-align: bottom; vertical-align: bottom; background-color: #cceeff">&#160;</td>
<td colspan="2" style="vertical-align: bottom; vertical-align: top; background-color: #cceeff">&#160;</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; background-color: #cceeff">&#160;</td>
<td colspan="2" style="vertical-align: bottom; vertical-align: top; background-color: #cceeff">&#160;</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; background-color: #cceeff">&#160;</td>
</tr>

<tr>
<td style="vertical-align: bottom; vertical-align: top; width: 76%; background-color: #ffffff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left">Laboratory equipment</div>
</td>
<td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">$</div>
</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">6,097</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">$</div>
</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">6,000</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff">&#160;</td>
</tr>

<tr>
<td style="vertical-align: bottom; vertical-align: top; width: 76%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left">Computers and peripheral equipment</div>
</td>
<td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">1,126</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">1,024</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff">&#160;</td>
</tr>

<tr>
<td style="vertical-align: bottom; vertical-align: top; width: 76%; background-color: #ffffff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left">Office furniture and equipment</div>
</td>
<td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">681</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">715</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff">&#160;</td>
</tr>

<tr>
<td style="vertical-align: bottom; vertical-align: top; width: 76%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left">Leasehold improvements</div>
</td>
<td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">8,603</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">9,349</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff">&#160;</td>
</tr>

<tr>
<td style="vertical-align: bottom; vertical-align: top; padding-bottom: 2px; width: 76%; background-color: #ffffff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left">Vehicles</div>
</td>
<td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #ffffff">
<div style="line-height: 1.25">
<div style="line-height: 1.25"></div>

<div style="font: 10pt/1.25 Times New Roman, Times, serif">-</div>
</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #ffffff">
<div style="line-height: 1.25">
<div style="line-height: 1.25"></div>

<div style="font: 10pt/1.25 Times New Roman, Times, serif">95</div>
</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff">&#160;</td>
</tr>

<tr style="height: 21px">
<td style="vertical-align: bottom; vertical-align: top; padding-bottom: 2px; width: 76%; background-color: #cceeff">
<div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: left">&#160;Total Cost</div>
</td>
<td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #cceeff">
<div style="line-height: 1.25">
<div style="line-height: 1.25"></div>

<div style="font: 10pt/1.25 Times New Roman, Times, serif">16,507</div>
</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #cceeff">
<div style="line-height: 1.25">
<div style="line-height: 1.25"></div>

<div style="font: 10pt/1.25 Times New Roman, Times, serif">17,183</div>
</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #cceeff">&#160;</td>
</tr>

<tr>
<td style="vertical-align: bottom; vertical-align: top; width: 76%; background-color: #ffffff">
<div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: left">Accumulated depreciation:</div>
</td>
<td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff">&#160;</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff">&#160;</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff">&#160;</td>
</tr>

<tr>
<td style="vertical-align: bottom; vertical-align: top; width: 76%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left">Laboratory equipment</div>
</td>
<td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">4,164</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">3,401</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff">&#160;</td>
</tr>

<tr>
<td style="vertical-align: bottom; vertical-align: top; width: 76%; background-color: #ffffff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left">Computers and peripheral equipment</div>
</td>
<td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">951</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">802</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff">&#160;</td>
</tr>

<tr>
<td style="vertical-align: bottom; vertical-align: top; width: 76%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left">Office furniture and equipment</div>
</td>
<td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">416</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">353</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff">&#160;</td>
</tr>

<tr>
<td style="vertical-align: bottom; vertical-align: top; width: 76%; background-color: #ffffff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left">Leasehold improvements</div>
</td>
<td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">3,699</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">3,374</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff">&#160;</td>
</tr>

<tr>
<td style="vertical-align: bottom; vertical-align: top; padding-bottom: 2px; width: 76%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left">Vehicles</div>
</td>
<td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #cceeff">
<div style="line-height: 1.25">
<div style="line-height: 1.25"></div>

<div style="font: 10pt/1.25 Times New Roman, Times, serif">-</div>
</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #cceeff">
<div style="line-height: 1.25">
<div style="line-height: 1.25"></div>

<div style="font: 10pt/1.25 Times New Roman, Times, serif">37</div>
</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #cceeff">&#160;</td>
</tr>

<tr>
<td style="vertical-align: bottom; vertical-align: top; padding-bottom: 2px; width: 76%; background-color: #ffffff">
<div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: left">Total accumulated depreciation</div>
</td>
<td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #ffffff">
<div style="line-height: 1.25">
<div style="line-height: 1.25"></div>

<div style="font: 10pt/1.25 Times New Roman, Times, serif">9,230</div>
</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #ffffff">
<div style="line-height: 1.25">
<div style="line-height: 1.25"></div>

<div style="font: 10pt/1.25 Times New Roman, Times, serif">7,967</div>
</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff">&#160;</td>
</tr>

<tr>
<td style="vertical-align: bottom; vertical-align: top; padding-bottom: 4px; width: 76%; background-color: #cceeff">
<div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: left">Property and equipment, net</div>
</td>
<td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 4px; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">$</div>
</td>
<td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">7,277</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 4px; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">$</div>
</td>
<td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">9,216</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #cceeff">&#160;</td>
</tr>
</table>
</div>

<div style="clear: both; line-height: 1.25">&#160;</div>

<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 34.1pt">Depreciation expenses amounted to $2,177, $2,150 and $2,074 for the years ended June 30, 2017, 2016 and 2015, respectively.</div><span></span></td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for long-lived, physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, accounting policies and methodology, roll forwards, depreciation, depletion and amortization expense, including composite depreciation, accumulated depreciation, depletion and amortization expense, useful lives and method used, income statement disclosures, assets held for sale and public utility disclosures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -URI http://asc.fasb.org/topic&amp;trid=2155823<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6644146080">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>OTHER ACCOUNTS PAYABLE<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_psti_OtherAccountsPayableAbstract', window );"><strong>OTHER ACCOUNTS PAYABLE [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock', window );">OTHER ACCOUNTS PAYABLE</a></td>
<td class="text"><div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 36pt; text-indent: -36pt">NOTE 7:-OTHER ACCOUNTS PAYABLE</div>

<div style="line-height: 1.25">&#160;</div>

<div>
<table id="z01e5cbd23ef84c7daf6df4bce26c373c" cellspacing="0" cellpadding="0" align="right" border="0" style="font: 10pt Times New Roman, Times, serif; width: 94%">
<tr>
<td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
<td colspan="6" style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid">
<div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center">June 30,</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; text-align: left">&#160;</td>
</tr>

<tr>
<td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
<td colspan="2" style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid">
<div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center">2017</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; text-align: left">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
<td colspan="2" style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid">
<div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center">2016</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; text-align: left">&#160;</td>
</tr>

<tr>
<td style="vertical-align: bottom; vertical-align: top; width: 76%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 8.65pt; text-indent: 0.7pt">Accrued payroll</div>
</td>
<td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">$</div>
</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">505</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">$</div>
</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">421</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff">&#160;</td>
</tr>

<tr>
<td style="vertical-align: bottom; vertical-align: top; width: 76%; background-color: #ffffff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 8.65pt; text-indent: 0.7pt">Payroll institutions</div>
</td>
<td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">345</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">309</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff">&#160;</td>
</tr>

<tr>
<td style="vertical-align: bottom; vertical-align: top; width: 76%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 8.65pt; text-indent: 0.7pt">Accrued vacation</div>
</td>
<td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">791</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">720</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff">&#160;</td>
</tr>

<tr>
<td style="vertical-align: bottom; vertical-align: top; padding-bottom: 2px; width: 76%; background-color: #ffffff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 8.65pt; text-indent: 0.7pt">Other payables</div>
</td>
<td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #ffffff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">342</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #ffffff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">251</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff">&#160;</td>
</tr>

<tr>
<td style="vertical-align: bottom; vertical-align: top; padding-bottom: 4px; width: 76%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 8.65pt; text-indent: 0.7pt">Total</div>
</td>
<td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 4px; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">$</div>
</td>
<td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">1,983</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 4px; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">$</div>
</td>
<td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">1,701</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #cceeff">&#160;</td></tr></table></div><span></span></td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_psti_OtherAccountsPayableAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Other Accounts Payable [Abstract].</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">psti_OtherAccountsPayableAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>psti_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for accounts payable and accrued liabilities at the end of the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a),20,24)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6807338256">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>COMMITMENTS AND CONTINGENCIES<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">COMMITMENTS AND CONTINGENCIES</a></td>
<td class="text"><div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 36pt; text-indent: -36pt">NOTE 8:-COMMITMENTS AND CONTINGENCIES</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">
<table id="zf3dda851cb664819a696bb696ff3f6a6" class="DSPFListTable" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, serif; width: 100%">
<tr>
<td style="width: 17.45pt"></td>
<td style="font: 10pt Times New Roman, Times, serif; width: 18pt; vertical-align: top">a.</td>
<td style="width: auto; vertical-align: top; text-align: justify">
<div style="font: 10pt Times New Roman, Times, serif">In February 2015, the Company signed an addendum to its facility operating lease agreement (the &#8220;Addendum&#8221;) with the lessor, which extended the lease period to December 2021.</div>
</td>
</tr>
</table>
</div>

<div style="line-height: 1.25">&#160;</div>

<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 35.45pt">The lessor paid a non-refundable leasehold improvement participation payment, of approximately $947 in October 2015, in addition to the non-refundable payment of approximately $816 received in January 2013.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 35.45pt">The payments are deductible against lease expenses as they are incurred. The lessor upfront payment is included in the balance sheet as advance payment and recognized as a deduction from lease expenses over the lease term.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 35.45pt">In June 2017, the Company terminated its operating lease agreement for a facility of 1,280 square meters.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 35.45pt">The Company recognizes lease expense, net of lessor participation, under such arrangements, on a straight-line basis over the lease term.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 35.45pt">As of June 30, 2017, aggregate minimum lease commitments under the active operating lease agreements are as follows:</div>

<div style="line-height: 1.25">&#160;</div>

<div>
<table id="za09af2fca2c7484d97018003bd3aaf5a" cellspacing="0" cellpadding="0" align="center" border="0" style="font: 10pt Times New Roman, Times, serif; width: 70%">
<tr>
<td style="vertical-align: top; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 6.95pt; text-indent: -6.95pt">Year ending June 30,</div>
</td>
<td style="vertical-align: bottom; vertical-align: bottom">&#160;</td>
<td colspan="2" style="vertical-align: bottom; vertical-align: bottom">&#160;</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="width: 88%; vertical-align: top; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 6.95pt; text-indent: -6.95pt">2018</div>
</td>
<td style="width: 1%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">$</div>
</td>
<td style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">884</div>
</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="width: 88%; vertical-align: top; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 6.95pt; text-indent: -6.95pt">2019</div>
</td>
<td style="width: 1%; vertical-align: bottom; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">884</div>
</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="width: 88%; vertical-align: top; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 6.95pt; text-indent: -6.95pt">2020</div>
</td>
<td style="width: 1%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">894</div>
</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="width: 88%; vertical-align: top; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 6.95pt; text-indent: -6.95pt">2021</div>
</td>
<td style="width: 1%; vertical-align: bottom; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">904</div>
</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="width: 88%; vertical-align: top; padding-bottom: 2px; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 6.95pt; text-indent: -6.95pt">2022</div>
</td>
<td style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">452</div>
</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="width: 88%; vertical-align: top; padding-bottom: 4px; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 6.95pt; text-indent: -6.95pt">Total</div>
</td>
<td style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">$</div>
</td>
<td style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">4,018</div>
</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff; vertical-align: bottom">&#160;</td>
</tr>
</table>
</div>

<div style="line-height: 1.25">&#160;</div>

<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 35.45pt">&#160;Lease expenses, net of lessor participation, amounted to $781, $824 and $704 for the years ended June 30, 2017, 2016 and 2015, respectively.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 35.45pt">&#160;The Subsidiary issued a bank guarantee in favor of the lessors in the amount of approximately $399.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">
<table id="z2db9cf5235734212b65a01ac2b1964a1" class="DSPFListTable" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, serif; width: 100%">
<tr>
<td style="width: 17.45pt"></td>
<td style="font: 10pt Times New Roman, Times, serif; width: 18pt; vertical-align: top">b.</td>
<td style="width: auto; vertical-align: top; text-align: justify">
<div style="font: 10pt Times New Roman, Times, serif">The Subsidiary leases several motor vehicles under operating lease agreements, which expire in various dates during years 2017 through June 2019.</div>
</td>
</tr>
</table>
</div>

<div style="line-height: 1.25">&#160;</div>

<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 35.45pt">As of June 30, 2017, future aggregate minimum lease commitments under non-cancelable operating lease agreements are as follows:</div>

<div style="line-height: 1.25">&#160;</div>

<div>
<table id="z4f5dd2bb987c46d5bc7bca52a9a11c62" cellspacing="0" cellpadding="0" align="center" border="0" style="font: 10pt Times New Roman, Times, serif; width: 70%">
<tr>
<td style="vertical-align: top; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left">Year ending June 30,</div>
</td>
<td style="vertical-align: bottom; vertical-align: bottom">&#160;</td>
<td colspan="2" style="vertical-align: bottom; vertical-align: bottom">&#160;</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="width: 88%; vertical-align: top; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left">2018</div>
</td>
<td style="width: 1%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">225</div>
</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="width: 88%; vertical-align: top; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left">2019</div>
</td>
<td style="width: 1%; vertical-align: bottom; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">142</div>
</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="width: 88%; vertical-align: top; padding-bottom: 2px; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left">2020</div>
</td>
<td style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">77</div>
</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="width: 88%; vertical-align: top; padding-bottom: 4px; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left">Total</div>
</td>
<td style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">$</div>
</td>
<td style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">444</div>
</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff; vertical-align: bottom">&#160;</td>
</tr>
</table>
</div>

<div style="line-height: 1.25">&#160;</div>

<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 37.35pt">Lease expenses amounted to $233, $210 and $218 for the years ended June 30, 2017, 2016 and 2015, respectively.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">
<table id="z021c6eda0cb942fc96000b93a8c74f76" class="DSPFListTable" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, serif; width: 100%">
<tr>
<td style="width: 17.45pt"></td>
<td style="font: 10pt Times New Roman, Times, serif; width: 18pt; vertical-align: top">c.</td>
<td style="width: auto; vertical-align: top; text-align: justify">
<div style="font: 10pt Times New Roman, Times, serif">An amount of $559 of cash and deposits was pledged by the Subsidiary to secure certain derivatives and hedging transactions, credit line and bank guarantees as of June 30, 2017.</div>
</td>
</tr>
</table>
</div>



<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">
<table id="zd06be3656474465ca4dfb34832da286c" class="DSPFListTable" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, serif; width: 100%">
<tr>
<td style="width: 17.45pt"></td>
<td style="font: 10pt Times New Roman, Times, serif; width: 18pt; vertical-align: top">d.</td>
<td style="width: auto; vertical-align: top; text-align: justify">
<div style="font: 10pt Times New Roman, Times, serif">Under the Law for the Encouragement of Industrial Research and Development, 1984, (the &#8220;Research Law&#8221;), research and development programs that meet specified criteria and are approved by the IIA are eligible for grants of up to 50% of the project&#8217;s expenditures, as determined by the research committee, in exchange for the payment of royalties from the sale of products developed under the program. Regulations under the Research Law generally provide for the payment of royalties to the IIA of 3%-4% on sales of products and services derived from a technology developed using these grants until 100% of the dollar-linked grant is repaid. The Company&#8217;s obligation to pay these royalties is contingent on its actual sale of such products and services. In the absence of such sales, no payment is required. Outstanding balance of the grants will be subject to interest at a rate equal to the 12 month LIBOR applicable to dollar deposits that is published on the first business day of each calendar year. Following the full repayment of the grant, there is no further liability for royalties.</div>
</td>
</tr>
</table>
</div>

<div style="line-height: 1.25">&#160;</div>

<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 35.45pt">Through June 30, 2017, total grants obtained aggregated to approximately $24,461. Through June 30, 2017, total royalties paid and accrued amounted to $166. As of June 30, 2017, the Company&#8217;s contingent liability in respect to royalties to the IIA amounted to $24,295, not including LIBOR interest as described above.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">
<table id="z5c8e462bca1044178dfdf963bc0b6f4e" class="DSPFListTable" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, serif; width: 100%">
<tr>
<td style="width: 17.45pt"></td>
<td style="font: 10pt Times New Roman, Times, serif; width: 18pt; vertical-align: top">e.</td>
<td style="width: auto; vertical-align: top; text-align: justify">
<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify">The Company has been awarded a marketing grant under the &#8220;Smart Money&#8221; program of the Israeli Ministry of Economy and Industry. The program&#8217;s aim is to assist companies to extend their activities in international markets. The goal market that was chosen was Japan. The Israeli government granted the Company budget resources that are intended to be used to advance the Company&#8217;s product candidate towards marketing in Japan and for regulatory activities there. As part of the program, the Company will repay royalties of 5% from the Company&#8217;s income in Japan during five years, starting the year in which the Company will not be entitled to reimbursement of expenses under the program and will be spread for a period of up to 5 years or until the amount of the grant is fully paid<font style="font: 10pt Times New Roman, Times, serif">.</font></div>
</td>
</tr>
</table>
</div>

<div style="line-height: 1.25">&#160;</div>

<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 35.45pt">Through June 30, 2017, total grants obtained under the Smart Money program amounted to approximately $112. No royalties were paid or accrued as of June 30, 2017.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">
<table id="z53e4cec222574e43af1e7d3c20564ad0" class="DSPFListTable" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, serif; width: 100%">
<tr>
<td style="width: 17.45pt"></td>
<td style="font: 10pt Times New Roman, Times, serif; width: 18pt; vertical-align: top">f.</td>
<td style="width: auto; vertical-align: top; text-align: justify">
<div style="font: 10pt Times New Roman, Times, serif">
<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify">The Company announced that it will collaborate with the New York Blood Center (&#8220;NYBC&#8221;) on preclinical studies of its placental expanded R-18 cells (&#8220;PLX-R18&#8221;) to enhance the efficacy of umbilical cord blood transplantation. The project has been selected to receive a conditional award of $900 from Israel-United States Binational Industrial Research and Development Foundation (&#8220;BIRD Foundation&#8221;), of which an amount of $585 is a direct grant allocated to the Company. Per the terms of the project, The Company will provide the PLX-R18 cells and the NYBC will be responsible for conducting and supporting the studies. Amounts received in connection with this award are presented in &#8220;Other long-term liabilities&#8221; as the Company does not expect to repay the liability in the next 12 months.</div>
</div>
</td>
</tr>
</table>
</div>

<div style="line-height: 1.25">&#160;</div>

<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 35.45pt">In accordance with the agreement between the Company and NYBC, if only one party elects to proceed with the development of the product, such party shall be responsible for all repayment obligations to the BIRD Foundation for both parties, if applicable. In addition, in case of conclusion of project development which will trigger the grant repayment to the BIRD Foundation, if the Company will elect to pursue the development of the product, and NYBC elects not to pursue the development of the product, then, unless otherwise agreed by the parties, the Company shall pay NYBC royalties in the amount of 2.5% from its revenues of the product, up to an aggregate royalty amount of approximately $550.</div>

<div style="line-height: 1.25">&#160;</div><span></span></td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -URI http://asc.fasb.org/topic&amp;trid=2127136<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -URI http://asc.fasb.org/topic&amp;trid=2144648<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6785329840">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCKHOLDERS' EQUITY<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteAbstract', window );"><strong>Stockholders' Equity Note [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">STOCKHOLDERS' EQUITY</a></td>
<td class="text"><div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 36pt; text-indent: -36pt">NOTE 9: - STOCKHOLDERS&#8217; EQUITY</div>

<div style="line-height: 1.25">&#160;</div>

<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify">The Company&#8217;s authorized common stock consists of 200,000,000 shares with a par value of $0.00001 per share.&#160; All shares have equal voting rights and are entitled to one vote per share in all matters to be voted upon by stockholders. The shares have no pre-emptive, subscription, conversion or redemption rights and may be issued only as fully paid and non-assessable shares. Holders of the common stock are entitled to equal ratable rights to dividends and distributions with respect to the common stock, as may be declared by the Board of Directors out of funds legally available.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify">The Company&#8217;s authorized preferred stock consists of 10,000,000 shares of preferred stock, par value $0.00001 per share, with series, rights, preferences, privileges and restrictions as may be designated from time to time by the Company&#8217;s Board of Directors.&#160; No shares of preferred stock have been issued.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">
<table id="z87d2780cdb124755b18b71a7b2347e8b" class="DSPFListTable" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, serif; width: 100%">
<tr>
<td style="width: 18pt"></td>
<td style="font: 10pt Times New Roman, Times, serif; width: 18pt; vertical-align: top">a.</td>
<td style="width: auto; vertical-align: top; text-align: justify">
<div style="font: 10pt Times New Roman, Times, serif">From July 2014 through June 2015, a total of 2,081,303 warrants were exercised via &#8220;cashless&#8221; exercise, resulting in the issuance of 963,876 shares of common stock to investors of the Company. &#160;In addition, 170,167 warrants were exercised for cash and resulted in the issuance of 170,167 shares of common stock to investors of the Company. The aggregate cash consideration received was $276.</div>
</td>
</tr>
</table>
</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">
<table id="z2b2818ce06104f87b76ea2231fa00945" class="DSPFListTable" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, serif; width: 100%">
<tr>
<td style="width: 18pt"></td>
<td style="width: 18pt; vertical-align: top"><font style="font: 10pt Times New Roman, Times, serif">b</font><font style="font: bold 10pt Times New Roman, Times, serif">.</font></td>
<td style="width: auto; vertical-align: top; text-align: justify">
<div style="font: 10pt Times New Roman, Times, serif">From October 2014 through May 2015, the Company issued shares of common stock in private placements to investors. In October 2014, the Company issued 200,000 shares of common stock to an investor for aggregate cash consideration of $528. In February 2015, the Company issued an additional 200,000 shares of common stock to an investor for aggregate cash consideration of $586. In May 2015, the Company issued an additional 300,000 shares of common stock to an investor, for which the consideration in the amount of $790 was received from the investor in September 2015.</div>
</td>
</tr>
</table>
</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">
<table id="z491d71b4839c4ba9afe1eabeb698efe0" class="DSPFListTable" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, serif; width: 100%">
<tr>
<td style="width: 18pt"></td>
<td style="font: 10pt Times New Roman, Times, serif; width: 18pt; vertical-align: top">c.</td>
<td style="width: auto; vertical-align: top; text-align: justify">
<div style="font: 10pt Times New Roman, Times, serif">On June 25, 2015, the Company entered into definitive agreements to sell 6,800,000 shares of common stock and warrants to purchase up to 4,080,000 shares of common stock at a combined price of $2.50 per share and related warrants (the &#8220;Offering&#8221;). The gross proceeds from the Offering were $17,000. Issuance costs amounted to $1,200. The warrants have an exercise price of $2.85 per share of common stock, are immediately exercisable and expire 5 years from the closing of the Offering. The Offering was closed on June 30, 2015.</div>
</td>
</tr>
</table>
</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">
<table id="zf73f74b46a0544509aace56c79dbe85b" class="DSPFListTable" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, serif; width: 100%">
<tr>
<td style="width: 18pt"></td>
<td style="font: 10pt Times New Roman, Times, serif; width: 18pt; vertical-align: top">d.</td>
<td style="width: auto; vertical-align: top; text-align: justify">
<div style="font: 10pt Times New Roman, Times, serif">In February 2015, the Subsidiary entered into an agreement with a contractor for the construction of its new laboratories facility for a consideration of approximately NIS 3.3 million (approximately $841). Under the terms of the agreement, the Subsidiary agreed to pay part of the NIS 3.3 million consideration using 100,004 restricted shares of common stock of the Company, linked to performance milestones with respect to the new laboratories construction and which serve as a guarantee. These restricted shares were released to the contractor in December 2014 upon the successful completion of the construction.</div>
</td>
</tr>
</table>
</div>

<div style="line-height: 1.25"><br style="line-height: 1.25" />
</div>

<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 36pt">In May 2015, the Subsidiary entered into an addendum to the agreement with the contractor for the design and construction of additional office space renovations in the Subsidiary leased facility for additional consideration of approximately NIS 4 million (approximately $1,032) which is comprised of NIS 3 million (approximately $774) in cash and 90,000 restricted shares which were issued to the contractor in February 2016.</div>

<div style="line-height: 1.25"><br style="line-height: 1.25" />
</div>

<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 36pt">The Company accounted for the abovementioned stock-based payment awards to the contractor in accordance with ASC 505-50, &#8220;Equity based payments to non-employees&#8221;.</div>



<div style="line-height: 1.25"><br style="line-height: 1.25" />
</div>

<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 36pt">As performance by the contractor was not deemed complete while the awards were forfeitable (or not issued), the Company measured the fair value of the awards at each reporting period through the performance completion date (until completion of the construction work).</div>

<div style="line-height: 1.25"><br style="line-height: 1.25" />
</div>

<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 36pt">The construction work was initiated in June 2015. On October 30, 2015, the contractor completed the agreed construction milestones. As a result, the Company recognized the fair value of the stock-based payments awards, using the fair value of the Company&#8217;s shares on October 30, 2015, totaling approximately $302 as stock-based payment to the contractor in &#8220;Additional paid-in capital&#8221; with a corresponding amount included in &#8220;Property and equipment, net&#8221;.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">
<table id="z521b28fde2ea495c878549854f5db083" class="DSPFListTable" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, serif; width: 100%">
<tr>
<td style="width: 18pt"></td>
<td style="font: 10pt Times New Roman, Times, serif; width: 18pt; vertical-align: top">e.</td>
<td style="width: auto; vertical-align: top; text-align: justify">
<div style="font: 10pt Times New Roman, Times, serif">
<div style="line-height: 1.25">On January 25, 2017, the Company issued, pursuant to an underwriting agreement relating to a firm commitment public offering, an aggregate of 14,081,633 shares of common stock and warrants to purchase an aggregate of 8,448,980 shares of common stock, inclusive of the underwriter&#8217;s over-allotment option, which was exercised in full, for aggregate gross proceeds of $17,250. The net proceeds, after deducting underwriting commissions, discounts and other expenses related to the offering were approximately $15,718.</div>
</div>
</td>
</tr>
</table>
</div>

<div style="line-height: 1.25"><br style="line-height: 1.25" />
</div>

<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 36pt">The warrants issued in the offering are exercisable for a period of five years commencing&#160;six months following issuance and have an exercise price of $1.40 per share. As of June 30, 2017, all of the warrants are outstanding.</div>

<div style="line-height: 1.25"><br style="line-height: 1.25" />
</div>

<div style="text-align: justify; line-height: 1.25">
<table id="z934cc2e6e6574d19885e34f2bb8a716e" class="DSPFListTable" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, serif; width: 100%">
<tr>
<td style="font: 10pt Times New Roman, Times, serif; width: 49px; vertical-align: top; text-align: center">&#160;f.</td>
<td style="width: auto; vertical-align: top; font-weight: normal; text-align: justify">
<div style="font: 10pt Times New Roman, Times, serif">Options, warrants and restricted stock units to employees, directors and consultants:</div>
</td>
</tr>
</table>
</div>

<div style="line-height: 1.25"><br style="line-height: 1.25" />
</div>

<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 35.45pt">The Company has approved incentive option plan from 2005 (the &#8220;2005 Plan&#8221;). Under the Plan, options, restricted stock (&#8220;RS&#8221;) and restricted stock units (&#8220;RSUs&#8221;) (collectively, the &#8220;Awards&#8221;) may be granted to the Company&#8217;s officers, directors, employees and consultants.&#160; Any Awards that are cancelled or forfeited before expiration become available for future grants.</div>

<div style="line-height: 1.25"><br style="line-height: 1.25" />
</div>

<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 35.45pt">In addition, at the Company&#8217;s annual meeting of its stockholders, held on May 31, 2016, the Company&#8217;s stockholders approved the 2016 Equity Compensation Plan (the &#8220;2016 Plan&#8221;). Under the 2016 Plan, options, RS and RSUs may be granted to the Company&#8217;s officers, directors, employees and consultants or the officers, directors, employees and consultants of our subsidiary.</div>

<div style="line-height: 1.25"><br style="line-height: 1.25" />
</div>

<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 36pt">As of June 30, 2017, the number of shares of common stock authorized for issuance under the 2005 Plan amounted to 19,166,082, of which 3,305,428 shares are available for future grant under the 2005 Plan.</div>

<div style="line-height: 1.25"><br style="line-height: 1.25" />
</div>

<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 36pt">As of June 30, 2017, the number of shares of common stock authorized for issuance under the 2016 Plan amounted to 2,584,147 for calendar year 2017, of which 343,327 shares are available for future grant under the 2016 Plan.</div>



<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25">
<div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 71.45pt; text-indent: -36pt"><u>(1) Options to employees and directors:</u></div>

<div style="line-height: 1.25">&#160;</div>

<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 36pt">The Company accounts for its options to employees and directors under the fair value method in accordance with ASC 718, &#8220;Compensation&#8212;Stock Compensation&#8221;. A summary of the Company&#8217;s activity for options granted to employees and directors under the 2005 Plan is as follows:</div>
</div>

<div style="line-height: 1.25">&#160;</div>

<div>
<table id="zc5d82afc4543485a9c7bd20b618b95e2" cellspacing="0" cellpadding="0" align="right" border="0" style="font: 10pt Times New Roman, Times, serif; width: 94%">
<tr>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"></td>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td colspan="14" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom">
<div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center; text-indent: 2pt">Year ended June 30, 2017</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom">
<div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center; text-indent: 2pt">Number</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom">
<div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center; text-indent: 2pt">Weighted Average Exercise Price</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom">
<div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center; text-indent: 2pt">Weighted Average Remaining Contractual Terms (in years)</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom">
<div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center; text-indent: 2pt">Aggregate Intrinsic Value Price</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="vertical-align: bottom; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 8.65pt; text-indent: 0.7pt">Options outstanding at beginning of period</div>
</td>
<td style="vertical-align: bottom; text-align: right; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">1,771,700</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">$</div>
</td>
<td style="vertical-align: bottom; text-align: right; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">3.76</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td colspan="2" style="vertical-align: bottom; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td colspan="2" style="vertical-align: bottom; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="vertical-align: bottom; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 8.65pt; text-indent: 0.7pt">Options exercised</div>
</td>
<td style="vertical-align: bottom; text-align: right; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">(16,000</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">)</div>
</td>
<td style="vertical-align: bottom; text-align: right; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">$</div>
</td>
<td style="vertical-align: bottom; text-align: right; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">0.62</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td colspan="2" style="vertical-align: bottom; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td colspan="2" style="vertical-align: bottom; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 8.65pt; text-indent: 0.7pt">Options forfeited</div>
</td>
<td style="vertical-align: bottom; padding-bottom: 2px; text-align: right; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">(940,050</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">)</div>
</td>
<td style="vertical-align: bottom; padding-bottom: 2px; text-align: right; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">$</div>
</td>
<td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">4.49</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td colspan="2" style="vertical-align: bottom; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td colspan="2" style="vertical-align: bottom; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="width: 52%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 8.65pt; text-indent: 0.7pt">Options outstanding at end of the period</div>
</td>
<td style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: right; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">815,650</div>
</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: right; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">$</div>
</td>
<td style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">2.98</div>
</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: right; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">0.82</div>
</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: right; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">$</div>
</td>
<td style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">231</div>
</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="width: 52%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 8.65pt; text-indent: 0.7pt">Options exercisable at the end of the period</div>
</td>
<td style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: right; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">815,650</div>
</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: right; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">$</div>
</td>
<td style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">2.98</div>
</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: right; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">0.82</div>
</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: right; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">$</div>
</td>
<td style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">231</div>
</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="width: 52%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 8.65pt; text-indent: 0.7pt">Options vested at the end of the period</div>
</td>
<td style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: right; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">815,650</div>
</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: right; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">$</div>
</td>
<td style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">2.98</div>
</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: right; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">0.82</div>
</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: right; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">$</div>
</td>
<td style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">231</div>
</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff; vertical-align: bottom">&#160;</td>
</tr>
</table>
</div>

<div style="clear: both; line-height: 1.25"><br style="line-height: 1.25" />
</div>

<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 35.45pt">Intrinsic value of exercisable options (the difference between the Company&#8217;s closing stock price on the last trading day in the period and the exercise price, multiplied by the number of in-the-money options) represents the amount that would have been received by the employees and directors option holders had all option holders exercised their options on June 30, 2017. This amount changes based on the fair market value of the Company&#8217;s common stock.</div>

<div style="line-height: 1.25"><br style="line-height: 1.25" />
</div>

<div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 71.45pt; text-indent: -36pt"><u>(2) Options to non-employees:</u></div>

<div style="line-height: 1.25">&#160;</div>

<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 36pt; text-indent: 0pt">A summary of the options to non-employee consultants is as follows:</div>

<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 36pt; text-indent: 0pt">&#160;</div>

<div>
<table id="zffa8b47d18a649d3a4152a165d92e716" cellspacing="0" cellpadding="0" align="right" border="0" style="font: 10pt Times New Roman, Times, serif; width: 94%">
<tr>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td colspan="14" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom">
<div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center; text-indent: 2pt">Year ended June 30, 2017</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom">&#160;</td>
</tr>

<tr style="height: 52px">
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom">
<div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center; text-indent: 2pt">Number</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom">
<div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center; text-indent: 2pt">Weighted Average Exercise Price</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom">
<div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center; text-indent: 2pt">Weighted Average Remaining Contractual Terms (in years)</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom">
<div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center; text-indent: 2pt">Aggregate Intrinsic Value Price</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="vertical-align: bottom; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 8.65pt; text-indent: 0.7pt">Options outstanding at beginning of period</div>
</td>
<td style="vertical-align: bottom; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">237,300</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">$</div>
</td>
<td style="vertical-align: bottom; text-align: right; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">5.40</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td colspan="2" style="vertical-align: bottom; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td colspan="2" style="vertical-align: bottom; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="vertical-align: bottom; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 8.65pt; text-indent: 0.7pt">Options granted</div>
</td>
<td style="vertical-align: bottom; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">46,800</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">$</div>
</td>
<td style="vertical-align: bottom; text-align: right; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">0.00</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td colspan="2" style="vertical-align: bottom; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td colspan="2" style="vertical-align: bottom; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="vertical-align: bottom; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 8.65pt; text-indent: 0.7pt">Options exercised</div>
</td>
<td style="vertical-align: bottom; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">(1,900</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">)</div>
</td>
<td style="vertical-align: bottom; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">$</div>
</td>
<td style="vertical-align: bottom; text-align: right; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">0.00</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td colspan="2" style="vertical-align: bottom; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td colspan="2" style="vertical-align: bottom; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 8.65pt; text-indent: 0.7pt">Options forfeited</div>
</td>
<td style="vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">(105,000</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">)</div>
</td>
<td style="vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">$</div>
</td>
<td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">10.98</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td colspan="2" style="vertical-align: bottom; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td colspan="2" style="vertical-align: bottom; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="width: 52%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 8.65pt; text-indent: 0.7pt">Options outstanding at end of the period</div>
</td>
<td style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">177,200</div>
</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">$</div>
</td>
<td style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">0.72</div>
</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">4.30</div>
</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">$</div>
</td>
<td style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">179</div>
</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="width: 52%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 8.65pt; text-indent: 0.7pt">Options exercisable at the end of the period</div>
</td>
<td style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">164,825</div>
</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">$</div>
</td>
<td style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">0.78</div>
</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">3.92</div>
</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">$</div>
</td>
<td style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">163</div>
</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="width: 52%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 8.65pt; text-indent: 0.7pt">Options vested&#160; and expected to vest at the end of the period</div>
</td>
<td style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">177,200</div>
</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">$</div>
</td>
<td style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">0.72</div>
</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">4.30</div>
</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">$</div>
</td>
<td style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">179</div>
</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
</tr>
</table>
</div>

<div style="clear: both; line-height: 1.25"><br style="line-height: 1.25" />
</div>



<div style="line-height: 1.25">&#160;</div>

<div style="margin-left: 36pt; line-height: 1.25">Compensation expenses related to options granted to consultants were recorded as follows:</div>

<div style="line-height: 1.25">&#160;</div>

<div>
<table id="zd480bd2b1cb94e0484682e7fd7793ed9" cellspacing="0" cellpadding="0" align="right" border="0" style="font: 10pt Times New Roman, Times, serif; width: 94%">
<tr>
<td style="vertical-align: top; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td colspan="10" style="vertical-align: middle; border-bottom: #000000 2px solid; vertical-align: bottom">
<div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center; text-indent: 2pt">Year ended June 30,</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="vertical-align: top; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td colspan="2" style="vertical-align: top; border-bottom: #000000 2px solid; vertical-align: bottom">
<div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center">2017</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td colspan="2" style="vertical-align: top; border-bottom: #000000 2px solid; vertical-align: bottom">
<div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center">2016</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td colspan="2" style="vertical-align: top; border-bottom: #000000 2px solid; vertical-align: bottom">
<div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center">2015</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="width: 64%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 8.65pt; text-indent: 0.7pt">Research and development expenses</div>
</td>
<td style="width: 1%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">$</div>
</td>
<td style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">7</div>
</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">$</div>
</td>
<td style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">22</div>
</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">$</div>
</td>
<td style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">1</div>
</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="width: 64%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 8.65pt; text-indent: 0.7pt">General and administrative expenses</div>
</td>
<td style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">39</div>
</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">2</div>
</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">1</div>
</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="width: 64%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">$</div>
</td>
<td style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">46</div>
</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">$</div>
</td>
<td style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">24</div>
</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">$</div>
</td>
<td style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">2</div>
</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
</tr>
</table>
</div>

<div style="clear: both; line-height: 1.25">&#160;</div>

<div style="line-height: 1.25">
<div id="DSPFPageHeader"></div>

<div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 71.45pt; text-indent: -36pt"><font style="font: 10pt Times New Roman, Times, serif">&#160;</font><font style="font: 10pt Times New Roman, Times, serif"><u>(3) RS and RSUs to employees and directors:</u></font></div>

<div style="line-height: 1.25">
<div></div>

<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 35.45pt">&#160;</div>

<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 35.45pt">The following table summarizes the activity related to unvested RS and RSUs granted to employees and directors under the 2005 Plan and 2016 Plan for the year ended June 30, 2017:</div>

<div style="line-height: 1.25">&#160;</div>
</div>
</div>

<div>
<table id="zdd176e5c456a4b89a1f51858b7a2875c" cellspacing="0" cellpadding="0" align="right" border="0" style="font: 10pt Times New Roman, Times, serif; width: 94%">
<tr>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom">
<div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center; text-indent: 2pt">Number</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="width: 88%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 8.65pt; text-indent: 0.7pt">Unvested at the beginning of period</div>
</td>
<td style="width: 1%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">1,906,619</div>
</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="width: 88%; vertical-align: bottom; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 8.65pt; text-indent: 0.7pt">Granted</div>
</td>
<td style="width: 1%; vertical-align: bottom; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">6,579,435</div>
</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="width: 88%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 8.65pt; text-indent: 0.7pt">Forfeited</div>
</td>
<td style="width: 1%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">(107,953</div>
</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">)</div>
</td>
</tr>

<tr>
<td style="width: 88%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 8.65pt; text-indent: 0.7pt">Vested</div>
</td>
<td style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">(2,313,200</div>
</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">)</div>
</td>
</tr>

<tr>
<td style="width: 88%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 8.65pt; text-indent: 0.7pt">Unvested at the end of the period</div>
</td>
<td style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">6,064,901</div>
</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="width: 88%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 8.65pt; text-indent: 0.7pt">Expected to vest after June 30, 2017</div>
</td>
<td style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">5,978,114</div>
</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff; vertical-align: bottom">&#160;</td>
</tr>
</table>
</div>

<div style="clear: both; line-height: 1.25">&#160;</div>

<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 36pt">Compensation expenses related to RS and RSUs granted to employees and directors were recorded as follows:</div>

<div style="line-height: 1.25">&#160;</div>

<div>
<table id="z89fbe625712c46c7854b12e39917d0a6" cellspacing="0" cellpadding="0" align="right" border="0" style="font: 10pt Times New Roman, Times, serif; width: 94%">
<tr>
<td style="vertical-align: top; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td colspan="10" style="vertical-align: middle; border-bottom: #000000 2px solid; vertical-align: bottom">
<div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center">Year ended June 30,</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="vertical-align: top; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td colspan="2" style="vertical-align: top; border-bottom: #000000 2px solid; vertical-align: bottom">
<div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center">2017</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td colspan="2" style="vertical-align: top; border-bottom: #000000 2px solid; vertical-align: bottom">
<div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center">2016</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td colspan="2" style="vertical-align: top; border-bottom: #000000 2px solid; vertical-align: bottom">
<div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center">2015</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="width: 64%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 8.65pt; text-indent: 0.7pt">Research and development expenses</div>
</td>
<td style="width: 1%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">$</div>
</td>
<td style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">1,558</div>
</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">$</div>
</td>
<td style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">960</div>
</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">$</div>
</td>
<td style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">1,469</div>
</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="width: 64%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 8.65pt; text-indent: 0.7pt">General and administrative expenses</div>
</td>
<td style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">1,645</div>
</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">1,905</div>
</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">2,277</div>
</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="width: 64%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">$</div>
</td>
<td style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">3,203</div>
</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">$</div>
</td>
<td style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">2,865</div>
</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">$</div>
</td>
<td style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">3,746</div>
</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
</tr>
</table>
</div>

<div style="clear: both; line-height: 1.25">&#160;</div>

<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 35.45pt">Unamortized compensation expenses related to RS and RSUs granted to employees and directors to be recognized over an average time of approximately 4 years are approximately $6,886.</div>





<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25">
<div></div>

<div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 71.45pt; text-indent: -36pt"><u>&#160;(4) RS and RSUs to consultants:</u></div>

<div style="line-height: 1.25">&#160;</div>
</div>

<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 36pt">The following table summarizes the activity related to unvested RS and RSUs granted to consultants for the year ended June 30, 2017:</div>

<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 36pt">&#160;</div>

<div>
<table id="z8e0bf2d3eaa64c13b2ffaf539d67195a" cellspacing="0" cellpadding="0" align="right" border="0" style="font: 10pt Times New Roman, Times, serif; width: 94%">
<tr>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom">
<div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center; text-indent: 2pt">Number</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="width: 88%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 8.65pt; text-indent: 0.7pt">Unvested at the beginning of period</div>
</td>
<td style="width: 1%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">26,000</div>
</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
</tr>

<tr style="height: 16px">
<td style="width: 88%; vertical-align: bottom; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 8.65pt; text-indent: 0.7pt">Granted</div>
</td>
<td style="width: 1%; vertical-align: bottom; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">273,557</div>
</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="width: 88%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 8.65pt; text-indent: 0.7pt">Vested</div>
</td>
<td style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">(257,057</div>
</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">)</div>
</td>
</tr>

<tr>
<td style="width: 88%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 8.65pt; text-indent: 0.7pt">Unvested at the end of the period</div>
</td>
<td style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">42,500</div>
</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff; vertical-align: bottom">&#160;</td>
</tr>
</table>
</div>

<div style="clear: both; line-height: 1.25">&#160;</div>

<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 36pt">Compensation expenses related to RS and RSUs granted to consultants were recorded as follows:</div>

<div style="line-height: 1.25">&#160;</div>

<div>
<table id="z3f959cbd462043d1b0e75a38e85ac309" cellspacing="0" cellpadding="0" align="right" border="0" style="font: 10pt Times New Roman, Times, serif; width: 94%">
<tr>
<td style="vertical-align: top; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td colspan="10" style="vertical-align: middle; border-bottom: #000000 2px solid; vertical-align: bottom">
<div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center">Year ended June 30,</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="vertical-align: top; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td colspan="2" style="vertical-align: top; border-bottom: #000000 2px solid; vertical-align: bottom">
<div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center">2017</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td colspan="2" style="vertical-align: top; border-bottom: #000000 2px solid; vertical-align: bottom">
<div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center">2016</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td colspan="2" style="vertical-align: top; border-bottom: #000000 2px solid; vertical-align: bottom">
<div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center">2015</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="width: 64%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 8.65pt; text-indent: 0.7pt">Research and development expenses</div>
</td>
<td style="width: 1%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">$</div>
</td>
<td style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">19</div>
</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">$</div>
</td>
<td style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">39</div>
</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">$</div>
</td>
<td style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">131</div>
</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="width: 64%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 8.65pt; text-indent: 0.7pt">General and administrative expenses</div>
</td>
<td style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">394</div>
</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">145</div>
</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">173</div>
</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="width: 64%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">$</div>
</td>
<td style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">413</div>
</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">$</div>
</td>
<td style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">184</div>
</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">$</div>
</td>
<td style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">304</div>
</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
</tr>
</table>
</div>

<div style="clear: both; line-height: 1.25">&#160;</div>



<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">
<table id="z6be9f75f757044cbae38753b21d4a708" class="DSPFListTable" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, serif; width: 100%">
<tr>
<td style="width: 18pt"></td>
<td style="font: 10pt Times New Roman, Times, serif; width: 18pt; vertical-align: top">a.</td>
<td style="width: auto; vertical-align: top; text-align: justify">
<div style="font: bold 10pt Times New Roman, Times, serif">Summary of warrants and options:</div>
</td>
</tr>
</table>
</div>

<div style="line-height: 1.25">&#160;</div>

<div>
<table id="z522be72775cb4488b2680c438abfc4d4" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, serif; width: 100%">
<tr style="height: 60px">
<td style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom">
<div style="line-height: 1.25">
<div style="line-height: 1.25">&#160;</div>

<div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center">Warrants / Options</div>
</div>
</td>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom">
<div style="line-height: 1.25">
<div style="line-height: 1.25"></div>

<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: center"><font style="font: bold 10pt Times New Roman, Times, serif">Exercise Price</font> </div>

<div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center">per Share</div>
</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom">
<div style="line-height: 1.25">
<div style="line-height: 1.25"></div>

<div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center">Options and Warrants </div>

<div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center">for Common Stock</div>
</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom">
<div style="line-height: 1.25">
<div style="line-height: 1.25"></div>

<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: center"><font style="font: bold 10pt Times New Roman, Times, serif">Options and Warrants</font> <font style="font: bold 10pt Times New Roman, Times, serif">Exercisable</font></div>
</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom">&#160;</td>
<td style="width: 18px; vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td colspan="2" style="width: 151px; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: center">
<div style="line-height: 1.25">
<div style="line-height: 1.25"></div>

<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: center"><font style="font: bold 10pt Times New Roman, Times, serif">Weighted Average Remaining Contractual Terms</font> <font style="font: bold 10pt Times New Roman, Times, serif">(in years)</font></div>
</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="width: 52%; vertical-align: top; background-color: #cceeff; vertical-align: bottom">
<div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 18pt">Warrants:</div>
</td>
<td style="width: 1%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">$</div>
</td>
<td style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">1.40</div>
</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">8,448,981</div>
</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">-</div>
</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 1.17%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">5.06</div>
</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="width: 52%; vertical-align: top; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">$</div>
</td>
<td style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">2.85</div>
</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">4,080,000</div>
</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">4,080,000</div>
</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 1.17%; vertical-align: bottom; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">3.00</div>
</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="width: 52%; vertical-align: top; padding-bottom: 2px; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">$</div>
</td>
<td style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">5.00</div>
</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">3,219,983</div>
</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">3,219,983</div>
</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 1.17%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">0.22</div>
</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="width: 52%; vertical-align: top; padding-bottom: 2px; background-color: #ffffff; vertical-align: bottom">
<div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 18pt">Total warrants</div>
</td>
<td style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 9%; vertical-align: bottom; padding-bottom: 2px; text-align: right; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff; vertical-align: bottom">
<div style="font: bold 10pt/1.25 Times New Roman, Times, serif">15,748,964</div>
</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff; vertical-align: bottom">
<div style="font: bold 10pt/1.25 Times New Roman, Times, serif">7,299,983</div>
</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 1.17%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 9%; vertical-align: bottom; padding-bottom: 2px; text-align: right; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="width: 52%; vertical-align: top; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 1.17%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="width: 52%; vertical-align: top; background-color: #ffffff; vertical-align: bottom">
<div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 18pt">Options:</div>
</td>
<td style="width: 1%; vertical-align: bottom; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">$</div>
</td>
<td style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">0.00</div>
</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">137,200</div>
</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">124,825</div>
</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 1.17%; vertical-align: bottom; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">5.32</div>
</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="width: 52%; vertical-align: top; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">$</div>
</td>
<td style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">0.62</div>
</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">345,500</div>
</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">345,500</div>
</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 1.17%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">1.28</div>
</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="width: 52%; vertical-align: top; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">$</div>
</td>
<td style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">1.04</div>
</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">25,000</div>
</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">25,000</div>
</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 1.17%; vertical-align: bottom; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">1.16</div>
</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="width: 52%; vertical-align: top; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">$</div>
</td>
<td style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">2.97</div>
</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">20,000</div>
</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">20,000</div>
</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 1.17%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">0.86</div>
</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="width: 52%; vertical-align: top; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">$</div>
</td>
<td style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">3.50</div>
</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">30,000</div>
</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">30,000</div>
</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 1.17%; vertical-align: bottom; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">0.14</div>
</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="width: 52%; vertical-align: top; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">$</div>
</td>
<td style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">3.80</div>
</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">1,000</div>
</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">1,000</div>
</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 1.17%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">0.14</div>
</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="width: 52%; vertical-align: top; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">$</div>
</td>
<td style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">4.38</div>
</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">372,500</div>
</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">372,500</div>
</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 1.17%; vertical-align: bottom; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">0.47</div>
</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="width: 52%; vertical-align: top; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">$</div>
</td>
<td style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">4.40</div>
</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">400</div>
</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">400</div>
</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 1.17%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">0.14</div>
</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="width: 52%; vertical-align: top; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">$</div>
</td>
<td style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">6.80</div>
</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">36,250</div>
</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">36,250</div>
</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 1.17%; vertical-align: bottom; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">0.37</div>
</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="width: 52%; vertical-align: top; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">$</div>
</td>
<td style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">8.20</div>
</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">20,000</div>
</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">20,000</div>
</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 1.17%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">0.16</div>
</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="width: 52%; vertical-align: top; padding-bottom: 2px; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">$</div>
</td>
<td style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">20.00</div>
</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">5,000</div>
</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">5,000</div>
</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 1.17%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">2.62</div>
</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="width: 52%; vertical-align: top; padding-bottom: 2px; background-color: #cceeff; vertical-align: bottom">
<div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 18pt">Total options</div>
</td>
<td style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 9%; vertical-align: bottom; padding-bottom: 2px; text-align: right; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff; vertical-align: bottom">
<div style="font: bold 10pt/1.25 Times New Roman, Times, serif">992,850</div>
</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff; vertical-align: bottom">
<div style="font: bold 10pt/1.25 Times New Roman, Times, serif">980,475</div>
</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 1.17%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 9%; vertical-align: bottom; padding-bottom: 2px; text-align: right; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td colspan="4" style="vertical-align: top; padding-bottom: 2px; background-color: #ffffff; vertical-align: bottom">
<div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: left; text-indent: 18pt">Total warrants and options</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff; vertical-align: bottom">
<div style="font: bold 10pt/1.25 Times New Roman, Times, serif">16,741,814</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff; vertical-align: bottom">
<div style="font: bold 10pt/1.25 Times New Roman, Times, serif">8,280,458</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 18px; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 12px; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 2px; text-align: right; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff; vertical-align: bottom">&#160;</td>
</tr>
</table>
</div>

<div style="line-height: 1.25">&#160;</div>

<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left">This summary does not include 6,107,401 RS and RSUs that are not vested as of June 30, 2017.</div><span></span></td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -URI http://asc.fasb.org/topic&amp;trid=2208762<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6806710912">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FINANCIAL INCOME, NET<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherIncomeAndExpensesAbstract', window );"><strong>Other Income and Expenses [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherIncomeAndOtherExpenseDisclosureTextBlock', window );">FINANCIAL INCOME, NET</a></td>
<td class="text"><div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 36pt; text-indent: -36pt">NOTE 10:-FINANCIAL INCOME, NET</div>

<div style="line-height: 1.25">&#160;</div>

<div>
<table id="za47e081f166149a880e695ce08148ece" cellspacing="0" cellpadding="0" align="right" border="0" style="font: 10pt Times New Roman, Times, serif; width: 94%">
<tr>
<td style="vertical-align: bottom; vertical-align: top; padding-bottom: 2px">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
<td colspan="10" style="vertical-align: bottom; vertical-align: middle; border-bottom: #000000 2px solid">
<div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center">Year ended June 30,</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; text-align: left">&#160;</td>
</tr>

<tr>
<td style="vertical-align: bottom; vertical-align: top; padding-bottom: 2px">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
<td colspan="2" style="vertical-align: bottom; vertical-align: top; border-bottom: #000000 2px solid">
<div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center">2017</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; text-align: left">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
<td colspan="2" style="vertical-align: bottom; vertical-align: top; border-bottom: #000000 2px solid">
<div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center">2016</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; text-align: left">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
<td colspan="2" style="vertical-align: bottom; vertical-align: top; border-bottom: #000000 2px solid">
<div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center">2015</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; text-align: left">&#160;</td>
</tr>

<tr>
<td style="vertical-align: bottom; vertical-align: middle; width: 64%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 8.65pt; text-indent: 0.7pt">Foreign currency translation differences, net</div>
</td>
<td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">$</div>
</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">182</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">$</div>
</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">(174</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">)</div>
</td>
<td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">$</div>
</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">(1,109</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">)</div>
</td>
</tr>

<tr>
<td style="vertical-align: bottom; vertical-align: middle; width: 64%; background-color: #ffffff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 8.65pt; text-indent: 0.7pt">Bank and broker commissions</div>
</td>
<td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">(67</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">)</div>
</td>
<td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">(85</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">)</div>
</td>
<td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">(37</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">)</div>
</td>
</tr>

<tr>
<td style="vertical-align: bottom; vertical-align: middle; width: 64%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 8.65pt; text-indent: 0.7pt">Interest income on deposits</div>
</td>
<td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">122</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">149</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">112</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff">&#160;</td>
</tr>

<tr>
<td style="vertical-align: bottom; vertical-align: middle; width: 64%; background-color: #ffffff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 8.65pt">Gain (loss) related to marketable securities, net</div>
</td>
<td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">(513</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">)</div>
</td>
<td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">190</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">1,229</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff">&#160;</td>
</tr>

<tr>
<td style="vertical-align: bottom; vertical-align: middle; width: 64%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 8.65pt; text-indent: 0.7pt">Gain (loss) from&#160; derivatives and fair value hedge derivatives</div>
</td>
<td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">481</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">(30</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">)</div>
</td>
<td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">395</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff">&#160;</td>
</tr>

<tr>
<td style="vertical-align: bottom; vertical-align: middle; padding-bottom: 2px; width: 64%; background-color: #ffffff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 8.65pt; text-indent: 0.7pt">Other financial income</div>
</td>
<td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #ffffff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">-</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #ffffff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">23</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #ffffff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">-</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff">&#160;</td>
</tr>

<tr>
<td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 4px; width: 64%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 4px; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">$</div>
</td>
<td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">205</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 4px; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">$</div>
</td>
<td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">73</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 4px; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">$</div>
</td>
<td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">590</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #cceeff">&#160;</td>
</tr>
</table>
</div><span></span></td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherIncomeAndExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherIncomeAndExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherIncomeAndOtherExpenseDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for other income or other expense items (both operating and nonoperating). Sources of nonoperating income or nonoperating expense that may be disclosed, include amounts earned from dividends, interest on securities, profits (losses) on securities, net and miscellaneous other income or income deductions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 720<br> -URI http://asc.fasb.org/topic&amp;trid=2122503<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 610<br> -URI http://asc.fasb.org/topic&amp;trid=49130413<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherIncomeAndOtherExpenseDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6796156192">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>TAXES ON INCOME<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">TAXES ON INCOME</a></td>
<td class="text"><div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 36pt; text-indent: -36pt">NOTE 11:-TAXES ON INCOME</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">
<table id="z7bcbacf0f42c4d5c93c73efec80a360c" class="DSPFListTable" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, serif; width: 100%">
<tr>
<td style="font: 10pt Times New Roman, Times, serif; width: 27pt; vertical-align: top">A.</td>
<td style="width: auto; vertical-align: top; text-align: justify">
<div style="font: 10pt Times New Roman, Times, serif">Tax assessments:</div>
</td>
</tr>
</table>
</div>

<div style="line-height: 1.25">&#160;</div>

<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 42.55pt">The Subsidiary has not received final tax assessments since its incorporation; however, the assessments of the Subsidiary are deemed final through 2012.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">
<table id="z0924a5ec76744668a468bba09bab2c68" class="DSPFListTable" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, serif; width: 100%">
<tr>
<td style="font: 10pt Times New Roman, Times, serif; width: 27pt; vertical-align: top">B.</td>
<td style="width: auto; vertical-align: top; text-align: justify">
<div style="font: 10pt Times New Roman, Times, serif">Tax rates applicable to the Company:-</div>
</td>
</tr>
</table>
</div>

<div style="line-height: 1.25"><br style="line-height: 1.25" />
</div>

<div style="text-align: justify; line-height: 1.25">
<table id="z66f1373608f746e1aae92f11f2a25673" class="DSPFListTable" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, serif; width: 100%">
<tr>
<td style="width: 28.35pt"></td>
<td style="font: 10pt Times New Roman, Times, serif; width: 14.2pt; vertical-align: top">1.</td>
<td style="width: auto; vertical-align: top; text-align: justify">
<div style="font: 10pt Times New Roman, Times, serif">Pluristem Therapeutics Inc.:</div>
</td>
</tr>
</table>
</div>

<div style="line-height: 1.25">&#160;</div>

<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 42.55pt">The tax rates applicable to Pluristem Therapeutics Inc., a Nevada corporation, are corporate (progressive) tax at the rate of up to 35%, excluding state tax and local tax if any, which rates depend on the state and city in which Pluristem Therapeutics Inc. conducts its business.</div>

<div style="line-height: 1.25"><br style="line-height: 1.25" />
</div>

<div style="text-align: justify; line-height: 1.25">
<table id="z1fb4eba8f33d44ab8cf4d66bb28cbda2" class="DSPFListTable" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, serif; width: 100%">
<tr>
<td style="width: 28.35pt"></td>
<td style="font: 10pt Times New Roman, Times, serif; width: 14.2pt; vertical-align: top">2.</td>
<td style="width: auto; vertical-align: top; text-align: justify">
<div style="font: 10pt Times New Roman, Times, serif">The Subsidiary:</div>
</td>
</tr>
</table>
</div>

<div style="line-height: 1.25">&#160;</div>

<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 42.55pt">Taxable income of Israeli companies is subject to tax at the rate of 24% in year 2017, 25% in 2016 and 26.5% in 2015.</div>

<div style="line-height: 1.25"><br style="line-height: 1.25" />
</div>

<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 42.55pt">In December 2016, the Israeli Parliament approved the Economic Efficiency Law (Legislative Amendments for Applying the Economic Policy for the 2017 and 2018 Budget Years), 2016, which reduces the corporate income tax rate to 23% effective from January 1, 2018.</div>

<div style="line-height: 1.25"><br style="line-height: 1.25" />
</div>

<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 42.55pt">Under the Foreign Exchange Regulations, the Subsidiary calculates its tax liability in U.S. Dollars according to certain orders. The tax liability, as calculated in U.S. Dollars is translated into New Israeli Shekels according to the exchange rate as of June 30 of each year.</div>



<div style="line-height: 1.25">&#160;</div>

<div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 42.55pt">Tax Benefits Under the Law for Encouragement of Capital Investments.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 42.55pt">According to the Law for Encouragement of Capital Investments, 1959 (the &#8220;Encouragement Law&#8221;), the Subsidiary is entitled to various tax benefits due to &#8220;Beneficiary Enterprise&#8221; status granted to its enterprise, as implied by the Encouragement Law. The principal benefits by virtue of the Encouragement Law are:</div>

<div style="line-height: 1.25">&#160;</div>

<div style="font: italic 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 42.55pt">Tax benefits and reduced tax rates:</div>

<div style="line-height: 1.25">&#160;</div>

<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 42.55pt">On July 7, 2010, the Subsidiary has received a letter of approval (the &#8220;Ruling&#8221;) from the Israeli Tax Authority. According to the Ruling, the Subsidiary&#8217;s expansion program of its plant was granted the status of a &#8220;Beneficiary Enterprise&#8221; under the &#8220;Alternative Track&#8221; (the &#8220;2007 Program&#8221;). The Subsidiary chose the year 2007 as the election year of the 2007 Program.</div>

<div style="line-height: 1.25"><br style="line-height: 1.25" />
</div>

<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 42.55pt">Under the 2007 Program &#8220;Alternative Track&#8221;, the Subsidiary, which was located in a National Priority Zone &#8220;B&#8221; with respect to the year 2007, is tax exempt in the first six years of the benefit period and subject to tax at the reduced rate of 10%-25% for a period of one to four years for the remaining benefit period (dependent on the level of foreign investments).</div>

<div style="line-height: 1.25"><br style="line-height: 1.25" />
</div>

<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 42.55pt">On June 6, 2013, the Subsidiary informed the Israeli Tax Authority that it has chosen the year 2012 as an election year to the expansion of its &#8220;Beneficiary Enterprise&#8221; program (the &#8220;2012 Program&#8221;).</div>

<div style="line-height: 1.25"><br style="line-height: 1.25" />
</div>

<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 42.55pt">Under the 2012 Program, the Subsidiary, which was located in the &#8220;Other National Priority Zone&#8221; with respect to the year 2012, would be tax exempt in the first two years of the benefit period and subject to tax at the reduced rate of 10%-25% for a period of five to eight years for the remaining benefit period (dependent on the level of foreign investments).</div>

<div style="line-height: 1.25"><br style="line-height: 1.25" />
</div>

<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 42.55pt">Following the enactment of Amendment No. 60 to the Encouragement<font style="font: bold 10pt Times New Roman, Times, serif">&#160;</font>Law, subsequent to April 1, 2005, companies whose election year entitled them to a Beneficiary Enterprise status are required, among others, to make a minimum qualifying investment. This condition requires an investment in the acquisition of productive assets such as machinery and equipment, which must be carried out within three years. The minimum qualifying investment required for setting up a plant is NIS&#160;300,000, linked to the Israeli CPI in accordance with the guidelines of the Israeli tax authorities. As for plant expansion, the minimum qualifying investment is the higher of NIS&#160;300,000, linked to the Israeli CPI as stated above, and an amount equivalent to the &#8220;qualifying percentage&#8221; of the value of the productive assets. Productive assets that are used by the plant but not owned by it will also be viewed as productive assets.</div>

<div style="line-height: 1.25"><br style="line-height: 1.25" />
</div>

<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 42.55pt">The qualifying percentage of the value of the productive assets is as follows:</div>

<div style="line-height: 1.25"><br style="line-height: 1.25" />
</div>

<div>
<table id="z7dd3f999d96e475daadaf09b843306b8" cellspacing="0" cellpadding="0" align="right" border="0" style="font: 10pt Times New Roman, Times, serif; width: 94%; border-collapse: collapse">
<tr>
<td style="width: 53.57%; vertical-align: top; border-bottom: #000000 2px solid">
<div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center; margin-left: 42.55pt">The value of productive</div>

<div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center; margin-left: 42.55pt">assets before the expansion</div>

<div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center; margin-left: 42.55pt">(NIS in millions)</div>
</td>
<td style="width: 3.58%; vertical-align: top">&#160;</td>
<td style="width: 42.85%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: center">
<div style="font: bold 10pt/1.25 Times New Roman, Times, serif">The new proportion that the required </div>

<div style="font: bold 10pt/1.25 Times New Roman, Times, serif">investment bears to the value of productive assets</div>
</td>
</tr>

<tr>
<td style="border-top: #000000 2px solid; width: 53.57%; vertical-align: top">&#160;</td>
<td style="width: 3.58%; vertical-align: top">&#160;</td>
<td style="width: 42.85%; vertical-align: top">&#160;</td>
</tr>

<tr>
<td style="width: 53.57%; vertical-align: top; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 42.55pt">Up to NIS&#160;140</div>
</td>
<td style="width: 3.58%; vertical-align: top; background-color: #cceeff">&#160;</td>
<td style="width: 42.85%; vertical-align: top; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: center; margin-left: 42.55pt">12%</div>
</td>
</tr>

<tr>
<td style="width: 53.57%; vertical-align: top; background-color: #ffffff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 42.55pt">NIS&#160;140 - NIS&#160;500</div>
</td>
<td style="width: 3.58%; vertical-align: top; background-color: #ffffff">&#160;</td>
<td style="width: 42.85%; vertical-align: top; background-color: #ffffff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: center; margin-left: 42.55pt">7%</div>
</td>
</tr>

<tr>
<td style="width: 53.57%; vertical-align: top; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 42.55pt">More than NIS&#160;500</div>
</td>
<td style="width: 3.58%; vertical-align: top; background-color: #cceeff">&#160;</td>
<td style="width: 42.85%; vertical-align: top; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: center; margin-left: 42.55pt">5%</div>
</td>
</tr>
</table>
</div>

<div style="clear: both; line-height: 1.25"><br style="line-height: 1.25" />
</div>





<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 42.55pt">&#160;</div>

<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 42.55pt">The income qualifying for tax benefits under the alternative track is the taxable income of a &#8220;beneficiary company&#8221; that has met certain conditions as determined by the Encouragement<font style="font: bold 10pt Times New Roman, Times, serif">&#160;</font>Law, and which is derived from an industrial enterprise. The Encouragement<font style="font: bold 10pt Times New Roman, Times, serif">&#160;</font>Law specifies the types of qualifying income that is entitled to tax benefits under the alternative track both in respect of an industrial enterprise and of a hotel, whereby income from an industrial enterprise includes, among others, revenues from the production and development of software products and revenues from industrial research and development activities performed for a foreign resident (and approved by the Head of the Administration of Industrial Research and Development).</div>

<div style="line-height: 1.25"><br style="line-height: 1.25" />
</div>

<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 42.55pt">As stated above, the Subsidiary&#8217;s 2007 Program and 2012 Program were granted the status of a &#8220;Beneficiary Enterprise&#8221;, in accordance with the Encouragement<font style="font: bold 10pt Times New Roman, Times, serif">&#160;</font>Law, under the alternative benefits track. Accordingly, income derived from the Beneficiary Enterprise is subject to the benefits and conditions stated above.</div>

<div style="line-height: 1.25"><br style="line-height: 1.25" />
</div>

<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 42.55pt">In respect of expansion
programs pursuant to Amendment No. 60 to the Encouragement<font style="font: bold 10pt Times New Roman, Times, serif">&#160;</font>Law,
the benefit period starts at the later of the election year and the first year the Company earns taxable income provided that
12 years have not passed since the beginning of the election year and for companies in National Priority Zone A - 14 years since the beginning of the election year. The benefit period for the Subsidiary&#8217;s 2007 Program will expire in 2018 (12 years since the beginning of the election year&#8211; 2007). The benefit period for the Subsidiary&#8217;s 2012 Program would expire in 2023 (12 years since the beginning of the election year &#8211; 2012).</div>

<div style="line-height: 1.25"><br style="line-height: 1.25" /></div>

<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 42.55pt">If a dividend is distributed out of tax exempt profits, as detailed above, the Subsidiary will become liable for tax at the rate applicable to its profits from the Beneficiary Enterprise in the year in which the income was earned, (tax at the rate of 10-25%, dependent on the level of foreign investments) and to a withholding tax rate of 15% (or lower, under an applicable tax treaty).</div>

<div style="line-height: 1.25"><br style="line-height: 1.25" />
</div>

<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 42.55pt">As for &#8220;Beneficiary Enterprises&#8221; pursuant to Amendment No. 60 to the Encouragement<font style="font: bold 10pt Times New Roman, Times, serif">&#160;</font>Law, the basic condition for receiving the benefits under this track is that the enterprise contributes to Israeli economic growth and is a competitive factor for the gross domestic product. In order to comply with this condition, the Encouragement<font style="font: bold 10pt Times New Roman, Times, serif">&#160;</font>Law prescribes various requirements regarding industrial enterprises.</div>

<div style="line-height: 1.25"><br style="line-height: 1.25" />
</div>

<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 42.55pt">As for industrial enterprises, in each tax year during the benefit period, one of the following conditions must be met:</div>

<div style="line-height: 1.25"><br style="line-height: 1.25" />
</div>

<div style="text-align: justify; line-height: 1.25">
<table id="z1f4f26a25e074c2091e8e557c8bf5801" class="DSPFListTable" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, serif; width: 100%">
<tr>
<td style="width: 27pt"></td>
<td style="font: 10pt Times New Roman, Times, serif; width: 23px; vertical-align: top">1.</td>
<td style="width: auto; vertical-align: top; text-align: justify">
<div style="font: 10pt Times New Roman, Times, serif">The industrial enterprise&#8217;s main field of activity is biotechnology or nanotechnology as approved by the Head of the Administration of Industrial Research and Development, prior to the approval of the relevant program.</div>

<div style="font: 10pt Times New Roman, Times, serif">&#160;</div>
</td>
</tr>
</table>
</div>

<div style="text-align: justify; line-height: 1.25">
<table id="z6cfa32b48c57460eab06454be6b3102b" class="DSPFListTable" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, serif; width: 100%">
<tr>
<td style="width: 27pt"></td>
<td style="font: 10pt Times New Roman, Times, serif; width: 18pt; vertical-align: top">2.</td>
<td style="width: auto; vertical-align: top; text-align: justify">
<div style="font: 10pt Times New Roman, Times, serif">The industrial enterprise&#8217;s sales revenues in a specific market during the tax year do not exceed 75% of its total sales for that tax year. A &#8220;market&#8221; is defined as a separate country or customs territory.</div>

<div style="font: 10pt Times New Roman, Times, serif">&#160;</div>
</td>
</tr>
</table>
</div>

<div style="text-align: justify; line-height: 1.25">
<table id="z9a10c1ef0035427c96f45e1f3b721a24" class="DSPFListTable" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, serif; width: 100%">
<tr>
<td style="width: 27pt"></td>
<td style="font: 10pt Times New Roman, Times, serif; width: 18pt; vertical-align: top">3.</td>
<td style="width: auto; vertical-align: top; text-align: justify">
<div style="font: 10pt Times New Roman, Times, serif">At least 25% of the industrial enterprise&#8217;s overall revenues during the tax year were generated from the enterprise&#8217;s sales in a specific market with a population of at least 14 million.</div>
</td>
</tr>
</table>
</div>

<div style="line-height: 1.25">&#160;</div>

<div style="font: italic 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 42.55pt">Accelerated depreciation:</div>

<div style="line-height: 1.25"><br style="line-height: 1.25" />
</div>

<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 42.55pt">The Subsidiary is eligible for deduction of accelerated depreciation on buildings, machinery and equipment used by the &#8220;Beneficiary Enterprise&#8221; at a rate of 200% (or 400% for buildings) from the first year of the assets operation.</div>



<div style="line-height: 1.25"><br style="line-height: 1.25" />
</div>

<div style="font: italic 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 42.55pt">Conditions for the entitlement to the benefits:</div>

<div style="line-height: 1.25"><br style="line-height: 1.25" />
</div>

<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 42.55pt">The abovementioned benefits are conditional upon the fulfillment of the conditions stipulated by the Encouragement<font style="font: bold 10pt Times New Roman, Times, serif">&#160;</font>Law, regulations promulgated thereunder, and the Ruling with respect to the beneficiary enterprise. Non-compliance with the conditions may cancel all or part of the benefits and refund of the amount of the benefits, including interest. The management believes that the Subsidiary is meeting the aforementioned conditions.</div>

<div style="line-height: 1.25"><br style="line-height: 1.25" />
</div>

<div style="font: italic 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 42.55pt">Amendment to the Encouragement Law:</div>

<div style="line-height: 1.25"><br style="line-height: 1.25" />
</div>

<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 42.55pt">Effective January 2011, the Knesset (Israeli parliament) enacted a reform to the Encouragement Law. According to the reform a flat rate tax would apply to companies eligible for the &#8220;Preferred Enterprise&#8221; status. In order to be eligible for a &#8220;Preferred Enterprise&#8221; status, a company must meet minimum requirements to establish that it contributes to the country&#8217;s economic growth and is a competitive factor for the Gross Domestic Product (a competitive enterprise).</div>

<div style="line-height: 1.25"><br style="line-height: 1.25" />
</div>

<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 42.55pt">Israeli companies which currently benefit from an Approved or Privileged Enterprise status and meet the criteria for qualification as a &#8220;Preferred Enterprise&#8221; can elect to apply the new &#8220;Preferred Enterprise&#8221; benefits by waiving their benefits under the &#8220;Approved&#8221; and &#8220;Beneficiary Enterprise&#8221; status.</div>

<div style="line-height: 1.25"><br style="line-height: 1.25" />
</div>

<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 42.55pt">Benefits granted to a &#8220;Preferred Enterprise&#8221; include reduced tax rates. Following the enactment of the National Priorities Law, effective January 1, 2014, the reduced tax rate is 9% in the Development Area A regions and 16% in other regions. &#8220;Preferred Enterprises&#8221; in peripheral regions are also eligible for Israeli government Investment Center grants, as well as the applicable reduced tax rates.</div>

<div style="line-height: 1.25"><br style="line-height: 1.25" />
</div>

<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 42.55pt">A distribution from a &#8220;Preferred Enterprise&#8221; out of the &#8220;Preferred Income&#8221; is&#160; subject to 20% withholding tax for Israeli-resident individuals and non-Israeli residents (subject to applicable treaty rates).</div>

<div style="line-height: 1.25"><br style="line-height: 1.25" />
</div>

<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 42.55pt">A distribution from a &#8220;Preferred Enterprise&#8221; out of the &#8220;Preferred Income&#8221; would be exempt from withholding tax for an Israeli-resident company.</div>

<div style="line-height: 1.25"><br style="line-height: 1.25" />
</div>

<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 42.55pt">The Subsidiary did not apply the Amendment to the Encouragement Law with respect to the Privileged Enterprise status, but may choose to apply the Amendment in the future<font style="font: 10pt Times New Roman, Times, serif">.</font></div>

<div style="line-height: 1.25"><br style="line-height: 1.25" />
</div>

<div style="font: italic 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 42.55pt">Amendment to the Law for the Encouragement of Capital Investments, 1959 (Amendment 71):</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25">
<div id="DSPFPageHeader"></div>

<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 42.55pt">In August 2013, the Law for Changing National Priorities (Legislative Amendments for Achieving Budget Targets for 2013 and 2014), 2013 which includes Amendment 71 to the Law for the Encouragement of Capital Investments (&#8220;Amendment 71&#8221;) was enacted. According to Amendment 71, the tax rate on preferred income from a preferred enterprise in 2014 and thereafter will be 16% (in development area A - 9%). As for changes in tax rates resulting from the enactment of Amendment 73 to the Law, see below.</div>
</div>

<div style="line-height: 1.25">
<div></div>

<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 42.55pt">&#160;</div>

<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 42.55pt">Amendment 71 also prescribes that any dividends distributed to individuals or foreign residents from the preferred enterprise&#8217;s earnings as above will be subject to tax at a rate of 20%.</div>
</div>



<div style="line-height: 1.25"><br style="line-height: 1.25" />
</div>

<div style="font: italic 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 42.55pt">Amendment to the Law for the Encouragement of Capital Investments, 1959 (Amendment 73):</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25">
<div></div>

<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 42.55pt">In December 2016, the Economic Efficiency Law (Legislative Amendments for Applying the Economic Policy for the 2017 and 2018 Budget Years), 2016 which includes Amendment 73 to the Law for the Encouragement of Capital Investments (&#8220;Amendment 73&#8221;) was published. According to Amendment 73, a preferred enterprise located in development area A will be subject to a tax rate of 7.5% instead of 9% effective from January 1, 2017 and thereafter (the tax rate applicable to preferred enterprises located in other areas remains at 16%).</div>
</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25">
<div></div>

<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 42.55pt">Amendment 73 also prescribes special tax tracks for technological enterprises, which are subject to rules that are to be issued by the Minister of Finance on May 28, 2017, the regulations were approved by the Minister of Finance and the amendment came into effect on January 1, 2017.</div>

<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 42.55pt">&#160;</div>

<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 42.55pt">The new tax tracks under Amendment 73 are as follows:</div>

<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 42.55pt">&#160;</div>

<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 42.55pt">Technological preferred enterprise - an enterprise for which total consolidated revenues of its parent company and all subsidiaries are less than NIS&#160;10 billion. A technological preferred enterprise, as defined in the Encouragement of Capital Investments Law, which is located in the center of Israel will be subject to tax at a rate of 12% on profits deriving from intellectual property (in development area A - a tax rate of 7.5%).</div>
</div>

<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 42.55pt">&#160;</div>

<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 42.55pt">Special technological preferred enterprise - an enterprise for which total consolidated revenues of its parent company and all subsidiaries exceed NIS&#160;10 billion. Such enterprise will be subject to tax at a rate of 6% on profits deriving from intellectual property, regardless of the enterprise&#8217;s geographical location.</div>

<div style="line-height: 1.25"><br style="line-height: 1.25" />
</div>

<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 42.55pt">Any dividends distributed to &#8220;foreign companies&#8221;, as defined in the Law, deriving from income from the technological enterprises will be subject to tax at a rate of 4%.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">
<table id="zb09b81bc113f46fc99d09e1082987950" class="DSPFListTable" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, serif; width: 100%">
<tr>
<td style="width: 27pt"></td>
<td style="font: 10pt Times New Roman, Times, serif; width: 18pt; vertical-align: top">C.</td>
<td style="width: auto; vertical-align: top; text-align: justify">
<div style="font: 10pt Times New Roman, Times, serif">Carryforward losses for tax purposes</div>
</td>
</tr>
</table>
</div>

<div style="line-height: 1.25"><br style="line-height: 1.25" />
</div>

<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 42.55pt">As of June 30, 2017, the Company had U.S. federal net operating loss carryforward for income tax purposes in the amount of approximately $32,519. Net operating loss carryforward arising in taxable years<font style="font: 10pt Times New Roman, Times, serif">,</font> can be carried forward and offset against taxable income for 20 years and expiring between <font style="font: 10pt Times New Roman, Times, serif">202</font>4 and 2037.</div>

<div style="line-height: 1.25"><br style="line-height: 1.25" />
</div>

<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 42.55pt">Utilization of U.S. net operating losses may be subject to substantial annual limitations due to the &#8220;change in ownership&#8221; provisions of the Internal Revenue Code of 1986 and similar state provisions. The annual limitation may result in the expiration of net operating losses before utilization.</div>

<div style="line-height: 1.25"><br style="line-height: 1.25" />
</div>

<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 42.55pt">The Subsidiary in Israel has accumulated losses for tax purposes as of June 30, 2017, in the amount of approximately $109,480, which may be carried forward and offset against taxable business income and business capital gain in the future for an indefinite period.</div>



<div style="line-height: 1.25"><br style="line-height: 1.25" />
</div>

<div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 42.55pt">Deferred income taxes:</div>

<div style="line-height: 1.25"><br style="line-height: 1.25" />
</div>

<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 42.55pt">Deferred income taxes reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. Significant components of the Company&#8217;s deferred tax assets are as follows:</div>

<div style="line-height: 1.25">&#160;</div>

<div>
<table id="z8c0d601e87a3487a842fe95c2270aaeb" cellspacing="0" cellpadding="0" align="right" border="0" style="font: 10pt Times New Roman, Times, serif; width: 94%">
<tr>
<td style="vertical-align: top; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td colspan="6" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom">
<div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center; text-indent: 2pt">June 30,</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="vertical-align: top; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom">
<div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center">2017</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom">
<div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center">2016</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="vertical-align: top; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 8.5pt; text-indent: -8.5pt">Deferred tax assets:</div>
</td>
<td style="vertical-align: bottom; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td colspan="2" style="vertical-align: bottom; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td colspan="2" style="vertical-align: bottom; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="width: 76%; vertical-align: top; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 17pt; text-indent: -8.5pt">U.S. net operating loss carryforward</div>
</td>
<td style="width: 1%; vertical-align: bottom; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">$</div>
</td>
<td style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">11,382</div>
</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">$</div>
</td>
<td style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">10,210</div>
</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="width: 76%; vertical-align: top; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 17pt; text-indent: -8.5pt">Israeli net operating loss carryforward</div>
</td>
<td style="width: 1%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">26,275</div>
</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">22,105</div>
</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="width: 76%; vertical-align: top; padding-bottom: 2px; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 17pt; text-indent: -8.5pt">Allowances and reserves</div>
</td>
<td style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">222</div>
</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">216</div>
</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="width: 76%; vertical-align: top; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="width: 76%; vertical-align: top; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 8.5pt; text-indent: -8.5pt">Total deferred tax assets before valuation allowance</div>
</td>
<td style="width: 1%; vertical-align: bottom; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">37,879</div>
</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">32,531</div>
</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="width: 76%; vertical-align: top; padding-bottom: 2px; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 8.5pt; text-indent: -8.5pt">Valuation allowance</div>
</td>
<td style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">(37,879</div>
</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">)</div>
</td>
<td style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">(32,531</div>
</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">)</div>
</td>
</tr>

<tr>
<td style="width: 76%; vertical-align: top; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="width: 76%; vertical-align: top; padding-bottom: 4px; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 8.5pt; text-indent: -8.5pt">Net deferred tax asset</div>
</td>
<td style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">$</div>
</td>
<td style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">-</div>
</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">$</div>
</td>
<td style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">-</div>
</td>
<td nowrap="nowrap" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
</tr>
</table>
</div>

<div style="clear: both; line-height: 1.25">&#160;</div>

<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 42.55pt">As of June 30, 2017 and 2016, the Company has provided full valuation allowances in respect of deferred tax assets resulting from tax loss carryforward and other temporary differences, since they have a history of operating losses and current uncertainty concerning its ability to realize these deferred tax assets in the future.</div>

<div style="line-height: 1.25"><br style="line-height: 1.25" />
</div>

<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 42.55pt">The Company accounts for its income tax uncertainties in accordance with ASC&#160;740 which clarifies the accounting for uncertainties in income taxes recognized in a Company&#8217;s financial statements and prescribes a recognition threshold and measurement attribute for the financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return.</div>

<div style="line-height: 1.25"><br style="line-height: 1.25" />
</div>

<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 42.55pt">As of June 30, 2017 and 2016, there were no unrecognized tax benefits that if recognized would affect the annual effective tax rate.</div>

<div style="line-height: 1.25"><br style="line-height: 1.25" />
</div>

<div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 70.9pt; text-indent: -28.35pt">Reconciliation of the theoretical tax expense (benefit) to the actual tax expense (benefit):</div>

<div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 70.9pt; text-indent: -28.35pt">&#160;</div>

<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 42.55pt"><font style="font: 10pt Times New Roman, Times, serif">In 2017, 2016 and 2015, the main reconciling item of the statutory tax rate of the Company (24% to 35% in 2017, 2016 and 2015) to the effective tax rate (0%) is tax loss carryforwards, </font>stock-based compensation<font style="font: 10pt Times New Roman, Times, serif"> and other deferred tax assets for which a full valuation allowance was provided.</font></div><span></span></td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -URI http://asc.fasb.org/topic&amp;trid=2144680<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6806645248">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUBSEQUENT EVENTS<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventsAbstract', window );"><strong>Subsequent Events [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventsTextBlock', window );">SUBSEQUENT EVENTS</a></td>
<td class="text"><div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: justify">NOTE 12:-SUBSEQUENT EVENTS</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">
<table id="z9d1d848799254f268142eae03288cd90" class="DSPFListTable" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, serif; width: 100%">
<tr>
<td style="width: 36.2pt"></td>
<td style="font: 10pt Times New Roman, Times, serif; width: 18pt; vertical-align: top">a.</td>
<td style="width: auto; vertical-align: top; text-align: justify">
<div style="font: 10pt Times New Roman, Times, serif">
<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify">Pursuant to a shelf registration on Form S-3 declared effective by the Securities and Exchange Commission on June 23, 2017, in July 2017 the Company entered into an At Market Issuance Sales Agreement (&#8220;ATM Agreement&#8221;) with FBR Capital Markets &#38; Co., MLV &#38; Co. LLC and Oppenheimer &#38; Co. Inc. (collectively, the &#8220;Agents&#8221;), which provides that, upon the terms and subject to the conditions and limitations in the ATM Agreement, the Company may elect, from time to time, to offer and sell shares of common stock having an aggregate offering price of up to $80,000 through the Agents acting as sales agent. As of September 5, 2017, the Company had sold 455,731 shares of common stock at an average price of $1.20 per share.</div>
</div>
</td>
</tr>
</table>
</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">
<table id="z359d4ff499e3488294820b8b25a6d506" class="DSPFListTable" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, serif; width: 100%">
<tr>
<td style="width: 36.2pt"></td>
<td style="font: 10pt Times New Roman, Times, serif; width: 18pt; vertical-align: top">b.</td>
<td style="width: auto; vertical-align: top; text-align: justify">
<div style="font: 10pt Times New Roman, Times, serif">In July 2017, the Company was awarded an additional &#8220;Smart Money&#8221; grant of approximately $229 from Israel&#8217;s Ministry of Economy and Industry to help penetrate the Chinese market, including Hong Kong, with its advanced cell therapy products.</div>
</td>
</tr>
</table>
</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25">
<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 54.2pt">The Israeli government granted the Company budget resources that are intended to be used to advance the Company&#8217;s product candidate towards marketing in the China-Hong Kong markets. The Company will also receive close support from Israel&#8217;s trade representatives stationed in China, including Hong Kong, along with experts appointed by the Smart Money program.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25">
<table id="z78ce9a509dd14812a7a6cb3f689514b3" class="DSPFListTable" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, serif; width: 100%">
<tr>
<td style="width: 36.2pt"></td>
<td style="font: 10pt Times New Roman, Times, serif; width: 18pt; vertical-align: top">c.</td>
<td style="width: auto; vertical-align: top; text-align: justify">
<div style="font: 10pt Times New Roman, Times, serif">
<div style="text-align: justify; line-height: 1.25">On September 5, 2017, the Company announced that its phase III study of PLX-PAD cells to support recovery following surgery for femoral neck fracture was awarded a Euro 7,400 (approximately $8,700) non-dilutive grant from the Horizon 2020 program. An amount of Euro 2,400 (approximately $2,800) is a direct grant allocated to the Company, and the Company also expects to benefit from cost savings resulting from grant amounts allocated to the other consortium members. Final approval of the grant is subject to the finalization of the consortium and Horizon 2020 grant agreements.</div></div></td></tr></table></div></div><span></span></td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 855<br> -URI http://asc.fasb.org/topic&amp;trid=2122774<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6814311280">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SIGNIFICANT ACCOUNTING POLICIES (Policies)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of estimates</a></td>
<td class="text"><div style="text-align: justify; line-height: 1.25"><table id="z1af1627d0e9e4dd3b8eac1b4ebf43a64" class="DSPFListTable" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, serif; width: 100%"><tr><td style="font: bold 10pt Times New Roman, Times, serif; vertical-align: top; width: 27pt">a.</td>
<td style="vertical-align: top; text-align: justify; width: auto">
<div style="font: bold 10pt Times New Roman, Times, serif">Use of estimates</div>
</td>
</tr>
</table>
</div>

<div style="line-height: 1.25">&#160;</div>

<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 27pt; text-indent: 0pt">The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates, judgments, and assumptions that are reasonable based upon information available at the time they are made. These estimates, judgments and assumptions can affect the amounts reported in the financial statements and accompanying notes. Actual results could differ from those estimates.</div><span></span></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock', window );">Functional currency</a></td>
<td class="text"><div style="text-align: justify; line-height: 1.25"><table id="za7bc05a3506840d5a83f52e5cf3b45b1" class="DSPFListTable" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, serif; width: 100%">
<tr>
<td style="font: bold 10pt Times New Roman, Times, serif; width: 27pt; vertical-align: top">b.</td>
<td style="width: auto; vertical-align: top; text-align: justify">
<div style="font: bold 10pt Times New Roman, Times, serif">Functional currency</div>
</td>
</tr>
</table>
</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25">
<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 27pt; text-indent: 0pt">Most of the Pluristem Therapeutics Inc. costs are denominated in United States dollars (&#8220;dollar&#8221;). The Company&#8217;s management believes that the dollar is the primary currency of the economic environment in which Pluristem Therapeutics Inc. and its subsidiary operate. Thus, the dollar is the Company&#8217;s functional and reporting currency. Accordingly, non-dollar denominated transactions and balances have been re-measured into the functional currency in accordance with ASC No. 830, &#8220;Foreign Currency Matters&#8221;. All transaction gains and losses from the re-measured monetary balance sheet items are reflected in the statements of income as financial income or expenses, as appropriate.</div></div><span></span></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConsolidationPolicyTextBlock', window );">Principles of consolidation</a></td>
<td class="text"><div style="text-align: justify; line-height: 1.25"><table id="z1f93aca01e5e4ee6a8fdf1dd94b2f8af" class="DSPFListTable" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, serif; width: 100%"><tr><td style="font: bold 10pt Times New Roman, Times, serif; vertical-align: top; width: 27pt">c.</td>
<td style="vertical-align: top; text-align: justify; width: auto">
<div style="font: bold 10pt Times New Roman, Times, serif">Principles of consolidation</div>
</td>
</tr>
</table>
</div>

<div style="line-height: 1.25">&#160;</div>

<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 27pt; text-indent: 0pt">The consolidated financial statements include the accounts of Pluristem Therapeutics Inc. and it&#8217;s Subsidiary. Intercompany transactions and balances have been eliminated upon consolidation.</div><span></span></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock', window );">Cash and cash equivalents</a></td>
<td class="text"><div style="text-align: justify; line-height: 1.25"><table id="ze0f636e14c5d4c1e86c453d6849bbd2f" class="DSPFListTable" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, serif; width: 100%"><tr><td style="font: bold 10pt Times New Roman, Times, serif; vertical-align: top; width: 27pt">d.</td>
<td style="vertical-align: top; text-align: justify; width: auto">
<div style="font: bold 10pt Times New Roman, Times, serif">Cash and cash equivalents</div>
</td>
</tr>
</table>
</div>

<div style="line-height: 1.25">&#160;</div>

<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 28.35pt; text-indent: -1.35pt">Cash equivalents are short-term highly liquid investments that are readily convertible to cash with maturities of three months or less at the date acquired.</div><span></span></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_psti_ShortTermBankDepositPolicyTextBlock', window );">Short-term bank deposit</a></td>
<td class="text"><div style="text-align: justify; line-height: 1.25"><table id="zbfbd29a4eb644edbb7c98dcc26a49d3f" class="DSPFListTable" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, serif; width: 100%"><tr><td style="font: bold 10pt Times New Roman, Times, serif; vertical-align: top; width: 28.35pt">e.</td>
<td style="vertical-align: top; text-align: justify; width: auto">
<div style="font: bold 10pt Times New Roman, Times, serif">Short-term bank deposit</div>
</td>
</tr>
</table>
</div>

<div style="line-height: 1.25">&#160;</div>

<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 28.35pt">Bank deposits with original maturities of more than three months but less than one year are presented as part of short-term investments. Deposits are presented at their cost which approximates market values including accrued interest. Interest on deposits is recorded as financial income.</div>

<div style="line-height: 1.25"><br style="line-height: 1.25" />
</div><span></span></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy', window );">Restricted cash and short-term bank deposits</a></td>
<td class="text"><div style="text-align: justify; line-height: 1.25"><table id="z978469e1fcb646049d8a05cb6166784c" class="DSPFListTable" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, serif; width: 100%"><tr><td style="font: bold 10pt Times New Roman, Times, serif; vertical-align: top; width: 27pt">f.</td>
<td style="vertical-align: top; text-align: justify; width: auto">
<div style="font: bold 10pt Times New Roman, Times, serif">Restricted cash and short-term bank deposits</div>
</td>
</tr>
</table>
</div>

<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 28.35pt">&#160;</div>

<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 28.35pt">Short-term restricted bank deposits and restricted cash used to secure derivative and hedging transactions and the Company&#8217;s credit line. The restricted cash and short-term bank deposits are presented at cost which approximates market values including accrued interest.</div><span></span></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_psti_LongTermRestrictedBankDepositPolicyTextBlock', window );">Long-term restricted bank deposits</a></td>
<td class="text"><div style="text-align: justify; line-height: 1.25"><table id="zd17e0f5d149c4b0dad19bc2e378a5f58" class="DSPFListTable" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, serif; width: 100%"><tr><td style="font: bold 10pt Times New Roman, Times, serif; vertical-align: top; width: 27pt">g.</td>
<td style="vertical-align: top; text-align: justify; width: auto">
<div style="font: bold 10pt Times New Roman, Times, serif">Long-term restricted bank deposits</div>
</td>
</tr>
</table>
</div>

<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 27pt; text-indent: 0pt">&#160;</div>

<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 27pt; text-indent: 0pt">Long-term restricted bank deposits with maturities of more than one year used to secure operating lease agreement are presented at cost which approximates market values including accrued interest.</div><span></span></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesPolicy', window );">Investment in marketable securities</a></td>
<td class="text"><div style="text-align: justify; line-height: 1.25"><table id="zb5071478f8d54ec5a96c5c5ab6b8e7f5" class="DSPFListTable" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, serif; width: 100%">
<tr>
<td style="font: bold 10pt Times New Roman, Times, serif; width: 27pt; vertical-align: top">h.</td>
<td style="width: auto; vertical-align: top; text-align: justify">
<div style="font: bold 10pt Times New Roman, Times, serif">Investment in marketable securities</div>
</td>
</tr>
</table>
</div>

<div style="line-height: 1.25">&#160;</div>

<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 28.35pt">The Company accounts for its investments in marketable securities in accordance with ASC 320,&#8220;Investments &#8211; Debt and Equity Securities&#8221;. The Company determines the classification of marketable securities at the time of purchase and re-evaluates such designations as of each balance sheet date. The Company classifies all of its marketable securities as available-for-sale. Available-for-sale marketable securities are carried at fair value, with the unrealized gain and loss reported at &#8220;Accumulated other comprehensive income (loss)&#8221; in the statement of changes in stockholders&#8217; equity.</div>



<div style="line-height: 1.25">&#160;</div>

<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 28.35pt">Realized gain and loss on sales of marketable securities are included in the Company&#8217;s &#8220;Financial income, net&#8221; and are derived using the specific identification basis for determining the cost of marketable securities sold. The amortized cost of available for sale debt marketable securities is adjusted for amortization of premiums and accretion of discount to maturity. Such amortization, together with coupon interest on available for sale marketable securities, is included in the &#8220;Financial income, net&#8221;.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 28.35pt">The Company recognizes an impairment charge when a decline in the fair value of its available-for-sale marketable securities below the cost basis is judged to be other-than-temporary. The Company considers various factors in determining whether to recognize an impairment charge, including the length of time the investment has been in a loss position, the extent to which the fair value has been less than the Company&#8217;s cost basis, the reason for the decline in value, the potential recovery period and the Company&#8217;s intent to sell, including whether it is more likely than not that the Company will be required to sell the investment before recovery of cost basis. ASC 320-10-35, &#8220;Investments - Debt and Equity Securities&#8221;, requires another-than-temporary impairment for debt securities to be separated into (a)&#160;the amount representing the credit loss and (b)&#160;the amount related to all other factors (provided that the Company does not intend to sell the security and it is not more likely than not that it will be required to sell it before recovery). For securities that are deemed other-than-temporarily impaired, the amount of impairment is recognized in &#8220;financial income, net&#8221;, in the statement of operations and is limited to the amount related to credit loss, while impairment related to other factors is recognized in &#8220;other comprehensive income (loss)&#8221;.</div>

<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 28.35pt">&#160;</div>

<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 28.35pt">During the years ended June 30, 2017 and 2016, the Company recognized other-than-temporary impairment loss of $767 and $38, respectively. During the year ended June 30, 2015 no impairment losses were identified (see note 3).</div><span></span></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRecognitionPolicyTextBlock', window );">Revenue Recognition from the license Agreement with United</a></td>
<td class="text"><div style="text-align: justify; line-height: 1.25"><table id="zb4e567880d2a4c168bd77962c3661dd1" class="DSPFListTable" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, serif; width: 100%">
<tr>
<td style="font: bold 10pt Times New Roman, Times, serif; width: 27pt; vertical-align: top">i.</td>
<td style="width: auto; vertical-align: top; text-align: justify">
<div style="font: bold 10pt Times New Roman, Times, serif">Revenue Recognition from the license Agreement with United</div>
</td>
</tr>
</table>
</div>

<div style="line-height: 1.25">&#160;</div>

<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 28.35pt">The Company recognized revenue pursuant to the License Agreement with United in accordance with ASC 605-25, &#8220;Revenue Recognition, Multiple-Element Arrangements&#8221;.</div>

<div style="line-height: 1.25"><br style="line-height: 1.25" />
</div>

<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 28.35pt">Pursuant to ASC 605-25, each deliverable is evaluated to determine whether it qualifies as a separate unit of accounting based on whether the deliverable has &#8220;stand-alone value&#8221; to the customer. The arrangement&#8217;s consideration that is fixed or determinable is then allocated to each separate unit of accounting based on the relative selling price of each deliverable. In general, the consideration allocated to each unit of accounting is recognized as the related goods or services are delivered, limited to the consideration that is not contingent upon future deliverables.</div>

<div style="line-height: 1.25"><br style="line-height: 1.25" />
</div>

<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 28.35pt">The Company received an up-front, non-refundable license payment of $5,000. Additional payments totaling $37,500 were subject to the achievement of certain regulatory milestones by United.</div>

<div style="line-height: 1.25"><br style="line-height: 1.25" />
</div>

<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 28.35pt">Since the deliverables in the United Agreement did not have stand-alone value, none of them qualified as a separate unit of accounting. Accordingly, the non-refundable upfront license fee of $5,000 was deferred and recognized on a straight line basis over the related performance period which was the development period in accordance with Staff Accounting Bulletin (&#8220;SAB&#8221;) 104, &#8220;Revenue Recognition&#8221;.</div>

<div style="line-height: 1.25"><br style="line-height: 1.25" />
</div>

<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 28.35pt">The Company also received an advanced payment for the development, of $2,000 that was deductible against development expenses as it was incurred. The upfront payment which was received was included in the balance sheet as advance payment. The Company deducted the payments from its research and development expenses in accordance with ASC 730-20, &#8220;Research and Development Agreements&#8221;.</div>



<div style="line-height: 1.25">&#160;</div>

<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 28.35pt">On December 8, 2015, the Company received a notice from United terminating the United Agreement, effective immediately. Pursuant to the United Agreement termination clause, Pluristem regained full rights to PLX in the field of PAH, as well as all clinical data and regulatory submissions. As the Company had no further obligations<font style="font: bold 10pt Times New Roman, Times, serif">&#160;</font>towards United, the Company recognized the remaining upfront payment received in 2011 as revenues during the year ended June 30, 2016.</div><span></span></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock', window );">Property and Equipment</a></td>
<td class="text"><div style="text-align: justify; line-height: 1.25"><table id="z18f60214b5e14ae396da878f15bb2f47" class="DSPFListTable" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, serif; width: 100%"><tr><td style="font: bold 10pt Times New Roman, Times, serif; vertical-align: top; width: 28.35pt">j.</td>
<td style="vertical-align: top; text-align: justify; width: auto">
<div style="font: bold 10pt Times New Roman, Times, serif">Property and Equipment</div>
</td>
</tr>
</table>
</div>

<div style="line-height: 1.25">&#160;</div>

<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 27pt; text-indent: 0pt">Property and equipment are stated at cost, net of accumulated depreciation. Depreciation is calculated by the straight-line method over the estimated useful lives of the assets, at the following annual rates:</div>

<div style="line-height: 1.25">&#160;</div>

<div>
<table id="z4239811fa84e426982a3190298cf9636" cellspacing="0" cellpadding="0" align="center" border="0" style="font: 10pt Times New Roman, Times, serif; width: 60%">
<tr>
<td style="vertical-align: top; padding-bottom: 2px; width: 40%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 2px; width: 1%; vertical-align: bottom">&#160;</td>
<td colspan="2" style="vertical-align: top; border-bottom: #000000 2px solid; vertical-align: bottom">
<div style="line-height: 1.25">
<div style="line-height: 1.25"></div>

<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: center">%</div>
</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="vertical-align: top; width: 40%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left">Laboratory equipment</div>
</td>
<td style="vertical-align: bottom; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right; width: 40%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: center">10-15</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
</tr>

<tr style="height: 16px">
<td style="vertical-align: top; width: 40%; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left">Computers and peripheral equipment</div>
</td>
<td style="vertical-align: bottom; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right; width: 40%; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: center">33</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="vertical-align: top; width: 40%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left">Office furniture and equipment</div>
</td>
<td style="vertical-align: bottom; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right; width: 40%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: center">15</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="vertical-align: top; width: 40%; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left">Vehicles</div>
</td>
<td style="vertical-align: bottom; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right; width: 40%; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: center">15</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
</tr>

<tr style="height: 15px">
<td style="vertical-align: top; width: 40%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left">Leasehold improvements</div>
</td>
<td style="vertical-align: bottom; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td colspan="2" style="vertical-align: top; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left">The shorter of the expected useful life or the reasonable assumed term of the lease.</div></td></tr></table></div><span></span></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock', window );">Impairment of long-lived assets</a></td>
<td class="text"><div style="text-align: justify; line-height: 1.25"><table id="z252d414105c7440bb6165d5bf6b4d15a" class="DSPFListTable" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, serif; width: 100%">
<tr>
<td style="font: bold 10pt Times New Roman, Times, serif; width: 28.35pt; vertical-align: top">k.</td>
<td style="width: auto; vertical-align: top; text-align: justify">
<div style="font: bold 10pt Times New Roman, Times, serif">Impairment of long-lived assets</div>
</td>
</tr>
</table>
</div>

<div style="line-height: 1.25">&#160;</div>

<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 27pt; text-indent: 0pt">The Company&#8217;s long-lived assets are reviewed for impairment in accordance with ASC 360, &#8220;Property, Plant and Equipment&#8221;, whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of the assets to the future undiscounted cash flows expected to be generated by the assets. If such assets are considered to be impaired, the impairment to be recognized is measured by the amount by which the carrying amount of the assets exceeds the fair value of the assets. During fiscal years 2017, 2016 and 2015, no impairment losses have been identified.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 27pt">
<div id="DSPFPageHeader"></div>

<div style="line-height: 1.25">As required by ASC 820, &#8220;Fair Value Measurements&#8221; (&#8220;ASC 820&#8221;), the Company applies assumptions that marketplace participants would consider in determining the fair value of long-lived assets.</div></div><span></span></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy', window );">Accounting for stock-based compensation</a></td>
<td class="text"><div style="text-align: justify; line-height: 1.25"><table id="zb79e5bb96e214148b3fac6f353132e61" class="DSPFListTable" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, serif; width: 100%">
<tr>
<td style="font: bold 10pt Times New Roman, Times, serif; width: 27pt; vertical-align: top">l.</td>
<td style="width: auto; vertical-align: top; text-align: justify">
<div style="font: bold 10pt Times New Roman, Times, serif">Accounting for stock-based compensation</div>
</td>
</tr>
</table>
</div>

<div style="line-height: 1.25">&#160;</div>

<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 27pt; text-indent: 0.05pt">The Company accounts for stock-based compensation in accordance with ASC 718, &#8220;Compensation-Stock Compensation&#8221; (&#8220;ASC 718&#8221;) and ASC 505-50, &#8220;Equity-Based Payments to Non-Employees&#8221; (&#8220;ASC 505-50&#8221;). ASC 718 requires companies to estimate the fair value of equity-based payment awards on the date of grant using an option-pricing model. The Company estimates the fair value of stock options granted using the Black-Scholes-Merton option-pricing model. The Company accounts for employee&#8217;s share-based payment awards classified as equity awards (restricted stocks or restricted stock units) using the grant-date fair value method. The fair value of share-based payment transactions is recognized as an expense over the requisite service period, net of estimated forfeitures. The Company estimates forfeitures based on historical experience and anticipated future conditions. The Company elected to recognize compensation cost for an award with service conditions and goals achievement that has a graded vesting schedule using the accelerated method based on the multiple-option award approach.</div>

<div style="line-height: 1.25"><br style="line-height: 1.25" />
</div>

<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 27.05pt; text-indent: 0.05pt">During fiscal years 2017, 2016 and 2015, there were no options granted to employees or directors.</div>

<div style="line-height: 1.25"><br style="line-height: 1.25" />
</div>

<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 28.35pt">The assumptions below are relevant to restricted stock and restricted stock units granted in 2017, 2016 and 2015:</div>

<div style="line-height: 1.25"><br style="line-height: 1.25" />
</div>

<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 28.35pt">In accordance with ASC 718, restricted stock and restricted stock units are measured at their fair value. All restricted stock and restricted stock units to employees, directors and non-employees granted in 2017, 2016 and 2015, were granted for no consideration; therefore, their fair value was equal to the share price at the date of grant.</div>



<div style="line-height: 1.25">&#160;</div>

<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 28.35pt">The fair value of all restricted stock and restricted stock units was determined based on the close trading price of the Company&#8217;s shares known at the grant date. The weighted average grant date fair value of shares granted during 2017, 2016 and 2015, was $1.41, $1.13 and $2.70, respectively.</div><span></span></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_psti_ResearchAndDevelopmentExpensesAndRoyaltyBearingGrantsPolicyTextBlock', window );">Research and Development expenses and royalty bearing grants</a></td>
<td class="text"><div style="text-align: justify; line-height: 1.25"><table id="z7e07885053824892bd52a1a2cb6999f9" class="DSPFListTable" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, serif; width: 100%">
<tr>
<td style="font: bold 10pt Times New Roman, Times, serif; width: 28.35pt; vertical-align: top">m.</td>
<td style="width: auto; vertical-align: top; text-align: justify">
<div style="font: bold 10pt Times New Roman, Times, serif">Research and Development expenses and royalty bearing grants</div>
</td>
</tr>
</table>
</div>

<div style="line-height: 1.25">&#160;</div>

<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 28.35pt; text-indent: 0pt">Research and development expenses, net of participations grants, are charged to the statement of operations as incurred.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25">
<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 28.35pt; text-indent: 0pt">Pluristem receives grants from the IIA in the Ministry of Economy and Industry (formerly the Office of Chief Scientist&#8217;s) for the purpose of partially funding approved research and development projects. The grants are not to be repaid, but instead Pluristem is obliged to pay royalties as a percentage of future sales if and when sales from the funded projects are generated. These grants are recognized as a deduction from research and development costs at the time the Company is entitled to such grants on the basis of the research and development costs incurred. Since the payment of royalties is not probable when the grants are received, the Company records a liability in the amount of the estimated royalties for each individual contract, when the related revenues are recognized, as part of Cost of revenues. For more information regarding such royalties commitments and regarding grants and participation received, see Note 8.</div></div><span></span></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_psti_NonroyaltyBearingGrantsPolicyTextBlock', window );">Non-royalty bearing grant</a></td>
<td class="text"><div style="text-align: justify; line-height: 1.25"><table id="zf79edeb6b6264cdebcff1930c5704a4a" class="DSPFListTable" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, serif; width: 100%">
<tr>
<td style="font: bold 10pt Times New Roman, Times, serif; width: 28.35pt; vertical-align: top">n.</td>
<td style="width: auto; vertical-align: top; text-align: justify">
<div style="font: bold 10pt Times New Roman, Times, serif">Non-royalty bearing grant</div>
</td>
</tr>
</table>
</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25">
<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 28.35pt; text-indent: -1.35pt">T<font style="font: 10pt Times New Roman, Times, serif">he Company&#8217;s CLI program participates in a European Union&#160;research and development consortium under Horizon 2020.&#160; In August 2016, the CLI program consortium was awarded a Euro 7,600 (approximately $8,700) non-royalty bearing grant. An amount of Euro 1,900 (approximately $2,200) is a direct grant allocated to the Company. </font>The non-royalty bearing grant for funding the projects is recognized at the time the Company is entitled to such grant on the basis of the related costs incurred and recorded as a deduction from research and development expenses.</div></div><span></span></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerSharePolicyTextBlock', window );">Loss per share</a></td>
<td class="text"><div style="text-align: justify; line-height: 1.25"><table id="zf823a2550b6d46c591eaa4a91db1adeb" class="DSPFListTable" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, serif; width: 100%"><tr><td style="font: bold 10pt Times New Roman, Times, serif; vertical-align: top; width: 28.35pt">o.</td>
<td style="vertical-align: top; text-align: justify; width: auto">
<div style="font: bold 10pt Times New Roman, Times, serif">Loss per share</div>
</td>
</tr>
</table>
</div>

<div style="line-height: 1.25">&#160;</div>

<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 28.35pt; text-indent: 0pt">Basic and diluted net loss per share is computed based on the weighted average number of shares of common stock outstanding during each year. All outstanding stock options and unvested restricted stock units have been excluded from the calculation of the diluted loss per common share because all such securities are anti-dilutive for each of the periods presented.</div><span></span></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxPolicyTextBlock', window );">Income taxes</a></td>
<td class="text"><div style="text-align: justify; line-height: 1.25"><table id="z06d5f9bd8e3e4f4981c1f51ed93f04fe" class="DSPFListTable" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, serif; width: 100%"><tr><td style="font: bold 10pt Times New Roman, Times, serif; vertical-align: top; width: 28.35pt">p.</td>
<td style="vertical-align: top; text-align: justify; width: auto">
<div style="font: bold 10pt Times New Roman, Times, serif">Income taxes</div>
</td>
</tr>
</table>
</div>

<div style="line-height: 1.25">&#160;</div>

<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 28.35pt; text-indent: 0pt">The Company accounts for income taxes in accordance with ASC 740, "Income Taxes" (&#8220;ASC 740&#8221;). This Topic prescribes the use of the liability method, whereby deferred tax assets and liability account balances are determined based on differences between financial reporting and tax bases of assets and liabilities and are measured using the enacted tax rates and laws that will be in effect when the differences are expected to reverse. The Company provides a valuation allowance, if necessary, to reduce deferred tax assets to their estimated realizable value.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 28.35pt; text-indent: -1.35pt">ASC 740 establishes a single model to address accounting for uncertain tax positions. ASC 740 clarified the accounting for income taxes by prescribing the minimum recognition threshold a tax position is required to meet before being recognized in the financial statements.</div><span></span></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskCreditRisk', window );">Concentration of credit risk</a></td>
<td class="text"><div style="text-align: justify; line-height: 1.25"><table id="z320736ccd85f45a8b8e69213c3f489d0" class="DSPFListTable" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, serif; width: 100%"><tr><td style="font: bold 10pt Times New Roman, Times, serif; vertical-align: top; width: 28.35pt">q.</td>
<td style="vertical-align: top; text-align: justify; width: auto">
<div style="font: bold 10pt Times New Roman, Times, serif">Concentration of credit risk</div>
</td>
</tr>
</table>
</div>

<div style="line-height: 1.25">&#160;</div>

<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 28.35pt; text-indent: 0pt">Financial instruments that potentially subject the Company to concentrations of credit risk consist principally of cash and cash equivalents, short-term deposits, long-term deposits, restricted deposits and marketable securities.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 28.35pt; text-indent: 0pt">The majority of the Company&#8217;s cash and cash equivalents and short-term and long-term deposits are mainly invested in dollar instruments of major banks in Israel and in the United States. Generally, these deposits may be redeemed upon demand and therefore bear minimal risk.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 27.35pt; text-indent: 0pt">The Company invests its surplus cash in cash deposits and marketable securities in financial institutions and has established guidelines, approved by the Company&#8217;s Investment Committee, relating to diversification and maturities to maintain safety and liquidity of the investments.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 27.35pt; text-indent: 0pt">The Company holds an investment portfolio consisting of corporate bonds, government bonds, stocks and index linked notes. The Company intends, and has the ability, to hold such investments until recovery of temporary declines in market value or maturity. However, the Company can provide no assurance that it will recover declines in the market value of its investments.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 27.35pt; text-indent: -27pt"><font style="font: 10pt Times New Roman, Times, serif">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>The Company utilizes forward and options contracts to protect against the risk of overall changes in exchange rates. The derivative instruments hedge a portion of the Company&#8217;s non-dollar currency exposure. Counterparties to the Company&#8217;s derivative instruments are all major financial institutions.</div><span></span></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_psti_SeverancePayPolicyTextBlock', window );">Severance pay</a></td>
<td class="text"><div style="text-align: justify; line-height: 1.25"><table id="zfcbc5e1a8b494fc7b89fd7aa0beaa363" class="DSPFListTable" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, serif; width: 100%">
<tr>
<td style="font: bold 10pt Times New Roman, Times, serif; width: 28.35pt; vertical-align: top">r.</td>
<td style="width: auto; vertical-align: top; text-align: justify">
<div style="font: bold 10pt Times New Roman, Times, serif">Severance pay</div>
</td>
</tr>
</table>
</div>

<div style="line-height: 1.25">&#160;</div>

<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 28.35pt; text-indent: -1.35pt">&#160;A majority of the Company&#8217;s agreements with employees in Israel are subject to Section 14 of the Israeli Severance Pay Law, 1963 (&#8220;Severance Pay Law&#8221;). The Company&#8217;s contributions for severance pay have replaced its severance obligation. Upon contribution of the full amount of the employee&#8217;s monthly salary for each year of employment, no additional calculations are conducted between the parties regarding the matter of severance pay and no additional payments are made by the Company to the employee. Further, the related obligation and amounts deposited on behalf of the employee for such obligation are not stated on the balance sheet, as the Company is legally released from the obligation to employees once the deposit amounts have been paid.</div>

<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 28.35pt; text-indent: -1.35pt">&#160;</div>

<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 28.35pt; text-indent: -1.35pt">&#160;For some employees, which their agreement is not subject to Section 14 of the Severance Pay Law, the Subsidiary&#8217;s liability for severance pay is calculated pursuant to Israeli Severance Pay Law, based on the most recent salary of the employees multiplied by the number of years of employment, as of the balance sheet date. Employees are entitled to one month&#8217;s salary for each year of employment or a portion thereof.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 28.35pt; text-indent: -1.35pt">The Company&#8217;s liability for all of its employees is fully provided by monthly deposits with insurance policies and by an accrual. The value of these policies is recorded as an asset in the Company&#8217;s balance sheet. The deposited funds include profits or losses accumulated up to the balance sheet date. The deposited funds may be withdrawn only upon the fulfillment of the obligation pursuant to the Severance Pay Law or labor agreements. The value of the deposited funds is based on the cash surrendered value of these policies, and includes immaterial profits or losses.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 28.35pt; text-indent: -1.35pt">Severance expenses for the years ended June 30, 2017, 2016 and 2015 were $524, $556 and $441, respectively.</div><span></span></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueOfFinancialInstrumentsPolicy', window );">Fair value of financial instruments</a></td>
<td class="text"><div style="text-align: justify; line-height: 1.25"><table id="zd2ea3862cd6c4798b79f39ca5827c19b" class="DSPFListTable" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, serif; width: 100%">
<tr>
<td style="font: bold 10pt Times New Roman, Times, serif; width: 28.35pt; vertical-align: top">s.</td>
<td style="width: auto; vertical-align: top; text-align: justify">
<div style="font: bold 10pt Times New Roman, Times, serif">Fair value of financial instruments</div>
</td>
</tr>
</table>
</div>

<div style="line-height: 1.25">&#160;</div>

<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 28.35pt; text-indent: -1.35pt">The carrying amounts of the Company&#8217;s financial instruments, including cash and cash equivalents, short-term and restricted bank deposits, accounts receivable and other current assets, trade payable and other accounts payable and accrued liabilities, approximate fair value because of their generally short term maturities.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25">
<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 28.35pt; text-indent: -1.35pt">The Company measures its investments in marketable securities and derivative instruments at fair value under ASC 820. Fair value is an exit price, representing the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants. As such, fair value is a market-based measurement that should be determined based on assumptions that market participants would use in pricing an asset or a liability. As a basis for considering such assumptions, ASC 820 establishes a three-tier value hierarchy, which prioritizes the inputs used in the valuation methodologies in measuring fair value:</div>

<div style="line-height: 1.25">&#160;</div>
</div>

<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 28.35pt; text-indent: -1.35pt"><font style="font: bold 10pt Times New Roman, Times, serif">&#160;Level 1</font> - Quoted prices (unadjusted) in active markets for identical assets or liabilities;</div>

<div style="line-height: 1.25">&#160;</div>

<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 28.35pt; text-indent: -1.35pt"><font style="font: bold 10pt Times New Roman, Times, serif">&#160;Level 2</font> - Inputs other than Level 1 that are observable for the asset or liability, either directly or indirectly; and</div>

<div style="line-height: 1.25">&#160;</div>

<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 28.35pt; text-indent: -1.35pt"><font style="font: bold 10pt Times New Roman, Times, serif">&#160;Level 3 </font>- Unobservable inputs for the asset or liability.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 28.35pt; text-indent: -1.35pt">The fair value hierarchy also requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. The Company categorized each of its fair value measurements in one of these three levels of hierarchy (see Note 4).</div><span></span></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesPolicyTextBlock', window );">Derivative financial instruments</a></td>
<td class="text"><div style="text-align: justify; line-height: 1.25"><table id="zcbe558bdfec34c1c9b3738ad0e5c22de" class="DSPFListTable" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, serif; width: 100%">
<tr>
<td style="font: bold 10pt Times New Roman, Times, serif; width: 28.35pt; vertical-align: top">t.</td>
<td style="width: auto; vertical-align: top; text-align: justify">
<div style="font: bold 10pt Times New Roman, Times, serif">Derivative financial instruments</div>
</td>
</tr>
</table>
</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25">
<div id="DSPFPageHeader"></div>

<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 28.35pt"><font style="font: 10pt Times New Roman, Times, serif">The Company accounts for derivatives and hedging based on ASC 815, </font><font style="font: 10pt Times New Roman, Times, serif">&#8220;Derivatives and hedging&#8221; </font>(&#8220;ASC 815&#8221;)<font style="font: 10pt Times New Roman, Times, serif">, as amended and related interpretations. ASC 815 requires the Company to recognize all derivatives on the balance sheet at fair value. If a derivative meets the definition of a hedge and is so designated, depending on the nature of the hedge, changes in the fair value of the derivative will either be offset against the change in fair value of the hedged assets, liabilities, or firm commitments through earnings (for fair value hedge transactions) or recognized in other comprehensive income (loss) until the hedged item is recognized in earnings (for cash flow hedge transactions).</font></div>
</div>

<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 28.35pt">&#160;</div>

<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 28.35pt"><font style="font: 10pt Times New Roman, Times, serif">The ineffective portion of a derivative&#8217;s change in fair value is recognized in earnings. If a derivative does not meet the definition of a hedge, the changes in the fair value are included in earnings. Cash flows related to such hedges are classified as operating activities. The Company enters into forward exchange contracts and option contracts in order to limit the exposure to exchange rate fluctuation associated with expenses mainly incurred in </font>New Israeli Shekels (&#8220;<font style="font: 10pt Times New Roman, Times, serif">NIS</font>&#8221;)<font style="font: 10pt Times New Roman, Times, serif">. Since the derivative instruments that the Company holds do not meet the definition of hedging instruments under ASC 815, any gain or loss derived from such instruments is recognized immediately as &#8220;financial income, net&#8221;.</font></div>

<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 28.35pt">&#160;</div>

<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 28.35pt">The Company measured the fair value of the contracts in accordance with ASC 820. Foreign currency derivative contracts are classified within Level 2 as the valuation inputs are based on quoted prices and market observable data of similar instruments. As of June 30, 2017 and 2016, the fair value of the<font style="font: 10pt Times New Roman, Times, serif">&#160;</font>options contracts was approximately$ 295<font style="font: 10pt Times New Roman, Times, serif">&#160;</font>and $65, respectively, presented in &#8220;other current assets&#8221; (see Note 4). The net gains (losses) recognized in &#8220;Financial income, net&#8221; during the years ended June 30, 2017, 2016 and 2015, were $230, ($205) and $248, respectively.</div><span></span></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock', window );">Comprehensive income (loss)</a></td>
<td class="text"><div style="text-align: justify; line-height: 1.25"><table id="z3defcc6bbc8f4d2eb779a57c2bdb4a38" class="DSPFListTable" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, serif; width: 100%"><tr><td style="font: bold 10pt Times New Roman, Times, serif; vertical-align: top; width: 28.35pt">u.</td>
<td style="vertical-align: top; text-align: justify; width: auto">
<div style="font: bold 10pt Times New Roman, Times, serif">Comprehensive income (loss):</div>
</td>
</tr>
</table>
</div>

<div style="line-height: 1.25">&#160;</div>

<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 28.35pt">The Company accounts for comprehensive income (loss) in accordance with ASC 220, &#8220;Comprehensive Income&#8221;.</div>

<div style="line-height: 1.25"><br style="line-height: 1.25" />
</div>

<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 28.35pt">Comprehensive income generally represents all changes in stockholders&#8217; equity during the period except those resulting from investments by, or distributions to, stockholders&#8217;. The Company determined that its items of other comprehensive income (loss) relate to unrealized gains and losses on available for sale marketable securities.</div>

<div style="line-height: 1.25"><br style="line-height: 1.25" />
</div>

<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 28.35pt">The following table summarizes the changes in accumulated balances of other comprehensive income for the year ended June 30, 2017:</div>

<div style="line-height: 1.25">&#160;</div>

<div>
<table id="z1a49afcc7d73463897c1b4177687276d" cellspacing="0" cellpadding="0" align="right" border="0" style="font: 10pt Times New Roman, Times, serif; width: 95%">
<tr>
<td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
<td colspan="2" style="vertical-align: bottom; vertical-align: top; border-bottom: #000000 2px solid; text-align: center">Year ended June 30, 2017</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; text-align: left">&#160;</td>
</tr>

<tr>
<td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
<td colspan="2" style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid">
<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: center">Unrealized<font style="font: 10pt Times New Roman, Times, serif"><br />
</font>gains (losses)<font style="font: 10pt Times New Roman, Times, serif"><br />
</font>on marketable<font style="font: 10pt Times New Roman, Times, serif"><br />
</font>securities</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; text-align: left">&#160;</td>
</tr>

<tr>
<td style="vertical-align: bottom; vertical-align: top; width: 88%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 4.7pt; text-indent: 5.05pt">Beginning balance</div>
</td>
<td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">$</div>
</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">1,480</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff">&#160;</td>
</tr>

<tr>
<td style="vertical-align: bottom; vertical-align: top; width: 88%; background-color: #ffffff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 9.75pt">Other comprehensive income before reclassifications</div>
</td>
<td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">924</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff">&#160;</td>
</tr>

<tr>
<td style="vertical-align: bottom; vertical-align: top; padding-bottom: 2px; width: 88%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 9.75pt">Amounts reclassified from accumulated other comprehensive loss, net</div>
</td>
<td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">(405</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">)</div>
</td>
</tr>

<tr>
<td style="vertical-align: bottom; vertical-align: top; padding-bottom: 2px; width: 88%; background-color: #ffffff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 12pt; text-indent: -2.25pt">Net current-period other comprehensive income</div>
</td>
<td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #ffffff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">519</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff">&#160;</td>
</tr>

<tr>
<td style="vertical-align: bottom; vertical-align: top; padding-bottom: 4px; width: 88%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 4.7pt; text-indent: 5.05pt">Ending balance</div>
</td>
<td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 4px; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">$</div>
</td>
<td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">1,999</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #cceeff">&#160;</td></tr></table></div><span></span></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">Recent Accounting Pronouncement</a></td>
<td class="text"><div style="text-align: justify; line-height: 1.25"><table id="z6ca6aeb30c4f45c4aa701f0c34367182" class="DSPFListTable" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, serif; width: 100%">
<tr>
<td style="font: bold 10pt Times New Roman, Times, serif; width: 28.35pt; vertical-align: top">v.</td>
<td style="width: auto; vertical-align: top; text-align: justify">
<div style="font: bold 10pt Times New Roman, Times, serif">Recent Accounting Pronouncement</div>
</td>
</tr>
</table>
</div>

<div style="line-height: 1.25">&#160;</div>

<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 27pt"><font style="font: 10pt Times New Roman, Times, serif"><u>Accounting Standards Update (&#8220;ASU&#8221;) 2014-09 &#8211; &#8220;Revenue from Contracts with Customers (Topic 606)&#8221;</u></font>:</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25">
<div id="DSPFPageHeader"></div>

<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 28.35pt">In May 2014, the Financial Accounting Standards Board (&#8220;FASB&#8221;) issued ASU No. 2014-09 (Topic 606) &#8220;Revenue from Contracts with Customers&#8221; (&#8220;Topic 606&#8221;). Topic 606 supersedes the revenue recognition requirements in ASC Topic 605, &#8220;Revenue Recognition&#8221;, and requires entities to recognize revenue when they transfer control of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled to in exchange for those goods or services. We intend to adopt Topic 606 as of July 1, 2017, using the modified retrospective transition method. Prior periods will not be retrospectively adjusted. As the Company currently does not have any contracts with customers which are not completed, as of June 30, 2017, we do not expect the adoption of Topic 606 will have a material impact on our consolidated financial statements, including the presentation of revenues in our consolidated statements of income.</div>
</div>

<div style="line-height: 1.25">&#160;</div>

<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 28.35pt"><u>ASU 2014-15 - Presentation of Financial Statements - Going Concern (Subtopic 205-40):</u></div>

<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left">&#160;</div>

<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left">
<div></div>

<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 28.35pt">In August 2014, the FASB issued guidance on disclosure of Uncertainties about an Entity&#8217;s Ability to Continue as a Going Concern (&#8220;ASU 2014-15&#8221;), which defines management&#8217;s responsibility to evaluate whether there is substantial doubt about a company&#8217;s ability to continue as a going concern. ASU 2014-15 also provides principles and definitions that are intended to reduce diversity in the timing and content of disclosures in the financial statement footnotes. This guidance is effective for the annual period ending after December 15, 2016, and for annual periods and interim periods thereafter. The Company adopted the provisions of ASU 2014-15 for the year ended December 31, 2016. The adoption of ASU 2014-15 did not have a material impact on the consolidated financial statements.</div>
</div>



<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25">
<div></div>

<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 28.35pt"><font style="font: 10pt Times New Roman, Times, serif"><u>ASU 2016-13 - Financial Instruments &#8211; Credit Losses (Topic 326), </u></font><font style="font: 10pt Times New Roman, Times, serif"><u>&#8220;Measurement of Credit Losses on Financial Instruments&#8221;:</u></font></div>
</div>

<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 28.35pt">&#160;</div>

<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 28.35pt">In June 2016, the FASB issued ASU 2016-13. This update requires an entity to utilize a new impairment model known as the current expected credit loss (&#8220;CECL&#8221;) model to estimate its lifetime &#8220;expected credit loss&#8221; on a financial asset and record an allowance that, when deducted from the amortized cost basis of the financial asset, presents the net amount expected to be collected on the financial asset. The CECL model is expected to result in more timely recognition of credit losses. The update also requires new disclosures for financial assets measured at amortized cost, loans and available-for-sale debt securities. The update is effective for the interim and annual periods beginning on or after December 15, 2019, or July 1, 2020, for the Company. Early adoption is permitted. The Company is currently evaluating the impact of the update on its consolidated financial statements.</div>

<div style="line-height: 1.25"><br style="line-height: 1.25" />
</div>

<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 28.35pt"><u>ASU 2016-18 - Restricted Cash (Topic 230):</u></div>

<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 28.35pt">&#160;</div>

<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 28.35pt">In November 2016, the FASB issued ASU 2016-18, &#8220;Statement of Cash Flows&#8221;. This standard requires the presentation of the statement of cash flows to show the changes in the total of cash, cash equivalents, restricted cash and restricted cash equivalents. The standard is effective for the interim and annual periods beginning on or after December 15, 2017, or July 1, 2018 for the Company. Early adoption is permitted. The Company is currently evaluating the impact of the standard on its consolidated financial statements.</div>

<div style="line-height: 1.25"><br style="line-height: 1.25" />
</div>

<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 28.35pt"><u>ASU 2016-02 - Leases (Topic 842):</u></div>

<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left">&#160;</div>

<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left">
<div></div>

<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 28.35pt">In February 2016, the FASB issued guidance on the recognition, measurement, presentation and disclosure of leases for both parties to a contract (i.e., lessees and lessors). The new standard requires lessees to apply a dual approach, classifying leases as either finance or operating leases based on the principle of whether or not the lease is effectively a financed purchase by the lessee. This classification will determine whether lease expense is recognized based on an effective interest method or on a straight-line basis over the term of the lease, respectively. A lessee is also required to record a right-of-use asset and a lease liability for all leases with a term of greater than 12 months regardless of their classification. Leases with a term of 12 months or less will be accounted for in a manner similar to the accounting under existing guidance for operating leases today. The new standard requires lessors to account for leases using an approach that is substantially equivalent to existing guidance for sales-type leases, direct financing leases and operating leases. Topic 842 supersedes the previous leases standard, ASC 840, &#8220;Leases&#8221;. The guidance is effective for the interim and annual periods beginning on or after December 15, 2018. Early adoption is permitted. The Company is currently evaluating the potential effect of the guidance on its consolidated financial statements.</div>
</div>

<div style="line-height: 1.25"><br style="line-height: 1.25" />
</div>

<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; text-indent: 28.35pt"><u>ASU 2016-01 - Financial Instruments - Overall (Subtopic 825-10):</u></div>

<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left">&#160;</div>

<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left">
<div></div>

<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 28.35pt">In January 2016, the FASB issued guidance on financial instruments - recognition and measurement of financial assets and financial liabilities. The pronouncement revises the classification and measurement of investments in certain equity investments and the presentation of certain fair value changes for certain financial liabilities measured at fair value. ASU 2016-01 is effective for fiscal years, beginning after December 15, 2017 and interim periods within those years. The Company is currently evaluating the impact of adopting the new standard on its consolidated financial statements.<br style="line-height: 1.25" />
</div>
</div>



<div style="line-height: 1.25"><br style="line-height: 1.25" />
</div>

<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; text-indent: 28.35pt"><u>ASU 2016-09 - Compensation - Stock Compensation (Topic 718):</u></div>

<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; text-indent: 28.35pt">&#160;</div>

<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left">
<div></div>

<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 28.35pt">In March 2016, the FASB issued guidance on improvements to employee share-based payments. The standard requires among others, that excess tax benefits or deficiencies for share-based payments be recorded as income tax benefit or expense, rather then within additional paid in capital, in the period in which the shares vest. Cash flows related to excess tax benefits will be included in operating activities instead of separately classified as a financing activity. The new guidance is effective for fiscal years beginning after December 15, 2016. Early adoption is permitted. The Company does not expect this guidance to have a material effect on its consolidated financial statements at the time of adoption of this standard.</div>
</div>

<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left">&#160;</div>

<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 28.35pt"><u>ASU 2017-11 - Earnings Per Share (Topic 260); Distinguishing Liabilities from Equity (Topic 480); Derivatives and Hedging (Topic 815): (Part I) Accounting for Certain Financial Instruments with Down Round Features, (Part II) Replacement of the Indefinite Deferral for Mandatorily Redeemable Financial Instruments of Certain Nonpublic Entities and Certain Mandatorily Redeemable Noncontrolling Interests with a Scope Exception:</u></div>

<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left">&#160;</div>

<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left">
<div></div>

<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 28.35pt"><font style="font: 10pt Times New Roman, Times, serif">In July 2017, the FASB issued ASU No. 2017-11.&#160;The ASU was issued to address the complexity associated with applying U.S. GAAP for certain financial instruments with characteristics of liabilities and equity. The ASU, among other things, eliminates the need to consider the effects of down round features when analyzing convertible debt, warrants and other financing instruments. As a result, a freestanding equity-linked financial instrument (or embedded conversion option) no longer would be accounted for as a derivative liability at fair value as a result of the existence of a down round feature. The amendments are effective for fiscal years beginning after December 15, 2018, and should be applied retrospectively. Early adoption is permitted, including adoption in an interim period. The Company plans to adopt ASU 2017-11 in the first quarter of the Company&#8217;s fiscal year 2018. </font>The Company does not expect the adoption of <font style="font: 10pt Times New Roman, Times, serif">ASU 2017-11</font> will have a material impact on its consolidated financial statements and related disclosures.</div></div><span></span></td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_psti_LongTermRestrictedBankDepositPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The policy disclosure regarding long-term restricted bank deposits for the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">psti_LongTermRestrictedBankDepositPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>psti_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_psti_NonroyaltyBearingGrantsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for non-royalty bearing grants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">psti_NonroyaltyBearingGrantsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>psti_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_psti_ResearchAndDevelopmentExpensesAndRoyaltyBearingGrantsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for research and development expenses and royalty bearing grants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">psti_ResearchAndDevelopmentExpensesAndRoyaltyBearingGrantsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>psti_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_psti_SeverancePayPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy related to severance pay.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">psti_SeverancePayPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>psti_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_psti_ShortTermBankDepositPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The policy disclosure regarding short-term bank deposits for the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">psti_ShortTermBankDepositPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>psti_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 305<br> -SubTopic 10<br> -Section 05<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6375392&amp;loc=d3e26790-107797<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=98513485&amp;loc=d3e4273-108586<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Entity's cash and cash equivalents accounting policy with respect to restricted balances.  Restrictions may include legally restricted deposits held as compensating balances against short-term borrowing arrangements, contracts entered into with others, or company statements of intention with regard to particular deposits; however, time deposits and short-term certificates of deposit are not generally included in legally restricted deposits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(1)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 305<br> -SubTopic 10<br> -Section 05<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6375392&amp;loc=d3e26790-107797<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=98513485&amp;loc=d3e4273-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomePolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskCreditRisk">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for credit risk.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 55<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=75027168&amp;loc=d3e14489-108613<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 825<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=75032840&amp;loc=d3e61082-112788<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 825<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=75027451&amp;loc=SL29635902-196195<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -URI http://asc.fasb.org/extlink&amp;oid=77997519&amp;loc=d3e13537-108611<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=77997519&amp;loc=d3e13531-108611<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 825<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=75032840&amp;loc=d3e61044-112788<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskCreditRisk</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting.  The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=84161450&amp;loc=d3e5614-111684<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.3A-03)<br> -URI http://asc.fasb.org/extlink&amp;oid=27015204&amp;loc=d3e355100-122828<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.3A-02)<br> -URI http://asc.fasb.org/extlink&amp;oid=27015204&amp;loc=d3e355033-122828<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConsolidationPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for its derivative instruments and hedging activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=84234895&amp;loc=d3e41620-113959<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(n))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=84234895&amp;loc=SL5579240-113959<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=84234895&amp;loc=SL5579245-113959<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=84234895&amp;loc=d3e41675-113959<br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=84234895&amp;loc=d3e41638-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerSharePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3630-109257<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerSharePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueOfFinancialInstrumentsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for determining the fair value of financial instruments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=77997519&amp;loc=d3e13279-108611<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 60<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=7493716&amp;loc=d3e21868-110260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueOfFinancialInstrumentsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450222&amp;loc=d3e30840-110895<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for recognizing and measuring the impairment of long-lived assets. An entity also may disclose its accounting policy for long-lived assets to be sold. This policy excludes goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.CC)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011434&amp;loc=d3e125687-122742<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 05<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=64802544&amp;loc=d3e202-110218<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32840-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 30<br> -Section 05<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=65884525&amp;loc=d3e40913-109327<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 740<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6491622&amp;loc=d3e9504-115650<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32809-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=84176650&amp;loc=d3e32247-109318<br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=84176650&amp;loc=d3e32280-109318<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecuritiesPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for investments in debt and equity securities that have readily determinable fair values (marketable securities). At a minimum, the disclosure might address accounting policies for investments classified as trading, available for sale, or held to maturity and may include how the entity determines whether impairments of available for sale or held to maturity investments are other than temporary, how the fair values of the entity's securities are determined, and the entity's accounting treatment for transfers between investment categories.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(6))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.M)<br> -URI http://asc.fasb.org/extlink&amp;oid=65877573&amp;loc=d3e87990-122713<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section S50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6381980&amp;loc=d3e87707-122711<br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=75019621&amp;loc=d3e62652-112803<br><br>Reference 8: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 9: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketableSecuritiesPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for long-lived, physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, basis of assets, depreciation and depletion methods used, including composite deprecation, estimated useful lives, capitalization policy, accounting treatment for costs incurred for repairs and maintenance, capitalized interest and the method it is calculated, disposals and impairments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.13(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRecognitionPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for revenue recognition. If the entity has different policies for different types of revenue transactions, the policy for each material type of transaction is generally disclosed. If a sales transaction has multiple element arrangements (for example, delivery of multiple products, services or the rights to use assets) the disclosure may indicate the accounting policy for each unit of accounting as well as how units of accounting are determined and valued. The disclosure may encompass important judgment as to appropriateness of principles related to recognition of revenue. The disclosure also may indicate the entity's treatment of any unearned or deferred revenue that arises from the transaction.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18823-107790<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 605<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 13.B.Q1)<br> -URI http://asc.fasb.org/extlink&amp;oid=65893310&amp;loc=d3e214044-122780<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18726-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRecognitionPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for stock option and stock incentive plans. This disclosure may include (1) the types of stock option or incentive plans sponsored by the entity (2) the groups that participate in (or are covered by) each plan (3) significant plan provisions and (4) how stock compensation is measured, and the methodologies and significant assumptions used to determine that measurement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=96867065&amp;loc=d3e5047-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b),(f)<br> -URI http://asc.fasb.org/extlink&amp;oid=96867065&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=84177426&amp;loc=d3e6061-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=84177426&amp;loc=d3e6143-108592<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=84177426&amp;loc=d3e6132-108592<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6636790720">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SIGNIFICANT ACCOUNTING POLICIES (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_psti_PropertyPlantAndEquipmentEstimatedUsefulLivesRateTableTextBlock', window );">Schedule of Property and Equipment, Estimated Useful Lives, Annual Rate</a></td>
<td class="text"><div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 27pt; text-indent: 0pt">Depreciation is calculated by the straight-line method over the estimated useful lives of the assets, at the following annual rates:</div>

<div style="line-height: 1.25">&#160;</div>

<div>
<table id="z4239811fa84e426982a3190298cf9636" cellspacing="0" cellpadding="0" align="center" border="0" style="font: 10pt Times New Roman, Times, serif; width: 60%">
<tr>
<td style="vertical-align: top; padding-bottom: 2px; width: 40%; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 2px; width: 1%; vertical-align: bottom">&#160;</td>
<td colspan="2" style="vertical-align: top; border-bottom: #000000 2px solid; vertical-align: bottom">
<div style="line-height: 1.25">
<div style="line-height: 1.25"></div>

<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: center">%</div>
</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="vertical-align: top; width: 40%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left">Laboratory equipment</div>
</td>
<td style="vertical-align: bottom; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right; width: 40%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: center">10-15</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
</tr>

<tr style="height: 16px">
<td style="vertical-align: top; width: 40%; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left">Computers and peripheral equipment</div>
</td>
<td style="vertical-align: bottom; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right; width: 40%; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: center">33</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="vertical-align: top; width: 40%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left">Office furniture and equipment</div>
</td>
<td style="vertical-align: bottom; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right; width: 40%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: center">15</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="vertical-align: top; width: 40%; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left">Vehicles</div>
</td>
<td style="vertical-align: bottom; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right; width: 40%; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: center">15</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
</tr>

<tr style="height: 15px">
<td style="vertical-align: top; width: 40%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left">Leasehold improvements</div>
</td>
<td style="vertical-align: bottom; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td colspan="2" style="vertical-align: top; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left">The shorter of the expected useful life or the reasonable assumed term of the lease.</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td></tr></table></div><span></span></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock', window );">Schedule of Accumulated Other Comprehensive Income (Loss)</a></td>
<td class="text"><div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 28.35pt">The following table summarizes the changes in accumulated balances of other comprehensive income for the year ended June 30, 2017:</div>

<div style="line-height: 1.25">&#160;</div>

<div>
<table id="z1a49afcc7d73463897c1b4177687276d" cellspacing="0" cellpadding="0" align="right" border="0" style="font: 10pt Times New Roman, Times, serif; width: 95%">
<tr>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td colspan="2" style="vertical-align: top; border-bottom: #000000 2px solid; text-align: center; vertical-align: bottom">Year ended June 30, 2017</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: center">Unrealized<font style="font: 10pt Times New Roman, Times, serif"><br />
</font>gains (losses)<font style="font: 10pt Times New Roman, Times, serif"><br />
</font>on marketable<font style="font: 10pt Times New Roman, Times, serif"><br />
</font>securities</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="vertical-align: top; width: 88%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 4.7pt; text-indent: 5.05pt">Beginning balance</div>
</td>
<td style="vertical-align: bottom; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">$</div>
</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">1,480</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="vertical-align: top; width: 88%; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 9.75pt">Other comprehensive income before reclassifications</div>
</td>
<td style="vertical-align: bottom; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">924</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="vertical-align: top; padding-bottom: 2px; width: 88%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 9.75pt">Amounts reclassified from accumulated other comprehensive loss, net</div>
</td>
<td style="vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">(405</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">)</div>
</td>
</tr>

<tr>
<td style="vertical-align: top; padding-bottom: 2px; width: 88%; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 12pt; text-indent: -2.25pt">Net current-period other comprehensive income</div>
</td>
<td style="vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">519</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="vertical-align: top; padding-bottom: 4px; width: 88%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 4.7pt; text-indent: 5.05pt">Ending balance</div>
</td>
<td style="vertical-align: bottom; padding-bottom: 4px; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">$</div>
</td>
<td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">1,999</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td></tr></table></div><span></span></td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_psti_PropertyPlantAndEquipmentEstimatedUsefulLivesRateTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Property Plant And Equipment Estimated Useful Lives Rate [Table Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">psti_PropertyPlantAndEquipmentEstimatedUsefulLivesRateTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>psti_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of accumulated other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=84228862&amp;loc=SL7669686-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6793542480">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>MARKETABLE SECURITIES (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesAbstract', window );"><strong>Marketable Securities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesTextBlock', window );">Schedule of Available-for-sale Marketable Securities</a></td>
<td class="text"><div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 35.45pt">As of June 30, 2017 and 2016, all of the Company&#8217;s marketable securities were classified as available-for-sale.</div>

<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 35.45pt">&#160;</div>

<div>
<table id="z17c89b572ecf496caa4468908301afa4" cellspacing="0" cellpadding="0" align="right" border="0" style="font: 10pt Times New Roman, Times, serif; width: 94%">
<tr style="height: 12px">
<td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
<td colspan="18" style="vertical-align: bottom; vertical-align: top; border-bottom: #000000 2px solid; font-weight: bold; text-align: center">June 30, 2017</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; text-align: left">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
<td colspan="18" style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid">
<div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center">June 30, 2016</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; text-align: left">&#160;</td>
</tr>

<tr>
<td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
<td colspan="2" style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid">
<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: center"><font style="font: bold 10pt Times New Roman, Times, serif">Amortized cos</font>t</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; text-align: left">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
<td colspan="2" style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid">
<div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center">Gross</div>

<div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center">unrealized</div>

<div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center">gain</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; text-align: left">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
<td colspan="2" style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid">
<div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center">Gross</div>

<div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center">unrealized</div>

<div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center">loss</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; text-align: left">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
<td colspan="2" style="vertical-align: bottom; vertical-align: top; border-bottom: #000000 2px solid">
<div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center">Other-than-temporary impairment</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; text-align: left">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
<td colspan="2" style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid">
<div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center">Fair</div>

<div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center">value</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; text-align: left">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
<td colspan="2" style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid">
<div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center">Amortized cost</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; text-align: left">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
<td colspan="2" style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid">
<div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center">Gross</div>

<div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center">unrealized</div>

<div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center">gain</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; text-align: left">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
<td colspan="2" style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid">
<div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center">Gross</div>

<div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center">unrealized</div>

<div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center">loss</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; text-align: left">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
<td colspan="2" style="vertical-align: bottom; vertical-align: top; border-bottom: #000000 2px solid">
<div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center">Other-than-temporary impairment</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; text-align: left">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
<td colspan="2" style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid">
<div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center">Fair</div>

<div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center">value</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; text-align: left">&#160;</td>
</tr>

<tr>
<td style="vertical-align: bottom; vertical-align: bottom; background-color: #cceeff">
<div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 8.65pt; text-indent: 0.7pt">Available-for-sale - matures within one year:</div>
</td>
<td style="vertical-align: bottom; vertical-align: bottom; background-color: #cceeff">&#160;</td>
<td colspan="2" style="vertical-align: bottom; vertical-align: bottom; background-color: #cceeff">&#160;</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; background-color: #cceeff">&#160;</td>
<td colspan="2" style="vertical-align: bottom; vertical-align: bottom; background-color: #cceeff">&#160;</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; background-color: #cceeff">&#160;</td>
<td colspan="2" style="vertical-align: bottom; vertical-align: bottom; background-color: #cceeff">&#160;</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; background-color: #cceeff">&#160;</td>
<td colspan="2" style="vertical-align: bottom; vertical-align: top; background-color: #cceeff">&#160;</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; background-color: #cceeff">&#160;</td>
<td colspan="2" style="vertical-align: bottom; vertical-align: bottom; background-color: #cceeff">&#160;</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; background-color: #cceeff">&#160;</td>
<td colspan="2" style="vertical-align: bottom; vertical-align: bottom; background-color: #cceeff">&#160;</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; background-color: #cceeff">&#160;</td>
<td colspan="2" style="vertical-align: bottom; vertical-align: bottom; background-color: #cceeff">&#160;</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; background-color: #cceeff">&#160;</td>
<td colspan="2" style="vertical-align: bottom; vertical-align: bottom; background-color: #cceeff">&#160;</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; background-color: #cceeff">&#160;</td>
<td colspan="2" style="vertical-align: bottom; vertical-align: top; background-color: #cceeff">&#160;</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; background-color: #cceeff">&#160;</td>
<td colspan="2" style="vertical-align: bottom; vertical-align: bottom; background-color: #cceeff">&#160;</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; background-color: #cceeff">&#160;</td>
</tr>

<tr>
<td style="vertical-align: bottom; vertical-align: bottom; width: 20%; background-color: #ffffff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 8.65pt; text-indent: 0.7pt">Stock and index linked notes</div>
</td>
<td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">$</div>
</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 5%; background-color: #ffffff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">11,988</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">$</div>
</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 5%; background-color: #ffffff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">2,014</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">$</div>
</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 5%; background-color: #ffffff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">(47</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">)</div>
</td>
<td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">$</div>
</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 5%; background-color: #ffffff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">(767</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">)</div>
</td>
<td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">$</div>
</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 5%; background-color: #ffffff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">13,188</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">$</div>
</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 5%; background-color: #ffffff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">11,599</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">$</div>
</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 5%; background-color: #ffffff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">1,594</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">$</div>
</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 5%; background-color: #ffffff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">(208</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">)</div>
</td>
<td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">$</div>
</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 5%; background-color: #ffffff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">(38</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">)</div>
</td>
<td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">$</div>
</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 5%; background-color: #ffffff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">12,947</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff">&#160;</td>
</tr>

<tr>
<td style="vertical-align: bottom; vertical-align: bottom; width: 20%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 8.65pt; text-indent: 0.7pt">Government debentures &#8211; fixed interest rate</div>
</td>
<td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 5%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">157</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 5%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">1</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 5%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">-</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 5%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">-</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 5%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">158</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 5%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">786</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 5%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">12</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 5%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">-</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 5%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">-</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 5%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">798</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff">&#160;</td>
</tr>

<tr>
<td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; width: 20%; background-color: #ffffff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 8.65pt; text-indent: 0.7pt">Corporate debentures &#8211; fixed interest rate</div>
</td>
<td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 5%; background-color: #ffffff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">47</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 5%; background-color: #ffffff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">1</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 5%; background-color: #ffffff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">-</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 5%; background-color: #ffffff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">-</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 5%; background-color: #ffffff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">48</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 5%; background-color: #ffffff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">439</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 5%; background-color: #ffffff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">7</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 5%; background-color: #ffffff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">-</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 5%; background-color: #ffffff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">-</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 5%; background-color: #ffffff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">446</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff">&#160;</td>
</tr>

<tr>
<td style="vertical-align: bottom; vertical-align: bottom; width: 20%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">$</div>
</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 5%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">12,192</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">$</div>
</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 5%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">2,016</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">$</div>
</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 5%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">(47</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">)</div>
</td>
<td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">$</div>
</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 5%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">(767</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">)</div>
</td>
<td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">$</div>
</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 5%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">13,394</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">$</div>
</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 5%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">12,824</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">$</div>
</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 5%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">1,613</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">$</div>
</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 5%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">(208</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">)</div>
</td>
<td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">$</div>
</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 5%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">(38</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">)</div>
</td>
<td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">$</div>
</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 5%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">14,191</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff">&#160;</td>
</tr>

<tr>
<td style="vertical-align: bottom; vertical-align: bottom; width: 20%; background-color: #ffffff">
<div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 8.65pt">Available-for-sale - matures after one year through five years:</div>
</td>
<td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 5%; background-color: #ffffff">&#160;</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 5%; background-color: #ffffff">&#160;</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 5%; background-color: #ffffff">&#160;</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 5%; background-color: #ffffff">&#160;</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 5%; background-color: #ffffff">&#160;</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 5%; background-color: #ffffff">&#160;</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 5%; background-color: #ffffff">&#160;</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 5%; background-color: #ffffff">&#160;</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 5%; background-color: #ffffff">&#160;</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 5%; background-color: #ffffff">&#160;</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff">&#160;</td>
</tr>

<tr>
<td style="vertical-align: bottom; vertical-align: bottom; width: 20%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 8.65pt; text-indent: 0.7pt">Government debentures &#8211; fixed interest rate</div>
</td>
<td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 5%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">468</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 5%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">23</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 5%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">-</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 5%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">-</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 5%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">491</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 5%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">717</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 5%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">27</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 5%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">-</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 5%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">-</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 5%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">744</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff">&#160;</td>
</tr>

<tr>
<td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; width: 20%; background-color: #ffffff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 8.65pt">Corporate debentures &#8211; fixed interest rate</div>
</td>
<td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 5%; background-color: #ffffff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">1,255</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 5%; background-color: #ffffff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">7</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 5%; background-color: #ffffff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">(1</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">)</div>
</td>
<td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 5%; background-color: #ffffff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">-</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 5%; background-color: #ffffff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">1,261</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 5%; background-color: #ffffff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">2,403</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 5%; background-color: #ffffff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">47</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 5%; background-color: #ffffff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">-</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 5%; background-color: #ffffff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">-</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 5%; background-color: #ffffff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">2,450</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff">&#160;</td>
</tr>

<tr>
<td style="vertical-align: bottom; vertical-align: bottom; width: 20%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">$</div>
</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 5%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">1,723</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">$</div>
</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 5%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">30</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">$</div>
</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 5%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">(1</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">)</div>
</td>
<td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">$</div>
</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 5%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">-</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">$</div>
</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 5%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">1,752</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">$</div>
</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 5%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">3,120</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">$</div>
</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 5%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">74</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">$</div>
</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 5%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">-</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">$</div>
</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 5%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">-</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">$</div>
</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 5%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">3,194</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff">&#160;</td>
</tr>

<tr>
<td style="vertical-align: bottom; vertical-align: bottom; width: 20%; background-color: #ffffff">
<div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 8.65pt; text-indent: 0.7pt">Available-for-sale - matures after five years through ten years:</div>
</td>
<td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 5%; background-color: #ffffff">&#160;</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 5%; background-color: #ffffff">&#160;</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 5%; background-color: #ffffff">&#160;</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 5%; background-color: #ffffff">&#160;</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 5%; background-color: #ffffff">&#160;</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 5%; background-color: #ffffff">&#160;</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 5%; background-color: #ffffff">&#160;</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 5%; background-color: #ffffff">&#160;</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 5%; background-color: #ffffff">&#160;</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 5%; background-color: #ffffff">&#160;</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff">&#160;</td>
</tr>

<tr>
<td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; width: 20%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 8.65pt; text-indent: 0.7pt">Corporate debentures &#8211; fixed interest rate</div>
</td>
<td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 5%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">17</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 5%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">1</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 5%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">-</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 5%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">-</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 5%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">18</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 5%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">29</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 5%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">1</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 5%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">-</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 5%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">-</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 5%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">30</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #cceeff">&#160;</td>
</tr>

<tr>
<td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; width: 20%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #ffffff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">$</div>
</td>
<td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 5%; background-color: #ffffff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">17</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #ffffff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">$</div>
</td>
<td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 5%; background-color: #ffffff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">1</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #ffffff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">$</div>
</td>
<td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 5%; background-color: #ffffff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">-</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #ffffff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">$</div>
</td>
<td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 5%; background-color: #ffffff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">-</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #ffffff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">$</div>
</td>
<td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 5%; background-color: #ffffff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">18</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #ffffff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">$</div>
</td>
<td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 5%; background-color: #ffffff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">29</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #ffffff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">$</div>
</td>
<td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 5%; background-color: #ffffff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">1</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #ffffff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">$</div>
</td>
<td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 5%; background-color: #ffffff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">-</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #ffffff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">$</div>
</td>
<td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 5%; background-color: #ffffff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">-</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #ffffff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">$</div>
</td>
<td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 5%; background-color: #ffffff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">30</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff">&#160;</td>
</tr>

<tr>
<td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 4px; width: 20%; background-color: #cceeff">
<div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 8.65pt; text-indent: 0.7pt">Total</div>
</td>
<td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 4px; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">$</div>
</td>
<td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 5%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">13,932</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 4px; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">$</div>
</td>
<td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 5%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">2,047</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 4px; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">$</div>
</td>
<td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 5%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">(48</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">)</div>
</td>
<td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 4px; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">$</div>
</td>
<td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 5%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">(767</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">)</div>
</td>
<td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 4px; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">$</div>
</td>
<td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 5%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">15,164</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 4px; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">$</div>
</td>
<td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 5%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">15,973</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 4px; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">$</div>
</td>
<td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 5%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">1,688</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 4px; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">$</div>
</td>
<td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 5%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">(208</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">)</div>
</td>
<td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 4px; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">$</div>
</td>
<td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 5%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">(38</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">)</div>
</td>
<td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 4px; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">$</div>
</td>
<td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 5%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">17,415</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #cceeff">&#160;</td></tr></table></div><span></span></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValueTableTextBlock', window );">Schedule of Investments in Continuous Unrealized Loss Position</a></td>
<td class="text"><div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 34.1pt">The following table presents gross unrealized losses and fair values for those investments that were in an unrealized loss position as of June 30, 2017 and June 30, 2016, and the length of time that those investments have been in a continuous loss position:</div>

<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 7.1pt">&#160;</div>

<div>
<table id="z2ddad5786c9049a9adbfbf0b1b61d13c" cellspacing="0" cellpadding="0" align="right" border="0" style="font: 10pt Times New Roman, Times, serif; width: 94%">
<tr>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td colspan="6" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom">
<div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center">12 months or less</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td colspan="6" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom">
<div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center">Greater than 12 months</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom">
<div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center">Fair Value</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom">
<div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center">Gross<font style="font: 10pt Times New Roman, Times, serif"><br />
</font>unrealized loss</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom">
<div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center">Fair Value</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom">
<div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center">Gross<font style="font: 10pt Times New Roman, Times, serif"><br />
</font>unrealized loss</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="vertical-align: bottom; width: 52%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 8.65pt; text-indent: 0.7pt">As of June 30, 2017</div>
</td>
<td style="vertical-align: bottom; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">$</div>
</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">869</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">$</div>
</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">(24</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">)</div>
</td>
<td style="vertical-align: bottom; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">$</div>
</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">106</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">$</div>
</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">(<font style="font: 10pt Times New Roman, Times, serif">2</font>4</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">)</div>
</td>
</tr>

<tr>
<td style="vertical-align: bottom; width: 52%; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 8.65pt">As of June 30, 2016</div>
</td>
<td style="vertical-align: bottom; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">$</div>
</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">1,258</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">$</div>
</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">(143</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">)</div>
</td>
<td style="vertical-align: bottom; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">$</div>
</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">563</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">$</div>
</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">(65</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">)</div>
</td></tr></table></div><span></span></td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValueTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of fair value of investments in debt and equity securities in an unrealized loss position categorized neither as held-to-maturity nor trading securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValueTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of available-for-sale securities which includes, but is not limited to, changes in the cost basis and fair value, fair value and gross unrealized gain (loss), fair values by type of security, contractual maturity and classification, amortized cost basis, contracts to acquire securities to be accounted for as available-for-sale, debt maturities, transfers to trading, change in net unrealized holding gain (loss) net of tax, continuous unrealized loss position fair value, aggregate losses qualitative disclosures, other than temporary impairment (OTTI) losses or other disclosures related to available for sale securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=75019621&amp;loc=d3e62557-112803<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=82897076&amp;loc=d3e27337-111563<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=82897076&amp;loc=d3e27198-111563<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=75019621&amp;loc=d3e62586-112803<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=82897076&amp;loc=d3e27161-111563<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=82897076&amp;loc=d3e27357-111563<br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=82897076&amp;loc=d3e27290-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecuritiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketableSecuritiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6806547600">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FAIR VALUE OF FINANCIAL INSTRUMENTS (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock', window );">Schedule of Fair Value of Financial Instruments</a></td>
<td class="text"><table id="z900a4c6ca5f447c0aafaf4e29e3bf035" cellspacing="0" cellpadding="0" align="right" border="0" style="font: 10pt Times New Roman, Times, serif; width: 94%">
<tr>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td colspan="6" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom">
<div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center">June 30, 2017</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td colspan="6" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom">
<div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center">June 30, 2016</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom">
<div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center">Level 1</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom">
<div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center">Level 2</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom">
<div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center">Level 1</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom">
<div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center">Level 2</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="vertical-align: bottom; width: 52%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 8.65pt; text-indent: 0.7pt">Marketable securities</div>
</td>
<td style="vertical-align: bottom; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">$</div>
</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">10,523</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">$</div>
</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">4,641</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">$</div>
</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">11,228</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">$</div>
</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">6,187</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="vertical-align: bottom; padding-bottom: 2px; width: 52%; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 8.65pt; text-indent: 0.7pt">Foreign currency derivative instruments not designated as hedge instruments</div>
</td>
<td style="vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">-</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">295</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">-</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">65</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="vertical-align: bottom; padding-bottom: 4px; width: 52%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 8.65pt; text-indent: 0.7pt">Total financial assets</div>
</td>
<td style="vertical-align: bottom; padding-bottom: 4px; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">$</div>
</td>
<td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">10,523</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 4px; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">$</div>
</td>
<td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">4,936</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 4px; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">$</div>
</td>
<td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">11,228</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 4px; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">$</div>
</td>
<td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">6,252</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
</tr>
</table><span></span></td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of financial instruments measured at fair value, including those classified in shareholders' equity measured on a recurring or nonrecurring basis. Disclosures include, but are not limited to, fair value measurements recorded and the reasons for the measurements, level within the fair value hierarchy in which the fair value measurements are categorized and transfers between levels 1 and 2. Nonrecurring fair value measurements are those that are required or permitted in the statement of financial position in particular circumstances.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=66048111&amp;loc=d3e19279-110258<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=66048111&amp;loc=d3e19207-110258<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66048111&amp;loc=d3e19207-110258<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66048111&amp;loc=d3e19207-110258<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2C<br> -URI http://asc.fasb.org/extlink&amp;oid=66048111&amp;loc=SL7498348-110258<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=66048111&amp;loc=d3e19190-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6785045760">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>OTHER CURRENT ASSETS (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract', window );"><strong>Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock', window );">Schedule of Other Current Assets</a></td>
<td class="text"><table id="zfa607ab951ff484e866f040412187dff" cellspacing="0" cellpadding="0" align="right" border="0" style="font: 10pt Times New Roman, Times, serif; width: 94%">
<tr>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td colspan="6" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom">
<div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center">June 30,</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom">
<div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center">2017</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom">
<div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center">2016</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="vertical-align: top; width: 76%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 8.65pt; text-indent: 0.7pt">Prepaid expenses</div>
</td>
<td style="vertical-align: bottom; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">$</div>
</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">882</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">$</div>
</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">300</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="vertical-align: top; width: 76%; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 8.65pt; text-indent: 0.7pt">Accounts receivable from the Ministry of Economy</div>
</td>
<td style="vertical-align: bottom; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">-</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">23</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="vertical-align: top; width: 76%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 8.65pt; text-indent: 0.7pt">Derivatives not designated as hedge instruments</div>
</td>
<td style="vertical-align: bottom; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">295</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">65</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="vertical-align: top; width: 76%; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 8.65pt; text-indent: 0.7pt">VAT receivables</div>
</td>
<td style="vertical-align: bottom; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">137</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">167</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="vertical-align: top; padding-bottom: 2px; width: 76%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 8.65pt; text-indent: 0.7pt">Other receivables</div>
</td>
<td style="vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">1</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">63</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="vertical-align: top; padding-bottom: 4px; width: 76%; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 8.65pt; text-indent: 0.7pt">Total</div>
</td>
<td style="vertical-align: bottom; padding-bottom: 4px; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">$</div>
</td>
<td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">1,315</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 4px; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">$</div>
</td>
<td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">618</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
</tr>
</table><span></span></td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the carrying amounts of other current assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6793635936">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>PROPERTY AND EQUIPMENT, NET (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentTextBlock', window );">Schedule of Property and Equipment, Net</a></td>
<td class="text"><table id="zdc26d7b242f24d7cab1183be09ef8d89" cellspacing="0" cellpadding="0" align="right" border="0" style="font: 10pt Times New Roman, Times, serif; width: 94%">
<tr>
<td style="vertical-align: middle; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td colspan="6" style="vertical-align: top; border-bottom: #000000 2px solid; vertical-align: bottom">
<div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center">June 30,</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="vertical-align: top; padding-bottom: 2px; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left">&#160;</div>
</td>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td colspan="2" style="vertical-align: top; border-bottom: #000000 2px solid; vertical-align: bottom">
<div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center">2017</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td colspan="2" style="vertical-align: top; border-bottom: #000000 2px solid; vertical-align: bottom">
<div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center">2016</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="vertical-align: top; background-color: #cceeff; vertical-align: bottom">
<div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: left">Cost:</div>
</td>
<td style="vertical-align: bottom; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td colspan="2" style="vertical-align: top; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td colspan="2" style="vertical-align: top; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="vertical-align: top; width: 76%; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left">Laboratory equipment</div>
</td>
<td style="vertical-align: bottom; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">$</div>
</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">6,097</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">$</div>
</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">6,000</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="vertical-align: top; width: 76%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left">Computers and peripheral equipment</div>
</td>
<td style="vertical-align: bottom; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">1,126</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">1,024</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="vertical-align: top; width: 76%; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left">Office furniture and equipment</div>
</td>
<td style="vertical-align: bottom; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">681</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">715</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="vertical-align: top; width: 76%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left">Leasehold improvements</div>
</td>
<td style="vertical-align: bottom; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">8,603</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">9,349</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="vertical-align: top; padding-bottom: 2px; width: 76%; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left">Vehicles</div>
</td>
<td style="vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom">
<div style="line-height: 1.25">
<div style="line-height: 1.25"></div>

<div style="font: 10pt/1.25 Times New Roman, Times, serif">-</div>
</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom">
<div style="line-height: 1.25">
<div style="line-height: 1.25"></div>

<div style="font: 10pt/1.25 Times New Roman, Times, serif">95</div>
</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
</tr>

<tr style="height: 21px">
<td style="vertical-align: top; padding-bottom: 2px; width: 76%; background-color: #cceeff; vertical-align: bottom">
<div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: left">&#160;Total Cost</div>
</td>
<td style="vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom">
<div style="line-height: 1.25">
<div style="line-height: 1.25"></div>

<div style="font: 10pt/1.25 Times New Roman, Times, serif">16,507</div>
</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom">
<div style="line-height: 1.25">
<div style="line-height: 1.25"></div>

<div style="font: 10pt/1.25 Times New Roman, Times, serif">17,183</div>
</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="vertical-align: top; width: 76%; background-color: #ffffff; vertical-align: bottom">
<div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: left">Accumulated depreciation:</div>
</td>
<td style="vertical-align: bottom; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="vertical-align: top; width: 76%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left">Laboratory equipment</div>
</td>
<td style="vertical-align: bottom; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">4,164</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">3,401</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="vertical-align: top; width: 76%; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left">Computers and peripheral equipment</div>
</td>
<td style="vertical-align: bottom; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">951</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">802</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="vertical-align: top; width: 76%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left">Office furniture and equipment</div>
</td>
<td style="vertical-align: bottom; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">416</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">353</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="vertical-align: top; width: 76%; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left">Leasehold improvements</div>
</td>
<td style="vertical-align: bottom; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">3,699</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">3,374</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="vertical-align: top; padding-bottom: 2px; width: 76%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left">Vehicles</div>
</td>
<td style="vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom">
<div style="line-height: 1.25">
<div style="line-height: 1.25"></div>

<div style="font: 10pt/1.25 Times New Roman, Times, serif">-</div>
</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom">
<div style="line-height: 1.25">
<div style="line-height: 1.25"></div>

<div style="font: 10pt/1.25 Times New Roman, Times, serif">37</div>
</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="vertical-align: top; padding-bottom: 2px; width: 76%; background-color: #ffffff; vertical-align: bottom">
<div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: left">Total accumulated depreciation</div>
</td>
<td style="vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom">
<div style="line-height: 1.25">
<div style="line-height: 1.25"></div>

<div style="font: 10pt/1.25 Times New Roman, Times, serif">9,230</div>
</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom">
<div style="line-height: 1.25">
<div style="line-height: 1.25"></div>

<div style="font: 10pt/1.25 Times New Roman, Times, serif">7,967</div>
</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="vertical-align: top; padding-bottom: 4px; width: 76%; background-color: #cceeff; vertical-align: bottom">
<div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: left">Property and equipment, net</div>
</td>
<td style="vertical-align: bottom; padding-bottom: 4px; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">$</div>
</td>
<td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">7,277</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 4px; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">$</div>
</td>
<td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">9,216</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
</tr>
</table><span></span></td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6607564720">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>OTHER ACCOUNTS PAYABLE (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_psti_OtherAccountsPayableAbstract', window );"><strong>OTHER ACCOUNTS PAYABLE [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock', window );">Schedule of Other Accounts Payable</a></td>
<td class="text"><table id="z01e5cbd23ef84c7daf6df4bce26c373c" cellspacing="0" cellpadding="0" align="right" border="0" style="font: 10pt Times New Roman, Times, serif; width: 94%">
<tr>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td colspan="6" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom">
<div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center">June 30,</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom">
<div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center">2017</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom">
<div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center">2016</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="vertical-align: top; width: 76%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 8.65pt; text-indent: 0.7pt">Accrued payroll</div>
</td>
<td style="vertical-align: bottom; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">$</div>
</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">505</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">$</div>
</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">421</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="vertical-align: top; width: 76%; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 8.65pt; text-indent: 0.7pt">Payroll institutions</div>
</td>
<td style="vertical-align: bottom; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">345</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">309</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="vertical-align: top; width: 76%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 8.65pt; text-indent: 0.7pt">Accrued vacation</div>
</td>
<td style="vertical-align: bottom; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">791</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">720</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="vertical-align: top; padding-bottom: 2px; width: 76%; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 8.65pt; text-indent: 0.7pt">Other payables</div>
</td>
<td style="vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">342</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">251</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="vertical-align: top; padding-bottom: 4px; width: 76%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 8.65pt; text-indent: 0.7pt">Total</div>
</td>
<td style="vertical-align: bottom; padding-bottom: 4px; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">$</div>
</td>
<td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">1,983</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 4px; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">$</div>
</td>
<td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">1,701</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
</tr>
</table><span></span></td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_psti_OtherAccountsPayableAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Other Accounts Payable [Abstract].</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">psti_OtherAccountsPayableAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>psti_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the (a) carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business (accounts payable); (b) other payables; and (c) accrued liabilities. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). An alternative caption includes accrued expenses.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6641413520">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>COMMITMENTS AND CONTINGENCIES (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2017</div></th></tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LandAndBuildingMember', window );">Leased Facilities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermPurchaseCommitmentLineItems', window );"><strong>Long-term Purchase Commitment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock', window );">Schedule of Future Minimum Rental Commitments</a></td>
<td class="text"><div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 35.45pt">As of June 30, 2017, aggregate minimum lease commitments under the active operating lease agreements are as follows:</div>

<div style="line-height: 1.25">&#160;</div>

<div>
<table id="za09af2fca2c7484d97018003bd3aaf5a" cellspacing="0" cellpadding="0" align="center" border="0" style="font: 10pt Times New Roman, Times, serif; width: 70%">
<tr>
<td style="vertical-align: bottom; vertical-align: top">
<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 6.95pt; text-indent: -6.95pt">Year ending June 30,</div>
</td>
<td style="vertical-align: bottom; vertical-align: bottom">&#160;</td>
<td colspan="2" style="vertical-align: bottom; vertical-align: bottom">&#160;</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left">&#160;</td>
</tr>

<tr>
<td style="vertical-align: bottom; vertical-align: top; width: 88%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 6.95pt; text-indent: -6.95pt">2018</div>
</td>
<td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">$</div>
</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">884</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff">&#160;</td>
</tr>

<tr>
<td style="vertical-align: bottom; vertical-align: top; width: 88%; background-color: #ffffff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 6.95pt; text-indent: -6.95pt">2019</div>
</td>
<td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">884</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff">&#160;</td>
</tr>

<tr>
<td style="vertical-align: bottom; vertical-align: top; width: 88%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 6.95pt; text-indent: -6.95pt">2020</div>
</td>
<td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">894</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff">&#160;</td>
</tr>

<tr>
<td style="vertical-align: bottom; vertical-align: top; width: 88%; background-color: #ffffff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 6.95pt; text-indent: -6.95pt">2021</div>
</td>
<td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">904</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff">&#160;</td>
</tr>

<tr>
<td style="vertical-align: bottom; vertical-align: top; padding-bottom: 2px; width: 88%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 6.95pt; text-indent: -6.95pt">2022</div>
</td>
<td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">452</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #cceeff">&#160;</td>
</tr>

<tr>
<td style="vertical-align: bottom; vertical-align: top; padding-bottom: 4px; width: 88%; background-color: #ffffff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 6.95pt; text-indent: -6.95pt">Total</div>
</td>
<td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 4px; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #ffffff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">$</div>
</td>
<td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; background-color: #ffffff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">4,018</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #ffffff">&#160;</td>
</tr>
</table>
</div><span></span></td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_AutomobilesMember', window );">Automobiles [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermPurchaseCommitmentLineItems', window );"><strong>Long-term Purchase Commitment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock', window );">Schedule of Future Minimum Rental Commitments</a></td>
<td class="text"><div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 35.45pt">As of June 30, 2017, future aggregate minimum lease commitments under non-cancelable operating lease agreements are as follows:</div>

<div style="line-height: 1.25">&#160;</div>

<div>
<table id="z4f5dd2bb987c46d5bc7bca52a9a11c62" cellspacing="0" cellpadding="0" align="center" border="0" style="font: 10pt Times New Roman, Times, serif; width: 70%">
<tr>
<td style="vertical-align: bottom; vertical-align: top">
<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left">Year ending June 30,</div>
</td>
<td style="vertical-align: bottom; vertical-align: bottom">&#160;</td>
<td colspan="2" style="vertical-align: bottom; vertical-align: bottom">&#160;</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left">&#160;</td>
</tr>

<tr>
<td style="vertical-align: bottom; vertical-align: top; width: 88%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left">2018</div>
</td>
<td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">225</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff">&#160;</td>
</tr>

<tr>
<td style="vertical-align: bottom; vertical-align: top; width: 88%; background-color: #ffffff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left">2019</div>
</td>
<td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">142</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff">&#160;</td>
</tr>

<tr>
<td style="vertical-align: bottom; vertical-align: top; padding-bottom: 2px; width: 88%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left">2020</div>
</td>
<td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">77</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #cceeff">&#160;</td>
</tr>

<tr>
<td style="vertical-align: bottom; vertical-align: top; padding-bottom: 4px; width: 88%; background-color: #ffffff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left">Total</div>
</td>
<td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 4px; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #ffffff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">$</div>
</td>
<td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; background-color: #ffffff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">444</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #ffffff">&#160;</td>
</tr>
</table>
</div><span></span></td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermPurchaseCommitmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermPurchaseCommitmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of future minimum payments required in the aggregate and for each of the five succeeding fiscal years for operating leases having initial or remaining noncancelable lease terms in excess of one year and the total minimum rentals to be received in the future under noncancelable subleases as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=77902758&amp;loc=d3e41502-112717<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LandAndBuildingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LandAndBuildingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_AutomobilesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_AutomobilesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6803499776">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCKHOLDERS' EQUITY (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_psti_StockholdersEquityNoteLineItems', window );"><strong>Stockholders Equity Note [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock', window );">Schedule of Stock Option and Warrant Activity</a></td>
<td class="text"><div><table id="z522be72775cb4488b2680c438abfc4d4" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, serif; width: 100%">
<tr style="height: 60px">
<td style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom">
<div style="line-height: 1.25">
<div style="line-height: 1.25">&#160;</div>

<div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center">Warrants / Options</div>
</div>
</td>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom">
<div style="line-height: 1.25">
<div style="line-height: 1.25"></div>

<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: center"><font style="font: bold 10pt Times New Roman, Times, serif">Exercise Price</font> </div>

<div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center">per Share</div>
</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom">
<div style="line-height: 1.25">
<div style="line-height: 1.25"></div>

<div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center">Options and Warrants </div>

<div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center">for Common Stock</div>
</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom">
<div style="line-height: 1.25">
<div style="line-height: 1.25"></div>

<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: center"><font style="font: bold 10pt Times New Roman, Times, serif">Options and Warrants</font> <font style="font: bold 10pt Times New Roman, Times, serif">Exercisable</font></div>
</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 2px; width: 18px; vertical-align: bottom">&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: center; width: 151px">
<div style="line-height: 1.25">
<div style="line-height: 1.25"></div>

<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: center"><font style="font: bold 10pt Times New Roman, Times, serif">Weighted Average Remaining Contractual Terms</font> <font style="font: bold 10pt Times New Roman, Times, serif">(in years)</font></div>
</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="vertical-align: top; width: 52%; background-color: #cceeff; vertical-align: bottom">
<div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 18pt">Warrants:</div>
</td>
<td style="vertical-align: bottom; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">$</div>
</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">1.40</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">8,448,981</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">-</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; width: 1.17%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">5.06</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="vertical-align: top; width: 52%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">$</div>
</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">2.85</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">4,080,000</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">4,080,000</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; width: 1.17%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">3.00</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="vertical-align: top; padding-bottom: 2px; width: 52%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">$</div>
</td>
<td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">5.00</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">3,219,983</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">3,219,983</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 2px; width: 1.17%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">0.22</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="vertical-align: top; padding-bottom: 2px; width: 52%; background-color: #ffffff; vertical-align: bottom">
<div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 18pt">Total warrants</div>
</td>
<td style="vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 2px; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom">
<div style="font: bold 10pt/1.25 Times New Roman, Times, serif">15,748,964</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom">
<div style="font: bold 10pt/1.25 Times New Roman, Times, serif">7,299,983</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 2px; width: 1.17%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 2px; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="vertical-align: top; width: 52%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; width: 1.17%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="vertical-align: top; width: 52%; background-color: #ffffff; vertical-align: bottom">
<div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 18pt">Options:</div>
</td>
<td style="vertical-align: bottom; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">$</div>
</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">0.00</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">137,200</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">124,825</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; width: 1.17%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">5.32</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="vertical-align: top; width: 52%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">$</div>
</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">0.62</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">345,500</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">345,500</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; width: 1.17%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">1.28</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="vertical-align: top; width: 52%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">$</div>
</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">1.04</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">25,000</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">25,000</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; width: 1.17%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">1.16</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="vertical-align: top; width: 52%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">$</div>
</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">2.97</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">20,000</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">20,000</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; width: 1.17%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">0.86</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="vertical-align: top; width: 52%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">$</div>
</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">3.50</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">30,000</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">30,000</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; width: 1.17%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">0.14</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="vertical-align: top; width: 52%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">$</div>
</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">3.80</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">1,000</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">1,000</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; width: 1.17%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">0.14</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="vertical-align: top; width: 52%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">$</div>
</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">4.38</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">372,500</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">372,500</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; width: 1.17%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">0.47</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="vertical-align: top; width: 52%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">$</div>
</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">4.40</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">400</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">400</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; width: 1.17%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">0.14</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="vertical-align: top; width: 52%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">$</div>
</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">6.80</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">36,250</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">36,250</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; width: 1.17%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">0.37</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="vertical-align: top; width: 52%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">$</div>
</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">8.20</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">20,000</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">20,000</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; width: 1.17%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">0.16</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="vertical-align: top; padding-bottom: 2px; width: 52%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">$</div>
</td>
<td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">20.00</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">5,000</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">5,000</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 2px; width: 1.17%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">2.62</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="vertical-align: top; padding-bottom: 2px; width: 52%; background-color: #cceeff; vertical-align: bottom">
<div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 18pt">Total options</div>
</td>
<td style="vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 2px; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom">
<div style="font: bold 10pt/1.25 Times New Roman, Times, serif">992,850</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom">
<div style="font: bold 10pt/1.25 Times New Roman, Times, serif">980,475</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 2px; width: 1.17%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 2px; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td colspan="4" style="vertical-align: top; padding-bottom: 2px; background-color: #ffffff; vertical-align: bottom">
<div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: left; text-indent: 18pt">Total warrants and options</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff; vertical-align: bottom">
<div style="font: bold 10pt/1.25 Times New Roman, Times, serif">16,741,814</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff; vertical-align: bottom">
<div style="font: bold 10pt/1.25 Times New Roman, Times, serif">8,280,458</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 2px; width: 18px; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 12px; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 2px; text-align: right; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff; vertical-align: bottom">&#160;</td>
</tr>
</table>
</div>

<div style="line-height: 1.25">&#160;</div><span></span></td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TitleOfIndividualAxis=psti_EmployeesAndDirectorsMember', window );">Employees and Directors [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_psti_StockholdersEquityNoteLineItems', window );"><strong>Stockholders Equity Note [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock', window );">Schedule of Stock Option Activity</a></td>
<td class="text"><div style="line-height: 1.25"><div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 36pt">A summary of the Company&#8217;s activity for options granted to employees and directors under the 2005 Plan is as follows:</div>
</div>

<div style="line-height: 1.25">&#160;</div>

<div>
<table id="zc5d82afc4543485a9c7bd20b618b95e2" cellspacing="0" cellpadding="0" align="right" border="0" style="font: 10pt Times New Roman, Times, serif; width: 94%">
<tr>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom"></td>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td colspan="14" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom">
<div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center; text-indent: 2pt">Year ended June 30, 2017</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom">
<div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center; text-indent: 2pt">Number</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom">
<div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center; text-indent: 2pt">Weighted Average Exercise Price</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom">
<div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center; text-indent: 2pt">Weighted Average Remaining Contractual Terms (in years)</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom">
<div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center; text-indent: 2pt">Aggregate Intrinsic Value Price</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="vertical-align: bottom; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 8.65pt; text-indent: 0.7pt">Options outstanding at beginning of period</div>
</td>
<td style="vertical-align: bottom; text-align: right; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">1,771,700</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">$</div>
</td>
<td style="vertical-align: bottom; text-align: right; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">3.76</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td colspan="2" style="vertical-align: bottom; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td colspan="2" style="vertical-align: bottom; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="vertical-align: bottom; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 8.65pt; text-indent: 0.7pt">Options exercised</div>
</td>
<td style="vertical-align: bottom; text-align: right; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">(16,000</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">)</div>
</td>
<td style="vertical-align: bottom; text-align: right; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">$</div>
</td>
<td style="vertical-align: bottom; text-align: right; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">0.62</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td colspan="2" style="vertical-align: bottom; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td colspan="2" style="vertical-align: bottom; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 8.65pt; text-indent: 0.7pt">Options forfeited</div>
</td>
<td style="vertical-align: bottom; padding-bottom: 2px; text-align: right; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">(940,050</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">)</div>
</td>
<td style="vertical-align: bottom; padding-bottom: 2px; text-align: right; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">$</div>
</td>
<td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">4.49</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td colspan="2" style="vertical-align: bottom; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td colspan="2" style="vertical-align: bottom; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="vertical-align: bottom; padding-bottom: 4px; width: 52%; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 8.65pt; text-indent: 0.7pt">Options outstanding at end of the period</div>
</td>
<td style="vertical-align: bottom; padding-bottom: 4px; text-align: right; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">815,650</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 4px; text-align: right; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">$</div>
</td>
<td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">2.98</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 4px; text-align: right; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">0.82</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 4px; text-align: right; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">$</div>
</td>
<td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">231</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="vertical-align: bottom; padding-bottom: 4px; width: 52%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 8.65pt; text-indent: 0.7pt">Options exercisable at the end of the period</div>
</td>
<td style="vertical-align: bottom; padding-bottom: 4px; text-align: right; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">815,650</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 4px; text-align: right; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">$</div>
</td>
<td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">2.98</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 4px; text-align: right; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">0.82</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 4px; text-align: right; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">$</div>
</td>
<td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">231</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="vertical-align: bottom; padding-bottom: 4px; width: 52%; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 8.65pt; text-indent: 0.7pt">Options vested at the end of the period</div>
</td>
<td style="vertical-align: bottom; padding-bottom: 4px; text-align: right; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">815,650</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 4px; text-align: right; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">$</div>
</td>
<td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">2.98</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 4px; text-align: right; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">0.82</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 4px; text-align: right; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">$</div>
</td>
<td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">231</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
</tr>
</table>
</div><span></span></td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TitleOfIndividualAxis=psti_EmployeesAndDirectorsMember', window );">Employees and Directors [Member] | Restricted stock units [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_psti_StockholdersEquityNoteLineItems', window );"><strong>Stockholders Equity Note [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock', window );">Schedule of Unvested Restricted Stock Units</a></td>
<td class="text"><div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 35.45pt">The following table summarizes the activity related to unvested RS and RSUs granted to employees and directors under the 2005 Plan&#160; and 2016 Plan&#160; for the year ended June 30, 2017:</div>

<div style="line-height: 1.25">&#160;</div>

<div>
<table id="zdd176e5c456a4b89a1f51858b7a2875c" cellspacing="0" cellpadding="0" align="right" border="0" style="font: 10pt Times New Roman, Times, serif; width: 94%">
<tr>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom">
<div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center; text-indent: 2pt">Number</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="vertical-align: bottom; width: 88%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 8.65pt; text-indent: 0.7pt">Unvested at the beginning of period</div>
</td>
<td style="vertical-align: bottom; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">1,906,619</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="vertical-align: bottom; width: 88%; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 8.65pt; text-indent: 0.7pt">Granted</div>
</td>
<td style="vertical-align: bottom; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">6,579,435</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="vertical-align: bottom; width: 88%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 8.65pt; text-indent: 0.7pt">Forfeited</div>
</td>
<td style="vertical-align: bottom; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">(107,953</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">)</div>
</td>
</tr>

<tr>
<td style="vertical-align: bottom; padding-bottom: 2px; width: 88%; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 8.65pt; text-indent: 0.7pt">Vested</div>
</td>
<td style="vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">(2,313,200</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">)</div>
</td>
</tr>

<tr>
<td style="vertical-align: bottom; padding-bottom: 4px; width: 88%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 8.65pt; text-indent: 0.7pt">Unvested at the end of the period</div>
</td>
<td style="vertical-align: bottom; padding-bottom: 4px; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">6,064,901</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="vertical-align: bottom; padding-bottom: 4px; width: 88%; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 8.65pt; text-indent: 0.7pt">Expected to vest after June 30, 2017</div>
</td>
<td style="vertical-align: bottom; padding-bottom: 4px; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">5,978,114</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
</tr>
</table>
</div>

<div style="clear: both; line-height: 1.25">&#160;</div><span></span></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock', window );">Schedule of Stock-based Compensation Expenses</a></td>
<td class="text"><div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 36pt">Compensation expenses related to RS and RSUs granted to employees and directors were recorded as follows:</div>

<div style="line-height: 1.25">&#160;</div>

<div>
<table id="z89fbe625712c46c7854b12e39917d0a6" cellspacing="0" cellpadding="0" align="right" border="0" style="font: 10pt Times New Roman, Times, serif; width: 94%">
<tr>
<td style="vertical-align: top; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td colspan="10" style="vertical-align: middle; border-bottom: #000000 2px solid; vertical-align: bottom">
<div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center">Year ended June 30,</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="vertical-align: top; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td colspan="2" style="vertical-align: top; border-bottom: #000000 2px solid; vertical-align: bottom">
<div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center">2017</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td colspan="2" style="vertical-align: top; border-bottom: #000000 2px solid; vertical-align: bottom">
<div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center">2016</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td colspan="2" style="vertical-align: top; border-bottom: #000000 2px solid; vertical-align: bottom">
<div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center">2015</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="vertical-align: bottom; width: 64%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 8.65pt; text-indent: 0.7pt">Research and development expenses</div>
</td>
<td style="vertical-align: bottom; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">$</div>
</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">1,558</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">$</div>
</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">960</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">$</div>
</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">1,469</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="vertical-align: bottom; padding-bottom: 2px; width: 64%; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 8.65pt; text-indent: 0.7pt">General and administrative expenses</div>
</td>
<td style="vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">1,645</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">1,905</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">2,277</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="vertical-align: bottom; padding-bottom: 4px; width: 64%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 4px; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">$</div>
</td>
<td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">3,203</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 4px; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">$</div>
</td>
<td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">2,865</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 4px; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">$</div>
</td>
<td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">3,746</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
</tr>
</table>
</div>

<div style="clear: both; line-height: 1.25">&#160;</div><span></span></td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TitleOfIndividualAxis=psti_NonemployeesMember', window );">Non-employee Consultants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_psti_StockholdersEquityNoteLineItems', window );"><strong>Stockholders Equity Note [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock', window );">Schedule of Stock Option Activity</a></td>
<td class="text"><div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 36pt; text-indent: 0pt">A summary of the options to non-employee consultants is as follows:</div>

<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 36pt; text-indent: 0pt">&#160;</div>

<div>
<table id="zffa8b47d18a649d3a4152a165d92e716" cellspacing="0" cellpadding="0" align="right" border="0" style="font: 10pt Times New Roman, Times, serif; width: 94%">
<tr>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td colspan="14" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom">
<div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center; text-indent: 2pt">Year ended June 30, 2017</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom">&#160;</td>
</tr>

<tr style="height: 52px">
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom">
<div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center; text-indent: 2pt">Number</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom">
<div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center; text-indent: 2pt">Weighted Average Exercise Price</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom">
<div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center; text-indent: 2pt">Weighted Average Remaining Contractual Terms (in years)</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom">
<div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center; text-indent: 2pt">Aggregate Intrinsic Value Price</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="vertical-align: bottom; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 8.65pt; text-indent: 0.7pt">Options outstanding at beginning of period</div>
</td>
<td style="vertical-align: bottom; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">237, 300</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">$</div>
</td>
<td style="vertical-align: bottom; text-align: right; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">5.40</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td colspan="2" style="vertical-align: bottom; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td colspan="2" style="vertical-align: bottom; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="vertical-align: bottom; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 8.65pt; text-indent: 0.7pt">Options granted</div>
</td>
<td style="vertical-align: bottom; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">46,800</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">$</div>
</td>
<td style="vertical-align: bottom; text-align: right; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">0.00</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td colspan="2" style="vertical-align: bottom; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td colspan="2" style="vertical-align: bottom; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; background-color: #ffffff; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="vertical-align: bottom; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 8.65pt; text-indent: 0.7pt">Options exercised</div>
</td>
<td style="vertical-align: bottom; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">(1,900</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">)</div>
</td>
<td style="vertical-align: bottom; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">$</div>
</td>
<td style="vertical-align: bottom; text-align: right; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">0.00</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td colspan="2" style="vertical-align: bottom; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td colspan="2" style="vertical-align: bottom; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; background-color: #cceeff; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 8.65pt; text-indent: 0.7pt">Options forfeited</div>
</td>
<td style="vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">(105,000</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">)</div>
</td>
<td style="vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">$</div>
</td>
<td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">10.98</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td colspan="2" style="vertical-align: bottom; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td colspan="2" style="vertical-align: bottom; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="vertical-align: bottom; padding-bottom: 4px; width: 52%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 8.65pt; text-indent: 0.7pt">Options outstanding at end of the period</div>
</td>
<td style="vertical-align: bottom; padding-bottom: 4px; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">177,200</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 4px; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">$</div>
</td>
<td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">0.72</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 4px; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">4.30</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 4px; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">$</div>
</td>
<td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">179</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="vertical-align: bottom; padding-bottom: 4px; width: 52%; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 8.65pt; text-indent: 0.7pt">Options exercisable at the end of the period</div>
</td>
<td style="vertical-align: bottom; padding-bottom: 4px; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">164,825</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 4px; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">$</div>
</td>
<td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">0.78</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 4px; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">3.92</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 4px; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">$</div>
</td>
<td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">163</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="vertical-align: bottom; padding-bottom: 4px; width: 52%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 8.65pt; text-indent: 0.7pt">Options vested&#160; and expected to vest at the end of the period</div>
</td>
<td style="vertical-align: bottom; padding-bottom: 4px; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">177,200</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 4px; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">$</div>
</td>
<td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">0.72</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 4px; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">4.30</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 4px; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">$</div>
</td>
<td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">179</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
</tr>
</table>
</div><span></span></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock', window );">Schedule of Stock-based Compensation Expenses</a></td>
<td class="text"><div style="margin-left: 36pt; line-height: 1.25">Compensation expenses related to options granted to consultants were recorded as follows:</div>

<div style="line-height: 1.25">&#160;</div>

<div>
<table id="zd480bd2b1cb94e0484682e7fd7793ed9" cellspacing="0" cellpadding="0" align="right" border="0" style="font: 10pt Times New Roman, Times, serif; width: 94%">
<tr>
<td style="vertical-align: top; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td colspan="10" style="vertical-align: middle; border-bottom: #000000 2px solid; vertical-align: bottom">
<div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center; text-indent: 2pt">Year ended June 30,</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="vertical-align: top; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td colspan="2" style="vertical-align: top; border-bottom: #000000 2px solid; vertical-align: bottom">
<div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center">2017</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td colspan="2" style="vertical-align: top; border-bottom: #000000 2px solid; vertical-align: bottom">
<div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center">2016</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td colspan="2" style="vertical-align: top; border-bottom: #000000 2px solid; vertical-align: bottom">
<div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center">2015</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="vertical-align: bottom; width: 64%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 8.65pt; text-indent: 0.7pt">Research and development expenses</div>
</td>
<td style="vertical-align: bottom; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">$</div>
</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">7</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">$</div>
</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">22</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">$</div>
</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">1</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="vertical-align: bottom; padding-bottom: 2px; width: 64%; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 8.65pt; text-indent: 0.7pt">General and administrative expenses</div>
</td>
<td style="vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">39</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">2</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">1</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="vertical-align: bottom; padding-bottom: 4px; width: 64%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 4px; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">$</div>
</td>
<td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">46</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 4px; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">$</div>
</td>
<td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">24</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 4px; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">$</div>
</td>
<td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">2</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
</tr>
</table>
</div>

<div style="clear: both; line-height: 1.25">&#160;</div><span></span></td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TitleOfIndividualAxis=psti_NonemployeesMember', window );">Non-employee Consultants [Member] | Restricted stock units [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_psti_StockholdersEquityNoteLineItems', window );"><strong>Stockholders Equity Note [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock', window );">Schedule of Unvested Restricted Stock Units</a></td>
<td class="text"><div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 36pt">The following table summarizes the activity related to unvested RS and RSUs granted to consultants for the year ended June 30, 2017:<br style="line-height: 1.25" />
</div>

<div>
<table id="z8e0bf2d3eaa64c13b2ffaf539d67195a" cellspacing="0" cellpadding="0" align="right" border="0" style="font: 10pt Times New Roman, Times, serif; width: 94%">
<tr>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom">
<div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center; text-indent: 2pt">Number</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="vertical-align: bottom; width: 88%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 8.65pt; text-indent: 0.7pt">Unvested at the beginning of period</div>
</td>
<td style="vertical-align: bottom; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">26,000</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
</tr>

<tr style="height: 16px">
<td style="vertical-align: bottom; width: 88%; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 8.65pt; text-indent: 0.7pt">Granted</div>
</td>
<td style="vertical-align: bottom; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">273,557</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="vertical-align: bottom; padding-bottom: 2px; width: 88%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 8.65pt; text-indent: 0.7pt">Vested</div>
</td>
<td style="vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">(257,057</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">)</div>
</td>
</tr>

<tr>
<td style="vertical-align: bottom; padding-bottom: 4px; width: 88%; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 8.65pt; text-indent: 0.7pt">Unvested at the end of the period</div>
</td>
<td style="vertical-align: bottom; padding-bottom: 4px; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">42,500</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
</tr>
</table>
</div>

<div style="clear: both; line-height: 1.25">&#160;</div><span></span></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock', window );">Schedule of Stock-based Compensation Expenses</a></td>
<td class="text"><div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 36pt">Compensation expenses related to RS and RSUs granted to consultants were recorded as follows:</div>

<div style="line-height: 1.25">&#160;</div>

<div>
<table id="z3f959cbd462043d1b0e75a38e85ac309" cellspacing="0" cellpadding="0" align="right" border="0" style="font: 10pt Times New Roman, Times, serif; width: 94%">
<tr>
<td style="vertical-align: top; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td colspan="10" style="vertical-align: middle; border-bottom: #000000 2px solid; vertical-align: bottom">
<div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center">Year ended June 30,</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="vertical-align: top; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td colspan="2" style="vertical-align: top; border-bottom: #000000 2px solid; vertical-align: bottom">
<div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center">2017</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td colspan="2" style="vertical-align: top; border-bottom: #000000 2px solid; vertical-align: bottom">
<div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center">2016</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td colspan="2" style="vertical-align: top; border-bottom: #000000 2px solid; vertical-align: bottom">
<div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center">2015</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="vertical-align: bottom; width: 64%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 8.65pt; text-indent: 0.7pt">Research and development expenses</div>
</td>
<td style="vertical-align: bottom; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">$</div>
</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">19</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">$</div>
</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">39</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">$</div>
</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">131</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="vertical-align: bottom; padding-bottom: 2px; width: 64%; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 8.65pt; text-indent: 0.7pt">General and administrative expenses</div>
</td>
<td style="vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">394</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">145</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">173</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="vertical-align: bottom; padding-bottom: 4px; width: 64%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 4px; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">$</div>
</td>
<td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">413</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 4px; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">$</div>
</td>
<td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">184</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 4px; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">$</div>
</td>
<td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">304</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
</tr>
</table>
</div>

<div style="clear: both; line-height: 1.25">&#160;</div><span></span></td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_psti_StockholdersEquityNoteLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Stockholders' Equity Note [Line Items].</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">psti_StockholdersEquityNoteLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>psti_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the allocation of equity-based compensation costs to a given line item on the balance sheet and income statement for the period. This may include the reporting line for the costs and the amount capitalized and expensed.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=96867065&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=96867065&amp;loc=d3e5047-113901<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -URI http://asc.fasb.org/extlink&amp;oid=27013229&amp;loc=d3e301413-122809<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the changes in outstanding nonvested restricted stock units.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=96867065&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure for share-based compensation plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=96867065&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=96867065&amp;loc=d3e5070-113901<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=96867065&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=96867065&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=96867065&amp;loc=d3e5070-113901<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=96867065&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TitleOfIndividualAxis=psti_EmployeesAndDirectorsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TitleOfIndividualAxis=psti_EmployeesAndDirectorsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TitleOfIndividualAxis=psti_NonemployeesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TitleOfIndividualAxis=psti_NonemployeesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6783574528">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FINANCIAL INCOME, NET (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherIncomeAndExpensesAbstract', window );"><strong>Other Income and Expenses [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock', window );">Schedule of Financial Expenses (Income), Net</a></td>
<td class="text"><table id="za47e081f166149a880e695ce08148ece" cellspacing="0" cellpadding="0" align="right" border="0" style="font: 10pt Times New Roman, Times, serif; width: 94%">
<tr>
<td style="vertical-align: top; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td colspan="10" style="vertical-align: middle; border-bottom: #000000 2px solid; vertical-align: bottom">
<div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center">Year ended June 30,</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="vertical-align: top; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td colspan="2" style="vertical-align: top; border-bottom: #000000 2px solid; vertical-align: bottom">
<div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center">2017</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td colspan="2" style="vertical-align: top; border-bottom: #000000 2px solid; vertical-align: bottom">
<div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center">2016</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 2px; vertical-align: bottom">&#160;</td>
<td colspan="2" style="vertical-align: top; border-bottom: #000000 2px solid; vertical-align: bottom">
<div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center">2015</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="vertical-align: middle; width: 64%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 8.65pt; text-indent: 0.7pt">Foreign currency translation differences, net</div>
</td>
<td style="vertical-align: bottom; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">$</div>
</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">182</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">$</div>
</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">(174</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">)</div>
</td>
<td style="vertical-align: bottom; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">$</div>
</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">(1,109</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">)</div>
</td>
</tr>

<tr>
<td style="vertical-align: middle; width: 64%; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 8.65pt; text-indent: 0.7pt">Bank and broker commissions</div>
</td>
<td style="vertical-align: bottom; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">(67</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">)</div>
</td>
<td style="vertical-align: bottom; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">(85</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">)</div>
</td>
<td style="vertical-align: bottom; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">(37</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">)</div>
</td>
</tr>

<tr>
<td style="vertical-align: middle; width: 64%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 8.65pt; text-indent: 0.7pt">Interest income on deposits</div>
</td>
<td style="vertical-align: bottom; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">122</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">149</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">112</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="vertical-align: middle; width: 64%; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 8.65pt">Gain (loss) related to marketable securities, net</div>
</td>
<td style="vertical-align: bottom; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">(513</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">)</div>
</td>
<td style="vertical-align: bottom; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">190</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">1,229</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="vertical-align: middle; width: 64%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 8.65pt; text-indent: 0.7pt">Gain (loss) from&#160; derivatives and fair value hedge derivatives</div>
</td>
<td style="vertical-align: bottom; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">481</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">(30</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">)</div>
</td>
<td style="vertical-align: bottom; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">395</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="vertical-align: middle; padding-bottom: 2px; width: 64%; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 8.65pt; text-indent: 0.7pt">Other financial income</div>
</td>
<td style="vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">-</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">23</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #ffffff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">-</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff; vertical-align: bottom">&#160;</td>
</tr>

<tr>
<td style="vertical-align: bottom; padding-bottom: 4px; width: 64%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 4px; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">$</div>
</td>
<td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">205</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 4px; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">$</div>
</td>
<td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">73</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 4px; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">$</div>
</td>
<td style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; background-color: #cceeff; vertical-align: bottom">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">590</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #cceeff; vertical-align: bottom">&#160;</td>
</tr>
</table><span></span></td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherIncomeAndExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherIncomeAndExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of non-operating income or non-operating expense that may include amounts earned from dividends, interest on securities, gains (losses) on securities sold, equity earnings of unconsolidated affiliates, net gain (loss) on sales of business, interest expense and other miscellaneous income or expense items.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6604031408">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>TAXES ON INCOME (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_psti_QualifyingPercentageOfValueOfProductiveAssetsTableTextBlock', window );">Qualifying Percentage of Value of Productive Assets</a></td>
<td class="text"><div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 42.55pt">The qualifying percentage of the value of the productive assets is as follows:</div>

<div style="line-height: 1.25"><br style="line-height: 1.25" />
</div>

<div>
<table id="z7dd3f999d96e475daadaf09b843306b8" cellspacing="0" cellpadding="0" align="right" border="0" style="font: 10pt Times New Roman, Times, serif; border-collapse: collapse; width: 94%">
<tr>
<td style="text-align: center; border-bottom: #000000 2px solid; width: 53.57%; vertical-align: bottom">
<div style="font: bold 10pt/1.25 Times New Roman, Times, serif; margin-left: 42.55pt">The value of productive</div>

<div style="font: bold 10pt/1.25 Times New Roman, Times, serif; margin-left: 42.55pt">assets before the expansion</div>

<div style="font: bold 10pt/1.25 Times New Roman, Times, serif; margin-left: 42.55pt">(NIS in millions)</div>
</td>
<td style="vertical-align: top; width: 3.58%">&#160;</td>
<td style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: center; width: 42.85%">
<div style="font: bold 10pt/1.25 Times New Roman, Times, serif">The new proportion that the required </div>

<div style="font: bold 10pt/1.25 Times New Roman, Times, serif">investment bears to the value of productive assets</div>
</td>
</tr>

<tr>
<td style="border-top: #000000 2px solid; vertical-align: top; width: 53.57%">&#160;</td>
<td style="vertical-align: top; width: 3.58%">&#160;</td>
<td style="vertical-align: top; width: 42.85%">&#160;</td>
</tr>

<tr>
<td style="vertical-align: top; width: 53.57%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 42.55pt">Up to NIS&#160;140</div>
</td>
<td style="vertical-align: top; width: 3.58%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: top; width: 42.85%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: center; margin-left: 42.55pt">12%</div>
</td>
</tr>

<tr>
<td style="vertical-align: top; width: 53.57%; background-color: #ffffff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 42.55pt">NIS&#160;140 - NIS&#160;500</div>
</td>
<td style="vertical-align: top; width: 3.58%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: top; width: 42.85%; background-color: #ffffff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: center; margin-left: 42.55pt">7%</div>
</td>
</tr>

<tr>
<td style="vertical-align: top; width: 53.57%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 42.55pt">More than NIS&#160;500</div>
</td>
<td style="vertical-align: top; width: 3.58%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: top; width: 42.85%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: center; margin-left: 42.55pt">5%</div></td></tr></table></div><span></span></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock', window );">Schedule of Deferred Tax Assets</a></td>
<td class="text"><div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 42.55pt">Significant components of the Company's deferred tax assets are as follows:</div>

<div style="line-height: 1.25">&#160;</div>

<div>
<table id="z8c0d601e87a3487a842fe95c2270aaeb" cellspacing="0" cellpadding="0" align="right" border="0" style="font: 10pt Times New Roman, Times, serif; width: 94%">
<tr>
<td style="vertical-align: bottom; vertical-align: top; padding-bottom: 2px">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
<td colspan="6" style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid">
<div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center; text-indent: 2pt">June 30,</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; text-align: left">&#160;</td>
</tr>

<tr>
<td style="vertical-align: bottom; vertical-align: top; padding-bottom: 2px">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
<td colspan="2" style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid">
<div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center">2017</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; text-align: left">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
<td colspan="2" style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid">
<div style="font: bold 10pt/1.25 Times New Roman, Times, serif; text-align: center">2016</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; text-align: left">&#160;</td>
</tr>

<tr>
<td style="vertical-align: bottom; vertical-align: top; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 8.5pt; text-indent: -8.5pt">Deferred tax assets:</div>
</td>
<td style="vertical-align: bottom; vertical-align: bottom; background-color: #cceeff">&#160;</td>
<td colspan="2" style="vertical-align: bottom; vertical-align: bottom; background-color: #cceeff">&#160;</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; background-color: #cceeff">&#160;</td>
<td colspan="2" style="vertical-align: bottom; vertical-align: bottom; background-color: #cceeff">&#160;</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; background-color: #cceeff">&#160;</td>
</tr>

<tr>
<td style="vertical-align: bottom; vertical-align: top; width: 76%; background-color: #ffffff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: left; margin-left: 17pt; text-indent: -8.5pt">U.S. net operating loss carryforward</div>
</td>
<td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">$</div>
</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">11,382</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">$</div>
</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">10,210</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff">&#160;</td>
</tr>

<tr>
<td style="vertical-align: bottom; vertical-align: top; width: 76%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 17pt; text-indent: -8.5pt">Israeli net operating loss carryforward</div>
</td>
<td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">26,275</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">22,105</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff">&#160;</td>
</tr>

<tr>
<td style="vertical-align: bottom; vertical-align: top; padding-bottom: 2px; width: 76%; background-color: #ffffff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 17pt; text-indent: -8.5pt">Allowances and reserves</div>
</td>
<td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #ffffff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">222</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #ffffff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">216</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff">&#160;</td>
</tr>

<tr>
<td style="vertical-align: bottom; vertical-align: top; width: 76%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff">&#160;</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff">&#160;</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff">&#160;</td>
</tr>

<tr>
<td style="vertical-align: bottom; vertical-align: top; width: 76%; background-color: #ffffff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 8.5pt; text-indent: -8.5pt">Total deferred tax assets before valuation allowance</div>
</td>
<td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">37,879</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">32,531</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff">&#160;</td>
</tr>

<tr>
<td style="vertical-align: bottom; vertical-align: top; padding-bottom: 2px; width: 76%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 8.5pt; text-indent: -8.5pt">Valuation allowance</div>
</td>
<td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">(37,879</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">)</div>
</td>
<td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">(32,531</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">)</div>
</td>
</tr>

<tr>
<td style="vertical-align: bottom; vertical-align: top; width: 76%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff">&#160;</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff">&#160;</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff">&#160;</td>
</tr>

<tr>
<td style="vertical-align: bottom; vertical-align: top; padding-bottom: 4px; width: 76%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif; text-align: justify; margin-left: 8.5pt; text-indent: -8.5pt">Net deferred tax asset</div>
</td>
<td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 4px; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">$</div>
</td>
<td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">-</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 4px; width: 1%; background-color: #cceeff">&#160;</td>
<td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">$</div>
</td>
<td style="vertical-align: bottom; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; background-color: #cceeff">
<div style="font: 10pt/1.25 Times New Roman, Times, serif">-</div>
</td>
<td nowrap="nowrap" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #cceeff">&#160;</td>
</tr>
</table>
</div><span></span></td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_psti_QualifyingPercentageOfValueOfProductiveAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Qualifying Percentage Of Value Of Productive Assets [Table Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">psti_QualifyingPercentageOfValueOfProductiveAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>psti_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6814255120">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>GENERAL (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">1 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2013</div></th>
<th class="th"><div>Aug. 31, 2011</div></th>
<th class="th"><div>Jun. 30, 2017</div></th>
<th class="th"><div>Jun. 30, 2016</div></th>
<th class="th"><div>Jun. 30, 2015</div></th>
<th class="th"><div>Jun. 30, 2014</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_psti_GeneralAbstract', window );"><strong>GENERAL [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 189,571<span></span>
</td>
<td class="nump">$ 161,757<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total stockholders' equity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30,251<span></span>
</td>
<td class="nump">38,156<span></span>
</td>
<td class="nump">$ 58,143<span></span>
</td>
<td class="nump">$ 62,123<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">27,814<span></span>
</td>
<td class="nump">23,246<span></span>
</td>
<td class="nump">24,677<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Cash flow operating activities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">21,611<span></span>
</td>
<td class="nump">$ 18,522<span></span>
</td>
<td class="nump">$ 20,605<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsAndShortTermInvestments', window );">Cash and cash equivalents, short-term bank deposits and marketable securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">26,106<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LicensesRevenue', window );">Upfront payment received</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_psti_NonrefundableAdvanceUnderTermsOfLicenseAgreement', window );">Nonrefundable upfront payments received</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromCustomers', window );">Advance payment on the development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesPurchaseOfAssets', window );">Issuance of common stock under CHA agreement</a></td>
<td class="nump">2,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_psti_AvailableForSaleMarketableSecuritiesNumber', window );">CHA shares classified as marketable securities</a></td>
<td class="nump">1,011,504<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValuePurchaseOfAssets', window );">Total consideration reflected under the CHA agreement</a></td>
<td class="nump">$ 10,414<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesCurrent', window );">Fair value of the remaining investment in CHA shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,358<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_psti_AvailableForSaleMarketableSecuritiesNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of equity financial securities classified as available-for-sale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">psti_AvailableForSaleMarketableSecuritiesNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>psti_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_psti_GeneralAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>General Disclosure Abstract</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">psti_GeneralAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>psti_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_psti_NonrefundableAdvanceUnderTermsOfLicenseAgreement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Nonrefundable upfront payment received from customer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">psti_NonrefundableAdvanceUnderTermsOfLicenseAgreement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>psti_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt and equity securities categorized neither as trading securities nor held-to-maturity securities and intended be sold or mature one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 25<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=75030427&amp;loc=d3e22054-111558<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=82896770&amp;loc=d3e26626-111562<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsAndShortTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash includes currency on hand as well as demand deposits with banks or financial institutions. It also includes other kinds of accounts that have the general characteristics of demand deposits in that the customer may deposit additional funds at any time and effectively may withdraw funds at any time without prior notice or penalty. Cash equivalents, excluding items classified as marketable securities, include short-term, highly liquid Investments that are both readily convertible to known amounts of cash, and so near their maturity that they present minimal risk of changes in value because of changes in interest rates. Generally, only investments with original maturities of three months or less qualify under that definition. Original maturity means original maturity to the entity holding the investment. For example, both a three-month US Treasury bill and a three-year Treasury note purchased three months from maturity qualify as cash equivalents. However, a Treasury note purchased three years ago does not become a cash equivalent when its remaining maturity is three months. Short-term investments, exclusive of cash equivalents, generally consist of marketable securities intended to be sold within one year (or the normal operating cycle if longer) and may include trading securities, available-for-sale securities, or held-to-maturity securities (if maturing within one year), as applicable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsAndShortTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LicensesRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Revenue earned during the period relating to consideration received from another party for the right to use, but not own, certain of the entity's intangible assets. Licensing arrangements include, but are not limited to, rights to use a patent, copyright, technology, manufacturing process, software or trademark. Licensing fees are generally, but not always, fixed as to amount and not dependent upon the revenue generated by the licensing party. An entity may receive licensing fees for licenses that also generate royalty payments to the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1(e))<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LicensesRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3521-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3602-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879574&amp;loc=d3e536633-122882<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879464&amp;loc=d3e573970-122913<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromCustomers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash receipts from customers during the current period which are usually for sales of goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromCustomers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesPurchaseOfAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of stock issued during the period as part of a transaction to acquire assets that do not qualify as a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesPurchaseOfAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValuePurchaseOfAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of shares of stock issued during the period as part of a transaction to acquire assets that do not qualify as a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValuePurchaseOfAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=27010918&amp;loc=d3e74512-122707<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6814269984">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SIGNIFICANT ACCOUNTING POLICIES (Narrative) (Details)<br> $ / shares in Units, &#8364; in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="3">1 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Aug. 31, 2016 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Aug. 31, 2016 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th">
<div>Aug. 31, 2011 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2017 </div>
<div>USD ($) </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Jun. 30, 2016 </div>
<div>USD ($) </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Jun. 30, 2015 </div>
<div>USD ($) </div>
<div>$ / shares</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherThanTemporaryImpairmentLossesInvestmentsPortionRecognizedInEarningsNet', window );">Other-than-temporary impairment loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 767<span></span>
</td>
<td class="nump">$ 38<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_psti_NonrefundableAdvanceUnderTermsOfLicenseAgreement', window );">Nonrefundable upfront payments received</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_psti_BusinessCombinationContingentConsiderationReceivableUponCertainRegulatoryMilestones', window );">Contingent consideration receivable if certain regulatory milestones are reached</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">37,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredRevenueAdditions', window );">Deferred revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_psti_AdvancePaymentForDeveplomentCosts', window );">Advance payment for development costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Granted, weighted-average grant date fair value | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.41<span></span>
</td>
<td class="nump">$ 1.13<span></span>
</td>
<td class="nump">$ 2.70<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PostemploymentBenefitsPeriodExpense', window );">Severance expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 524<span></span>
</td>
<td class="nump">$ 556<span></span>
</td>
<td class="nump">$ 441<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeGainLossOnDerivativeNet', window );">Net gain (loss) realized on derivatives</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">230<span></span>
</td>
<td class="num">(205)<span></span>
</td>
<td class="nump">$ 248<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue', window );">Fair value of other derivatives</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 295<span></span>
</td>
<td class="nump">$ 65<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_psti_TotalGrantsAwardedToCliProgram', window );">Total grants awared to CLI program consortium under the European Union's Horizon 2020 program</a></td>
<td class="nump">$ 8,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_psti_AmountOfGrantsAwardedToCliProgramAllocatedToCompany', window );">Amount of grants awared under CLI program allocated to Company</a></td>
<td class="nump">$ 2,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrencyAxis=currency_EUR', window );">Euro [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_psti_TotalGrantsAwardedToCliProgram', window );">Total grants awared to CLI program consortium under the European Union's Horizon 2020 program | &#8364;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 7,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_psti_AmountOfGrantsAwardedToCliProgramAllocatedToCompany', window );">Amount of grants awared under CLI program allocated to Company | &#8364;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 1,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_psti_AdvancePaymentForDeveplomentCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The advance payment for any development costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">psti_AdvancePaymentForDeveplomentCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>psti_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_psti_AmountOfGrantsAwardedToCliProgramAllocatedToCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of grants awared under CLI program allocated to Company.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">psti_AmountOfGrantsAwardedToCliProgramAllocatedToCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>psti_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_psti_BusinessCombinationContingentConsiderationReceivableUponCertainRegulatoryMilestones">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business combination contingent consideration receivable upon certain regulatory milestones.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">psti_BusinessCombinationContingentConsiderationReceivableUponCertainRegulatoryMilestones</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>psti_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_psti_NonrefundableAdvanceUnderTermsOfLicenseAgreement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Nonrefundable upfront payment received from customer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">psti_NonrefundableAdvanceUnderTermsOfLicenseAgreement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>psti_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_psti_TotalGrantsAwardedToCliProgram">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total grants awarded to CLI program under the European Union's Horizon 2020 program.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">psti_TotalGrantsAwardedToCliProgram</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>psti_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredRevenueAdditions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred revenue recognized for transactions arising during the current reporting period. Deferred revenue is a liability as of the balance sheet date related to a revenue producing activity for which revenue has not yet been recognized. Generally, an Entity records deferred revenue when it receives consideration from a customer before achieving certain criteria that must be met for revenue to be recognized in conformity with GAAP.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 605<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 13.A.4(a).Q1)<br> -URI http://asc.fasb.org/extlink&amp;oid=65893310&amp;loc=d3e214044-122780<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 605<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 13.A.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=65893310&amp;loc=d3e214044-122780<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredRevenueAdditions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeGainLossOnDerivativeNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the fair value of derivatives recognized in the income statement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84234895&amp;loc=SL5618551-113959<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (a),(c),(d),(e)<br> -URI http://asc.fasb.org/extlink&amp;oid=84234895&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeGainLossOnDerivativeNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value as of the balance sheet date of derivative instrument not designated as hedging instrument and classified as an asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=84234895&amp;loc=SL5624163-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherThanTemporaryImpairmentLossesInvestmentsPortionRecognizedInEarningsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of other than temporary impairment (OTTI) losses on equity securities, OTTI related to credit losses on debt securities, and OTTI losses on debt securities when the entity intends to sell the securities or it is more likely than not that the entity will be required to sell the securities before recovery of its amortized cost basis. Additionally, this item includes OTTI losses recognized during the period on investments accounted for under the cost method of accounting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8B<br> -URI http://asc.fasb.org/extlink&amp;oid=82897076&amp;loc=SL6284393-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherThanTemporaryImpairmentLossesInvestmentsPortionRecognizedInEarningsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PostemploymentBenefitsPeriodExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period expense related to postemployment benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PostemploymentBenefitsPeriodExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=96867065&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrencyAxis=currency_EUR">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrencyAxis=currency_EUR</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6801914320">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SIGNIFICANT ACCOUNTING POLICIES (Schedule of Property and Equipment Depreciation Rate) (Details)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2017</div></th></tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_OtherMachineryAndEquipmentMember', window );">Laboratory equipment [Member] | Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_psti_PropertyPlantAndEquipmentAnnualRateOfDepreciation', window );">Depreciation rate</a></td>
<td class="nump">10.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_OtherMachineryAndEquipmentMember', window );">Laboratory equipment [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_psti_PropertyPlantAndEquipmentAnnualRateOfDepreciation', window );">Depreciation rate</a></td>
<td class="nump">15.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember', window );">Computers and peripheral equipment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_psti_PropertyPlantAndEquipmentAnnualRateOfDepreciation', window );">Depreciation rate</a></td>
<td class="nump">33.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_OfficeEquipmentMember', window );">Office furniture and equipment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_psti_PropertyPlantAndEquipmentAnnualRateOfDepreciation', window );">Depreciation rate</a></td>
<td class="nump">15.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_VehiclesMember', window );">Vehicles [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_psti_PropertyPlantAndEquipmentAnnualRateOfDepreciation', window );">Depreciation rate</a></td>
<td class="nump">15.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember', window );">Leasehold Improvements [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_psti_LeaseholdImprovementsAnnualRateOfDepreciationDescription', window );">Depreciation, leasehold</a></td>
<td class="text"><p style="margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">The shorter
of the expected useful life or the reasonable assumed term of the lease.</font></p><span></span></td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_psti_LeaseholdImprovementsAnnualRateOfDepreciationDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The depreciation description for leasehold improvements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">psti_LeaseholdImprovementsAnnualRateOfDepreciationDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>psti_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_psti_PropertyPlantAndEquipmentAnnualRateOfDepreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The depreciation rate applied annually using the straight-line method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">psti_PropertyPlantAndEquipmentAnnualRateOfDepreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>psti_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_OtherMachineryAndEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_OtherMachineryAndEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RangeAxis=us-gaap_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RangeAxis=us-gaap_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RangeAxis=us-gaap_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RangeAxis=us-gaap_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_OfficeEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_OfficeEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_VehiclesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_VehiclesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6816097200">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SIGNIFICANT ACCOUNTING POLICIES (Comprehensive Income) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2017</div></th>
<th class="th"><div>Jun. 30, 2016</div></th>
<th class="th"><div>Jun. 30, 2015</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Beginning balance</a></td>
<td class="nump">$ 1,480<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Net current-period other comprehensive income</a></td>
<td class="nump">519<span></span>
</td>
<td class="num">$ (660)<span></span>
</td>
<td class="num">$ (819)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Ending balance</a></td>
<td class="nump">1,999<span></span>
</td>
<td class="nump">1,480<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember', window );">Unrealized gains (losses) on marketable securities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Beginning balance</a></td>
<td class="nump">1,480<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax', window );">Other comprehensive income before reclassifications</a></td>
<td class="nump">924<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax', window );">Amounts reclassified from accumulated other comprehensive loss, net</a></td>
<td class="num">(405)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Net current-period other comprehensive income</a></td>
<td class="nump">519<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Ending balance</a></td>
<td class="nump">$ 1,999<span></span>
</td>
<td class="nump">$ 1,480<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=84228862&amp;loc=d3e637-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=84228862&amp;loc=d3e681-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=84228862&amp;loc=SL7669686-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax, before reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=84158357&amp;loc=d3e1436-108581<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=84228862&amp;loc=SL7669686-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=84159872&amp;loc=d3e21463-112644<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=84228862&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -URI http://asc.fasb.org/extlink&amp;oid=84228862&amp;loc=SL7669625-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=84158357&amp;loc=d3e1436-108581<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=84228862&amp;loc=SL7669686-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=84158357&amp;loc=d3e1436-108581<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6817821680">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>MARKETABLE SECURITIES (Schedule of Available-for-sale Marketable Securities) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Jun. 30, 2017</div></th>
<th class="th"><div>Jun. 30, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Schedule of Available-for-sale Securities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecurities', window );">Fair value</a></td>
<td class="nump">$ 15,164<span></span>
</td>
<td class="nump">$ 17,415<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross unrealized gain</a></td>
<td class="nump">2,047<span></span>
</td>
<td class="nump">1,688<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross unrealized loss</a></td>
<td class="num">(48)<span></span>
</td>
<td class="num">(208)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_psti_OtherthantemporaryImpairment', window );">Other-than-temporary impairment</a></td>
<td class="num">(767)<span></span>
</td>
<td class="num">(38)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesAmortizedCost', window );">Amortized cost</a></td>
<td class="nump">13,932<span></span>
</td>
<td class="nump">15,973<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_psti_MaturityDateRangeAxis=psti_AvailableForSaleSecuritiesMaturesWithinOneYearMember', window );">Within One Year [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Schedule of Available-for-sale Securities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecurities', window );">Fair value</a></td>
<td class="nump">13,394<span></span>
</td>
<td class="nump">14,191<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross unrealized gain</a></td>
<td class="nump">2,016<span></span>
</td>
<td class="nump">1,613<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross unrealized loss</a></td>
<td class="num">(47)<span></span>
</td>
<td class="num">(208)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_psti_OtherthantemporaryImpairment', window );">Other-than-temporary impairment</a></td>
<td class="num">(767)<span></span>
</td>
<td class="num">(38)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesAmortizedCost', window );">Amortized cost</a></td>
<td class="nump">12,192<span></span>
</td>
<td class="nump">12,824<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_psti_MaturityDateRangeAxis=psti_AvailableForSaleSecuritiesMaturesAfterOneYearThroughFiveYearsMember', window );">One to Five Years [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Schedule of Available-for-sale Securities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecurities', window );">Fair value</a></td>
<td class="nump">1,752<span></span>
</td>
<td class="nump">3,194<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross unrealized gain</a></td>
<td class="nump">30<span></span>
</td>
<td class="nump">74<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross unrealized loss</a></td>
<td class="num">(1)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_psti_OtherthantemporaryImpairment', window );">Other-than-temporary impairment</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesAmortizedCost', window );">Amortized cost</a></td>
<td class="nump">1,723<span></span>
</td>
<td class="nump">3,120<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_psti_MaturityDateRangeAxis=psti_AvailableForSaleSecuritiesMaturesAfterFiveYearsThroughTenYearsMember', window );">After Five Years through Ten Years [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Schedule of Available-for-sale Securities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecurities', window );">Fair value</a></td>
<td class="nump">18<span></span>
</td>
<td class="nump">30<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross unrealized gain</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross unrealized loss</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_psti_OtherthantemporaryImpairment', window );">Other-than-temporary impairment</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesAmortizedCost', window );">Amortized cost</a></td>
<td class="nump">17<span></span>
</td>
<td class="nump">29<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis=us-gaap_EquitySecuritiesMember', window );">Stock and Index Linked Notes [Member] | Within One Year [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Schedule of Available-for-sale Securities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecurities', window );">Fair value</a></td>
<td class="nump">13,188<span></span>
</td>
<td class="nump">12,947<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross unrealized gain</a></td>
<td class="nump">2,014<span></span>
</td>
<td class="nump">1,594<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross unrealized loss</a></td>
<td class="num">(47)<span></span>
</td>
<td class="num">(208)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_psti_OtherthantemporaryImpairment', window );">Other-than-temporary impairment</a></td>
<td class="num">(767)<span></span>
</td>
<td class="num">(38)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesAmortizedCost', window );">Amortized cost</a></td>
<td class="nump">11,988<span></span>
</td>
<td class="nump">11,599<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis=psti_GovernmentDebtSecuritiesMember', window );">Government Debentures [Member] | Within One Year [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Schedule of Available-for-sale Securities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecurities', window );">Fair value</a></td>
<td class="nump">158<span></span>
</td>
<td class="nump">798<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross unrealized gain</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">12<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross unrealized loss</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_psti_OtherthantemporaryImpairment', window );">Other-than-temporary impairment</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesAmortizedCost', window );">Amortized cost</a></td>
<td class="nump">157<span></span>
</td>
<td class="nump">786<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis=psti_GovernmentDebtSecuritiesMember', window );">Government Debentures [Member] | One to Five Years [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Schedule of Available-for-sale Securities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecurities', window );">Fair value</a></td>
<td class="nump">491<span></span>
</td>
<td class="nump">744<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross unrealized gain</a></td>
<td class="nump">23<span></span>
</td>
<td class="nump">27<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross unrealized loss</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_psti_OtherthantemporaryImpairment', window );">Other-than-temporary impairment</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesAmortizedCost', window );">Amortized cost</a></td>
<td class="nump">468<span></span>
</td>
<td class="nump">717<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis=us-gaap_CorporateDebtSecuritiesMember', window );">Corporate Debentures [Member] | Within One Year [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Schedule of Available-for-sale Securities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecurities', window );">Fair value</a></td>
<td class="nump">48<span></span>
</td>
<td class="nump">446<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross unrealized gain</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross unrealized loss</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_psti_OtherthantemporaryImpairment', window );">Other-than-temporary impairment</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesAmortizedCost', window );">Amortized cost</a></td>
<td class="nump">47<span></span>
</td>
<td class="nump">439<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis=us-gaap_CorporateDebtSecuritiesMember', window );">Corporate Debentures [Member] | One to Five Years [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Schedule of Available-for-sale Securities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecurities', window );">Fair value</a></td>
<td class="nump">1,261<span></span>
</td>
<td class="nump">2,450<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross unrealized gain</a></td>
<td class="nump">7<span></span>
</td>
<td class="nump">47<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross unrealized loss</a></td>
<td class="num">(1)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_psti_OtherthantemporaryImpairment', window );">Other-than-temporary impairment</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesAmortizedCost', window );">Amortized cost</a></td>
<td class="nump">1,255<span></span>
</td>
<td class="nump">2,403<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis=us-gaap_CorporateDebtSecuritiesMember', window );">Corporate Debentures [Member] | After Five Years through Ten Years [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Schedule of Available-for-sale Securities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecurities', window );">Fair value</a></td>
<td class="nump">18<span></span>
</td>
<td class="nump">30<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross unrealized gain</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross unrealized loss</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_psti_OtherthantemporaryImpairment', window );">Other-than-temporary impairment</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesAmortizedCost', window );">Amortized cost</a></td>
<td class="nump">$ 17<span></span>
</td>
<td class="nump">$ 29<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_psti_OtherthantemporaryImpairment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Other-than-temporary impairment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">psti_OtherthantemporaryImpairment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>psti_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedGainBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before tax of unrealized gain in accumulated other comprehensive income (AOCI) on investments in equity securities classified as available-for-sale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=82897076&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedGainBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before tax of unrealized loss in accumulated other comprehensive income (AOCI) on investments in equity securities classified as available-for-sale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=82897076&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt and equity securities categorized neither as held-to-maturity nor trading.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 25<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=75030427&amp;loc=d3e22054-111558<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (aa)<br> -URI http://asc.fasb.org/extlink&amp;oid=82897076&amp;loc=d3e27232-111563<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=82896770&amp;loc=d3e26610-111562<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesAmortizedCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This item represents the cost of debt and equity securities, which are categorized neither as held-to-maturity nor trading, net of adjustments including accretion, amortization, collection of cash, previous other-than-temporary impairments recognized in earnings (less any cumulative-effect adjustments recognized, as defined), and fair value hedge accounting adjustments, if any.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesAmortizedCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_psti_MaturityDateRangeAxis=psti_AvailableForSaleSecuritiesMaturesWithinOneYearMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">psti_MaturityDateRangeAxis=psti_AvailableForSaleSecuritiesMaturesWithinOneYearMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_psti_MaturityDateRangeAxis=psti_AvailableForSaleSecuritiesMaturesAfterOneYearThroughFiveYearsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">psti_MaturityDateRangeAxis=psti_AvailableForSaleSecuritiesMaturesAfterOneYearThroughFiveYearsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_psti_MaturityDateRangeAxis=psti_AvailableForSaleSecuritiesMaturesAfterFiveYearsThroughTenYearsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">psti_MaturityDateRangeAxis=psti_AvailableForSaleSecuritiesMaturesAfterFiveYearsThroughTenYearsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis=us-gaap_EquitySecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis=us-gaap_EquitySecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis=psti_GovernmentDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis=psti_GovernmentDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis=us-gaap_CorporateDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis=us-gaap_CorporateDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6753227952">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>MARKETABLE SECURITIES (Schedule of Investments in Unrealized Loss) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Jun. 30, 2017</div></th>
<th class="th"><div>Jun. 30, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesAbstract', window );"><strong>Marketable Securities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue', window );">Less than 12 months, fair value</a></td>
<td class="nump">$ 869<span></span>
</td>
<td class="nump">$ 1,258<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss', window );">Less than 12 months, gross unrealized loss</a></td>
<td class="num">(24)<span></span>
</td>
<td class="num">(143)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValue', window );">12 months or greater, fair value</a></td>
<td class="nump">106<span></span>
</td>
<td class="nump">563<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss', window );">12 months or greater, gross unrealized loss</a></td>
<td class="num">(24)<span></span>
</td>
<td class="num">(65)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestReceivable', window );">Interest receivable</a></td>
<td class="nump">$ 11<span></span>
</td>
<td class="nump">$ 28<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated unrealized loss on investments in debt and equity securities classified as available-for-sale that have been in a continuous loss position for twelve months or longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=82897076&amp;loc=d3e27290-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=82897076&amp;loc=d3e27337-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated unrealized loss on investments in debt and equity securities classified as available-for-sale that have been in a continuous loss position for less than twelve months.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=82897076&amp;loc=d3e27290-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=82897076&amp;loc=d3e27337-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This item represents the aggregate fair value of investments in debt and equity securities categorized neither as held-to-maturity nor trading securities that have been in a continuous unrealized loss position for less than twelve months.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=82897076&amp;loc=d3e27337-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=82897076&amp;loc=d3e27290-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This item represents the aggregate fair value of investments in debt and equity securities categorized neither as held-to-maturity nor trading securities that have been in a continuous unrealized loss position for twelve months or longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=82897076&amp;loc=d3e27290-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=82897076&amp;loc=d3e27337-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of interest earned but not received. Also called accrued interest or accrued interest receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.8)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecuritiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketableSecuritiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6817869552">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>FAIR VALUE OF FINANCIAL INSTRUMENTS (Schedule of Fair Value of Financial Instruments) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Jun. 30, 2017</div></th>
<th class="th"><div>Jun. 30, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesCurrent', window );">Marketable securities</a></td>
<td class="nump">$ 15,164<span></span>
</td>
<td class="nump">$ 17,415<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Measurements, Recurring [Member] | Level 1 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesCurrent', window );">Marketable securities</a></td>
<td class="nump">10,523<span></span>
</td>
<td class="nump">11,228<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet', window );">Foreign currency derivative instruments not designated as hedge instruments</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueNetAssetLiability', window );">Total financial assets</a></td>
<td class="nump">10,523<span></span>
</td>
<td class="nump">11,228<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Measurements, Recurring [Member] | Level 2 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesCurrent', window );">Marketable securities</a></td>
<td class="nump">4,641<span></span>
</td>
<td class="nump">6,187<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet', window );">Foreign currency derivative instruments not designated as hedge instruments</a></td>
<td class="nump">295<span></span>
</td>
<td class="nump">65<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueNetAssetLiability', window );">Total financial assets</a></td>
<td class="nump">$ 4,936<span></span>
</td>
<td class="nump">$ 6,252<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair values as of the balance sheet date of the net amount of all assets and liabilities resulting from contracts that meet the criteria of being accounted for as derivative instruments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=6945355&amp;loc=d3e41228-113958<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueNetAssetLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of asset after deduction of liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueNetAssetLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecuritiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investments in debt and equity securities, including, but not limited to, held-to-maturity, trading and available-for-sale expected to be converted to cash, sold or exchanged within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=82887183&amp;loc=d3e6676-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=82896770&amp;loc=d3e26626-111562<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketableSecuritiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6816666336">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>OTHER CURRENT ASSETS (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Jun. 30, 2017</div></th>
<th class="th"><div>Jun. 30, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract', window );"><strong>Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseCurrent', window );">Prepaid expenses</a></td>
<td class="nump">$ 882<span></span>
</td>
<td class="nump">$ 300<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_psti_AccountsReceivableFromMinistryOfEconomyCurrent', window );">Accounts receivable from the Ministry of Economy</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">23<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue', window );">Derivatives not designated as hedge instruments</a></td>
<td class="nump">295<span></span>
</td>
<td class="nump">65<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValueAddedTaxReceivableCurrent', window );">VAT receivables</a></td>
<td class="nump">137<span></span>
</td>
<td class="nump">167<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherReceivablesNetCurrent', window );">Other receivables</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">63<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsCurrent', window );">Total</a></td>
<td class="nump">$ 1,315<span></span>
</td>
<td class="nump">$ 618<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_psti_AccountsReceivableFromMinistryOfEconomyCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The carrying amount of accounts receivable from the Ministry of Economy due within one year of the balance sheet date (or one operating cycle, if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">psti_AccountsReceivableFromMinistryOfEconomyCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>psti_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value as of the balance sheet date of derivative instrument not designated as hedging instrument and classified as an asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=84234895&amp;loc=SL5624163-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.8)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherReceivablesNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance, of receivables classified as other, due within one year or the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherReceivablesNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=82887183&amp;loc=d3e6787-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 10<br> -Section 05<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=68074540&amp;loc=d3e5879-108316<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=82887183&amp;loc=d3e6676-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValueAddedTaxReceivableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of value added taxes due either from customers arising from sales on credit terms, or as previously overpaid to tax authorities. For classified balance sheets, represents the current amount receivable, that is amounts expected to be collected within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.8)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValueAddedTaxReceivableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6814299056">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>PROPERTY AND EQUIPMENT, NET (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2017</div></th>
<th class="th"><div>Jun. 30, 2016</div></th>
<th class="th"><div>Jun. 30, 2015</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment, cost</a></td>
<td class="nump">$ 16,507<span></span>
</td>
<td class="nump">$ 17,183<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Property and equipment, accumulated depreciation</a></td>
<td class="nump">9,230<span></span>
</td>
<td class="nump">7,967<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="nump">7,277<span></span>
</td>
<td class="nump">9,216<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation</a></td>
<td class="nump">2,177<span></span>
</td>
<td class="nump">2,150<span></span>
</td>
<td class="nump">$ 2,074<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_OtherMachineryAndEquipmentMember', window );">Laboratory equipment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment, cost</a></td>
<td class="nump">6,097<span></span>
</td>
<td class="nump">6,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Property and equipment, accumulated depreciation</a></td>
<td class="nump">4,164<span></span>
</td>
<td class="nump">3,401<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember', window );">Computers and peripheral equipment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment, cost</a></td>
<td class="nump">1,126<span></span>
</td>
<td class="nump">1,024<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Property and equipment, accumulated depreciation</a></td>
<td class="nump">951<span></span>
</td>
<td class="nump">802<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_OfficeEquipmentMember', window );">Office furniture and equipment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment, cost</a></td>
<td class="nump">681<span></span>
</td>
<td class="nump">715<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Property and equipment, accumulated depreciation</a></td>
<td class="nump">416<span></span>
</td>
<td class="nump">353<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember', window );">Leasehold Improvements [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment, cost</a></td>
<td class="nump">8,603<span></span>
</td>
<td class="nump">9,349<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Property and equipment, accumulated depreciation</a></td>
<td class="nump">3,699<span></span>
</td>
<td class="nump">3,374<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_VehiclesMember', window );">Vehicles [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment, cost</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">95<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Property and equipment, accumulated depreciation</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 37<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.14)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Depreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Depreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.13)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_OtherMachineryAndEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_OtherMachineryAndEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_OfficeEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_OfficeEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_VehiclesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_VehiclesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6796757376">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>OTHER ACCOUNTS PAYABLE (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Jun. 30, 2017</div></th>
<th class="th"><div>Jun. 30, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_psti_OtherAccountsPayableAbstract', window );"><strong>OTHER ACCOUNTS PAYABLE [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeRelatedLiabilitiesCurrent', window );">Accrued payroll</a></td>
<td class="nump">$ 505<span></span>
</td>
<td class="nump">$ 421<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_psti_OtherAccountsPayablePayrollInstitutions', window );">Payroll institutions</a></td>
<td class="nump">345<span></span>
</td>
<td class="nump">309<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedVacationCurrent', window );">Accrued vacation</a></td>
<td class="nump">791<span></span>
</td>
<td class="nump">720<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAccruedLiabilitiesCurrent', window );">Other payables</a></td>
<td class="nump">342<span></span>
</td>
<td class="nump">251<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableOtherCurrent', window );">Total</a></td>
<td class="nump">$ 1,983<span></span>
</td>
<td class="nump">$ 1,701<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_psti_OtherAccountsPayableAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Other Accounts Payable [Abstract].</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">psti_OtherAccountsPayableAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>psti_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_psti_OtherAccountsPayablePayrollInstitutions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Other accounts payable related to payroll institutions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">psti_OtherAccountsPayablePayrollInstitutions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>psti_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableOtherCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of obligations incurred classified as other, payable within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=82887183&amp;loc=d3e6935-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableOtherCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedVacationCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable for unused vacation time owed to employees based on the entity's vacation benefit given to its employees. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 710<br> -SubTopic 10<br> -Section 25<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=6409733&amp;loc=d3e19396-108361<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=82887183&amp;loc=d3e6911-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedVacationCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeRelatedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeRelatedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=82887183&amp;loc=d3e7018-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=82887183&amp;loc=d3e6911-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=82887183&amp;loc=d3e6935-107765<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6816707408">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>COMMITMENTS AND CONTINGENCIES (Operating Lease) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">1 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Oct. 31, 2015</div></th>
<th class="th"><div>Jan. 31, 2013</div></th>
<th class="th"><div>Jun. 30, 2017</div></th>
<th class="th"><div>Jun. 30, 2016</div></th>
<th class="th"><div>Jun. 30, 2015</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LandAndBuildingMember', window );">Leased Facilities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasedAssetsLineItems', window );"><strong>Operating Leased Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_psti_OperatingLeasedAssetsParticipationFromLessor', window );">Participation from lessor</a></td>
<td class="nump">$ 947<span></span>
</td>
<td class="nump">$ 816<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GuaranteeObligationsCurrentCarryingValue', window );">Lessor favored bank guarantee</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 399<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesRentExpenseNet', window );">Lease expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">781<span></span>
</td>
<td class="nump">$ 824<span></span>
</td>
<td class="nump">$ 704<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent', window );">Year ending June 30, 2018</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">884<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears', window );">Year ending June 30, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">884<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears', window );">Year ending June 30, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">894<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears', window );">Year ending June 30, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">904<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears', window );">Year ending June 30, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">452<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDue', window );">Total</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,018<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_AutomobilesMember', window );">Automobiles [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasedAssetsLineItems', window );"><strong>Operating Leased Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesRentExpenseNet', window );">Lease expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">233<span></span>
</td>
<td class="nump">$ 210<span></span>
</td>
<td class="nump">$ 218<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent', window );">Year ending June 30, 2018</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">225<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears', window );">Year ending June 30, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">142<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears', window );">Year ending June 30, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">77<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDue', window );">Total</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 444<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_psti_OperatingLeasedAssetsParticipationFromLessor">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Operating Leased Assets, Participation From Lessor.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">psti_OperatingLeasedAssetsParticipationFromLessor</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>psti_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GuaranteeObligationsCurrentCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The current carrying amount of the liability for the freestanding or embedded guarantor's obligations under the guarantee or each group of similar guarantees.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=82913245&amp;loc=d3e12069-110248<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GuaranteeObligationsCurrentCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasedAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasedAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of required minimum rental payments for leases having an initial or remaining non-cancelable letter-terms in excess of one year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 10<br> -Section 55<br> -Paragraph 40<br> -Subparagraph (Note 3)<br> -URI http://asc.fasb.org/extlink&amp;oid=82846649&amp;loc=d3e38371-112697<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=77902758&amp;loc=d3e41502-112717<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesFutureMinimumPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the next fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 10<br> -Section 55<br> -Paragraph 40<br> -Subparagraph (Note 3)<br> -URI http://asc.fasb.org/extlink&amp;oid=82846649&amp;loc=d3e38371-112697<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=77902758&amp;loc=d3e41502-112717<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the fifth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=77902758&amp;loc=d3e41502-112717<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 10<br> -Section 55<br> -Paragraph 40<br> -Subparagraph (Note 3)<br> -URI http://asc.fasb.org/extlink&amp;oid=82846649&amp;loc=d3e38371-112697<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the fourth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=77902758&amp;loc=d3e41502-112717<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 10<br> -Section 55<br> -Paragraph 40<br> -Subparagraph (Note 3)<br> -URI http://asc.fasb.org/extlink&amp;oid=82846649&amp;loc=d3e38371-112697<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the third fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=77902758&amp;loc=d3e41502-112717<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 10<br> -Section 55<br> -Paragraph 40<br> -Subparagraph (Note 3)<br> -URI http://asc.fasb.org/extlink&amp;oid=82846649&amp;loc=d3e38371-112697<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the second fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 10<br> -Section 55<br> -Paragraph 40<br> -Subparagraph (Note 3)<br> -URI http://asc.fasb.org/extlink&amp;oid=82846649&amp;loc=d3e38371-112697<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=77902758&amp;loc=d3e41502-112717<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesRentExpenseNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Rental expense for the reporting period incurred under operating leases, including minimum and any contingent rent expense, net of related sublease income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=77902758&amp;loc=d3e41499-112717<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesRentExpenseNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LandAndBuildingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LandAndBuildingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_AutomobilesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_AutomobilesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6817269488">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>COMMITMENTS AND CONTINGENCIES (Other) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2017</div></th>
<th class="th"><div>Jun. 30, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherCommitmentsLineItems', window );"><strong>Other Commitments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue', window );">Restricted cash and short-term-bank deposits</a></td>
<td class="nump">$ 559<span></span>
</td>
<td class="nump">$ 542<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_psti_AggregateGrantsReceived', window );">Grants received</a></td>
<td class="nump">$ 24,461<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_psti_PercentageOfQualifiedExpenditures', window );">Percentage of qualified expenditures eligible for grant</a></td>
<td class="nump">50.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_psti_RoyaltyRatePayableOnGrantsReceived', window );">Royalty payable based on grants received</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_psti_RoyaltiesAmountPaidAndAccrued', window );">Accrued and paid royalties</a></td>
<td class="nump">$ 166<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RoyaltyGuaranteesCommitmentsAmount', window );">Contingent liability amount</a></td>
<td class="nump">24,295<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=psti_SmartMoneyGrantMember', window );">Smart Money Grant [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherCommitmentsLineItems', window );"><strong>Other Commitments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_psti_AggregateGrantsReceived', window );">Grants received</a></td>
<td class="nump">$ 112<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_psti_RoyaltyRateSales', window );">Royalty rate</a></td>
<td class="nump">5.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_psti_TermOfRoyaltyGrantReceived', window );">Term of royalty grant received</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=psti_BinationalIndustrialResearchAndDevelopmentFoundationMember', window );">BIRD [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherCommitmentsLineItems', window );"><strong>Other Commitments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_psti_AmountOfGrantsReceivedConditionalAward', window );">Amount of grants received conditional award</a></td>
<td class="nump">$ 900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_psti_AmountOfDirectGrantAllocatedToTheCompany', window );">Amount of direct grant allocated to the Company</a></td>
<td class="nump">$ 585<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=psti_NewYorkBloodCenterIncMember', window );">NYBC [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherCommitmentsLineItems', window );"><strong>Other Commitments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_psti_RoyaltyRatePayableOnGrantsReceived', window );">Royalty payable based on grants received</a></td>
<td class="nump">2.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RoyaltyGuaranteesCommitmentsAmount', window );">Contingent liability amount</a></td>
<td class="nump">$ 550<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RangeAxis=us-gaap_MinimumMember', window );">Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherCommitmentsLineItems', window );"><strong>Other Commitments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_psti_RoyaltyRateSales', window );">Royalty rate</a></td>
<td class="nump">3.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RangeAxis=us-gaap_MaximumMember', window );">Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherCommitmentsLineItems', window );"><strong>Other Commitments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_psti_RoyaltyRateSales', window );">Royalty rate</a></td>
<td class="nump">4.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_psti_AggregateGrantsReceived">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate revenue received from grants as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">psti_AggregateGrantsReceived</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>psti_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_psti_AmountOfDirectGrantAllocatedToTheCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of grants awared allocated to Company.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">psti_AmountOfDirectGrantAllocatedToTheCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>psti_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_psti_AmountOfGrantsReceivedConditionalAward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of grants awared received conditional award.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">psti_AmountOfGrantsReceivedConditionalAward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>psti_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_psti_PercentageOfQualifiedExpenditures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage Of Qualified Expenditures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">psti_PercentageOfQualifiedExpenditures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>psti_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_psti_RoyaltiesAmountPaidAndAccrued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of royalty paid or accrued.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">psti_RoyaltiesAmountPaidAndAccrued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>psti_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_psti_RoyaltyRatePayableOnGrantsReceived">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Maximum royalty payable based on a percentage of grants received.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">psti_RoyaltyRatePayableOnGrantsReceived</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>psti_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_psti_RoyaltyRateSales">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Royalty rate payable calculated as a percentage of the sale of products and other related revenues generated from such projects.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">psti_RoyaltyRateSales</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>psti_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_psti_TermOfRoyaltyGrantReceived">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Term of royalty grant received.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">psti_TermOfRoyaltyGrantReceived</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>psti_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherCommitmentsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherCommitmentsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents restricted as to withdrawal or usage, classified as current. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=98513485&amp;loc=SL98516268-108586<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3044-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=82887183&amp;loc=d3e6676-107765<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RoyaltyGuaranteesCommitmentsAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount the entity has committed to make for future royalty guarantees.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 928<br> -SubTopic 440<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6473578&amp;loc=d3e63223-108013<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RoyaltyGuaranteesCommitmentsAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=psti_SmartMoneyGrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=psti_SmartMoneyGrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=psti_BinationalIndustrialResearchAndDevelopmentFoundationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=psti_BinationalIndustrialResearchAndDevelopmentFoundationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=psti_NewYorkBloodCenterIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=psti_NewYorkBloodCenterIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RangeAxis=us-gaap_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RangeAxis=us-gaap_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RangeAxis=us-gaap_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RangeAxis=us-gaap_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6820064384">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCKHOLDERS' EQUITY (Narrative) (Details)<br> $ / shares in Units, &#8362; in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="9">1 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Jan. 25, 2017 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Feb. 29, 2016 </div>
<div>shares</div>
</th>
<th class="th">
<div>Oct. 31, 2015 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>May 31, 2015 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>May 31, 2015 </div>
<div>ILS (&#8362;) </div>
<div>shares</div>
</th>
<th class="th">
<div>Feb. 28, 2015 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Feb. 28, 2015 </div>
<div>ILS (&#8362;) </div>
<div>shares</div>
</th>
<th class="th">
<div>Oct. 31, 2014 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2013 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Jun. 30, 2017 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Jun. 30, 2016 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Jun. 30, 2015 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value per share | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.00001<span></span>
</td>
<td class="nump">$ 0.00001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">200,000,000<span></span>
</td>
<td class="nump">200,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, shares authorized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value per share | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.00001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts', window );">Issuance of common stock and warrants, issuance costs | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,532<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,200<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesPurchaseOfAssets', window );">Issuance of common stock under CHA agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_psti_AvailableForSaleMarketableSecuritiesNumber', window );">CHA shares classified as marketable securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,011,504<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValuePurchaseOfAssets', window );">Issuance of common stock under CHA Agreement (Note 1c) | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,414<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices', window );">Stock-based compensation to contractor, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100,004<span></span>
</td>
<td class="nump">100,004<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of common stock and warrants, net of issuance costs, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,800,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Offering price per unit | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2.50<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Warrants for common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,080,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Proceeds from issuance of stock | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 15,718<span></span>
</td>
<td class="nump">$ 790<span></span>
</td>
<td class="nump">$ 16,914<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_psti_StockIssuedDuringPeriodValuePrivatePlacement', window );">Issuance of common stock in a private placement | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 790<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 586<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 528<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">790<span></span>
</td>
<td class="nump">1,114<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_psti_StockIssuedDuringPeriodSharesPrivatePlacement', window );">Issuance of common stock in a private placement, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">300,000<span></span>
</td>
<td class="nump">300,000<span></span>
</td>
<td class="nump">200,000<span></span>
</td>
<td class="nump">200,000<span></span>
</td>
<td class="nump">200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueIssuedForServices', window );">Stock based compensation to contractor | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 841<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 39<span></span>
</td>
<td class="nump">263<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConstructionInProgressExpendituresIncurredButNotYetPaid', window );">Cash paid to construction contractor | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 774<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceSheetAmount', window );">Unrecorded Unconditional Purchase Obligation | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,032<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionCapitalizedCost', window );">Amount of share-based compensation included in additional paid-in capital and property and equipment | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 302<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=psti_Plan2005Member', window );">2005 Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Options authorized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">19,166,082<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Options available for future grant</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,305,428<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=psti_Plan2016Member', window );">2016 Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Options authorized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,584,147<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Options available for future grant</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">343,327<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=psti_UnderwritingAgreementMember', window );">Underwriting Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrant exercise price | $ / shares</a></td>
<td class="nump">$ 1.40<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Proceeds from issuance of stock | $</a></td>
<td class="nump">$ 15,718<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_psti_NumberOfSharesAgreedToBeSoldThroughUnderwriterAgreement', window );">Number of shares agreed to be sold through Underwriter Agreement</a></td>
<td class="nump">14,081,633<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_psti_NumberOfWarrantsAgreedToBeSoldThroughUnderwriterAgreement', window );">Number of warrants agreed to be sold through Underwriter Agreement</a></td>
<td class="nump">8,448,980<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_psti_GrossProceedsFromIssuanceOfCommonStock', window );">Proceeds from public offering, gross | $</a></td>
<td class="nump">$ 17,250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis=psti_ContractorMember', window );">Contractor [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_psti_ShareBasedGoodsAndNonemployeeServicesTransactionQuantityOfSecuritiesToBeIssued', window );">Stock-based compensation to contractor, shares to be issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">90,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrencyAxis=currency_ILS', window );">Israel, New Shekels [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueIssuedForServices', window );">Stock based compensation to contractor | &#8362;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8362; 3,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherConstructionCosts', window );">Costs paid to construction contractor | &#8362;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8362; 4,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConstructionInProgressExpendituresIncurredButNotYetPaid', window );">Cash paid to construction contractor | &#8362;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8362; 3,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=psti_InvestorWarrantsMember', window );">Investor Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConversionOfStockSharesConverted1', window );">Warrants exercised via cashless exercise</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,081,303<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConversionOfStockSharesIssued1', window );">Warrants exercised via cashless exercise, shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">963,876<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesOther', window );">Warrants exercised for cash</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">170,167<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromWarrantExercises', window );">Aggregate cash consideration received | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 276<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_psti_SharebasedCompensationArrangementWarrantsExercised', window );">Number of warrants exercised</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">170,167<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=us-gaap_WarrantMember', window );">Warrant [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrant exercise price | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2.85<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_psti_ExpirationPeriodOfWarrantsSoldInOffering', window );">Expiration period of warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_psti_AvailableForSaleMarketableSecuritiesNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of equity financial securities classified as available-for-sale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">psti_AvailableForSaleMarketableSecuritiesNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>psti_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_psti_ExpirationPeriodOfWarrantsSoldInOffering">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Expiration period of the warrants sold in the offering.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">psti_ExpirationPeriodOfWarrantsSoldInOffering</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>psti_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_psti_GrossProceedsFromIssuanceOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gross proceeds from the additional capital contribution to the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">psti_GrossProceedsFromIssuanceOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>psti_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_psti_NumberOfSharesAgreedToBeSoldThroughUnderwriterAgreement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares agreed to be sold through Underwriter Agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">psti_NumberOfSharesAgreedToBeSoldThroughUnderwriterAgreement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>psti_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_psti_NumberOfWarrantsAgreedToBeSoldThroughUnderwriterAgreement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of warrants agreed to be sold through Underwriter Agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">psti_NumberOfWarrantsAgreedToBeSoldThroughUnderwriterAgreement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>psti_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_psti_ShareBasedGoodsAndNonemployeeServicesTransactionQuantityOfSecuritiesToBeIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares or units of entity securities to be issued in the transaction in which equity securities will be issued to pay for goods or nonemployee services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">psti_ShareBasedGoodsAndNonemployeeServicesTransactionQuantityOfSecuritiesToBeIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>psti_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_psti_SharebasedCompensationArrangementWarrantsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of warrants exercised during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">psti_SharebasedCompensationArrangementWarrantsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>psti_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_psti_StockIssuedDuringPeriodSharesPrivatePlacement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the number of stock issued during the period under the private placement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">psti_StockIssuedDuringPeriodSharesPrivatePlacement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>psti_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_psti_StockIssuedDuringPeriodValuePrivatePlacement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the equity impact of the value of private placement issued during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">psti_StockIssuedDuringPeriodValuePrivatePlacement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>psti_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in additional paid in capital (APIC) resulting from direct costs associated with issuing stock. Includes, but is not limited to, legal and accounting fees and direct costs associated with stock issues under a shelf registration.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=84159872&amp;loc=d3e21463-112644<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Exercise price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(i)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConstructionInProgressExpendituresIncurredButNotYetPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Future cash outflow to pay for construction in progress expenditures that have occurred.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=98513485&amp;loc=d3e4332-108586<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=98513485&amp;loc=d3e4304-108586<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=98513485&amp;loc=d3e4313-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConstructionInProgressExpendituresIncurredButNotYetPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConversionOfStockSharesConverted1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares converted in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=98513485&amp;loc=d3e4332-108586<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=98513485&amp;loc=d3e4304-108586<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=98513485&amp;loc=d3e4313-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConversionOfStockSharesConverted1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConversionOfStockSharesIssued1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of new shares issued in the conversion of stock in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=98513485&amp;loc=d3e4313-108586<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=98513485&amp;loc=d3e4332-108586<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=98513485&amp;loc=d3e4304-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConversionOfStockSharesIssued1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherConstructionCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Other costs incurred and are directly related to construction and development services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherConstructionCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the additional capital contribution to the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromWarrantExercises">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from holders exercising their stock warrants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromWarrantExercises</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of shares (or other type of equity) originally approved (usually by shareholders and board of directors), net of any subsequent amendments and adjustments, for awards under the equity-based compensation plan. As stock or unit options and equity instruments other than options are awarded to participants, the shares or units remain authorized and become reserved for issuance under outstanding awards (not necessarily vested).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=96867065&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=96867065&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionCapitalizedCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount by which an asset or assets increased resulting from the transaction in which equity securities were issued to pay for goods or nonemployee services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.I)<br> -URI http://asc.fasb.org/extlink&amp;oid=27013229&amp;loc=d3e301413-122809<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=96867065&amp;loc=d3e5070-113901<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 50<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=68057994&amp;loc=d3e25284-112666<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionCapitalizedCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesIssuedPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per share or per unit amount of equity securities issued.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesIssuedPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued in lieu of cash for services contributed to the entity. Number of shares includes, but is not limited to, shares issued for services contributed by vendors and founders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesIssuedForServices</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=84159872&amp;loc=d3e21463-112644<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of stock issued attributable to transactions classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesPurchaseOfAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of stock issued during the period as part of a transaction to acquire assets that do not qualify as a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesPurchaseOfAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueIssuedForServices">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued in lieu of cash for services contributed to the entity. Value of the stock issued includes, but is not limited to, services contributed by vendors and founders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueIssuedForServices</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValuePurchaseOfAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of shares of stock issued during the period as part of a transaction to acquire assets that do not qualify as a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValuePurchaseOfAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceSheetAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the unrecorded obligation to transfer funds in the future for fixed or minimum amounts or quantities of goods or services at fixed or minimum prices (for example, as in take-or-pay contracts or throughput contracts).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=77896938&amp;loc=d3e25336-109308<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceSheetAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=psti_Plan2005Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=psti_Plan2005Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=psti_Plan2016Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=psti_Plan2016Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=psti_UnderwritingAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=psti_UnderwritingAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis=psti_ContractorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis=psti_ContractorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrencyAxis=currency_ILS">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrencyAxis=currency_ILS</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=psti_InvestorWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=psti_InvestorWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=us-gaap_WarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=us-gaap_WarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6805086736">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCKHOLDERS' EQUITY (Summary of Option Activity) (Details) - Employees and Directors [Member]<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Jun. 30, 2017 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward', window );"><strong>Number</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Options outstanding at beginning of period | shares</a></td>
<td class="nump">1,771,700<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Options exercised | shares</a></td>
<td class="num">(16,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod', window );">Options forfeited | shares</a></td>
<td class="num">(940,050)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Options outstanding at end of the period | shares</a></td>
<td class="nump">815,650<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber', window );">Options exercisable at the end of the period | shares</a></td>
<td class="nump">815,650<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber', window );">Options vested at the end of the period | shares</a></td>
<td class="nump">815,650<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract', window );"><strong>Weighted average exercise price</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Options outstanding at beginning of period | $ / shares</a></td>
<td class="nump">$ 3.76<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Options exercised | $ / shares</a></td>
<td class="nump">0.62<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice', window );">Options forfeited | $ / shares</a></td>
<td class="nump">4.49<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Options outstanding at end of the period | $ / shares</a></td>
<td class="nump">2.98<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice', window );">Options exercisable at the end of the period | $ / shares</a></td>
<td class="nump">2.98<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice', window );">Options vested at the end of the period | $ / shares</a></td>
<td class="nump">$ 2.98<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_psti_WeightedAverageRemainingContractualTermsAbstract', window );"><strong>Weighted average remaining contractual term</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Weighted Average Remaining Contractual Terms (in years)</a></td>
<td class="text">9 months 25 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1', window );">Options exercisable at the end of the period</a></td>
<td class="text">9 months 25 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1', window );">Options vested at the end of the period</a></td>
<td class="text">9 months 25 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_psti_AggregateIntrinsicValueAbstract', window );"><strong>Aggregate intrinsic value price</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Options outstanding at end of the period | $</a></td>
<td class="nump">$ 231<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1', window );">Options exercisable at the end of the period | $</a></td>
<td class="nump">231<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue', window );">Options vested at the end of the period | $</a></td>
<td class="nump">$ 231<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_psti_AggregateIntrinsicValueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate Intrinsic Value [Abstract].</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">psti_AggregateIntrinsicValueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>psti_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_psti_WeightedAverageRemainingContractualTermsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted Average Remaining Contractual Terms [Abstract].</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">psti_WeightedAverageRemainingContractualTermsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>psti_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=96867065&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=96867065&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price of options that were either forfeited or expired.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(3)-(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=96867065&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=96867065&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=96867065&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=96867065&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=96867065&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=96867065&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest exercisable or convertible options. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=96867065&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of fully vested and expected to vest options outstanding that can be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=96867065&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=96867065&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which option holders acquired shares when converting their stock options into shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=96867065&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=96867065&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=96867065&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for fully vested and expected to vest exercisable or convertible options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=96867065&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=84159872&amp;loc=d3e21463-112644<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=96867065&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TitleOfIndividualAxis=psti_EmployeesAndDirectorsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TitleOfIndividualAxis=psti_EmployeesAndDirectorsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6804383216">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCKHOLDERS' EQUITY (Summary of Option Activity to Non-employee Consultants) (Details) - Non-employee Consultants [Member]<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Jun. 30, 2017 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward', window );"><strong>Number</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Options outstanding at beginning of period | shares</a></td>
<td class="nump">237,300<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Option granted | shares</a></td>
<td class="nump">46,800<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Options exercised | shares</a></td>
<td class="num">(1,900)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod', window );">Options forfeited | shares</a></td>
<td class="num">(105,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Options outstanding at end of the period | shares</a></td>
<td class="nump">177,200<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber', window );">Options exercisable at the end of the period | shares</a></td>
<td class="nump">164,825<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber', window );">Options vested and expected to vest at the end of the period | shares</a></td>
<td class="nump">177,200<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract', window );"><strong>Weighted average exercise price</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Options outstanding at beginning of period | $ / shares</a></td>
<td class="nump">$ 5.40<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Options granted | $ / shares</a></td>
<td class="nump">0.00<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Options exercised | $ / shares</a></td>
<td class="nump">0.00<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice', window );">Options forfeited | $ / shares</a></td>
<td class="nump">10.98<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Options outstanding at end of the period | $ / shares</a></td>
<td class="nump">0.72<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice', window );">Options exercisable at the end of the period | $ / shares</a></td>
<td class="nump">0.78<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice', window );">Options vested and expected to vest at the end of the period | $ / shares</a></td>
<td class="nump">$ 0.72<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_psti_WeightedAverageRemainingContractualTermsAbstract', window );"><strong>Weighted average remaining contractual term</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Weighted Average Remaining Contractual Terms (in years)</a></td>
<td class="text">4 years 3 months 19 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1', window );">Options exercisable at the end of the period</a></td>
<td class="text">3 years 11 months 1 day<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1', window );">Options vested and expected to vest at the end of the period</a></td>
<td class="text">4 years 3 months 19 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_psti_AggregateIntrinsicValueAbstract', window );"><strong>Aggregate intrinsic value price</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Options outstanding at end of the period | $</a></td>
<td class="nump">$ 179<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1', window );">Options exercisable at the end of the period | $</a></td>
<td class="nump">163<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue', window );">Options vested and expected to vest at the end of the period | $</a></td>
<td class="nump">$ 179<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_psti_AggregateIntrinsicValueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate Intrinsic Value [Abstract].</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">psti_AggregateIntrinsicValueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>psti_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_psti_WeightedAverageRemainingContractualTermsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted Average Remaining Contractual Terms [Abstract].</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">psti_WeightedAverageRemainingContractualTermsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>psti_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=96867065&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=96867065&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price of options that were either forfeited or expired.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(3)-(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=96867065&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=96867065&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=96867065&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=96867065&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=96867065&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=96867065&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest exercisable or convertible options. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=96867065&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of fully vested and expected to vest options outstanding that can be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=96867065&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=96867065&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which option holders acquired shares when converting their stock options into shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=96867065&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=96867065&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=96867065&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for fully vested and expected to vest exercisable or convertible options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=96867065&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=84159872&amp;loc=d3e21463-112644<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=96867065&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TitleOfIndividualAxis=psti_NonemployeesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TitleOfIndividualAxis=psti_NonemployeesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6801737616">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCKHOLDERS' EQUITY (Schedule of Compensation Expense) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2017</div></th>
<th class="th"><div>Jun. 30, 2016</div></th>
<th class="th"><div>Jun. 30, 2015</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Option [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Compensation expenses</a></td>
<td class="nump">$ 46<span></span>
</td>
<td class="nump">$ 24<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Option [Member] | Research and development expenses [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Compensation expenses</a></td>
<td class="nump">7<span></span>
</td>
<td class="nump">22<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Option [Member] | General and administrative expenses [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Compensation expenses</a></td>
<td class="nump">39<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted stock units [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Compensation expenses</a></td>
<td class="nump">3,203<span></span>
</td>
<td class="nump">2,865<span></span>
</td>
<td class="nump">3,746<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized', window );">Unrecognized compensation expense</a></td>
<td class="nump">$ 6,886<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Unrecognized compensation expense, recognition period</a></td>
<td class="text">4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted stock units [Member] | Consultants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Compensation expenses</a></td>
<td class="nump">$ 413<span></span>
</td>
<td class="nump">184<span></span>
</td>
<td class="nump">304<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted stock units [Member] | Research and development expenses [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Compensation expenses</a></td>
<td class="nump">1,558<span></span>
</td>
<td class="nump">960<span></span>
</td>
<td class="nump">1,469<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted stock units [Member] | Research and development expenses [Member] | Consultants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Compensation expenses</a></td>
<td class="nump">19<span></span>
</td>
<td class="nump">39<span></span>
</td>
<td class="nump">131<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted stock units [Member] | General and administrative expenses [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Compensation expenses</a></td>
<td class="nump">1,645<span></span>
</td>
<td class="nump">1,905<span></span>
</td>
<td class="nump">2,277<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted stock units [Member] | General and administrative expenses [Member] | Consultants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Compensation expenses</a></td>
<td class="nump">$ 394<span></span>
</td>
<td class="nump">$ 145<span></span>
</td>
<td class="nump">$ 173<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the expense recognized during the period arising from equity-based compensation arrangements (for example, shares of stock, unit, stock options or other equity instruments) with employees, directors and certain consultants qualifying for treatment as employees.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -URI http://asc.fasb.org/extlink&amp;oid=27013229&amp;loc=d3e301413-122809<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=96867065&amp;loc=d3e5047-113901<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=96867065&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Unrecognized cost of unvested share-based compensation awards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=96867065&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average period over which unrecognized compensation is expected to be recognized for equity-based compensation plans, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=96867065&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis=psti_ConsultantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis=psti_ConsultantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6796098480">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCKHOLDERS' EQUITY (Summary of RSU Activity to Employees and Directors) (Details)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Jun. 30, 2017 </div>
<div>shares</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Unvested at the end of the period</a></td>
<td class="nump">6,107,401<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted stock units [Member] | Employees and Directors [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Unvested at the beginning of period</a></td>
<td class="nump">1,906,619<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted</a></td>
<td class="nump">6,579,435<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod', window );">Forfeited</a></td>
<td class="num">(107,953)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Vested</a></td>
<td class="num">(2,313,200)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Unvested at the end of the period</a></td>
<td class="nump">6,064,901<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_psti_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVest', window );">Expected to vest after June 30, 2017</a></td>
<td class="nump">5,978,114<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_psti_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share based compensation arrangement by share based payment award equity instruments other than options expected to vest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">psti_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>psti_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=96867065&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=96867065&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=96867065&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=96867065&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TitleOfIndividualAxis=psti_EmployeesAndDirectorsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TitleOfIndividualAxis=psti_EmployeesAndDirectorsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6640236000">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCKHOLDERS' EQUITY (Summary of RSU Activity to Consultants) (Details)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Jun. 30, 2017 </div>
<div>shares</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Unvested at the end of the period</a></td>
<td class="nump">6,107,401<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis=psti_ConsultantsMember', window );">Consultants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Unvested at the beginning of period</a></td>
<td class="nump">26,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted</a></td>
<td class="nump">273,557<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Vested</a></td>
<td class="num">(257,057)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Unvested at the end of the period</a></td>
<td class="nump">42,500<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=96867065&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=96867065&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=96867065&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis=psti_ConsultantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis=psti_ConsultantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6820068032">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCKHOLDERS' EQUITY (Summary of Warrants and Options) (Details)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Jun. 30, 2017 </div>
<div>$ / shares </div>
<div>shares</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions', window );">Options and Warrants for Common Stock</a></td>
<td class="nump">16,741,814<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions', window );">Options and Warrants Exercisable</a></td>
<td class="nump">8,280,458<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Restricted stock not included in summary of options and warrants</a></td>
<td class="nump">6,107,401<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Option [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions', window );">Options and Warrants for Common Stock</a></td>
<td class="nump">992,850<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions', window );">Options and Warrants Exercisable</a></td>
<td class="nump">980,475<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Option [Member] | $0.00 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Exercise Price per Share | $ / shares</a></td>
<td class="nump">$ 0.00<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions', window );">Options and Warrants for Common Stock</a></td>
<td class="nump">137,200<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions', window );">Options and Warrants Exercisable</a></td>
<td class="nump">124,825<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Weighted Average Remaining Contractual Terms (in years)</a></td>
<td class="text">5 years 3 months 26 days<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Option [Member] | $0.62 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Exercise Price per Share | $ / shares</a></td>
<td class="nump">$ 0.62<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions', window );">Options and Warrants for Common Stock</a></td>
<td class="nump">345,500<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions', window );">Options and Warrants Exercisable</a></td>
<td class="nump">345,500<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Weighted Average Remaining Contractual Terms (in years)</a></td>
<td class="text">1 year 3 months 11 days<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Option [Member] | $1.04 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Exercise Price per Share | $ / shares</a></td>
<td class="nump">$ 1.04<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions', window );">Options and Warrants for Common Stock</a></td>
<td class="nump">25,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions', window );">Options and Warrants Exercisable</a></td>
<td class="nump">25,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Weighted Average Remaining Contractual Terms (in years)</a></td>
<td class="text">1 year 1 month 27 days<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Option [Member] | $2.97 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Exercise Price per Share | $ / shares</a></td>
<td class="nump">$ 2.97<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions', window );">Options and Warrants for Common Stock</a></td>
<td class="nump">20,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions', window );">Options and Warrants Exercisable</a></td>
<td class="nump">20,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Weighted Average Remaining Contractual Terms (in years)</a></td>
<td class="text">10 months 10 days<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Option [Member] | $3.50 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Exercise Price per Share | $ / shares</a></td>
<td class="nump">$ 3.50<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions', window );">Options and Warrants for Common Stock</a></td>
<td class="nump">30,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions', window );">Options and Warrants Exercisable</a></td>
<td class="nump">30,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Weighted Average Remaining Contractual Terms (in years)</a></td>
<td class="text">1 month 20 days<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Option [Member] | $3.80 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Exercise Price per Share | $ / shares</a></td>
<td class="nump">$ 3.80<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions', window );">Options and Warrants for Common Stock</a></td>
<td class="nump">1,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions', window );">Options and Warrants Exercisable</a></td>
<td class="nump">1,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Weighted Average Remaining Contractual Terms (in years)</a></td>
<td class="text">1 month 20 days<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Option [Member] | $4.38 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Exercise Price per Share | $ / shares</a></td>
<td class="nump">$ 4.38<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions', window );">Options and Warrants for Common Stock</a></td>
<td class="nump">372,500<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions', window );">Options and Warrants Exercisable</a></td>
<td class="nump">372,500<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Weighted Average Remaining Contractual Terms (in years)</a></td>
<td class="text">5 months 20 days<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Option [Member] | $4.40 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Exercise Price per Share | $ / shares</a></td>
<td class="nump">$ 4.40<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions', window );">Options and Warrants for Common Stock</a></td>
<td class="nump">400<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions', window );">Options and Warrants Exercisable</a></td>
<td class="nump">400<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Weighted Average Remaining Contractual Terms (in years)</a></td>
<td class="text">1 month 20 days<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Option [Member] | $6.80 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Exercise Price per Share | $ / shares</a></td>
<td class="nump">$ 6.80<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions', window );">Options and Warrants for Common Stock</a></td>
<td class="nump">36,250<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions', window );">Options and Warrants Exercisable</a></td>
<td class="nump">36,250<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Weighted Average Remaining Contractual Terms (in years)</a></td>
<td class="text">4 months 13 days<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Option [Member] | $8.20 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Exercise Price per Share | $ / shares</a></td>
<td class="nump">$ 8.20<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions', window );">Options and Warrants for Common Stock</a></td>
<td class="nump">20,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions', window );">Options and Warrants Exercisable</a></td>
<td class="nump">20,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Weighted Average Remaining Contractual Terms (in years)</a></td>
<td class="text">1 month 27 days<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Option [Member] | $20.00 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Exercise Price per Share | $ / shares</a></td>
<td class="nump">$ 20.00<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions', window );">Options and Warrants for Common Stock</a></td>
<td class="nump">5,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions', window );">Options and Warrants Exercisable</a></td>
<td class="nump">5,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Weighted Average Remaining Contractual Terms (in years)</a></td>
<td class="text">2 years 7 months 13 days<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=us-gaap_WarrantMember', window );">Warrant [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions', window );">Options and Warrants for Common Stock</a></td>
<td class="nump">15,748,964<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions', window );">Options and Warrants Exercisable</a></td>
<td class="nump">7,299,983<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=us-gaap_WarrantMember', window );">Warrant [Member] | $1.4 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Exercise Price per Share | $ / shares</a></td>
<td class="nump">$ 1.40<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions', window );">Options and Warrants for Common Stock</a></td>
<td class="nump">8,448,981<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions', window );">Options and Warrants Exercisable</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Weighted Average Remaining Contractual Terms (in years)</a></td>
<td class="text">5 years 22 days<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=us-gaap_WarrantMember', window );">Warrant [Member] | $2.85 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Exercise Price per Share | $ / shares</a></td>
<td class="nump">$ 2.85<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions', window );">Options and Warrants for Common Stock</a></td>
<td class="nump">4,080,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions', window );">Options and Warrants Exercisable</a></td>
<td class="nump">4,080,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Weighted Average Remaining Contractual Terms (in years)</a></td>
<td class="text">3 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=us-gaap_WarrantMember', window );">Warrant [Member] | $5.00 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Exercise Price per Share | $ / shares</a></td>
<td class="nump">$ 5.00<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions', window );">Options and Warrants for Common Stock</a></td>
<td class="nump">3,219,983<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions', window );">Options and Warrants Exercisable</a></td>
<td class="nump">3,219,983<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Weighted Average Remaining Contractual Terms (in years)</a></td>
<td class="text">2 months 19 days<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=96867065&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=96867065&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares reserved for issuance pertaining to the outstanding exercisable stock options as of the balance sheet date in the customized range of exercise prices for which the market and performance vesting condition has been satisfied.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=96867065&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares reserved for issuance pertaining to the outstanding stock options as of the balance sheet date for all option plans in the customized range of exercise prices.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=96867065&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=96867065&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=psti_ExercisePriceRangeFourMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=psti_ExercisePriceRangeFourMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=psti_ExercisePriceRangeFiveMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=psti_ExercisePriceRangeFiveMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=psti_ExercisePriceRangeSixMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=psti_ExercisePriceRangeSixMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=psti_ExercisePriceRangeSevenMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=psti_ExercisePriceRangeSevenMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=psti_ExercisePriceRangeEightMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=psti_ExercisePriceRangeEightMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=psti_ExercisePriceRangeNineMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=psti_ExercisePriceRangeNineMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=psti_ExercisePriceRangeTenMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=psti_ExercisePriceRangeTenMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=psti_ExercisePriceRangeElevenMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=psti_ExercisePriceRangeElevenMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=psti_ExercisePriceRangeTwelveMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=psti_ExercisePriceRangeTwelveMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=psti_ExercisePriceRangeThirteenMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=psti_ExercisePriceRangeThirteenMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=psti_ExercisePriceRangeFourteenMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=psti_ExercisePriceRangeFourteenMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=us-gaap_WarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=us-gaap_WarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=psti_ExercisePriceRangeOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=psti_ExercisePriceRangeOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=psti_ExercisePriceRangeTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=psti_ExercisePriceRangeTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=psti_ExercisePriceRangeThreeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=psti_ExercisePriceRangeThreeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6791710800">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FINANCIAL INCOME, NET (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2017</div></th>
<th class="th"><div>Jun. 30, 2016</div></th>
<th class="th"><div>Jun. 30, 2015</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherIncomeAndExpensesAbstract', window );"><strong>Other Income and Expenses [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax', window );">Foreign currency translation differences, net</a></td>
<td class="nump">$ 182<span></span>
</td>
<td class="num">$ (174)<span></span>
</td>
<td class="num">$ (1,109)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_psti_InterestOnShortTermBankCreditAndBankExpenses', window );">Bank and broker commissions</a></td>
<td class="num">(67)<span></span>
</td>
<td class="num">(85)<span></span>
</td>
<td class="num">(37)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestIncomeDepositsWithFinancialInstitutions', window );">Interest income on deposits</a></td>
<td class="nump">122<span></span>
</td>
<td class="nump">149<span></span>
</td>
<td class="nump">112<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesGainLoss', window );">Gain (loss) related to marketable securities, net</a></td>
<td class="num">(513)<span></span>
</td>
<td class="nump">190<span></span>
</td>
<td class="nump">1,229<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnDerivativeInstrumentsNetPretax', window );">Gain (loss) from derivatives and fair value hedge derivatives</a></td>
<td class="nump">481<span></span>
</td>
<td class="num">(30)<span></span>
</td>
<td class="nump">395<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncome', window );">Other financial income</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">23<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpense', window );">Financial income, net</a></td>
<td class="nump">$ 205<span></span>
</td>
<td class="nump">$ 73<span></span>
</td>
<td class="nump">$ 590<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_psti_InterestOnShortTermBankCreditAndBankExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Interest on short-term bank credit and bank expenses.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">psti_InterestOnShortTermBankCreditAndBankExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>psti_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before tax of foreign currency transaction realized and unrealized gain (loss) recognized in the income statement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450222&amp;loc=d3e30840-110895<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=64836518&amp;loc=d3e30700-110894<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=64836518&amp;loc=d3e30690-110894<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyTransactionGainLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnDerivativeInstrumentsNetPretax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate net gain (loss) on all derivative instruments recognized in earnings during the period, before tax effects.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84234895&amp;loc=SL5618551-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnDerivativeInstrumentsNetPretax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestIncomeDepositsWithFinancialInstitutions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Interest income derived from funds deposited with both domestic and foreign financial institutions including funds in money market and other accounts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=6879574&amp;loc=d3e536633-122882<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestIncomeDepositsWithFinancialInstitutions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecuritiesGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This item represents the net total realized and unrealized gain (loss) included in earnings for the period as a result of selling or holding marketable securities categorized as trading, available-for-sale, or held-to-maturity, including the unrealized holding gain (loss) of held-to-maturity securities transferred to the trading security category and the cumulative unrealized gain (loss) which was included in other comprehensive income (a separate component of shareholders' equity) for available-for-sale securities transferred to trading securities during the period. Additionally, this item would include any losses recognized for other than temporary impairments (OTTI) of the subject investments in debt and equity securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a),(c)-(e)<br> -URI http://asc.fasb.org/extlink&amp;oid=82897076&amp;loc=d3e27357-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=82897076&amp;loc=d3e27405-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketableSecuritiesGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherIncomeAndExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherIncomeAndExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6798947360">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>TAXES ON INCOME (Narrative) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2017</div></th>
<th class="th"><div>Jun. 30, 2016</div></th>
<th class="th"><div>Jun. 30, 2015</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate', window );">Statutory tax rate</a></td>
<td class="nump">24.00%<span></span>
</td>
<td class="nump">25.00%<span></span>
</td>
<td class="nump">26.50%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations', window );">Effective income tax rate</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total consolidated revenues of its parent company and all subsidiaries</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 2,847<span></span>
</td>
<td class="nump">$ 379<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_psti_CorporateStatutoryTaxRateOn2018AndThereafter', window );">Corporate statutory tax rate on 2018 and thereafter</a></td>
<td class="nump">23.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_InternalRevenueServiceIRSMember', window );">Internal Revenue Service (IRS) [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Net operating loss carryforwards</a></td>
<td class="nump">$ 32,519<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_InternalRevenueServiceIRSMember', window );">Internal Revenue Service (IRS) [Member] | Earliest Tax Year [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsExpirationDate', window );">Net federal operating loss carry forward expiration date</a></td>
<td class="text">Dec. 31,  2024<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_InternalRevenueServiceIRSMember', window );">Internal Revenue Service (IRS) [Member] | Latest Tax Year [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsExpirationDate', window );">Net federal operating loss carry forward expiration date</a></td>
<td class="text">Dec. 31,  2037<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_IsraelTaxAuthorityMember', window );">Israel Tax Authority [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Net operating loss carryforwards</a></td>
<td class="nump">$ 109,480<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=psti_TechnologicalPreferredEnterpriseMember', window );">Technological Preferred Enterprise [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_psti_CorporateStatutoryTaxRateOn2017AndThereafter', window );">Corporate statutory tax rate on 2017 and thereafter</a></td>
<td class="nump">12.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=psti_TechnologicalPreferredEnterpriseMember', window );">Technological Preferred Enterprise [Member] | Development Area A [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_psti_CorporateStatutoryTaxRateOn2017AndThereafter', window );">Corporate statutory tax rate on 2017 and thereafter</a></td>
<td class="nump">7.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=psti_TechnologicalEnterpriseMember', window );">Technological Enterprise [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_psti_CorporateStatutoryTaxRateForDividendsDistributedToForeignCompanies', window );">Corporate statutory tax rate for dividends distributed to foreign companies</a></td>
<td class="nump">4.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=psti_SpecialTechnologicalPreferredEnterpriseMember', window );">Special Technological Preferred Enterprise [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_psti_CorporateStatutoryTaxRateOnProfitsDerivingFromIntellectualProperty', window );">Corporate statutory tax rate on profits deriving from intellectual property</a></td>
<td class="nump">6.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=psti_PreferredEnterpriseMember', window );">Preferred Enterprise [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_psti_CorporateStatutoryTaxRateForDividendsDistributedToIndividualsOrForeignResidentsDistributedFromPreferredEnterpriseProfits', window );">Corporate statutory tax rate for any dividends distributed to individuals or foreign residents from the preferred enterprise's earnings</a></td>
<td class="nump">20.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=psti_PreferredEnterpriseMember', window );">Preferred Enterprise [Member] | Development Area A [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_psti_CorporateStatutoryTaxRateOn2017AndThereafter', window );">Corporate statutory tax rate on 2017 and thereafter</a></td>
<td class="nump">7.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_psti_CorporateStatutoryTaxRateOn2016', window );">Corporate statutory tax rate on 2016</a></td>
<td class="nump">9.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=psti_PreferredEnterpriseMember', window );">Preferred Enterprise [Member] | Rest Of Country [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_psti_CorporateStatutoryTaxRateOn2016AndThereafter', window );">Corporate statutory tax rate on 2016 and thereafter</a></td>
<td class="nump">16.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RangeAxis=us-gaap_MaximumMember', window );">Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate', window );">Statutory tax rate</a></td>
<td class="nump">35.00%<span></span>
</td>
<td class="nump">35.00%<span></span>
</td>
<td class="nump">35.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RangeAxis=us-gaap_MinimumMember', window );">Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate', window );">Statutory tax rate</a></td>
<td class="nump">24.00%<span></span>
</td>
<td class="nump">24.00%<span></span>
</td>
<td class="nump">24.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_psti_CorporateStatutoryTaxRateForDividendsDistributedToForeignCompanies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Corporate statutory tax rate for dividends distributed to foreign companies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">psti_CorporateStatutoryTaxRateForDividendsDistributedToForeignCompanies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>psti_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_psti_CorporateStatutoryTaxRateForDividendsDistributedToIndividualsOrForeignResidentsDistributedFromPreferredEnterpriseProfits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Corporate statutory tax rate for any dividends distributed to individuals or foreign residents from the preferred enterprise's earnings.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">psti_CorporateStatutoryTaxRateForDividendsDistributedToIndividualsOrForeignResidentsDistributedFromPreferredEnterpriseProfits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>psti_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_psti_CorporateStatutoryTaxRateOn2016">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Corporate statutory tax rate on 2016.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">psti_CorporateStatutoryTaxRateOn2016</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>psti_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_psti_CorporateStatutoryTaxRateOn2016AndThereafter">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Corporate statutory tax rate on 2016 and thereafter.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">psti_CorporateStatutoryTaxRateOn2016AndThereafter</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>psti_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_psti_CorporateStatutoryTaxRateOn2017AndThereafter">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Corporate statutory tax rate on 2017 and thereafter.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">psti_CorporateStatutoryTaxRateOn2017AndThereafter</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>psti_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_psti_CorporateStatutoryTaxRateOn2018AndThereafter">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Corporate statutory tax rate on 2018 and thereafter.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">psti_CorporateStatutoryTaxRateOn2018AndThereafter</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>psti_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_psti_CorporateStatutoryTaxRateOnProfitsDerivingFromIntellectualProperty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Corporate statutory tax rate on profits deriving from intellectual property for an enterprise which total consolidated revenues of its parent company and all subsidiaries exceed NIS 10 billion.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">psti_CorporateStatutoryTaxRateOnProfitsDerivingFromIntellectualProperty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>psti_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32698-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(h)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of domestic federal statutory tax rate applicable to pretax income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I)<br> -URI http://asc.fasb.org/extlink&amp;oid=34349781&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32698-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32559-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLossCarryforwardsExpirationDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Expiration date of each operating loss carryforward included in operating loss carryforward, in CCYY-MM-DD format.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32559-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLossCarryforwardsExpirationDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_InternalRevenueServiceIRSMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_InternalRevenueServiceIRSMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxPeriodAxis=us-gaap_EarliestTaxYearMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxPeriodAxis=us-gaap_EarliestTaxYearMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxPeriodAxis=us-gaap_LatestTaxYearMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxPeriodAxis=us-gaap_LatestTaxYearMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_IsraelTaxAuthorityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_IsraelTaxAuthorityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=psti_TechnologicalPreferredEnterpriseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=psti_TechnologicalPreferredEnterpriseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementGeographicalAxis=psti_DevelopmentAreaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementGeographicalAxis=psti_DevelopmentAreaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=psti_TechnologicalEnterpriseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=psti_TechnologicalEnterpriseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=psti_SpecialTechnologicalPreferredEnterpriseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=psti_SpecialTechnologicalPreferredEnterpriseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=psti_PreferredEnterpriseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=psti_PreferredEnterpriseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementGeographicalAxis=psti_RestOfCountryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementGeographicalAxis=psti_RestOfCountryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RangeAxis=us-gaap_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RangeAxis=us-gaap_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RangeAxis=us-gaap_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RangeAxis=us-gaap_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6816070464">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>TAXES ON INCOME (Schedule of Significant Components of Deferred Tax Assets) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Jun. 30, 2017</div></th>
<th class="th"><div>Jun. 30, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic', window );">U.S. net operating loss carryforward</a></td>
<td class="nump">$ 11,382<span></span>
</td>
<td class="nump">$ 10,210<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign', window );">Israeli net operating loss carryforward</a></td>
<td class="nump">26,275<span></span>
</td>
<td class="nump">22,105<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals', window );">Allowances and reserves</a></td>
<td class="nump">222<span></span>
</td>
<td class="nump">216<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsGross', window );">Total deferred tax assets before valuation allowance</a></td>
<td class="nump">37,879<span></span>
</td>
<td class="nump">32,531<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowance', window );">Valuation allowance</a></td>
<td class="num">(37,879)<span></span>
</td>
<td class="num">(32,531)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsNet', window );">Net deferred tax asset</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b),(c)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible domestic operating loss carryforwards. Excludes state and local operating loss carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32621-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 25<br> -Paragraph 20<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=96869850&amp;loc=d3e28680-109314<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32632-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible foreign operating loss carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32621-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32632-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 25<br> -Paragraph 20<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=96869850&amp;loc=d3e28680-109314<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from reserves and accruals.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32621-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32632-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 25<br> -Paragraph 20<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=96869850&amp;loc=d3e28680-109314<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6804930704">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUBSEQUENT EVENTS (Narrative) (Details) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">2 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 05, 2017</div></th>
<th class="th"><div>Sep. 05, 2017</div></th>
<th class="th"><div>Jun. 30, 2015</div></th>
<th class="th"><div>Jul. 31, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Stock issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Equity issuance, price per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Equity issuance, price per share</a></td>
<td class="nump">$ 1.20<span></span>
</td>
<td class="nump">$ 1.20<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_psti_TotalNondilutiveGrantAwardedFromHorizon2020Program', window );">Total non-dilutive grants awarded under the European Union's Horizon 2020 program</a></td>
<td class="nump">$ 8,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_psti_AmountOfDirectGrantsAwardedAllocatedToCompany', window );">Amount of direct grants awarded allocated to Company</a></td>
<td class="nump">2,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | Euro [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_psti_TotalNondilutiveGrantAwardedFromHorizon2020Program', window );">Total non-dilutive grants awarded under the European Union's Horizon 2020 program</a></td>
<td class="nump">7,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_psti_AmountOfDirectGrantsAwardedAllocatedToCompany', window );">Amount of direct grants awarded allocated to Company</a></td>
<td class="nump">$ 2,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | ATM Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_psti_ValueOfCommonStockCompanyCanPeriodicallyIssueThroughAgentsPerTermsOfAtmAgreement', window );">Value of common stock company can periodically issue through Agents, per terms of ATM Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 80,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Stock issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">455,731<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | Smart Money Grant [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GrantsReceivable', window );">Additonal grant awarded</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 229<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_psti_AmountOfDirectGrantsAwardedAllocatedToCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of direct grants awarded allocated to Company.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">psti_AmountOfDirectGrantsAwardedAllocatedToCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>psti_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_psti_TotalNondilutiveGrantAwardedFromHorizon2020Program">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total non-dilutive grants awarded under the European Union's Horizon 2020 program.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">psti_TotalNondilutiveGrantAwardedFromHorizon2020Program</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>psti_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_psti_ValueOfCommonStockCompanyCanPeriodicallyIssueThroughAgentsPerTermsOfAtmAgreement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of common stock company can periodically issue through Agents, per terms of ATM Agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">psti_ValueOfCommonStockCompanyCanPeriodicallyIssueThroughAgentsPerTermsOfAtmAgreement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>psti_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GrantsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of amounts due under the terms of governmental, corporate, or foundation grants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.8)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GrantsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesIssuedPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per share or per unit amount of equity securities issued.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesIssuedPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=84159872&amp;loc=d3e21463-112644<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrencyAxis=currency_EUR">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrencyAxis=currency_EUR</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAxis=psti_AtMarketIssuanceSalesAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAxis=psti_AtMarketIssuanceSalesAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=psti_SmartMoneyGrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=psti_SmartMoneyGrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>75
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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MMWF\81AU8\K(XK%T-8943OTJDH\ Q:X831F:3LTXXFBD(3^ G/,6+V2?$9/
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MZP^_F[#KC#W8?VQ\%6QJ^'47S1=02P,$%     @ 38$G2YE<G",0!@  G"<
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M.AQG0GS/]O:1I24RS^_Y"NM./&<?5I:P7<_/Y)Z,<B.[W?98??9/1VXCUZG
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M4D\C->=#=Q@6DG5CX\-3]\W_ 5!+ P04    " !-@2=+6C?I834#  #=#
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M]GWBWEIG/"B[]8A'_ZUQ'91F[[K;U-\W0\,]#)P]C1\3T?6+9O4/4$L#!!0
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MQ^1+UYOK4*XN/[;AI>V_IMWW^G1D>OK15H?S<?#T<B8]_P]02P,$%     @
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M2-:=3DFD7J>JDU;IU&G;9RYQ$E2(,R"7]M\/2)IE6[0O@(W?\[,QV8CFQ;8
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M/1RS$!\#'CF,=G5&H9*SUL_!^%87. F"0$#E @/SVP7N0(A Y&7\GCGQDC(
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M\R\;^U\C.O!2DBL_0JW_8(NAH';A>.O/9AJSR7#8SS^(+=^X^ 502P,$%
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M:&5E=#(R+GAM;&U4;6_;(!#^*X@?4!(2+U5D6VHZ59VT25&G;9^)?;91>?$
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MX >;#0F5#\=O>+;CF(V&-]WT@]C\C?/_4$L#!!0    ( $V!)TM$FT>\MP$
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M_P5NH! >,L$8A5$NKJ3HG3=Z4L%4M'@;=]G&?1AO#H>)MD[@$X'/A&.,P\9
M,?,GX46>6C,0._:^$^&)MR>.O2F",[8BWF'R#KVWG.^3E-V"T(0YCQB^P&QG
M!$/U.01?"W'F_]'Y.GVWFN$NTG?+Z,?]ND"R*I!$@>2?$N\_E+B&^1B$+7JJ
MP=9QFAPI3-_&25YXYX%]X/%-_L+':?\J;"U;1Z[&X\O&_E?&>,!4-G<X0@U^
ML-E04/EP/.#9CF,V&MYTTP]B\S?._P!02P,$%     @ 38$G2[66_/&W 0
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M@Y0&;"[1@_W#I7U&C L!!^.F2SM7?2_M%T:VPSN!C(^5_!]02P,$%     @
M38$G2W]L^1VY 0  T@,  !D   !X;"]W;W)K<VAE971S+W-H965T,S N>&UL
M;5/;;MP@$/T5Q <$+^NDNRO;4C95E$J)M$K5])FUQS8*%P?P.OW[ G9<-_$+
M,,,Y9RX,V:#-JVT!''J70MD<M\YU!T)LV8)D]DIWH/Q-K8UDSINF(;8SP*I(
MDH+0)+DADG&%BRSZ3J;(=.\$5W RR/92,O/G"$(/.=[@#\<S;UH7'*3(.M;
M3W"_NI/Q%IE5*BY!6:X5,E#G^'9S.*8!'P$O' :[.*-0R5GKUV#\J'*<A(1
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M2Z9R(.1=3KX=U[8K(T(895Q*0'&[HAW"6"J)./YH4;OSE,3^^*;^124ODCE
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MP7- X2QU-U%]/CY$8R!9/[VQ:'[H\[]02P,$%     @ 38$G2_)I^W-6 @
M(P@  !D   !X;"]W;W)K<VAE971S+W-H965T,S@N>&ULC5;;CILP$/T5Q >L
ML;F$1 2IFZIJI5:*MFK[["23@-9@:CMA^_>U#4$$G-V\Q!?.',X9QN-D+1>O
ML@!0WEO%:KGV"Z6:%4)R7T!%Y1-OH-9/CEQ45.FE."'9"* '&U0Q1((@014M
M:S_/[-Y6Y!D_*U;6L!6>/%<5%?^>@?%V[6/_NO%2G@IE-E">-?0$/T']:K9"
MK]# <B@KJ&7):T_ <>U_PJL-#DV 1?PNH96CN6>L[#A_-8MOA[4?&$7 8*\,
M!=7#!3; F&'2.O[VI/[P3A,XGE_9OUCSVLR.2MAP]J<\J&+MI[YW@",],_7"
MVZ_0&XI]KW?_'2[ --PHT>_8<R;MK[<_2\6KGD5+J>A;-Y:U'=N>_QKF#B!]
M !D"</1N0-@'A), U"FS5C]31?-,\-83W==JJ"D*O IU,O=FT^;./M-NI=Z]
MY&$:9^ABB'K,<X<A(PRY16SFB# 8($@+&%00IPIBX\,;%8F;('02A)8@&A-,
M7720Q$)J"\$Q3J*)$P=J$>'8K25R:HGF6M*%FR!V$L2/9R-Q$B0?9Z.#Q&.?
M04S"238<*$Q(ZM:R<&I9.+*13L3,,='TN[P+N9&1.F6D#AG+B8STH9PX4/=S
MLG2*6<[%+.^<%QRXCVWP>(W@.R<??UPE/69L-DHB/#W]<U2"[Y4\=G< 3!ZH
MDQXT?A%9QE,U<U!RY_QB=S/!CFXR*Q8\[Q31,DRF8N:HA,1D(@>-NK6Y/G]0
M<2IKZ>VXTHW?MN<CYPHT8_"DC17ZQAX6#([*3!=Z+KIKJULHWO17,AK^%^3_
M 5!+ P04    " !-@2=+F:(_M!X"  !X!@  &0   'AL+W=O<FMS:&5E=',O
M<VAE970S.2YX;6Q]E>UNFS 4AF\%<0$U8+X:$:0ET[1)FQ1U6O?;24X"JL',
M=D)W][,-1=1V]P=_O><]S\'&5"/C+Z(!D,%K1WNQ#1LIAPU"XM1 1\0#&Z!7
M*Q?&.R+5D%^1&#B0LPGJ*$JB*$<=:?NPKLS<@=<5NTG:]G#@@;AU'>%_=T#9
MN WC\&WBJ;TV4D^@NAK(%7Z"_#4<N!JAQ>7<=M"+EO4!A\LV_!1O]J76&\%S
M"Z-8]0-=R9&Q%SWX=MZ&D08""B>I'8AJ[K '2K61PO@S>X9+2AVX[K^Y?S&U
MJUJ.1,">T=_M63;;L R#,US(C<HG-GZ%N9XL#.;BO\,=J))K$I7CQ*@PS^!T
M$Y)ULXM"Z<CKU+:]:<=II2CF,'] ,@<D2T"<_C< SP'8"D 3F2GU,Y&DKC@;
M SYMUD#TF8@W6+W,DYXT[\ZLJ6J%FKW7^#&NT%T;S9K=I$E6FN2]8N\J<+1(
MD )8*!(O16+B\2H^+G._ ?8:8&.0OBO#@MQ-FMQH>J,I2[L05X.C#RI)O2"I
M!P1;(*XF32V.29*M.!+LQ\B\&)D'P\JQR]P<CYG%X6KRS,^1>SER#X>58Y<[
M.6)<6!P>35[X00HO2.$!R2V0PDUB8;B*_(-M*;T4I4,11_8Q+9TC&./8WA=7
ME,>E18)6=X"^DW\0?FU[$1R95->)^>@OC$E0?M&#JJE1OX%E0.$B=;=0?3Y=
MAM- LF&^Y]'RLZG_ 5!+ P04    " !-@2=++7#RPEH#  "B#@  &0   'AL
M+W=O<FMS:&5E=',O<VAE970T,"YX;6R55]MNVS ,_17#'U!+E'PKD@!-BF$#
M-J#HL.W9393$J&UEMM)T?S_Y4M>1J,)]B2WYD#PBI1-J<9'U<W,40GFO95$U
M2_^HU.DV")KM4919<R-/HM)?]K(N,Z6']2%H3K7(=IU1601 2!2465[YJT4W
M]U"O%O*LBKP2#[77G,LRJ_^M12$O2Y_Z;Q./^>&HVHE@M3AE!_%3J%^GAUJ/
M@M'++B]%U>2R\FJQ7_IW]/8>XM:@0_S.Q:69O'OM4IZD?&X'WW9+G[2,1"&V
MJG61Z<>+V(BB:#UI'G\'I_X8LS6<OK]Y_](M7B_F*6O$1A9_\ITZ+OW$]W9B
MGYT+]2@O7\6PH-#WAM5_%R^BT/"6B8ZQE473_7K;<Z-D.7C15,KLM7_F5?>\
M]%\B-ICA!C 8P&A HP\-V&# W@WXAP9\,."&0= OI<O-?::RU:*6%Z_NRWO*
MVEU$;[G._K:=[)+=?=/I:?3LRXJE\2)X:1T-F'6/@0F&CHA >Q]# !9B#98Y
M7 ?8V A&KB'W-B1VD&#H.EEGSZ8A.,,=<-0![QSPJT0E1J)Z3-1AJCY144B,
M=&X05$P3!YD0)1,B9%*#3(\))V%2,-.ZL4%Q&L4XE0BE$EE4N%'>=60'@=C,
MB@U*@48XDQAE$EM,*.,&E=B* M2B@H%"<T/&5A6!Q!SGFZ!\$SMSA. .4M1!
M.G]/4X*??C)C5P^@:3XB8HK$!D6YUD,=8D1G[.L!- W$:<1-.C:*<>*0#(H*
MUQT%FPY/'"YPV:&?T!V*"P^=HSP#:+I<2B$RDX*@"#@V+<6EA\[1'HJ(3TA-
M-C8H(> @@XL/M=6'A:X]AZL&C3]1(?P@4_LD(Q5*[/.16"FQ03$-'61P4:#I
MG/JDV!DRR=@@%CHR [B^ *(OH:/$@&L"T/GU ?P< W*.K?H,H*O=&!%FY 1!
MI8RG#CJX)@";4:$!=)7\R$1M,!1S_0L!KB^ Z$OH:O!P38#P$S7"3S(@)]FN
M$=)LF,(/2"/A.$& *P+8C012'QMD4[%[!&;V5L&D42]%?>@N08VWE>=*M?WN
M9':\:-U!V^@;\VM] >NO2^]N^MO;CZP^Y%7C/4FEKQ%=L[^74@E-D=SH/!WU
MA7$<%&*OVM=8O]?]K:D?*'D:;H3!>"U=_0=02P,$%     @ 38$G2\H#UUH-
M @  ]@4  !D   !X;"]W;W)K<VAE971S+W-H965T-#$N>&UL?93M;ILP%(9O
M!7$!-9BO)")(#=6T29L4=5KWVTD. =5@9CNAN_O9AB)JW/W!7^\Y?EX?['Q@
M_%74 -)[:VDG]GXM9;]#2)QK:(EX8#UT:J5BO"52#?D5B9X#N9B@EB(<!"EJ
M2=/Y16[FCKS(V4W2IH,C]\2M;0G_>P#*AKT?^N\3S\VUEGH"%7E/KO 3Y*_^
MR-4(S5DN30N=:%CG<:CV_F.X*S.M-X*7!@:QZ'O:R8FQ5SWX=MG[@08""F>I
M,Q#5W*$$2G4BA?%GRNG/6^K 9?\]^Q?C77DY$0$EH[^;BZSW_L;W+E"1&Y7/
M;/@*DY_$]R;SW^$.5,DUB=KCS*@P7^]\$Y*U4Q:%TI*WL6TZTP[C2K*9PMP!
M> K <T 8_S<@F@(B*P"-9,;J$Y&DR#D;/#X6JR?ZGPAWD3K,LYXT9V?6E%NA
M9N]%'(0YNNM$D^8P:O!"@S\JRK4B"F8)4@ S!7928!,?+>+#+78GB)P)(I,@
M_F##@CR,FM1H.J-)@L0RLM;$.'2#Q$Z0V $262"C)EEL$L4VB$,3;-T@B1,D
M<8#$%DBRVB3;6L4O'1K\26U3)TCJ +'<'E+'B=C_V%J#DT]*DSE!LA5(N/I'
MLE7]P^W&JE_I$&6!C8(6-U"_B#\(OS:=\$Y,JLMLKES%F 25,'A0KFKU",\#
M"I74W4SU^?@4C0/)^NF51?-37_P#4$L#!!0    ( $V!)TLT"O@2#0,  #(,
M   9    >&PO=V]R:W-H965T<R]S:&5E=#0R+GAM;(U7[6Z;,!1]%<0#%-N8
MKRB)U"2--FF3JD[=?M/$25 !,W"2[NUG&Y<2^U+U3\#FG'ON]<?1S?S*V]?N
MQ)CPWJJR[A;^28AF%@3=[L2JO+OC#:OEEP-OJUS(87L,NJ9E^5Z3JC(@",5!
ME1>UOYSKN<=V.>=G418U>VR][EQ5>?MOQ4I^7?C8?Y]X*HXGH2:"Y;S)C^P7
M$\_-8RM'P1!E7U2L[@I>>RT[+/Q[/-L2I @:\;M@UV[T[JE27CA_58/O^X6/
M5$:L9#NA0N3R<6%K5I8JDLSCKPGJ#YJ*.'Y_C[[5Q<MB7O*.K7GYI]B+T\)/
M?6_/#OFY%$_\^HV9@B+?,]7_8!=62KC*1&KL>-GI7V]W[@2O3!292I6_]<^B
MUL^KB?].@PG$$,A D-J?$4)#"#\(]%,"-03Z08@_)42&$'U5(3:$V"($_6+I
MU=_D(E_.6W[UVOX -;DZIW@6R_W=J4F]G?J;W(!.SEZ6%,7SX*("&<RJQY 1
M)D3)+6;C8O" "&0&0QH$2F-%'#JU)=80)K72<#'D%O'@(D)T"]FZD&2BF!!<
MTU#SZ3B)A,(!*!B Z@#A3:49'" " T1.!A1;5:YZ3*PQM<9DU%YR%Y/B&$XD
M!A.)@42PM6>Q(Q)F$]4FH$@"B%C;ONDQT4@D2:U$'A*W6D*ML^%B$C2QMRF8
M; HD&UK)IDZR:3HADH$B&2!B5;+)OBZ"$>P=")");&- KDXVI3/A41C0B6T=
M[.AD4SN#01.ZQP30<8R..#HT(A,ZL#]@UR PL@^L =WH()Q.",$^@BG@1%,A
M8"?!T=>]",,>@"$3<,J-G7)):-V+!^Q:!;%];0N"IHJ&#05#CF)?4NQ:"B'1
MA [L!1@R _N>8M<-,)TZ<+ =8,@/G(OJ&D*2P#($]@/B^H%[K@UHO#V4VO<T
M&+4O%6N/NOGLO!T_UT(=QM'LT.#>$]7^6/,K/%MC8'XC&^*^??T(WW?3/_/V
M6-2=]\*%;+IT:W3@7#"9.[J3BW.2#?PP*-E!J-=$OK=]%]L/!&],AQX,?Q.6
M_P%02P,$%     @ 38$G2]6_W^SS @  C0P  !D   !X;"]W;W)K<VAE971S
M+W-H965T-#,N>&ULE5=A;YLP$/TKB!]0\-D04B61VDS3)FU2U6G;9R=Q$E3
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M:+!<$P?R>9HPP.8G!):D,0P<&4NGY&XD1(PA*J9!M?CA0 ?CN4- R@!M>,!
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M9);A#"$81$$0!4"9 Z(ST ><(A\G!3DIP,D=3CKG% E"U /*0% &@ H'E,U
M.::ICY.#G'S&H9,3&3CYNS@%R"D #G8XQ;LX&,&Y0K.7EB+BL?!$$P/%QFXV
M!U$^J39>9*D'! ;T'A, -/L2&$083TAHD?I:@I.,8X!$75(\)R6+I/"0X,CC
M>>8I<C-O13<DLI@DZ98$9Q[/0T^1&WHK>BL)3CV>QYXB-_96E+\-!*<>9\#+
MZSM_.- 82#1V$PV*/#\-& XT!A*-B<N!1+[?,#C/! $6;AA!D8\#AY[@^='C
MQ&,!QYD <<9NR*PHG;XFL:]4.,P$"#-V(V9%]$T<.,H$B#)V V9%_^\GFDQ%
M-9<',P]VP5:<&C.,3E;'F?.>F*GJGWP86+\Q>2B;+G@62L]F9H+:"Z&XK@4M
M=+='/2./#Q7?J_XVT_=R&!2'!R5:.P1'XR2^_@M02P,$%     @ 38$G2Q;T
M^9H$ P  7PP  !D   !X;"]W;W)K<VAE971S+W-H965T-#8N>&ULC9=O;YLP
M$,:_"N+]@GU@_E1)I*;3M$F;5'7:]MI-G 05< 9.TGW[&4,9L<]3WQ3L/+[?
MG?$#U^55MB_=40@5O-95TZW"HU*GNRCJMD=1\VXA3Z+1O^QE6W.EA^TAZDZM
MX#NSJ*XB("2-:EXVX7IIYA[;]5*>554VXK$-NG-=\_;/1E3RN@II^#;Q5!Z.
MJI^(ULL3/XCO0OTX/;9Z%$U1=F4MFJZ43="*_2J\IW<;2/L%1O&S%-=N=A_T
MI3Q+^=(/ONQ6(>DS$I78JCX$UY>+>!!5U4?2>?P>@X83LU\XOW^+_LD4KXMY
MYIUXD-6O<J>.JS /@YW8\W.EGN3ULQ@+8F$P5O]57$2EY7TFFK&556?^!MMS
MIV0]1M&IU/QUN):-N5['^&_+\ 4P+H!I09R96@:0R?PC5WR];.4U:(?-/_'^
M&=,[T'NS[2?-5IC?=/*=GKVL&<V7T:4/-&HV@P9F&CHI(AU]0@"&V("S/&&>
M #&:8VP"Q/, !<,#)&B Q 1(;@*D5I&#AAE-8S009S$A.(>A'.9P&"TL#G,X
M29K[,"F*29%R,@N3.I@/M/!A,A23(1C[:&0(AC#B ^4H*$= ]K;E#HAF&?@X
M!<HIW,<S"S!P"I>3)CEXCALEN*F(2P*;-(K>6Q+U^)<ZYF $/"%0?]Y30/8E
MMK,=1/DL6[9(/!S<QC1&=H7:G-C9%=^&X%ZGKMD926R*ZW8?!7<Z1:Q.F$T9
M1)3.'S%9S$QTB\+=3EV[,V*_O4;1#8HL,M]!P U/7<<S8K]81I%-\M6$.YZZ
MEF< -BEWCMQ_2L(M3PO$'H7GZX6;&1 S4]O,F AB#P=W,E"$8^\))@*/#0&W
M.R!V!_OHHB)?/;C=P?UL,^I+%?<R(%ZF3JJ#*+UYC_H>,>YFP#[<ML7 _7+3
MU+<EN)4!L3(XG/0=]42S_JX6[<%TMEVPE>?&M-6SV:E[O@?3'_Z3#ZWW-]X>
MRJ8+GJ727:;I!?=2*J%S(0M=[5%W^].@$GO5WV;ZOAU:WF&@Y&ELYZ/I?XKU
M7U!+ P04    " !-@2=+W<]DM%P#  ":#P  &0   'AL+W=O<FMS:&5E=',O
M<VAE970T-RYX;6R55VUOFS 0_BN('U#PV;Q52:0FT;1)FU1UVO:9)DZ""C@#
MI^G^_8RA%,RY(E\"F.<>WSWQ'7>+JZA>ZA/GTGDK\K)>NB<IS_>>5^].O$CK
M.W'FI7IS$%612O58';WZ7/%TKXV*W /?#[TBS4IWM=!KC]5J(2XRSTK^6#GU
MI2C2ZM^:Y^*Z=(G[OO"4'4^R6?!6BW-ZY#^Y_'5^K-23U[/LLX*7=29*I^*'
MI?M [K=4&VC$[XQ?Z\&]TX3R+,1+\_!MOW3]QB.>\YUL*%)U>>4;GN<-D_+C
M;T?J]GLVAL/[=_8O.G@5S'-:\XW(_V1[>5JZL>OL^2&]Y/))7+_R+J# =;KH
MO_-7GBMXXXG:8R?R6O\ZNTLM1=&Q*%>*]*V]9J6^7CO^=S/< #H#Z U(^*D!
M[0SHAP'[U(!U!LPP\-I0M#;;5*:K126N3M7^O>>T.47DGBGU=\VB%EN_4_+4
M:O5U%4"T\%X;H@ZS;C$PP) >X2GV?@O MEC#Q!S&&VRF".J/(=LI)+(X0=$X
MJ;9GHSACG("A!$P3T!%!@A,$*$$P]<",<MUB0HTI-8:%AE93"#!#*P2".QJB
MCH:(HQ:M(Y0@FB]5C!+$,Z1J,<$@2./8;J8(, [>=@JQ!)J@?B:(GQ:IB8^G
MGS]?*V+)8#)#K0XTC)0FAEX(QM0+@5@$(V@M>"" .$LM%'@F$WJ#9'@N$S9'
M,C:5#'QJBC9%01P&IFX(5S1([;'3>/T@6 %AIM/3W _CV+81GO\$*P"!N1$&
MLNV#EPD2(121A0(O%"2^X2S@.4RP))Z<A61:F,GD*"33Y(C-VHR J,]PCP&O
M&> C'EN^98#7#"#S=0,\DP'+9%.W#C22) AB0S@$E823!@"A8J'-9[QT -(%
M4!L%7CK@ACX \$2&.9U !QJ%:Q9L!&,6]2W&8_N: UX/ $EUYELH\%2'&UH"
MP%,=YC0%@'S00Q:8NB&HQ#=K-H("B"SU"?#B DAQ8;:^%<]V>D.'0/%LIW,Z
MA X4C@Z34;TV"(B8\FXQ4&1^X[W!@%+PZJB'O]K9B4LIFSY_L-H/F _0##C&
M^EH-GNV8^$'33JT_TNJ8E;7S+*0:G_20<Q!"<N6C?Z?^UI,:E/N'G!]D<QNI
M^ZJ=%ML'*<[=).SUX_CJ/U!+ P04    " !-@2=+#LJQOT8"  #;!@  &0
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M;\C^.[U1IN$F$JU1<";MURNN4O%Z8-&AU.2M'ZO&CMW ?W=S.^#! 8\.V#J
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MS;A@]*S,--%ST;?;?J%X.SPE8'S/\G]02P,$%     @ 38$G2WHX;O@: @
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MZD80AF\%<0'@_=Z-"%)RJJJ56BDZ5=O?#FP".C:FMI.<WGUMXT,)^PX:YT<
M,Y[9CWEVWS&[^JCJ;\TNQG;VO2P.S?U\U[;'N^6RV>QBF3>+ZA@/W3<O55WF
M;?>Q?ETVQSKFV^&FLEC*++/+,M\?YNO5<.VI7J^JM[;8'^)3/6O>RC*O_WV,
M1?5Q/Q?S'Q>^[E]W;7]AN5X=\]?X1VS_/#[5W:?EV<MV7\9#LZ\.LSJ^W,\?
MQ-UC\/T-@\5?^_C17+R?]5UYKJIO_8=?M_?SK&]1+.*F[5WDW<M[_!*+HO?4
MM>.?T>G\'+._\?+]#^\_#YWO.O.<-_%+5?R]W[:[^[F?S[;Q)7\KVJ_5QR]Q
M[)"9S\;>_Q;?8]&9]RWI8FRJHAG^SS9O35N5HY>N*67^_?2Z/PRO'Z=O7!AO
MPS?(\09YOD$-<9:G0$/+?\K;?+VJJX]9?1K\8][/L;B3W=AL^HO#4 S?=8UO
MNJOO:V/4:OG>.QIM'D\V\L)&G"V6G?=S"(E"/,KD=F,T=J!@&]7@0%TX4-)A
M!QHZT(,#_:D%YJJ3)QLSV!Q.G;1."R^(IAH8R8!(]BJ222)YZ3-M/ YD82 +
M KFK0#8)9$7F=$;,GH.!7!I($BWUT('GSUZ #@)C]D+2U1"D-QF.(S+,0L:8
MO='H4ZAN]IPA0A'8"1"*&%8!L7H0DC^P H,E%&A%N.[PR<A>=)@:5DR?X. G
M '_*=;L+$0KC)SC\B11 (;67U QB  4@4&37H8"1I;J$^1, 0$L0+#"!8@*"
M C,H$(1)IIR,_&6F+*PD]@K,H$0,7B>+3!E4VA@J621F4"(&KY-E-&*'PJQ*
MR4@69$2.'@9: J"M(EQ@6J7F)XO$%$I$X76RC$:7R2(6&;'92LR@1+M@DBSI
M-BB[^:,F$%,H 85IKKA)D3"LTG-2!1A9:NPPT1(0;8DE4&%65<9/%8495(C!
MZU09C2Y312X"%0@3J !<2:J,1I\F,",G4!%J%6VJUZDR&G$C8505V%B35$%&
MUA)Q,,\*\&RIX<>D*CLA53"""B&8I(I+4D4MJ*S& "K 5IHI/MT6;LP?1E"A
M337)E%3:WHBD,:D:[*I)IB C2VA2C7'6 &<;"!<85#U!UFI,H.;(VM'H<Z90
MO27*2E9="80M/7T80,V1M1K(6CH0QE1S1"TR(O,$LZP!RXYJ*L943Q"U&O.G
M.:)6IZ)6+Q3178/Q,QQ1:X"H=9)4F@83:#BBU@!1>RL4)M5P1"TR<D3Y8C#.
M!N#L"%UL,*EF@J@UQ),=CJ@UJ:C5"^H!$D;0<#2M236M)F</(V@XBM:DBI:.
M@SDU'#V+C*@EQ6"8#8#9$:6/Q9C:"7K68OPL1\_:5,]::NNQF#W+D;,VE;/*
M2NJAF,7T68Z<M:F<O14)0VHY<A89.8(PBTFV@&3J\9TEGKY.D+,6\V<Y<M:F
M<M8O1/CT1T3%-%J.N+6IN+U1G%C,H^6(6YN*VQN1',;6<<0M,G)$&>0PVPZP
M[8A)=QA;-T'<.LRCXXA;ESZSE=2@8A@=1]NZ5-O2SSL<IM%QM*U+M>V-0)A9
MQ]&VR,@12[,C?C!)P=:!D"L.4^HF:%N'\7.<7TU<BI_H5E,?J&=)'A/H.3^<
M^%3?.MFM7Y[8I#VFT",*B4708PK]! H]IM!S*/1IB2DH->@QAIZ#H4\Q]+J;
M14_H;(])]!P2@9&FNH0Y]!P.D9$G>/>80P\V6')$B)\N)W#H,8>>4V/ZM,:4
M"T](DH 9#)P:,Z0,ZLS3.V[ # 9.D1G2(O-V+ QKX%29R,@3:V[ 1 = -+4T
M!0QKF%!E!LQ@X%29H]'E[D[E"D8P<&K,D-:82@IZO0X8P\"I,T-:9]Z.A7D-
MG%H3&?GK)6QY<7ZFC/7K<'*HF6VJMT/;'Y>YN'H^G?0@A_,W_YN?CC;]GM>O
M^T,S>Z[:MBJ'LS8O5=7&KBW9HNOQ+N;;\X<BOK3]VU[PU*<C1:</;74<CTLM
MSV>VUO\!4$L#!!0    ( $V!)TNOVUQ#E@(  .X(   9    >&PO=V]R:W-H
M965T<R]S:&5E=#4Q+GAM;'V6VX[:,!"&7R7*_6YBYXP :0.J6JF5T%9MKPT8
MB#:)4]O ]NUK.]ELL =NB.W\,_/-8&<\OS+^)DZ42N^]J5NQ\$]2=K,@$+L3
M;8AX9AUMU9L#XPV1:LJ/@>@X)7MCU-0!#L,T:$C5^LNY6=OPY9R=95VU=,,]
M<6X:PO^5M&;7A8_\CX77ZGB2>B%8SCMRI#^I_-5MN)H%HY=]U=!65*SU.#TL
M_!<T6Z-0&QC%[XI>Q63LZ52VC+WIR;?]P@\U$:WI3FH71#TN=$7K6GM2''\'
MI_X84QM.QQ_>OYCD53);(NB*U7^JO3PM_-SW]O1 SK5\9=>O=$@H\;TA^^_T
M0FLEUR0JQH[5POQZN[.0K!F\*)2&O/?/JC7/:_\FQ8,9;( ' SP:H/2A0308
M1)\&\4.#>#"(+8.@3\749DTD6<XYNWJ\_WL[HG<1FL6J^CN]:(IMWJGR"+5Z
M629Y,@\NVM&@*7L-GFC0J B4]S$$AD*4V#''MP%6KB(*;R5K5Y+=@8C /"-C
M'TUS* K800PZB(V#^*90J56H7I,:3=L'R>U<7<T3RF(K6TB$PCN\"<B; +R9
MQ=MKDFF8U-*L (V]0=: )LI@V!2$30'8W()-G2 (V\4%-'%AP0(:A&'8#(3-
M %@K2)FY%4E09-&Z(E38^Q[08'QG(^0@;N[BVE'*W(D2Y\BB=35/SBEU-5&1
MP+ %"%L L!9(Z6IBZ_RL"H<#6\5?/_1R0ZK:&OCE#!T/=LW*03,]R#BT3L\*
M$&4V+:"9_HL];S#YZ#>4'TU#%=Z.G5NIOYV3U;%IOY@^9JV7NIF;9O+IIK\)
M_"#\6+7"VS*I6I)I' ?&)%6,X;.J]TE=/L9)30]2#S,UYGT'[B>2=</M(ABO
M.,O_4$L#!!0    ( $V!)TO;)9>.6P,   (0   9    >&PO=V]R:W-H965T
M<R]S:&5E=#4R+GAM;(V7[V[:,!3%7R7* S3QM1.@ J0"FC9IDZI.VSZG8"!J
M$K/$0/?V<_XT!>>XY4N3F'.OCYW[<W.G9U6^5'LIM?>:9T4U\_=:'^Z#H%KO
M99Y4=^H@"_/+5I5YHLUCN0NJ0RF331.49P&%81SD25KX\VDS]EC.I^JHL[20
MCZ57'?,\*?\M9*;.,Y_Y;P-/Z6ZOZX%@/CTD._E3ZE^'Q](\!7V639K+HDI5
MX95R._,?V/V*\SJ@4?Q.Y;FZN/?JI3PK]5(_?-O,_+!V)#.YUG6*Q%Q.<BFS
MK,YD?/SMDOK]G'7@Y?U;]B_-XLUBGI-*+E7V)]WH_<P?^]Y&;I-CII_4^:OL
M%A3Y7K?Z[_(D,R.OG9@YUBJKFK_>^EAIE7=9C)4\>6VO:=%<SUW^MS <0%T
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MF?NR[4K;!ZT.7<<=]&W__#]02P,$%     @ 38$G2QW93P(= @  C08  !D
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MQ?A2-EL6*]*Z-WBH6F7Y(ZJ5J&4M8+T-==7Q+A_*Z%<_Y!MZ.0'CA?2&1U*
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M*1R2B@QE_A'P/\SY??:<#"BEJS_H)3L&38"L,.Y7L% 6STGY%?->JNTMT*H
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MKNQP/M/143B?X628U+?AX\VOYY\2,#$^G6/[]NOK\^96O55@(T2<@X-[QBY
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M%_5!(>=FEJ';SHPH2'I=/F0S5NK"'WME>T-I=DK FD/R6 !X96**'! @_Y*
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MV#6._VE8UF"[B=O.0O77%D"@_=YLCR2UOO&=#3B[K:TW@VV UYT*B!R!/YN
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MI2QLXA-&-4./B?\L:6L9 5LIDAB#EF98I.<FH6Y<!PX3TC^U2:)GDN&BSW*
MEN*]ML*!45NX% C[(KDI4;.WC2\]\ \J*= ;8T^V(0P&^CY@H.^D(<)0M8]*
ME+W">*M>IW6 SDT2$?)GEQ>NY86?KN(Q8[G18YY1)0*MH)6-7!$.PSC9,AR*
M]WCT0(W&F@^;UZ/U5$>[ZZFBRXT53E%_[4CAU/#["J=Z#9?E)66P:*%D_;<E
M)H3:!Q(PZ8H[IB+6@L$7\"Y8A \5;*9M-_4[O''I^K[U+06>MCFXW+RF&15J
M5_:)T/@B]Y#VC&W1.$R:_#=Q]#N!J2Y34[.EBW8+ULG2NF_S.W1;"X 3Q2"#
M]#HT(GP-G9,-I>UA6_E,UTB6JH=&J/_N$=-1#7)"J_$8X"NT8S>DR4^^QV%>
M_12Z ,;&1*>.G3?E(_!% *Y(M:'.9^ID)]L@)/S6^>US'"'%0+BXZ?O:!HZ)
M-M7$&%A,#/F%TJ$0,2&K\EW(,9K*Z%1\;U4I4+=I8H@O9U_%\Z0I-MC'@.O"
MG+"WL\31K5<1A?JZJJ6_NB+R+ 8KD.*=OP()7574M(=&063>*&59'H!Z:VXK
MRABE6U&-%H'O<(#;]&U<.Z;WH7."*WYG:ZK&: 'T") P*C^JPH',U#RU;P?<
M>?OL.$KI[K'!HY >(?I&85R/F)^)$3O);[K-<<0PE8=C2,T*GL8Y/$/(E95I
MXB#)1*"_?=GKMOM;K[-KC,3F<8+8VIH:&I?DMWCV@73#+ 3Q;H:NZF.3#5AM
M?+NY!6?@M17]I+:&03/\4_:(UGYF9&Q0A!'-"&4>7V9_Y9Y1+:9<Z[3JU16<
MZ5R?DU1S%BO,2-.K +V]4KIGJ$MIQG_%W@79ZDME@+PHHRQ(*N"RQE[RB]:V
MDF) &#OR60'D K)SDARE8,SR);N29M[RIJN?N1I%%&Q0>/9YTI54(ZX?%UNA
M"89=\,^7"9T4JZ!V!P[^9NMO2/0C^8,^2^ZW!>93K*B2KH:C6=\="QM.:N4F
MSU-)J&$DU1DF9IA* I[EQF19XNZ0N*BR>2ZQ3RX@,VP1E$-9^N"QYQ1F/Q44
M\_-R493*Z])OWO<#O2U7B.EB,!#D)^(%Y2V?Y=AY<_4EGVE);K@SF(LI9<@/
M"H^N;3H1S@$E$JD!MLP#99U)T W!SCBMU]2"J!=B;9++?[7M?%U>=+;2>P(=
M/>A.6PL>@\GYE,\&'R*I&GQL7J]-::J-US@#37NH_W+=ZP2_3TY?/.:^TETP
M%IR;RYS#,'7H6AKG#<8.)5"[G+J/7V7/#!DYF!Z-? Y+_?>[*Y%=DPG7EJ0*
M5D<J)"@7&&62LF'W>Y\MT$L^2_&E1XZ7>5-&0\V6K'OXJ:(013[H0 +KX/1@
M\GW3"YR L2HMAHG18GU/%$Y*L8!Z9$)1&;Z:@\P8V@4T7#.[(^UG7'*+UL_7
M9(:#7I*5@=G*&16:X"XE,HY@K'U)(;U(.5;S;O.';#&ODXIW!H^;'4/<+I(^
M449R>%+-P3,>B@40 >]%]#^3<NEL C-VZ-'VN6A</*HS]P8&NGPDFQI5'./F
M=4%<T,M\U9NX+':R?(35Z<?-5G%>G6YR<)@>8I->=QRI,(B 3@ET$ZPVRJ*U
M[:DTT& :X7KKSW5XM'R<^9Z/D0(Q%T9D)=KXE#"1C\Z+;=3TPJE)N"FDZV$(
MUW,YC\N#D)*F(,T(K8H.];-'&X05ZQ$.JR3A/A9)_2B('5S'_4S!(:Q;S"04
M:"/VE7F\5J;K,BM::K@"6O+(_G2AC]!7K"M,,'6-8Q!"DV_$ %!MVQ,;5[0B
M7/=LG7W%4E"@QZZ^3.:XU7.Q&RQ)T\1T(XN;TJ!<<[%5+<Z 6E5%R ><K]%"
M]U2T! &L+Y9H35'GL0;9>F:RS@.OWN;6(H!:=($#.J\FPW$*_YWP+UZ-,=:P
M,[3P+@AFS&.61?V5JM?9XRV&/XC@L,:X+CJ"+3C:S_ZHQ8Z"JN/4^SG88<D)
M7 ZW3\$S-7>-$:% _M6><Z/87VD%L7$/I+;VV,:,U W$I( ?>PP<6@HGDWDM
MF(&Y'(@;.QNJ_0N$V:?I"MGM%@45K I4SZDT<!7YWQ02<B\V'%E+F[5-HJ"P
M=T/;T[A<4:T@<M('N!LO/#JM&.HGX+G0A9Y)$[%%@&/AM!)12FW>#B5GXAV?
MVF61_Y.?EB0#"\I)$P:ZRXQC?J.6O*%8RM"6NYYHIH9=KED=S3,SA:T:>'7^
M>//)5'>DYF\A*(DN[+"K'82_HA/[V:,+<K>:_Q9_6[%ZW"I^L4A_[S!BOQL!
MHXN%040BQXNCY>ODDKJ,#N3/H?PYJ@=WW5PTH]L5V_%5_,RF'1P.0:!59V!Y
MBSX0::M+TR63$ W@VI/;5?-9<J+%)EZK$H43>8^.?""$NEBI=ZO-5O')9D@-
MG_U/W=L1Q8,:KI)$\ZL]<!&0<;/4Z:T_A/O(V;AO:-/KO#1.("\"YZX7 U4
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M::(C O?ZM)C/R8BT(A.VQ@=#S #*<<0J(BJ>U97:!:A#1Y-82=1.)/#,C-,
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MCK:B,TPK\IYTKC]&,KX0C+\;]&H^6AT=K,^"U/+Y,\9,[ R"(,=AV.FU',S
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M*,](?4D09?Z)<H_PP2=NK/GO&>("KA!<F_4_[E<==1OD>K:SP[T>Q+^%%_\
M+_\>4>R@KY]=R%#GH,JRJ'NLCH]J(L5PL,DH!_HKN T0\:AJ")@0YP!7=S Y
MOT^&)SAD0SQ69(+)DO)(V$4BZ 0'=",PKOOWL#>A1_^RP\]MW/ V1^%. <Y:
M??#Q0!S9=L),"P>./A96K(R&/;^9TM1NIG<''Q7E"^"_FAT^<F3T[&6?PC0[
MZO7C/D@ 'WELH(L5@U&<9P7:$Q1-)CW0# JTPOQ$77:.4E!#,[H5CKT7^00!
M5-_/X54)W+PF602?$ENF>^;1)#B,DR0@?Y09G81/.?%@$]'M6^VO\Z0&W;!V
M<L\-)$.?'<%5Q^(L?041YMRR,:'*+^Q/(+/8J,\FYKP/F\>X!QR8.O_"E@JV
M_.@GD[@/&@YN.,A\HL/A#F9DIAWV"_I[D/LZW:55]@BY*08MT+VVGQ1<OEW4
M!;);.X65*')$O>'_WRV1@C 592*I@8ARY5ZCG;P?#^E;DCM"5PA6HI ;Q&KQ
M8)_60M\R20\Y<.LK)!FPJ(>=#U(4L-@!,-KO"DGZ+"E2-R"B=<F)E/0S[PI9
MS9W\,68)E=U6C:Y,L@<>]8!(8Q/C-S_:>"136JE6)SH;=5+RP)"OCIQOOM6U
M\?#N?<7^6^])>_W?].9+61)3UUXZR("O#LS]5@Q "ANTNMUR4CS>B 9;K,.W
MOV+049.1?R]K2XIY)\'KA5QY.3F DR'I;CW_%K?],Z=7%Y/V%FKCD5&7?'3$
M03G'[<W4+5;)\Z409(24HK'JARBC:$(2[E$R8.<6,.FD-X)?OT=\5((3WJS_
M+M5JI,YYYXA<H4=##'$YRO!W%5JJ FRH9 %CJX+R#6<=M($D23L?,;33 0#B
M\AHAQY%$TA0)2F_)"#7H-!TY79"+HPQ<Z(':60TZ^3"!(>,-DXT*,8R6(;S8
M.7)"*C3>!$09Q<@[)W^^'?_79!I=70HQ5-+!CW U2QK=M5-_3?OKKC=KJI &
ME!GT$A&3^H?IQBWCAB?:P=%Z,MU)VDE)'+FUG_!;2WR4A*TAY @F*R!X&^9'
M+Q\?"9FOH^+;H0,#?RW,1F>V6=45/K'+?^T.V'M]YX[@H?%U28[&F]]WY/?H
MA#Y%8\G@]YT+'N-LI3\L?E]W!-^KHC:WL]_V<<9-X3Q1C-B*<4[6*Q6>;9D:
M_K -ER,J630#Q_:]_]B[#@5%4ZU$8RU%KS>!)@NZ'SLN,SK 22].DUY'@:XW
M/0EW2#H :3J%TUYTQBIM7Y5UHXEOX>NTD\((V2@4FIX02J"V4 >DQ2%(7QE<
M,<"*?PJT.)(FR$2X%4?,^2]2L1K>"?PXN9S< #<^>@_L8_D(+.$DNIN^CXZ^
M.XZ^0V*]_77]O(5)>0<JB2XX9F""[-2'8[WO*F"+S#>G?]9?>J&ZL,%==:_G
MGB]% UV&,DV"K1MQK1T@Z^I2+N7.[YZ >6+%$REYJ."8 U+89H%PY]3?L_O4
MMO*Q\?RKJA' >1%2P,I<VUZ%LBUBM',,N5/'C0T+IS^,C:? 6RGX4M* W/#!
M5DO!Y.TB0@E8%(;K:KM&[1 ^>&"&&ZVA62P08WST8/<.\[Y$NRQRRF.+XK^+
M_J@FOURQ?8@21;-^_B?G",0-1\*FZ[Z<HMHVD[L; AO!-]6V3"IZLP_+0-J8
MZ=2U[N_5NFAL/;4RVAQ)=XR6<,8[PCAVNYU4IX_&!+5:YQIJB/HD!AVH%(;\
M82&5)FW2U"$>2Y.R"5H^>L?1D_\%'7V[]6JABH'.\!+T69QP6<'":CK!C!%=
MJJ+J\6.6^V-=KO&DOD;ROZ*:+?$*'WB\"2Z+SXY$*=%I)'YJH:_^J') =DUS
M9@^JPBGL-<NL%;4\#;MPZXB"?&#7!U6/>JNN:_FX+Q0F:+W3*=0I0HAGI,8"
MH%7VYF\Z+]A980QO.\/J?AN99W.\4.3DL&#FB\5GO;B%0.B,;9I0H0A5RZ^&
M$)-Q?%<:21TW<4:Y\?-S_IR@?<T3A1L'C)#[-0-.BE"OS0%"E1UF6:C#^C"B
MRLY4S%!UG(F..SJSLZ>KFMN+''.D CX<TLLDT:?S5HD^>U-V*-7G^ "9>*\D
MHEH2];)R0JR[=6:,Q]:<)!E/LBW#"1]QT/,Q7@OAQ),J(C@@A2C,[EZ53=0R
M^>>0+)]#J*3A/5-K66LHQ%S"O@P12*=I;!02H1K$KL!666D]Y6]_YHR;*Y@1
MF>$J:69%^?4?< M_(8-'5<LQ.1"MABH9XG:Q:GC49/N<4;;/.6?[8(R28Q]O
M.V@K->6]2;KX%AVU7QZ3!_*Z(37U\W8C>L6&MCC3I5214G[((2?YG-/T[1P)
MNSI2J^;!#!-/=+ S- 27JNY-X?:M7J4MT49-.BCE8L_<BD.6WW0;BSF23K0-
M>7&A,'50'D7&NE% M&2741]\3SADC>Q6WF5AGL(&FFXM2E:EG*K(]0TS-L)J
M23EKXTWFDU8S[6"&Q]X[6L[1" A8>Z5I^$+I7@D;GHSL)FZ$I9V:!K59&@<L
M5CA8/W3Y5K6MR@K82_<)$X.?"7"(/&U'\GN3"@3S5W6A8OK#>Z9"^[T+JSYV
M_TH;H4DY.H2'7=WOM)6O\$QPLU6U%;WT\KEB@75<[%I5U2/5ETX. _^%KBJJ
M;_5UO5E(L<?/SS.R3@7N-0L=TIMA* :=$#O:-ARU;)CVVC;TG Y5#=-]"0*I
MZ2 R4-JB#OVOV\:/;/BI\AVX/E+V>J+61#LT7[+8M7A<?EZJHC!D22IW4P2M
M(#?KE]DC,!)5H5/#?WZN'U32"W:GSB<9/Y#U;ZC_D#?'V',M:!W2#CWI_@M"
M2UVL5XN7B-:JDE6IV82L0$%SS:U8&S;R()MEJR9=<!B9I]V?W;ROUFK*]CU=
MZ!.KARN -S3Z^4XC_:@@:O+H'#N@Y7+U; J_?']:.:RT6_BKT62C"QJHFNQD
M>>BA</K)GOZ<=#]_#K'?M*CPKH2-[A\6G^"9$?M8PDT<EE_AV,&Z.*4FX<[L
MAF?G4W$GI7^J:,[#&[;HV&G9HF=[5GEMSXYON+9EO7OK$"?7(:ZN\#.G:(TR
M61=U[/K4\L;&B$$MSA-,/J+.:]TX(!.+HTDZ$-J>/>]^Y3JKC4_L^\I*5S)R
M:97;$A-D'34C5Q;VV+HCXY,>*X<PG&;,$$ONCT,]V2'?][9_4:J;8 #O>A._
M;D(4]?%0FE=5GU<8"D:Q1#J3#(,G:Q?622RS!Q*0U^\7B[E@-BZMX?.X]UEK
M0G]X(L5G$1FDQ==W4;4R?"*:]BHT (K84+6KT7D&FMB]4VHS_!S:<B0H\FYE
M7Y,Z)?;*5+,//&\N3AN9U1F[#7-: EH],4"K+,<$E:W0>TVF1Z4NI1(.*T^[
M;N&4^9,DTZ!@9S)*JMYZA\?SGVB%!OHV)[2JN4K.5+'J<B3J3@+'Z^H5WW)@
MB"I&LD4WDS+^Z<%@CGA5^(CIS^3>O:Y']P@*>NA:#KTRIH5HV%!JK?6Y-3.3
M&3! J']D,6 -(V#_&4U_7?P=JV;7&[U;G$NYZ?V9(9MO/IY5C[<[W!5/L_46
M6F@>VD"-5NI$]'4YHR P MU7'Q_ZG-Z7\(X$NE$UFCVVHY-+*$(M%*8"3P=H
M+$#M^FU5A[-JN2:_/2WEE<J1:+IM)X9/37I/*?O4U84;<_Z"HGN]D,Y+4<44
MF]-R8'DK[O=R DYC2YV(T]BR*1NG[:!J<W$:.VG(;JA\7N=2J=@DE^^_:B^J
M;XS0?C2WMO>DN76+?6D]P*:]:>ZH>7]J),WR'IEHRGLKWPV#)RH?W2]5KMS-
M2+F@TB*:SUY>M5P'KE UOUWJ9#[1B_8@W.!&O)887D$#K^71E"M0D2OF\N_F
MC+(#&+B,1F4\M65:^Z0/-G9J7M[^5.XY@.J.<X%RS-2!24;! Y-)NR31#;'=
M6X[SK>?<DC0M5W$HG?L@@SI35:4H_-IPY=A]#$7C)AN0G_W7,&C.SZS/V6M0
M'.V^6F3S5=O)]X-B8'U<"H3=!Z:^]P.Q4R@H3*UYV-K>,'98F1:9[2UZ.7RO
MWK+O-YO.-R27/7MO.:7&>^]F>N=<>A7J2$W,LF.0#G/SQJ3A_==J7TR@%DG0
M08^BKSMJ()#R%YPL'5 E&R$^7KUK8>DD8(5Y/<'\;,,XR5W8ECJ:_ >M\,9:
M/63!CS72%@:]V)9,"YAC;?5=I?[[E\IWZ-6ML2V$T=9JY:&B+ ^E_1H%HC28
M?G6,4L+P 4;,2MIVBYAF3=V*4!:E@[:](AY:=:\]/<Q>VPX11JUFF#*^/;H;
M5G<7:(^8;)7M"[V9K=^/.&[[O+]?-]Y<+V?6]OV(#->\G.VWN_:DI$+T@X9Q
MEJUY3)[5U*D.4YJV[@YA!JL]^F$9*]1/43_?>F6G BAB_QC1?> <R@_78#CX
MYNE*  ?OKMT7PZ&N@[T1'#Q*#4(XE%MY2 W!R(O6&1"[V>Z9@@DQ0ST4>Y,&
M@T#28$A.V@^%IDRL4L2ZD&+H5<&P))/2K*OX29HG^?R7Y ?9+ 30 //J2)!]
M?*2"N,OY<K8)AC"I^/>MMP(1)0 F0P7ROUF0\.1--AA20]2'[L@;'F0T76R^
MXHU[='8S/:X\A)?U* =A(F]^#8JLL\WC$H\#0D749A?@&!X6<U(&0F.)9#"H
M%B@_Q3RPC2JJI/.[WZ6]U$,.:#_T<ZR$U6+@S@LS3ZYEQQQ#9;#O%L37RE32
MQ?VOJ_7C^O,2:YJ9^(T)COII@Q)4<TY%)4T-&F@J2<.1;JW'!*OVWM))Q_">
M:%PYXD'HN+IO>^V\*=<:-(8Y:%];K D/4O"G9V&T#^I*H),;.*;3IP6QPF^X
M*T^;-151)<9,E30IS@,Z?D38!*HO+5$$Y:[[H<UZN\%1*4,L@%JU?,L5?05#
MI.P2M9IP^6'[W=8$Y#_I02WTH/ZPC192P=1C;4%._(:$U^*H]#TOQB%C0K4K
MND)CYO,*$Q)>,Z"FLQLDARP<NUJ^Q!U,30NDY]0!Z0G _AQRZ;=!Y DST48X
M'L_/$\;C"5_R^\'R>(:0YB9A2!Z/Z=Q]/YW\>(?I,Y.?.(6J4<;:V]<R73QU
MHUX1ML3\Y?E1QV7Z9AH0:Q;_>,93-OG:6%B @\:"X1&"!J]"VF(K?(XFT_SB
M6C@&Q!.=+Q^?2?*S !+F#A+-*Z$E[.AJTWT;0(G*V:#,5 <V4??@^/:B19"6
MSK]S(ON4^ KG7DR#>-D]\@8M=,34^#,GA^$V[<CQB\G+]GOW&7#[^/PQ1MI1
MH)V$LO-:FV9_W&YW?_Y?4$L#!!0    ( $V!)TLD_-L09P(  ( ,   -
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MY>NM0&_EZZU ;^7KK4!OY>NM0&_EZVU ;^/K;4!OX^MM0&^[PED).BSAZVU
M;^/K;4!OX^MM0&_CZVU ;^/K;4!OX^MM0&_CZ^U ;^?K[4!OY^OM0&_GZ^U
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M> -02P$"% ,4    " !-@2=+'R// \     3 @  "P              @ $
M    7W)E;',O+G)E;'-02P$"% ,4    " !-@2=+9O,+8((   "Q    $
M            @ 'I    9&]C4')O<',O87!P+GAM;%!+ 0(4 Q0    ( $V!
M)TMXT#$8[P   "L"   1              "  9D!  !D;V-0<F]P<R]C;W)E
M+GAM;%!+ 0(4 Q0    ( $V!)TN97)PC$ 8  )PG   3              "
M ;<"  !X;"]T:&5M92]T:&5M93$N>&UL4$L! A0#%     @ 38$G2U:=S>.=
M @  H@D  !@              ( !^ @  'AL+W=O<FMS:&5E=',O<VAE970Q
M+GAM;%!+ 0(4 Q0    ( $V!)TMQU?1P_@,  "D3   8              "
M <L+  !X;"]W;W)K<VAE971S+W-H965T,BYX;6Q02P$"% ,4    " !-@2=+
M1HU@A_D!  ")!0  &               @ '_#P  >&PO=V]R:W-H965T<R]S
M:&5E=#,N>&UL4$L! A0#%     @ 38$G2UHWZ6$U P  W0P  !@
M     ( !+A(  'AL+W=O<FMS:&5E=',O<VAE970T+GAM;%!+ 0(4 Q0    (
M $V!)TO8=RT;H@(  $$)   8              "  9D5  !X;"]W;W)K<VAE
M971S+W-H965T-2YX;6Q02P$"% ,4    " !-@2=+SA>23)@&  !3*   &
M            @ %Q&   >&PO=V]R:W-H965T<R]S:&5E=#8N>&UL4$L! A0#
M%     @ 38$G2U^ZHBC: 0  9 0  !@              ( !/Q\  'AL+W=O
M<FMS:&5E=',O<VAE970W+GAM;%!+ 0(4 Q0    ( $V!)TLA=H?:I 4  )\>
M   8              "  4\A  !X;"]W;W)K<VAE971S+W-H965T."YX;6Q0
M2P$"% ,4    " !-@2=+582C6K,!  #2 P  &               @ $I)P
M>&PO=V]R:W-H965T<R]S:&5E=#DN>&UL4$L! A0#%     @ 38$G2S9&/*FT
M 0  T@,  !D              ( !$BD  'AL+W=O<FMS:&5E=',O<VAE970Q
M,"YX;6Q02P$"% ,4    " !-@2=+B$*>7[4!  #2 P  &0
M@ ']*@  >&PO=V]R:W-H965T<R]S:&5E=#$Q+GAM;%!+ 0(4 Q0    ( $V!
M)TL5V\1KM $  -(#   9              "  >DL  !X;"]W;W)K<VAE971S
M+W-H965T,3(N>&UL4$L! A0#%     @ 38$G2R;[&D.T 0  T@,  !D
M         ( !U"X  'AL+W=O<FMS:&5E=',O<VAE970Q,RYX;6Q02P$"% ,4
M    " !-@2=+OMWO6;4!  #2 P  &0              @ &_,   >&PO=V]R
M:W-H965T<R]S:&5E=#$T+GAM;%!+ 0(4 Q0    ( $V!)TNSDA#OLP$  -(#
M   9              "  :LR  !X;"]W;W)K<VAE971S+W-H965T,34N>&UL
M4$L! A0#%     @ 38$G2WE:]NVV 0  T ,  !D              ( !E30
M 'AL+W=O<FMS:&5E=',O<VAE970Q-BYX;6Q02P$"% ,4    " !-@2=+85HO
MG;<!  #0 P  &0              @ &"-@  >&PO=V]R:W-H965T<R]S:&5E
M=#$W+GAM;%!+ 0(4 Q0    ( $V!)TO'P==?M@$  -(#   9
M  "  7 X  !X;"]W;W)K<VAE971S+W-H965T,3@N>&UL4$L! A0#%     @
M38$G2ZQ?.N*S 0  T@,  !D              ( !73H  'AL+W=O<FMS:&5E
M=',O<VAE970Q.2YX;6Q02P$"% ,4    " !-@2=+06"-IK4!  #2 P  &0
M            @ %'/   >&PO=V]R:W-H965T<R]S:&5E=#(P+GAM;%!+ 0(4
M Q0    ( $V!)TO#I!NZS0(  $L,   9              "  3,^  !X;"]W
M;W)K<VAE971S+W-H965T,C$N>&UL4$L! A0#%     @ 38$G2P994PK% 0
M-P0  !D              ( !-T$  'AL+W=O<FMS:&5E=',O<VAE970R,BYX
M;6Q02P$"% ,4    " !-@2=+'AL><<8!   W!   &0              @ $S
M0P  >&PO=V]R:W-H965T<R]S:&5E=#(S+GAM;%!+ 0(4 Q0    ( $V!)TLO
MA+7'M0$  -(#   9              "  3!%  !X;"]W;W)K<VAE971S+W-H
M965T,C0N>&UL4$L! A0#%     @ 38$G2T2;1[RW 0  T@,  !D
M     ( !'$<  'AL+W=O<FMS:&5E=',O<VAE970R-2YX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( $V!)TM_;/D=N0$  -(#   9              "
M 891  !X;"]W;W)K<VAE971S+W-H965T,S N>&UL4$L! A0#%     @ 38$G
M2RZP$ES# 0  -P0  !D              ( !=E,  'AL+W=O<FMS:&5E=',O
M<VAE970S,2YX;6Q02P$"% ,4    " !-@2=+K1=W5! #  !^"P  &0
M        @ %P50  >&PO=V]R:W-H965T<R]S:&5E=#,R+GAM;%!+ 0(4 Q0
M   ( $V!)TNM9YC.'0,  'L,   9              "  ;=8  !X;"]W;W)K
M<VAE971S+W-H965T,S,N>&UL4$L! A0#%     @ 38$G2R*RHD9+ @  L0@
M !D              ( !"UP  'AL+W=O<FMS:&5E=',O<VAE970S-"YX;6Q0
M2P$"% ,4    " !-@2=+<K$?SW8"  !^"   &0              @ &-7@
M>&PO=V]R:W-H965T<R]S:&5E=#,U+GAM;%!+ 0(4 Q0    ( $V!)TN>P@PN
ML04  & C   9              "  3IA  !X;"]W;W)K<VAE971S+W-H965T
M,S8N>&UL4$L! A0#%     @ 38$G2S+K^JT) @  ] 4  !D
M ( !(F<  'AL+W=O<FMS:&5E=',O<VAE970S-RYX;6Q02P$"% ,4    " !-
M@2=+\FG[<U8"   C"   &0              @ %B:0  >&PO=V]R:W-H965T
M<R]S:&5E=#,X+GAM;%!+ 0(4 Q0    ( $V!)TN9HC^T'@(  '@&   9
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M970T,RYX;6Q02P$"% ,4    " !-@2=+NFZU79@%  #?'0  &0
M    @ &'>@  >&PO=V]R:W-H965T<R]S:&5E=#0T+GAM;%!+ 0(4 Q0    (
M $V!)TO)#0K<WP(  )4+   9              "  5:   !X;"]W;W)K<VAE
M971S+W-H965T-#4N>&UL4$L! A0#%     @ 38$G2Q;T^9H$ P  7PP  !D
M             ( !;(,  'AL+W=O<FMS:&5E=',O<VAE970T-BYX;6Q02P$"
M% ,4    " !-@2=+W<]DM%P#  ":#P  &0              @ &GA@  >&PO
M=V]R:W-H965T<R]S:&5E=#0W+GAM;%!+ 0(4 Q0    ( $V!)TL.RK&_1@(
M -L&   9              "  3J*  !X;"]W;W)K<VAE971S+W-H965T-#@N
M>&UL4$L! A0#%     @ 38$G2WHX;O@: @  _04  !D              ( !
MMXP  'AL+W=O<FMS:&5E=',O<VAE970T.2YX;6Q02P$"% ,4    " !-@2=+
M[FLA-M<%  "_)0  &0              @ $(CP  >&PO=V]R:W-H965T<R]S
M:&5E=#4P+GAM;%!+ 0(4 Q0    ( $V!)TNOVUQ#E@(  .X(   9
M      "  1:5  !X;"]W;W)K<VAE971S+W-H965T-3$N>&UL4$L! A0#%
M  @ 38$G2]LEEXY; P   A   !D              ( !XY<  'AL+W=O<FMS
M:&5E=',O<VAE970U,BYX;6Q02P$"% ,4    " !-@2=+'=E/ AT"  "-!@
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M 'AL+W-T>6QE<RYX;6Q02P$"% ,4    " !-@2=+S;'$.A<$  !](P  #P
M            @ '7- $ >&PO=V]R:V)O;VLN>&UL4$L! A0#%     @ 38$G
M2Z][ K;S 0  YR   !H              ( !&SD! 'AL+U]R96QS+W=O<FMB
M;V]K+GAM;"YR96QS4$L! A0#%     @ 38$G2Y #]W/4 0  K"   !,
M         ( !1CL! %M#;VYT96YT7U1Y<&5S72YX;6Q02P4&     #\ /P K
)$0  2ST!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/**
 * Rivet Software Inc.
 *
 * @copyright Copyright (c) 2006-2011 Rivet Software, Inc. All rights reserved.
 * Version 2.4.0.3
 *
 */

var Show = {};
Show.LastAR = null,

Show.hideAR = function(){
	Show.LastAR.style.display = 'none';
};

Show.showAR = function ( link, id, win ){
	if( Show.LastAR ){
		Show.hideAR();
	}

	var ref = link;
	do {
		ref = ref.nextSibling;
	} while (ref && ref.nodeName != 'TABLE');

	if (!ref || ref.nodeName != 'TABLE') {
		var tmp = win ?
			win.document.getElementById(id) :
			document.getElementById(id);

		if( tmp ){
			ref = tmp.cloneNode(true);
			ref.id = '';
			link.parentNode.appendChild(ref);
		}
	}

	if( ref ){
		ref.style.display = 'block';
		Show.LastAR = ref;
	}
};

Show.toggleNext = function( link ){
	var ref = link;

	do{
		ref = ref.nextSibling;
	}while( ref.nodeName != 'DIV' );

	if( ref.style &&
		ref.style.display &&
		ref.style.display == 'none' ){
		ref.style.display = 'block';

		if( link.textContent ){
			link.textContent = link.textContent.replace( '+', '-' );
		}else{
			link.innerText = link.innerText.replace( '+', '-' );
		}
	}else{
		ref.style.display = 'none';

		if( link.textContent ){
			link.textContent = link.textContent.replace( '-', '+' );
		}else{
			link.innerText = link.innerText.replace( '-', '+' );
		}
	}
};
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>77
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>79
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='UTF-8'?>
<FilingSummary>
  <Version>3.7.0.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>212</ContextCount>
  <ElementCount>298</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>true</FootnotesReported>
  <SegmentCount>68</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>6</UnitCount>
  <MyReports>
    <Report instance="psti-20170630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://pluristem.com/role/DocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="psti-20170630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>00000002 - Statement - CONSOLIDATED BALANCE SHEETS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://pluristem.com/role/ConsolidatedBalanceSheets</Role>
      <ShortName>CONSOLIDATED BALANCE SHEETS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="psti-20170630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>00000003 - Statement - CONSOLIDATED BALANCE SHEETS (PARENTHETICAL)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://pluristem.com/role/ConsolidatedBalanceSheetsParenthetical</Role>
      <ShortName>CONSOLIDATED BALANCE SHEETS (PARENTHETICAL)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="psti-20170630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>00000004 - Statement - CONSOLIDATED STATEMENTS OF  OPERATIONS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://pluristem.com/role/InterimCondensedConsolidatedStatementsOfOperations</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF  OPERATIONS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="psti-20170630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>00000005 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE  LOSS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://pluristem.com/role/ConsolidatedStatementsOfComprehensiveLoss</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF COMPREHENSIVE  LOSS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="psti-20170630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>00000006 - Statement - STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://pluristem.com/role/StatementsOfChangesInStockholdersEquity</Role>
      <ShortName>STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="psti-20170630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>00000007 - Statement - STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://pluristem.com/role/StatementsOfChangesInStockholdersEquityParenthetical</Role>
      <ShortName>STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="psti-20170630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>00000008 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://pluristem.com/role/ConsolidatedStatementsOfCashFlows</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF CASH FLOWS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="psti-20170630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>00000009 - Disclosure - GENERAL</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://pluristem.com/role/psti-g1</Role>
      <ShortName>GENERAL</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="psti-20170630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>00000010 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://pluristem.com/role/Disclosure-BASISOFPRESENTATIONANDSIGNIFICANTACCOUNTINGPOLICIES</Role>
      <ShortName>SIGNIFICANT ACCOUNTING POLICIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="psti-20170630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>00000011 - Disclosure - MARKETABLE SECURITIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://pluristem.com/role/psti-ms</Role>
      <ShortName>MARKETABLE SECURITIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="psti-20170630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>00000012 - Disclosure - FAIR VALUE OF FINANCIAL INSTRUMENTS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://pluristem.com/role/psti-fvofi12</Role>
      <ShortName>FAIR VALUE OF FINANCIAL INSTRUMENTS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="psti-20170630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>00000013 - Disclosure - OTHER CURRENT ASSETS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://pluristem.com/role/OtherCurrentAssets</Role>
      <ShortName>OTHER CURRENT ASSETS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="psti-20170630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>00000014 - Disclosure - PROPERTY AND EQUIPMENT, NET</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://pluristem.com/role/PropertyAndEquipmentNet</Role>
      <ShortName>PROPERTY AND EQUIPMENT, NET</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="psti-20170630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>00000015 - Disclosure - OTHER ACCOUNTS PAYABLE</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://pluristem.com/role/OtherAccountsPayable</Role>
      <ShortName>OTHER ACCOUNTS PAYABLE</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="psti-20170630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>00000016 - Disclosure - COMMITMENTS AND CONTINGENCIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://pluristem.com/role/psti-cac1</Role>
      <ShortName>COMMITMENTS AND CONTINGENCIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="psti-20170630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>00000017 - Disclosure - STOCKHOLDERS' EQUITY</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://pluristem.com/role/psti-se12</Role>
      <ShortName>STOCKHOLDERS' EQUITY</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="psti-20170630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>00000018 - Disclosure - FINANCIAL INCOME, NET</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://pluristem.com/role/FinancialIncomeNet</Role>
      <ShortName>FINANCIAL INCOME, NET</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="psti-20170630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>00000019 - Disclosure - TAXES ON INCOME</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://pluristem.com/role/TaxesOnIncome</Role>
      <ShortName>TAXES ON INCOME</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="psti-20170630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>00000020 - Disclosure - SUBSEQUENT EVENTS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://pluristem.com/role/SubsequentEvents</Role>
      <ShortName>SUBSEQUENT EVENTS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="psti-20170630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>00000021 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://pluristem.com/role/SignificantAccountingPoliciesPolicies</Role>
      <ShortName>SIGNIFICANT ACCOUNTING POLICIES (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="psti-20170630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>00000022 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://pluristem.com/role/SignificantAccountingPoliciesTables</Role>
      <ShortName>SIGNIFICANT ACCOUNTING POLICIES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://pluristem.com/role/Disclosure-BASISOFPRESENTATIONANDSIGNIFICANTACCOUNTINGPOLICIES</ParentRole>
      <Position>22</Position>
    </Report>
    <Report instance="psti-20170630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>00000023 - Disclosure - MARKETABLE SECURITIES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://pluristem.com/role/psti-mst1</Role>
      <ShortName>MARKETABLE SECURITIES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://pluristem.com/role/psti-ms</ParentRole>
      <Position>23</Position>
    </Report>
    <Report instance="psti-20170630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>00000024 - Disclosure - FAIR VALUE OF FINANCIAL INSTRUMENTS (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://pluristem.com/role/psti-fvofit1</Role>
      <ShortName>FAIR VALUE OF FINANCIAL INSTRUMENTS (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://pluristem.com/role/psti-fvofi12</ParentRole>
      <Position>24</Position>
    </Report>
    <Report instance="psti-20170630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>00000025 - Disclosure - OTHER CURRENT ASSETS (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://pluristem.com/role/OtherCurrentAssetsTables</Role>
      <ShortName>OTHER CURRENT ASSETS (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://pluristem.com/role/OtherCurrentAssets</ParentRole>
      <Position>25</Position>
    </Report>
    <Report instance="psti-20170630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>00000026 - Disclosure - PROPERTY AND EQUIPMENT, NET (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://pluristem.com/role/PropertyAndEquipmentNetTables</Role>
      <ShortName>PROPERTY AND EQUIPMENT, NET (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://pluristem.com/role/PropertyAndEquipmentNet</ParentRole>
      <Position>26</Position>
    </Report>
    <Report instance="psti-20170630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>00000027 - Disclosure - OTHER ACCOUNTS PAYABLE (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://pluristem.com/role/OtherAccountsPayableTables</Role>
      <ShortName>OTHER ACCOUNTS PAYABLE (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://pluristem.com/role/OtherAccountsPayable</ParentRole>
      <Position>27</Position>
    </Report>
    <Report instance="psti-20170630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>00000028 - Disclosure - COMMITMENTS AND CONTINGENCIES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://pluristem.com/role/CommitmentsAndContingenciesTables</Role>
      <ShortName>COMMITMENTS AND CONTINGENCIES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://pluristem.com/role/psti-cac1</ParentRole>
      <Position>28</Position>
    </Report>
    <Report instance="psti-20170630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>00000029 - Disclosure - STOCKHOLDERS' EQUITY (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://pluristem.com/role/Disclosure-STOCKHOLDERSEQUITYTables</Role>
      <ShortName>STOCKHOLDERS' EQUITY (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://pluristem.com/role/psti-se12</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="psti-20170630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>00000030 - Disclosure - FINANCIAL INCOME, NET (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://pluristem.com/role/FinancialIncomeNetTables</Role>
      <ShortName>FINANCIAL INCOME, NET (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://pluristem.com/role/FinancialIncomeNet</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="psti-20170630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>00000031 - Disclosure - TAXES ON INCOME (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://pluristem.com/role/TaxesOnIncomeTables</Role>
      <ShortName>TAXES ON INCOME (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://pluristem.com/role/TaxesOnIncome</ParentRole>
      <Position>31</Position>
    </Report>
    <Report instance="psti-20170630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>00000032 - Disclosure - GENERAL (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://pluristem.com/role/psti-gd</Role>
      <ShortName>GENERAL (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://pluristem.com/role/psti-g1</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="psti-20170630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>00000033 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://pluristem.com/role/SignificantAccountingPoliciesNarrativeDetails</Role>
      <ShortName>SIGNIFICANT ACCOUNTING POLICIES (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://pluristem.com/role/SignificantAccountingPoliciesTables</ParentRole>
      <Position>33</Position>
    </Report>
    <Report instance="psti-20170630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>00000034 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Schedule of Property and Equipment Depreciation Rate) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://pluristem.com/role/SignificantAccountingPoliciesScheduleOfPropertyAndEquipmentDepreciationRateDetails</Role>
      <ShortName>SIGNIFICANT ACCOUNTING POLICIES (Schedule of Property and Equipment Depreciation Rate) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://pluristem.com/role/SignificantAccountingPoliciesTables</ParentRole>
      <Position>34</Position>
    </Report>
    <Report instance="psti-20170630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>00000035 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Comprehensive Income) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://pluristem.com/role/Disclosure-BASISOFPRESENTATIONANDSIGNIFICANTACCOUNTINGPOLICIESComprehensiveIncomeDetails</Role>
      <ShortName>SIGNIFICANT ACCOUNTING POLICIES (Comprehensive Income) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://pluristem.com/role/SignificantAccountingPoliciesTables</ParentRole>
      <Position>35</Position>
    </Report>
    <Report instance="psti-20170630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>00000036 - Disclosure - MARKETABLE SECURITIES (Schedule of Available-for-sale Marketable Securities) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://pluristem.com/role/psti-mssoamsd1</Role>
      <ShortName>MARKETABLE SECURITIES (Schedule of Available-for-sale Marketable Securities) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://pluristem.com/role/psti-mst1</ParentRole>
      <Position>36</Position>
    </Report>
    <Report instance="psti-20170630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>00000037 - Disclosure - MARKETABLE SECURITIES (Schedule of Investments in Unrealized Loss) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://pluristem.com/role/psti-mssoiiuld</Role>
      <ShortName>MARKETABLE SECURITIES (Schedule of Investments in Unrealized Loss) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://pluristem.com/role/psti-mst1</ParentRole>
      <Position>37</Position>
    </Report>
    <Report instance="psti-20170630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>00000038 - Disclosure - FAIR VALUE OF FINANCIAL INSTRUMENTS (Schedule of Fair Value of Financial Instruments) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://pluristem.com/role/psti-fvofisofvofid1</Role>
      <ShortName>FAIR VALUE OF FINANCIAL INSTRUMENTS (Schedule of Fair Value of Financial Instruments) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://pluristem.com/role/psti-fvofit1</ParentRole>
      <Position>38</Position>
    </Report>
    <Report instance="psti-20170630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>00000039 - Disclosure - OTHER CURRENT ASSETS (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://pluristem.com/role/OtherCurrentAssetsDetails</Role>
      <ShortName>OTHER CURRENT ASSETS (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://pluristem.com/role/OtherCurrentAssetsTables</ParentRole>
      <Position>39</Position>
    </Report>
    <Report instance="psti-20170630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>00000040 - Disclosure - PROPERTY AND EQUIPMENT, NET (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://pluristem.com/role/PropertyAndEquipmentNetDetails</Role>
      <ShortName>PROPERTY AND EQUIPMENT, NET (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://pluristem.com/role/PropertyAndEquipmentNetTables</ParentRole>
      <Position>40</Position>
    </Report>
    <Report instance="psti-20170630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>00000041 - Disclosure - OTHER ACCOUNTS PAYABLE (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://pluristem.com/role/OtherAccountsPayableDetails</Role>
      <ShortName>OTHER ACCOUNTS PAYABLE (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://pluristem.com/role/OtherAccountsPayableTables</ParentRole>
      <Position>41</Position>
    </Report>
    <Report instance="psti-20170630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>00000042 - Disclosure - COMMITMENTS AND CONTINGENCIES (Operating Lease) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://pluristem.com/role/CommitmentsAndContingenciesOperatingLeaseDetails</Role>
      <ShortName>COMMITMENTS AND CONTINGENCIES (Operating Lease) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://pluristem.com/role/CommitmentsAndContingenciesTables</ParentRole>
      <Position>42</Position>
    </Report>
    <Report instance="psti-20170630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>00000043 - Disclosure - COMMITMENTS AND CONTINGENCIES (Other) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://pluristem.com/role/CommitmentsAndContingenciesOtherDetails</Role>
      <ShortName>COMMITMENTS AND CONTINGENCIES (Other) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://pluristem.com/role/CommitmentsAndContingenciesTables</ParentRole>
      <Position>43</Position>
    </Report>
    <Report instance="psti-20170630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>00000044 - Disclosure - STOCKHOLDERS' EQUITY (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://pluristem.com/role/psti-send1</Role>
      <ShortName>STOCKHOLDERS' EQUITY (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://pluristem.com/role/Disclosure-STOCKHOLDERSEQUITYTables</ParentRole>
      <Position>44</Position>
    </Report>
    <Report instance="psti-20170630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>00000045 - Disclosure - STOCKHOLDERS' EQUITY (Summary of Option Activity) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://pluristem.com/role/StockholdersEquitySummaryOfOptionActivityDetails</Role>
      <ShortName>STOCKHOLDERS' EQUITY (Summary of Option Activity) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://pluristem.com/role/Disclosure-STOCKHOLDERSEQUITYTables</ParentRole>
      <Position>45</Position>
    </Report>
    <Report instance="psti-20170630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>00000046 - Disclosure - STOCKHOLDERS' EQUITY (Summary of Option Activity to Non-employee Consultants) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://pluristem.com/role/StockholdersEquitySummaryOfOptionActivityToNon-employeeConsultantsDetails</Role>
      <ShortName>STOCKHOLDERS' EQUITY (Summary of Option Activity to Non-employee Consultants) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://pluristem.com/role/Disclosure-STOCKHOLDERSEQUITYTables</ParentRole>
      <Position>46</Position>
    </Report>
    <Report instance="psti-20170630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>00000047 - Disclosure - STOCKHOLDERS' EQUITY (Schedule of Compensation Expense) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://pluristem.com/role/psti-sesoced1</Role>
      <ShortName>STOCKHOLDERS' EQUITY (Schedule of Compensation Expense) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://pluristem.com/role/Disclosure-STOCKHOLDERSEQUITYTables</ParentRole>
      <Position>47</Position>
    </Report>
    <Report instance="psti-20170630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>00000048 - Disclosure - STOCKHOLDERS' EQUITY (Summary of RSU Activity to Employees and Directors) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://pluristem.com/role/psti-sesorateadd1</Role>
      <ShortName>STOCKHOLDERS' EQUITY (Summary of RSU Activity to Employees and Directors) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://pluristem.com/role/Disclosure-STOCKHOLDERSEQUITYTables</ParentRole>
      <Position>48</Position>
    </Report>
    <Report instance="psti-20170630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>00000049 - Disclosure - STOCKHOLDERS' EQUITY (Summary of RSU Activity to Consultants) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://pluristem.com/role/psti-sesoratcd1</Role>
      <ShortName>STOCKHOLDERS' EQUITY (Summary of RSU Activity to Consultants) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://pluristem.com/role/Disclosure-STOCKHOLDERSEQUITYTables</ParentRole>
      <Position>49</Position>
    </Report>
    <Report instance="psti-20170630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>00000050 - Disclosure - STOCKHOLDERS' EQUITY (Summary of Warrants and Options) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://pluristem.com/role/StockholdersEquitySummaryOfWarrantsAndOptionsDetails</Role>
      <ShortName>STOCKHOLDERS' EQUITY (Summary of Warrants and Options) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://pluristem.com/role/Disclosure-STOCKHOLDERSEQUITYTables</ParentRole>
      <Position>50</Position>
    </Report>
    <Report instance="psti-20170630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>00000051 - Disclosure - FINANCIAL INCOME, NET (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://pluristem.com/role/FinancialIncomeNetDetails</Role>
      <ShortName>FINANCIAL INCOME, NET (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://pluristem.com/role/FinancialIncomeNetTables</ParentRole>
      <Position>51</Position>
    </Report>
    <Report instance="psti-20170630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>00000052 - Disclosure - TAXES ON INCOME (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://pluristem.com/role/TaxesOnIncomeNarrativeDetails</Role>
      <ShortName>TAXES ON INCOME (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://pluristem.com/role/TaxesOnIncomeTables</ParentRole>
      <Position>52</Position>
    </Report>
    <Report instance="psti-20170630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>00000053 - Disclosure - TAXES ON INCOME (Schedule of Significant Components of Deferred Tax Assets) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://pluristem.com/role/TaxesOnIncomeScheduleOfSignificantComponentsOfDeferredTaxAssetsDetails</Role>
      <ShortName>TAXES ON INCOME (Schedule of Significant Components of Deferred Tax Assets) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://pluristem.com/role/TaxesOnIncomeTables</ParentRole>
      <Position>53</Position>
    </Report>
    <Report instance="psti-20170630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>00000054 - Disclosure - SUBSEQUENT EVENTS (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://pluristem.com/role/SubsequentEventsNarrativeDetails</Role>
      <ShortName>SUBSEQUENT EVENTS (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://pluristem.com/role/SubsequentEvents</ParentRole>
      <Position>54</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File>psti-20170630.xml</File>
    <File>psti-20170630.xsd</File>
    <File>psti-20170630_cal.xml</File>
    <File>psti-20170630_def.xml</File>
    <File>psti-20170630_lab.xml</File>
    <File>psti-20170630_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies/>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>81
<FILENAME>0001178913-17-002643-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001178913-17-002643-xbrl.zip
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M8DVD,GVS_'>_[#V_+[>_O<\=M3EA"?%_\N _0VSK"J@Z,%/'R=M(.RM1NDU
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MKMF-6-7ZE+'\3AXTFT=2_#*XY,6-,H@,")&>T[#4]%J"KY%%GI=/8ZXQ-]_
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M&??^SO< M).3>R:@+>#[Q+W>0\V<OEJ.M0R7IS'_"<]O\U&*OT&M WW-F\K
M [R=-CR2_#%XY'>4$/@=/-"_)T+"\7',J6-^#"TD-N?E-&#RX+E(8,$:[RT#
MQ-WM/T.+M'?^N-[?'>=*8% @Q?-5%4AD8CL%T@11M0$2^3<#$M5 BN>K&I#B
MB>W8(O%B8L$2+T7M#R/T/.@8ZS_NOCR-'3?7,2\10#:<?4"<#6Q8B-@KKU!X
M?KK&@YS @XP-"\-#'WB0Z^!![LP^[+:[&AICL&EO8U.H)83428,XY5(01RVD
MF(%.A13OSL<KI(%:SHU,8)3W9RMQ4GWM+I>N0R[&3L-W?@J0_/#OL=,<K/&=
MH.N@/_VTU[S'-SL +G, S. R$%PHBG>8FJ:%K]"!_0 L\\ZY!BLK /99X>&@
M#)@I*6-*&(PH@Q%%)N81&M!Z!3,;^OAI8G<7KFW"$[DD+PF/8V)@AJ:,H6%@
MHA),%)F;J6&$R]!&8C3O@P7TL @]N,""?H51;,!90:6T/)@!*N7I,'B- UX4
MF:1'& #+@>8M\!S+>?'/"B#YS#-C4\[;8< 9&#@4F1%B7[\"8X&DXJV3H029
M2.23"N>K%#]Q3$3'T5.%-*HC#>DS<JU"_)1"$D<&<6JB)4<)<;S<A0'T,M-V
M5A@ND $#4V5[.9];!CQG*.5*@ &I*I!^A0O+L.&)[# J(2C-.H-.5>A\@<"'
M^/#Y;KGRW%>RLSM''!V0 P-5@U/\;S#X[G@0V#CU_\YYA7Z 1?096,X7US\1
MI%4_;2TE%@:\BF?Z#&SC 5M?1W,9U,2%8*:OP++Q#>PGUWL"-GR"1NA9@84<
M"1"$N%[)'.UP<*]JG)CN/R\\-WQ9/$.'_#EN()&**H1-1"W6SVRUE3:$P^!4
M56*),P9OY7IH7F[@+$B\B8&N.>BJ&-JOX!^NASU%-.5X*F(7,ECO2,L>C!R8
M.*80^[-Y[Y#)C.=R.[=,'TKKPT$),G4X)76(7_49;4X]!TN$J<,HU(&0?WC6
MF#)4G$H&\R8P/RLP_68%"\N))<8\BS(8RQ$9<R5&#7CF.XP$\,Q9:-.^9V7,
M<$X+SK=5;G-GB$'\V+0Q#%?"\$G 96/5/@'+^Q78(;QS5F'@?X&OT!8REF_[
MS%<(?"0V<IW]B&7IG4QMMBV/']?;?_X=C0,\8[$F4DG;F@-R:]<*)@A+B/^3
M!_\9[FI [3U\8*88P&V1 ;P6P$4&</H ?BP*?.S [3DD_J2PP2+,J8DP']I*
ML/!P&L+#!T8!"]"E+D!W8$2P:/\3G_<2$=8GE23,,G%;A\<I)=BR+-9*\"CR
M(UA[!AK:,PSL.TS#P%VZ,^L\W8<][D]U]HO+>B>JT_B!9QD!-$G]N>^.%?B/
M3]]/ Q4%?7 /\CSH,D)?Q?+"HD8,-H/"AH)-2'QO?>TZ?FCC(4]D+=GUK_[L
MNJ:/5I-OK@,WO;.C]JC^LP<<'QBX5O#']5.X0B^%7N(">T\JS#TM$0/!L$0E
ME@;V5H]T*!X[1CIOT#Q.,.Q6'BWAO&JIEF"WWQ_'/OL%+<$09T.O&%H=3U3K
MNF5@#A[&W*.(9CD7>7P?+0=$31+N'#/$3C$V3C[$ 2EHA;O! 2<NV7U_<D/'
M),^>AJG.[ S(ZEQ?&D,K^"A<PJ<E(NPK<IK6GY&;="+7WWDXRF7T]!?W(B/#
MYIV9A@IP^09__.YZ?WZTT3;K&F*/&;G5IPN: ^PRZ)1851A<AH)+_RN,F-@N
MB)>BGCAL"CQ@!.[(DVG:/FM*"65H:U*]3WD\RYTN1/*EP._ZE*-_CWL3&K-3
M3<XQWUU;;>%2E#<:^]TQH?<#YX$Y+],7#\+Q!\2:T/KP!;X ^Y;0F]#$ \P.
M:[/QC'1JL\D8.S>/(6!X!*3,13P_E9V\)'#ZWA_<QNL@7A9O+ _B%>Y$[IB>
MK<"&]_,[Q[1>+3,$=@)"!]@>>F6G<Y^@,-C0!9O$VJ/T>/?(YI^^^1_X1#*Q
MFSH#".QSRQ:,$@L& \DY+0]LMD]Z,9 2BX&<"4K:+)$D%O1^=;)WW-L2347\
M#KHL2'66!7G8JZH#SM5YQ%=WYGFV '.J@KS'Y0&5PNX9;*RZ0185"G82OAO#
M*<,IE5[G#J<JCG+>X/0IG/FDI%9P^[J] #CI,*D,Q_L8S15)I_X!/:%::32J
MB2O8KM"H7_+R830RP/4_\WA6NKZ&36YACJ-@6\DV^ J\/V%PY_LA< R("[CZ
M)W);2Y.)>H2DK]\#,DKK1%Q/LHQNB9D8^BJYUJ8F"?Z^]^_/T%@XKNV^6 :P
M'SPXAYX'S5L<5;?R+!^>!L"+LM((KLJ)@&V7J\:\KZ!A 9L![$,E23"<5<19
MH20W#R22EJ8>!&< N ;@JN0V;+KV?H;NBP=6"PSL!!FY@F?X;AO?^(SC?G[M
MAD[@K1FZ^T)WCM@9MCOQ/L_7D+?E,C"K3AORS],39EYO)Y;SK#!TD'.&H\9Q
MH"QLHTYH6(/;&!:MT>147[_DI?*G^F.'[3CN=K*GXGB.Z#L5KPR>DRK51<.=
M#Z7EPNA ;(CL/X'K]Z>;/; MH[YCOUB^*XF"^@$]LWG9YJOT$/AM!>\/?1-1
MY>.$^[UQR.J8PSC^\;=P"3T0N#FS7X' +)%Y;TT,>@,==XF+5!T>-IXYS)-?
M;MR\%V^^3TFAA$1)\0*_<-*.$U=BC(<P9[K2(ZS0/VN_W[*+&=A,ZMV7I]KO
MAZ'G'AU@:PG*#+!KI(!OB7&_U5VCU<C2!%RL:8]P_O.[NUVHWCL.OXA\BK6-
M,Z%A+8'M__SN<O+N%T&5!!G9YK^]+S%$76H*XD];:XQZF$-!%#6*.*S5&?,@
MAXJ@J3TQJ);"E"PH4K\$]8TI7A8G%''8/J8D11+J,DBV>#B2!9HW(1[P@3@&
MT<J!;+NQ #[:GTY]'P9^BN78>YU<"MM:0.3?$R%!;;P")0B^^_;IW2\B-F-)
MBBN1D>6!=+G$?0T]N,"NW2N,#FZ^N+[_#0;W\V?PEB+]9K>7_./9_:.LKLB"
MGB*ZS+BMT"JE:)7+T'JI444L;KVY=!TRS?F0?O.M#XYE__PN\$+XCGO?"BUR
MBI:-Q9\:1K@,29A7T5O+J-VEHO##B#B?K4>D\I8#S5O@.4B#_,'E3-6<FZ85
M%91] )9YYUR#E14 NT>Z\O6"6KI:TA'*S!!:5Z'UBE=&'Z]?!)NX\27T!I?X
M0.I;JIW1P$(KII%&"UVBAV#_EK$$4<.:HA($TH+#@T)LQVX.XFJ6FH(AC51)
MP:-7?'<\"&SK7Q#A^!7Z 8DC093C$?J2_PW:PKR" #T;;5N^6&!FV60S-@VV
MNS[TZR'/7XY-5>=,='#$DCXC*\U!JZSW==;1Z?P-<YPAZ@TG, IVSS]1(,\^
MD!?"!QL8A+XV-MR"($3G:)5'[YCLX\X&N8MTW>"2YR_Y8D@UIZ_E[7C?A#9;
M_+JBJK8OV=E\MN%'=J4,E8C+:+C.4ZKA%&I0.]OOS'9.U7DZ)V!(R]#!!CXM
M=BJD3FJIQU*7XN+PASWX^")Q0*K1E,@IK,A'J:9 UG+4'V!'M7@I:D=DK2E#
M4EWW>*A38<=75^V[; 57:BI_G)E\FEKEYK">%ET'TD#[,6TMH'U"">T'=;8S
MN>^W2<&^!W(\2$>^J><!YX7\X.-Z]\@#6).L'1Q^?/O/T K6=XZ/UD2R520.
MS/,".%$Y1/^;2PYPH/DM).%[!9$S.5V.C[.OI.^@^^*!#N$51HD42$L1>%7"
MP==,7@>;:Q\5I(2C'\Y=C*W7-SPJ=K1]4Q1!/W?!MUZP[[CAX!5)/W'#04J7
M^7=.M&:6O;NH;T-$=2++:A\B37,V$HDVKP9\'-6RJDL3^92GX%>B2CV"6E;Y
M?D"=YFPD$NT!U.)$F(C].">'I^ VW6$QGXRMM2<C^L]N .SD]]>N'WQS@]\A
MXMEP7QQ\'1P-]\GUXH_P<T+U6_"#&:D/TN\["?;+2<GPWN@2CWR,7K!I8]G&
M-9BHI&.M*Q'0 _75;L.$XQ>LS6CLZ4:L2V+;"0GI@K)*4RT.--7U[Z,F.MV:
MUH UZJT(I1K:3]!K-S0.:T4&"(-M;$ZJ7M-HF32A@;1J)^IMXE!,_BZQ_>[+
M4X(7G .:-7Z;<W=JF*EV]]2#\8Y\_"[\I*(3-CPC4LFDKJZYJNX2%'"E5\A4
MZX&I.O<\[4X,WMDCDT;*8J/]F^>^H%_YMV]HMX(6_!"_PB&*;'X,XUT+=@!:
MN1Y7T[FJ-4GI@J.=(9 35@VS5,6J\1FKUI#!Z&)ON^7\[+HF/CU(%!;:3'*B
MU/G_A(#4K+B?[[)'G]V/L1TJV"N+">N'0*DGCH$"#^"CBHKZU@'IQ><\Y=X>
M.[!X\XTWY/G33R[ X^DO$:8RX<6"2\A:-&U8Q/W/;XDH'N&+A2"$Y/(-+&')
M--A?'KY\?[Q[>K[]RCW__?9Q^G#[_?GN^HF[^W;]M_=%[TZ.?>,:Y-@G,BRW
M41&2LH.+B:)-A2]+CA;G-G^R? /8OT/@51SP,CE:T<OV1?O)LI'GC[YZ<;UU
MV;'0S@':N+((4B7R@J1 4V_,D^>.JD_HD_T%XH!$T[+,O"@YUA1];Y)G;/!2
M=H0Y0C2,ADC]OFSJQRYA8Y.F<>_L K_]J6?Y:)U*KE;-,KOKIJBT2&>=TS4M
M'1K?/I4]RZ&\^]Q\POZ.]FJ(FAV]NS6B=7BEITT7I8K35H_6P612IT"!0*X:
M3E4JM5-6!5X5J!(+?N4C-&S@^];<,J(+(/,?8914A_F<WE_?I;1_&-/<)J&U
M;C[*P;D!F7U+HBZ()65<DL";78#+L.X4ITWS+_'E5NW&Q XGE3H+@)@Y63DQ
ML=1> 219I4\NF]\\N!X9)P@\:Q:2&E//[@/8*XC58XFE R1US6%?A9D&8K'7
MNAL5>,QY4YOV^E)4LSG(!T9L0EPMLRE+NM(U<;5G7ISH?&WJ.HN5:1P(>Z3B
M@*:E>>Z,D?U#J&N(#UCM.\>$;_\-2Q]#)4L\%[ZL^ 1J$WQ4X0SJT^]Y)U")
M%^6-ALM!EQU X"__.ST$_G5KP7UQW-I]&."VL'C#]1NT7A9X_EZA!U[@[1OT
M#,O'V6(&+(.XWX"WZWB\C?)+ON41$W7O[,<2)&LE[]WV7$EM1/!5XW?\8G[^
MX582LWBEM1']>W9B7GBP&I[EJU8B4D]&T-O%!2]3T>N/"?V3&^[?OQV2.<]D
MWECFR-VI*'-%9#)O)/,GZZWB4ID*BV BKR%R^ J=B@NGWD:2QSD+_1:/6$GH
MDRN9&?1F0O]F573$)U<:DWDSF3]7M"W2U41C(F]F6^S*%EUB.\[&0/\![8K^
MHL+,2V.I+RPO@!71KEV)3.[-]Z.5Y2Z>^Z9T$\1>J2C#80=%5<Y9H.43K,MO
M;<[:_<@@=+^!;>DC/^90M"%'_DJEY$AI=GS86>5A'^$26#A=<)-E$ +[&7I+
ML6I"?^6;F%\>Y-_YKZ)XDY%NOVR>KJ1WES&_/$Q^9T+N1LB)JYA?'OC?Q:^"
MS@!=4=;-;F.P'9E\%14F]A[$OKN0^>5!0&(7!";V[L6^NY/!4A>^BBJ3>@]2
M3QSB8=LN\%\%G@F^>\$GKV:(X+^*3.X]R#UQ.\/$WI_8GU-61F92[\?(V%GS
MS@3?#]R3US18\-)78<($WX/@TS<U,>:9*]G3=C4E>O%WE:&^O.A+W"Y@..M?
M19G)M)I,<P[&<?75"74'6=>[NE,/P+OWG@)< "1J+@,],GI19XL*$;M\LLIZ
MB2&;4EG80J)'0LGW_C0,%JZWE^J3+\;H)P7=4+*Y2T7CU"6I:MN-EJG**>)4
M24@:+RJ:KNL'J,DOME2&DJJRT15]HJE:=6*B1J)QI9\2PL@KW"3+F32\U$O+
MCUC(=&YK5$1=A4$-PPV=P$<V#:=3-N)75#-9[/DOKT%"%0$(NJ+4H\)#,$AT
MCFTD"V&BZ%DJ\M]?CY!*$I&4O7DI34M2=%&.;B.QJ+QP:'*2(]0EIAI8M$E=
M>MJ"BJRJZ>DY/B\M@D.6!*GBZ ^N'T0^%?&,H /GUJ[G\AIY7$83>>A">BTK
M/5P[=%81GBZU1"K!64+R364H"!F'H'B FJ14$I.84\^@%#$MBD3D,[AJB8!*
MYD;+K JE:$AX+,3EK0F)(@>1O+/2F)58KC1L04'XFASKFI0I(%;P_CID5'+*
M!%43:U&2+7J>J"I_@XR+8=74ADM!$=1,%9GC8S6DKHK(+@5-ES-USJH3F-"O
MJ6,FZK'[4?>9>L*39#U3)_W8.(WHJB*VB2I/"M?S4J1= W^!'L3_P0^\ AN9
M)'\:7 //6R.I-S!!BBBFO:U28[5#8+D";:*2Z?C9(X52*>A)^B BK()!2>75
MYC1^L0SH^-!_Q/=8X7Z)#^&2UW8E/LA?1VN#9X]),F/L.9">:T!HDEX.U^0X
M$6E-&X2(64)R1TJ5Z)Z^ LO&6Y*X6M=7X/T)20FD1-6NPI:.DTM!+-6K6, U
M7W#&<\5!J[1+> @]8P%\>#^/CB;R3G0)P?&)[C[QN7Y&=B-3A80]!R##^([=
MIOLM:2)K:4?@V%!9VG:U#O/JZGZ#K519(X8Z0>7109M36:>@IJ3U267]DE>9
M@['*=)9H)I0LE%;37R;23!^&5!FU(Z*3G930L[NBMG>D.!;>:6^D6*82%TU<
M5CNJTO=.%.F@>WMSW/)$M<SPH=]\A'/7@]E2F0>K=AZZ0F]7$&5K@Y=@9'\#
MEWZ0E 0]+N9X93I>W+H_(64KZ+;)67GO8+K$)2KSNG^4M\*RKDY*>@BIX=J@
MLJ#U>K13W+T@'0]2/-!70!K0_&8%"\NY=R!N)E%*]9$0=$ID$#/YV7V%GH-1
M>0-G07^B4#-U(X<'P[7KK5S<G:1?04B3P1"1<D;:![NH90S\J8!].@^@%TOB
M>>&YX<L"9]C@/TO9=%50:9CRPX#O7 H('(.M!Y60WY31B2#RE.A!N[:."&8K
MBE@TS] I#X%QF+X1\UEI)S;1L]=*0Q':'P2',\7=<5Q.S4]1+@>M="MB$67Y
M] 13RCTZUOBF[/'O>.1R3$/$H?>S55G.\>';4 II;+8B3PXMZ( @GX(@#A^.
M'#O@T+6QV8$:&UM![\1/RDH\<:[WV7-]/]UY,CH2K7\KHAR9J9K4],$D+<=Y
MLG[X@&,\(ASX-% XK$_CD>/ AXF'UQ^*Q=CQ4:0B'';5*)8,U2>9XDD ;N"#
MT"/N\TB$V/VI^:FLM90=P@IC%6N_9[BC%5.E@'Y^O,9HL!-D)K!.#J#/4:R=
MGU^?I79W?OA]Y"#X',5ZY$K\\(7XZ0FLHY/W<S.271W<,S$V.O;'60Y,A$=E
M=#CB<7 9[>*L:U\JB'Q;=PHI8OK@D9([A=.18.]7"F^^]<&Q[)_?!5X(WW'O
M!T1-;\?_0_#<[5D]4X"V7.ZAL='[L?K0#)\(2[0=5X]C6NGGJ5(Z]]B-< _'
MP,//X?!GMF.30?<!PN>H-QT<L)X4L!AD.CD+'1%&6CNX'#G/34X96[N:'K&B
MT"BAW0OK%L^5A+))-35IH>1P3Q#UTKD2[7 Z=):_7C8;H-V)'2J77RI;U*"Y
M3G4!3TG0#SLC=,.S>81AV7H%+4S?X-GW<MFD]#ZPVCS'_D@J!MV6IG$0VI&
MB@$FDV9N*F7%RX+2#[3ZCUSL9W&FYK!J/-SWD,>N]+/2TW*>E''4>O)S^L])
ME\MFIO;+6%>9YW3J<&?YY>-AM\E!CS 12F>1#\[I,58F'3BFUX@3RPG=,'-D
M\^#Z%BX*^07Z:-T$3MRS%3V]\#\!RVO29D,L7]^Y"75#"*&*.YCM=#(:,0AB
M-$3BT \_5K>D<MG2)PW)&T8.E5*FRJHW-9)( N[>^^(Z+\C=;F8=9*4M/!PD
M;@@95&L*5/;\CQ(Q;+"V&:(5XY#MRM<5=<.(81#;4%$26Z1\@P%I!+%MU5;F
M2&O[ZSMG%0;^%_@*;2'CUFV?^0J!CSPC[-#ZCY@?W)&B7*D@44Q[%,54=\^?
MV#I_BIC9BG7%7K;^>$_3Q\N9K+<A^6M_^B1]HE1D+VHM\_+BP1>DF)\]$(T)
MT0:^9+/?7!,BQ2<UAU[?D(3-_N=I";P 61JX)C\MJ<;5J'N GH%F [S ^_G_
MA,C4S2UHWKZMH&-:9(]5N<W+0YC;:UO>4'5TQ!1]C^X:V,'Z$7&!;71N%Y]#
MY?^_6HZU#)=[LBN@DI_$5&;';9<H\%:)**E+HDJ"K8@VN2)MFY:WS@%UJ TS
MX6H+_N-#-J'PN#R_P1^_N]Z?'VW7-:\1WJ%WYQBEI2KFB+4\&Q:I=!<Z 6[Z
M.'7,N!-S?4<Z[G5]?(B]SA\1^9]#@&F&V+5:+BW2=B/^?0-3+.J99AQ'!VN5
MO&HSG;=-R]SY5J=_:MNN@=U.TF?M(_!Q9<,E,J4^Z49"K*H/JYJG1^@'GF7@
MU^+F9M\1"_[CT_=25X5BMHI\*0K[X>N6]$R&D'!UO\)O*E=+=U".<OJ E9NI
MY%,0> 9NCGB#W3-WA2$5#UE& KK"#R."PH9M1SAOS+$@90\6:6?Y,W2@!VQL
MBLTE<GK0LZ3-6P6F15%51\7TL2:U0VGNS4YM8W:4MF#[Q[7K^*$=8 ^@E!!&
M!N,.1"!,A''!H)0J5Y:")(\+"=U((=OTC'8L5.5/D\8URU7-&3\0?R6<L4+W
MLCU'3!0'Y5Y*<"_WS_U 9KPU/[P%%TW0^8',>"L*T(:3.F(-: , X]M=MV<
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ML8Z_(L4FD<0/V"ZX#O)/W1<'KW5WSN86N:4[#55)SUJ+Y/7)>2G,'#O1[8K
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MO7#D>A,S243<'GI[/3)B\>W5CR>&;G<7FBZ47WQG2J[GH?^;%:!-Q[T#?X?
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ME4?BGTQ4"KDJA:<BMG194G5-;YLM?.61O?9PS%;O%D1%X-.K1OE!4Z[;LQL
M.W*8IK@C!#2?W6O;0DO BP>6!5>R6D+46BH8X?;[8X)P&'KN_N%E\F;Y\/#M
M4WKD=%*M2=MTB2\3[^>%3T]MVS5P-!+ZT%VN@+/N0+3D8&-W:5^=IIYX.N;]
M=<?%9D]P[3J;L#GRRK*A!W$-QH]Q7 >P[QPSQ!>>N%5+GHOZ"8UN@EV/U2/7
M(<6<%U&>R^R-Y4$C(#],B.=Y 0_/4]_LRIJ\S^XQVM,V 5DVY%&Y:V#'V[Y#
MN\T#+#XMT<;QJ^O Z"V;*)('^?>-,2@<*450:L6(RG(BZC_")]=&&U3/#5\6
MI'GK#\\*H+<MVUFP#@B7HKRA</LSM/Y4+O<I2+PF*)--:8>:5.9RNBD"00VO
MFB1INL9G6*U,9OJ (]X6&>BW)+IU4WWU?IX(_\W#G)H(/JS%96ZE,5%.&(IR
MQ.TY*3;P_:U<[KU'[/FD>@COA!9_ZPMY<Y?M=!C_:(^1T#=7T//QI.WG)UUI
MB1YPM4CKC+]:LW:(6>%*XEMF-C]C:XI_]4((_+C>/1*'\9'E(ZZ=E?!M(X7)
M$X22-IF;/N(^<82QT7:]_8CF(H.DJKA>WK'&UPTX&$1$:HLBPAW4Y).34 9$
MW]"2NQ%2Z63&";Z>.#7!J,T%@Y1*')5@/KG>'%I!B)BY<Z(,U(I^6R,-TR6>
M;U/#<MBA3V*U@,5G QFI%U2\@I+ WE&:ZST&:)!0+? HDI;L\4R]8'Z%/CX"
M=,S;.'[_V<4?C=X!*,L7Q?*D857L3(Q^.>#O;&;FM#JU:>AD'3VTJ^&O%+&"
MD%ME=E2B/HCAPQ*N!.-A)5S> X@T*>[]32>VI2M)[\3[J<[[F">B-O(%_DK7
M3G0"$NY,:5$W<38.'\.U*>:2G-$KT :66AV_'(_[.2>&UV8,CT[\3=!=Q=/K
M7^JSX]3,*NO:(UP""U?MP,G\'C""$-CX4E!HT1OYY8'_7?\JRC<9\?;+T/AD
MF@/E7QXFOPO"5^&T1%F@+">'VO;X/)D9R,6X]/ODJZ"/1_#M7$;<H9$LQ[>,
M8Z4+JGD:N:'R0JL'WX5,T"2M@XY!;CB"/J"0VC'HZ8&*X@"ZPU0G7% EK\JH
MRN1C]RRF]CW:! '3EQ</OH  CM>2U69R3-(>VA)2(^0H!G5S/$8"SGJX=I9P
ME_;VI)G#1.L7!^DQ:#@[;?G6H#R#K6$09S0$ZSM2KI"02(K5/"^ DS[/A6;[
M022)TIV;NE8DFO([$KW_^/2]? 2%JLN3%K!<71BI0-;NQDV;J$/&M91(6[E!
MEW55$P1IT]"N)][WDS9W ?RDX%^^;-1D7=*G<.;#?X9HL-M7N(DO/1RL?B2I
M(KTR96G:4U9C <W0AO?S3R&^*/F*]GC+</F(:,&5AHEL,-32]4_]9_RN9\3;
M1[L@'OI@0<?<8JRDE*-IO>Y79GPO7(ER87E&'Y=GS"WX^!,7%82\M.$<O6HB
M7TGR*B"5'*<^KL#X7Z$#N0E_P6$B+SBP662Y922&J#PC8F^YM.)$KA"'!9/2
MC6@/;+U";EL!)GX8;&*%?0YAC ,^-W=MV_WA?R"%'1&#I,@C+A\9_4^::]MR
MX.6"F%O$/.([JEH)EJN?_DU0^)\.OF3W(?H[(!C$[7G^!7@=S,6Y 41#E33)
MU%4>5SR;S,P) ',9O.,,:-O^"AB(CY_?\='?*V":F[^)8']^9R"^, 1GKH?$
M0+XI7T<SGJ@?EADL/G J_Y=W:7J]])_FYM5HS0DL ]B;V9VY =*.G[CLYX&[
M2K^Q'3!A\&20I%SI"$CQ8Q9"!'[Y9?0I(>%W"#P.DJWM%F3[,X<_",R&7$>?
MYZ%D_]6&BR<9S:/XKLMA'/>'!U8_OXO^6W.H_4DH,?C[)(C:!-86MIKVEY^X
M&3#^?/%P#M0E$JGK?>#^S3 @G,]IP1^R9UJG>-O*0S@NCF-P:0D>54AJ.D/D
M+?_>L823#'IX0=ARJ/?$H:9)97GL2.=;P]EPEF%._H\BRZ /:AF2XJ#$,O1,
M4BE=;A,U(]'ETM/ 5OF-+HL\6^4')6F@=5FG79?9NEQ=EP6V+I_ANJSSM.LR
M#>MR?!9U&3WT@1-7;^-;K,6.%?R0D(9;+J.SPBU1_Q9U',+$<;YK6R:5:WPU
MHH?Q B2Y-*!:LARY !NC:Y!E1"IA3NCR%TC1LI[MB73<GO2P9!>H)B*.,]UP
M9L-F*]PHC@8KRF 8ST:ZJ' *W9&%DNI8J'H.#_D;W[FE/XIY3X0$M''E2L4]
M[C1$,G9GN'TA-7>X<\)^A:M<QW4N#5Q%RR;WI6.XSI7FLFF*LYFNJ8:DF/+,
M4&<&D$6@ T$P%)%=YQY9;-D=+;NC[094[.)U<)*&V8R)HDSY,0X-^ZY!MUCL
M_I,.DH;9C0A2WZ<E[)RU1:WM_*:3'9Z>U>&IJK*STU,Y.V4'HNQ =!0'HE+?
M5[WG=AP:M0)P'0_.<8,*G#AION+#/5+-'=<K\._G7RP#MY/+;U2 NR<)42N3
MN'N24*:9B<PG6WI4I2!%/DGL3)7TCSMB7(,XTPO/M+W&U?]AW-A@^H*E]+ =
M8!HL\]G;=2M(GNKJE[Q<+B5I&GP%WI\PV+0>> )VW%AB"<ME*&E\2E1M<[O7
M$!H&N%O2@^>^6B8T/ZZ_^SAE;HNF*<[BL0*K;D.V;-MA01'2"=CE"6B1]%K]
MFWDEVPN\;])K=WL6-%D4NZ4]:JS5.F(D4=?*$)XS?(N$U^DN*L@3=5C*:_=K
MG BEP%*?\D^6@ZQCZV 19%4O)?.<\5NDO$Z#3E7D2]G%[BBOBQ:-;RIRLM#E
M-NN9.N:FY\LCM*,66/\%G!!XZ^<?:#5;/^'NEP&$SOU\CE9#YP6-?C_?O LW
M&O6CG.BJ=[<)(FHVE^J8H7Z$MU\AI+YJ"MK.K>F6X*%DTQ!71&SX!ON3ZP:7
M/'\I",4=;2GD;6IN6O(]  NI_#5866B34JIB#(-'7 MB4XF =# CQ"Q<&VV-
M\J4X)G081K@,R8BD;@3>QWAP@39ZUBN\<PQW"4?/XR,,@.5 \Q9XN!9@0;&D
M8TVJ,UOYU+Y_L^._"2%>4U\A#M,XU#_W2%6)P\ZWG/8#JQ.692W9GB]Y>($!
MT9%3J*0K?E2DH&T&2OF&QP#2A(CR;MY!O;MVO96+P "? A"$@8LT"[P]HK_O
M'1SC@8#VC(B!8!YD&IJ4F<6',+> D[AQK:H,7H%JM9CJX\63GJ&Q<%S;?<'G
M,0\>1';%0X8 !Y"M/,O?MVVY3%X)8BD>U4%X+&1K\T"B!>X4#5&.9_Z*5V6*
MN2XWLXU$T+T$%%JF6B_%IU*%M4XAC:MS8><B= )O799+02G'9:W91-9_;J&%
M%CDNK\C.DTZWB'C;AJ3J,/H:+=-!U>;63RO$!*Y9W(H9XTL(H"0?Y<2"EK\;
M"Q\X.*9_8^&":K.0^'UWCHD_1R_T[SWT%+1>'#2G^,D@^2192_?YC8EL"U5'
M!2?RQP37,:<-Q1V/&UU2%/@>96UM5>$AZR+5EEZ6\*S/%1UV$E?KSKF!LP#I
M;G37@W=K46F\)VB$'G&YT)?7"+QH,_#L >QN3WT?DEDP;-='Q.<G%10[1_F9
M S.T-6P8%_#M_OF6FWRXY+Y.'__[]GGZ\<LM]W1[_?WQ[OGN]JE)$#]Z:.85
M/\.]S[WY+!REW02R(XD2'-HLX7\H%QRP;?PU+FD77[U%M[R:**@_^?BM,0;0
MR)OIYWX@H\X9N*6U-;>@B?,BP"NP2 [%Y=SU+GU@PZN!^6Z89B&HAJ;/9%6$
MQES2%0, 25(TG=<FO #F0"J=9D&B#5K)LM"EO2R+S;NVV!-7;^\ZBG?9OKJC
M2);:XVV3)@2M<JP$"6HZ'K*&Y^KR1RQD;)?24(Q3:3!A*46C(*CL]*:L;*#A
MD=B=^JM+P6PK-,84#A8M.%XK4C?UJC$BFX(1OQ2_J0#G)6+4IDL7<?8OB*7A
M$SGA=^!O@I&"^RR!U(II(Z7S*_APK0P:.AY$GR($]CWR"]K-,(PSC)\RQNU<
M;AG&6\=XJ5U%'P GEV:7P0(XEP%<XD,C;\U9:)]O>?BPAX'AS S>)S3Q?5N=
M5QQKP)!V9DA+;268H3FWZ3\SSXKM'AC&3QWC;/? =@]L]W#.!H_M'FBZ6:E;
M**-96$7FQEV[4O9+U?)7ZB;X8"\L@+M$+\"1U3[WPPH6EL.Y#N36$'@Y-15;
MU=Z&Y5#:T.%F%'16F6B@0C%L/MA\L/F@<#XB!Y1-!A63P92#S0>;#S8?;#[8
M?+#%?.23<<K*T>UI1QP#+_(4].<Y<NA!LO1)C@7^[HVS+>=/B"<M@*4/T,^Q
M^G33>>NEUF1Q(4FYKUK6PH6N]=U:A\*JXH,3P+#>.8?B!2^<3(=,!G4&]6(.
M_RKU791\\$G]3^8-,;5IJC:JPO2&Z0W3FZJ[B,F%P'81%!# L-['CEG62S?^
M8EAG6!\QUA'4V8YY> (8U+MW_45^3 X,<_U'(>$ST)L)4QNF-DQMJGI6XH4^
MJC-:>F_KNVT:6^VV_K.+F'!(KS03SM!_2&["M@JB\!,WM]X@OLL/(/HFX'#A
MS4'-">OR7LH M-XU5I!IU_X>IF%P BB4"0709, <G  *93(\,"\9, <G@$*9
M,&!2, F#$T"A3(8'IB#3?CK#H#DX2<- 4]7ZKG%-X30,3@"%,AD>FH+(D#DX
M 13*9'AD,D=S> (HE D#)@63,#@!%,ID>&"J^LGL@'KOK3*J1-EM'SMZ;MX.
MB72XV_WC#:HH#,&K1O0P=_J]W^>7*BU(P>0Q/3@K/>C[_I"I 5,#"M6@[RT1
M4P.F!DP-F!HP-:!1#:2^CR&8'C ]H%$/)GWGSC)%8(I H2*PPR*F!E01S;8'
M-,T=4P.F!DP-F!J<EQI(4M]!H?TJ C6)LBP&IJ-X$^I2USN(CKT0=!8A.SP!
M#.N=<XA+1K,TA>$)8%#OG$/Z2T:WSO*PA7R8VIR$VM!?,IKIS>@D?/IZ(TPN
M)M37%F6N%<-Z.SMF3618'YX AO7NL7ZA"!,&]<$)8%#OWO6GOV0T<_U')^$S
MT!OJ2T8SM1F=A$]?;03I0M!/IC8G_0V>9ZYMMIR\3D:<O@++!C,;7LY=[]('
M-N0NT<-1PCJ8!]#C7 =R:P@\+E@@PE\6W-QZC3[Q/PQJ27H(4Z$P<J917,Q@
M[=<'%]O@!% H$P8E!B4&)08ENF3"H,2@Q*#$H$273!B4&)08E!B4Z)()@Q*#
M$H,2@Q)=,CEK*%&35=?TGH>UGZ1 6\^B++:DC.D.G@5IG1$T118^.#P!%,ID
M>&2R)A?#$T"A3!@P*9B$P0F@4";# U,ZG8 U!LW3@J8JC"EOET'SC* I,F0.
M3P"%,AD>F<S1')X "F7"@$G!) Q. (4R&1Z8JG0RB?^L_Z3,>DU6HXH5RNVH
M4*YP(<IRSX:%U8QFJD"A*K!&&DP-J")Z&#7XZ^C;KK8BAJXK+3"M.BNM8GTY
MF!I01?1@VPUE].L+4P6F"BU<SEU(?-\1BDP5F"I0J J]=PQ@>L#T@$(]8)L$
MI@94$<W4@*:Y8VIP5FJ -@@R?]*J0$V^+8ND8=5T:Y]HJ2S1D ("&-0[YW#2
M]VK$<,YP/D1?@3'EFHWBLIMIS>EK#8N<'YX !O,^_'V9-:T?G@ &]>[]_0M!
M9"[_\ 0PJ/>07<5P/C@!#.?,26<P9S!G,&<P9S OYZ#K)^.XG&4CQ\(*S"6:
M.^YZ.6[;.P;08=T=:2#I[$JG,R@Q* TNML$)H% F#$H,2@Q*#$ITR81!B4&)
M08E!B2Z9,"@Q*#$H,2C1)1,&)08E!B7:L\WJE)VEJ>7C:92B[>%>L_U\5^J(
M'BBR=I150'J8/*8'YZ4'3 V8&M!$]'G$<#$U8&K U("I 5,#&M5 Z+O-/-,#
MI@<4ZH&H,SU@>D 3T6R33-/<,34X*S5@NP.F!E01S=2 IKEC:G!6:M![@;Y^
M]8"^"_P>0C;.L>CS*-)_QU!">IQ7ZDRKF%91K55,J9A2,:5J5P:CW,(QI6)*
MQ92**153JC-2JG&&(C"M8EI%LU:-,["!:173*IJUBAU5,*5B2L5V54RIF%(Q
MI6)*Q93JK)1JG $AI?';;T"(U%9%AS[K2#^[ ; [UH1#@J(N8 L1QYEN.+/A
M&92HKRB#@4+Y)Q?ZI.^6:KF8I3#LD.D6TZTFIZH7O#1T#!A3+:9:)ZA:?Y6&
MO@=LK%BMR*'KWM%,39F:-E%351G] LCTE.GIJ>NI(%\(2M_-S)BKRG3K/'1+
M5R=,MYAN,=UJ7;<N%&WT&T&F6DRUZ%.MOXK\Z#6+;=V8GIZ\GDZ8FC(U96I*
MN9H*ZH4DR&/7U/(!0>1OW$(]_5&*]QS!VI8#+Q<03Q$B"(DV&A<]-/.*G^'>
M5QNE06^7?X1^8,W7F3B@B70E;&)^%I";N[;M_D"2YX@(N)4'?>@$/H=$Z_M<
MZ'@0O>Y?T.1L]#?N*>^8W!Q8'O<*[!#]/7<]+EBX/N0LYQ7ZP9+\.EB @/L!
M/?PI^DGV/=S*]:W <M%W/N?.N?\*'<A-^ M.Y 65#)'\1+D@'P6(7!LZ+\$"
M_R1 ?$?#[(^^ *^0FT'HD-$Y \G0<D(W]-.#?QAF!M3M!&1 6D1)6N7(-%GF
MS^_^)9HF,&554PR=EW2@ W,VG\WYF3!3!%.8&.\X ]JVOP(&FM^?W_'1W[&F
MD;\)G3^_(W;F76R=R!=[O!]C.U9,7?I+VA)U67:I[WC:<N,A8X1$CJ2JU#:&
MQT)&.XL;-"!NVQ2M B*W1&];(/WTD-KY_L +0FZ$*$- APCXC$PV^C<VL@ZW
MA<-(8=![33C*H2F.&IJ?L /R*W9 1@I'-O7UK9(;K47XG57]E*2+GG'$\2OP
M)QE/E>'KS/#%3,O93CTS+<-[4INS+K'[PZZF*5/3_:.+CH\/!S_#/?D#VN+3
M5[TG#C6E[P(W% 8$#$X  WH/M_9]1W$./JE=7_PQM3E]M1%X941JP]8'!O2Z
MZT.CG9B8VGFQE8:^K5R;14Q*;N4*MFVE#6HGUJJ'*CPG7V.GLK5JOX#BA2CW
M'=U&816JP0E@4.^<P[\*4M\Y0H//ZK [-Z8WIZ WLC(FM6$+! -ZW05"Z3MZ
M>/!)K;'?LNN%'1LV!![A?/$3-]889"41@7SM+E? 67/!>H6GUE['H;P^#MY=
M(++M]:4' H@4 AJA9P46]*^XWQ;0X2".008!B5Y>I$. <5@R$A'T+G'XVF4
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MOGFJ%S$9F=J+4& !FM:[\)B=SN>,:UK7M-X'K3-2UQYS_PO0I-Z^Z6^-AV3
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MT](F?_\+T*3>07>5IO/>%Z#I7!OIFLPUF6LRUV2NR7P_ WU^,H;+60YRW(G
MO,=PQVJ68SG>,:>QGNZHPI+.#CI=DY(FI=ZWK?<%*+@GFI0T*6E2TJ2DUIYH
M4M*DI$E)DY):>Z))29.2)B5-2FKMB28E34J:E%3O-GL.[*Q*(Q]/ XJV@[SF
M\?M=E5MT3Y6U@T0!Z>#P-!^<%Q]H-M!LH-*BSZ.&2[.!9@/-!IH--!NHR 9F
MUV/F-1]H/E"0#ZRYY@/-!RHM6CO)*IV=9H.S8@/M'6@V4&K1F@U4.CO-!F?%
M!IT#]'7+!^HE\#LHV3A'T.=!M/\. 4)ZF"EUS56:JY3F*LU4FJDT4QUW#P;I
MPFFFTDREF4HSE6:J,V*J898B:*[27*4R5PVSL$%SE>8JE;E*ARHT4VFFTEZ5
M9BK-5)JI-%-IICHKIAIF0<C>]-MM08A]+$2'+G&DOR0Y6;3,"0]ME'(%6VQQ
M1I"LO04] XCZ)^Y!3Z7\D]%\TO5(M4::5;#L4/.6YJU#HJJCL=UW#9AF+<U:
M)\A:+^V^\X ',]91]J'MV=&:336;'L*F4W?P"E#SJ>;34^=3TQF9;M?#S+2I
MJGGK/'AK/IUHWM*\I7GKZ+PU<F>#=P0U:VG64H^U7EKCP7.6=MTTGYX\GTXT
MFVHVU6RJ.)N:TY%M.D/GU$8J7E2U0/@C#$XO?Q,O^]?OU]G%#2&K'\K9ZC\G
MZ359T&OJK],HCVCVA2WLIT7B__GW__P/@_W[Z^-?><W.(8K7R3K[/4XI>ZE_
MT^!]DF6?DHS]/8E_)E'Z#[)8TR_P]?(!AL^^QW[Y3,._O7ACC4WW8CR]&)M_
M?$G^8+^Q']V+R?C%WP\Y]?I&_W.=Y5%XOU$^-+$OS:)4Z)8:8;)8)%_9@1FX
MA\8JI1F-\\Q@)Y)EQKI\16/!?H=1]'%@A.P5C3MXQXS=(#7RVR2C1A3?T2Q?
MXK?S6Y(;7VD*G[*O;-['6(G-,DAF)*'QW^N8&I/QR("=P$?(G[@C_"AGRUW0
M^":_A:_D[+WY8[:??DONJ.%1&N/3<>?YB=4?_L,V:QS*=_N<P+0\@ W:WK62
M.J?B,47!WU[\VPH"$CC3F>O/Q_:<S$G@A5XX]DS/-0-SXK\P?+I89"OBL_/]
MVXLQ_UTP*/Z.Z_S;"Q1/+X10PS]LO?MCKRWX>6[_I2[ GER<UUA0V'SQ4;3<
MT9_'9!C;<K:K[J,R]/&*TH<6TD*YH4]AVA-7'I:Q9'>[9?R9,K;+LI;TR)X%
MI)H".J> 7YC(9C^#D(V-DAP&2@;'J1P^'>%D#9HTP<8RT,@:*#GJHW^^5$JX
M+H)[/M5.>5'X"%YJ?%\G&;@%?+)AJ6KZ.C/ZTJ+E;(]>BY;N+*DB%&8]% !Z
M)C%TU&EUM1VZ.%+4<9_@6*L2XGGQNG:/ZZAQW=W!V7G/;SASV\+%:>-0#Z2S
MWA>@";VW-WQIM57\J>RA'BM?J-GF?-G&'+L#8ANM'S2A/U<_'.2)637/2VN:
M_EPY#NZAA"NWPVW;6Z >)*WVV8>.I5471].OM.KL#<V1Y;15%-?&L;:JF#6I
MGS*IOS3MMEJ+E#W5;CPWS3>GS#>..R2VT0I"$_IS%83;5M&QLH?ZL'Z07*W%
M(=7*SRP]WJQM+B^[RC*:9U=Q\#XB7K3 9_Q&2;9.:? Q_@S/3:/XAEWP(6$/
M%+_^1+(H>WYQLU3 .A^/B>V[/G%"VY[Z8T)"$MK4FM.)%XXGCBY@U>6+S\[F
M/RLQJUBN79_^,4Z_K8#Y,"HM3D<>#;NZZ#V]HPNCK?D<IRR)3N'<VX*[U>>N
M]KEK?C_/<Q\JO^OJ3I$F_(VD?U+NJV:E ]Y)%%B7-9QR68,Y'CF6*H%@7<*C
M:;W%-[1'KMV6 :1)79.Z0J1NFB/+4J4 1-.ZIO46W] =F;.V(NJ=DWJ+0=;A
M%$;N]()^3E+*OFI ZH_&_KW!W.[HCN31'2#N9'FZYH@[<9*S/V7L4I+3 %!]
M;FEP4[OF2&SQ[/&(K4JCML8C*K1HM6H,VIH>>L1YAMU'WWI?E6:#CMG FK=5
M:J,903/"@!A!ZP/-!IH-?FRM\E(-/FC'6;/W<-:&D++"T<]&&,4D]B/V$\'R
MSI;\KKVQJ/O@U<.QJ <4*#H(B[KO6%*KZ; C8E%WJKPU;VG>.DKZ;3[IJO95
MLY9FK3-BK5;3?9JW-&^=,6^Y(\OIJGRR'];Z?L-EK3H"JR[ XS?I;;8!7ONW
M-%@OZ,?P8WY+T]>8XLOYXX[2WA<2=SPEWMPQP]">V73FNN'8'MNF9<ZF01CJ
M]C[=X'5P@U>_\2[%(EG#)<9AU_SK%M/S//3S["S-DU6I4*?N<./EGU*Z(E%@
MT&\K&F>ZNV,P[HVZOLMLUI;GHJ#_W_L"-*'W]H:3\?A4"+U]93B$2M\KWV=K
MSC,CI3Z-[M"+#]-DB6,W?XOB*,O3>T!.?>LG<;*\[T19#A0G[(A+4JN\I*TJ
M*P4/H?<%*+@GZA*F,AVU/9<XG8IK]J9L,^FRM^0D#=JN>;XS$[2]VG<%CZ'W
M!2BX)^J2IC( J-HY.HHZ^L?5%\DOZD;=:!-3+1/3G*C2\ZR]G]Z7I!AINB=#
MFD?0-P^U0@W9)\(JG1;4T#-:Q_HKXSN@=4RY1:MEL_:,5-G[V6DVT&P KEM7
MS4C]\$$+^M7>0[\.P<G#]LF6=.H>I?']=38?4AK?F8VK<FE\=X;^:&)VU>']
MK-+X'I .-&MIUCJ&WC>5;N<ZKF.]:.XYV;\C9+.7Y%.:K-C*[C\M"/M"'+S]
MUSI:06KNT!Z2P+?<8.I9MA5:=C#UB6>:LXE'QW,:SH+9?% ]),LH"( +3J=L
M?W</"9J**I=OGW4#R>Y 6;<6>M.+MA31:KEC07EZUSTJ9WCB9]R@<NP@TO./
MI!1TKY,L_^%8QG8[D;V]Z;Z=QQ^<GNHIX*D/HZO#.-6"%+SO>\+T"<F3]-Z@
MA0=U)'G1>X3DY,,?"L<V1N/YR50(:%+7I/X@J2O3F:9",8R2=2_"&%ZNULQ5
MR0P2!\:*7;FZI2E9=*SY=.FT6OEW<V1:;7FM"AY$[PM0<$]4)LZQ99\*<9ZT
M)_4Q#".?&N$ZC:-\G5)4,MJG.N<J:7>FRBQ*[0/UOB2U2'/:6E6/]EF.&I^C
M)*.WD B(EJLTN:.Z^U@QENT.Z6GDCE4!'=!^2N]+4HLXYZ.)/3\5XNRI):Q'
MY^4?]#;R>VWPZJ]B5L\&VX_.%E%,+VXI/(%M"*.TIUZY15M'D3P[$*(4;:?I
MH5Q=,Y]FOK:8;Q<@SJERWP[+H%A\L>V6N?KV8D]:ZZ>#_ BU9=5.\3& 4&O6
MG_V@7).I(BZ#.IVQBHHPTQTYXQVU*HJ*,=V;KCGPE#AP.C)G.R);I\J!BJ="
MCV >7/G^>KE>(()F0%<I]2.21TE\K'+TWIT#!?V55KR1UHNV>]^VWA>@X)YH
M4CJ[5&-?K0 ZEZ-6+L<>F>[)U)QIXCPMXIR,[+$J556G[@6<1+F]-M_4JCR;
M.ZJPK_8L>E^26J0Y&ZLR2T][*HJ7VFNS4"VST&X->$3!8^A] 0KNB;JD.7%.
MIFKWI/V5'DOMM2&HEB$X&;ES5:J9M9?2^Y)4(\[)5)7PK I^RG"FKRA2:J]<
MS8LB)J0NU#FI4GM=):>9[X28;]<PP%/EOB$VX1VA;([7TI,=Q7/]&0W*==LH
MXB?H%J%'.X.MR0Y\/$5%5P=4HQE0,V!7##@=S7=-:SU5!NQIYES?'7G%3)QZ
M/G1DQ+2MQKP]1F'UYSL<,@JKL^R0RJ.P.MN$Z<B:=C4JY%G#L'J()6C6TJQU
M'/.[LYDL_;#6/G/F'I\6MSE?KII,=^7[;,%Y]HG<PXW9M]DGZ9H&[R/B18LH
MC^C&K+IG3IX;F]3QO<":T'!F^]. A&X0VIY/+=>?3"?^H";//6@0=NU9'?(\
M__')<_N[(AU;AGKXW*D2X^[Y/$,@1CT9[CP/_8R'PRE9D/"T<?7"[&&[?9\F
MBV,-KN_=Q3EY_T5=Y\09JX)"K:NV-:&WV9Y@J=+TID)>7LD:\*?IPD]<!QI1
MG.51OH;<O"X5/\MJ7%L5%:8+Q7M?DF*D.3Z9'@;M@,D.V!WQCUD-=I*&Z<FV
M$T[G)V-*:M(\,=*T5!F$JX*7,YP1($_30A_S6YI"$! REWIBB'(&J3H%D<_Q
MIMI"8%&C,%$S@K*+5HL1K-90LM1@A"%6Z':D7[$#J"6UJHL*5<E5#+JHT!S-
M=P'VGTA1H68MS5H]L=:T-7Q;-5AKGWK=0ZIO=U?RHN?Z(8FA%ICD;"?>Q7ZR
MI&^_K6B<T:/4\!)[2L<S,S1=U[3G9#8;4W?N^/"9/:,^'50-[^XPQB#+Y\SQ
M3@Y91D$ <D'E^KG_HR0U*#,7 ^.LBWE/C"IW%W7BBZI,D;J,]PQ/?*@UO/K$
MGWOB;16XJ*UF"I- 6%&N/=R(TL])2ME7#7^=IC3V[XT\)7&VP!H"(XC"D,+'
M\+CC=8KW[@F?O)NKL \[4P5'7Y<H:$)O\0U?FLH@L7;VSJ^T@M!\<S#?C$QE
MBE,5XYQ.K-8AU!G]1.(_$<G(2Y,_:<J\J>4RRC+=::%6=6%G)1$O=Z&8*5G.
M/B!=JPE=,4*?#:FE2!.Z)O3G$OHN3.MS)W0=N10VX#N(0],L-R+,U!L0KZ2K
M)(LZ&LPT4#?T9#M,3$M'%C5IJDF:]I "&IHTSXDTS9.1FN<6'<.'_4*BV'BY
M2++LE9%2/A4D3^#R/RFO/<RHOTZQ%K*['*[VIA3SIAQ3E4&SBKE3FM)/B]+-
MN2I]YAT<0^\+4'!/%";-D66IX@?TW*1Y0F$HV0 +TV19;9L1L/O?D3RZ8T^'
M9&5(HM2X(XLU-6YI<$/E"W3(2AV)T!WTXTSC]6C25)(T7^X:S*<D:0[(8="$
MKA:A3^:J9-05"8 ]A#(S@*C8(]A48123V(_(0J0-C\3S&IJGIT6KY>)=M"1*
MU #FT6R@[*+58@.K*P 8S0>:#Q3F@]-6!^W,7;/W,#<UA%.=&32$TU @G*S6
MIAJI >"D&4LS5C_XXAIS4/.5YJNC;X+36CV%&HSU-,3!IZ $%EB#JRR/?OB?
M-5M8>,^^\8FF *%#;MCM_@&YX(_AIS0)UCZD@:^RC.8'3 P_3FSUGVNVY/!^
M([QJ6Y=.477XY98:_RI?R5B5[V0DH<'V2&2YQ2^K\OT,@B]H1!G[R0B3Q2+Y
MFOVP36 -I+N(8GIQ2X$YV&NQ-^*'RR[RTMW7&-_73W?74^JT7&$V3H-@$L[G
M\V#N4GOJ!(0$)!S/O9D]F8Q=;]8E9J.0(XST%V25T1^,XJ=GP#EN(SKMXVF+
MQSB32V?ZETZ0IQZDP)+(*@+;BY2.NA!!T1X-DY0BN=-O*Q)GC3.8VE[,RP_O
MKHTH-I;18@'-\(>F-.7I6.S09W_I(:13D*=8!GO=F?.7(Q)924XQ^SNCI%62
M(OA5?DMR/,^4_FL=I30P6CI/7$ 4W]$L7[)W9:1$T@R*N/-F&A="=*^C?5J,
M1AP,._6]D.9DZN RX2#R."ZQR7>3:::C67*%C-QILW24%)6EP^\KH"HF(JI-
M,.V]S;M]3^W1=S[:@7:\NX4@VKF_IO67%ICRF53&P[L]4-DF?1D7=9)SQMV0
MG+P![9)<>UO]*,E-%:*XWN3:;]SR(G$_A'86LLVI$YKT=A)YU?QG^?J_?G^H
M%[P;N?\-#6G*S+,OY!O_XE6\>P" BL[T-;LN"ADY,-O/3Y:K)&8[DQ7.\VOV
M"8GO_Y_,",2+&CGY5CC2)*7'\J3KI/M41WGFCP-W;-+9E$QL]G\SVPKIW/$M
M:SHFA'J#&FY0."J-;-J0?#V*5_2$9.]^SRLAIMU'8W'/]=2.ZNLWR:-:+9\E
M&*;E$0<'9=T[RYN?"&WNAC]7G#9%.K>U*0=M4Z$^= 4''0Q8]/3M$,PNMXN_
M+_!#7,";;>.IP5HZ*I\<Z"H<@UL.6\&1B'?[X-IQHO1Y]'$>+8J4O0:B=R1>
MS.E#TN7WR^M+ %<QRL2P 1W!AD_2]#Y,TJ\D#5J6-OL4>[;*7L^K/U6P7N-H
M/6Q'?T/3'$U:FY_1QKFV1&J]+T#3>ONT/AY99ENU1YW3>G]:LCTCO#FR^;"B
M?)>EA"XBI75E!Z;H\\K<.EO2$TH0CUD;[XZL:5OE\0,ZB=X7H.">*$"=ULAL
MK7FC\Y/H-@;=HROW'"5U!<DT E,/$;8II>R^QX-H.GK/:+M!DY9Z1A5:=#_V
MK=4:7'D'7:-=YQ<46)5FA+880<ULRHFY?MI6'8:MVEL.H/=MZWT!"N[)69/2
M*6:6FMV11W+77Y*<+!K+_T37$32)$&Q:(87KHK--O2ZI'U-J,AW-IFU!3 _H
M)'I?@()[H@!U6B-GTA;@\2EE=)X30>LZS?.(ROI'YQKI&5&#+FJ.CAXU4&[1
M_83C7_:BZXX2.3CZ7AP+N%JSEF*+[HNU^E#40V8M-3Q5;4P/PYA6-"ZC2:GW
M)9T=*77H1-G#<Z(^T+PAZM>QL;<WCF ?=M/A.((#JLEM#T?PB)O0%N3UD\A5
M0<-?LY5F*\U63P;AK#XJD40.1 #9#21R?4M2^A/): "8&S3.,(!YG;,O?5S!
MC]D5P)-$^?T#F"(_I\FR@A7)DPI4Y ^?V0#)\H^WR]4BN:<45ODF2JF?)VGV
M&UUZ--W"'=D->MFF63)QBT)((ULOV9_N-\!(^&G.+'/Z8V80L2E&F*1&PC?*
MN$E)+$:1T^)]L9@R*-[88)1"4[RK-1X[QJ<%B1_%!=WZH(&Y6H$W\9U@9I'0
MMQU[8L\<,O>G7F"-/=><>7.'6H.$-VD,N31?7-+=D6:A//24O1MQ3?M1^?9X
MO.VAE>P4W2T!F_P?):E!V8>!46"<&"U"3.P9<GOV6;4S(.1@^NF-7A]O'!\6
MN7Y8@](:*'%J0C@>(?PO:ELFM:[8J@ %_.TWFOI11HU/:;1_YE=3R/E0R&>Z
M)%$,S9^OV7-39D2NR<+X0M-E9KR,8N,>0)#W3FQJRCE9RKFZN4GI#<FI\8[1
M211GD6\@8N2@9<MQ3*.>!H,</(E7.(G).L]RYA2"%"" >\[N@"(!X,[9@Y)C
M]8$WQ&_Z'X/]"/1.9^LX;$..$MTR1],I^]_^>+T'3^(>^K:K0H=*17@5H^K)
MY;2MSC95"+JEIS[%F&EG!?H\]'GT9\3Q^HEA&'%4N/K=VFK[[% 7.K+C=1RV
M(<>I#C7=T;A?2ZVS=SU68?7IT?0 [;[.7FM\Z;8%[:&*3&KIJ8?9&<=8@3X/
M?1Y]YC4''M$+DS2D47XT8_#1,&RO493G=" -8:4*Q$Y>SNWQ:.QT-7MZ1WB_
MSQTXENVI64A%DW5P#&E?VFTUV[;+C&TD:G6839^</CFEK&>YG\*Q'FI+&X8E
MO9$;IW%0U& ?-3/^:)U_O=WAP7Z_/@R%0SI5U%OU$_H_.U#Y,],9N9V9X,_J
M,.G@"#6'#-^L'@:_69?SF68VS6S*K%HM]AA?MC;Z2K/':;"'UD5'TT6MX3^I
MP6O].:%#2N>(VAYL@V5.*'B?:CNB_46L#X=,4&G53P YT(YH3_%,S2%GIOP[
MVP35'5'-;+TSVSFK(]4=4<T>O;.'UD5GXHCJ;&@GCN@=S0 \8! ^Z.F&UQ14
M^CH9J@/0"G'(R>M]G0S5S*8*LYVS.E+=!]7LT3M[:%UT)C[H<9.A^/N3X)>?
MBYO<.Q+SAR0NP8EW # ?U]L%8.5-7W<7U'*!I)PGC*CBBV*A\(K9>I&3.,\>
MA4MNW7U_X(4.!%P.0S+S[&E@SHAKSX,)L4W'(J;K!'.+3DWW/ "7E449U-#+
MQQ7\'>$+%LLJX-$=]MP7?1-5;T1\:E"9&H]9$P(^4.,Q:PK1>,R:<C0><[=I
MV(&7^W:&QSQPT%ME4("/%-V:CIB[<^K8R_V?]>F@ERA&P<ZEK:FW=2M%"=P*
M?1[G>!X::+D:J=B>"=9!*E05O$S%$&-M=S13'U)938S2KMY^@ 98A]4HFGK[
M4/C'6($^#WT>.CS6QZ2+@4<D3BL*]M(<S=6/@1WE58^%+-P_W?2_ER<:4>O;
MH-,1'+4,"'T>)W8>W8ZP&%*8K9,1%DHU(CP5;%^YE2H0 7EICIT6QZ(]'ZZ[
MLQUH=5[%$*BP_R-0;3A%9R]NCKOK%CTNZW4TX^ L0V/ZY/3)*6(8GQHP:)_3
M*<X54TK!=O?.XE'F=#JR.K.N!X6ZUONJ-,3:P)F+B7>EL20T9VE%T]V8PXG6
M,IH7M)9IP83K:GZH!O)4UW'L>Z+$N8)!*:C3NXL.N_9H9CDJ2Y\> HYGS0XG
MK]8[+/V>:IQ.S5E:T;"[3"[G2@=2-"]H+3-,SC+=R4DSELXZ[C\%HMI)@S#7
MD7Y;41^0C/($+U#0K3S=\)B"VE[G)'6T6$>+A\Y<.B>I.4LK&IV3U+R@M8S.
M21[%K<3?>Q[L\%9,,;BFZ5WDT^8'7"W83?"GC^%GZB<W<?1O&GQ")^YUDN59
MB_,>&J8;+**87A2 Z4!8N/'R@M$'C3-&;"E=$.&+)G78)OA('MWPE::47>X#
M^P1/GN+0O*8#1RX$]FSL!99G^M[<IF-[9KLSBT[#8#J=3V@P']3(A3Q9G1)4
MO3G>*7*641" F!T6C'##O(6.1+%:T,$G1J>[.TSP116E4;S]@*=]Z!-_[HF[
M^L3/[,2[J@-22\T4JQ1VE6L/-QOTF6;,=O!O,?L3T#NZ2%9+=DUIA1_)L^T]
MO'#RL0-U P-M&0(*AM9Z7X F\_Y&/[258]%TKNE<(3IO:WSOB3296%(V99=E
M.(0FDU]H3%.R0,.0!,LHCK(\)7ET1X]M&SZT@\J5.3Z(5S2P1:M5ECCI*GVT
MPYGL_? T'V@^ #M2LX%F \T&;9F9:K!!^S7JAT0E=8'1B7J5@RXPLKO*+^G"
M/<U79\17EJWY2O.5YJNA.G+*E\/NK+ST%Y2D^,S;7:6AS668306V1RZ'5;7N
MMGAZ=A4';Z*4^GF2B@+</\1:__A,LSR-H)$3ZXM_CZ,\^WS]^XXRW0/"RO]D
M:XK"^XW(,I3Z[E?7^_D:X\ML;;7:WK*PF)<E%&^I8IWO;!YZU+6<J6GYMNM/
M9X[MF1:=S.?F-!@35]?YZCK?9]97Z:K>DZ3*85?\Z:K><SMQ7=5[;B>NJWIU
M5>]3MDJ7@9UC&=C(<=H"*U0P1MC[ C2I]_:&<[>[^;V]TUGO"]"$WJ-,M]VV
MJO!T>:]2)J(N[]7U7-W6<XU<NV?'LO?STZR@60%983[6K*!90;/"C];(FO:<
M4M"5OKIRZO2<S$%73DU&UEAIC'K-6IJUALE:UFCF*CV]2[.69JUALM9D-#WQ
M%A5=\ZL*UN[)E/HJ#N,[">?.W/<"V[7&]B0PO3&=.F0RHS.'^).QAO'5Y;VZ
MO%>7]YY,Z9\N[SVW$]?EO>=VXKJ\5Y?W/F6K="G8.9:"G4P=F*9S3><]H YJ
M.M=TKA"=FQ.-V[MW 9(N[-4E7 HO6JT2KLF\*_PH7<NH&4%A1C!U?;MF!,T(
M, FXJ^(]7=*KBZ-T<=00BJ-L4Q?T:L;2C'5\93O3\+V:L31C'3^N,3YMQCK?
M8MX/27Q'LYP&3<6S5WX>W47Y_1?8C5,&Z74N;4?$C+_<4E%KR\C2X.6OV7K)
MKF>;FQDY^S,1VR*7]*[%-NZJ[=T%X\O(F*9X5VL\=HQ/"Q)75(+7PNYN?AXF
M_#OWVW63</VTQRKA(#"G+G5\VW&)[<WFQ P=<^;,O"FQ9E/''U25<&OE4PJ6
M:^T?;>FE8FLCR6,)=OVP!A'1;XA%C2JNV6RX55R_%]*3Y"C7/,J^&H, 3D)C
MA0KM2&98[[:P@DZ#NG8GH(.X(_=T"K ZX?A!I.:Y:=0)5W>0HE P:Z)N3L0=
M.=/YR)ZTE2(<:!+D!/3XSTD:TJ@KOM;:6BUM_=(<3T=SIZWDAK(APE=[O7#[
MI7I#M@?^@?;_D<2&KKW0M1<@CZS1Q 3\I+8@JSLKP1B\F++W$%-#,' V Q4T
M#B!$ 3\>-4RA\WB]K5HMF\H=C5U[-!]W-0)>@?Q;IT)G"+;1VV\KZHL\$H@?
M@X0Y3>L9G_[D3G]&R"%R1[U5JV4[.:/Y=#8R3:7S_L<-W*B0]W]&.K[/W/X
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M"\TA0_0BZB[SWZH)-N*O AD%SO:[R11@6+@ME*V]?TH )(P<H&&H#%,R98F
M?A70V9(9X8P_8CX/B<O3LSFC:YQ<MR%CRO%B6["Y010@F6/U^Y;HP0,M8"66
MI=0+'I5Z&ZU/\.@=.,L%B8245N2! ]:"8FHJ#_)7UCG$5K(\)3@7 J,</%X$
M#F=-"C!O#MMP$;*9QSEXV.6K$!<UV"Q^08/>O<Y)&,IH'S^M%PO*?JKUOUU?
M_51#&3#']F-J^ASU<"UG!9!%LB 1^-I!*3 :@-5'?'H?D@D*:DXKB'2&3=;8
MHY;7SK9H&1/X7%^EJ9-<A6["*E=D4BY/?*D6)JXGE( IZ@#AF[DO6*0 IRJ%
M'IK9#T[I*U>_PR:<3L87&V RG^5[O9'N54VKV(/XAFN*:YCRI\*4!SM@RN'4
MMN=9/<6WW*"+8G;3T>'/.\<][Q;O91:Z8\NT/8>:-J&3N1N0V706FH[G6:&M
M_@CFH_=G_%/QF,HG@0A=9A]6)5;\&<=+=A?=U?:+%OO%F[ER(I7%82Q?V)O2
MM.@5$P81[]&$AHOR-_#DV,G[ZQJX9&% 7J !N62N.3/^2@NR #J!=#N%^8P+
M'*$JL <(#BL;%54I80)C5?G@QAAA5* 4I6$:U+%/:9>LL*W)?&::(9G9U+;<
M^<PB$W,^MN8S/YR[$_=QJ8!G^+<7/D*MOF!D#Y.(#Y(7[M[B0GS!'O]E!]N*
MA5YX29XG2T93JV_;5_(_-NWF8P+#;'@NOUL+C_83. >VU5:YM8WOS$^@?.Y_
MC?$?/-_ WN2'5[$_X3W)Z6A3? C2@]O_I5EF/B9$<S!IOJ9D];<7_+\O#CWH
M[0EGSS[ZFH0_G"4\XO]YDS+_-+A@%)6DC$)\GS(C]<ET<>#0-UX^33P8UP9&
M)WV2WGL2+S[SG8\G#+;)H9,E-5)!TYK0?U"$-B1V-L<7IM,^!W=S.COXN%AG
M*3;=U;<71V3N$/_UPMS@HZT!* CM-(B:K0"18]$QJ^^S QVS^O&7= 16[YY2
M)%:?3!3A\X./YJ3U]4>8-@Z 8FD<87:KYH%IS:T0._>KN4]=;9^&AOX'O8W\
MQ9Z=4EH/GX$>5H9QV]+#6_:V<UQ[NT]G&CJ%H?D*:D5A\MUR;U P%93RW@$N
MI3;]RZU $*N&W$ 6UJ]%A$.$(ZV:+SC&-R!UBQ1B\55L]FY(-9V [NPS.7%@
M1LURK, V;7/L^%/;'GL %N0$CA>ZGAV8#CF_C-J?BF?4WE7%\HRS%@#2L.!)
M?$S(Z-3:0]BK39U=6ULHP!#O(OI5M&[*_38[FL7=>NU)D<>#P@8HA:BG/^46
M'&@CA$& ?-XAUFM*7<=^E/KK)=2D^?@!#B"E57<3=$_C#(.J.0A*B. ]V,;<
M8UF;5W8B\;K3S\4OT0)ZGN K_+UY ]<MU%; >A&W UK:"DAK[]X@V))#TBBK
MAG<UK*%*$!HE4#<ZU4P(B^;6 N H7"1?LTJQ\#74YG-6-[LTWH6\NUTZJ:)L
MM?QRO6M*.CO^9[GEJ/YR4G,3^ZUJ3GSX!>DWIDR"K*'[4UZX:(4)V=N3A>C+
MX4.FH 2C:,=Q1LW],!4N;]44,^B>VQ(I17X::"30,Y_(#?V5DD 8[@>\YU56
M]>>Q(P5.G6U4B?T,1_8//++?."UL5H9M3C"#6]3GBLME.WRP4K8]*(4W_:X6
MQ!?S"OV(?0%0='#02$'&FUVZVV2U); &#/KN3>?4\;RY2RUFA=@S;Q(2WPTG
MSL2<6-0]MQ:IA>+&AU3_BX "@(EQP1L@0"_0.",: +[1"+D</PI8LVLW=Y:\
MFK.:)'LM?>?B&F>TRA\])-'8K>K3X9@Z@L^=L7/AU.4E;R&_^ F7^:GJ6C ^
ML*>^7:X6R3VE#XI/?M/ZD!2QB*H%G6/5B[;RHA*I01AR^!6Q:T5%).%5E:(G
M!\&HV:4X]UA AP ^&0KG"VC0@4^624 7]5KE<M)3PW/Y#-Q$"/AB(G2%2_(3
MD_-_7ES[M\F"9A>_,59-]GEDC2"HV,WM>97-[UN?W\EWIOC;2PG$#=>.EN;F
MA]C%D+V2W@/?[ *W4-H 7BK6-'JS:7DU-,RMEB5V%**X6VY>8(O/HIP6O4NB
M,Z&L>JMJT]A&A10S-MFNTY,NJ;JU;IDR25(L%(;'IQ$%YD(LEICK9KP[-UMA
MBCAV*VP^8U%:K16$1HUW$:X!X5]B?A1B7K9XK>K&^.B;A"RR6G</F@ZWV&K"
MC@)J=P'8 4XG\V]IL(8NDO*P8.+;0AC.HIJOUIVV+!HB.2&*!2&T'GOF:;=?
M3%$"[Q;+>QOH4!Q.>5<6L]4W)0!(JT((8H,ADV:(=G#:N[O1W"(;OQS6AOO4
M"WHG&@.V),\&V*XDCLJ]Y?7MFR=R4(WID#;VW0-FP%.V$P<N%FYO";]>B7$^
M\>HI=Y2)?E21/'X%6MXJCGCX*$><K8J+0&PR%JOUI?[(^0_P549;*\?^) H=
M>D78 =61:,*59U,4YL#I=?ULJV3RQ-/DO62BX7M#@\",:@H*/:@U-^]"31+#
MM?^,DZ]QL?_<#*N ![_B;@(I0E#J1KZ@R;:H:$BTMC33$7N'[\Q+VQS!?\P)
M1RBQ+J?C#8R2P43JIW0\G<V8[3R96?9L;GF!8Q&36+[GSN?S<'YZGO)CD?JE
MXL[RSO[#JA,3F#"Y)PMFIWOL6B!GI.ZS#^,WSCL:E]"4CS2)EFY"&6>3C#3H
M60&3'J'M2O"#G1!84I=L=QO:YP#5![=>;M/$KL-B4RNDG'?OKHH^S=^BF%W,
M<>O>XJQ2WMCT+@[6^/E+:$VGZ8+'WD4)'KOX-7. 0N/:CR#8G=40/5Z5_="K
M=;I*^$AQ/&<<>@V]]>C@K[!.(-C=4<S^#I *PJ,3;T'0JJ]2!2L2,:<31N!
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MG4%):3+Y-X$_57I,!;!%5-6D%2]=OG"Q6'QOC_J .H21412<&^,K( -X@;<
M<*/2.1#WYJG(K!I5-9P@XM@-G'#N!3,ZH79HSV>F;X:.28/Y)!S;(3T_D;=2
M7.2]XYCG.?FFISX]*/!V5E%$T@[N+*6QQQOC$_ [7W#7'ZJ;L3?J6+[<,IGZ
M)5DQV0OBP4\C3Y2/K+,R4U(%*'B2'B,,*?7N*[A'MMJRQA5&[Y3?$*]6H.X5
MF*[;V9H@"MF]*%[CT?PKB,YJ(  ?GL0K8?C3X(N95 PL/S82L>I:YK J.Z Q
MX540[#8(^\._3+Z*RL=B5 +;? X95T54Y%7"W>4Z8(B<I-G&>"HQX %,50Y0
M7&#E?H7M&$%@+:;L;AE) 7,3[L(,6MJXL]QXCU(Y)(13CU!@\ESH*>4''_ J
M!3'#3K"7C[);W&$X81A7 W5*.' C"%(8RD+J98#KN "@A<TMAKV(^21P5Z94
M4EZ7)*I4Y&_7^-.[+_FFH"ZH@UVNEX5/),")V478#T9JS^2^4S608PF0E&(:
MAT?ACO6!$QQ,L&"*,@?0FE=S?(T^L<;3B>O[P<P);8?,O!EUYY8Y\2>A/9L'
MX_/3Z/]27*._3F+("J2EO2JFIZ11]J?6\ ]H>'D(&?,1UJ+R%#1,.=-I<5]!
M94M:(\<JDFK;LXU]YS4F&20>F#B*5G@CN*08P8T_@&!A6H%B#E$:REW,PQWQ
MTOR-SR2'IC99O'$(V*";.AZUSY;DGTDJ>HYVE8SLW/+-4>A\).'F?G,;A>DB
M&)]4^)304I$LF!*J40[. &0+PJ'&:!J^RU+"-!V./:IAA5^#9F *[1>.UR_@
MO#-:/1::K3!C*"8Z(4Y^0)>\H#2HJI8P"LB5&MAAC/@&?>;3?6UR?A@9HCPS
M W*U6(NSABXW^._CS &7AC4A$.7K*H0 5;*5_1(8-^L(X-]C>*$R'2S:O)HH
M3YJ[^QJ3;SFE(S'1 6R1A%FK8)%60R;Y2G-I !I0'EI"&0FI@/%<1(R( XGL
MI:FTYW'V8*GQ*8K5%H/_$2:+*"ED+^PQ1I52&#:5,T9)XH"MYP:JPF,^#H]_
M(NK7.9L&]!N82W]2Q/#?+ +GP]Z   2!H '*?2ET#]"(Q!B0/"L8S%-I/B"<
M6SD#2TP5E 8*%Q5JJ32M\]?D*[@O]1RUS[9 .#!0V,CLLG5*>#Y<&BHG'EM[
M$!K"M8>%FP..3X^4Z@/5GYWSDEZN@Y^V4T#%Z3-1M<!QHDP-\,)[1I-%#+2H
M-D IPF@D!Q.F@/''# Z8*5";=(<:2&X2IM_X+]SYY@R DW()!V>7=!Z3B^PZ
M@MPGA4N;Q"%DKH36Q&Q1[-^#>YZ ]W_)O@$]O"DF"VFVD0>KW6?'2C#.RMZ#
MJ^!FL3X<-RST/=^A)O._[+D=^E-O-@^#*2%CINW)Q)V<GQN6*NZ&78-X+N94
M:+_KD?A0M<*KO:QX4H[8X$'6J@- ,K/K<XVN*<\[FW9Q8WY=9%1']8E9V>_)
MUY%ASMU)??+,YC6;<=E=$X29V(T\845B%Z9,%SSME%+LV@ZX[5K^O1H0<6G\
MOL)>K^IFQ3O@$(N- K2FMKXE^^XM>*]D 49&F7/"H0W0\(9?XG,W8HS$%9.C
MI.Q7"8@@9JP4<5]>;L<E=55'QFV*7,#[U-^;=V[(CREGM7 'BUDP=5.Z4 '%
MVUT:/_-!&L5H9EZ 4&T:CR@O>:!>&/\\=.W16[((-[>+GPY8:O(]1+VF ,=/
M&D;2C(JY:%+EQ()M KCXT)&$ ?,RERC=N][*54V4PI66*Z\2DU KVN\HVKT8
M6/T5XK!DB E+344E&D>45L*E*!=]4(HT2 _\>.UES"MCS%9'@RDS+=O"H#Y#
M01YE^8"DJC=@0E$HE&F"*<LY?8/*LZ)),ZJ<U2KYSML2-\0!*:M\ZJ.8>(M-
MV9+-\RM2R1!,-4.Q4V_9>50 @:-369 8V$C"07L?CQ?=[<(.JE$+SB/G?IFD
M[S+4 67F"D^UD/9ES .5)#-]A3^X8HZQ7V3= '8'TY;IFHAV<1EB)I,N%Z5C
M93E7 04D/,BF5ZC13.$[%,(8ZM/*B5_P!F'$(8H$+HT\?&2]*E1 $QDVW5?$
MS.#=@Y1\93H3HG88.1.J,V3^<%$DOB&=-R?);K$>+A- ^"5C9'OWME\VV^AX
M@]A4A@X0!QG:L?<C$8_ K<I@(A9[[Q0\FJUM.VU>J0ZB[',J.C9VCB/?Z-_C
M;:#?.98]8O_O\#]\9T,WWS[->RH[BH%%R63F6G[@^O9T/O.F\W R]XDSLZ:^
M.3_#HL-,<4?QYUH/:MB4A-+NXQ[Z<P-%+7O(?6S<Y9&0KG"/_1)S&TW.D.>1
M$G-EE1#OF^'(I1"2 Y-&Q+SR<LX5]#RC&;AQ77D7^4^HK&FM@$;D('AUN=S8
M7!0C\NU@']\422;^*AQ%M4HSG',;X@Z;K"A*RC9CXE6,?C.5Q.O9FR.3N7P\
MO(%!P+XQI[;Z2R2P:Z*<-\*#<A(UH24@"W?\>144PKQY5?\:ENWCX,K"3&-J
M$IQ(-&D ,R<$^JKWLP%P$4S!@I;)"E:G]/1%CD#&E\,YE^ WC^37PJ8&?K5
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MCF]9P1DVJ^2*N\IO*H/Z!/SDQ[V?0J+WB_AU4'',SK:9RCD2U74TN 'I53H
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M1T+.UY"&)9(R-&N\C"[I);-4*+-F1  "?D[2K$3S^-H@^HKKX6:K%7"X$8
M00@3 FC?H@X7,??%4F!"+L=IXUR*0TLKC"AQ56W^21D;@3<J(C7L6^"CP]_Q
M.S7QAFL1]\<Q24S29N6X,+YN(='KK0 \>%QVEY=/XX\0 %$;^$05'GDL"5@4
MK$PVBS@[OB58W4Q:$Q =%R!&"GOYCH>>.,Z^D'#XR VH$N-*+![!TR4[-2A2
M(6"\\W*,BR2\ $38RK@GXC6V1P:)7<<(/2E7<9-2"'UPM&73XB.#BO%ML(YJ
M8$!]%R\+:;-QP^H>@ ,%-\#M9B:_ 'B@/$8$N1<(XL7LX06"CYBQ0ZK$&<>8
MHM_$X-Z29\(F@LJ3@-P_1LR,X)&8^3/P1N+K/+$";I&@;0$[4 L4@LXJM2^'
M'FM:&QC^V45^OQ)GS,0(1Y\N]);$+ AY5G^5(@7'1/AF"HX)@[LH66?%UXNW
M%%#U=AT$@Y_1AHU#'PGZ'6POS(YD#JP2"&Z"CN>++-A&%IW/-0Q.PE+@A4BU
MTKY'S 1S9\CLPO@H9OY6*9J9Y5R8.D73:P"+Q'L:$8U8R.Q8Y: ((JG5@Y%;
M@0Z,XI<?2D"IG'%7<B40)$FCK  %J:O9AF=MS$P16:0":$;^*WRYR>TJOB*A
MMQ4>%N(&%7]N6G\MA",CWLKLL2410V9LL?L@*-E($H [7*7&;(> P.-% 'BG
MY_A$7)J*CVL:[DER\-FRZRB9C2$+SSGC)C@R9B!R@KPPK@')J/ZA<+^FYJQK
MP?G0VVAQ*HJUF)^PAS!E7)="G(F'LJL1O49V2U(J9AD5PXHW@C!5_H!9PC>\
MB0=&>X$U"=!9S";.R3<F2F):3&R$7+ ?T1C':Z(!V? 8,=6IG+LI.IZE>\&M
MA ,S BQ<D>Z."P%4&[0<(4:C3U913A:C(D E4KWLMZK:"1>3&2"==^$#-[U7
M8?C+.,--2,&HKR@)^'QHYKYR'-@ZQ#"1+&?Q5<G6WVW0RN+[4>GM/L%P+<N@
MRF(E.9O.MF0SM5S8L'O*:D/ ]&+>IY3^1?!1BE,^T[@=EI'V])C8],($8_=M
M 9S^B1WS-1!R&6=WQZ]^--YP]VT=9;= %^\E<P$38&^Y;2*^8\_P.QM3 WX5
MZ,A%X,UT7OU@O/Q$TMQX]TJN P6"?"U,E&8K'+WI-Y!*_ R=!<;/%&'SV::(
M^[$;?N:#XN6)M>]B44U"V>)"FC(['A_V&Y!(GJ01H^G/S(>D2RS+;WXVQ,7%
MXCXD\6KM+=C+O"WJ,.%%BS_ON"W[EJC"7,#;OA/AD3)&<.TS]C?>(GH@HV3M
M5@RQ#@.3ZHM[D1=HRKZ(JF5@P,MJOT%VPE\! %E<C!6O08J* ZMMH#[T&[ ;
MV8!MQ]@CT-3OE]>7QB]75Y]VF/O1)B\Q[P#BGVSY;%=\)'+9)0"JYNX'E^YL
MA2-9;X.H9=)C9%! GH?9%D5FFZ^_J!'F5<$HX?$9 ; P-@<9H6!AGEXG3/G>
M_UM4C&%KAR=RQ".V-8QQ"^\GD0*H&]#K8H8ASX&/0#6FE*(Z@ OYZT#L\<^:
M:JEN8+P$.X$IOB# %':,!6:@6I O7S&U9BS8%K#GE^,DZ]$[5,@2^'<5;JR/
MM235.LL1]! PHVAFX6B#K8T2A5LP"$4HPI0>HM1GO#"MFC,)Q+15-KUX.(<E
M%PM7%V \N.[LU8T$)JCCK*KLEE536:.79KGQ+^;CP]H?'%9;OK.(L=5*@1XV
M3>J%< ?QO_0.M04\5I.]I]$CS;V12C(>MG'^^OTZN[@A9/7#-9. &(&(\TKM
M?A*ST[\P(?G3@OEK?__/_S#8O[\6WWI=S7VYB@->J'K#C?$WY1K*;_.BRV_Y
M9QK^[<4;[AE.+\;F'U^2/W!CQN[%9/SB[XT2O>S".D9K[\3=!A2 SSB<P,<O
M;XW9#Q>O/_[VV[LOO[W]\.7:N/KPQGC]\<.7=Q]^>?OA];NWU]T5J!_80QA.
M@H#,'-/W7->>F7/BSEW/8_\7AI/0):["/83%-Z:7MJR =W?_/7TQLX>:#4D/
MS8;[VQ)REM09U5I.8)@4Y85J3%'%P7J)G34XJ]#GVF8C<6*0&Z8)N8J#.\EE
MY>(6M6H[M!"*=&&2%C7F['5%$7:9>11N,7M^J5ZLL67ND$MGTPHY<2JB_E+N
M(P\N$*:"XHN4ADRW(R/C3@+JMQQ=J28YHW82L8X1&@?RF SCN[D]!:7YT<\3
M4?WC8-2B"&H4Z<.-IXH[-MQP9KK5E.RH%FJ?#'E@Z>:AE/$C,*1X>2<:G<7H
MM%KB.Q,UK/?%B"@<C\2M&G&ZZQ7SC/'D^,Y&62W$DV\/F&,W#>[P@^([12&J
MR*\+>Q*7!JD,\+PWEE4FT/GGD&\^E4.2ZI2G=1'(:Q3X%, \>T#<H5$NR<70
M,$?6;&QD8%G"##\8OW4J^R7;NB41976"0:@W7AXC1)(D9D:BL(#/>P>GZZ;H
M"7R\@./TZ*]A6!+SF6YNH HDIWP \;I@2'E((M]%7K.!SME. N7"AV1BL$#6
M(\0_&<]):(4^L?RI/;.#^91Y4^/QQ LFA(0.V1OB7P!T'P/C?[JW-=EHH/4*
M,.1>SAO&8_-/:R#Z0!8%D>UE-SV.%=\1+/PACWDBIKB&#S\Z_4&TY(GTIC'#
M%0"H4@Q]:C93!4Q8(X8?3S+LC2>F@<%/"!A<'5Y6#=MRP%K>VGNBPSEJ^:YY
MN3N]/%>%E[5>/AXOFUHOJ\/+W0WL&*O"RZKIY4$-[-B'P:WC,[B>PZ$<A'UG
M5H#M[$U0JH[A4!'"?ACVPA= 56A?GARR2>IAUW>FU%7&KN]L$^S1$Z+0?6#7
M']?@69QJE4NUEO>U^H1'\LT<!8O7#'\WG9DCX[N996,9Q'?3L5U#-,R:)D[S
M_A3\ J]\J8$&G-SF0HK_>NUE41!!28XH&">,<.,_C9LU@3II@$B 3M"[)*T
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M)L95>Q^F<<PR!5!'/Q/M-A VIH*?5CF>U(>S90KI!18FWU.N*\IE:]9K6K+
M' .QCQT,U)X3Y$/C OM \*)JQ,\5/AW]FO;%1% \#?%$->7H&Y^7BP)[3^&>
MJ$8%8@L4$&Z^]/])>&QIV3H$N\DA5"]'W#X6J[-1;32,CQ]^_?Q50-8%))?A
M!V(#2S6I^E009&=^HS?50W Y'T\%019#1L@@''M;!-C!(H11T(#L&^\I]:S
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M#%##P__])6A\F.^SU'*[Y)L]]5WN,V\Z&(2NRWPOF+KA:.3[CA?X(7,Z^?:
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M65)C^,*:53)/RKJM))F2DZOR"=[:))_.Y51UD5)NQ8:BHK:9G^'OV1KIL:'
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M'58C)BS#6G"Z>D?A[8(<5T'J]"S+CQM32Z>YGJ*Y!NW27.U@X>96",=K=?"
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M:G8;!5RE]V@*:'W6#,#FK4+C&!4GO([NU&(L0MR$U5?35#?X,GFH)N X!:[
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MTO>\@#I=,%KY? R"%8Y*5QI+=D]\.G:!8L0Z40Q$H9?Z.,Q5>82?3WP9X*:
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M :1[1@"M'_?0M;'IT/X(\8)K I]SF&&!YUH9IXS9MU"9Z'[FPJ?VPE0<H".
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MC?D,T-*+X:P&LF3%-NIOFJ$L%PF,O=;?".\0^",DI9@?<R=T60@OR_;I]MK
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M4&. 4C&+IAB C#CD]0*$NU3?*GA;+C]165=F\.H;I,3S/72Q[*/D<A&19I*
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MWL5WP&A!0H(B^>_.1 !_\R]02P,$%     @ 38$G2S\'6%ID-@  3[ # !4
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M3IM1$$$@)T.+3(I\$6.(4#VO<1&!W+>,TXW4) WP J=S^- N1+^HK'4.B2^
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M)K+7;)_Y84O=@621K:=_(=*T2*>LF]"SW46L:_%[2T/T(_H5LU""2/^&X%:
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M)R98)*3BFB+5)%6VYM-?), W'@0IBDQY]D2<G78I,YD)_)!( (G$O_WOSYN
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MTZ##?^[D/ZKT4Z)#4MN$CH(8+3J:&BK0\6:XQ\6LT?'@?^X"C@KYA-B0E#9
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M]0[Q:IVEC%N1H)>)]2H%G42@@6D_O57W'H04X?_ $28%JL\1HEI<L'<> _I
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M?4CH:A? F65RS_Z]A,PDXSKE8)&CK64&,KY8[QPH;W)$#VB$M&YRGZBW"WC
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MLY+T+G!<]4YK%V8\_=A?=>MUIQ\2!^8 $$.VN1Q$_2O"LKX=K.8^C1YNT?W
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M!I []FD:Q]2[AL/2;<Q3!:,5FQ@Z->S1=9E^J(S4W.W#[LB*(!_"XUC?R1U
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M;OW0WC65Q-@[0M)4%=A]C\4U+3KTP>)4NJ"IJ-P#KU_\\!<D/?#0*;)^.)W
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MDT(R$:()ETU >/:D-0'YA']@$J<AYN*]>/:QF-NS9V:9;1[$6,]4[$NUH.4
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M:I[3ONS'O^\I'"WVQUGC,/84H?.L.ZQWX^E4G[WTR$?-2+&=K;BZEER/9Y*
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M_% I<P^.A9^#V)OS5.TPN/<V))!@V&Q4*.;&(F^M8-Z&9"MTY.0UD7D*V_)
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M /'$ @#$1M 9 /P\HG6(=#EK!Z-VYMM33$:+/F5@Y22RLA[%=N#"Z=;1$3"
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MK<&@J..),C60F2%GF'IYA [*?/%;NI;X(3<X^]238#X)MXZ?;&]H*\KG?>2
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MQ6:^AF.AJM1D4+&TIORCB#L?:NORF?$4>$D\F3ZI IR*;K:#G2:G1ZGN*4"
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MWD&/UILYBO_;VO&]Q9;56Z(VG"&XI(J3%10=1^%\S3P+ KRJRH9L-*+E^0;
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MQ")?..PO.^.G_B:S8&,G&D73A)W:\R3Y,8FXWRJ)]4$Z6[Y)(#V.+$;]X,)
MAQZG+NZNDY<P\OY9F6%7YK+<R?9=@9IPB;C' =-X5Y=($RE5/R3G3""P8#+
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M;WM']-H35D\@)GT<C32EOZT=GH= .=R;E5EX0U(%E?D_+7X$"K+=Z(L)SL_
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M$_8 ICR@*^GR9< O$0".8[5* E5!7&DG', JE14"%*H ;4::ZGYXH9GM+3-
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M82R$^-H^_W$G*'*7YXY4">^$41$O2HB^I2QT@Z)W>5Y)M0!/&A^I@5^Q&_@
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MP,AD"36^3W@U#_IKZC,D6WWK 1[8=KI18YNB*4(TEF9W#S]<O3J!)[SAWL;
MML][3,U^D0BMK/??U5KBOT-P!-3&LOZ=7=DW][6*0UA/[VL%%:BS9?>:8^Z%
M0SJ=O87G.D'"9G48L'5\M+C-5FZ6NQ+'A%E[R7W(;Y3W(7<?[(2+3NZ3G<,W
MV6]V7^W0SW;2[U[O3[;.3 E;<9CDEC) ==X5,UEK,,MQ>?TKF U$AB.FI,%
MML:W OE^+-L!>J.0%R2&%''&_&X_EM[?I_LV$FU(3->LKNM&;$^G@3IP/-N1
M_A:0UY(<4O3O(VEY'U%[VZ'^%M [XKS54A48</W%\=<I&KX??G8"665Z4&?;
M)PHM("Z6R?E7:BLQ.R02%[2ZM>USAQ8@SG%]WM5GINOGF/QC3<?K;]@V"%:
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M['_L 6[ZD_\/4$L! A0#%     @ 38$G2T"UIJ,[/P$ T:T4 !$
M     ( !     '!S=&DM,C Q-S V,S N>&UL4$L! A0#%     @ 38$G2]'F
MTBJE%   L,L  !$              ( !:C\! '!S=&DM,C Q-S V,S N>'-D
M4$L! A0#%     @ 38$G2]ET&BLD%P  AR4! !4              ( !/E0!
M '!S=&DM,C Q-S V,S!?8V%L+GAM;%!+ 0(4 Q0    ( $V!)TL_!UA:9#8
M $^P P 5              "  95K 0!P<W1I+3(P,3<P-C,P7V1E9BYX;6Q0
M2P$"% ,4    " !-@2=+^0\%-8Y\  "AJP8 %0              @ $LH@$
M<'-T:2TR,#$W,#8S,%]L86(N>&UL4$L! A0#%     @ 38$G2_I(S9FF3@
MT3T% !4              ( ![1X" '!S=&DM,C Q-S V,S!?<')E+GAM;%!+
4!08     !@ & (H!  #&;0(    !

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
